Psyllid ID: psy15818

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-----
Protein Sequence
MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK
Secondary Structure (PSIPRED)
cccccEEEEEEEccccccccccEEEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccccHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHccccHHHHHcccEEEEcccEEEEcccccccccccccEEEEccccccccccccHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHccccccccccEEEEEEEccccccHHHHHHHHHHHHHHHHHcccccEccEEEEEccccccEEEEEcccccEHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccEcccccHHHEEEcccccEEEcccccccHHHHHHcEEHHHccEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHc
Coil and Loop (DISEMBL)
mdcfsvevrkhpmspergregpcIVAVKTLKENAGERERLDLLQELTvmktldphpnvvrllgcctekepFFVIMEyvpygklqsFLRSSRAQRYynnmhgksnsltsrdLTSFCYQVARGMQFLSSRGIIHRDLAARNVligenhcckvadfgfardlMTSSVYerksegrlpirwmapeslydnIFSVKSDIWSFGVLIWEIVtlgstpypgmAAAEVMKKSK
Flexible Loop (DISEMBL)
mdcfsvevrkhpmspergregpcIVAVKTlkenagereRLDLLQELTvmktldphpnVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNmhgksnsltsrDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYerksegrlpirwmapESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK
Low Complexity Region (SEG)
MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK
Disordered region (IsUnstruct)
**********************CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH*****LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY*************
Disordered Region (DISOPRED)
MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS*****************TSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK
Disordered Region (DISEMBL)
******************REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA********
Disordered Region (DISPRO)
*DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR***NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	225	2.2.26 [Sep-21-2011]
Q9VBW3	773	Tyrosine kinase receptor	yes	N/A	0.915	0.266	0.752	2e-90
Q26614	972	Fibroblast growth factor	no	N/A	0.902	0.208	0.497	2e-57
P16092	822	Fibroblast growth factor	no	N/A	0.88	0.240	0.492	1e-56
P11362	822	Fibroblast growth factor	yes	N/A	0.88	0.240	0.492	1e-56
Q91285	816	Fibroblast growth factor	N/A	N/A	0.88	0.242	0.492	3e-56
Q04589	822	Fibroblast growth factor	yes	N/A	0.88	0.240	0.487	1e-55
P22607	806	Fibroblast growth factor	no	N/A	0.977	0.272	0.446	2e-55
Q91743	828	Fibroblast growth factor	N/A	N/A	0.977	0.265	0.464	5e-55
Q03364	813	Fibroblast growth factor	N/A	N/A	0.915	0.253	0.471	8e-55
P22182	812	Fibroblast growth factor	N/A	N/A	0.88	0.243	0.497	1e-54

>sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster GN=Cad96Ca PE=2 SV=2

 Score =  331 bits (849), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 155/206 (75%), Positives = 182/206 (88%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G EG   VAVKTLKE+A E +R DLL EL VMK+L+PH NVV LLGCCT+K+P FVI+EY
Sbjct: 494 GNEGITTVAVKTLKESATEVDRKDLLSELEVMKSLEPHINVVHLLGCCTDKDPTFVILEY 553

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQ++LRSSRA+R+Y N HGKSN LTS DLTSF YQVA+GM +L+SRGIIHRDLAA
Sbjct: 554 VNRGKLQTYLRSSRAERHYGNTHGKSNVLTSCDLTSFMYQVAKGMDYLTSRGIIHRDLAA 613

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI ++H CKVADFGFARD++TS +YERKSEG+LPIRWMA ESLYDNIFSVKSDIWSF
Sbjct: 614 RNILITDDHTCKVADFGFARDVITSKIYERKSEGKLPIRWMATESLYDNIFSVKSDIWSF 673

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           G+L+WEIVTLGSTPYPG++AA+VM+K
Sbjct: 674 GILMWEIVTLGSTPYPGISAADVMRK 699

Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1

>sp|Q26614|FGFR_STRPU Fibroblast growth factor receptor OS=Strongylocentrotus purpuratus GN=FGFR PE=2 SV=1

 Score =  221 bits (564), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 102/205 (49%), Positives = 144/205 (70%), Gaps = 2/205 (0%)

Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           +E    VAVK LK NA +RE  DL+ EL +MK +  +PN++ LLGCCT++ P +VI+E+ 
Sbjct: 664 QEKTSTVAVKMLKANAMDREFSDLISELAMMKMIGKNPNIINLLGCCTQEGPPYVIVEFA 723

Query: 79  PYGKLQSFLRSSRAQRYYNN--MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            +G L+ FLRS R    Y    +   S +LT++DL S  YQVARGM FL+S+  IHRDLA
Sbjct: 724 HHGNLRDFLRSRRPPEEYEKSILLTTSQTLTNKDLMSMAYQVARGMDFLASKKCIHRDLA 783

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+ E+   K+ DFG ARD+     Y + ++GRLP++WMAPE+L+D +F+ +SD+WS
Sbjct: 784 ARNVLVTEDFEMKICDFGLARDIHYIDFYRKTTDGRLPVKWMAPEALFDRMFTTQSDVWS 843

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVM 221
           FG+L+WEI+TLG TPYP +   ++ 
Sbjct: 844 FGILLWEIMTLGGTPYPSVPVEQMF 868

Receptor for basic fibroblast growth factor.

Strongylocentrotus purpuratus (taxid: 7668)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus GN=Fgfr1 PE=1 SV=2

 Score =  219 bits (558), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 511 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 570

Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 571 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 630

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 631 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 690

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 691 WEIFTLGGSPYPGVPVEELFK 711

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P11362|FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3

 Score =  219 bits (558), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 511 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 570

Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 571 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 630

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 631 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 690

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 691 WEIFTLGGSPYPGVPVEELFK 711

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q91285|FGFR1_PLEWA Fibroblast growth factor receptor 1 OS=Pleurodeles waltl GN=FGFR1 PE=2 SV=1

 Score =  218 bits (555), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 507 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 566

Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  YN +H   + L+ +DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 567 EYLRARRPPGMEYCYNPIHVSKDMLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 626

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E+   K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 627 VTEDSVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 686

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 687 WEIFTLGGSPYPGVPVEELFK 707

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and normal skeletogenesis. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by ubiquitination, internalization and degradation.

Pleurodeles waltl (taxid: 8319)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus GN=Fgfr1 PE=1 SV=1

 Score =  216 bits (549), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 98/201 (48%), Positives = 141/201 (70%), Gaps = 3/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 511 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 570

Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 571 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 630

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 631 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 690

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +P PG+   E+ K
Sbjct: 691 WEIFTLGGSPNPGVPVEELFK 711

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P22607|FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1

 Score =  215 bits (548), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 100/224 (44%), Positives = 148/224 (66%), Gaps = 4/224 (1%)

Query: 3   CFSVEVRKHPMSPERGREG-PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ R   P  VAVK LK++A +++  DL+ E+ +MK +  H N++ L
Sbjct: 482 CFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL 541

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +V++EY   G L+ FLR+ R       ++        LT +DL S  YQV
Sbjct: 542 LGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQV 601

Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDLAARNVL+ E++  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 602 ARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWM 661

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 662 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 705

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q91743|FGFR4_XENLA Fibroblast growth factor receptor 4 OS=Xenopus laevis GN=fgfr4 PE=2 SV=1

 Score =  214 bits (544), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 104/224 (46%), Positives = 146/224 (65%), Gaps = 4/224 (1%)

Query: 3   CFSVEVRKHPMSPERGR-EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   VR      E+ R E P  VAVK LK+N  +++  DL+ E+ +MK +  H N++ L
Sbjct: 500 CFGQVVRAEGYGIEKDRPEKPVTVAVKMLKDNGTDKDLSDLISEMELMKVIGKHKNIINL 559

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT++ P FVI+EY   G L+ FLR+ R    +  ++        L+ +DL S  YQV
Sbjct: 560 LGVCTQEGPLFVIVEYASKGNLREFLRARRPPTPEDAFDITKVPEELLSFKDLVSCAYQV 619

Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L S+  IHRDLAARNVL+ E++  K+ADFG AR +     Y++ S GRLP++WM
Sbjct: 620 ARGMEYLESKRCIHRDLAARNVLVAEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM 679

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SDIWSFGVL WEI TLG +PYP +   E+ K
Sbjct: 680 APEALFDRVYTHQSDIWSFGVLTWEIFTLGGSPYPVIPYEELFK 723

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q03364|FGFR2_XENLA Fibroblast growth factor receptor 2 OS=Xenopus laevis GN=fgfr2 PE=2 SV=1

 Score =  213 bits (542), Expect = 8e-55,   Method: Compositional matrix adjust.
 Identities = 99/210 (47%), Positives = 144/210 (68%), Gaps = 4/210 (1%)

Query: 16  ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           ER +E    VAVK LK+NA E++  DL+ E+ +MK +  H N++ LLG CT+    +VI+
Sbjct: 496 ERPKES-VTVAVKMLKDNATEKDLADLVSEMEMMKMIGKHKNIINLLGACTQGGTLYVIV 554

Query: 76  EYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           EY   G L+ +LR+ R    +  ++        +T +DL S  YQ+ARGM++L+S+  IH
Sbjct: 555 EYAAKGNLRQYLRARRPLEMEYSFDVTRVPDEQMTFKDLVSCTYQIARGMEYLASQKCIH 614

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           RDLAARNVL+ EN+  K+ADFG ARD+     Y++ S GRLP++WMAPE+L+D +++ +S
Sbjct: 615 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 674

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           D+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 675 DVWSFGVLMWEIFTLGGSPYPGIPVEELFK 704

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P22182|FGFR1_XENLA Fibroblast growth factor receptor 1 OS=Xenopus laevis GN=fgfr1 PE=1 SV=1

 Score =  213 bits (541), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 100/201 (49%), Positives = 140/201 (69%), Gaps = 3/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 505 VAVKMLKSDASEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYTSKGNLR 564

Query: 85  SFLRSSR--AQRY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R  A  Y YN        L+ +DL S  YQVARGM +L+S+  IHRDLAARNVL
Sbjct: 565 EYLRARRPPAMEYCYNPTCVPDQLLSFKDLVSCAYQVARGMDYLASKKCIHRDLAARNVL 624

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 625 VTEDNIMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 684

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 685 WEIFTLGGSPYPGVPMEELFK 705

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and normal skeletogenesis. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by ubiquitination, internalization and degradation.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	225
91076662	625	PREDICTED: similar to AGAP011648-PA [Tri	0.915	0.329	0.800	2e-96
270002918	609	cadherin 96Ca [Tribolium castaneum]	0.915	0.338	0.800	2e-96
242024461	630	tyrosine kinase receptor, putative [Pedi	0.915	0.326	0.781	4e-94
332019653	606	Tyrosine kinase receptor Cad96Ca [Acromy	0.902	0.334	0.788	1e-91
158301106	706	AGAP011648-PA [Anopheles gambiae str. PE	0.915	0.291	0.766	4e-91
157110899	706	tyrosine kinase receptor [Aedes aegypti]	0.915	0.291	0.762	6e-91
350400619	622	PREDICTED: tyrosine kinase receptor Cad9	0.902	0.326	0.778	3e-90
195038776	765	GH19569 [Drosophila grimshawi] gi|193895	0.884	0.260	0.778	4e-90
307206332	608	Tyrosine kinase receptor Cad96Ca [Harpeg	0.902	0.333	0.774	1e-89
195388552	324	GJ23604 [Drosophila virilis] gi|19415102	0.924	0.641	0.745	2e-89

>gi|91076662|ref|XP_971319.1| PREDICTED: similar to AGAP011648-PA [Tribolium castaneum]

 Score =  357 bits (917), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 165/206 (80%), Positives = 187/206 (90%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+EG  +VAVKTLKENA E+E+ DLL EL VMK L+ HPNVVRLLGCCT+KEP F+IMEY
Sbjct: 346 GKEGVSVVAVKTLKENANEKEKSDLLSELRVMKMLETHPNVVRLLGCCTDKEPIFLIMEY 405

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  GKLQS+LR+SRA+RYYNNMHG+S SLTSRDLTSF YQVA+GM+FLS+ GIIHRDLAA
Sbjct: 406 ISKGKLQSYLRNSRAERYYNNMHGQSKSLTSRDLTSFVYQVAKGMEFLSANGIIHRDLAA 465

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI E H CKVADFGFARD++ S VYERKSEGRLPIRWMAPESLYDNIFSVKSD+WSF
Sbjct: 466 RNILITEEHTCKVADFGFARDVIVSHVYERKSEGRLPIRWMAPESLYDNIFSVKSDVWSF 525

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           GVLIWE+VTLGSTPYPG++AAEVMKK
Sbjct: 526 GVLIWEVVTLGSTPYPGLSAAEVMKK 551

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270002918|gb|EEZ99365.1| cadherin 96Ca [Tribolium castaneum]

 Score =  357 bits (916), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 165/206 (80%), Positives = 187/206 (90%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+EG  +VAVKTLKENA E+E+ DLL EL VMK L+ HPNVVRLLGCCT+KEP F+IMEY
Sbjct: 330 GKEGVSVVAVKTLKENANEKEKSDLLSELRVMKMLETHPNVVRLLGCCTDKEPIFLIMEY 389

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  GKLQS+LR+SRA+RYYNNMHG+S SLTSRDLTSF YQVA+GM+FLS+ GIIHRDLAA
Sbjct: 390 ISKGKLQSYLRNSRAERYYNNMHGQSKSLTSRDLTSFVYQVAKGMEFLSANGIIHRDLAA 449

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI E H CKVADFGFARD++ S VYERKSEGRLPIRWMAPESLYDNIFSVKSD+WSF
Sbjct: 450 RNILITEEHTCKVADFGFARDVIVSHVYERKSEGRLPIRWMAPESLYDNIFSVKSDVWSF 509

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           GVLIWE+VTLGSTPYPG++AAEVMKK
Sbjct: 510 GVLIWEVVTLGSTPYPGLSAAEVMKK 535

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242024461|ref|XP_002432646.1| tyrosine kinase receptor, putative [Pediculus humanus corporis] gi|212518116|gb|EEB19908.1| tyrosine kinase receptor, putative [Pediculus humanus corporis]

 Score =  350 bits (897), Expect = 4e-94,   Method: Compositional matrix adjust.
 Identities = 161/206 (78%), Positives = 187/206 (90%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           GREG  +VAVKTLKE+AGE+ER DLLQEL VMK+L+PHPN+VRLLGCCT+K+P FVIME+
Sbjct: 351 GREGTTVVAVKTLKESAGEKERKDLLQELEVMKSLEPHPNIVRLLGCCTKKDPLFVIMEF 410

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQS+LR+SRA+R Y NMHG+S +LTSRDLTSF YQ ARGM+FLS++GIIHRDLAA
Sbjct: 411 VSLGKLQSYLRNSRAERCYGNMHGESKTLTSRDLTSFAYQCARGMEFLSNKGIIHRDLAA 470

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+L+  +  CKVADFGFARD++ S VYERKSEGRLPIRWMAPESLYDNIFSVKSD+W F
Sbjct: 471 RNILVNNDQVCKVADFGFARDIIGSHVYERKSEGRLPIRWMAPESLYDNIFSVKSDVWGF 530

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           GVLIWEIVTLGSTPYPG+AAA+VM+K
Sbjct: 531 GVLIWEIVTLGSTPYPGLAAADVMRK 556

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332019653|gb|EGI60127.1| Tyrosine kinase receptor Cad96Ca [Acromyrmex echinatior]

 Score =  341 bits (875), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 164/208 (78%), Positives = 181/208 (87%), Gaps = 5/208 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+ GP IVAVKTLKENA ERERLDL QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EY
Sbjct: 332 GKSGPTIVAVKTLKENAAERERLDLAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEY 391

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQSFLR+SR +R     HG S  LTSRDLT F YQ+A+GM++L+S+GIIHRDLAA
Sbjct: 392 VSGGKLQSFLRASREER----NHG-SAGLTSRDLTGFVYQIAKGMEYLASKGIIHRDLAA 446

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI EN  CKVADFGFARD+  + +YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF
Sbjct: 447 RNILIDENRACKVADFGFARDVAANQIYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 506

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           GVLIWEIVTLGSTPYPG+AAAEVM+K K
Sbjct: 507 GVLIWEIVTLGSTPYPGLAAAEVMRKIK 534

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158301106|ref|XP_320863.4| AGAP011648-PA [Anopheles gambiae str. PEST] gi|157013481|gb|EAA00411.4| AGAP011648-PA [Anopheles gambiae str. PEST]

 Score =  340 bits (871), Expect = 4e-91,   Method: Compositional matrix adjust.
 Identities = 158/206 (76%), Positives = 181/206 (87%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G EG  + AVKTLKENA E ER DLL EL V+K+L+PH NVVRLLGCCTEK+P FVI+EY
Sbjct: 427 GHEGVSVTAVKTLKENASEAERNDLLSELQVLKSLEPHINVVRLLGCCTEKDPIFVILEY 486

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQ+FLR+SR +++Y N HGKS  LTS DLTSF YQVARGM FL+SRGIIHRDLAA
Sbjct: 487 VNMGKLQTFLRNSRVEKHYGNTHGKSKILTSGDLTSFMYQVARGMDFLTSRGIIHRDLAA 546

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI ++H CKVADFGFARD++TS VYERKSEGRLPIRWMA ESLYDNIF+VKSDIWSF
Sbjct: 547 RNILITDDHTCKVADFGFARDIVTSKVYERKSEGRLPIRWMATESLYDNIFTVKSDIWSF 606

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           G+L+WEIVTLGSTPYPG+AAA+VM+K
Sbjct: 607 GILMWEIVTLGSTPYPGIAAADVMRK 632

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157110899|ref|XP_001651299.1| tyrosine kinase receptor [Aedes aegypti] gi|108883900|gb|EAT48125.1| AAEL000850-PA, partial [Aedes aegypti]

 Score =  339 bits (869), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 157/206 (76%), Positives = 182/206 (88%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G++G  I AVKTLKENA + ER DLL EL V+K+L+PH NVVRLLGCCTEK+P FVI+EY
Sbjct: 427 GKDGVSITAVKTLKENASDAERNDLLSELQVLKSLEPHINVVRLLGCCTEKDPIFVILEY 486

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQ+FLR+SR +++Y N HGKS  LTS DLTSF YQVARGM FL+SRGIIHRDLAA
Sbjct: 487 VNMGKLQTFLRNSRVEKHYGNTHGKSKILTSGDLTSFMYQVARGMDFLTSRGIIHRDLAA 546

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI ++H CKVADFGFARD++TS VYERKSEGRLPIRWMA ESLYDNIF+VKSDIWSF
Sbjct: 547 RNILITDDHTCKVADFGFARDIITSKVYERKSEGRLPIRWMATESLYDNIFTVKSDIWSF 606

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           G+L+WEIVTLGSTPYPG+AAA+VM+K
Sbjct: 607 GILMWEIVTLGSTPYPGIAAADVMRK 632

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350400619|ref|XP_003485901.1| PREDICTED: tyrosine kinase receptor Cad96Ca-like [Bombus impatiens]

 Score =  337 bits (863), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 162/208 (77%), Positives = 180/208 (86%), Gaps = 5/208 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+ G  IVAVKTLKENA ERERLDL QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EY
Sbjct: 348 GKSGATIVAVKTLKENATERERLDLAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEY 407

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQSFLR+SR +R     HG    LTSRDLT F YQ+A+GM++L+S+GIIHRDLAA
Sbjct: 408 VSGGKLQSFLRASREERN----HGGP-GLTSRDLTGFVYQIAKGMEYLASKGIIHRDLAA 462

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI ENH CKVADFGFARD+  + +YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF
Sbjct: 463 RNILIDENHACKVADFGFARDVAANQIYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 522

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           GVLIWEIVTLGSTPYPG+AAAEVM++ K
Sbjct: 523 GVLIWEIVTLGSTPYPGLAAAEVMRRIK 550

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195038776|ref|XP_001990810.1| GH19569 [Drosophila grimshawi] gi|193895006|gb|EDV93872.1| GH19569 [Drosophila grimshawi]

 Score =  336 bits (862), Expect = 4e-90,   Method: Compositional matrix adjust.
 Identities = 155/199 (77%), Positives = 181/199 (90%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+AGE E+ DLL EL VMKTL+PH NVVRLLGCCT+K+P FVI+EYV  GKLQ
Sbjct: 493 VAVKTLKESAGEVEKKDLLSELEVMKTLEPHVNVVRLLGCCTDKDPTFVILEYVTRGKLQ 552

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           ++LR+SRA+R+Y N HGKSN LTS DLTSF YQVA+GM +L+SRGIIHRDLAARN+LI E
Sbjct: 553 TYLRNSRAERHYGNTHGKSNLLTSGDLTSFMYQVAKGMDYLTSRGIIHRDLAARNILITE 612

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +H CKVADFGFARD++TS +YERKSEG+LPIRWMA ESLYDNIFSVKSDIWSFG+L+WEI
Sbjct: 613 DHTCKVADFGFARDIITSKIYERKSEGKLPIRWMATESLYDNIFSVKSDIWSFGILMWEI 672

Query: 205 VTLGSTPYPGMAAAEVMKK 223
           VTLGSTPYPG++AA+VM+K
Sbjct: 673 VTLGSTPYPGISAADVMRK 691

Source: Drosophila grimshawi

Species: Drosophila grimshawi

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307206332|gb|EFN84389.1| Tyrosine kinase receptor Cad96Ca [Harpegnathos saltator]

 Score =  334 bits (857), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 161/208 (77%), Positives = 180/208 (86%), Gaps = 5/208 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+ G  IVAVKTLKENA ERERLDL QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EY
Sbjct: 334 GKAGATIVAVKTLKENATERERLDLAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEY 393

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQSFLR+SR +R     HG +  LTSRDLT F YQ+A+GM++L+S+GIIHRDLAA
Sbjct: 394 VSGGKLQSFLRASREER----NHGGA-GLTSRDLTGFVYQIAKGMEYLASKGIIHRDLAA 448

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI EN  CKVADFGFARD+  + +YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF
Sbjct: 449 RNILIDENRACKVADFGFARDVAANQIYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 508

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           GVLIWEIVTLGSTPYPG+AAAEVM++ K
Sbjct: 509 GVLIWEIVTLGSTPYPGLAAAEVMRRIK 536

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195388552|ref|XP_002052943.1| GJ23604 [Drosophila virilis] gi|194151029|gb|EDW66463.1| GJ23604 [Drosophila virilis]

 Score =  334 bits (857), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 155/208 (74%), Positives = 183/208 (87%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G  G   VAVKTLKE+A E E+ DLL EL VMKTLDPH NVVRLLGCC+EK+P FVI+EY
Sbjct: 45  GSGGVTTVAVKTLKESADEVEKKDLLSELEVMKTLDPHVNVVRLLGCCSEKDPTFVILEY 104

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  GKLQ++LR+SRA+R+Y N HGKSN LTS DLTSF YQVA+GM +L+SRGIIHRDLAA
Sbjct: 105 VSRGKLQTYLRNSRAERHYGNTHGKSNVLTSGDLTSFMYQVAKGMDYLTSRGIIHRDLAA 164

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN+LI ++H CKVADFGFARD++TS +YERKSEG+LPIRWMA ESLYDNIFS+KSDIWSF
Sbjct: 165 RNILITDDHTCKVADFGFARDIITSKIYERKSEGKLPIRWMATESLYDNIFSIKSDIWSF 224

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           G+L+WEIVTLGSTPYPG++AA+VM+K +
Sbjct: 225 GILMWEIVTLGSTPYPGISAADVMRKVR 252

Source: Drosophila virilis

Species: Drosophila virilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	225
FB|FBgn0022800	773	Cad96Ca "Cadherin 96Ca" [Droso	0.915	0.266	0.752	4.5e-82
UNIPROTKB|E7EU09	733	FGFR1 "Fibroblast growth facto	0.893	0.274	0.495	1.3e-52
UNIPROTKB|K7GL40	733	FGFR1 "Fibroblast growth facto	0.893	0.274	0.495	1.3e-52
UNIPROTKB|K7GL48	733	FGFR1 "Fibroblast growth facto	0.893	0.274	0.495	1.3e-52
UNIPROTKB|K7GQJ1	731	FGFR1 "Fibroblast growth facto	0.893	0.274	0.495	1.3e-52
UNIPROTKB|F1LPM6	733	Fgfr1 "Fibroblast growth facto	0.893	0.274	0.495	1.3e-52
UNIPROTKB|A4IFL5	820	FGFR1 "Fibroblast growth facto	0.991	0.271	0.462	2.4e-52
UNIPROTKB|F1M7N5	801	Fgfr1 "Fibroblast growth facto	0.893	0.250	0.495	2.4e-52
UNIPROTKB|F1RZJ8	820	FGFR1 "Fibroblast growth facto	0.893	0.245	0.495	3.2e-52
UNIPROTKB|E2R186	822	FGFR1 "Fibroblast growth facto	0.893	0.244	0.495	3.2e-52

FB|FBgn0022800 Cad96Ca "Cadherin 96Ca" [Drosophila melanogaster (taxid:7227)]

 Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
 Identities = 155/206 (75%), Positives = 182/206 (88%)

Query:    18 GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             G EG   VAVKTLKE+A E +R DLL EL VMK+L+PH NVV LLGCCT+K+P FVI+EY
Sbjct:   494 GNEGITTVAVKTLKESATEVDRKDLLSELEVMKSLEPHINVVHLLGCCTDKDPTFVILEY 553

Query:    78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
             V  GKLQ++LRSSRA+R+Y N HGKSN LTS DLTSF YQVA+GM +L+SRGIIHRDLAA
Sbjct:   554 VNRGKLQTYLRSSRAERHYGNTHGKSNVLTSCDLTSFMYQVAKGMDYLTSRGIIHRDLAA 613

Query:   138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
             RN+LI ++H CKVADFGFARD++TS +YERKSEG+LPIRWMA ESLYDNIFSVKSDIWSF
Sbjct:   614 RNILITDDHTCKVADFGFARDVITSKIYERKSEGKLPIRWMATESLYDNIFSVKSDIWSF 673

Query:   198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
             G+L+WEIVTLGSTPYPG++AA+VM+K
Sbjct:   674 GILMWEIVTLGSTPYPGISAADVMRK 699

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;NAS

GO:0004713 "protein tyrosine kinase activity" evidence=ISS;NAS

GO:0004714 "transmembrane receptor protein tyrosine kinase activity" evidence=ISS

GO:0005887 "integral to plasma membrane" evidence=ISS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0016339 "calcium-dependent cell-cell adhesion" evidence=ISS

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0045792 "negative regulation of cell size" evidence=IMP

GO:0007030 "Golgi organization" evidence=IMP

UNIPROTKB|E7EU09 FGFR1 "Fibroblast growth factor receptor" [Homo sapiens (taxid:9606)]

 Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   422 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 481

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   482 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 541

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   542 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 601

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   602 WEIFTLGGSPYPGVPVEELFKLLK 625

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|K7GL40 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   422 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 481

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   482 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 541

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   542 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 601

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   602 WEIFTLGGSPYPGVPVEELFKLLK 625

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|K7GL48 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   422 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 481

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   482 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 541

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   542 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 601

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   602 WEIFTLGGSPYPGVPVEELFKLLK 625

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|K7GQJ1 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   420 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 479

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   480 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 539

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   540 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 599

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   600 WEIFTLGGSPYPGVPVEELFKLLK 623

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|F1LPM6 Fgfr1 "Fibroblast growth factor receptor" [Rattus norvegicus (taxid:10116)]

 Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   422 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 481

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   482 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 541

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   542 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 601

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   602 WEIFTLGGSPYPGVPVEELFKLLK 625

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|A4IFL5 FGFR1 "Fibroblast growth factor receptor" [Bos taurus (taxid:9913)]

 Score = 546 (197.3 bits), Expect = 2.4e-52, P = 2.4e-52
 Identities = 105/227 (46%), Positives = 150/227 (66%)

Query:     3 CFSVEVRKHPMSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
             CF   V    +  ++ R      VAVK LK +A E++  DL+ E+ +MK +  H N++ L
Sbjct:   486 CFGQVVLAEAIGLDKDRPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 545

Query:    62 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQV 118
             LG CT+  P +VI+EY   G L+ +L++ R     Y YN  H     L+S+DL S  YQV
Sbjct:   546 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHHPEEQLSSKDLVSCAYQV 605

Query:   119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
             ARGM++L+S+  IHRDLAARNVL+ E++  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct:   606 ARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 665

Query:   179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
             APE+L+D I++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K  K
Sbjct:   666 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 712

GO:0090080 "positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway" evidence=IEA

GO:0060665 "regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling" evidence=IEA

GO:0060484 "lung-associated mesenchyme development" evidence=IEA

GO:0060445 "branching involved in salivary gland morphogenesis" evidence=IEA

GO:0060117 "auditory receptor cell development" evidence=IEA

GO:0060045 "positive regulation of cardiac muscle cell proliferation" evidence=IEA

GO:0048762 "mesenchymal cell differentiation" evidence=IEA

GO:0048469 "cell maturation" evidence=IEA

GO:0048378 "regulation of lateral mesodermal cell fate specification" evidence=IEA

GO:0048339 "paraxial mesoderm development" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045787 "positive regulation of cell cycle" evidence=IEA

GO:0045666 "positive regulation of neuron differentiation" evidence=IEA

GO:0043406 "positive regulation of MAP kinase activity" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0042803 "protein homodimerization activity" evidence=IEA

GO:0042474 "middle ear morphogenesis" evidence=IEA

GO:0042473 "outer ear morphogenesis" evidence=IEA

GO:0042472 "inner ear morphogenesis" evidence=IEA

GO:0035607 "fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development" evidence=IEA

GO:0030901 "midbrain development" evidence=IEA

GO:0030326 "embryonic limb morphogenesis" evidence=IEA

GO:0021847 "ventricular zone neuroblast division" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0017134 "fibroblast growth factor binding" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IEA

GO:0010863 "positive regulation of phospholipase C activity" evidence=IEA

GO:0008201 "heparin binding" evidence=IEA

GO:0007605 "sensory perception of sound" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0002062 "chondrocyte differentiation" evidence=IEA

GO:0002053 "positive regulation of mesenchymal cell proliferation" evidence=IEA

GO:0001759 "organ induction" evidence=IEA

GO:0001701 "in utero embryonic development" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0001525 "angiogenesis" evidence=IEA

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1M7N5 Fgfr1 "Fibroblast growth factor receptor" [Rattus norvegicus (taxid:10116)]

 Score = 545 (196.9 bits), Expect = 2.4e-52, P = 2.4e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   490 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 549

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   550 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 609

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   610 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 669

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   670 WEIFTLGGSPYPGVPVEELFKLLK 693

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1RZJ8 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 545 (196.9 bits), Expect = 3.2e-52, P = 3.2e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   509 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 568

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   569 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 628

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   629 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 688

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   689 WEIFTLGGSPYPGVPVEELFKLLK 712

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|E2R186 FGFR1 "Fibroblast growth factor receptor" [Canis lupus familiaris (taxid:9615)]

 Score = 545 (196.9 bits), Expect = 3.2e-52, P = 3.2e-52
 Identities = 101/204 (49%), Positives = 143/204 (70%)

Query:    25 VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct:   511 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 570

Query:    85 SFLRSSRAQ--RY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
              +L++ R     Y YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct:   571 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 630

Query:   142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
             + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct:   631 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 690

Query:   202 WEIVTLGSTPYPGMAAAEVMKKSK 225
             WEI TLG +PYPG+   E+ K  K
Sbjct:   691 WEIFTLGGSPYPGVPVEELFKLLK 714

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9VBW3	CAD96_DROME	2, ., 7, ., 1, 0, ., 1	0.7524	0.9155	0.2664	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.10	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	225
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-111
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-100
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-99
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-99
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-93
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-76
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-75
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-73
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-72
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-71
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-71
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-69
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-68
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-68
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-67
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-67
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-66
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-66
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-65
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-63
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-63
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-62
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-61
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-61
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-61
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-59
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-58
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-58
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-58
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-57
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-57
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-57
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-57
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-57
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-56
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-56
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-56
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-56
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-56
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-56
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-55
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-53
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-52
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-52
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-50
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-50
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-49
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-48
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-48
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-48
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-48
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-47
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-47
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-47
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-46
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-46
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-45
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-45
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-45
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-45
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-45
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-45
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-44
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-44
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-43
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-43
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-43
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-43
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-42
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-42
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-41
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-41
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-41
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-41
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-41
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-41
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-41
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-41
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-40
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-38
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-37
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-37
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-35
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-28
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-12
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-12
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  320 bits (822), Expect = e-111
 Identities = 108/208 (51%), Positives = 146/208 (70%), Gaps = 5/208 (2%)

Query: 16  ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           +        VAVKTLKE+A E ER D L+E  VMK L  HPNVVRLLG CTE+EP ++++
Sbjct: 17  KGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVL 75

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY+  G L  +LR SR            ++L+ +DL SF  Q+A+GM++L+S+  +HRDL
Sbjct: 76  EYMEGGDLLDYLRKSRPVFPSPE----KSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDL 131

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARN L+GE+   K++DFG +RD+     Y +K+ G+LPIRWMAPESL D IF+ KSD+W
Sbjct: 132 AARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVW 191

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SFGVL+WEI TLG+TPYPG++  EV++ 
Sbjct: 192 SFGVLLWEIFTLGATPYPGLSNEEVLEY 219

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  292 bits (749), Expect = e-100
 Identities = 101/206 (49%), Positives = 133/206 (64%), Gaps = 13/206 (6%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G      VAVKTLKE A E ER + L+E ++MK L  HPN+VRLLG CT+ EP +++ EY
Sbjct: 24  GEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-HPNIVRLLGVCTQGEPLYIVTEY 82

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +P G L  FLR                 LT +DL     Q+A+GM++L S+  +HRDLAA
Sbjct: 83  MPGGDLLDFLRKHG------------EKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAA 130

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN L+ EN   K++DFG +RD+     Y ++  G+LPI+WMAPESL D  F+ KSD+WSF
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           GVL+WEI TLG  PYPGM+  EV++ 
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLEL 216

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  289 bits (741), Expect = 2e-99
 Identities = 106/201 (52%), Positives = 139/201 (69%), Gaps = 13/201 (6%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+A E++  + L+E  +M+ LD HPN+V+LLG CTE+EP  ++MEY+P G L 
Sbjct: 31  VAVKTLKEDASEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR +R              L+  DL SF  Q+ARGM++L S+  IHRDLAARN L+GE
Sbjct: 90  DYLRKNR-----------PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE 138

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   K++DFG +RDL     Y +   G+LPIRWMAPESL +  F+ KSD+WSFGVL+WEI
Sbjct: 139 NLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 197

Query: 205 VTLGSTPYPGMAAAEVMKKSK 225
            TLG  PYPGM+ AEV++  K
Sbjct: 198 FTLGEEPYPGMSNAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  288 bits (739), Expect = 3e-99
 Identities = 108/201 (53%), Positives = 140/201 (69%), Gaps = 14/201 (6%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+A E++  + L+E  +M+ LD HPNVV+LLG CTE+EP +++MEY+  G L 
Sbjct: 31  VAVKTLKEDASEQQIEEFLREARIMRKLD-HPNVVKLLGVCTEEEPLYIVMEYMEGGDLL 89

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LR +R              L+  DL SF  Q+ARGM++L S+  IHRDLAARN L+GE
Sbjct: 90  SYLRKNR------------PKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE 137

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   K++DFG +RDL     Y RK  G+LPIRWMAPESL +  F+ KSD+WSFGVL+WEI
Sbjct: 138 NLVVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 196

Query: 205 VTLGSTPYPGMAAAEVMKKSK 225
            TLG  PYPGM+  EV++  K
Sbjct: 197 FTLGEQPYPGMSNEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  274 bits (702), Expect = 4e-93
 Identities = 100/207 (48%), Positives = 142/207 (68%), Gaps = 3/207 (1%)

Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
                 VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT++ P +V++EY 
Sbjct: 39  PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA 98

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNS---LTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
            +G L+ FLR+ R    Y +          LT +DL SF YQVARGM+FL+S+  IHRDL
Sbjct: 99  AHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+ E+H  K+ADFG ARD+     Y + + GRLP++WMAPE+L+D +++ +SD+W
Sbjct: 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           SFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 219 SFGVLLWEIFTLGGSPYPGIPVEELFK 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  231 bits (590), Expect = 4e-76
 Identities = 97/199 (48%), Positives = 124/199 (62%), Gaps = 12/199 (6%)

Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
            +    + VAVK LK  A   ER  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 60  SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           Y  YG L +FLR  R            + LT  DL SF YQVA+GM FL+S+  IHRDLA
Sbjct: 120 YCCYGDLLNFLRRKR-----------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLA 168

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+      K+ DFG ARD+M  S Y  K   RLP++WMAPES+++ +++ +SD+WS
Sbjct: 169 ARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 228

Query: 197 FGVLIWEIVTLGSTPYPGM 215
           +G+L+WEI +LGS PYPGM
Sbjct: 229 YGILLWEIFSLGSNPYPGM 247

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  227 bits (580), Expect = 9e-75
 Identities = 103/211 (48%), Positives = 142/211 (67%), Gaps = 12/211 (5%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +GR G   VAVK LKENA   E  DLL E  ++K ++ HP+V++L G C++  P  +I+E
Sbjct: 25  KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLLLIVE 83

Query: 77  YVPYGKLQSFLRSSR-AQRYYNNMHGKSNS----------LTSRDLTSFCYQVARGMQFL 125
           Y  YG L+SFLR SR     Y    G  NS          LT  DL SF +Q++RGMQ+L
Sbjct: 84  YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143

Query: 126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD 185
           +   ++HRDLAARNVL+ E    K++DFG +RD+     Y ++S+GR+P++WMA ESL+D
Sbjct: 144 AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
           +I++ +SD+WSFGVL+WEIVTLG  PYPG+A
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  225 bits (575), Expect = 1e-73
 Identities = 101/224 (45%), Positives = 147/224 (65%), Gaps = 4/224 (1%)

Query: 3   CFSVEVRKHPMSPERGR-EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   VR      ++ R +    VAVK LK+NA +++  DL+ E+ +MK +  H N++ L
Sbjct: 24  CFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINL 83

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT++ P +VI+EY   G L+ FLR+ R       ++        L+ +DL S  YQV
Sbjct: 84  LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQV 143

Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L SR  IHRDLAARNVL+ E++  K+ADFG AR +     Y++ S GRLP++WM
Sbjct: 144 ARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM 203

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFG+L+WEI TLG +PYPG+   E+ K
Sbjct: 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  221 bits (563), Expect = 7e-72
 Identities = 99/201 (49%), Positives = 140/201 (69%), Gaps = 3/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 85  SFLRSSR--AQRY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R     Y YN        L+ +DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 232

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 233 WEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  219 bits (559), Expect = 1e-71
 Identities = 87/198 (43%), Positives = 127/198 (64%), Gaps = 4/198 (2%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ ENA  RER++ L E +VMK  + H +VVRLLG  +  +P  V+ME +  G L+
Sbjct: 39  VAIKTVNENASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLK 97

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   N   G     T +       ++A GM +L+++  +HRDLAARN ++ E
Sbjct: 98  SYLRSRRPEAENNPGLG---PPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWMAPESL D +F+ KSD+WSFGV++WE+
Sbjct: 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  EV+K
Sbjct: 215 ATLAEQPYQGLSNEEVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  217 bits (555), Expect = 8e-71
 Identities = 100/224 (44%), Positives = 149/224 (66%), Gaps = 4/224 (1%)

Query: 3   CFSVEVRKHPMSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ +    + VAVK LK++A E++  DL+ E+ +MK +  H N++ L
Sbjct: 27  CFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 86

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +VI+EY   G L+ +LR+ R    +  Y+        +T +DL S  YQV
Sbjct: 87  LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQV 146

Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDLAARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 147 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWM 206

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 207 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  215 bits (549), Expect = 2e-69
 Identities = 98/224 (43%), Positives = 148/224 (66%), Gaps = 4/224 (1%)

Query: 3   CFSVEVRKHPMSPERGREG-PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ +   P  VAVK LK++A +++  DL+ E+ +MK +  H N++ L
Sbjct: 24  CFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL 83

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +V++EY   G L+ +LR+ R       ++        LT +DL S  YQV
Sbjct: 84  LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQV 143

Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDLAARNVL+ E++  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 144 ARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM 203

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 204 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  209 bits (535), Expect = 3e-68
 Identities = 89/201 (44%), Positives = 116/201 (57%), Gaps = 15/201 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVKTLK      E    LQE  +MK L  H  +V+L   C+E+EP +++ EY+  
Sbjct: 29  GTTKVAVKTLKPGTMSPE--AFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSK 85

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+S           G+   L    L     Q+A GM +L SR  IHRDLAARN+
Sbjct: 86  GSLLDFLKS-----------GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CK+ADFG AR L+    Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 135 LVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGIL 193

Query: 201 IWEIVTLGSTPYPGMAAAEVM 221
           + EIVT G  PYPGM   EV+
Sbjct: 194 LTEIVTYGRVPYPGMTNREVL 214

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  209 bits (534), Expect = 4e-68
 Identities = 94/207 (45%), Positives = 131/207 (63%), Gaps = 12/207 (5%)

Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
            GP  VAVKTL++ A ++E+ + L+E  +M   + HPN+V+LLG C   EP ++IME + 
Sbjct: 24  SGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIMELME 82

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            G L S+LR +R +R+   +      LT ++L   C  VA+G  +L     IHRDLAARN
Sbjct: 83  GGDLLSYLRDARVERFGPPL------LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN 136

Query: 140 VLIGE-----NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
            L+ E     +   K+ DFG ARD+  S  Y ++ EG LP+RWMAPESL D  F+ +SD+
Sbjct: 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDV 196

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           WSFGVL+WEI+TLG  PYP +   EV+
Sbjct: 197 WSFGVLMWEILTLGQQPYPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  208 bits (530), Expect = 4e-67
 Identities = 101/201 (50%), Positives = 132/201 (65%), Gaps = 6/201 (2%)

Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           A+K LKE A E +  D   EL V+  L  HPN++ LLG C  +   ++ +EY PYG L  
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92

Query: 86  FLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           FLR SR       +   HG +++LTS+ L  F   VA GMQ+LS +  IHRDLAARNVL+
Sbjct: 93  FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           GEN   K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++ KSD+WSFGVL+W
Sbjct: 153 GENLASKIADFGLSRG---EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EIV+LG TPY GM  AE+ +K
Sbjct: 210 EIVSLGGTPYCGMTCAELYEK 230

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  209 bits (533), Expect = 6e-67
 Identities = 100/245 (40%), Positives = 137/245 (55%), Gaps = 49/245 (20%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGK 82
            VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+EY  +G 
Sbjct: 39  TVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGN 98

Query: 83  LQSFLRSSR----------------------AQRYYNNMHGKSNS--------------- 105
           L ++LRS R                       QR  +    +S++               
Sbjct: 99  LSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158

Query: 106 -----------LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG 154
                      LT  DL S+ +QVARGM+FL+SR  IHRDLAARN+L+ EN+  K+ DFG
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 218

Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            ARD+     Y RK + RLP++WMAPES++D +++ +SD+WSFGVL+WEI +LG++PYPG
Sbjct: 219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278

Query: 215 MAAAE 219
           +   E
Sbjct: 279 VQIDE 283

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  204 bits (520), Expect = 6e-66
 Identities = 92/201 (45%), Positives = 125/201 (62%), Gaps = 15/201 (7%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
             VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG 
Sbjct: 32  LTVAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGN 88

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L  +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+
Sbjct: 89  LLDYLRECNRQ-----------EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           GENH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+W
Sbjct: 138 GENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 196

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EI T G +PYPG+  ++V + 
Sbjct: 197 EIATYGMSPYPGIDLSQVYEL 217

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  204 bits (520), Expect = 6e-66
 Identities = 92/201 (45%), Positives = 131/201 (65%), Gaps = 6/201 (2%)

Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L  
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85

Query: 86  FLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHRDLAARN+L+
Sbjct: 86  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 145

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           GEN+  K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++  SD+WS+GVL+W
Sbjct: 146 GENYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EIV+LG TPY GM  AE+ +K
Sbjct: 203 EIVSLGGTPYCGMTCAELYEK 223

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  203 bits (517), Expect = 1e-65
 Identities = 90/199 (45%), Positives = 121/199 (60%), Gaps = 15/199 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLK   G  +  D L E  +MK L  HP +++L   CT +EP +++ E + YG L 
Sbjct: 33  VAVKTLK--PGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +L+            G   +L    L     QVA GM +L ++  IHRDLAARNVL+GE
Sbjct: 90  EYLQ-----------GGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE 138

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N+ CKVADFG AR +    +YE +   + PI+W APE+   N FS+KSD+WSFG+L+ EI
Sbjct: 139 NNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197

Query: 205 VTLGSTPYPGMAAAEVMKK 223
           VT G  PYPGM  AEV+++
Sbjct: 198 VTYGRMPYPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  197 bits (503), Expect = 7e-63
 Identities = 92/201 (45%), Positives = 131/201 (65%), Gaps = 6/201 (2%)

Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L  
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97

Query: 86  FLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHRDLAARN+L+
Sbjct: 98  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           GEN+  K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++  SD+WS+GVL+W
Sbjct: 158 GENYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EIV+LG TPY GM  AE+ +K
Sbjct: 215 EIVSLGGTPYCGMTCAELYEK 235

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  199 bits (508), Expect = 9e-63
 Identities = 95/250 (38%), Positives = 129/250 (51%), Gaps = 59/250 (23%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL ++  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 71  VAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLL 130

Query: 85  SFLRSSRAQRY----------------YNNMH---------------GKSNSLTSR---- 109
           +FLR  +A+ +                Y N+                G    +  R    
Sbjct: 131 NFLRK-KAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189

Query: 110 -----------------------DLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH 146
                                  DL  F  QVA+GM FL+S+  IHRD+AARNVL+ +  
Sbjct: 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR 249

Query: 147 CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
             K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD+WS+G+L+WEI +
Sbjct: 250 VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Query: 207 LGSTPYPGMA 216
           LG +PYPG+ 
Sbjct: 310 LGKSPYPGIL 319

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  193 bits (492), Expect = 6e-62
 Identities = 80/198 (40%), Positives = 118/198 (59%), Gaps = 15/198 (7%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
             VAVKT +       +   LQE  ++K  D HPN+V+L+G C +K+P +++ME VP G 
Sbjct: 20  TEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPGGS 78

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L +FLR             K N LT + L       A GM++L S+  IHRDLAARN L+
Sbjct: 79  LLTFLR------------KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV 126

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           GEN+  K++DFG +R+     +Y       ++PI+W APE+L    ++ +SD+WS+G+L+
Sbjct: 127 GENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILL 185

Query: 202 WEIVTLGSTPYPGMAAAE 219
           WE  +LG TPYPGM+  +
Sbjct: 186 WETFSLGDTPYPGMSNQQ 203

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  192 bits (490), Expect = 3e-61
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 15/200 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK  + +++RLD L E ++M   D HPN++RL G  T+  P  +I EY+  G L 
Sbjct: 35  VAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSLD 93

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FLR +  +             T   L      +A GM++LS    +HRDLAARN+L+  
Sbjct: 94  KFLRENDGK------------FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS 141

Query: 145 NHCCKVADFGFARDLMTS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG +R L  S + Y  K  G++PIRW APE++    F+  SD+WSFG+++WE
Sbjct: 142 NLVCKVSDFGLSRRLEDSEATYTTKG-GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           +++ G  PY  M+  +V+K 
Sbjct: 201 VMSYGERPYWDMSNQDVIKA 220

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  194 bits (493), Expect = 5e-61
 Identities = 98/245 (40%), Positives = 131/245 (53%), Gaps = 50/245 (20%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  YG L
Sbjct: 40  VAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99

Query: 84  QSFLRSSR---------------------------------AQRYYNNMHGKSNS----- 105
            +FLR+ R                                       +    S S     
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159

Query: 106 -----------LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG 154
                      LT  DL  + +QVARGM+FL+SR  IHRDLAARN+L+ EN+  K+ DFG
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219

Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            ARD+     Y RK   RLP++WMAPES++D +++ +SD+WSFGVL+WEI +LG++PYPG
Sbjct: 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279

Query: 215 MAAAE 219
           +   E
Sbjct: 280 VQINE 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  191 bits (488), Expect = 6e-61
 Identities = 92/211 (43%), Positives = 126/211 (59%), Gaps = 13/211 (6%)

Query: 17  RGREG---PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           RGR+G      VAVKTL E+  E++  D L E  +M   + H N+VRL+G   E+ P F+
Sbjct: 28  RGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERLPRFI 86

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           ++E +  G L+SFLR +R          + +SLT +DL      VA+G ++L     IHR
Sbjct: 87  LLELMAGGDLKSFLRENR------PRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR 140

Query: 134 DLAARNVLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSV 190
           D+AARN L+   G     K+ADFG ARD+  +S Y +     LPI+WM PE+  D IF+ 
Sbjct: 141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTS 200

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           K+D+WSFGVL+WEI +LG  PYPG    EVM
Sbjct: 201 KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  188 bits (478), Expect = 2e-59
 Identities = 86/201 (42%), Positives = 123/201 (61%), Gaps = 6/201 (2%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLKENA  + + +  QE  +M  L  HPN+V LLG CT+++P  ++ EY+ +G L 
Sbjct: 38  VAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLH 96

Query: 85  SFLRS----SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            FL      S       +   KS SL   D      Q+A GM++LSS   +HRDLAARN 
Sbjct: 97  EFLVRNSPHSDVGAESGDETVKS-SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GE    K++DFG +RD+ ++  Y  +S+  LP+RWM PE++    F+ +SDIWSFGV+
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215

Query: 201 IWEIVTLGSTPYPGMAAAEVM 221
           +WEI + G  PY G +  EV+
Sbjct: 216 LWEIFSYGLQPYYGFSNQEVI 236

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  184 bits (469), Expect = 2e-58
 Identities = 79/200 (39%), Positives = 116/200 (58%), Gaps = 21/200 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK+++   +    L E +VM TL  HPN+V+LLG   +  P +++ EY+  G L 
Sbjct: 32  VAVKCLKDDSTAAQAF--LAEASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88

Query: 85  SFLRS-SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            +LRS  RA             +T      F   V  GM++L  +  +HRDLAARNVL+ 
Sbjct: 89  DYLRSRGRA------------VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   KV+DFG A++    +   + S G+LP++W APE+L +  FS KSD+WSFG+L+WE
Sbjct: 137 EDLVAKVSDFGLAKE----ASQGQDS-GKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           I + G  PYP +   +V+  
Sbjct: 192 IYSFGRVPYPRIPLKDVVPH 211

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  187 bits (477), Expect = 4e-58
 Identities = 99/253 (39%), Positives = 128/253 (50%), Gaps = 62/253 (24%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 68  VAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLL 127

Query: 85  SFLRSSR-------------AQRYYNNMHGKSNSLTSR---------------------- 109
           +FLR  R             A  Y N +H +  S  S                       
Sbjct: 128 NFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187

Query: 110 ---------------------------DLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
                                      DL SF YQVA+GM FL+S+  IHRDLAARN+L+
Sbjct: 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
                 K+ DFG ARD+   S Y  K   RLP++WMAPES+++ +++ +SD+WS+G+L+W
Sbjct: 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 307

Query: 203 EIVTLGSTPYPGM 215
           EI +LGS+PYPGM
Sbjct: 308 EIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  183 bits (467), Expect = 6e-58
 Identities = 83/220 (37%), Positives = 124/220 (56%), Gaps = 17/220 (7%)

Query: 8   VRKHPMSPERGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
           V +  +S + G +    VAVKT+K +     E  + L E   MK  D HPNV++L+G C 
Sbjct: 15  VMEGQLSQDDGSQLK--VAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCF 71

Query: 67  EKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR 120
           E           VI+ ++ +G L SFL  SR       + G    L  + L  F   +A 
Sbjct: 72  EASSLQKIPKPMVILPFMKHGDLHSFLLYSR-------LGGLPEKLPLQTLLKFMVDIAL 124

Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAP 180
           GM++LS+R  IHRDLAARN ++ E+    VADFG ++ + +   Y +    ++P++W+A 
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184

Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
           ESL D +++ KSD+W+FGV +WEI T G TPYPG+   E+
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  182 bits (464), Expect = 3e-57
 Identities = 80/200 (40%), Positives = 115/200 (57%), Gaps = 2/200 (1%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVKTLKE A    R D  +E  ++     H N+V+  G CTE +P  ++ EY+ +G L
Sbjct: 37  LVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGDL 95

Query: 84  QSFLRS-SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
             FLRS      +  +       LT   L     Q+A GM +L+S+  +HRDLA RN L+
Sbjct: 96  NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           G +   K+ DFG +RD+ T+  Y       LPIRWM PES+    F+ +SD+WSFGV++W
Sbjct: 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215

Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           EI T G  P+ G++  EV++
Sbjct: 216 EIFTYGKQPWYGLSNEEVIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  182 bits (464), Expect = 3e-57
 Identities = 75/202 (37%), Positives = 118/202 (58%), Gaps = 15/202 (7%)

Query: 20  EGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           E   I VA+K L+E    +   ++L E  VM ++D HP+VVRLLG C   +   +I + +
Sbjct: 33  EKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLSSQ-VQLITQLM 90

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
           P G L  ++R+ +              + S+ L ++C Q+A+GM +L  + ++HRDLAAR
Sbjct: 91  PLGCLLDYVRNHKDN------------IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAAR 138

Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           NVL+      K+ DFG A+ L           G++PI+WMA ES+   I++ KSD+WS+G
Sbjct: 139 NVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYG 198

Query: 199 VLIWEIVTLGSTPYPGMAAAEV 220
           V +WE++T G+ PY G+ A E+
Sbjct: 199 VTVWELMTFGAKPYEGIPAVEI 220

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  182 bits (464), Expect = 5e-57
 Identities = 86/204 (42%), Positives = 124/204 (60%), Gaps = 8/204 (3%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
            P +VAVK L+ +A +  R D L+E+ ++  L   PN+ RLLG CT   P  +IMEY+  
Sbjct: 45  APVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMEN 103

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+   A+   + +   S SL+   L     Q+A GM++L S   +HRDLA RN 
Sbjct: 104 GDLNQFLQKHVAET--SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGR--LPIRWMAPESLYDNIFSVKSDIWSFG 198
           L+G+N+  K+ADFG +R+L +S  Y  + +GR  LPIRWMA ES+    F+ KSD+W+FG
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219

Query: 199 VLIWEIVTLG-STPYPGMAAAEVM 221
           V +WEI+TL    PY  +   +V+
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVI 243

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  181 bits (460), Expect = 6e-57
 Identities = 81/196 (41%), Positives = 113/196 (57%), Gaps = 15/196 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K LK +   +++ D  +E+  +K L  H +++ L   C+  EP ++I E +  G L 
Sbjct: 33  VAIKILKSDDLLKQQ-DFQKEVQALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLL 90

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLRS   Q            L    L     QVA GM +L  +  IHRDLAARN+L+GE
Sbjct: 91  AFLRSPEGQ-----------VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE 139

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CKVADFG AR L+   VY   S+ ++P +W APE+     FS KSD+WSFG+L++E+
Sbjct: 140 DLVCKVADFGLAR-LIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197

Query: 205 VTLGSTPYPGMAAAEV 220
            T G  PYPGM   EV
Sbjct: 198 FTYGQVPYPGMNNHEV 213

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  181 bits (461), Expect = 6e-57
 Identities = 80/205 (39%), Positives = 120/205 (58%), Gaps = 16/205 (7%)

Query: 20  EGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           E   I VAVKT K       R   LQE  +M+  D HP++V+L+G  TE  P +++ME  
Sbjct: 31  ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPVWIVMELA 88

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
           P G+L+S+L+ ++             SL    L  + YQ++  + +L S+  +HRD+AAR
Sbjct: 89  PLGELRSYLQVNK------------YSLDLASLILYSYQLSTALAYLESKRFVHRDIAAR 136

Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           NVL+    C K+ DFG +R L   S Y + S+G+LPI+WMAPES+    F+  SD+W FG
Sbjct: 137 NVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFG 195

Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V +WEI+ LG  P+ G+   +V+ +
Sbjct: 196 VCMWEILMLGVKPFQGVKNNDVIGR 220

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  181 bits (460), Expect = 1e-56
 Identities = 81/220 (36%), Positives = 129/220 (58%), Gaps = 8/220 (3%)

Query: 6   VEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC 65
           V + K     E G E    V VK L++   E  + +  +EL + + L  H NVVRLLG C
Sbjct: 21  VFLAKAKGIEEEGGETL--VLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLC 77

Query: 66  TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 125
            E EP ++I+EY   G L+ FLR+++++        K   L+++   + C Q+A GM  L
Sbjct: 78  REAEPHYMILEYTDLGDLKQFLRATKSKDEKL----KPPPLSTKQKVALCTQIALGMDHL 133

Query: 126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD 185
           S+   +HRDLAARN L+      KV+    ++D+  S  Y+ ++   +P+RW+APE++ +
Sbjct: 134 SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA-LIPLRWLAPEAVQE 192

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           + FS KSD+WSFGVL+WE+ T G  P+ G++  EV+ + +
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score =  182 bits (464), Expect = 1e-56
 Identities = 94/250 (37%), Positives = 135/250 (54%), Gaps = 55/250 (22%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 40  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99

Query: 84  QSFL---------------RSSRAQRYYNNM-------------HGKSNS---------- 105
            ++L               R  + +  Y ++                S S          
Sbjct: 100 SNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159

Query: 106 ----------------LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCK 149
                           LT  DL  + +QVA+GM+FL+SR  IHRDLAARN+L+ EN+  K
Sbjct: 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVK 219

Query: 150 VADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGS 209
           + DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+WEI +LG+
Sbjct: 220 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279

Query: 210 TPYPGMAAAE 219
           +PYPG+   E
Sbjct: 280 SPYPGVKIDE 289

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  181 bits (460), Expect = 1e-56
 Identities = 72/187 (38%), Positives = 104/187 (55%), Gaps = 16/187 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGK 82
           VAVK+L  +  E+ R D  +E+ +++TLD H N+V+  G C +       +IMEY+P G 
Sbjct: 36  VAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+ +L+  R Q            +  + L  F  Q+ +GM +L S+  IHRDLAARN+L+
Sbjct: 95  LRDYLQRHRDQ------------INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142

Query: 143 GENHCCKVADFGFARDLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K++DFG A+ L     Y   K  G  PI W APE L  + FS  SD+WSFGV +
Sbjct: 143 ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202

Query: 202 WEIVTLG 208
           +E+ T G
Sbjct: 203 YELFTYG 209

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  181 bits (460), Expect = 1e-56
 Identities = 83/209 (39%), Positives = 122/209 (58%), Gaps = 10/209 (4%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
            +VAVK LKE A    + D  +E  +M   D HPN+V+LLG C   +P  ++ EY+ YG 
Sbjct: 36  TMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGD 94

Query: 83  LQSFLRSSRAQRYYNNMHGKSNS---------LTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           L  FLR    +   +  H  S++         L+  +      QVA GM +LS R  +HR
Sbjct: 95  LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR 154

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DLA RN L+GEN   K+ADFG +R++ ++  Y+      +PIRWM PES++ N ++ +SD
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESD 214

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           +W++GV++WEI + G  PY GMA  EV+ 
Sbjct: 215 VWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  180 bits (459), Expect = 2e-56
 Identities = 84/198 (42%), Positives = 129/198 (65%), Gaps = 4/198 (2%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+
Sbjct: 39  VAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLK 97

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN ++  
Sbjct: 98  SYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWMAPESL D +F+  SD+WSFGV++WEI
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Query: 205 VTLGSTPYPGMAAAEVMK 222
            +L   PY G++  +V+K
Sbjct: 215 TSLAEQPYQGLSNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  179 bits (456), Expect = 3e-56
 Identities = 83/200 (41%), Positives = 114/200 (57%), Gaps = 16/200 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLK+      + + L+E +VM  LD HP +VRL+G C + EP  ++ME  P G L 
Sbjct: 26  VAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVC-KGEPLMLVMELAPLGPLL 83

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +L+  R              +   DL    +QVA GM +L S+  +HRDLAARNVL+  
Sbjct: 84  KYLKKRR-------------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN 130

Query: 145 NHCCKVADFGFARDLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            H  K++DFG +R L   S Y R  + GR P++W APE +    FS KSD+WS+GV +WE
Sbjct: 131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
             + G+ PY  M  AEV+  
Sbjct: 191 AFSYGAKPYGEMKGAEVIAM 210

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  177 bits (449), Expect = 3e-55
 Identities = 83/198 (41%), Positives = 126/198 (63%), Gaps = 4/198 (2%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 39  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 97

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   N +       + + +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 98  SYLRSLRPEMENNPVQAPP---SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY GM+  +V++
Sbjct: 215 ATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  171 bits (435), Expect = 2e-53
 Identities = 80/191 (41%), Positives = 117/191 (61%), Gaps = 14/191 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT KE+  +  ++  L E  ++K  D HPN+V+L+G CT+++P +++ME VP G   
Sbjct: 22  VAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR             K + L ++ L  F    A GM +L S+  IHRDLAARN L+GE
Sbjct: 81  SFLRK------------KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE 128

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N+  K++DFG +R      +Y      ++PI+W APE+L    +S +SD+WS+G+L+WE 
Sbjct: 129 NNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWET 187

Query: 205 VTLGSTPYPGM 215
            +LG  PYPGM
Sbjct: 188 FSLGVCPYPGM 198

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  169 bits (430), Expect = 2e-52
 Identities = 80/192 (41%), Positives = 116/192 (60%), Gaps = 16/192 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF-FVIMEYVPYGKL 83
            AVK+L       E    L+E  +MK    HPNV+ LLG C   E    V++ Y+ +G L
Sbjct: 26  CAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+RS            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 85  RNFIRS------------ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD 132

Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E+   KVADFG ARD+     Y     +  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 133 ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192

Query: 202 WEIVTLGSTPYP 213
           WE++T G+ PYP
Sbjct: 193 WELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  168 bits (428), Expect = 3e-52
 Identities = 80/201 (39%), Positives = 114/201 (56%), Gaps = 24/201 (11%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K ++E A   +  D ++E  VM  L  HPN+V+L G CT++ P F++ EY+  G L 
Sbjct: 31  VAIKMIREGAMSED--DFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           ++LR  +         GK  +     L   C  V   M++L S G IHRDLAARN L+GE
Sbjct: 88  NYLRERK---------GKLGTEW---LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135

Query: 145 NHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           ++  KV+DFG AR    D  TSS        + P++W  PE    + FS KSD+WSFGVL
Sbjct: 136 DNVVKVSDFGLARYVLDDQYTSSQ-----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVL 190

Query: 201 IWEIVTLGSTPYPGMAAAEVM 221
           +WE+ + G  PY   + +EV+
Sbjct: 191 MWEVFSEGKMPYERFSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  164 bits (417), Expect = 2e-50
 Identities = 84/203 (41%), Positives = 119/203 (58%), Gaps = 15/203 (7%)

Query: 25  VAVKTLKENAGERERL-DLLQELTVMKTLDPHPNVVRLLGCC---TEKEPF---FVIMEY 77
           VAVKT+K     R  + D L E   MK  D HPNV+RL+G C    E E +    VI+ +
Sbjct: 29  VAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPSPVVILPF 87

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           + +G L SFL  SR       +      L ++ L  F   +A GM++LSS+  IHRDLAA
Sbjct: 88  MKHGDLHSFLLYSR-------LGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAA 140

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN ++ EN    VADFG ++ +     Y +    ++P++W+A ESL D +++ KSD+WSF
Sbjct: 141 RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200

Query: 198 GVLIWEIVTLGSTPYPGMAAAEV 220
           GV +WEI T G TPYPG+  +E+
Sbjct: 201 GVTMWEIATRGQTPYPGVENSEI 223

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  163 bits (413), Expect = 7e-50
 Identities = 81/198 (40%), Positives = 113/198 (57%), Gaps = 16/198 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K+LK+  G       L E  +MK L  HP +VRL    T +EP ++I EY+  G L 
Sbjct: 33  VAIKSLKQ--GSMSPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIYIITEYMENGSLV 88

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL++    +           LT   L     Q+A GM F+  +  IHRDL A N+L+ E
Sbjct: 89  DFLKTPEGIK-----------LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE 137

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
             CCK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L+ EI
Sbjct: 138 TLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196

Query: 205 VTLGSTPYPGMAAAEVMK 222
           VT G  PYPGM   EV++
Sbjct: 197 VTYGRIPYPGMTNPEVIQ 214

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  161 bits (409), Expect = 7e-49
 Identities = 78/204 (38%), Positives = 118/204 (57%), Gaps = 4/204 (1%)

Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P +VAVK L+E+A +  R D L+E+ +M  L   PN++RLL  C   +P  +I EY+  G
Sbjct: 46  PVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENG 104

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L  FL     Q           +++   L     Q+A GM++LSS   +HRDLA RN L
Sbjct: 105 DLNQFLSRHEPQE--AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +G+N+  K+ADFG +R+L +   Y  +    LPIRWM+ ES+    F+  SD+W+FGV +
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 202 WEIVTL-GSTPYPGMAAAEVMKKS 224
           WEI+TL    PY  ++  +V++ +
Sbjct: 223 WEILTLCKEQPYSQLSDEQVIENT 246

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  159 bits (403), Expect = 3e-48
 Identities = 77/200 (38%), Positives = 116/200 (58%), Gaps = 16/200 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++ L G  T+ +P  ++ EY+  G L 
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR    Q             T   L      +A GM++LS  G +HRDLAARN+L+  
Sbjct: 94  AFLRKHDGQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS 141

Query: 145 NHCCKVADFGFARDLMT--SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW APE++    F+  SD+WS+G+++W
Sbjct: 142 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 200

Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 201 EVMSYGERPYWEMSNQDVIK 220

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  159 bits (404), Expect = 3e-48
 Identities = 77/193 (39%), Positives = 112/193 (58%), Gaps = 11/193 (5%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYG 81
             V VKT+K++A E +   LLQE  ++  L  H N++ +L  C E  EP FV+  Y+ +G
Sbjct: 36  EEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYPYMNWG 94

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ FL+  R             +L+++ L     Q+A GM +L  RG+IH+D+AARN +
Sbjct: 95  NLKLFLQQCR-----LGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149

Query: 142 IGENHCCKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           I E    K+ D   +RDL     Y     +E R P++WMA ESL +  +S  SD+WSFGV
Sbjct: 150 IDEELQVKITDNALSRDLFPMD-YHCLGDNENR-PVKWMALESLVNKEYSSASDVWSFGV 207

Query: 200 LIWEIVTLGSTPY 212
           L+WE++TLG TPY
Sbjct: 208 LLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  158 bits (400), Expect = 6e-48
 Identities = 81/197 (41%), Positives = 116/197 (58%), Gaps = 15/197 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLK   G       L+E  +MKTL  H  +VRL    T++EP ++I EY+  G L 
Sbjct: 33  VAVKTLK--PGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S    +           +    L  F  Q+A GM ++  +  IHRDL A NVL+ E
Sbjct: 90  DFLKSDEGGK-----------VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE 138

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR ++  + Y  +   + PI+W APE++    F++KSD+WSFG+L++EI
Sbjct: 139 SLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197

Query: 205 VTLGSTPYPGMAAAEVM 221
           VT G  PYPGM+ ++VM
Sbjct: 198 VTYGKIPYPGMSNSDVM 214

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  158 bits (402), Expect = 7e-48
 Identities = 78/216 (36%), Positives = 122/216 (56%), Gaps = 9/216 (4%)

Query: 13  MSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
                    P +VAVK L+ +  +  R D L+E+ +M  L  +PN++RLLG C   +P  
Sbjct: 35  EGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLC 93

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS---RDLTSFCYQVARGMQFLSSRG 129
           +I EY+  G L  FL    +QR   +    +N++ S    +L     Q+A GM++L+S  
Sbjct: 94  MITEYMENGDLNQFL----SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149

Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS 189
            +HRDLA RN L+G ++  K+ADFG +R+L +   Y  +    LPIRWMA ES+    F+
Sbjct: 150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT 209

Query: 190 VKSDIWSFGVLIWEIVTL-GSTPYPGMAAAEVMKKS 224
             SD+W+FGV +WE+ TL    PY  ++  +V++ +
Sbjct: 210 TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  157 bits (399), Expect = 1e-47
 Identities = 81/209 (38%), Positives = 125/209 (59%), Gaps = 5/209 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G +   +VA+KTLK+    ++  +  QE ++M  L  HPN+V LLG  T+++P  ++ EY
Sbjct: 30  GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQPVCMLFEY 88

Query: 78  VPYGKLQSFL--RSSRAQRYYNNMHGKS--NSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +  G L  FL  RS  +    ++    +  +SL   D      Q+A GM++LSS   +H+
Sbjct: 89  LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DLAARN+LIGE    K++D G +R++ ++  Y  + +  LPIRWM PE++    FS  SD
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD 208

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           IWSFGV++WEI + G  PY G +  EV++
Sbjct: 209 IWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  157 bits (398), Expect = 2e-47
 Identities = 82/214 (38%), Positives = 119/214 (55%), Gaps = 7/214 (3%)

Query: 11  HPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP 70
           H + PE+ +    +VAVK LKE A E  R D  +E  ++  L  H ++VR  G CTE  P
Sbjct: 27  HNLLPEQDK---MLVAVKALKE-ASESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGRP 81

Query: 71  FFVIMEYVPYGKLQSFLRS--SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 128
             ++ EY+ +G L  FLRS    A+            LT   + +   Q+A GM +L+S 
Sbjct: 82  LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141

Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF 188
             +HRDLA RN L+G+    K+ DFG +RD+ ++  Y       LPIRWM PES+    F
Sbjct: 142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 201

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           + +SDIWSFGV++WEI T G  P+  ++  E ++
Sbjct: 202 TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  157 bits (398), Expect = 2e-47
 Identities = 76/203 (37%), Positives = 117/203 (57%), Gaps = 15/203 (7%)

Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPF------FVIMEY 77
           VAVK LK +      ++  L+E   MK  D HPNV++L+G               VI+ +
Sbjct: 30  VAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRLPIPMVILPF 88

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           + +G L +FL  SR       +  +  +L  + L  F   +A GM++LSS+  IHRDLAA
Sbjct: 89  MKHGDLHTFLLMSR-------IGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN ++ EN    VADFG ++ + +   Y +    +LP++W+A ESL DN+++  SD+W+F
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201

Query: 198 GVLIWEIVTLGSTPYPGMAAAEV 220
           GV +WEI+T G TPY G+  +E+
Sbjct: 202 GVTMWEIMTRGQTPYAGVENSEI 224

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  155 bits (394), Expect = 6e-47
 Identities = 76/200 (38%), Positives = 113/200 (56%), Gaps = 16/200 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++ L G  T+  P  +I E++  G L 
Sbjct: 35  VAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVMIITEFMENGALD 93

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR +  Q             T   L      +A GM++LS    +HRDLAARN+L+  
Sbjct: 94  SFLRQNDGQ------------FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS 141

Query: 145 NHCCKVADFGFARDLMTSS---VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           N  CKV+DFG +R L   +    Y     G++PIRW APE++    F+  SD+WS+G+++
Sbjct: 142 NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201

Query: 202 WEIVTLGSTPYPGMAAAEVM 221
           WE+++ G  PY  M+  +V+
Sbjct: 202 WEVMSYGERPYWDMSNQDVI 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (393), Expect = 7e-47
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 28/205 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +K+   +++R  +L+E+ ++K L  HPN+VRL     +++  +++MEY   G L
Sbjct: 26  LVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCEGGDL 84

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L+                 L+  +   +  Q+   +++L S+GI+HRDL   N+L+ 
Sbjct: 85  FDLLKKRG-------------RLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD 131

Query: 144 ENHCCKVADFGFARDL-----MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           E+   K+ADFG AR L     +T+ V            +MAPE L    +    DIWS G
Sbjct: 132 EDGHVKLADFGLARQLDPGEKLTTFVG--------TPEYMAPEVLLGKGYGKAVDIWSLG 183

Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++E++T G  P+PG      + K
Sbjct: 184 VILYELLT-GKPPFPGDDQLLELFK 207

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  153 bits (389), Expect = 1e-46
 Identities = 58/183 (31%), Positives = 96/183 (52%), Gaps = 17/183 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K +K+        +LL+E+ ++K L+ HPN+V+L G   ++   +++MEY   G L
Sbjct: 20  KVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGSL 78

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           +  L+                 L+  ++     Q+  G+++L S GIIHRDL   N+L+ 
Sbjct: 79  KDLLKE------------NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD 126

Query: 144 E-NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLI 201
             N   K+ADFG ++ L +     +   G     +MAPE L     +S KSDIWS GV++
Sbjct: 127 SDNGKVKLADFGLSKLLTSDKSLLKTIVG--TPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184

Query: 202 WEI 204
           +E+
Sbjct: 185 YEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  153 bits (388), Expect = 3e-46
 Identities = 76/203 (37%), Positives = 108/203 (53%), Gaps = 24/203 (11%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P +++ EY+  G L 
Sbjct: 31  VAIKMIKE--GSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           ++LR                      L   C  V  GM +L S+  IHRDLAARN L+ +
Sbjct: 88  NYLREHG------------KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135

Query: 145 NHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
             C KV+DFG +R    D  TSSV       + P+RW  PE L  + FS KSD+W+FGVL
Sbjct: 136 QGCVKVSDFGLSRYVLDDEYTSSV-----GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVL 190

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           +WE+ +LG  PY     +E ++K
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  153 bits (387), Expect = 1e-45
 Identities = 77/210 (36%), Positives = 119/210 (56%), Gaps = 5/210 (2%)

Query: 13  MSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
           + PE+ +    +VAVKTLK+ A +  R D  +E  ++  L  H ++V+  G C E +P  
Sbjct: 29  LCPEQDK---ILVAVKTLKD-ASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLI 83

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           ++ EY+ +G L  FLR+            +   LT   +     Q+A GM +L+S+  +H
Sbjct: 84  MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           RDLA RN L+GEN   K+ DFG +RD+ ++  Y       LPIRWM PES+    F+ +S
Sbjct: 144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 203

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           D+WS GV++WEI T G  P+  ++  EV++
Sbjct: 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  155 bits (393), Expect = 1e-45
 Identities = 65/113 (57%), Positives = 86/113 (76%)

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
           S  LT+ DL SF YQVARGM+FL+S+  +HRDLAARNVL+ +    K+ DFG ARD+M  
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 163 SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           S Y  K    LP++WMAPES++DN+++  SD+WS+G+L+WEI +LG TPYPGM
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  150 bits (381), Expect = 3e-45
 Identities = 76/198 (38%), Positives = 113/198 (57%), Gaps = 16/198 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT++E A   E  D ++E  VM  L  HP +V+L G CTE+ P  ++ E++ +G L 
Sbjct: 31  VAIKTIREGAMSEE--DFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVFEFMEHGCLS 87

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R               +   L   C  V  GM +L S  +IHRDLAARN L+GE
Sbjct: 88  DYLRAQRG------------KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 136 NQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194

Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G TPY   + +EV++
Sbjct: 195 FSEGKTPYENRSNSEVVE 212

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  150 bits (381), Expect = 4e-45
 Identities = 78/198 (39%), Positives = 117/198 (59%), Gaps = 17/198 (8%)

Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK LK +N     + +LL+E  VM+ LD +P +VR++G C E E + ++ME    G L
Sbjct: 25  VAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGIC-EAESWMLVMELAELGPL 82

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             FL+ ++              +T +++T   +QV+ GM++L     +HRDLAARNVL+ 
Sbjct: 83  NKFLQKNK-------------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV 129

Query: 144 ENHCCKVADFGFARDLMT-SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
             H  K++DFG ++ L    + Y+ K+ G+ P++W APE +    FS KSD+WSFGVL+W
Sbjct: 130 TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMW 189

Query: 203 EIVTLGSTPYPGMAAAEV 220
           E  + G  PY GM   EV
Sbjct: 190 EAFSYGQKPYKGMKGNEV 207

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  150 bits (380), Expect = 4e-45
 Identities = 72/200 (36%), Positives = 112/200 (56%), Gaps = 13/200 (6%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R     VAVK+ +E      +   LQE  ++K    HPN+VRL+G CT+K+P +++ME
Sbjct: 15  RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVME 73

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            V  G   +FLR+   +            L  ++L       A GM++L S+  IHRDLA
Sbjct: 74  LVQGGDFLTFLRTEGPR------------LKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARN L+ E +  K++DFG +R+             ++P++W APE+L    +S +SD+WS
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWS 181

Query: 197 FGVLIWEIVTLGSTPYPGMA 216
           FG+L+WE  +LG+ PY  ++
Sbjct: 182 FGILLWEAFSLGAVPYANLS 201

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  150 bits (380), Expect = 7e-45
 Identities = 78/200 (39%), Positives = 112/200 (56%), Gaps = 16/200 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M     H N++RL G  T+ +P  +I EY+  G L 
Sbjct: 36  VAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPAMIITEYMENGALD 94

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR                  +S  L      +A GM++LS    +HRDLAARN+L+  
Sbjct: 95  KYLRD------------HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS 142

Query: 145 NHCCKVADFGFARDL--MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L       Y   S G++PIRW APE++    F+  SD+WSFG+++W
Sbjct: 143 NLECKVSDFGLSRVLEDDPEGTYT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201

Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  EVMK
Sbjct: 202 EVMSFGERPYWDMSNHEVMK 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  151 bits (382), Expect = 8e-45
 Identities = 81/224 (36%), Positives = 121/224 (54%), Gaps = 18/224 (8%)

Query: 12  PMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           P +  +GR  P +VAVK L+ +A +  R D L+E+ ++  L   PN++RLLG C +++P 
Sbjct: 38  PFNVRKGR--PLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPNIIRLLGVCVDEDPL 94

Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD----------LTSFCYQVARG 121
            +I EY+  G L  FL S     + ++     N                L     Q+A G
Sbjct: 95  CMITEYMENGDLNQFLSS----HHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
           M++LSS   +HRDLA RN L+GEN   K+ADFG +R+L     Y  +    LPIRWMA E
Sbjct: 151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210

Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVTL-GSTPYPGMAAAEVMKKS 224
            +    F+  SD+W+FGV +WEI+ L    PY  +   +V++ +
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENA 254

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  148 bits (375), Expect = 4e-44
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 19/198 (9%)

Query: 19  REGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           +    IVAVK L K +   ++     +E+ +++ L  HPN+VRL+    +K+  +++MEY
Sbjct: 21  KGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPNIVRLIDAFEDKDHLYLVMEY 79

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G L  +L              +   L+  +      Q+ RG+++L S GIIHRDL  
Sbjct: 80  CEGGDLFDYLS-------------RGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKP 126

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE-SLYDNIFSVKSDIWS 196
            N+L+ EN   K+ADFG A+ L+ SS     +       +MAPE  L  N +  K D+WS
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184

Query: 197 FGVLIWEIVTLGSTPYPG 214
            GV+++E++T G  P+ G
Sbjct: 185 LGVILYELLT-GKPPFSG 201

Length = 260

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  151 bits (383), Expect = 6e-44
 Identities = 68/146 (46%), Positives = 95/146 (65%), Gaps = 1/146 (0%)

Query: 75  MEYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +E   Y      +L S+  +   + +  +S +L+  DL  F YQVA GM+FL+S+  +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DLAARNVLI E    K+ DFG ARD+M  S Y  K    LP++WMAPES+++N+++  SD
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD 323

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAE 219
           +WSFG+L+WEI TLG TPYP +   E
Sbjct: 324 VWSFGILLWEIFTLGGTPYPELPMNE 349

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  147 bits (371), Expect = 1e-43
 Identities = 72/198 (36%), Positives = 112/198 (56%), Gaps = 15/198 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K LK    +  R ++++E  +M  LD +P +VR++G C E E   ++ME    G L 
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVC-EAEALMLVMEMASGGPLN 82

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL             GK + +T  ++    +QV+ GM++L  +  +HRDLAARNVL+  
Sbjct: 83  KFLS------------GKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130

Query: 145 NHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            H  K++DFG ++ L    S Y+ +S G+ P++W APE +    FS +SD+WS+G+ +WE
Sbjct: 131 QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190

Query: 204 IVTLGSTPYPGMAAAEVM 221
             + G  PY  M   EVM
Sbjct: 191 AFSYGQKPYKKMKGPEVM 208

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  145 bits (368), Expect = 3e-43
 Identities = 80/198 (40%), Positives = 112/198 (56%), Gaps = 16/198 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT+K   G       L E  VMKTL  H  +V+L    T KEP ++I E++  G L 
Sbjct: 33  VAVKTMK--PGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLL 88

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S            + +      L  F  Q+A GM F+  R  IHRDL A N+L+  
Sbjct: 89  DFLKSD-----------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 137

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR ++  + Y  +   + PI+W APE++    F++KSD+WSFG+L+ EI
Sbjct: 138 SLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 196

Query: 205 VTLGSTPYPGMAAAEVMK 222
           VT G  PYPGM+  EV++
Sbjct: 197 VTYGRIPYPGMSNPEVIR 214

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  145 bits (367), Expect = 4e-43
 Identities = 72/199 (36%), Positives = 109/199 (54%), Gaps = 18/199 (9%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K + E A   E  D ++E  VM  L  HP +V+L G CT+++P +++ E++  G L 
Sbjct: 31  VAIKAINEGAMSEE--DFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++LR  + +              S+D L S C  V  GM++L     IHRDLAARN L+ 
Sbjct: 88  NYLRQRQGK-------------LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS 134

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
                KV+DFG  R ++    Y   S  + P++W  PE    + +S KSD+WSFGVL+WE
Sbjct: 135 STGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWE 193

Query: 204 IVTLGSTPYPGMAAAEVMK 222
           + T G  P+   +  EV++
Sbjct: 194 VFTEGKMPFEKKSNYEVVE 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  147 bits (371), Expect = 5e-43
 Identities = 74/197 (37%), Positives = 122/197 (61%), Gaps = 16/197 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 39  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLL 96

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 97  DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT 144

Query: 145 NHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
               K+ DFG A+ L+ +   E  +E G++PI+WMA ES+   I++ +SD+WS+GV +WE
Sbjct: 145 PQHVKITDFGLAK-LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203

Query: 204 IVTLGSTPYPGMAAAEV 220
           ++T GS PY G+ A+E+
Sbjct: 204 LMTFGSKPYDGIPASEI 220

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  143 bits (362), Expect = 2e-42
 Identities = 77/200 (38%), Positives = 112/200 (56%), Gaps = 21/200 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKL 83
           VAVK +K +A  +     L E +VM  L  H N+V+LLG   E K   +++ EY+  G L
Sbjct: 32  VAVKCIKNDATAQA---FLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +LRS           G+S  L    L  F   V   M++L +   +HRDLAARNVL+ 
Sbjct: 88  VDYLRS----------RGRS-VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E++  KV+DFG     +T      +  G+LP++W APE+L +  FS KSD+WSFG+L+WE
Sbjct: 137 EDNVAKVSDFG-----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           I + G  PYP +   +V+ +
Sbjct: 192 IYSFGRVPYPRIPLKDVVPR 211

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  143 bits (363), Expect = 2e-42
 Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +       D L+E  +M +LD H N++RL G      P  ++ E  P G L 
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLTH-PLMMVTELAPLGSLL 83

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             LR               + L S  L  +  Q+A GM++L S+  IHRDLAARN+L+  
Sbjct: 84  DRLRK----------DALGHFLIST-LCDYAVQIANGMRYLESKRFIHRDLAARNILLAS 132

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGR-LPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +   K+ DFG  R L  +  +    E   +P  W APESL    FS  SD+W FGV +WE
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWE 192

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           + T G  P+ G++ ++++KK
Sbjct: 193 MFTYGEEPWAGLSGSQILKK 212

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  142 bits (359), Expect = 1e-41
 Identities = 72/202 (35%), Positives = 113/202 (55%), Gaps = 5/202 (2%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK LK+      R D  +E  ++  L  H ++V+  G C + +P  ++ EY+ +G L
Sbjct: 37  LVAVKALKD-PTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94

Query: 84  QSFLRS--SRAQRYYNNMHGKSN-SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             FLR+    A    +    ++   L    +     Q+A GM +L+S+  +HRDLA RN 
Sbjct: 95  NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 154

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+G N   K+ DFG +RD+ ++  Y       LPIRWM PES+    F+ +SD+WSFGV+
Sbjct: 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214

Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           +WEI T G  P+  ++  EV++
Sbjct: 215 LWEIFTYGKQPWFQLSNTEVIE 236

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  140 bits (354), Expect = 4e-41
 Identities = 78/203 (38%), Positives = 113/203 (55%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVKTLK      E    L+E  +MK L  H  +V+L    +E EP +++ EY+  
Sbjct: 29  GNTKVAVKTLKPGTMSPE--SFLEEAQIMKKLR-HDKLVQLYAVVSE-EPIYIVTEYMSK 84

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+            G+  +L   +L     QVA GM ++     IHRDL + N+
Sbjct: 85  GSLLDFLKD-----------GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 133

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+G+   CK+ADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 134 LVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+VT G  PYPGM   EV+++
Sbjct: 193 LTELVTKGRVPYPGMNNREVLEQ 215

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  140 bits (355), Expect = 4e-41
 Identities = 73/201 (36%), Positives = 116/201 (57%), Gaps = 4/201 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK+ A    R +   E  +M++   HPN+V LLG  T+++P  +I  Y  +  L 
Sbjct: 38  VAIKTLKDKAEGPLREEFKHE-AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96

Query: 85  SFL--RSSRAQ-RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            FL  RS  +     ++     ++L   D      Q+A GM+FLSS  ++H+DLA RNVL
Sbjct: 97  EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + +    K++D G  R++  +  Y+      LPIRWM+PE++    FS+ SDIWS+GV++
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WE+ + G  PY G +  +V++
Sbjct: 217 WEVFSYGLQPYCGYSNQDVIE 237

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  140 bits (353), Expect = 5e-41
 Identities = 76/198 (38%), Positives = 110/198 (55%), Gaps = 25/198 (12%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK +K +   +  L+   E  VM  L  H N+VRLLG        +++ME +  G L 
Sbjct: 32  VAVKNIKCDVTAQAFLE---ETAVMTKLH-HKNLVRLLGVILH-NGLYIVMELMSKGNLV 86

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR+           G++  ++   L  F   VA GM++L S+ ++HRDLAARN+L+ E
Sbjct: 87  NFLRT----------RGRA-LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135

Query: 145 NHCCKVADFGFARDLMTSSVYERKS--EGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           +   KV+DFG AR                +LP++W APE+L    FS KSD+WS+GVL+W
Sbjct: 136 DGVAKVSDFGLAR-------VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLW 188

Query: 203 EIVTLGSTPYPGMAAAEV 220
           E+ + G  PYP M+  EV
Sbjct: 189 EVFSYGRAPYPKMSLKEV 206

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  141 bits (356), Expect = 6e-41
 Identities = 70/196 (35%), Positives = 114/196 (58%), Gaps = 14/196 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L E  G +  ++ + E  +M ++D HP++VRLLG C       ++ + +P+G L 
Sbjct: 39  VAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLL 96

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++            H   +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 97  DYV------------HEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS 144

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
            +  K+ DFG AR L           G++PI+WMA E ++   F+ +SD+WS+GV IWE+
Sbjct: 145 PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204

Query: 205 VTLGSTPYPGMAAAEV 220
           +T G  PY G+   E+
Sbjct: 205 MTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  140 bits (353), Expect = 7e-41
 Identities = 79/203 (38%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 29  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 84

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+                 L    L     Q+A GM ++     +HRDL A N+
Sbjct: 85  GSLLDFLKGE-----------MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 133

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 134 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 193 LTELTTKGRVPYPGMVNREVLDQ 215

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  140 bits (353), Expect = 9e-41
 Identities = 72/196 (36%), Positives = 113/196 (57%), Gaps = 14/196 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+EN   +   ++L E  VM  +   P V RLLG C       ++ + +PYG L 
Sbjct: 39  VAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICL-TSTVQLVTQLMPYGCLL 96

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R ++            + + S+DL ++C Q+A+GM +L    ++HRDLAARNVL+  
Sbjct: 97  DYVRENK------------DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS 144

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
            +  K+ DFG AR L           G++PI+WMA ES+    F+ +SD+WS+GV +WE+
Sbjct: 145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204

Query: 205 VTLGSTPYPGMAAAEV 220
           +T G+ PY G+ A E+
Sbjct: 205 MTFGAKPYDGIPAREI 220

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  140 bits (353), Expect = 9e-41
 Identities = 73/186 (39%), Positives = 104/186 (55%), Gaps = 18/186 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
           +VAVKTLK   G++      +E+ ++KTL  H N+V+  GCC+E+  +   +IMEYVP G
Sbjct: 35  MVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLG 93

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +L                + L    L  F  Q+  GM +L S+  IHRDLAARNVL
Sbjct: 94  SLRDYL--------------PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVL 139

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           +  +   K+ DFG A+ +     Y R  E G  P+ W A E L +N FS  SD+WSFGV 
Sbjct: 140 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVT 199

Query: 201 IWEIVT 206
           ++E++T
Sbjct: 200 LYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  138 bits (349), Expect = 2e-40
 Identities = 78/203 (38%), Positives = 110/203 (54%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  +MK L  H  +V L    +E EP +++ E++  
Sbjct: 29  GTTKVAIKTLKPGTMMPEAF--LQEAQIMKKLR-HDKLVPLYAVVSE-EPIYIVTEFMGK 84

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+            G    L    L     Q+A GM ++     IHRDL A N+
Sbjct: 85  GSLLDFLK-----------EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+G+N  CK+ADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 134 LVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+VT G  PYPGM   EV+++
Sbjct: 193 LTELVTKGRVPYPGMVNREVLEQ 215

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (349), Expect = 3e-40
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 18/193 (9%)

Query: 24  IVAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEP--FFVIMEYVPY 80
           ++AVK+++ +    E L+ L +E+ ++ +L  HPN+VR  G   ++E     + +EYV  
Sbjct: 27  LMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSG 85

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L S L+                 L    +  +  Q+  G+ +L S GI+HRD+   N+
Sbjct: 86  GSLSSLLKKFGK-------------LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI 132

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+  +   K+ADFG A+ L      E     R    WMAPE +    +   +DIWS G  
Sbjct: 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT 192

Query: 201 IWEIVTLGSTPYP 213
           + E+ T G  P+ 
Sbjct: 193 VIEMAT-GKPPWS 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  136 bits (345), Expect = 9e-40
 Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 16/204 (7%)

Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           RE P  VA+ TL+    +++R   L E   +   D H N+VRL G  T      ++ EY+
Sbjct: 32  RELP--VAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTMMIVTEYM 88

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L SFLR    Q            L +  L      +A GM++LS  G +H+ LAA 
Sbjct: 89  SNGALDSFLRKHEGQ------------LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136

Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
            VL+  +  CK++ F   ++  + ++Y   S G+ P+ W APE++  + FS  SD+WSFG
Sbjct: 137 KVLVNSDLVCKISGFRRLQEDKSEAIYTTMS-GKSPVLWAAPEAIQYHHFSSASDVWSFG 195

Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           +++WE+++ G  PY  M+  +V+K
Sbjct: 196 IVMWEVMSYGERPYWDMSGQDVIK 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  132 bits (333), Expect = 8e-38
 Identities = 67/196 (34%), Positives = 110/196 (56%), Gaps = 14/196 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+++ +G +   ++   +  M +LD H  +VRLLG C       ++ +  P G L 
Sbjct: 39  VAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPGAS-LQLVTQLSPLGSLL 96

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +R  R            +SL  + L ++C Q+A+GM +L    ++HR+LAARN+L+  
Sbjct: 97  DHVRQHR------------DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   ++ADFG A  L         SE + PI+WMA ES+    ++ +SD+WS+GV +WE+
Sbjct: 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204

Query: 205 VTLGSTPYPGMAAAEV 220
           ++ G+ PY GM   EV
Sbjct: 205 MSYGAEPYAGMRPHEV 220

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  132 bits (333), Expect = 1e-37
 Identities = 75/206 (36%), Positives = 115/206 (55%), Gaps = 22/206 (10%)

Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 19  SVELCRYDPLQDNTGE----VVAVKKLQHSTAEHLR-DFEREIEILKSLQ-HDNIVKYKG 72

Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    ++MEY+PYG L+ +L+  R +            L  R L  +  Q+ +G
Sbjct: 73  VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------------LDHRKLLLYASQICKG 120

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAP 180
           M++L S+  +HRDLA RN+L+   +  K+ DFG  + L     Y +  E G  PI W AP
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180

Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  131 bits (330), Expect = 2e-37
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 16/206 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V VK L+ +A   E+L  LQE+   + L+ HPNV++ LG C E  P+ +++E+ P G L+
Sbjct: 25  VVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           ++LRS+R       +   +       L     +VA G+ +L     IH DLA RN  +  
Sbjct: 84  NYLRSNRGM-----VAQMAQKDV---LQRMACEVASGLLWLHQADFIHSDLALRNCQLTA 135

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVK----SDIWSF 197
           +   K+ D+G A +      Y  K    +P+RW+APE       ++        S+IWS 
Sbjct: 136 DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           GV +WE+ T    PYP ++  +V+K+
Sbjct: 196 GVTMWELFTAADQPYPDLSDEQVLKQ 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  125 bits (315), Expect = 4e-35
 Identities = 70/205 (34%), Positives = 107/205 (52%), Gaps = 17/205 (8%)

Query: 15  PERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFF 72
           PE    G   VAVK+LK  +G     DL +E+ +++ L  H N+V+  G CTE       
Sbjct: 27  PEGDNTGE-QVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIK 84

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           +IME++P G L+ +L  ++            N +  +    +  Q+ +GM +L SR  +H
Sbjct: 85  LIMEFLPSGSLKEYLPRNK------------NKINLKQQLKYAVQICKGMDYLGSRQYVH 132

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTS-SVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           RDLAARNVL+   H  K+ DFG  + + T    Y  K +   P+ W APE L  + F + 
Sbjct: 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA 192

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMA 216
           SD+WSFGV ++E++T   +    M 
Sbjct: 193 SDVWSFGVTLYELLTYCDSESSPMT 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score =  124 bits (313), Expect = 7e-35
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 20/209 (9%)

Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  V VK L+ +A  +E++  L+E    ++L  H N+++ LG CTE  P+ ++ME+ P G
Sbjct: 22  PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFCPLG 80

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTS--RDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            L+ +LRS R          K+  +T     L     ++A G+  L     IH DLA RN
Sbjct: 81  DLKGYLRSCR----------KAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRN 130

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSV----KS 192
            L+  +   K+ D+G + +      Y    +  +P+RW+APE    ++ N+  V    +S
Sbjct: 131 CLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKES 190

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           ++WS GV IWE+  LGS PY  ++  +V+
Sbjct: 191 NVWSLGVTIWELFELGSQPYRHLSDEQVL 219

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 2e-34
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 18/199 (9%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
            VA+K +  E   E     ++QE+ ++K L  HPN+V+ +G     +  ++I+EY   G 
Sbjct: 27  FVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIILEYAENGS 85

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+  ++             K        +  + YQV +G+ +L  +G+IHRD+ A N+L 
Sbjct: 86  LRQIIK-------------KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT 132

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            ++   K+ADFG A  L   S  +    G     WMAPE +  +  S  SDIWS G  + 
Sbjct: 133 TKDGVVKLADFGVATKLNDVSKDDASVVGTP--YWMAPEVIEMSGASTASDIWSLGCTVI 190

Query: 203 EIVTLGSTPYPGMAAAEVM 221
           E++T G+ PY  +     +
Sbjct: 191 ELLT-GNPPYYDLNPMAAL 208

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (291), Expect = 2e-31
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 21/196 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K ++     +E +  + E+ +MK    HPN+V         +  +V+MEY+  G L 
Sbjct: 47  VAIKKMRLRKQNKELI--INEILIMKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +                  +    +   C +V +G+++L S+ +IHRD+ + N+L+ +
Sbjct: 104 DIIT------------QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK 151

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ADFGFA  L T    +R S    P  WMAPE +    +  K DIWS G++  E+
Sbjct: 152 DGSVKLADFGFAAQL-TKEKSKRNSVVGTPY-WMAPEVIKRKDYGPKVDIWSLGIMCIEM 209

Query: 205 VTLGSTPY---PGMAA 217
              G  PY   P + A
Sbjct: 210 AE-GEPPYLREPPLRA 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (286), Expect = 5e-31
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 18/201 (8%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
             VA+K +K  + E++   ++ E+ ++K    HPN+V+  G   +K+  +++ME+   G 
Sbjct: 26  KEVAIKVIKLESKEKKE-KIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGGS 83

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+  L+S             + +LT   +   C ++ +G+++L S GIIHRD+ A N+L+
Sbjct: 84  LKDLLKS------------TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
             +   K+ DFG +  L + +       G     WMAPE +    +  K+DIWS G+   
Sbjct: 132 TSDGEVKLIDFGLSAQL-SDTKARNTMVGTPY--WMAPEVINGKPYDYKADIWSLGITAI 188

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           E+   G  PY  +   + + K
Sbjct: 189 ELAE-GKPPYSELPPMKALFK 208

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (276), Expect = 2e-29
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 13/185 (7%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           +  +K +   N  E+ER D L E+ ++K L+ HPN+++      EK    ++MEY   G 
Sbjct: 27  LYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVMEYADGGD 85

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   ++  + +                 +  +  Q+   +++L SR I+HRD+  +N+ +
Sbjct: 86  LSQKIKKQKKEGKP---------FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL 136

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
             N   K+ DFG ++ L ++    +   G     +++PE   +  ++ KSDIWS G +++
Sbjct: 137 TSNGLVKLGDFGISKVLSSTVDLAKTVVG--TPYYLSPELCQNKPYNYKSDIWSLGCVLY 194

Query: 203 EIVTL 207
           E+ TL
Sbjct: 195 ELCTL 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  109 bits (273), Expect = 7e-29
 Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 30/213 (14%)

Query: 24  IVAVKTLKENAGERERLD---------LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           ++AVK ++  A    R D         L  E+  +K LD H N+V+ LG  T +E   + 
Sbjct: 28  MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTEEYLSIF 86

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EYVP G + S LR           +G+      R  T    QV  G+ +L S+GI+HRD
Sbjct: 87  LEYVPGGSIGSCLR----------TYGRFEEQLVRFFTE---QVLEGLAYLHSKGILHRD 133

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL--PIRWMAPE--SLYDNIFSV 190
           L A N+L+  +  CK++DFG ++   +  +Y+      +   + WMAPE    Y   +S 
Sbjct: 134 LKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSA 191

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           K DIWS G ++ E+   G  P+    A   M K
Sbjct: 192 KVDIWSLGCVVLEMFA-GRRPWSDEEAIAAMFK 223

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (271), Expect = 1e-28
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 48/227 (21%)

Query: 24  IVAVKTL---------KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
             A+K L         K    + E+        V+  L+ HP +++L     ++E  + +
Sbjct: 28  EYAIKILDKRQLIKEKKVKYVKIEK-------EVLTRLNGHPGIIKLYYTFQDEENLYFV 80

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G+L  ++R             K  SL  +    +  ++   +++L S+GIIHRD
Sbjct: 81  LEYAPNGELLQYIR-------------KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRD 127

Query: 135 LAARNVLIGENHCCKVADFGFARDL---------MTSSVYERKSEGRLPIR--------- 176
           L   N+L+ ++   K+ DFG A+ L            +        +   R         
Sbjct: 128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAE 187

Query: 177 WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +++PE L +      SD+W+ G +I++++T G  P+ G       +K
Sbjct: 188 YVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSNEYLTFQK 233

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  107 bits (268), Expect = 2e-28
 Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 27/204 (13%)

Query: 24  IVAVKTLKENAG-------ERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           ++AVK ++  +        +R  LD L  E+ ++K L  H N+V+ LG   + +   + +
Sbjct: 27  LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDADHLNIFL 85

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EYVP G + + L          N +G   +     + +F  Q+ +G+ +L +RGIIHRD+
Sbjct: 86  EYVPGGSVAALL----------NNYG---AFEETLVRNFVRQILKGLNYLHNRGIIHRDI 132

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----WMAPESLYDNIFSVK 191
              N+L+      K++DFG ++ L  +S+  + +  R  ++    WMAPE +    ++ K
Sbjct: 133 KGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK 192

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGM 215
           +DIWS G L+ E++T G  P+P  
Sbjct: 193 ADIWSLGCLVVEMLT-GKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  109 bits (271), Expect = 5e-28
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 21/201 (10%)

Query: 24  IVAVKTL--KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K L  K  +  +E    L+E+ ++ +L+  PN+V+L     ++   +++MEYV  G
Sbjct: 24  LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+  L+            G+   L+  +      Q+   +++L S+GIIHRD+   N+L
Sbjct: 84  SLEDLLKK----------IGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL 133

Query: 142 IGEN-HCCKVADFGFARDL----MTSSVYERKSEGRLPIRWMAPESLYDNIF---SVKSD 193
           +  +    K+ DFG A+ L     TSS+    S       +MAPE L        S  SD
Sbjct: 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSD 193

Query: 194 IWSFGVLIWEIVTLGSTPYPG 214
           IWS G+ ++E++T G  P+ G
Sbjct: 194 IWSLGITLYELLT-GLPPFEG 213

Length = 384

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score =  103 bits (258), Expect = 9e-27
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V VK LK NA  +E+ + LQ+    + L  HPN+++ LG C E  P+ ++ EY   G L+
Sbjct: 25  VVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCELGDLK 83

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+L   +  R        S  L    L     ++A G+  +     +H DLA RN  +  
Sbjct: 84  SYLSQEQWHR------RNSQLL---LLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS 134

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVK----SDIWSF 197
           +   KV D+G           E + +  +P+RW+APE     +  + + +    S++W+ 
Sbjct: 135 DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVM 221
           GV +WE+    + PY  ++  EV+
Sbjct: 195 GVTLWELFENAAQPYSHLSDREVL 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.1 bits (242), Expect = 2e-24
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 20/188 (10%)

Query: 27  VKTLKENAGERERL-DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           V    +    +E +  L QE+ ++  L  HPN+V+ LG   E++  ++ +E VP G L  
Sbjct: 33  VSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLAK 91

Query: 86  FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN 145
            L+             K  S     +  +  Q+  G+++L  R  +HRD+   N+L+  N
Sbjct: 92  LLK-------------KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138

Query: 146 HCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEI 204
              K+ADFG A+ ++  S    KS    P  WMAPE +     + + +DIWS G  + E+
Sbjct: 139 GVVKLADFGMAKQVVEFS--FAKSFKGSPY-WMAPEVIAQQGGYGLAADIWSLGCTVLEM 195

Query: 205 VTLGSTPY 212
            T G  P+
Sbjct: 196 AT-GKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.9 bits (242), Expect = 2e-24
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 22/194 (11%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTL--DPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
            I A+K +  +  E  R  LL+EL   KTL     P VV+  G   ++    +++EY+  
Sbjct: 27  KIYALKKIHVDGDEEFRKQLLREL---KTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARN 139
           G L   L+             K   +    L     Q+ +G+ +L + R IIHRD+   N
Sbjct: 84  GSLADLLK-------------KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +LI      K+ADFG ++ L  +        G +   +M+PE +    +S  +DIWS G+
Sbjct: 131 LLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT--YMSPERIQGESYSYAADIWSLGL 188

Query: 200 LIWEIVTLGSTPYP 213
            + E   LG  P+ 
Sbjct: 189 TLLECA-LGKFPFL 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 1e-23
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 27/202 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +       +  ++++E++++K  D  P +V+  G   +    +++MEY   G +
Sbjct: 30  VVAIKVVPVEE---DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              ++ +              +LT  ++ +  YQ  +G+++L S   IHRD+ A N+L+ 
Sbjct: 86  SDIMKITN------------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFGV 199
           E    K+ADFG +  L T ++ +R +    P  WMAPE +    Y+N    K+DIWS G+
Sbjct: 134 EEGQAKLADFGVSGQL-TDTMAKRNTVIGTPF-WMAPEVIQEIGYNN----KADIWSLGI 187

Query: 200 LIWEIVTLGSTPYPGMAAAEVM 221
              E+   G  PY  +     +
Sbjct: 188 TAIEMAE-GKPPYSDIHPMRAI 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 2e-23
 Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 19/195 (9%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V + T    A E+E   L +E+ ++K+L  H N+V+ LG C +     + ME+VP G + 
Sbjct: 32  VELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTISIFMEFVPGGSIS 90

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S L              +   L       +  Q+  G+ +L +  ++HRD+   NV++  
Sbjct: 91  SILN-------------RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP 137

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIR----WMAPESLYDNIFSVKSDIWSFGVL 200
           N   K+ DFG AR L    ++   S     +     WMAPE + ++ +  KSDIWS G  
Sbjct: 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCT 197

Query: 201 IWEIVTLGSTPYPGM 215
           ++E+ T G  P   M
Sbjct: 198 VFEMAT-GKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.3 bits (232), Expect = 4e-23
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 14/174 (8%)

Query: 33  NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA 92
               RER + + E  V+  LD    ++R      +K    ++MEY   G L   L+  R 
Sbjct: 37  KMNRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG 95

Query: 93  QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD 152
           +            L    +  F  Q+  G+  L S+ I+HRD+ + N+ +      K+ D
Sbjct: 96  RP-----------LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGD 144

Query: 153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
            G A+ L  ++ +     G  P  +++PE   D  ++ KSD+W+ GV+++E  T
Sbjct: 145 LGVAKLLSDNTNFANTIVGT-PY-YLSPELCEDKPYNEKSDVWALGVVLYECCT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 93.7 bits (233), Expect = 4e-23
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VAVK +     +R  L L  E+ +M+    HPN+V +       +  +V+ME++  G L
Sbjct: 46  QVAVKKMDLRKQQRREL-LFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + + FL ++G+IHRD+ + ++L+ 
Sbjct: 104 TDIVTHTR--------------MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RKS    P  WMAPE +    +  + DIWS G+++ E
Sbjct: 150 SDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPY-WMAPEVISRLPYGTEVDIWSLGIMVIE 207

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           +V  G  PY      + MK+
Sbjct: 208 MVD-GEPPYFNEPPLQAMKR 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 93.3 bits (232), Expect = 5e-23
 Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 15/193 (7%)

Query: 24  IVAVKTLK--ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K ++  E    + R D L+E+ ++K LD HPNV++ L    E     +++E    G
Sbjct: 29  VVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIVLELADAG 87

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  + Q+           +  R +  +  Q+   ++ + S+ I+HRD+   NV 
Sbjct: 88  DLSRMIKHFKKQK---------RLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           I      K+ D G  R   +S      S    P  +M+PE +++N ++ KSDIWS G L+
Sbjct: 139 ITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLL 196

Query: 202 WEIVTLGSTPYPG 214
           +E+  L S P+ G
Sbjct: 197 YEMAALQS-PFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 6e-23
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 18/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+  +      P + +  G   +    ++IMEY   G  
Sbjct: 28  VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKGSKLWIIMEYCGGGSC 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L+  +              L    +     +V  G+++L   G IHRD+ A N+L+ 
Sbjct: 87  LDLLKPGK--------------LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS 132

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E    K+ADFG +  L TS++ +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 133 EEGDVKLADFGVSGQL-TSTMSKRNTFVGTPF-WMAPEVIKQSGYDEKADIWSLGITAIE 190

Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P   +    V+
Sbjct: 191 LAK-GEPPLSDLHPMRVL 207

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 2e-22
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTL--DPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K +  +  + +  D+ +E+ ++  L     PN+ +  G   +    ++IMEY   G
Sbjct: 28  VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG 87

Query: 82  KLQSFLRSSR-AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            +++ +++   A++Y         S+  R       +V   ++++   G+IHRD+ A N+
Sbjct: 88  SVRTLMKAGPIAEKYI--------SVIIR-------EVLVALKYIHKVGVIHRDIKAANI 132

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGV 199
           L+      K+ DFG A  L  +S  +R +    P  WMAPE + +   +  K+DIWS G+
Sbjct: 133 LVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPY-WMAPEVITEGKYYDTKADIWSLGI 190

Query: 200 LIWEIVTLGSTPYPGMAAAEVM 221
            I+E+ T G+ PY  + A   M
Sbjct: 191 TIYEMAT-GNPPYSDVDAFRAM 211

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 19/202 (9%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +     +    +L +E+  M   + HPNVV+        +  +++M Y+  G L 
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             ++SS               L    + +   +V +G+++L S G IHRD+ A N+L+GE
Sbjct: 88  DIMKSSY----------PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIR----WMAPESLY-DNIFSVKSDIWSFGV 199
           +   K+ADFG +  L      +R  + R        WMAPE +   + +  K+DIWSFG+
Sbjct: 138 DGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI 195

Query: 200 LIWEIVTLGSTPYPGMAAAEVM 221
              E+ T G+ PY      +V+
Sbjct: 196 TAIELAT-GAAPYSKYPPMKVL 216

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 1e-21
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 60/206 (29%)

Query: 24  IVAVKTLK-ENAGE-------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           IVA+K ++ +N  E       RE + LL+EL        HPN+V+LL     +   +++ 
Sbjct: 26  IVALKKIRLDNEEEGIPSTALRE-ISLLKELK-------HPNIVKLLDVIHTERKLYLVF 77

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY     L+ +L              +   L+   + S  YQ+ RG+ +  S  I+HRDL
Sbjct: 78  EYCDM-DLKKYLDK------------RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDL 124

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR---------WM-APESL-- 183
             +N+LI  +   K+ADFG AR               +P+R         W  APE L  
Sbjct: 125 KPQNILINRDGVLKLADFGLARAF------------GIPLRTYTHEVVTLWYRAPEILLG 172

Query: 184 ---YDNIFSVKSDIWSFGVLIWEIVT 206
              Y    +V  DIWS G +  E++T
Sbjct: 173 SKHYST--AV--DIWSVGCIFAEMIT 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.0 bits (221), Expect = 2e-21
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 29/203 (14%)

Query: 30  LKE----NAGERERLDLLQELTVMKTLDPHPNVVR-----LLGCCTEKEPFFVIMEYVPY 80
           LKE    +  ++ER D + E+ ++ +++ HPN++      L G         ++MEY P+
Sbjct: 30  LKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDGN-----KLCIVMEYAPF 83

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L   +   + +R           +  +++     Q+ RG+Q L  + I+HRDL + N+
Sbjct: 84  GDLSKAISKRKKKR---------KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANI 134

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+  N   K+ D G ++ ++  ++   K++   P  +MAPE      +S KSDIWS G L
Sbjct: 135 LLVANDLVKIGDLGISK-VLKKNM--AKTQIGTPH-YMAPEVWKGRPYSYKSDIWSLGCL 190

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           ++E+ T  + P+   +  ++  K
Sbjct: 191 LYEMATF-APPFEARSMQDLRYK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.8 bits (221), Expect = 2e-21
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 11/205 (5%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLG--CCTEKEPFFVIMEYVPY 80
           I+  K +   N  E+E+  L+ E+ +++ L  HPN+VR          +  +++MEY   
Sbjct: 27  ILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEG 85

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L   ++  + +R Y         LT   L    Y+            ++HRDL   N+
Sbjct: 86  GDLAQLIQKCKKERKYIEEEFIWRILT--QLLLALYECHNRSD--PGNTVLHRDLKPANI 141

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            +  N+  K+ DFG A+ L   S + +   G     +M+PE L    +  KSDIWS G L
Sbjct: 142 FLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY--YMSPEQLNHMSYDEKSDIWSLGCL 199

Query: 201 IWEIVTLGSTPYPGMAAAEVMKKSK 225
           I+E+  L S P+      ++  K K
Sbjct: 200 IYELCAL-SPPFTARNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.8 bits (220), Expect = 2e-21
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 23/197 (11%)

Query: 24  IVAVKTLK---ENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           ++AVK +      + E+E +   L +E+ +M  L+ HP+++R+LG   E   F + +E++
Sbjct: 27  LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFNLFVEWM 85

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G +   L         +       ++       +  Q+ RG+ +L    IIHRD+   
Sbjct: 86  AGGSVSHLL---------SKYGAFKEAVIIN----YTEQLLRGLSYLHENQIIHRDVKGA 132

Query: 139 NVLI-GENHCCKVADFGFARDLMTSSVYERKSEGRL--PIRWMAPESLYDNIFSVKSDIW 195
           N+LI       ++ADFG A  L        + +G+L   I +MAPE L    +    D+W
Sbjct: 133 NLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVW 192

Query: 196 SFGVLIWEIVTLGSTPY 212
           S G +I E+ T    P+
Sbjct: 193 SVGCVIIEMAT-AKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 88.6 bits (219), Expect = 4e-21
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 18/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P + R  G   +    ++IMEY+  G  
Sbjct: 31  VVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIMEYLGGGSA 89

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L+    +  Y              + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 90  LDLLKPGPLEETY--------------IATILREILKGLDYLHSERKIHRDIKAANVLLS 135

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E    K+ADFG A  L T +  +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 136 EQGDVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIKQSAYDFKADIWSLGITAIE 193

Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P   +    V+
Sbjct: 194 LAK-GEPPNSDLHPMRVL 210

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 4e-21
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 27/183 (14%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +K   G+ +   + QE++++K    HPN+V   G    ++  +++MEY   G L
Sbjct: 30  LVAIKVIKLEPGD-DFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           Q   + +R              L+   +   C +  +G+ +L   G IHRD+   N+L+ 
Sbjct: 88  QDIYQVTRG------------PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL-------YDNIFSVKSDIWS 196
           E+   K+ADFG +  L T+++ +RKS    P  WMAPE         YD     K DIW+
Sbjct: 136 EDGDVKLADFGVSAQL-TATIAKRKSFIGTPY-WMAPEVAAVERKGGYDG----KCDIWA 189

Query: 197 FGV 199
            G+
Sbjct: 190 LGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.8 bits (217), Expect = 7e-21
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 18/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 31  VVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIMEYLGGGSA 89

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              LR+     +               + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 90  LDLLRAGPFDEF--------------QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E    K+ADFG A  L T +  +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 136 EQGDVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKADIWSLGITAIE 193

Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P   M    V+
Sbjct: 194 LAK-GEPPNSDMHPMRVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.8 bits (217), Expect = 1e-20
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK +     +R  L L  E+ +M+    H NVV +       E  +V+ME++  G L 
Sbjct: 49  VAVKMMDLRKQQRREL-LFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLMEFLQGGALT 106

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +R              L    + + C  V + + +L S+G+IHRD+ + ++L+  
Sbjct: 107 DIVSQTR--------------LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K++DFGF   + +  V +RKS    P  WMAPE +    +  + DIWS G+++ E+
Sbjct: 153 DGRVKLSDFGFCAQI-SKDVPKRKSLVGTPY-WMAPEVISRTPYGTEVDIWSLGIMVIEM 210

Query: 205 VTLGSTPYPGMAAAEVMKK 223
           V  G  PY   +  + MK+
Sbjct: 211 VD-GEPPYFSDSPVQAMKR 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.1 bits (213), Expect = 3e-20
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 19/188 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +      ++ L ++ E+ VM+  + HPN+V  L      +  +V+MEY+  G L 
Sbjct: 47  VAIKQMNLQQQPKKEL-IINEILVMRE-NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHRD+ + N+L+G 
Sbjct: 105 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 150

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R +    P  WMAPE +    +  K DIWS G++  E+
Sbjct: 151 DGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Query: 205 VTLGSTPY 212
           V  G  PY
Sbjct: 209 VE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 6e-20
 Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 24/189 (12%)

Query: 24  IVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           IVA+K +K   E+ G  +    L+E+ ++K L+ HPN+++LL     K   +++ E++  
Sbjct: 26  IVAIKKIKLRFESEGIPKTA--LREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFEFM-- 80

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
                          Y  +  +   L    + S+ YQ+ +G+ F  S GI+HRDL   N+
Sbjct: 81  -----------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFG 198
           LI      K+ADFG AR   +           +  RW  APE L  D  +S   DIWS G
Sbjct: 130 LINTEGVLKLADFGLARSFGSPVRPYTH---YVVTRWYRAPELLLGDKGYSTPVDIWSVG 186

Query: 199 VLIWEIVTL 207
            +  E+++ 
Sbjct: 187 CIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.1 bits (211), Expect = 6e-20
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 35/200 (17%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           I+AVKT++    E  +  +L+EL ++   +  P +V   G         + MEY+  G L
Sbjct: 28  IMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICMEYMDGGSL 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARNVLI 142
              L+  + +            +  R L      V +G+ +L     IIHRD+   N+L+
Sbjct: 87  DKILKEVQGR------------IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV 134

Query: 143 GENHCCKVADFGFARDLMTS--------SVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
                 K+ DFG +  L+ S        S Y            MAPE +  N +SVKSDI
Sbjct: 135 NSRGQIKLCDFGVSGQLVNSLAKTFVGTSSY------------MAPERIQGNDYSVKSDI 182

Query: 195 WSFGVLIWEIVTLGSTPYPG 214
           WS G+ + E+ T G  PYP 
Sbjct: 183 WSLGLSLIELAT-GRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 9e-20
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 24/187 (12%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEY 77
           +VA+K +     E E  ++ +E  +++    HPN+    G   +K P       +++ME 
Sbjct: 33  LVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G                 +  K   L    +     +  RG+ +L    +IHRD+  
Sbjct: 91  CGGGS---------VTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG 141

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL-----YDNIFSVKS 192
           +N+L+ +N   K+ DFG +  L  S++  R +    P  WMAPE +      D  +  +S
Sbjct: 142 QNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARS 199

Query: 193 DIWSFGV 199
           D+WS G+
Sbjct: 200 DVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 84.3 bits (209), Expect = 9e-20
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 21/199 (10%)

Query: 23  CIVAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
            ++AVK ++    + + +  +  E+ V++ L  HPN+V+  G    +E  ++ MEY   G
Sbjct: 26  ELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFMEYCSGG 84

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+  L            HG+   L    +  +  Q+  G+ +L S GI+HRD+   N+ 
Sbjct: 85  TLEELLE-----------HGRI--LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131

Query: 142 IGENHCCKVADFGFARDLM--TSSVYERKSEGRLPIRWMAPESLYDNIFSVK---SDIWS 196
           +  N   K+ DFG A  L   T+++ E          +MAPE +           +DIWS
Sbjct: 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191

Query: 197 FGVLIWEIVTLGSTPYPGM 215
            G ++ E+ T G  P+  +
Sbjct: 192 LGCVVLEMAT-GKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 1e-19
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 45/210 (21%)

Query: 13  MSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-- 70
           +  E  +EG  I A++ +K          LLQ+L        HPN+VRL    T K    
Sbjct: 32  IRMENEKEGFPITAIREIK----------LLQKLR-------HPNIVRLKEIVTSKGKGS 74

Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            +++ EY+ +  L   L S                 T   +  +  Q+  G+Q+L S GI
Sbjct: 75  IYMVFEYMDH-DLTGLLDS------------PEVKFTESQIKCYMKQLLEGLQYLHSNGI 121

Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----WM-APESLY- 184
           +HRD+   N+LI  +   K+ADFG AR       Y +++      R    W   PE L  
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLAR------PYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 185 DNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              +  + D+WS G ++ E+   G   + G
Sbjct: 176 ATRYGPEVDMWSVGCILAELFL-GKPIFQG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 1e-19
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 42/207 (20%)

Query: 24  IVAVKTLKENAGERERLD------LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           IVA+K +K   GER+          L+E+ +++ L  HPN++ LL     K    ++ E+
Sbjct: 27  IVAIKKIK--LGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINLVFEF 83

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +    L+  ++             KS  LT  D+ S+     RG+++L S  I+HRDL  
Sbjct: 84  ME-TDLEKVIKD------------KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP 130

Query: 138 RNVLIGENHCCKVADFGFARDL------MTSSVYERKSEGRLPIRWM-APESLYD-NIFS 189
            N+LI  +   K+ADFG AR        MT  V           RW  APE L+    + 
Sbjct: 131 NNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---------TRWYRAPELLFGARHYG 181

Query: 190 VKSDIWSFGVLIWEIVTLGSTPY-PGM 215
           V  D+WS G +  E+  L   P+ PG 
Sbjct: 182 VGVDMWSVGCIFAEL--LLRVPFLPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.4 bits (208), Expect = 1e-19
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 18/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 31  VVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSA 89

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L              +   L    + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 90  LDLL--------------EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 135

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ADFG A  L  + +      G  P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 136 EHGEVKLADFGVAGQLTDTQIKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIE 193

Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P+  +   +V+
Sbjct: 194 LAK-GEPPHSELHPMKVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 1e-19
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 39/210 (18%)

Query: 26  AVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           A+K L K+   +R+ ++  L E  ++  ++ HP +V+L      +E  ++++EY P G+L
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80

Query: 84  QSFLRS------SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
            S L         RA+ Y                     ++   +++L S GII+RDL  
Sbjct: 81  FSHLSKEGRFSEERARFY-------------------AAEIVLALEYLHSLGIIYRDLKP 121

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSD 193
            N+L+  +   K+ DFG A++L +         G     ++APE L    Y    +V  D
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE--YLAPEVLLGKGYG--KAV--D 175

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            WS GVL++E++T G  P+      E+ +K
Sbjct: 176 WWSLGVLLYEMLT-GKPPFYAEDRKEIYEK 204

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 2e-19
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 27/196 (13%)

Query: 18  GREGPCIVAVK---TLKENAGERERLDLL-QELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           GRE    +AVK      ++   ++ ++ L  E+ ++K L  H  +V+  GC  + E   +
Sbjct: 27  GRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI 81

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGK-SNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
            MEY+P G ++  L++          +G  + ++T +    +  Q+  G+++L S  I+H
Sbjct: 82  FMEYMPGGSVKDQLKA----------YGALTETVTRK----YTRQILEGVEYLHSNMIVH 127

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMT--SSVYERKSEGRLPIRWMAPESLYDNIFSV 190
           RD+   N+L       K+ DFG ++ L T  SS    KS    P  WM+PE +    +  
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP-YWMSPEVISGEGYGR 186

Query: 191 KSDIWSFGVLIWEIVT 206
           K+D+WS G  + E++T
Sbjct: 187 KADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.3 bits (206), Expect = 2e-19
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 18/191 (9%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +A+K + E    R    L +E+ +   L  H N+V+ LG  +E   F + ME VP G L 
Sbjct: 36  IAIKEIPER-DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           + LRS      +  +     +     +  +  Q+  G+++L    I+HRD+   NVL+  
Sbjct: 94  ALLRSK-----WGPLKDNEQT-----IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143

Query: 145 -NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLI 201
            +   K++DFG ++ L   +       G L  ++MAPE +      +   +DIWS G  I
Sbjct: 144 YSGVVKISDFGTSKRLAGINPCTETFTGTL--QYMAPEVIDKGPRGYGAPADIWSLGCTI 201

Query: 202 WEIVTLGSTPY 212
            E+ T G  P+
Sbjct: 202 VEMAT-GKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.2 bits (205), Expect = 4e-19
 Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 19/188 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +      ++ L ++ E+ VMK L  +PN+V  L      +  FV+MEY+  G L 
Sbjct: 47  VAIKQINLQKQPKKEL-IINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL +  +IHRD+ + NVL+G 
Sbjct: 105 DVVTET--------------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM 150

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R +    P  WMAPE +    +  K DIWS G++  E+
Sbjct: 151 DGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Query: 205 VTLGSTPY 212
           V  G  PY
Sbjct: 209 VE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 5e-19
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R +    IVA+K  KE+  + + +   L+E+ V++ L  H N+V L      K   +++ 
Sbjct: 21  RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF 79

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-SFCYQVARGMQFLSSRGIIHRD 134
           EYV    L+        +     +          D   S+ +Q+ + + +  S  IIHRD
Sbjct: 80  EYVERTLLELL------EASPGGL--------PPDAVRSYIWQLLQAIAYCHSHNIIHRD 125

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLY-DNIFSVKS 192
           +   N+L+ E+   K+ DFGFAR L             +  RW  APE L  D  +    
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRARP--ASPLTDYVATRWYRAPELLVGDTNYGKPV 183

Query: 193 DIWSFGVLIWEIVTLGSTPYPG 214
           D+W+ G ++ E++  G   +PG
Sbjct: 184 DVWAIGCIMAELLD-GEPLFPG 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 8e-19
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 23/195 (11%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +K+     E    L+E+  ++ L+ HPN+V+L     E +  + + EY+     
Sbjct: 26  LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLY 85

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           Q  L   R  +            +   + S  YQ+ +G+  +   G  HRDL   N+L+ 
Sbjct: 86  Q--LMKDRKGKP----------FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133

Query: 144 ENHCCKVADFGFARDLMTSSVY-ERKSEGRLPIRWM-APES-LYDNIFSVKSDIWSFGVL 200
                K+ADFG AR++ +   Y +  S      RW  APE  L    +S   DIW+ G +
Sbjct: 134 GPEVVKIADFGLAREIRSRPPYTDYVS-----TRWYRAPEILLRSTSYSSPVDIWALGCI 188

Query: 201 IWEIVTLGSTP-YPG 214
           + E+ TL   P +PG
Sbjct: 189 MAELYTL--RPLFPG 201

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.0 bits (202), Expect = 1e-18
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 23/197 (11%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K + E   E E  D + E+ ++ T + HP +V+LLG        ++++E
Sbjct: 32  KNKETGALAAAKVI-ETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWIMIE 89

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           + P G + +             M      LT   +   C Q+   +Q+L S  IIHRDL 
Sbjct: 90  FCPGGAVDAI------------MLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137

Query: 137 ARNVLIGENHCCKVADFGF-ARDLMTSSVYERKSEGRLPIRWMAP-----ESLYDNIFSV 190
           A NVL+  +   K+ADFG  A+++ T  +  R S    P  WMAP     E++ D  +  
Sbjct: 138 AGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPY-WMAPEVVMCETMKDTPYDY 194

Query: 191 KSDIWSFGVLIWEIVTL 207
           K+DIWS G+ + E+  +
Sbjct: 195 KADIWSLGITLIEMAQI 211

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 81.7 bits (202), Expect = 1e-18
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 33/207 (15%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--FFVI 74
           R +    I A+KT+  +     +  +L+EL + K+    P +V+  G   ++      + 
Sbjct: 21  RLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIA 79

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           MEY   G L S          Y  +  +   +  + L      V +G+ +L SR IIHRD
Sbjct: 80  MEYCEGGSLDSI---------YKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRD 130

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTS--------SVYERKSEGRLPIRWMAPESLYDN 186
           +   N+L+      K+ DFG + +L+ S        S Y            MAPE +   
Sbjct: 131 IKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFY------------MAPERIQGK 178

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYP 213
            +S+ SD+WS G+ + E+      P+P
Sbjct: 179 PYSITSDVWSLGLTLLEVA-QNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.2 bits (200), Expect = 2e-18
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 14/191 (7%)

Query: 24  IVAVKTLK--ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
            VA+K ++  +    + R D ++E+ ++K L+ HPNV++      E     +++E    G
Sbjct: 29  PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 87

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  + Q+           +  + +  +  Q+   ++ + SR ++HRD+   NV 
Sbjct: 88  DLSRMIKHFKKQKRL---------IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           I      K+ D G  R   +S      S    P  +M+PE +++N ++ KSDIWS G L+
Sbjct: 139 ITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLL 196

Query: 202 WEIVTLGSTPY 212
           +E+  L S  Y
Sbjct: 197 YEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 81.2 bits (200), Expect = 2e-18
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 19/199 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 47  LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 104

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 105 TDIVTHTR--------------MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RKS    P  WMAPE +    +  + DIWS G+++ E
Sbjct: 151 HDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 208

Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 209 MVD-GEPPYFNEPPLKAMK 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.2 bits (200), Expect = 2e-18
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L 
Sbjct: 50  VAVKKMDLRKQQRREL-LFNEVVIMRDYH-HENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +R              +    + + C  V R + +L ++G+IHRD+ + ++L+  
Sbjct: 108 DIVTHTR--------------MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 153

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K++DFGF   + +  V +RKS    P  WMAPE +    +  + DIWS G+++ E+
Sbjct: 154 DGRIKLSDFGFCAQV-SKEVPKRKSLVGTPY-WMAPEVISRLPYGTEVDIWSLGIMVIEM 211

Query: 205 VTLGSTPYPGMAAAEVMKK 223
           +  G  PY      + M++
Sbjct: 212 ID-GEPPYFNEPPLQAMRR 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 3e-18
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 52/206 (25%)

Query: 24  IVAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             A+K L +    + +    +L E  +++++  HP +V L G   +    +++MEYVP G
Sbjct: 28  YYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVMEYVPGG 86

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
           +L S LR  ++ R+   +              F Y  QV   +++L S  I++RDL   N
Sbjct: 87  ELFSHLR--KSGRFPEPV------------ARF-YAAQVVLALEYLHSLDIVYRDLKPEN 131

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR---------WMAPESL----YDN 186
           +L+  +   K+ DFGFA+              R+  R         ++APE +    Y  
Sbjct: 132 LLLDSDGYIKITDFGFAK--------------RVKGRTYTLCGTPEYLAPEIILSKGYG- 176

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPY 212
             +V  D W+ G+LI+E++  G  P+
Sbjct: 177 -KAV--DWWALGILIYEMLA-GYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.2 bits (198), Expect = 5e-18
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 36/195 (18%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           IVA+K ++ E+  E      ++E++++K L  HPN+V L     ++   ++I E++    
Sbjct: 27  IVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSM-D 84

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+ +L S    +Y +    KS          + YQ+ +G+ F  SR ++HRDL  +N+LI
Sbjct: 85  LKKYLDSLPKGQYMDAELVKS----------YLYQILQGILFCHSRRVLHRDLKPQNLLI 134

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----------WMAPESLYDNI-FSVK 191
                 K+ADFG AR               +P+R          + APE L  +  +S  
Sbjct: 135 DNKGVIKLADFGLARAF------------GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182

Query: 192 SDIWSFGVLIWEIVT 206
            DIWS G +  E+ T
Sbjct: 183 VDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 79.7 bits (196), Expect = 6e-18
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 14/190 (7%)

Query: 25  VAVKTLK--ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VA+K ++  E    + R D ++E+ ++K L+ HPNV++ L    E     +++E    G 
Sbjct: 30  VALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIVLELADAGD 88

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   ++  + Q+           +  R +  +  Q+   ++ + SR ++HRD+   NV I
Sbjct: 89  LSQMIKYFKKQKRL---------IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
                 K+ D G  R   +S      S    P  +M+PE +++N ++ KSDIWS G L++
Sbjct: 140 TATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLLY 197

Query: 203 EIVTLGSTPY 212
           E+  L S  Y
Sbjct: 198 EMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.1 bits (198), Expect = 7e-18
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 30/199 (15%)

Query: 24  IVAVKTLKENA-GERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + AVK LK++   + + ++    E  V+     HP + +L  C   K+  F +MEYV  G
Sbjct: 22  LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81

Query: 82  KLQSFLRSSRA-----QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            L   ++ S        R+Y                    ++  G+QFL  RGII+RDL 
Sbjct: 82  DLMFHIQRSGRFDEPRARFY------------------AAEIVLGLQFLHERGIIYRDLK 123

Query: 137 ARNVLI-GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
             NVL+  E H  K+ADFG  ++ +   V      G  P  ++APE L    +    D W
Sbjct: 124 LDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGT-P-DYIAPEILSYQPYGPAVDWW 180

Query: 196 SFGVLIWEIVTLGSTPYPG 214
           + GVL++E++  G +P+ G
Sbjct: 181 ALGVLLYEML-AGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 79.4 bits (195), Expect = 9e-18
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 27/203 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEY 77
           + A+K +     E E +   QE+ ++K    H N+    G   +K P       +++ME+
Sbjct: 33  LAAIKVMDVTGDEEEEIK--QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G +   ++++           K N+L    +   C ++ RG+  L    +IHRD+  
Sbjct: 91  CGAGSVTDLIKNT-----------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 139

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKS 192
           +NVL+ EN   K+ DFG +  L   +V  R +    P  WMAPE +      D  +  KS
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKS 197

Query: 193 DIWSFGVLIWEIVTLGSTPYPGM 215
           D+WS G+   E+   G+ P   M
Sbjct: 198 DLWSLGITAIEMAE-GAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 79.7 bits (197), Expect = 9e-18
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 29/203 (14%)

Query: 26  AVKTLK-ENAGERERLD-LLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           A+K LK  +   R+ ++ L+ E  + +T +   HP +V L  C   ++    +MEY   G
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L               MH  ++  +      +   V  G+Q+L    I++RDL   N+L
Sbjct: 88  DLM--------------MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLL 133

Query: 142 IGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           +      K+ADFG  ++ M     +S +    E      ++APE L +  ++   D W  
Sbjct: 134 LDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE------FLAPEVLTETSYTRAVDWWGL 187

Query: 198 GVLIWEIVTLGSTPYPGMAAAEV 220
           GVLI+E++ +G +P+PG    EV
Sbjct: 188 GVLIYEML-VGESPFPGDDEEEV 209

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.8 bits (195), Expect = 1e-17
 Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 42/183 (22%)

Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 101
           +  E  +++  + HP +V+L     +K+  +++MEY   G+L + LR            G
Sbjct: 40  IFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR----------DRG 88

Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
             +  T+R   +    V    ++L +RGII+RDL   N+L+  N   K+ DFGFA+ L  
Sbjct: 89  LFDEYTARFYIA---CVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-- 143

Query: 162 SSVYERKSEGRLPIRW--------MAPESL----YDNIFSVKSDIWSFGVLIWEIVTLGS 209
               ++         W        +APE +    YD  FSV  D WS G+L++E++T G 
Sbjct: 144 -KSGQKT--------WTFCGTPEYVAPEIILNKGYD--FSV--DYWSLGILLYELLT-GR 189

Query: 210 TPY 212
            P+
Sbjct: 190 PPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.0 bits (195), Expect = 1e-17
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 23/202 (11%)

Query: 17  RGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           + +E   IVA+K   E+  ++  +   ++E+ ++K L  H N+V L+     K+  +++ 
Sbjct: 21  KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF 79

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E+V +  L             +++    N L    +  + +Q+ RG++F  S  IIHRD+
Sbjct: 80  EFVDHTVL-------------DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSS-VYERKSEGRLPIRWM-APESLY-DNIFSVKS 192
              N+L+ ++   K+ DFGFAR L     VY       +  RW  APE L  D  +    
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVY----TDYVATRWYRAPELLVGDTKYGRAV 182

Query: 193 DIWSFGVLIWEIVTLGSTPYPG 214
           DIW+ G L+ E++T G   +PG
Sbjct: 183 DIWAVGCLVTEMLT-GEPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.0 bits (194), Expect = 1e-17
 Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 19/188 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA++ +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 48  VAIRQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHRD+ + N+L+G 
Sbjct: 106 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   +       ++S       WMAPE +    +  K DIWS G++  E+
Sbjct: 152 DGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

Query: 205 VTLGSTPY 212
           +  G  PY
Sbjct: 210 IE-GEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.9 bits (195), Expect = 2e-17
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 22/188 (11%)

Query: 24  IVAVKTLKENAGERERLDL--LQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP 79
           IVA+K ++ +  ER+ + +  L+E+T++  L  HPN+V L      K  +  F++MEY  
Sbjct: 34  IVALKKVRMDN-ERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCE 91

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
              L S L         +NM       +   +     Q+ RG+Q+L    IIHRDL   N
Sbjct: 92  Q-DLASLL---------DNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN 138

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS-DIWSFG 198
           +L+ +  C K+ADFG AR        +  +   + + + APE L        + D+W+ G
Sbjct: 139 LLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG 196

Query: 199 VLIWEIVT 206
            ++ E++ 
Sbjct: 197 CILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.6 bits (193), Expect = 2e-17
 Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 19/188 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 47  VAIKQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + + FL S  +IHRD+ + N+L+G 
Sbjct: 105 DVVTET--------------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R +    P  WMAPE +    +  K DIWS G++  E+
Sbjct: 151 DGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Query: 205 VTLGSTPY 212
           V  G  PY
Sbjct: 209 VE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 3e-17
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 21/193 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E     A K ++  + E E  D + E+ ++     HPN+V L      +   ++++E
Sbjct: 25  QHKETGLFAAAKIIQIESEE-ELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWILIE 82

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +   G L S             M      LT   +   C Q+   + FL S  +IHRDL 
Sbjct: 83  FCDGGALDSI------------MLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAP-----ESLYDNIFSVK 191
           A N+L+  +   K+ADFG +     S++ +R +    P  WMAP     E+  DN +  K
Sbjct: 131 AGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTP-YWMAPEVVACETFKDNPYDYK 188

Query: 192 SDIWSFGVLIWEI 204
           +DIWS G+ + E+
Sbjct: 189 ADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.7 bits (191), Expect = 4e-17
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 27/203 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEY 77
           + A+K +  +  E E  ++  E+ ++K    H N+    G   +K P       +++ME+
Sbjct: 43  LAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G +   ++++           K N+L    +   C ++ RG+  L +  +IHRD+  
Sbjct: 101 CGAGSVTDLVKNT-----------KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKG 149

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKS 192
           +NVL+ EN   K+ DFG +  L   +V  R +    P  WMAPE +      D  +  +S
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDYRS 207

Query: 193 DIWSFGVLIWEIVTLGSTPYPGM 215
           DIWS G+   E+   G+ P   M
Sbjct: 208 DIWSLGITAIEMAE-GAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 78.7 bits (194), Expect = 6e-17
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 25  VAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VA+K ++E+  E   L    L+E  +   L  HP +V +   C++ +P +  M Y+    
Sbjct: 30  VALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIEGYT 88

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+S L+S   +   +    +  S+ +    S  +++   ++++ S+G++HRDL   N+L+
Sbjct: 89  LKSLLKSVWQKESLSKELAEKTSVGA--FLSIFHKICATIEYVHSKGVLHRDLKPDNILL 146

Query: 143 GENHCCKVADFGFAR-------DLMTSSVYERK---SEGRLP------IRWMAPESLYDN 186
           G      + D+G A        DL+   V ER    S   +P        +MAPE L   
Sbjct: 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV 206

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPY 212
             S  +DI++ GV++++++TL S PY
Sbjct: 207 PASESTDIYALGVILYQMLTL-SFPY 231

Length = 932

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 76.9 bits (190), Expect = 7e-17
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 40/196 (20%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----FFVIMEYVP 79
            A+K +K++    E+++ L+E+  ++ L PHPN++RL+    +++       F +M+   
Sbjct: 27  YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD--- 83

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
                           Y  + G+   L  + + S+ YQ+ + +  +   GI HRD+   N
Sbjct: 84  -------------MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPEN 130

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP------IRWM-APESLY-DNIFSVK 191
           +LI ++   K+ADFG  R      +Y      + P       RW  APE L  D  +  K
Sbjct: 131 ILIKDD-ILKLADFGSCR-----GIY-----SKPPYTEYISTRWYRAPECLLTDGYYGPK 179

Query: 192 SDIWSFGVLIWEIVTL 207
            DIW+ G + +EI++L
Sbjct: 180 MDIWAVGCVFFEILSL 195

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.9 bits (190), Expect = 7e-17
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 26/204 (12%)

Query: 17  RGREGPCIVAVKTL----KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
           + RE    VA+K +     E     +    L+E+  ++    HP VV+LL        F 
Sbjct: 20  KDRETGETVALKKVALRRLEGGIPNQ---ALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           ++MEY+P   L   LR                 L    + S+   + +G+ ++ + GI+H
Sbjct: 76  LVMEYMPSD-LSEVLRDEE------------RPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW-MAPESLY-DNIFSV 190
           RDL   N+LI  +   K+ADFG AR  + S    R    ++  RW  APE LY    +  
Sbjct: 123 RDLKPANLLISADGVLKIADFGLAR--LFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPG 214
             D+W+ G +  E++  GS  +PG
Sbjct: 181 GVDLWAVGCIFAELLN-GSPLFPG 203

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.4 bits (188), Expect = 1e-16
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R    IVA+K +  +A E      ++E+++MK L  H N+VRL      +    ++ E
Sbjct: 20  RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVFE 78

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           Y+            +  + Y + HG   +L    + SF YQ+ +G+ F     ++HRDL 
Sbjct: 79  YM-----------DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLK 127

Query: 137 ARNVLIGENHCCKVADFGFAR------DLMTSSVYERKSEGRLPIRWMAPESLY-DNIFS 189
            +N+LI +    K+ADFG AR      +  ++ V        + + + AP+ L     +S
Sbjct: 128 PQNLLINKRGELKLADFGLARAFGIPVNTFSNEV--------VTLWYRAPDVLLGSRTYS 179

Query: 190 VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
              DIWS G ++ E++T G   +PG    + + K
Sbjct: 180 TSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLK 212

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 1e-16
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 20/187 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           + A+K +K   GE     ++Q+  +M     H N+V   G    ++  ++ ME+   G L
Sbjct: 36  LAAIKVIKLEPGED--FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           Q             +++  +  L+   +     +  +G+ +L S+G +HRD+   N+L+ 
Sbjct: 94  Q-------------DIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL---YDNIFSVKSDIWSFGVL 200
           +N   K+ADFG +  + T+++ +RKS    P  WMAPE         ++   DIW+ G+ 
Sbjct: 141 DNGHVKLADFGVSAQI-TATIAKRKSFIGTPY-WMAPEVAAVERKGGYNQLCDIWAVGIT 198

Query: 201 IWEIVTL 207
             E+  L
Sbjct: 199 AIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 17  RGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           + RE   IVA+K ++ ++  E      L+E+ ++K L  H N+VRL       +   ++ 
Sbjct: 20  KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY               ++Y+++ +G  +    +   SF +Q+ +G+ F  S  ++HRDL
Sbjct: 79  EYC----------DQDLKKYFDSCNGDIDPEIVK---SFMFQLLKGLAFCHSHNVLHRDL 125

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLYD-NIFSVKSD 193
             +N+LI +N   K+ADFG AR      +  R     +   W   P+ L+   ++S   D
Sbjct: 126 KPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 182

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +WS G +  E+   G   +PG    + +K+
Sbjct: 183 MWSAGCIFAELANAGRPLFPGNDVDDQLKR 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 40/185 (21%), Positives = 82/185 (44%), Gaps = 28/185 (15%)

Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
            E   + +   H ++V+L G C  ++   ++ EYV +G L  FL   +            
Sbjct: 49  FETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREK------------ 95

Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-------GENHCCKVADFGFA 156
           N+++         Q+A  + +L  + ++H ++  +N+L+       G     K++D G  
Sbjct: 96  NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             ++       + E    I W+APE + +     ++ +D WSFG  + EI + G  P   
Sbjct: 156 ITVL------SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209

Query: 215 MAAAE 219
           ++++E
Sbjct: 210 LSSSE 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 74.2 bits (183), Expect = 6e-16
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K + K +   + ++D +L E  ++      P VV+L      K+  +++MEY+P G
Sbjct: 20  IYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGG 78

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC-YQVARGMQFLSSRGIIHRDLAARNV 140
            L S L +        ++          D+      ++   +++L S GIIHRDL   N+
Sbjct: 79  DLASLLEN------VGSL--------DEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI 124

Query: 141 LIGENHCCKVADFGFAR----DLMTSSVYERKSEGRL---PIRWMAPESLYDNIFSVKSD 193
           LI  N   K+ DFG ++        +   + K + R+   P  ++APE +     S   D
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP-DYIAPEVILGQGHSKTVD 183

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            WS G +++E +  G  P+ G    E+ + 
Sbjct: 184 WWSLGCILYEFLV-GIPPFHGETPEEIFQN 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.9 bits (181), Expect = 9e-16
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 20/187 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           + AVK +K   G+     L+Q+   M     H N+V   G    +E  ++ MEY   G L
Sbjct: 36  LAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           Q             +++  +  L+   +   C +  +G+ +L S+G +HRD+   N+L+ 
Sbjct: 94  Q-------------DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           +N   K+ADFG A  + T+++ +RKS    P  WMAPE      +  ++   DIW+ G+ 
Sbjct: 141 DNGDVKLADFGVAAKI-TATIAKRKSFIGTPY-WMAPEVAAVEKNGGYNQLCDIWAVGIT 198

Query: 201 IWEIVTL 207
             E+  L
Sbjct: 199 AIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 19/196 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           I+AVK ++    E+E+  LL +L V+      P +V+  G    +   ++ ME       
Sbjct: 31  IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME------- 83

Query: 84  QSFLRSSRAQRYYNNMHGKSNS-LTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVL 141
              L      ++Y  ++    S +    L        + + +L     IIHRD+   N+L
Sbjct: 84  ---LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI---FSVKSDIWSFG 198
           +  N   K+ DFG +  L+  S+ + +  G  P  +MAPE +  +    + V+SD+WS G
Sbjct: 141 LDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRP--YMAPERIDPSARDGYDVRSDVWSLG 197

Query: 199 VLIWEIVTLGSTPYPG 214
           + ++E+ T G  PYP 
Sbjct: 198 ITLYEVAT-GKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.5 bits (180), Expect = 1e-15
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 15/161 (9%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HPN+V       E    F++MEY   G L       R  R    +  +   L      S+
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDGGDLMK-----RINRQRGVLFSEDQIL------SW 106

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGFARDLMTSSVYERKSEGRL 173
             Q++ G++ +  R I+HRD+ ++N+ + +N    K+ DFG AR L  S        G  
Sbjct: 107 FVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT- 165

Query: 174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
           P  +++PE   +  ++ K+DIWS G +++E+ TL   P+ G
Sbjct: 166 PY-YLSPEICQNRPYNNKTDIWSLGCVLYELCTL-KHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 23/171 (13%)

Query: 55  HPNVVRLLGCCTEKEPFFV--IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 112
           HP ++RL    TE +  F+  +MEYVP G+L S+LR+S          G+ ++ T     
Sbjct: 60  HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNS----------GRFSNSTGLFYA 107

Query: 113 SFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
           S   ++   +++L S+ I++RDL   N+L+ +    K+ DFGFA+ L      +R     
Sbjct: 108 S---EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-----DRTWTLC 159

Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
               ++APE +     +   D W+ G+LI+E++  G  P+       + +K
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEK 209

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.1 bits (177), Expect = 4e-15
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 15/177 (8%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L+E+++++ L     +VRLL     +E       Y+ +  L S L+       + + +G+
Sbjct: 48  LREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK------FMDSNGR 101

Query: 103 SNS--LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFGFARDL 159
                L ++ + SF YQ+ +G+      G++HRDL  +N+L+  +    K+AD G  R  
Sbjct: 102 GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Query: 160 MTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              S+  +     +   W  APE L  +  +S   DIWS G +  E+       +PG
Sbjct: 162 ---SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPG 214

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 5e-15
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 22/200 (11%)

Query: 26  AVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           A+K LK++    + +  ++  E  +M      P V +L      K+  +++MEY+  G  
Sbjct: 25  AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            S ++                 L       +  +V  G++ L  RGIIHRD+   N+LI 
Sbjct: 85  ASLIK-------------TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    K+ DFG +R     +  E K     P  ++APE++        SD WS G +I+E
Sbjct: 132 QTGHLKLTDFGLSR-----NGLENKKFVGTP-DYLAPETILGVGDDKMSDWWSLGCVIFE 185

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
            +  G  P+       V   
Sbjct: 186 FLF-GYPPFHAETPDAVFDN 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.6 bits (175), Expect = 6e-15
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 22/190 (11%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           ++A   + +   E E  D + E+ ++ + D HPN+V+LL     +   ++++E+   G +
Sbjct: 31  VLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAV 89

Query: 84  QS-FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            +  L   R              LT   +   C Q    + +L    IIHRDL A N+L 
Sbjct: 90  DAVMLELERP-------------LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF 136

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSF 197
             +   K+ADFG +    T ++  R S    P  WMAPE +      D  +  K+D+WS 
Sbjct: 137 TLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYDYKADVWSL 194

Query: 198 GVLIWEIVTL 207
           G+ + E+  +
Sbjct: 195 GITLIEMAQI 204

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 6e-15
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 31/193 (16%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCC----TEKE-PFFVIM 75
            VA+K ++   + E   L  L+E+ ++K L+   HPN+VRLL  C    T++E    ++ 
Sbjct: 26  FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVF 85

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E+V    L ++L                  L    +     Q+ RG+ FL S  I+HRDL
Sbjct: 86  EHVDQ-DLATYLS-----------KCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDL 133

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI---RWM-APESLYDNIFSVK 191
             +N+L+  +   K+ADFG AR      +Y  +      +    W  APE L  + ++  
Sbjct: 134 KPQNILVTSDGQVKIADFGLAR------IYSFEMA-LTSVVVTLWYRAPEVLLQSSYATP 186

Query: 192 SDIWSFGVLIWEI 204
            D+WS G +  E+
Sbjct: 187 VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.4 bits (175), Expect = 8e-15
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 47  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------PLSGI 97

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 98  PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 150

Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.9 bits (174), Expect = 8e-15
 Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 14/175 (8%)

Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY 95
           E+ER D L E+ ++  L  HPN++       +     + MEY   G L           Y
Sbjct: 40  EKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEMEYANGGTL-----------Y 87

Query: 96  YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF 155
              +  K        +  + +Q+   + ++   GI+HRD+   N+ + +    K+ DFG 
Sbjct: 88  DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI 147

Query: 156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
           ++ L +         G     +M+PE      ++ KSDIW+ G +++E++TL  T
Sbjct: 148 SKILGSEYSMAETVVGTP--YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 9e-15
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 22/171 (12%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL--- 111
           HP +  L      KE  F +MEY+  G L   ++S    ++              DL   
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKF--------------DLPRA 98

Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEG 171
           T +  ++  G+QFL S+GI++RDL   N+L+  +   K+ADFG  ++ M          G
Sbjct: 99  TFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158

Query: 172 RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
             P  ++APE L    ++   D WSFGVL++E++ +G +P+ G    E+ +
Sbjct: 159 T-P-DYIAPEILLGQKYNTSVDWWSFGVLLYEML-IGQSPFHGHDEEELFQ 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.4 bits (172), Expect = 1e-14
 Identities = 56/185 (30%), Positives = 90/185 (48%), Gaps = 17/185 (9%)

Query: 27  VKTLKE-NAGE---RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           +K LKE   GE    E +   QE  ++  LD HP +V+      E++ F +I EY     
Sbjct: 30  LKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCIITEYCEGRD 88

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   L   +             +L+   +  +  Q+  G+ ++  R I+HRDL A+N+ +
Sbjct: 89  LDCKLEELKHT---------GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL 139

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            +N+  K+ DFG +R LM S        G  P  +M+PE+L    +  KSDIWS G +++
Sbjct: 140 -KNNLLKIGDFGVSRLLMGSCDLATTFTGT-P-YYMSPEALKHQGYDSKSDIWSLGCILY 196

Query: 203 EIVTL 207
           E+  L
Sbjct: 197 EMCCL 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.6 bits (173), Expect = 2e-14
 Identities = 45/118 (38%), Positives = 61/118 (51%), Gaps = 18/118 (15%)

Query: 106 LTSRDLTS-----FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR--- 157
           LTSR L       F YQ+ RG++++ S G++HRDL   N+LI EN   K+ DFG AR   
Sbjct: 100 LTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159

Query: 158 DLMTSSVYERKSEGRLPIRWMAPE-SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             MT  V  R         + APE  L    + V+ DIWS G +  E++  G   +PG
Sbjct: 160 PQMTGYVSTR--------YYRAPEIMLTWQKYDVEVDIWSAGCIFAEML-EGKPLFPG 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.8 bits (171), Expect = 2e-14
 Identities = 42/173 (24%), Positives = 85/173 (49%), Gaps = 23/173 (13%)

Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           D++ E+T++K    HPN+VR      E +  +++M+ +    L           ++N++ 
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE---------HFNSLK 104

Query: 101 GKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
            K    T   + +   Q+   +++L   + I+HRDL   N+++GE+    + DFG A+  
Sbjct: 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164

Query: 158 ---DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL 207
                +TS V          I +  PE + +  +  K+D+W+FG +++++ TL
Sbjct: 165 QPESKLTSVVGT--------ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 69.6 bits (170), Expect = 2e-14
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 15/177 (8%)

Query: 32  ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIMEYVPYGKLQSFLRSS 90
            NA  RER    QE  ++  L  HPN+V        E    +++M +   G L   L+  
Sbjct: 36  RNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94

Query: 91  RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV 150
           + +            L    +  +  Q+A  +Q+L  + I+HRDL  +NV +   +  KV
Sbjct: 95  KGKL-----------LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKV 143

Query: 151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL 207
            D G AR L   +  +  S       +M+PE   +  ++ KSD+W+ G  ++E+ TL
Sbjct: 144 GDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 3e-14
 Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 42/217 (19%)

Query: 24  IVAVKTLKENAGERERLD-------------LLQELTVMKTLDPHPNVVRLLGCCTEKEP 70
           IVA+K +K      +                 L+EL +M  +  H N++ L+    E + 
Sbjct: 36  IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLVDVYVEGDF 94

Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             ++M+ +     +   R  R              LT   +     Q+  G+  L     
Sbjct: 95  INLVMDIMASDLKKVVDRKIR--------------LTESQVKCILLQILNGLNVLHKWYF 140

Query: 131 IHRDLAARNVLIGENHCCKVADFGFAR------------DLMTSSVYERKSEGRLPIRWM 178
           +HRDL+  N+ I     CK+ADFG AR               T    E  +   + + + 
Sbjct: 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR 200

Query: 179 APESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
           APE L     +    D+WS G +  E++T G   +PG
Sbjct: 201 APELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFPG 236

Length = 335

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.1 bits (169), Expect = 3e-14
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 25/197 (12%)

Query: 17  RGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R +    +V +K +  E   + ERL    E  V+K L  HPN++       E +   ++M
Sbjct: 20  RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRD 134
           EY P G L  +++               NSL   D +  F  Q+   +  + ++ I+HRD
Sbjct: 79  EYAPGGTLAEYIQKRC------------NSLLDEDTILHFFVQILLALHHVHTKLILHRD 126

Query: 135 LAARNVLIGENH-CCKVADFGFARDLMTSSVYERKSEGRLPI---RWMAPESLYDNIFSV 190
           L  +N+L+ ++    K+ DFG ++ L +      KS+    +    +++PE      ++ 
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSS------KSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 191 KSDIWSFGVLIWEIVTL 207
           KSDIW+ G +++E+ +L
Sbjct: 181 KSDIWALGCVLYELASL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.9 bits (171), Expect = 4e-14
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 42/210 (20%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP---------HPNVVRLLGCCTE 67
           R +E   + AVK LK++        +LQ+  V  T+           HP + +L  C   
Sbjct: 15  RLKESGRLYAVKVLKKDV-------ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT 67

Query: 68  KEPFFVIMEYVPYGKLQSFLRSSRA-----QRYYNNMHGKSNSLTSRDLTSFCYQVARGM 122
            +  F +ME+V  G L   ++ SR       R+Y           + ++TS        +
Sbjct: 68  PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-----------AAEITS-------AL 109

Query: 123 QFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES 182
            FL  +GII+RDL   NVL+     CK+ADFG  ++ + +        G  P  ++APE 
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT-P-DYIAPEI 167

Query: 183 LYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           L + ++    D W+ GVL++E++  G  P+
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLC-GHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 4e-14
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 24  IVAVKTLKENAGER--ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           IVA+K +K++   +  E   +L E  ++ T      +V+LL    + E  ++ MEYVP G
Sbjct: 28  IVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
             ++ L         NN       L+      +  ++   +  L   G IHRDL   N L
Sbjct: 87  DFRTLL---------NN----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFL 133

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           I  +   K+ DFG ++ ++T +     S    P  +MAPE L    +    D WS G ++
Sbjct: 134 IDASGHIKLTDFGLSKGIVTYA----NSVVGSP-DYMAPEVLRGKGYDFTVDYWSLGCML 188

Query: 202 WEIVTLGSTPYPGMAAAEVM 221
           +E +  G  P+ G    E  
Sbjct: 189 YEFLC-GFPPFSGSTPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 69.3 bits (169), Expect = 4e-14
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 19/200 (9%)

Query: 17  RGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R +E   IVA+K  K++    E +   L+EL +++TL    N+V L      +   +++ 
Sbjct: 21  RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF 79

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EYV    L+              +    N +    + S+ YQ+ + + +     I+HRD+
Sbjct: 80  EYVEKNMLEL-------------LEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLYDNIFSVKSDI 194
              N+LI  N   K+ DFGFAR+L   S         +  RW  +PE L    +    D+
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGS--NANYTEYVATRWYRSPELLLGAPYGKAVDM 184

Query: 195 WSFGVLIWEIVTLGSTPYPG 214
           WS G ++ E+ + G   +PG
Sbjct: 185 WSVGCILGEL-SDGQPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.0 bits (169), Expect = 5e-14
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 21/195 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           I+AVK ++     +E+  LL +L + M+++D  P  V   G    +   ++ ME      
Sbjct: 28  IMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVTFYGALFREGDVWICME------ 80

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVL 141
               +  +   ++Y  ++ K  ++    L      + + +++L S+  +IHRD+   NVL
Sbjct: 81  ----VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSF 197
           I  N   K+ DFG +  L   SV +    G  P  +MAPE +   +    + VKSD+WS 
Sbjct: 137 INRNGQVKLCDFGISGYL-VDSVAKTIDAGCKP--YMAPERINPELNQKGYDVKSDVWSL 193

Query: 198 GVLIWEIVTLGSTPY 212
           G+ + E+ T G  PY
Sbjct: 194 GITMIELAT-GRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 5e-14
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 20/198 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K ++    E      ++E++++K L  H N+V L      +    ++ EY+     
Sbjct: 32  LVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLVFEYL----- 85

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                 S  ++Y +N     N ++  ++  F +Q+ RG+ +   R I+HRDL  +N+LI 
Sbjct: 86  -----DSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN 137

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
           E    K+ADFG AR     SV  +     +   W  P    L    +S   D+W  G ++
Sbjct: 138 EKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 194

Query: 202 WEIVTLGSTPYPGMAAAE 219
           +E+ T G   +PG    E
Sbjct: 195 YEMAT-GRPMFPGSTVKE 211

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.1 bits (169), Expect = 7e-14
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 26/165 (15%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKL----QSFLRSSRAQ-RYYNNMHGKSNSLTSR 109
           HP +  L      KE  F +MEY+  G L    QS  R   A+ R+Y             
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAA----------- 103

Query: 110 DLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKS 169
                  ++  G+QFL  +GII+RDL   NVL+ ++   K+ADFG  ++ M         
Sbjct: 104 -------EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156

Query: 170 EGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            G  P  ++APE L    ++   D WSFGVL++E++ +G +P+ G
Sbjct: 157 CGT-P-DYIAPEILKGQKYNESVDWWSFGVLLYEML-IGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.3 bits (169), Expect = 7e-14
 Identities = 42/118 (35%), Positives = 63/118 (53%), Gaps = 15/118 (12%)

Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172

Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG
Sbjct: 173 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 7e-14
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 31/198 (15%)

Query: 19  REGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCT-----EKEP 70
           + G   VA+K ++ +   E   L  ++E+ V++ L+   HPNVVRL   CT      +  
Sbjct: 24  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83

Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             ++ E+V    L ++L                  + +  +    +Q+ RG+ FL S  +
Sbjct: 84  LTLVFEHVDQ-DLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLHSHRV 131

Query: 131 IHRDLAARNVLIGENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDN 186
           +HRDL  +N+L+  +   K+ADFG AR     +  +SV        + + + APE L  +
Sbjct: 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-------VTLWYRAPEVLLQS 184

Query: 187 IFSVKSDIWSFGVLIWEI 204
            ++   D+WS G +  E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 9e-14
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 20/194 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K ++    E      ++E +++K L  H N+V L      KE   ++ EYV     
Sbjct: 32  LVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLVFEYVHTDLC 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           Q           Y + H     L   ++  F +Q+ RG+ ++  R I+HRDL  +N+LI 
Sbjct: 91  Q-----------YMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS 137

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
           +    K+ADFG AR     SV        +   W  P    L    +S   D+W  G + 
Sbjct: 138 DTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIF 194

Query: 202 WEIVTLGSTPYPGM 215
            E++  G   +PGM
Sbjct: 195 VEMIQ-GVAAFPGM 207

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.9 bits (166), Expect = 1e-13
 Identities = 44/172 (25%), Positives = 87/172 (50%), Gaps = 16/172 (9%)

Query: 37  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
           +ER +  +E+ V+  +  HPN+V+      E    +++M+Y   G L            Y
Sbjct: 41  KEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVMDYCEGGDL------------Y 87

Query: 97  NNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF 155
             ++ +   L   D +  +  Q+   ++ +  R I+HRD+ ++N+ + ++   K+ DFG 
Sbjct: 88  KKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGI 147

Query: 156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL 207
           AR L ++    R   G  P  +++PE   +  ++ KSDIW+ G +++E+ TL
Sbjct: 148 ARVLNSTVELARTCIGT-PY-YLSPEICENRPYNNKSDIWALGCVLYEMCTL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)

Query: 17  RGREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
            G +   + A+K LK+   + R+R+    E  ++  ++ HP +V+L      +   ++I+
Sbjct: 19  TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLIL 77

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           +++  G L  F R S           K    T  D+  +  ++A  +  L S GII+RDL
Sbjct: 78  DFLRGGDL--FTRLS-----------KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDL 124

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDI 194
              N+L+ E    K+ DFG +++   S  +E+K+      + +MAPE +     +  +D 
Sbjct: 125 KPENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 181

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           WSFGVL++E++T GS P+ G    E M
Sbjct: 182 WSFGVLMFEMLT-GSLPFQGKDRKETM 207

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 36/175 (20%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L  HPN+VRLL     +   +++ E++    L+ ++ SS            
Sbjct: 46  IREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSS-----------P 92

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ YQ+ +G+ +  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 93  LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--- 149

Query: 163 SVYERKSEGRLPIR---------WM-APESLY-DNIFSVKSDIWSFGVLIWEIVT 206
                     +P+R         W  APE L     +S   DIWS G +  E+V 
Sbjct: 150 ---------GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L  C   K+  F +MEYV  G L   ++ SR          K +   SR    +
Sbjct: 55  HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR----------KFDEPRSR---FY 101

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             +V   + FL   G+I+RDL   N+L+     CK+ADFG  ++ + + V      G  P
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT-P 160

Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L +  +    D W+ GVL++E++  G  P+
Sbjct: 161 -DYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.7 bits (165), Expect = 2e-13
 Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 20/198 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K ++    E      ++E++++K L  H N+V L      ++   ++ EY+    L
Sbjct: 33  LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLD-KDL 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           + +L                NS+   ++  F +Q+ RG+ +   R ++HRDL  +N+LI 
Sbjct: 91  KQYLDDC------------GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN 138

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
           E    K+ADFG AR     S+  +     +   W  P    L    +S + D+W  G + 
Sbjct: 139 ERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 195

Query: 202 WEIVTLGSTPYPGMAAAE 219
           +E+ T G   +PG    E
Sbjct: 196 YEMST-GRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 2e-13
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 35/186 (18%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEP-----FFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           L+E+ +++ L  H N++ LL       P      +++ E +    L   ++S +      
Sbjct: 47  LREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ------ 98

Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCC--KVADFGF 155
                   LT   +  F YQ+ RG+++L S  +IHRDL   N+L+  N  C  K+ DFG 
Sbjct: 99  -------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN--CDLKICDFGL 149

Query: 156 ARDLMTSSVYERKSEGRLPIRWM-APESL-----YDNIFSVKSDIWSFGVLIWEIVTLGS 209
           AR +      +      +  RW  APE L     Y    ++  DIWS G +  E++T   
Sbjct: 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK--AI--DIWSVGCIFAELLT-RK 204

Query: 210 TPYPGM 215
             +PG 
Sbjct: 205 PLFPGR 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.4 bits (165), Expect = 3e-13
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFF----VIMEYVPYGKLQSFLRSSRAQRYYNN 98
           L+EL +++    H N++ +          F    V+M+ +    L   + S +       
Sbjct: 52  LRELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ------- 102

Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD 158
                  LT   +  F YQ+ RG++++ S  +IHRDL   N+L+ E+   ++ DFG AR 
Sbjct: 103 ------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156

Query: 159 LMTSSV-YERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIV 205
           L +S   ++      +  RW  APE L     ++   D+WS G +  E++
Sbjct: 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 23/180 (12%)

Query: 45  ELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           E+ ++K L  H  +V+  GC  ++  +   + MEY+P G ++  L++  A          
Sbjct: 54  EIQLLKNLQ-HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---------- 102

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT- 161
              LT      +  Q+  GM +L S  I+HRD+   N+L       K+ DFG ++ L T 
Sbjct: 103 ---LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159

Query: 162 --SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGS--TPYPGMAA 217
             S    R   G  P  WM+PE +    +  K+D+WS G  + E++T       Y  MAA
Sbjct: 160 CMSGTGIRSVTGT-PY-WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 18/173 (10%)

Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 101
           +L E  +++ L+ HP +V L     ++E  +++++ +  G L          RY+ +   
Sbjct: 47  VLNERRILQELN-HPFLVNLWYSFQDEENMYLVVDLLLGGDL----------RYHLSQKV 95

Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K +    +    +  ++   +++L S+GIIHRD+   N+L+ E     + DF  A  +  
Sbjct: 96  KFSEEQVK---FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152

Query: 162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            ++    S G     +MAPE L    +SV  D WS GV  +E +  G  PY G
Sbjct: 153 DTLTTSTS-GTPG--YMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.9 bits (163), Expect = 4e-13
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 16/170 (9%)

Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 104
           E  V+   D  P + +L  C    +  + +MEYV  G L           Y+    GK  
Sbjct: 50  EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLM----------YHIQQVGK-- 97

Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSV 164
                    +  +++ G+ FL  RGII+RDL   NV++      K+ADFG  ++ M   V
Sbjct: 98  -FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156

Query: 165 YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             R   G  P  ++APE +    +    D W++GVL++E++  G  P+ G
Sbjct: 157 TTRTFCGT-P-DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.8 bits (160), Expect = 7e-13
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 20/197 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E      ++E +++K L  H N+V L      KE    + EY+     
Sbjct: 32  LVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYM----- 85

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                +  AQ  Y   H     L   ++  F +Q+ RG+ ++  + I+HRDL  +N+LI 
Sbjct: 86  ----HTDLAQ--YMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS 137

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
                K+ADFG AR     S+  +     +   W  P    L    +S   DIW  G + 
Sbjct: 138 YLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIF 194

Query: 202 WEIVTLGSTPYPGMAAA 218
            E++  G   +PG++  
Sbjct: 195 IEMLQ-GQPAFPGVSDV 210

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 8e-13
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 37/181 (20%)

Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           EL ++K +D H NV+ LL   T           +++   +    L + ++  +       
Sbjct: 64  ELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQK------- 114

Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR- 157
                  L+   +    YQ+ RG++++ S GIIHRDL   N+ + E+   K+ DFG AR 
Sbjct: 115 -------LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167

Query: 158 --DLMTSSVYERKSEGRLPIRW-MAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPYP 213
             D MT         G +  RW  APE + + +   ++ DIWS G ++ E++T G T +P
Sbjct: 168 TDDEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GKTLFP 217

Query: 214 G 214
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.4 bits (159), Expect = 9e-13
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 37/204 (18%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC- 65
           +V+  P SPE  +E            NA E E + LL+ L        H  +V+  GC  
Sbjct: 34  QVQFDPESPETSKE-----------VNALECE-IQLLKNLL-------HERIVQYYGCLR 74

Query: 66  -TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
              +    + ME++P G ++  L+S  A             LT      +  Q+  G+ +
Sbjct: 75  DPMERTLSIFMEHMPGGSIKDQLKSYGA-------------LTENVTRKYTRQILEGVSY 121

Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPES 182
           L S  I+HRD+   N+L       K+ DFG ++ L T   S    KS    P  WM+PE 
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY-WMSPEV 180

Query: 183 LYDNIFSVKSDIWSFGVLIWEIVT 206
           +    +  K+DIWS G  + E++T
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.6 bits (160), Expect = 9e-13
 Identities = 53/185 (28%), Positives = 84/185 (45%), Gaps = 33/185 (17%)

Query: 24  IVAVKTLKENAGERER--LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K +  +  +      D+++E+  ++ L  HPN +   GC   +   +++MEY   G
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYC-LG 99

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                L           +H K   L   ++ + C+   +G+ +L S   IHRD+ A N+L
Sbjct: 100 SASDIL----------EVHKKP--LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL 147

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL-------YDNIFSVKSDI 194
           + E    K+ADFG A     S V    S    P  WMAPE +       YD     K D+
Sbjct: 148 LTEPGTVKLADFGSA-----SLVSPANSFVGTPY-WMAPEVILAMDEGQYDG----KVDV 197

Query: 195 WSFGV 199
           WS G+
Sbjct: 198 WSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.4 bits (159), Expect = 1e-12
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 27/193 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF-----FVIMEYV 78
           + AVK L   +   E ++   E  ++++L  HPNVV+  G   + +       ++++E  
Sbjct: 49  LAAVKILDPISDVDEEIE--AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106

Query: 79  PYGKLQSFLRS--SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
             G +   ++      QR    M           ++   Y    G+Q L +  IIHRD+ 
Sbjct: 107 NGGSVTELVKGLLICGQRLDEAM-----------ISYILYGALLGLQHLHNNRIIHRDVK 155

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL-----YDNIFSVK 191
             N+L+      K+ DFG +  L TS+   R +    P  WMAPE +     YD  +  +
Sbjct: 156 GNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDAR 213

Query: 192 SDIWSFGVLIWEI 204
            D+WS G+   E+
Sbjct: 214 CDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 30/200 (15%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           ++AVK ++    + E   +L +L V+      P +V+  G        F+ ME       
Sbjct: 42  VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME------- 94

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLI 142
              L S+   +    + G    +    L      + + + +L  + G+IHRD+   N+L+
Sbjct: 95  ---LMSTCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL 148

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL--------YDNIFSVKSDI 194
             +   K+ DFG +  L+ S    R S G     +MAPE +        YD    +++D+
Sbjct: 149 DASGNVKLCDFGISGRLVDSKAKTR-SAGCAA--YMAPERIDPPDPNPKYD----IRADV 201

Query: 195 WSFGVLIWEIVTLGSTPYPG 214
           WS G+ + E+ T G  PY  
Sbjct: 202 WSLGISLVELAT-GQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 40/120 (33%), Positives = 61/120 (50%), Gaps = 18/120 (15%)

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR----- 157
           S +L+      F YQ+ RG++++ S  ++HRDL   N+L+  N   K+ DFG AR     
Sbjct: 102 SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161

Query: 158 -DLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTP-YPG 214
            D MT  V  R         + APE L + + ++   D+WS G +  E+  LG  P +PG
Sbjct: 162 GDFMTEYVVTR--------WYRAPELLLNCSEYTTAIDVWSVGCIFAEL--LGRKPLFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.6 bits (157), Expect = 1e-12
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 27/160 (16%)

Query: 55  HPNVVRLLGCCTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 108
           HPN+V        KE F      +++MEY   G L   ++  R + +  +          
Sbjct: 57  HPNIV------AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT--------- 101

Query: 109 RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERK 168
             +  +  Q+  G+Q +  + ++HRD+ ++N+ + +N   K+ DFG AR L +   Y   
Sbjct: 102 --ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159

Query: 169 SEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTL 207
             G     +  P  +++N+ ++ KSDIWS G +++E+ TL
Sbjct: 160 YVG---TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 1e-12
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 20/193 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K ++    E      ++E++++K L  H N+V L       +   ++ EY+     
Sbjct: 33  LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEYL----- 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                    ++Y   M    N ++  ++  F YQ+ RG+ +   R ++HRDL  +N+LI 
Sbjct: 87  -----DKDLKQY---MDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN 138

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
           E    K+ADFG AR     SV  +     +   W  P    L  + +S + D+W  G + 
Sbjct: 139 ERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 195

Query: 202 WEIVTLGSTPYPG 214
           +E+ + G   +PG
Sbjct: 196 FEMAS-GRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 31/67 (46%), Positives = 41/67 (61%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK  A   E+  L+ EL +M  L PH N+V LLG CT+  P ++I EY  YG L 
Sbjct: 70  VAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLV 129

Query: 85  SFLRSSR 91
           ++L  +R
Sbjct: 130 NYLHKNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 16/160 (10%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           +P +  L      KE  F +ME++  G L   ++       Y               T +
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR-------------ATFY 101

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++  G+QFL S+GII+RDL   NV++  +   K+ADFG  ++ +      R S     
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGT 159

Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             ++APE L    ++   D WSFGVL++E++ +G +P+ G
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEML-IGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 64.7 bits (157), Expect = 2e-12
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 25/186 (13%)

Query: 24  IVAVKTLKENAGERER--LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VAVK +  +  +      D+++E+  ++ L  HPN +   GC  ++   +++MEY   G
Sbjct: 48  VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYC-LG 105

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                L           +H K   L   ++ +  +   +G+ +L S  +IHRD+ A N+L
Sbjct: 106 SASDLLE----------VHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL 153

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVKSDIWSFG 198
           + E    K+ADFG A     S      S    P  WMAPE   ++ +  +  K D+WS G
Sbjct: 154 LTEPGQVKLADFGSA-----SKSSPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLG 207

Query: 199 VLIWEI 204
           +   E+
Sbjct: 208 ITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 21/201 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R RE   IVA+K   E+  +   +   L+E+ ++K L  HPN+V L+     K    ++ 
Sbjct: 21  RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLVF 79

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY  +  L    +         N  G    +    +    +Q  + + F      IHRD+
Sbjct: 80  EYCDHTVLNELEK---------NPRG----VPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLY-DNIFSVKSD 193
              N+LI +    K+ DFGFAR L   +         +  RW  APE L  D  +    D
Sbjct: 127 KPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183

Query: 194 IWSFGVLIWEIVTLGSTPYPG 214
           +W+ G +  E++T G   +PG
Sbjct: 184 VWAIGCVFAELLT-GQPLWPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 2/90 (2%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK  A   E+  L+ EL +M  L PH N+V LLG CT+  P ++I EY  YG L 
Sbjct: 70  VAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLV 129

Query: 85  SFLRSSRAQ--RYYNNMHGKSNSLTSRDLT 112
            +L  ++    +YY + +    SL S   T
Sbjct: 130 DYLHRNKHTFLQYYLDKNRDDGSLISGGST 159

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.8 bits (158), Expect = 3e-12
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 38/199 (19%)

Query: 42  LLQELTVMKTLDPHPNVVRL--------------LGCCTEKEPFFVIMEYVPYGKLQSFL 87
            L+E+ +++ LD H N+V++              +G  TE    +++ EY+     ++ L
Sbjct: 49  ALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL 102

Query: 88  RSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENH 146
            +   Q            L+      F YQ+ RG++++ S  ++HRDL   NV I  E+ 
Sbjct: 103 ANVLEQ----------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152

Query: 147 CCKVADFGFARDLMTSSVYERK---SEGRLPIRWMAPE-SLYDNIFSVKSDIWSFGVLIW 202
             K+ DFG AR  +    Y  K   SEG +   + +P   L  N ++   D+W+ G +  
Sbjct: 153 VLKIGDFGLAR--IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 210

Query: 203 EIVTLGSTPYPGMAAAEVM 221
           E++T G   + G    E M
Sbjct: 211 EMLT-GKPLFAGAHELEQM 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 3e-12
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           H ++V L G C       ++ E+V +G L  F            MH KS+ LT+      
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF------------MHRKSDVLTTPWKFKV 110

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIG----ENHC---CKVADFGFARDLMTSSVYER 167
             Q+A  + +L  + ++H ++  +N+L+     +  C    K++D G    +++     +
Sbjct: 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQ 166

Query: 168 KSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           +   R+P  W+APE + D+   S+ +D WSFG  +WEI   G  P      AE
Sbjct: 167 ECVERIP--WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 32/196 (16%)

Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           A+K +  N  +  R  + +E+ +++ ++ HPNVV+            V++E++  G L+ 
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161

Query: 86  FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN 145
              +                     L     Q+  G+ +L  R I+HRD+   N+LI   
Sbjct: 162 THIADEQF-----------------LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA 204

Query: 146 HCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL--------YDNIFSVKSDIWSF 197
              K+ADFG +R L  +      S G   I +M+PE +        YD       DIWS 
Sbjct: 205 KNVKIADFGVSRILAQTMDPCNSSVG--TIAYMSPERINTDLNHGAYD---GYAGDIWSL 259

Query: 198 GVLIWEIVTLGSTPYP 213
           GV I E   LG  P+ 
Sbjct: 260 GVSILEFY-LGRFPFG 274

Length = 353

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.1 bits (157), Expect = 3e-12
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 27/114 (23%)

Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
           YQ+ + ++++ S  +IHRDL   N+L+  +   K+ADFG AR     S+ E +     P+
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR-----SLSELEENPENPV 168

Query: 176 -------RWM-APESLYDNIFSVKS-------DIWSFGVLIWEIVTLGSTPYPG 214
                  RW  APE L      + S       D+WS G ++ E++ LG   +PG
Sbjct: 169 LTDYVATRWYRAPEIL------LGSTRYTKGVDMWSVGCILGEML-LGKPLFPG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 23/176 (13%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS-FLRSSRAQRYYNNMHG 101
           L+EL +++    H N+  L             M+ V  G     +L     +   + +  
Sbjct: 49  LRELKLLRHFRGHKNITCL-----------YDMDIVFPGNFNELYLYEELMEADLHQIIR 97

Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
               LT     SF YQ+  G++++ S  ++HRDL   N+L+  +   K+ DFG AR    
Sbjct: 98  SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF-- 155

Query: 162 SSVYERKSEGRL----PIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP 211
            S    ++ G +      RW  APE +       K+ D+WS G ++ E+  LG  P
Sbjct: 156 -SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL--LGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 63.8 bits (155), Expect = 4e-12
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 24  IVAVK-TLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           +V V+ T  EN  E E L  LQ   V+     HPN++      T     +VI  ++ YG 
Sbjct: 27  LVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
             S L++     Y+    G S +L    + +  +   RG+ +L   G IHR++ A ++LI
Sbjct: 86  ANSLLKT-----YFP--EGMSEAL----IGNILFGALRGLNYLHQNGYIHRNIKASHILI 134

Query: 143 GENHCCKVADFGFARDLM-----TSSVYE--RKSEGRLPIRWMAPESLYDNI--FSVKSD 193
             +    ++       L+        VY+  + S   LP  W++PE L  ++  ++VKSD
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP--WLSPELLRQDLYGYNVKSD 192

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           I+S G+   E+ T G  P+  M   +++
Sbjct: 193 IYSVGITACELAT-GRVPFQDMLRTQML 219

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.3 bits (154), Expect = 6e-12
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 32/195 (16%)

Query: 25  VAVKTLKENAGERERL------DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
            A+K LK+    RE L       + QE +++  L  HP +V ++    ++   + ++E+V
Sbjct: 46  YAIKCLKK----REILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFLLEFV 100

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF-CYQVARGMQFLSSRGIIHRDLAA 137
             G+L + LR   A R+ N            D+  F   ++    ++L S+ II+RDL  
Sbjct: 101 VGGELFTHLRK--AGRFPN------------DVAKFYHAELVLAFEYLHSKDIIYRDLKP 146

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
            N+L+      KV DFGFA+      V +R         ++APE +         D W+ 
Sbjct: 147 ENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTM 201

Query: 198 GVLIWEIVTLGSTPY 212
           GVL++E +  G  P+
Sbjct: 202 GVLLYEFIA-GYPPF 215

Length = 329

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.1 bits (153), Expect = 6e-12
 Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 23/196 (11%)

Query: 17  RGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLD--PHPNVVRLLGCC----TEKE 69
           R       VA+K+++    E    L  ++E+ ++K L+   HPN+VRL+  C    T++E
Sbjct: 20  RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79

Query: 70  -PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 128
               ++ E+V    L+++L                  L +  +     Q  RG+ FL + 
Sbjct: 80  TKVTLVFEHVDQ-DLRTYLDKVPPP-----------GLPAETIKDLMRQFLRGLDFLHAN 127

Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF 188
            I+HRDL   N+L+      K+ADFG AR     S     +   + + + APE L  + +
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPEVLLQSTY 184

Query: 189 SVKSDIWSFGVLIWEI 204
           +   D+WS G +  E+
Sbjct: 185 ATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.9 bits (153), Expect = 8e-12
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 28/196 (14%)

Query: 24  IVAVKTLK-ENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY 80
           I A+K +K E   + E +D +Q E  V +T   HP +V L  C  TE   FFVI E+V  
Sbjct: 22  IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI-EFVSG 80

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L   ++    QR     H +           +  +++  + FL  RGII+RDL   NV
Sbjct: 81  GDLMFHMQR---QRKLPEEHARF----------YSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 141 LIGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           L+      K+ D+G  ++ +    T+S +           ++APE L    +    D W+
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN------YIAPEILRGEDYGFSVDWWA 181

Query: 197 FGVLIWEIVTLGSTPY 212
            GVL++E++  G +P+
Sbjct: 182 LGVLMFEMMA-GRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 30/212 (14%)

Query: 25  VAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLL--GCCTEKEPFFVIMEYVPY 80
           VA+K L+ +A   E +R    +E  +   L  HPN+V LL  G        F + EYVP 
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEA-PPGLLFAVFEYVPG 63

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             L+  L +  A             L + +      QV   +    ++GI+HRDL  +N+
Sbjct: 64  RTLREVLAADGA-------------LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI 110

Query: 141 LI---GENHCCKVADFGF------ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           ++   G     KV DFG        RD   +++  R +E      + APE L     +  
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL-TRTTEVLGTPTYCAPEQLRGEPVTPN 169

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD++++G++  E +T G     G + AE++ +
Sbjct: 170 SDLYAWGLIFLECLT-GQRVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.8 bits (153), Expect = 1e-11
 Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 41/184 (22%)

Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +EL +MK ++ H N++ LL   T            P   L+ F      Q  Y  M    
Sbjct: 64  RELVLMKLVN-HKNIIGLLNVFT------------PQKSLEEF------QDVYLVMELMD 104

Query: 104 NSL---TSRDL-----TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF 155
            +L      DL     +   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG 
Sbjct: 105 ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164

Query: 156 ARD-----LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
           AR      +MT  V  R         + APE +    +    DIWS G ++ E++  G+ 
Sbjct: 165 ARTAGTSFMMTPYVVTR--------YYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGTV 215

Query: 211 PYPG 214
            +PG
Sbjct: 216 LFPG 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.2 bits (152), Expect = 1e-11
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 44/199 (22%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFVIMEYV 78
           IVA+K LK E   E   +  L+E+ ++  L  HPN+V +    +G   +K   +++MEYV
Sbjct: 32  IVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDK--IYMVMEYV 88

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
            +  L+S +           M          ++     Q+  G+  L    I+HRDL   
Sbjct: 89  EH-DLKSLM---------ETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135

Query: 139 NVLIGENHCCKVADFGFAR------DLMTSSV----YERKSEGRLPIRWMAPESLYD-NI 187
           N+L+      K+ DFG AR         T  V    Y             APE L     
Sbjct: 136 NLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR------------APELLLGAKE 183

Query: 188 FSVKSDIWSFGVLIWEIVT 206
           +S   D+WS G +  E++T
Sbjct: 184 YSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.8 bits (152), Expect = 1e-11
 Identities = 40/118 (33%), Positives = 62/118 (52%), Gaps = 15/118 (12%)

Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   L+   +    YQ+ RG++++ S GIIHRDL   NV + E+   ++ DFG AR   D
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170

Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            MT         G +  RW  APE + + + ++   DIWS G ++ E++  G   +PG
Sbjct: 171 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPG 218

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 1e-11
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 26/195 (13%)

Query: 24  IVAVKTLK-ENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +K E   + E +D +Q E  V +    HP +V L  C   +   F ++EYV  G
Sbjct: 22  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  R              L       +  +++  + +L  RGII+RDL   NVL
Sbjct: 82  DLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 128

Query: 142 IGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           +      K+ D+G  ++ +    T+S +           ++APE L    +    D W+ 
Sbjct: 129 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIAPEILRGEDYGFSVDWWAL 182

Query: 198 GVLIWEIVTLGSTPY 212
           GVL++E++  G +P+
Sbjct: 183 GVLMFEMMA-GRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.1 bits (151), Expect = 2e-11
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGII 131
           + ME++  G L   L+  +A R   N+ GK               V RG+ +L     I+
Sbjct: 76  ICMEHMDGGSLDQVLK--KAGRIPENILGK-----------ISIAVLRGLTYLREKHKIM 122

Query: 132 HRDLAARNVLIGENHCCKVADFGFARDL---MTSSVYERKSEGRLPIRWMAPESLYDNIF 188
           HRD+   N+L+      K+ DFG +  L   M +S    +S       +M+PE L    +
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-------YMSPERLQGTHY 175

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
           +V+SDIWS G+ + E+   G  P P   A E+
Sbjct: 176 TVQSDIWSLGLSLVEMAI-GRYPIPPPDAKEL 206

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 34/197 (17%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           ++A K +   A    R  +L+EL +M      P +V   G    +    + ME++  G L
Sbjct: 32  VMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMCMEFMDCGSL 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
               +          + GK        LT + Y V R         I+HRD+   N+L+ 
Sbjct: 91  DRIYKKGGPIPV--EILGKIAVAVVEGLT-YLYNVHR---------IMHRDIKPSNILVN 138

Query: 144 ENHCCKVADFGFARDLMTS--------SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
                K+ DFG + +L+ S        S Y            M+PE +    ++VKSD+W
Sbjct: 139 SRGQIKLCDFGVSGELINSIADTFVGTSTY------------MSPERIQGGKYTVKSDVW 186

Query: 196 SFGVLIWEIVTLGSTPY 212
           S G+ I E+  LG  P+
Sbjct: 187 SLGISIIELA-LGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 21/170 (12%)

Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKE-----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           E  ++K L  HPNVV+  G   +K+       ++++E    G +   ++           
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---------F 114

Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL 159
             +   +    +    ++   G+Q L     IHRD+   N+L+      K+ DFG +  L
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Query: 160 MTSSVYERKSEGRLPIRWMAPESL-----YDNIFSVKSDIWSFGVLIWEI 204
            TS+   R +    P  WMAPE +      D+ +  + D+WS G+   E+
Sbjct: 175 -TSTRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 62.0 bits (150), Expect = 2e-11
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 32/206 (15%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL-----LGCC--TEKEPFF-VIME 76
           VA+K + ++   + R     EL +MK L+ H N++ L       C    EK  F  V+ME
Sbjct: 94  VAIKKVLQDPQYKNR-----ELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVME 147

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++P              +Y  +    +++L    +  + YQ+ R + ++ S+ I HRDL 
Sbjct: 148 FIP----------QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197

Query: 137 ARNVLIGEN-HCCKVADFGFARDLMTSSVYERKSEGRLPIR-WMAPESLYDNI-FSVKSD 193
            +N+LI  N H  K+ DFG A++L+      ++S   +  R + APE +     ++   D
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAG----QRSVSYICSRFYRAPELMLGATNYTTHID 253

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAE 219
           +WS G +I E++ LG   + G ++ +
Sbjct: 254 LWSLGCIIAEMI-LGYPIFSGQSSVD 278

Length = 440

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 20/198 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K ++    E      ++E +++K L  H N+V L      K+   ++ EY+     
Sbjct: 32  LVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLVFEYL----- 85

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            + L+       Y +  G    L+  ++  F +Q+ RG+ +   R ++HRDL  +N+LI 
Sbjct: 86  DTDLKQ------YMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS 137

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
           E    K+ADFG AR     SV  +     +   W  P    L    +S   D+W  G + 
Sbjct: 138 ERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIF 194

Query: 202 WEIVTLGSTPYPGMAAAE 219
           +E+ T G   +PG    E
Sbjct: 195 YEMAT-GRPLFPGSTDVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 16/159 (10%)

Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P + +L  C    +  + +MEYV  G L           Y     G+           + 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLM----------YQIQQVGR---FKEPHAVFYA 107

Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            ++A G+ FL S+GII+RDL   NV++      K+ADFG  ++ M   V  +   G  P 
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGT-P- 165

Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            ++APE +    +    D W+FGVL++E++  G  P+ G
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.5 bits (149), Expect = 3e-11
 Identities = 42/158 (26%), Positives = 80/158 (50%), Gaps = 19/158 (12%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP  V L G   ++   ++++E+V  G+  +FLR  R +R+ N++              +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVG-----------CFY 136

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             Q+    ++L S  I++RDL   N+L+ ++   K+ DFGFA+ + T +     +     
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTP---- 192

Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L +      +D W+ G+ I+EI+ +G  P+
Sbjct: 193 -EYIAPEILLNVGHGKAADWWTLGIFIYEIL-VGCPPF 228

Length = 340

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 33/108 (30%), Positives = 60/108 (55%), Gaps = 1/108 (0%)

Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
           YQ+   +  + SR ++HRDL + N+ +      K+ DFGF++    S   +  S      
Sbjct: 176 YQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235

Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            ++APE      +S K+D+WS GV+++E++TL   P+ G +  E+M++
Sbjct: 236 YYLAPELWERKRYSKKADMWSLGVILYELLTL-HRPFKGPSQREIMQQ 282

Length = 478

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.3 bits (149), Expect = 4e-11
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 16/172 (9%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           + E  V+      P + +L  C    +  + +MEYV  G L           Y+    GK
Sbjct: 48  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----------YHIQQVGK 97

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                +     +  ++A G+ FL S+GII+RDL   NV++      K+ADFG  ++ +  
Sbjct: 98  FKEPHA---VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154

Query: 163 SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
               R   G  P  ++APE +    +    D W+FGVL++E++  G  P+ G
Sbjct: 155 GKTTRTFCGT-P-DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 21/179 (11%)

Query: 45  ELTVMKTLDPHPNVVRLLGCCT--EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           E+ ++K L  H  +V+  GC    E++   + +EY+P G ++  L++  A          
Sbjct: 54  EIQLLKNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---------- 102

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT- 161
              LT      +  Q+ +G+ +L S  I+HRD+   N+L       K+ DFG ++ + T 
Sbjct: 103 ---LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159

Query: 162 -SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGS--TPYPGMAA 217
             S    KS    P  WM+PE +    +  K+D+WS    + E++T       Y  MAA
Sbjct: 160 CMSGTGIKSVTGTPY-WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 25/186 (13%)

Query: 24  IVAVKTLKENAGERER--LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K +  +  +      D+++E+  ++ L  HPN ++  GC   +   +++MEY   G
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYC-LG 99

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                L           +H K   L   ++ +  +   +G+ +L S  +IHRD+ A N+L
Sbjct: 100 SASDLLE----------VHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVKSDIWSFG 198
           + E    K+ DFG A  +  ++ +           WMAPE   ++ +  +  K D+WS G
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANXFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLG 201

Query: 199 VLIWEI 204
           +   E+
Sbjct: 202 ITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 4e-11
 Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 32/179 (17%)

Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +ELT++K +  H NV+ LL   T      E + F+++M Y     +Q+ L+         
Sbjct: 63  RELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHP--- 113

Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                   L+   +    YQ+  G++++ S GIIHRDL   N+ + E+   K+ DFG AR
Sbjct: 114 --------LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Query: 158 DLMTSSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPYPG 214
                   + +  G +  RW  APE + + +   ++ DIWS G ++ E++T G T + G
Sbjct: 166 HA------DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT-GKTLFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.9 bits (147), Expect = 4e-11
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 25/186 (13%)

Query: 24  IVAVKTLKENAGERER--LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K +  +  +      D+++E+  ++ +  HPN +   GC   +   +++MEY   G
Sbjct: 52  VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWLVMEYC-LG 109

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                L           +H K   L   ++ +  +   +G+ +L S  +IHRD+ A N+L
Sbjct: 110 SASDLLE----------VHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL 157

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVKSDIWSFG 198
           + E    K+ADFG A     S      S    P  WMAPE   ++ +  +  K D+WS G
Sbjct: 158 LTEPGQVKLADFGSA-----SIASPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLG 211

Query: 199 VLIWEI 204
           +   E+
Sbjct: 212 ITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.8 bits (147), Expect = 5e-11
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 26/195 (13%)

Query: 24  IVAVKTLK-ENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +K E   + E +D +Q E  V +    +P +V L  C       F+++EYV  G
Sbjct: 22  IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  R              L       +  ++   + FL  RGII+RDL   NVL
Sbjct: 82  DLMFHMQRQR-------------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128

Query: 142 IGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           +  +   K+ D+G  ++ +    T+S +           ++APE L    +    D W+ 
Sbjct: 129 LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN------YIAPEILRGEEYGFSVDWWAL 182

Query: 198 GVLIWEIVTLGSTPY 212
           GVL++E++  G +P+
Sbjct: 183 GVLMFEMMA-GRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 5e-11
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            +A+K ++    E +   ++ EL ++      P +V   G    +   ++ MEY+  G L
Sbjct: 28  TMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCMEYMDAGSL 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLI 142
                   A        G    +  R      Y V +G++FL     IIHRD+   NVL+
Sbjct: 87  DKLYAGGVA------TEGIPEDVLRR----ITYAVVKGLKFLKEEHNIIHRDVKPTNVLV 136

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPI---RWMAPESLYDN------IFSVKSD 193
             N   K+ DFG + +L+        S  +  I    +MAPE +          ++V+SD
Sbjct: 137 NGNGQVKLCDFGVSGNLV-------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189

Query: 194 IWSFGVLIWEIVTLGSTPYP 213
           +WS G+ I E+  LG  PYP
Sbjct: 190 VWSLGLSILEM-ALGRYPYP 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.5 bits (147), Expect = 6e-11
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)

Query: 7   EVRKHPMSPERGREGPCIVAVK-TLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC 65
           EV K      R ++   IVA+K  L EN  E   +  L+E+ +++ L  H NVV L+  C
Sbjct: 27  EVFK-----ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEIC 80

Query: 66  -TEKEP-------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 117
            T+  P       F+++ E+  +  L   L         +N + K    T  ++      
Sbjct: 81  RTKATPYNRYKGSFYLVFEFCEH-DLAGLL---------SNKNVK---FTLSEIKKVMKM 127

Query: 118 VARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYER-KSEGRLPIR 176
           +  G+ ++    I+HRD+ A N+LI ++   K+ADFG AR    S   +  +   R+   
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 177 WM-APESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
           W   PE L  +  +    D+W  G ++ E+     T  P M  
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEM----WTRSPIMQG 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 7e-11
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 35/199 (17%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT----------EKEPFF 72
           +VA+K ++ +N  E   +  ++E+ +++ L+ H N+V L    T          +K  F+
Sbjct: 34  LVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFY 92

Query: 73  VIMEYVP---YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
           ++ EY+     G L+S L        ++  H          + SF  Q+  G+ +   + 
Sbjct: 93  LVFEYMDHDLMGLLESGLVH------FSEDH----------IKSFMKQLLEGLNYCHKKN 136

Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY--DNI 187
            +HRD+   N+L+      K+ADFG AR  + +S   R    ++   W  P  L   +  
Sbjct: 137 FLHRDIKCSNILLNNKGQIKLADFGLAR--LYNSEESRPYTNKVITLWYRPPELLLGEER 194

Query: 188 FSVKSDIWSFGVLIWEIVT 206
           +    D+WS G ++ E+ T
Sbjct: 195 YGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.1 bits (146), Expect = 7e-11
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 29/203 (14%)

Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK +  ++  +E L LLQ E+   + L  HPN++  +         +V+   + YG  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSC 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
           +  L++     +   +   + +   +D       V   + ++ S+G IHR + A ++L+ 
Sbjct: 87  EDLLKTH----FPEGLPELAIAFILKD-------VLNALDYIHSKGFIHRSVKASHILLS 135

Query: 143 --------GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKS 192
                   G  +   +   G  + ++    + + S   LP  W++PE L  N+  ++ KS
Sbjct: 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHD--FPKSSVKNLP--WLSPEVLQQNLQGYNEKS 191

Query: 193 DIWSFGVLIWEIVTLGSTPYPGM 215
           DI+S G+   E+   G  P+  M
Sbjct: 192 DIYSVGITACELAN-GHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 7e-11
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 35/181 (19%)

Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEYV--PYGKLQSFLRSSRAQRY 95
           +EL ++K +  H NV+ LL   T          F+++M ++    GKL            
Sbjct: 63  RELRLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM----------- 110

Query: 96  YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF 155
                 K   L+   +    YQ+ +G++++ + GIIHRDL   N+ + E+   K+ DFG 
Sbjct: 111 ------KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164

Query: 156 ARDLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYP 213
           AR        + +  G +  RW  APE + + + ++   DIWS G ++ E++T G   + 
Sbjct: 165 ARQT------DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT-GKPLFK 217

Query: 214 G 214
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.4 bits (146), Expect = 8e-11
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 32/199 (16%)

Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 108

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209

Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G ++ E++  G   +PG
Sbjct: 210 SVGCIMGEMIK-GGVLFPG 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 9e-11
 Identities = 35/115 (30%), Positives = 59/115 (51%), Gaps = 3/115 (2%)

Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+  N   K+ DFG AR    
Sbjct: 99  KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158

Query: 162 SSVYERKSEGRLPIRWM-APE-SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              +       +  RW  APE  L    ++   DIWS G ++ E+++     +PG
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 22/112 (19%)

Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR------- 157
            L+S  +  F YQ+ RG+++L S GI+HRD+   N+L+  N   K+ DFG AR       
Sbjct: 99  PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158

Query: 158 DLMTSSV---YERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIV 205
             MT  V   Y R           APE L  +  ++   DIWS G +  E++
Sbjct: 159 KHMTQEVVTQYYR-----------APEILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 37/176 (21%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K +  H N+VRL      ++  +++ EY+    L+  + SS    +  N    
Sbjct: 49  IREISLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSS--PDFAKNP--- 101

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARDLMT 161
                 R + ++ YQ+ RG+ +  S  ++HRDL  +N+LI    +  K+ADFG AR    
Sbjct: 102 ------RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-- 153

Query: 162 SSVYERKSEGRLPIR----------WMAPESLY-DNIFSVKSDIWSFGVLIWEIVT 206
                      +P+R          + APE L     +S   DIWS G +  E+V 
Sbjct: 154 ----------GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 47/197 (23%), Positives = 87/197 (44%), Gaps = 41/197 (20%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
            +  ++M  L  H ++V   G C   +   ++ EYV +G L ++L+ ++           
Sbjct: 47  FEAASMMSQLS-HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK----------- 94

Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI--------GENHCCKVADFG 154
            N +          Q+A  + FL  +G+ H ++ A+NVL+        G     K++D G
Sbjct: 95  -NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153

Query: 155 -----FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLG 208
                  ++++     ER       I W+ PE + +    S+ +D WSFG  +WEI + G
Sbjct: 154 ISITVLPKEILL----ER-------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG 202

Query: 209 STPYPGMAAAEVMKKSK 225
             P   ++A +  KK +
Sbjct: 203 DKP---LSALDSQKKLQ 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 21/190 (11%)

Query: 26  AVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           A+K LK+     + E    L E  V+K    HP +  L      K+    +MEYV  G+L
Sbjct: 24  AMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNGGEL 82

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC-YQVARGMQFLSSRGIIHRDLAARNVLI 142
             F   SR + +            S D T F   ++   + +L S  I++RDL   N+++
Sbjct: 83  --FFHLSRERVF------------SEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            ++   K+ DFG  ++ +T +   +   G     ++APE L DN +    D W  GV+++
Sbjct: 129 DKDGHIKITDFGLCKEGITDAATMKTFCG--TPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186

Query: 203 EIVTLGSTPY 212
           E++  G  P+
Sbjct: 187 EMMC-GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 42/204 (20%)

Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VAVK L    +N    +R    +EL ++K ++ H N++ LL   T      E +  +++M
Sbjct: 49  VAVKKLSRPFQNQTHAKRA--YRELVLLKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 106 ELMDANLCQVIHMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 149

Query: 136 AARNVLIGENHCCKVADFGFARD-----LMTSSVYERKSEGRLPIRWMAPESLYDNIFSV 190
              N+++  +   K+ DFG AR      +MT  V  R         + APE +    +  
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR--------YYRAPEVILGMGYKE 201

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPG 214
             DIWS G ++ E+V  GS  + G
Sbjct: 202 NVDIWSVGCIMGELVK-GSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.0 bits (140), Expect = 4e-10
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 9/98 (9%)

Query: 118 VARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS--SVYERKSEGRLPI 175
           V +G+ +L S  I+HRD+   N+L+      K+ DFG +  L+ S    Y   +      
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA----- 158

Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP 213
            +MAPE +    + + SD+WS G+   E+  LG  PYP
Sbjct: 159 -YMAPERISGEQYGIHSDVWSLGISFMEL-ALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 26/186 (13%)

Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+ ++  R    
Sbjct: 47  RNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEE 103

Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
           + GK +             V RG+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 104 ILGKVS-----------IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152

Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 153 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEL-AIGRYPIPP 204

Query: 215 MAAAEV 220
             A E+
Sbjct: 205 PDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.7 bits (140), Expect = 5e-10
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 32/182 (17%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEP--------FFVIMEYVPYGKLQSFLRSSRAQR 94
           L+E+ ++K L  HPNVV L+    E+           +++  Y+ +  L   L +   + 
Sbjct: 55  LREIKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVK- 111

Query: 95  YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG 154
                      LT   +  +  Q+  G+ +L    I+HRD+ A N+LI      K+ADFG
Sbjct: 112 -----------LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160

Query: 155 FARDLMTSS--------VYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFGVLIWEI 204
            AR                 RK    +  RW   PE L  +  ++   DIW  G +  E+
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220

Query: 205 VT 206
            T
Sbjct: 221 FT 222

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.0 bits (140), Expect = 6e-10
 Identities = 38/112 (33%), Positives = 65/112 (58%), Gaps = 9/112 (8%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR---- 172
           QV   +  + S+ +IHRD+ + N+L+  N   K+ DFGF++ +  ++V +    GR    
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSD--DVGRTFCG 207

Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS 224
            P  ++APE      +S K+D++S GVL++E++TL   P+ G    EVM K+
Sbjct: 208 TPY-YVAPEIWRRKPYSKKADMFSLGVLLYELLTL-KRPFDGENMEEVMHKT 257

Length = 496

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 57.3 bits (138), Expect = 7e-10
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 4/96 (4%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR 176
           Q+  G+  L S  I++RD+   NVL+ +   C+++D G A +L       +++       
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN---G 159

Query: 177 WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           +MAPE L +  +S   D ++ G  I+E+V  G TP+
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 56.7 bits (137), Expect = 8e-10
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 6/97 (6%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR 176
           Q+  G++ L  R I++RDL   NVL+ ++   +++D G A +L        K +GR    
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KIKGRAGTP 158

Query: 177 -WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            +MAPE L   ++    D ++ G  ++E++  G +P+
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.1 bits (138), Expect = 9e-10
 Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 11/114 (9%)

Query: 110 DLTS-----FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSV 164
           DLT      F YQ+ R ++++ +  + HRDL  +N+L   +   K+ DFG AR     + 
Sbjct: 99  DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158

Query: 165 YERKSEGRLPIRWM-APESLYDNIFSVKS---DIWSFGVLIWEIVTLGSTPYPG 214
                   +  RW  APE L  + FS  +   DIWS G +  E++T G   +PG
Sbjct: 159 TAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 210

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 1e-09
 Identities = 35/130 (26%), Positives = 56/130 (43%), Gaps = 29/130 (22%)

Query: 37  RERLDLLQELTVMKTLDPHPNVVRLLGCC---TEKEPFFVIMEYVPYGKLQ--SFLRSSR 91
           RE + LL+EL        H NVV L+       +K  + +  +Y  +   Q   F R ++
Sbjct: 51  RE-IALLRELK-------HENVVSLVEVFLEHADKSVYLLF-DYAEHDLWQIIKFHRQAK 101

Query: 92  AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-GENHCC-- 148
                 +M           + S  +Q+  G+ +L S  ++HRDL   N+L+ GE      
Sbjct: 102 RVSIPPSM-----------VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV 150

Query: 149 -KVADFGFAR 157
            K+ D G AR
Sbjct: 151 VKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)

Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 45  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVM 101

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 102 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 145

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 202

Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 203 SVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)

Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 47  RNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 95

Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 96  ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152

Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 153 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AIGRYPIPP 204

Query: 215 MAAAEV 220
             A E+
Sbjct: 205 PDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 17/170 (10%)

Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 104
           E  V++ +   P +V L           +I++Y+  G+L  F   S+ +R+         
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERF--------- 102

Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSV 164
               +++  +  ++   ++ L   GII+RD+   N+L+  N    + DFG +++     V
Sbjct: 103 --KEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160

Query: 165 YERKSEGRLPIRWMAPESLY--DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            ER       I +MAP+ +   D       D WS GVL++E++T G++P+
Sbjct: 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 29/200 (14%)

Query: 24  IVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           I A+K +K++    +E +   +E   + ++   P + +L     +K+  +++MEY P G 
Sbjct: 28  IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD 87

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF-CYQVARGMQFLSSRGIIHRDLAARNVL 141
           L S L      RY +            D+  F   ++   +  +   G +HRD+   NVL
Sbjct: 88  LLSLL-----NRYEDQF--------DEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPI---RWMAPESL------YDNIFSVKS 192
           I      K+ADFG A  L       +    +LP+    ++APE L          + V+ 
Sbjct: 135 IDRTGHIKLADFGSAARLTA----NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190

Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D WS GV+ +E++  G +P+
Sbjct: 191 DWWSLGVIAYEMI-YGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.2 bits (133), Expect = 4e-09
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 38/217 (17%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQ---ELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           G +   I A+K LK+    R + D      E  +++ +  HP +V L+         ++I
Sbjct: 20  GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLI 78

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF-CYQVARGMQFLSSRGIIHR 133
           +EY+  G+L  F            MH +   +   D   F   +++  ++ L  +GII+R
Sbjct: 79  LEYLSGGEL--F------------MHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR 124

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL------PIRWMAPESLYDNI 187
           DL   N+L+      K+ DFG  +        E   EG +       I +MAPE L  + 
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCK--------ESIHEGTVTHTFCGTIEYMAPEILMRSG 176

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS 224
                D WS G L+++++T G+ P+     AE  KK+
Sbjct: 177 HGKAVDWWSLGALMYDMLT-GAPPF----TAENRKKT 208

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.6 bits (131), Expect = 7e-09
 Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 24/176 (13%)

Query: 34  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 93
           AG+R       E  +++ ++ HP++++L G  T             Y K    +      
Sbjct: 124 AGQRG--GTATEAHILRAIN-HPSIIQLKGTFT-------------YNKFTCLILPRYKT 167

Query: 94  RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF 153
             Y  +  K N +   D+ +    V R +Q+L    IIHRD+ A N+ I       + DF
Sbjct: 168 DLYCYLAAKRN-IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226

Query: 154 G---FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
           G   F  D+  +  Y         I   APE L  + +    DIWS G++++E+ T
Sbjct: 227 GAACFPVDINANKYYGWAGT----IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.0 bits (129), Expect = 2e-08
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 42/205 (20%)

Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQ 93
           ERE+  L+ E+ VM+ L  H N+VR +     K  +  +++ME+   G L     S   Q
Sbjct: 53  EREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDL-----SRNIQ 106

Query: 94  RYYNNMHGKSNSLTSRDLT-------SFCYQVARGMQFLSSRGIIHRDLAARNVLI--GE 144
           + Y  M GK       D+T       ++C+ +  G    +   ++HRDL  +N+ +  G 
Sbjct: 107 KCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGP---NGERVLHRDLKPQNIFLSTGI 162

Query: 145 NHC---------------CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS 189
            H                 K+ DFG ++++   S+    S    P  W +PE L     S
Sbjct: 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH--SCVGTPYYW-SPELLLHETKS 219

Query: 190 V--KSDIWSFGVLIWEIVTLGSTPY 212
              KSD+W+ G +I+E+ + G TP+
Sbjct: 220 YDDKSDMWALGCIIYELCS-GKTPF 243

Length = 1021

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 20/161 (12%)

Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P VV+L     + +  +++MEY+P G L + + +      +                 + 
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--------------YT 148

Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            +V   +  + S G+IHRD+   N+L+ ++   K+ADFG    +  + +    +    P 
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP- 207

Query: 176 RWMAPESLY----DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML-VGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 37/159 (23%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +            + +   F
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF------------TEERARF 99

Query: 115 C-YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
              ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G  
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT- 158

Query: 174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           P  ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 159 P-EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 7e-08
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 26/187 (13%)

Query: 28  KTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 87
           KT +    ER+ L+ ++           P +V L           +I++YV  G+L + L
Sbjct: 46  KTAEHTRTERQVLEAVRR---------CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL 96

Query: 88  RSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC 147
                QR +          T  ++  +  ++   +  L   GII+RD+   N+L+     
Sbjct: 97  ----YQREH---------FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH 143

Query: 148 CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY--DNIFSVKSDIWSFGVLIWEIV 205
             + DFG +++ +     ER       I +MAPE +           D WS GVL +E++
Sbjct: 144 VVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202

Query: 206 TLGSTPY 212
           T G++P+
Sbjct: 203 T-GASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 9e-08
 Identities = 28/101 (27%), Positives = 50/101 (49%), Gaps = 17/101 (16%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-------DLMTSSVYERKS 169
           Q+  G+++L ++ IIHRD+   N+ I +     + D G A+        L  +   E   
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN- 223

Query: 170 EGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
                    APE L  + ++ K+DIWS G++++E++   ST
Sbjct: 224 ---------APEVLARDKYNSKADIWSAGIVLFEMLAYPST 255

Length = 357

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.5 bits (120), Expect = 2e-07
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 20/188 (10%)

Query: 30  LKENAGERERLDLLQELTVMKTLDPHPNVVRL--LGCCTEKEPFFVIMEYVPYG--KLQS 85
           LK+  G    +   +E+ +++ L  HPNV+ L  +         +++ +Y  +    +  
Sbjct: 33  LKQIEGTGISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIK 91

Query: 86  FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI--- 142
           F R+S+A +       K   L    + S  YQ+  G+ +L +  ++HRDL   N+L+   
Sbjct: 92  FHRASKANK-------KPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144

Query: 143 -GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR--WMAPESLYDNIFSVKS-DIWSFG 198
             E    K+AD GFAR L  S +        + +   + APE L       K+ DIW+ G
Sbjct: 145 GPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 203

Query: 199 VLIWEIVT 206
            +  E++T
Sbjct: 204 CIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 23/191 (12%)

Query: 26  AVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           A+K LK+     + E    L E  V++    HP +  L       +    +MEY   G+L
Sbjct: 24  AMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANGGEL 82

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARNVL 141
              L   R              + S D   F Y  ++   + +L S  +++RDL   N++
Sbjct: 83  FFHLSRER--------------VFSEDRARF-YGAEIVSALGYLHSCDVVYRDLKLENLM 127

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + ++   K+ DFG  ++ ++     +   G  P  ++APE L DN +    D W  GV++
Sbjct: 128 LDKDGHIKITDFGLCKEGISDGATMKTFCGT-P-EYLAPEVLEDNDYGRAVDWWGLGVVM 185

Query: 202 WEIVTLGSTPY 212
           +E++  G  P+
Sbjct: 186 YEMMC-GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 28/165 (16%)

Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS----SRAQRYYNNMHGKSNSLTSRDL 111
           P VV+L     +    +++MEY+P G L + + +     +  R+Y               
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA------------- 149

Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEG 171
                +V   +  + S G IHRD+   N+L+ ++   K+ADFG    +    +    +  
Sbjct: 150 -----EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 172 RLPIRWMAPESLY----DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             P  +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 205 GTP-DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 2e-07
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 20/188 (10%)

Query: 30  LKENAGERERLDLLQELTVMKTLDPHPNVVRL--LGCCTEKEPFFVIMEYVPYG--KLQS 85
           LK+  G    +   +E+ +++ L  HPNV+ L  +         +++ +Y  +    +  
Sbjct: 33  LKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK 91

Query: 86  FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI--- 142
           F R+S+A +       K   L    + S  YQ+  G+ +L +  ++HRDL   N+L+   
Sbjct: 92  FHRASKANK-------KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144

Query: 143 -GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR--WMAPESLYDNIFSVKS-DIWSFG 198
             E    K+AD GFAR L  S +        + +   + APE L       K+ DIW+ G
Sbjct: 145 GPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 203

Query: 199 VLIWEIVT 206
            +  E++T
Sbjct: 204 CIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 25/186 (13%)

Query: 26  AVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           AVK L++     ++E+  ++ E  V+     HP +V L       E  + +++YV  G+L
Sbjct: 24  AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL 83

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             F    R + +          L  R    +  +VA  + +L S  II+RDL   N+L+ 
Sbjct: 84  --FFHLQRERCF----------LEPR-ARFYAAEVASAIGYLHSLNIIYRDLKPENILLD 130

Query: 144 ENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
                 + DFG  ++ +    T+S +    E      ++APE L    +    D W  G 
Sbjct: 131 SQGHVVLTDFGLCKEGVEPEETTSTFCGTPE------YLAPEVLRKEPYDRTVDWWCLGA 184

Query: 200 LIWEIV 205
           +++E++
Sbjct: 185 VLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 44/208 (21%), Positives = 96/208 (46%), Gaps = 35/208 (16%)

Query: 25  VAVKTLKE-NAGERERLDLLQ-ELTVMKTLDPHPNVVRLLG----CCTEKEPFFVIMEYV 78
           V ++T K+ + G +  +D+ + E+  ++ +D + N++++ G       +     +I+EY 
Sbjct: 46  VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAA 137
             G L+  L   +   +           T  D+   C    +G+  L       +++L +
Sbjct: 105 TRGYLREVLDKEKDLSFK----------TKLDMAIDC---CKGLYNLYKYTNKPYKNLTS 151

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMA--PESLYDNIFS---VKS 192
            + L+ EN+  K+   G  + +++S  ++        + +M      + ++IFS   +K 
Sbjct: 152 VSFLVTENYKLKIICHGLEK-ILSSPPFKN-------VNFMVYFSYKMLNDIFSEYTIKD 203

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
           DI+S GV++WEI T G  P+  +   E+
Sbjct: 204 DIYSLGVVLWEIFT-GKIPFENLTTKEI 230

Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 4e-07
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 10/113 (8%)

Query: 96  YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADF 153
           Y  +  +   L    +T+   Q+   + ++   GIIHRD+   NVL+   E+ C  + DF
Sbjct: 247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDF 304

Query: 154 G---FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           G   FAR   ++  +   +     +   APE L  + ++   DIWS G++I+E
Sbjct: 305 GAACFARGSWSTPFHYGIAG---TVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 5e-07
 Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 54/222 (24%)

Query: 34  AGERERLDLLQEL--------TVMKTLDP--------------------HPNVVRLLGCC 65
             E E  D L E          V+K LDP                    H ++  + G C
Sbjct: 26  EDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVC 85

Query: 66  TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 125
                  ++ E+V +G L   LR  + +     +  K          +   Q+A  + +L
Sbjct: 86  VRGSENIMVEEFVEHGPLDVCLRKEKGRV---PVAWK---------ITVAQQLASALSYL 133

Query: 126 SSRGIIHRDLAARNVLIGENHCC-------KVADFGFARDLMTSSVYERKSEGRLPIRWM 178
             + ++H ++ A+N+L+             K++D G +    T+   E + E R+P  W+
Sbjct: 134 EDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS---FTALSREERVE-RIP--WI 187

Query: 179 APESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           APE +   N  S  +D WSFG  + EI   G  P      +E
Sbjct: 188 APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 26/102 (25%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  ++  G++ L     ++RDL   N+L+ +    +++D G A  +           GR+
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI----RGRV 162

Query: 174 -PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             + +MAPE L +  +++  D W  G LI+E++  G +P+ G
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 36/215 (16%)

Query: 17  RGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R +      AVK L++ A   ++E   ++ E  V+     HP +V L       +  + +
Sbjct: 15  RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 74

Query: 75  MEYVPYGKLQSFLRSSRA-----QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
           ++Y+  G+L   L+  R       R+Y                    ++A  + +L S  
Sbjct: 75  LDYINGGELFYHLQRERCFLEPRARFY------------------AAEIASALGYLHSLN 116

Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYD 185
           I++RDL   N+L+       + DFG  ++ +    T+S +    E      ++APE L+ 
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE------YLAPEVLHK 170

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
             +    D W  G +++E++  G  P+     AE+
Sbjct: 171 QPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.8 bits (116), Expect = 7e-07
 Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 25/186 (13%)

Query: 28  KTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 87
           KT++    ER  L+ +++          P +V L      +    +I++YV  G++ + L
Sbjct: 46  KTVEHTRTERNVLEHVRQ---------SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL 96

Query: 88  RSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC 147
                QR            +  ++  +  ++   ++ L   GI++RD+   N+L+     
Sbjct: 97  Y----QRDN---------FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH 143

Query: 148 CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVT 206
             + DFG +++ ++    ER       I +MAPE +       K+ D WS G+LI+E++T
Sbjct: 144 VVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202

Query: 207 LGSTPY 212
            G++P+
Sbjct: 203 -GASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 7e-07
 Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 78/236 (33%)

Query: 26  AVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           A+K L K+   +R ++  +L E  ++ TLD HP +  L      +    ++M+Y P G+L
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGEL 88

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR--------GMQFLSSRGIIHRDL 135
              L+    +                       +VAR         +++L   GI++RDL
Sbjct: 89  FRLLQRQPGKC-------------------LSEEVARFYAAEVLLALEYLHLLGIVYRDL 129

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR------------------- 176
              N+L+ E+    ++DF    DL   S      E     +                   
Sbjct: 130 KPENILLHESGHIMLSDF----DLSKQS----DVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 177 ----------------WMAPE--SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
                           ++APE  S   +  +V  D W+ G+L++E++  G+TP+ G
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEML-YGTTPFKG 234

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 43/199 (21%), Positives = 78/199 (39%), Gaps = 47/199 (23%)

Query: 58  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 117
           VV++     +K   ++IME++P G + + L              K ++LT  +   +  +
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-------------KKDTLTEEETQFYIAE 109

Query: 118 VARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG------------FARDLMTS--- 162
               +  +   G IHRD+   N+L+      K++DFG            F R+L  S   
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 163 -SVYERKSEGRLPIRW-----------------MAPESLYDNIFSVKSDIWSFGVLIWEI 204
              ++  +  R    W                 +APE      ++   D WS GV+++E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 205 VTLGSTPYPGMAAAEVMKK 223
           + +G  P+      E  KK
Sbjct: 230 L-IGYPPFCSETPQETYKK 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 39/183 (21%)

Query: 51  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA-----QRYYNNMHGKSNS 105
           T   +P VV +      K    ++MEYV  G   + L++  A      R Y         
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY--------- 106

Query: 106 LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-DLM--TS 162
                   F   V   +++L + GI+HRDL   N+LI      K+ DFG ++  LM  T+
Sbjct: 107 --------FAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157

Query: 163 SVYER--KSEGR---------LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTP 211
           ++YE   + + R          P  ++APE +    +    D W+ G++++E + +G  P
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTP-EYIAPEVILRQGYGKPVDWWAMGIILYEFL-VGCVP 215

Query: 212 YPG 214
           + G
Sbjct: 216 FFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 22/162 (13%)

Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF- 114
             +V+L     + +  +++MEY+P G L + +               SN         F 
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---------------SNYDIPEKWARFY 147

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             +V   +  + S G IHRD+   N+L+ ++   K+ADFG     M ++   R       
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MDANGMVRCDTAVGT 206

Query: 175 IRWMAPESL----YDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 17  RGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R R+   I A+KT+++       E    L E TV+  ++  P +V L       E  +++
Sbjct: 13  RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLV 71

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           + ++  G+L   L     QR      G+ +   +R  T+   ++   ++ L    +I+RD
Sbjct: 72  LAFINGGELFHHL-----QR-----EGRFDLSRARFYTA---ELLCALENLHKFNVIYRD 118

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           L   N+L+       + DFG  +  M     ++ +       ++APE L  + ++   D 
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           W+ GVL++E++T G  P+      E+ +K
Sbjct: 177 WTLGVLLYEMLT-GLPPFYDENVNEMYRK 204

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 5e-06
 Identities = 21/133 (15%), Positives = 49/133 (36%), Gaps = 26/133 (19%)

Query: 30  LKENAGERERLDLLQELTVMKTLDPHPNVV-RLLGCCTEKEPFFVIMEYVPYGKLQSFLR 88
           LK N    +  D  +E+ +++ L      V ++L         +++ME++          
Sbjct: 26  LKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE--------- 76

Query: 89  SSRAQRYYNNMHGKS-NSLTSRDLTSFCYQVARGMQFL---SSRGIIHRDLAARNVLIGE 144
                       G++ + ++  +      Q+A  +  L       + H DL   N+L+ +
Sbjct: 77  ------------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124

Query: 145 NHCCKVADFGFAR 157
                + D+ +A 
Sbjct: 125 GKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 35/151 (23%), Positives = 67/151 (44%), Gaps = 13/151 (8%)

Query: 68  KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN----MHGKSNSLTSRDLTSFC-YQVARGM 122
           + PF   ++Y      Q+  R      Y N      H     + S D   F   ++   +
Sbjct: 53  RHPFLTALKY----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 108

Query: 123 QFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
            +L S + +++RDL   N+++ ++   K+ DFG  ++ +      +   G     ++APE
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG--TPEYLAPE 166

Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            L DN +    D W  GV+++E++  G  P+
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 45.6 bits (108), Expect = 6e-06
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 2/89 (2%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR 176
           Q+  G++ L  R II+RDL   NVL+  +   +++D G A +L       +   G  P  
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT-P-G 162

Query: 177 WMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
           +MAPE L    +    D ++ GV ++E++
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 45.6 bits (108), Expect = 7e-06
 Identities = 25/97 (25%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PI 175
           ++  G++ L    I++RDL   N+L+ +    +++D G A ++           GR+  +
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI----RGRVGTV 165

Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            +MAPE + +  ++   D W  G LI+E++  G +P+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.2 bits (108), Expect = 8e-06
 Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           +PN ++L    T  +   +IM+Y+  G L   L+                 L+  ++   
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-------------LSEAEVKKI 114

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLI-GENHCCKVADFGFARDLMTSSVYERKSEGRL 173
             Q+   +  L    IIH D+   NVL         + D+G  + + T S Y+   +   
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--- 171

Query: 174 PIRWMAPESL----YDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              + +PE +    YD  F    D W+ GVL +E++T G  P+
Sbjct: 172 ---YFSPEKIKGHNYDVSF----DWWAVGVLTYELLT-GKHPF 206

Length = 267

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.4 bits (107), Expect = 9e-06
 Identities = 41/199 (20%), Positives = 76/199 (38%), Gaps = 47/199 (23%)

Query: 58  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 117
           VV++     +K   ++IME++P G + + L              K ++L+      +  +
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-------------KKDTLSEEATQFYIAE 109

Query: 118 VARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYE----------- 166
               +  +   G IHRD+   N+L+      K++DFG    L  +   E           
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 167 ----------RKSEGRLPIR------------WMAPESLYDNIFSVKSDIWSFGVLIWEI 204
                     RK+E     R            ++APE      ++   D WS GV+++E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 205 VTLGSTPYPGMAAAEVMKK 223
           + +G  P+      E  +K
Sbjct: 230 L-IGYPPFCSETPQETYRK 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMA 179
           G++ L    I++RDL   N+L+ +    +++D G A  +           GR+  + +MA
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRGRVGTVGYMA 169

Query: 180 PESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           PE + +  ++   D W  G LI+E++  G +P+
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 19/207 (9%)

Query: 16  ERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           +R  +G C  AVK L++      +E+  ++ E  V+     HP +V L       E  + 
Sbjct: 15  KRKLDGKC-YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF 73

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           ++++V  G+L   L+  R             S        +  ++A  + +L S  I++R
Sbjct: 74  VLDFVNGGELFFHLQRER-------------SFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DL   N+L+       + DFG  ++ +  S       G  P  ++APE +    +    D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT-P-EYLAPEVIRKQPYDNTVD 178

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            W  G +++E++  G  P+     AE+
Sbjct: 179 WWCLGAVLYEML-YGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 24/100 (24%), Positives = 54/100 (54%), Gaps = 6/100 (6%)

Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  ++  G++ L    I++RDL   N+L+ ++   +++D G A  +          +GR+
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----KGRV 162

Query: 174 -PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             + +MAPE + +  ++   D W+ G L++E++  G +P+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 36/150 (24%), Positives = 75/150 (50%), Gaps = 17/150 (11%)

Query: 70  PFFVIMEYVPYG--KLQSF---LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
           PF V M Y  +   KL SF   L +     Y+ + HG     +  ++  +  ++  G++ 
Sbjct: 57  PFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEH 112

Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR-WMAPESL 183
           + +R +++RDL   N+L+ E+   +++D G A D       ++K    +    +MAPE L
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-----KKKPHASVGTHGYMAPEVL 167

Query: 184 YDNI-FSVKSDIWSFGVLIWEIVTLGSTPY 212
              + +   +D +S G ++++++  G +P+
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLR-GHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 3e-05
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 12/87 (13%)

Query: 124 FLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM----- 178
           +L  RGIIHRD+   N+ + E     + DFG A  L  +     +  G     W      
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL-DAHPDTPQCYG-----WSGTLET 253

Query: 179 -APESLYDNIFSVKSDIWSFGVLIWEI 204
            +PE L  + +  K+DIWS G++++E+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 4e-05
 Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 13/86 (15%)

Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           +++MEY+  G ++S L          +++G  +   +    S   +VA  + +L   GII
Sbjct: 80  YLVMEYLIGGDVKSLL----------HIYGYFDEEMAVKYIS---EVALALDYLHRHGII 126

Query: 132 HRDLAARNVLIGENHCCKVADFGFAR 157
           HRDL   N+LI      K+ DFG ++
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.7 bits (100), Expect = 5e-05
 Identities = 26/120 (21%), Positives = 63/120 (52%), Gaps = 11/120 (9%)

Query: 95  YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG 154
           Y+ + HG     + +++  +  ++  G++ + +R +++RDL   N+L+ E+   +++D G
Sbjct: 86  YHLSQHG---VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 155 FARDLMTSSVYERKSEGRLPIR-WMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPY 212
            A D       ++K    +    +MAPE L     +   +D +S G ++++++  G +P+
Sbjct: 143 LACDFS-----KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (100), Expect = 6e-05
 Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 4/92 (4%)

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
           ++ L    I++RDL   N+L+       + DFG ++  +T +       G     ++APE
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG--TTEYLAPE 166

Query: 182 SLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPY 212
            L D   ++   D WS GVL++E+   G +P+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 31/162 (19%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HPN+V+L+G C  ++  ++I EY+    L   LR+   +R      G + +L  R L   
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKAL--RFLHCR 799

Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFARDL--MTSSVYERKS 169
           C           S  ++  +L+   ++I    E H           D     SS Y    
Sbjct: 800 C-----------SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAY---- 844

Query: 170 EGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTP 211
                   +APE+      + KSDI+ FG+++ E++T G +P
Sbjct: 845 --------VAPETRETKDITEKSDIYGFGLILIELLT-GKSP 877

Length = 968

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 45/208 (21%), Positives = 75/208 (36%), Gaps = 57/208 (27%)

Query: 58  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF-CY 116
           VV+L     +K+  + +M+Y+P G + S L                  +   DL  F   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--------------GIFEEDLARFYIA 108

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA---RDLMTSSVYERKSEGR- 172
           ++   ++ +   G IHRD+   N+LI  +   K+ DFG     R    S  Y++    R 
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168

Query: 173 ----LPIRW---------------------------------MAPESLYDNIFSVKSDIW 195
                   W                                 +APE L    ++   D W
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S GV+++E++ +G  P+     AE   K
Sbjct: 229 SVGVILYEML-VGQPPFLADTPAETQLK 255

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 1/67 (1%)

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR 176
           QV  G++ L   GI+HRD+   N+L+  +   K+ DFG A D M + +      G L  R
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD-MCTGINFNPLYGMLDPR 375

Query: 177 WMAPESL 183
           +  PE L
Sbjct: 376 YSPPEEL 382

Length = 507

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 45/212 (21%), Positives = 77/212 (36%), Gaps = 61/212 (28%)

Query: 58  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF-CY 116
           VVRL     +K+  + +M+Y+P G + S L                  +   DL  F   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--------------GIFPEDLARFYIA 108

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA-------------------R 157
           ++   ++ +   G IHRD+   N+LI  +   K+ DFG                     +
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168

Query: 158 DLMT-SSVYERKSEGRL-----PIRW--------------------MAPESLYDNIFSVK 191
           D M  S+ +   +  R      P+                      +APE L    ++  
Sbjct: 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            D WS GV+++E++ +G  P+      E   K
Sbjct: 229 CDWWSVGVILYEML-VGQPPFLAQTPLETQMK 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 33/138 (23%), Positives = 56/138 (40%), Gaps = 28/138 (20%)

Query: 58  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFL-----RSSRAQRYYNNMHGKSNSLTSRDLT 112
           VV+L     +K+  + +M+Y+P G + S L           R+Y                
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY---------------- 106

Query: 113 SFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA---RDLMTSSVYERKS 169
               ++   ++ +   G IHRD+   N+LI  +   K+ DFG     R    S  Y++ S
Sbjct: 107 --IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGS 164

Query: 170 EGRLPIRWMAPESLYDNI 187
             R     M P  L+D++
Sbjct: 165 HIRQDS--MEPSDLWDDV 180

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 40.2 bits (94), Expect = 4e-04
 Identities = 44/193 (22%), Positives = 83/193 (43%), Gaps = 35/193 (18%)

Query: 24  IVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             AVK L++ A   ++E+  ++ E  V+     HP +V L       +  + +++YV  G
Sbjct: 22  FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81

Query: 82  KLQSFLRSSRA-----QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +L   L+  R+      R+Y                    ++A  + +L S  II+RDL 
Sbjct: 82  ELFFHLQRERSFPEPRARFY------------------AAEIASALGYLHSLNIIYRDLK 123

Query: 137 ARNVLIGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
             N+L+       + DFG  ++ +    T+S +    E      ++APE L    +    
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE------YLAPEVLRKQPYDRTV 177

Query: 193 DIWSFGVLIWEIV 205
           D W  G +++E++
Sbjct: 178 DWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 29/209 (13%)

Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           V V+ +   A   E +  LQ EL V K  + HPN+V            +V+  ++ YG  
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSA 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           +  + +              + ++   +      V + + ++   G +HR + A ++LI 
Sbjct: 87  KDLICTHF-----------MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135

Query: 144 ENHCCKVADFGF---------ARDLMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKS 192
            +   KV   G           + L     + + S   LP  W++PE L  N+  +  KS
Sbjct: 136 VDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKS 191

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           DI+S G+   E+   G  P+  M A +++
Sbjct: 192 DIYSVGITACELAN-GHVPFKDMPATQML 219

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 28/111 (25%)

Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFA--------RDLMTSSVYERKSEGRLPIRW--- 177
           G IHRD+   N+LI  +   K+ADFG          R+   +  +       + +R    
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 178 ----------------MAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
                           +APE L    + ++ D WS GV+++E++  G  P+
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 7e-04
 Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 68/228 (29%)

Query: 24  IVAVKTL-KENAGERERL-------DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           I A+K L K    E+E++       D+L E         +P VV+L     ++   ++IM
Sbjct: 28  IYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-------NPWVVKLYYSFQDENYLYLIM 80

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHR 133
           EY+P G + + L              K ++ T  + T F Y  +    +  +   G IHR
Sbjct: 81  EYLPGGDMMTLLM-------------KKDTFT-EEETRF-YIAETILAIDSIHKLGYIHR 125

Query: 134 DLAARNVLIGENHCCKVADFG------------FARDLMTSSVYERKSEGRLPIR----- 176
           D+   N+L+      K++DFG            F R L  +           P+      
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185

Query: 177 -------------------WMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
                              ++APE      ++ + D WS GV+++E++
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 39.7 bits (92), Expect = 7e-04
 Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 7/98 (7%)

Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----D 185
           +HRD+   N+L+  N   ++ADFG    LM     +       P  +++PE L       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP-DYISPEILQAMEDGK 182

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +  + D WS GV ++E++  G TP+   +  E   K
Sbjct: 183 GKYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 219

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 37.9 bits (88), Expect = 0.002
 Identities = 32/159 (20%), Positives = 69/159 (43%), Gaps = 20/159 (12%)

Query: 50  KTLDPH--PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 107
            T+ PH  PN+V L      ++  F+++++   GKL S +              K  ++ 
Sbjct: 37  LTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------------SKFLNIP 83

Query: 108 SRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYER 167
              +  +  ++   +  L   GI+ RDL   N+L+ +    ++  F    ++  S   + 
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DG 141

Query: 168 KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ++   +   + APE    +  +   D WS G +++E++T
Sbjct: 142 EAVENM---YCAPEVGGISEETEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 7/98 (7%)

Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNI 187
           +HRD+   NVL+  N   ++ADFG    +      +       P  +++PE   ++ D +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP-DYISPEILQAMEDGM 182

Query: 188 --FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +  + D WS GV ++E++  G TP+   +  E   K
Sbjct: 183 GKYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 219

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	225
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0591|consensus	375		100.0
KOG0575|consensus	592		100.0
KOG0616|consensus	355		100.0
KOG0581|consensus	364		100.0
KOG0593|consensus	396		100.0
KOG0605|consensus	550		100.0
KOG0592|consensus	604		100.0
KOG0615|consensus	475		100.0
KOG0597|consensus	808		100.0
KOG0600|consensus	560		100.0
KOG0583|consensus	370		100.0
KOG0659|consensus	318		100.0
KOG0694|consensus	694		100.0
KOG0661|consensus	538		100.0
KOG0610|consensus	459		100.0
KOG0192|consensus	362		100.0
KOG0611|consensus	668		100.0
KOG0663|consensus	419		100.0
KOG0197|consensus	468		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588|consensus	786		100.0
KOG0594|consensus	323		100.0
KOG0198|consensus	313		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1026|consensus	774		100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0585|consensus	576		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0589|consensus	426		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0582|consensus	516		100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0578|consensus	550		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0580|consensus	281		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0667|consensus	586		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0032|consensus	382		100.0
KOG0658|consensus	364		100.0
KOG0660|consensus	359		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG4250|consensus	732		100.0
KOG1095|consensus	1025		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0033|consensus	355		100.0
KOG0599|consensus	411		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4717|consensus	864		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0194|consensus	474		100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0607|consensus	463		100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0201|consensus	467		100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1989|consensus	738		100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG1187|consensus	361		100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0690|consensus	516		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4236|consensus	888		100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG4721|consensus	904		100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0986|consensus	591		100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0696|consensus	683		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0577|consensus	948		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0662|consensus	292		100.0
KOG0612|consensus	1317		100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0614|consensus	732		100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0574|consensus	502		100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG2345|consensus	302		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0604|consensus	400		100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0608|consensus	1034		100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0586|consensus	596		100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG4279|consensus	1226		100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0983|consensus	391		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0196|consensus	996		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1094|consensus	807		100.0
KOG0666|consensus	438		100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0199|consensus	1039		100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0984|consensus	282		100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0584|consensus	632		100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0603|consensus	612		100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4257|consensus	974		100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG4278|consensus	1157		100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0579|consensus	1187		100.0
KOG1006|consensus	361		100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1025|consensus	1177		100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0695|consensus	593		100.0
KOG4645|consensus	1509		100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0596|consensus	677		100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0669|consensus	376		99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
KOG0200|consensus	609		99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
KOG0671|consensus	415		99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0664|consensus	449		99.97
KOG3653|consensus	534		99.97
KOG0587|consensus	953		99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0668|consensus	338		99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152|consensus	772		99.97
KOG1035|consensus	1351		99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG1027|consensus	903		99.97
KOG2052|consensus	513		99.97
KOG1024|consensus	563		99.96
KOG0670|consensus	752		99.96
KOG1345|consensus	378		99.96
KOG1151|consensus	775		99.96
KOG1167|consensus	418		99.95
KOG0665|consensus	369		99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG1290|consensus	590		99.94
KOG1163|consensus	341		99.94
KOG1164|consensus	322		99.93
KOG1165|consensus	449		99.93
KOG0576|consensus	829		99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG0603|consensus	612		99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG1240|consensus	1431		99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG0590|consensus	601		99.86
KOG1166|consensus	974		99.86
PRK10345	210	hypothetical protein; Provisional	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG0195|consensus	448		99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
smart00090	237	RIO RIO-like kinase.	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG4158|consensus	598		99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
KOG0606|consensus	1205		99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG1033|consensus	516		99.65
KOG1243|consensus	690		99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG1023|consensus	484		99.62
KOG0590|consensus	601		99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG0601|consensus	524		99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.32
KOG3087|consensus	229		99.27
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
KOG3741|consensus	655		99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG1266|consensus	458		99.17
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.05
COG4248	637	Uncharacterized protein with protein kinase and he	99.05
KOG0606|consensus	1205		99.04
KOG0601|consensus	524		99.0
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.86
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.78
PRK09902	216	hypothetical protein; Provisional	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
KOG2137|consensus	700		98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
PLN02876	822	acyl-CoA dehydrogenase	98.31
KOG1235|consensus	538		98.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.16
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.14
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.95
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
KOG0576|consensus	829		97.84
PRK10593	297	hypothetical protein; Provisional	97.8
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.72
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.65
PRK05231	319	homoserine kinase; Provisional	97.63
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.63
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.62
KOG1035|consensus	1351		97.6
PLN02236	344	choline kinase	97.43
KOG2268|consensus	465		97.38
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.18
PRK11768	325	serine/threonine protein kinase; Provisional	97.1
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.98
KOG2270|consensus	520		96.95
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.84
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.78
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.73
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.73
PLN02756	418	S-methyl-5-thioribose kinase	96.69
PRK06148	1013	hypothetical protein; Provisional	96.53
PTZ00384	383	choline kinase; Provisional	96.44
KOG1826|consensus	2724		96.41
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.19
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.67
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.53
PRK12396	409	5-methylribose kinase; Reviewed	95.45
PRK10271	188	thiK thiamine kinase; Provisional	95.16
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.14
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.93

>KOG0595|consensus

Probab=100.00  E-value=1.1e-49  Score=309.42  Aligned_cols=201  Identities=31%  Similarity=0.552  Sum_probs=181.9

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      +|+|| +||+++     +++++..||||.+.... ..+.++.+..|+.+++.++ ||||+.++|++.+++.+|+|||||.
T Consensus        20 ~Gsfa-vVykg~-----h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~lVMEyC~   92 (429)
T KOG0595|consen   20 SGSFA-VVYKGR-----HKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYLVMEYCN   92 (429)
T ss_pred             CcceE-EEEEeE-----eccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEEEEEeCC
Confidence            69999 999999     57888999999998664 6667778999999999999 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC------CceeEeee
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN------HCCKVADF  153 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~------~~~~l~d~  153 (225)
                      ||||..+++...             .++|.+++.++.||+.|+++||+++|+||||||+||+++..      ...||.||
T Consensus        93 gGDLs~yi~~~~-------------~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   93 GGDLSDYIRRRG-------------RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             CCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            999999998753             68999999999999999999999999999999999999754      46899999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      |+++.+...   ......+|+|-|||||++..+.|+.++|+||+|+++|+|++ |.+||+..+..|+...||
T Consensus       160 GfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~~~~~  227 (429)
T KOG0595|consen  160 GFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETPKELLLYIK  227 (429)
T ss_pred             chhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHHh
Confidence            999877533   34556788999999999999999999999999999999999 999999999988876553

>KOG0598|consensus

Probab=100.00  E-value=3.6e-47  Score=292.41  Aligned_cols=200  Identities=24%  Similarity=0.443  Sum_probs=180.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .|+.++.     +.+++.||+|.+++..  ..........|..++.++. ||+|++++..|++.+.+|+|++|+.
T Consensus        36 G~fG-kV~~Vrk-----~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   36 GSFG-KVFQVRK-----KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             cCCc-eEEEEEE-----cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEEEeccC
Confidence            8999 9999994     5889999999998763  3445667889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||.|...+.+.             ..++|..+..|++.|+.||.|||++||+||||||+||+++..|.++|+|||+|...
T Consensus       109 GGeLf~hL~~e-------------g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  109 GGELFYHLQRE-------------GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             CccHHHHHHhc-------------CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999854             47999999999999999999999999999999999999999999999999999743


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      -..  ........||+.|||||++.+..++.++|+||||+++|+|++ |.+||.+.+..+++++|
T Consensus       176 ~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~~~~~~~~I  237 (357)
T KOG0598|consen  176 LKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAEDVKKMYDKI  237 (357)
T ss_pred             ccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCccHHHHHHHH
Confidence            222  122334688999999999999999999999999999999999 99999999999999887

>KOG0591|consensus

Probab=100.00  E-value=1.9e-47  Score=284.48  Aligned_cols=205  Identities=25%  Similarity=0.449  Sum_probs=182.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeee-EEecCCC-eEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG-CCTEKEP-FFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~-~~~~~~~-~~lv~e~~   78 (225)
                      |+|| +||++.     ...+|+.||.|.++-. .....+.....|+.++++++ ||||+++++ .|.+++. ++||||+|
T Consensus        30 GsFg-~vykv~-----~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evlnivmE~c  102 (375)
T KOG0591|consen   30 GSFG-EVYKVQ-----CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLNIVMELC  102 (375)
T ss_pred             Ccch-heEEee-----eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhHHHHHhh
Confidence            8999 999999     5789999999999854 46777778999999999999 999999998 4555544 99999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCCEEecCCCceeEeeec
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS--RG--IIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~--~~--i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      .+|||.+.++..+.++         ..++|.++|.++.|++.||..+|.  .+  ++||||||.||+++.+|.|||+|||
T Consensus       103 ~~GDLsqmIk~~K~qk---------r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen  103 DAGDLSQMIKHFKKQK---------RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             cccCHHHHHHHHHhcc---------ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            9999999998877654         368999999999999999999998  44  9999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      ++..+.....  ......|||.||+||.+.+.+|+.+|||||+||++|||+. =++||.+.+-.++-++|.
T Consensus       174 L~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~n~~~L~~KI~  241 (375)
T KOG0591|consen  174 LGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGDNLLSLCKKIE  241 (375)
T ss_pred             hHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCcccccHHHHHHHHH
Confidence            9987765543  3456678999999999999999999999999999999999 899999999999888873

>KOG0575|consensus

Probab=100.00  E-value=5.4e-46  Score=301.27  Aligned_cols=201  Identities=29%  Similarity=0.504  Sum_probs=184.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|. .+|.++     ...+|+.||+|++...  .++..+..+.+|+.+.++++ |||||+++++|++++.+|+|.|+|.
T Consensus        29 GgFA-~cYe~~-----~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYivLELC~  101 (592)
T KOG0575|consen   29 GGFA-RCYEAR-----DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIVLELCH  101 (592)
T ss_pred             Ccce-EEEEEE-----EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEEEEecC
Confidence            7888 888888     4688999999999865  36667778999999999999 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      .++|..+++..             ..++|.+++.+++||+.||.|||+++|+|||||..|++++++.+|||+|||+|..+
T Consensus       102 ~~sL~el~Krr-------------k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen  102 RGSLMELLKRR-------------KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             CccHHHHHHhc-------------CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee
Confidence            99999999843             36999999999999999999999999999999999999999999999999999766


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      ..  ...+..+.+|||.|+|||++.+...+..+||||+||++|.|+. |++||+..+-.+.+++||
T Consensus       169 e~--~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~Ik  231 (592)
T KOG0575|consen  169 EY--DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNKIK  231 (592)
T ss_pred             cC--cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHHHH
Confidence            43  3356678889999999999999999999999999999999999 999999999999999986

>KOG0616|consensus

Probab=100.00  E-value=3.4e-45  Score=273.95  Aligned_cols=198  Identities=27%  Similarity=0.477  Sum_probs=180.3

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      +|+|| .|.+++     ++.+|..+|+|++....  .-...+....|-++++.+. ||+++++++.+.+.+.+++||||.
T Consensus        54 tGSFG-rV~LVr-----~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymvmeyv  126 (355)
T KOG0616|consen   54 TGSFG-RVHLVR-----EKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMVMEYV  126 (355)
T ss_pred             cCccc-eEEEEE-----EccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEEEecc
Confidence            59999 999999     57789999999997653  3344456778999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +||.|.+++++.             .++++..++.++.|++.||+|||+++|++|||||+||+++.+|.+|++|||+|..
T Consensus       127 ~GGElFS~Lrk~-------------~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  127 PGGELFSYLRKS-------------GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             CCccHHHHHHhc-------------CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999865             3799999999999999999999999999999999999999999999999999975


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..     .+..+.+|||.|+|||++...++..++|+||||+++|||+. |.+||.+.++.+++.+|
T Consensus       194 v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~~~iY~KI  253 (355)
T KOG0616|consen  194 VS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQIYEKI  253 (355)
T ss_pred             ec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCChHHHHHHH
Confidence            43     23457789999999999999999999999999999999999 99999999999998886

>KOG0581|consensus

Probab=100.00  E-value=6e-45  Score=280.28  Aligned_cols=197  Identities=28%  Similarity=0.435  Sum_probs=177.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-eEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~~   80 (225)
                      |..| +||+++     |+.+++.+|+|.+.....+..+..+.+|+.++..+. ||+|+++|+.|..++. +.++|||+++
T Consensus        90 G~gG-~V~kv~-----Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   90 GNGG-TVYKVR-----HKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             CCCc-EEEEEE-----EcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            7889 999999     688999999999988888888889999999999997 9999999999999995 9999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |+|..++...             +.++|..+..++.++++||.|||+ .+|+||||||+||+++..|+|||+|||.+..+
T Consensus       163 GSLd~~~k~~-------------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  163 GSLDDILKRV-------------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             CCHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999754             368999999999999999999995 89999999999999999999999999998766


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC-----CHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM-----AAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~-----~~~~~~~~  223 (225)
                      ...    -.....||..|||||.+.+..|+.++||||||+.++|+.+ |+.||...     +..+++..
T Consensus       230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~-GrfP~~~~~~~~~~~~~Ll~~  293 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI-GRFPYPPPNPPYLDIFELLCA  293 (364)
T ss_pred             hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh-CCCCCCCcCCCCCCHHHHHHH
Confidence            444    3345667888999999999999999999999999999999 99999764     55555543

>KOG0593|consensus

Probab=100.00  E-value=2.1e-45  Score=276.09  Aligned_cols=201  Identities=26%  Similarity=0.444  Sum_probs=175.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| .||+++     ++.+|+.||||++..+.+ +....-.++|+++++++. |||++.++.+|......++|+|||+.
T Consensus        13 GSYG-vV~KCr-----nk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLVFE~~dh   85 (396)
T KOG0593|consen   13 GSYG-VVMKCR-----NKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLVFEYCDH   85 (396)
T ss_pred             Ccce-EEEEec-----cCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEEeeecch
Confidence            8999 999999     689999999999998765 555555789999999999 99999999999999999999999974


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                       ++.+.+..            ....++++.+..+++|++.|+.|+|+++++||||||+||+++.++.+||||||+|+.+.
T Consensus        86 -TvL~eLe~------------~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   86 -TVLHELER------------YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             -HHHHHHHh------------ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence             55555554            23578999999999999999999999999999999999999999999999999998776


Q ss_pred             CccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      .+..  ..+....|..|+|||.+.+ ..|+..+||||+||++.||++ |.+.|++..+-|++-.|+
T Consensus       153 ~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~  215 (396)
T KOG0593|consen  153 APGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIR  215 (396)
T ss_pred             CCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHH
Confidence            4332  2233344566999999987 679999999999999999999 999999999999887763

>KOG0605|consensus

Probab=100.00  E-value=2.4e-44  Score=287.88  Aligned_cols=202  Identities=26%  Similarity=0.436  Sum_probs=178.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||+++     .+.+|..+|+|+++++.  .......++.|-.+|.... +|+||+++..|.+...+||||||++
T Consensus       152 GAfG-eVrLar-----Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  152 GAFG-EVRLAR-----KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             ccce-eEEEEE-----EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEEEEEecC
Confidence            8999 999999     57899999999998774  4555667889999999976 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |||+..++...             ..+++.++..++.+++.|+..+|+.|++||||||+|++++..|.+||+|||++..+
T Consensus       225 GGD~mTLL~~~-------------~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  225 GGDMMTLLMRK-------------DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             CccHHHHHHhc-------------CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999764             36899999999999999999999999999999999999999999999999998633


Q ss_pred             cC---------------------ccccc------------------------cccCCCCCccccCCccccCCCCCcchhH
Q psy15818        160 MT---------------------SSVYE------------------------RKSEGRLPIRWMAPESLYDNIFSVKSDI  194 (225)
Q Consensus       160 ~~---------------------~~~~~------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di  194 (225)
                      ..                     +....                        -.....|||.|+|||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                     00000                        0013568999999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       195 ~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |||||++|||+. |.+||.+.++.+...+|
T Consensus       372 WSLG~ImyEmLv-GyPPF~s~tp~~T~rkI  400 (550)
T KOG0605|consen  372 WSLGCIMYEMLV-GYPPFCSETPQETYRKI  400 (550)
T ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            999999999999 99999999999998886

>KOG0592|consensus

Probab=100.00  E-value=1e-44  Score=290.26  Aligned_cols=203  Identities=24%  Similarity=0.445  Sum_probs=179.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|+ +|++|+     ...+++.||||++.+.  ..+.....+.+|-..|.++.+||+|++++-.|.+...+|+|+||++
T Consensus        84 GSYS-tV~~A~-----~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   84 GSYS-TVVLAR-----EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             ccce-eEEEee-----ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            8999 999999     4679999999998654  3444445577888899999789999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +|+|.+++++.             +.+++...+.++.+|+.||+|||++||+||||||+|||++++++++|.|||.|..+
T Consensus       158 nGdll~~i~K~-------------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  158 NGDLLDLIKKY-------------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             CCcHHHHHHHh-------------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999875             37999999999999999999999999999999999999999999999999999876


Q ss_pred             cCcccc---------cc--ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVY---------ER--KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~---------~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......         ..  .....||..|.+||++.+...+.++|+|+|||++|+|+. |.+||.+.++--+.++|
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-GQPPFRAANEYLIFQKI  299 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-CCCCCccccHHHHHHHH
Confidence            443322         11  134568999999999999999999999999999999999 99999999998887776

>KOG0615|consensus

Probab=100.00  E-value=1.6e-45  Score=286.41  Aligned_cols=199  Identities=24%  Similarity=0.391  Sum_probs=168.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (225)
                      |+|| .|-+|.     .+.+|+.||+|+++....      .....++.+|+.+|++++ ||||++++++|+.+...|+||
T Consensus       183 Gafg-~Vkla~-----e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~~ds~YmVl  255 (475)
T KOG0615|consen  183 GAFG-LVKLAY-----EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEVPDSSYMVL  255 (475)
T ss_pred             Ccee-EEEEEE-----EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeecCCceEEEE
Confidence            8899 898888     688999999999976432      123345789999999998 999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC---CceeEee
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN---HCCKVAD  152 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~---~~~~l~d  152 (225)
                      ||+.||+|.+.+..+             +.+.+..-..+++|++.|+.|||++||+||||||+||+++.+   -.+||+|
T Consensus       256 E~v~GGeLfd~vv~n-------------k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  256 EYVEGGELFDKVVAN-------------KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             EEecCccHHHHHHhc-------------cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999765             357788889999999999999999999999999999999755   5689999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCC---CcchhHHHHHHHHHHHHHcCCCCCCCCCHHH-Hhhhc
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF---SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE-VMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~-~~~~i  224 (225)
                      ||+|......   ....+.+|||.|.|||++.+...   ..++|+||+||+||-+++ |.+||.+..... +.++|
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~~~~sl~eQI  394 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPPFSEEYTDPSLKEQI  394 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCCcccccCCccHHHHH
Confidence            9999866533   34556789999999999986553   457899999999999999 999998655544 44433

>KOG0597|consensus

Probab=100.00  E-value=4.7e-44  Score=287.95  Aligned_cols=199  Identities=26%  Similarity=0.505  Sum_probs=180.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| .||+++     .+.+.+.||+|.+.+. ..+.+...+.+|+++++.++ ||||+.++++|+....+|+|.|||.|
T Consensus        13 Gsfg-~VYKgr-----rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen   13 GSFG-RVYKGR-----RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             Cccc-eeeecc-----cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEEehhhhh
Confidence            8999 999999     5789999999999765 45667778999999999999 99999999999999999999999986


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                       +|..++...             ..++|+.+..++.|+++||.|||+.+|.|+|+||.||+++.++.+|++|||+|+.++
T Consensus        86 -~L~~il~~d-------------~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   86 -DLFTILEQD-------------GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             -hHHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence             999999753             479999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..+  .-.....|||-|||||...+++|+..+|+||+||++||+++ |++||-...-.++.+.|
T Consensus       152 ~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I  212 (808)
T KOG0597|consen  152 TNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSI  212 (808)
T ss_pred             cCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHH
Confidence            543  23445678999999999999999999999999999999999 99999988888887776

>KOG0600|consensus

Probab=100.00  E-value=1.8e-43  Score=281.01  Aligned_cols=201  Identities=27%  Similarity=0.500  Sum_probs=176.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.|| .||+++     +..+|+.||+|.+..+. .+....-..+||.+|+++. ||||+++.+...+.  +.+|+|+||+
T Consensus       128 GTyg-~VYkAr-----~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~siYlVFeYM  200 (560)
T KOG0600|consen  128 GTYG-QVYKAR-----DLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSIYLVFEYM  200 (560)
T ss_pred             cchh-heeEee-----ecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceEEEEEecc
Confidence            8999 999999     57899999999998653 5555556789999999998 99999999998765  7899999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      + -||.-++..            ....+++.++..++.||++||+|+|++|++|||||.+|||++++|..||+|||+|..
T Consensus       201 d-hDL~GLl~~------------p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  201 D-HDLSGLLSS------------PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             c-chhhhhhcC------------CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence            7 788877764            345799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +..... ...+....|..|+|||.+.|. .|+.++|+||.||+|.||++ |++.|++.++-+++.+|
T Consensus       268 y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl~kI  332 (560)
T KOG0600|consen  268 YTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQLHKI  332 (560)
T ss_pred             ccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHHHHHH
Confidence            644432 224555667789999999875 59999999999999999999 99999999999999886

>KOG0583|consensus

Probab=100.00  E-value=1.5e-42  Score=279.16  Aligned_cols=201  Identities=24%  Similarity=0.435  Sum_probs=175.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---ch-HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |+|| .|+++.     +..++..||+|++....   .. .....+.+|+.+++.+..||||+++++++.....+++||||
T Consensus        28 Gsfg-kV~~a~-----~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy  101 (370)
T KOG0583|consen   28 GSFG-KVKLAK-----HRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY  101 (370)
T ss_pred             CCCe-eEEEee-----eccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence            8899 999998     46788999999776531   11 33445778999999998899999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEeeeccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGFA  156 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g~~  156 (225)
                      |.||+|.+++...             .++.|.++..++.|+++|++|||++||+||||||+||+++.+ +++||+|||++
T Consensus       102 ~~gGdL~~~i~~~-------------g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen  102 CSGGDLFDYIVNK-------------GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             cCCccHHHHHHHc-------------CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999863             368999999999999999999999999999999999999988 99999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCC-C-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNI-F-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  ..........|++.|+|||++.+.. | +.++|+||+|++||.|++ |..||.+.+...+..+|
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~-G~~PF~d~~~~~l~~ki  235 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC-GRLPFDDSNVPNLYRKI  235 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCccHHHHHHHH
Confidence            7553  2233456678899999999999877 7 478999999999999999 99999998888887765

>KOG0659|consensus

Probab=100.00  E-value=1.6e-42  Score=256.13  Aligned_cols=200  Identities=25%  Similarity=0.460  Sum_probs=175.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||+++     +.++|+.||||.++... .........+|+..++.+. |+||+.++|+|...+.+.+|+||++ 
T Consensus        13 G~~g-vVyka~-----d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lVfEfm~-   84 (318)
T KOG0659|consen   13 GTYG-VVYKAR-----DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLVFEFMP-   84 (318)
T ss_pred             cceE-EEEEEE-----ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEEEEecc-
Confidence            8999 999999     57899999999998653 3333446889999999999 9999999999999999999999997 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      .+|...++..            ...++..++..|+.++++|++|||++.|+||||||.|++++.+|.+|+.|||+++.+.
T Consensus        85 tdLe~vIkd~------------~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   85 TDLEVVIKDK------------NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             ccHHHHhccc------------ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            8999999763            4578999999999999999999999999999999999999999999999999998776


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .+....  +....|..|+|||.+.|. .|+..+|+||.||++.||+- |.+.|.|.++-|++..|
T Consensus       153 ~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~I  214 (318)
T KOG0659|consen  153 SPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKI  214 (318)
T ss_pred             CCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHH
Confidence            554332  222556679999999875 58999999999999999998 99999999999998765

>KOG0694|consensus

Probab=100.00  E-value=7.8e-43  Score=286.21  Aligned_cols=201  Identities=30%  Similarity=0.519  Sum_probs=180.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .|+++..     +.+++.+|||.+++..  ..++.+..+.|-+++....+||+++.++.+|.+..++|+||||+.
T Consensus       379 GsFG-kV~lae~-----k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~  452 (694)
T KOG0694|consen  379 GSFG-KVLLAEL-----KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA  452 (694)
T ss_pred             CcCc-eEEEEEE-----cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence            8999 9999995     6788999999999763  566667788999999988889999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||++...++.              ..+++..+..|+..++.||.|||++||+|||||.+||+++..|.+||+|||+|...
T Consensus       453 Ggdm~~~~~~--------------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  453 GGDLMHHIHT--------------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             CCcEEEEEec--------------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence            9996555543              36899999999999999999999999999999999999999999999999999754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      ...  .....+..|||.|+|||++.+..|+.++|+||||+++|||+. |..||++.+++|+-+.|.
T Consensus       519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEee~FdsI~  581 (694)
T KOG0694|consen  519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEEEVFDSIV  581 (694)
T ss_pred             CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Confidence            322  234556789999999999999999999999999999999999 999999999999987763

>KOG0661|consensus

Probab=100.00  E-value=1.2e-42  Score=274.62  Aligned_cols=200  Identities=26%  Similarity=0.512  Sum_probs=175.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-CeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~   80 (225)
                      |+|| +||++.     ...+|..||||.++.....-+...-.||+..+++++.||||+++.+++.+.. .+++||||++ 
T Consensus        21 GTfG-sV~la~-----~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-   93 (538)
T KOG0661|consen   21 GTFG-SVYLAK-----SKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-   93 (538)
T ss_pred             Ccce-eEEEee-----ecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-
Confidence            8999 999999     5788999999999977554444567899999999999999999999998877 8999999996 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      -.|.++++..            +..++++.+..|+.||++||+|+|++|++|||+||+||++.....+||+|||+|+...
T Consensus        94 ~NLYqLmK~R------------~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   94 CNLYQLMKDR------------NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             hhHHHHHhhc------------CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence            7899999763            4579999999999999999999999999999999999999988899999999998765


Q ss_pred             CccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..+..   +....|..|+|||++.. ..|+...|+||+||+++|+.+ =++.|.|.++.|.+.+|
T Consensus       162 SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s-LrPLFPG~sE~Dqi~KI  222 (538)
T KOG0661|consen  162 SKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS-LRPLFPGASEIDQIYKI  222 (538)
T ss_pred             cCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH-hcccCCCCcHHHHHHHH
Confidence            54433   23334556999998874 568999999999999999999 88999999999999886

>KOG0610|consensus

Probab=100.00  E-value=1.9e-41  Score=263.83  Aligned_cols=204  Identities=22%  Similarity=0.406  Sum_probs=176.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.-| +||+++.     +.++..+|+|++.+..  ..+...++..|-.||..+. ||.++++|..|+.+...|++||||+
T Consensus        88 GdiG-~VyL~~l-----~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   88 GDIG-TVYLVEL-----RGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             CCce-eEEEEEe-----cCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEEEecCC
Confidence            6779 9999995     5667999999997653  4566677889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||+|..+.+++           ....++++.++.++..++-||+|||-.||++|||||+||++.++|.+.|+||+++...
T Consensus       161 GGdL~~LrqkQ-----------p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  161 GGDLHSLRQKQ-----------PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             CccHHHHHhhC-----------CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999877           3557999999999999999999999999999999999999999999999999987543


Q ss_pred             cCccc------------------------------c------------------------ccccCCCCCccccCCccccC
Q psy15818        160 MTSSV------------------------------Y------------------------ERKSEGRLPIRWMAPESLYD  185 (225)
Q Consensus       160 ~~~~~------------------------------~------------------------~~~~~~~~~~~~~~PE~~~~  185 (225)
                      ...+.                              .                        .+.....||-.|.|||++.|
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            21000                              0                        01112346677999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       186 ~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...+.++|+|+||+++|||+. |..||.+.+..+.+.+|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLy-G~TPFKG~~~~~Tl~NI  347 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLY-GTTPFKGSNNKETLRNI  347 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHh-CCCCcCCCCchhhHHHH
Confidence            999999999999999999999 99999999999888765

>KOG0192|consensus

Probab=100.00  E-value=4.8e-41  Score=268.39  Aligned_cols=197  Identities=34%  Similarity=0.630  Sum_probs=169.9

Q ss_pred             CcccceeeecCCCCCCCCccceE-EEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-CeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCI-VAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~-vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~   78 (225)
                      |+|| +||.+.+       .|.. ||+|++.... ....+..+.+|+.++.+++ ||||+++++++.++. ..++||||+
T Consensus        52 G~~g-~V~~~~~-------~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   52 GSFG-TVYKGKW-------RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             CCce-eEEEEEe-------CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEEEEeC
Confidence            8999 9999996       2445 9999998653 3333678999999999998 999999999998887 799999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEEecCCC-ceeEeeeccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-IIHRDLAARNVLIGENH-CCKVADFGFA  156 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~-i~h~dl~~~nil~~~~~-~~~l~d~g~~  156 (225)
                      ++|+|.+++...           ....++...+..++.||+.|++|||+++ |+||||||+||+++... ++||+|||++
T Consensus       123 ~~GsL~~~l~~~-----------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-----------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CCCcHHHHHhhc-----------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            999999999874           1236899999999999999999999999 99999999999999997 9999999999


Q ss_pred             ccccCccccccccCCCCCccccCCcccc--CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLY--DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .......  .......||+.|||||++.  +..++.++|+||+|+++|||+| |..||.+....++.
T Consensus       192 r~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~~~~~  255 (362)
T KOG0192|consen  192 REKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAPVQVA  255 (362)
T ss_pred             eeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH-CCCCCCCCCHHHHH
Confidence            7543322  2233367889999999999  5689999999999999999999 99999999875443

>KOG0611|consensus

Probab=100.00  E-value=1e-41  Score=265.65  Aligned_cols=200  Identities=23%  Similarity=0.489  Sum_probs=179.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .|-++.     .+..|+.||||.++.+.  .+.+...+++|+.+|..++ ||||+.++.+|+..+.+.+||||..
T Consensus        64 GTYG-KVk~A~-----e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkdKIvivMEYaS  136 (668)
T KOG0611|consen   64 GTYG-KVKLAY-----EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKDKIVIVMEYAS  136 (668)
T ss_pred             Cccc-ceeehh-----hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCceEEEEEEecC
Confidence            7788 666666     67899999999998763  5666778999999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +|.|.+++++..             .+++.+++.+++||++|+.|+|+++++|||||.+||+++.++++||.|||++..+
T Consensus       137 ~GeLYDYiSer~-------------~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  137 GGELYDYISERG-------------SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             CccHHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence            999999998753             7999999999999999999999999999999999999999999999999998766


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      .....   ..+.+|+|-|.+||+..+.+| ++.+|-||||++||.|+. |..||.+.+..-+.++|+
T Consensus       204 ~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVy-GtMPFDG~Dhk~lvrQIs  266 (668)
T KOG0611|consen  204 ADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVY-GTMPFDGRDHKRLVRQIS  266 (668)
T ss_pred             ccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhh-cccccCCchHHHHHHHhh
Confidence            44433   345567888999999999987 688999999999999998 999999999998888874

>KOG0663|consensus

Probab=100.00  E-value=1.3e-41  Score=258.58  Aligned_cols=200  Identities=26%  Similarity=0.472  Sum_probs=174.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (225)
                      |+|| .||+++     ++.+++.||+|.++... ....-....+|+.++.+++ ||||+.+..+.+.  -+.+|+|||||
T Consensus        87 GtyG-iVYRak-----dk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy~VMe~~  159 (419)
T KOG0663|consen   87 GTYG-VVYRAK-----DKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIYIVMEYV  159 (419)
T ss_pred             Ccce-eEEEec-----cCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceeeeeHHHH
Confidence            8999 999999     58899999999998653 2223335789999999998 9999999998764  35699999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      + -||.+++..-            ..++.+.++..++.|+++|++|||++.|+||||||+|+++++.|.+|++|||+|+.
T Consensus       160 E-hDLksl~d~m------------~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  160 E-HDLKSLMETM------------KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             H-hhHHHHHHhc------------cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence            7 7999999764            34789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.+.  ...+....|..|+|||.+.+.. |+.+.|+||+||++.||++ +.+.|.+..+.+++++|
T Consensus       227 ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl~~I  290 (419)
T KOG0663|consen  227 YGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQLDKI  290 (419)
T ss_pred             hcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHHHHH
Confidence            76653  2344445567799999999865 8999999999999999999 99999999999999876

>KOG0197|consensus

Probab=100.00  E-value=2.1e-41  Score=271.39  Aligned_cols=201  Identities=44%  Similarity=0.805  Sum_probs=176.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+      .+...||+|.++.......  .+.+|+.+|++++ |++|+++++++..++.++|||||++.|
T Consensus       217 G~FG-~V~~g~~------~~~~~vavk~ik~~~m~~~--~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  217 GQFG-EVWLGKW------NGSTKVAVKTIKEGSMSPE--AFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             Cccc-eEEEEEE------cCCCcccceEEeccccChh--HHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEEEecccC
Confidence            8999 9999996      4455899999987544332  5779999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.++++..           ....++......++.||++|++||++++++||||...|||++++..+||+|||+++.. .
T Consensus       287 sLl~yLr~~-----------~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~  354 (468)
T KOG0197|consen  287 SLLDYLRTR-----------EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI-G  354 (468)
T ss_pred             cHHHHhhhc-----------CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc-C
Confidence            999999862           3456889999999999999999999999999999999999999999999999999833 2


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +.-.........+..|.|||.+....++.+|||||||++|+|++|.|+.|+.+.+..+.++.+
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l  417 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL  417 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH
Confidence            233334444555667999999999999999999999999999999999999999999998876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.8e-40  Score=269.42  Aligned_cols=202  Identities=23%  Similarity=0.406  Sum_probs=171.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|++....  .......+.+|+.++..+. ||+|+++++.+.+....++||||++
T Consensus        12 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628          12 GAFG-EVRLVQ-----KKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEEEcCCC
Confidence            8999 999998     45678999999997543  2333456778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus        85 gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          85 GGDMMTLLMKK-------------DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            99999998753             25899999999999999999999999999999999999999999999999998644


Q ss_pred             cCcccc---------------------------------ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHH
Q psy15818        160 MTSSVY---------------------------------ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       160 ~~~~~~---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~  206 (225)
                      ......                                 .......+|+.|+|||++.+..++.++|+||+|+++|+|++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            221100                                 00113457889999999999899999999999999999999


Q ss_pred             cCCCCCCCCCHHHHhhhc
Q psy15818        207 LGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       207 ~g~~p~~~~~~~~~~~~i  224 (225)
                       |..||.+.+..+..++|
T Consensus       232 -G~~Pf~~~~~~~~~~~i  248 (363)
T cd05628         232 -GYPPFCSETPQETYKKV  248 (363)
T ss_pred             -CCCCCCCCCHHHHHHHH
Confidence             99999998888777654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588|consensus

Probab=100.00  E-value=6.8e-41  Score=273.79  Aligned_cols=200  Identities=27%  Similarity=0.473  Sum_probs=177.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+-| .|.+|+     |..+|+.+|||++...  ........+.+|+-+|+-+. |||++.++|++++...+|+|.||++
T Consensus        23 Gstg-~vrlak-----h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   23 GSTG-CVRLAK-----HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             CCCc-eehhhh-----cccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEEEEecC
Confidence            5566 666666     7899999999999754  23444456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||.|.+++.++             +++++.++.++++||+.|+.|+|..+|+||||||+|++++..+++||+|||+|..-
T Consensus        96 gGELFdylv~k-------------G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   96 GGELFDYLVRK-------------GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             CchhHHHHHhh-------------CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            99999999865             47999999999999999999999999999999999999998888999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      ..+..   ..+.+|+|.|.+||+..|.+| +.++||||-|++||.|++ |.+||.+.+...++.|+|
T Consensus       163 ~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt-G~LPFdDdNir~LLlKV~  225 (786)
T KOG0588|consen  163 VPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT-GKLPFDDDNIRVLLLKVQ  225 (786)
T ss_pred             cCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh-CCCCCCCccHHHHHHHHH
Confidence            44443   345678899999999999987 678999999999999999 999999999999999875

>KOG0594|consensus

Probab=100.00  E-value=2.5e-40  Score=254.12  Aligned_cols=203  Identities=28%  Similarity=0.497  Sum_probs=172.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCC-eeeeeeEEecCC------CeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPN-VVRLLGCCTEKE------PFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~------~~~l   73 (225)
                      |+|| +||+|+     .+.+|+.||+|.+....+ +-.-....+|+.+++.++ |+| |+.++|++.+.+      .+++
T Consensus        22 Gtyg-~Vykar-----~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~~~~l~l   94 (323)
T KOG0594|consen   22 GTYG-VVYKAR-----SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRGIGKLYL   94 (323)
T ss_pred             CCce-EEEEEE-----EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccccceEEE
Confidence            8999 999999     578889999999986543 223345789999999998 999 999999998766      7899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      |+||++ .+|..++......         ...++...+..+++||+.||+|||+++|+||||||+||+++++|.+||+||
T Consensus        95 vfe~~d-~DL~~ymd~~~~~---------~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   95 VFEFLD-RDLKKYMDSLPKK---------PQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             EEEeec-ccHHHHHHhcccc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence            999996 8999999875421         135677899999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |+|.....+..  .......|..|+|||++.+. .|+...||||+||+++||++ +++.|.+..+.+++.+|
T Consensus       165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~I  233 (323)
T KOG0594|consen  165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRI  233 (323)
T ss_pred             chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Confidence            99985543322  23344456669999999987 68999999999999999999 99999999998887765

>KOG0198|consensus

Probab=100.00  E-value=1.4e-40  Score=258.87  Aligned_cols=192  Identities=28%  Similarity=0.531  Sum_probs=163.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--CeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~   79 (225)
                      |+|| +||++.     +.++|...|||......... ...+.+|+.++.++. |||||++++......  .++++|||++
T Consensus        28 Gs~G-~V~l~~-----~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~mEy~~   99 (313)
T KOG0198|consen   28 GSFG-SVYLAT-----NKKTGELMAVKSVELEDSPT-SESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFMEYAP   99 (313)
T ss_pred             ccce-EEEEEE-----ecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeeeeccC
Confidence            8999 999999     45669999999987664333 556899999999999 999999999754444  6999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeeccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARD  158 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~  158 (225)
                      +|+|.+++...           .+ .+++..+..+.+|+++||+|||++|++|+||||+||+++. ++.+||+|||.+..
T Consensus       100 ~GsL~~~~~~~-----------g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen  100 GGSLSDLIKRY-----------GG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             CCcHHHHHHHc-----------CC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            99999999874           22 6899999999999999999999999999999999999998 69999999998876


Q ss_pred             ccC-ccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        159 LMT-SSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       159 ~~~-~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ... ...........+|+.|||||++... .....+||||+||++.||+| |..||.+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~  224 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSE  224 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchh
Confidence            543 2222334457789999999999853 33459999999999999999 9999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.1e-40  Score=263.36  Aligned_cols=199  Identities=21%  Similarity=0.360  Sum_probs=169.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++.     +..+|+.||+|+++...  .........+|+.++..+. ||||+++++.+...+..++||||++
T Consensus         6 G~~g-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           6 GTFG-KVILVR-----EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            8899 999998     46778999999997643  3334456778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+.+...             ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        79 ~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          79 GGELFFHLSRE-------------RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99998888653             25789999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+.....+.
T Consensus       146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  206 (323)
T cd05571         146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFEL  206 (323)
T ss_pred             ccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhc-CCCCCCCCCHHHHHHH
Confidence            2111  11223457888999999998889999999999999999999 9999998877766554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1026|consensus

Probab=100.00  E-value=2.6e-40  Score=277.33  Aligned_cols=223  Identities=38%  Similarity=0.690  Sum_probs=195.0

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      +|+|| .||+++-..--.......||||.++.......+.++++|+.++..++ |||||+++|++..++.+++|+||+..
T Consensus       496 egaFG-kVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P~~MvFEYm~~  573 (774)
T KOG1026|consen  496 EGAFG-KVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDPLCMVFEYMDH  573 (774)
T ss_pred             Cchhh-hhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCeeEEEEEeccc
Confidence            69999 99999976555566789999999999888888899999999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHG-KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |||.+++....+......-.. ...+++..+.+.++.||+.|+.||.++.++||||...|++++++-.|||+|||+++..
T Consensus       574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdi  653 (774)
T KOG1026|consen  574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDI  653 (774)
T ss_pred             ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhh
Confidence            999999987765433221111 1345889999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      -.............+.+|||||.+..++++..|||||+|++|||+++.|.-||.+...+|.++-||
T Consensus       654 YssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  654 YSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             hhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            444444444455567889999999999999999999999999999999999999999999998775

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-39  Score=259.92  Aligned_cols=201  Identities=28%  Similarity=0.470  Sum_probs=168.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|.++...  ..........|..++.....||||+++++++...+..++||||++
T Consensus         6 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           6 GSFG-KVMLAEL-----KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            8999 9999984     5678899999997643  223333456677777666569999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++...             ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus        80 gg~L~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          80 GGDLMFHIQSS-------------GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999888653             25889999999999999999999999999999999999999999999999998643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..++...+
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~Pf~~~~~~~~~~~i  208 (316)
T cd05592         147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI-GQSPFHGEDEDELFDSI  208 (316)
T ss_pred             CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            2221  12223457888999999998889999999999999999999 99999998887776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=259.40  Aligned_cols=200  Identities=23%  Similarity=0.379  Sum_probs=170.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|.++...  .......+.+|+.++.++. ||||+++++++.+.+..++||||++
T Consensus         4 G~~g-~Vy~~~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   76 (312)
T cd05585           4 GSFG-KVMQVR-----KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN   76 (312)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence            8899 999998     35678899999997542  3344456788999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        77 ~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          77 GGELFHHLQRE-------------GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN  143 (312)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence            99999988653             25789999999999999999999999999999999999999999999999998643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..+++
T Consensus       144 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~  205 (312)
T cd05585         144 MKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKI  205 (312)
T ss_pred             ccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh-CCCCcCCCCHHHHHHHH
Confidence            2221  11223457888999999999899999999999999999999 99999988877765543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-39  Score=259.46  Aligned_cols=199  Identities=21%  Similarity=0.372  Sum_probs=169.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+|+.||+|.++...  .........+|+.++..+. ||||+++++.+...+..++||||++
T Consensus         6 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           6 GTFG-KVILVR-----EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCC
Confidence            8999 999998     45678999999997642  2334445678999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++..++.++.|++.||.|||++|++|+||||+||++++++.++|+|||++...
T Consensus        79 ~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          79 GGELFFHLSRE-------------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99998887643             25789999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+..+.
T Consensus       146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~  206 (323)
T cd05595         146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFEL  206 (323)
T ss_pred             cCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            2211  11223457788999999988889999999999999999999 9999998887766554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-39  Score=260.18  Aligned_cols=217  Identities=45%  Similarity=0.790  Sum_probs=169.7

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-CCeEEEEeecC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVP   79 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   79 (225)
                      .|+|| .||++.........+++.||+|.++..........+.+|+.++..+..||||+++++++... +.++++|||++
T Consensus        17 ~G~fg-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~   95 (338)
T cd05102          17 HGAFG-KVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCK   95 (338)
T ss_pred             cCCcc-eEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCC
Confidence            38999 99999754333445678899999986555555567889999999995599999999988764 46899999999


Q ss_pred             CCCHHHHHHHhhhhhhh--c-----------------------------------------------ccCCCCCCCChHH
Q psy15818         80 YGKLQSFLRSSRAQRYY--N-----------------------------------------------NMHGKSNSLTSRD  110 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~  110 (225)
                      +++|.+++...+.....  .                                               ........+++.+
T Consensus        96 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  175 (338)
T cd05102          96 YGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED  175 (338)
T ss_pred             CCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHH
Confidence            99999999764211000  0                                               0000123578889


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCc
Q psy15818        111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSV  190 (225)
Q Consensus       111 ~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~  190 (225)
                      +..++.|+++||.|||++|++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.
T Consensus       176 ~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  255 (338)
T cd05102         176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT  255 (338)
T ss_pred             HHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCc
Confidence            99999999999999999999999999999999999999999999987543332222222334456799999998888999


Q ss_pred             chhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        191 KSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       191 ~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ++|+||+|+++|+|++.|..||.+....
T Consensus       256 ~sDiwslG~il~el~~~g~~pf~~~~~~  283 (338)
T cd05102         256 QSDVWSFGVLLWEIFSLGASPYPGVQIN  283 (338)
T ss_pred             ccCHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence            9999999999999997699999876543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.7e-40  Score=262.09  Aligned_cols=197  Identities=24%  Similarity=0.418  Sum_probs=170.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.||+|.++...  .......+.+|+.++.++. ||||+++++++.+.+..+++|||+.
T Consensus        29 G~~g-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~  101 (329)
T PTZ00263         29 GSFG-RVRIAKH-----KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFLLEFVV  101 (329)
T ss_pred             cCCe-EEEEEEE-----CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEEEcCCC
Confidence            8899 9999984     5678999999997543  2234456789999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+.+...             ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus       102 ~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263        102 GGELFTHLRKA-------------GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             CChHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            99999988753             25788999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+.++++
T Consensus       169 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  227 (329)
T PTZ00263        169 PDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKI  227 (329)
T ss_pred             CCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            322     123457788999999998889999999999999999999 99999988877766554

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-39  Score=265.97  Aligned_cols=201  Identities=22%  Similarity=0.369  Sum_probs=168.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ...+++.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        12 G~~g-~Vy~~~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626          12 GAFG-EVCLAC-----KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             cCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEEecCC
Confidence            8999 999998     46778999999997543  3344456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..+..++.|++.||++||+.||+||||||+||+++.+++++|+|||++...
T Consensus        85 gg~L~~~l~~~-------------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          85 GGDMMSLLIRM-------------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999998753             25789999999999999999999999999999999999999999999999987532


Q ss_pred             cCccc---------------------------------------------cccccCCCCCccccCCccccCCCCCcchhH
Q psy15818        160 MTSSV---------------------------------------------YERKSEGRLPIRWMAPESLYDNIFSVKSDI  194 (225)
Q Consensus       160 ~~~~~---------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di  194 (225)
                      .....                                             ........+|+.|+|||.+.+..++.++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             000112357889999999988889999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       195 ~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ||+|+++|+|++ |..||...+..+...+
T Consensus       232 wSlG~il~ellt-G~~Pf~~~~~~~~~~~  259 (381)
T cd05626         232 WSVGVILFEMLV-GQPPFLAPTPTETQLK  259 (381)
T ss_pred             eehhhHHHHHHh-CCCCCcCCCHHHHHHH
Confidence            999999999999 9999988877665443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=266.92  Aligned_cols=202  Identities=23%  Similarity=0.382  Sum_probs=168.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|.+....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        12 G~~g-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~   84 (377)
T cd05629          12 GAFG-EVRLVQ-----KKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLIMEFLP   84 (377)
T ss_pred             cCCE-EEEEEE-----ECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEEEeCCC
Confidence            7899 999998     46788999999986542  2334456788999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        85 gg~L~~~l~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          85 GGDLMTMLIKY-------------DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999988653             25789999999999999999999999999999999999999999999999988532


Q ss_pred             cCccc-------------cc--------------------------------cccCCCCCccccCCccccCCCCCcchhH
Q psy15818        160 MTSSV-------------YE--------------------------------RKSEGRLPIRWMAPESLYDNIFSVKSDI  194 (225)
Q Consensus       160 ~~~~~-------------~~--------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di  194 (225)
                      .....             ..                                ......+|+.|+|||++.+..++.++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            11000             00                                0012357888999999998889999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       195 ~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||+|+++|+|++ |..||.+.+..+...+|
T Consensus       232 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i  260 (377)
T cd05629         232 WSLGAIMFECLI-GWPPFCSENSHETYRKI  260 (377)
T ss_pred             Eecchhhhhhhc-CCCCCCCCCHHHHHHHH
Confidence            999999999999 99999988877665543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=261.10  Aligned_cols=197  Identities=26%  Similarity=0.433  Sum_probs=170.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+++.||+|+++...  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        12 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   84 (333)
T cd05600          12 GGYG-QVFLAKK-----KDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAMEYVP   84 (333)
T ss_pred             cCCe-EEEEEEE-----CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEEeCCC
Confidence            8899 9999984     5678899999997643  2234456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        85 g~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          85 GGDFRTLLNNL-------------GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            99999999653             25789999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..     ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+...++
T Consensus       152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i  210 (333)
T cd05600         152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENL  210 (333)
T ss_pred             cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh-CCCCCCCCCHHHHHHHH
Confidence            32     2234457788999999998899999999999999999999 99999988887765543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0585|consensus

Probab=100.00  E-value=1e-39  Score=258.16  Aligned_cols=202  Identities=23%  Similarity=0.420  Sum_probs=167.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-------------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-------------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   68 (225)
                      |+|| .|-+++     +..+++.||+|++.+..             .-...++..+|+.+++++. |||||+++.+..++
T Consensus       108 G~yG-kVkLar-----~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~LiEvLDDP  180 (576)
T KOG0585|consen  108 GQYG-KVKLAR-----DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKLIEVLDDP  180 (576)
T ss_pred             Cccc-eEEEEe-----ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEEEEeecCc
Confidence            8899 999988     67889999999996421             1222357899999999998 99999999999774


Q ss_pred             --CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCC-CChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC
Q psy15818         69 --EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS-LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN  145 (225)
Q Consensus        69 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~  145 (225)
                        ..+|+|+|||..|.+.+.-              .... +++.+++.++.+++.||+|||.+||+||||||+|++++++
T Consensus       181 ~s~~~YlVley~s~G~v~w~p--------------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  181 ESDKLYLVLEYCSKGEVKWCP--------------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             ccCceEEEEEeccCCccccCC--------------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence              5699999999988764332              2234 8999999999999999999999999999999999999999


Q ss_pred             CceeEeeecccccccCcc---ccccccCCCCCccccCCccccCCC----CCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        146 HCCKVADFGFARDLMTSS---VYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       146 ~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      |+|||+|||.+.......   .........|||.|+|||...+..    .+.+.|+||+|+.||+|+. |+.||-+....
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf-G~~PF~~~~~~  325 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF-GQLPFFDDFEL  325 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh-ccCCcccchHH
Confidence            999999999987552221   111222367899999999887633    2678999999999999999 99999999999


Q ss_pred             HHhhhcC
Q psy15818        219 EVMKKSK  225 (225)
Q Consensus       219 ~~~~~i~  225 (225)
                      ++..+|+
T Consensus       326 ~l~~KIv  332 (576)
T KOG0585|consen  326 ELFDKIV  332 (576)
T ss_pred             HHHHHHh
Confidence            9998874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-39  Score=265.36  Aligned_cols=201  Identities=23%  Similarity=0.373  Sum_probs=168.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|.+....  .......+.+|+.++.++. ||||+++++.+.+.+..++||||++
T Consensus        12 G~~g-~Vy~a~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625          12 GAFG-EVCLAR-----KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            8999 999998     46778999999987543  2344456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||.+||++||+||||||+||+++.++.++|+|||++..+
T Consensus        85 gg~L~~~l~~~-------------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          85 GGDMMSLLIRM-------------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999988653             25789999999999999999999999999999999999999999999999987532


Q ss_pred             cCccc---------------------------------------------cccccCCCCCccccCCccccCCCCCcchhH
Q psy15818        160 MTSSV---------------------------------------------YERKSEGRLPIRWMAPESLYDNIFSVKSDI  194 (225)
Q Consensus       160 ~~~~~---------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di  194 (225)
                      .....                                             ........+|+.|+|||++.+..++.++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            10000                                             000112357888999999998899999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       195 ~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ||+||++|+|++ |..||.+.+..+...+
T Consensus       232 wSlGvil~ellt-G~~Pf~~~~~~~~~~~  259 (382)
T cd05625         232 WSVGVILYEMLV-GQPPFLAQTPLETQMK  259 (382)
T ss_pred             EechHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            999999999999 9999998877665543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0589|consensus

Probab=100.00  E-value=7e-40  Score=261.49  Aligned_cols=202  Identities=24%  Similarity=0.409  Sum_probs=181.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-eEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~   79 (225)
                      |+|| .+++++     ++.+++.|++|.+.... ....+....+|+.++.++. ||||+.+.+.|+.++. .+|+|+||+
T Consensus        15 GafG-~a~lvr-----hk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen   15 GAFG-SALLVR-----HKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCIVMEYCE   87 (426)
T ss_pred             cccc-hhhhhh-----hccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEEEEeecC
Confidence            8999 999999     57788899999997653 4444457899999999998 9999999999999998 999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||++.+.+.+++           +..++++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.|+|.|||++..+
T Consensus        88 Gg~l~~~i~~~k-----------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   88 GGDLAQLIKEQK-----------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             CCCHHHHHHHHh-----------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            999999998874           235899999999999999999999999999999999999999999999999999877


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......||+.|++||.+.+.+|..++|+|||||++|||++ =+++|...+-..+..+|
T Consensus       157 ~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~-lk~aF~a~~m~~Li~ki  218 (426)
T KOG0589|consen  157 NPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT-LKPAFKASNMSELILKI  218 (426)
T ss_pred             CCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh-cccccCccchHHHHHHH
Confidence            6554  34556778999999999999999999999999999999999 88999999988887765

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=264.78  Aligned_cols=201  Identities=24%  Similarity=0.440  Sum_probs=170.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|++....  .......+.+|+.++..+. ||||+++++++.+++..++||||++
T Consensus        12 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~   84 (364)
T cd05599          12 GAFG-EVRLVQ-----KKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIMEYLP   84 (364)
T ss_pred             cCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEECCCC
Confidence            8999 999998     45678999999997542  2334456778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus        85 ~g~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          85 GGDMMTLLMKK-------------DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CcHHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            99999998653             25899999999999999999999999999999999999999999999999998644


Q ss_pred             cCccccc------------------------------------cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHH
Q psy15818        160 MTSSVYE------------------------------------RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE  203 (225)
Q Consensus       160 ~~~~~~~------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~  203 (225)
                      .......                                    ......+|+.|+|||++.+..++.++|+||+|+++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            2211000                                    0012347889999999998889999999999999999


Q ss_pred             HHHcCCCCCCCCCHHHHhhh
Q psy15818        204 IVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       204 l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |++ |..||.+.+..+...+
T Consensus       232 l~~-G~~Pf~~~~~~~~~~~  250 (364)
T cd05599         232 MLV-GYPPFCSDNPQETYRK  250 (364)
T ss_pred             hhc-CCCCCCCCCHHHHHHH
Confidence            999 9999998887766554

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=256.65  Aligned_cols=197  Identities=25%  Similarity=0.439  Sum_probs=169.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     ...+++.||+|.+....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        12 G~~g-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   84 (291)
T cd05612          12 GTFG-RVHLVR-----DRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLMEYVP   84 (291)
T ss_pred             CCCe-EEEEEE-----EcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEEeCCC
Confidence            8899 999998     35678999999987542  2234456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          85 GGELFSYLRNS-------------GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            99999998653             25789999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+..+++
T Consensus       152 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~i  210 (291)
T cd05612         152 RDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKI  210 (291)
T ss_pred             cCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            321     123346788999999988889999999999999999999 99999998887766553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.3e-39  Score=258.76  Aligned_cols=201  Identities=25%  Similarity=0.464  Sum_probs=169.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ...+++.||+|+++...  ..........|..++..+..||||+++++++.+.+..++||||++
T Consensus         6 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           6 GSFG-KVMLAR-----LKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CCCe-EEEEEE-----EcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            8999 999998     45678999999987542  233344567788888877669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        80 ~g~L~~~i~~~-------------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          80 GGDLMFHIQKS-------------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             CchHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999888653             25889999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++.+.|
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i  208 (320)
T cd05590         147 IFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAI  208 (320)
T ss_pred             CcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            2111  11223457888999999988889999999999999999999 99999998888776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-39  Score=258.86  Aligned_cols=200  Identities=24%  Similarity=0.378  Sum_probs=170.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+++.||+|++....  .........+|+.++..+. ||||+++++++...+..++||||++
T Consensus         6 G~~g-~Vy~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           6 GTFG-KVILVR-----EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCC
Confidence            8899 999998     46778999999997542  2344456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++.++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        79 ~g~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          79 GGELFFHLSRE-------------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            99998887643             25789999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..+.+
T Consensus       146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         146 ITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI  207 (328)
T ss_pred             CCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh-CCCCCCCCCHHHHHHHh
Confidence            2211  11223457888999999988889999999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0582|consensus

Probab=100.00  E-value=6.1e-39  Score=252.00  Aligned_cols=202  Identities=26%  Similarity=0.443  Sum_probs=174.2

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      +|..+ +||+++-     .-.+..||||++....-......+++|+..+..+. ||||++++-.|..+..+|+||+|+.+
T Consensus        36 ~G~sa-~V~~A~c-----~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWvVmpfMa~  108 (516)
T KOG0582|consen   36 VGASA-VVYLARC-----IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWVVMPFMAG  108 (516)
T ss_pred             cccee-Eeeeeee-----cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEEeehhhcC
Confidence            56777 8999984     55679999999987665555678999999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      |++.++++..-           ...++|..+..+++++++||.|||.+|-+|||||+.||+++.+|.|+|+|||....+.
T Consensus       109 GS~ldIik~~~-----------~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  109 GSLLDIIKTYY-----------PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             CcHHHHHHHHc-----------cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999998863           3358999999999999999999999999999999999999999999999999887654


Q ss_pred             Ccccc-c-cccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVY-E-RKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~-~-~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..... . +.....++++|||||++..  ..|+.++||||||+...||.+ |+.||....+..++
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pPmkvL  241 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPPMKVL  241 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc-CCCCcccCChHHHH
Confidence            33211 1 2245678999999999654  458999999999999999999 99999988876644

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-39  Score=258.04  Aligned_cols=201  Identities=24%  Similarity=0.438  Sum_probs=169.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+++.||+|+++...  ..........|..++..+..||+|+++++++.+.+..++||||++
T Consensus         6 G~~g-~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           6 GSFG-KVMLAEL-----KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            8999 9999983     5678899999997643  233344567788888877569999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          80 GGDLMFQIQRS-------------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999888653             25788999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||...+..+.++++
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i  208 (321)
T cd05591         147 ILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESI  208 (321)
T ss_pred             ccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            2211  11223456788999999988889999999999999999999 99999999888777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-39  Score=265.83  Aligned_cols=201  Identities=23%  Similarity=0.370  Sum_probs=168.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|++....  .......+.+|+.++..+. ||||+++++.+.+.+.+++||||++
T Consensus        12 G~~g-~V~~a~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~   84 (376)
T cd05598          12 GAFG-EVCLVR-----KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVMDYIP   84 (376)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEEeCCC
Confidence            8899 999998     45678999999986542  2233456778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||++||++||+||||||+||+++.++.++|+|||++..+
T Consensus        85 ~g~L~~~i~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          85 GGDMMSLLIRL-------------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999998653             25788999999999999999999999999999999999999999999999987422


Q ss_pred             cCccc-----------------------------------------cccccCCCCCccccCCccccCCCCCcchhHHHHH
Q psy15818        160 MTSSV-----------------------------------------YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG  198 (225)
Q Consensus       160 ~~~~~-----------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg  198 (225)
                      .....                                         ........+|+.|+|||++.+..++.++|+||+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            10000                                         0000123578889999999998899999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        199 VLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       199 ~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +++|+|++ |..||.+.+..+.+.+
T Consensus       232 vilyell~-G~~Pf~~~~~~~~~~~  255 (376)
T cd05598         232 VILYEMLV-GQPPFLADTPAETQLK  255 (376)
T ss_pred             ceeeehhh-CCCCCCCCCHHHHHHH
Confidence            99999999 9999998887765544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.9e-39  Score=262.64  Aligned_cols=200  Identities=23%  Similarity=0.398  Sum_probs=168.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++.     +..+++.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        54 G~fg-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05621          54 GAFG-EVQLVR-----HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEEcCCC
Confidence            8899 999998     46778999999986532  2233345678899999987 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...              .+++..+..++.|++.||++||+++++||||||+||++++++.++|+|||++...
T Consensus       127 gg~L~~~l~~~--------------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         127 GGDLVNLMSNY--------------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             CCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999998643              4788999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCC----CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... ........+|+.|+|||++.+..    ++.++|+||+|+++|+|++ |..||.+.+..+.+.+|
T Consensus       193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~~~~~~~~~i  259 (370)
T cd05621         193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV-GDTPFYADSLVGTYSKI  259 (370)
T ss_pred             ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            3221 11223456788999999987543    6789999999999999999 99999988876666554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-39  Score=259.57  Aligned_cols=198  Identities=24%  Similarity=0.414  Sum_probs=168.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++...    ..++..||+|.+....  .......+.+|+.++..+. ||||+++++++.+.+..++||||+.
T Consensus        41 G~~g-~Vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         41 GSFG-RVILATYK----NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             cCCe-EEEEEEEE----CCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEEEEeCCC
Confidence            8899 99999741    2334789999986542  2334456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus       115 ~g~L~~~i~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        115 GGEFFTFLRRN-------------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999998753             25789999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+.....+++
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i  240 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV-GCPPFYANEPLLIYQKI  240 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            321     223457888999999988889999999999999999999 99999988877666554

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-39  Score=263.26  Aligned_cols=202  Identities=22%  Similarity=0.415  Sum_probs=170.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ...+++.||+|+++...  .......+..|+.++..+. ||+++++++.+.+.+..++||||++
T Consensus        12 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627          12 GAFG-EVRLVQ-----KKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            8899 999998     35678999999997542  2334456778999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++...
T Consensus        85 gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          85 GGDMMTLLMKK-------------DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             CccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999998653             25789999999999999999999999999999999999999999999999998644


Q ss_pred             cCcccc---------------------------------ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHH
Q psy15818        160 MTSSVY---------------------------------ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       160 ~~~~~~---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~  206 (225)
                      ......                                 .......+|+.|+|||++.+..++.++|+||+|+++|+|++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            221000                                 00112357889999999999999999999999999999999


Q ss_pred             cCCCCCCCCCHHHHhhhc
Q psy15818        207 LGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       207 ~g~~p~~~~~~~~~~~~i  224 (225)
                       |..||.+.+..+..+++
T Consensus       232 -G~~Pf~~~~~~~~~~~i  248 (360)
T cd05627         232 -GYPPFCSETPQETYRKV  248 (360)
T ss_pred             -CCCCCCCCCHHHHHHHH
Confidence             99999988887766543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0578|consensus

Probab=100.00  E-value=1.2e-39  Score=262.49  Aligned_cols=198  Identities=29%  Similarity=0.521  Sum_probs=175.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+-| .||.+.     ...+++.||+|.+........ +-+..|+.+|+... |+||+.+++.|-..+.+|+||||++||
T Consensus       284 gaSG-~vy~A~-----~~~~~~~VaiK~m~l~~Q~~k-eLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLWVVMEym~gg  355 (550)
T KOG0578|consen  284 GATG-GVYVAR-----KISTKQEVAIKRMDLRKQPKK-ELLLNEILVMRDLH-HPNIVNFLDSYLVGDELWVVMEYMEGG  355 (550)
T ss_pred             cccc-ceeeee-----eccCCceEEEEEEEeccCCch-hhhHHHHHHHHhcc-chHHHHHHHHhcccceeEEEEeecCCC
Confidence            6778 899888     467888999999976544332 36889999999998 999999999999889999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+...              .++|.++..+++.++.||+|||.+||+|||||.+||++..++++||+|||+|..+..
T Consensus       356 sLTDvVt~~--------------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  356 SLTDVVTKT--------------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             chhhhhhcc--------------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999998654              589999999999999999999999999999999999999999999999999987755


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...  ......|||.|||||+.....|+.+.||||||++++||+. |.+||-..++...+..|
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyLI  481 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLI  481 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCCChHHHHHHH
Confidence            443  4456678999999999999999999999999999999998 99999887777666654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-38  Score=251.14  Aligned_cols=199  Identities=26%  Similarity=0.503  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|.++............+|+.++.++. ||||+++++++.+.+..++||||+++ 
T Consensus        16 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~-   87 (288)
T cd07871          16 GTYA-TVFKGR-----SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLVFEYLDS-   87 (288)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence            8899 999998     456789999999975543333446778999999998 99999999999999999999999974 


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..+..++.|+++||++||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~l~~~l~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          88 DLKQYLDNC------------GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            888887642            22468899999999999999999999999999999999999999999999999864322


Q ss_pred             ccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..  .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+..
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~  215 (288)
T cd07871         156 PT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHL  215 (288)
T ss_pred             CC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            21  11123345778999998865 557899999999999999999 9999998887766543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.1e-39  Score=255.17  Aligned_cols=201  Identities=27%  Similarity=0.434  Sum_probs=168.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+|+.||+|.++...  ..........|..++.....||+++++++++.+.+..++||||+.
T Consensus         6 G~~g-~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           6 GSFG-KVLLAEL-----KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            8999 9999984     5678999999997642  123334566777777766559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|..++...             ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus        80 ~g~L~~~i~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          80 GGDLMFHIQDK-------------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            99999888653             25789999999999999999999999999999999999999999999999987532


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++.+.+
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~Pf~~~~~~~~~~~~  208 (316)
T cd05620         147 VFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI-GQSPFHGDDEDELFESI  208 (316)
T ss_pred             ccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            1111  11223456788999999999899999999999999999999 99999988887776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-38  Score=254.34  Aligned_cols=201  Identities=24%  Similarity=0.435  Sum_probs=168.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.||+|+++...  ..........|..++..+..|++++++++++.+.+..++||||++
T Consensus        11 G~~g-~Vy~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (324)
T cd05587          11 GSFG-KVMLAER-----KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (324)
T ss_pred             ccCe-EEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence            8899 9999983     5678899999997642  233445677888888888856678999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+.+...             ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~g~L~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          85 GGDLMYHIQQV-------------GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999888653             25789999999999999999999999999999999999999999999999988642


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+..+++
T Consensus       152 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i  213 (324)
T cd05587         152 IFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSI  213 (324)
T ss_pred             CCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            2111  11223346788999999999889999999999999999999 99999988887776654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-38  Score=249.48  Aligned_cols=194  Identities=20%  Similarity=0.370  Sum_probs=164.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.+....  .........+|+.++..+. |++++++.+++.+.+..++++||++
T Consensus        11 G~~g-~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631          11 GGFG-EVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             CCCE-EEEEEEE-----ecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEEecC
Confidence            8899 9999984     5678999999987543  2223345678999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...           ....+++..+..++.|++.||++||+.+++|+||||+||++++++.++|+|||++...
T Consensus        84 ~g~L~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          84 GGDLKFHIYNM-----------GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             CCcHHHHHHhh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            99998887543           1235789999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ....   ......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+.
T Consensus       153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~  206 (285)
T cd05631         153 PEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKE  206 (285)
T ss_pred             CCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh-CCCCCCCCCc
Confidence            3221   1223456788999999998899999999999999999999 9999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-38  Score=254.56  Aligned_cols=203  Identities=23%  Similarity=0.418  Sum_probs=168.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| .||++...  .+...++.||+|+++...   ..........|+.+++.+. ||||+++++++...+..+++|||+
T Consensus         7 G~~g-~V~~~~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e~~   82 (323)
T cd05584           7 GGYG-KVFQVRKV--TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILEYL   82 (323)
T ss_pred             cCCe-EEEEEEEc--ccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEeCC
Confidence            8999 99998742  234568999999997542   2233345678999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+.+...             ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          83 SGGELFMHLERE-------------GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CCchHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            999999888653             2578889999999999999999999999999999999999999999999998864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~pf~~~~~~~~~~~~  212 (323)
T cd05584         150 SIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKI  212 (323)
T ss_pred             cccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            32211  11223457888999999988888999999999999999999 99999988877665543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-38  Score=259.33  Aligned_cols=200  Identities=23%  Similarity=0.389  Sum_probs=167.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+++.||+|++....  .......+.+|+.+++.+. ||||+++++.+.+.+..++||||++
T Consensus        54 G~fg-~Vy~~~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv~Ey~~  126 (371)
T cd05622          54 GAFG-EVQLVR-----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEYMP  126 (371)
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            8999 999998     46789999999986432  2333345678888888887 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...              .+++..+..++.|++.||.+||++|++||||||+||+++.++.++|+|||++...
T Consensus       127 gg~L~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         127 GGDLVNLMSNY--------------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             CCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999988643              4788999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCC----CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+|+.|+|||++.+..    ++.++|+||+|+++|+|++ |..||.+.+.....++|
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i  259 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKI  259 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            32211 1123445788999999987543    6789999999999999999 99999988876665543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-38  Score=253.36  Aligned_cols=201  Identities=27%  Similarity=0.466  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.++...  ..........|..++.....||||+++++++.+.+..++||||++
T Consensus         6 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           6 GSFG-KVFLAEL-----KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CCCE-EEEEEEE-----CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            8999 9999984     5678999999997642  223334566677777766559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          80 GGDLMFHIQSC-------------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999988653             25788999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+..+.+
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~i  208 (316)
T cd05619         147 MLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI-GQSPFHGHDEEELFQSI  208 (316)
T ss_pred             CCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            2111  11223346788999999998889999999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0580|consensus

Probab=100.00  E-value=8.1e-40  Score=238.48  Aligned_cols=201  Identities=25%  Similarity=0.472  Sum_probs=178.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||+++     .++++..||+|++..+.  .......+.+|+++...++ ||||++++++|-+....|+++||.+
T Consensus        33 gkFG-~vYlar-----ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLilEya~  105 (281)
T KOG0580|consen   33 GKFG-NVYLAR-----EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLILEYAP  105 (281)
T ss_pred             Cccc-cEeEee-----eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEEEEecC
Confidence            7899 999999     57889999999987653  3334456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      .|++...+...+           ...+++...+.++.|++.|+.|+|..+++||||||+|++++..+..+++|||.+.-.
T Consensus       106 ~gel~k~L~~~~-----------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  106 RGELYKDLQEGR-----------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             CchHHHHHHhcc-----------cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999998653           346899999999999999999999999999999999999999999999999977432


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                          ........++|..|.+||+..+...+..+|+|++|++.||++. |.+||+.....+.+++|+
T Consensus       175 ----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~etYkrI~  235 (281)
T KOG0580|consen  175 ----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSHSETYKRIR  235 (281)
T ss_pred             ----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhhHHHHHHHH
Confidence                1344556678889999999999999999999999999999999 999999999999988874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.4e-38  Score=249.08  Aligned_cols=220  Identities=37%  Similarity=0.677  Sum_probs=172.1

Q ss_pred             CcccceeeecCCCCCC-----------CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC
Q psy15818          2 DCFSVEVRKHPMSPER-----------GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (225)
                      |.|| .||++.+....           ...++..||+|.+...........+.+|+.++.++. ||||+++++++.+.+.
T Consensus        16 G~fg-~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   93 (304)
T cd05096          16 GQFG-EVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPNIIRLLGVCVDEDP   93 (304)
T ss_pred             cCCe-EEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEecCCc
Confidence            8999 99999754322           233566899999987655556667889999999997 9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHhhhhhhhccc------CCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC
Q psy15818         71 FFVIMEYVPYGKLQSFLRSSRAQRYYNNM------HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE  144 (225)
Q Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~  144 (225)
                      .+++|||+.+++|.+++............      ......++...++.++.|++.||.+||+.|++|+||||+||+++.
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~  173 (304)
T cd05096          94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE  173 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcC
Confidence            99999999999999998654321110000      011234677889999999999999999999999999999999999


Q ss_pred             CCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHhhh
Q psy15818        145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL-GSTPYPGMAAAEVMKK  223 (225)
Q Consensus       145 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~-g~~p~~~~~~~~~~~~  223 (225)
                      ++.++|+|||++................++..|+|||.+.+..++.++|+||+|+++|+|+++ +..||.+.+..+.+.+
T Consensus       174 ~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~  253 (304)
T cd05096         174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN  253 (304)
T ss_pred             CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHH
Confidence            999999999998754333222222223346679999998888899999999999999999862 5678988777665543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.4e-38  Score=257.82  Aligned_cols=217  Identities=44%  Similarity=0.769  Sum_probs=173.4

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      .|+|| +||++.++......++..||+|+++..........+.+|+.++..+..||||+++++++.+.+..++||||+++
T Consensus        45 ~G~fG-~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~  123 (375)
T cd05104          45 AGAFG-KVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCY  123 (375)
T ss_pred             CCccc-eEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccC
Confidence            48999 99999866555667788999999986655555567889999999995599999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhh--------------------------------------------------------------cc
Q psy15818         81 GKLQSFLRSSRAQRYY--------------------------------------------------------------NN   98 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~--------------------------------------------------------------~~   98 (225)
                      ++|.+++.........                                                              ..
T Consensus       124 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (375)
T cd05104         124 GDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEI  203 (375)
T ss_pred             CcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHH
Confidence            9999999764311000                                                              00


Q ss_pred             cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCcccc
Q psy15818         99 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM  178 (225)
Q Consensus        99 ~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~  178 (225)
                      .......+++..+..++.|+++||.|||+.+++|+||||+||++++++.++|+|||++................++..|+
T Consensus       204 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  283 (375)
T cd05104         204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM  283 (375)
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCccee
Confidence            00012357888999999999999999999999999999999999999999999999987553332222222233455699


Q ss_pred             CCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       179 ~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      |||.+.+..++.++|+||+|+++|+|++.|..||.+....
T Consensus       284 aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~  323 (375)
T cd05104         284 APESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD  323 (375)
T ss_pred             ChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence            9999998899999999999999999998789999876543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0667|consensus

Probab=100.00  E-value=5.2e-39  Score=262.92  Aligned_cols=197  Identities=24%  Similarity=0.363  Sum_probs=168.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCC-----CCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-----HPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~-----~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| .|-++.     .+++++.||||+++....  .......|+.+|..++.     .-|+++++|+|...+..|||+|
T Consensus       197 GtFG-QVvk~~-----d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE  268 (586)
T KOG0667|consen  197 GSFG-QVVKAY-----DHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE  268 (586)
T ss_pred             cccc-eeEEEE-----ecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence            8999 888888     578999999999986443  33356778888888872     3499999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CCCceeEeeec
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADFG  154 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~~~~~l~d~g  154 (225)
                      .+. .+|.++++.++.           ..++...++.++.||+.+|.+||+.+|+|+||||+|||+.  ....|||+|||
T Consensus       269 LL~-~NLYellK~n~f-----------~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  269 LLS-TNLYELLKNNKF-----------RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             hhh-hhHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            985 899999998743           4589999999999999999999999999999999999996  34579999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++........     .-..+..|+|||++.|.+|+.+.|||||||+++||++ |.+.|.|.++.|+++.|
T Consensus       337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQLARI  400 (586)
T ss_pred             cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhc-CccccCCCCHHHHHHHH
Confidence            9864433221     2223456999999999999999999999999999999 99999999999999876

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-38  Score=253.77  Aligned_cols=201  Identities=24%  Similarity=0.444  Sum_probs=169.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     ...+++.||+|+++...  ..........|..++..+..|++++++++++.+.+..++||||++
T Consensus        11 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~   84 (323)
T cd05615          11 GSFG-KVMLAE-----RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN   84 (323)
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence            8999 999998     35678999999997542  233344567788888888767889999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++.++..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~g~L~~~i~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          85 GGDLMYHIQQV-------------GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            99999888653             25889999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++.+++
T Consensus       152 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i  213 (323)
T cd05615         152 MVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSI  213 (323)
T ss_pred             CCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            2221  11223446788999999988889999999999999999999 99999998877666543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.1e-39  Score=257.26  Aligned_cols=200  Identities=21%  Similarity=0.363  Sum_probs=168.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+++.||+|+++...  ..........|+.++..+. ||||+++++++...+..++||||++
T Consensus         6 G~~g-~V~~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           6 GTFG-KVILVK-----EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCC
Confidence            8999 999998     45678999999997642  2334456678899999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +++|...+...             ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          79 GGELFFHLSRE-------------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            99998887643             257899999999999999999997 7999999999999999999999999998864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+..+.+
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-G~~Pf~~~~~~~~~~~i  208 (325)
T cd05594         146 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI  208 (325)
T ss_pred             cCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeecc-CCCCCCCCCHHHHHHHH
Confidence            32111  11223357788999999988889999999999999999999 99999988877665543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-38  Score=253.89  Aligned_cols=201  Identities=25%  Similarity=0.428  Sum_probs=169.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++...  ..........|..++.....|++++++++++.+.+..++||||++
T Consensus        11 G~~g-~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616          11 GSFG-KVMLAER-----KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            8899 9999983     5678899999997643  233334566777888777669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~g~L~~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          85 GGDLMYQIQQV-------------GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            99999888643             25789999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++...|
T Consensus       152 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i  213 (323)
T cd05616         152 MWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSI  213 (323)
T ss_pred             CCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            2211  11223457788999999999999999999999999999999 99999998887776654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-38  Score=258.73  Aligned_cols=200  Identities=22%  Similarity=0.385  Sum_probs=167.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|.+....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        54 G~~g-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05596          54 GAFG-EVQLVR-----HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEEEcCCC
Confidence            8899 999988     45678999999997532  2233334678899999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...              .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus       127 gg~L~~~l~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         127 GGDLVNLMSNY--------------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             CCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999988643              4788999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCC----CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDN----IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+++.|+|||++.+.    .++.++|+||+|+++|+|++ |..||.+.+..+.+.+|
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i  259 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKI  259 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh-CCCCcCCCCHHHHHHHH
Confidence            32211 122344578899999988653    36889999999999999999 99999988877666554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0032|consensus

Probab=100.00  E-value=2.7e-38  Score=254.55  Aligned_cols=199  Identities=25%  Similarity=0.428  Sum_probs=176.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||.+.     ...+|+.+|+|.++....  ......+.+|+.+|+++.+|||++.+.+.|++...+++|||+|.
T Consensus        46 G~Fg-~v~~~~-----~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~  119 (382)
T KOG0032|consen   46 GQFG-VVYLCR-----EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE  119 (382)
T ss_pred             CCce-EEEEEE-----ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence            8999 999999     567799999999976543  33456799999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC----CCceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE----NHCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~----~~~~~l~d~g~  155 (225)
                      |+.|.+.+...              .+++..+..++.|++.+++|||+.|++|+||||+|+++..    ++.++++|||+
T Consensus       120 GGeLfd~i~~~--------------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  120 GGELFDRIVKK--------------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CchHHHHHHHc--------------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999763              2799999999999999999999999999999999999952    34799999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +.....   ........||+.|+|||++....++..+|+||+|+++|.|++ |..||.+.+..+...+|
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~~~~~~~i  250 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETEFEIFLAI  250 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCChhHHHHHH
Confidence            976544   445667789999999999999999999999999999999999 99999999887766544

>KOG0658|consensus

Probab=100.00  E-value=1.8e-39  Score=249.64  Aligned_cols=197  Identities=28%  Similarity=0.499  Sum_probs=162.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-----CeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-----PFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e   76 (225)
                      |+|| .||.+..     ..+++.||||..-.+..     .--+|+.+|+.+. ||||+++.-+|....     ...+|||
T Consensus        35 GsFg-~Vyq~~~-----~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   35 GSFG-VVYQAKL-----RETEEEVAIKKVLQDKR-----YKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             cccc-eEEEEEE-----cCCCceeEEEEecCCCC-----cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            8999 9999997     45589999999865433     2346889999887 999999998885422     3578999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeeecc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFGF  155 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~g~  155 (225)
                      |++ .+|.+.++....         .+..++...+.-+.+||++||.|||+.||+||||||+|++++ +++.+||||||+
T Consensus       103 ymP-~tL~~~~r~~~~---------~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen  103 YMP-ETLYRVIRHYTR---------ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             hch-HHHHHHHHHHhh---------cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence            997 789999875321         234688899999999999999999999999999999999999 558999999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |..+..+....   .--.+..|+|||.+.|. .|+.+.|+||.||++.||+- |++.|.|.+..+++..|
T Consensus       173 AK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~dQL~eI  238 (364)
T KOG0658|consen  173 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSSVDQLVEI  238 (364)
T ss_pred             ceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCHHHHHHHH
Confidence            98765544332   22335569999999876 58999999999999999998 99999999998888764

>KOG0660|consensus

Probab=100.00  E-value=4.8e-39  Score=246.90  Aligned_cols=202  Identities=26%  Similarity=0.420  Sum_probs=174.9

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeec-cccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-----CCCeEEE
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-----KEPFFVI   74 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   74 (225)
                      .|+|| .|..+.     .+.+|+.||+|.+. .........+..+|+.+++.++ |+||+.+.|++..     -+.+|+|
T Consensus        32 ~GAyG-vVcsA~-----~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~f~DvYiV  104 (359)
T KOG0660|consen   32 RGAYG-VVCSAK-----DKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDKFNDVYLV  104 (359)
T ss_pred             Cccee-eEEEEE-----EcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccccccceeEEe
Confidence            48999 999988     46788999999997 4456667778999999999999 9999999999865     3458999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      +|++ +.||.+.+++.+             .++...+..+++|++.||.|+|+.+++||||||.|++++.+...|++|||
T Consensus       105 ~elM-etDL~~iik~~~-------------~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  105 FELM-ETDLHQIIKSQQ-------------DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             hhHH-hhHHHHHHHcCc-------------cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccc
Confidence            9999 599999998652             48999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +|+.....+.....+....|..|+|||.+.. ..|+.+.||||+||++.||++ |++.|.|.+.-++++.|
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI  240 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLI  240 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHH
Confidence            9987654422333355556778999998864 579999999999999999999 99999999999888765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.4e-38  Score=255.64  Aligned_cols=218  Identities=43%  Similarity=0.750  Sum_probs=172.3

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      .|.|| .||++.........++..||+|.++..........+.+|+.+++.+..||||+++++++...+..++||||+++
T Consensus        48 ~G~fg-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~  126 (374)
T cd05106          48 AGAFG-KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY  126 (374)
T ss_pred             CCCcc-cEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccC
Confidence            48899 99998864333455677899999987655555667889999999995599999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhc---------------------------------------------------------ccCCCC
Q psy15818         81 GKLQSFLRSSRAQRYYN---------------------------------------------------------NMHGKS  103 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~---------------------------------------------------------~~~~~~  103 (225)
                      ++|.+++..........                                                         ......
T Consensus       127 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (374)
T cd05106         127 GDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDS  206 (374)
T ss_pred             CcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCC
Confidence            99999987543210000                                                         000012


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccc
Q psy15818        104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL  183 (225)
Q Consensus       104 ~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~  183 (225)
                      ..+++..++.++.|+++||.|||++|++||||||+||++++++.++|+|||++................++..|+|||++
T Consensus       207 ~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  286 (374)
T cd05106         207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI  286 (374)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHh
Confidence            35788899999999999999999999999999999999999999999999998755433222222222345569999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        184 YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       184 ~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      .+..++.++|+||+|+++|+|++.|..||......+
T Consensus       287 ~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~  322 (374)
T cd05106         287 FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS  322 (374)
T ss_pred             cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence            888899999999999999999976999998765443

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.5e-38  Score=251.70  Aligned_cols=201  Identities=28%  Similarity=0.471  Sum_probs=169.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++...  ..........|..++..+..||||+++++++.+.+..++||||++
T Consensus         6 G~~g-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           6 GSFG-KVLLAEL-----KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            8899 9999984     5678899999998643  233444567888888888669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||++...
T Consensus        80 ~~~L~~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          80 GGDLMFHIQRS-------------GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            99999888653             25889999999999999999999999999999999999999999999999988532


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+....+
T Consensus       147 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~-G~~pf~~~~~~~~~~~i  208 (318)
T cd05570         147 ILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSI  208 (318)
T ss_pred             CcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            1111  11122346788999999999999999999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-38  Score=253.29  Aligned_cols=200  Identities=24%  Similarity=0.415  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHH-HhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||++.     +..+|+.||+|++....  .......+..|... ++.+. ||||+++++.+.+.+..++||||+
T Consensus         6 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           6 GSFG-KVLLAK-----HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCC
Confidence            8899 999999     46778999999997542  22223345555554 45676 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|..++...             ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          79 NGGELFFHLQRE-------------RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             CCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            999999888643             2578999999999999999999999999999999999999999999999998864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..++.+++
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i  208 (323)
T cd05575         146 GIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNI  208 (323)
T ss_pred             cccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc-CCCCCCCCCHHHHHHHH
Confidence            32111  12223457888999999998889999999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.1e-38  Score=252.67  Aligned_cols=199  Identities=27%  Similarity=0.483  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHh---hcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMK---TLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~---~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| .||++..     ..+++.||+|.++...  .......+.+|..++.   .+. ||||+++++++.+.+..++|||
T Consensus        10 G~~g-~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589          10 GHFG-KVLLAEY-----KKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             cCCE-EEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEEEEc
Confidence            8899 9999984     5678999999997543  2233345666666554   455 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+++++|...+..              ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        83 ~~~~~~L~~~~~~--------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          83 YAAGGDLMMHIHT--------------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             CCCCCcHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence            9999999887753              25899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .......  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+...++
T Consensus       149 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-G~~pf~~~~~~~~~~~i  213 (324)
T cd05589         149 KEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV-GESPFPGDDEEEVFDSI  213 (324)
T ss_pred             ccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            6432111  11223457788999999998889999999999999999999 99999998887766543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=260.96  Aligned_cols=206  Identities=24%  Similarity=0.374  Sum_probs=170.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..    ....++.||+|.+.... ......+.+|+.++..+. ||||+++++++...+..++||||++++
T Consensus        78 G~~g-~vy~a~~----~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~E~~~gg  150 (478)
T PTZ00267         78 NPTT-AAFVATR----GSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGG  150 (478)
T ss_pred             CCCc-EEEEEEE----cCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEEEEECCCCC
Confidence            7899 9999973    12226788888775433 233346778999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+.....         ....+++.++..++.|++.||.+||+.+|+||||||+||+++.++.++|+|||++.....
T Consensus       151 ~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        151 DLNKQIKQRLK---------EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             CHHHHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99998865321         123578999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+++.++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~Pf~~~~~~~~~~~~  283 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-LHRPFKGPSQREIMQQV  283 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            322222334457888999999988889999999999999999999 99999988877766543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-38  Score=253.09  Aligned_cols=200  Identities=22%  Similarity=0.400  Sum_probs=164.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHH-HhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||++.     +..+++.||+|++....  .......+..|... ++.+. ||||+++++++...+..++||||+
T Consensus         6 G~fg-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           6 GSFG-KVLLAR-----HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCC
Confidence            8899 999998     35678899999997542  12222344455444 55676 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|.+.+...             ..+++..+..++.|+++||.+||+.|++||||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          79 NGGELFYHLQRE-------------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             CCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            999999888653             2578889999999999999999999999999999999999999999999999864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.++++
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  208 (325)
T cd05602         146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNI  208 (325)
T ss_pred             cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            32211  11223457888999999999889999999999999999999 99999988887766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=258.21  Aligned_cols=202  Identities=23%  Similarity=0.426  Sum_probs=172.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++...  .......+..|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        12 G~~g-~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   84 (350)
T cd05573          12 GAFG-EVWLVRD-----KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLVMEYMP   84 (350)
T ss_pred             CCcE-EEEEEEE-----CCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEEEcCCC
Confidence            8899 9999994     5679999999997543  2234456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          85 GGDLMNLLIRK-------------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            99999998753             25889999999999999999999999999999999999999999999999998755


Q ss_pred             cCcc---------------------------ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        160 MTSS---------------------------VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       160 ~~~~---------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                      ....                           .........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf  230 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPF  230 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc-CCCCC
Confidence            3322                           0011223457888999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHhhhc
Q psy15818        213 PGMAAAEVMKKS  224 (225)
Q Consensus       213 ~~~~~~~~~~~i  224 (225)
                      .+.+..+...++
T Consensus       231 ~~~~~~~~~~~i  242 (350)
T cd05573         231 YSDTLQETYNKI  242 (350)
T ss_pred             CCCCHHHHHHHH
Confidence            988877665543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-38  Score=253.80  Aligned_cols=200  Identities=22%  Similarity=0.396  Sum_probs=165.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHH-HhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||++.     +..+|+.||+|++....  .......+..|... ++.+. ||||+++++++...+..++||||+
T Consensus         6 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           6 GSFG-KVLLAK-----RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCC
Confidence            8999 999998     35678999999997542  22333345566554 45566 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|...+...             ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          79 NGGELFFHLQRE-------------RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             CCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            999998887643             3588999999999999999999999999999999999999999999999999864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||...+..++.+++
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~~  208 (325)
T cd05604         146 GIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPFYCRDVAEMYDNI  208 (325)
T ss_pred             CCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc-CCCCCCCCCHHHHHHHH
Confidence            32111  12233457888999999999889999999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-37  Score=243.87  Aligned_cols=221  Identities=39%  Similarity=0.708  Sum_probs=178.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.............|++|.++..........+.+|+..+..+. |||++++++++...+..++++||++++
T Consensus        16 G~~g-~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~   93 (283)
T cd05048          16 GAFG-KVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHG   93 (283)
T ss_pred             ccCC-cEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCCceEEEEecCCCC
Confidence            7899 99999875444455678999999987666566667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhccc---CCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNM---HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++............   ......+++.+++.++.|++.||.+||+.+++|+||||+||++++++.++|+|||++..
T Consensus        94 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~  173 (283)
T cd05048          94 DLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD  173 (283)
T ss_pred             cHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceee
Confidence            999999764321110000   00114578899999999999999999999999999999999999999999999999865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..............+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++...|
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             ccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            433222222223344677999999988889999999999999999997799999988888877654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-38  Score=252.26  Aligned_cols=200  Identities=23%  Similarity=0.407  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHH-HHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELT-VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||++.     +..+++.||+|++....  .......+..|.. +++.+. ||||+++++.+.+.+..++||||+
T Consensus         6 G~~g-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           6 GSFG-KVLLAK-----RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCC
Confidence            8899 999998     45678999999987542  2233344556655 456676 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|...+...             ..+++..+..++.|+++||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          79 NGGELFFHLQRE-------------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             CCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            999998877542             2578999999999999999999999999999999999999999999999998864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..+.+
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  208 (321)
T cd05603         146 GVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNI  208 (321)
T ss_pred             CCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc-CCCCCCCCCHHHHHHHH
Confidence            32211  11223456788999999988889999999999999999999 99999988877665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4250|consensus

Probab=100.00  E-value=4.8e-39  Score=264.74  Aligned_cols=192  Identities=29%  Similarity=0.495  Sum_probs=169.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv~   75 (225)
                      |+|| .||+++     ++.+|+.||||.++.......++++-+|+.++++++ |||||++.++-++..      ...+||
T Consensus        24 Ga~g-~V~rgr-----nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   24 GAFG-NVYRGR-----NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             Cccc-eeeeec-----ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccceEEE
Confidence            8999 999999     689999999999998777778889999999999999 999999999866544      468999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CCC--ceeEe
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENH--CCKVA  151 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~~--~~~l~  151 (225)
                      |||.||||...+.+..          ....+++.+++.++.++..|+.|||++||+||||||.||++.  .+|  -.||+
T Consensus        97 EyC~gGsL~~~L~~PE----------N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPE----------NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             eecCCCcHHHHhcCcc----------cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence            9999999999997643          345799999999999999999999999999999999999985  323  37999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      |||.|+.+..+.   ......||+.|.+||.+.. ..++..+|.||+|+++|++.| |..||..
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT-G~lPF~p  226 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT-GELPFIP  226 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc-cCCCCCc
Confidence            999998776554   4566788999999999985 778999999999999999999 9999963

>KOG1095|consensus

Probab=100.00  E-value=2.8e-38  Score=273.40  Aligned_cols=214  Identities=46%  Similarity=0.830  Sum_probs=191.8

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      +|+|| .||.+..+.-.+......||+|.++...+......+.+|..+|..+. ||||++++|++-+.+..+|++||+.|
T Consensus       702 ~G~FG-~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~~~~~i~leyM~g  779 (1025)
T KOG1095|consen  702 KGAFG-EVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDSGPPLILLEYMEG  779 (1025)
T ss_pred             ccccc-ceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCCCCcEEEehhccc
Confidence            69999 99999988777766678899999999888888889999999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      |||.+++++.+...+.      ...++..++..++.|+++|+.||+++.++||||...|+|++....||+.|||+|+.+.
T Consensus       780 GDL~sflr~~r~~~~~------~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  780 GDLLSFLRESRPAPFQ------PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             CcHHHHHHhcccccCC------CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            9999999998765543      4568999999999999999999999999999999999999999999999999998554


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .............+..|||||.+.+..++.++||||||+++||+++.|..||.+.+..+++.
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~  915 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL  915 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence            44433333334555679999999999999999999999999999999999999999998876

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.8e-38  Score=252.63  Aligned_cols=191  Identities=25%  Similarity=0.451  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.||+|+++...  .......+.+|..++..+..||||+++++++.+.+..++||||++
T Consensus         6 G~~g-~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           6 GSYA-KVLLVEL-----KKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            8899 9999984     5678999999998643  233344577889999888669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|..++...             ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~g~L~~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          80 GGDLMFHMQRQ-------------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            99998887643             25899999999999999999999999999999999999999999999999988642


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~  198 (329)
T cd05588         147 IRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI  198 (329)
T ss_pred             ccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH-CCCCccc
Confidence            1111  11223456788999999999889999999999999999999 9999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-37  Score=247.33  Aligned_cols=193  Identities=27%  Similarity=0.511  Sum_probs=160.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|++.............+|+.+++.+. ||||+++++++.+....++||||+. +
T Consensus        16 G~~g-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~-~   87 (303)
T cd07869          16 GSYA-TVYKGKS-----KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLVFEYVH-T   87 (303)
T ss_pred             cCCE-EEEEEEE-----CCCCCEEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEEEECCC-c
Confidence            8899 9999984     56789999999976544333446778999999998 9999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...++++.+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~l~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          88 DLCQYMDKH------------PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            787777542            23578899999999999999999999999999999999999999999999998864322


Q ss_pred             ccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ..  .......+++.|+|||++.+ ..++.++|+||+|+++|+|++ |..||.+..+
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  209 (303)
T cd07869         156 PS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKD  209 (303)
T ss_pred             CC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCcc
Confidence            21  11223446778999998865 457889999999999999999 9999987543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-37  Score=244.35  Aligned_cols=196  Identities=21%  Similarity=0.335  Sum_probs=163.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|.+.....  ......+..|+.++..+. ||+++++.+++...+..+++|||++
T Consensus         4 G~~g-~Vy~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   76 (280)
T cd05608           4 GGFG-EVSACQM-----RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN   76 (280)
T ss_pred             CCce-eEEEEEE-----ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence            8999 9999983     56789999999875432  223345678999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+.....         ....+++..+..++.|+++||.|||+.+++|+||||+||++++++.++|+|||.+...
T Consensus        77 ~g~L~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  147 (280)
T cd05608          77 GGDLRYHIYNVDE---------ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL  147 (280)
T ss_pred             CCCHHHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence            9999888754211         2235899999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .....  ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||....
T Consensus       148 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  201 (280)
T cd05608         148 KDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRARG  201 (280)
T ss_pred             CCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Confidence            33221  1223356778999999999999999999999999999999 999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-37  Score=238.04  Aligned_cols=202  Identities=37%  Similarity=0.696  Sum_probs=168.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|.+......+....+.+|+.+++.+. ||||+++++++...+..++|+||+.++
T Consensus         6 g~~g-~vy~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           6 GNFG-EVFSGRL-----RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             ccCc-cEEEEEE-----ecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            7899 9999984     55788999999876555556667899999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.+++.++.|+++||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~L~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          79 DFLTFLRTE------------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             cHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc
Confidence            999988642            23578999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ............+..|+|||.+.+..++.++|+||+|+++|++++.|..||......+...
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~  207 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE  207 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence            2111111111223469999999888899999999999999999977999998777665544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-38  Score=253.56  Aligned_cols=203  Identities=27%  Similarity=0.456  Sum_probs=170.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||+++..  .+..+|+.||+|+++... .........+|+.++.++. ||||+++++++.+.+..++||||+.+
T Consensus         7 G~~g-~Vy~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~   82 (318)
T cd05582           7 GSFG-KVFLVRKI--TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDFLRG   82 (318)
T ss_pred             CCCE-EEEEEEEe--ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcCCCC
Confidence            8899 99988732  234578999999997643 2333445678999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+...             ..+++..++.++.|+++||.|||+.|++|+||||+||++++++.++|+|||++....
T Consensus        83 ~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          83 GDLFTRLSKE-------------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            9999888643             257999999999999999999999999999999999999999999999999886442


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+..+
T Consensus       150 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i  210 (318)
T cd05582         150 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMI  210 (318)
T ss_pred             CCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHH
Confidence            221  11223456788999999988888999999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-38  Score=254.76  Aligned_cols=201  Identities=24%  Similarity=0.401  Sum_probs=168.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|.++...  .......+.+|+.++..+. ||+|+++++++.+.+..++||||++
T Consensus        12 G~~g-~Vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   84 (330)
T cd05601          12 GHFG-EVQVVR-----EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLVMEYQP   84 (330)
T ss_pred             ccCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEEECCCC
Confidence            7899 999998     45678999999998653  2334455778888888887 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....            ..+++..+..++.|++.||.+||+.+++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~l~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          85 GGDLLSLLNRYE------------DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            999999997641            35899999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCcccc------CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY------DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...... ......+++.|+|||++.      +..++.++|+||+|+++|+|++ |..||...+..+.+.+
T Consensus       153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~  220 (330)
T cd05601         153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNN  220 (330)
T ss_pred             CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc-CCCCCCCCCHHHHHHH
Confidence            332221 122335678899999886      4556789999999999999999 9999988777665554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.2e-38  Score=251.19  Aligned_cols=191  Identities=24%  Similarity=0.446  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|+++...  .......+.+|..++.++..||+|+++++++.+.+.+++||||++
T Consensus         6 G~~g-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           6 GSYA-KVLLVRL-----KKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            8999 9999984     6778999999998643  233445577889999888779999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|..++...             ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~L~~~~~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          80 GGDLMFHMQRQ-------------RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            99998888643             25899999999999999999999999999999999999999999999999988642


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||..
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~-g~~pf~~  198 (327)
T cd05617         147 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDI  198 (327)
T ss_pred             cCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh-CCCCCCc
Confidence            2111  11223457888999999999899999999999999999999 9999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0033|consensus

Probab=100.00  E-value=5.3e-39  Score=235.50  Aligned_cols=200  Identities=25%  Similarity=0.404  Sum_probs=175.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|+ .||++-     +..+|+.+|+|++... ......+.+.+|+++.+.++ ||||+++++.+.+.+..|+|+|+++|
T Consensus        22 G~FS-vVrRc~-----~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~ylvFe~m~G   94 (355)
T KOG0033|consen   22 GAFS-VVRRCV-----HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTG   94 (355)
T ss_pred             CchH-HHHHHH-----hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhcccceeEEEEecccc
Confidence            7899 888888     5788999999998644 23335567899999999999 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~  157 (225)
                      ++|...+....             -.+|..+..++.||+++|+|+|.+||+|||+||+|+++.   .+--+||+|||.+.
T Consensus        95 ~dl~~eIV~R~-------------~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   95 GELFEDIVARE-------------FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             hHHHHHHHHHH-------------HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence            99988876541             368999999999999999999999999999999999995   34469999999998


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      .++   .........|||.|++||++...+++..+|||+-|++||-++. |.+||.+.+...+.++|+
T Consensus       162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rlye~I~  225 (355)
T KOG0033|consen  162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYEQIK  225 (355)
T ss_pred             EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHh
Confidence            765   2334455678999999999999999999999999999999999 999999998888888774

>KOG0599|consensus

Probab=100.00  E-value=1.7e-38  Score=236.20  Aligned_cols=190  Identities=25%  Similarity=0.449  Sum_probs=163.5

Q ss_pred             CCccceEEEEeeecccc-------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHh
Q psy15818         18 GREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS   90 (225)
Q Consensus        18 ~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   90 (225)
                      ++.+|+.+|+|++....       ...-++...+|+.+++++.+||+|+++.|+++.+..+++|+|.++-|.|.+++.+.
T Consensus        38 ~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~  117 (411)
T KOG0599|consen   38 HKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK  117 (411)
T ss_pred             hcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh
Confidence            57888999999985321       22334456789999999999999999999999999999999999999999999875


Q ss_pred             hhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccC
Q psy15818         91 RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE  170 (225)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  170 (225)
                      -             .+++.+.+.+++|+++++.|||.++|+||||||+||+++++-+++|+|||++..+..+.   ....
T Consensus       118 V-------------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLre  181 (411)
T KOG0599|consen  118 V-------------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRE  181 (411)
T ss_pred             e-------------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch---hHHH
Confidence            3             58999999999999999999999999999999999999999999999999998765443   3456


Q ss_pred             CCCCccccCCccccC------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        171 GRLPIRWMAPESLYD------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       171 ~~~~~~~~~PE~~~~------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .+|||+|.|||.+..      ..|+..+|+|+.|+++|.++. |.+||-.....-++..|
T Consensus       182 lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwHRkQmlMLR~I  240 (411)
T KOG0599|consen  182 LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFWHRKQMLMLRMI  240 (411)
T ss_pred             hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchhHHHHHHHHHHH
Confidence            788999999998864      346778999999999999999 99999877666665554

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.4e-38  Score=251.13  Aligned_cols=202  Identities=22%  Similarity=0.328  Sum_probs=167.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|++....  .......+..|..++..+. |++|+++++++.+.+..++||||++
T Consensus        12 G~fg-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv~Ey~~   84 (331)
T cd05624          12 GAFG-EVAVVKM-----KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLVMDYYV   84 (331)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            8899 9999984     5678899999987532  2233344677888888887 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...            ...+++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        85 gg~L~~~l~~~------------~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          85 GGDLLTLLSKF------------EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             CCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            99999999753            135789999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+++.|+|||++.+     ..++.++|+||+|+++|+|++ |..||.+.+..+...++
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i  220 (331)
T cd05624         153 NQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI  220 (331)
T ss_pred             cCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh-CCCCccCCCHHHHHHHH
Confidence            33221 11223457888999998865     457889999999999999999 99999988777665543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-37  Score=246.97  Aligned_cols=195  Identities=27%  Similarity=0.408  Sum_probs=169.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.     ...++..||+|.+...........+.+|+.++.+++ ||||+++++++...+..++||||++++
T Consensus        16 G~~g-~V~~~~-----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (331)
T cd06649          16 GNGG-VVTKVQ-----HKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGG   88 (331)
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEeecCCCC
Confidence            8899 999998     466789999999987655556667899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus        89 ~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          89 SLDQVLKEA-------------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             cHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            999998753             2578999999999999999999986 69999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...    .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..++.
T Consensus       156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~  211 (331)
T cd06649         156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI-GRYPIPPPDAKELE  211 (331)
T ss_pred             ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            221    223346778999999998889999999999999999999 99999877766543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.9e-37  Score=240.64  Aligned_cols=221  Identities=37%  Similarity=0.656  Sum_probs=178.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..........++.||+|.++.....+....+.+|+.+++.+. |||++++++++...+..+++|||++++
T Consensus        16 g~~~-~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   93 (280)
T cd05049          16 GAFG-KVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHG   93 (280)
T ss_pred             cCCc-eEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCCCeEEEEecCCCC
Confidence            7899 99999875544456678999999987655555668899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc-cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNN-MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++........... .......+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        94 ~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~  173 (280)
T cd05049          94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY  173 (280)
T ss_pred             CHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecc
Confidence            99999976432111000 01123457889999999999999999999999999999999999999999999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .............++.|+|||.+.+..++.++|+||+|+++++|++.|..||.+.+..+..+.+
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             cCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            2222122223334567999999999899999999999999999997799999888877766654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0193|consensus

Probab=100.00  E-value=1.8e-38  Score=257.31  Aligned_cols=198  Identities=27%  Similarity=0.469  Sum_probs=170.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.|     +   -.||||++.... ..+..+.+..|+..+++-+ |.||+-+.|++..++. .||..+|+|
T Consensus       403 GsFG-tV~Rg~w-----h---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AIiTqwCeG  471 (678)
T KOG0193|consen  403 GSFG-TVYRGRW-----H---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AIITQWCEG  471 (678)
T ss_pred             cccc-ceeeccc-----c---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-eeeehhccC
Confidence            8999 9999998     2   259999998653 5556778999999999998 9999999999988876 999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      .+|..+++-.+            .++...+.+.|+.|+++|+.|||.++|+|+|||..|||+.+++.|+|+|||++..-.
T Consensus       472 sSLY~hlHv~e------------tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  472 SSLYTHLHVQE------------TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             chhhhhccchh------------hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            99999998654            368889999999999999999999999999999999999999999999999997544


Q ss_pred             CccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .-..........++..|||||+++   ..+|+..+||||||+++|||++ |.+||...+.++++..
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt-g~lPysi~~~dqIifm  604 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT-GELPYSIQNRDQIIFM  604 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh-CcCCcCCCChhheEEE
Confidence            333333444555677899999887   4568999999999999999999 9999998887777654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=249.66  Aligned_cols=201  Identities=22%  Similarity=0.346  Sum_probs=166.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ...+++.||+|++....  .......+.+|..++..+. |++|+++++++.+.+..++||||++
T Consensus        12 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   84 (331)
T cd05597          12 GAFG-EVAVVK-----MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLVMDYYV   84 (331)
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEEEecCC
Confidence            8899 999998     45678999999997532  2333445778888888887 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...            ...+++..+..++.|++.||++||+++++|+||||+||+++.++.++|+|||++...
T Consensus        85 g~~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          85 GGDLLTLLSKF------------EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             CCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            99999998652            235789999999999999999999999999999999999999999999999988654


Q ss_pred             cCccccccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..... .......+++.|+|||++..     ..++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~  219 (331)
T cd05597         153 LADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  219 (331)
T ss_pred             CCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh-CCCCCCCCCHHHHHHH
Confidence            32221 11122357888999998863     446789999999999999999 9999998777665544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=253.56  Aligned_cols=201  Identities=20%  Similarity=0.372  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |+|| +||++.     +..+++.||+|++....  ..........|..++....  .||+|+++++++.+....++||||
T Consensus         4 G~~g-~Vy~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~   77 (330)
T cd05586           4 GTFG-QVYQVR-----KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY   77 (330)
T ss_pred             CCce-EEEEEE-----ECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence            8999 999998     46778999999986532  2223334555666666553  699999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +++++|.+.+...             ..+++..+..++.|+++||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          78 MSGGELFWHLQKE-------------GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             CCCChHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            9999999888643             358899999999999999999999999999999999999999999999999886


Q ss_pred             cccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......  .......+++.|+|||++.+. .++.++|+||+|+++|+|++ |..||.+.+..+.++++
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~i  209 (330)
T cd05586         145 ANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPFYAEDTQQMYRNI  209 (330)
T ss_pred             CCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc-CCCCCCCCCHHHHHHHH
Confidence            432211  112234578889999988764 47899999999999999999 99999988887776654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.5e-38  Score=250.57  Aligned_cols=190  Identities=24%  Similarity=0.455  Sum_probs=161.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++...  .......+.+|+.++.++..||||+++++++.+.+..++||||++
T Consensus         6 G~~g-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           6 GSYA-KVLLVRL-----KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            8899 9999984     5778999999998642  333444577888888887669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          80 GGDLMFHMQRQ-------------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99998887643             25899999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      ....  .......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~  197 (329)
T cd05618         147 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFD  197 (329)
T ss_pred             cCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh-CCCCCc
Confidence            2111  11223456788999999999889999999999999999999 999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.7e-38  Score=250.85  Aligned_cols=196  Identities=21%  Similarity=0.387  Sum_probs=162.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||+++.  ..+..+++.||+|++....   ..........|+.++..+..||+|+++++++...+.+++||||+
T Consensus        11 G~~g-~Vy~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (332)
T cd05614          11 GAYG-KVFLVRK--VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYV   87 (332)
T ss_pred             cCCE-EEEEEEE--cccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCC
Confidence            8999 9999874  2234568999999997542   22334457789999999977999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|.+.+...             ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        88 ~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          88 SGGEMFTHLYQR-------------DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             CCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999988653             2578999999999999999999999999999999999999999999999999865


Q ss_pred             ccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |..||...
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  210 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPFTLE  210 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc-CCCCCCCC
Confidence            4322211 11234578889999998765 47889999999999999999 99999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.7e-37  Score=239.33  Aligned_cols=206  Identities=31%  Similarity=0.605  Sum_probs=170.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+...  ...+..||+|.++..........+.+|+..+..+. |||++++++++...+..++||||++++
T Consensus        16 G~fg-~V~~~~~~~~--~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   91 (266)
T cd05064          16 GRFG-ELCRGCLKLP--SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTMMIVTEYMSNG   91 (266)
T ss_pred             cCCC-eEEEEEEecC--CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCcEEEEEeCCCC
Confidence            8899 9999874221  34578999999987655555567889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||++||+.+++|+||||+||+++.++.++++|||.+.....
T Consensus        92 ~L~~~l~~~------------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          92 ALDSFLRKH------------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             cHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999998653            23578999999999999999999999999999999999999999999999997654322


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... .......++..|+|||.+.+..++.++|+||+|+++|++++.|..||.+.+..+.++.+
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~  221 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV  221 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            211 11112334567999999988889999999999999999875599999988887766553

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-37  Score=244.55  Aligned_cols=198  Identities=27%  Similarity=0.493  Sum_probs=164.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..     ..+++.||+|+++... .........+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07848          12 GAYG-VVLKCRH-----KETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVFEYVEK   84 (287)
T ss_pred             cCCE-EEEEEEE-----CCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEEecCCC
Confidence            7899 9999984     5678899999997543 2333456788999999998 99999999999999999999999997


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +.+..+...             ...+++..++.++.|++.||.+||+.+++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~~l~~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          85 NMLELLEEM-------------PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             CHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            766544321             2357899999999999999999999999999999999999999999999999987653


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..... ......+++.|+|||++.+..++.++|+||+|+++|+|++ |.+||.+.+..+.+
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~pf~~~~~~~~~  210 (287)
T cd07848         152 EGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD-GQPLFPGESEIDQL  210 (287)
T ss_pred             ccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            32211 1223346778999999988889999999999999999999 99999987765543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.8e-37  Score=240.15  Aligned_cols=220  Identities=35%  Similarity=0.649  Sum_probs=175.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.........++..+|+|.+.... ......+.+|+.++.++. |||++++++++...+..++++||++++
T Consensus        16 G~~~-~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (288)
T cd05093          16 GAFG-KVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHG   92 (288)
T ss_pred             cCCe-eEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCccEEEEEcCCCC
Confidence            7899 9999986554445667889999987543 233456889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..................+++..++.++.|++.||++||++|++|+||||+||++++++.++|+|||.+.....
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  172 (288)
T cd05093          93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS  172 (288)
T ss_pred             CHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccC
Confidence            99999975432111100001223589999999999999999999999999999999999999999999999999875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........++..|+|||.+.+..++.++|+||||+++++|+++|..||......+...++
T Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             CceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            322222223334567999999988889999999999999999998789999988877765543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-36  Score=238.38  Aligned_cols=217  Identities=39%  Similarity=0.700  Sum_probs=172.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+..........+..||+|.+...........+.+|+.+++.+. |||++++++++.+.+..++||||++++
T Consensus        17 G~~g-~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~~~   94 (277)
T cd05062          17 GSFG-MVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRG   94 (277)
T ss_pred             ccCC-eEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCeEEEEecCCCC
Confidence            7899 99998753322344578899999876544445556889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...+......   .....++...+..++.|+++||.+||+.+++|+||||+||++++++.++|+|||++.....
T Consensus        95 ~L~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  171 (277)
T cd05062          95 DLKSYLRSLRPEMENN---PVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE  171 (277)
T ss_pred             CHHHHHHHcCcccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCC
Confidence            9999987643211000   0112457788999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........+++.|+|||.+.+..++.++|+||||+++|+|+++|..||.+.+..+..+.
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             cceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            32222222233456799999998888999999999999999999867899998887766543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-36  Score=249.07  Aligned_cols=215  Identities=46%  Similarity=0.813  Sum_probs=172.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..........+..||+|.++..........+.+|+.++..+.+||||+++++++.+.+..++||||++++
T Consensus        48 G~fG-~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g  126 (400)
T cd05105          48 GAFG-KVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYG  126 (400)
T ss_pred             CCCc-eEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCC
Confidence            8999 999998654444556778999999866555556678999999999977999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc---------------------------------------------------------------
Q psy15818         82 KLQSFLRSSRAQRYYNN---------------------------------------------------------------   98 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~---------------------------------------------------------------   98 (225)
                      +|.+++...........                                                               
T Consensus       127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (400)
T cd05105         127 DLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRS  206 (400)
T ss_pred             cHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccC
Confidence            99999876532110000                                                               


Q ss_pred             --------------------cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         99 --------------------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        99 --------------------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                                          .......+++..+..++.|+++||.|||+.+++|+||||+||++++++.++|+|||++..
T Consensus       207 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~  286 (400)
T cd05105         207 NYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARD  286 (400)
T ss_pred             cccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCccee
Confidence                                000123478888999999999999999999999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ..............+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.....
T Consensus       287 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             ccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            43332222222334556799999998888999999999999999999768899986543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-37  Score=241.64  Aligned_cols=210  Identities=36%  Similarity=0.692  Sum_probs=175.1

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      +|.|| .||++.+.. .....+..|+||.++.....+....+.+|+..+.+++ ||||+++++++...+..++|+||+++
T Consensus         9 ~G~fg-~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~lv~e~~~~   85 (259)
T PF07714_consen    9 EGSFG-KVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFLVMEYCPG   85 (259)
T ss_dssp             EESSE-EEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEEEEE--TT
T ss_pred             cCCCc-EEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccc-cccccccccccccccccccccccccc
Confidence            48999 999999865 4455689999999977666666778999999999996 99999999999988889999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...           ....++...+..++.|++.||.|||+++++|++|+++||++++++.+||+|||++....
T Consensus        86 g~L~~~L~~~-----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   86 GSLDDYLKSK-----------NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EBHHHHHHHT-----------CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccc-----------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999875           12358899999999999999999999999999999999999999999999999987653


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ................|+|||.+.+..++.++||||||++++|+++.|..||.+.+..++..++
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~  218 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL  218 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3322233334445567999999988889999999999999999999778999999888876654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-36  Score=239.27  Aligned_cols=221  Identities=34%  Similarity=0.601  Sum_probs=176.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..........++.||+|.++..........+.+|+.++..+. ||||+++++++.+.+..++++||+.++
T Consensus        16 G~~g-~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~~~~e~~~~~   93 (283)
T cd05091          16 DRFG-KVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQPLSMIFSYCSHS   93 (283)
T ss_pred             CCCC-eEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCceEEEEEcCCCC
Confidence            7899 99999865544455678999999986655555566888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc---cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++...........   .......+++..+..++.|++.||.+||+.|++|+||||+||++++++.++|+|||++..
T Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (283)
T cd05091          94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE  173 (283)
T ss_pred             cHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccc
Confidence            99999864321100000   000123478888999999999999999999999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...............++.|+|||.+.+..++.++|+||+|+++++|+++|..||.+....+..+.+
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             cccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            533322222223334567999999988889999999999999999998799999998888777654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-37  Score=256.70  Aligned_cols=205  Identities=22%  Similarity=0.325  Sum_probs=170.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--------CeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--------PFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--------~~~   72 (225)
                      |.|| +||++..     ..+++.||+|.+... ..........+|+..+..+. |++++++++.+....        .++
T Consensus        43 G~fG-~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~~~~~~~i~  115 (496)
T PTZ00283         43 GATG-TVLCAKR-----VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRNPENVLMIA  115 (496)
T ss_pred             CCCE-EEEEEEE-----cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccCcccceEEE
Confidence            8999 9999983     567899999998754 34455566788999999997 999999988775432        268


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +||||+++++|.+.+.....         ....+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|
T Consensus       116 lV~Ey~~~gsL~~~l~~~~~---------~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        116 LVLDYANAGDLRQEIKSRAK---------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             EEEeCCCCCcHHHHHHHhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence            99999999999999875421         234688999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ||++................+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+++.+
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt-G~~Pf~~~~~~~~~~~  256 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHK  256 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence            999875533322222234457888999999999889999999999999999999 9999998887776654

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-36  Score=238.48  Aligned_cols=194  Identities=23%  Similarity=0.375  Sum_probs=162.4

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      .|.|| +||++..     ..+|+.||+|.+.....  .........|+.++..+. ||||+++++.+.+....+++|||+
T Consensus         3 ~G~~g-~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           3 KGGFG-EVCAVQV-----KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCce-EEEEEEE-----ccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecC
Confidence            38999 9999984     56799999999865322  122234567899999997 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|++|.+.+....           ...+++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~g~~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~  144 (277)
T cd05607          76 NGGDLKYHIYNVG-----------ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE  144 (277)
T ss_pred             CCCCHHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence            9999988875431           23478889999999999999999999999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ......   .....++..|+|||++.+..++.++|+||+|+++|+|++ |..||.+..
T Consensus       145 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~p~~~~~  198 (277)
T cd05607         145 LKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHK  198 (277)
T ss_pred             cCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCc
Confidence            533221   123456778999999988889999999999999999999 999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=240.57  Aligned_cols=198  Identities=19%  Similarity=0.346  Sum_probs=165.6

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      .|.|| +||++..     ..+++.||+|.+.....  ........+|+.+++.++ |||++++++.+.++...+++|||+
T Consensus        10 ~G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605          10 KGGFG-EVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             cCCCe-EEEEEEE-----cCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEEecc
Confidence            38999 9999984     56789999999875432  222345678999999997 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|...+...           ....+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++..
T Consensus        83 ~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          83 NGGDLKFHIYNM-----------GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             CCCcHHHHHHhc-----------CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            999999887643           123588999999999999999999999999999999999999999999999998865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      .....   ......+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+....
T Consensus       152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~-g~~pf~~~~~~~~  209 (285)
T cd05605         152 IPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVK  209 (285)
T ss_pred             cCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH-CCCCCCCCchhhH
Confidence            43221   1123356778999999988889999999999999999999 9999998766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4717|consensus

Probab=100.00  E-value=2.3e-37  Score=247.47  Aligned_cols=200  Identities=24%  Similarity=0.415  Sum_probs=173.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|. .|-+++     +..+|..||||++.+. ...-....+.+|++.|+.++ ||||+++|.+...+..+|||+|+-++
T Consensus        29 GHFA-VVKLAr-----HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKlyLiLELGD~  101 (864)
T KOG4717|consen   29 GHFA-VVKLAR-----HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKLYLILELGDG  101 (864)
T ss_pred             Ccee-hhhhhh-----hhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceEEEEEEecCC
Confidence            5555 555555     7999999999999765 34555567899999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~g~~~~~  159 (225)
                      |+|.+++-++            ...++|.....|++||+.|+.|+|+.-++||||||+|+++. .-|-|||.|||+...+
T Consensus       102 GDl~DyImKH------------e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen  102 GDLFDYIMKH------------EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             chHHHHHHhh------------hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999874            34789999999999999999999999999999999998775 6788999999999876


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .++.   .....+|+..|.|||++.|..| .+++||||||++||.|++ |++||+..++.|.+-+|
T Consensus       170 ~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTmI  231 (864)
T KOG4717|consen  170 QPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTMI  231 (864)
T ss_pred             CCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh-CCCccccccchhhhhhh
Confidence            5543   3456677888999999998876 689999999999999998 99999999999887655

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.5e-37  Score=246.59  Aligned_cols=197  Identities=22%  Similarity=0.414  Sum_probs=160.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (225)
                      |.|| .||++.     +..+++.||+|.+.... ......++.+|+.+++.++ ||||+++++++...     ...++||
T Consensus        11 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv~   83 (338)
T cd07859          11 GSYG-VVCSAI-----DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVF   83 (338)
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceEEEEE
Confidence            8899 999998     45778999999987532 2233446789999999998 99999999987543     2479999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+. ++|.+.+...             ..+++..+..++.|+++||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus        84 e~~~-~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          84 ELME-SDLHQVIKAN-------------DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             ecCC-CCHHHHHHhc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence            9995 6888887643             2578999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccc-cccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        156 ARDLMTSSV-YERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      +........ ........+++.|+|||++.+  ..++.++|+||+|+++|+|++ |.+||.+.+..+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t-g~~pf~~~~~~~~  216 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ  216 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Confidence            865422211 111223457788999998865  568899999999999999999 9999988765443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.9e-37  Score=240.53  Aligned_cols=221  Identities=47%  Similarity=0.873  Sum_probs=176.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.............+|+|.+...........+.+|+.++..+..|||++++++++...+..+++|||++++
T Consensus        23 g~~g-~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~  101 (293)
T cd05053          23 GAFG-QVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG  101 (293)
T ss_pred             cccc-cEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCC
Confidence            7899 999998644433456789999999865555555678899999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccC---CCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMH---GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++.............   .....+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||.+..
T Consensus       102 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~  181 (293)
T cd05053         102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD  181 (293)
T ss_pred             cHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccc
Confidence            9999997643211111100   1234688999999999999999999999999999999999999999999999999876


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...............+..|+|||.+.+..++.++|+||+|+++|++++.|..||.+....+..+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             cccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            54332222222233455699999988888999999999999999999779999998877666553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.7e-37  Score=240.82  Aligned_cols=202  Identities=27%  Similarity=0.507  Sum_probs=161.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEe-----cCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLD--PHPNVVRLLGCCT-----EKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~-----~~~~~~l   73 (225)
                      |.|| +||++...    ..+++.||+|.++.... ........+|+.++..+.  .||||+++++++.     .....++
T Consensus        12 G~~g-~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l   86 (290)
T cd07862          12 GAYG-KVFKARDL----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   86 (290)
T ss_pred             CCCe-EEEEEEEc----CCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence            8899 99999741    24578899999875432 222234556777766653  3999999999975     3456899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++|++. ++|.+++....           ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+||
T Consensus        87 v~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          87 VFEHVD-QDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             EEccCC-CCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            999996 68888886531           235789999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |++......   .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |.+||.+.+..+.+.+|
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~i  221 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKI  221 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc-CCCCcCCCCHHHHHHHH
Confidence            998654322   12233456788999999988889999999999999999999 99999998887766543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-36  Score=243.42  Aligned_cols=218  Identities=45%  Similarity=0.785  Sum_probs=170.9

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVP   79 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (225)
                      .|+|| .||.+.........+++.||+|.++..........+.+|+.++.++..||||+++++++.. ....++++||++
T Consensus        17 ~G~fg-~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~   95 (337)
T cd05054          17 RGAFG-KVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK   95 (337)
T ss_pred             cCcCc-eEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCC
Confidence            48999 9999986544455667899999997654444555678899999999559999999998764 457889999999


Q ss_pred             CCCHHHHHHHhhhhhhhcc------------------------------------------------cCCCCCCCChHHH
Q psy15818         80 YGKLQSFLRSSRAQRYYNN------------------------------------------------MHGKSNSLTSRDL  111 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~  111 (225)
                      +++|.+++...........                                                .......++...+
T Consensus        96 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  175 (337)
T cd05054          96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL  175 (337)
T ss_pred             CCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHH
Confidence            9999999875432100000                                                0000125788999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcc
Q psy15818        112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK  191 (225)
Q Consensus       112 ~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  191 (225)
                      ..++.|+++||+|||++|++|+||||+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.+
T Consensus       176 ~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  255 (337)
T cd05054         176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ  255 (337)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCcc
Confidence            99999999999999999999999999999999999999999999976543332222233344567999999999999999


Q ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        192 SDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       192 ~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      +|+||+|+++++|++.|..||.+....+
T Consensus       256 ~Di~SlGv~l~el~t~g~~p~~~~~~~~  283 (337)
T cd05054         256 SDVWSFGVLLWEIFSLGASPYPGVQIDE  283 (337)
T ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCCccH
Confidence            9999999999999976999998755433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.6e-37  Score=246.63  Aligned_cols=202  Identities=22%  Similarity=0.345  Sum_probs=166.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|++....  .......+..|..++..+. |++|+++++.+.+.+..++||||++
T Consensus        12 G~fg-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ey~~   84 (332)
T cd05623          12 GAFG-EVAVVKL-----KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLVMDYYV   84 (332)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEEEeccC
Confidence            8999 9999984     5678899999986432  2233334677888888887 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...            ...+++..+..++.|++.||.+||+.+++||||||+||+++.++.++|+|||++...
T Consensus        85 ~g~L~~~l~~~------------~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          85 GGDLLTLLSKF------------EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             CCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            99999999753            125788999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+++.|+|||++.     ...++.++|+||+|+++|+|++ |..||...+..+.+.+|
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~~~~~~~~i  220 (332)
T cd05623         153 MEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI  220 (332)
T ss_pred             ccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            32211 1122345788899999886     3457889999999999999999 99999988877766554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-36  Score=236.95  Aligned_cols=209  Identities=33%  Similarity=0.603  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++....   ......+++|.+...........+.+|+..++.+. ||||+++++.+......+++|||++++
T Consensus         6 G~fg-~v~~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           6 GWFG-KVLLGEAHR---GMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCc-eEEEEEEec---CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeCCCC
Confidence            8999 999986432   23466799998876555555556788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...+...        ....++..+..++.|++.||.|||+.+++|+||||+||+++++++++|+|||.+.....
T Consensus        81 ~L~~~l~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          81 DLKNYLRSNRGMV--------AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             cHHHHHHhccccc--------cccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccccc
Confidence            9999997653211        12346778899999999999999999999999999999999999999999998864332


Q ss_pred             ccccccccCCCCCccccCCccccC-------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........++..|+|||++..       ..++.++|+||+|+++|+|++.|..||......+.+.+
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  221 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ  221 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            222222233344567999998642       34678999999999999999878899988877665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-36  Score=239.55  Aligned_cols=206  Identities=48%  Similarity=0.839  Sum_probs=171.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..........+..||+|.++..........+.+|+.+++++..||||+++++.+...+..++++||++++
T Consensus        46 G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~  124 (302)
T cd05055          46 GAFG-KVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG  124 (302)
T ss_pred             cCCe-eEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCC
Confidence            7899 999987654445667889999999876555556678899999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++.++..++.|++.||.|||+++++|+||+|+||+++.++.++++|||++.....
T Consensus       125 ~L~~~i~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         125 DLLNFLRRKR-----------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             cHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            9999987532           12378999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...........++..|+|||.+.+..++.++|+||+|+++|++++.|..||.+....+
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~  251 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS  251 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence            3221112223345679999999888899999999999999999976899998766544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-36  Score=238.22  Aligned_cols=220  Identities=46%  Similarity=0.844  Sum_probs=176.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++......+..+...+++|.+..........++.+|+.++..+. ||||+++++.+...+..++++||+.++
T Consensus        11 g~~g-~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (290)
T cd05045          11 GEFG-KVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYG   88 (290)
T ss_pred             cCCc-ceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCCcEEEEEecCCC
Confidence            7899 99999865444555667899999886655555567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhc-----------ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         82 KLQSFLRSSRAQRYYN-----------NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      +|.+++...+......           ........++...++.++.|++.+|.+||+.+++|+||+|+||++++++.++|
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl  168 (290)
T cd05045          89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKI  168 (290)
T ss_pred             CHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEe
Confidence            9999987643211000           00012245788999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +|||++.................+..|++||.+.+..++.++|+||||+++++|++.|..||.+....++.+.
T Consensus       169 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  241 (290)
T cd05045         169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL  241 (290)
T ss_pred             ccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999987543332222222333455799999988888999999999999999999879999998887776554

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0194|consensus

Probab=100.00  E-value=1.2e-37  Score=252.79  Aligned_cols=206  Identities=42%  Similarity=0.738  Sum_probs=176.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecc--ccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKE--NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.+........ ..||+|..+.  ....+....+++|.+++++++ ||||++++|+.....++++|||+|.
T Consensus       168 GaFG-eV~~G~l~~~~~~~~-~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~Pl~ivmEl~~  244 (474)
T KOG0194|consen  168 GAFG-EVFKGKLKLKNGFKV-VPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEPLMLVMELCN  244 (474)
T ss_pred             cccc-EEEEEEEEecCCcee-eeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCccEEEEEecC
Confidence            8999 999999854433222 2299999985  356777788999999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||+|.+++++..            ..++..+...++.+.+.||+|||+++++||||-..|++++.++.+|++|||++...
T Consensus       245 gGsL~~~L~k~~------------~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  245 GGSLDDYLKKNK------------KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CCcHHHHHHhCC------------CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999998752            25899999999999999999999999999999999999999998999999997643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .  ...........+..|+|||.+....++.++||||+|+++||+++.|..||.+....++..+|
T Consensus       313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI  375 (474)
T KOG0194|consen  313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI  375 (474)
T ss_pred             c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence            2  11111112234567999999999999999999999999999999899999999999998877

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=236.20  Aligned_cols=218  Identities=40%  Similarity=0.708  Sum_probs=175.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++..........+..||+|.+...........+.+|+.++..+. |||++++++++......+++|||++++
T Consensus        17 g~~g-~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~   94 (277)
T cd05032          17 GSFG-MVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTGQPTLVVMELMAKG   94 (277)
T ss_pred             CCCc-eEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCCCCcEEEEecCCCC
Confidence            8899 99999865444345678999999876655555567888999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.........   ......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~  171 (277)
T cd05032          95 DLKSYLRSRRPEAEN---NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE  171 (277)
T ss_pred             CHHHHHHhcccchhh---ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhcc
Confidence            999999764321110   00123467889999999999999999999999999999999999999999999999875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........++..|+|||.+.+..++.++|+||+|+++|++++.|..||.+.+..+..+.+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             CcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            322222223334567999999988888999999999999999997799999988877766543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0607|consensus

Probab=100.00  E-value=9.8e-38  Score=236.59  Aligned_cols=197  Identities=22%  Similarity=0.446  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|+ .|--+.     +..+|+-||||++.+. ....+.++.+|++++.++++|+||+.++++|+++..+|||||.+.||
T Consensus        89 GAya-sVqtcv-----~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   89 GAYA-SVQTCV-----SIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             ccce-eeeeee-----eeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            5666 555555     6788999999999876 44566789999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g~~~~  158 (225)
                      +|.+.+.+.+             .++|.++.++..+|++||.+||.+||.|||+||+||+..+.+   -|||+||++..-
T Consensus       162 plLshI~~~~-------------~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  162 PLLSHIQKRK-------------HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             hHHHHHHHhh-------------hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999998764             689999999999999999999999999999999999997544   489999988753


Q ss_pred             ccCcc-----ccccccCCCCCccccCCcccc---C--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        159 LMTSS-----VYERKSEGRLPIRWMAPESLY---D--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       159 ~~~~~-----~~~~~~~~~~~~~~~~PE~~~---~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      .....     ......+..|+..|||||+..   +  ..|+.+.|.||||+++|-|+. |.+||.+....+
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg~d  298 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCGAD  298 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccCCc
Confidence            32111     111222345677899999764   3  347889999999999999999 999999876543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-36  Score=238.74  Aligned_cols=222  Identities=45%  Similarity=0.833  Sum_probs=176.7

Q ss_pred             CcccceeeecCCCC--CCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSP--ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++....  ......+..||+|.+...........+.+|+.++..+..||||+++++.+...+..+++|||+.
T Consensus        26 G~~g-~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  104 (304)
T cd05101          26 GCFG-QVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  104 (304)
T ss_pred             cCCc-eEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCC
Confidence            7899 999997432  1223456789999998655555556788999999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhccc---CCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNM---HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++...+........   ......++..++..++.|+++||.|||++|++|+||||+||++++++.++|+|||.+
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~  184 (304)
T cd05101         105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  184 (304)
T ss_pred             CCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccc
Confidence            99999999875422111000   011235788889999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ................+++.|+|||.+.+..++.++|+||+|+++|++++.|..||.+.+..++.+++
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  252 (304)
T cd05101         185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  252 (304)
T ss_pred             eecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            76543332222233344567999999988889999999999999999998789999988888776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-36  Score=236.22  Aligned_cols=214  Identities=43%  Similarity=0.745  Sum_probs=173.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+....+...+..|++|.+...........+.+|+..++.+. |+||+++++++.+.+..+++|||++++
T Consensus        17 g~~g-~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g~   94 (277)
T cd05036          17 GAFG-EVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERLPRFILLELMAGG   94 (277)
T ss_pred             CCCC-cEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCcEEEEecCCCC
Confidence            7899 99999875444445788999999876655555567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g~~~~  158 (225)
                      +|.+++...+...      .....+++..+..++.|++.+|.+||+++++|+||+|+||+++.++   .++|+|||++..
T Consensus        95 ~L~~~i~~~~~~~------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~  168 (277)
T cd05036          95 DLKSFLRENRPRP------ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD  168 (277)
T ss_pred             CHHHHHHHhCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccc
Confidence            9999997653211      0123578899999999999999999999999999999999997543   589999999876


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...............+..|+|||.+.+..++.++|+||||+++|+|++.|..||.+.+..+.++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             cCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            53222211111222345699999998888999999999999999999769999998887776654

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0201|consensus

Probab=100.00  E-value=1.7e-38  Score=248.96  Aligned_cols=194  Identities=30%  Similarity=0.494  Sum_probs=177.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.     ...+++.||+|++.........+++.+|+..+.++. ++||-++++.+-.+..+|++||||.||
T Consensus        24 GsfG-~Vyk~~-----d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~LwiiMey~~gG   96 (467)
T KOG0201|consen   24 GSFG-EVYKAI-----DNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWIIMEYCGGG   96 (467)
T ss_pred             cccc-eeeeee-----eccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHHHHHhcCc
Confidence            8999 999999     578899999999998888888889999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      ++.+.++..             ..+.+..+..++++++.|+.|||.++.+|+|||+.||++..++.++|+|||.+..+..
T Consensus        97 sv~~lL~~~-------------~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   97 SVLDLLKSG-------------NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             chhhhhccC-------------CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence            999999753             3458889999999999999999999999999999999999999999999999976655


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      .....  ....|||.|||||++.+..|+.++||||||++.+||.+ |.+||.+..+.
T Consensus       164 ~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPm  217 (467)
T KOG0201|consen  164 TVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPM  217 (467)
T ss_pred             hhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcc
Confidence            54333  67789999999999998899999999999999999999 99999988763

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-36  Score=236.30  Aligned_cols=219  Identities=37%  Similarity=0.661  Sum_probs=173.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+. ..+...++.|++|.++..........+.+|+.+++.+. |||++++++++......+++|||++++
T Consensus        16 g~~g-~vy~~~~~-~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~   92 (283)
T cd05090          16 CAFG-KIYKGHLY-LPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQG   92 (283)
T ss_pred             cCCc-ceEEEEEe-cCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCceEEEEEcCCCC
Confidence            8899 99998752 22345678999999986555555567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhccc---C-CCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         82 KLQSFLRSSRAQRYYNNM---H-GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +|.+++...........-   . .....+++..+..++.|++.||.|||+++++|+||||+||++++++.++|+|||++.
T Consensus        93 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (283)
T cd05090          93 DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR  172 (283)
T ss_pred             cHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccc
Confidence            999998654211000000   0 012347888899999999999999999999999999999999999999999999987


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...............++..|+|||.+.+..++.++|+||+|+++++|++.|..||.+.+..++++.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             cccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            653332222223333456799999998888999999999999999999879999988777665554

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.8e-36  Score=242.21  Aligned_cols=194  Identities=26%  Similarity=0.408  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..++..+|+|.+...........+.+|+.++.++. ||||+++++++.+++..++||||+.++
T Consensus        16 g~~g-~V~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (333)
T cd06650          16 GNGG-VVFKVSH-----KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGG   88 (333)
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEEEEecCCCC
Confidence            7899 9999983     56788999999887655555667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus        89 ~L~~~l~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          89 SLDQVLKKA-------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             cHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999998653             2578899999999999999999975 79999999999999999999999999886442


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...    .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......++
T Consensus       156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~  210 (333)
T cd06650         156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI-GRYPIPPPDAKEL  210 (333)
T ss_pred             hhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcchhHH
Confidence            211    122346778999999988889999999999999999999 9999987665544

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.6e-36  Score=235.42  Aligned_cols=217  Identities=39%  Similarity=0.701  Sum_probs=172.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..........+..||+|.+...........+.+|+..++.+. |||++++++++.+++..+++|||++++
T Consensus        17 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g   94 (288)
T cd05061          17 GSFG-MVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKGQPTLVVMELMAHG   94 (288)
T ss_pred             CCCc-EEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEEEeCCCCC
Confidence            7899 99998754323334567899999876554455556788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.........   ......++...+..++.|++.||.+||+++++|+||||+||++++++.++|+|||++.....
T Consensus        95 ~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~  171 (288)
T cd05061          95 DLKSYLRSLRPEAEN---NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE  171 (288)
T ss_pred             CHHHHHHHhcccccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccc
Confidence            999999764321100   00123456678899999999999999999999999999999999999999999999875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........++..|+|||.+.+..++.++|+||+|+++++|++.|..||.+....+.++.
T Consensus       172 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             cccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            32222222233456699999998888999999999999999999878999998887776653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-36  Score=240.62  Aligned_cols=204  Identities=38%  Similarity=0.735  Sum_probs=166.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+.. .+......||+|.++.........++.+|+.++..+. ||||+++++++... ..+++++|++++
T Consensus        18 G~~g-~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~~~~v~e~~~~g   93 (316)
T cd05108          18 GAFG-TVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TVQLITQLMPFG   93 (316)
T ss_pred             CCCc-eEEEEEEec-CCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-CceeeeecCCCC
Confidence            8899 999998532 1223345699999986655556667889999999998 99999999998764 577999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..++...++.++.|++.||+|||+.|++|+||||+||++++++.++|+|||++.....
T Consensus        94 ~l~~~l~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          94 CLLDYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999987532            2478889999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ............+..|++||.+.+..++.++|+||+|+++|++++.|..||.+....++.
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~  221 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  221 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            332222222334567999999988889999999999999999987699999887766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4e-36  Score=238.71  Aligned_cols=222  Identities=45%  Similarity=0.827  Sum_probs=173.5

Q ss_pred             CcccceeeecCCCCC--CCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPE--RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++.....  ........+|+|.++..........+..|+.++..+.+|||++++++++...+..++++||++
T Consensus        29 G~~g-~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (307)
T cd05098          29 GCFG-QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  107 (307)
T ss_pred             CCCe-eEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCC
Confidence            7899 9999875321  122345689999998665455556788899999999669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhh---cccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++...+.....   .........++..++..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+
T Consensus       108 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a  187 (307)
T cd05098         108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  187 (307)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccc
Confidence            99999999765321100   000011235788899999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .................++.|+|||.+.+..++.++|+||+|+++|+|+++|..||.+.+..+..+.+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             ccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            65432221111222233457999999988889999999999999999998789999988877765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-36  Score=233.35  Aligned_cols=207  Identities=39%  Similarity=0.733  Sum_probs=172.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+...  ..+...||+|.++..........+.+|+..+.+++ |||++++++.+...+..+++|||++++
T Consensus        15 g~~g-~vy~~~~~~~--~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~   90 (266)
T cd05033          15 GEFG-EVCRGRLKLP--GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENG   90 (266)
T ss_pred             Cccc-eEEEEEEccC--CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCceEEEEEcCCCC
Confidence            7899 9999986322  22457899999886655555667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|++.|+.+||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        91 ~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          91 SLDKFLREND------------GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             CHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999987532            2578999999999999999999999999999999999999999999999999986642


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ............+..|+|||.+.+..++.++|+||+|++++++++.|..||......+..+.+
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  221 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV  221 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence            222112222334567999999988889999999999999999997799999887777665543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-36  Score=240.63  Aligned_cols=198  Identities=25%  Similarity=0.510  Sum_probs=163.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     ...+++.||+|.++............+|+.++++++ |||++++++++...+..++||||+. +
T Consensus        17 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~   88 (309)
T cd07872          17 GTYA-TVFKGR-----SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEYLD-K   88 (309)
T ss_pred             cCCE-EEEEEE-----ecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEEEeCCC-C
Confidence            8899 999998     356788999999875544333445778999999998 9999999999999999999999997 4


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+...            ...+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        89 ~l~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          89 DLKQYMDDC------------GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            787777542            23478899999999999999999999999999999999999999999999999864332


Q ss_pred             ccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...  ......+++.|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.
T Consensus       157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~  215 (309)
T cd07872         157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELH  215 (309)
T ss_pred             Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            221  1122345678999998865 457889999999999999999 999999887766544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5e-36  Score=232.48  Aligned_cols=204  Identities=35%  Similarity=0.682  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+.   ...++..||+|.+...........+.+|+.+++++. |||+++++++++ ....++||||++++
T Consensus         6 G~~g-~v~~~~~~---~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           6 GNFG-CVKKGVYK---MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             CCcc-cEEEEEEe---cCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            7899 99998642   234566799999987665556667889999999997 999999999876 45789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        80 ~L~~~l~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          80 PLNKFLSGK------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999988642            23578999999999999999999999999999999999999999999999999875433


Q ss_pred             ccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..... .......+..|+|||.+....++.++|+||||+++|++++.|..||.+....+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  210 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF  210 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            22211 122223345799999988888899999999999999999559999998887766543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1989|consensus

Probab=100.00  E-value=2.7e-37  Score=259.95  Aligned_cols=201  Identities=26%  Similarity=0.393  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeE-Ee---cC---CCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC-CT---EK---EPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-~~---~~---~~~~lv   74 (225)
                      |.|+ .||++..     ..+|..||+|++... .+.....+.+|+.+|+.|.+|+|||.++|. ..   ..   -.++|.
T Consensus        48 GGFa-~VYla~~-----~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL  120 (738)
T KOG1989|consen   48 GGFA-QVYLAQD-----VKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL  120 (738)
T ss_pred             CCcE-EEEEEEe-----cCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence            8899 9999995     455599999999876 666677899999999999999999999993 21   11   247899


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCceeEee
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      ||||.|+.|-+++.....           ..|+|.++++|++|+++|+.+||...  |+|||||-+|||++.++.+||||
T Consensus       121 mEyC~gg~Lvd~mn~Rlq-----------~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRLQ-----------TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             hhhccCCcHHHHHHHHHh-----------ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence            999999999999986532           35899999999999999999999997  99999999999999999999999


Q ss_pred             ecccccccCcc-cc------ccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        153 FGFARDLMTSS-VY------ERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       153 ~g~~~~~~~~~-~~------~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ||.+.-..... ..      .......-|+.|++||++.   +.+.+.++|||+|||+||-|+. ...||++.....|+
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy-~t~PFe~sg~laIl  267 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY-FTTPFEESGKLAIL  267 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH-hCCCcCcCcceeEE
Confidence            99986432222 10      1111344578899999774   6778999999999999999999 99999987554443

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4e-36  Score=232.73  Aligned_cols=215  Identities=52%  Similarity=0.911  Sum_probs=177.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++......  ..+..|++|.++..........+.+|+..+..+. |+|++++++++.+....+++|||++++
T Consensus         6 g~~g-~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           6 GAFG-EVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             CCce-EEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEeccCC
Confidence            7899 99999963221  3388999999987665555667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.......    .......+++..++.++.|+++||.+||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          82 DLLDYLRKSRPVF----PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             cHHHHHhhccccc----cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999987642110    000124689999999999999999999999999999999999999999999999999976544


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........++..|+|||.+....++.++|+||+|+++++|+++|..||......++.+++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  220 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL  220 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            332223334455678999999888888999999999999999999679999998887766554

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.3e-36  Score=236.64  Aligned_cols=195  Identities=20%  Similarity=0.312  Sum_probs=163.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~   75 (225)
                      |.+| .||++.       .+|+.||+|.++....  ......+.+|+.++.++. ||||+++++++.+    ....+++|
T Consensus        31 g~~~-~v~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         31 NDQN-SIYKGI-------FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             CCce-EEEEEE-------ECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEE
Confidence            6678 899887       3688999999976432  222356779999999998 9999999999876    45689999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeec
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ||+++++|.+++...             ..+++.....++.|++.|+.+||+. +++|+||||+||++++++.++|+|||
T Consensus       102 Ey~~~g~L~~~l~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        102 EYCTRGYLREVLDKE-------------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             EeCCCCcHHHHHhhC-------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence            999999999999753             2578889999999999999999984 89999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.......     ....+++.|+|||.+.+  ..++.++|+||||+++|+|++ |..||.+.+..++.+.+
T Consensus       169 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        169 LEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLI  234 (283)
T ss_pred             hHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            986543221     23345678999999876  678999999999999999999 99999998887776543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=246.30  Aligned_cols=186  Identities=27%  Similarity=0.420  Sum_probs=155.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|++...........+.+|+.+++.+. |+||+++++++.+.+.+++||||+.++
T Consensus        85 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         85 GAGG-TVYKVIH-----RPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEEEecCCCC
Confidence            7899 9999983     56789999999976655555667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|....                 ...+..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.....
T Consensus       158 ~L~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        158 SLEGTH-----------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             cccccc-----------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            885322                 356778899999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ..  .......++..|+|||.+..     ...+.++||||||+++|+|++ |..||..
T Consensus       221 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~  275 (353)
T PLN00034        221 TM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL-GRFPFGV  275 (353)
T ss_pred             cc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh-CCCCCCC
Confidence            21  11223456788999998743     233568999999999999999 9999974

>KOG1187|consensus

Probab=100.00  E-value=7.3e-37  Score=245.67  Aligned_cols=190  Identities=32%  Similarity=0.543  Sum_probs=161.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-eEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~~   80 (225)
                      |.|| +||++..      .+|..||||.+....... ...+.+|+.++.+++ |||+++++|+|.+.+. .+||+||++.
T Consensus        86 Ggfg-~VYkG~l------~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYEym~n  156 (361)
T KOG1187|consen   86 GGFG-TVYKGVL------SDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYEYMPN  156 (361)
T ss_pred             CCCe-EEEEEEE------CCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEEccCC
Confidence            7899 9999995      445899999887665542 345999999999999 9999999999999884 9999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---IIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~---i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      |+|.+.+....           ...++.....+|+.+++.||+|||+..   |+|||||++||+++++.+.||+|||++.
T Consensus       157 GsL~d~L~~~~-----------~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  157 GSLEDHLHGKK-----------GEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             CCHHHHhCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            99999997532           116799999999999999999999864   9999999999999999999999999996


Q ss_pred             cccC-ccccccccCC-CCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        158 DLMT-SSVYERKSEG-RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       158 ~~~~-~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      .... ...   .... .+|.+|++||.......+.++||||+|++++|+++ |+.|....
T Consensus       226 ~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit-gr~~~d~~  281 (361)
T KOG1187|consen  226 LGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT-GRKAVDQS  281 (361)
T ss_pred             cCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh-CCcccCCC
Confidence            4433 211   1112 77888999999988889999999999999999999 98887754

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.5e-36  Score=235.43  Aligned_cols=219  Identities=33%  Similarity=0.637  Sum_probs=174.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.........++..+++|.+...... ....+.+|+..++++. |||++++++++......++||||++++
T Consensus        16 g~~g-~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (291)
T cd05094          16 GAFG-KVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHG   92 (291)
T ss_pred             cCCC-eEEEeEeeccCCCCcceeeEEEecCCccHH-HHHHHHHHHHHHhcCC-CCCcceEEEEEccCCceEEEEecCCCC
Confidence            7899 999998655555567788999998754432 2346788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhh--cc-cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYY--NN-MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++.......-.  .. .......+++..++.++.|++.|+++||++|++|+||||+||+++.++.++|+|||++..
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~  172 (291)
T cd05094          93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD  172 (291)
T ss_pred             cHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccc
Confidence            999999764321000  00 000123578899999999999999999999999999999999999999999999999865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..............++..|+|||.+.+..++.++|+||+|+++|+|+++|..||...+..+.++.
T Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            43332222223334566799999998888999999999999999999879999988877766554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.5e-36  Score=242.42  Aligned_cols=194  Identities=26%  Similarity=0.396  Sum_probs=159.9

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEE
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFV   73 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~l   73 (225)
                      .|+|| .||++.     +..+|+.||+|.+... ..........+|+.++..+. ||||+++++++...+      ..++
T Consensus        31 ~G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~l  103 (359)
T cd07876          31 SGAQG-IVCAAF-----DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLEEFQDVYL  103 (359)
T ss_pred             cCCCE-EEEEEE-----EcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCccccceeEE
Confidence            38999 999998     4567899999998754 23344456788999999998 999999999986543      4799


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      +|||+.+ ++.+.+..               .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+||
T Consensus       104 v~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876         104 VMELMDA-NLCQVIHM---------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             EEeCCCc-CHHHHHhc---------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecC
Confidence            9999974 56655532               3788899999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      |++.......   ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+
T Consensus       168 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~  231 (359)
T cd07876         168 GLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQW  231 (359)
T ss_pred             CCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            9986432211   1223456778999999999899999999999999999999 99999988765543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-35  Score=230.05  Aligned_cols=200  Identities=36%  Similarity=0.676  Sum_probs=166.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+      .++..+|+|.+.......  ..+.+|+.+++.+. |||++++++++...+..+++|||++++
T Consensus        15 G~~~-~vy~~~~------~~~~~~a~K~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114          15 GQFG-VVHLGKW------RAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             CcCc-eEEEEEe------ccCceEEEEecccCCccH--HHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            8899 9999985      334679999887543322  35788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.++++|||.+.....
T Consensus        85 ~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          85 CLLNYLRQRQ------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             cHHHHHHhCc------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999886431            2478899999999999999999999999999999999999999999999998875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......+..|+|||.+.+..++.++|+||+|+++|++++.|..||...+..+..+++
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i  214 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI  214 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            2211 1112233456999999988888999999999999999998789999988887776654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-35  Score=242.84  Aligned_cols=217  Identities=44%  Similarity=0.791  Sum_probs=172.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.+........++.||+|+++..........+.+|+.++.++.+||||+++++.+...+..++|+||++++
T Consensus        48 G~fG-~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g  126 (401)
T cd05107          48 GAFG-RVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYG  126 (401)
T ss_pred             CCce-eEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCC
Confidence            8999 999999765545566789999999866555555578899999999977999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhc----------------------------------------------------------------
Q psy15818         82 KLQSFLRSSRAQRYYN----------------------------------------------------------------   97 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~----------------------------------------------------------------   97 (225)
                      +|.+++...+......                                                                
T Consensus       127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (401)
T cd05107         127 DLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIES  206 (401)
T ss_pred             cHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhc
Confidence            9999997653210000                                                                


Q ss_pred             ---------------------ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         98 ---------------------NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        98 ---------------------~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                                           ........++...+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla  286 (401)
T cd05107         207 SNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA  286 (401)
T ss_pred             cCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcc
Confidence                                 00011234677788999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ................++..|++||.+.+..++.++|+||+|++++||++.|..||......+
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         287 RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             eecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            754332221122223456679999999888889999999999999999986889997655444

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.3e-36  Score=259.02  Aligned_cols=208  Identities=23%  Similarity=0.334  Sum_probs=167.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|.+....  ......++.+|+.++..+. |||++++++++.+++..+++|||++
T Consensus        13 GgfG-~VYlA~-----d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLVMEY~e   85 (932)
T PRK13184         13 GGMG-EVYLAY-----DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYTMPYIE   85 (932)
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEEEEcCC
Confidence            8999 999998     45678999999997543  3344557889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++.........  ........+...+..++.|+++||++||+.|++||||||+||+++.++.++|+|||++...
T Consensus        86 GGSL~~lL~s~~~~~~l--~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         86 GYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             CCCHHHHHHHhhhcccc--chhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceec
Confidence            99999998754221100  0001224566788999999999999999999999999999999999999999999998754


Q ss_pred             cCccc----------------cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        160 MTSSV----------------YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       160 ~~~~~----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      .....                ........+|+.|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus       164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT-G~~PF~~~~~~k  238 (932)
T PRK13184        164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSFPYRRKKGRK  238 (932)
T ss_pred             ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCcchhh
Confidence            21110                001112357889999999999899999999999999999999 999998765544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.4e-36  Score=245.12  Aligned_cols=200  Identities=24%  Similarity=0.401  Sum_probs=164.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-----CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-----PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (225)
                      |+|| +||++.     +..+++.||+|.+.... ......++.+|+.+++.++ ||||+++++++...+     ..++|+
T Consensus        11 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853          11 GAFG-VVWSVT-----DPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceEEEEe
Confidence            8999 999998     35678999999986532 3334456889999999998 999999999998776     789999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+. ++|.+.+...             ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus        84 e~~~-~~l~~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          84 ELMQ-SDLHKIIVSP-------------QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             eccc-cCHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccc
Confidence            9996 6787777532             3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +........ .......+++.|+|||.+.+. .++.++|+||+|+++++|++ |..||.+.+..+.++.|
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  217 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQQLDLI  217 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            864432211 112233456789999998774 47889999999999999999 99999988877766543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-35  Score=233.49  Aligned_cols=196  Identities=20%  Similarity=0.367  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||.+..     ..+++.||+|.+....  .........+|+.+++.++ |++++++.+.+...+..++++||+.
T Consensus        11 G~~g-~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632          11 GGFG-EVCACQV-----RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEEecc
Confidence            8899 9999984     5678899999986543  2222345678999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...           ....+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++...
T Consensus        84 ~~~L~~~~~~~-----------~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          84 GGDLKFHIYNM-----------GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             CccHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            99998887643           1235899999999999999999999999999999999999999999999999988644


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ....   ......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.+.....
T Consensus       153 ~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~P~~~~~~~~  208 (285)
T cd05632         153 PEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKV  208 (285)
T ss_pred             CCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            3221   1123456788999999988889999999999999999999 999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-35  Score=230.71  Aligned_cols=207  Identities=31%  Similarity=0.614  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.+.   +..++..+|+|.+...........+.+|+.++.+++ |||++++++++.+....++||||++++
T Consensus         6 G~~g-~Vy~~~~~---~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           6 GWFG-KVILGEVN---SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             cCCc-eEEEEEEc---CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            8899 99999753   234467899999876655455557888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...+..        .....++..+..++.|++.|+++||+.+++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          81 DLKGYLRSCRKA--------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             cHHHHHHHhhhc--------ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            999999764321        112356678889999999999999999999999999999999999999999998864433


Q ss_pred             ccccccccCCCCCccccCCccccCC-------CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDN-------IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...........++..|+|||.+.+.       .++.++|+||+|+++|+|++.|..||......+..
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  219 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL  219 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            2222222234456779999987532       35789999999999999995599999877766543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-35  Score=229.63  Aligned_cols=204  Identities=39%  Similarity=0.718  Sum_probs=166.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.+.   ...++..+|+|+++... .......+..|+.++..+. |||++++++++. ....+++|||+++
T Consensus         6 G~~g-~v~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           6 GNFG-TVKKGMYK---MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCc-ceEEeEEe---cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecCCC
Confidence            7899 99998642   34567889999987543 3344556888999999997 999999999876 4467899999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++..+..++.|++.||++||++|++|+||||.||++++++.++|+|||++....
T Consensus        80 ~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          80 GPLNKFLQKN-------------KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             CcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            9999998643             257899999999999999999999999999999999999999999999999987654


Q ss_pred             Cccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...... ......++..|+|||.+....++.++|+||||+++|+|++.|..||.+.+..+..+.+
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i  211 (257)
T cd05116         147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI  211 (257)
T ss_pred             CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            332211 1122233467999999888888999999999999999997689999988877766554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-35  Score=231.66  Aligned_cols=219  Identities=36%  Similarity=0.652  Sum_probs=172.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..........+..+++|.++... ......+.+|+..+..+. ||||+++++++.+.+..++++||++++
T Consensus        16 g~~g-~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (280)
T cd05092          16 GAFG-KVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHG   92 (280)
T ss_pred             ccCC-eEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCCceEEEEecCCCC
Confidence            7899 9999875333345567889999887543 334457889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhh--cccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYY--NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +|.+++.........  .........+++..+..++.|++.|+++||+.|++|+||||+||++++++.++|+|||++...
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  172 (280)
T cd05092          93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  172 (280)
T ss_pred             CHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEc
Confidence            999999764321100  000111235788999999999999999999999999999999999999999999999988654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .............+++.|+|||.+.+..++.++|+||||+++|+|+++|.+||......+.+..
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             CCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            3322212122223356799999998888999999999999999999879999988777665543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-35  Score=231.20  Aligned_cols=214  Identities=46%  Similarity=0.853  Sum_probs=171.9

Q ss_pred             CcccceeeecCCCCCCC-CccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERG-REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++.+..... ..+++.+++|.+...........+.+|+..++.+. ||||+++++++......++++||+++
T Consensus         6 g~~g-~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (269)
T cd05044           6 GAFG-EVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIMELMEG   83 (269)
T ss_pred             ccce-eEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEEEeccCC
Confidence            7899 999998643331 33457899999876554455567889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-----ceeEeeecc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-----CCKVADFGF  155 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-----~~~l~d~g~  155 (225)
                      ++|.+++........      ....+++..+..++.|++.||++||+.+++|+||+|+||+++.++     .++++|||+
T Consensus        84 ~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          84 GDLLSYLRDARVERF------GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             CcHHHHHHHhhhccc------CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999976532211      123468899999999999999999999999999999999998776     899999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +.................+..|+|||.+.+..++.++|+||||+++|+|++.|..||...+..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH  225 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence            86543332222222233456799999998888999999999999999999779999988777666544

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-35  Score=234.84  Aligned_cols=221  Identities=45%  Similarity=0.839  Sum_probs=173.1

Q ss_pred             CcccceeeecCCCCC--CCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPE--RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++.....  ........||+|.++..........+..|+.+++++..||||+++++++.+.+..++++||++
T Consensus        23 G~~g-~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  101 (314)
T cd05099          23 GCFG-QVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA  101 (314)
T ss_pred             CCcc-cEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCC
Confidence            7899 9999874221  123356789999988655555556788999999999669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcc---cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++...+.......   .......++..++..++.|++.||.+||++|++|+||||+||++++++.++|+|||.+
T Consensus       102 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~  181 (314)
T cd05099         102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA  181 (314)
T ss_pred             CCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccc
Confidence            9999999976532110000   0001235788899999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .................+..|+|||.+.+..++.++|+||+|+++|++++.|..||.+.+..+..+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             ccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            7543322211122223345699999998888999999999999999999878999998887776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.5e-36  Score=230.41  Aligned_cols=201  Identities=21%  Similarity=0.373  Sum_probs=169.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++..     ..+++.||+|.++............+|+.+++.+. |||++++++.+.+.+..++++||++++
T Consensus        11 g~~g-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   83 (255)
T cd08219          11 GSFG-RALLVQH-----VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVMEYCDGG   83 (255)
T ss_pred             cCCe-EEEEEEE-----cCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEEeeCCCC
Confidence            7899 9999983     56788999999875544455567888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+....           ...+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++++|||.+.....
T Consensus        84 ~l~~~~~~~~-----------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          84 DLMQKIKLQR-----------GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             cHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9998886532           23578999999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  ......+++.|+|||++.+..++.++|+||+|+++++|++ |..||...+.......
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~  211 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILK  211 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh-ccCCCCCCCHHHHHHH
Confidence            221  1122345677999999988889999999999999999999 9999998776665443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-35  Score=233.12  Aligned_cols=220  Identities=38%  Similarity=0.698  Sum_probs=173.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.........++..||+|.+...........+.+|+..+..+. |||++++++++.+....++++||++++
T Consensus        16 g~~g-~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   93 (288)
T cd05050          16 GAFG-RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYG   93 (288)
T ss_pred             cccc-cEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCccEEEEecCCCC
Confidence            7899 99998853222234678999999986655555567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc---------cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         82 KLQSFLRSSRAQRYYNN---------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +|.+++...........         .......+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|
T Consensus        94 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~d  173 (288)
T cd05050          94 DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD  173 (288)
T ss_pred             CHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECc
Confidence            99999975432111110         011223578889999999999999999999999999999999999999999999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ||.+.................+..|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+....
T Consensus       174 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~  244 (288)
T cd05050         174 FGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY  244 (288)
T ss_pred             cccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99886543332222222223345699999988888999999999999999999768889988877776554

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-35  Score=228.20  Aligned_cols=201  Identities=25%  Similarity=0.452  Sum_probs=170.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .||++..     ..+++.|++|.+... ........+.+|+.+++.+. |||++++++.+.+.+..++++||+++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529          11 GSFG-VVFKVVR-----KADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEEEeCCC
Confidence            7889 9999984     567899999998754 34445567889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....           ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~L~~~l~~~~-----------~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          84 GDLHKLLKMQR-----------GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             CcHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999987642           2357899999999999999999999999999999999999999999999999887554


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....  .....+++.|+|||+..+..++.++|+||+|+++++|++ |..||...+..+...+
T Consensus       153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~  212 (256)
T cd08529         153 DNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPFDANNQGALILK  212 (256)
T ss_pred             Cccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            33221  223345677999999988888999999999999999999 9999988887665544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.5e-36  Score=234.25  Aligned_cols=193  Identities=19%  Similarity=0.360  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.+.....  ........+|+.+++.++ |++++++++.+.+.+..+++|||+.
T Consensus        11 G~~g-~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630          11 GGFG-EVCACQV-----RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             CCCe-EEEEEEE-----cCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEEEecC
Confidence            7899 9999994     66789999999875432  222334678999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....           ...+++..+..++.|++.||.+||+.+++|+||||+||+++.++.++|+|||++...
T Consensus        84 g~~L~~~l~~~~-----------~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          84 GGDLKFHIYHMG-----------EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             CCcHHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999998886432           235889999999999999999999999999999999999999999999999988644


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ....   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....
T Consensus       153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~  205 (285)
T cd05630         153 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK  205 (285)
T ss_pred             CCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCC
Confidence            3221   1123356788999999988889999999999999999999 999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-35  Score=231.25  Aligned_cols=204  Identities=38%  Similarity=0.718  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+.+. +......||+|.++..........+.+|+.++..+. |||++++++++... ..++++++++++
T Consensus        18 G~~g-~vy~~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~l~~~~~~~g   93 (279)
T cd05109          18 GAFG-TVYKGIWIPD-GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-TVQLVTQLMPYG   93 (279)
T ss_pred             CCCc-eEEEEEEecC-CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-CcEEEEEcCCCC
Confidence            7899 9999985322 222244689999986665556667889999999998 99999999998754 577999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+...            ...+++.++..++.|++.||.+||+++++|+||||+||++++++.++|+|||++.....
T Consensus        94 ~l~~~l~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          94 CLLDYVREN------------KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999988653            23578999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ............++.|++||...+..++.++|+||||+++||+++.|..||......++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  221 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP  221 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            322222222334567999999988889999999999999999998799999877665544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-35  Score=229.35  Aligned_cols=208  Identities=28%  Similarity=0.552  Sum_probs=163.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+.   .......+++|.+...........+.+|+..+..+. |||++++++.+.+....+++|||++++
T Consensus         6 G~~g-~v~~~~~~---~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           6 GWFG-KVLLSEIY---TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCc-eEEEEEEE---cCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCCCC
Confidence            8899 99998742   122345677887776555555667889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++......         ....++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~L~~~l~~~~~~---------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          81 DLKSYLSQEQWH---------RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             cHHHHHHhhhcc---------cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            999999764211         12356778889999999999999999999999999999999999999999998753222


Q ss_pred             ccccccccCCCCCccccCCccccC-------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........++..|+|||++..       ..++.++|+||+|+++|+|+++|..||...+..+.+..
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  220 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH  220 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            111112223345677999998743       23567899999999999999867889988777665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=228.74  Aligned_cols=200  Identities=39%  Similarity=0.732  Sum_probs=164.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+      .++..+|+|.+.......  ..+.+|+.+++.+. |||++++++++...+..++++||++++
T Consensus        15 G~~~-~v~~~~~------~~~~~~~iK~~~~~~~~~--~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059          15 GQFG-VVHLGKW------RGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             CCCc-eEEEeEe------cCCccEEEEEeccCCCCH--HHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            7899 9999974      245679999987544332  25778999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        85 ~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          85 CLLNYLRERK------------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999986532            2578999999999999999999999999999999999999999999999998865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......+..|+|||.+.+..++.++|+||+|+++|+++++|..||...+..+..+++
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV  214 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            2111 1111122346999999988889999999999999999998789999888877766554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=228.85  Aligned_cols=201  Identities=45%  Similarity=0.776  Sum_probs=166.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++..      .+++.||+|.++.....  ...+.+|+..++++. |||++++++++...+..++++|+++++
T Consensus        17 g~~~-~v~~~~~------~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (261)
T cd05068          17 GQFG-EVWEGLW------NNTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYG   86 (261)
T ss_pred             cCCc-cEEEEEe------cCCeEEEEEeeCCCccc--HHHHHHHHHHHHHCC-CCCccceeEEEecCCCeeeeeecccCC
Confidence            7899 9999873      33567999998764432  235788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...++...+..++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus        87 ~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          87 SLLEYLQGGA-----------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999986531           23578999999999999999999999999999999999999999999999999876542


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... ........+..|+|||...+..++.++|+||+|+++++|++.|..||.+.+..+.+..+
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  217 (261)
T cd05068         156 DIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV  217 (261)
T ss_pred             Ccc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            211 11112222346999999988889999999999999999998899999988877766543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.1e-35  Score=226.82  Aligned_cols=201  Identities=41%  Similarity=0.787  Sum_probs=167.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..      .++..||+|.+...........+.+|+.++..+. |||++++++++...+..+++|||++++
T Consensus         6 g~~g-~vy~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           6 GNFG-EVFKGTL------KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CCCc-eEEEEEe------cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCCC
Confidence            7899 9999983      3577899999876655555567889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 ~L~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          78 DFLSFLRKK------------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            999988643            12468899999999999999999999999999999999999999999999998864322


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... ........+..|+|||.+.+..++.++|+||+|+++|++++.|..||.+....+...+
T Consensus       146 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~  206 (250)
T cd05085         146 GIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ  206 (250)
T ss_pred             ccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            211 1111223345699999998888899999999999999999879999988877665544

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=228.27  Aligned_cols=200  Identities=26%  Similarity=0.439  Sum_probs=165.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc----hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG----ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.+| .||.+.     +..+++.|++|.+.....    ......+.+|+.+++++. ||||+++++++.+....++++|+
T Consensus        13 g~~~-~vy~~~-----~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   85 (263)
T cd06625          13 GAFG-RVYLCY-----DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSIFMEY   85 (263)
T ss_pred             CCce-EEEEEE-----EcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEEEEEE
Confidence            7789 999997     456789999999875421    223345788999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +++++|.+.+...             ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.
T Consensus        86 ~~~~~l~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          86 MPGGSVKDQLKAY-------------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             CCCCcHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9999999988753             247889999999999999999999999999999999999999999999999986


Q ss_pred             cccCcccccc-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        158 DLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .......... .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~  217 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIF  217 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh-CCCCccccchHHHHH
Confidence            5432211111 122335567999999998889999999999999999999 999998766655443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-35  Score=235.23  Aligned_cols=198  Identities=26%  Similarity=0.512  Sum_probs=163.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     ...+++.||+|.++............+|+.++..+. ||||+++++++...+..++|+||+. +
T Consensus        17 g~~g-~vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~-~   88 (301)
T cd07873          17 GTYA-TVYKGR-----SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLD-K   88 (301)
T ss_pred             CcCE-EEEEEE-----EcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEEEeccc-c
Confidence            7899 999998     356788999999875544444446778999999998 9999999999999999999999997 5


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+...            ...+++..+..++.|+++||.+||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus        89 ~l~~~l~~~------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          89 DLKQYLDDC------------GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            888877642            23578899999999999999999999999999999999999999999999998865432


Q ss_pred             ccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...  ......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |.+||.+.+..+.+.
T Consensus       157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~~f~~~~~~~~~~  215 (301)
T cd07873         157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST-GRPLFPGSTVEEQLH  215 (301)
T ss_pred             CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            211  11223346779999987654 47889999999999999999 999999887765543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-35  Score=229.41  Aligned_cols=200  Identities=41%  Similarity=0.723  Sum_probs=166.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .++..||+|.+.....  ....+.+|+.+++.+. |||++++++.+.+.+..++++||++++
T Consensus        17 g~~g-~v~~~~~------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (261)
T cd05072          17 GQFG-EVWMGYY------NNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKG   86 (261)
T ss_pred             cCCc-eEEEEEe------cCCceEEEEEccCCch--hHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence            7899 9999983      3456799998865432  2346888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...++...+..++.|+++||++||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        87 ~L~~~l~~~~-----------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          87 SLLDFLKSDE-----------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             cHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999987542           23578889999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .... ......++..|+|||.+.+..++.++|+||+|+++|+|+++|..||.+.+..+...+
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~  216 (261)
T cd05072         156 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA  216 (261)
T ss_pred             Ccee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence            2211 112223455699999988888899999999999999999779999988877766554

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-35  Score=230.07  Aligned_cols=201  Identities=44%  Similarity=0.795  Sum_probs=167.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ...++.||+|.+..+..  ....+.+|+..++.+. |||++++++++...+..+++|||++++
T Consensus        17 g~~~-~v~~~~~-----~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (263)
T cd05052          17 GQYG-EVYEGVW-----KKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYG   87 (263)
T ss_pred             cccc-eEEEEEE-----ecCCceEEEEEecCCch--HHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEEEEeCCCC
Confidence            7889 9999884     45688999999875432  2346788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++..++.++.|++++|.+||++|++|+||+|+||++++++.++|+|||.+.....
T Consensus        88 ~L~~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          88 NLLDYLRECN-----------RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             cHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999986531           23578899999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .... .......+..|++||.+.+..++.++|+||||+++|+|++.|..||.+.+..+...+
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~  217 (263)
T cd05052         157 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL  217 (263)
T ss_pred             ceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            3211 111222345699999998888999999999999999999778999998877766544

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0690|consensus

Probab=100.00  E-value=4.3e-37  Score=233.87  Aligned_cols=198  Identities=23%  Similarity=0.390  Sum_probs=175.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .|-+++     .+.+++.||+|++++.  ...+.......|-+.+...+ ||.+..+...|....++|+||||..
T Consensus       179 GTFG-KVIL~r-----EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  179 GTFG-KVILCR-----EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             Cccc-eEEEEe-----ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEEEEEcc
Confidence            7899 999988     6789999999999876  34555566778899999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||.|...+++.+             .+++...+.+...|++||.|||+++|++||||.+|.+++.+|.+|+.|||+|...
T Consensus       252 GGeLf~HLsrer-------------~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  252 GGELFFHLSRER-------------VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             CceEeeehhhhh-------------cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            999998887653             6899999999999999999999999999999999999999999999999999643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .  .........+|||.|.|||++.+..|+.++|+|.+|+++|||++ |++||...+...+-.
T Consensus       319 I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC-GRLPFyn~dh~kLFe  378 (516)
T KOG0690|consen  319 I--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC-GRLPFYNKDHEKLFE  378 (516)
T ss_pred             c--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHh-ccCcccccchhHHHH
Confidence            2  22334556789999999999999999999999999999999999 999999887766544

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-35  Score=242.47  Aligned_cols=183  Identities=22%  Similarity=0.271  Sum_probs=154.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.     ...+++.||+|....       ....+|+.+++++. ||||+++++++......++++|++. +
T Consensus       103 G~~g-~V~~~~-----d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~-~  167 (391)
T PHA03212        103 GAEG-FAFACI-----DNKTCEHVVIKAGQR-------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYK-T  167 (391)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEechhh-------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEEEEecCC-C
Confidence            8999 999998     467889999996532       24678999999998 9999999999999999999999995 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..++...             ..+++.+++.++.|++.||.|||++||+||||||+||+++..+.++|+|||++.....
T Consensus       168 ~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        168 DLYCYLAAK-------------RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             CHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            888777543             2578999999999999999999999999999999999999999999999999853221


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      . .........+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus       235 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~  285 (391)
T PHA03212        235 I-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT-CHDSLFE  285 (391)
T ss_pred             c-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH-CCCCcCC
Confidence            1 1112223457889999999988889999999999999999999 8777643

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-35  Score=233.52  Aligned_cols=200  Identities=27%  Similarity=0.482  Sum_probs=158.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-HHHHHHHHHHHHHhhcC--CCCCeeeeeeEEec-----CCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLD--PHPNVVRLLGCCTE-----KEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~-----~~~~~l   73 (225)
                      |.|| +||++.     ...+++.||+|.++..... .......+|+.++..+.  .||||+++++++..     ....++
T Consensus        11 g~~g-~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863          11 GAYG-TVYKAR-----DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            8899 999998     4677899999998754221 11123455666665552  39999999998764     245899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++|++. ++|.+++....           ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus        85 v~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          85 VFEHVD-QDLRTYLDKVP-----------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             EEcccc-cCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcc
Confidence            999997 58888876531           234789999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |++.......   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |.+||.+.+..+.+.+
T Consensus       153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~~f~~~~~~~~~~~  218 (288)
T cd07863         153 GLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGK  218 (288)
T ss_pred             CccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh-CCcCcCCCCHHHHHHH
Confidence            9886543221   1123345778999999988889999999999999999999 9999988877665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.2e-35  Score=231.74  Aligned_cols=196  Identities=26%  Similarity=0.459  Sum_probs=168.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ...++.||+|.++...  .......+.+|+.+++++. ||||+++++++.+.+..+++|||++
T Consensus        12 g~~~-~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~   84 (290)
T cd05580          12 GSFG-RVMLVRH-----KGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVMEYVP   84 (290)
T ss_pred             CCCe-EEEEEEE-----cCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEEecCC
Confidence            7889 9999985     4578899999987543  2334456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~~~~~-------------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          85 GGELFSHLRKS-------------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            99999998653             35889999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...     .....+++.|++||.+.+...+.++|+||+|+++++|++ |..||...+..+..++
T Consensus       152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~  209 (290)
T cd05580         152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDDNPIQIYEK  209 (290)
T ss_pred             CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            332     223346778999999988888899999999999999999 9999988776655543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.5e-35  Score=226.82  Aligned_cols=207  Identities=36%  Similarity=0.623  Sum_probs=170.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++.+...  ......||+|.+...........+.+|+..+.++. |||++++++.+.+ ...++++||++++
T Consensus         6 g~~~-~v~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           6 GSFG-VVRRGEWSTS--GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCcc-cEEeeeEecC--CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEecCCC
Confidence            7899 9999986322  22344799999987655456667889999999998 9999999999988 8899999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+....           ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          81 SLLDRLRKDA-----------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             cHHHHHHhcc-----------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            9999987642           13578999999999999999999999999999999999999999999999999876543


Q ss_pred             cccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......++..|+|||.+.+..++.++|+||+|+++++|++.|..||...+..++.+.+
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  213 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI  213 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            2211 11112334567999999988889999999999999999997799999888877766543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-35  Score=229.74  Aligned_cols=192  Identities=32%  Similarity=0.605  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHH-HHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     +..+++.||+|.+........ .....+|+.++.++. ||||+++++++.+....+++||++.+
T Consensus        10 G~~g-~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen   10 GGFG-TVYKAK-----NKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             ESSE-EEEEEE-----ETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             CCCE-EEEEEE-----ECCCCeEEEEEEeccccccccccchhhhhhhcccccc-cccccccccccccccccccccccccc
Confidence            8899 999999     467888999999987643333 234466999999996 99999999999999999999999998


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++.+++.++.|++.||.+||+.+++|+||+|+||++++++.++|+|||.+... 
T Consensus        83 ~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-  148 (260)
T PF00069_consen   83 GSLQDYLQKN-------------KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-  148 (260)
T ss_dssp             EBHHHHHHHH-------------SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-
T ss_pred             cccccccccc-------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence            8999999832             26899999999999999999999999999999999999999999999999998643 


Q ss_pred             CccccccccCCCCCccccCCcccc-CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                       ...........+++.|+|||++. +...+.++|+||+|+++++|++ |..||....
T Consensus       149 -~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~p~~~~~  203 (260)
T PF00069_consen  149 -SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT-GKLPFEESN  203 (260)
T ss_dssp             -TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH-SSSSSTTSS
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence             11222334555677899999988 7788999999999999999999 999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.7e-35  Score=235.20  Aligned_cols=222  Identities=44%  Similarity=0.834  Sum_probs=173.4

Q ss_pred             CcccceeeecCCCCC--CCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPE--RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.....  .....+..||+|.++..........+.+|+.++.++..||||+++++++...+..++++||++
T Consensus        23 G~~g-~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  101 (334)
T cd05100          23 GCFG-QVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS  101 (334)
T ss_pred             ccCC-cEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCC
Confidence            8899 9999974221  122334579999988655555556788999999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcc---cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++.+.........   .......++..++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~  181 (334)
T cd05100         102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA  181 (334)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccc
Confidence            9999999976432110000   0011234777889999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .................+..|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+..+.+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             eecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            65433222222222333456999999988889999999999999999998789999998888776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-35  Score=228.41  Aligned_cols=207  Identities=37%  Similarity=0.699  Sum_probs=168.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.....  ...+..||+|.++..........+..|+.+++.+. |||++++.+++.+++..++++||++++
T Consensus        15 g~~g-~vy~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T cd05065          15 GEFG-EVCRGRLKLP--GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVMIITEFMENG   90 (269)
T ss_pred             CCCC-eEEEEEEecC--CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceEEEEecCCCC
Confidence            7899 9999985311  11245799999976555556667899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        91 ~L~~~l~~~------------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          91 ALDSFLRQN------------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             cHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999988653            23578899999999999999999999999999999999999999999999998865433


Q ss_pred             cccccccc---CCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKS---EGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ........   ....+..|++||.+.+..++.++|+||+|+++|++++.|..||.+.+..+..+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            22111111   1112346999999988889999999999999999886699999888777665543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-35  Score=225.28  Aligned_cols=202  Identities=40%  Similarity=0.760  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     .. ++.|++|.+...........+.+|+.+++++. ||||+++++++.+.+..++++||+.++
T Consensus         6 g~~g-~v~~~~~-----~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           6 GNFG-DVYKGVL-----KG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CCCc-eEEEEEE-----eC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            7899 9999984     33 89999999887655555667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...++...+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        78 ~l~~~l~~~------------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  145 (251)
T cd05041          78 SLLTFLRKK------------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG  145 (251)
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence            999988653            22578889999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ............+..|+|||.+.+..++.++|+||+|+++++|+++|..||.+....+...+
T Consensus       146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~  207 (251)
T cd05041         146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER  207 (251)
T ss_pred             CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH
Confidence            21111111122244599999988888999999999999999999878999988776655443

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.1e-35  Score=230.41  Aligned_cols=217  Identities=37%  Similarity=0.679  Sum_probs=170.4

Q ss_pred             CcccceeeecCCCCC-----------CCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC
Q psy15818          2 DCFSVEVRKHPMSPE-----------RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~-----------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (225)
                      |.|| +||+++....           ....++..||+|.+...........+.+|+.+++.+. |||++++++++...+.
T Consensus        16 G~~g-~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~   93 (296)
T cd05095          16 GQFG-EVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDP   93 (296)
T ss_pred             CCCC-eEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCc
Confidence            8899 9999864221           2234567899999987655555667889999999998 9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         71 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      .+++|||+++++|.+++.........  .......+++.++..++.|++.||++||+.|++|+||||+||+++.++.++|
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l  171 (296)
T cd05095          94 LCMITEYMENGDLNQFLSRHEPQEAA--EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKI  171 (296)
T ss_pred             cEEEEEeCCCCcHHHHHHhcCccccc--ccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEe
Confidence            99999999999999998764321110  0111234778899999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHhh
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL-GSTPYPGMAAAEVMK  222 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~-g~~p~~~~~~~~~~~  222 (225)
                      +|||++.................++.|++||...+..++.++|+||+|+++|+|+++ |..||...+..+.+.
T Consensus       172 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~  244 (296)
T cd05095         172 ADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE  244 (296)
T ss_pred             ccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999998755333221111222334579999988888899999999999999999973 678998777666543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.5e-35  Score=229.21  Aligned_cols=204  Identities=35%  Similarity=0.660  Sum_probs=162.7

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      .|+|| +||++.+... +......+++|.+..........++..|+..+.++. ||||+++++++. ....++++||+++
T Consensus        17 ~G~~~-~vy~~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~~~~i~e~~~~   92 (279)
T cd05111          17 SGVFG-TVHKGIWIPE-GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GASLQLVTQLSPL   92 (279)
T ss_pred             ccCCc-ceEEEEEcCC-CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCccEEEEEeCCC
Confidence            38999 9999985211 122234688888865544444456777888888887 999999999875 4457889999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||.+....
T Consensus        93 gsL~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          93 GSLLDHVRQH------------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CcHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999753            2357899999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ............++..|++||.+.+..++.++|+||+|+++||+++.|..||.+....+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~  220 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV  220 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            332222222334556799999998888999999999999999999779999998876654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7e-35  Score=230.23  Aligned_cols=218  Identities=40%  Similarity=0.701  Sum_probs=172.8

Q ss_pred             CcccceeeecCCCC-----------CCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC
Q psy15818          2 DCFSVEVRKHPMSP-----------ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~-----------~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (225)
                      |.|| .||++....           ......+..||+|.+...........+.+|+.++.++. |||++++++++...+.
T Consensus        16 G~~g-~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   93 (296)
T cd05051          16 GQFG-EVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIARLLGVCTVDPP   93 (296)
T ss_pred             CCCc-cEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCEeEEEEEEecCCC
Confidence            8899 999987643           22334567899999987665566667889999999998 9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         71 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      .++++|++.+++|.+++..........  ......+++..++.++.|+++||++||+.|++|+||||+||+++.++.++|
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l  171 (296)
T cd05051          94 LCMIMEYMENGDLNQFLQKHVAETSGL--ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKI  171 (296)
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccc--cccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEE
Confidence            999999999999999987643111000  011235789999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHhhh
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL-GSTPYPGMAAAEVMKK  223 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~-g~~p~~~~~~~~~~~~  223 (225)
                      +|||.+................+++.|+|||.+.+..++.++|+||+|+++|++++. +..||...+..+.++.
T Consensus       172 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05051         172 ADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN  245 (296)
T ss_pred             ccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHH
Confidence            999998654333222222233345679999998888899999999999999999863 6788887776665543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-35  Score=227.95  Aligned_cols=211  Identities=39%  Similarity=0.688  Sum_probs=168.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC------eEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------~~lv   74 (225)
                      |+|| .||.+.....  ...+..||+|.++... .......+.+|+..++.+. |||++++++.+.....      .+++
T Consensus        10 G~~g-~v~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v   85 (273)
T cd05035          10 GEFG-SVMEGQLSQD--DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKIPKPMVI   85 (273)
T ss_pred             CCCc-eEEEEEEecC--CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccCcccEEE
Confidence            8999 9999985321  2235789999987643 3344456889999999998 9999999998765443      7999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      +||+++++|..++...+...       ....+++..+..++.|++.||.+||+.+++|+||||+||++++++.++|+|||
T Consensus        86 ~e~~~~~~l~~~l~~~~~~~-------~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          86 LPFMKHGDLHSFLLYSRLGG-------LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             EeccCCCCHHHHHHHhhccC-------CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence            99999999999986643211       22357899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .+.................+..|++||.+.+..++.++|+||+|+++|+|+++|..||.+....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~  227 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY  227 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            987553332222222223345699999998888999999999999999999889999998887776554

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-35  Score=228.52  Aligned_cols=201  Identities=40%  Similarity=0.714  Sum_probs=168.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      ..++.+++|.+...... ....+..|+.+++.++ |||++++++++.+....+++|||++++
T Consensus        17 g~~~-~vy~~~~------~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148          17 GYFG-EVWEGLW------KNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             CCCc-cEEEeEe------cCCCcEEEEeccccchh-hHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEEEeecccC
Confidence            7899 9999994      23788999998765432 2346788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...++...++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        88 ~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          88 SLLAFLRSPE-----------GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             CHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            9999997532           23578899999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .....++..|++||...+..++.++|+||+|+++++|++.|..||.+.+..+...++
T Consensus       157 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~  217 (261)
T cd05148         157 DVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI  217 (261)
T ss_pred             cccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            2211  113334567999999888888999999999999999998789999988877766543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.3e-35  Score=233.08  Aligned_cols=214  Identities=43%  Similarity=0.766  Sum_probs=166.9

Q ss_pred             CcccceeeecCCCCCCCCccc--eEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGP--CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.+     ..++  ..+++|.++..........+.+|+.++.++..|||++++++++...+..++++||++
T Consensus        18 G~~g-~V~~a~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (303)
T cd05088          18 GNFG-QVLKARI-----KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   91 (303)
T ss_pred             CCCc-eEEEEEE-----ccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence            7899 9999985     2334  356777776544445556788899999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhc---ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYN---NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++..........   ........+++..++.++.|++.|+++||++|++|+||||+||+++.++.++|+|||++
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~  171 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  171 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence            999999997653211000   00001235789999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   ........+..|+|||.+.+..++.++|+||+|+++++|++.|..||.+.+..+..+++
T Consensus       172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         172 RGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             cccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            532111   11112223456999999888888999999999999999997689999887777665543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4236|consensus

Probab=100.00  E-value=5.5e-37  Score=245.89  Aligned_cols=190  Identities=28%  Similarity=0.430  Sum_probs=164.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||-+.     ++++|+.||||++.+- ........++.|+++++.+. ||+|+.+.-.|++..++++|||.+. 
T Consensus       575 GQFG-~VYgg~-----hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~-  646 (888)
T KOG4236|consen  575 GQFG-TVYGGK-----HRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLH-  646 (888)
T ss_pred             Ccce-eeecce-----ecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhc-
Confidence            7899 999998     6899999999999643 33444457899999999998 9999999999999999999999996 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~  157 (225)
                      |+..+.+-+.           ..+.+++..-..++.||+.||+|||.++|+|+||||+||++.   .-.++||||||+|+
T Consensus       647 GDMLEMILSs-----------EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  647 GDMLEMILSS-----------EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             chHHHHHHHh-----------hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence            5555554333           345799999999999999999999999999999999999995   34589999999998


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      .++..+.   .....|||.|.|||++....|..+-|+||+|+++|--++ |..||..
T Consensus       716 iIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS-GTFPFNE  768 (888)
T KOG4236|consen  716 IIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS-GTFPFNE  768 (888)
T ss_pred             ecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec-ccccCCC
Confidence            8766544   345678999999999999999999999999999999999 9999953

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=233.71  Aligned_cols=203  Identities=22%  Similarity=0.373  Sum_probs=168.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch--HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE--RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.+......  .....+..|+..+..+. ||+|+++++.+.+....+++|||+.
T Consensus        12 g~~g-~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   84 (316)
T cd05574          12 GDVG-RVFLVRL-----KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVMDYCP   84 (316)
T ss_pred             CccE-EEEEEEE-----cCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEEEecC
Confidence            7889 9999984     457899999999765432  34456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...           ....+++..+..++.|++++|.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~~~~~-----------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          85 GGELFRLLQRQ-----------PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             CCCHHHHHHhC-----------CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            99999988653           1236889999999999999999999999999999999999999999999999988644


Q ss_pred             cCccccc---------------------------cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        160 MTSSVYE---------------------------RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       160 ~~~~~~~---------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                      .......                           ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf  232 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY-GTTPF  232 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh-CCCCC
Confidence            2221100                           0011235677999999988888999999999999999999 99999


Q ss_pred             CCCCHHHHhhh
Q psy15818        213 PGMAAAEVMKK  223 (225)
Q Consensus       213 ~~~~~~~~~~~  223 (225)
                      .+.+..+.+.+
T Consensus       233 ~~~~~~~~~~~  243 (316)
T cd05574         233 KGSNRDETFSN  243 (316)
T ss_pred             CCCchHHHHHH
Confidence            88877665543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5e-35  Score=235.84  Aligned_cols=215  Identities=44%  Similarity=0.793  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.........+++.||+|.++..........+.+|+.++.++..||||+++++++.. .+..+++|||+++
T Consensus        18 G~fg-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~   96 (343)
T cd05103          18 GAFG-QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF   96 (343)
T ss_pred             Cccc-eEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCC
Confidence            8999 9999986543345678999999998665555556788999999999769999999998765 4568999999999


Q ss_pred             CCHHHHHHHhhhhhhhc------------------------------------------------------ccCCCCCCC
Q psy15818         81 GKLQSFLRSSRAQRYYN------------------------------------------------------NMHGKSNSL  106 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~  106 (225)
                      ++|.+++..........                                                      ........+
T Consensus        97 g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (343)
T cd05103          97 GNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVL  176 (343)
T ss_pred             CcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccC
Confidence            99999987542110000                                                      000001246


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCC
Q psy15818        107 TSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN  186 (225)
Q Consensus       107 ~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~  186 (225)
                      +...+..++.|+++||.|||+++++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       177 ~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  256 (343)
T cd05103         177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR  256 (343)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCC
Confidence            77888999999999999999999999999999999999999999999998754332222222223345569999999888


Q ss_pred             CCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       187 ~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .++.++|+||+|++++++++.|..||.+...
T Consensus       257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  287 (343)
T cd05103         257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  287 (343)
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence            8999999999999999999769999976543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3e-35  Score=244.00  Aligned_cols=196  Identities=26%  Similarity=0.444  Sum_probs=155.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--------CCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--------EPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~~~~l   73 (225)
                      |+|| .||++..     ..+++.||+|.+.....     ...+|+.+++.+. ||||+++++++...        ..+++
T Consensus        77 G~fg-~Vy~~~~-----~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         77 GSFG-VVYEAIC-----IDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCCE-EEEEEEE-----CCCCCEEEEEEEecCcc-----hHHHHHHHHHhcC-CCCCcceeeeEeecccccCCCceEEEE
Confidence            8999 9999983     56788999998864322     2346899999998 99999999886432        23678


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVAD  152 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d  152 (225)
                      ||||++ +++.+.+.....         ....+++..++.++.|++.||.|||+.||+||||||+||+++.+ +.++|+|
T Consensus       145 vmE~~~-~~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        145 VMEFIP-QTVHKYMKHYAR---------NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEecCC-ccHHHHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence            999997 467776654321         23468899999999999999999999999999999999999855 4799999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ||++.......   ......+++.|+|||++.+. .++.++|+||+|+++|+|++ |.+||.+.+..+.+.+
T Consensus       215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~  282 (440)
T PTZ00036        215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVR  282 (440)
T ss_pred             cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            99997553322   12233457789999988764 68999999999999999999 9999998877665543

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.9e-35  Score=239.01  Aligned_cols=195  Identities=27%  Similarity=0.416  Sum_probs=161.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv   74 (225)
                      |+|| .||++.     +...++.||+|.+.... .........+|+.+++.+. ||||+++++++...      ...++|
T Consensus        35 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~~~~~~lv  107 (364)
T cd07875          35 GAQG-IVCAAY-----DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIV  107 (364)
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeecccccccccCeEEEE
Confidence            8899 999998     35678899999987542 3344456788999999998 99999999987543      357999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+. ++|...+..               .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus       108 ~e~~~-~~l~~~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         108 MELMD-ANLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             EeCCC-CCHHHHHHh---------------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            99997 467666643               36888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ++.......   ......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+++
T Consensus       172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  236 (364)
T cd07875         172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNK  236 (364)
T ss_pred             CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            987543321   1123356778999999999899999999999999999999 9999998887666544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.9e-35  Score=227.17  Aligned_cols=207  Identities=38%  Similarity=0.701  Sum_probs=168.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++....  ....+..+|+|.++..........+..|+.++.++. |||++++++++..++..+++|||++++
T Consensus        15 g~~g-~v~~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (267)
T cd05066          15 GEFG-EVCSGRLKL--PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENG   90 (267)
T ss_pred             cCCC-ceEEEEEec--CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCccEEEEEcCCCC
Confidence            7899 999987421  122355899999876555555667889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...++..++..++.|++.|+++||+.+++|+||+|+||+++.++.++++|||.+.....
T Consensus        91 ~L~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          91 SLDAFLRKH------------DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999998753            23578899999999999999999999999999999999999999999999999876543


Q ss_pred             cccccc-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...... ......+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+..+..+.+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~  222 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI  222 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH
Confidence            321111 111222456999999988889999999999999999886599999888776665543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.8e-35  Score=227.26  Aligned_cols=211  Identities=40%  Similarity=0.688  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec------CCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE------KEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------~~~~~lv   74 (225)
                      |+|| .||++.+..   ......||+|.++... .......+.+|+..++.++ ||||+++++.+..      ....+++
T Consensus        10 G~~g-~V~~~~~~~---~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v   84 (272)
T cd05075          10 GEFG-SVMEGQLNQ---DDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPSPVVI   84 (272)
T ss_pred             ccCc-eEEEeEEcc---CCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCCCcEEE
Confidence            8899 999998521   1112479999987653 3444567888999999997 9999999997632      2246899


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      +||+.+++|.+++...+...       ....+++..+..++.|++.||.|||+++++|+||||+||++++++.++|+|||
T Consensus        85 ~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          85 LPFMKHGDLHSFLLYSRLGD-------CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             EEeCCCCcHHHHHHHhcccC-------CcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            99999999998875432111       12357899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.................++.|++||...+..++.++|+||+|+++|+|+++|..||.+....++.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  227 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL  227 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9876543322122222334567999999988889999999999999999998789999988777665543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.4e-35  Score=228.17  Aligned_cols=217  Identities=37%  Similarity=0.680  Sum_probs=175.1

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      .|+|| +||++...........+.|++|.+...........+.+|+.+++++. |||++++++++.+.+..++||||+++
T Consensus        15 ~g~~g-~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   92 (275)
T cd05046          15 RGEFG-EVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAEPHYMILEYTDL   92 (275)
T ss_pred             cccee-EEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCCcceEEEEecCC
Confidence            38999 99999976555556678899999876655555667899999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++.........    .....+++..+..++.|++.+|.|||+.+++|+||||+||+++.++.++++|||++....
T Consensus        93 ~~L~~~i~~~~~~~~~----~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~  168 (275)
T cd05046          93 GDLKQFLRATKSKDEK----LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY  168 (275)
T ss_pred             CcHHHHHHhccccccc----ccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccC
Confidence            9999999764311100    011257899999999999999999999999999999999999999999999999876432


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... ........++..|++||.+.+...+.++|+||+|++++++++.|..||.+....+....+
T Consensus       169 ~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         169 NSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             ccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            221 112222334566999999888888899999999999999998788999887776655543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=228.16  Aligned_cols=197  Identities=27%  Similarity=0.470  Sum_probs=168.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.||+|.+...........+.+|+..++.+. |||++++.+.+.+....++++||++++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (274)
T cd06609          12 GSFG-EVYKAID-----KRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWIIMEYCGGG   84 (274)
T ss_pred             CCCe-EEEEEEE-----CCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence            7889 9999984     56789999999876554445556789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++..++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        85 ~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          85 SCLDLLKPG--------------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             cHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            999988643              578999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+...
T Consensus       151 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~  208 (274)
T cd06609         151 TM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLF  208 (274)
T ss_pred             cc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHH
Confidence            32  11223345667999999988889999999999999999999 999998766555443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.2e-35  Score=234.47  Aligned_cols=201  Identities=23%  Similarity=0.395  Sum_probs=156.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |+|| +||++...   ...+++.||+|.+......   ....+|+.+++.+. ||||+++++++..  ....++++||+.
T Consensus        12 G~~g-~Vy~~~~~---~~~~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868          12 GTYG-HVYKAKRK---DGKDDRDYALKQIEGTGIS---MSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             CCCe-EEEEEEEc---cCCCCceEEEEEECCCCCc---HHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEeccC
Confidence            8999 99999842   2245788999998754332   24678999999998 9999999999854  456899999986


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe----cCCCceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~----~~~~~~~l~d~g~  155 (225)
                       ++|.+++........    ......+++..++.++.|++.||.|||++|++|+||||+||++    +.++.++|+|||+
T Consensus        84 -~~l~~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          84 -HDLWHIIKFHRASKA----NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CCHHHHHHhcccccc----cCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence             688888764422110    0112358899999999999999999999999999999999999    3567899999999


Q ss_pred             cccccCccc-cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        156 ARDLMTSSV-YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      +........ ........+|+.|+|||++.+. .++.++|+||+|+++++|++ |.+||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh-CCCCccCCc
Confidence            976533221 1122334567889999988764 57899999999999999999 999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.8e-35  Score=229.51  Aligned_cols=184  Identities=24%  Similarity=0.405  Sum_probs=159.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     +..+++.||+|.+...........+.+|+.++.++. |||++++++.+...+..++++||++++
T Consensus        12 g~~~-~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619          12 GNGG-TVYKAY-----HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            7899 999997     456789999999876544455556889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..+.                 .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~l~~~~-----------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          85 SLDVYR-----------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             ChHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            886442                 368889999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      .    ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..
T Consensus       148 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~  195 (279)
T cd06619         148 S----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL-GRFPYPQ  195 (279)
T ss_pred             c----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh-CCCCchh
Confidence            2    1223456778999999988889999999999999999999 9999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-35  Score=237.84  Aligned_cols=193  Identities=26%  Similarity=0.389  Sum_probs=159.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv   74 (225)
                      |.|| .||++.     +...++.||+|.+.... ......+..+|+.+++.+. ||||+++++++...      ...+++
T Consensus        28 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv  100 (355)
T cd07874          28 GAQG-IVCAAY-----DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLEEFQDVYLV  100 (355)
T ss_pred             cCCE-EEEEEE-----ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccccccceeEEE
Confidence            8899 999998     35678899999987542 3344456788999999998 99999999998644      347999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+.+ ++.+.+..               .+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||
T Consensus       101 ~e~~~~-~l~~~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874         101 MELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             hhhhcc-cHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence            999974 66666543               37888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ++.......   ......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+..
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~  227 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQW  227 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            986543221   1223456778999999998889999999999999999999 99999987765544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.4e-35  Score=231.59  Aligned_cols=193  Identities=27%  Similarity=0.409  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     +..++..+|+|.++..........+.+|+.++.++. ||||+++++.+.+++..++++||++++
T Consensus        12 G~~g-~v~~~~-----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ey~~~~   84 (308)
T cd06615          12 GNGG-VVTKVL-----HRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGG   84 (308)
T ss_pred             CCCe-EEEEEE-----EcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence            7899 999998     356788999999876655555667889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          85 SLDQVLKKA-------------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999998753             257899999999999999999997 589999999999999999999999999886442


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...    .....+++.|++||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus       152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~  205 (308)
T cd06615         152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIPPPDAKE  205 (308)
T ss_pred             ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCcchhh
Confidence            221    122345678999999888888999999999999999999 999997655444

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7e-35  Score=225.89  Aligned_cols=199  Identities=37%  Similarity=0.731  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+      .++..+|+|.++......  ..+.+|+..+..+. ||||+++++++......+++|||+.++
T Consensus        15 G~~~-~vy~~~~------~~~~~~aik~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113          15 GQFG-VVKYGKW------RGQYDVAIKMIKEGSMSE--DEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             cccc-eEEEEEe------cCCCcEEEEEcCCCcccH--HHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            7899 9999974      234469999987543322  35788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        85 ~l~~~i~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          85 CLLNYLREHG------------KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             cHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999986531            2578999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... .......++..|++||.+.+..++.++|+||||+++|+|++.|..||...+..+...+
T Consensus       153 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05113         153 DEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK  213 (256)
T ss_pred             Cce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            221 1112223445699999998888899999999999999999879999988877665543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=242.74  Aligned_cols=189  Identities=23%  Similarity=0.326  Sum_probs=159.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++...   +...++.|++|.+....      ...+|+.+++.+. ||||+++++++...+..+++||++. +
T Consensus       103 G~~g-~Vy~~~~~---~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~  170 (392)
T PHA03207        103 GSEG-EVFVCTKH---GDEQRKKVIVKAVTGGK------TPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYK-C  170 (392)
T ss_pred             CCCe-EEEEEEEc---CCccceeEEEEeccccc------cHHHHHHHHHhcC-CCCccceeeeEeeCCEEEEEehhcC-C
Confidence            8899 99998632   34457889999886432      2457999999998 9999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...             ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       171 ~l~~~l~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        171 DLFTYVDRS-------------GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             CHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            788777432             3689999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ...........+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+..
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~  291 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQ  291 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence            333222334567889999999998889999999999999999999 999997654

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-34  Score=227.37  Aligned_cols=196  Identities=31%  Similarity=0.517  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+..     ..++..||+|.+...........+.+|+.++..+. |||++++++.+.+++..++||||++++
T Consensus        15 g~~~-~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640          15 GSFG-EVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             CCCe-EEEEEEE-----ccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            7899 9999983     56789999999886655555567889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||++.....
T Consensus        88 ~L~~~i~~~--------------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          88 SALDLLRAG--------------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             cHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            999988642              478889999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...  ......++..|.|||.+.+..++.++|+||+|+++|+|++ |..||...+.....
T Consensus       154 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~  210 (277)
T cd06640         154 TQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVL  210 (277)
T ss_pred             Ccc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH-CCCCCCCcChHhHh
Confidence            221  1122234567999999988888999999999999999999 99999877655543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-35  Score=237.49  Aligned_cols=194  Identities=26%  Similarity=0.434  Sum_probs=159.6

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEE
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFV   73 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~l   73 (225)
                      .|+|| +||++.     +..+++.||+|.+.... .........+|+.+++++. ||||+++++++...      ...++
T Consensus        25 ~G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~   97 (343)
T cd07878          25 SGAYG-SVCSAY-----DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIENFNEVYL   97 (343)
T ss_pred             cCCCe-EEEEEE-----ECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccccccCcEEE
Confidence            38999 999998     35678899999987542 2233345778999999998 99999999987543      34789


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      +++++ +++|.+++..              ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+||
T Consensus        98 ~~~~~-~~~l~~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          98 VTNLM-GADLNNIVKC--------------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             EeecC-CCCHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCC
Confidence            99987 6888877743              25899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      |++......     .....+++.|+|||++.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+.
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  226 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLK  226 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence            998754322     223346778999999876 467889999999999999999 999998877655544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-34  Score=224.25  Aligned_cols=201  Identities=22%  Similarity=0.407  Sum_probs=170.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| .||.++     +..+++.+++|.+... .......++.+|+.+++++. |+|++++++++.+.+..++++||+++
T Consensus        11 g~~g-~v~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (256)
T cd08221          11 GAFG-EATLYR-----RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEMEYANG   83 (256)
T ss_pred             cCCc-eEEEEE-----EcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEEEecCC
Confidence            7889 888888     4577889999998754 24445556889999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+....           ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++|+|||.+....
T Consensus        84 ~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          84 GTLYDKIVRQK-----------GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             CcHHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999987542           2357899999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  ......+++.|.|||.+.+..++.++|+||+|+++++|++ |..||...+..+....
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~  212 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-LKRTFDATNPLNLVVK  212 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence            3321  1223346778999999988888899999999999999999 9999998877776554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=227.09  Aligned_cols=206  Identities=38%  Similarity=0.724  Sum_probs=169.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.... .+......||+|.+...........+.+|+..+.++. |||++++++++.. ...++++||++++
T Consensus        18 g~~g-~v~~~~~~~-~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~~v~e~~~~g   93 (279)
T cd05057          18 GAFG-TVYKGVWIP-EGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQVQLITQLMPLG   93 (279)
T ss_pred             CCCc-cEEEEEEec-CCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-CceEEEEecCCCC
Confidence            8899 999998532 1222345799999887666666667889999999997 9999999999887 7899999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        94 ~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          94 CLLDYVRNH------------KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             cHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999998753            22478999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ............+..|++||.+....++.++|+||+|++++++++.|..||.+....++...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  223 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL  223 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            32222222223345699999988888899999999999999999769999998887765543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.9e-35  Score=232.68  Aligned_cols=198  Identities=19%  Similarity=0.332  Sum_probs=160.3

Q ss_pred             cccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          3 CFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         3 ~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      .|| +||++.     .+.+|+.||+|.+.... .......+.+|+.+++.++ ||||+++++++..++..++|+||++++
T Consensus        12 ~~~-~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~   84 (327)
T cd08227          12 DLM-TVNLAR-----YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYG   84 (327)
T ss_pred             ceE-EEEEEe-----ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEeccCCC
Confidence            678 999988     46789999999997653 3334445778999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++..+..++.|++.||+|||+++++|+||||+||+++.++.++++||+.......
T Consensus        85 ~l~~~~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          85 SAKDLICTHF-----------MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             cHHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999986542           22478999999999999999999999999999999999999999999999986543321


Q ss_pred             ccccc-----cccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        162 SSVYE-----RKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       162 ~~~~~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      .....     ......++..|+|||.+.+  ..++.++|+||+|+++++|++ |..||......+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  217 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQ  217 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchhH
Confidence            11100     1112234556999999876  457899999999999999999 999998765544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-35  Score=227.16  Aligned_cols=213  Identities=44%  Similarity=0.773  Sum_probs=167.2

Q ss_pred             CcccceeeecCCCCCCCCccc--eEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGP--CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..++  ..+++|.++..........+.+|+.++.++..|||++++++++...+..+++|||++
T Consensus         6 g~~g-~v~~~~~-----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           6 GNFG-QVLKARI-----KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CCCc-eEEEEEE-----cCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            8899 9999985     2333  357888887554445555788999999999669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhc---ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYN---NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++...+......   ........+++.++..++.|++.|+++||+.|++|+||||+||++++++.++++|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999997643211000   00012235788999999999999999999999999999999999999999999999987


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ......   ........+..|+|||.+.+..++.++|+||||+++++|++.|..||.+.+..+..+.
T Consensus       160 ~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~  223 (270)
T cd05047         160 RGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  223 (270)
T ss_pred             cccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence            532111   1111222345699999988888999999999999999999669999988777665544

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-34  Score=225.94  Aligned_cols=207  Identities=39%  Similarity=0.678  Sum_probs=168.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++....  .......+++|.++..........+..|+.++..+. |||++++.+++.+.+..+++|||++++
T Consensus        16 g~~g-~vy~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (268)
T cd05063          16 GEFG-EVFRGILKM--PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPAMIITEYMENG   91 (268)
T ss_pred             CCCc-cEEEEEEec--CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCcEEEEEcCCCC
Confidence            7899 999998521  112245899999976655555567889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus        92 ~L~~~~~~~------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          92 ALDKYLRDH------------DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999998653            23578899999999999999999999999999999999999999999999998875533


Q ss_pred             cccccc-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...... ......+..|++||.+.+..++.++|+||+|+++|++++.|..||...+..+..+.|
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i  223 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI  223 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence            221111 111222346999999988888999999999999999986699999888777766654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-35  Score=225.83  Aligned_cols=201  Identities=44%  Similarity=0.782  Sum_probs=166.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .+++.||+|.+.......  ..+.+|+.+++++. |||++++++.+......++++||++++
T Consensus        17 g~~~-~v~~~~~------~~~~~~~vK~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~   86 (261)
T cd05034          17 GQFG-EVWMGTW------NGTTKVAVKTLKPGTMSP--EAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKG   86 (261)
T ss_pred             Ccce-EEEEEEE------cCCceEEEEEecCCccCH--HHHHHHHHHHhhCC-CCCEeeeeeeeecCCceEEEEeccCCC
Confidence            7899 9999883      345779999987654332  35888999999998 999999999999989999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...           ....++...+..++.|++.|+.+||+++++|+||+|+||++++++.++|+|||.+.....
T Consensus        87 ~L~~~i~~~-----------~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          87 SLLDFLKSG-----------EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             CHHHHHhcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999998753           223578999999999999999999999999999999999999999999999998865533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. .........+..|+|||.+.+..++.++|+||+|++++++++.|..||.+.+..+.++++
T Consensus       156 ~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  217 (261)
T cd05034         156 DE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV  217 (261)
T ss_pred             hh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            21 111112223456999999988889999999999999999998799999988877766553

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=224.28  Aligned_cols=207  Identities=53%  Similarity=0.938  Sum_probs=172.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++...... ...+..||+|.++..........+..|+..+..+. |+|++++++++.+.+..+++||+++++
T Consensus        10 g~~g-~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~i~e~~~~~   86 (258)
T smart00219       10 GAFG-EVYKGTLKGLS-GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMIVMEYMEGG   86 (258)
T ss_pred             CCCc-ceEEEEecCCC-CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEEEEeccCCC
Confidence            7899 99999964321 13468999999987665545667889999999996 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+.....           ..+++..+..++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        87 ~l~~~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       87 DLLDYLRKNRP-----------KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             CHHHHHHhhhh-----------ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999876421           1279999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....... ...+++.|++||.+.+..++.++|+||+|+++++|++.|.+||...+..+....
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~  216 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY  216 (258)
T ss_pred             ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            3221111 223567799999988888899999999999999999878999988777766554

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4721|consensus

Probab=100.00  E-value=1.6e-36  Score=244.98  Aligned_cols=187  Identities=32%  Similarity=0.592  Sum_probs=163.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+-| .|++++.       .++.||||..+.        .-..+|.=|++++ ||||++|.++|...-++|||||||..|
T Consensus       135 GaQG-AVF~Grl-------~netVAVKKV~e--------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  135 GAQG-AVFLGRL-------HNETVAVKKVRE--------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             Cccc-ceeeeec-------cCceehhHHHhh--------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccccc
Confidence            7788 9999984       588999998753        2234577788998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      .|...++..             ..+..+.+..|..+|+.|+.|||.+.|+|||||.-||+|+.+..|||+|||-...+..
T Consensus       198 qL~~VLka~-------------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  198 QLYEVLKAG-------------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             cHHHHHhcc-------------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            999999854             4789999999999999999999999999999999999999999999999998865533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .   .......||-.|||||++...+.+.++||||||++||||+| |..||.+-+...+++
T Consensus       265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT-~EiPYkdVdssAIIw  321 (904)
T KOG4721|consen  265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT-GEIPYKDVDSSAIIW  321 (904)
T ss_pred             h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh-cCCCccccchheeEE
Confidence            2   44556678888999999999999999999999999999999 999999877665543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=224.19  Aligned_cols=205  Identities=41%  Similarity=0.707  Sum_probs=166.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.....  ...+..||+|.+...........+.+|+.++..+. |||++++++++. ....++++||+.++
T Consensus         6 G~~g-~v~~~~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           6 GNFG-SVVKGVYLMK--SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             cCce-eEEEeEeecc--CCCcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            8899 9999874211  11347899999987665455567889999999998 999999999876 45689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...             ..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          81 PLLKYLKKR-------------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             cHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            999999753             2578999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... ......++..|+|||...+..++.++|+||||+++|++++.|..||...+..+..+.+
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~  211 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML  211 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            32211 1112223456999999988889999999999999999997699999888877665543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-34  Score=229.90  Aligned_cols=201  Identities=21%  Similarity=0.368  Sum_probs=166.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++.     +...++.|++|.+.....  ......+.+|+.++..+. ||||+++++.+...+..+++|||++
T Consensus        12 g~~~-~v~~~~-----~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   84 (305)
T cd05609          12 GAYG-AVYLVR-----HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVMEYVE   84 (305)
T ss_pred             CCCe-eEEEEE-----ECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEEecCC
Confidence            7899 999988     467788999999876532  333446778999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        85 g~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          85 GGDCATLLKNI-------------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            99999998653             25788999999999999999999999999999999999999999999999987531


Q ss_pred             cCcccc-------------ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVY-------------ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~-------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ......             .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+..+.+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~-g~~pf~~~~~~~~~~~  227 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFGQ  227 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            110000             01112235667999999988889999999999999999999 9999998877766554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0986|consensus

Probab=100.00  E-value=1.6e-36  Score=238.99  Aligned_cols=197  Identities=20%  Similarity=0.380  Sum_probs=170.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||.+.+     +.+|+.||+|.+.+.  .+.....-.+.|-.++.+++ .++||.+-..|++.+.+|+|+..+.
T Consensus       196 GGFG-EV~acqv-----raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClVLtlMN  268 (591)
T KOG0986|consen  196 GGFG-EVCACQV-----RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLVLTLMN  268 (591)
T ss_pred             cccc-ceeEEEE-----ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEEEEeec
Confidence            7899 9999995     689999999998543  22333335678888999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||||.-.+...           +++.++++.+..++.+|+.||++||..+|++||+||+||++++.|+++|+|+|+|..+
T Consensus       269 GGDLkfHiyn~-----------g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  269 GGDLKFHIYNH-----------GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             CCceeEEeecc-----------CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99998777543           4467999999999999999999999999999999999999999999999999999876


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      .....   .....||.+|||||++.+..|+.+.|+|||||++|+|+. |+.||+.....+-
T Consensus       338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~KeKvk  394 (591)
T KOG0986|consen  338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRKEKVK  394 (591)
T ss_pred             CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhhhhhh
Confidence            55443   334478888999999999999999999999999999999 9999987665443

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-34  Score=227.36  Aligned_cols=196  Identities=38%  Similarity=0.653  Sum_probs=160.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~   79 (225)
                      |+|| +||++... .....+++.||+|.++..........+.+|+..++.+. |||++++++++...  ...+++|||+.
T Consensus        15 g~~g-~v~~~~~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (283)
T cd05080          15 GHFG-KVSLYCYD-PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVP   91 (283)
T ss_pred             CCCc-EEEEeeEc-cccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCceEEEEecCCC
Confidence            7899 99886532 22355688999999986654445567889999999997 99999999987653  45899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...              .+++..++.++.|++.||.+||+++++|+||||+||++++++.++|+|||++...
T Consensus        92 ~~~l~~~~~~~--------------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          92 LGSLRDYLPKH--------------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             CCCHHHHHHHc--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999998653              4899999999999999999999999999999999999999999999999998765


Q ss_pred             cCcccccc-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ........ .....++..|++||.+.+..++.++|+||||+++++|++ |..||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~  213 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSP  213 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHh-CCCCCCCC
Confidence            43322111 122234456899999888888999999999999999999 99998643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0696|consensus

Probab=100.00  E-value=1.4e-36  Score=237.47  Aligned_cols=201  Identities=25%  Similarity=0.423  Sum_probs=174.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .|-++.     .+.+.+.+|||+++.+-  ..++.+-.+.|-++|..-...|.++.++.+|...+++|+||||+.
T Consensus       360 GSFG-KVlLae-----rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn  433 (683)
T KOG0696|consen  360 GSFG-KVLLAE-----RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN  433 (683)
T ss_pred             Cccc-eeeeec-----ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence            8999 999999     47789999999998762  333434456666677666678999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||+|-..+++.             +++.|..+..++..|+-||-+||++||++||||.+||+++..|.+||.|||++..-
T Consensus       434 GGDLMyhiQQ~-------------GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  434 GGDLMYHIQQV-------------GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             CchhhhHHHHh-------------cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999888764             36889999999999999999999999999999999999999999999999999643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..+  .....+..|||.|+|||++..++|+.++|+||+|++||||+. |++||++.+++++..+|
T Consensus       501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~elF~aI  562 (683)
T KOG0696|consen  501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQAI  562 (683)
T ss_pred             ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            222  123345678999999999999999999999999999999999 99999999999988766

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-34  Score=227.13  Aligned_cols=218  Identities=36%  Similarity=0.666  Sum_probs=167.7

Q ss_pred             CcccceeeecCCCCCC---------CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeE
Q psy15818          2 DCFSVEVRKHPMSPER---------GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   72 (225)
                      |.|| .||++......         .......||+|.++..........+.+|+.++.++. |||++++++++...+..+
T Consensus        16 G~~g-~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   93 (295)
T cd05097          16 GQFG-EVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLC   93 (295)
T ss_pred             CCCc-eEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCCccE
Confidence            8899 99998752210         112244699999987655555667889999999998 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +||||+++++|.+++.......... .......++...++.++.|++.||.+||+.|++|+||||+||++++++.++|+|
T Consensus        94 lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~d  172 (295)
T cd05097          94 MITEYMENGDLNQFLSQREIESTFT-HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIAD  172 (295)
T ss_pred             EEEecCCCCcHHHHHHhcccccccc-ccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecc
Confidence            9999999999999986532111000 000122467888999999999999999999999999999999999999999999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHhh
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL-GSTPYPGMAAAEVMK  222 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~-g~~p~~~~~~~~~~~  222 (225)
                      ||++................++..|+|||.+.+..++.++|+||||+++++|+++ +..||...+..+...
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         173 FGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             cccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            9998754332211111222335679999999888899999999999999999872 567888777666543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-34  Score=228.20  Aligned_cols=215  Identities=47%  Similarity=0.794  Sum_probs=166.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++....   ......+++|.++..........+.+|+..+.++..|||++++++++...+..++++||++++
T Consensus        13 g~~g-~v~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   88 (297)
T cd05089          13 GNFG-QVIRAMIKK---DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG   88 (297)
T ss_pred             CCcc-eEEEEEecC---CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCC
Confidence            8899 999997421   111235788888754444445578889999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc---cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++...........   .......+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  168 (297)
T cd05089          89 NLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG  168 (297)
T ss_pred             cHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcc
Confidence            99999976432111000   001123578899999999999999999999999999999999999999999999998753


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....   ........+..|++||...+..++.++|+||||+++|+|++.|..||.+....+...+
T Consensus       169 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         169 EEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             ccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            2111   1111222234699999998888999999999999999999669999998887765544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.2e-34  Score=223.61  Aligned_cols=205  Identities=40%  Similarity=0.714  Sum_probs=162.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe-cCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.+..  ....+..||+|.+...........+.+|+.+++.+. |||++++++++. .++..++++||+.+
T Consensus         6 g~~g-~v~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           6 GHFG-CVYHGTLID--SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cCCc-eEEEEEEec--CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEecCCC
Confidence            7899 999987521  123467899999865444445567888999999997 999999999765 45668999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....            ..++...+..++.|+++||.+||+.+++|+||+|+||++++++.++|+|||++....
T Consensus        82 ~~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          82 GDLRNFIRSET------------HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999986531            235677788999999999999999999999999999999999999999999986543


Q ss_pred             Ccccc--ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .....  .......++..|+|||.+.+..++.++|+||||+++|+|+++|.+||...+..+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~  213 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV  213 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            22111  111123345579999998888899999999999999999996788888776655443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-34  Score=224.89  Aligned_cols=197  Identities=25%  Similarity=0.465  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.|++|.+....  .......+.+|+.+++.+. |||++++++.+.+....++++||++
T Consensus         4 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   76 (262)
T cd05572           4 GGFG-RVELVKV-----KSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL   76 (262)
T ss_pred             CCce-EEEEEEE-----CCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence            7899 9999994     4568999999997543  2344456889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.+.             ..+++..+..++.|+++||++||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~~L~~~l~~~-------------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~  143 (262)
T cd05572          77 GGELWTILRDR-------------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL  143 (262)
T ss_pred             CCcHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence            99999999753             24788999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC--HHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA--AAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~--~~~~~~  222 (225)
                      ....   ......+++.|++||.+.+..++.++|+||+|+++|++++ |..||....  ..+.+.
T Consensus       144 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~  204 (262)
T cd05572         144 KSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYN  204 (262)
T ss_pred             Cccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh-CCCCcCCCCCCHHHHHH
Confidence            4332   1122345667999999888888999999999999999999 999998776  444443

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-34  Score=222.42  Aligned_cols=195  Identities=40%  Similarity=0.753  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+..       .|+.||+|.++....  ...++.+|+.++..+. |+|++++++++.+.+..++++||++++
T Consensus        17 g~~g-~v~~~~~-------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039          17 GEFG-DVMLGDY-------RGQKVAVKCLKDDST--AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             CCCc-eEEEEEe-------cCcEEEEEEeccchh--HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            7899 9999983       378899999976544  3456888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        86 ~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          86 SLVDYLRSRG-----------RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             cHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            9999987531           22578999999999999999999999999999999999999999999999999876532


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...     ....+..|.|||.+.+..++.++|+||+|++++++++.|..||...+..++.+.
T Consensus       155 ~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         155 GQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             ccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            221     223345699999998888899999999999999999669999988877766543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0577|consensus

Probab=100.00  E-value=3.1e-36  Score=244.25  Aligned_cols=194  Identities=26%  Similarity=0.473  Sum_probs=169.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||.++     ...+.++||||.+..+  ...+...++.+|+.+++++. |||.+.+.++|-.....|||||||-
T Consensus        37 GSFG-AVYfAr-----d~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLVMEYCl  109 (948)
T KOG0577|consen   37 GSFG-AVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLVMEYCL  109 (948)
T ss_pred             Cccc-eeEEee-----ccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHHHHHHh
Confidence            8999 999999     5788999999999765  34566678999999999999 9999999999999999999999996


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       |+-.+++.-.+            .++.+-++..+..+.+.||+|||+.+.+|||||..||++++.|.|||.|||.+...
T Consensus       110 -GSAsDlleVhk------------KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  110 -GSASDLLEVHK------------KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             -ccHHHHHHHHh------------ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence             66667765532            37889999999999999999999999999999999999999999999999998543


Q ss_pred             cCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                            .......|||.|||||++.   .+.|+.++||||||+.+.|+.. ..+|+...+.-..+.
T Consensus       177 ------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSALY  235 (948)
T KOG0577|consen  177 ------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALY  235 (948)
T ss_pred             ------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchHHHHHH
Confidence                  3345667899999999886   3568999999999999999998 999998888766554

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.9e-35  Score=228.72  Aligned_cols=195  Identities=30%  Similarity=0.514  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.||+|.+...........+.+|+.++.++. |||++++++.+...+..++|+||++++
T Consensus        15 g~~~-~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642          15 GSFG-EVYKGID-----NRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             CCCe-eEEEEEE-----cCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEEEEccCCC
Confidence            7899 9999973     56788999999876554555567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..              ..+++..+..++.|++.|+.+||+++++|+||+|+||++++++.++++|||++.....
T Consensus        88 ~L~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          88 SALDLLKP--------------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             cHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99988853              2578899999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++++|++ |..||......+.
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~  209 (277)
T cd06642         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRV  209 (277)
T ss_pred             cch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh-CCCCCcccchhhH
Confidence            221  1122345667999999988888999999999999999999 9999986655443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0662|consensus

Probab=100.00  E-value=1.6e-35  Score=208.39  Aligned_cols=201  Identities=28%  Similarity=0.478  Sum_probs=173.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +|++++     ++.+++.||+|....+. .+..-....+|+-+++.++ |.||++++|+...+..+-+|+|||. 
T Consensus        13 gtyg-tvfkar-----n~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlhsdkkltlvfe~cd-   84 (292)
T KOG0662|consen   13 GTYG-TVFKAR-----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCD-   84 (292)
T ss_pred             Ccce-eeEecc-----cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeHHHhh-
Confidence            7899 999999     68999999999998653 2223345889999999999 9999999999999999999999996 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      -+|..+..+.            ++.++.+.++.++.|++.+|.++|+++++|||+||+|.++..+|+.|+.|||+++.++
T Consensus        85 qdlkkyfdsl------------ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   85 QDLKKYFDSL------------NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             HHHHHHHHhc------------CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            7888777663            4568999999999999999999999999999999999999999999999999998776


Q ss_pred             CccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .+......  ...|..|.+|.++.+.. |+.+.|+||.||++.|+..-|++.|++.+-.+++++|
T Consensus       153 ipvrcysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri  215 (292)
T KOG0662|consen  153 IPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  215 (292)
T ss_pred             CceEeeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence            55422222  12345699999998865 7999999999999999998899999999999999876

>KOG0612|consensus

Probab=100.00  E-value=2e-36  Score=259.61  Aligned_cols=201  Identities=24%  Similarity=0.365  Sum_probs=173.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .|.+++     ++.+++.||.|++.+-.  +.....-+..|-.+|.-.. .+.|+.++..|.+...+|+||||++
T Consensus        86 GaFG-EV~lVr-----~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYlVMdY~p  158 (1317)
T KOG0612|consen   86 GAFG-EVALVR-----HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYLVMDYMP  158 (1317)
T ss_pred             cccc-eeEEEE-----eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEEEEeccc
Confidence            8999 999999     57899999999997532  2333334566677777776 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||||..+++..            . ++++..++.|...++-||..+|+.|++||||||+||+++..|.+||.|||.|..+
T Consensus       159 GGDlltLlSk~------------~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  159 GGDLLTLLSKF------------D-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             CchHHHHHhhc------------C-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence            99999999863            2 6899999999999999999999999999999999999999999999999999877


Q ss_pred             cCccccccccCCCCCccccCCcccc----C-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY----D-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~----~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..+.. .......|||.|++||++.    + +.|+...|+||+|+++|||+. |..||.....-+.+-+|
T Consensus       226 ~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~TPFYadslveTY~KI  293 (1317)
T KOG0612|consen  226 DADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GETPFYADSLVETYGKI  293 (1317)
T ss_pred             CCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CCCcchHHHHHHHHHHH
Confidence            54432 3345677899999999986    3 568899999999999999999 99999888777776655

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-34  Score=224.05  Aligned_cols=199  Identities=40%  Similarity=0.719  Sum_probs=162.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..      .+...||+|.++......  ..+.+|+.++..+. |||++++++.+.. ...+++|||++++
T Consensus        17 g~~~-~v~~~~~------~~~~~valK~~~~~~~~~--~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~lv~e~~~~~   85 (262)
T cd05071          17 GCFG-EVWMGTW------NGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG   85 (262)
T ss_pred             CCCC-cEEEEEe------cCCceEEEEecccCccCH--HHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEEEEEcCCCC
Confidence            7899 9999974      223469999987543322  35788999999998 9999999998754 5689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.+..           ...+++..+..++.|++.||++||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        86 ~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          86 SLLDFLKGEM-----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             cHHHHHhhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            9999997531           23468899999999999999999999999999999999999999999999999865533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .... ......++..|++||...+..++.++|+||+|+++|+++++|..||.+....+.+++
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~  215 (262)
T cd05071         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ  215 (262)
T ss_pred             cccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Confidence            3211 111233455699999988888999999999999999999988999998877776554

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-34  Score=222.53  Aligned_cols=200  Identities=25%  Similarity=0.397  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (225)
                      |.+| .||++..     ..+++.||+|.+.... .......+.+|+..++++. |||++++.+.+.. .+..++++||++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (257)
T cd08223          11 GSYG-EVSLVRH-----RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIVMGFCE   83 (257)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEEecccC
Confidence            7899 9999983     5668899999987543 3344456788999999997 9999999998864 446799999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+.+....           ...+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        84 ~~~l~~~l~~~~-----------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          84 GGDLYHKLKEQK-----------GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             CCcHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            999999887532           235789999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .....  ......+++.|+|||.+.+..++.++|+||+|++++++++ |..||...+..+...
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~  212 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVY  212 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Confidence            32221  1223345677999999988888999999999999999999 999998877655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-34  Score=227.16  Aligned_cols=194  Identities=20%  Similarity=0.358  Sum_probs=162.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+|+.||+|.+....  .......+..|+.++++++ ||+++++++.+...+..++|+||++
T Consensus         4 g~~g-~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05577           4 GGFG-EVCACQV-----KATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN   76 (277)
T ss_pred             CCce-eEEEEEE-----cCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence            7899 9999883     5678899999987542  2223345678999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....           ...+++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++|+|||.+...
T Consensus        77 ~~~L~~~l~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~  145 (277)
T cd05577          77 GGDLKYHIYNVG-----------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL  145 (277)
T ss_pred             CCcHHHHHHHcC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence            999999887542           235789999999999999999999999999999999999999999999999988654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ....   ......++..|++||.+.+..++.++|+||+|+++++|++ |..||.....
T Consensus       146 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~  199 (277)
T cd05577         146 KGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKE  199 (277)
T ss_pred             ccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh-CCCCCCCCcc
Confidence            3211   1122344567999999888888999999999999999999 9999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=223.17  Aligned_cols=196  Identities=26%  Similarity=0.473  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.+++|.+...... ....+.+|+.++.+++ |||++++++.+.+.+..+++|||++++
T Consensus        14 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613          14 GTYG-DVYKARD-----IATGELVAIKVIKLEPGD-DFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             CCce-EEEEeEe-----cCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            7899 9999984     456788999999765433 4457889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        86 ~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          86 SLQDIYQVT------------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             cHHHHHHhh------------ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999988653            13588999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccCC---CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDN---IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ..  .......++..|++||.+.+.   .++.++|+||+|+++++|++ |..||.+.+..+.
T Consensus       154 ~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~~~~~  212 (262)
T cd06613         154 TI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDLHPMRA  212 (262)
T ss_pred             hh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            21  112223456679999998766   78889999999999999999 9999987765443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-34  Score=226.72  Aligned_cols=197  Identities=29%  Similarity=0.518  Sum_probs=162.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     ...+++.|++|.+.... ......+.+|+..++.+. |||++++++.+..++..++||||++++
T Consensus        23 g~~g-~vy~~~-----~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   94 (292)
T cd06644          23 GAFG-KVYKAK-----NKETGALAAAKVIETKS-EEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWIMIEFCPGG   94 (292)
T ss_pred             CCCe-EEEEEE-----ECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEEEEEecCCCC
Confidence            7899 999998     35678999999987543 334556788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..++...            ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.+++++|+|||.+.....
T Consensus        95 ~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          95 AVDAIMLEL------------DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             cHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            998887543            23578999999999999999999999999999999999999999999999998764322


Q ss_pred             ccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..  .......+++.|+|||.+.     ...++.++|+||+|+++|+|++ |..||...+..+..
T Consensus       163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~  224 (292)
T cd06644         163 TL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVL  224 (292)
T ss_pred             cc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc-CCCCCccccHHHHH
Confidence            21  1112233566799999875     3446778999999999999999 99999876655433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-34  Score=227.53  Aligned_cols=197  Identities=28%  Similarity=0.488  Sum_probs=161.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| +||++..     ..+++.||+|.++... .......+.+|+.+++++. |||++++++++.+++..++|+||+. 
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861          11 GTYG-VVYKGRN-----KKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             cCce-EEEEEEE-----CCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            7889 9999983     5678899999987543 2223345778999999998 9999999999999999999999997 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....          ....+++..++.++.|+++||.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~~l~~~~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          83 MDLKKYLDSLP----------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CCHHHHHhcCC----------CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            57888776432          12458899999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...  .......+++.|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+....+
T Consensus       153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~~~~~~~~~~  209 (285)
T cd07861         153 IPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEID  209 (285)
T ss_pred             CCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHH
Confidence            221  111223446779999988654 46889999999999999999 999998766544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0614|consensus

Probab=100.00  E-value=7.2e-37  Score=243.93  Aligned_cols=200  Identities=24%  Similarity=0.415  Sum_probs=177.7

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      ||.|| .|-++..     ......+|+|++++..  .....+.+..|-++|..+. .|+|+++|-.|.++...|+.||.|
T Consensus       430 vGgFG-RVELV~~-----~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLmEaC  502 (732)
T KOG0614|consen  430 VGGFG-RVELVKV-----NSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLMEAC  502 (732)
T ss_pred             cCccc-eEEEEEe-----cccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhHHhh
Confidence            69999 9999885     2233369999998653  5566667889999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      -||.+...++..             +.+.+.+...++..+++|++|||++||++|||||+|++++.+|.+||.|||+|..
T Consensus       503 lGGElWTiLrdR-------------g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  503 LGGELWTILRDR-------------GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             cCchhhhhhhhc-------------CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999753             4789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +..+.   ...+.+|||.|.|||++.+...+.++|.||||+++|||++ |.+||++.++-..++.|
T Consensus       570 i~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpmktYn~I  631 (732)
T KOG0614|consen  570 IGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPMKTYNLI  631 (732)
T ss_pred             hccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHH
Confidence            65443   3456788999999999999999999999999999999999 99999999998877765

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-34  Score=223.35  Aligned_cols=199  Identities=41%  Similarity=0.756  Sum_probs=163.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .+++.||+|.+.......  ..+.+|+.+++++. |||++++++.+. .+..++++||+.++
T Consensus        17 G~~g-~v~~~~~------~~~~~~a~K~~~~~~~~~--~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05067          17 GQFG-EVWMGYY------NGHTKVAIKSLKQGSMSP--EAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIYIITEYMENG   85 (260)
T ss_pred             Cccc-eEEeeec------CCCceEEEEEecCCCCcH--HHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcEEEEEcCCCC
Confidence            7899 9999984      356789999987654432  36788999999998 999999999874 45689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...           ....++..++..++.|++.||++||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        86 ~L~~~~~~~-----------~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          86 SLVDFLKTP-----------EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             CHHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            999988653           233578899999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... .......++..|+|||.+.+..++.++|+||+|++++++++.|.+||.+.+..+..++
T Consensus       155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  215 (260)
T cd05067         155 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN  215 (260)
T ss_pred             CCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence            211 1112223445799999998888899999999999999999779999998887766554

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-34  Score=228.44  Aligned_cols=193  Identities=25%  Similarity=0.495  Sum_probs=162.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     ...+++.|++|.+....... ...+.+|+.+++.+. |||++++++.+......++|+||++++
T Consensus        31 g~~~-~v~~~~-----~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~~lv~e~~~~~  102 (296)
T cd06654          31 GASG-TVYTAM-----DVATGQEVAIRQMNLQQQPK-KELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGG  102 (296)
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEEEEeecccCCC
Confidence            7889 999997     35678899999987654333 346788999999987 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       103 ~L~~~~~~~--------------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654         103 SLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             CHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999988542              468889999999999999999999999999999999999999999999998865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...  ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+
T Consensus       169 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~~~~  223 (296)
T cd06654         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLR  223 (296)
T ss_pred             ccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            211  1122346678999999988888999999999999999999 999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-34  Score=223.96  Aligned_cols=199  Identities=26%  Similarity=0.422  Sum_probs=162.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~   75 (225)
                      |.|| .||.+.     ...+++.||+|.+....    .......+.+|+.++.++. |||++++++++.+.  ..+++++
T Consensus        13 g~~g-~v~~~~-----~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652          13 GAFG-RVYLCY-----DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             CCce-EEEEEE-----EcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCceEEEEE
Confidence            7899 999998     35778999999885322    2233456788999999998 99999999998764  4688999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+++++|.+++...             ..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.
T Consensus        86 e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          86 EHMPGGSIKDQLKSY-------------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             EecCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcc
Confidence            999999999988653             2468888999999999999999999999999999999999999999999998


Q ss_pred             cccccCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        156 ARDLMTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      +......... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~  218 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAI  218 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh-CCCCCCccchHHHH
Confidence            8754322111 11222346677999999988888999999999999999999 99999876554443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6e-35  Score=230.99  Aligned_cols=197  Identities=26%  Similarity=0.493  Sum_probs=165.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+.     ...+++.||+|.+...... ....+.+|+.++..+. |||++++++.+...+..++++||++++
T Consensus        32 g~~g-~v~~~~-----~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          32 GSTG-IVCIAR-----EKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             CCce-eEEEEE-----EcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEEEecCCCC
Confidence            7899 999987     3567889999998654332 3346788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       104 ~L~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         104 ALTDIVSQT--------------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             CHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            999877542              478999999999999999999999999999999999999999999999998864432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+.+..
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~  228 (297)
T cd06659         170 DVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKR  228 (297)
T ss_pred             ccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            211  1223346678999999988888999999999999999999 9999987776665544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.7e-34  Score=227.19  Aligned_cols=194  Identities=27%  Similarity=0.501  Sum_probs=164.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     ...+++.|++|.+...... ....+.+|+..++.+. |||++++++.+......++|+||++++
T Consensus        30 g~~g-~vy~~~-----~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          30 GASG-TVFTAI-----DVATGQEVAIKQINLQKQP-KKELIINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEEEEEecCCC
Confidence            7789 999887     4567899999998754333 2346788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..++...              .+++.++..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~L~~~~~~~--------------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655         102 SLTDVVTET--------------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             cHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999988642              478999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ....  .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+..+.
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt-g~~pf~~~~~~~~  223 (296)
T cd06655         168 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRA  223 (296)
T ss_pred             cccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            2211  122345667999999988888999999999999999999 9999988766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-34  Score=224.82  Aligned_cols=193  Identities=24%  Similarity=0.440  Sum_probs=161.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     ...+++.||+|.++...... ...+.+|+.+++.+. |||++++++.+...+..++++||++++
T Consensus        20 g~~~-~v~~~~-----~~~~~~~~~ik~~~~~~~~~-~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~lv~e~~~~~   91 (267)
T cd06645          20 GTYG-DVYKAR-----NVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWICMEFCGGG   91 (267)
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEEecCchhH-HHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence            7899 999997     35678899999987654332 345778999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...             ..+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        92 ~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          92 SLQDIYHVT-------------GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             cHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999988643             2589999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ..  .......++..|+|||.+.   ...++.++|+||+|+++|+|++ |..||......
T Consensus       159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~~~  215 (267)
T cd06645         159 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPM  215 (267)
T ss_pred             cc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc-CCCCcccccch
Confidence            21  1122334667899999874   4457889999999999999999 99998765443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=228.17  Aligned_cols=192  Identities=27%  Similarity=0.511  Sum_probs=157.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| +||++..     ..+++.||+|.+.............+|+.+++++. ||||+++++++.+....++|+||+.+ 
T Consensus        16 g~~~-~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~-   87 (291)
T cd07844          16 GSYA-TVYKGRS-----KLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLVFEYLDT-   87 (291)
T ss_pred             cCCe-EEEEEEE-----cCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEEEecCCC-
Confidence            7899 9999983     56788999999875433322334678999999998 99999999999999999999999974 


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|+++||.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        88 ~L~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          88 DLKQYMDDC------------GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            898887653            23578999999999999999999999999999999999999999999999998864322


Q ss_pred             ccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ...  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+..
T Consensus       156 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~  208 (291)
T cd07844         156 PSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT-GRPLFPGST  208 (291)
T ss_pred             CCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCc
Confidence            211  1112234567999998865 457889999999999999999 999997665

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-34  Score=224.26  Aligned_cols=199  Identities=28%  Similarity=0.544  Sum_probs=164.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l   73 (225)
                      |.+| .||.+..     ..+++.||+|.+.....        ......+.+|+.++.++. |||++++++++...+..++
T Consensus        11 g~~~-~v~~a~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628          11 GSFG-SVYLGMN-----ASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             CCCe-EEEEEEe-----cCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCccEE
Confidence            7899 9999983     56688999998864321        122345778999999998 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++||+++++|.+++...             ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+||
T Consensus        84 v~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          84 FLEYVPGGSVAALLNNY-------------GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEEecCCCCHHHHHHhc-------------cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999653             25788899999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccc----cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        154 GFARDLMTSSVYE----RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       154 g~~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      |.+..........    ......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+....+
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~  221 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAI  221 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh-CCCCCCCccHHHHH
Confidence            9987654221111    1112235677999999988888999999999999999999 99999877665544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-34  Score=224.01  Aligned_cols=195  Identities=26%  Similarity=0.458  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+++.||+|.++..  ........+.+|+.+++.+. |||++++++.+.+.+..++++||++
T Consensus        13 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~   85 (267)
T cd08228          13 GQFS-EVYRATC-----LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIVLELAD   85 (267)
T ss_pred             CCCe-eEEEEEE-----eCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEEEEecC
Confidence            8899 9999983     567899999987643  23444456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.....         ....+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus        86 ~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          86 AGDLSQMIKYFKK---------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             CCcHHHHHHHhhh---------ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999998865432         1235788999999999999999999999999999999999999999999999988754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      .....  ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...
T Consensus       157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~  209 (267)
T cd08228         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGD  209 (267)
T ss_pred             cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc-CCCCCccc
Confidence            33221  1123346677999999988888999999999999999999 99998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=222.56  Aligned_cols=196  Identities=26%  Similarity=0.404  Sum_probs=160.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ...++.||+|.++....  .........|...+.....|||++++++.+...+..++++||+.
T Consensus         7 g~~~-~v~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           7 GAFG-SVYLAKK-----RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CCCe-eEEEEEe-----cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            7899 9999983     56788999999875431  22222344555554444459999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.||.+||+.+++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          81 GGDCASLIKTL-------------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999998653             25789999999999999999999999999999999999999999999999987643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..      .....++..|++||.+.+..++.++|+||+|++++++++ |..||...+..+...+
T Consensus       148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  204 (260)
T cd05611         148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDN  204 (260)
T ss_pred             cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence            22      122345567999999988888999999999999999999 9999988877765443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.3e-34  Score=222.46  Aligned_cols=200  Identities=38%  Similarity=0.697  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++..      .++..||+|.+.......  ..+.+|+.+++++. ||+++++++++. .+..+++|||++++
T Consensus        17 g~~~-~v~~~~~------~~~~~~~~k~~~~~~~~~--~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~lv~e~~~~~   85 (260)
T cd05070          17 GQFG-EVWMGTW------NGNTKVAVKTLKPGTMSP--ESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIYIVTEYMSKG   85 (260)
T ss_pred             ccCc-eEEEEEe------cCCceeEEEEecCCCCCH--HHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcEEEEEecCCC
Confidence            7899 9999974      345679999987654332  35889999999998 999999999875 45688999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...           ....+++..++.++.|++.||++||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        86 ~L~~~~~~~-----------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          86 SLLDFLKDG-----------EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             cHHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            999998653           123578999999999999999999999999999999999999999999999999875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... ......++..|+|||...+..++.++|+||||+++|+++++|.+||.+.+..+....+
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  216 (260)
T cd05070         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV  216 (260)
T ss_pred             cccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            2211 1112223456999999888888999999999999999998789999888777666543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-34  Score=223.95  Aligned_cols=204  Identities=39%  Similarity=0.746  Sum_probs=166.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++......  .....|++|.............+.+|+.++..+. |||++++++++.+ +..+++|||++++
T Consensus        17 g~~g-~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~~lv~e~~~~~   91 (270)
T cd05056          17 GQFG-DVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPVWIVMELAPLG   91 (270)
T ss_pred             ccce-eEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCcEEEEEcCCCC
Confidence            7899 99999752111  2345799999887665556667889999999998 9999999999875 4578999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        92 ~L~~~l~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          92 ELRSYLQVN------------KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             cHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999653            12478999999999999999999999999999999999999999999999998875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..... ......+..|+|||.+....++.++|+||+|++++++++.|..||.+.+..+...+
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~  220 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR  220 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            32111 12233345699999988888899999999999999988669999988887766544

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.7e-34  Score=223.44  Aligned_cols=197  Identities=29%  Similarity=0.500  Sum_probs=163.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| +||++..      .+++.+|+|.+....     .......+.+|+..++.+. |+|++++.+++.+.+..++++|
T Consensus        11 g~~~-~v~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631          11 GAYG-TVYCGLT------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cCCe-EEEEEEE------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEEEEEe
Confidence            7899 9999973      467899999886432     2233345788999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+++++|.+++.+.             ..+++..+..++.|++.+|++||+.+++|+||+|+||++++++.++|+|||.+
T Consensus        83 ~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          83 FVPGGSISSILNRF-------------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             cCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999998653             24788999999999999999999999999999999999999999999999988


Q ss_pred             ccccCcc----ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        157 RDLMTSS----VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       157 ~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      .......    .........++..|+|||.+.+..++.++|+||+|++++++++ |..||...+....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~  216 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAA  216 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh-CCCccccCChHHH
Confidence            6542211    1111122346677999999988888999999999999999999 9999987665443

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.9e-34  Score=229.91  Aligned_cols=201  Identities=23%  Similarity=0.391  Sum_probs=156.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |.|| +||++...   ....+..||+|.+......   ....+|+.++..+. |||++++++++..  +...++++||+.
T Consensus        12 G~~g-~Vy~~~~~---~~~~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867          12 GTYG-HVYKAKRK---DGKDEKEYALKQIEGTGIS---MSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             CCCe-eEEEEEec---CCCccceEEEEEecCCCCc---HHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            8999 99999842   2345688999998754332   24678999999998 9999999999853  567899999986


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe----cCCCceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~----~~~~~~~l~d~g~  155 (225)
                       ++|.+++........    ......+++..++.++.|++.||.+||+.+++|+||||+||++    +.+++++|+|||+
T Consensus        84 -~~l~~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          84 -HDLWHIIKFHRASKA----NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CcHHHHHHhhhcccc----CCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence             578777754322110    0112357889999999999999999999999999999999999    4567899999999


Q ss_pred             cccccCcccc-ccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        156 ARDLMTSSVY-ERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      +......... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |.+||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t-g~~~f~~~~  220 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  220 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh-CCCCccccc
Confidence            9755333211 122234567789999988764 57899999999999999999 999997544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=224.91  Aligned_cols=198  Identities=28%  Similarity=0.470  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..++..||+|.+.... ......+.+|+.+++++. |||++++++.+..++..++||||++++
T Consensus        16 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (280)
T cd06611          16 GAFG-KVYKAQH-----KETGLFAAAKIIQIES-EEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWILIEFCDGG   87 (280)
T ss_pred             CCCc-eEEEEEE-----cCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEEeeccCCC
Confidence            7899 9999984     4578899999987543 233456788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        88 ~L~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          88 ALDSIMLEL------------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             cHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999998653            23589999999999999999999999999999999999999999999999998754322


Q ss_pred             ccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...  ......+++.|++||.+.     ...++.++|+||+|+++|+|++ |..||...+..+.+.
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~~~~~~~  218 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLL  218 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh-CCCCcccCCHHHHHH
Confidence            211  112234567799999874     3446778999999999999999 999998877655443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=241.84  Aligned_cols=194  Identities=18%  Similarity=0.288  Sum_probs=152.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC-----CCCCeeeeeeEEecC-CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLGCCTEK-EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~-~~~~lv~   75 (225)
                      |.|| +||++..     ...++.||||+++....  .......|+.++..+.     .|++++++++++... +.+++||
T Consensus       140 G~fg-~V~~a~~-----~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~  211 (467)
T PTZ00284        140 GTFG-KVVEAWD-----RKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM  211 (467)
T ss_pred             ccCE-EEEEEEE-----cCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence            8999 9999983     56789999999964322  1223445666655554     255688999988764 5688999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCC--------
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENH--------  146 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~--------  146 (225)
                      +++ |++|.+++...             ..+++..+..++.|++.||.|||+ .||+||||||+||+++..+        
T Consensus       212 ~~~-g~~l~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        212 PKY-GPCLLDWIMKH-------------GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             ecc-CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            988 67888877643             258899999999999999999998 5999999999999997654        


Q ss_pred             --------ceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        147 --------CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       147 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                              .+||+|||.+....     .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~  351 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT-GKLLYDTHDNL  351 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChH
Confidence                    49999999874321     11234457888999999999999999999999999999999 99999988876


Q ss_pred             HHhhh
Q psy15818        219 EVMKK  223 (225)
Q Consensus       219 ~~~~~  223 (225)
                      +.+..
T Consensus       352 ~~~~~  356 (467)
T PTZ00284        352 EHLHL  356 (467)
T ss_pred             HHHHH
Confidence            65543

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.5e-34  Score=221.76  Aligned_cols=199  Identities=39%  Similarity=0.712  Sum_probs=161.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |++| +||++..      .++..+|+|.+......  ...+.+|+.+++.+. |||++++++++. .+..+++|||+.++
T Consensus        17 g~~~-~v~~~~~------~~~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069          17 GCFG-EVWMGTW------NGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             cCCC-eEEEEEE------cCCceEEEEEcccCCcc--HHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            7899 9999984      23346899988654332  235788999999998 999999999875 45688999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...           ....++...+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        86 ~L~~~~~~~-----------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          86 SLLDFLKEG-----------DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CHHHHHhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999998653           123478889999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .... ......++..|++||...+...+.++|+||+|+++|+|+++|..||.+....+.+..
T Consensus       155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  215 (260)
T cd05069         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ  215 (260)
T ss_pred             Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            2211 112223445699999988888999999999999999999878999998877766554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-34  Score=223.69  Aligned_cols=194  Identities=26%  Similarity=0.446  Sum_probs=160.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.||+|++...... ....+.+|+.++.++. |||++++++.+...+..++|+||++++
T Consensus        20 g~~g-~vy~~~~-----~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~iv~e~~~~~   91 (267)
T cd06646          20 GTYG-DVYKARN-----LHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWICMEYCGGG   91 (267)
T ss_pred             CCCe-EEEEEEE-----CCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence            7899 9999983     567889999998754332 2235778999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...             ..+++..+..++.|++.|+.+||+.+++|+||+|+||++++++.++|+|||++.....
T Consensus        92 ~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          92 SLQDIYHVT-------------GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             cHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            999988643             2578999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...  ......+++.|+|||.+.   ...++.++|+||+|+++++|++ |..||...+..+
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~-g~~p~~~~~~~~  216 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMR  216 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhh
Confidence            211  112234566799999874   3446789999999999999999 999997655443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.6e-34  Score=224.57  Aligned_cols=214  Identities=36%  Similarity=0.597  Sum_probs=171.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   80 (225)
                      |.|| .||++.+... +..++..|++|.+...........+.+|+.+++.+. |||++++++++.. +...+++++|+++
T Consensus        17 g~~g-~V~~~~~~~~-~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~~~~~   93 (280)
T cd05043          17 GTFG-RIFYGILIDE-KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDGEPPFVLYPYMNW   93 (280)
T ss_pred             cCCc-eEEEEEEecC-CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCCCCEEEEEcCCC
Confidence            7899 9999986321 123478899999887666666677889999999997 9999999998655 5778999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|..++...+....     .....+++..++.++.|++.||+|||+.+++|+||+|+||++++++.++++|||++..+.
T Consensus        94 ~~L~~~l~~~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~  168 (280)
T cd05043          94 GNLKLFLQQCRLGEA-----NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLF  168 (280)
T ss_pred             CcHHHHHHhcccccc-----ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence            999999876432110     012458899999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ............++..|+|||.+.+..++.++|+||+|++++++++.|..||...+..++.+.
T Consensus       169 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  231 (280)
T cd05043         169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY  231 (280)
T ss_pred             CCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            332221122233455699999998888999999999999999999879999988777666543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.1e-34  Score=223.52  Aligned_cols=198  Identities=27%  Similarity=0.486  Sum_probs=163.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     ...++..+++|.+.... ........+|+.+++.+. |||++++++.+...+..++++||++++
T Consensus        16 g~~g-~v~~~~-----~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643          16 GAFG-KVYKAQ-----NKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             CCCe-EEEEEE-----ECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            7899 999998     45678899999986543 233456788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|...+...            ...+++..+..++.|+++||.+||+.|++|+||+|+||+++.+++++|+|||++.....
T Consensus        88 ~l~~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          88 AVDAVMLEL------------ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc
Confidence            998877542            23578999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..  .......+++.|+|||.+.     +..++.++|+||+|+++|+|++ |.+||...+..+...
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~  218 (282)
T cd06643         156 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ-IEPPHHELNPMRVLL  218 (282)
T ss_pred             cc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc-CCCCccccCHHHHHH
Confidence            21  1122334667899999874     3456789999999999999999 999998777655443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.3e-35  Score=229.67  Aligned_cols=196  Identities=24%  Similarity=0.489  Sum_probs=164.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+.     +..++..||+|.+..... .....+.+|+..+..+. |||++++++.+...+..++++||++++
T Consensus        33 g~~g-~v~~~~-----~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          33 GSTG-IVCIAT-----EKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            7899 999987     456788999999865332 33446788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++.+++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||++.....
T Consensus       105 ~L~~~~~~~--------------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         105 ALTDIVTHT--------------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             cHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            998887432              478899999999999999999999999999999999999999999999998864432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+.+.
T Consensus       171 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~  228 (292)
T cd06658         171 EVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMR  228 (292)
T ss_pred             ccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            211  1122345678999999988888999999999999999999 999998877665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=251.10  Aligned_cols=197  Identities=22%  Similarity=0.435  Sum_probs=160.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (225)
                      |.|| +||++..     ..++..||+|.+... ........+..|+.++.++. ||||++++++|.+  ...+++||||+
T Consensus        24 GgFG-tVYLAkd-----k~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~lyIVMEY~   96 (1021)
T PTZ00266         24 GRFG-EVFLVKH-----KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFC   96 (1021)
T ss_pred             CCCe-EEEEEEE-----CCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCEEEEEEeCC
Confidence            8899 9999984     567899999998754 34444567889999999998 9999999999854  45689999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCCEEecC-------
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-------GIIHRDLAARNVLIGE-------  144 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-------~i~h~dl~~~nil~~~-------  144 (225)
                      ++++|..++.....         ....+++..++.++.||+.||.|||+.       +|+|+||||+||+++.       
T Consensus        97 ~gGSL~~lL~k~~~---------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         97 DAGDLSRNIQKCYK---------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             CCCcHHHHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            99999999976421         123589999999999999999999984       4999999999999953       


Q ss_pred             ----------CCceeEeeecccccccCccccccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        145 ----------NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       145 ----------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                                .+.++|+|||++........   .....+++.|+|||++.+  ..++.++|||||||++|+|++ |..||
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT-Gk~PF  243 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS-GKTPF  243 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH-CCCCC
Confidence                      23489999999875433221   223457888999998864  447889999999999999999 99999


Q ss_pred             CCCCHH
Q psy15818        213 PGMAAA  218 (225)
Q Consensus       213 ~~~~~~  218 (225)
                      ...+..
T Consensus       244 ~~~~~~  249 (1021)
T PTZ00266        244 HKANNF  249 (1021)
T ss_pred             CcCCcH
Confidence            765543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.8e-34  Score=223.38  Aligned_cols=197  Identities=26%  Similarity=0.514  Sum_probs=160.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv~   75 (225)
                      |.|| .||++..     ..+++.||+|.+.......  ..+.+|+.++.++..|||++++++.+...      ...++++
T Consensus        17 g~~g-~vy~~~~-----~~~~~~~aik~~~~~~~~~--~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~   88 (272)
T cd06637          17 GTYG-QVYKGRH-----VKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM   88 (272)
T ss_pred             cCCe-EEEEEEE-----cCCCcEEEEEEEEcCCccH--HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence            7899 9999984     5678899999987544332  36788999999986699999999998653      3589999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+.+++|.+++....           ...+++..+..++.|++.|++|||+.+++|+||+|+||++++++.++|+|||+
T Consensus        89 e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          89 EFCGAGSVTDLIKNTK-----------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EcCCCCcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            9999999999987532           23578999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      +.......  .......+++.|+|||++.     +..++.++|+||+|+++|+|++ |..||........
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~~~~~  224 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRA  224 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh-CCCCccccCHHHH
Confidence            86442221  1222344667799999886     3357789999999999999999 9999976654443

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.4e-34  Score=221.26  Aligned_cols=194  Identities=39%  Similarity=0.737  Sum_probs=160.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEE-ecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..       .|..|++|.++....   ...+.+|+..++++. |++++++++++ ..++..++++||+++
T Consensus        17 g~~~-~v~~~~~-------~~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082          17 GEFG-DVMLGDY-------RGNKVAVKCIKNDAT---AQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             cCCC-eEEEEEE-------cCCcEEEEEeCCCch---HHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            7789 9999862       377899999865432   235788999999997 99999999975 456779999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....           ...+++..+..++.|++.+|++||++|++|+||+|+||++++++.++|+|||++....
T Consensus        85 ~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          85 GSLVDYLRSRG-----------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            99999987531           2247889999999999999999999999999999999999999999999999886442


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...     .....+..|+|||.+.+..++.++|+||+|+++|+|++.|..||...+..+....
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  211 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            221     1222345699999998888999999999999999999769999988777666544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.6e-34  Score=224.36  Aligned_cols=199  Identities=28%  Similarity=0.451  Sum_probs=165.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+|+.|++|.+..... ......+.+|+.+++++. |||++++++++......++|+||+ +
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~-~   82 (286)
T cd07832          11 GAHG-IVFKAKD-----RETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVMEYM-P   82 (286)
T ss_pred             CCCc-EEEEEEE-----CCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEeccc-C
Confidence            7899 9999984     55689999999875532 334456889999999998 999999999999999999999999 9


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        83 ~~L~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          83 SDLSEVLRDE------------ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999988653            2358999999999999999999999999999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .... .......++..|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+.++.+.+.
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~  211 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GSPLFPGENDIEQLA  211 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc-CCcCcCCCCHHHHHH
Confidence            3321 112234566779999988654 46889999999999999999 899998776655443

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.3e-34  Score=221.85  Aligned_cols=199  Identities=40%  Similarity=0.704  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++..      ..+..+++|.++....  ....+.+|+.+++++. |+|++++.+.+.+ ...++++||++++
T Consensus        17 g~~~-~vy~~~~------~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~v~e~~~~~   85 (260)
T cd05073          17 GQFG-EVWMATY------NKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIYIITEFMAKG   85 (260)
T ss_pred             ccce-EEEEEEe------cCCccEEEEecCCChh--HHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence            7899 9999974      3345699998875432  2346788999999998 9999999999887 7789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        86 ~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          86 SLLDFLKSDE-----------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             cHHHHHHhCC-----------ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999987531           23567888999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .... ......++..|+|||.+....++.++|+||+|+++++++++|..||.+.+..++..+
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~  215 (260)
T cd05073         155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA  215 (260)
T ss_pred             CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            2111 111223345699999998888899999999999999999879999998877766654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-34  Score=227.09  Aligned_cols=203  Identities=37%  Similarity=0.720  Sum_probs=163.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+... +......||+|.+...........+.+|+.++..+. |||++++++++... ..+++++|++++
T Consensus        18 G~~g-~vy~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~~~~v~e~~~~g   93 (303)
T cd05110          18 GAFG-TVYKGIWVPE-GETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-TIQLVTQLMPHG   93 (303)
T ss_pred             CCCc-cEEEEEEecC-CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-CceeeehhcCCC
Confidence            7899 9999975321 112234689999887655555556888999999997 99999999998654 467899999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.|||+++++|+||||+||++++++.++|+|||++.....
T Consensus        94 ~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          94 CLLDYVHEH------------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999988653            22478889999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ............+..|++||.+.+..++.++|+||+|+++|++++.|..||.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~  220 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI  220 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            32222222233456799999998888999999999999999999768999988765544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.2e-34  Score=226.15  Aligned_cols=197  Identities=26%  Similarity=0.431  Sum_probs=161.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+++.||+|.+..... ......+.+|+.+++++. |||++++++.+..+...++++||+++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~~   84 (286)
T cd07847          12 GSYG-VVFKCRN-----RETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH   84 (286)
T ss_pred             cCCe-EEEEEEE-----CCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEEEeccCc
Confidence            7899 9999884     56789999999875432 222335678999999998 99999999999999999999999998


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +.|..++...             ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~~l~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          85 TVLNELEKNP-------------RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             cHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence            8877765432             257899999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ....  ......++..|++||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+
T Consensus       152 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~-g~~p~~~~~~~~~~  210 (286)
T cd07847         152 GPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKSDVDQL  210 (286)
T ss_pred             CCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Confidence            3321  1112234567999998876 457889999999999999999 99999987765544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-34  Score=226.49  Aligned_cols=196  Identities=28%  Similarity=0.476  Sum_probs=162.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ...++.||+|.++..........+.+|+.++.++. |||++++++.+...+..++++||++++
T Consensus        12 g~~g-~v~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (286)
T cd06622          12 GNYG-SVYKVLH-----RPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMCMEYMDAG   84 (286)
T ss_pred             cCCe-EEEEEEE-----cCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEEEeecCCC
Confidence            7899 9999984     56789999999876545555567889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++....          ....+++..+..++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        85 ~l~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          85 SLDKLYAGGV----------ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             CHHHHHHhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998886531          12357999999999999999999997 599999999999999999999999999886542


Q ss_pred             CccccccccCCCCCccccCCccccCCC------CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI------FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...    .....+++.|++||.+.+..      ++.++|+||+|+++|+|++ |..||.......
T Consensus       155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  214 (286)
T cd06622         155 ASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPPETYAN  214 (286)
T ss_pred             CCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh-CCCCCCCcchhh
Confidence            221    12233566799999885443      4789999999999999999 999997655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=223.36  Aligned_cols=197  Identities=26%  Similarity=0.522  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.||+|.+...........+.+|+.+++.+.  .|||++++++++.+....+++|||++
T Consensus        12 g~~g-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917          12 GAYG-AVYRGKH-----VPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             cCCc-eEEEEEE-----cCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            7899 9999984     56789999999876555555566788999888885  59999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...              .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        86 ~~~L~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          86 GGSVRTLMKAG--------------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             CCcHHHHHHcc--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            99999887542              5789999999999999999999999999999999999999999999999988765


Q ss_pred             cCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .....  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.......
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~  211 (277)
T cd06917         152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAM  211 (277)
T ss_pred             CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh-CCCCCCCCChhhhh
Confidence            43321  1222345667999998765 456889999999999999999 99999877655443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0574|consensus

Probab=100.00  E-value=3.4e-36  Score=227.03  Aligned_cols=192  Identities=26%  Similarity=0.522  Sum_probs=171.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ++.+|..||+|..+...   +...+.+|+.+++++. .|+++++++.+-....+|+|||||..|
T Consensus        44 GSYG-SV~KAI-----H~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   44 GSYG-SVHKAI-----HRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             Ccch-HHHHHH-----HhccCcEEEEEecCccc---hHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeehhhcCCC
Confidence            8999 999999     68999999999988643   4456899999999998 999999999998889999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +..++++..            +..+++.++..+++..++||+|||...-+|||||..||++..+|..||.|||.+..+..
T Consensus       114 SiSDI~R~R------------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  114 SISDIMRAR------------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             cHHHHHHHh------------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            999999763            45799999999999999999999999999999999999999999999999999865533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                        ........-|||.|||||++..-.|...+||||||+...||.. |++||.+..+.
T Consensus       182 --TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHPM  235 (502)
T KOG0574|consen  182 --TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHPM  235 (502)
T ss_pred             --hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCccccccc
Confidence              2334556778999999999998899999999999999999998 99999887653

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.8e-34  Score=219.93  Aligned_cols=195  Identities=27%  Similarity=0.544  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+     ..+++.|++|.+.....   ...+.+|+..++++. |||++++++.+.+....++++|+++++
T Consensus        14 g~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~   83 (256)
T cd06612          14 GSYG-SVYKAIH-----KETGQVVAIKVVPVEED---LQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIVMEYCGAG   83 (256)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEEEecCCCC
Confidence            7789 9999984     45678999999875433   457889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        84 ~L~~~l~~~------------~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          84 SVSDIMKIT------------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             cHHHHHHhC------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999998642            23578999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...  ......++..|++||.+.+..++.++|+||+|+++++|++ |..||......+.+
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~-g~~p~~~~~~~~~~  208 (256)
T cd06612         152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIHPMRAI  208 (256)
T ss_pred             Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCcchhhhh
Confidence            321  1122335667999999988889999999999999999999 99999876655443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-33  Score=220.03  Aligned_cols=198  Identities=24%  Similarity=0.446  Sum_probs=157.5

Q ss_pred             CcccceeeecCCCCCC-------CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPER-------GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |.|| .||.+.+....       .......|++|.+..... .....+.+|+.++..+. ||||+++++++......+++
T Consensus         6 G~~~-~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   82 (262)
T cd05077           6 GTRT-QIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVS-HKHIVLLYGVCVRDVENIMV   82 (262)
T ss_pred             CCcc-eEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCCEEE
Confidence            7899 99999864322       123456789998765432 33345777888899998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc-------
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC-------  147 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~-------  147 (225)
                      |||+++++|..++...            ...+++..++.++.|+++|++|||+++++|+||||+||+++.++.       
T Consensus        83 ~e~~~~~~l~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          83 EEFVEFGPLDLFMHRK------------SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EecccCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence            9999999998887642            235789999999999999999999999999999999999976553       


Q ss_pred             eeEeeecccccccCccccccccCCCCCccccCCcccc-CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        148 CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ++++|||.+......      ....++..|+|||.+. +..++.++|+||+|+++|+|++.|..||......+.
T Consensus       151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~  218 (262)
T cd05077         151 IKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK  218 (262)
T ss_pred             eEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence            899999987543221      1233456799999886 466889999999999999998559999987665443

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-34  Score=226.90  Aligned_cols=192  Identities=26%  Similarity=0.496  Sum_probs=162.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     +..+++.||+|.+....... ...+.+|+.+++.+. |||++++++.+..++..++|+||++++
T Consensus        30 g~~g-~v~~~~-----~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (297)
T cd06656          30 GASG-TVYTAI-----DIATGQEVAIKQMNLQQQPK-KELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGG  101 (297)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEecCccch-HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEEEEeecccCCC
Confidence            7899 999998     35678899999987544332 345788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.+.              .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       102 ~L~~~~~~~--------------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656         102 SLTDVVTET--------------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             CHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999988642              478889999999999999999999999999999999999999999999998865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ...  ......+++.|++||.+.+..++.++|+||+|+++|++++ |..||.+.+..
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t-g~~pf~~~~~~  221 (297)
T cd06656         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPL  221 (297)
T ss_pred             Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcc
Confidence            221  1122345677999999988888999999999999999999 99999776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-34  Score=238.98  Aligned_cols=183  Identities=23%  Similarity=0.274  Sum_probs=152.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.     +...++.||+|....       ....+|+.+++++. ||||+++++++...+..+++++++. +
T Consensus       180 G~~G-~Vy~a~-----~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~lv~e~~~-~  244 (461)
T PHA03211        180 GSEG-CVFESS-----HPDYPQRVVVKAGWY-------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKYR-S  244 (461)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEecccc-------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEEccC-C
Confidence            7899 999998     456788999996432       23567999999998 9999999999999999999999995 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..++...            ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus       245 ~L~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        245 DLYTYLGAR------------LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            888777542            22589999999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                      ...........+|+.|++||++.+..++.++|+||||+++|||++ |..|+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~-g~~~l  362 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV-HTASL  362 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHH-cCCCc
Confidence            222112223457889999999999889999999999999999999 55443

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.5e-34  Score=227.07  Aligned_cols=197  Identities=28%  Similarity=0.510  Sum_probs=158.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+|+.||+|.++.... ......+.+|+.+++++. |||++++++++.+.+..++++||+. 
T Consensus        11 g~~~-~vy~~~~-----~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~-   82 (284)
T cd07839          11 GTYG-TVFKAKN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVFEYCD-   82 (284)
T ss_pred             cCCe-EEEEEEE-----CCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEEecCC-
Confidence            7899 9999984     56788999999875432 222335678999999998 9999999999999999999999997 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+...            ...+++..++.++.|+++||.+||+.+++|+||+|+||+++.+++++|+|||++....
T Consensus        83 ~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          83 QDLKKYFDSC------------NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            5777776542            2358999999999999999999999999999999999999999999999999987543


Q ss_pred             CccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCC-CCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTP-YPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p-~~~~~~~~~~  221 (225)
                      ...  .......+++.|+|||.+.+.. ++.++|+||+|+++++|++ |..| |.+.+..+.+
T Consensus       151 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~  210 (284)
T cd07839         151 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQL  210 (284)
T ss_pred             CCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHh-cCCCCcCCCCHHHHH
Confidence            321  1112234567799999887644 6889999999999999999 5555 5665554443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG2345|consensus

Probab=100.00  E-value=3.3e-35  Score=215.47  Aligned_cols=195  Identities=22%  Similarity=0.376  Sum_probs=163.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e   76 (225)
                      |.|+ .||++.     +..++..||+|.+.... .+..+..++|+...++++ |||+++++++...+     ...|++++
T Consensus        32 GGfs-fv~LV~-----~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~~~yll~P  103 (302)
T KOG2345|consen   32 GGFS-FVDLVK-----GLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKHEAYLLLP  103 (302)
T ss_pred             CCce-eeeeec-----ccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCceeEEEEee
Confidence            7788 999999     68899999999998665 455568999999999998 99999999986433     34899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCceeEeeec
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |...|+|.+.+....-         ++..++|.++.+|+.++++||++||+..  +.|+||||.||++++++.++++|||
T Consensus       104 yy~~Gsl~d~i~~~k~---------kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen  104 YYKRGSLLDEIERLKI---------KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             hhccccHHHHHHHHhh---------cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence            9999999999987643         2346899999999999999999999998  9999999999999999999999999


Q ss_pred             ccccccCccc-------cccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        155 FARDLMTSSV-------YERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       155 ~~~~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      .+....-...       .........|..|+|||.+.-   ...+.++|||||||+||+||. |.-||+.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf-~~sPfe~  243 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF-GESPFER  243 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH-cCCcchH
Confidence            9875422211       112223456778999998863   446789999999999999999 9999964

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.8e-34  Score=224.13  Aligned_cols=200  Identities=29%  Similarity=0.517  Sum_probs=164.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++.     +..+|+.||+|.++............+|+.++.++. |||++++++.+.+.+..++|+||+++ 
T Consensus        11 g~~~-~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~-   82 (284)
T cd07836          11 GTYA-TVYKGR-----NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDK-   82 (284)
T ss_pred             CCce-EEEEEE-----ECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence            7889 999998     456789999999976544433445778999999997 99999999999999999999999984 


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....          ....+++..+..++.|+++||.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        83 ~l~~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          83 DLKKYMDTHG----------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             cHHHHHHhcC----------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            8888776432          123589999999999999999999999999999999999999999999999998865432


Q ss_pred             ccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...  ......++..|++||.+.+. .++.++|+||+|++++++++ |..||.+.+..+...
T Consensus       153 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~  211 (284)
T cd07836         153 PVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLL  211 (284)
T ss_pred             Ccc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Confidence            211  11223346679999987654 46889999999999999999 999999887665544

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.4e-34  Score=222.55  Aligned_cols=196  Identities=30%  Similarity=0.506  Sum_probs=166.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.||+|.+...........+.+|+..+.++. |||++++++.+..+...++|+||++++
T Consensus        15 G~~~-~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06641          15 GSFG-EVFKGID-----NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGG   87 (277)
T ss_pred             cCCe-EEEEEEE-----CCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence            7899 9999973     56789999999876555555567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus        88 ~l~~~i~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          88 SALDLLEPG--------------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             cHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999888532              578999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ....  .....++..|+|||.+.+..++.++|+||+|++++++++ |..||...+.....
T Consensus       154 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~  210 (277)
T cd06641         154 TQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVL  210 (277)
T ss_pred             chhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCccchHHHH
Confidence            2211  112335667999999888888899999999999999999 99999876655443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.7e-34  Score=222.98  Aligned_cols=201  Identities=26%  Similarity=0.446  Sum_probs=168.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.|++|.+.....  ......+.+|+.++.++. |||++++++.+......++++||+.
T Consensus         4 g~~~-~vy~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~   76 (265)
T cd05579           4 GAYG-RVFLAKK-----KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP   76 (265)
T ss_pred             CCce-EEEEEEE-----CCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence            7899 9999984     55689999999875432  344556888999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||++...
T Consensus        77 ~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~  143 (265)
T cd05579          77 GGDLASLLENV-------------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG  143 (265)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence            99999998753             15789999999999999999999999999999999999999999999999988644


Q ss_pred             cCccc------cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSV------YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....      ........++..|++||...+...+.++|+||+|++++++++ |..||......+...+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~  212 (265)
T cd05579         144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQN  212 (265)
T ss_pred             ccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            32211      012223345567999999888888899999999999999999 9999988877765544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5e-34  Score=222.13  Aligned_cols=196  Identities=24%  Similarity=0.454  Sum_probs=163.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.|++|.+....  ......++.+|+.+++.+. |||++++++.+...+..++++||++
T Consensus        13 g~~g-~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~   85 (267)
T cd08229          13 GQFS-EVYRATC-----LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELAD   85 (267)
T ss_pred             cCCe-EEEEEee-----cCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEEEEecC
Confidence            7899 9999984     5678899999886532  3334456788999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.....         ....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++++|||++...
T Consensus        86 ~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          86 AGDLSRMIKHFKK---------QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             CCCHHHHHHHhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999998875321         1235789999999999999999999999999999999999999999999999988654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ......  .....++..|+|||.+.+..++.++|+||+|+++++|++ |..||.+..
T Consensus       157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  210 (267)
T cd08229         157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDK  210 (267)
T ss_pred             ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh-CCCCccccc
Confidence            332211  122345677999999988888999999999999999999 999997544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.1e-34  Score=221.02  Aligned_cols=202  Identities=28%  Similarity=0.464  Sum_probs=168.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..++..+++|.+...........+.+|+..++.+. |+|++++++.+......++++|+++++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (267)
T cd06610          12 GATA-VVYAAIC-----LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLVMPYLSGG   84 (267)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence            7899 9999984     45788999999876544445567889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....          ...+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        85 ~l~~~~~~~~~----------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          85 SLLDIMKSSYP----------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             cHHHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999976421          13578999999999999999999999999999999999999999999999998875544


Q ss_pred             ccccc--cccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYE--RKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .....  ......++..|++||.+... .++.++|+||+|+++++|++ |..||...+..+..
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~  216 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVL  216 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh-CCCCccccChhhhH
Confidence            32221  12223456779999988776 67899999999999999999 99999877665443

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-33  Score=218.92  Aligned_cols=199  Identities=38%  Similarity=0.710  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.+      ..+..+|+|.++......  ..+.+|+.+++++. ||+++++++++......++++||+.++
T Consensus        15 g~~g-~v~~~~~------~~~~~~~~k~~~~~~~~~--~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112          15 GQFG-LVWLGYW------LEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             cccc-eEEEEEE------eCCCeEEEEECCCCCCCH--HHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            7899 9999874      235679999987554332  25778999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...++++.++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        85 ~L~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          85 CLSDYLRAQ------------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             cHHHHHHhC------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999888653            22478899999999999999999999999999999999999999999999998865432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... ........+..|+|||.+.+..++.++|+||+|+++|++++.|..||......+..+.
T Consensus       153 ~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05112         153 DQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET  213 (256)
T ss_pred             Ccc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            211 1111222345699999998888899999999999999999779999988877666554

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.5e-34  Score=222.72  Aligned_cols=190  Identities=31%  Similarity=0.484  Sum_probs=165.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.|++|.+...........+.+|+..++++. |||++++++.+...+..++++||++++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (265)
T cd06605          12 GNSG-VVSKVLH-----RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICMEYMDGG   84 (265)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEEEecCCC
Confidence            7899 9999984     56789999999987655566667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++...+            ..+++..+..++.|++.++.+||+ .+++|+||+|+||++++++.++|+|||.+....
T Consensus        85 ~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          85 SLDKILKEVQ------------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             cHHHHHHHcc------------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999987642            357899999999999999999999 999999999999999999999999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      .....    ...++..|+|||.+.+..++.++|+||+|++++++++ |..||...
T Consensus       153 ~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  202 (265)
T cd06605         153 NSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYPPE  202 (265)
T ss_pred             HHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Confidence            22111    1445667999999988889999999999999999999 99999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.4e-34  Score=220.66  Aligned_cols=199  Identities=26%  Similarity=0.445  Sum_probs=162.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~   75 (225)
                      |.|| .||++.     ...++..|++|.+....    .......+.+|+.+++++. |||++++++.+.+  ....++++
T Consensus        13 g~~g-~vy~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651          13 GAFG-RVYLCY-----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             CCCE-EEEEEE-----EcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEEEEEE
Confidence            7899 999997     45678899999886432    2233456788999999998 9999999999875  35688999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+++++|.+.+...             ..+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        86 e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          86 EYMPGGSVKDQLKAY-------------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             eCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence            999999999988653             2478889999999999999999999999999999999999999999999998


Q ss_pred             cccccCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        156 ARDLMTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      +......... .......++..|+|||.+.+..++.++|+||+|++++++++ |..||......+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~-g~~pf~~~~~~~~~  218 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAI  218 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH-CCCCccccchHHHH
Confidence            8654321111 11122335677999999988888999999999999999999 99999877655443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0604|consensus

Probab=100.00  E-value=1.3e-35  Score=223.16  Aligned_cols=179  Identities=23%  Similarity=0.407  Sum_probs=153.3

Q ss_pred             CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEeecCCCCHHHHHHHhhhh
Q psy15818         18 GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQ   93 (225)
Q Consensus        18 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~   93 (225)
                      ++.+|+.+|+|++..      ....++|+.......+||||+.++|+|+.    -.++.+|||.++||.|.+.++..   
T Consensus        83 ~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~---  153 (400)
T KOG0604|consen   83 HKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR---  153 (400)
T ss_pred             eccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc---
Confidence            678899999999853      23577888888888899999999999864    35688999999999999999876   


Q ss_pred             hhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeecccccccCccccccccC
Q psy15818         94 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERKSE  170 (225)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~  170 (225)
                              ....++|.++..+++||..|++|||+.+|.||||||+|+++..   +-.+||+|||+|.....   ......
T Consensus       154 --------g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~T  222 (400)
T KOG0604|consen  154 --------GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMT  222 (400)
T ss_pred             --------ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC---CccccC
Confidence                    3456899999999999999999999999999999999999963   44689999999975433   233445


Q ss_pred             CCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        171 GRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       171 ~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...||.|.|||++....|+.+.|+||+|+++|-|+. |.+||.....
T Consensus       223 Pc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~hg  268 (400)
T KOG0604|consen  223 PCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHG  268 (400)
T ss_pred             CcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCcccccCC
Confidence            667889999999999999999999999999999998 9999976654

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-34  Score=223.71  Aligned_cols=195  Identities=35%  Similarity=0.636  Sum_probs=160.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~   79 (225)
                      |.|| .||++... ..+..++..||+|.++..........+.+|+.+++.+. |||++++.+++.+.  ...+++|||++
T Consensus        15 g~~g-~v~~~~~~-~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (284)
T cd05079          15 GHFG-KVELCRYD-PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLP   91 (284)
T ss_pred             CCce-eEEEEEEc-cCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCceEEEEEccC
Confidence            7899 99998642 33456788999999986655555667899999999998 99999999998775  56899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++.+.            ...+++.++..++.|++.||++||++|++|+||||+||++++++.++|+|||.+...
T Consensus        92 g~~L~~~l~~~------------~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          92 SGSLKEYLPRN------------KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999998653            124788999999999999999999999999999999999999999999999998765


Q ss_pred             cCccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        160 MTSSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       160 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                      ....... ......++..|+|||.+.+..++.++|+||+|++++++++ +..|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt-~~~~~  212 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-YCDSE  212 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc-CCCCC
Confidence            4332211 1122334556999999888888999999999999999999 66554

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.9e-34  Score=219.45  Aligned_cols=201  Identities=21%  Similarity=0.404  Sum_probs=167.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .+|.+.     ...+++.||+|.+.... .......+.+|+.+++++. |||++++.+++...+..++|+||+.+
T Consensus        11 g~~g-~~~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08218          11 GSFG-KAILVK-----SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVMDYCEG   83 (256)
T ss_pred             CCce-EEEEEE-----EcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEEecCCC
Confidence            7899 999988     35678899999987542 3334456888999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+....           ...+++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+....
T Consensus        84 ~~l~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          84 GDLYKKINAQR-----------GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             CcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999886532           2347889999999999999999999999999999999999999999999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....  .....+++.|+|||.+.+...+.++|+||+|++++++++ |..||...+..+...+
T Consensus       153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~  212 (256)
T cd08218         153 STVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLK  212 (256)
T ss_pred             cchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc-CCCCccCCCHHHHHHH
Confidence            32211  112335667999999988888999999999999999999 9999987776665543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-33  Score=220.29  Aligned_cols=195  Identities=27%  Similarity=0.465  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+|+.||+|.++..  ........+.+|+.+++++. |++++++++.+.+.+..+++|||++
T Consensus        13 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   85 (267)
T cd08224          13 GQFS-VVYKAIC-----LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIVLELAD   85 (267)
T ss_pred             CCce-EEEEEEE-----cCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEEEecCC
Confidence            7899 9999984     467889999998643  23344567889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.....         ....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        86 ~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          86 AGDLSRMIKHFKK---------QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             CCCHHHHHHHhcc---------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9999999865321         1235789999999999999999999999999999999999999999999999988654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ......  .....+++.|.|||.+.+..++.++|+||+|+++++|++ |..||...
T Consensus       157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~  209 (267)
T cd08224         157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGD  209 (267)
T ss_pred             cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH-CCCCcccC
Confidence            332211  122345667999999988889999999999999999999 99999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0608|consensus

Probab=100.00  E-value=5.6e-35  Score=238.58  Aligned_cols=203  Identities=23%  Similarity=0.365  Sum_probs=172.3

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      .|+|| +|-+++.     .++...||.|.+.+.+  .......+..|..||.... .+.||+++..|.+..++|+||+|.
T Consensus       639 vGAFG-eV~Lv~K-----vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVMdYI  711 (1034)
T KOG0608|consen  639 VGAFG-EVCLVRK-----VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVMDYI  711 (1034)
T ss_pred             ccccc-eeEEEee-----cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEEecc
Confidence            38999 9999994     6778899999997653  4555556778899999987 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|||+-+++.+.             +.+.|..++.++..+..|+++.|+.|++||||||+||+|+.+|.+||.|||+|.-
T Consensus       712 PGGDmMSLLIrm-------------gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  712 PGGDMMSLLIRM-------------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             CCccHHHHHHHh-------------ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence            999999998764             3578889999999999999999999999999999999999999999999999974


Q ss_pred             ccC--cc------cc--------------------------------ccccCCCCCccccCCccccCCCCCcchhHHHHH
Q psy15818        159 LMT--SS------VY--------------------------------ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG  198 (225)
Q Consensus       159 ~~~--~~------~~--------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg  198 (225)
                      +-.  +.      ..                                .......||+.|+|||++....++...|+||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            311  00      00                                001134578889999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        199 VLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       199 ~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++||||+. |++||-..+..+...+|
T Consensus       859 vil~em~~-g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  859 VILYEMLV-GQPPFLADTPGETQYKV  883 (1034)
T ss_pred             HHHHHHhh-CCCCccCCCCCcceeee
Confidence            99999999 99999888777665544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.4e-34  Score=227.12  Aligned_cols=201  Identities=21%  Similarity=0.381  Sum_probs=161.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+|+.||+|++.... .......+.+|+.++..+. ||||++++++|..++..++++||+.+
T Consensus        11 ~~~~-~v~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226          11 CNLT-SVYLAR-----HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             cCce-eEEEEE-----EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecccC
Confidence            5889 999998     46789999999987543 3344456788888888887 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +++.+++....           ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++||+.+....
T Consensus        84 ~~l~~~l~~~~-----------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~  152 (328)
T cd08226          84 GSANSLLKTYF-----------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV  152 (328)
T ss_pred             CCHHHHHHhhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence            99999887642           2247899999999999999999999999999999999999999999999997654322


Q ss_pred             Cccccc-----cccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYE-----RKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ......     .......+..|++||.+.+.  .++.++|+||+|+++++|++ |..||.+....+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  219 (328)
T cd08226         153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDMLRTQML  219 (328)
T ss_pred             ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcChHHHH
Confidence            111110     01112234569999998763  46889999999999999999 99999877655443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=219.73  Aligned_cols=200  Identities=25%  Similarity=0.409  Sum_probs=163.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc----cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~   75 (225)
                      |.|| .||++..     ..+++.||+|.+...    ........+.+|+.+++++. |||++++++.+.+.  +.+++++
T Consensus        13 g~~g-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653          13 GAFG-EVYLCYD-----ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             CCCe-EEEEEEE-----cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCEEEEEE
Confidence            7899 9999983     567899999987532    12344456788999999998 99999999998764  4588999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+++++|.+++...             ..+++..+..++.|+++||.+||+.+++|+||+|+||+++.++.++|+|||.
T Consensus        86 e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          86 EYMPGGSIKDQLKAY-------------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             EeCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccc
Confidence            999999999988643             2478889999999999999999999999999999999999999999999999


Q ss_pred             cccccCccc-cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        156 ARDLMTSSV-YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      +........ ........++..|+|||.+.+..++.++|+||+|++++++++ |..||.+....+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~  219 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIF  219 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCccCHHHHHH
Confidence            875432111 111122345677999999988888999999999999999999 999998776555443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0586|consensus

Probab=100.00  E-value=8.3e-35  Score=236.59  Aligned_cols=197  Identities=28%  Similarity=0.484  Sum_probs=171.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|+ .|-++.     +..++..||+|++.+.. ....+..+.+|+.++..+. ||||++++.+.+....+|+||||+.+
T Consensus        67 g~f~-~V~La~-----~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   67 GNFA-KVKLAR-----HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             ceeE-EEEeeE-----ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeEEEEEeccC
Confidence            6677 777777     57789999999998764 5555566899999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +.+.+++..+.             ...+.++..++.|+++|++|||+++|+|||||.+|++++.+.+++|+|||++..+.
T Consensus       140 ge~~~yl~~~g-------------r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  140 GELFDYLVKHG-------------RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             chhHHHHHhcc-------------cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence            99999998653             56779999999999999999999999999999999999999999999999997664


Q ss_pred             CccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...   ......+++.|.|||++.+..+ ++.+|+||+|+++|.|+. |.+||.+.+..+.-.
T Consensus       207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~-GsLPFDG~~lk~Lr~  265 (596)
T KOG0586|consen  207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE-GSLPFDGQNLKELRP  265 (596)
T ss_pred             ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee-cccccCCcccccccc
Confidence            332   3345667888999999998776 789999999999999999 999999887766543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-33  Score=218.23  Aligned_cols=193  Identities=40%  Similarity=0.695  Sum_probs=159.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+.       ..++.||+|.++....   ...+.+|+.++..+. |||++++++++...+ .+++|||++++
T Consensus        17 g~~g-~v~~~~-------~~~~~~~iK~~~~~~~---~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v~e~~~~~   83 (254)
T cd05083          17 GEFG-AVLQGE-------YTGQKVAVKNIKCDVT---AQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIVMELMSKG   83 (254)
T ss_pred             CCCC-ceEecc-------cCCCceEEEeecCcch---HHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEEEECCCCC
Confidence            7899 999876       3577899999875432   235788999999998 999999999987654 78999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          84 NLVNFLRTRG-----------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             CHHHHHHhcC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999987531           23578899999999999999999999999999999999999999999999998864322


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .     ......+..|+|||.+.+..++.++|+||+|+++++|++.|..||...+..+....
T Consensus       153 ~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  209 (254)
T cd05083         153 G-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC  209 (254)
T ss_pred             c-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            1     11222345699999988888899999999999999999769999998877665543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-33  Score=221.79  Aligned_cols=190  Identities=19%  Similarity=0.356  Sum_probs=152.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhc--CCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTL--DPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |+|| .||++..     ..+++.||+|.+.....  ........+|...+..+  ..||+++.+++.+...+..++||||
T Consensus         5 G~~g-~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           5 GGFG-EVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            8899 9999983     56789999999865421  11112233333333322  2499999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +++++|.+++...             ..+++..+..++.|++.||.+||+.+++|+||||+||++++++.++|+|||++.
T Consensus        79 ~~~~~L~~~i~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          79 MNGGDLHYHLSQH-------------GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             CCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            9999999888653             258999999999999999999999999999999999999999999999999886


Q ss_pred             cccCccccccccCCCCCccccCCcccc-CCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ......    .....+++.|+|||.+. +..++.++|+||+|+++++|++ |..||...
T Consensus       146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  199 (279)
T cd05633         146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQH  199 (279)
T ss_pred             eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcCCC
Confidence            443221    12335677899999886 4557889999999999999999 99999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-33  Score=221.27  Aligned_cols=189  Identities=20%  Similarity=0.359  Sum_probs=152.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHH---HHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQEL---TVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~---~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| .||++.     +..+++.||+|.+.....  .........|.   ..+.... ||+++++.+.+.+....++|+|
T Consensus         5 g~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (278)
T cd05606           5 GGFG-EVYGCR-----KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILD   77 (278)
T ss_pred             CCCe-EEEEEE-----EecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCEEEEEEe
Confidence            8899 999988     356789999999865321  11111222333   2333344 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+.|++|..++...             ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~~~g~~L~~~l~~~-------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~  144 (278)
T cd05606          78 LMNGGDLHYHLSQH-------------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  144 (278)
T ss_pred             cCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence            99999999887642             25899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ......    ......++..|+|||.+.+. .++.++|+||+|+++++|++ |..||.+.
T Consensus       145 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~-g~~p~~~~  199 (278)
T cd05606         145 CDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQH  199 (278)
T ss_pred             cccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Confidence            644322    11233567789999998754 57899999999999999999 99999766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-33  Score=221.94  Aligned_cols=197  Identities=26%  Similarity=0.510  Sum_probs=164.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++..     ..+++.+++|.+..... .....+.+|+.+++.+. |||++++++++...+..++++||++++
T Consensus        30 g~~g-~v~~~~~-----~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~e~~~~~  101 (285)
T cd06648          30 GSTG-IVCIATD-----KSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGG  101 (285)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEEeccCCC
Confidence            7889 9999873     45678999998864332 23345788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++.++..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       102 ~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         102 ALTDIVTHT--------------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            999988652              478899999999999999999999999999999999999999999999998764432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+.+.+
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~-g~~p~~~~~~~~~~~~  226 (285)
T cd06648         168 EVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKR  226 (285)
T ss_pred             CCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh-CCCCCcCCCHHHHHHH
Confidence            221  1122345677999999988888999999999999999999 9999988776655543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-33  Score=220.60  Aligned_cols=197  Identities=27%  Similarity=0.524  Sum_probs=160.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~   79 (225)
                      |.|| .||++.     ...+++.||+|.++............+|+..+.++.+|||++++++++.+.  +..++|+||+.
T Consensus        10 g~~~-~v~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (282)
T cd07831          10 GTFS-EVLKAQ-----SRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD   83 (282)
T ss_pred             cccc-eEEEEE-----EcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence            7899 999998     356788999999876543333334567888888887799999999999887  88999999997


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       +++.+.+...            ...+++..++.++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+...
T Consensus        84 -~~l~~~l~~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          84 -MNLYELIKGR------------KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             -ccHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence             5777777542            125789999999999999999999999999999999999999 99999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ......   ....++..|+|||.+.. ..++.++|+||+|+++++|++ |..||++.+..+...
T Consensus       150 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~  209 (282)
T cd07831         150 YSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIA  209 (282)
T ss_pred             ccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHH
Confidence            332221   12335677999997654 456889999999999999999 999999887665443

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-33  Score=219.61  Aligned_cols=211  Identities=37%  Similarity=0.688  Sum_probs=166.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |+|| +||++.+..  ...+++.||+|.++... .......+.+|+..++++. |||++++++++....      ..+++
T Consensus        10 g~~g-~v~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~   85 (273)
T cd05074          10 GEFG-SVREAQLKS--EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRLPIPMVI   85 (273)
T ss_pred             CCCC-CEEeeEeec--cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcccceEEE
Confidence            7899 999997532  23457899999987653 3344556888999999998 999999999876432      24788


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ++|+.+++|..++...+...       ....++...+..++.|++.||++||+.|++|+||||+||+++.++.++++|||
T Consensus        86 ~~~~~~~~l~~~~~~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          86 LPFMKHGDLHTFLLMSRIGE-------EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             EecCCCCcHHHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence            99999999988875432111       12247888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .+.................++.|++||.+.+..++.++|+||+|+++|+++++|.+||.+.+..+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~  227 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY  227 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH
Confidence            987653332222222233445699999998888899999999999999999878999988877665543

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-33  Score=220.35  Aligned_cols=197  Identities=31%  Similarity=0.510  Sum_probs=161.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc---------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG---------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   72 (225)
                      |.|| .||++.     ...+++.||+|.++....         ......+..|+..+..+. |||++++++++...+..+
T Consensus        12 g~~~-~vy~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   84 (272)
T cd06629          12 GTYG-RVYLAL-----NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTEEYLS   84 (272)
T ss_pred             cCce-EEEEEe-----ecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccCCceE
Confidence            7899 999998     356788999998853211         112235678999999998 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +|+||+++++|.+++...             ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|
T Consensus        85 lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY-------------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EEEecCCCCcHHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEee
Confidence            999999999999998653             2578899999999999999999999999999999999999999999999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCC--CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ||.+................++..|++||.+....  ++.++|+||+|++++++++ |..||......+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  219 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAIA  219 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh-CCCCCcCcchHH
Confidence            99986543222122222344667799999887654  7889999999999999999 999997665544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-34  Score=221.73  Aligned_cols=191  Identities=25%  Similarity=0.469  Sum_probs=164.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.||+|.+....  .......+.+|+..++++. |||++++++.+.+....++++||+.
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   83 (258)
T cd05578          11 GAFG-KVCIVQK-----RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVVDLLL   83 (258)
T ss_pred             CCCc-eEEEEEE-----ccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEEeCCC
Confidence            7899 9999983     5678999999997543  2244567889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|...+...             ..+++..+..++.|++++|.+||+.+++|+||+|+||++++++.++|+|||.+...
T Consensus        84 ~~~L~~~l~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          84 GGDLRYHLSQK-------------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             CCCHHHHHHhc-------------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999998753             25789999999999999999999999999999999999999999999999988755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ....   ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  203 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHS  203 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh-CCCCCCCCC
Confidence            4332   1223345667999999988888999999999999999999 999998776

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-33  Score=221.96  Aligned_cols=193  Identities=27%  Similarity=0.470  Sum_probs=156.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+..     ..+++.|++|.+.............+|+..++.+. |+|++++++++.+.+..++++||+. +
T Consensus        16 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07870          16 GSYA-TVYKGIS-----RINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMH-T   87 (291)
T ss_pred             cCCE-EEEEEEE-----cCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEEEeccc-C
Confidence            7899 9999983     56688999999875543333335678999999998 9999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      ++.+.+...            ...+++..+..++.|+++||.+||+.+++|+||||+||+++.+++++|+|||++.....
T Consensus        88 ~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          88 DLAQYMIQH------------PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            776666432            12467888999999999999999999999999999999999999999999998864322


Q ss_pred             ccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...  ......+++.|+|||.+.+. .++.++|+||+|+++++|++ |..||.+.+.
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~~  209 (291)
T cd07870         156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQPAFPGVSD  209 (291)
T ss_pred             CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCchh
Confidence            211  11222346779999988754 47889999999999999999 9999976553

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.6e-33  Score=218.40  Aligned_cols=198  Identities=22%  Similarity=0.368  Sum_probs=156.1

Q ss_pred             CcccceeeecCCCCC-------------------CCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeee
Q psy15818          2 DCFSVEVRKHPMSPE-------------------RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   62 (225)
Q Consensus         2 g~~g~~v~~~~~~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~   62 (225)
                      |+|| .||++.+...                   ++......|++|.+..... .....+.+|+.++..+. ||||++++
T Consensus         6 G~~~-~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~-h~niv~~~   82 (274)
T cd05076           6 GTRT-NIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVS-HIHLAFVH   82 (274)
T ss_pred             cccc-ceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCC-CCCeeeEE
Confidence            8999 9999875321                   1233356789999865432 23345677888888888 99999999


Q ss_pred             eEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe
Q psy15818         63 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI  142 (225)
Q Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~  142 (225)
                      +++.+....++||||+++++|..++...            ...+++..+..++.|++.||+|||+++++|+||||+||++
T Consensus        83 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill  150 (274)
T cd05076          83 GVCVRGSENIMVEEFVEHGPLDVCLRKE------------KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL  150 (274)
T ss_pred             EEEEeCCceEEEEecCCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEE
Confidence            9999999999999999999998888642            2357889999999999999999999999999999999999


Q ss_pred             cCCC-------ceeEeeecccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        143 GENH-------CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       143 ~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      +..+       .++++|||.+......      ....++..|+|||.+.+ ..++.++|+||||+++|++++.|..||..
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            7533       4799999987532111      12234566999998865 55789999999999999996449999987


Q ss_pred             CCHHHH
Q psy15818        215 MAAAEV  220 (225)
Q Consensus       215 ~~~~~~  220 (225)
                      ....+.
T Consensus       225 ~~~~~~  230 (274)
T cd05076         225 RTPSEK  230 (274)
T ss_pred             cChHHH
Confidence            765543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-34  Score=230.15  Aligned_cols=183  Identities=22%  Similarity=0.331  Sum_probs=152.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++..     ..+++.||+|+....       ....|+.++.++. ||||+++++++...+..++|+|++. +
T Consensus        77 G~~g-~Vy~~~~-----~~~~~~valK~~~~~-------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~  141 (357)
T PHA03209         77 GSEG-RVFVATK-----PGQPDPVVLKIGQKG-------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMVLPHYS-S  141 (357)
T ss_pred             CCCe-EEEEEEE-----CCCCceEEEEeCCcc-------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEEEEccC-C
Confidence            8899 9999984     566789999985432       2345888999998 9999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..+..++.|++.||.|||+.||+||||||+||+++..+.++|+|||.+.....
T Consensus       142 ~l~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        142 DLYTYLTKR------------SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             cHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            788777542            23578999999999999999999999999999999999999999999999998864322


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ..   ......+++.|+|||++.+..++.++|+||+|+++|+|++++..+|.+
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            11   112344678899999999888999999999999999999966666654

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.9e-34  Score=220.78  Aligned_cols=194  Identities=27%  Similarity=0.458  Sum_probs=161.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-----hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-----ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| .||.+.     ...+++.||+|.+.....     ......+.+|+..++.++ |||++++++++.+.+..++++|
T Consensus        11 g~~~-~v~~~~-----~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630          11 GAFS-SCYQAR-----DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             cCce-EEEEEE-----EcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEEEEEe
Confidence            7899 999987     456788999999864321     223456889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-ceeEeeecc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGF  155 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-~~~l~d~g~  155 (225)
                      |+.+++|.+++...             ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        84 ~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          84 WMAGGSVSHLLSKY-------------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             ccCCCcHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            99999999998653             2578999999999999999999999999999999999998665 699999999


Q ss_pred             cccccCcccccc--ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        156 ARDLMTSSVYER--KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       156 ~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      +...........  .....++..|+|||.+.+..++.++|+||+|++++++++ |..||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  212 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEK  212 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Confidence            876543311111  112345677999999988888999999999999999999 999997544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-33  Score=223.81  Aligned_cols=199  Identities=21%  Similarity=0.407  Sum_probs=161.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .||.++     +..+++.||+|.+... ........+.+|+..+..++ ||||+++++++.+.+..+++|||+++
T Consensus        11 ~~~~-~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216          11 EDLM-IVHLAK-----HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             cCCc-eEEEEE-----ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCC
Confidence            3455 667666     3457999999999765 34455567899999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....           ...+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.++++||+.+....
T Consensus        84 ~~l~~~l~~~~-----------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          84 GSCEDLLKTHF-----------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             CCHHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeec
Confidence            99999987642           2357889999999999999999999999999999999999999999999999886442


Q ss_pred             Cccc-----cccccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        161 TSSV-----YERKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       161 ~~~~-----~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ....     ........++..|+|||.+.+.  .++.++|+||+|+++++|++ |..||.+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~  217 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQ  217 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            2111     0111222345679999988763  57889999999999999999 999998765543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.1e-33  Score=220.43  Aligned_cols=201  Identities=23%  Similarity=0.440  Sum_probs=160.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e   76 (225)
                      |.|| .||++.     ...+++.+|+|.+......  ...+.+|+.++.++..|||++++++++...     +..++|+|
T Consensus        33 g~~~-~vy~~~-----~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e  104 (291)
T cd06639          33 GTYG-KVYKVT-----NKKDGSLAAVKILDPISDV--DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE  104 (291)
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEecccccH--HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence            7789 999988     3567899999998654322  235678888999985699999999998643     35899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+++++|.+++.....         ....+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+
T Consensus       105 y~~~~sL~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639         105 LCNGGSVTELVKGLLI---------CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             ECCCCcHHHHHHHhhh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence            9999999998865321         1235789999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccccCCCCCccccCCccccCC-----CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDN-----IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ........  ......++..|+|||.+...     .++.++|+||+|+++|+|++ |..||...+..+.+.
T Consensus       176 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~~~~~~~  243 (291)
T cd06639         176 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD-GDPPLFDMHPVKTLF  243 (291)
T ss_pred             hhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh-CCCCCCCCcHHHHHH
Confidence            65433221  11223456779999987543     25789999999999999999 999998877655443

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=222.67  Aligned_cols=199  Identities=27%  Similarity=0.473  Sum_probs=163.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+++.|++|.++... .......+.+|+.+++.+. |+|++++++.+..++..++++||+++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~   84 (288)
T cd07833          12 GAYG-VVLKCRN-----KATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVFEYVER   84 (288)
T ss_pred             cCCe-eEEEEEe-----CCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEEecCCC
Confidence            7889 9999984     5678899999987543 3334456889999999998 99999999999999999999999997


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +.+..+...             ...+++..++.++.|++.|+.+||+.+++|+||+|+||++++++.++|+|||.+....
T Consensus        85 ~~l~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          85 TLLELLEAS-------------PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             CHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            666554432             2257899999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..... ......++..|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+.+..+.+.
T Consensus       152 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~  212 (288)
T cd07833         152 ARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQLY  212 (288)
T ss_pred             CCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            43221 11223345679999999887 78899999999999999999 999998776655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.1e-33  Score=218.00  Aligned_cols=192  Identities=27%  Similarity=0.440  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++..     ..+++.|++|.+...........+.+|+..+.++. |||++++++.+...+..++++||++++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623          12 GSSG-VVYKVRH-----KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             cCCe-EEEEEEE-----cCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            6788 9999984     55789999999987655455667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++..++.++.|+++++.+||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        85 ~L~~~l~~~-------------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          85 SLADLLKKV-------------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             cHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999753             258999999999999999999999 999999999999999999999999999887553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ......  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus       152 ~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~  204 (264)
T cd06623         152 NTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPFLPPG  204 (264)
T ss_pred             cCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccc
Confidence            322211  12335667999999988888999999999999999999 999998774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-33  Score=219.87  Aligned_cols=185  Identities=23%  Similarity=0.382  Sum_probs=153.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||.+.     ++.+++.+|+|.+........      |+.....+..|||++++++.+...+..++||||++++
T Consensus        27 g~~g-~v~~~~-----~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~   94 (267)
T PHA03390         27 GKFG-KVSVLK-----HKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDG   94 (267)
T ss_pred             CCce-EEEEEE-----EcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCC
Confidence            7899 999998     467789999999875432211      2222222335999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-ceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++.+++.++.|+++||.+||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        95 ~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         95 DLFDLLKKE-------------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             cHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999753             2589999999999999999999999999999999999999887 99999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ..      ....++..|+|||.+.+..++.++|+||+|+++++|++ |..||......
T Consensus       162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~  212 (267)
T PHA03390        162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT-GKHPFKEDEDE  212 (267)
T ss_pred             CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCcc
Confidence            22      12345677999999988889999999999999999999 99999865443

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-33  Score=218.07  Aligned_cols=195  Identities=24%  Similarity=0.510  Sum_probs=157.2

Q ss_pred             CcccceeeecCCCCCCC-----CccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERG-----REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| .||++.......     ......+++|.+......  ...+.+|+.+++.+. |||++++++++.. ...++|+|
T Consensus         6 G~~~-~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e   80 (259)
T cd05037           6 GTFT-NIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLS-HKHLVKLYGVCVR-DENIMVEE   80 (259)
T ss_pred             cccc-eEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCC-CcchhheeeEEec-CCcEEEEE
Confidence            7899 999999643221     122356888887654432  456788999999997 9999999999887 77899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-------cee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-------CCK  149 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-------~~~  149 (225)
                      |+++++|.+++....            ..++...+..++.|++.||.|||++|++|+||||+||+++.++       .++
T Consensus        81 ~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k  148 (259)
T cd05037          81 YVKFGPLDVFLHREK------------NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK  148 (259)
T ss_pred             cCCCCcHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence            999999999987642            2578899999999999999999999999999999999998776       799


Q ss_pred             EeeecccccccCccccccccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        150 VADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       150 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      |+|||++.....      .....++..|+|||.+.+.  .++.++|+||+|+++++++++|..||...+..+
T Consensus       149 l~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~  214 (259)
T cd05037         149 LSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE  214 (259)
T ss_pred             eCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence            999998865432      1122344569999998876  688999999999999999996788887775443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-33  Score=221.48  Aligned_cols=199  Identities=25%  Similarity=0.466  Sum_probs=162.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.|| .||++..     ..+++.+++|.++..... .......+|+.++.++. |||++++++++...  +..++++||+
T Consensus        16 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~lv~e~~   88 (293)
T cd07843          16 GTYG-VVYRARD-----KKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYV   88 (293)
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEEEEehhc
Confidence            7899 9999984     566889999999755432 22334678999999998 99999999998877  8899999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      . ++|.+++....            ..+++.++..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        89 ~-~~L~~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          89 E-HDLKSLMETMK------------QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             C-cCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence            7 58888886532            2589999999999999999999999999999999999999999999999998875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....  .......+++.|+|||.+.+.. ++.++|+||+|+++++|++ |.+||......+.+.+
T Consensus       156 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~f~~~~~~~~~~~  218 (293)
T cd07843         156 YGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNK  218 (293)
T ss_pred             ccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            54332  1112233466799999887644 5889999999999999999 9999998776665543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-33  Score=227.92  Aligned_cols=194  Identities=26%  Similarity=0.419  Sum_probs=159.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv   74 (225)
                      |.|| .||++.     +..+++.||+|.+... ........+.+|+.++.++. |||++++++++...      ...++|
T Consensus        27 g~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv   99 (353)
T cd07850          27 GAQG-IVCAAY-----DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEEFQDVYLV   99 (353)
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCccccCcEEEE
Confidence            7899 999998     4567899999998643 23334456778999999998 99999999998644      347999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      +||+. ++|.+.+..               .+++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||
T Consensus       100 ~e~~~-~~l~~~~~~---------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850         100 MELMD-ANLCQVIQM---------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             EeccC-CCHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            99996 578777643               27888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .+........   .....+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+..+
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~  227 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWN  227 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence            9875433221   122345677999999999899999999999999999999 999998777655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-33  Score=216.73  Aligned_cols=195  Identities=28%  Similarity=0.528  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.+| .||++..     ..+++.|++|.+....    ..+....+.+|+..++.+. |||++++.+++.+....++++||
T Consensus        11 g~~~-~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632          11 GSFG-SVYEGLN-----LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             cCCc-eEEEEEE-----cCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEEEEEe
Confidence            7899 9999984     4578899999986533    1334456889999999997 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +++++|.+++...             ..+++..++.++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        84 ~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          84 VPGGSLAKLLKKY-------------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             cCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999998653             247889999999999999999999999999999999999999999999999886


Q ss_pred             cccCccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ......   ......++..|++||.+.... ++.++|+||+|++++++++ |..||......+.
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~-g~~pf~~~~~~~~  210 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAA  210 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcccCcHHHH
Confidence            543322   122344667799999887666 8899999999999999999 9999977665443

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-33  Score=220.55  Aligned_cols=197  Identities=25%  Similarity=0.497  Sum_probs=158.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec------CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE------KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------~~~~~lv~   75 (225)
                      |.|| .||++..     ...++.||+|.+.....  ....+..|+.++.++..|||++++++++..      ....+++|
T Consensus        27 g~~~-~v~~~~~-----~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~   98 (282)
T cd06636          27 GTYG-QVYKGRH-----VKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM   98 (282)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence            7899 9999984     56788999999865432  234577888999988669999999999843      45689999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+.+++|.+++...+           ...+++..+..++.|+++|+.|||+.|++|+||+|+||++++++.++|+|||.
T Consensus        99 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          99 EFCGAGSVTDLVKNTK-----------GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             EeCCCCcHHHHHHHcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence            9999999999987542           23578888999999999999999999999999999999999999999999998


Q ss_pred             cccccCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      +.......  .......+++.|+|||.+.     +..++.++|+||+|+++|+|++ |..||......+.
T Consensus       168 ~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~  234 (282)
T cd06636         168 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPPLCDMHPMRA  234 (282)
T ss_pred             hhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh-CCCCccccCHHhh
Confidence            86442211  1122334567799999875     3456788999999999999999 9999976655443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-33  Score=220.20  Aligned_cols=200  Identities=22%  Similarity=0.411  Sum_probs=159.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe-----cCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-----EKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e   76 (225)
                      |.|| .||++..     ..+++.+|+|.+......  ...+..|+.++..+.+|||++++++++.     ..+..+++||
T Consensus        29 g~~~-~vy~~~~-----~~~~~~~~ik~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e  100 (286)
T cd06638          29 GTYG-KVFKVLN-----KKNGSKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE  100 (286)
T ss_pred             CCCc-EEEEEEE-----CCCCceeEEEeeccccch--HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence            7899 9999884     566889999988653322  2356788899999856999999999873     3456899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+++++|.+++.....         ....+++..++.++.|+++||.+||+.+++|+||+|+||+++.++.++|+|||++
T Consensus       101 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638         101 LCNGGSVTDLVKGFLK---------RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             ecCCCCHHHHHHHhhc---------cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            9999999998764321         1235788999999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .......  .......+++.|+|||.+..     ..++.++|+||+|+++|+|++ |..||......+.+
T Consensus       172 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~~~~~~  238 (286)
T cd06638         172 AQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLHPMRAL  238 (286)
T ss_pred             eecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc-CCCCCCCCchhHHH
Confidence            6543221  11223346778999998753     446889999999999999999 99999877654443

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.7e-33  Score=216.61  Aligned_cols=203  Identities=26%  Similarity=0.455  Sum_probs=167.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (225)
                      |.|| .||++.     +..+++.||+|.+... ........+..|+..++.+. |||++++++.+..  ....++++||+
T Consensus        11 g~~~-~v~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~e~~   83 (265)
T cd08217          11 GSFG-TVRKVR-----RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIVMEYC   83 (265)
T ss_pred             CCCe-EEEEee-----ecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEEehhc
Confidence            7899 999998     4567889999998754 34444556888999999998 9999999998754  45689999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS-----SRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-----~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++++|.+++...+.         ....+++..++.++.|++.||.+||     +.+++|+||+|+||++++++.++|+||
T Consensus        84 ~~~~L~~~l~~~~~---------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          84 EGGDLAQLIQKCKK---------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             cCCCHHHHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            99999999976432         2346889999999999999999999     899999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |.+.........  .....+++.|+|||.+.+...+.++|+||+|+++++|++ |..||...+..+..+.
T Consensus       155 g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  221 (265)
T cd08217         155 GLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASK  221 (265)
T ss_pred             cccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH-CCCcccCcCHHHHHHH
Confidence            998765433211  122345678999999988888999999999999999999 9999998876655444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-33  Score=221.46  Aligned_cols=191  Identities=25%  Similarity=0.419  Sum_probs=164.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|++...........+.+|+.++..+. |||++++++.+...+..++|+||++++
T Consensus        16 g~~g-~v~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (284)
T cd06620          16 GNGG-SVSKVKH-----IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMCMEFMDCG   88 (284)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEEEecCCCC
Confidence            7899 9999984     56789999999876555555667889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++..+..++.|++.+|.+||+ .+++|+||+|+||++++++.++|+|||++....
T Consensus        89 ~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          89 SLDRIYKKG-------------GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CHHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999888653             257899999999999999999997 589999999999999999999999999876432


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...    .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.....
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~  207 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNI  207 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh-CCCCCcccch
Confidence            211    122346778999999888888999999999999999999 9999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-33  Score=218.73  Aligned_cols=193  Identities=26%  Similarity=0.473  Sum_probs=162.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |.+| .||++..     ..+++.||+|.+...........+.+|+.++..+. ||||+++++++.+  .+..+++|||++
T Consensus        12 g~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621          12 GAGG-SVTKCRL-----KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             CCce-EEEEEEE-----CCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            7899 9999994     45789999999986655555667889999999998 9999999998854  447899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.....         ....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          85 GGSLDSIYKKVKK---------RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             CCCHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            9999998765432         1235788999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      .....    ....++..|++||.+.+..++.++|+||+|+++|+|++ |..||...
T Consensus       156 ~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~  206 (287)
T cd06621         156 VNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ-NRFPFPPE  206 (287)
T ss_pred             ccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Confidence            32211    12234567999999988889999999999999999999 99999765

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279|consensus

Probab=100.00  E-value=4.4e-35  Score=241.42  Aligned_cols=192  Identities=29%  Similarity=0.496  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||.++     ...+....|||-++...+.. ..-+..|+.+.++++ |.||++++|.+..++.+-++||-++||
T Consensus       586 GTYG-~VYA~R-----D~~tqvrIaIKEIpekdsr~-~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  586 GTYG-TVYAAR-----DMDTQVRIAIKEIPEKDSRE-VQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             Ccee-EEEeec-----cccceeEEEeeecccccchh-hccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            8999 999999     47889999999998654433 345788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCC--ChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSL--TSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~g~~~~  158 (225)
                      +|.+++++.            .+++  +|.++..+.+||++||.|||++.|+|||||-+|++++ -+|.+||+|||-+.+
T Consensus       658 SLSsLLrsk------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  658 SLSSLLRSK------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKR  725 (1226)
T ss_pred             cHHHHHHhc------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchh
Confidence            999999874            4455  8999999999999999999999999999999999996 688999999999876


Q ss_pred             ccCccccccccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      +..-..  -..+..||..|||||++..+  .|+.++|||||||.+.||.| |++||-...
T Consensus       726 LAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~Elg  782 (1226)
T KOG4279|consen  726 LAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELG  782 (1226)
T ss_pred             hccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecC
Confidence            532211  11234567889999998754  48899999999999999999 999996544

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-33  Score=222.48  Aligned_cols=196  Identities=28%  Similarity=0.505  Sum_probs=160.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+++.||+|.+..... ......+.+|+.++..+. |||++++++++.+++..++++||+++
T Consensus        12 g~~~-~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (286)
T cd07846          12 GSYG-MVMKCKH-----KETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVFEFVDH   84 (286)
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEEecCCc
Confidence            7899 9999984     55688999999865432 233446778999999997 99999999999999999999999998


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.......             ..+++..+..++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||++....
T Consensus        85 ~~l~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          85 TVLDDLEKYP-------------NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             cHHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            8887765432             247899999999999999999999999999999999999999999999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ....  ......++..|+|||.+.+. .++.++|+||+|+++++|++ |.+||......+.
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~-g~~~~~~~~~~~~  209 (286)
T cd07846         152 APGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQ  209 (286)
T ss_pred             CCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc-CCCCCCCCchHHH
Confidence            3221  11122346679999988753 46788999999999999999 9999987665443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0983|consensus

Probab=100.00  E-value=1.6e-34  Score=214.98  Aligned_cols=197  Identities=26%  Similarity=0.495  Sum_probs=166.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+.| .||+++.     +++|...|||.+......+...+++..+.++.....+|+|++.+++|..+...++.||.+. .
T Consensus       103 GtcG-~V~k~~~-----rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~  175 (391)
T KOG0983|consen  103 GTCG-QVWKMRF-----RSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T  175 (391)
T ss_pred             CCcc-ceEEEEE-----cccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence            7889 9999994     7889999999999988888888999999988887779999999999999999999999774 5


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      .+..++++..            .+++|..+..+...+++||.||-++ +|+|||+||+||++++.|++||||||++.++.
T Consensus       176 C~ekLlkrik------------~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  176 CAEKLLKRIK------------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHHHHhc------------CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence            6666666542            3689999999999999999999865 89999999999999999999999999998775


Q ss_pred             CccccccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA-AAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~-~~~~~  221 (225)
                      ......+.   .|-+.||+||.+.-   ..|+.++|+||||+.++||.| |+.||.+.+ +.+.+
T Consensus       244 dSkAhtrs---AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT-g~yPy~~c~tdFe~l  304 (391)
T KOG0983|consen  244 DSKAHTRS---AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT-GQYPYKGCKTDFEVL  304 (391)
T ss_pred             cccccccc---cCCccccCccccCCCCCCccchhhhhhhhccchhhhhc-ccCCCCCCCccHHHH
Confidence            55443333   33356999998863   458899999999999999999 999999743 34444

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-33  Score=215.85  Aligned_cols=200  Identities=24%  Similarity=0.436  Sum_probs=166.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||.+..     ..+++.+|+|.+.... .......+.+|+.+++++. |||++++++.+...+..++|+||+++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08220          11 GAFG-IVHLCRR-----KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPG   83 (256)
T ss_pred             cCce-EEEEEEE-----cCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEEecCCC
Confidence            7889 9999884     4578899999987542 3444567889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g~~~~~  159 (225)
                      ++|.+++....           ...+++..+..++.|++.++.+||++|++|+||+|+||+++++ +.++|+|||.+...
T Consensus        84 ~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          84 GTLAEYIQKRC-----------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             CCHHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999997642           2347899999999999999999999999999999999999854 56899999998765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....   .....++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+......+
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~  212 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-LKRAFEAANLPALVLK  212 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh-CCCCcccCchHHHHHH
Confidence            33321   112345667999999988888999999999999999999 9999988776555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0196|consensus

Probab=100.00  E-value=6.5e-35  Score=242.48  Aligned_cols=207  Identities=39%  Similarity=0.707  Sum_probs=184.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |-|| +|++++++...  +....||||.+|..-.+..+.+++.|..||-++. ||||+++.++........||.||++++
T Consensus       640 GEFG-EVc~GrLk~pg--kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMIiTEyMENG  715 (996)
T KOG0196|consen  640 GEFG-EVCSGRLKLPG--KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMIITEYMENG  715 (996)
T ss_pred             cccc-ceecccccCCC--CcceeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEEEhhhhhCC
Confidence            7899 99999985333  4468999999999888888889999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.++++.+            ...++..++..+++.|++|++||.+.|++||||...||+++.+..+|++|||+++.+..
T Consensus       716 sLDsFLR~~------------DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  716 SLDSFLRQN------------DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             cHHHHHhhc------------CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999874            35688899999999999999999999999999999999999999999999999987655


Q ss_pred             cc-ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SS-VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++ .......+..+.+|.|||.+.-.+++.+||+||+|+++||.|++|.-||=+...+|.++.|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI  847 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI  847 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH
Confidence            54 1222223334568999999999999999999999999999999999999999999999986

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-33  Score=222.08  Aligned_cols=199  Identities=28%  Similarity=0.486  Sum_probs=162.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch----HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.|| .||++..     ..+++.|++|.++.....    .....+..|+..+.++. |+|++++++++.+.+..++||||
T Consensus        11 g~~~-~vy~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841          11 GTYA-VVYKARD-----KETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             cccc-EEEEEEE-----CCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEEEEcc
Confidence            7899 9999983     556889999999765322    22335678999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      + +++|.+++...            ...+++..+..++.|+++||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~-~~~L~~~i~~~------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          84 M-ETDLEKVIKDK------------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             c-CCCHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence            9 89999998643            1258899999999999999999999999999999999999999999999999986


Q ss_pred             cccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .......  .......++.|+|||.+.+ ..++.++|+||+|+++++|++ |.+||.+.++.+.+++
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~-g~~~~~~~~~~~~~~~  214 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGK  214 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc-CCccccCCccHHHHHH
Confidence            5433211  1122234567999998755 456889999999999999999 8888987776655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.4e-33  Score=222.92  Aligned_cols=199  Identities=27%  Similarity=0.497  Sum_probs=161.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.|| .||++..     ..+|+.||+|.++.... ........+|+.++.++. |+|++++++++...  +..++|+||+
T Consensus        18 g~~~-~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (309)
T cd07845          18 GTYG-IVYRARD-----TTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYC   90 (309)
T ss_pred             cCCE-EEEEEEE-----CCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEEEEEecC
Confidence            7899 9999984     56789999999875432 222234567999999998 99999999998754  5689999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      . ++|.+++....            ..+++.+++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+..
T Consensus        91 ~-~~l~~~l~~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          91 E-QDLASLLDNMP------------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             C-CCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            7 57888876531            3578999999999999999999999999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....  ........++.|+|||.+.+ ..++.++|+||+|+++|+|++ |.+||.+.+..+.+..
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~~f~~~~~~~~~~~  220 (309)
T cd07845         158 YGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA-HKPLLPGKSEIEQLDL  220 (309)
T ss_pred             cCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            53321  11122233567999998865 457899999999999999999 9999998887776554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-33  Score=221.07  Aligned_cols=195  Identities=25%  Similarity=0.496  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||.+..     ..+++.||+|.+.... ......+.+|+..++.+. |+|++++++.+...+..+++|||++++
T Consensus        31 g~~g-~v~~~~~-----~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          31 GSTG-IVCIATV-----KSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             CCCe-EEEEEEE-----cCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEecCCCC
Confidence            7899 9999873     5678999999885433 234456888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++..+..++.|++.++++||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus       103 ~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         103 ALTDIVTHT--------------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             cHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            998877432              478899999999999999999999999999999999999999999999998765432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...  ......+++.|++||.+.+..++.++|+||+|+++++|++ |..||.+....+.+
T Consensus       169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t-g~~p~~~~~~~~~~  225 (292)
T cd06657         169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAM  225 (292)
T ss_pred             ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            211  1122345677999999888888999999999999999999 99999877655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1094|consensus

Probab=100.00  E-value=3.1e-34  Score=232.15  Aligned_cols=203  Identities=38%  Similarity=0.727  Sum_probs=177.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .|.++.+      .++.+||||+++.......+.++.+|+++|.+++ ||||+.+.++|..+..+++++||++.|
T Consensus       549 GqFG-EVhLCev------eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  549 GQFG-EVHLCEV------EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             cccc-eeEEEEe------cCceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            7899 9999995      5589999999999888888889999999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..+..           ..+..+....++.||++|++||.+.+++||||.+.|++++.+.++|++|||+++.+-.
T Consensus       621 DLnqFl~ahea-----------pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  621 DLNQFLSAHEL-----------PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             cHHHHHHhccC-----------cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence            99999987631           1134455667999999999999999999999999999999999999999999987655


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHH-cCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT-LGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~-~g~~p~~~~~~~~~~~~  223 (225)
                      ......+.....+.+|||+|.+.-++++.++|+|++|+.+||+++ ...-||...+++++.++
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven  752 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN  752 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence            555555545556778999999999999999999999999999843 27889999999888765

>KOG0666|consensus

Probab=100.00  E-value=5.4e-35  Score=220.97  Aligned_cols=202  Identities=23%  Similarity=0.399  Sum_probs=163.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (225)
                      |.|| .||++-- ...+.+-.+.+|+|.++... ........-+|+.+++.+. |||++.+..+|-. +..+++++||.+
T Consensus        35 GTYG-~VykA~~-~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~~v~l~fdYAE  111 (438)
T KOG0666|consen   35 GTYG-KVYKAVR-KNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSHDKKVWLLFDYAE  111 (438)
T ss_pred             cccc-eeeEeee-ccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhccCceEEEEehhhh
Confidence            8899 9999942 22222225689999998652 2333345789999999998 9999999998866 888999999996


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC----CceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN----HCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~----~~~~l~d~g~  155 (225)
                       -||.++++-++..+        ...++...+..+++||+.|+.|||++-++||||||.||++..+    |+|||.|+|+
T Consensus       112 -hDL~~II~fHr~~~--------~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  112 -HDLWHIIKFHRASK--------AKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             -hhHHHHHHHhccch--------hccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence             79999998776443        2468999999999999999999999999999999999999755    8999999999


Q ss_pred             cccccCccccc-cccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        156 ARDLMTSSVYE-RKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       156 ~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ++.+..+-... .......|..|+|||.+.|.. |+.+.|+|++||++.||++ -.+.|.+..
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt-l~PlF~g~E  244 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT-LEPLFKGRE  244 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc-cCccccchh
Confidence            98765543222 333445577799999998864 8999999999999999999 777776543

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.4e-33  Score=220.53  Aligned_cols=202  Identities=25%  Similarity=0.456  Sum_probs=160.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-----eEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----FFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~   75 (225)
                      |.|| +||++..     ..+++.||+|.+..... ......+.+|+.++..+..|||++++++++.....     .+++|
T Consensus        12 g~~g-~vy~~~~-----~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837          12 GTYG-KVYKARD-----KNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             cCCe-EEEEEEE-----CCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            7899 9999984     56789999999875432 22234577899999999768999999999877655     89999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeec
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFG  154 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g  154 (225)
                      ||+++ +|.+++......        ....+++..++.++.|+++||.+||+.|++|+||+|+||+++. ++.++|+|||
T Consensus        86 e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRG--------PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             eccCc-CHHHHHHHhccc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            99985 788887654211        1235799999999999999999999999999999999999998 8899999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .+........  ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~  221 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQL  221 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Confidence            8875433211  1122234567999998865 456889999999999999999 99999877655443

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-33  Score=219.27  Aligned_cols=193  Identities=27%  Similarity=0.447  Sum_probs=156.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     +..+|+.||+|.++.............|+..+.+...|||++++++++..++..++++||++ +
T Consensus        12 g~~g-~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (283)
T cd06617          12 GAYG-VVDKMR-----HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T   84 (283)
T ss_pred             cCCe-EEEEEE-----EcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence            7899 999998     45779999999998665444445666777765555459999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++.....         ....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus        85 ~l~~~l~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          85 SLDKFYKKVYD---------KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             cHHHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            88888765321         123689999999999999999999997 99999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccC----CCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD----NIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ...   ......++..|+|||.+.+    ..++.++|+||+|+++|+|++ |..||..
T Consensus       156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~  209 (283)
T cd06617         156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPYDS  209 (283)
T ss_pred             ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh-CCCCCCc
Confidence            221   1122345667999998865    345789999999999999999 9999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=217.54  Aligned_cols=200  Identities=24%  Similarity=0.467  Sum_probs=161.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv~   75 (225)
                      |.+| +||++..     ..+++.+++|.+......  ...+.+|+.++.++..|||++++++++....      ..+++|
T Consensus        17 g~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~   88 (275)
T cd06608          17 GTYG-KVYKARH-----KKTGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM   88 (275)
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence            6789 9999984     456889999998765432  2468899999999966999999999997654      489999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+++++|.+++.....         ....+++..+..++.|++.||.+||+.+++|+||+|+||++++++.++|+|||.
T Consensus        89 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          89 ELCGGGSVTDLVKGLRK---------KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EcCCCCcHHHHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            99999999998875431         123688999999999999999999999999999999999999999999999998


Q ss_pred             cccccCccccccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      +.......  .......++..|+|||.+..     ..++.++|+||+|++++++++ |..||........+
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~  227 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMHPMRAL  227 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh-CCCCccccchHHHH
Confidence            86543222  11223345677999998753     345778999999999999999 99999876554443

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-33  Score=215.92  Aligned_cols=201  Identities=26%  Similarity=0.479  Sum_probs=169.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+++.+++|.+.... .........+|+.+++.+. |||++++.+.+.+....++++||+++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530          11 GSYG-SVYKVKR-----LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             CCce-eEEEEEE-----CCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEehhcCC
Confidence            7889 9999873     5678899999987543 3444556778999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+.....         ....+++..++.++.|++.||.+||+.|++|+||+|+||+++++++++|+|||.+....
T Consensus        84 ~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          84 GDLSKAISKRKK---------KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             CCHHHHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            999999876432         12357889999999999999999999999999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..    ......+++.|++||.+.+..++.++|+||+|++++++++ |..||...+..+...+
T Consensus       155 ~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~  212 (256)
T cd08530         155 KN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYK  212 (256)
T ss_pred             cC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            33    1122345677999999988888999999999999999999 9999998887655443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.9e-33  Score=220.99  Aligned_cols=194  Identities=26%  Similarity=0.497  Sum_probs=162.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.|++|.+....... ...+.+|+.+++.+. |||++++++.+...+..++|+||++++
T Consensus        30 g~~g-~v~~~~~-----~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~  101 (293)
T cd06647          30 GASG-TVYTAID-----VATGQEVAIKQMNLQQQPK-KELIINEILVMRENK-HPNIVNYLDSYLVGDELWVVMEYLAGG  101 (293)
T ss_pred             CCCe-EEEEEEE-----cCCCCEEEEEEeccccchH-HHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEEEEecCCCC
Confidence            7899 9999973     4567889999986543322 346788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.+.              .+++.++..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~L~~~~~~~--------------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647         102 SLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             cHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999988643              468889999999999999999999999999999999999999999999998764433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...  ......+++.|++||.+.+..++.++|+||+|++++++++ |..||...+..+.
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~-g~~pf~~~~~~~~  223 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRA  223 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhh
Confidence            221  1122345667999999888888999999999999999999 9999987665443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-33  Score=219.99  Aligned_cols=197  Identities=27%  Similarity=0.509  Sum_probs=160.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .||++.     ...+++.||+|.+.... .......+.+|+..+.++. |||++++++++.+.+..+++|||+. 
T Consensus        11 g~~~-~v~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860          11 GTYG-VVYKAR-----NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             CCce-EEEEEE-----ECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEeeccc-
Confidence            7889 999998     35678899999987543 2223346788999999998 9999999999999999999999996 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...           ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        83 ~~l~~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          83 QDLKKFMDAS-----------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             cCHHHHHHhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            6788877653           22457899999999999999999999999999999999999999999999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...  .......+++.|+|||.+.+.. ++.++|+||+|+++|+|+| |..||.+.+..+.
T Consensus       152 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~  209 (284)
T cd07860         152 VPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ  209 (284)
T ss_pred             cCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Confidence            221  1122223466799999887644 5788999999999999999 9999987765543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0199|consensus

Probab=100.00  E-value=5.9e-34  Score=234.63  Aligned_cols=207  Identities=34%  Similarity=0.607  Sum_probs=179.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .|+++.|....  .+.-.||||+++.........++++|+..|.++. |||++++|++.-+ ....+|+|++++|
T Consensus       121 GsFg-vV~rg~Wt~ps--gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~mMV~ELaplG  195 (1039)
T KOG0199|consen  121 GSFG-VVKRGTWTQPS--GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAMMVFELAPLG  195 (1039)
T ss_pred             ccee-eEeeccccCCC--CcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhhHHhhhcccc
Confidence            8999 99999995422  2356799999987765556678999999999998 9999999999776 6788999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.++..           ....+....+..|+.||+.|+.||.+++++||||...|+++.....|||+|||+.+.+..
T Consensus       196 SLldrLrka-----------~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  196 SLLDRLRKA-----------KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hHHHHHhhc-----------cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999873           234677889999999999999999999999999999999999888999999999987766


Q ss_pred             ccccccccC-CCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~-~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......... ......|+|||.+....++.++|+|++|+.+|||+++|..||.+....+++++|
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i  328 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI  328 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence            544433222 233446999999999999999999999999999999999999999999999987

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6e-33  Score=219.11  Aligned_cols=199  Identities=26%  Similarity=0.469  Sum_probs=158.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| +||++..     ..+++.||+|.+..... ......+.+|+.+++++. |||++++++++.++...++|+||++ 
T Consensus        13 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~-   84 (294)
T PLN00009         13 GTYG-VVYKARD-----RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEYLD-   84 (294)
T ss_pred             CCCE-EEEEEEe-----cCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEEEeccc-
Confidence            7889 9999984     56788999999865432 223345778999999997 9999999999999999999999996 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~~  159 (225)
                      ++|.+.+...           ....+++..++.++.|++.||++||+++++|+||+|+||+++. ++.++|+|||++...
T Consensus        85 ~~l~~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         85 LDLKKHMDSS-----------PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             ccHHHHHHhC-----------CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            5777776543           1223578889999999999999999999999999999999984 567999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ....  .......+++.|+|||.+.+. .++.++|+||+|+++++|++ |..||...+..+.+.
T Consensus       154 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~~~~~~~  214 (294)
T PLN00009        154 GIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELF  214 (294)
T ss_pred             CCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            3221  111222346679999988664 57889999999999999999 999998776655443

>KOG0984|consensus

Probab=100.00  E-value=1.2e-33  Score=202.51  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |++| .|-..+     +..+|...|+|.++.....+...+...|+.+..+...+|+++.+++..-..+..|+.||.+. .
T Consensus        57 GayG-~vekmr-----h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t  129 (282)
T KOG0984|consen   57 GAYG-VVEKMR-----HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T  129 (282)
T ss_pred             Cccc-hhhhee-----eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence            6677 555555     67899999999999887777778899999998877779999999999999999999999985 7


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|..+..+.-.         .+..++|..+.+++..++.||.|||++ .++|||+||+||+++..|+||+||||++..+.
T Consensus       130 Sldkfy~~v~~---------~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  130 SLDKFYRKVLK---------KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             hHHHHHHHHHh---------cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            88877765432         355789999999999999999999986 89999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCccccC----CCCCcchhHHHHHHHHHHHHHcCCCCCC-CCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD----NIFSVKSDIWSFGVLIWEIVTLGSTPYP-GMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slg~ll~~l~~~g~~p~~-~~~~~~~~~~i  224 (225)
                      ......   ...|-..|+|||.+..    ..|+.++|+||||+.++||.+ ++.||. ..++.++++++
T Consensus       201 dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~-lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  201 DSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI-LRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             hhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh-ccccccccCCHHHHHHHH
Confidence            433222   1222234999998863    368899999999999999999 999997 55666776654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=225.46  Aligned_cols=195  Identities=22%  Similarity=0.411  Sum_probs=158.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e   76 (225)
                      |.|| .||++..     ..+|+.||+|.+..........+..+|+.++..++ |||++++++++...     ...++++|
T Consensus        16 G~~g-~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e   88 (336)
T cd07849          16 GAYG-MVCSATH-----KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQE   88 (336)
T ss_pred             cCCe-EEEEEEE-----cCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccceEEEEeh
Confidence            7899 9999983     56788999999875444444556788999999998 99999999986543     34799999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+. +++.+.+...              .+++..++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~-~~l~~~~~~~--------------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          89 LME-TDLYKLIKTQ--------------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             hcc-cCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence            996 5787776432              5899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccc-cccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        157 RDLMTSSVYE-RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      .......... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~-G~~~f~~~~~~~  217 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLFPGKDYLH  217 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            6543322111 1122346778999998654 467889999999999999999 999998765543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0584|consensus

Probab=100.00  E-value=4.9e-34  Score=232.58  Aligned_cols=197  Identities=27%  Similarity=0.454  Sum_probs=165.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeee---ccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC--eEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTL---KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--FFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~---~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--~~lv~e   76 (225)
                      |+|- +||+|-     ...+|.-||=-.+   .....+....++..|+++|..|+ ||||+++++++.+...  +.+|.|
T Consensus        51 GafK-tVYka~-----De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   51 GAFK-TVYKAF-----DEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             ccce-eeeecc-----ccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeeee
Confidence            7888 899988     3566666663222   23346666789999999999999 9999999999987655  889999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEec-CCCceeEeee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIG-ENHCCKVADF  153 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~  153 (225)
                      .++.|+|..+.++.+             ..+...+..|++||++||.|||++.  |+|||||=+|||++ ..|.|||+|+
T Consensus       124 L~TSGtLr~Y~kk~~-------------~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR-------------RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             cccCCcHHHHHHHhc-------------cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence            999999999999875             6889999999999999999999996  99999999999997 6789999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG-MAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~-~~~~~~~~~i  224 (225)
                      |+|.....    ......-|||.|||||++. ..|...+||||||++++||+| +..||.. .+..++++++
T Consensus       191 GLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n~AQIYKKV  256 (632)
T KOG0584|consen  191 GLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT-SEYPYSECTNPAQIYKKV  256 (632)
T ss_pred             hHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh-ccCChhhhCCHHHHHHHH
Confidence            99975422    2334467999999999876 889999999999999999999 9999974 5566666664

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-32  Score=212.05  Aligned_cols=194  Identities=29%  Similarity=0.596  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++..     ..+++.+++|.+..... .....+.+|+..+..+. ||+++++.+.+..++..++++||++++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~   82 (253)
T cd05122          11 GGFG-EVYKARH-----KRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGG   82 (253)
T ss_pred             CCce-EEEEEEE-----CCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEecCCCC
Confidence            6789 9999984     45788999999976544 34457889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        83 ~L~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          83 SLKDLLKSTN------------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             cHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999887531            3579999999999999999999999999999999999999999999999998876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...   .....++..|++||.+.+...+.++|+||+|+++++|++ |..||...+..+
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~  204 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSELPPMK  204 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCchHH
Confidence            321   223345667999999988888999999999999999999 999998774444

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0603|consensus

Probab=100.00  E-value=4.9e-34  Score=233.15  Aligned_cols=193  Identities=26%  Similarity=0.457  Sum_probs=160.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|+ .|-.+.     +..+++..++|++....     .+..+|+.++.....|||+++..+.+.++...|+|||.+.|+
T Consensus       333 gs~s-~~~~~~-----~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~  401 (612)
T KOG0603|consen  333 GSFS-AVKYCE-----SSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG  401 (612)
T ss_pred             CCcc-ceeeee-----ccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence            6777 666666     46778889999997651     234567777777778999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe-cCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-GENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~-~~~~~~~l~d~g~~~~~~  160 (225)
                      -+.+.+...+              ....++..|+++|+.|+.+||++|++||||||+||++ ++.++++|+|||.+....
T Consensus       402 ell~ri~~~~--------------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  402 ELLRRIRSKP--------------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             HHHHHHHhcc--------------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            8888776542              3337788899999999999999999999999999999 588899999999997543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH-HHhhhcC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA-EVMKKSK  225 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~-~~~~~i~  225 (225)
                      ..     ......|..|.|||++....++.++||||||++||+|++ |+.||...... +++.+|+
T Consensus       468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~~i~  527 (612)
T KOG0603|consen  468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHTRIQ  527 (612)
T ss_pred             hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHHhhc
Confidence            33     223345667999999999999999999999999999999 99999866555 7777764

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-32  Score=215.91  Aligned_cols=197  Identities=36%  Similarity=0.665  Sum_probs=156.8

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeec
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYV   78 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (225)
                      .|.|| +||.+.... .+...++.||+|.++.... .....+.+|+.++.++. |||++++.+++..  ....++++||+
T Consensus        14 ~g~~g-~v~~~~~~~-~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~   89 (284)
T cd05081          14 KGNFG-SVELCRYDP-LQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLRLVMEYL   89 (284)
T ss_pred             CCCCc-eEEEEEecC-CcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCCceEEEEEec
Confidence            38899 999986422 2345688999999875432 33456789999999998 9999999998643  45689999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+++...+            ..+++..++.++.|++.||++||++|++|+||||+||++++++.++|+|||++..
T Consensus        90 ~~~~L~~~l~~~~------------~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          90 PYGSLRDYLQKHR------------ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             CCCCHHHHHHhcC------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999986531            2478899999999999999999999999999999999999999999999999875


Q ss_pred             ccCcccccc-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        159 LMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ......... ......+..|+|||.+.+..++.++|+||+|+++++|++ |..|+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~~~~~~~  213 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCS  213 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhh-cCCcCCC
Confidence            533221111 111223345899999988889999999999999999999 7666543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.6e-33  Score=218.50  Aligned_cols=195  Identities=23%  Similarity=0.413  Sum_probs=159.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| .||.+...  .+..+|+.||+|+++...   .........+|+.++.++..|++|+++++.++.++..++++||+
T Consensus        11 G~~g-~v~~~~~~--~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (290)
T cd05613          11 GAYG-KVFLVRKV--SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI   87 (290)
T ss_pred             CCcc-eEEEEEec--cCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecC
Confidence            7899 99998742  123468899999987532   22334457789999999977999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+++...             ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        88 ~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          88 NGGELFTHLSQR-------------ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             CCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999988653             2578899999999999999999999999999999999999999999999998865


Q ss_pred             ccCccccccccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ...... .......++..|++||.+.+.  .++.++|+||+|+++|+|++ |..||..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~  210 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPFTV  210 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc-CCCCCCc
Confidence            432211 111223456779999988653  46788999999999999999 9999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.1e-33  Score=217.33  Aligned_cols=198  Identities=38%  Similarity=0.665  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |.|| +||++.+... +..+++.||+|.++..........+.+|+..++.+. |||++++++++..  ....++++||++
T Consensus        15 g~~~-~v~~~~~~~~-~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (284)
T cd05038          15 GHFG-KVELCRYDPL-GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLP   91 (284)
T ss_pred             CCCe-eEEEeeecCC-CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCCceEEEEecCC
Confidence            7899 9999985322 244688999999986655445567899999999997 9999999999877  557899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....            ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        92 ~~~l~~~l~~~~------------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          92 SGSLRDYLQRHR------------DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCCHHHHHHhCc------------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999997542            24789999999999999999999999999999999999999999999999998765


Q ss_pred             cCcccccc-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ........ ......+..|++||.+.+..++.++|+||+|+++++|++ |..|+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~  215 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSP  215 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec-cCCCcccc
Confidence            42221111 112233445999999988888999999999999999999 88888654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.6e-33  Score=219.83  Aligned_cols=198  Identities=26%  Similarity=0.445  Sum_probs=157.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--------CeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--------PFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--------~~~   72 (225)
                      |.|| .||++.     ...+++.||+|.+.... .........+|+.+++++. |||++++++++...+        ..+
T Consensus        23 g~~~-~v~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~   95 (310)
T cd07865          23 GTFG-EVFKAR-----HKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFY   95 (310)
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccccCCCceEE
Confidence            7899 999998     35678999999986543 2222334668999999998 999999999986543        459


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +++||+. ++|.+.+...            ...+++.+++.++.|+++||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        96 lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          96 LVFEFCE-HDLAGLLSNK------------NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             EEEcCCC-cCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence            9999996 5787777542            22578999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCcccc--ccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        153 FGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       153 ~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ||.+.........  .......++..|+|||.+.+. .++.++|+||+|+++|+|++ |..||.+.+....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t-~~~~~~~~~~~~~  232 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQ  232 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            9998755332211  111223345679999987664 36889999999999999999 9999987766544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-33  Score=213.52  Aligned_cols=199  Identities=27%  Similarity=0.491  Sum_probs=167.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||.+..     ...++.+++|.+....  .......+..|+.+++++. |||++++++.+..+...+++||++.
T Consensus         4 G~~~-~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~   76 (250)
T cd05123           4 GSFG-KVLLVRK-----KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP   76 (250)
T ss_pred             CCce-EEEEEEE-----CCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence            7899 9999984     4468899999987653  2334556888999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..+..++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  143 (250)
T cd05123          77 GGELFSHLSKE-------------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL  143 (250)
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence            99999998753             25789999999999999999999999999999999999999999999999988654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  .......++..|++||...+...+.++|+||+|++++++++ |..||...+..+..++
T Consensus       144 ~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~  204 (250)
T cd05123         144 SSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYEK  204 (250)
T ss_pred             ccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence            3321  11223345667999999988888899999999999999999 9999987776555443

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.2e-33  Score=222.58  Aligned_cols=199  Identities=25%  Similarity=0.436  Sum_probs=161.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHH-------------HHHHHHHHHHHhhcCCCCCeeeeeeEEecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERE-------------RLDLLQELTVMKTLDPHPNVVRLLGCCTEK   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   68 (225)
                      |.|| +||++..     ..+++.||+|.++.......             ...+.+|+.++.++. |||++++++++...
T Consensus        20 G~~g-~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   92 (335)
T PTZ00024         20 GTYG-KVEKAYD-----TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLVDVYVEG   92 (335)
T ss_pred             CCce-eEEEEEE-----CCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-CcceeeeeEEEecC
Confidence            7899 9999983     56789999999875432221             124678999999998 99999999999999


Q ss_pred             CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCce
Q psy15818         69 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCC  148 (225)
Q Consensus        69 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~  148 (225)
                      +..+++|||+. ++|.+.+...             ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRK-------------IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            99999999997 6888887542             257899999999999999999999999999999999999999999


Q ss_pred             eEeeecccccccCccc------------cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        149 KVADFGFARDLMTSSV------------YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      +|+|||.+........            ........+++.|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~  237 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFPGE  237 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCC
Confidence            9999998875541110            1111122346679999988764 46889999999999999999 99999988


Q ss_pred             CHHHHhh
Q psy15818        216 AAAEVMK  222 (225)
Q Consensus       216 ~~~~~~~  222 (225)
                      +..+.+.
T Consensus       238 ~~~~~~~  244 (335)
T PTZ00024        238 NEIDQLG  244 (335)
T ss_pred             CHHHHHH
Confidence            8776554

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-32  Score=214.61  Aligned_cols=194  Identities=27%  Similarity=0.442  Sum_probs=157.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..++..|++|.+...... ....+.+|+.++..++ |+||+++++++...+..++++||++++
T Consensus        19 g~~g-~v~~~~~-----~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          19 GTYG-IVYAARD-----LSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             CCce-EEEEeEe-----cCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            7899 9999984     567889999988754432 3346889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~~~  160 (225)
                      +|.+.+.....          ....++..+..++.|++.|+.+||++|++|+||+|+||+++. .+.++|+|||.+....
T Consensus        91 ~L~~~l~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          91 SLSALLRSKWG----------PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             CHHHHHHHhcc----------cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999875310          112277888999999999999999999999999999999975 6789999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCCC--CCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ....  ......+++.|+|||.+.+..  ++.++|+||+|+++++|++ |..||....
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~  215 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELG  215 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh-CCCCCcccc
Confidence            2211  112234567799999886543  7889999999999999999 999997543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-32  Score=213.86  Aligned_cols=194  Identities=26%  Similarity=0.496  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+++.|++|.++.... ......+..|+.+++.+. |+||+++++.+...+..++++||+++
T Consensus        11 G~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06626          11 GTFG-KVYTAVN-----LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFMEYCSG   83 (264)
T ss_pred             CCCc-EEEEEEE-----CCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEEecCCC
Confidence            7899 9999973     55789999999876543 345667889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+...             ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+....
T Consensus        84 ~~L~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          84 GTLEELLEHG-------------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             CcHHHHHhhc-------------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999988653             246888999999999999999999999999999999999999999999999987654


Q ss_pred             Cccccccc--cCCCCCccccCCccccCCC---CCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        161 TSSVYERK--SEGRLPIRWMAPESLYDNI---FSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       161 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~---~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ........  ....+++.|++||.+.+..   .+.++|+||+|++++++++ |..||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~  210 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELD  210 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh-CCCCccCCc
Confidence            43322111  1234567799999987765   7889999999999999999 999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.1e-33  Score=213.68  Aligned_cols=181  Identities=19%  Similarity=0.257  Sum_probs=150.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     +..+++.||+|.++....      ..+|...+.... |||++++++++.+....+++|||++++
T Consensus         4 g~~~-~v~~~~-----~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVID-KVLLVM-----DTRTQQTFILKGLRKSSE------YSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccc-eEEEEE-----EccCCcEEEEEeecchhh------hhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCC
Confidence            8899 999998     477899999999976432      122333344444 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+.+..             .+++..+..++.|+++||.+||+.|++|+||||+||+++.++.++++|||.+.....
T Consensus        71 ~L~~~l~~~~-------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          71 KLWSHISKFL-------------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             CHHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence            9999986532             478999999999999999999999999999999999999999999999998754432


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ..     .....+..|++||...+..++.++|+||+|+++|+|++ |..|+..
T Consensus       138 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~~~~~  184 (237)
T cd05576         138 SC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLT-GKTLVEC  184 (237)
T ss_pred             cc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHH-Ccchhhc
Confidence            21     12233456999999888888999999999999999999 9887754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-32  Score=216.41  Aligned_cols=196  Identities=28%  Similarity=0.513  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||.+..     ..++..|++|.+.....  ....+..|+..+..+. |+|++++++.+...+..++++||++++
T Consensus        30 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~  100 (286)
T cd06614          30 GASG-EVYKATD-----RATGKEVAIKKMRLRKQ--NKELIINEILIMKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGG  100 (286)
T ss_pred             CCCe-EEEEEEE-----ccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEEEEEEeccCCC
Confidence            6789 9999884     44688999999976544  3446788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       101 ~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614         101 SLTDIITQNF------------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             cHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999997642            2578999999999999999999999999999999999999999999999998764433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...  ......++..|++||.+.+..++.++|+||+|+++|+|++ |..||...+....+
T Consensus       169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~-g~~p~~~~~~~~~~  225 (286)
T cd06614         169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRAL  225 (286)
T ss_pred             chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            221  1122235567999999988888999999999999999999 99999877665444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-33  Score=217.21  Aligned_cols=200  Identities=27%  Similarity=0.516  Sum_probs=164.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.|| .||++..     ..+++.+|+|.+.... .......+.+|+.+++.+. |||++++++++.+.  +..++|+||+
T Consensus        10 g~~~-~vy~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840          10 GTYG-QVYKARN-----KKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             CCCe-EEEEEEE-----CCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEeccc
Confidence            7899 9999984     4568999999998654 3333446778999999998 99999999999888  8899999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      + ++|.+++...            ...+++..++.++.|+++||++||+.|++|+||+|+||++++++.++|+|||.+..
T Consensus        83 ~-~~l~~~~~~~------------~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~  149 (287)
T cd07840          83 D-HDLTGLLDSP------------EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARP  149 (287)
T ss_pred             c-ccHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceee
Confidence            7 4888777542            13688999999999999999999999999999999999999999999999999876


Q ss_pred             ccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...... .......++..|+|||.+.+ ..++.++|+||+|+++++|++ |..||...+..+.+.+
T Consensus       150 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-~~~p~~~~~~~~~~~~  213 (287)
T cd07840         150 YTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEK  213 (287)
T ss_pred             ccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            544321 11222334567999997765 457889999999999999999 9999988776655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-32  Score=212.72  Aligned_cols=202  Identities=25%  Similarity=0.481  Sum_probs=170.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+++.|++|.+.... .......+.+|+..++.++ |||++++.+.+......++++|++++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215          11 GSFG-KVYLVRR-----KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEEEecCC
Confidence            7899 9999994     4568899999997653 3345557889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++.....         ....+++..+..++.|+++||.+||+.|++|+||+|+||++++++.++|+|||.+....
T Consensus        84 ~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          84 GDLSQKIKKQKK---------EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             CcHHHHHHHhhc---------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            999999976431         12468999999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...  .......+++.|+|||...+..++.++|+||+|+++++|++ |..||...+..+..+
T Consensus       155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~  213 (258)
T cd08215         155 STV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT-LKHPFEGENLLELAL  213 (258)
T ss_pred             cCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc-CCCCCCCCcHHHHHH
Confidence            332  11222345677999999888888999999999999999999 999998877665544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-33  Score=216.75  Aligned_cols=199  Identities=29%  Similarity=0.496  Sum_probs=164.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .||++..     ..+++.+++|.+..... ........+|+.+++++. ||+++++++.+.++...++++||+++
T Consensus        10 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118          10 GTYG-VVYKARD-----KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             CCCc-eEEEEEc-----CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEeccCC
Confidence            6789 9999984     56789999999876532 234456788999999998 99999999999999999999999974


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                       ++.+.+...            ...+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        83 -~l~~~l~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          83 -DLYKLIKDR------------QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             -CHHHHHHhh------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence             888877653            1357899999999999999999999999999999999999999999999999887654


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  .......++..|+|||.+.+. .++.++|+||+|+++|++++ |..||...+..+.+.+
T Consensus       150 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~  210 (283)
T cd05118         150 SPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFK  210 (283)
T ss_pred             CCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            432  111223345669999998776 67899999999999999999 9999988877665443

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-32  Score=213.59  Aligned_cols=203  Identities=23%  Similarity=0.460  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc---------cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN---------AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   72 (225)
                      |.|| .||.+...    ..+++.+|+|.+...         .......+..+|+.++.+...|||++++++++..++..+
T Consensus        11 G~~~-~v~~~~~~----~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   85 (269)
T cd08528          11 GAFG-CVYKVRKK----NNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY   85 (269)
T ss_pred             CCCc-eEEEEEEc----CCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence            7899 99999952    125789999988532         122333456778888776445999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEe
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVA  151 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~  151 (225)
                      +++||+++++|.+++.....         ....+++..++.++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+
T Consensus        86 lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          86 IVMDLIEGAPLGEHFNSLKE---------KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             EEEecCCCCcHHHHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            99999999999998865432         22358899999999999999999996 689999999999999999999999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      |||.+.......   ......++..|++||.+.+..++.++|+||+|+++|++++ |..||...+......
T Consensus       157 dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~-g~~p~~~~~~~~~~~  223 (269)
T cd08528         157 DFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLAT  223 (269)
T ss_pred             cccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh-CCCcccccCHHHHHH
Confidence            999987543332   2233445677999999988888999999999999999999 999998776655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-32  Score=216.96  Aligned_cols=192  Identities=27%  Similarity=0.475  Sum_probs=158.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.+....  ..+....+.+|+.++..+. |||++++.+++.+.+..++|+||+.
T Consensus        26 g~~g-~vy~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~   98 (307)
T cd06607          26 GSFG-AVYFARD-----VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCL   98 (307)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeEEEEHHhhC
Confidence            7899 9999984     4568899999986432  3334456889999999998 9999999999999999999999997


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       +++.+.+...            ...+++..+..++.|++.+|.|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus        99 -g~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          99 -GSASDILEVH------------KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             -CCHHHHHHHc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence             5676666532            125789999999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...      ....+++.|+|||.+.   ...++.++|+||+|+++|+|++ |..||.+.+....
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~~~~~  222 (307)
T cd06607         166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSA  222 (307)
T ss_pred             CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCccHHHH
Confidence            221      1234556799999874   3557889999999999999999 9999987766554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-32  Score=216.75  Aligned_cols=197  Identities=27%  Similarity=0.472  Sum_probs=159.4

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      .|.|| .||++.     +..+++.||+|.+...........+.+|+..+.++..|||++++++++...+..+++||++. 
T Consensus        14 ~G~~g-~vy~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-   86 (288)
T cd06616          14 RGAFG-TVNKML-----HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-   86 (288)
T ss_pred             CCCce-EEEEEE-----ECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence            38899 999988     45678999999998665555566788999999998779999999999999999999999986 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      .++.++.......        ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus        87 ~~l~~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          87 ISLDKFYKYVYEV--------LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             CCHHHHHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            5665544321110        123689999999999999999999975 9999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCC---CCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDN---IFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .....   .....+++.|+|||.+.+.   .++.++|+||+|+++++|++ |..||....
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  214 (288)
T cd06616         159 VDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKWN  214 (288)
T ss_pred             ccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh-CCCCchhcc
Confidence            32211   1223456679999998765   57889999999999999999 999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-33  Score=215.16  Aligned_cols=197  Identities=24%  Similarity=0.447  Sum_probs=155.8

Q ss_pred             CcccceeeecCCCCCC--CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPER--GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++......  +......|++|.+.... ......+..|+.++..+. |||++++++++..+...++||||+.
T Consensus         6 G~~~-~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd05078           6 GTFT-KIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIMVQEYVK   82 (258)
T ss_pred             ccch-hheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEEEEecCC
Confidence            8899 99999863211  12235568888876433 233346778888999997 9999999999999899999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc--------eeEe
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC--------CKVA  151 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~--------~~l~  151 (225)
                      +++|.+++....            ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.        ++++
T Consensus        83 ~g~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~  150 (258)
T cd05078          83 FGSLDTYLKKNK------------NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS  150 (258)
T ss_pred             CCcHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence            999999987532            25788899999999999999999999999999999999976554        6899


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      |||.+......      ....++..|+|||.+.+ ..++.++|+||+|+++|++++++.+||...+...
T Consensus       151 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~  213 (258)
T cd05078         151 DPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK  213 (258)
T ss_pred             ccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence            99987543221      12234567999999876 4578899999999999999994367877766554

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=216.22  Aligned_cols=197  Identities=28%  Similarity=0.506  Sum_probs=160.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| +||++..     ..+|+.||+|++..... ......+.+|+..++.+. ||+++++++++.+.+..++++||+. 
T Consensus        10 g~~~-~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835          10 GTYG-VVYKARD-----KLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             CCCe-EEEEEEE-----cCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEeccC-
Confidence            7789 9999984     45789999999875432 222245778999999998 9999999999999999999999995 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...+           ...+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~~l~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          82 LDLKKYMDSSP-----------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             cCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            68988886542           1357899999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...  .......++..|+|||.+.+. .++.++|+||+|+++|+|++ |..||...+..+.
T Consensus       151 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  208 (283)
T cd07835         151 VPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQ  208 (283)
T ss_pred             CCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            221  111222346679999987664 46889999999999999999 9999987766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.4e-33  Score=217.49  Aligned_cols=200  Identities=27%  Similarity=0.476  Sum_probs=167.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..+++.|++|++....  .......+.+|..++.++.+||||+++++++.+++..+++||++.
T Consensus        12 g~~~-~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581          12 GSFS-TVVLAKE-----KETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             CCce-EEEEEEE-----cCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            7899 9999984     4578999999987532  233345677888999888779999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+++++++|||.+...
T Consensus        86 ~~~L~~~l~~~-------------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          86 NGELLQYIRKY-------------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            99999998753             25899999999999999999999999999999999999999999999999998765


Q ss_pred             cCcccc------------------ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        160 MTSSVY------------------ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       160 ~~~~~~------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ......                  .......++..|++||......++.++|+||+|++++++++ |..||...+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~  231 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSNEYLTF  231 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCccHHHHH
Confidence            433321                  11222345677999999888888999999999999999999 99999887754443

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-32  Score=210.15  Aligned_cols=197  Identities=30%  Similarity=0.530  Sum_probs=166.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .||++..     ..+++.|++|.+..... ......+.+|+.++.++. |||++++.+++.+.+..++++|++++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (254)
T cd06627          11 GAFG-VVYKGLN-----LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIILEYAEN   83 (254)
T ss_pred             cCCe-EEEEEEE-----cCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEecCCC
Confidence            7789 9999873     56678999999976543 244557889999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        84 ~~L~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          84 GSLRQIIKKF-------------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             CcHHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999988653             258999999999999999999999999999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .....  .....++..|++||...+...+.++|+||+|++++++++ |..||...+....+
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~~~~~~  208 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAAL  208 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCccHHHHH
Confidence            33221  122345667999999887778899999999999999999 99999876655444

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=214.87  Aligned_cols=200  Identities=28%  Similarity=0.490  Sum_probs=161.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCCC-----eEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEP-----FFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~-----~~l   73 (225)
                      |.|| .||++..     ..+++.||+|.++.... ........+|+.++.++.  .|||++++++++.+...     .++
T Consensus        10 g~~~-~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838          10 GAYG-TVYKARD-----LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             cCce-EEEEEEE-----CCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            7899 9999995     44688999999975432 222334556777666653  39999999999987776     999


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++|++. ++|.+++....           ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+||
T Consensus        84 ~~e~~~-~~l~~~l~~~~-----------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          84 VFEHVD-QDLATYLSKCP-----------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             Eehhcc-cCHHHHHHHcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEecc
Confidence            999997 47888876532           225789999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |.+.........   ....++..|+|||.+.+..++.++|+||+|+++++|++ |.+||.+....+.+.+
T Consensus       152 g~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~-~~~~~~~~~~~~~~~~  217 (287)
T cd07838         152 GLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDK  217 (287)
T ss_pred             CcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh-CCCcccCCChHHHHHH
Confidence            988765333211   12234667999999988889999999999999999999 9999998877665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-32  Score=212.50  Aligned_cols=200  Identities=23%  Similarity=0.445  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||++..     ..+|..||+|.+.... .......+.+|+.+++.++ |+|++++++.+.+.+..++++||+++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (257)
T cd08225          11 GSFG-KIYLAKA-----KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVMEYCDG   83 (257)
T ss_pred             CCcc-eEEEEEE-----cCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEEecCCC
Confidence            7889 9999884     5678889999987542 2233346778999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-ceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-~~~l~d~g~~~~~  159 (225)
                      ++|.+++...           ....+++..+..++.|+++++.+||+.+++|+||+|+||++++++ .++++|||.+...
T Consensus        84 ~~L~~~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          84 GDLMKRINRQ-----------RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             CcHHHHHHhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            9999988653           223478999999999999999999999999999999999998775 5699999988755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .....  ......+++.|+|||.+.+..++.++|+||+|++++++++ |..||...+..+...
T Consensus       153 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~  212 (257)
T cd08225         153 NDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVL  212 (257)
T ss_pred             cCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHH
Confidence            33221  1122346677999999888888999999999999999999 999998776655543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.4e-32  Score=209.65  Aligned_cols=194  Identities=30%  Similarity=0.535  Sum_probs=166.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.+| .||.+..     ..+++.|++|.+.... .......+.+|+..++++. |||++++++.+.+.  ...++++|++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606          11 GSFG-SVYLALD-----KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             cCce-EEEEEEE-----CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEEEEec
Confidence            7889 9999984     4578999999987554 2344567889999999998 99999999999988  8899999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+++....             .+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        84 ~~~~L~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          84 SGGSLSSLLKKFG-------------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             CCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            9999999987532             588999999999999999999999999999999999999999999999999876


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ..............++..|++||.+.+...+.++|+||+|++++++++ |..||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  207 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELG  207 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            544432212334456677999999888888999999999999999999 999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-33  Score=219.89  Aligned_cols=202  Identities=23%  Similarity=0.377  Sum_probs=159.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   77 (225)
                      |.|| .||++.....   ..++.||+|.+....  .........+|+.++..+. |||++++++++.+.  ...++|+||
T Consensus        11 g~~g-~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842          11 GTYG-RVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             CCcE-EEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceEEEEEeC
Confidence            7899 9999995311   268999999998632  1222345678999999998 99999999999888  789999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC----CCceeEeee
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE----NHCCKVADF  153 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~----~~~~~l~d~  153 (225)
                      +. +++.+.+......        ....+++..++.++.|++.||.+||+.+++|+||+|+||+++.    ++.++|+||
T Consensus        86 ~~-~~l~~~~~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          86 AE-HDLWQIIKFHRQA--------KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             CC-cCHHHHHHhhccC--------CCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            97 5677776543211        1236789999999999999999999999999999999999998    889999999


Q ss_pred             cccccccCccc-cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        154 GFARDLMTSSV-YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      |++........ ........+++.|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~  222 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAK  222 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-cCCCCcCCccc
Confidence            99875533322 1112223456779999987764 57889999999999999999 99999876654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4257|consensus

Probab=100.00  E-value=4.8e-33  Score=226.91  Aligned_cols=205  Identities=39%  Similarity=0.826  Sum_probs=177.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+.-- ...+...-.||||..+.+...+..+.+++|..+|+.+. ||||++++|++.+. ..|+|||.++.|
T Consensus       400 GqFG-dVy~gvYt-~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P~WivmEL~~~G  475 (974)
T KOG4257|consen  400 GQFG-DVYKGVYT-DPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-PMWIVMELAPLG  475 (974)
T ss_pred             Cccc-ceeeeEec-ccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-ceeEEEecccch
Confidence            7899 99998642 11133456799999999888888899999999999998 99999999998754 699999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      .|++++...+            ..++...+..++.||+.||.|||+.+.+||||...||++....+|||+|||+++.+..
T Consensus       476 ELr~yLq~nk------------~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  476 ELREYLQQNK------------DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             hHHHHHHhcc------------ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            9999998753            4688899999999999999999999999999999999999999999999999987655


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..... ...+..+.-||+||.+.-..++.++|+|-||+.+||+++.|.-||.+-...|.+-.
T Consensus       544 ~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~  604 (974)
T KOG4257|consen  544 DAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH  604 (974)
T ss_pred             cchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence            54433 33555667799999999999999999999999999999999999999877776543

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.2e-32  Score=214.92  Aligned_cols=194  Identities=25%  Similarity=0.432  Sum_probs=159.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++..     ..++..||+|.+....  ..+....+.+|+..++.+. |||++++++++.+....++||||+.
T Consensus        36 G~~~-~v~~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  108 (317)
T cd06635          36 GSFG-AVYFARD-----VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWLVMEYCL  108 (317)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEEEEeCCC
Confidence            7899 9999884     5678899999986432  2334456788999999998 9999999999999999999999997


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      | ++.+.+...            ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus       109 g-~l~~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         109 G-SASDLLEVH------------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             C-CHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            4 777766542            235789999999999999999999999999999999999999999999999987543


Q ss_pred             cCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..      .....+++.|+|||.+.   ...++.++|+||+|+++++|++ |..||...+..+...
T Consensus       176 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~  234 (317)
T cd06635         176 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALY  234 (317)
T ss_pred             CC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHH
Confidence            22      12334566799999874   3457889999999999999999 999998766555443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4278|consensus

Probab=100.00  E-value=3.2e-33  Score=228.21  Aligned_cols=200  Identities=45%  Similarity=0.813  Sum_probs=176.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||.+-|     ++-..+||||.++.+..+-  +.++.|.++|+.+. |||+++++++|.....+|||.||+..|
T Consensus       278 GQYG-eVYeGvW-----KkyslTvAVKtLKEDtMev--eEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  278 GQYG-EVYEGVW-----KKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             Cccc-ceeeeee-----eccceeeehhhhhhcchhH--HHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEecccCc
Confidence            7899 9999998     5668899999999876543  47999999999999 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      .|.++++++-.           ..++.-.+..++.||.+|++||..++++||||...|+++.++..||+.|||+++.+..
T Consensus       349 NLLdYLRecnr-----------~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  349 NLLDYLRECNR-----------SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             cHHHHHHHhch-----------hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999988632           3467778899999999999999999999999999999999999999999999987655


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ++ ..........+-|.|||.+.-+.++.++|+|+||++|||+.|+|..||.+.+..+++.
T Consensus       418 DT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~  477 (1157)
T KOG4278|consen  418 DT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG  477 (1157)
T ss_pred             Cc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH
Confidence            43 2233334445669999999999999999999999999999999999999999887764

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.6e-32  Score=214.78  Aligned_cols=194  Identities=26%  Similarity=0.466  Sum_probs=159.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.|++|.+....  .......+.+|+.+++.++ |||++++++++.+....+++|||+.
T Consensus        32 g~~g-~v~~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  104 (313)
T cd06633          32 GSFG-AVYFATN-----SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCL  104 (313)
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEEEEecCC
Confidence            7899 9999983     5678999999986542  2333456788999999998 9999999999999999999999996


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       +++.+.+...            ...+++.++..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       105 -~~l~~~l~~~------------~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         105 -GSASDLLEVH------------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             -CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence             5677766542            235789999999999999999999999999999999999999999999999987532


Q ss_pred             cCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..      .....++..|+|||.+.   ...++.++|+||+|+++++|++ |..||...+....+.
T Consensus       172 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~-g~~p~~~~~~~~~~~  230 (313)
T cd06633         172 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALY  230 (313)
T ss_pred             CC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            11      12334567799999874   3557889999999999999999 999998776655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2e-32  Score=216.77  Aligned_cols=200  Identities=23%  Similarity=0.439  Sum_probs=158.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC----------C
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE----------P   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----------~   70 (225)
                      |.|| +||++..     ..+++.||+|.++... .........+|+.++++++ |||++++++++.+..          .
T Consensus        18 g~~g-~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~   90 (302)
T cd07864          18 GTYG-QVYKARD-----KDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGA   90 (302)
T ss_pred             cCCE-EEEEEEE-----CCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhhccccCCc
Confidence            7899 9999994     4568899999987543 2223345678999999998 999999999987654          7


Q ss_pred             eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         71 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      .++++||+++ ++...+...            ...+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|
T Consensus        91 ~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          91 FYLVFEYMDH-DLMGLLESG------------LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             EEEEEcccCc-cHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence            8999999985 666666432            235789999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +|||.+........ ........+..|++||.+.+. .++.++|+||+|+++++|++ |.+||...+..+.+..
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~-g~~~~~~~~~~~~~~~  229 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLEL  229 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            99998875533321 111112335569999987654 46889999999999999999 9999987776655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0579|consensus

Probab=100.00  E-value=9.9e-34  Score=231.57  Aligned_cols=200  Identities=29%  Similarity=0.497  Sum_probs=172.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||++.     ++.++..-|-|.+.-. ..+...+++-|+.|+..+. ||+|+++++.|...+.+|+..|||.||
T Consensus        43 GAFG-KVyKA~-----nket~~lAAaKvIetk-seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   43 GAFG-KVYKAV-----NKETKLLAAAKVIETK-SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             ccch-hhhhhh-----cccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEEEEeecCCc
Confidence            8999 999888     5677777788877543 3455678999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      ....++-..            +..+.+.++.-+++|++.||.|||+++|+|||||..||+++-+|.++|.|||.+...  
T Consensus       115 AVDaimlEL------------~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--  180 (1187)
T KOG0579|consen  115 AVDAIMLEL------------GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--  180 (1187)
T ss_pred             hHhHHHHHh------------ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc--
Confidence            999888653            347899999999999999999999999999999999999999999999999987533  


Q ss_pred             ccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..........-|||.|||||+..     +.+|+..+||||||+.|.+|.. +.+|....++.-++-+|
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRVllKi  247 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKI  247 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHHHHHH
Confidence            22333444566899999999875     5778999999999999999998 99999999888777655

>KOG1006|consensus

Probab=100.00  E-value=1.5e-34  Score=214.31  Aligned_cols=197  Identities=24%  Similarity=0.427  Sum_probs=162.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +|++-.     ++.+|+..|||.+.....+.+..+++.|.....+-...|||+++++..-..+..|+.||.++ .
T Consensus        75 G~fG-~V~KM~-----hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   75 GAFG-TVNKML-----HKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             Ccch-hhhhhh-----cCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            8899 888887     68899999999999887777777889998887777779999999999988999999999996 7


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++..+....-..        ....++|..+..+....+.||.||-+. .|+|||+||+||+++..|.+||||||++..+.
T Consensus       148 SlDklYk~vy~v--------q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  148 SLDKLYKRVYSV--------QKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             hHHHHHHHHHHH--------HhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            777765543211        123689999999999999999999865 89999999999999999999999999997554


Q ss_pred             CccccccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .....   +...|-..|+|||.+..  ..+..+||+||||+.|+|+.| |..|+++.+.
T Consensus       220 ~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt-G~fPyr~w~s  274 (361)
T KOG1006|consen  220 DSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT-GNFPYRKWDS  274 (361)
T ss_pred             HHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeec-CCCCcchHHH
Confidence            33222   22223345999998863  458899999999999999999 9999998765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-32  Score=213.73  Aligned_cols=198  Identities=26%  Similarity=0.496  Sum_probs=162.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| +||++..     ..+++.|++|.+.............+|+..+.++.+|||++++++.+.+++..++||||+ ++
T Consensus        10 g~~g-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   82 (283)
T cd07830          10 GTFG-SVYLARN-----KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG   82 (283)
T ss_pred             CCce-EEEEEEE-----CCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence            7899 9999994     456889999998765443333345678888888877999999999999999999999999 68


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+....           ...+++..+..++.|++++|.+||++|++|+||+|+||++++++.++|+|||.+.....
T Consensus        83 ~l~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          83 NLYQLMKDRK-----------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             CHHHHHHhcc-----------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            8988886542           23578999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...   .....++..|+|||.+.+ ..++.++|+||+|+++++|++ |.+||......+..
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~-g~~~~~~~~~~~~~  208 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQL  208 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh-CCCccCCCChHHHH
Confidence            221   122335567999998754 457889999999999999999 99999877765544

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=221.10  Aligned_cols=200  Identities=26%  Similarity=0.437  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-----CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-----PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (225)
                      |.+| .||++..     ..+++.|++|.+..... ......+.+|+..++.+. |||++++.+++....     ..++++
T Consensus        11 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~   83 (330)
T cd07834          11 GAYG-VVCSAVD-----KRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVT   83 (330)
T ss_pred             CCCe-EEEEEEe-----CCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccceEEEe
Confidence            7899 9999983     56689999999876432 344456888999999998 999999999987765     789999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      +|+. ++|.+.+...             ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        84 e~~~-~~l~~~l~~~-------------~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          84 ELME-TDLHKVIKSP-------------QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cchh-hhHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9997 5787777542             2688999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcccc-ccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        156 ARDLMTSSVY-ERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +......... .......+++.|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+.+..+.++.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~~~~~~  218 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNL  218 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc-CCCCcCCCCHHHHHHH
Confidence            8765443211 112223456679999999877 78999999999999999999 9999998887766554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.8e-32  Score=218.61  Aligned_cols=199  Identities=25%  Similarity=0.470  Sum_probs=157.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.|| .||++..     ..+++.||+|.+... ..........+|+.++.++.+||||+++++++...  ...++|+||+
T Consensus        18 g~~~-~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~   91 (337)
T cd07852          18 GAYG-IVWKAID-----RRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM   91 (337)
T ss_pred             CCCe-eEEEEEE-----cCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence            7899 9999983     456889999988643 22333445778999999994499999999998643  3589999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      . ++|.+++...              .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        92 ~-~~L~~~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          92 E-TDLHAVIRAN--------------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             c-cCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            7 5888877542              467888899999999999999999999999999999999999999999998875


Q ss_pred             ccCcccc---ccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        159 LMTSSVY---ERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       159 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .......   .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t-g~~pf~~~~~~~~~~  223 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLE  223 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            5332211   11122345677999998765 457889999999999999999 999998776655433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-32  Score=218.18  Aligned_cols=192  Identities=26%  Similarity=0.464  Sum_probs=157.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |.|| +||++.     ...+++.||+|.+.... .......+.+|+.+++.+. ||||+++++++....      .+++|
T Consensus        26 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          26 GAYG-TVCSAL-----DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCccccccceEEEE
Confidence            7899 999987     45678999999986432 3333446788999999998 999999999987654      35899


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ++++ +++|..++...              .+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||
T Consensus        99 ~e~~-~~~l~~~~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          99 MPFM-GTDLGKLMKHE--------------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             EecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            9998 67888877532              57899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ++......     .....+++.|++||.+.+ ..++.++|+||+|++++++++ |..||.+.+.....
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~  225 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT-GKPLFKGHDHLDQL  225 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            98654321     122344667999998876 457889999999999999999 99999877665443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-32  Score=212.92  Aligned_cols=199  Identities=30%  Similarity=0.523  Sum_probs=164.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .||.+..     ..+++.|++|.+.... ..........|+..++.+. |||++++++++.+.+..++++|++. 
T Consensus        10 g~~~-~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829          10 GTYG-VVYKARD-----KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             cCcc-eEEEeee-----cCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEecCcC-
Confidence            6789 9999884     5678999999998653 2233345678999999998 9999999999999999999999997 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....            ..+++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++|+|||.+....
T Consensus        82 ~~l~~~i~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          82 MDLKKYLDKRP------------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             cCHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            58999987641            258899999999999999999999999999999999999999999999999886543


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  .......+..|+|||.+.+. .++.++|+||+|++++++++ |.+||...+..+.+.+
T Consensus       150 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~  210 (282)
T cd07829         150 IPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GKPLFPGDSEIDQLFK  210 (282)
T ss_pred             CCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHH
Confidence            3221  11122334569999988766 78899999999999999999 9999988776655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3e-32  Score=214.55  Aligned_cols=196  Identities=23%  Similarity=0.387  Sum_probs=159.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| .||++...  .+...++.||+|.++...   ..........|+.++.++..||+++++++.+......++||||+
T Consensus        11 G~~~-~vy~~~~~--~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (288)
T cd05583          11 GAYG-KVFLVRKV--GGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV   87 (288)
T ss_pred             CCCc-eEEEEEEe--ccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecC
Confidence            7899 99998632  223467889999987532   22333457789999999977999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|.+.+...             ..+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        88 ~~~~L~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          88 NGGELFTHLYQR-------------EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             CCCcHHHHHhhc-------------CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999888642             2578899999999999999999999999999999999999999999999998865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCC--CCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ....... ......++..|++||.+.+..  .+.++|+||+|+++++|++ |..||...
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~  211 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTVD  211 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh-CCCCcccC
Confidence            4332111 112234567799999887654  6789999999999999999 99999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-32  Score=221.30  Aligned_cols=197  Identities=24%  Similarity=0.422  Sum_probs=158.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e   76 (225)
                      |.|| .||++.     ...+++.||+|.+.... .......+.+|+.+++++. ||||+++++++..    ....++|+|
T Consensus        16 g~~g-~v~~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e   88 (334)
T cd07855          16 GAYG-VVCSAI-----DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMD   88 (334)
T ss_pred             CCCe-EEEEEE-----EcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCceEEEEEe
Confidence            7889 999988     45678999999987543 2333456778999999998 9999999998753    346899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+. ++|.+.+...             ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+
T Consensus        89 ~~~-~~l~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          89 LME-SDLHHIIHSD-------------QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             hhh-hhHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence            996 5888777532             25899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccc--cccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        157 RDLMTSSVYE--RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ..........  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~~~  220 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQ  220 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc-CCCccCCCChHHH
Confidence            6543322111  1122345677999998765 457889999999999999999 9999987765443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.7e-32  Score=216.73  Aligned_cols=200  Identities=23%  Similarity=0.375  Sum_probs=157.8

Q ss_pred             CcccceeeecCCCCCCCCcc--ceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREG--PCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv   74 (225)
                      |.|| .||++..     ...  +..||+|.+.... .........+|+.++.++..||||+++++....    ....+++
T Consensus        11 G~~g-~vy~~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857          11 GAYG-IVCSARN-----AETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             cCCe-EEEEEEe-----CCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            7899 9999995     333  7889999987542 222344677899999999679999999987532    2457888


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ++++. .+|.+.+...             ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||
T Consensus        85 ~e~~~-~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg  150 (332)
T cd07857          85 EELME-ADLHQIIRSG-------------QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG  150 (332)
T ss_pred             Eeccc-CCHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCC
Confidence            89885 6888887532             358899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCcccc--ccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        155 FARDLMTSSVY--ERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       155 ~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .+.........  .......+++.|+|||.+.+ ..++.++|+||+|++++++++ |.+||.+.+..+.+.
T Consensus       151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~-g~~pf~~~~~~~~~~  220 (332)
T cd07857         151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKDYVDQLN  220 (332)
T ss_pred             CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCcCCCCCCHHHHHH
Confidence            98754332211  11122346778999998765 467899999999999999999 999998877554443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-32  Score=230.53  Aligned_cols=167  Identities=17%  Similarity=0.269  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHH
Q psy15818         38 ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ  117 (225)
Q Consensus        38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  117 (225)
                      ....+.+|+.++.++. ||||+++++++.+.+..+++++++. +++..++......        .........+..++.|
T Consensus       206 ~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~~i~~q  275 (501)
T PHA03210        206 AAIQLENEILALGRLN-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD--------WKDRPLLKQTRAIMKQ  275 (501)
T ss_pred             HHHHHHHHHHHHHhCC-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc--------ccccccHHHHHHHHHH
Confidence            3445789999999998 9999999999999999999999985 6777766432210        1123346778899999


Q ss_pred             HHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHH
Q psy15818        118 VARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF  197 (225)
Q Consensus       118 l~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl  197 (225)
                      ++.||.|||++||+||||||+||+++.++.++|+|||++..+..... .......++..|+|||++.+..++.++||||+
T Consensus       276 l~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  354 (501)
T PHA03210        276 LLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSC  354 (501)
T ss_pred             HHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence            99999999999999999999999999999999999999875533211 11223457888999999999899999999999


Q ss_pred             HHHHHHHHHcCCCCCCCC
Q psy15818        198 GVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       198 g~ll~~l~~~g~~p~~~~  215 (225)
                      |+++|+|++++.+||.+.
T Consensus       355 Gvil~ell~~~~~p~~~~  372 (501)
T PHA03210        355 GLILLDMLSHDFCPIGDG  372 (501)
T ss_pred             HHHHHHHHHCCCCCccCC
Confidence            999999999455566543

>KOG1025|consensus

Probab=100.00  E-value=2.3e-33  Score=234.52  Aligned_cols=208  Identities=39%  Similarity=0.718  Sum_probs=187.5

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      +|+|| +||++-|.|+ +..-.-+||+|++......+....++.|+..|.++. |||++++++++..+. ..||++|+++
T Consensus       706 sgAfG-tV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~qlvtq~mP~  781 (1177)
T KOG1025|consen  706 SGAFG-TVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQLVTQLMPL  781 (1177)
T ss_pred             cccce-eEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HHHHHHhccc
Confidence            69999 9999999999 666789999999998888777788999999999998 999999999987665 8899999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      |.|.++++.++.            .+.....+.|..||++|+.|||+++++||||-..|+++..-..+|+.|||++..+.
T Consensus       782 G~LlDyvr~hr~------------~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  782 GCLLDYVREHRD------------NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             chHHHHHHHhhc------------cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999998653            57889999999999999999999999999999999999999999999999998887


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ............-.+-|+|-|.+....+++++||||+|+.+||++|.|.-|+.+...+|+-+-+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll  913 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL  913 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH
Confidence            7666666666666677999999999999999999999999999999999999999998876543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-32  Score=217.66  Aligned_cols=193  Identities=27%  Similarity=0.437  Sum_probs=156.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv   74 (225)
                      |.|| .||++..     ..+++.||+|.++... .........+|+.++.+++ ||||+++.+++...      ...+++
T Consensus        28 G~~g-~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv  100 (345)
T cd07877          28 GAYG-SVCAAFD-----TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLV  100 (345)
T ss_pred             cCCe-EEEEEEE-----cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccccccccEEEE
Confidence            7899 9999973     5678899999987542 2233445778999999998 99999999988643      346788


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ++++ +++|.+.+...              .+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||
T Consensus       101 ~~~~-~~~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg  165 (345)
T cd07877         101 THLM-GADLNNIVKCQ--------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  165 (345)
T ss_pred             ehhc-ccCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence            8876 68888777532              47899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||+|+++++|++ |..||...+..+.++
T Consensus       166 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~  228 (345)
T cd07877         166 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLK  228 (345)
T ss_pred             cccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            88643221     122345677999998766 467889999999999999999 999998776655443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0695|consensus

Probab=100.00  E-value=4.3e-33  Score=213.16  Aligned_cols=190  Identities=25%  Similarity=0.435  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|. .|-+++     .+++.+.||+|++++..  ..++..=.+.|-....+..+||+++-++.+|....++++|.||+.
T Consensus       261 gsya-kvl~~~-----~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  261 GSYA-KVLLVR-----LKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             cchh-hhhhee-----hcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            5566 555555     57889999999998753  222333356777788888889999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|--.+++++             +++++.++.+...|.-||.|||++||++||||.+|++++..|.+||.|+|+|...
T Consensus       335 ggdlmfhmqrqr-------------klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  335 GGDLMFHMQRQR-------------KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             Ccceeeehhhhh-------------cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            999987776654             6899999999999999999999999999999999999999999999999999754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      -.+  .....+..+||.|+|||++++..|+.++|+|+||++++||+. |+.||.
T Consensus       402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemma-grspfd  452 (593)
T KOG0695|consen  402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFD  452 (593)
T ss_pred             CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHc-CCCCcc
Confidence            332  223445678999999999999999999999999999999999 999996

>KOG4645|consensus

Probab=100.00  E-value=1.3e-34  Score=251.39  Aligned_cols=199  Identities=27%  Similarity=0.447  Sum_probs=166.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||-+-     +-.+|...|+|.++-+. .......+.+|+.++..+. |||+++++++-......+|.||||++
T Consensus      1246 G~fG-~VYtav-----N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1246 GTFG-KVYTAV-----NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred             ccee-eeEEee-----cCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecHHHHHHHHHHhcc
Confidence            5677 777766     78999999999997543 3344445789999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      |+|.+.+...+             -.++.....+-.|++.|+.+||+.||+||||||.||+++.+|-+|++|||.|..+.
T Consensus      1319 GsLa~ll~~gr-------------i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1319 GSLASLLEHGR-------------IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             CcHHHHHHhcc-------------hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            99999997542             45677788888999999999999999999999999999999999999999998765


Q ss_pred             Ccc--ccccccCCCCCccccCCccccCCC---CCcchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHh
Q psy15818        161 TSS--VYERKSEGRLPIRWMAPESLYDNI---FSVKSDIWSFGVLIWEIVTLGSTPYPGM-AAAEVM  221 (225)
Q Consensus       161 ~~~--~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slg~ll~~l~~~g~~p~~~~-~~~~~~  221 (225)
                      ...  .........||+-|||||++.+..   ...+.|||||||++.||+| |+-||... +...+|
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT-GKRPWAELDNEWAIM 1451 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec-CCCchhhccchhHHH
Confidence            542  223334567899999999998644   5679999999999999999 99999744 344444

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.7e-32  Score=218.09  Aligned_cols=193  Identities=25%  Similarity=0.462  Sum_probs=156.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (225)
                      |+|| +||.+.     +..+++.||+|.+.... .........+|+.+++.+. |||++++++++...     ...++++
T Consensus        16 G~~~-~vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858          16 GAYG-IVCSAK-----NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             CCCe-EEEEEE-----ecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccccccCcEEEEE
Confidence            7899 999988     45678999999987532 2223345678999999997 99999999987654     3479999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+. ++|.+.+...             ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        89 e~~~-~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          89 ELMD-TDLHQIIRSS-------------QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             eCCC-CCHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            9996 6788777542             3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      +.......  .......++..|+|||.+.. ..++.++|+||+|+++++|++ |..||.+.+..
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~  215 (337)
T cd07858         155 ARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYV  215 (337)
T ss_pred             ccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCChH
Confidence            87543321  11222345667999998764 458899999999999999999 99999876543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0596|consensus

Probab=100.00  E-value=3.1e-32  Score=219.31  Aligned_cols=193  Identities=24%  Similarity=0.355  Sum_probs=160.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecc-ccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |..+ .||++.      ..+...||+|.... ..+.....-+..|+..|.++++|.+|+.++|+-..++.+|+|||+= .
T Consensus       372 GGSS-kV~kV~------~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d  443 (677)
T KOG0596|consen  372 GGSS-KVFKVL------NSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-D  443 (677)
T ss_pred             CCcc-eeeeee------cCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-c
Confidence            4556 788888      34556677777654 3455556678999999999999999999999999999999999954 5


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      -||.+.+++..            ..++...++.+..|++.++..+|+.||+|.||||.|+++- .|.+||+|||+|..+.
T Consensus       444 ~DL~kiL~k~~------------~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  444 IDLNKILKKKK------------SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             ccHHHHHHhcc------------CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            89999998742            2334358999999999999999999999999999999986 4569999999999887


Q ss_pred             CccccccccCCCCCccccCCccccCCC-----------CCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-----------FSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .++..--.....||..||+||.+....           .++++|||||||+||+|+. |.+||....
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY-gktPf~~~~  576 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY-GKTPFGQII  576 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh-cCCchHHHH
Confidence            777766677788999999999886432           3568999999999999999 999997543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.5e-32  Score=218.09  Aligned_cols=197  Identities=26%  Similarity=0.449  Sum_probs=156.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-------------
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-------------   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-------------   68 (225)
                      |+|| .||++.     ...+++.||+|.+..... .....+.+|+.+++.++ |||++++++.+...             
T Consensus        16 g~~g-~vy~~~-----~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (342)
T cd07854          16 GSNG-LVFSAV-----DSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTE   87 (342)
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcC-CCcchhhHhhhcccccccccccccccc
Confidence            7899 999998     457789999999865443 33346778999999997 99999999876544             


Q ss_pred             -CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCC
Q psy15818         69 -EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENH  146 (225)
Q Consensus        69 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~  146 (225)
                       ...++++||++ ++|.+.+...              .+++..++.++.|+++||.+||+.|++|+||+|+||+++ +++
T Consensus        88 ~~~~~lv~e~~~-~~L~~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          88 LNSVYIVQEYME-TDLANVLEQG--------------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cceEEEEeeccc-ccHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence             34789999997 5887777432              578999999999999999999999999999999999997 556


Q ss_pred             ceeEeeecccccccCccccc-cccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        147 CCKVADFGFARDLMTSSVYE-RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       147 ~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .++++|||.+.......... ......++..|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~~~  229 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKPLFAGAHELEQMQ  229 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            78999999886543221111 1112235667999997654 457889999999999999999 999998877655544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-32  Score=216.98  Aligned_cols=192  Identities=28%  Similarity=0.464  Sum_probs=154.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |.|| .||++..     ..+++.||+|.++... .......+.+|+.+++.+. ||||+++++++....      .++++
T Consensus        26 g~~g-~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          26 GAYG-SVCSAID-----KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             cCCe-EEEEEEe-----CCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCCCCceEEEE
Confidence            7899 9999983     5678899999986532 2233345788999999997 999999999987543      46999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      +||+. .+|.....               ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||
T Consensus        99 ~e~~~-~~l~~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          99 MPYMQ-TDLQKIMG---------------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             ecccc-cCHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence            99986 46655442               147899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.
T Consensus       163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~-g~~pf~~~~~~~~~~  225 (342)
T cd07879         163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLT  225 (342)
T ss_pred             CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            88643221     112234667999998876 457889999999999999999 999999877655443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.5e-31  Score=211.36  Aligned_cols=192  Identities=26%  Similarity=0.470  Sum_probs=157.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.+++|.+...  .......++.+|+.+++.+. |+|++++.+++......++|+||+.
T Consensus        26 g~~g-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   98 (308)
T cd06634          26 GSFG-AVYFARD-----VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCL   98 (308)
T ss_pred             CCCE-EEEEEEE-----cCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeEEEEEccC
Confidence            7899 9999984     467889999998643  22333446778999999997 9999999999999999999999997


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       +++.+.+...            ...+++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        99 -~~l~~~~~~~------------~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          99 -GSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             -CCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence             5777766532            235789999999999999999999999999999999999999999999999988644


Q ss_pred             cCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...      ....+++.|+|||.+.   ....+.++|+||+|+++++|++ |..||...+..+.
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~  222 (308)
T cd06634         166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSA  222 (308)
T ss_pred             cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc-CCCCCccccHHHH
Confidence            221      2234566799999874   3456789999999999999999 9999977665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-32  Score=218.18  Aligned_cols=193  Identities=27%  Similarity=0.466  Sum_probs=158.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC------eEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------~~lv   74 (225)
                      |.|| +||++..     ..+++.||+|.+.... .......+.+|+.+++++. |||++++.+++.....      .++|
T Consensus        26 g~~g-~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          26 GAYG-QVCSAFD-----TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             CCce-EEEEEEE-----CCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccccccccccEEEE
Confidence            7789 9999984     5678899999986532 2333445778999999997 9999999998866554      8999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      +||+ +++|.+++...              .+++..++.++.|+++||.+||+.|++|+||+|+||++++++.++|+|||
T Consensus        99 ~e~~-~~~L~~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          99 THLM-GADLNNIVKCQ--------------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             EecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence            9998 57898888642              58999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .+......     .....++..|+|||.+.+ ..++.++|+||+|++++++++ |..||.+.+..+.+.
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~  226 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GKTLFPGSDHIDQLK  226 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            98754322     122345667999998765 357889999999999999999 999998877665544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-31  Score=210.78  Aligned_cols=191  Identities=24%  Similarity=0.474  Sum_probs=155.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.||+|.++.............|+..+....+|||++++++++.+....+++|||+. +
T Consensus        26 g~~~-~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   98 (296)
T cd06618          26 GTCG-QVYKMRF-----KKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T   98 (296)
T ss_pred             cCCe-EEEEEEE-----CCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence            7899 9999984     4568999999998655444455667777777777679999999999999999999999985 5


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++.+++...            ...+++..+..++.|++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....
T Consensus        99 ~l~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          99 CLDKLLKRI------------QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             CHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            777776542            1257889999999999999999997 599999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCCC----CCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ....   .....++..|+|||.+.+..    ++.++|+||+|+++|+|++ |..||...
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~  221 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNC  221 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh-CCCCCCcc
Confidence            3221   12223556799999887553    6789999999999999999 99999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.4e-32  Score=213.94  Aligned_cols=200  Identities=26%  Similarity=0.452  Sum_probs=156.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--------CCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--------EPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~~~~   72 (225)
                      |.|| .||++..     ..+++.||+|.+..... ........+|+.+++.+. ||||+++++.+.+.        ..++
T Consensus        19 g~~~-~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~   91 (311)
T cd07866          19 GTFG-EVYKARQ-----IKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVY   91 (311)
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccccccCceEE
Confidence            7899 9999983     56788999999865432 222235678999999998 99999999987543        3469


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      ++++|+. .++...+...            ...+++..+..++.|+++||.+||+.|++|+||+|+||++++++.++|+|
T Consensus        92 lv~~~~~-~~l~~~~~~~------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          92 MVTPYMD-HDLSGLLENP------------SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             EEEecCC-cCHHHHHhcc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence            9999986 5676666432            23589999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCcccccc---------ccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        153 FGFARDLMTSSVYER---------KSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ||.+...........         .....+++.|+|||.+.+. .++.++|+||+|+++++|++ |.+||.+.+..+...
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~-g~~~~~~~~~~~~~~  237 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKSDIDQLH  237 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            998875433221111         1122345679999987654 47889999999999999999 999998877665443

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0669|consensus

Probab=99.98  E-value=8.9e-34  Score=208.97  Aligned_cols=202  Identities=26%  Similarity=0.444  Sum_probs=168.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecc-ccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--------CCCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--------KEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--------~~~~~   72 (225)
                      |.|| +|++++     .+.+|+.||+|+... +.++..-....+|+.++..+. |+|++.++..|..        .+.++
T Consensus        28 Gtfg-eVFkAr-----~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r~r~t~y  100 (376)
T KOG0669|consen   28 GTFG-EVFKAR-----SKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNRDRATFY  100 (376)
T ss_pred             chHH-HHHHHh-----hcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcccccceee
Confidence            7899 999998     578899999998653 344444456889999999999 9999999888632        23589


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +||++|+ -+|.-++..            ....++..++..++.++++||.|+|...|+|||+|+.|++++.++.++|.|
T Consensus       101 lVf~~ce-hDLaGlLsn------------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen  101 LVFDFCE-HDLAGLLSN------------RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             eeHHHhh-hhHHHHhcC------------ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeec
Confidence            9999996 788888854            234689999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCcccc--ccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||+++.++.....  .+.+....|..|.+||.+.|. .+++..|+|+.||++.+|++ +++.+++.+++..+..|
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt-rspimqgnteqqql~~I  241 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT-RSPIMQGNTEQQQLHLI  241 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc-cCccccCChHHHHHHHH
Confidence            9999765444322  233334457789999988875 58999999999999999999 99999999999888765

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=2.4e-31  Score=210.12  Aligned_cols=196  Identities=14%  Similarity=0.249  Sum_probs=141.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHH----------HHHHHHHHHHhhcCCCCCeeeeeeEEecCC--
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERER----------LDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   69 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--   69 (225)
                      |+|| +||++.....  ...+..+|+|...........          .....+...+..+. |+++++++++.....  
T Consensus        23 G~fG-~Vy~~~~~~~--~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~   98 (294)
T PHA02882         23 GGFG-CVYETQCASD--HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKYYGCGSFKRCR   98 (294)
T ss_pred             CCCc-eEEEEEEcCC--cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcEEEeeeEecCC
Confidence            8999 9999985211  111556777764332211100          01122233444565 999999998765433  


Q ss_pred             --CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc
Q psy15818         70 --PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC  147 (225)
Q Consensus        70 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~  147 (225)
                        ..+++++++. .++.+.+...             ...++..+..++.|++.||.+||+.+++||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~~~-~~~~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         99 MYYRFILLEKLV-ENTKEIFKRI-------------KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             ceEEEEEEehhc-cCHHHHHHhh-------------ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence              2367777764 4666665432             13577889999999999999999999999999999999999999


Q ss_pred             eeEeeecccccccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        148 CKVADFGFARDLMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ++|+|||++.........     .......+|+.|+|||...+..++.++|+||+|+++++|++ |..||.+..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~-g~~P~~~~~  237 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG-IKLPWKGFG  237 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCccc
Confidence            999999998755322111     11223457889999999998899999999999999999999 999998773

>KOG0200|consensus

Probab=99.98  E-value=2.1e-31  Score=227.91  Aligned_cols=222  Identities=48%  Similarity=0.822  Sum_probs=181.0

Q ss_pred             CcccceeeecCCCCCCCC--ccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGR--EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| .||++........  .....||||.++......+...+..|+..+..+..|||++.+++++...+..++|.||+.
T Consensus       307 g~fG-~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~  385 (609)
T KOG0200|consen  307 GAFG-QVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAE  385 (609)
T ss_pred             cccc-ceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEecc
Confidence            7899 9999986544433  247899999999887778888999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhccc-CCCC--CCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNM-HGKS--NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      .|+|..+++..+.......- ....  ..++..++..++.||+.|++||++..++||||...||++.++..+|++|||++
T Consensus       386 ~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGla  465 (609)
T KOG0200|consen  386 HGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLA  465 (609)
T ss_pred             CCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccce
Confidence            99999999988711000000 0011  23889999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCC-CCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEG-RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA-AAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~-~~~~~~~i  224 (225)
                      +.............. ..+..|||||.+....++.++|+||+|++|||++++|..||.+.. ..++++.+
T Consensus       466 r~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l  535 (609)
T KOG0200|consen  466 RDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL  535 (609)
T ss_pred             eccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence            855444333322221 244569999999999999999999999999999999999999865 55555443

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=5.3e-31  Score=211.18  Aligned_cols=188  Identities=28%  Similarity=0.435  Sum_probs=154.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (225)
                      |.|| .||++.     ...+++.||+|.+.... .......+.+|+.++..+. |||++++.+++.. ....++++||+ 
T Consensus        21 g~~g-~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          21 GAFG-LVCSAR-----DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCcEEEEeehh-
Confidence            7899 999998     45678999999876432 2233446778999999998 9999999999875 55789999998 


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...              .+++..+..++.|+++||.+||+.+++|+||+|+||++++++.++|+|||.+...
T Consensus        93 ~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          93 GTDLHRLLTSR--------------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             ccCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            46888777532              4688889999999999999999999999999999999999999999999988643


Q ss_pred             cCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...     .....+++.|++||.+.+ ..++.++|+||+|+++++|++ |..||.....
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~~f~~~~~  211 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE-GKPLFPGKDH  211 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh-CCCCCCCCCH
Confidence            221     122234567999998765 567899999999999999999 9999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0671|consensus

Probab=99.98  E-value=7.2e-33  Score=214.12  Aligned_cols=193  Identities=23%  Similarity=0.305  Sum_probs=158.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCC-----CCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-----HPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~-----~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| .|-.+..     ++.+..||||+++.-  ...++..+-|+..+.++..     --.++.+.+||+..+..|+|+|
T Consensus       100 GtFG-kV~ec~D-----~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe  171 (415)
T KOG0671|consen  100 GTFG-KVVECWD-----RETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE  171 (415)
T ss_pred             Cccc-ceEEEee-----cCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence            7888 6666663     455899999999753  3344567888998888842     2367888999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC------------
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE------------  144 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~------------  144 (225)
                      .+ |.++.+++..+.           -.+++...++.+++|+++++++||+.+++|.||||+||++.+            
T Consensus       172 ll-G~S~~dFlk~N~-----------y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  172 LL-GLSTFDFLKENN-----------YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cc-ChhHHHHhccCC-----------ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            88 689999997652           346889999999999999999999999999999999999821            


Q ss_pred             --------CCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        145 --------NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       145 --------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                              +..|+++|||.|.....     .......|..|+|||++.+-.++..+|+||+||+|+|+.+ |...|++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt-G~~LFqtHe  313 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT-GETLFQTHE  313 (415)
T ss_pred             cceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeec-cceecccCC
Confidence                    23589999999864322     2234455777999999999999999999999999999999 999999888


Q ss_pred             HHHH
Q psy15818        217 AAEV  220 (225)
Q Consensus       217 ~~~~  220 (225)
                      ..|-
T Consensus       314 n~EH  317 (415)
T KOG0671|consen  314 NLEH  317 (415)
T ss_pred             cHHH
Confidence            7773

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=5.5e-31  Score=204.33  Aligned_cols=202  Identities=27%  Similarity=0.441  Sum_probs=158.1

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeecc---c-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKE---N-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~---~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      .|.|| .||++...     ..+..+++|..+.   . ..........+|+.++..+. |||++++++++.+....++++|
T Consensus        10 ~g~~g-~v~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222          10 KGSFG-TVYLVKDK-----KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             CCCCc-eEEEEEec-----CCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEEEEE
Confidence            38899 99998752     3333344444432   2 22333345677888999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+++++|...+.....         ....+++..++.++.|+++|+.+||+.|++|+||+|+||++++ +.++|+|||.+
T Consensus        83 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          83 YCEGRDLDCKLEELKH---------TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             eCCCCCHHHHHHHHhh---------cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCce
Confidence            9999999998875432         1236899999999999999999999999999999999999975 56999999988


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ........  ......+++.|++||...+..++.++|+||+|+++++|++ |..||......+...
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~  215 (260)
T cd08222         153 RLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFLSVVL  215 (260)
T ss_pred             eecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHH
Confidence            65433221  1122345667999999888888899999999999999999 999998766655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.3e-30  Score=224.22  Aligned_cols=136  Identities=24%  Similarity=0.394  Sum_probs=120.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++...  .......+.+|+.++..+. ||||+++++.+...+..++||||+.
T Consensus        15 G~fg-~Vy~a~~-----~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lVmEy~~   87 (669)
T cd05610          15 GAFG-KVYLGRK-----KNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLVMEYLI   87 (669)
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEEEeCCC
Confidence            8899 9999994     5678999999997542  3344456788999999987 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      |++|.+++...             ..+++..++.++.|++.||.|||..+|+|+||||+||+++.++.++|+|||++.
T Consensus        88 g~~L~~li~~~-------------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          88 GGDVKSLLHIY-------------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999998643             247889999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0664|consensus

Probab=99.97  E-value=3.2e-33  Score=208.44  Aligned_cols=200  Identities=24%  Similarity=0.425  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-----eEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----FFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~   75 (225)
                      |+|| .||.+.     ...+|+.||+|.+..- ..-....++.+|+..+..++ |.|++..+|.....+.     +|++.
T Consensus        64 GAFG-VVWsVT-----DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   64 GAFG-VVWSVT-----DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             ccee-EEEecc-----CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHHHH
Confidence            8999 999999     4778999999998642 23333457889999999998 9999999998766543     56777


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      |.+. ++|..++.+             ...++...+.-+++||+.||+|||+.+|+||||||.|.+++.+-..|+||||+
T Consensus       137 ELmQ-SDLHKIIVS-------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVS-------------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHH-hhhhheecc-------------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccc
Confidence            8774 788777754             34689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++...... ....+....|..|++||++.|. .|+.+.||||+||++.|++. .+..|+..++-+.+..|
T Consensus       203 ARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~lI  270 (449)
T KOG0664|consen  203 ARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQMI  270 (449)
T ss_pred             ccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh-hhhhhhccChHHHHHHH
Confidence            97543322 1222233345679999999975 58999999999999999998 99999988888777654

>KOG3653|consensus

Probab=99.97  E-value=3.7e-31  Score=209.56  Aligned_cols=178  Identities=28%  Similarity=0.506  Sum_probs=150.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHh--hcCCCCCeeeeeeEEecCC----CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMK--TLDPHPNVVRLLGCCTEKE----PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~--~~~~~~~i~~~~~~~~~~~----~~~lv~   75 (225)
                      |-|| +||++..       .++.||||+++....    ..+..|-+++.  .++ |+||+++++.-....    .++||+
T Consensus       221 Grfg-~V~KaqL-------~~~~VAVKifp~~~k----qs~~~Ek~Iy~lp~m~-h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  221 GRFG-CVWKAQL-------DNRLVAVKIFPEQEK----QSFQNEKNIYSLPGMK-HENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             Cccc-eeehhhc-------cCceeEEEecCHHHH----HHHHhHHHHHhccCcc-chhHHHhhchhccCCccccceeEEe
Confidence            8899 9999995       469999999986443    34566665555  455 999999998855444    799999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCEEecCCC
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---------GIIHRDLAARNVLIGENH  146 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~---------~i~h~dl~~~nil~~~~~  146 (225)
                      +|.+.|+|.+++..+              .++.....+++..++.||+|||+.         .|.|||||..||++-++.
T Consensus       288 ~fh~kGsL~dyL~~n--------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN--------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             eeccCCcHHHHHHhc--------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            999999999999875              589999999999999999999964         599999999999999999


Q ss_pred             ceeEeeecccccccCccccccccCCCCCccccCCccccCCCC-C-----cchhHHHHHHHHHHHHH
Q psy15818        147 CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-S-----VKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       147 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~-----~~~Di~slg~ll~~l~~  206 (225)
                      +..|+|||++..+..+..........||.+|||||++.+... .     .+.||||+|.+|||+++
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S  419 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS  419 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence            999999999998876666566666789999999999987542 2     36999999999999987

>KOG0587|consensus

Probab=99.97  E-value=9.9e-31  Score=219.96  Aligned_cols=198  Identities=26%  Similarity=0.485  Sum_probs=170.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe-----cCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-----EKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e   76 (225)
                      |.+| .||+++     ++++++..|+|+.......+.  .+..|.++++....|||++.++++|.     .++.+|||||
T Consensus        30 Gtyg-kv~k~k-----~~~~~~~aa~kI~~~~~d~de--EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME  101 (953)
T KOG0587|consen   30 GTYG-KVYKGR-----HVKTGQLAAIKIMDPTEDEEE--EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME  101 (953)
T ss_pred             ccce-eEEEEe-----eeecCceeeeEeecCCccccH--HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence            7889 899988     688999999999987665544  57778888999989999999999984     3567999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ||.||+.-++++...           +..+.|+.+..+++.++.|+.+||.+.++|||||-.||+++.++.|||+|||.+
T Consensus       102 fC~gGSVTDLVKn~~-----------g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTK-----------GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             ccCCccHHHHHhhhc-----------ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence            999999999998753           456899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..+  +....+..+.-|||.|||||++..     ..|+.++|+||||++..||.. |.+|+-+..+.-.+
T Consensus       171 aQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHPmraL  237 (953)
T KOG0587|consen  171 AQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHPMRAL  237 (953)
T ss_pred             eee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC-CCCCccCcchhhhh
Confidence            654  333445566778999999998864     336779999999999999998 99999988776554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2.8e-30  Score=197.47  Aligned_cols=195  Identities=32%  Similarity=0.599  Sum_probs=164.0

Q ss_pred             cccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCC
Q psy15818          3 CFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK   82 (225)
Q Consensus         3 ~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (225)
                      +|| .||++..     ..+++.+++|.+...........+.+|+..+.+++ |++++++.+.+......++++|++.+++
T Consensus         1 ~~g-~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFG-KVYLARD-----KKTGKLVAIKVIKKEKIKKKRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             Cce-EEEEEEE-----CCCCcEEEEEEecccccccHHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            478 9999985     45689999999976544332567889999999996 9999999999999999999999999889


Q ss_pred             HHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCc
Q psy15818         83 LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS  162 (225)
Q Consensus        83 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  162 (225)
                      |.+++....             .++...++.++.+++.++.+||+.+++|+||+|+||++++++.++++|||.+......
T Consensus        74 L~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       74 LFDLLKKRG-------------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             HHHHHHhcc-------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            999987532             2788999999999999999999999999999999999999999999999998765443


Q ss_pred             cccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHh
Q psy15818        163 SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG-MAAAEVM  221 (225)
Q Consensus       163 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~-~~~~~~~  221 (225)
                      .   ......++..|++||.+.+..++.++|+||+|++++++++ |..||.. .+...+.
T Consensus       141 ~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~  196 (244)
T smart00220      141 G---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT-GKPPFPGDDQLLELF  196 (244)
T ss_pred             c---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Confidence            2   2223345567999999988888899999999999999999 9999987 4444433

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668|consensus

Probab=99.97  E-value=5.4e-31  Score=191.83  Aligned_cols=194  Identities=22%  Similarity=0.399  Sum_probs=157.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~   79 (225)
                      |.|+ +|+.+.     +..+.+.+++|++++-.    ...+.+|+.+++.+.++|||++++|+..++  ....+++||..
T Consensus        49 GKYS-EVFeg~-----~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~  118 (338)
T KOG0668|consen   49 GKYS-EVFEGI-----NITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN  118 (338)
T ss_pred             ccHh-hHhccc-----ccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence            6677 777776     56788899999998633    335889999999999999999999998764  45789999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeeccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARD  158 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~  158 (225)
                      +.+...+..                .++...+..++.++++||.|+|+.||.|||+||.|++++. ....+|+|+|+|..
T Consensus       119 n~Dfk~ly~----------------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  119 NTDFKQLYP----------------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             cccHHHHhh----------------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence            998887775                3788899999999999999999999999999999999984 45689999999987


Q ss_pred             ccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..+....   .....+..|-.||.+.+ +.++.+-|+||+||++..|+....+.|.|.+..+++-+|
T Consensus       183 YHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  183 YHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             cCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            6554322   22233445889998886 457899999999999999999444445677777776554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=7.9e-30  Score=193.18  Aligned_cols=202  Identities=31%  Similarity=0.556  Sum_probs=165.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| +||++..     ..+++.+++|.+...........+.+|+..+..+. |+|++++++.+......++++|+++++
T Consensus        10 g~~~-~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221       10 GAFG-KVYLARD-----KGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEeccCCC
Confidence            6789 9999984     45688999999986544334557888999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+....            ..+++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.....
T Consensus        83 ~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       83 DLFDYLRKKG------------GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             CHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            9999987642            1168899999999999999999999999999999999999999999999998876543


Q ss_pred             ccccccccCCCCCccccCCccc-cCCCCCcchhHHHHHHHHHHHHHcCCCCCCC--CCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESL-YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG--MAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~--~~~~~~~~~i  224 (225)
                      ... .......++..|++||.+ ....++.++|+|++|++++++++ |..||..  .+..++.+.|
T Consensus       151 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      151 DLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             ccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHHH
Confidence            320 011223345569999988 56677889999999999999999 9999977  4444666554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152|consensus

Probab=99.97  E-value=9.2e-32  Score=217.59  Aligned_cols=189  Identities=23%  Similarity=0.381  Sum_probs=158.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hH------HHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCCCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ER------ERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~------~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~   72 (225)
                      |+|| .|+++..     ++...-|++|.+.+..- .+      ..-.+-.|+.+|..++  .|+||++++++|++++.+|
T Consensus       572 GAyG-kV~lai~-----K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  572 GAYG-KVNLAIH-----KENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             cccc-eEEEeee-----cccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            8999 9999994     56677899999875421 11      1111446889988876  6999999999999999999


Q ss_pred             EEEeecC-CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEe
Q psy15818         73 VIMEYVP-YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVA  151 (225)
Q Consensus        73 lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~  151 (225)
                      |++|... |.+|.+++..+             +.++|.++..+++|++.|+++||+.||+|||||-+|++++.+|.+||+
T Consensus       646 l~te~hg~gIDLFd~IE~k-------------p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFK-------------PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             EEecCCCCCcchhhhhhcc-------------CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence            9999753 67899999765             368999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      |||.+.....++    .....||..|.|||++.|.+| +..-|||++|++||.++. ...||..
T Consensus       713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy-kenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY-KENPYYN  771 (772)
T ss_pred             eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe-ccCCCcC
Confidence            999986543333    345567788999999999887 667999999999999998 9999864

>KOG1035|consensus

Probab=99.97  E-value=7.4e-31  Score=227.01  Aligned_cols=200  Identities=26%  Similarity=0.465  Sum_probs=157.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-------------
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-------------   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-------------   68 (225)
                      |.|| .||+++     ++-+|+-||||+++.........++.+|+..+.++. |||+++++..+.+.             
T Consensus       490 GGFG-~VvkVR-----NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~~ei~~~~  562 (1351)
T KOG1035|consen  490 GGFG-SVVKVR-----NKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTVLEIVASD  562 (1351)
T ss_pred             CCCc-eEEEEe-----ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCccccccccccc
Confidence            8999 999999     689999999999987666667778999999999998 99999998653110             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15818         69 --------------------------------------------------------------------------------   68 (225)
Q Consensus        69 --------------------------------------------------------------------------------   68 (225)
                                                                                                      
T Consensus       563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~  642 (1351)
T KOG1035|consen  563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL  642 (1351)
T ss_pred             hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence                                                                                            


Q ss_pred             --------------------------CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHH
Q psy15818         69 --------------------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM  122 (225)
Q Consensus        69 --------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (225)
                                                ..+||-||||+...+.++++.+..            .-.....|+++++|++||
T Consensus       643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~------------~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF------------NSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc------------chhhHHHHHHHHHHHHHH
Confidence                                      013677888887777777766421            004678999999999999


Q ss_pred             HHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc----------------CccccccccCCCCCccccCCccccCC
Q psy15818        123 QFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM----------------TSSVYERKSEGRLPIRWMAPESLYDN  186 (225)
Q Consensus       123 ~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~----------------~~~~~~~~~~~~~~~~~~~PE~~~~~  186 (225)
                      .|+|++||+||||||.|||+++++.|||+|||++....                ..+.....+...||.-|+|||.+.+.
T Consensus       711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999999999999999999997621                00111133455678889999998764


Q ss_pred             C---CCcchhHHHHHHHHHHHHHcCCCCCC-CCCHHHHhhhc
Q psy15818        187 I---FSVKSDIWSFGVLIWEIVTLGSTPYP-GMAAAEVMKKS  224 (225)
Q Consensus       187 ~---~~~~~Di~slg~ll~~l~~~g~~p~~-~~~~~~~~~~i  224 (225)
                      .   |+.++|+||||++++||+.    ||. .+....+++++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~L  828 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNL  828 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhc
Confidence            4   8999999999999999986    464 44444555444

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.2e-29  Score=228.81  Aligned_cols=176  Identities=23%  Similarity=0.388  Sum_probs=146.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++..     ..+++.||+|.+......     ...|+..+.+++ ||||+++++++.+.+..++||||++++
T Consensus       701 G~~g-~Vy~~~~-----~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        701 GKKG-ASYKGKS-----IKNGMQFVVKEINDVNSI-----PSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             CCCe-eEEEEEE-----CCCCcEEEEEEccCCccc-----cHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            8899 9999984     567899999998653322     124577888887 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS---SRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh---~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.++++.                +++..+..++.|+++|++|||   +.+++||||||+||+++.++..++. ++....
T Consensus       769 ~L~~~l~~----------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        769 NLSEVLRN----------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             cHHHHHhc----------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            99999852                678889999999999999999   6699999999999999988877764 444322


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      ..      ......+++.|+|||.+.+..++.++||||+|+++|||++ |..||.
T Consensus       832 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t-g~~p~~  879 (968)
T PLN00113        832 LC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT-GKSPAD  879 (968)
T ss_pred             cc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHh-CCCCCC
Confidence            11      1122245678999999998889999999999999999999 999985

>KOG1027|consensus

Probab=99.97  E-value=7.2e-31  Score=219.81  Aligned_cols=197  Identities=28%  Similarity=0.389  Sum_probs=161.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+-|+.||++.       -.|+.||||++..    +....+.+|+..++.-..||||++++..-.+.+..||..|.|. -
T Consensus       520 Gs~Gt~Vf~G~-------ye~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~  587 (903)
T KOG1027|consen  520 GSNGTVVFRGV-------YEGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C  587 (903)
T ss_pred             CCCCcEEEEEe-------eCCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence            66677788887       5688999999864    3333578999999998899999999999888999999999996 7


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-----CCceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-----NHCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-----~~~~~l~d~g~~  156 (225)
                      +|.+++.... .+        .....-...+..+.|+++||++||+.+|+||||||.||+|+.     ..+++|+|||++
T Consensus       588 sL~dlie~~~-~d--------~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  588 SLQDLIESSG-LD--------VEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             hHHHHHhccc-cc--------hhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            8999997641 00        001122567888999999999999999999999999999964     247899999999


Q ss_pred             ccccCcc-ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        157 RDLMTSS-VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       157 ~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ..+..+. ...+.....||-+|+|||++.....+.++||||+||++|+.+++|..||.+.-..+
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~  722 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ  722 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh
Confidence            9876654 33345566788899999999998888999999999999999998899998765553

>KOG2052|consensus

Probab=99.97  E-value=1.3e-29  Score=199.57  Aligned_cols=178  Identities=26%  Similarity=0.468  Sum_probs=145.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhc-CCCCCeeeeeeEEecCC----CeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL-DPHPNVVRLLGCCTEKE----PFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~----~~~lv~e   76 (225)
                      |-|| +||+++|       -|..||||++...++    ..+.+|.++++.+ -+|+||+.++..=..+.    .+|||.+
T Consensus       222 GRyG-EVwrG~w-------rGe~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  222 GRFG-EVWRGRW-------RGEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             cccc-ceeeccc-------cCCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            7899 9999996       388999999975433    3578888887752 25999999988743322    4899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEecCCCce
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR--------GIIHRDLAARNVLIGENHCC  148 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--------~i~h~dl~~~nil~~~~~~~  148 (225)
                      |.+.|+|.+++.+.              .++.+...+++..+++||++||..        .|.|||||..||++-.++.+
T Consensus       290 YHe~GSL~DyL~r~--------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  290 YHEHGSLYDYLNRN--------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             cccCCcHHHHHhhc--------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            99999999999874              589999999999999999999953        49999999999999999999


Q ss_pred             eEeeecccccccCcc--ccccccCCCCCccccCCccccCCCC------CcchhHHHHHHHHHHHH
Q psy15818        149 KVADFGFARDLMTSS--VYERKSEGRLPIRWMAPESLYDNIF------SVKSDIWSFGVLIWEIV  205 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~------~~~~Di~slg~ll~~l~  205 (225)
                      .|.|+|+|.......  .-.......||.+|||||++.....      -..+||||||.++||+.
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            999999997654432  3334556779999999999865332      13699999999999985

>KOG1024|consensus

Probab=99.96  E-value=1.4e-29  Score=197.03  Aligned_cols=217  Identities=31%  Similarity=0.500  Sum_probs=182.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEE-ecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~   80 (225)
                      |.|| .||.+.|+..+.--+.+.|-+|..+...++-....+.+|...+..+. |||++.+.++. ++....++++++..-
T Consensus       295 GtFG-ri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~~~P~V~y~~~~~  372 (563)
T KOG1024|consen  295 GTFG-RIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDYATPFVLYPATGV  372 (563)
T ss_pred             Cchh-heeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeeccCcceEEEeccCc
Confidence            8999 99999998887777788899999999888888888999999999998 99999999986 456678889999988


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +.|-.++...+..+-.     ....++..++..++.|+..|+++||..|++|.||...|+++++..+|||+|-.+++.+.
T Consensus       373 gNLK~FL~~Cr~~~~~-----~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF  447 (563)
T KOG1024|consen  373 GNLKSFLQICRGDDPS-----YAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLF  447 (563)
T ss_pred             chHHHHHHHhccCCCc-----cccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccC
Confidence            9999999866543311     23456778889999999999999999999999999999999999999999988887554


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhcC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK  225 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i~  225 (225)
                      +.....--.....+..||+||.+....++.++|+||||+++|||+|.|..|+-..++.|+..-+|
T Consensus       448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            33322211122234569999999999999999999999999999999999999999999875543

>KOG0670|consensus

Probab=99.96  E-value=9.1e-31  Score=209.75  Aligned_cols=197  Identities=23%  Similarity=0.398  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC-----CCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| +|-+|.     ....|..||||++..+..-.  ..=++|+.+|.+|.     .--+++.++.+|...+.+|+|||
T Consensus       443 GvFs-~Vvra~-----D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE  514 (752)
T KOG0670|consen  443 GVFS-TVVRAR-----DQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE  514 (752)
T ss_pred             ceee-eeeecc-----ccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence            7889 887777     45667799999998653211  13567899999886     23388999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEeeecc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGF  155 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g~  155 (225)
                      .+. ..|.+.+++.          +.+..+....+..|+.|++-||..|-..|++|.||||+||++.++ ...||||||.
T Consensus       515 ~Ls-lNLRevLKKy----------G~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  515 PLS-LNLREVLKKY----------GRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hhh-chHHHHHHHh----------CcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            885 8899999764          356678999999999999999999999999999999999999865 5679999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      |...+..    ..+....+..|.|||++.|-+|+...|+||+||.|||+.| |...|+|.+..++++
T Consensus       584 A~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYt-GkIlFpG~TNN~MLr  645 (752)
T KOG0670|consen  584 ASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYT-GKILFPGRTNNQMLR  645 (752)
T ss_pred             ccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeec-cceecCCCCcHHHHH
Confidence            8654322    2222233446999999999999999999999999999999 999999999988875

>KOG1345|consensus

Probab=99.96  E-value=1.6e-30  Score=193.44  Aligned_cols=186  Identities=22%  Similarity=0.425  Sum_probs=150.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeE-EecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC-CTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-~~~~~~~~lv~e~~~~   80 (225)
                      |.|| .+-+++     |+.++..+++|.++.....  ..++.+|...--.++.|.||+..+++ |+..+.+++++||++.
T Consensus        35 G~Fg-kIlL~e-----Hr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~  106 (378)
T KOG1345|consen   35 GRFG-KILLAE-----HRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPR  106 (378)
T ss_pred             ccee-eEEeee-----ccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCcc
Confidence            7788 888887     6888999999998764433  33688898877778889999998877 7888899999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CCCceeEeeeccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADFGFARD  158 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~~~~~l~d~g~~~~  158 (225)
                      |+|.+-+.              ...+.|..-..++.|+++|+.|||+++++|||||.+||++-  +..+|||||||....
T Consensus       107 gdL~snv~--------------~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  107 GDLRSNVE--------------AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             chhhhhcC--------------cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence            99987663              34688999999999999999999999999999999999994  445899999998764


Q ss_pred             ccCccccccccCCCCCccccCCccccC---C--CCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYD---N--IFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~---~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      .+..     ......+..|.+||....   .  ...+++|+|+||+++|.++| |.+||+..
T Consensus       173 ~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt-G~~PWQka  228 (378)
T KOG1345|consen  173 VGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT-GKFPWQKA  228 (378)
T ss_pred             cCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec-CCCcchhh
Confidence            3222     122223344899986642   2  23678999999999999999 99999844

>KOG1151|consensus

Probab=99.96  E-value=5.8e-29  Score=196.60  Aligned_cols=194  Identities=27%  Similarity=0.435  Sum_probs=158.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe-cCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG------ERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv   74 (225)
                      |.|+ .||++-.     -..++.||||+-..+..      ........+|-.+.+.+. ||.|++++|+|. +...+|-|
T Consensus       474 GGFS-EVyKAFD-----l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  474 GGFS-EVYKAFD-----LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             ccHH-HHHHhcc-----cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeeeccccceee
Confidence            7899 9999983     56788999999754432      233344678999999998 999999999996 56679999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCEEecC---CCcee
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR--GIIHRDLAARNVLIGE---NHCCK  149 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--~i~h~dl~~~nil~~~---~~~~~  149 (225)
                      +|||+|-+|.=+++.++             .+++.+++.|+-||+.||.||.+.  -|+|-||||.||++.+   .|.+|
T Consensus       547 LEYceGNDLDFYLKQhk-------------lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQHK-------------LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeecCCCchhHHHHhhh-------------hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            99999999999998764             689999999999999999999987  4999999999999953   46799


Q ss_pred             EeeecccccccCccccc-----cccCCCCCccccCCccccCC----CCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        150 VADFGFARDLMTSSVYE-----RKSEGRLPIRWMAPESLYDN----IFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       150 l~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      |.|||++..+...+...     -.....||-.|.+||.+.-.    ..+.++|+||+|+++|+++. |+.||...-
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY-GrKPFGhnq  688 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY-GRKPFGHNQ  688 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc-cCCCCCCch
Confidence            99999998665443221     12235577789999988633    35789999999999999999 999997543

>KOG1167|consensus

Probab=99.95  E-value=1.4e-28  Score=192.59  Aligned_cols=197  Identities=22%  Similarity=0.403  Sum_probs=162.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|+ +||++..+..  ....+.||+|.+.....+.   ++..|++.+..+.++.||+++.+++...+...+|+||++..
T Consensus        47 GsFs-sv~~a~~~~~--~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~  120 (418)
T KOG1167|consen   47 GSFS-SVYKATDIEQ--DTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD  120 (418)
T ss_pred             cchh-hhhhhhHhhh--ccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence            8999 9999997642  3468899999998766655   58999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~g~~~~~~  160 (225)
                      +..++...                ++..++..+++.++.||.++|++||+||||||+|++++ ..+.-.|+|||++....
T Consensus       121 ~f~~l~~~----------------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  121 RFRDLYRS----------------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CHHHHHhc----------------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            88888864                68899999999999999999999999999999999998 56788999999987210


Q ss_pred             C------------------------------------------ccccccccCCCCCccccCCccccCCC-CCcchhHHHH
Q psy15818        161 T------------------------------------------SSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSF  197 (225)
Q Consensus       161 ~------------------------------------------~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~sl  197 (225)
                      .                                          ...........||++|+|||++.+.+ .++++|+||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            0                                          00001111345789999999998654 6899999999


Q ss_pred             HHHHHHHHHcCCCCCC-CCCHHHHh
Q psy15818        198 GVLIWEIVTLGSTPYP-GMAAAEVM  221 (225)
Q Consensus       198 g~ll~~l~~~g~~p~~-~~~~~~~~  221 (225)
                      |+++..+++ ++.||- ..++.+.+
T Consensus       265 GVI~Lslls-~~~PFf~a~dd~~al  288 (418)
T KOG1167|consen  265 GVILLSLLS-RRYPFFKAKDDADAL  288 (418)
T ss_pred             cceeehhhc-cccccccCccccchH
Confidence            999999999 888874 44444433

>KOG0665|consensus

Probab=99.95  E-value=8.4e-29  Score=187.84  Aligned_cols=184  Identities=27%  Similarity=0.436  Sum_probs=154.5

Q ss_pred             ccceEEEEeeecc-ccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEEEeecCCCCHHHHHHHhhh
Q psy15818         20 EGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVIMEYVPYGKLQSFLRSSRA   92 (225)
Q Consensus        20 ~~~~~vavK~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~   92 (225)
                      ..+++||+|.... ........+..+|...+..+. |+|+++++.+|.-..      ..|+|||++. .+|.+.+..   
T Consensus        39 v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~---  113 (369)
T KOG0665|consen   39 VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM---  113 (369)
T ss_pred             hccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH---
Confidence            4578889888643 333444557889999999998 999999999986543      4799999996 788888763   


Q ss_pred             hhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCC
Q psy15818         93 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR  172 (225)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  172 (225)
                                  .++-+.+..++.|.+.|+++||+.||+||||||+||++..+...|+.|||++..-...   ...+...
T Consensus       114 ------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyV  178 (369)
T KOG0665|consen  114 ------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYV  178 (369)
T ss_pred             ------------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---cccCchh
Confidence                        3688899999999999999999999999999999999999999999999999754333   2233344


Q ss_pred             CCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       173 ~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .+..|.|||++.+-.+...+||||+||++.||++ |...|.+.+.-+...+|
T Consensus       179 vtRyyrapevil~~~~ke~vdiwSvGci~gEli~-~~Vlf~g~d~idQ~~ki  229 (369)
T KOG0665|consen  179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL-GTVLFPGKDHIDQWNKI  229 (369)
T ss_pred             heeeccCchheeccCCcccchhhhhhhHHHHHhh-ceEEecCchHHHHHHHH
Confidence            5667999999999889999999999999999999 99999999988887765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.8e-26  Score=172.41  Aligned_cols=182  Identities=32%  Similarity=0.579  Sum_probs=152.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.+| .||++..     ..+++.+++|++...........+.+|+..+..+. |++++++++++......++++|++.+.
T Consensus         4 g~~~-~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           4 GGFG-TVYLARD-----KKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCce-EEEEEEe-----cCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            7899 9999994     34689999999987655434457889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++....            ..++...++.++.++++++.+||+.|++|+||+|.||+++. ++.++|+||+.+....
T Consensus        77 ~l~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          77 SLKDLLKENE------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             cHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence            9999987531            24789999999999999999999999999999999999998 8999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEI  204 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l  204 (225)
                      ....  ..........|.+||..... ..+.+.|+|++|++++++
T Consensus       145 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         145 SDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            3321  12223345569999988776 778999999999998876

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.1e-26  Score=193.44  Aligned_cols=209  Identities=19%  Similarity=0.214  Sum_probs=142.0

Q ss_pred             CcccceeeecCCCCC-----------CCCccceEEEEeeeccccchH-------------HHHHHHHHHHHHhhcCCCCC
Q psy15818          2 DCFSVEVRKHPMSPE-----------RGREGPCIVAVKTLKENAGER-------------ERLDLLQELTVMKTLDPHPN   57 (225)
Q Consensus         2 g~~g~~v~~~~~~~~-----------~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~   57 (225)
                      |.|| +||++.....           .....++.||||.+.......             ..+....|+..+.++. |.+
T Consensus       156 GgFG-~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~-~~~  233 (507)
T PLN03224        156 GNFG-ITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIK-RNP  233 (507)
T ss_pred             CCCe-EEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhh-ccc
Confidence            8999 9999864211           123456789999986532211             1112334666666666 443


Q ss_pred             -----eeeeeeEEec--------CCCeEEEEeecCCCCHHHHHHHhhhhh------hh---ccc--CCCCCCCChHHHHH
Q psy15818         58 -----VVRLLGCCTE--------KEPFFVIMEYVPYGKLQSFLRSSRAQR------YY---NNM--HGKSNSLTSRDLTS  113 (225)
Q Consensus        58 -----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~------~~---~~~--~~~~~~~~~~~~~~  113 (225)
                           ++++++++..        .+..++|+||+++++|.+++.......      +.   ..+  ......++...+..
T Consensus       234 l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~  313 (507)
T PLN03224        234 IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKG  313 (507)
T ss_pred             chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHH
Confidence                 4666676643        356899999999999999987532100      00   000  00112356678999


Q ss_pred             HHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCC-----
Q psy15818        114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-----  188 (225)
Q Consensus       114 ~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-----  188 (225)
                      ++.|++.+|.+||+.+++|+||||+||+++.++.++|+|||++........ ........++.|++||.+.....     
T Consensus       314 i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~  392 (507)
T PLN03224        314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAP  392 (507)
T ss_pred             HHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccc
Confidence            999999999999999999999999999999999999999999865432211 11223344678999998753221     


Q ss_pred             -----------------CcchhHHHHHHHHHHHHHcCCC-CCCC
Q psy15818        189 -----------------SVKSDIWSFGVLIWEIVTLGST-PYPG  214 (225)
Q Consensus       189 -----------------~~~~Di~slg~ll~~l~~~g~~-p~~~  214 (225)
                                       ....|+||+|+++++|++ +.. ||.+
T Consensus       393 ~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~-~~l~p~~~  435 (507)
T PLN03224        393 APAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV-PELRPVAN  435 (507)
T ss_pred             hhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh-CCCCCccc
Confidence                             124699999999999999 654 7754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=6.4e-27  Score=198.65  Aligned_cols=202  Identities=19%  Similarity=0.268  Sum_probs=129.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeE------EecCCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC------CTEKEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~------~~~~~~~~lv~   75 (225)
                      |+|| .||++....... ..+..||+|.+......+.   ...+.  +.... +.++..+...      .......++|+
T Consensus       143 G~FG-~VYka~~~~~~~-~~~~~vAvK~~~~~~~~e~---~~~e~--l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~LV~  214 (566)
T PLN03225        143 GAFG-VVYKASLVNKQS-KKEGKYVLKKATEYGAVEI---WMNER--VRRAC-PNSCADFVYGFLEPVSSKKEDEYWLVW  214 (566)
T ss_pred             CCCe-EEEEEEEcCCcc-ccCcEEEEEEecccchhHH---HHHHH--HHhhc-hhhHHHHHHhhhcccccccCCceEEEE
Confidence            8999 999999632211 2388999998764322111   11111  11111 2222222111      24566799999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcc-cCC------CCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNN-MHG------KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHC  147 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~  147 (225)
                      ||+.+++|.+++........... +.+      ......+..+..++.|++.||.|||+++|+||||||+||+++. ++.
T Consensus       215 ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~  294 (566)
T PLN03225        215 RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS  294 (566)
T ss_pred             EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCc
Confidence            99999999999865321000000 000      0111234557789999999999999999999999999999985 678


Q ss_pred             eeEeeecccccccCccccccccCCCCCccccCCccccCCC----------------------CCcchhHHHHHHHHHHHH
Q psy15818        148 CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI----------------------FSVKSDIWSFGVLIWEIV  205 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----------------------~~~~~Di~slg~ll~~l~  205 (225)
                      ++|+|||++..+...... ......+++.|+|||.+....                      ++.++||||+||++|||+
T Consensus       295 ~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~  373 (566)
T PLN03225        295 FKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA  373 (566)
T ss_pred             EEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH
Confidence            999999999754322211 122345678899999664322                      234569999999999999


Q ss_pred             HcCCCCCC
Q psy15818        206 TLGSTPYP  213 (225)
Q Consensus       206 ~~g~~p~~  213 (225)
                      + +..|+.
T Consensus       374 ~-~~~~~~  380 (566)
T PLN03225        374 F-PNLRSD  380 (566)
T ss_pred             h-CcCCCc
Confidence            8 666543

>KOG1290|consensus

Probab=99.94  E-value=5.7e-26  Score=180.94  Aligned_cols=122  Identities=25%  Similarity=0.366  Sum_probs=102.1

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCC-------CCeeeeeeEEecC----C
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-------PNVVRLLGCCTEK----E   69 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~-------~~i~~~~~~~~~~----~   69 (225)
                      .|+|+ |||++.     .....+.||+|+.+...  ...+..+.||.++++++.+       ..|++++|.|...    .
T Consensus        88 WGHFS-TVWLaw-----Dtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~  159 (590)
T KOG1290|consen   88 WGHFS-TVWLAW-----DTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ  159 (590)
T ss_pred             ccccc-eeEEEe-----eccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence            38999 999999     46788999999998643  3444678899999988633       3899999999754    4


Q ss_pred             CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEe
Q psy15818         70 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLI  142 (225)
Q Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~  142 (225)
                      .+|+|+|++ |..|...|....           =..++...+..|++|++.||.|||++ ||+|.||||+||++
T Consensus       160 HVCMVfEvL-GdnLLklI~~s~-----------YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  160 HVCMVFEVL-GDNLLKLIKYSN-----------YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             EEEEEehhh-hhHHHHHHHHhC-----------CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            589999998 788988887652           23688999999999999999999976 99999999999998

>KOG1163|consensus

Probab=99.94  E-value=2.6e-26  Score=168.60  Aligned_cols=197  Identities=21%  Similarity=0.270  Sum_probs=164.2

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      -|+|| .+|++.     +-.+|..||+|.-.......   .+..|..++..+++..+|..+.-+..+...-.+||+.+ |
T Consensus        25 sGSFG-dIy~~~-----~i~~ge~VAiK~Es~~a~hp---qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   25 SGSFG-DIYLGI-----SITSGEEVAIKLESSKAKHP---QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G   94 (341)
T ss_pred             CCchh-heeeee-----eccCCceEEEEeecccCCCc---chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence            38999 999999     57899999999977655443   36788999999998999999988888888899999988 7


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~  157 (225)
                      .+|.++..-+.            ..++..+++-++-|++.-++|+|.++++||||||+|++..   ....+.|+|||++.
T Consensus        95 PsLEdLfnfC~------------R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   95 PSLEDLFNFCS------------RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ccHHHHHHHHh------------hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence            99999987653            3589999999999999999999999999999999999996   44568899999998


Q ss_pred             cccCcc-----ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        158 DLMTSS-----VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       158 ~~~~~~-----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      .+-...     ...+.....||.+|.+-....+...+.+.|+-|+|.+|.++-- |..||++......
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnr-G~LPWQglka~tk  229 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNR-GSLPWQGLKAATK  229 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeec-CCCcccccchhhH
Confidence            653222     2233334557888988877778888999999999999999887 9999998876543

>KOG1164|consensus

Probab=99.93  E-value=3.3e-25  Score=177.02  Aligned_cols=197  Identities=21%  Similarity=0.287  Sum_probs=157.2

Q ss_pred             CcccceeeecCCCCCCCCcc-ceEEEEeeeccccchHHHHHHHHHHHHHhhcC---CCCCeeeeeeEE-ecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREG-PCIVAVKTLKENAGERERLDLLQELTVMKTLD---PHPNVVRLLGCC-TEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~---~~~~i~~~~~~~-~~~~~~~lv~e   76 (225)
                      |.|| .||.+...     .+ ...+|+|........... .+..|..++..+.   +.+++..+++.. ......++||+
T Consensus        29 G~fG-~V~~v~~~-----~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~  101 (322)
T KOG1164|consen   29 GGFG-AVYLVSDK-----SEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS  101 (322)
T ss_pred             cCCc-eEEEEEec-----CCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence            8899 99999942     22 468899988765433322 4667777777776   357999999998 57778899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-----CceeEe
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-----HCCKVA  151 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-----~~~~l~  151 (225)
                      .+ |.+|.++.....           ...++..++..++.|++.+|++||+.|++||||||+|+.+...     ..+.|+
T Consensus       102 l~-G~sL~dl~~~~~-----------~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen  102 LL-GPSLEDLRKRNP-----------PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             cc-CccHHHHHHhCC-----------CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence            77 799999886542           3478999999999999999999999999999999999999744     358999


Q ss_pred             eecccc--cccCccc----cc-c-ccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        152 DFGFAR--DLMTSSV----YE-R-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       152 d~g~~~--~~~~~~~----~~-~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      |||++.  .......    .. . .....||..|+++....+...+++.|+||++.++.++.. |..||++....
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~-g~LPW~~~~~~  243 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK-GSLPWEALEMT  243 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc-CCCCCcccccc
Confidence            999998  4322221    11 1 224558999999999999999999999999999999998 99999877643

>KOG1165|consensus

Probab=99.93  E-value=4.7e-25  Score=168.68  Aligned_cols=196  Identities=17%  Similarity=0.262  Sum_probs=163.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .++.+.     +--.++.||||.-+..+...   .+..|.+.++.+.+.++|..++.+...+-.-.+|+|.+ |.
T Consensus        39 GsFG-~lf~G~-----Nl~nne~VAIKfEPrkS~AP---QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP  108 (449)
T KOG1165|consen   39 GSFG-VLFLGK-----NLYNNEPVAIKFEPRKSEAP---QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP  108 (449)
T ss_pred             Ccce-eeeccc-----ccccCceEEEEeccccCCcc---hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence            8899 888888     56789999999866443332   36778888899989999999998878777888999988 79


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-----CceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-----HCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-----~~~~l~d~g~~  156 (225)
                      +|.++..-+            +..++..++..++.|++.-++++|++.+++|||||+|++|...     ..+.++|||+|
T Consensus       109 SLEDLFD~C------------gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  109 SLEDLFDLC------------GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             CHHHHHHHh------------cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            999998764            3468999999999999999999999999999999999999632     34789999999


Q ss_pred             ccccCcc-----ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        157 RDLMTSS-----VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       157 ~~~~~~~-----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...-.+.     ...+.....||.+||+=....+...+.+.|+-|||-++++++- |.+||++.....+
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLR-GsLPWQGLKA~tn  244 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKADTN  244 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhcc-CCCccccccCcch
Confidence            8654443     3334445678999999888889999999999999999999998 9999998765543

>KOG0576|consensus

Probab=99.92  E-value=4.4e-26  Score=187.43  Aligned_cols=196  Identities=24%  Similarity=0.475  Sum_probs=164.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| .||+++     ++.+++..|+|.++...... ..-+++|+-+++.++ ||||+.+++.+......|+.||||.|+
T Consensus        26 gTyg-dvyKaR-----d~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~-h~nivay~gsylr~dklwicMEycggg   97 (829)
T KOG0576|consen   26 GTYG-DVYKAR-----DKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKLWICMEYCGGG   97 (829)
T ss_pred             Cccc-chhhhc-----ccccCchhhheeeeccCCcc-ccccccceeeeecCC-CcChHHHHhhhhhhcCcEEEEEecCCC
Confidence            8899 999998     57889999999998654432 235788999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|++...-             ..++++.++..+.+..+.+++|||+.|-+|||||-.||++++.+.+++.|||.+..++.
T Consensus        98 slQdiy~~-------------TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   98 SLQDIYHV-------------TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cccceeee-------------cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99988753             35789999999999999999999999999999999999999999999999998865543


Q ss_pred             ccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      .  .......-||+.||+||+..   ...|...+|+|++|+...|+-. =++|..+......+
T Consensus       165 t--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr~l  224 (829)
T KOG0576|consen  165 T--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLFDLHPMRAL  224 (829)
T ss_pred             h--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh-cCCcccccchHHHH
Confidence            3  23344566889999999774   5668889999999999998876 56666665555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=6.5e-24  Score=170.08  Aligned_cols=154  Identities=22%  Similarity=0.189  Sum_probs=114.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc----cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.|| +||++...    ..+++.||||+....    ........+.+|+.++.++. |+|+++.+..   .+..++||||
T Consensus        29 G~fg-~Vy~a~~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~---~~~~~LVmE~   99 (365)
T PRK09188         29 DVFS-TVERGYFA----GDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA---TGKDGLVRGW   99 (365)
T ss_pred             cCcE-EEEEEEEc----CCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE---cCCcEEEEEc
Confidence            8899 99999841    236778899987533    12334556889999999998 9998853322   2468999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCEEecCCCceeEeeeccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL-AARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl-~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ++|++|.. ..                ...   ...++.|++++|.+||+.|++|||| ||+||+++.+++++|+|||++
T Consensus       100 ~~G~~L~~-~~----------------~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188        100 TEGVPLHL-AR----------------PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cCCCCHHH-hC----------------ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            99998862 11                011   1467889999999999999999999 999999998889999999999


Q ss_pred             ccccCccccccc------cCCCCCccccCCcccc
Q psy15818        157 RDLMTSSVYERK------SEGRLPIRWMAPESLY  184 (225)
Q Consensus       157 ~~~~~~~~~~~~------~~~~~~~~~~~PE~~~  184 (225)
                      ..+.........      ....+++.|.+||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            866444322221      2334556688999775

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.1e-24  Score=192.76  Aligned_cols=145  Identities=15%  Similarity=0.178  Sum_probs=107.9

Q ss_pred             CCeeeeeeEE-------ecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC
Q psy15818         56 PNVVRLLGCC-------TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  128 (225)
Q Consensus        56 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~  128 (225)
                      +||..+.|+|       .....++.++|++ +.+|.+.+...            ...+++.++..++.||++||+|||++
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~   99 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP------------DRSVDAFECFHVFRQIVEIVNAAHSQ   99 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc------------cccccHHHHHHHHHHHHHHHHHHHhC
Confidence            4666666666       2234677888877 57999999642            23589999999999999999999999


Q ss_pred             CcccCCCCCCCEEecCCCceeEeeecccccccCc-------------------cc--------------cccccCCCCCc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTS-------------------SV--------------YERKSEGRLPI  175 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-------------------~~--------------~~~~~~~~~~~  175 (225)
                      ||+||||||+||+++..+.++++|||.+......                   ..              ........+|+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            9999999999999976555555555444221110                   00              00001124677


Q ss_pred             cccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       176 ~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      .|+|||++.+..++.++||||+||++|||++ |.+|+..
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~-~~~~~~~  217 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFC-PVSSREE  217 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhh-CCCchhh
Confidence            8999999999999999999999999999999 9888764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.4e-22  Score=147.12  Aligned_cols=181  Identities=18%  Similarity=0.123  Sum_probs=129.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch---HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE---RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |+|| +||++.       ..+.+++.+.+......   -....+.+|+.+++++.+++++++++++    +..+++|+|+
T Consensus        13 ~~f~-~v~~~~-------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274         13 DTFG-RILLVR-------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             CCcc-eEEEee-------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            7899 999777       36788887877655432   2223578999999999867899999886    4579999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCEEecCCCceeEeeecccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL-AARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl-~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .|.+|.+...                   .. ...++.|++.+|.++|+.|++|+|| ||+||+++.++.++|+|||++.
T Consensus        81 ~G~~L~~~~~-------------------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         81 AGAAMYQRPP-------------------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             cCccHHhhhh-------------------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            9988864321                   11 1346789999999999999999999 7999999988999999999997


Q ss_pred             cccCccccccc-----------cCCCCCccccCCccccCC-CCC-cchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        158 DLMTSSVYERK-----------SEGRLPIRWMAPESLYDN-IFS-VKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       158 ~~~~~~~~~~~-----------~~~~~~~~~~~PE~~~~~-~~~-~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ...........           .-...++.+..|+...-- ..+ .+.++++.|+-+|.++|+|-+-|.+
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            54333210000           011134456666533221 222 6789999999999999944444444

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1.6e-21  Score=154.81  Aligned_cols=195  Identities=30%  Similarity=0.537  Sum_probs=160.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH--HHHHHHHHHHHHhhcCCCC-CeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER--ERLDLLQELTVMKTLDPHP-NVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~-~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| .||++...        ..+++|.+.......  ....+.+|...+..+. |+ +++++.+.+...+..+++++++
T Consensus        11 g~~~-~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515          11 GSFG-EVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             CCCe-EEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEEecC
Confidence            7788 99999953        788999998665433  4667889999999998 66 7999999998777789999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-ceeEeeecccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFAR  157 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-~~~l~d~g~~~  157 (225)
                      .++++.+.+......          ..+.+.....++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.+.
T Consensus        81 ~~~~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          81 DGGSLEDLLKKIGRK----------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCcHHHHHHhcccc----------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            999999666543110          2578999999999999999999999999999999999999887 79999999987


Q ss_pred             cccCccccc----cccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        158 DLMTSSVYE----RKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       158 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .........    ......++..|++||.+.+   ...+...|+|++|++++++++ |..||.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~~  216 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKN  216 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCc
Confidence            443332221    2355667888999999887   577889999999999999999 9999877663

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.7e-22  Score=148.26  Aligned_cols=133  Identities=16%  Similarity=0.121  Sum_probs=100.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-HH------------------------HHHHHHHHHHHhhcCCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-RE------------------------RLDLLQELTVMKTLDPHP   56 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~~~~~~~~~~   56 (225)
                      |+|| +||++..     . +|+.||+|+++..... ..                        .....+|...+.++. ++
T Consensus         8 G~~~-~Vy~a~~-----~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           8 GKEA-NVYHATT-----A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             ccce-EEEEEEC-----C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            8999 9999983     3 7899999999764211 00                        112345888999987 77


Q ss_pred             CeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHH-HhCCcccCCC
Q psy15818         57 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDL  135 (225)
Q Consensus        57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-h~~~i~h~dl  135 (225)
                      ++.........  ..++||||++|+++......             ...+++.++..++.|++.+|.++ |+.|++|+||
T Consensus        80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDl  144 (190)
T cd05147          80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-------------DAPLSESKARELYLQVIQIMRILYQDCRLVHADL  144 (190)
T ss_pred             CCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-------------cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            66444333222  23899999998776544321             12578899999999999999999 7999999999


Q ss_pred             CCCCEEecCCCceeEeeeccccc
Q psy15818        136 AARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       136 ~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ||+||+++ ++.++|+|||++..
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             CHHHEEEE-CCcEEEEEcccccc
Confidence            99999998 47899999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=3.1e-22  Score=146.51  Aligned_cols=109  Identities=22%  Similarity=0.361  Sum_probs=92.2

Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      |+|.+++...            ...+++.+++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+....
T Consensus         1 GsL~~~l~~~------------~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEVR------------GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec
Confidence            5777888642            235899999999999999999999998      999999999999998  99886443


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ..       ...+++.|+|||++.+..++.++||||+|+++|+|++ |..||.....
T Consensus        61 ~~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~  109 (176)
T smart00750       61 PE-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALD-YELPYNEERE  109 (176)
T ss_pred             cc-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHh-CCCCccccch
Confidence            22       1246788999999999999999999999999999999 9999976543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0603|consensus

Probab=99.88  E-value=1e-23  Score=172.95  Aligned_cols=188  Identities=24%  Similarity=0.391  Sum_probs=158.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| .|++++  ...+.+.|..+|.|.++... ..........|..++....+||.+++++..++.++..+++.++..|
T Consensus         5 g~~g-kvfLvr--k~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    5 GSYG-KVFLVR--KAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCCc-chHHHH--HhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7888 888887  45566779999999987643 3333335667788888888899999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +++...+...             ..+.+.....+...++-+++++|+.+++|+|+|++||+++..|.+++.|||......
T Consensus        82 g~lft~l~~~-------------~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   82 GDLFTRLSKE-------------VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             chhhhccccC-------------CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence            9998777643             357888899999999999999999999999999999999999999999999876432


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ..      ...++|..|||||+..  ....++|+||+|++.++|++ |..||..
T Consensus       149 ~~------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fellt-g~~pf~~  193 (612)
T KOG0603|consen  149 KE------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLT-GTLPFGG  193 (612)
T ss_pred             hh------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhh-CCCCCch
Confidence            22      1227788899999887  55678999999999999999 9999998

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=6.2e-22  Score=148.48  Aligned_cols=159  Identities=11%  Similarity=0.120  Sum_probs=117.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch--HHHHH------HHHHHHHHhhcCCCCCeeeeeeEEecC-----
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE--RERLD------LLQELTVMKTLDPHPNVVRLLGCCTEK-----   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~------~~~e~~~~~~~~~~~~i~~~~~~~~~~-----   68 (225)
                      |.|| .||+...       ++..+|+|.+.+....  ....+      ..+|+..+.++. ||++..+.+++...     
T Consensus        42 ~~f~-~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~~~~~~~~  112 (232)
T PRK10359         42 IDDT-KVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYLLAERKTL  112 (232)
T ss_pred             CCce-EEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeeeecccccc
Confidence            6789 9998652       3557999999765322  22222      468888999997 99999999986543     


Q ss_pred             ---CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC
Q psy15818         69 ---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN  145 (225)
Q Consensus        69 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~  145 (225)
                         +..+++|||++|.+|.+...                 +++.    ...+++.++..+|+.|++|+|++|+||+++++
T Consensus       113 ~~~~~~~lvmEyi~G~tL~~~~~-----------------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        113 RYAHTYIMLIEYIEGVELNDMPE-----------------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccCCeEEEEEEECCccHHHhhh-----------------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence               45899999999999976631                 2332    35589999999999999999999999999988


Q ss_pred             CceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHH
Q psy15818        146 HCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIV  205 (225)
Q Consensus       146 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~  205 (225)
                      + ++++|||...........              ........+..++|+||||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999976433111110              01233444667899999998876553

>KOG1240|consensus

Probab=99.87  E-value=5.1e-23  Score=177.62  Aligned_cols=173  Identities=18%  Similarity=0.256  Sum_probs=131.9

Q ss_pred             EEEeeeccccchHH---HHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCC
Q psy15818         25 VAVKTLKENAGERE---RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG  101 (225)
Q Consensus        25 vavK~~~~~~~~~~---~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  101 (225)
                      |+||++......-.   ..+...|+. .... .+||++++.-+.+.+...|+|-+|.. ..|.+.++..+          
T Consensus        49 vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRP----------  115 (1431)
T KOG1240|consen   49 VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRP----------  115 (1431)
T ss_pred             EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccch----------
Confidence            88999865543222   223334444 3334 59999999999888888889999886 78888887543          


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc----Ccc-ccccccCCCCCcc
Q psy15818        102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM----TSS-VYERKSEGRLPIR  176 (225)
Q Consensus       102 ~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~----~~~-~~~~~~~~~~~~~  176 (225)
                         -+..-+..+++.||+.||.++|+.||+|||||.+||+++.-+++.|+||....+.-    ++. ......+.....+
T Consensus       116 ---FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtC  192 (1431)
T KOG1240|consen  116 ---FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTC  192 (1431)
T ss_pred             ---HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceee
Confidence               46788899999999999999999999999999999999999999999998765321    111 1112223334457


Q ss_pred             ccCCccccCC----------C-CCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        177 WMAPESLYDN----------I-FSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       177 ~~~PE~~~~~----------~-~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      |.|||.+...          . .+++.||||+||+++|+++.|++||+
T Consensus       193 YiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  193 YIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             ecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            9999987531          1 56789999999999999999999995

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=5.2e-21  Score=141.75  Aligned_cols=134  Identities=20%  Similarity=0.127  Sum_probs=103.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-------------------------HHHHHHHHHHHHHhhcCCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-------------------------RERLDLLQELTVMKTLDPHP   56 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~~~~~~~~~   56 (225)
                      |++| .||++..     . +|+.||||+++.....                         ........|...+.++. ++
T Consensus         8 G~~~-~Vy~a~~-----~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           8 GKEA-NVYHART-----G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CCCc-EEEEEEc-----C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            8899 9999983     3 7899999999764211                         00122357888888887 88


Q ss_pred             CeeeeeeEEecCCCeEEEEeecCCCCHHHH-HHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCC
Q psy15818         57 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSF-LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRD  134 (225)
Q Consensus        57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~d  134 (225)
                      ++.....+....  .++||||++|+++... +..              ..+++.++..++.|++.++.++|+ .|++|+|
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrD  143 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--------------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGD  143 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhh--------------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence            875555443332  4899999998755433 322              246788999999999999999999 9999999


Q ss_pred             CCCCCEEecCCCceeEeeeccccccc
Q psy15818        135 LAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus       135 l~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      |||+||+++ ++.++|+|||++....
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecC
Confidence            999999998 7889999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590|consensus

Probab=99.86  E-value=8e-23  Score=173.68  Aligned_cols=163  Identities=29%  Similarity=0.469  Sum_probs=133.8

Q ss_pred             HHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHH
Q psy15818         42 LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG  121 (225)
Q Consensus        42 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~  121 (225)
                      +..|..+-..+. |||++..++.+.+.....-.||||++ ||..++...             ..+...++..++.|++.|
T Consensus       368 i~sE~~i~~~l~-h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-------------~~~~~~e~~c~fKqL~~G  432 (601)
T KOG0590|consen  368 ITSEFCIGSSLS-HPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-------------GKLTPLEADCFFKQLLRG  432 (601)
T ss_pred             hhhheeeccccc-CCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-------------cccchhhhhHHHHHHHHH
Confidence            556666677787 99998888777666655556999998 999998653             257889999999999999


Q ss_pred             HHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCcccc--ccccCCCCCccccCCccccCCCCC-cchhHHHHH
Q psy15818        122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFG  198 (225)
Q Consensus       122 l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slg  198 (225)
                      ++|+|+.|+.|||+|++|+++..++.++++|||.+..+..+...  .......++..|+|||++.+..|. ...|+||.|
T Consensus       433 v~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~  512 (601)
T KOG0590|consen  433 VKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCG  512 (601)
T ss_pred             HHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhcc
Confidence            99999999999999999999999999999999988754333222  334455677789999999988875 569999999


Q ss_pred             HHHHHHHHcCCCCCCCCCHHHH
Q psy15818        199 VLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       199 ~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      +++..|.+ |+.||......+.
T Consensus       513 ii~~~m~~-~~~~Wk~a~~~~~  533 (601)
T KOG0590|consen  513 IIYICMIL-GRFPWKVAKKSDN  533 (601)
T ss_pred             ceEEEEec-CCCcccccccccc
Confidence            99999999 9999987665543

>KOG1166|consensus

Probab=99.86  E-value=1.1e-21  Score=170.94  Aligned_cols=185  Identities=16%  Similarity=0.197  Sum_probs=148.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||.|.-      ..|++||||.-++....+...  -.++..-.+..--+.++.+...+...+..+||++|.+.|
T Consensus       709 g~y~-~vy~a~~------~~~~~~alK~e~P~~~WEfYI--~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G  779 (974)
T KOG1166|consen  709 GSYG-SVYVATH------SNGKLVALKVEKPPNPWEFYI--CLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG  779 (974)
T ss_pred             ccce-EEEEeec------CCCcEEEEEeecCCCceeeee--hHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence            8999 9999993      349999999998766544421  111111111223567777877778888899999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-------CCCceeEeeec
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-------ENHCCKVADFG  154 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-------~~~~~~l~d~g  154 (225)
                      +|.+++..             ...+++..+..++.|++..++.||..+|+|+||||+|+++.       +...++|+|||
T Consensus       780 tlld~~N~-------------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  780 TLLDLINT-------------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             cHHHhhcc-------------CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            99999973             34689999999999999999999999999999999999994       23358999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCC
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGS  209 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~  209 (225)
                      .+..+..-+........+.|-.|-++|+..|++++...|.|.++.+++.|+. |.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF-G~  900 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF-GK  900 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH-HH
Confidence            9986655555555566667777999999999999999999999999999998 64

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=2.8e-19  Score=133.52  Aligned_cols=129  Identities=17%  Similarity=0.234  Sum_probs=97.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC----CCCCeeeeeeEEecCC---C-eEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----PHPNVVRLLGCCTEKE---P-FFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~~~~~---~-~~l   73 (225)
                      |+|| .||..       ..++.. +||++...... ....+.+|+.+++.+.    .||||++++++++++.   . +.+
T Consensus        13 G~~~-~Vy~h-------p~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345         13 GRHR-KCYAH-------PEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCce-EEEEC-------CCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            8899 99962       234445 58888654322 3346899999999994    3899999999998863   3 337


Q ss_pred             EEee--cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCCEEecC----CC
Q psy15818         74 IMEY--VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM-QFLSSRGIIHRDLAARNVLIGE----NH  146 (225)
Q Consensus        74 v~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l-~~Lh~~~i~h~dl~~~nil~~~----~~  146 (225)
                      |+||  +.+++|.+++.+.              .+++.  ..++.|++.++ +|||+++|+|+||||+||+++.    ..
T Consensus        83 I~e~~G~~~~tL~~~l~~~--------------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC--------------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EecCCCCcchhHHHHHHcc--------------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCC
Confidence            8999  5579999999642              24444  35678888777 9999999999999999999973    33


Q ss_pred             ceeEee-eccc
Q psy15818        147 CCKVAD-FGFA  156 (225)
Q Consensus       147 ~~~l~d-~g~~  156 (225)
                      +++|+| ||..
T Consensus       147 ~~~LiDg~G~~  157 (210)
T PRK10345        147 IPVVCDNIGES  157 (210)
T ss_pred             cEEEEECCCCc
Confidence            799999 4543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1.5e-19  Score=139.66  Aligned_cols=197  Identities=20%  Similarity=0.249  Sum_probs=122.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCC---------CCCeeeeeeEEecC--
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDP---------HPNVVRLLGCCTEK--   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~---------~~~i~~~~~~~~~~--   68 (225)
                      |.++ .||.+.     +..+++.+|+|++...  ........+.+|......+.+         |-.++..+|.....  
T Consensus        23 g~~~-~v~~v~-----d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   23 GGFS-IVFEVT-----DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             ETTE-EEEEEE-----ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             CCce-EEEEEE-----EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            5678 899998     5788999999998533  333345556666544444332         33455555553211  


Q ss_pred             ----------C-----CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccC
Q psy15818         69 ----------E-----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR  133 (225)
Q Consensus        69 ----------~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~  133 (225)
                                +     +.+++|+-.. .+|..++........      ....+.......+-.|+++.+++||..|++|+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~------~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQ------THSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTT------TSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhccc------ccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence                      1     2367778774 788888764322110      00112223334455899999999999999999


Q ss_pred             CCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCC--------CCCcchhHHHHHHHHHHHH
Q psy15818        134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN--------IFSVKSDIWSFGVLIWEIV  205 (225)
Q Consensus       134 dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--------~~~~~~Di~slg~ll~~l~  205 (225)
                      ||+|+|++++.+|.+.|+||+.....+.....     ...+..|.|||.....        .++.+.|.|+||+++|.++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999887654333221     1222458899866432        3678899999999999999


Q ss_pred             HcCCCCCCCCCH
Q psy15818        206 TLGSTPYPGMAA  217 (225)
Q Consensus       206 ~~g~~p~~~~~~  217 (225)
                      + +..||.....
T Consensus       245 C-~~lPf~~~~~  255 (288)
T PF14531_consen  245 C-GRLPFGLSSP  255 (288)
T ss_dssp             H-SS-STCCCGG
T ss_pred             H-ccCCCCCCCc
Confidence            9 9999986544

>KOG0195|consensus

Probab=99.79  E-value=1.6e-19  Score=135.48  Aligned_cols=190  Identities=25%  Similarity=0.468  Sum_probs=145.9

Q ss_pred             cccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          3 CFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         3 ~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      ..| +.|+++|       .|..++.|+++... ......++..|.-.++.+. ||||+++++.+..+....++..|++.+
T Consensus       202 hsg-elwrgrw-------qgndivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  202 HSG-ELWRGRW-------QGNDIVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             CCc-ccccccc-------cCcchhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeeeeccch
Confidence            357 7888885       46667778887543 3334445778888888887 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +|...+...           .+...+..++.+++.+++.|+.|||+..  |.---|....++++++.+.+++--+ +   
T Consensus       273 slynvlhe~-----------t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad-~---  337 (448)
T KOG0195|consen  273 SLYNVLHEQ-----------TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD-T---  337 (448)
T ss_pred             HHHHHHhcC-----------ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc-c---
Confidence            999999875           3345677889999999999999999875  3334678888999988877764211 1   


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC---CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF---SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                         ............|.|++||.+...+.   -.+.|+|||++++||+.| ...||.+..+.|.
T Consensus       338 ---kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t-revpfadlspmec  397 (448)
T KOG0195|consen  338 ---KFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT-REVPFADLSPMEC  397 (448)
T ss_pred             ---eeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc-cccccccCCchhh
Confidence               11111122334577999999876553   357999999999999999 9999999887765

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=4.5e-18  Score=128.06  Aligned_cols=130  Identities=21%  Similarity=0.227  Sum_probs=107.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |++| .||++..       .|..|++|.......       .....+..+|+.++..+. ++++.....++.+.+..+++
T Consensus         7 G~~~-~vy~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv   77 (211)
T PRK14879          7 GAEA-EIYLGDF-------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIV   77 (211)
T ss_pred             CceE-EEEEEee-------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEE
Confidence            7899 9999983       567788998654321       112235778999999997 88888887777777889999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||++|.+|.+.+...                .. ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++++|||
T Consensus        78 ~e~~~G~~L~~~~~~~----------------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         78 MEYIEGEPLKDLINSN----------------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             EEEeCCcCHHHHHHhc----------------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECC
Confidence            9999999999888542                22 7889999999999999999999999999999999 7789999999


Q ss_pred             cccc
Q psy15818        155 FARD  158 (225)
Q Consensus       155 ~~~~  158 (225)
                      .+..
T Consensus       140 ~a~~  143 (211)
T PRK14879        140 LAEF  143 (211)
T ss_pred             cccC
Confidence            8764

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=4.5e-18  Score=129.84  Aligned_cols=134  Identities=17%  Similarity=0.128  Sum_probs=98.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----------------------HHHHHHHHHHHHHhhcCCCC--
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----------------------RERLDLLQELTVMKTLDPHP--   56 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~e~~~~~~~~~~~--   56 (225)
                      |+|| .||++..    +..+|+.||+|+++.....                       ........|...+.++. +.  
T Consensus        39 G~~g-~Vy~a~~----~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~-~~~i  112 (237)
T smart00090       39 GKEA-NVYHALD----FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY-EAGV  112 (237)
T ss_pred             Ccce-eEEEEEe----cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH-hcCC
Confidence            7899 9999961    1356899999998754210                       01123567899999886 43  


Q ss_pred             CeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-cccCCC
Q psy15818         57 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-IIHRDL  135 (225)
Q Consensus        57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~-i~h~dl  135 (225)
                      .+.++++.    +..++||||+.|.++......             ...+...++..++.|++.++.+||+.| ++|+||
T Consensus       113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di  175 (237)
T smart00090      113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-------------DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDL  175 (237)
T ss_pred             CCCeeeEe----cCceEEEEEecCCcccccccc-------------cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence            33444432    235899999998877654321             123456677899999999999999999 999999


Q ss_pred             CCCCEEecCCCceeEeeecccccc
Q psy15818        136 AARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       136 ~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 788999999987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=9.8e-18  Score=125.11  Aligned_cols=127  Identities=15%  Similarity=0.198  Sum_probs=100.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--c-----hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--G-----ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |.|| +||++.+       .+..|++|......  .     .....+..+|+.++..+. ++++.....++......+++
T Consensus         5 G~~~-~vy~~~~-------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv   75 (199)
T TIGR03724         5 GAEA-IIYLGDF-------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIV   75 (199)
T ss_pred             CceE-EEEEeec-------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEE
Confidence            8899 9999983       45778899865321  1     112345678999999997 77766555555566678999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||++|++|.+.+...                 ..   .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||
T Consensus        76 ~e~~~g~~l~~~~~~~-----------------~~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEG-----------------ND---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             EEEECCccHHHHHhhc-----------------HH---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECC
Confidence            9999999998877532                 11   7889999999999999999999999999999 7889999999


Q ss_pred             cccc
Q psy15818        155 FARD  158 (225)
Q Consensus       155 ~~~~  158 (225)
                      .+..
T Consensus       135 ~a~~  138 (199)
T TIGR03724       135 LGKY  138 (199)
T ss_pred             CCcC
Confidence            8764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=3e-17  Score=122.46  Aligned_cols=128  Identities=20%  Similarity=0.168  Sum_probs=96.4

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccch---------------------HHHHHHHHHHHHHhhcCCCC--C
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE---------------------RERLDLLQELTVMKTLDPHP--N   57 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~~~~~~~~~--~   57 (225)
                      .|+|| .||++..      .+|+.||||++......                     ........|..++..+. ++  .
T Consensus        25 ~G~~g-~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~   96 (198)
T cd05144          25 VGKES-DVYLALD------PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEGFP   96 (198)
T ss_pred             cCcce-EEEEEEc------CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcCCC
Confidence            38899 9999983      36899999987643210                     01123567888888886 65  3


Q ss_pred             eeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy15818         58 VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA  137 (225)
Q Consensus        58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~  137 (225)
                      +...++    .+..+++|||++|.+|.....                   ......++.+++.++.++|+.|++|+||+|
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p  153 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRV-------------------LEDPEEVLDEILEEIVKAYKHGIIHGDLSE  153 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhccc-------------------cccHHHHHHHHHHHHHHHHHCCCCcCCCCc
Confidence            444443    245689999999988864431                   134567888999999999999999999999


Q ss_pred             CCEEecCCCceeEeeecccccc
Q psy15818        138 RNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       138 ~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +||++++++.++|+|||.+...
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158|consensus

Probab=99.73  E-value=2.8e-17  Score=129.22  Aligned_cols=147  Identities=24%  Similarity=0.355  Sum_probs=112.4

Q ss_pred             CCCCCeeeeeeEEecC---------------------------CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCC
Q psy15818         53 DPHPNVVRLLGCCTEK---------------------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS  105 (225)
Q Consensus        53 ~~~~~i~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~  105 (225)
                      ..||||+.+...|.+.                           ..+|+||.-.+ -+|.+++...              .
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--------------~  337 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--------------H  337 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--------------C
Confidence            3699999998887432                           24789998775 6898888654              5


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CC--CceeEeeecccccccCcc----ccccccCCCCCccc
Q psy15818        106 LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--EN--HCCKVADFGFARDLMTSS----VYERKSEGRLPIRW  177 (225)
Q Consensus       106 ~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~--~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~  177 (225)
                      .+.....-++.|+++|+.+||++|+.|||+|.+||++.  ++  .+..+.|||.|--.....    ..+......|....
T Consensus       338 ~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l  417 (598)
T KOG4158|consen  338 RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL  417 (598)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence            68888899999999999999999999999999999994  33  357899999875332211    12223334556678


Q ss_pred             cCCccccCCCC------CcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        178 MAPESLYDNIF------SVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       178 ~~PE~~~~~~~------~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ||||+....+-      -.+.|.|+.|.+.||+++ ...||.+.
T Consensus       418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg-~~NPFY~r  460 (598)
T KOG4158|consen  418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFG-RSNPFYKR  460 (598)
T ss_pred             cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhc-cCCccccc
Confidence            99998764321      247999999999999998 99999763

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=1.3e-16  Score=135.81  Aligned_cols=128  Identities=16%  Similarity=0.195  Sum_probs=99.0

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeec-cc-c-----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEE
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLK-EN-A-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~-~~-~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l   73 (225)
                      .|.|| +||++.+.       +..+++|... .. .     ......+..+|+.++..+. |++++....+..+....++
T Consensus       343 ~G~~g-~Vy~~~~~-------~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        343 KGAEA-DIKKGEYL-------GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             cCCcE-EEEEEeec-------CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCCCCEE
Confidence            38899 99998741       2223333321 11 1     1122346788999999998 9999888777777778899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ||||++|++|.+.+.                     ....++.|++.+|.+||+.|++|+||||+||++ +++.++|+||
T Consensus       414 v~E~~~g~~L~~~l~---------------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        414 VMEYIGGKDLKDVLE---------------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             EEEecCCCcHHHHHH---------------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeC
Confidence            999999999988774                     235688899999999999999999999999999 5778999999


Q ss_pred             cccccc
Q psy15818        154 GFARDL  159 (225)
Q Consensus       154 g~~~~~  159 (225)
                      |++...
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998643

>KOG0606|consensus

Probab=99.71  E-value=1.2e-17  Score=144.47  Aligned_cols=104  Identities=25%  Similarity=0.505  Sum_probs=89.0

Q ss_pred             HHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC--cc-----------ccccccCCCCCccccCCccccC
Q psy15818        119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT--SS-----------VYERKSEGRLPIRWMAPESLYD  185 (225)
Q Consensus       119 ~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~--~~-----------~~~~~~~~~~~~~~~~PE~~~~  185 (225)
                      +.+++|||..||+|+|+||+|.++..-|.+|+.|||+......  .+           ........++||.|+|||+...
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            7789999999999999999999999999999999998763211  11           1112234578999999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       186 ~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +.|+..+|+|++|+++|+.+- |..||.+.+++++...
T Consensus       233 qgygkpvdwwamGiIlyeFLV-gcvpffGdtpeelfg~  269 (1205)
T KOG0606|consen  233 QGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFGQ  269 (1205)
T ss_pred             hccCCCccHHHHHHHHHHHhe-eeeeccCCCHHHHHhh
Confidence            999999999999999999999 9999999999988754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=3.8e-16  Score=119.47  Aligned_cols=130  Identities=14%  Similarity=0.165  Sum_probs=95.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc------------chHHHHHHHHHHHHHhhcCCCCCe--eeeeeEEec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA------------GERERLDLLQELTVMKTLDPHPNV--VRLLGCCTE   67 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~~~~~~~~~~i--~~~~~~~~~   67 (225)
                      |..| +||.+..       .+..++||.+....            ......+..+|+..+..+. ++++  +..++....
T Consensus        43 ~g~g-tv~~v~~-------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         43 KGRG-TTWFVQT-------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             CCCc-cEEEEEe-------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            4456 7777762       36678888885311            1123346788999999997 7774  666665433


Q ss_pred             C-CC---eEEEEeecCC-CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe
Q psy15818         68 K-EP---FFVIMEYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI  142 (225)
Q Consensus        68 ~-~~---~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~  142 (225)
                      . +.   .++|+|+++| .+|.+++...              .+++..    +.|++.++.+||+.||+|+||||.||++
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~--------------~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv  175 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA--------------PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL  175 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC--------------CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence            2 22   3599999997 6888887532              244432    5689999999999999999999999999


Q ss_pred             cCCCceeEeeeccccc
Q psy15818        143 GENHCCKVADFGFARD  158 (225)
Q Consensus       143 ~~~~~~~l~d~g~~~~  158 (225)
                      +.++.++|+|||.+..
T Consensus       176 ~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        176 DPDGKFWLIDFDRGEL  191 (239)
T ss_pred             cCCCCEEEEECCCccc
Confidence            9888999999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=1.3e-15  Score=112.56  Aligned_cols=131  Identities=19%  Similarity=0.178  Sum_probs=89.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH-HHHH----------------------HHHHHHHHhhcCCC-CC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER-ERLD----------------------LLQELTVMKTLDPH-PN   57 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~e~~~~~~~~~~-~~   57 (225)
                      |+|| +||.+..      .+++.||+|++....... ....                      ...|...+..+..+ ..
T Consensus         8 G~~g-~Vy~a~~------~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           8 GKEA-DVYLALD------GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             ccce-eEEEEEC------CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            8899 9999984      268899999987542111 1001                      13455555555411 22


Q ss_pred             eeeeeeEEecCCCeEEEEeecCCCCHHH-HHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCC
Q psy15818         58 VVRLLGCCTEKEPFFVIMEYVPYGKLQS-FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDL  135 (225)
Q Consensus        58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl  135 (225)
                      +.++++.    ...+++|||++++++.. .+...               .....+..++.+++.++.++|. .+++|+||
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---------------~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl  141 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---------------RLLEDPEELYDQILELMRKLYREAGLVHGDL  141 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh---------------hhcccHHHHHHHHHHHHHHHhhccCcCcCCC
Confidence            4444433    24689999999854321 11111               0116678899999999999999 99999999


Q ss_pred             CCCCEEecCCCceeEeeecccccc
Q psy15818        136 AARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       136 ~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +|+||+++ ++.++++|||.+...
T Consensus       142 ~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         142 SEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ChhhEEEE-CCcEEEEECcccccc
Confidence            99999999 888999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033|consensus

Probab=99.65  E-value=2.9e-17  Score=133.01  Aligned_cols=124  Identities=22%  Similarity=0.454  Sum_probs=106.5

Q ss_pred             CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCcee
Q psy15818         70 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCK  149 (225)
Q Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~  149 (225)
                      .+++.|++|.-.+|.+-+...+          .....+......++.|+..+++|   ++.+|+|+||.||+...+..++
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~----------~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR----------TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC----------cccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence            4789999999999998886543          22345778899999999999999   9999999999999999988999


Q ss_pred             EeeecccccccCcc----ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHH
Q psy15818        150 VADFGFARDLMTSS----VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       150 l~d~g~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~  206 (225)
                      |.|||+........    .....+...+|..||+||.+.++.|+.++||||||++|+|++.
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            99999998665444    3345556778899999999999999999999999999999987

>KOG1243|consensus

Probab=99.63  E-value=6.2e-15  Score=122.89  Aligned_cols=166  Identities=20%  Similarity=0.329  Sum_probs=129.9

Q ss_pred             CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhc
Q psy15818         18 GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN   97 (225)
Q Consensus        18 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   97 (225)
                      .+.++.+|.|...+.+.. .......+.+..++.++ ||||+++++.++..+..|+|+|-+.  .|..++++        
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------  100 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------  100 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------
Confidence            467788999999887666 44556778888999998 9999999999999999999999884  67778875        


Q ss_pred             ccCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCcc
Q psy15818         98 NMHGKSNSLTSRDLTSFCYQVARGMQFLS-SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR  176 (225)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~  176 (225)
                              +....+..-++||+.||-||| +.+++|+++..+.|+++..|..+|.+|..+.............  ..-..
T Consensus       101 --------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~--~~~~s  170 (690)
T KOG1243|consen  101 --------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL--YLIES  170 (690)
T ss_pred             --------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc--hhhhc
Confidence                    457788889999999999998 6689999999999999999999999999885443222111111  11112


Q ss_pred             ccCCccccCCCCCcchhHHHHHHHHHHHHHcC
Q psy15818        177 WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLG  208 (225)
Q Consensus       177 ~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g  208 (225)
                      |..|+......  -..|.|.||+++++++. |
T Consensus       171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~n-g  199 (690)
T KOG1243|consen  171 FDDPEEIDPSE--WSIDSWGLGCLIEELFN-G  199 (690)
T ss_pred             ccChhhcCccc--cchhhhhHHHHHHHHhC-c
Confidence            66666432222  35799999999999998 6

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=5.4e-15  Score=104.93  Aligned_cols=125  Identities=16%  Similarity=0.182  Sum_probs=101.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCC-CCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.++ .||++..       .+..+++|.......   ...+.+|+..++.+..+ ..+++++.+....+..++++||+.|
T Consensus         9 g~~~-~v~~~~~-------~~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           9 GLTN-RVYLLGT-------KDEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cccc-ceEEEEe-------cCCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            6788 9999983       236789999876443   34678899999998733 6888999888888889999999988


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---GIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~---~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      ..+..+                    +......++.+++++++.+|..   +++|+|++|.||++++.+.++++||+.+.
T Consensus        78 ~~~~~~--------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          78 ETLDEV--------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             eecccC--------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            766422                    3345566788999999999985   69999999999999988899999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023|consensus

Probab=99.62  E-value=9e-16  Score=126.00  Aligned_cols=151  Identities=29%  Similarity=0.510  Sum_probs=122.0

Q ss_pred             hhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC
Q psy15818         50 KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  129 (225)
Q Consensus        50 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~  129 (225)
                      +.+. |.|+.++++.+.++...++|.+||..|+|.+.+...            ...++......++++++.|+.|+|.-.
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~------------~~~~d~~F~~s~~rdi~~Gl~ylh~s~   68 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE------------DIKLDYFFILSFIRDISKGLAYLHNSP   68 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc------------ccCccHHHHHHHHHHHHHHHHHHhcCc
Confidence            4555 999999999999999999999999999999999752            345778888899999999999999876


Q ss_pred             c-ccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCC-------CCcchhHHHHHHHH
Q psy15818        130 I-IHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-------FSVKSDIWSFGVLI  201 (225)
Q Consensus       130 i-~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~Di~slg~ll  201 (225)
                      + +|+.++..|++++....+|+.|||+....................-|.|||.+....       .+.+.|+||+|+++
T Consensus        69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~  148 (484)
T KOG1023|consen   69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM  148 (484)
T ss_pred             ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence            5 999999999999999999999999886553211111111112223489999887531       35679999999999


Q ss_pred             HHHHHcCCCCCCC
Q psy15818        202 WEIVTLGSTPYPG  214 (225)
Q Consensus       202 ~~l~~~g~~p~~~  214 (225)
                      +|+++ ..-||..
T Consensus       149 ~ei~~-r~~~~~~  160 (484)
T KOG1023|consen  149 YEILF-RSGPFDL  160 (484)
T ss_pred             HHHHh-ccCcccc
Confidence            99999 9999975

>KOG0590|consensus

Probab=99.61  E-value=6.8e-17  Score=137.73  Aligned_cols=188  Identities=23%  Similarity=0.373  Sum_probs=151.0

Q ss_pred             CccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhc
Q psy15818         19 REGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN   97 (225)
Q Consensus        19 ~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   97 (225)
                      ......+|.|.+... .......+...|..+...+..|+|++.+++...+....++++++..|+++...+...       
T Consensus        43 ~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~-------  115 (601)
T KOG0590|consen   43 RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHP-------  115 (601)
T ss_pred             CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccC-------
Confidence            344566777776544 244444556677887777777999999999999999999999999999988777311       


Q ss_pred             ccCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEecCCC-ceeEeeecccccccC-ccccccccCCCC-
Q psy15818         98 NMHGKSNSLTSRDLTSFCYQVARGMQFLS-SRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMT-SSVYERKSEGRL-  173 (225)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~~i~h~dl~~~nil~~~~~-~~~l~d~g~~~~~~~-~~~~~~~~~~~~-  173 (225)
                          .....+....-.++.|+..++.|+| ..++.|+||+|+|.+++.++ ..++.|||++..... ...........+ 
T Consensus       116 ----~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~  191 (601)
T KOG0590|consen  116 ----DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGS  191 (601)
T ss_pred             ----CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCC
Confidence                1225677788999999999999999 99999999999999999888 999999999987766 444444445556 


Q ss_pred             CccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        174 PIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       174 ~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ++.|.+||...+. ......|+||.|+++..+++ |..||......
T Consensus       192 s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~-g~~p~~~~~~~  236 (601)
T KOG0590|consen  192 SPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT-GELPWDFPSRK  236 (601)
T ss_pred             CCCCCCcccccchhhcCCCccccccccccccccc-CCCCccccccc
Confidence            8889999998884 45788999999999999999 99999765543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3.3e-14  Score=117.72  Aligned_cols=138  Identities=20%  Similarity=0.218  Sum_probs=93.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHH---------------------------------------HH
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERL---------------------------------------DL   42 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------------------------------------~~   42 (225)
                      |++| .||+|..      .+|+.||||+.++........                                       ++
T Consensus       128 aSig-QVh~A~l------~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       128 ASIA-QVHRARL------VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             eehh-heEEEEe------cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            7889 9999995      468899999997653221110                                       12


Q ss_pred             HHHHHHHhhc----CCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHH
Q psy15818         43 LQELTVMKTL----DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV  118 (225)
Q Consensus        43 ~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql  118 (225)
                      .+|...+.++    ..++++.-..-+....+.-++||||++|.+|.+......            ...   ....++.++
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~------------~~~---~~~~ia~~~  265 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE------------AGL---DRKALAENL  265 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh------------cCC---CHHHHHHHH
Confidence            3344444433    234544333333334556799999999999988765321            011   233455555


Q ss_pred             HH-HHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818        119 AR-GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus       119 ~~-~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +. .+..+|..|++|+|++|.||+++++++++++|||++..++.
T Consensus       266 ~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       266 ARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            55 46789999999999999999999999999999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601|consensus

Probab=99.49  E-value=4e-14  Score=116.64  Aligned_cols=194  Identities=24%  Similarity=0.279  Sum_probs=151.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.+| .+|.++.-   +..++..+|+|..+.. ..+....+-.+|+.....+..|++.++.+..++..+..++-+|.|. 
T Consensus       127 g~~~-s~~~~~~~---~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-  201 (524)
T KOG0601|consen  127 GSKG-SVFKSRCT---NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-  201 (524)
T ss_pred             CCCc-eeecccCC---cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-
Confidence            6788 88888742   2677889999986533 3333334566788888888889999999999999999999999985 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCCEEecCC-CceeEeeecc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR----GMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGF  155 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~----~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g~  155 (225)
                      .+|.++...            ....++...++..+.+..+    |+.++|..+++|.|++|.||+...+ ...+++||+.
T Consensus       202 ~sl~~~~~~------------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  202 ESLQSYCHT------------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             chhHHhhhc------------ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            788777764            3445788899999999999    9999999999999999999999988 7889999999


Q ss_pred             cccccCcccccccc---CCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        156 ARDLMTSSVYERKS---EGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       156 ~~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ...+..........   ...+...|++||.. ...++..+|+|++|.+..+..+ +..++..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l-~~~~~~~  329 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAIL-GSHLPSV  329 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHh-hcccccC
Confidence            98776554322222   11344569999954 5666889999999999999888 6666543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=5.1e-13  Score=96.98  Aligned_cols=122  Identities=15%  Similarity=0.064  Sum_probs=86.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |..+ .||+.+.       .+..|++|........  .....+|...++.+.....+.+++....  ...++|||+++|.
T Consensus         9 G~~~-~vy~~~~-------~~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~   76 (170)
T cd05151           9 GMTN-KNYRVEV-------ANKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS   76 (170)
T ss_pred             cccC-ceEEEEE-------CCeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence            6778 8888873       3778999998654321  2245678888887763323344554432  3457999999998


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI-----IHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i-----~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ++....                  ..   ....+.+++++|+.||+.++     +|+|++|.||+++ ++.++++||+.+
T Consensus        77 ~l~~~~------------------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          77 ELLTED------------------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             cccccc------------------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            764320                  11   12356789999999999885     9999999999998 567999999987


Q ss_pred             c
Q psy15818        157 R  157 (225)
Q Consensus       157 ~  157 (225)
                      .
T Consensus       135 ~  135 (170)
T cd05151         135 G  135 (170)
T ss_pred             c
Confidence            5

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=3.9e-13  Score=112.97  Aligned_cols=141  Identities=17%  Similarity=0.185  Sum_probs=86.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH---------------------------------HHH------HH
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER---------------------------------ERL------DL   42 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------~~~------~~   42 (225)
                      |++| .||++..     +.+|+.||||+.++.....                                 ...      ++
T Consensus       130 aSia-QVh~A~l-----~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~  203 (537)
T PRK04750        130 ASIA-QVHFARL-----KDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL  203 (537)
T ss_pred             CCcc-EEEEEEE-----CCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence            7899 9999995     3458999999998653211                                 111      13


Q ss_pred             HHHHHHHhhcC---CCCCeeeeeeEE-ecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHH
Q psy15818         43 LQELTVMKTLD---PHPNVVRLLGCC-TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV  118 (225)
Q Consensus        43 ~~e~~~~~~~~---~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql  118 (225)
                      .+|...+.++.   .+...+.+=.++ +..+.-++||||+.|..+.+.-.-.. .+.      ....+.+..+..++.|+
T Consensus       204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~------d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGT------DMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCC------CHHHHHHHHHHHHHHHH
Confidence            34444444332   122222222222 22456789999999999977432110 000      00123344444444444


Q ss_pred             HHHHHHHHhCCcccCCCCCCCEEecCCC----ceeEeeecccccccCc
Q psy15818        119 ARGMQFLSSRGIIHRDLAARNVLIGENH----CCKVADFGFARDLMTS  162 (225)
Q Consensus       119 ~~~l~~Lh~~~i~h~dl~~~nil~~~~~----~~~l~d~g~~~~~~~~  162 (225)
                             ...|++|+|++|.||+++.++    +++++|||++..++..
T Consensus       277 -------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   468999999999999998777    8999999999766443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=8.7e-12  Score=91.86  Aligned_cols=98  Identities=16%  Similarity=0.243  Sum_probs=72.6

Q ss_pred             HHHHHHHhhcCC-CCCeeeeeeEEecCCCeEEEEeecCCCCHH-HHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHH
Q psy15818         43 LQELTVMKTLDP-HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ-SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR  120 (225)
Q Consensus        43 ~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~  120 (225)
                      .+|.+.|.++.. .-.+.+++++    ...++||||+.+..+. ..++.              ..+++++...+..+++.
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--------------~~~~~~~~~~i~~~i~~  135 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--------------AKLNDEEMKNAYYQVLS  135 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--------------cccCHHHHHHHHHHHHH
Confidence            378888888762 2456666654    4578999999764332 11211              13455667788899999


Q ss_pred             HHHHH-HhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818        121 GMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       121 ~l~~L-h~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ++..| |+.|++|+||++.||++.+ +.+.++|||.+...
T Consensus       136 ~l~~l~H~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         136 MMKQLYKECNLVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHHHHHhCCeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            99988 8999999999999999974 56999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.32  E-value=5.2e-11  Score=92.35  Aligned_cols=126  Identities=17%  Similarity=0.094  Sum_probs=88.6

Q ss_pred             ccceEEEEeeeccccchH----------HHHHHHHHHHHHhhcCCCCCeee--eeeEEec-----CCCeEEEEeecCCC-
Q psy15818         20 EGPCIVAVKTLKENAGER----------ERLDLLQELTVMKTLDPHPNVVR--LLGCCTE-----KEPFFVIMEYVPYG-   81 (225)
Q Consensus        20 ~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~~~~~~~~~~i~~--~~~~~~~-----~~~~~lv~e~~~~~-   81 (225)
                      .+|+.|.||.........          ......+|...+.++. .-+|..  +..+.+.     ....++|+|++++. 
T Consensus        43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~  121 (268)
T PRK15123         43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTI  121 (268)
T ss_pred             ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCc
Confidence            457889999775433211          1113667887777764 223322  2333332     23578999999986 


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-------CCceeEeeec
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-------NHCCKVADFG  154 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-------~~~~~l~d~g  154 (225)
                      +|.+++....           ....++.....++.+++..+..||+.|++|+|+++.||+++.       ...+.++||+
T Consensus       122 sL~~~~~~~~-----------~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        122 SLEDYCADWA-----------TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             cHHHHHHhhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            7888875321           113456778899999999999999999999999999999974       4578999999


Q ss_pred             ccc
Q psy15818        155 FAR  157 (225)
Q Consensus       155 ~~~  157 (225)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            774

>KOG3087|consensus

Probab=99.27  E-value=2e-10  Score=82.38  Aligned_cols=127  Identities=16%  Similarity=0.178  Sum_probs=93.4

Q ss_pred             CccceEEEEeeeccc-------cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC-CCHHHHHHHh
Q psy15818         19 REGPCIVAVKTLKEN-------AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY-GKLQSFLRSS   90 (225)
Q Consensus        19 ~~~~~~vavK~~~~~-------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~   90 (225)
                      ...|+..+||.=...       ...-...+..+|.+++.++. --+|.-..-+|.+...-.++|||.+| .++.+++.+.
T Consensus        27 ~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~  105 (229)
T KOG3087|consen   27 SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILST  105 (229)
T ss_pred             ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHH
Confidence            356777777753211       12333456778999999887 55777777778888888999999987 5777777665


Q ss_pred             hhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-C--ceeEeeecccc
Q psy15818         91 RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-H--CCKVADFGFAR  157 (225)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~--~~~l~d~g~~~  157 (225)
                      -.           .....+....++.++-+.+.-||.++++|+||..+||++... +  .+.++|||+..
T Consensus       106 ~~-----------~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen  106 ME-----------DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             cc-----------CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            21           122333347889999999999999999999999999999643 3  35899999874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=4.7e-11  Score=87.63  Aligned_cols=125  Identities=22%  Similarity=0.221  Sum_probs=80.3

Q ss_pred             eeecCCCCCCCCccceEEEEeeecccc-------------------------chHHHHHHHHHHHHHhhcCCC-CCeeee
Q psy15818          8 VRKHPMSPERGREGPCIVAVKTLKENA-------------------------GERERLDLLQELTVMKTLDPH-PNVVRL   61 (225)
Q Consensus         8 v~~~~~~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~e~~~~~~~~~~-~~i~~~   61 (225)
                      ||.+.      ..+|..+|+|+.+...                         .........+|.+.|.++... -++.++
T Consensus         2 Vy~~~------~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p   75 (188)
T PF01163_consen    2 VYHAI------DPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP   75 (188)
T ss_dssp             EEEEE------ECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E
T ss_pred             EEEEE------CCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE
Confidence            66666      3457799999985410                         011223467899999998833 256666


Q ss_pred             eeEEecCCCeEEEEeecC--CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHH-HHhCCcccCCCCCC
Q psy15818         62 LGCCTEKEPFFVIMEYVP--YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF-LSSRGIIHRDLAAR  138 (225)
Q Consensus        62 ~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~-Lh~~~i~h~dl~~~  138 (225)
                      +++-    ...+||||++  |..+..+...               .++.++...++.+++..+.. +|+.|++|+||++.
T Consensus        76 ~~~~----~~~ivME~I~~~G~~~~~l~~~---------------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~  136 (188)
T PF01163_consen   76 YDYN----RNVIVMEYIGEDGVPLPRLKDV---------------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEY  136 (188)
T ss_dssp             EEEE----TTEEEEE--EETTEEGGCHHHC---------------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STT
T ss_pred             EEEe----CCEEEEEecCCCccchhhHHhc---------------cccchhHHHHHHHHHHHHHHHHHhcCceecCCChh
Confidence            6552    3569999998  6666544432               12345667777888885554 67999999999999


Q ss_pred             CEEecCCCceeEeeeccccc
Q psy15818        139 NVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       139 nil~~~~~~~~l~d~g~~~~  158 (225)
                      ||+++++ .+.++|||.+..
T Consensus       137 NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  137 NILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             SEEEETT-CEEE--GTTEEE
T ss_pred             hEEeecc-eEEEEecCccee
Confidence            9999887 899999998753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1e-10  Score=83.92  Aligned_cols=97  Identities=21%  Similarity=0.318  Sum_probs=78.1

Q ss_pred             HHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHH
Q psy15818         39 RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV  118 (225)
Q Consensus        39 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql  118 (225)
                      ..+..+|..++.++. ..+|....-+..++....++|||.+|..|.+.+...                .    ..++..+
T Consensus        43 r~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------------~----~~~~r~v  101 (204)
T COG3642          43 RERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------------R----PDLLREV  101 (204)
T ss_pred             HHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------------c----hHHHHHH
Confidence            445678899998887 667777776777888889999999998888888652                1    3455566


Q ss_pred             HHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       119 ~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      -.-+.-||..||+|+||.++||++..++ +.++|||++.
T Consensus       102 G~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642         102 GRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             HHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            6667789999999999999999998665 9999999875

>KOG3741|consensus

Probab=99.21  E-value=2.9e-10  Score=93.07  Aligned_cols=190  Identities=15%  Similarity=0.181  Sum_probs=128.8

Q ss_pred             ccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe----cCCCeEEEEeecC
Q psy15818          4 FSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT----EKEPFFVIMEYVP   79 (225)
Q Consensus         4 ~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~----~~~~~~lv~e~~~   79 (225)
                      |..+.|++.     +..+|..|++|+++-+..... .....-+.+++++. |+|++++.++|.    .+..+++|++|.+
T Consensus       288 ~~~Ttyk~~-----s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  288 FSITTYKAT-----SNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             ccceeEeee-----eccCCceeeeeeeccccccCc-ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCC
Confidence            434666666     567899999999943221111 01233467788888 999999999986    3557899999988


Q ss_pred             C-CCHHHHHHHhhhhh--hhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 Y-GKLQSFLRSSRAQR--YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~-~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      + .+|.++.-......  ...-.+..+.+.+|..+|.++.||..||.++|+.|+.-+-|.|.+|+++.+.+++++..|+.
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence            6 45555543222211  00011224567889999999999999999999999999999999999998889999877765


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ..+..++              .  +-+.   -..+.|.=.||.+++.|.++-..-+......+
T Consensus       441 Dvl~~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~  484 (655)
T KOG3741|consen  441 DVLQEDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQS  484 (655)
T ss_pred             eeecCCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHH
Confidence            4332221              0  1111   12467899999999999993334444444333

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=1.5e-10  Score=87.59  Aligned_cols=78  Identities=18%  Similarity=0.135  Sum_probs=54.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCC-CCCeeeeeeEEecC---CCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEK---EPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~---~~~~lv~e~   77 (225)
                      |..+ .+|++..      .+|+.+++|...............+|..++..+.. +..+.+++.+....   +..+++||+
T Consensus         9 G~~n-~~~~v~~------~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           9 GQSN-LTYLLTA------GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             Cccc-eEEEEEe------cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            6778 8998873      22578999998654332233467888999888873 23456677766553   367899999


Q ss_pred             cCCCCHHHH
Q psy15818         78 VPYGKLQSF   86 (225)
Q Consensus        78 ~~~~~L~~~   86 (225)
                      ++|.++.+.
T Consensus        82 i~G~~l~~~   90 (223)
T cd05154          82 VDGRVLRDR   90 (223)
T ss_pred             eCCEecCCC
Confidence            998776543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1266|consensus

Probab=99.17  E-value=1e-10  Score=90.62  Aligned_cols=151  Identities=25%  Similarity=0.388  Sum_probs=111.0

Q ss_pred             HHHHhhcCCCCCeeeeeeEEecC-----CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHH
Q psy15818         46 LTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR  120 (225)
Q Consensus        46 ~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~  120 (225)
                      +..+.++- |.||++++.++.+.     ....++.||+.-+++.+++++.+...         ..+......+|+.||++
T Consensus       118 Fdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~---------~a~~~~~wkkw~tqIls  187 (458)
T KOG1266|consen  118 FDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ---------KALFQKAWKKWCTQILS  187 (458)
T ss_pred             HHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh---------hhhhHHHHHHHHHHHHh
Confidence            34556666 99999999987553     45789999999999999998765322         34778889999999999


Q ss_pred             HHHHHHhCC--cccCCCCCCCEEecCCCceeEeee--cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHH
Q psy15818        121 GMQFLSSRG--IIHRDLAARNVLIGENHCCKVADF--GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS  196 (225)
Q Consensus       121 ~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~d~--g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s  196 (225)
                      ||.|||+..  ++|+++.-+.|++..++-+|+.--  ...................+-++|.+||.=.....+.++|||+
T Consensus       188 al~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~  267 (458)
T KOG1266|consen  188 ALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK  267 (458)
T ss_pred             hhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence            999999985  999999999999998887776421  1111111111111222233456799998655556678999999


Q ss_pred             HHHHHHHHHH
Q psy15818        197 FGVLIWEIVT  206 (225)
Q Consensus       197 lg~ll~~l~~  206 (225)
                      +|+...+|.-
T Consensus       268 fgmcAlemai  277 (458)
T KOG1266|consen  268 FGMCALEMAI  277 (458)
T ss_pred             hhHHHHHHHH
Confidence            9999998866

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=2.8e-09  Score=79.91  Aligned_cols=124  Identities=19%  Similarity=0.183  Sum_probs=86.2

Q ss_pred             ccceEEEEeeeccccch------HHHHHHHHHHHHHhhcCCCCC--eeeeeeEEecC----CCeEEEEeecCCC-CHHHH
Q psy15818         20 EGPCIVAVKTLKENAGE------RERLDLLQELTVMKTLDPHPN--VVRLLGCCTEK----EPFFVIMEYVPYG-KLQSF   86 (225)
Q Consensus        20 ~~~~~vavK~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~   86 (225)
                      ..++.+-+|........      -...+..+|...+..+. .-+  .++++.+.+..    ...++|+|++++. +|.++
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~  108 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL  108 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence            44666666764322111      12335677777666654 222  33334444332    2468999999874 78888


Q ss_pred             HHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeecccc
Q psy15818         87 LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFGFAR  157 (225)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g~~~  157 (225)
                      +....             ..+......++.++...+.-||+.|++|+|+++.||++..++   .+.++||+-+.
T Consensus       109 ~~~~~-------------~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  109 LQQWE-------------QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHhhc-------------ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            86531             246677888999999999999999999999999999998776   79999999765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.05  E-value=1.4e-09  Score=87.34  Aligned_cols=135  Identities=16%  Similarity=0.149  Sum_probs=99.2

Q ss_pred             eEEEEeecCCCC-HHHHHHHh-hhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCce
Q psy15818         71 FFVIMEYVPYGK-LQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCC  148 (225)
Q Consensus        71 ~~lv~e~~~~~~-L~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~  148 (225)
                      +.+.|+.++|.. ...+++.. +.+        .....+...+.+.++.++.+.+.||..|-.-+|+.++|+++++++.|
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRq--------s~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V  156 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQ--------SYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKV  156 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcc--------cCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceE
Confidence            778888887642 22222111 111        12245667789999999999999999999999999999999999999


Q ss_pred             eEeeecccccccCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        149 KVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      +|+|-+....   +....-..+..+.+.|.+||.-.     +-.-+...|.|.||+++++++.+|+.||.+..
T Consensus       157 ~LVdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         157 VLVDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             EEEcccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            9998654321   22333344556778899999554     33346679999999999999998899998753

>KOG0606|consensus

Probab=99.04  E-value=9.9e-11  Score=102.43  Aligned_cols=167  Identities=24%  Similarity=0.337  Sum_probs=127.0

Q ss_pred             HHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHH
Q psy15818         43 LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM  122 (225)
Q Consensus        43 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (225)
                      .++-++..... +|.++...-.+......+|+++|..+++|.+.++..             +..+++-.+.+...+..++
T Consensus       852 r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~-------------~~~saepaRs~i~~~vqs~  917 (1205)
T KOG0606|consen  852 RSKSNILITPR-SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS-------------GCLSAEPARSPILERVQSL  917 (1205)
T ss_pred             CCccCccccCC-CCceecccCCCCCCCCcchhhHHhccCCchhhhhcC-------------CCcccccccchhHHHHhhh
Confidence            33333333333 677776666666677889999999999998888653             2456666777778889999


Q ss_pred             HHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC------c-------------------cc----cccccCCCC
Q psy15818        123 QFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT------S-------------------SV----YERKSEGRL  173 (225)
Q Consensus       123 ~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~------~-------------------~~----~~~~~~~~~  173 (225)
                      ++||...+.|+|++|.|++....+..++.||+.......      .                   ..    ........+
T Consensus       918 e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  997 (1205)
T KOG0606|consen  918 ESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVG  997 (1205)
T ss_pred             hccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccC
Confidence            999999999999999999999999999998873322100      0                   00    011223457


Q ss_pred             CccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       174 ~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.|.+||.+.+......+|+|+.|.++++.++ |.+||.....+.+-.+|
T Consensus       998 t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~-g~pp~na~tpq~~f~ni 1047 (1205)
T KOG0606|consen  998 TPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT-GIPPFNAETPQQIFENI 1047 (1205)
T ss_pred             CCcccCCcccccccCCCcchhhhhhhhhhhhhc-CCCCCCCcchhhhhhcc
Confidence            888999999999999999999999999999999 99999998888776554

>KOG0601|consensus

Probab=99.00  E-value=2.7e-10  Score=94.32  Aligned_cols=171  Identities=23%  Similarity=0.257  Sum_probs=127.7

Q ss_pred             CccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhc
Q psy15818         19 REGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN   97 (225)
Q Consensus        19 ~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   97 (225)
                      ..++..|++|-..... ..........|+-+...+..|.+.+.....+......++-.|||.++++.-.....       
T Consensus       288 ~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-------  360 (524)
T KOG0601|consen  288 PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-------  360 (524)
T ss_pred             CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHH-------
Confidence            3678889999887553 33333456678877778878999999888877777777999999988877665322       


Q ss_pred             ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEeeecccccccCccccccccCCCCCcc
Q psy15818         98 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGFARDLMTSSVYERKSEGRLPIR  176 (225)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~  176 (225)
                            ..+.+...+....|++.++.++|+..++|.|++|+||++..+ +..++.||+.+..+....    .........
T Consensus       361 ------~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~  430 (524)
T KOG0601|consen  361 ------QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRL  430 (524)
T ss_pred             ------HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec----ccccccccc
Confidence                  247888899999999999999999999999999999999875 777899999876422211    111112222


Q ss_pred             c-cCCccccCCCCCcchhHHHHHHHHHHHHH
Q psy15818        177 W-MAPESLYDNIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       177 ~-~~PE~~~~~~~~~~~Di~slg~ll~~l~~  206 (225)
                      | .++.......+-...|+||||.-+.+..+
T Consensus       431 ~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~  461 (524)
T KOG0601|consen  431 YPIAEILLEDYPHLSKADIFSLGLSVDEAIT  461 (524)
T ss_pred             cccchhhcccccccccccccccccccccccc
Confidence            3 24444456667889999999999998887

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=2.5e-08  Score=76.00  Aligned_cols=125  Identities=24%  Similarity=0.253  Sum_probs=91.8

Q ss_pred             cceeeecCCCCCCCCccceEEEEeeeccc-------------------cc--hHHHHHHHHHHHHHhhcCCC-CCeeeee
Q psy15818          5 SVEVRKHPMSPERGREGPCIVAVKTLKEN-------------------AG--ERERLDLLQELTVMKTLDPH-PNVVRLL   62 (225)
Q Consensus         5 g~~v~~~~~~~~~~~~~~~~vavK~~~~~-------------------~~--~~~~~~~~~e~~~~~~~~~~-~~i~~~~   62 (225)
                      | .||.+.      ...|..+|||.=+..                   .+  .-.+....+|..+|.++.+. -.+.+.+
T Consensus       105 s-dVY~~~------~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~  177 (304)
T COG0478         105 S-DVYVAI------DPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI  177 (304)
T ss_pred             c-eEEEEE------CCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcc
Confidence            5 788887      346888999975321                   01  12234467899999999744 4666666


Q ss_pred             eEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe
Q psy15818         63 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI  142 (225)
Q Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~  142 (225)
                      ++    +...+|||+.+|..|...                  +++.+....++..++.-+.-+-..|++|+|+++-||++
T Consensus       178 ~~----nRHaVvMe~ieG~eL~~~------------------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV  235 (304)
T COG0478         178 AW----NRHAVVMEYIEGVELYRL------------------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV  235 (304)
T ss_pred             cc----ccceeeeehcccceeecc------------------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE
Confidence            54    567899999998665321                  23455666677777777777779999999999999999


Q ss_pred             cCCCceeEeeeccccc
Q psy15818        143 GENHCCKVADFGFARD  158 (225)
Q Consensus       143 ~~~~~~~l~d~g~~~~  158 (225)
                      +++|.+.++||..+..
T Consensus       236 ~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         236 TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ecCCCEEEEeCccccc
Confidence            9999999999987653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.86  E-value=4.1e-08  Score=73.12  Aligned_cols=114  Identities=13%  Similarity=0.160  Sum_probs=71.4

Q ss_pred             cceEEEEeeeccccchHH--HHH------HHHHHHHHhhcC--CCCCeeeeeeE-----EecCCCeEEEEeecCCCCHHH
Q psy15818         21 GPCIVAVKTLKENAGERE--RLD------LLQELTVMKTLD--PHPNVVRLLGC-----CTEKEPFFVIMEYVPYGKLQS   85 (225)
Q Consensus        21 ~~~~vavK~~~~~~~~~~--~~~------~~~e~~~~~~~~--~~~~i~~~~~~-----~~~~~~~~lv~e~~~~~~L~~   85 (225)
                      +|+.+++|.+++......  ...      ..+.+....++.  +-....+++-+     +......+++|||++|..|.+
T Consensus        53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d  132 (229)
T PF06176_consen   53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND  132 (229)
T ss_pred             CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence            578889999875321111  000      122333333332  13333333333     233445679999999988754


Q ss_pred             HHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         86 FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ...                 +++    .+...+.+++..+|+.|++|+|.+|.|+++++++ ++++|++..
T Consensus       133 ~~~-----------------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k  181 (229)
T PF06176_consen  133 IED-----------------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGK  181 (229)
T ss_pred             chh-----------------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccc
Confidence            432                 232    2345677889999999999999999999998655 999999754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.78  E-value=8.4e-08  Score=80.67  Aligned_cols=140  Identities=18%  Similarity=0.214  Sum_probs=92.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHH---------------------------------------H
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLD---------------------------------------L   42 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------------------------------------~   42 (225)
                      ++-| -||.|.+      .+|+.||||+.+++..+....+                                       +
T Consensus       136 ASIa-QVH~A~L------~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         136 ASIA-QVHRAVL------KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             hhHh-hheeEEe------cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            3567 8999996      4499999999977433222111                                       2


Q ss_pred             HHHHHHHhhc----CCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHH
Q psy15818         43 LQELTVMKTL----DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV  118 (225)
Q Consensus        43 ~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql  118 (225)
                      .+|...+.++    .+.|++.-..=+.+..+.-.++|||++|..+.+......            ...+...+...+.++
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------------~g~d~k~ia~~~~~~  276 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------------AGIDRKELAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh------------cCCCHHHHHHHHHHH
Confidence            3344433332    346666555555566677899999999988888754321            134433333333222


Q ss_pred             HHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCc
Q psy15818        119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS  162 (225)
Q Consensus       119 ~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  162 (225)
                        .+..+=..|++|.|.+|.||++..++++.+.|||+...+...
T Consensus       277 --f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         277 --FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              233445589999999999999999999999999998766443

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=2.8e-07  Score=68.41  Aligned_cols=123  Identities=13%  Similarity=0.109  Sum_probs=84.0

Q ss_pred             ceEEEEeeeccccc-----hHHHHHHHHHHHHHhhcCCCCC--eeeeeeEEe---c--CCCeEEEEeecCC-CCHHHHHH
Q psy15818         22 PCIVAVKTLKENAG-----ERERLDLLQELTVMKTLDPHPN--VVRLLGCCT---E--KEPFFVIMEYVPY-GKLQSFLR   88 (225)
Q Consensus        22 ~~~vavK~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~--i~~~~~~~~---~--~~~~~lv~e~~~~-~~L~~~~~   88 (225)
                      |+.+-+|.......     +-....+.+|+..+..+. .-+  +.++. ++.   .  .-..+||+|-+.| .+|.+.+.
T Consensus        41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~  118 (216)
T PRK09902         41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYA  118 (216)
T ss_pred             CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHh
Confidence            44677887752211     223345788888887765 222  33333 221   1  1236889997754 57777765


Q ss_pred             HhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc--eeEeeecccc
Q psy15818         89 SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC--CKVADFGFAR  157 (225)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~--~~l~d~g~~~  157 (225)
                      ...           ....++.....++.++...++.||+.|+.|+|+.+.||+++..+.  +.++||.-+.
T Consensus       119 ~~~-----------~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        119 QHA-----------VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             cCC-----------cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            421           123567778899999999999999999999999999999985556  9999998653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=4.2e-07  Score=69.11  Aligned_cols=58  Identities=7%  Similarity=-0.011  Sum_probs=40.6

Q ss_pred             ceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCC-CeeeeeeEEecCCCeEEEEeecCCCC
Q psy15818         22 PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP-NVVRLLGCCTEKEPFFVIMEYVPYGK   82 (225)
Q Consensus        22 ~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (225)
                      +..+++|........   ....+|.+.+..+.... -+.+.+++.++.+...++|++++|.+
T Consensus        22 ~~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        22 TGKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             CCCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            345778988754322   24678888888876332 24677777777888899999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.63  E-value=8.4e-07  Score=68.27  Aligned_cols=69  Identities=12%  Similarity=0.069  Sum_probs=48.7

Q ss_pred             eeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHH
Q psy15818          7 EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF   86 (225)
Q Consensus         7 ~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   86 (225)
                      .||+...       .+..+++|+.....    .....+|+.++..+..+--+.+++++....+..++||++++|.++.+.
T Consensus        14 ~v~~~~~-------~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          14 TVYRLDG-------KNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             eEEEEcC-------CCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            6777772       23567888876543    224667888888776555566778777777778999999999877644

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=1.3e-06  Score=66.08  Aligned_cols=129  Identities=20%  Similarity=0.211  Sum_probs=84.9

Q ss_pred             eeeecCCCCCCCCccceEEEEeeeccccchHHH----------------------HH-HHHHHHHHhhcC-CCCCeeeee
Q psy15818          7 EVRKHPMSPERGREGPCIVAVKTLKENAGERER----------------------LD-LLQELTVMKTLD-PHPNVVRLL   62 (225)
Q Consensus         7 ~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------------------~~-~~~e~~~~~~~~-~~~~i~~~~   62 (225)
                      .||+|.      ..++..+|+|+++.+...-..                      .. ..+|...|.++. .+-.+.+.+
T Consensus        63 ~Vy~a~------~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi  136 (268)
T COG1718          63 NVYLAE------TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPI  136 (268)
T ss_pred             EEEeec------cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCce
Confidence            677776      366899999999754221110                      00 345677776654 234455555


Q ss_pred             eEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEE
Q psy15818         63 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVL  141 (225)
Q Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil  141 (225)
                      .+..    -.|||||......     ..       +.. ...++..++...+..++++.+.-|-. .+++|+||+.-||+
T Consensus       137 ~~~~----nVLvMEfIg~~g~-----pA-------P~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         137 AFRN----NVLVMEFIGDDGL-----PA-------PRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             eecC----CeEEEEeccCCCC-----CC-------CCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            5433    4599999854310     00       000 12233344678888899999988877 89999999999999


Q ss_pred             ecCCCceeEeeecccccc
Q psy15818        142 IGENHCCKVADFGFARDL  159 (225)
Q Consensus       142 ~~~~~~~~l~d~g~~~~~  159 (225)
                      +. .+.+.++|++.+...
T Consensus       200 ~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         200 VH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             EE-CCeEEEEECcccccc
Confidence            99 777999999988644

>KOG2137|consensus

Probab=98.44  E-value=3e-08  Score=83.91  Aligned_cols=104  Identities=24%  Similarity=0.379  Sum_probs=77.7

Q ss_pred             HHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeecccccccCcccccccc-------CCCCCccccCCcccc
Q psy15818        113 SFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKS-------EGRLPIRWMAPESLY  184 (225)
Q Consensus       113 ~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~-------~~~~~~~~~~PE~~~  184 (225)
                      .=+.+...|+.++|.. +++|+.|.|++|+++.++.+|++.|+++.....+.......       .......|.+||.+.
T Consensus       103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3344566899999965 79999999999999999999999999886544422211000       111234599999998


Q ss_pred             CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        185 DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       185 ~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ....+.++|+||+|+++|.+...|..-+...+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~  214 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANG  214 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccC
Confidence            88888999999999999988854666665543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=4.2e-06  Score=63.54  Aligned_cols=73  Identities=21%  Similarity=0.235  Sum_probs=46.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCC-CeeeeeeEE---ecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP-NVVRLLGCC---TEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~---~~~~~~~lv~e~   77 (225)
                      |..+ .+|+...      . +..+++|.....   .....+.+|..++..+..+. -+.+++...   ...+..+++|++
T Consensus         8 G~~n-~~~~v~~------~-~~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    8 GFSN-RVYRVTT------D-DGRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             SSSS-EEEEEEE------T-TSEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CCee-eEEEEEE------C-CcEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            5566 7888882      2 358889997654   33345667777777765331 244555432   334457999999


Q ss_pred             cCCCCHHH
Q psy15818         78 VPYGKLQS   85 (225)
Q Consensus        78 ~~~~~L~~   85 (225)
                      ++|..+..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.31  E-value=7.4e-06  Score=73.67  Aligned_cols=77  Identities=16%  Similarity=0.147  Sum_probs=48.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCe--eeeeeEEecC---CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV--VRLLGCCTEK---EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i--~~~~~~~~~~---~~~~lv~e   76 (225)
                      |.+. .+|+.....   ......+++|+.+..........+.+|..+++.+..|+++  .+++.++.+.   +..|+|||
T Consensus        49 G~sn-~ty~l~~~~---~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME  124 (822)
T PLN02876         49 GQSN-PTFLLEVGN---GGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME  124 (822)
T ss_pred             CCcC-ceEEEEECC---CCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence            4555 666654311   1111457778765443222234678999999988645554  6777776654   56889999


Q ss_pred             ecCCCC
Q psy15818         77 YVPYGK   82 (225)
Q Consensus        77 ~~~~~~   82 (225)
                      +++|..
T Consensus       125 ~v~G~~  130 (822)
T PLN02876        125 YLEGRI  130 (822)
T ss_pred             ecCCcc
Confidence            999864

>KOG1235|consensus

Probab=98.16  E-value=2e-05  Score=66.57  Aligned_cols=80  Identities=16%  Similarity=0.201  Sum_probs=54.9

Q ss_pred             CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---
Q psy15818         68 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---  144 (225)
Q Consensus        68 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---  144 (225)
                      ...-.|+|||++|..+.+.-.-.            ...++...+..-+.+...  +.+=..|.+|+|-+|.||++..   
T Consensus       274 st~RVLtME~~~G~~i~Dl~~i~------------~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~  339 (538)
T KOG1235|consen  274 STKRVLTMEYVDGIKINDLDAID------------KRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPE  339 (538)
T ss_pred             CcceEEEEEecCCccCCCHHHHH------------HcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCC
Confidence            44568999999997665552211            124666655544444332  2344678999999999999983   


Q ss_pred             -CCceeEeeecccccccC
Q psy15818        145 -NHCCKVADFGFARDLMT  161 (225)
Q Consensus       145 -~~~~~l~d~g~~~~~~~  161 (225)
                       +.++.+.|||+...++.
T Consensus       340 ~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  340 GDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccEEEEcccccccccH
Confidence             56899999999875543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.16  E-value=1.6e-05  Score=61.63  Aligned_cols=142  Identities=13%  Similarity=0.152  Sum_probs=72.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |..+ .+|+..       .+++.+++|........- ..+..+|..+++.+..+.-..+++....    -++|++|++|.
T Consensus         7 G~tn-~~y~~~-------~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         7 GLTN-RSWRIE-------HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             cCcC-CeEEEE-------eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            4445 667665       345678899865432221 0134667777777763322234443322    36899999986


Q ss_pred             CHHHH-------HHHhhhhhhhcccCCC---CCCCCh-HHHHHHHHHH---------HHHHHHHHh--------CCcccC
Q psy15818         82 KLQSF-------LRSSRAQRYYNNMHGK---SNSLTS-RDLTSFCYQV---------ARGMQFLSS--------RGIIHR  133 (225)
Q Consensus        82 ~L~~~-------~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~ql---------~~~l~~Lh~--------~~i~h~  133 (225)
                      .+...       ...  -.+....++..   ...++. ..+..+..++         ...+..+-.        ..++|+
T Consensus        74 ~~~~~~~~~~~~~~~--la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        74 VITLDQFVALDLLLE--LAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             ccccccccCchhHHH--HHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            64321       000  00000111111   111111 1122222111         111222221        258999


Q ss_pred             CCCCCCEEecCCCceeEeeecccccc
Q psy15818        134 DLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       134 dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |+.|.||++++++ +.++||..+...
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCcC
Confidence            9999999998776 789999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.14  E-value=1.5e-05  Score=58.82  Aligned_cols=102  Identities=19%  Similarity=0.196  Sum_probs=77.5

Q ss_pred             HHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHH
Q psy15818         43 LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM  122 (225)
Q Consensus        43 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (225)
                      ..|..+++.+.+.+++++++|+|.    -+++.|+...+++.......  .        .....+...+.+++.++++.+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l--~--------~~~~~~w~~R~~iA~~lL~~l   72 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL--S--------QFLQSPWEQRAKIALQLLELL   72 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc--c--------cccccCHHHHHHHHHHHHHHH
Confidence            357778888886679999999984    35788998765543210000  0        001347888999999999999


Q ss_pred             HHHHh---CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        123 QFLSS---RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       123 ~~Lh~---~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+|+.   ..+...|++++|+.++++++++++|.+.+..
T Consensus        73 ~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   73 EELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99997   4588899999999999999999999988754

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.04  E-value=7.5e-05  Score=53.82  Aligned_cols=121  Identities=20%  Similarity=0.160  Sum_probs=82.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |..| .||++.|       .|..+|+|.-+.++.   +..+..|..++..+.+..--.+++.+-.    .++.|||..|.
T Consensus        33 G~~s-~Vyl~~~-------~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          33 GTTS-VVYLGEW-------RGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             cccc-EEEEeec-------cCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            6788 9999995       356889998776444   3468889998888885555555665533    34569999988


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCCEEecCCCceeEeeecccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA-ARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~-~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .|.+....                .....+    ..+++..--|-..||-|+.|+ |...++.+++.+.|+||..|.
T Consensus        98 ~L~~~~~~----------------~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIG----------------GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhc----------------ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            88655531                122222    334555455677899999886 445555555589999999886

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.03  E-value=7.3e-05  Score=57.09  Aligned_cols=29  Identities=28%  Similarity=0.502  Sum_probs=25.8

Q ss_pred             CcccCCCCCCCEEecC-CCceeEeeecccc
Q psy15818        129 GIIHRDLAARNVLIGE-NHCCKVADFGFAR  157 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~-~~~~~l~d~g~~~  157 (225)
                      .++|+|+.+.||++++ ++.+.++||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5899999999999997 5779999999774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.95  E-value=0.00078  Score=50.07  Aligned_cols=81  Identities=19%  Similarity=0.325  Sum_probs=59.4

Q ss_pred             CCCCeeeeeeEEecCCCeEEEEeecCC------CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q psy15818         54 PHPNVVRLLGCCTEKEPFFVIMEYVPY------GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS  127 (225)
Q Consensus        54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~  127 (225)
                      .+..|.+++|+.+++....+|+|....      .+|.+++...              .+++ .+.   ..+-+..++|-+
T Consensus        75 ~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--------------~~~~-~~~---~~L~~f~~~l~~  136 (199)
T PF10707_consen   75 DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--------------GLTE-ELR---QALDEFKRYLLD  136 (199)
T ss_pred             cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--------------CccH-HHH---HHHHHHHHHHHH
Confidence            488999999999999999999988653      3677777432              3444 333   334455567888


Q ss_pred             CCcccCCCCCCCEEecC--CC--ceeEee
Q psy15818        128 RGIIHRDLAARNVLIGE--NH--CCKVAD  152 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~--~~--~~~l~d  152 (225)
                      .+|+.+|++|.||++..  ++  .+.|+|
T Consensus       137 ~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  137 HHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            99999999999999963  22  467777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=0.00015  Score=55.44  Aligned_cols=30  Identities=33%  Similarity=0.467  Sum_probs=25.1

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .+++|+|+.+.|++++++...-++||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            358999999999999876555699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576|consensus

Probab=97.84  E-value=7.8e-06  Score=69.35  Aligned_cols=151  Identities=21%  Similarity=0.235  Sum_probs=103.3

Q ss_pred             HHHHHHHHHhhcCCCCC-eeeeeeEEecCCCeEEEEeecCCC-CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHH
Q psy15818         41 DLLQELTVMKTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYG-KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV  118 (225)
Q Consensus        41 ~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql  118 (225)
                      ...-++.+|.+++ ||| .+..++.++.....++.++++.++ +-......            ....+.+-++....+.-
T Consensus       279 ~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~------------se~~~~~~~~~~~~r~e  345 (829)
T KOG0576|consen  279 SRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV------------SEIALEQYQFAYPLRKE  345 (829)
T ss_pred             hhHHHHHHHHHcc-CCCCcccccccCCcccccchhhhhhcCCccccccCCh------------hhHhhhhhhhhhhhhhh
Confidence            4556788899998 999 666666666677789999999876 11111100            01113333445555666


Q ss_pred             HHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHH
Q psy15818        119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG  198 (225)
Q Consensus       119 ~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg  198 (225)
                      .++++++|+.--+|+|    ||+..+ +..+..+|+....+....   ......+++.+++||+.....+....|.|+++
T Consensus       346 t~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~  417 (829)
T KOG0576|consen  346 TRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLA  417 (829)
T ss_pred             cccccccccccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCC
Confidence            7788899988767887    666544 568899999886654443   33445567889999998888888999999999


Q ss_pred             HHHHHHHHcCCCCCC
Q psy15818        199 VLIWEIVTLGSTPYP  213 (225)
Q Consensus       199 ~ll~~l~~~g~~p~~  213 (225)
                      .-..++-- |.+|-.
T Consensus       418 ~~~~~~ap-~~pPr~  431 (829)
T KOG0576|consen  418 VSAIQMAP-GLPPRS  431 (829)
T ss_pred             cchhhcCC-CCCCCC
Confidence            76666655 666654

>PRK10593 hypothetical protein; Provisional

Probab=97.80  E-value=0.00076  Score=53.53  Aligned_cols=71  Identities=10%  Similarity=-0.025  Sum_probs=45.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCC--CCeeeeeeEEec---CCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH--PNVVRLLGCCTE---KEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~--~~i~~~~~~~~~---~~~~~lv~e   76 (225)
                      |..+ .||...      ..++ .+++|..+.....   ..+..|...++.+.+.  ..+.++++++.+   .+..++|||
T Consensus        25 G~~~-~vy~~~------~~~~-~~~~k~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         25 QPYA-ALWALY------DSQG-NPMPLMARSFSTP---GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             ccce-eEEEEE------cCCC-CEEEEEecccccc---hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            4455 666654      1223 4667775431122   2477888888877643  467788877654   467899999


Q ss_pred             ecCCCCH
Q psy15818         77 YVPYGKL   83 (225)
Q Consensus        77 ~~~~~~L   83 (225)
                      +++|.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.72  E-value=0.00063  Score=54.11  Aligned_cols=139  Identities=20%  Similarity=0.224  Sum_probs=74.2

Q ss_pred             ceEEEEeeeccccchHHHHHHHHHHHHHhhcCC-CCCeeeeeeEEecC--CCeEEEEeecCCCCHHH-------------
Q psy15818         22 PCIVAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQS-------------   85 (225)
Q Consensus        22 ~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~-------------   85 (225)
                      +++++++...............+|...+..+.. ..-+...++.+.+.  +..+.||+++.|....+             
T Consensus        48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~  127 (321)
T COG3173          48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL  127 (321)
T ss_pred             CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence            677888833223344445567788888888753 12233335555444  47799999999832211             


Q ss_pred             -----HHHHhhhhhhhcccCCCC--CCCChHHHHHHHHHH--------------HHHHHHHHhC--------CcccCCCC
Q psy15818         86 -----FLRSSRAQRYYNNMHGKS--NSLTSRDLTSFCYQV--------------ARGMQFLSSR--------GIIHRDLA  136 (225)
Q Consensus        86 -----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ql--------------~~~l~~Lh~~--------~i~h~dl~  136 (225)
                           .+....... -....+..  ......++..+..+.              .....+|+++        .++|+|+.
T Consensus       128 ~~l~~~La~LH~id-a~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         128 DALADFLAELHSID-AAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHhCCC-CcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                 111111111 00000000  001112222222222              1123344432        58999999


Q ss_pred             CCCEEecCCCceeEeeecccccccC
Q psy15818        137 ARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus       137 ~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +.|+++++++-+-|+||+.+....+
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccCCc
Confidence            9999999877789999998875433

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.0029  Score=50.08  Aligned_cols=31  Identities=45%  Similarity=0.628  Sum_probs=26.9

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|+|+.|.|+++++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999877678999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.0037  Score=49.81  Aligned_cols=30  Identities=47%  Similarity=0.637  Sum_probs=26.8

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .+++|+|+.+.|+++++++.+.++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999887766899999885

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.65  E-value=0.00019  Score=53.98  Aligned_cols=29  Identities=34%  Similarity=0.535  Sum_probs=20.6

Q ss_pred             CcccCCCCCCCEEe-cCCCceeEeeecccc
Q psy15818        129 GIIHRDLAARNVLI-GENHCCKVADFGFAR  157 (225)
Q Consensus       129 ~i~h~dl~~~nil~-~~~~~~~l~d~g~~~  157 (225)
                      -++|+|+.+.||++ ..++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 788899999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK05231 homoserine kinase; Provisional

Probab=97.63  E-value=0.0047  Score=49.46  Aligned_cols=31  Identities=42%  Similarity=0.609  Sum_probs=26.2

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|+|+.|.||+++++...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999998665557999998853

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.63  E-value=0.0012  Score=54.33  Aligned_cols=72  Identities=17%  Similarity=0.002  Sum_probs=44.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-----c-chHHHHHHHHHHHHHhhcCC--CCCeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-----A-GERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~l   73 (225)
                      |.+. .||+...     ..+++.|+||.-.+.     . .+....+...|...|..+..  ...+++++.+  +....++
T Consensus        37 Gn~N-~VyrV~~-----~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         37 GNLN-LVFRVSD-----TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             CceE-EEEEEEe-----CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            5667 7888873     233357899985422     1 12234456667777776542  3456667765  4456789


Q ss_pred             EEeecCCC
Q psy15818         74 IMEYVPYG   81 (225)
Q Consensus        74 v~e~~~~~   81 (225)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999863

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.62  E-value=0.00052  Score=54.50  Aligned_cols=31  Identities=26%  Similarity=0.299  Sum_probs=27.0

Q ss_pred             CcccCCCCCCCEEecCC----CceeEeeecccccc
Q psy15818        129 GIIHRDLAARNVLIGEN----HCCKVADFGFARDL  159 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~----~~~~l~d~g~~~~~  159 (225)
                      .++|+|+.+.||+++++    +.+.++||..+...
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            58999999999999874    78999999988643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035|consensus

Probab=97.60  E-value=0.00062  Score=61.91  Aligned_cols=155  Identities=21%  Similarity=0.242  Sum_probs=98.8

Q ss_pred             HHHHHHHHHHhhcCCCCCeeeeeeEEecCC----CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHH
Q psy15818         40 LDLLQELTVMKTLDPHPNVVRLLGCCTEKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC  115 (225)
Q Consensus        40 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  115 (225)
                      .....|...+.... |+|+..++.+--...    ...+..++|...++.+.+...             ..++....+.+.
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-------------~~i~~~~~r~~~  292 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-------------GSIPLETLRILH  292 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-------------cccCHHHHHHHH
Confidence            33455666677777 999999988854322    233555788888888887654             367889999999


Q ss_pred             HHHHHHHHHHHhCCcccCCCCCCCEE---ecCCCceeEe--eecccccccCccccccccCCCCCccccCCccccCCCC--
Q psy15818        116 YQVARGMQFLSSRGIIHRDLAARNVL---IGENHCCKVA--DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF--  188 (225)
Q Consensus       116 ~ql~~~l~~Lh~~~i~h~dl~~~nil---~~~~~~~~l~--d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--  188 (225)
                      .++++++.++|+..+.|.-+..+...   .+..+.+...  ||+....+........   ...+..+.+||.......  
T Consensus       293 ~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~  369 (1351)
T KOG1035|consen  293 QKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKK  369 (1351)
T ss_pred             HHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchh
Confidence            99999999999985555444433221   1223334444  7776655433322211   112233677776554443  


Q ss_pred             CcchhHHHHHHHHHHHHHcCCCC
Q psy15818        189 SVKSDIWSFGVLIWEIVTLGSTP  211 (225)
Q Consensus       189 ~~~~Di~slg~ll~~l~~~g~~p  211 (225)
                      +...|+|++|.+...+..+...+
T Consensus       370 ~r~~dL~~lgll~~~~~~~~~i~  392 (1351)
T KOG1035|consen  370 SRLTDLWCLGLLLLQLSQGEDIS  392 (1351)
T ss_pred             hhhhHHHHHHHHHhhhhhcCccc
Confidence            34479999999999988744443

>PLN02236 choline kinase

Probab=97.43  E-value=0.0022  Score=51.99  Aligned_cols=132  Identities=21%  Similarity=0.282  Sum_probs=70.6

Q ss_pred             cceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHH----------HHHh
Q psy15818         21 GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----------LRSS   90 (225)
Q Consensus        21 ~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~----------~~~~   90 (225)
                      .++.|++|+......  ...+..+|..+++.+....--.++++.+.. +   .|.+|+++.++...          +...
T Consensus        64 ~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~  137 (344)
T PLN02236         64 LGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHARTLSAADLRDPEISALIAAK  137 (344)
T ss_pred             CCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHH
Confidence            357888998865432  222346788888877644444456666543 2   57899887665421          1000


Q ss_pred             hhhhhhcc-cCCCCCCCChHHHHHHHHHHH-----------------HHHHHH----H----hCCcccCCCCCCCEEecC
Q psy15818         91 RAQRYYNN-MHGKSNSLTSRDLTSFCYQVA-----------------RGMQFL----S----SRGIIHRDLAARNVLIGE  144 (225)
Q Consensus        91 ~~~~~~~~-~~~~~~~~~~~~~~~~~~ql~-----------------~~l~~L----h----~~~i~h~dl~~~nil~~~  144 (225)
                       ..+.+.. ..+.........+..+..++.                 ..+..|    .    ...++|+|+++.||++++
T Consensus       138 -L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~  216 (344)
T PLN02236        138 -LREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDE  216 (344)
T ss_pred             -HHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeC
Confidence             0111111 011110111222333332221                 111111    1    225899999999999986


Q ss_pred             -CCceeEeeecccccc
Q psy15818        145 -NHCCKVADFGFARDL  159 (225)
Q Consensus       145 -~~~~~l~d~g~~~~~  159 (225)
                       ++.+.++||..+...
T Consensus       217 ~~~~~~lID~Eya~~~  232 (344)
T PLN02236        217 ETRAITIIDYEYASYN  232 (344)
T ss_pred             CCCcEEEEeehhcccc
Confidence             467999999988643

>KOG2268|consensus

Probab=97.38  E-value=0.00032  Score=55.57  Aligned_cols=96  Identities=20%  Similarity=0.235  Sum_probs=69.5

Q ss_pred             HHHHHHHHHhhcCCCCC-eeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHH
Q psy15818         41 DLLQELTVMKTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA  119 (225)
Q Consensus        41 ~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~  119 (225)
                      ...+|.+.|..+..|.. +.+.+    +.++.++||+++.|..|.+.-.                ..++   ..+...+.
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----------------v~d~---~~ly~~lm  212 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH----------------VEDP---PTLYDDLM  212 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee----------------cCCh---HHHHHHHH
Confidence            35678888888874332 23334    3467889999999888764432                1223   33444566


Q ss_pred             HHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818        120 RGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       120 ~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ..+.-|...|++|+|..--||++.+++.++++||..+...
T Consensus       213 ~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  213 GLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             HHHHHHHHcCceecccchheeEEecCCCEEEeechHhhcc
Confidence            6677888999999999999999999999999999877543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.18  E-value=0.0059  Score=49.27  Aligned_cols=29  Identities=24%  Similarity=0.406  Sum_probs=25.4

Q ss_pred             cccCCCCCCCEEecC-CCceeEeeeccccc
Q psy15818        130 IIHRDLAARNVLIGE-NHCCKVADFGFARD  158 (225)
Q Consensus       130 i~h~dl~~~nil~~~-~~~~~l~d~g~~~~  158 (225)
                      ++|+|+.+.||++++ ++.++++||..+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999974 56899999998863

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.10  E-value=0.019  Score=46.28  Aligned_cols=29  Identities=24%  Similarity=0.150  Sum_probs=24.4

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|+|+.+.||+++ + .+.++||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4689999999999995 3 578999998853

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.98  E-value=0.045  Score=43.01  Aligned_cols=31  Identities=26%  Similarity=0.329  Sum_probs=25.3

Q ss_pred             CcccCCCCCCCEEecCCCc-eeEeeecccccc
Q psy15818        129 GIIHRDLAARNVLIGENHC-CKVADFGFARDL  159 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~-~~l~d~g~~~~~  159 (225)
                      .++|+|++|.||+++++++ .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 459999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270|consensus

Probab=96.95  E-value=0.0062  Score=49.35  Aligned_cols=128  Identities=19%  Similarity=0.181  Sum_probs=80.2

Q ss_pred             eeeecCCCCCCCCccceEEEEeeeccccc-----------------------hHHHH-H-HHHHHHHHhhcCCCCCeeee
Q psy15818          7 EVRKHPMSPERGREGPCIVAVKTLKENAG-----------------------ERERL-D-LLQELTVMKTLDPHPNVVRL   61 (225)
Q Consensus         7 ~v~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~-~-~~~e~~~~~~~~~~~~i~~~   61 (225)
                      .||.+.      ..+|..+|||+++.+.-                       +.... . +..|++.|.++. ..+|.-.
T Consensus       159 NVYHat------~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~aGIP~P  231 (520)
T KOG2270|consen  159 NVYHAT------EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NAGIPCP  231 (520)
T ss_pred             eeEeee------cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hcCCCCC
Confidence            577766      45677799999975321                       11111 1 356788888876 4444322


Q ss_pred             eeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCE
Q psy15818         62 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS-SRGIIHRDLAARNV  140 (225)
Q Consensus        62 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~~i~h~dl~~~ni  140 (225)
                      --+.-  ....|||+|+. .+-...-..            ....++...+..+-.|++.-++-|- ..+++|.||+--|+
T Consensus       232 ePIlL--k~hVLVM~FlG-rdgw~aPkL------------Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  232 EPILL--KNHVLVMEFLG-RDGWAAPKL------------KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL  296 (520)
T ss_pred             Cceee--ecceEeeeecc-CCCCcCccc------------ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence            22111  23569999995 322111000            2335677778888888888777765 45899999999999


Q ss_pred             EecCCCceeEeeecccc
Q psy15818        141 LIGENHCCKVADFGFAR  157 (225)
Q Consensus       141 l~~~~~~~~l~d~g~~~  157 (225)
                      ++.++ .+.++|.+.+.
T Consensus       297 LyhdG-~lyiIDVSQSV  312 (520)
T KOG2270|consen  297 LYHDG-KLYIIDVSQSV  312 (520)
T ss_pred             eEECC-EEEEEEccccc
Confidence            98654 58888887654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.84  E-value=0.014  Score=43.40  Aligned_cols=113  Identities=23%  Similarity=0.232  Sum_probs=71.3

Q ss_pred             cceeeecCCCCCCCCccceEEEEeeecc---cc--------ch---------HHHHHHHHHHHHHhhcCC--CCCe--ee
Q psy15818          5 SVEVRKHPMSPERGREGPCIVAVKTLKE---NA--------GE---------RERLDLLQELTVMKTLDP--HPNV--VR   60 (225)
Q Consensus         5 g~~v~~~~~~~~~~~~~~~~vavK~~~~---~~--------~~---------~~~~~~~~e~~~~~~~~~--~~~i--~~   60 (225)
                      | .||+++       -.|+.||+|+++.   ..        ..         ....-+..|.+...+++.  +.++  ++
T Consensus        52 ~-~V~kv~-------I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avk  123 (207)
T PF13095_consen   52 G-YVFKVE-------IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVK  123 (207)
T ss_pred             e-EEEEEE-------ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEE
Confidence            6 788888       4588999999321   10        00         111235567777666652  4444  88


Q ss_pred             eeeEEecC------------------CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHH
Q psy15818         61 LLGCCTEK------------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM  122 (225)
Q Consensus        61 ~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (225)
                      .++|..-.                  ....||.||.+...                      .++.+.    +.++++-+
T Consensus       124 c~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------------~~~~~~----~~~~~~dl  177 (207)
T PF13095_consen  124 CHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------------PLQIRD----IPQMLRDL  177 (207)
T ss_pred             eeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------------ccchhH----HHHHHHHH
Confidence            88886211                  01356666655322                      123333    34667778


Q ss_pred             HHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818        123 QFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus       123 ~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ..+|+.||+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            8899999999999999986     3589999864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.78  E-value=0.023  Score=45.39  Aligned_cols=30  Identities=20%  Similarity=0.193  Sum_probs=27.3

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +++|+|+.++|+++++++.+-++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999888899999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.73  E-value=0.0057  Score=49.43  Aligned_cols=84  Identities=18%  Similarity=0.235  Sum_probs=59.7

Q ss_pred             CCCeeeeeeEE-ecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-Cccc
Q psy15818         55 HPNVVRLLGCC-TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIH  132 (225)
Q Consensus        55 ~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h  132 (225)
                      .++..+.+-+- .+....|++|++. |+.+.. ++                -...+++..++++.++.+.-+..+ ..-|
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik----------------~~~~~e~lsff~s~~sil~~lekkf~feh  345 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK----------------ADRSEEELSFFWSCISILDILEKKFPFEH  345 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee-ee----------------cccHHHHHHHHHHHHHHHhhhhhcCCccc
Confidence            55555544443 2333457777765 455532 21                235677888888888888887765 5789


Q ss_pred             CCCCCCCEEecCCCceeEeeecccc
Q psy15818        133 RDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       133 ~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      |++..+||+++ .|+|.|+||-+++
T Consensus       346 rnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         346 RNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             ccccccceeee-cCceEEEEeeeee
Confidence            99999999999 8899999999887

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.73  E-value=0.019  Score=46.58  Aligned_cols=71  Identities=17%  Similarity=0.038  Sum_probs=41.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecc------ccchHHHHHHHHHHHHHhhcCC-CC-CeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKE------NAGERERLDLLQELTVMKTLDP-HP-NVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~~e~~~~~~~~~-~~-~i~~~~~~~~~~~~~~l   73 (225)
                      |... .||++..     ..+++.|+||.-.+      ...+-...+...|...|+.... .| .+++++.+  +.....+
T Consensus         6 GnlN-~VfrV~~-----~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~   77 (370)
T TIGR01767         6 GNLN-LVFHVYD-----QEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT   77 (370)
T ss_pred             CceE-EEEEEEc-----CCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence            4455 7888873     33346788988532      1224444556667777766542 23 45555543  5556678


Q ss_pred             EEeecCC
Q psy15818         74 IMEYVPY   80 (225)
Q Consensus        74 v~e~~~~   80 (225)
                      |||+++.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            9998853

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.69  E-value=0.031  Score=46.21  Aligned_cols=29  Identities=28%  Similarity=0.471  Sum_probs=24.1

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      ..++|||+.+.||++.+++ .+++|..++.
T Consensus       230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             cceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            3699999999999998765 8888877654

>PRK06148 hypothetical protein; Provisional

Probab=96.53  E-value=0.065  Score=49.79  Aligned_cols=30  Identities=30%  Similarity=0.463  Sum_probs=25.4

Q ss_pred             CCcccCCCCCCCEEecCCC--cee-Eeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENH--CCK-VADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~--~~~-l~d~g~~~  157 (225)
                      .+++|+|+.+.||+++.++  ++. |+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998664  555 99999875

>PTZ00384 choline kinase; Provisional

Probab=96.44  E-value=0.033  Score=45.90  Aligned_cols=40  Identities=20%  Similarity=0.256  Sum_probs=28.8

Q ss_pred             HHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHH
Q psy15818         41 DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ   84 (225)
Q Consensus        41 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   84 (225)
                      +-.+|..++..+..+..-.++++.+..    +++.||++|.++.
T Consensus        98 dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~  137 (383)
T PTZ00384         98 DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG  137 (383)
T ss_pred             ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence            346688888888756666667776653    5999999987654

>KOG1826|consensus

Probab=96.41  E-value=0.00073  Score=63.38  Aligned_cols=157  Identities=14%  Similarity=0.041  Sum_probs=106.0

Q ss_pred             HHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHH
Q psy15818         44 QELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG  121 (225)
Q Consensus        44 ~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~  121 (225)
                      .|....+... |+++....+-...  +...+..++++.+|.+.+.+-+....         ...+...-+.....+.+..
T Consensus      1278 ~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee---------~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1278 SERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE---------SPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred             hhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc---------CCcchhchHHHHHHHHHhc
Confidence            3444445555 8888776665543  33468899999999999998764321         1234444444444444666


Q ss_pred             HHHHHhC-C----cccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHH
Q psy15818        122 MQFLSSR-G----IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS  196 (225)
Q Consensus       122 l~~Lh~~-~----i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s  196 (225)
                      ..-.|+. +    .+|.++++-|.++..+.++++.++|+......  .........+++.|+.|+....-.++.++|+|.
T Consensus      1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred             cchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence            5665543 2    68999999999999999999999998862211  122222334456678888776677888899999


Q ss_pred             HHHHHHHHHHcCCCCCC
Q psy15818        197 FGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       197 lg~ll~~l~~~g~~p~~  213 (225)
                      .++.+|.... |..+|.
T Consensus      1426 ~s~~ly~rs~-~n~~fi 1441 (2724)
T KOG1826|consen 1426 RSLSLYLRSD-GNAYFI 1441 (2724)
T ss_pred             HHHHHHHHhc-ccHHHH
Confidence            9999998876 766653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.19  E-value=0.13  Score=40.60  Aligned_cols=58  Identities=17%  Similarity=0.211  Sum_probs=33.6

Q ss_pred             ccceEEEEeeeccccchHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818         20 EGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus        20 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      .+++.+.||+-......    .+..|..-|+.+.  ..-.+.+++.+....+..+|++||++.+
T Consensus        38 ~~~~~~FvK~~~~~~~~----~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   38 TDGGSYFVKVNSESGRD----MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             TTS-EEEEEEEEGGGCC----HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             CCCccEEEEecChhhHH----HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            46778889987632222    3556666666552  3567888899888777789999998865

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.85  E-value=0.04  Score=41.71  Aligned_cols=84  Identities=17%  Similarity=0.173  Sum_probs=55.4

Q ss_pred             HHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHH
Q psy15818         42 LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG  121 (225)
Q Consensus        42 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~  121 (225)
                      +..+.+++.++.   +|+++..-  ..-.+.++.|.|--..                       .....   ++.-=+++
T Consensus       105 y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~-----------------------i~~~N---~i~agi~~  153 (308)
T PF07387_consen  105 YFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIK-----------------------INFSN---FITAGIKD  153 (308)
T ss_pred             hhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCcc-----------------------cchhH---HHHHhHHH
Confidence            456666666653   45666521  3445789999985221                       11111   11222567


Q ss_pred             HHHHHhC--CcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818        122 MQFLSSR--GIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus       122 l~~Lh~~--~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |.-.|+.  +.+|+|-.|+||+.+..|-+||.|-+..
T Consensus       154 L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  154 LMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            7888844  6999999999999999999999997643

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.67  E-value=0.029  Score=44.68  Aligned_cols=29  Identities=34%  Similarity=0.637  Sum_probs=25.3

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 568899999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.53  E-value=0.027  Score=44.05  Aligned_cols=45  Identities=18%  Similarity=0.242  Sum_probs=33.9

Q ss_pred             HHHHHHHHHHHHHHhC--CcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        113 SFCYQVARGMQFLSSR--GIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       113 ~~~~ql~~~l~~Lh~~--~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      ..+..+-..+...+..  -++|+|+.|+|++.++.+.+.|+||..+.
T Consensus       136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            3444444444444444  48999999999999998999999998875

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.45  E-value=0.064  Score=44.22  Aligned_cols=29  Identities=34%  Similarity=0.508  Sum_probs=24.7

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +.++|||++|.||+++++. ++++|..++.
T Consensus       227 ~aLlHGDlHtGSI~v~~~~-~kvIDpEFAf  255 (409)
T PRK12396        227 QALIHGDLHTGSVFVKNDS-TKVIDPEFAF  255 (409)
T ss_pred             hhhccCcCCCCCEEecCCc-eEEEcccccc
Confidence            4699999999999998764 8999987774

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.16  E-value=0.018  Score=42.30  Aligned_cols=30  Identities=23%  Similarity=0.376  Sum_probs=25.7

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      -.+|+|+.|.|+++++++ ++++|++.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            468999999999998777 889999988643

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.14  E-value=0.27  Score=37.49  Aligned_cols=61  Identities=18%  Similarity=0.311  Sum_probs=40.9

Q ss_pred             ccceEEEEeeeccccchHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCCCeEEEEeecCCCCHH
Q psy15818         20 EGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ   84 (225)
Q Consensus        20 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   84 (225)
                      .+..++.||+-...    ...-+..|+.-|+.+.  +.-.+.+++.+-.+.+..|+|++|++.+.+.
T Consensus        37 dg~~~~FvK~n~~~----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          37 DGTDPFFVKCNQRE----QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cCCcceEEEecchh----hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            45677888876532    2223455555544443  1457888888888899999999999875544

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.93  E-value=0.09  Score=40.71  Aligned_cols=73  Identities=19%  Similarity=0.113  Sum_probs=46.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec-CC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV-PY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   80 (225)
                      |+.+ .|+.++      ..+|.+.++|+..+......   .......|+... ..+.+++++.-  ...-.+++|.+ ++
T Consensus        13 g~~s-~V~pv~------~~dG~~avLKl~~p~~~~~~---E~~g~~~L~~w~-G~GaVrll~~d--~~~~AlLLErl~~g   79 (253)
T PF04655_consen   13 GSSS-LVVPVR------RADGTPAVLKLAPPHAEAEH---EARGEAALRWWN-GRGAVRLLAAD--PERGALLLERLDPG   79 (253)
T ss_pred             Ccce-EEEEEE------cCCCCeEEEEecCCcccchh---hhhHHhHhheeC-CCCceeeeccc--cccchhhhhhccCC
Confidence            4556 777776      46789999999876443222   111224467776 67778998863  33455778888 45


Q ss_pred             CCHHHHH
Q psy15818         81 GKLQSFL   87 (225)
Q Consensus        81 ~~L~~~~   87 (225)
                      .+|.+..
T Consensus        80 ~~L~~~~   86 (253)
T PF04655_consen   80 RSLASLP   86 (253)
T ss_pred             Cchhhcc
Confidence            5665554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	225
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-58
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-58
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-58
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-58
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-58
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-57
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-57
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-57
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-56
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-56
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-56
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-56
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-56
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-56
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-55
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-55
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-55
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-55
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-55
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-55
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-55
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-55
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-54
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-54
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-53
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-53
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-52
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-51
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-51
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-50
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-50
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-50
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-50
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-49
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-49
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-49
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-49
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-49
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-48
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-48
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-48
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-48
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-48
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-48
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-48
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-48
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-48
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-48
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-48
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-48
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-47
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-47
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-47
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-47
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-47
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-47
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-46
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-46
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-46
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-46
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-46
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-46
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-46
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-46
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-46
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-46
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-46
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-46
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-46
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-46
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-46
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-46
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-46
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-46
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-46
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-46
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-46
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-45
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-45
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-45
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-45
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-45
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-44
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-44
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-44
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-44
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-44
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-44
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-44
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-44
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-44
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-44
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-44
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-44
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-44
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-44
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-44
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-43
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-43
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-41
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-40
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-40
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-40
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-40
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-39
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-39
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-39
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-39
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-39
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-39
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-39
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-39
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-39
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-39
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-39
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-39
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-39
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-39
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-39
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-39
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-39
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-39
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-38
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-38
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-38
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-38
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-38
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-38
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-38
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-38
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-38
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-38
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-37
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-37
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-37
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-37
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-37
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-37
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-37
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-37
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-37
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-37
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-37
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-37
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-37
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-37
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-37
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-37
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-37
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-37
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-37
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-37
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-37
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-37
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-37
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-37
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-37
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-37
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-37
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-37
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-37
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-37
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-36
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-36
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-36
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-36
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-36
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-36
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-36
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-36
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-36
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-36
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-36
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-36
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-36
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-36
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-36
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-36
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-36
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-36
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-36
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-36
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-35
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-35
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-35
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-35
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-35
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-35
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-35
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-35
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-35
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-35
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-35
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-35
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-35
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-35
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-35
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-35
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-35
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-35
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-35
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-35
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-35
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-35
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-35
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-35
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-35
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-35
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-35
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-35
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-35
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-35
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-35
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-34
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-34
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-34
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-34
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-34
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-34
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-34
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-34
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-34
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-34
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-34
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-34
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-34
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-34
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-34
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-34
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-34
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-34
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-34
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-34
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-34
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-34
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-34
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-34
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-34
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-34
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-34
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-33
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-33
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-33
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-33
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-33
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-33
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-33
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-33
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-33
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-33
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-33
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-33
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-33
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-33
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-33
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-33
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-33
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-33
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-33
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-33
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-33
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-33
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-33
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-33
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-33
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-33
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-33
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-33
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-33
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-33
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-33
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-33
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-33
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-32
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-32
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-32
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-32
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-32
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-32
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-32
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-32
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-32
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-32
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-32
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-32
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-32
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-32
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-29
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-29
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-28
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-28
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-28
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-28
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-28
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-28
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-28
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-28
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-28
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-28
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-28
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-28
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-28
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-28
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-28
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-28
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-28
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-28
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-28
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-27
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-27
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-27
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-27
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-27
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-27
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-27
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-27
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-27
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-27
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-27
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-27
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-27
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-26
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-26
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-16
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-13
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-06

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  220 bits (560), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 171
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 172 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 231
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 232 WEIFTLGGSPYPGVPVEELFK 252

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  220 bits (560), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 243 WEIFTLGGSPYPGVPVEELFK 263

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  220 bits (560), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 175
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 176 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 235
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 236 WEIFTLGGSPYPGVPVEELFK 256

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  220 bits (560), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 174
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 175 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 234
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 235 WEIFTLGGSPYPGVPVEELFK 255

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  219 bits (559), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 284 WEIFTLGGSPYPGVPVEELFK 304

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  219 bits (558), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 243 WEIFTLGGSPYPGVPVEELFK 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  219 bits (557), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 142/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 228 WEIFTLGGSPYPGVPVEELFK 248

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 98/201 (48%), Positives = 141/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++      +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 243 WEIFTLGGSPYPGVPVEELFK 263

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 97/201 (48%), Positives = 141/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  +N  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+      ++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 243 WEIFTLGGSPYPGVPVEELFK 263

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  213 bits (543), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 99/224 (44%), Positives = 149/224 (66%), Gaps = 4/224 (1%)
Query: 3   CFSVEVRKHPMSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ +    + VAVK LK++A E++  DL+ E+ +MK +  H N++ L
Sbjct: 36  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 95
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +VI+EY   G L+ +LR+ R    +  Y+        +T +DL S  YQ+
Sbjct: 96  LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 155
Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDLAARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 156 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 215
Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 216 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  213 bits (543), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 99/224 (44%), Positives = 149/224 (66%), Gaps = 4/224 (1%)
Query: 3   CFSVEVRKHPMSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ +    + VAVK LK++A E++  DL+ E+ +MK +  H N++ L
Sbjct: 93  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 152
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +VI+EY   G L+ +LR+ R    +  Y+        +T +DL S  YQ+
Sbjct: 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDLAARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 213 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 272
Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  213 bits (543), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 99/224 (44%), Positives = 149/224 (66%), Gaps = 4/224 (1%)
Query: 3   CFSVEVRKHPMSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ +    + VAVK LK++A E++  DL+ E+ +MK +  H N++ L
Sbjct: 39  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 98
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +VI+EY   G L+ +LR+ R    +  Y+        +T +DL S  YQ+
Sbjct: 99  LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 158
Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDLAARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 159 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 218
Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 219 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  213 bits (542), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 96/201 (47%), Positives = 141/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  213 bits (542), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 96/201 (47%), Positives = 141/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  212 bits (540), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 96/201 (47%), Positives = 140/201 (69%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E +  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  212 bits (540), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 96/201 (47%), Positives = 140/201 (69%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+     Y+  + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  212 bits (539), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 95/201 (47%), Positives = 141/201 (70%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  ++ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  211 bits (538), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 148/224 (66%), Gaps = 4/224 (1%)
Query: 3   CFSVEVRKHPMSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           CF   V    +  ++ +    + VAVK LK++A E++  DL+ E+ +MK +  H N++ L
Sbjct: 34  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 93
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG CT+  P +VI+EY   G L+ +LR+ R    +  Y+        +T +DL S  YQ+
Sbjct: 94  LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 153
Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           ARGM++L+S+  IHRDL ARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WM
Sbjct: 154 ARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 213
Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE+L+D +++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K
Sbjct: 214 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  211 bits (537), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 95/201 (47%), Positives = 140/201 (69%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+ Y   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  211 bits (536), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 95/201 (47%), Positives = 140/201 (69%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+      ++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  210 bits (535), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 95/201 (47%), Positives = 140/201 (69%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+ Y   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  210 bits (535), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 95/201 (47%), Positives = 140/201 (69%), Gaps = 3/201 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLAARNVL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + EN+  K+ADFG ARD+      ++ + GRLP++WMAPE+L+D +++ +SD+WSFGVL+
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WEI TLG +PYPG+   E+ K
Sbjct: 250 WEIFTLGGSPYPGIPVEELFK 270

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 98/210 (46%), Positives = 140/210 (66%), Gaps = 12/210 (5%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +GR G   VAVK LKENA   E  DLL E  V+K ++ HP+V++L G C++  P  +I+E
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVE 106
Query: 77  YVPYGKLQSFLRSSR--AQRYYNNM---------HGKSNSLTSRDLTSFCYQVARGMQFL 125
           Y  YG L+ FLR SR     Y  +          H    +LT  DL SF +Q+++GMQ+L
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD 185
           +   ++HRDLAARN+L+ E    K++DFG +RD+     Y ++S+GR+P++WMA ESL+D
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226
Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           +I++ +SD+WSFGVL+WEIVTLG  PYPG+
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  206 bits (525), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 100/202 (49%), Positives = 130/202 (64%), Gaps = 4/202 (1%)
Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G+E   + VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 77  YVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           Y  YG L +FLR  R    +  YN  H     L+SRDL  F  QVA+GM FL+S+  IHR
Sbjct: 131 YCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHR 190
Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           D+AARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD
Sbjct: 191 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 250
Query: 194 IWSFGVLIWEIVTLGSTPYPGM 215
           +WS+G+L+WEI +LG  PYPG+
Sbjct: 251 VWSYGILLWEIFSLGLNPYPGI 272

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  206 bits (523), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 97/210 (46%), Positives = 139/210 (66%), Gaps = 12/210 (5%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +GR G   VAVK LKENA   E  DLL E  V+K ++ HP+V++L G C++  P  +I+E
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVE 106
Query: 77  YVPYGKLQSFLRSSR--AQRYYNNM---------HGKSNSLTSRDLTSFCYQVARGMQFL 125
           Y  YG L+ FLR SR     Y  +          H    +LT  DL SF +Q+++GMQ+L
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD 185
           +   ++HRDLAARN+L+ E    K++DFG +RD+       ++S+GR+P++WMA ESL+D
Sbjct: 167 AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFD 226
Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           +I++ +SD+WSFGVL+WEIVTLG  PYPG+
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  205 bits (522), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 97/210 (46%), Positives = 139/210 (66%), Gaps = 12/210 (5%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +GR G   VAVK LKENA   E  DLL E  V+K ++ HP+V++L G C++  P  +I+E
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVE 106
Query: 77  YVPYGKLQSFLRSSR--AQRYYNNM---------HGKSNSLTSRDLTSFCYQVARGMQFL 125
           Y  YG L+ FLR SR     Y  +          H    +LT  DL SF +Q+++GMQ+L
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD 185
           +   ++HRDLAARN+L+ E    K++DFG +RD+       ++S+GR+P++WMA ESL+D
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFD 226
Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           +I++ +SD+WSFGVL+WEIVTLG  PYPG+
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  200 bits (508), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 97/201 (48%), Positives = 128/201 (63%), Gaps = 10/201 (4%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LKE A   ER  L+ EL +M  L  H N+V LLG CT   P ++I EY  YG L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 85  SFLRSSRAQ------RYYNNMHGKS----NSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           ++LRS R +       Y N    +     N LT  DL  F YQVA+GM+FL  +  +HRD
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           LAARNVL+      K+ DFG ARD+M+ S Y  +   RLP++WMAPESL++ I+++KSD+
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 195 WSFGVLIWEIVTLGSTPYPGM 215
           WS+G+L+WEI +LG  PYPG+
Sbjct: 258 WSYGILLWEIFSLGVNPYPGI 278

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  199 bits (505), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 97/200 (48%), Positives = 130/200 (65%), Gaps = 2/200 (1%)
Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G+E   + VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 77  YVPYGKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           Y  YG L +FLR  SR           +++L++RDL  F  QVA+GM FL+S+  IHRD+
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDV 190
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD+W
Sbjct: 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 196 SFGVLIWEIVTLGSTPYPGM 215
           S+G+L+WEI +LG  PYPG+
Sbjct: 251 SYGILLWEIFSLGLNPYPGI 270

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  197 bits (500), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 96/200 (48%), Positives = 129/200 (64%), Gaps = 2/200 (1%)
Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G+E   + VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 77  YVPYGKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           Y  YG L +FLR  SR           +++ ++RDL  F  QVA+GM FL+S+  IHRD+
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD+W
Sbjct: 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 196 SFGVLIWEIVTLGSTPYPGM 215
           S+G+L+WEI +LG  PYPG+
Sbjct: 251 SYGILLWEIFSLGLNPYPGI 270

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  196 bits (497), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 97/199 (48%), Positives = 129/199 (64%), Gaps = 4/199 (2%)
Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G+E   + VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 63  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 122
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           Y  YG L +FLR  +A+   +   G+   L  RDL  F  QVA+GM FL+S+  IHRD+A
Sbjct: 123 YCCYGDLLNFLRR-KAEADLDKEDGRP--LELRDLLHFSSQVAQGMAFLASKNCIHRDVA 179
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD+WS
Sbjct: 180 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239
Query: 197 FGVLIWEIVTLGSTPYPGM 215
           +G+L+WEI +LG  PYPG+
Sbjct: 240 YGILLWEIFSLGLNPYPGI 258

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  195 bits (496), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 97/199 (48%), Positives = 129/199 (64%), Gaps = 4/199 (2%)
Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G+E   + VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           Y  YG L +FLR  +A+   +   G+   L  RDL  F  QVA+GM FL+S+  IHRD+A
Sbjct: 131 YCCYGDLLNFLRR-KAEADLDKEDGRP--LELRDLLHFSSQVAQGMAFLASKNCIHRDVA 187
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD+WS
Sbjct: 188 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 197 FGVLIWEIVTLGSTPYPGM 215
           +G+L+WEI +LG  PYPG+
Sbjct: 248 YGILLWEIFSLGLNPYPGI 266

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  194 bits (492), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 92/197 (46%), Positives = 134/197 (68%), Gaps = 4/197 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 84  QSFLRSSRAQRY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            ++LRS R +   Y +++   + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+
Sbjct: 120 STYLRSKRNEFVPYKDLY--KDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILL 177
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+W
Sbjct: 178 SEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 203 EIVTLGSTPYPGMAAAE 219
           EI +LG++PYPG+   E
Sbjct: 238 EIFSLGASPYPGVKIDE 254

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  193 bits (490), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 92/197 (46%), Positives = 134/197 (68%), Gaps = 4/197 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 84  QSFLRSSRAQRY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            ++LRS R +   Y +++   + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+
Sbjct: 120 STYLRSKRNEFVPYKDLY--KDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILL 177
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+W
Sbjct: 178 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 203 EIVTLGSTPYPGMAAAE 219
           EI +LG++PYPG+   E
Sbjct: 238 EIFSLGASPYPGVKIDE 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  191 bits (484), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 92/202 (45%), Positives = 131/202 (64%), Gaps = 6/202 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L 
Sbjct: 55  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 85  SFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHRDLAARN+L
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +GEN+  K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++  SD+WS+GVL+
Sbjct: 175 VGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WEIV+LG TPY GM  AE+ +K
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEK 253

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  191 bits (484), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 92/202 (45%), Positives = 131/202 (64%), Gaps = 6/202 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L 
Sbjct: 45  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 104
Query: 85  SFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHRDLAARN+L
Sbjct: 105 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 164
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +GEN+  K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++  SD+WS+GVL+
Sbjct: 165 VGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 221
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WEIV+LG TPY GM  AE+ +K
Sbjct: 222 WEIVSLGGTPYCGMTCAELYEK 243

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  190 bits (482), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 99/214 (46%), Positives = 127/214 (59%), Gaps = 21/214 (9%)
Query: 18  GREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G+E   + VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI E
Sbjct: 56  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 115
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKS---------------NSLTSRDLTSFCYQVARG 121
           Y  YG L +FLR     R    M G S                 L  RDL  F  QVA+G
Sbjct: 116 YCCYGDLLNFLR-----RKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQG 170
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
           M FL+S+  IHRD+AARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPE
Sbjct: 171 MAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 230
Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           S++D +++V+SD+WS+G+L+WEI +LG  PYPG+
Sbjct: 231 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 264

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  189 bits (481), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 91/199 (45%), Positives = 132/199 (66%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 276
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 277 LWEIFSLGASPYPGVKIDE 295

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  189 bits (481), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 91/199 (45%), Positives = 132/199 (66%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 240 LWEIFSLGASPYPGVKIDE 258

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 91/197 (46%), Positives = 130/197 (65%), Gaps = 2/197 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 84  QSFLRSSRAQRY-YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            ++LRS R +   Y       + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILL 181
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E +  K+ DFG ARD+       RK + RLP++WMAPE+++D +++++SD+WSFGVL+W
Sbjct: 182 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 203 EIVTLGSTPYPGMAAAE 219
           EI +LG++PYPG+   E
Sbjct: 242 EIFSLGASPYPGVKIDE 258

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 91/199 (45%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI E+  +G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 231 LWEIFSLGASPYPGVKIDE 249

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 91/202 (45%), Positives = 131/202 (64%), Gaps = 6/202 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L 
Sbjct: 52  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 111
Query: 85  SFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHR+LAARN+L
Sbjct: 112 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNIL 171
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +GEN+  K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++  SD+WS+GVL+
Sbjct: 172 VGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 228
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WEIV+LG TPY GM  AE+ +K
Sbjct: 229 WEIVSLGGTPYCGMTCAELYEK 250

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 91/199 (45%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI E+  +G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 231 LWEIFSLGASPYPGVKIDE 249

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  188 bits (478), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 91/199 (45%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +        +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 181
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 182 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 241
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 242 LWEIFSLGASPYPGVKIDE 260

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  188 bits (477), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 91/198 (45%), Positives = 130/198 (65%), Gaps = 3/198 (1%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 84  QSFLRSSRAQ--RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            ++LRS R +   Y        + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E +  K+ DFG ARD+       RK + RLP++WMAPE+++D +++++SD+WSFGVL+
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 202 WEIVTLGSTPYPGMAAAE 219
           WEI +LG++PYPG+   E
Sbjct: 241 WEIFSLGASPYPGVKIDE 258

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  187 bits (475), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 93/196 (47%), Positives = 126/196 (64%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF+++ EY+PYG L 
Sbjct: 60  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    +            +T+  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 117 DYLRECNREE-----------VTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 165
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 166 NHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 225 ATYGMSPYPGIDLSQV 240

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  187 bits (474), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 90/199 (45%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+       RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 231 LWEIFSLGASPYPGVKIDE 249

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  187 bits (474), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 105/250 (42%), Positives = 140/250 (56%), Gaps = 55/250 (22%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT++  P  VI+EY  YG L
Sbjct: 60  VAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNL 119
Query: 84  QSFLRSSRAQRYYNN---MH--------------GKS---NSLTS--------------- 108
            ++L+S R   + N    +H              GK    +S+TS               
Sbjct: 120 SNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSL 179
Query: 109 -------------------RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCK 149
                               DL S+ +QVARGM+FLSSR  IHRDLAARN+L+ EN+  K
Sbjct: 180 SDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVK 239
Query: 150 VADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGS 209
           + DFG ARD+  +  Y RK + RLP++WMAPES++D I+S KSD+WS+GVL+WEI +LG 
Sbjct: 240 ICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGG 299
Query: 210 TPYPGMAAAE 219
           +PYPG+   E
Sbjct: 300 SPYPGVQMDE 309

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  187 bits (474), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 90/199 (45%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+       RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 240 LWEIFSLGASPYPGVKIDE 258

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  186 bits (473), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 90/199 (45%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+       RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 240 LWEIFSLGASPYPGVKIDE 258

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  186 bits (472), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 90/199 (45%), Positives = 130/199 (65%), Gaps = 4/199 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI E+  +G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 84  QSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ E +  K+ DFG ARD+       RK + RLP++WMAPE+++D +++++SD+WSFGVL
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 201 IWEIVTLGSTPYPGMAAAE 219
           +WEI +LG++PYPG+   E
Sbjct: 231 LWEIFSLGASPYPGVKIDE 249

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  184 bits (466), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 126/196 (64%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 206 ATYGMSPYPGIDLSQV 221

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  184 bits (466), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 126/196 (64%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 206 ATYGMSPYPGIDLSQV 221

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  183 bits (464), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 125/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L 
Sbjct: 46  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 103 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 211 ATYGMSPYPGIDLSQV 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  183 bits (464), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 125/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 206 ATYGMSPYPGIDLSQV 221

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 125/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 206 ATYGMSPYPGIDLSQV 221

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 125/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 46  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 103 DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 211 ATYGMSPYPGIDLSQV 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 43  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 100 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 148
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 149 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 208 ATYGMSPYPGIDLSQV 223

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 46  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 103 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 211 ATYGMSPYPGIDLSQV 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 46  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 103 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 211 ATYGMSPYPGIDLSQV 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 43  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 100 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 148
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 149 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 208 ATYGMSPYPGIDLSQV 223

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 54  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 111 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 159
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 160 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 219 ATYGMSPYPGIDLSQV 234

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 206 ATYGMSPYPGIDLSQV 221

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 206 ATYGMSPYPGIDLSQV 221

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 42  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 99  DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 147
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 148 NHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 207 ATYGMSPYPGIDLSQV 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 43  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 100 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 148
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 149 NHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 208 ATYGMSPYPGIDLSQV 223

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 45  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 102 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 150
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 151 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 210 ATYGMSPYPGIDLSQV 225

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  181 bits (460), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 91/196 (46%), Positives = 125/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 39  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 96  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 144
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   +   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 145 NHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 204 ATYGMSPYPGIDPSQV 219

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 91/198 (45%), Positives = 126/198 (63%), Gaps = 15/198 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 248 VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHR+LAARN L+GE
Sbjct: 305 DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 354 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 205 VTLGSTPYPGMAAAEVMK 222
            T G +PYPG+  ++V +
Sbjct: 413 ATYGMSPYPGIDLSQVYE 430

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  181 bits (459), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 93/196 (47%), Positives = 123/196 (62%), Gaps = 5/196 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 85  SFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +FLR  R     +      M     +L   DL SF YQVA+GM FL+S+  IHRDLAARN
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 191
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+      K+ DFG ARD+   S Y  K   RLP++WMAPES+++ +++ +SD+WS+G+
Sbjct: 192 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 251
Query: 200 LIWEIVTLGSTPYPGM 215
            +WE+ +LGS+PYPGM
Sbjct: 252 FLWELFSLGSSPYPGM 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  181 bits (458), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 93/196 (47%), Positives = 123/196 (62%), Gaps = 5/196 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 85  SFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +FLR  R     +      M     +L   DL SF YQVA+GM FL+S+  IHRDLAARN
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+      K+ DFG ARD+   S Y  K   RLP++WMAPES+++ +++ +SD+WS+G+
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 200 LIWEIVTLGSTPYPGM 215
            +WE+ +LGS+PYPGM
Sbjct: 236 FLWELFSLGSSPYPGM 251

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  181 bits (458), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 93/196 (47%), Positives = 123/196 (62%), Gaps = 5/196 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 85  SFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +FLR  R     +      M     +L   DL SF YQVA+GM FL+S+  IHRDLAARN
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 198
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+      K+ DFG ARD+   S Y  K   RLP++WMAPES+++ +++ +SD+WS+G+
Sbjct: 199 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 258
Query: 200 LIWEIVTLGSTPYPGM 215
            +WE+ +LGS+PYPGM
Sbjct: 259 FLWELFSLGSSPYPGM 274

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  181 bits (458), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 93/196 (47%), Positives = 123/196 (62%), Gaps = 5/196 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 74  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 133
Query: 85  SFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +FLR  R     +      M     +L   DL SF YQVA+GM FL+S+  IHRDLAARN
Sbjct: 134 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 193
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+      K+ DFG ARD+   S Y  K   RLP++WMAPES+++ +++ +SD+WS+G+
Sbjct: 194 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 253
Query: 200 LIWEIVTLGSTPYPGM 215
            +WE+ +LGS+PYPGM
Sbjct: 254 FLWELFSLGSSPYPGM 269

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  181 bits (458), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 91/198 (45%), Positives = 125/198 (63%), Gaps = 15/198 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 287 VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHR+LAARN L+GE
Sbjct: 344 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 392
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 393 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451
Query: 205 VTLGSTPYPGMAAAEVMK 222
            T G +PYPG+  ++V +
Sbjct: 452 ATYGMSPYPGIDLSQVYE 469

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  180 bits (457), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 91/196 (46%), Positives = 125/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L 
Sbjct: 39  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 96  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 144
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT       +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 145 NHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 204 ATYGMSPYPGIDPSQV 219

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  180 bits (456), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 91/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L 
Sbjct: 42  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 99  DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 147
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT       +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 148 NHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 207 ATYGMSPYPGIDLSQV 222

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  180 bits (456), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 91/196 (46%), Positives = 124/196 (63%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 39  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 96  DYLRECNRQE-----------VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 144
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT       +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 145 NHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 204 ATYGMSPYPGIDPSQV 219

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  179 bits (454), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 91/196 (46%), Positives = 123/196 (62%), Gaps = 15/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 46  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            + +  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 103 DYLRECNRQE-----------VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT       +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 152 NHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 205 VTLGSTPYPGMAAAEV 220
            T G +PYPG+  ++V
Sbjct: 211 ATYGMSPYPGIDLSQV 226

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 92/196 (46%), Positives = 122/196 (62%), Gaps = 5/196 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY  YG L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 85  SFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +FLR  R     +      M     +L   DL SF YQVA+GM FL+S+  IHRDLAARN
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 198
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+      K+ DFG AR +   S Y  K   RLP++WMAPES+++ +++ +SD+WS+G+
Sbjct: 199 ILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 258
Query: 200 LIWEIVTLGSTPYPGM 215
            +WE+ +LGS+PYPGM
Sbjct: 259 FLWELFSLGSSPYPGM 274

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  177 bits (449), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 85/203 (41%), Positives = 131/203 (64%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 103
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN
Sbjct: 104 HGDLKSYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 160
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  ++ Y +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  177 bits (448), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 85/203 (41%), Positives = 130/203 (64%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 44  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 102
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN
Sbjct: 103 HGDLKSYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 159
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +  Y +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 160 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 219
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 220 VLWEITSLAEQPYQGLSNEQVLK 242

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  176 bits (447), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 85/203 (41%), Positives = 130/203 (64%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 103
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN
Sbjct: 104 HGDLKSYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 160
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +  Y +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  175 bits (443), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 84/203 (41%), Positives = 130/203 (64%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 103
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HR+LAARN
Sbjct: 104 HGDLKSYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRNLAARN 160
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +  Y +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  174 bits (442), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 84/203 (41%), Positives = 130/203 (64%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 46  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 104
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HR+LAARN
Sbjct: 105 HGDLKSYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRNLAARN 161
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +  Y +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 162 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 221
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 222 VLWEITSLAEQPYQGLSNEQVLK 244

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  174 bits (442), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 109
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 110 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 166
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 167 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 227 ATLAEQPYQGLSNEQVLR 244

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  174 bits (442), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 117 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 234 ATLAEQPYQGLSNEQVLR 251

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  174 bits (442), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 49  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 107
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 108 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 164
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 165 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 225 ATLAEQPYQGLSNEQVLR 242

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  174 bits (442), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 109
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 110 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 166
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 167 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 227 ATLAEQPYQGLSNEQVLR 244

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  174 bits (441), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 110
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 111 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 167
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 168 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 228 ATLAEQPYQGLSNEQVLR 245

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  174 bits (441), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 103
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 104 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 160
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 161 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 221 ATLAEQPYQGLSNEQVLR 238

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  174 bits (441), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 127/198 (64%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 80  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 138
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 139 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 195
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 196 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 256 ATLAEQPYQGLSNEQVLR 273

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  174 bits (440), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 84/203 (41%), Positives = 129/203 (63%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 42  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 100
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN
Sbjct: 101 HGDLKSYLRSLRPE--AENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 157
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +    +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 158 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 217
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 218 VLWEITSLAEQPYQGLSNEQVLK 240

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  174 bits (440), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 84/203 (41%), Positives = 129/203 (63%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 103
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN
Sbjct: 104 HGDLKSYLRSLRPEA--ENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 160
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +    +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  174 bits (440), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 126/198 (63%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R     NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 117 SYLRSLRPA-MANNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 234 ATLAEQPYQGLSNEQVLR 251

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  174 bits (440), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 84/203 (41%), Positives = 129/203 (63%), Gaps = 4/203 (1%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E    VAVKT+ E+A  RER++ L E +VMK    H +VVRLLG  ++ +P  V+ME + 
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMA 103
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           +G L+S+LRS R +    N  G+    T +++     ++A GM +L+++  +HRDLAARN
Sbjct: 104 HGDLKSYLRSLRPE--AENNPGRPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 160
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            ++  +   K+ DFG  RD+  +    +  +G LP+RWMAPESL D +F+  SD+WSFGV
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 200 LIWEIVTLGSTPYPGMAAAEVMK 222
           ++WEI +L   PY G++  +V+K
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  173 bits (439), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 126/198 (63%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 48  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R     NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 107 SYLRSLRPA-MANNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 163
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 164 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 224 ATLAEQPYQGLSNEQVLR 241

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  173 bits (438), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 126/198 (63%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 103
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN  + E
Sbjct: 104 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCXVAE 160
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 161 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 221 ATLAEQPYQGLSNEQVLR 238

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  172 bits (435), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 84/198 (42%), Positives = 126/198 (63%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 43  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 101
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 102 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 158
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +    +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 159 DFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 219 ATLAEQPYQGLSNEQVLR 236

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  172 bits (435), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 84/198 (42%), Positives = 126/198 (63%), Gaps = 4/198 (2%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+ E A  RER++ L E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLK 110
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           S+LRS R +   NN      SL+   +     ++A GM +L++   +HRDLAARN ++ E
Sbjct: 111 SYLRSLRPE-MENNPVLAPPSLSK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 167
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG  RD+  +    +  +G LP+RWM+PESL D +F+  SD+WSFGV++WEI
Sbjct: 168 DFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227
Query: 205 VTLGSTPYPGMAAAEVMK 222
            TL   PY G++  +V++
Sbjct: 228 ATLAEQPYQGLSNEQVLR 245

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  164 bits (414), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 82/209 (39%), Positives = 121/209 (57%), Gaps = 12/209 (5%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK LKE A    + D  +E  +M   D +PN+V+LLG C   +P  ++ EY+ YG L
Sbjct: 79  MVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 84  QSFLRSSRAQRYYNNMHGKSNS-----------LTSRDLTSFCYQVARGMQFLSSRGIIH 132
             FLRS       +  H   ++           L+  +      QVA GM +LS R  +H
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197
Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           RDLA RN L+GEN   K+ADFG +R++ ++  Y+      +PIRWM PES++ N ++ +S
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 257
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           D+W++GV++WEI + G  PY GMA  EV+
Sbjct: 258 DVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  160 bits (406), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 89/249 (35%), Positives = 132/249 (53%), Gaps = 54/249 (21%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIME------- 76
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E       
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 77  ----------YVPYGKLQSFLRSSR-----------------------------AQRYYN 97
                     +VPY    +  R  +                              ++  +
Sbjct: 120 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 179
Query: 98  NMHGKS-------NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV 150
           ++  +        + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+ E +  K+
Sbjct: 180 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 239
Query: 151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
            DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+WEI +LG++
Sbjct: 240 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 299
Query: 211 PYPGMAAAE 219
           PYPG+   E
Sbjct: 300 PYPGVKIDE 308

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  160 bits (406), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 89/249 (35%), Positives = 132/249 (53%), Gaps = 54/249 (21%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIME------- 76
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E       
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 77  ----------YVPYGKLQSFLRSSR-----------------------------AQRYYN 97
                     +VPY    +  R  +                              ++  +
Sbjct: 122 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 181
Query: 98  NMHGKS-------NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV 150
           ++  +        + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+ E +  K+
Sbjct: 182 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 241
Query: 151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
            DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+WEI +LG++
Sbjct: 242 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 301
Query: 211 PYPGMAAAE 219
           PYPG+   E
Sbjct: 302 PYPGVKIDE 310

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score =  160 bits (406), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 89/249 (35%), Positives = 132/249 (53%), Gaps = 54/249 (21%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIME------- 76
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E       
Sbjct: 53  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 112
Query: 77  ----------YVPYGKLQSFLRSSR-----------------------------AQRYYN 97
                     +VPY    +  R  +                              ++  +
Sbjct: 113 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 172
Query: 98  NMHGKS-------NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV 150
           ++  +        + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+ E +  K+
Sbjct: 173 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 232
Query: 151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
            DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+WEI +LG++
Sbjct: 233 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 292
Query: 211 PYPGMAAAE 219
           PYPG+   E
Sbjct: 293 PYPGVKIDE 301

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  160 bits (406), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 89/249 (35%), Positives = 132/249 (53%), Gaps = 54/249 (21%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIME------- 76
           VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E       
Sbjct: 55  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
Query: 77  ----------YVPYGKLQSFLRSSR-----------------------------AQRYYN 97
                     +VPY    +  R  +                              ++  +
Sbjct: 115 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
Query: 98  NMHGKS-------NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV 150
           ++  +        + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+ E +  K+
Sbjct: 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 234
Query: 151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
            DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+WEI +LG++
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 211 PYPGMAAAE 219
           PYPG+   E
Sbjct: 295 PYPGVKIDE 303

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG AR L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLARVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  157 bits (398), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 82/204 (40%), Positives = 118/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++  L+ H N+VR +G   +  P F+++E +  G
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 120 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 173
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 174 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 234 VLLWEIFSLGYMPYPSKSNQEVLE 257

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  157 bits (398), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 82/204 (40%), Positives = 118/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++  L+ H N+VR +G   +  P F+++E +  G
Sbjct: 75  PLQVAVKTLPEVCSEQDELDFLMEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 134 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 187
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 247
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 248 VLLWEIFSLGYMPYPSKSNQEVLE 271

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  157 bits (398), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 82/204 (40%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F++ME +  G
Sbjct: 75  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGG 133
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 134 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 187
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 247
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 248 VLLWEIFSLGYMPYPSKSNQEVLE 271

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 82/204 (40%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F++ME +  G
Sbjct: 60  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 119 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEVLE 256

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  157 bits (397), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 123 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 170
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 171 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 229
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 230 EVMSYGERPYWEMSNQDVIK 249

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 133 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 180
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 181 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 239
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 240 EVMSYGERPYWEMSNQDVIK 259

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 106 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 153
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 154 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 212
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 213 EVMSYGERPYWEMSNQDVIK 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  157 bits (396), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  157 bits (396), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  157 bits (396), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 118/200 (59%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  157 bits (396), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 80/200 (40%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG  R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  156 bits (395), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 87  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 145
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 146 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 199
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 200 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 259
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 260 VLLWEIFSLGYMPYPSKSNQEVLE 283

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  156 bits (395), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 77  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 135
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 136 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 189
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 190 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 249
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 250 VLLWEIFSLGYMPYPSKSNQEVLE 273

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  156 bits (395), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 67  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 125
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 126 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 179
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 180 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 239
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 240 VLLWEIFSLGYMPYPSKSNQEVLE 263

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 60  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 118
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 119 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEVLE 256

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 120 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 173
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 174 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 234 VLLWEIFSLGYMPYPSKSNQEVLE 257

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 52  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 110
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 111 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 164
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 165 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 224
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 225 VLLWEIFSLGYMPYPSKSNQEVLE 248

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 75  PLQVAVKTLPEVYSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 134 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 187
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 247
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 248 VLLWEIFSLGYMPYPSKSNQEVLE 271

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  155 bits (391), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/204 (39%), Positives = 116/204 (56%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 159
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 160 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 213
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +  Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 274 VLLWEIFSLGYMPYPSKSNQEVLE 297

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  155 bits (391), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/204 (39%), Positives = 116/204 (56%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 78  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 136
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 137 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 190
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG ARD+  +  Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 191 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 250
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 251 VLLWEIFSLGYMPYPSKSNQEVLE 274

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  154 bits (390), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 80/204 (39%), Positives = 117/204 (57%), Gaps = 10/204 (4%)
Query: 22  PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E +  G
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AARN L
Sbjct: 120 DLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 173
Query: 142 I---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           +   G     K+ DFG A+D+  +S Y +     LP++WM PE+  + IF+ K+D WSFG
Sbjct: 174 LTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMK 222
           VL+WEI +LG  PYP  +  EV++
Sbjct: 234 VLLWEIFSLGYMPYPSKSNQEVLE 257

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  154 bits (388), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 79/200 (39%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ E +  G L 
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 106 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 153
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 154 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 212
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 213 EVMSYGERPYWEMSNQDVIK 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  154 bits (388), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 79/200 (39%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ E +  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  154 bits (388), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 79/200 (39%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ E +  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW +PE++    F+  SD+WS+G+++W
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 242 EVMSYGERPYWEMSNQDVIK 261

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  153 bits (387), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 77/210 (36%), Positives = 118/210 (56%), Gaps = 5/210 (2%)
Query: 13  MSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
           + PE+ +    +VAVKTLK+ A +  R D  +E  ++  L  H ++V+  G C E +P  
Sbjct: 37  LCPEQDK---ILVAVKTLKD-ASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLI 91
Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           ++ EY+ +G L  FLR+                LT   +     Q+A GM +L+S+  +H
Sbjct: 92  MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVH 151
Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           RDLA RN L+GEN   K+ DFG +RD+ ++  Y       LPIRWM PES+    F+ +S
Sbjct: 152 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 211
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           D+WS GV++WEI T G  P+  ++  EV++
Sbjct: 212 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 76/201 (37%), Positives = 112/201 (55%), Gaps = 16/201 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPNV+ L G  T+  P  +I E++  G L 
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR +  Q             T   L      +A GM++L+    +HRDLAARN+L+  
Sbjct: 123 SFLRQNDGQ------------FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 170
Query: 145 NHCCKVADFGFAR---DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           N  CKV+DFG +R   D  +   Y     G++PIRW APE++    F+  SD+WS+G+++
Sbjct: 171 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 230
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WE+++ G  PY  M   +V+ 
Sbjct: 231 WEVMSYGERPYWDMTNQDVIN 251

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 80/206 (38%), Positives = 119/206 (57%), Gaps = 18/206 (8%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           RE P  VA+KTLK    E++R D L E ++M   D HPN++ L G  T+ +P  ++ EY+
Sbjct: 49  RELP--VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYM 105
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L +FL+ +  Q             T   L      ++ GM++LS  G +HRDLAAR
Sbjct: 106 ENGSLDTFLKKNDGQ------------FTVIQLVGMLRGISAGMKYLSDMGYVHRDLAAR 153
Query: 139 NVLIGENHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           N+LI  N  CKV+DFG +R L     + Y  +  G++PIRW APE++    F+  SD+WS
Sbjct: 154 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG-GKIPIRWTAPEAIAFRKFTSASDVWS 212
Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMK 222
           +G+++WE+V+ G  PY  M   +V+K
Sbjct: 213 YGIVMWEVVSYGERPYWEMTNQDVIK 238

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 118
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 119 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 166
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 167 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 226
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 227 WELMTRGAPPYPDVNTFDI 245

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 81  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 138
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 139 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 186
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 187 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 246
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 247 WELMTRGAPPYPDVNTFDI 265

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 59  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 116
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 117 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 164
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 165 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 225 WELMTRGAPPYPDVNTFDI 243

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 119
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 120 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 167
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 168 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 228 WELMTRGAPPYPDVNTFDI 246

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 80  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 137
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 138 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 185
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 186 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 245
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 246 WELMTRGAPPYPDVNTFDI 264

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 111
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 112 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 159
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 160 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 219
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 220 WELMTRGAPPYPDVNTFDI 238

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 119
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 120 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 167
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 168 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 228 WELMTRGAPPYPDVNTFDI 246

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 57  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 114
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 115 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 163 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 223 WELMTRGAPPYPDVNTFDI 241

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 117
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 118 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 165
Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 166 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 225
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 226 WELMTRGAPPYPDVNTFDI 244

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 120/199 (60%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 120
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 121 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 168
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD++         K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 169 EKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 228
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 229 WELMTRGAPPYPDVNTFDI 247

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 113/197 (57%), Gaps = 15/197 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLK   G       L+E  +MKTL  H  +VRL    T +EP ++I EY+  G L 
Sbjct: 40  VAVKTLK--PGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTREEPIYIITEYMAKGSLL 96
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S    +           +    L  F  Q+A GM ++  +  IHRDL A NVL+ E
Sbjct: 97  DFLKSDEGGK-----------VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE 145
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR ++  + Y  +   + PI+W APE++    F++KSD+WSFG+L++EI
Sbjct: 146 SLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEI 204
Query: 205 VTLGSTPYPGMAAAEVM 221
           VT G  PYPG   A+VM
Sbjct: 205 VTYGKIPYPGRTNADVM 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 119/199 (59%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 178
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 179 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 227 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 287 WELMTRGAPPYPDVNTFDI 305

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 83/207 (40%), Positives = 123/207 (59%), Gaps = 20/207 (9%)
Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIM 75
           G++  C  AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++
Sbjct: 54  GKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVL 109
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
            Y+ +G L++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDL
Sbjct: 110 PYMKHGDLRNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 157
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           AARN ++ E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD
Sbjct: 158 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 217
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEV 220
           +WSFGVL+WE++T G+ PYP +   ++
Sbjct: 218 VWSFGVLLWELMTRGAPPYPDVNTFDI 244

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 119/199 (59%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 124
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 125 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 172
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 173 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 232
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 233 WELMTRGAPPYPDVNTFDI 251

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 119/199 (59%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 120
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 121 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 168
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 169 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 228
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 229 WELMTRGAPPYPDVNTFDI 247

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 119/199 (59%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 119
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 120 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 167
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 168 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 228 WELMTRGAPPYPDVNTFDI 246

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 81/199 (40%), Positives = 119/199 (59%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 119
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 120 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 167
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 168 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 228 WELMTRGAPPYPDVNTFDI 246

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  150 bits (379), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 79/198 (39%), Positives = 108/198 (54%), Gaps = 14/198 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K LK    ER+R D L E ++M   D HPN++RL G  T      ++ EY+  G L 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR+   Q             T   L      V  GM++LS  G +HRDLAARNVL+  
Sbjct: 139 TFLRTHDGQ------------FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186
Query: 145 NHCCKVADFGFARDLMTS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG +R L          + G++PIRW APE++    FS  SD+WSFGV++WE
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 204 IVTLGSTPYPGMAAAEVM 221
           ++  G  PY  M   +V+
Sbjct: 247 VLAYGERPYWNMTNRDVI 264

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  150 bits (378), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 77/202 (38%), Positives = 119/202 (58%), Gaps = 14/202 (6%)
Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF-----FVIMEYV 78
           VAVKT+K +N+ +RE  + L E   MK    HPNV+RLLG C E          VI+ ++
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
            YG L ++L        Y+ +      +  + L  F   +A GM++LS+R  +HRDLAAR
Sbjct: 124 KYGDLHTYL-------LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176
Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           N ++ ++    VADFG ++ + +   Y +    ++P++W+A ESL D +++ KSD+W+FG
Sbjct: 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 199 VLIWEIVTLGSTPYPGMAAAEV 220
           V +WEI T G TPYPG+   E+
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEM 258

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 79/198 (39%), Positives = 108/198 (54%), Gaps = 14/198 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K LK    ER+R D L E ++M   D HPN++RL G  T      ++ EY+  G L 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR+   Q             T   L      V  GM++LS  G +HRDLAARNVL+  
Sbjct: 139 TFLRTHDGQ------------FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186
Query: 145 NHCCKVADFGFARDLMTS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG +R L          + G++PIRW APE++    FS  SD+WSFGV++WE
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 204 IVTLGSTPYPGMAAAEVM 221
           ++  G  PY  M   +V+
Sbjct: 247 VLAYGERPYWNMTNRDVI 264

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 83/212 (39%), Positives = 122/212 (57%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 412 MSPE----NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 465
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+  +             SL    L  + YQ++  + +L S+  +
Sbjct: 466 WIIMELCTLGELRSFLQVRKF------------SLDLASLILYAYQLSTALAYLESKRFV 513
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 60  MSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 113
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 114 WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 161
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 221 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 252

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 34  MSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 87
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 88  WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 135
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 195 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 226

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  149 bits (377), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 35  MSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 88
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 89  WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 136
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 196 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 227

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  149 bits (377), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 37  MSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 90
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 91  WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 138
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 29  MSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 82
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 83  WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 130
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 111/201 (55%), Gaps = 16/201 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPNV+ L G  T+  P  +I E++  G L 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR +  Q             T   L      +A GM++L+    +HR LAARN+L+  
Sbjct: 97  SFLRQNDGQ------------FTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNS 144
Query: 145 NHCCKVADFGFAR---DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           N  CKV+DFG +R   D  +   Y     G++PIRW APE++    F+  SD+WS+G+++
Sbjct: 145 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 204
Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           WE+++ G  PY  M   +V+ 
Sbjct: 205 WEVMSYGERPYWDMTNQDVIN 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 32  MSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 85
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 86  WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 133
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 79/197 (40%), Positives = 114/197 (57%), Gaps = 15/197 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLK   G       L+E  +MKTL  H  +VRL    T++EP ++I E++  G L 
Sbjct: 39  VAVKTLK--PGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEFMAKGSLL 95
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S    +           +    L  F  Q+A GM ++  +  IHRDL A NVL+ E
Sbjct: 96  DFLKSDEGGK-----------VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE 144
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR ++  + Y  +   + PI+W APE++    F++KS++WSFG+L++EI
Sbjct: 145 SLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEI 203
Query: 205 VTLGSTPYPGMAAAEVM 221
           VT G  PYPG   A+VM
Sbjct: 204 VTYGKIPYPGRTNADVM 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/212 (39%), Positives = 124/212 (58%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 32  MSPE----NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 85
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+    ++Y         SL    L  + YQ++  + +L S+  +
Sbjct: 86  WIIMELCTLGELRSFLQ---VRKY---------SLDLASLILYAYQLSTALAYLESKRFV 133
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPNVV L G  T  +P  +++E++  G L 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASIMGQFD-HPNVVHLEGVVTRGKPVMIVIEFMENGALD 132
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR    Q             T   L      +A GM++L+  G +HRDLAARN+L+  
Sbjct: 133 AFLRKHDGQ------------FTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNS 180
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R +     +VY   + G++P+RW APE++    F+  SD+WS+G+++W
Sbjct: 181 NLVCKVSDFGLSRVIEDDPEAVYT-TTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMW 239
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 240 EVMSYGERPYWDMSNQDVIK 259

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 80/199 (40%), Positives = 119/199 (59%), Gaps = 18/199 (9%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKL 83
           AVK+L       E    L E  +MK    HPNV+ LLG C  +E  P  V++ Y+ +G L
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 118
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+            ++++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 119 RNFIRN------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 166
Query: 144 ENHCCKVADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 167 EKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 226
Query: 202 WEIVTLGSTPYPGMAAAEV 220
           WE++T G+ PYP +   ++
Sbjct: 227 WELMTRGAPPYPDVNTFDI 245

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/213 (38%), Positives = 116/213 (54%), Gaps = 7/213 (3%)
Query: 11  HPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP 70
           H + PE+ +    +VAVK LKE A E  R D  +E  ++  L  H ++VR  G CTE  P
Sbjct: 63  HNLLPEQDK---MLVAVKALKE-ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRP 117
Query: 71  FFVIMEYVPYGKLQSFLRSS--RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 128
             ++ EY+ +G L  FLRS    A+            L    L +   QVA GM +L+  
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF 188
             +HRDLA RN L+G+    K+ DFG +RD+ ++  Y       LPIRWM PES+    F
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           + +SD+WSFGV++WEI T G  P+  ++  E +
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/213 (38%), Positives = 116/213 (54%), Gaps = 7/213 (3%)
Query: 11  HPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP 70
           H + PE+ +    +VAVK LKE A E  R D  +E  ++  L  H ++VR  G CTE  P
Sbjct: 34  HNLLPEQDK---MLVAVKALKE-ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRP 88
Query: 71  FFVIMEYVPYGKLQSFLRSS--RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 128
             ++ EY+ +G L  FLRS    A+            L    L +   QVA GM +L+  
Sbjct: 89  LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 148
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF 188
             +HRDLA RN L+G+    K+ DFG +RD+ ++  Y       LPIRWM PES+    F
Sbjct: 149 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 208
Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           + +SD+WSFGV++WEI T G  P+  ++  E +
Sbjct: 209 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 241

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/213 (38%), Positives = 116/213 (54%), Gaps = 7/213 (3%)
Query: 11  HPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP 70
           H + PE+ +    +VAVK LKE A E  R D  +E  ++  L  H ++VR  G CTE  P
Sbjct: 40  HNLLPEQDK---MLVAVKALKE-ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRP 94
Query: 71  FFVIMEYVPYGKLQSFLRSS--RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 128
             ++ EY+ +G L  FLRS    A+            L    L +   QVA GM +L+  
Sbjct: 95  LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 154
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF 188
             +HRDLA RN L+G+    K+ DFG +RD+ ++  Y       LPIRWM PES+    F
Sbjct: 155 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 214
Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           + +SD+WSFGV++WEI T G  P+  ++  E +
Sbjct: 215 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 247

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  147 bits (372), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 112/199 (56%), Gaps = 14/199 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R+D L E  +M     H N++RL G  ++ +P  +I EY+  G L 
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-NIIRLEGVISKYKPMMIITEYMENGALD 134
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FLR             K    +   L      +A GM++L++   +HRDLAARN+L+  
Sbjct: 135 KFLRE------------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 182
Query: 145 NHCCKVADFGFARDLMTS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG +R L          S G++PIRW APE++    F+  SD+WSFG+++WE
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           ++T G  PY  ++  EVMK
Sbjct: 243 VMTYGERPYWELSNHEVMK 261

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 121/212 (57%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 412 MSPE----NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 465
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+  +             SL    L  + YQ++  + +L S+  +
Sbjct: 466 WIIMELCTLGELRSFLQVRKF------------SLDLASLILYAYQLSTALAYLESKRFV 513
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+    C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 77/208 (37%), Positives = 117/208 (56%), Gaps = 17/208 (8%)
Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G++  C VA+KTLK    ER+R + L E ++M   + HPN++RL G  T   P  ++ E+
Sbjct: 39  GKKESC-VAIKTLKGGYTERQRREFLSEASIMGQFE-HPNIIRLEGVVTNSMPVMILTEF 96
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G L SFLR +  Q             T   L      +A GM++L+    +HRDLAA
Sbjct: 97  MENGALDSFLRLNDGQ------------FTVIQLVGMLRGIASGMRYLAEMSYVHRDLAA 144
Query: 138 RNVLIGENHCCKVADFGFARDLMTSS---VYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           RN+L+  N  CKV+DFG +R L  +S    Y     G++PIRW APE++    F+  SD 
Sbjct: 145 RNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDA 204
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           WS+G+++WE+++ G  PY  M+  +V+ 
Sbjct: 205 WSYGIVMWEVMSFGERPYWDMSNQDVIN 232

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  147 bits (370), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGXLL 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 106 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 153
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 154 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 213
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 214 MTFGSKPYDGIPASEI 229

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  147 bits (370), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 115/200 (57%), Gaps = 13/200 (6%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R    +VAVK+ +E      +   LQE  ++K    HPN+VRL+G CT+K+P +++ME
Sbjct: 134 RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVME 192
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            V  G   +FLR+  A+            L  + L       A GM++L S+  IHRDLA
Sbjct: 193 LVQGGDFLTFLRTEGAR------------LRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARN L+ E +  K++DFG +R+             ++P++W APE+L    +S +SD+WS
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 197 FGVLIWEIVTLGSTPYPGMA 216
           FG+L+WE  +LG++PYP ++
Sbjct: 301 FGILLWETFSLGASPYPNLS 320

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  147 bits (370), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 115/200 (57%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    +++R D L E ++M   D HPN++ L G  T+ +P  +I EY+  G L 
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSLD 118
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR +  +             T   L      +  GM++LS    +HRDLAARN+L+  
Sbjct: 119 AFLRKNDGR------------FTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNS 166
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW APE++    F+  SD+WS+G+++W
Sbjct: 167 NLVCKVSDFGMSRVLEDDPEAAYTTRG-GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 225
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 226 EVMSYGERPYWDMSNQDVIK 245

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  147 bits (370), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 115/200 (57%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    +++R D L E ++M   D HPN++ L G  T+ +P  +I EY+  G L 
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSLD 103
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR +  +             T   L      +  GM++LS    +HRDLAARN+L+  
Sbjct: 104 AFLRKNDGR------------FTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNS 151
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW APE++    F+  SD+WS+G+++W
Sbjct: 152 NLVCKVSDFGMSRVLEDDPEAAYTTRG-GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 210
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 211 EVMSYGERPYWDMSNQDVIK 230

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  146 bits (369), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 115/200 (57%), Gaps = 13/200 (6%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R    +VAVK+ +E      +   LQE  ++K    HPN+VRL+G CT+K+P +++ME
Sbjct: 134 RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVME 192
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            V  G   +FLR+  A+            L  + L       A GM++L S+  IHRDLA
Sbjct: 193 LVQGGDFLTFLRTEGAR------------LRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARN L+ E +  K++DFG +R+             ++P++W APE+L    +S +SD+WS
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 197 FGVLIWEIVTLGSTPYPGMA 216
           FG+L+WE  +LG++PYP ++
Sbjct: 301 FGILLWETFSLGASPYPNLS 320

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  146 bits (369), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 115/200 (57%), Gaps = 16/200 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    +++R D L E ++M   D HPN++ L G  T+ +P  +I EY+  G L 
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSLD 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR +  +             T   L      +  GM++LS    +HRDLAARN+L+  
Sbjct: 98  AFLRKNDGR------------FTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNS 145
Query: 145 NHCCKVADFGFARDLMTS--SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           N  CKV+DFG +R L     + Y  +  G++PIRW APE++    F+  SD+WS+G+++W
Sbjct: 146 NLVCKVSDFGMSRVLEDDPEAAYTTRG-GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 204
Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+++ G  PY  M+  +V+K
Sbjct: 205 EVMSYGERPYWDMSNQDVIK 224

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  146 bits (369), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 121/212 (57%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 32  MSPE----NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 85
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+  +             SL    L  + YQ++  + +L S+  +
Sbjct: 86  WIIMELCTLGELRSFLQVRKF------------SLDLASLILYAYQLSTALAYLESKRFV 133
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+    C K+ DFG +R  M  S Y + S+G+LPI+WMAPES+    F+  
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  146 bits (369), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 82/198 (41%), Positives = 113/198 (57%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT+K  +   E    L E  VMKTL  H  +V+L    T KEP ++I E++  G L 
Sbjct: 42  VAVKTMKPGSMSVEAF--LAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLL 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S           G    L    L  F  Q+A GM F+  R  IHRDL A N+L+  
Sbjct: 98  DFLKSD---------EGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR ++  + Y  +   + PI+W APE++    F++KSD+WSFG+L+ EI
Sbjct: 147 SLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 205
Query: 205 VTLGSTPYPGMAAAEVMK 222
           VT G  PYPGM+  EV++
Sbjct: 206 VTYGRIPYPGMSNPEVIR 223

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  146 bits (369), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 82/198 (41%), Positives = 113/198 (57%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT+K  +   E    L E  VMKTL  H  +V+L    T KEP ++I E++  G L 
Sbjct: 215 VAVKTMKPGSMSVEAF--LAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S           G    L    L  F  Q+A GM F+  R  IHRDL A N+L+  
Sbjct: 271 DFLKSD---------EGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 319
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR ++  + Y  +   + PI+W APE++    F++KSD+WSFG+L+ EI
Sbjct: 320 SLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 205 VTLGSTPYPGMAAAEVMK 222
           VT G  PYPGM+  EV++
Sbjct: 379 VTYGRIPYPGMSNPEVIR 396

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  146 bits (368), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 121/212 (57%), Gaps = 20/212 (9%)
Query: 13  MSPERGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF 71
           MSPE     P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE  P 
Sbjct: 32  MSPE----NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITEN-PV 85
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
           ++IME    G+L+SFL+  +             SL    L  + YQ++  + +L S+  +
Sbjct: 86  WIIMELCTLGELRSFLQVRKF------------SLDLASLILYAYQLSTALAYLESKRFV 133
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           HRD+AARNVL+  N C K+ DFG +R  M  S   + S+G+LPI+WMAPES+    F+  
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 106 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 153
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 154 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 213
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 214 MTFGSKPYDGIPASEI 229

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 107
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 108 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 155
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 156 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 216 MTFGSKPYDGIPASEI 231

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 213 MTFGSKPYDGIPASEI 228

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 107 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 155 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 215 MTFGSKPYDGIPASEI 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 111
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 112 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 159
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 160 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 220 MTFGSKPYDGIPASEI 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 108
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 109 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 156
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 157 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 216
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 217 MTFGSKPYDGIPASEI 232

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 76/208 (36%), Positives = 118/208 (56%), Gaps = 17/208 (8%)
Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G++  C VA+KTLK    ER+R + L E ++M   + HPN++RL G  T   P  ++ E+
Sbjct: 41  GKKESC-VAIKTLKGGYTERQRREFLSEASIMGQFE-HPNIIRLEGVVTNSMPVMILTEF 98
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G L SFLR +  Q             T   L      +A GM++L+    +HRDLAA
Sbjct: 99  MENGALDSFLRLNDGQ------------FTVIQLVGMLRGIASGMRYLAEMSYVHRDLAA 146
Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSE---GRLPIRWMAPESLYDNIFSVKSDI 194
           RN+L+  N  CKV+DFG +R L  +S    ++    G++PIRW APE++    F+  SD 
Sbjct: 147 RNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDA 206
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           WS+G+++WE+++ G  PY  M+  +V+ 
Sbjct: 207 WSYGIVMWEVMSFGERPYWDMSNQDVIN 234

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  145 bits (365), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 81/202 (40%), Positives = 112/202 (55%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 46  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 101
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 102 GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 150
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 151 LVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 209
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 210 LTEIVTHGRIPYPGMTNPEVIQ 231

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 81/202 (40%), Positives = 112/202 (55%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 31  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 86
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 87  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 135
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 136 LVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 194
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 195 LTEIVTHGRIPYPGMTNPEVIQ 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 81/202 (40%), Positives = 112/202 (55%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 42  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 97
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 98  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 146
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 147 LVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 206 LTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGXLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 213 MTFGSKPYDGIPASEI 228

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 81/202 (40%), Positives = 112/202 (55%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 41  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 97  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 146 LVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 205 LTEIVTHGRIPYPGMTNPEVIQ 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 81/202 (40%), Positives = 112/202 (55%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 36  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 92  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 141 LVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 108
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 109 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 156
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 157 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 216
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 217 MTFGSKPYDGIPASEI 232

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 107 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 155 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 215 MTFGSKPYDGIPASEI 230

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 118/196 (60%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +IM+ +P+G L 
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 107 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 155 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 215 MTFGSKPYDGIPASEI 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 53  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 110
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 111 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 158
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 159 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 218
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 219 MTFGSKPYDGIPASEI 234

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 129
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 130 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 177
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 178 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 237
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 238 MTFGSKPYDGIPASEI 253

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 213 MTFGSKPYDGIPASEI 228

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 117/203 (57%), Gaps = 15/203 (7%)
Query: 25  VAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-----PF-FVIMEY 77
           VAVK LK +     +  + L+E   MK  D HP+V +L+G           P   VI+ +
Sbjct: 54  VAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           + +G L +FL +SR      N       L  + L  F   +A GM++LSSR  IHRDLAA
Sbjct: 113 MKHGDLHAFLLASRIGENPFN-------LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165
Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN ++ E+    VADFG +R + +   Y +    +LP++W+A ESL DN+++V SD+W+F
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 198 GVLIWEIVTLGSTPYPGMAAAEV 220
           GV +WEI+T G TPY G+  AE+
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEI 248

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 57  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 114
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 115 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 162
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 163 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 222
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 223 MTFGSKPYDGIPASEI 238

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 112 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 159
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 160 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 220 MTFGSKPYDGIPASEI 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 108 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 155
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 156 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 216 MTFGSKPYDGIPASEI 231

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 213 MTFGSKPYDGIPASEI 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 213 MTFGSKPYDGIPASEI 228

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 108 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 155
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 156 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 216 MTFGSKPYDGIPASEI 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 108 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 155
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 156 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 216 MTFGSKPYDGIPASEI 231

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 107 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 155 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 215 MTFGSKPYDGIPASEI 230

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 112 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 159
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 160 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 220 MTFGSKPYDGIPASEI 235

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 98
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 99  DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 207 MTFGSKPYDGIPASEI 222

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 112/203 (55%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 32  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 87
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHR+L A N+
Sbjct: 88  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANI 136
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 137 LVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 195
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + EIVT G  PYPGM   EV++ 
Sbjct: 196 LTEIVTHGRIPYPGMTNPEVIQN 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 114/196 (58%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L E  G +  ++ + E  +M ++D HP++VRLLG C       ++ + +P+G L 
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLL 127
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++            H   +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 128 EYV------------HEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS 175
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
            +  K+ DFG AR L           G++PI+WMA E ++   F+ +SD+WS+GV IWE+
Sbjct: 176 PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 235
Query: 205 VTLGSTPYPGMAAAEV 220
           +T G  PY G+   E+
Sbjct: 236 MTFGGKPYDGIPTREI 251

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  142 bits (358), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 114/196 (58%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L E  G +  ++ + E  +M ++D HP++VRLLG C       ++ + +P+G L 
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++            H   +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 EYV------------HEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
            +  K+ DFG AR L           G++PI+WMA E ++   F+ +SD+WS+GV IWE+
Sbjct: 153 PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T G  PY G+   E+
Sbjct: 213 MTFGGKPYDGIPTREI 228

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  142 bits (358), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L 
Sbjct: 34  VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R                +  L   C  V  GM +L    +IHRDLAARN L+GE
Sbjct: 91  DYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGE 138
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 139 NQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 197
Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G  PY   + +EV++
Sbjct: 198 FSEGKIPYENRSNSEVVE 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 116/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 44  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 101
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A GM +L  R ++HRDLAARNVL+  
Sbjct: 102 DYVREHK------------DNIGSQYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKT 149
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 150 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 209
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 210 MTFGSKPYDGIPASEI 225

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/204 (38%), Positives = 110/204 (53%), Gaps = 16/204 (7%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           +G   VAVK +KE  G     +  QE   M  L  HP +V+  G C+++ P +++ EY+ 
Sbjct: 30  KGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYIS 86
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            G L ++LRS          HGK   L    L   CY V  GM FL S   IHRDLAARN
Sbjct: 87  NGCLLNYLRS----------HGKG--LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
            L+  + C KV+DFG  R ++    Y      + P++W APE  +   +S KSD+W+FG+
Sbjct: 135 CLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGI 193
Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           L+WE+ +LG  PY     +EV+ K
Sbjct: 194 LMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 112 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 159
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 160 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 220 MTFGSKPYDGIPASEI 235

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 107 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 155 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 215 MTFGSKPYDGIPASEI 230

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 117/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 105 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 153 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 213 MTFGSKPYDGIPASEI 228

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 44  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 99
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 100 GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 148
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 149 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 207
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 208 LTEIVTHGRIPYPGMTNPEVIQ 229

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 42  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 97
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 98  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 146
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 147 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 206 LTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 36  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 92  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 141 LVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 45  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 100
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 101 GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 149
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 150 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 208
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 209 LTEIVTHGRIPYPGMTNPEVIQ 230

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 36  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 92  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 141 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L 
Sbjct: 32  VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R                +  L   C  V  GM +L    +IHRDLAARN L+GE
Sbjct: 89  DYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 137 NQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 195
Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G  PY   + +EV++
Sbjct: 196 FSEGKIPYENRSNSEVVE 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 37  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 92
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 93  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 141
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 142 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 200
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 201 LTEIVTHGRIPYPGMTNPEVIQ 222

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 38  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 93
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 94  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 142
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 143 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 201
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 202 LTEIVTHGRIPYPGMTNPEVIQ 223

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+  G       L E  +MK L  H  +VRL    T+ EP ++I EY+  
Sbjct: 36  GHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 92  GSLVDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR L+  +    +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 141 LVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 201 IWEIVTLGSTPYPGMAAAEVMK 222
           + EIVT G  PYPGM   EV++
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L 
Sbjct: 34  VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R                +  L   C  V  GM +L    +IHRDLAARN L+GE
Sbjct: 91  DYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 138
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 139 NQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 197
Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G  PY   + +EV++
Sbjct: 198 FSEGKIPYENRSNSEVVE 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/224 (35%), Positives = 121/224 (54%), Gaps = 5/224 (2%)
Query: 2   DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           D F    + H   P  G +    VA+KTLK+ A    R +   E  +   L  HPNVV L
Sbjct: 37  DRFGKVYKGHLFGPAPGEQTQA-VAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCL 94
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFL--RSSRAQ-RYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG  T+ +P  +I  Y  +G L  FL  RS  +     ++     ++L   D      Q+
Sbjct: 95  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 154
Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           A GM++LSS  ++H+DLA RNVL+ +    K++D G  R++  +  Y+      LPIRWM
Sbjct: 155 AAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM 214
Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE++    FS+ SDIWS+GV++WE+ + G  PY G +  +V++
Sbjct: 215 APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/224 (35%), Positives = 121/224 (54%), Gaps = 5/224 (2%)
Query: 2   DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL 61
           D F    + H   P  G +    VA+KTLK+ A    R +   E  +   L  HPNVV L
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQA-VAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCL 77
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFL--RSSRAQ-RYYNNMHGKSNSLTSRDLTSFCYQV 118
           LG  T+ +P  +I  Y  +G L  FL  RS  +     ++     ++L   D      Q+
Sbjct: 78  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 119 ARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM 178
           A GM++LSS  ++H+DLA RNVL+ +    K++D G  R++  +  Y+      LPIRWM
Sbjct: 138 AAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM 197
Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           APE++    FS+ SDIWS+GV++WE+ + G  PY G +  +V++
Sbjct: 198 APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L 
Sbjct: 37  VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R                +  L   C  V  GM +L    +IHRDLAARN L+GE
Sbjct: 94  DYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 141
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 142 NQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 200
Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G  PY   + +EV++
Sbjct: 201 FSEGKIPYENRSNSEVVE 218

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 116/196 (59%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+  L+E    +   ++L E  VM ++D +P+V RLLG C       +I + +P+G L 
Sbjct: 81  VAIMELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLL 138
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++R  +            +++ S+ L ++C Q+A+GM +L  R ++HRDLAARNVL+  
Sbjct: 139 DYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 186
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+WS+GV +WE+
Sbjct: 187 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 246
Query: 205 VTLGSTPYPGMAAAEV 220
           +T GS PY G+ A+E+
Sbjct: 247 MTFGSKPYDGIPASEI 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  140 bits (354), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 110/203 (54%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDLAA N+
Sbjct: 97  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  140 bits (354), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L 
Sbjct: 35  VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R                +  L   C  V  GM +L    +IHRDLAARN L+GE
Sbjct: 92  DYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 139
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 140 NQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 198
Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G  PY   + +EV++
Sbjct: 199 FSEGKIPYENRSNSEVVE 216

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  140 bits (352), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KT+KE  G     D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L 
Sbjct: 54  VAIKTIKE--GSMSEDDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLS 110
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR+ R                +  L   C  V  GM +L    +IHRDLAARN L+GE
Sbjct: 111 DYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 158
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N   KV+DFG  R ++    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE+
Sbjct: 159 NQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 217
Query: 205 VTLGSTPYPGMAAAEVMK 222
            + G  PY   + +EV++
Sbjct: 218 FSEGKIPYENRSNSEVVE 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  140 bits (352), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 74/196 (37%), Positives = 112/196 (57%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K L+EN   +   ++L E  VM  +   P V RLLG C       ++ + +PYG L 
Sbjct: 49  VAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVSRLLGICLTST-VQLVTQLMPYGCLL 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +R +R +            L S+DL ++C Q+A+GM +L    ++HRDLAARNVL+  
Sbjct: 107 DHVRENRGR------------LGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKS 154
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
            +  K+ DFG AR L           G++PI+WMA ES+    F+ +SD+WS+GV +WE+
Sbjct: 155 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWEL 214
Query: 205 VTLGSTPYPGMAAAEV 220
           +T G+ PY G+ A E+
Sbjct: 215 MTFGAKPYDGIPAREI 230

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  140 bits (352), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/198 (40%), Positives = 108/198 (54%), Gaps = 26/198 (13%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT+K  +   E    L E  VMKTL  H  +V+L    T KEP ++I E++  G L 
Sbjct: 209 VAVKTMKPGSMSVEAF--LAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLL 264
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+S           G    L    L  F  Q+A GM F+  R  IHRDL A N+L+  
Sbjct: 265 DFLKSD---------EGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 313
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +  CK+ADFG AR              + PI+W APE++    F++KSD+WSFG+L+ EI
Sbjct: 314 SLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 362
Query: 205 VTLGSTPYPGMAAAEVMK 222
           VT G  PYPGM+  EV++
Sbjct: 363 VTYGRIPYPGMSNPEVIR 380

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 110/203 (54%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++MEY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVMEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GCLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 290 GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 345
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 346 GSLLDFLKGETGKY-----------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 395 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 454 LTELTTKGRVPYPGMVNREVLDQ 476

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 207 GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 262
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 263 GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 312 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQ 393

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 110/203 (54%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP ++++EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVIEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 207 GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 262
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 263 GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 312 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQ 393

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 76/190 (40%), Positives = 114/190 (60%), Gaps = 16/190 (8%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF-FVIMEYVPYGKLQ 84
           A+K+L      ++    L+E  +M+ L+ HPNV+ L+G     E    V++ Y+ +G L 
Sbjct: 53  AIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            F+RS +             + T +DL SF  QVARGM++L+ +  +HRDLAARN ++ E
Sbjct: 112 QFIRSPQ------------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE 159
Query: 145 NHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           +   KVADFG ARD++    Y  ++    RLP++W A ESL    F+ KSD+WSFGVL+W
Sbjct: 160 SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219
Query: 203 EIVTLGSTPY 212
           E++T G+ PY
Sbjct: 220 ELLTRGAPPY 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 114/213 (53%), Gaps = 8/213 (3%)
Query: 13  MSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
           +SP + +    +VAVK LK+      R D  +E  ++  L  H ++V+  G C + +P  
Sbjct: 39  LSPTKDK---MLVAVKALKDPT-LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLI 93
Query: 73  VIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
           ++ EY+ +G L  FLR+                   L    +     Q+A GM +L+S+ 
Sbjct: 94  MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS 189
            +HRDLA RN L+G N   K+ DFG +RD+ ++  Y       LPIRWM PES+    F+
Sbjct: 154 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 213
Query: 190 VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            +SD+WSFGV++WEI T G  P+  ++  EV++
Sbjct: 214 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 207 GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVGEYMSK 262
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 263 GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 312 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQ 393

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 34  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 89
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 90  GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 138
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 139 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 197
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 198 LTELTTKGRVPYPGMVNREVLDQ 220

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 32  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 87
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 88  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 136
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 137 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 195
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 196 LTELTTKGRVPYPGMVNREVLDQ 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 30  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 85
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 86  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 134
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 135 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 193
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 194 LTELTTKGRVPYPGMVNREVLDQ 216

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  138 bits (347), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 114/206 (55%), Gaps = 15/206 (7%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R+    VA+K LK+   + +  ++++E  +M  LD +P +VRL+G C + E   ++ME
Sbjct: 32  RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEALMLVME 89
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
               G L  FL             GK   +   ++    +QV+ GM++L  +  +HRDLA
Sbjct: 90  MAGGGPLHKFLV------------GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 137 ARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           ARNVL+   H  K++DFG ++ L    S Y  +S G+ P++W APE +    FS +SD+W
Sbjct: 138 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S+GV +WE ++ G  PY  M   EVM
Sbjct: 198 SYGVTMWEALSYGQKPYKKMKGPEVM 223

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  138 bits (347), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 38  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMNK 93
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 94  GSLLDFLKGETGK-----------YLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANI 142
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 143 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 201
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 202 LTELTTKGRVPYPGMVNREVLDQ 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  137 bits (346), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK +  H  +V+L    +E EP +++ EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKIR-HEKLVQLYAVVSE-EPIYIVTEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  137 bits (346), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVCEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 58  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 106
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 107 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 163 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 220 V 220
           V
Sbjct: 223 V 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 58  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 106
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 107 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 163 ADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 220 V 220
           V
Sbjct: 223 V 223

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 52  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 101 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 156
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 157 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216
Query: 220 V 220
           V
Sbjct: 217 V 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 54  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 102
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 103 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 220 V 220
           V
Sbjct: 219 V 219

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK   G       LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 208 GTTRVAIKTLK--PGNMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 263
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 264 GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 312
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG  R L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 313 LVGENLVCKVADFGLGR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 371
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 372 LTELTTKGRVPYPGMVNREVLDQ 394

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 74  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 122
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 123 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 178
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 179 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 220 V 220
           V
Sbjct: 239 V 239

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 74  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 122
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 123 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 178
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 179 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 220 V 220
           V
Sbjct: 239 V 239

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  137 bits (345), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 64  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 112
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 113 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
Query: 220 V 220
           V
Sbjct: 229 V 229

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  137 bits (345), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 72  ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 120
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 121 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 176
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 177 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236
Query: 220 V 220
           V
Sbjct: 237 V 237

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  137 bits (345), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 417 ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 465
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 466 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 521
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 522 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 581
Query: 220 V 220
           V
Sbjct: 582 V 582

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  137 bits (345), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 111/197 (56%), Gaps = 15/197 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT K++     +   + E  +MK LD HP++V+L+G   E+EP ++IME  PYG+L 
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGI-IEEEPTWIIMELYPYGELG 96
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +L  ++            NSL    L  +  Q+ + M +L S   +HRD+A RN+L+  
Sbjct: 97  HYLERNK------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS 144
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
             C K+ DFG +R +     Y + S  RLPI+WM+PES+    F+  SD+W F V +WEI
Sbjct: 145 PECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 203
Query: 205 VTLGSTPYPGMAAAEVM 221
           ++ G  P+  +   +V+
Sbjct: 204 LSFGKQPFFWLENKDVI 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  137 bits (345), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 106/181 (58%), Gaps = 16/181 (8%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           +LL E  VM+ LD +P +VR++G C E E + ++ME    G L  +L+ +R         
Sbjct: 416 ELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--------- 464
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +  +++    +QV+ GM++L     +HRDLAARNVL+   H  K++DFG ++ L 
Sbjct: 465 ----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520
Query: 161 TS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
              + Y+ ++ G+ P++W APE +    FS KSD+WSFGVL+WE  + G  PY GM  +E
Sbjct: 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580
Query: 220 V 220
           V
Sbjct: 581 V 581

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  137 bits (344), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 111/197 (56%), Gaps = 15/197 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT K++     +   + E  +MK LD HP++V+L+G   E+EP ++IME  PYG+L 
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGI-IEEEPTWIIMELYPYGELG 100
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +L  ++            NSL    L  +  Q+ + M +L S   +HRD+A RN+L+  
Sbjct: 101 HYLERNK------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS 148
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
             C K+ DFG +R +     Y + S  RLPI+WM+PES+    F+  SD+W F V +WEI
Sbjct: 149 PECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 207
Query: 205 VTLGSTPYPGMAAAEVM 221
           ++ G  P+  +   +V+
Sbjct: 208 LSFGKQPFFWLENKDVI 224

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  137 bits (344), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GCLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  137 bits (344), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 111/197 (56%), Gaps = 15/197 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKT K++     +   + E  +MK LD HP++V+L+G   E+EP ++IME  PYG+L 
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGI-IEEEPTWIIMELYPYGELG 112
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +L  ++            NSL    L  +  Q+ + M +L S   +HRD+A RN+L+  
Sbjct: 113 HYLERNK------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS 160
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
             C K+ DFG +R +     Y + S  RLPI+WM+PES+    F+  SD+W F V +WEI
Sbjct: 161 PECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 219
Query: 205 VTLGSTPYPGMAAAEVM 221
           ++ G  P+  +   +V+
Sbjct: 220 LSFGKQPFFWLENKDVI 236

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  136 bits (343), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 38  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMNK 93
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 94  GSLLDFLKGETGK-----------YLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANI 142
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR L+  + +  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 143 LVGENLVCKVADFGLAR-LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 201
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 202 LTELTTKGRVPYPGMVNREVLDQ 224

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  136 bits (343), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP ++++EY+  
Sbjct: 41  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVIEYMSK 96
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 97  GSLLDFLKGEMGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 145
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR +  +    R+   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQ 227

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 76/203 (37%), Positives = 111/203 (54%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    L+E  +MK L  H  +V+L    +E EP +++ EY+  
Sbjct: 32  GNTKVAIKTLKPGTMSPE--SFLEEAQIMKKLK-HDKLVQLYAVVSE-EPIYIVTEYMNK 87
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+            G+  +L   +L     QVA GM ++     IHRDL + N+
Sbjct: 88  GSLLDFLKD-----------GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 136
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+G    CK+ADFG AR +  +    R+   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 137 LVGNGLICKIADFGLARLIEDNEXTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGIL 195
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+VT G  PYPGM   EV+++
Sbjct: 196 LTELVTKGRVPYPGMNNREVLEQ 218

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  135 bits (341), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 15/206 (7%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R+    VA+K LK+   + +  ++++E  +M  LD +P +VRL+G C + E   ++ME
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEALMLVME 415
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
               G L  FL             GK   +   ++    +QV+ GM++L  +  +HR+LA
Sbjct: 416 MAGGGPLHKFLV------------GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 137 ARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           ARNVL+   H  K++DFG ++ L    S Y  +S G+ P++W APE +    FS +SD+W
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S+GV +WE ++ G  PY  M   EVM
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVM 549

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 27  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMAN 83
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 84  GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R ++    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 132 LVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190
Query: 201 IWEIVTLGSTPYPGMAAAEV 220
           +WEI +LG  PY     +E 
Sbjct: 191 MWEIYSLGKMPYERFTNSET 210

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 32  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMAN 88
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 89  GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 136
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R ++    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 137 LVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 195
Query: 201 IWEIVTLGSTPYPGMAAAEV 220
           +WEI +LG  PY     +E 
Sbjct: 196 MWEIYSLGKMPYERFTNSET 215

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 32  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMAN 88
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 89  GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 136
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R ++    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 137 LVNDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 195
Query: 201 IWEIVTLGSTPYPGMAAAEV 220
           +WEI +LG  PY     +E 
Sbjct: 196 MWEIYSLGKMPYERFTNSET 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 31  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMAN 87
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 88  GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 135
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R ++    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 136 LVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 194
Query: 201 IWEIVTLGSTPYPGMAAAEV 220
           +WEI +LG  PY     +E 
Sbjct: 195 MWEIYSLGKMPYERFTNSET 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 38  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMAN 94
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 95  GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 142
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R ++    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 143 LVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 201
Query: 201 IWEIVTLGSTPYPGMAAAEV 220
           +WEI +LG  PY     +E 
Sbjct: 202 MWEIYSLGKMPYERFTNSET 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 47  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMAN 103
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 104 GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R ++    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210
Query: 201 IWEIVTLGSTPYPGMAAAEV 220
           +WEI +LG  PY     +E 
Sbjct: 211 MWEIYSLGKMPYERFTNSET 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 113/201 (56%), Gaps = 23/201 (11%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKL 83
           VAVK +K +A  +     L E +VM  L  H N+V+LLG   E K   +++ EY+  G L
Sbjct: 38  VAVKCIKNDATAQA---FLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 93
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
             +LRS            +  S+   D L  F   V   M++L     +HRDLAARNVL+
Sbjct: 94  VDYLRS------------RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 141
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E++  KV+DFG  ++  ++     +  G+LP++W APE+L +  FS KSD+WSFG+L+W
Sbjct: 142 SEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLW 196
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EI + G  PYP +   +V+ +
Sbjct: 197 EIYSFGRVPYPRIPLKDVVPR 217

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 113/201 (56%), Gaps = 23/201 (11%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKL 83
           VAVK +K +A  +     L E +VM  L  H N+V+LLG   E K   +++ EY+  G L
Sbjct: 47  VAVKCIKNDATAQA---FLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
             +LRS            +  S+   D L  F   V   M++L     +HRDLAARNVL+
Sbjct: 103 VDYLRS------------RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 150
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E++  KV+DFG  ++  ++     +  G+LP++W APE+L +  FS KSD+WSFG+L+W
Sbjct: 151 SEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 205
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EI + G  PYP +   +V+ +
Sbjct: 206 EIYSFGRVPYPRIPLKDVVPR 226

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 112/199 (56%), Gaps = 23/199 (11%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKL 83
           VAVK +K +A  +     L E +VM  L  H N+V+LLG   E K   +++ EY+  G L
Sbjct: 32  VAVKCIKNDATAQA---FLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
             +LRS            +  S+   D L  F   V   M++L     +HRDLAARNVL+
Sbjct: 88  VDYLRS------------RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 135
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E++  KV+DFG  ++  ++     +  G+LP++W APE+L +  FS KSD+WSFG+L+W
Sbjct: 136 SEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 203 EIVTLGSTPYPGMAAAEVM 221
           EI + G  PYP +   +V+
Sbjct: 191 EIYSFGRVPYPRIPLKDVV 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 113/201 (56%), Gaps = 23/201 (11%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKL 83
           VAVK +K +A  +     L E +VM  L  H N+V+LLG   E K   +++ EY+  G L
Sbjct: 219 VAVKCIKNDATAQA---FLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
             +LRS            +  S+   D L  F   V   M++L     +HRDLAARNVL+
Sbjct: 275 VDYLRS------------RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 322
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            E++  KV+DFG  ++  ++     +  G+LP++W APE+L +  FS KSD+WSFG+L+W
Sbjct: 323 SEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 377
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           EI + G  PYP +   +V+ +
Sbjct: 378 EIYSFGRVPYPRIPLKDVVPR 398

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  134 bits (337), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 78/204 (38%), Positives = 109/204 (53%), Gaps = 24/204 (11%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 47  GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMAN 103
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R            +   ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 104 GCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151
Query: 141 LIGENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           L+ +    KV+DFG +R    D  TSSV       + P+RW  PE L  + FS KSDIW+
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEETSSV-----GSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 197 FGVLIWEIVTLGSTPYPGMAAAEV 220
           FGVL+WEI +LG  PY     +E 
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSET 230

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  134 bits (336), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP  ++ EY+  
Sbjct: 31  GTTRVAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE-EPIXIVTEYMSK 86
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 87  GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 135
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR +  +    R+   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 136 LVGENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGIL 194
Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 195 LTELTTKGRVPYPGMVNREVLDQ 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 110/196 (56%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V +K +++ +G +    +   +  + +LD H ++VRLLG C       ++ +Y+P G L 
Sbjct: 63  VCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPGSS-LQLVTQYLPLGSLL 120
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +R  R             +L  + L ++  Q+A+GM +L   G++HR+LAARNVL+  
Sbjct: 121 DHVRQHRG------------ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS 168
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               +VADFG A  L         SE + PI+WMA ES++   ++ +SD+WS+GV +WE+
Sbjct: 169 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 228
Query: 205 VTLGSTPYPGMAAAEV 220
           +T G+ PY G+  AEV
Sbjct: 229 MTFGAEPYAGLRLAEV 244

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 110/196 (56%), Gaps = 14/196 (7%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V +K +++ +G +    +   +  + +LD H ++VRLLG C       ++ +Y+P G L 
Sbjct: 45  VCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPGSS-LQLVTQYLPLGSLL 102
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +R  R             +L  + L ++  Q+A+GM +L   G++HR+LAARNVL+  
Sbjct: 103 DHVRQHRG------------ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS 150
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               +VADFG A  L         SE + PI+WMA ES++   ++ +SD+WS+GV +WE+
Sbjct: 151 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 210
Query: 205 VTLGSTPYPGMAAAEV 220
           +T G+ PY G+  AEV
Sbjct: 211 MTFGAEPYAGLRLAEV 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/207 (36%), Positives = 119/207 (57%), Gaps = 24/207 (11%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV---R 60
           SVE+ R  P+    G     +VAVK L+ +  +++R D  +E+ ++K L  H + +   R
Sbjct: 38  SVELCRYDPLGDNTG----ALVAVKQLQHSGPDQQR-DFQREIQILKAL--HSDFIVKYR 90
Query: 61  LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR 120
            +     ++   ++MEY+P G L+ FL+  RA+            L +  L  +  Q+ +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDASRLLLYSSQICK 138
Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMA 179
           GM++L SR  +HRDLAARN+L+      K+ADFG A+ L +    Y  +  G+ PI W A
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 180 PESLYDNIFSVKSDIWSFGVLIWEIVT 206
           PESL DNIFS +SD+WSFGV+++E+ T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/207 (36%), Positives = 119/207 (57%), Gaps = 24/207 (11%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV---R 60
           SVE+ R  P+    G     +VAVK L+ +  +++R D  +E+ ++K L  H + +   R
Sbjct: 25  SVELCRYDPLGDNTG----ALVAVKQLQHSGPDQQR-DFQREIQILKAL--HSDFIVKYR 77
Query: 61  LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR 120
            +     ++   ++MEY+P G L+ FL+  RA+            L +  L  +  Q+ +
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDASRLLLYSSQICK 125
Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMA 179
           GM++L SR  +HRDLAARN+L+      K+ADFG A+ L +    Y  +  G+ PI W A
Sbjct: 126 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 185
Query: 180 PESLYDNIFSVKSDIWSFGVLIWEIVT 206
           PESL DNIFS +SD+WSFGV+++E+ T
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/207 (36%), Positives = 119/207 (57%), Gaps = 24/207 (11%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV---R 60
           SVE+ R  P+    G     +VAVK L+ +  +++R D  +E+ ++K L  H + +   R
Sbjct: 26  SVELCRYDPLGDNTG----ALVAVKQLQHSGPDQQR-DFQREIQILKAL--HSDFIVKYR 78
Query: 61  LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR 120
            +     ++   ++MEY+P G L+ FL+  RA+            L +  L  +  Q+ +
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDASRLLLYSSQICK 126
Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMA 179
           GM++L SR  +HRDLAARN+L+      K+ADFG A+ L +    Y  +  G+ PI W A
Sbjct: 127 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 186
Query: 180 PESLYDNIFSVKSDIWSFGVLIWEIVT 206
           PESL DNIFS +SD+WSFGV+++E+ T
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 25  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 78
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 79  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 126
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L      ++ K  G  PI W AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 26  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 79
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 80  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 127
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHR+LA RN+L+   +  K+ DFG  + L      Y+ K  G  PI W AP
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  120 bits (300), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 56  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 109
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 157
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  120 bits (300), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 43  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 96
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 97  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 144
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 25  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 78
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 79  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 126
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 23  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 76
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 77  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 124
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 32  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 85
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 86  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 133
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 25  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 78
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 79  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 126
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 104/186 (55%), Gaps = 18/186 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
           +VAVK LK + G + R    QE+ +++TL  H ++++  GCC ++  +   ++MEYVP G
Sbjct: 45  MVAVKALKADCGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +L                +S+    L  F  Q+  GM +L S+  IHR+LAARNVL
Sbjct: 104 SLRDYL--------------PRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVL 149
Query: 142 IGENHCCKVADFGFARDLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           +  +   K+ DFG A+ +     Y R + +G  P+ W APE L +  F   SD+WSFGV 
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 201 IWEIVT 206
           ++E++T
Sbjct: 210 LYELLT 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 102/186 (54%), Gaps = 18/186 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
           +VAVK LK +AG + R    QE+ +++TL  H ++++  GCC +       ++MEYVP G
Sbjct: 62  MVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +L                +S+    L  F  Q+  GM +L ++  IHRDLAARNVL
Sbjct: 121 SLRDYL--------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVL 166
Query: 142 IGENHCCKVADFGFARDLMTS-SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           +  +   K+ DFG A+ +      Y  + +G  P+ W APE L +  F   SD+WSFGV 
Sbjct: 167 LDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 201 IWEIVT 206
           ++E++T
Sbjct: 227 LYELLT 232

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 28  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 81
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L++  A+R           +    L  +  Q+ +G
Sbjct: 82  VCYSAGRRNLKLIMEYLPYGSLRDYLQA-HAER-----------IDHIKLLQYTSQICKG 129
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 28  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 81
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 82  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 129
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 30  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 83
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 84  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 131
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 24  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 77
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 78  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 125
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 31  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 84
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 85  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 132
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 29  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 82
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 83  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 130
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 43  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 96
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IMEY+PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 97  VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------------IDHIKLLQYTSQICKG 144
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 16/195 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGK 82
           VAVK+LK  +G     DL +E+ +++ L  H N+V+  G CTE       +IME++P G 
Sbjct: 53  VAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGS 111
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+ +L  ++            N +  +    +  Q+ +GM +L SR  +HRDLAARNVL+
Sbjct: 112 LKEYLPKNK------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGR-LPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
              H  K+ DFG  + + T        + R  P+ W APE L  + F + SD+WSFGV +
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 202 WEIVTLGSTPYPGMA 216
            E++T   +    MA
Sbjct: 220 HELLTYCDSDSSPMA 234

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 104/186 (55%), Gaps = 18/186 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
           +VAVK LK + G + R    QE+ +++TL  H ++++  GCC ++  +   ++MEYVP G
Sbjct: 45  MVAVKALKADCGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +L                +S+    L  F  Q+  GM +L ++  IHR+LAARNVL
Sbjct: 104 SLRDYL--------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVL 149
Query: 142 IGENHCCKVADFGFARDLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           +  +   K+ DFG A+ +     Y R + +G  P+ W APE L +  F   SD+WSFGV 
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 201 IWEIVT 206
           ++E++T
Sbjct: 210 LYELLT 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 16/195 (8%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGK 82
           VAVK+LK  +G     DL +E+ +++ L  H N+V+  G CTE       +IME++P G 
Sbjct: 41  VAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGS 99
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+ +L  ++            N +  +    +  Q+ +GM +L SR  +HRDLAARNVL+
Sbjct: 100 LKEYLPKNK------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 147
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGR-LPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
              H  K+ DFG  + + T        + R  P+ W APE L  + F + SD+WSFGV +
Sbjct: 148 ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 207
Query: 202 WEIVTLGSTPYPGMA 216
            E++T   +    MA
Sbjct: 208 HELLTYCDSDSSPMA 222

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG 63
           SVE+ R  P+    G     +VAVK L+ +  E  R D  +E+ ++K+L  H N+V+  G
Sbjct: 28  SVEMCRYDPLQDNTGE----VVAVKKLQHSTEEHLR-DFEREIEILKSLQ-HDNIVKYKG 81
Query: 64  CCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
            C    +    +IME++PYG L+ +L+  + +            +    L  +  Q+ +G
Sbjct: 82  VCYSAGRRNLKLIMEFLPYGSLREYLQKHKER------------IDHIKLLQYTSQICKG 129
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAP 180
           M++L ++  IHRDLA RN+L+   +  K+ DFG  + L       + K  G  PI W AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVT 206
           ESL ++ FSV SD+WSFGV+++E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 75/207 (36%), Positives = 117/207 (56%), Gaps = 24/207 (11%)
Query: 5   SVEV-RKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV---R 60
           SVE+ R  P+    G     +VAVK L+ +  +++R D  +E+ ++K L  H + +   R
Sbjct: 22  SVELCRYDPLGDNTG----ALVAVKQLQHSGPDQQR-DFQREIQILKAL--HSDFIVKYR 74
Query: 61  LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR 120
            +     +    ++MEY+P G L+ FL+  RA+            L +  L  +  Q+ +
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR------------LDASRLLLYSSQICK 122
Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMA 179
           GM++L SR  +HRDLAARN+L+      K+ADFG A+ L +       +  G+ PI W A
Sbjct: 123 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
Query: 180 PESLYDNIFSVKSDIWSFGVLIWEIVT 206
           PESL DNIFS +SD+WSFGV+++E+ T
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  117 bits (293), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 106
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 107 LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGR-LPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L  +  +    E R +P  W APESL    FS  SD W FGV +
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 215 WEMFTYGQEPWIGLNGSQILHK 236

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L E     ER++  L+E+ +MK L  HPN+V  +G  T+     ++ EY+  G L
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVL 141
              L  S          G    L  R   S  Y VA+GM +L +R   I+HR+L + N+L
Sbjct: 122 YRLLHKS----------GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + + +  KV DFG +R L  S+    KS    P  WMAPE L D   + KSD++SFGV++
Sbjct: 172 VDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 202 WEIVTLGSTPYPGMAAAEVM 221
           WE+ TL   P+  +  A+V+
Sbjct: 230 WELATL-QQPWGNLNPAQVV 248

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  117 bits (292), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 96
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 97  LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGR-LPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L  +  +    E R +P  W APESL    FS  SD W FGV +
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 205 WEMFTYGQEPWIGLNGSQILHK 226

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  117 bits (292), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 106
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 107 LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 143 GENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L      Y  +   ++P  W APESL    FS  SD W FGV +
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 215 WEMFTYGQEPWIGLNGSQILHK 236

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  117 bits (292), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 96
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 97  LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144
Query: 143 GENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L      Y  +   ++P  W APESL    FS  SD W FGV +
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 205 WEMFTYGQEPWIGLNGSQILHK 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  117 bits (292), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 96
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 97  LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144
Query: 143 GENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L      Y  +   ++P  W APESL    FS  SD W FGV +
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 205 WEMFTYGQEPWIGLNGSQILHK 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  117 bits (292), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 100
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 101 LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 148
Query: 143 GENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L      Y  +   ++P  W APESL    FS  SD W FGV +
Sbjct: 149 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 208
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 209 WEMFTYGQEPWIGLNGSQILHK 230

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  117 bits (292), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 25  VAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK LK +   +     D ++E+  M +LD H N++RL G      P  ++ E  P G 
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGS 100
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   LR  +                   L+ +  QVA GM +L S+  IHRDLAARN+L+
Sbjct: 101 LLDRLRKHQGHFLLGT------------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 148
Query: 143 GENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG  R L      Y  +   ++P  W APESL    FS  SD W FGV +
Sbjct: 149 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 208
Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE+ T G  P+ G+  ++++ K
Sbjct: 209 WEMFTYGQEPWIGLNGSQILHK 230

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (291), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 74/200 (37%), Positives = 105/200 (52%), Gaps = 17/200 (8%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L E     ER++  L+E+ +MK L  HPN+V  +G  T+     ++ EY+  G L
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVL 141
              L  S          G    L  R   S  Y VA+GM +L +R   I+HRDL + N+L
Sbjct: 122 YRLLHKS----------GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLL 171
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + + +  KV DFG +R L  S     K     P  WMAPE L D   + KSD++SFGV++
Sbjct: 172 VDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTP-EWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 202 WEIVTLGSTPYPGMAAAEVM 221
           WE+ TL   P+  +  A+V+
Sbjct: 230 WELATL-QQPWGNLNPAQVV 248

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 102/186 (54%), Gaps = 18/186 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
           +VAVK LKE  G + R    +E+ +++TL  H ++V+  GCC ++  +   ++MEYVP G
Sbjct: 40  MVAVKALKEGCGPQLRSGWQREIEILRTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLG 98
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +L                + +    L  F  Q+  GM +L ++  IHR LAARNVL
Sbjct: 99  SLRDYL--------------PRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVL 144
Query: 142 IGENHCCKVADFGFARDLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           +  +   K+ DFG A+ +     Y R + +G  P+ W APE L +  F   SD+WSFGV 
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 204
Query: 201 IWEIVT 206
           ++E++T
Sbjct: 205 LYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 102/186 (54%), Gaps = 18/186 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
           +VAVK LKE  G + R    +E+ +++TL  H ++V+  GCC ++  +   ++MEYVP G
Sbjct: 39  MVAVKALKEGCGPQLRSGWQREIEILRTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLG 97
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +L                + +    L  F  Q+  GM +L ++  IHR LAARNVL
Sbjct: 98  SLRDYL--------------PRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVL 143
Query: 142 IGENHCCKVADFGFARDLMTSSVYER-KSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           +  +   K+ DFG A+ +     Y R + +G  P+ W APE L +  F   SD+WSFGV 
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 203
Query: 201 IWEIVT 206
           ++E++T
Sbjct: 204 LYELLT 209

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 25  VAVKTLKENAGE--RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK  + +  E   + ++ +++   +  +  HPN++ L G C ++    ++ME+   G 
Sbjct: 33  VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP 92
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI---IHRDLAARN 139
           L   L   R              +    L ++  Q+ARGM +L    I   IHRDL + N
Sbjct: 93  LNRVLSGKR--------------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138
Query: 140 VLIGE--------NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           +LI +        N   K+ DFG AR+   ++    K        WMAPE +  ++FS  
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKG 194
Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
           SD+WS+GVL+WE++T G  P+ G+    V
Sbjct: 195 SDVWSYGVLLWELLT-GEVPFRGIDGLAV 222

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 22/182 (12%)
Query: 29  TLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLR 88
            +K+   E ER   + EL  +  ++ HPN+V+L G C    P  ++MEY   G L + L 
Sbjct: 36  AIKQIESESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLH 92
Query: 89  SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS---RGIIHRDLAARNVL-IGE 144
            +    YY   H            S+C Q ++G+ +L S   + +IHRDL   N+L +  
Sbjct: 93  GAEPLPYYTAAHA----------MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG 142
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A D+ T     + S       WMAPE    + +S K D++S+G+++WE+
Sbjct: 143 GTVLKICDFGTACDIQTHMTNNKGSAA-----WMAPEVFEGSNYSEKCDVFSWGIILWEV 197
Query: 205 VT 206
           +T
Sbjct: 198 IT 199

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 22/182 (12%)
Query: 29  TLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLR 88
            +K+   E ER   + EL  +  ++ HPN+V+L G C    P  ++MEY   G L + L 
Sbjct: 35  AIKQIESESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLH 91
Query: 89  SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS---RGIIHRDLAARNVL-IGE 144
            +    YY   H            S+C Q ++G+ +L S   + +IHRDL   N+L +  
Sbjct: 92  GAEPLPYYTAAHA----------MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG 141
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+ DFG A D+ T     + S       WMAPE    + +S K D++S+G+++WE+
Sbjct: 142 GTVLKICDFGTACDIQTHMTNNKGSAA-----WMAPEVFEGSNYSEKCDVFSWGIILWEV 196
Query: 205 VT 206
           +T
Sbjct: 197 IT 198

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 32/202 (15%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           RE   ++ +K L     E +R   L+E+ VM+ L+ HPNV++ +G   + +    I EY+
Sbjct: 32  RETGEVMVMKELIRFDEETQRT-FLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYI 89
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L+  ++S  +Q  ++               SF   +A GM +L S  IIHRDL + 
Sbjct: 90  KGGTLRGIIKSMDSQYPWSQR------------VSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEG----RLPIR-----------WMAPESL 183
           N L+ EN    VADFG AR ++       + EG    + P R           WMAPE +
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKT---QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 184 YDNIFSVKSDIWSFGVLIWEIV 205
               +  K D++SFG+++ EI+
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEII 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK +     +R  L L  E+ +M+    H NVV +       E  +V+ME++  G L 
Sbjct: 73  VAVKMMDLRKQQRREL-LFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +   R              L    + + C  V + + +L ++G+IHRD+ + ++L+  
Sbjct: 131 DIVSQVR--------------LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL 176
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K++DFGF   + +  V +RK     P  WMAPE +  ++++ + DIWS G+++ E+
Sbjct: 177 DGRVKLSDFGFCAQI-SKDVPKRKXLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 205 VTLGSTPYPGMAAAEVMKK 223
           V  G  PY   +  + MK+
Sbjct: 235 VD-GEPPYFSDSPVQAMKR 252

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 106
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H        + L     Q ARGM +L ++ IIHRDL + N+ + 
Sbjct: 107 ------------YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 154
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E++  K+ DFG A +    S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 215 LYELMT-GQLPYSNI 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +     +    +LL+E+  M     HPN+V        K+  +++M+ +  G + 
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             ++   A+  +     KS  L    + +   +V  G+++L   G IHRD+ A N+L+GE
Sbjct: 97  DIIKHIVAKGEH-----KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIR---WMAPESLYD-NIFSVKSDIWSFGVL 200
           +   ++ADFG +  L T     R    +  +    WMAPE +     +  K+DIWSFG+ 
Sbjct: 152 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 211
Query: 201 IWEIVTLGSTPY 212
             E+ T G+ PY
Sbjct: 212 AIELAT-GAAPY 222

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 23/197 (11%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K + E   E E  D + E+ ++ T D HP +V+LLG        ++++E
Sbjct: 39  KNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIE 96
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           + P G + +             M      LT   +   C Q+   + FL S+ IIHRDL 
Sbjct: 97  FCPGGAVDAI------------MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 137 ARNVLIGENHCCKVADFGF-ARDLMTSSVYERKSEGRLPIRWMAP-----ESLYDNIFSV 190
           A NVL+      ++ADFG  A++L T  + +R S    P  WMAP     E++ D  +  
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPY-WMAPEVVMCETMKDTPYDY 201
Query: 191 KSDIWSFGVLIWEIVTL 207
           K+DIWS G+ + E+  +
Sbjct: 202 KADIWSLGITLIEMAQI 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +     +    +LL+E+  M     HPN+V        K+  +++M+ +  G + 
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             ++   A+  +     KS  L    + +   +V  G+++L   G IHRD+ A N+L+GE
Sbjct: 102 DIIKHIVAKGEH-----KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 156
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIR---WMAPESLYD-NIFSVKSDIWSFGVL 200
           +   ++ADFG +  L T     R    +  +    WMAPE +     +  K+DIWSFG+ 
Sbjct: 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
Query: 201 IWEIVTLGSTPY 212
             E+ T G+ PY
Sbjct: 217 AIELAT-GAAPY 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 23/197 (11%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K + E   E E  D + E+ ++ T D HP +V+LLG        ++++E
Sbjct: 31  KNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIE 88
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           + P G + +             M      LT   +   C Q+   + FL S+ IIHRDL 
Sbjct: 89  FCPGGAVDAI------------MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 137 ARNVLIGENHCCKVADFGF-ARDLMTSSVYERKSEGRLPIRWMAP-----ESLYDNIFSV 190
           A NVL+      ++ADFG  A++L T  + +R S    P  WMAP     E++ D  +  
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTP-YWMAPEVVMCETMKDTPYDY 193
Query: 191 KSDIWSFGVLIWEIVTL 207
           K+DIWS G+ + E+  +
Sbjct: 194 KADIWSLGITLIEMAQI 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T  +   ++ ++     L
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTAPQ-LAIVTQWCEGSSL 106
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H        + L     Q ARGM +L ++ IIHRDL + N+ + 
Sbjct: 107 ------------YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 154
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E++  K+ DFG A +    S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 215 LYELMT-GQLPYSNI 228

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 94
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H        + L     Q ARGM +L ++ IIHRDL + N+ + 
Sbjct: 95  ------------YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 142
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E++  K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 143 EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 202
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 203 LYELMT-GQLPYSNI 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 23/202 (11%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDL-LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R ++   IVA+K   E+  ++    + ++E+ ++K L  H N+V LL  C +K+ ++++ 
Sbjct: 45  RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVF 103
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E+V +  L             +++    N L  + +  + +Q+  G+ F  S  IIHRD+
Sbjct: 104 EFVDHTIL-------------DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 136 AARNVLIGENHCCKVADFGFARDLMT-SSVYERKSEGRLPIRWM-APESLYDNI-FSVKS 192
              N+L+ ++   K+ DFGFAR L     VY+ +    +  RW  APE L  ++ +    
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE----VATRWYRAPELLVGDVKYGKAV 206
Query: 193 DIWSFGVLIWEIVTLGSTPYPG 214
           D+W+ G L+ E+  +G   +PG
Sbjct: 207 DVWAIGCLVTEMF-MGEPLFPG 227

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 37/225 (16%)
Query: 6   VEVRKHPMSPERGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGC 64
           V++ +H ++   GRE    VA+K + +       L  L +E+ +MK L+ HPN+V+L   
Sbjct: 31  VKLARHILT---GRE----VAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEV 82
Query: 65  CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
              ++  ++IMEY   G++  +L +          HG+   +  ++  S   Q+   +Q+
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVA----------HGR---MKEKEARSKFRQIVSAVQY 129
Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY 184
              + I+HRDL A N+L+  +   K+ADFGF+ +            G+L     AP    
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--------GKLDAFCGAPPYAA 181
Query: 185 DNIFSVKS------DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +F  K       D+WS GV+++ +V+ GS P+ G    E+ ++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRER 225

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L 
Sbjct: 73  VAVKKMDLRKQQRREL-LFNEVVIMRDYH-HDNVVDMYSSYLVGDELWVVMEFLEGGALT 130
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +R              +    + + C  V R + +L ++G+IHRD+ + ++L+  
Sbjct: 131 DIVTHTR--------------MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 176
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K++DFGF   + +  V +RK     P  WMAPE +    +  + DIWS G+++ E+
Sbjct: 177 DGRIKLSDFGFCAQV-SKEVPKRKXLVGTPY-WMAPEVISRLPYGTEVDIWSLGIMVIEM 234
Query: 205 VTLGSTPYPGMAAAEVMKK 223
           +  G  PY      + M++
Sbjct: 235 ID-GEPPYFNEPPLQAMRR 252

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 20/197 (10%)
Query: 17  RGREGPCIVAVKTLKENAGER-ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R R      A+K LK+    R ++++   +  +M ++  HP ++R+ G   + +  F+IM
Sbjct: 26  RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           +Y+  G+L S LR S  QR+ N +              +  +V   +++L S+ II+RDL
Sbjct: 86  DYIEGGELFSLLRKS--QRFPNPV-----------AKFYAAEVCLALEYLHSKDIIYRDL 132
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+L+ +N   K+ DFGFA+ +   +     +       ++APE +    ++   D W
Sbjct: 133 KPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD-----YIAPEVVSTKPYNKSIDWW 187
Query: 196 SFGVLIWEIVTLGSTPY 212
           SFG+LI+E++  G TP+
Sbjct: 188 SFGILIYEMLA-GYTPF 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 37  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
           + R D ++E+ ++K L+ HPNV++      E     +++E    G L   ++  + Q+  
Sbjct: 74  KARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-- 130
Query: 97  NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA 156
                    +  R +  +  Q+   ++ + SR ++HRD+   NV I      K+ D G  
Sbjct: 131 -------RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           R   +S      S    P  +M+PE +++N ++ KSDIWS G L++E+  L S  Y
Sbjct: 184 R-FFSSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEY 77
           + A+K +     E E  ++ QE+ ++K    H N+    G   +K P       +++ME+
Sbjct: 51  LAAIKVMDVTGDEEE--EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G +   ++++           K N+L    +   C ++ RG+  L    +IHRD+  
Sbjct: 109 CGAGSVTDLIKNT-----------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 157
Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKS 192
           +NVL+ EN   K+ DFG +  L   +V  R +    P  WMAPE +      D  +  KS
Sbjct: 158 QNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKS 215
Query: 193 DIWSFGVLIWEIVTLGSTP 211
           D+WS G+   E+   G+ P
Sbjct: 216 DLWSLGITAIEMAE-GAPP 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 37/225 (16%)
Query: 6   VEVRKHPMSPERGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGC 64
           V++ +H ++   GRE    VA+K + +       L  L +E+ +MK L+ HPN+V+L   
Sbjct: 28  VKLARHILT---GRE----VAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEV 79
Query: 65  CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
              ++  ++IMEY   G++  +L +          HG+   +  ++  S   Q+   +Q+
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVA----------HGR---MKEKEARSKFRQIVSAVQY 126
Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY 184
              + I+HRDL A N+L+  +   K+ADFGF+ +            G+L     +P    
Sbjct: 127 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--------GKLDTFCGSPPYAA 178
Query: 185 DNIFSVKS------DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +F  K       D+WS GV+++ +V+ GS P+ G    E+ ++
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRER 222

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP++V L+G C E+    +I +Y+  G L+  L       Y +++   S S   R     
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-------YGSDLPTMSMSWEQR--LEI 144
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
           C   ARG+ +L +R IIHRD+ + N+L+ EN   K+ DFG ++              +  
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
           + ++ PE       + KSD++SFGV+++E++
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP++V L+G C E+    +I +Y+  G L+  L       Y +++   S S   R     
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-------YGSDLPTMSMSWEQR--LEI 144
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
           C   ARG+ +L +R IIHRD+ + N+L+ EN   K+ DFG ++              +  
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
           + ++ PE       + KSD++SFGV+++E++
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA++ +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 48  VAIRQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHRD+ + N+L+G 
Sbjct: 106 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   +       ++SE      WMAPE +    +  K DIWS G++  E+
Sbjct: 152 DGSVKLTDFGFCAQITPEQ--SKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 205 VTLGSTPY 212
           +  G  PY
Sbjct: 210 IE-GEPPY 216

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 17/182 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P + R  G   +    ++IMEY+  G  
Sbjct: 46  VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYFGSYLKSTKLWIIMEYLGGGSA 104
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L+    +  Y              + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 105 LDLLKPGPLEETY--------------IATILREILKGLDYLHSERKIHRDIKAANVLLS 150
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E    K+ADFG A  L  + +      G  P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 151 EQGDVKLADFGVAGQLTDTQIKRNXFVGT-PF-WMAPEVIKQSAYDFKADIWSLGITAIE 208
Query: 204 IV 205
           + 
Sbjct: 209 LA 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 46  LTVMKTLDPHP-------NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           + ++K +DP P       N V +L   T      + M Y+    L    +       Y +
Sbjct: 63  VKILKVVDPTPEQFQAFRNEVAVLRK-TRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKH 121
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD 158
           +H +        L     Q A+GM +L ++ IIHRD+ + N+ + E    K+ DFG A  
Sbjct: 122 LHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181
Query: 159 LMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               S  ++  +    + WMAPE +    +N FS +SD++S+G++++E++T G  PY
Sbjct: 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPY 237

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA++ +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 48  VAIRQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHRD+ + N+L+G 
Sbjct: 106 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R +    P  WMAPE +    +  K DIWS G++  E+
Sbjct: 152 DGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 205 VTLGSTPY 212
           +  G  PY
Sbjct: 210 IE-GEPPY 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 101 LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 158
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 159 TDIVTHTR--------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 204
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RK     P  WMAPE +    +  + DIWS G+++ E
Sbjct: 205 HDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 263 MVD-GEPPYFNEPPLKAMK 280

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 51  LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 108
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 109 TDIVTHTR--------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 154
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RK     P  WMAPE +    +  + DIWS G+++ E
Sbjct: 155 HDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 212
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 213 MVD-GEPPYFNEPPLKAMK 230

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 58  LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 115
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 116 TDIVTHTR--------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 161
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RK     P  WMAPE +    +  + DIWS G+++ E
Sbjct: 162 HDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 219
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 220 MVD-GEPPYFNEPPLKAMK 237

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 56  LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 113
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 114 TDIVTHTR--------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 159
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RK     P  WMAPE +    +  + DIWS G+++ E
Sbjct: 160 HDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 217
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 218 MVD-GEPPYFNEPPLKAMK 235

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 178 LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 236 TDIVTHTR--------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RK     P  WMAPE +    +  + DIWS G+++ E
Sbjct: 282 HDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 339
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 340 MVD-GEPPYFNEPPLKAMK 357

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK +     +R  L L  E+ +M+    H NVV +       +  +V+ME++  G L
Sbjct: 47  LVAVKKMDLRKQQRREL-LFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +  +R              +    + + C  V + +  L ++G+IHRD+ + ++L+ 
Sbjct: 105 TDIVTHTR--------------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 150
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V  RK     P  WMAPE +    +  + DIWS G+++ E
Sbjct: 151 HDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIE 208
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           +V  G  PY      + MK
Sbjct: 209 MVD-GEPPYFNEPPLKAMK 226

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 49  VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L              +   L    + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 108 LDLL--------------EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ADFG A  L  + +      G  P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 154 EHGEVKLADFGVAGQLTDTQIKRNXFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIE 211
Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P+  +   +V+
Sbjct: 212 LAR-GEPPHSELHPMKVL 228

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 34  VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSA 92
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L              +   L    + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 93  LDLL--------------EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 138
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ADFG A  L  + + +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 139 EHGEVKLADFGVAGQLTDTQI-KRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIE 196
Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P+  +   +V+
Sbjct: 197 LAR-GEPPHSELHPMKVL 213

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 112/220 (50%), Gaps = 27/220 (12%)
Query: 6   VEVRKHPMSPERGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGC 64
           V++ +H ++   GRE    VAVK + +       L  L +E+ +MK L+ HPN+V+L   
Sbjct: 31  VKLARHVLT---GRE----VAVKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEV 82
Query: 65  CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
              ++  +++MEY   G++  +L +          HG+   +  ++  +   Q+   +Q+
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVA----------HGR---MKEKEARAKFRQIVSAVQY 129
Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY 184
              + I+HRDL A N+L+  +   K+ADFGF+ +    +  +    G  P  + APE   
Sbjct: 130 CHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC-GSPP--YAAPELFQ 186
Query: 185 DNIFS-VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
              +   + D+WS GV+++ +V+ GS P+ G    E+ ++
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRER 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 54  VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSA 112
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L              +   L    + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 113 LDLL--------------EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 158
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ADFG A  L T +  +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 159 EHGEVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIE 216
Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P+  +   +V+
Sbjct: 217 LAR-GEPPHSELHPMKVL 233

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK + +       L  L +E+ +MK L+ HPN+V+L      ++  +++MEY   G++
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +L +          HG+   +  ++  +   Q+   +Q+   + I+HRDL A N+L+ 
Sbjct: 101 FDYLVA----------HGR---MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            +   K+ADFGF+ +    +  +    G  P  + APE      +   + D+WS GV+++
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDTFC-GSPP--YAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
            +V+ GS P+ G    E+ ++
Sbjct: 205 TLVS-GSLPFDGQNLKELRER 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA++ +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 49  VAIRQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHRD+ + N+L+G 
Sbjct: 107 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R      P  WMAPE +    +  K DIWS G++  E+
Sbjct: 153 DGSVKLTDFGFCAQI-TPEQSKRSXMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 210
Query: 205 VTLGSTPY 212
           +  G  PY
Sbjct: 211 IE-GEPPY 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA++ +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 48  VAIRQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHRD+ + N+L+G 
Sbjct: 106 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R      P  WMAPE +    +  K DIWS G++  E+
Sbjct: 152 DGSVKLTDFGFCAQI-TPEQSKRSXMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 205 VTLGSTPY 212
           +  G  PY
Sbjct: 210 IE-GEPPY 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 34  VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSA 92
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L              +   L    + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 93  LDLL--------------EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 138
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ADFG A  L  + +      G  P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 139 EHGEVKLADFGVAGQLTDTQIKRNXFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIE 196
Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P+  +   +V+
Sbjct: 197 LAR-GEPPHSELHPMKVL 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK + +       L  L +E+ +MK L+ HPN+V+L      ++  +++MEY   G++
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +L +          HG+   +  ++  +   Q+   +Q+   + I+HRDL A N+L+ 
Sbjct: 101 FDYLVA----------HGR---MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            +   K+ADFGF+ +    +  +    G  P  + APE      +   + D+WS GV+++
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDTFC-GSPP--YAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
            +V+ GS P+ G    E+ ++
Sbjct: 205 TLVS-GSLPFDGQNLKELRER 224

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK + +       L  L +E+ +MK L+ HPN+V+L      ++  +++MEY   G++
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +L +          HG+   +  ++  +   Q+   +Q+   + I+HRDL A N+L+ 
Sbjct: 101 FDYLVA----------HGR---MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            +   K+ADFGF+ +    +  +    G  P  + APE      +   + D+WS GV+++
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDAFC-GAPP--YAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
            +V+ GS P+ G    E+ ++
Sbjct: 205 TLVS-GSLPFDGQNLKELRER 224

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           +E   IVA+K +     E +  ++++E+++M+  D  P+VV+  G   +    +++MEY 
Sbjct: 51  KETGQIVAIKQV---PVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G +   +R             ++ +LT  ++ +      +G+++L     IHRD+ A 
Sbjct: 107 GAGSVSDIIRL------------RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154
Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           N+L+      K+ADFG A  L T  + +R      P  WMAPE + +  ++  +DIWS G
Sbjct: 155 NILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPF-WMAPEVIQEIGYNCVADIWSLG 212
Query: 199 VLIWEIVTLGSTPY 212
           +   E+   G  PY
Sbjct: 213 ITAIEMAE-GKPPY 225

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 95/183 (51%), Gaps = 19/183 (10%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 101
           L +E+ +MK L+ HPN+V+L      ++  +++MEY   G++  +L +          HG
Sbjct: 60  LFREVRIMKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA----------HG 108
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           +   +  ++  +   Q+   +Q+   + I+HRDL A N+L+  +   K+ADFGF+ +   
Sbjct: 109 R---MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 162 SSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            +  +    G  P  + APE      +   + D+WS GV+++ +V+ GS P+ G    E+
Sbjct: 166 GNKLDEFC-GSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKEL 221
Query: 221 MKK 223
            ++
Sbjct: 222 RER 224

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  +      KE  F +MEY+  G L   ++S              +       T +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-------------HKFDLSRATFY 124
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++  G+QFL S+GI++RDL   N+L+ ++   K+ADFG  ++ M      + +E    
Sbjct: 125 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNEFCGT 182
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
             ++APE L    ++   D WSFGVL++E++ +G +P+ G    E+ 
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELF 228

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 20/200 (10%)
Query: 24  IVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           + A+K LK+   + R+R+    E  ++  ++ HP VV+L      +   ++I++++  G 
Sbjct: 58  LYAMKVLKKATLKVRDRVRTKMERDILADVN-HPFVVKLHYAFQTEGKLYLILDFLRGGD 116
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L  F R S+   +           T  D+  +  ++A G+  L S GII+RDL   N+L+
Sbjct: 117 L--FTRLSKEVMF-----------TEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL 163
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIWSFGVLI 201
            E    K+ DFG +++ +    +E+K+      + +MAPE +     S  +D WS+GVL+
Sbjct: 164 DEEGHIKLTDFGLSKEAID---HEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLM 220
Query: 202 WEIVTLGSTPYPGMAAAEVM 221
           +E++T GS P+ G    E M
Sbjct: 221 FEMLT-GSLPFQGKDRKETM 239

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 90
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 91  ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A +    S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 139 EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198
Query: 201 IWEIVTLGSTPY 212
           ++E++T G  PY
Sbjct: 199 LYELMT-GQLPY 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 118
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 119 ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 166
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A +    S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 167 EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 226
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 227 LYELMT-GQLPYSNI 240

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 95/183 (51%), Gaps = 19/183 (10%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 101
           L +E+ +MK L+ HPN+V+L      ++  +++MEY   G++  +L +          HG
Sbjct: 60  LFREVRIMKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA----------HG 108
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           +   +  ++  +   Q+   +Q+   + I+HRDL A N+L+  +   K+ADFGF+ +   
Sbjct: 109 R---MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 162 SSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            +  +    G  P  + APE      +   + D+WS GV+++ +V+ GS P+ G    E+
Sbjct: 166 GNKLDTFC-GSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKEL 221
Query: 221 MKK 223
            ++
Sbjct: 222 RER 224

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA++ +      ++ L ++ E+ VM+  + +PN+V  L      +  +V+MEY+  G L 
Sbjct: 49  VAIRQMNLQQQPKKEL-IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             +  +               +    + + C +  + ++FL S  +IHR++ + N+L+G 
Sbjct: 107 DVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGM 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFGF   + T    +R +    P  WMAPE +    +  K DIWS G++  E+
Sbjct: 153 DGSVKLTDFGFCAQI-TPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 210
Query: 205 VTLGSTPY 212
           +  G  PY
Sbjct: 211 IE-GEPPY 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 110
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 111 ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 158
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A +    S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 159 EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 218
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 219 LYELMT-GQLPYSNI 232

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D    V +  G   +    ++IMEY+  G  
Sbjct: 50  VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS-YVTKYYGSYLKGSKLWIIMEYLGGGSA 108
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              LR+     +               + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 109 LDLLRAGPFDEF--------------QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 154
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E    K+ADFG A  L T +  +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 155 EQGDVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKADIWSLGITAIE 212
Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P   M    V+
Sbjct: 213 LAK-GEPPNSDMHPMRVL 229

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 16/167 (9%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  +      KE  F +MEY+  G L   ++S              +       T +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-------------HKFDLSRATFY 123
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++  G+QFL S+GI++RDL   N+L+ ++   K+ADFG  ++ M          G   
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCG--T 181
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
             ++APE L    ++   D WSFGVL++E++ +G +P+ G    E+ 
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELF 227

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R R+   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 32  RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 90
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 91  LEYAPLGTVYRELQ-------------KLSRFDEQRTATYITELANALSYCHSKRVIHRD 137
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G N   K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 138 IKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 193
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  ++
Sbjct: 194 WSLGVLCYEFL-VGMPPFEAHTYQETYRR 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK + +       L  L +E+ +MK L+ HPN+V+L      ++  +++MEY   G++
Sbjct: 35  VAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEV 93
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +L +          HG    +  ++  +   Q+   +Q+   + I+HRDL A N+L+ 
Sbjct: 94  FDYLVA----------HG---WMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 140
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            +   K+ADFGF+ +    +  +    G  P  + APE      +   + D+WS GV+++
Sbjct: 141 ADMNIKIADFGFSNEFTFGNKLDTFC-GSPP--YAAPELFQGKKYDGPEVDVWSLGVILY 197
Query: 203 EIVTLGSTPYPGMAAAEV 220
            +V+ GS P+ G    E+
Sbjct: 198 TLVS-GSLPFDGQNLKEL 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R R+   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 32  RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 90
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 91  LEYAPLGTVYRELQ-------------KLSRFDEQRTATYITELANALSYCHSKRVIHRD 137
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G N   K+ADFG++    +S    R+      + ++ PE +   +   K D+
Sbjct: 138 IKPENLLLGSNGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPEMIEGRMHDEKVDL 193
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  ++
Sbjct: 194 WSLGVLCYEFL-VGMPPFEAHTYQETYRR 221

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++E    + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 92
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 93  ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 140
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 141 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 200
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 201 LYELMT-GQLPYSNI 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 95
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 96  ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 143
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 144 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 203
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 204 LYELMT-GQLPYSNI 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 19/192 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 90
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 91  ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198
Query: 201 IWEIVTLGSTPY 212
           ++E++T G  PY
Sbjct: 199 LYELMT-GQLPY 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 19/192 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 95
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 96  ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 143
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 144 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 203
Query: 201 IWEIVTLGSTPY 212
           ++E++T G  PY
Sbjct: 204 LYELMT-GQLPY 214

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 117
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 118 ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 165
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 166 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 225
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 226 LYELMT-GQLPYSNI 239

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T K    ++ ++     L
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL 118
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 119 ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 166
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 167 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 226
Query: 201 IWEIVTLGSTPYPGM 215
           ++E++T G  PY  +
Sbjct: 227 LYELMT-GQLPYSNI 240

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 33  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 91
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G++   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 92  LEYAPRGEVYKELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 138
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+      + ++ PE +   +   K D+
Sbjct: 139 IKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLXGTLDYLPPEMIEGRMHDEKVDL 194
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 195 WSLGVLCYEFL-VGKPPFEANTYQETYKR 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 19/192 (9%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L   A   ++L   + E+ V++    H N++  +G  T  +   ++ ++     L
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTAPQ-LAIVTQWCEGSSL 90
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                       Y+++H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 91  ------------YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198
Query: 201 IWEIVTLGSTPY 212
           ++E++T G  PY
Sbjct: 199 LYELMT-GQLPY 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 29  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 87
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 88  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 134
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+++    + ++ PE +   +   K D+
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDL 190
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 191 WSLGVLCYEFL-VGKPPFEANTYQETYKR 218

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 33  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 91
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 92  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 138
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+++    + ++ PE +   +   K D+
Sbjct: 139 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDL 194
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 195 WSLGVLCYEFL-VGKPPFEANTYQETYKR 222

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+++    + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+++    + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 18  GREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G +   + A+K LK+   + R+R+    E  ++  ++ HP +V+L      +   ++I++
Sbjct: 49  GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILD 107
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++  G L  F R S+   +           T  D+  +  ++A  +  L S GII+RDL 
Sbjct: 108 FLRGGDL--FTRLSKEVMF-----------TEEDVKFYLAELALALDHLHSLGIIYRDLK 154
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIW 195
             N+L+ E    K+ DFG +++   S  +E+K+      + +MAPE +     +  +D W
Sbjct: 155 PENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 211
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           SFGVL++E++T G+ P+ G    E M
Sbjct: 212 SFGVLMFEMLT-GTLPFQGKDRKETM 236

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 18  GREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G +   + A+K LK+   + R+R+    E  ++  ++ HP +V+L      +   ++I++
Sbjct: 48  GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILD 106
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++  G L  F R S+   +           T  D+  +  ++A  +  L S GII+RDL 
Sbjct: 107 FLRGGDL--FTRLSKEVMF-----------TEEDVKFYLAELALALDHLHSLGIIYRDLK 153
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIW 195
             N+L+ E    K+ DFG +++   S  +E+K+      + +MAPE +     +  +D W
Sbjct: 154 PENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           SFGVL++E++T G+ P+ G    E M
Sbjct: 211 SFGVLMFEMLT-GTLPFQGKDRKETM 235

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 18  GREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           G +   + A+K LK+   + R+R+    E  ++  ++ HP +V+L      +   ++I++
Sbjct: 48  GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILD 106
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++  G L  F R S           K    T  D+  +  ++A  +  L S GII+RDL 
Sbjct: 107 FLRGGDL--FTRLS-----------KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIW 195
             N+L+ E    K+ DFG +++   S  +E+K+      + +MAPE +     +  +D W
Sbjct: 154 PENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           SFGVL++E++T G+ P+ G    E M
Sbjct: 211 SFGVLMFEMLT-GTLPFQGKDRKETM 235

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L ++  E+E ++  L +E+ +   L  HPN++R+     +++  +++
Sbjct: 35  REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM 93
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +E+ P G+L   L+           HG+ +   S    +F  ++A  + +   R +IHRD
Sbjct: 94  LEFAPRGELYKELQK----------HGRFDEQRS---ATFMEELADALHYCHERKVIHRD 140
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++  +   S+  R   G L   ++ PE +       K D+
Sbjct: 141 IKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTL--DYLPPEMIEGKTHDEKVDL 196
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           W  GVL +E + +G  P+   +  E  ++
Sbjct: 197 WCAGVLCYEFL-VGMPPFDSPSHTETHRR 224

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L ++  E+E ++  L +E+ +   L  HPN++R+     +++  +++
Sbjct: 34  REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM 92
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +E+ P G+L   L+           HG+ +   S    +F  ++A  + +   R +IHRD
Sbjct: 93  LEFAPRGELYKELQK----------HGRFDEQRS---ATFMEELADALHYCHERKVIHRD 139
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++  +   S+  R   G L   ++ PE +       K D+
Sbjct: 140 IKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTL--DYLPPEMIEGKTHDEKVDL 195
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           W  GVL +E + +G  P+   +  E  ++
Sbjct: 196 WCAGVLCYEFL-VGMPPFDSPSHTETHRR 223

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 29  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 87
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 88  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 134
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 135 IKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLDYLPPEMIEGRMHDEKVDL 190
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 191 WSLGVLCYEFL-VGKPPFEANTYQETYKR 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           +KT+ ++  +     +  E+ V+K+LD HPN++++     +    +++ME    G+L   
Sbjct: 52  IKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-- 144
           + S++A         +  +L+   +     Q+   + +  S+ ++H+DL   N+L  +  
Sbjct: 111 IVSAQA---------RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS 161
Query: 145 -NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K+ DFG A +L  S  +   + G     +MAPE    ++ + K DIWS GV+++ 
Sbjct: 162 PHSPIKIIDFGLA-ELFKSDEHSTNAAGT--ALYMAPEVFKRDV-TFKCDIWSAGVVMYF 217
Query: 204 IVTLGSTPYPGMAAAEVMKKS 224
           ++T G  P+ G +  EV +K+
Sbjct: 218 LLT-GCLPFTGTSLEEVQQKA 237

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 33  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 91
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G++   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 92  LEYAPRGEVYKELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 138
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 139 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 194
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 195 WSLGVLCYEFL-VGKPPFEANTYQETYKR 222

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K + +   E E  D + E+ ++ + D HPN+V+LL     +   ++++E
Sbjct: 57  QNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIE 114
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +   G + +             M      LT   +   C Q    + +L    IIHRDL 
Sbjct: 115 FCAGGAVDAV------------MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVK 191
           A N+L   +   K+ADFG +    T ++  R S    P  WMAPE +      D  +  K
Sbjct: 163 AGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYDYK 220
Query: 192 SDIWSFGVLIWEIVTL 207
           +D+WS G+ + E+  +
Sbjct: 221 ADVWSLGITLIEMAEI 236

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 54  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 112
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 113 LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 159
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+ +    + ++ PE +   +   K D+
Sbjct: 160 IKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLDYLPPEMIEGRMHDEKVDL 215
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 216 WSLGVLCYEFL-VGKPPFEANTYQETYKR 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L  C  + E  +  + Y   G+L  ++R            G  
Sbjct: 86  RERDVMSRLD-HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 134
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 135 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 191
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 192 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 239

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 31  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 89
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 90  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 136
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+ +    + ++ PE +   +   K D+
Sbjct: 137 IKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 193 WSLGVLCYEFL-VGKPPFEANTYQETYKR 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 25/175 (14%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 101
           QE+ ++K LD HPNVV+L+    +  ++  +++ E V  G +               M  
Sbjct: 85  QEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------------MEV 128
Query: 102 KSNSLTSRDLTSFCYQ-VARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
            +    S D   F +Q + +G+++L  + IIHRD+   N+L+GE+   K+ADFG + +  
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 161 TSSVYERKSEGRLPIRWMAPESLYDN--IFSVKS-DIWSFGVLIWEIVTLGSTPY 212
            S      + G     +MAPESL +   IFS K+ D+W+ GV ++  V  G  P+
Sbjct: 189 GSDALLSNTVGT--PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV-FGQCPF 240

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 17  RGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           + RE   IVA+K ++ ++  E      L+E+ ++K L  H N+VRL       +   ++ 
Sbjct: 22  KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E+               ++Y+++ +G    L    + SF +Q+ +G+ F  SR ++HRDL
Sbjct: 81  EFC----------DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY--DNIFSVKSD 193
             +N+LI  N   K+A+FG AR      +  R     +   W  P  +     ++S   D
Sbjct: 128 KPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +WS G +  E+   G   +PG    + +K+
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKR 214

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 54  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 112
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 113 LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 159
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 160 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 215
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 216 WSLGVLCYEFL-VGKPPFEANTYQETYKR 243

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 45  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 103
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 104 LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 150
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 151 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 206
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 207 WSLGVLCYEFL-VGKPPFEANTYQETYKR 234

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 31  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 89
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 90  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 136
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 137 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 193 WSLGVLCYEFL-VGKPPFEANTYQETYKR 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 33  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 91
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 92  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 138
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 139 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 194
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 195 WSLGVLCYEFL-VGKPPFEANTYQETYKR 222

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 31  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 89
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 90  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 136
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 137 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 193 WSLGVLCYEFL-VGKPPFEANTYQETYKR 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 27  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 85
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 86  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 132
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 133 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 188
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 189 WSLGVLCYEFL-VGKPPFEANTYQETYKR 216

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 33  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 91
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 92  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 138
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +       K D+
Sbjct: 139 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEXIEGRXHDEKVDL 194
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 195 WSLGVLCYEFL-VGKPPFEANTYQETYKR 222

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 31  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 89
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 90  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 136
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 137 IKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 193 WSLGVLCYEFL-VGKPPFEANTYQETYKR 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 32  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 90
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 91  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 137
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 138 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 193
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 194 WSLGVLCYEFL-VGKPPFEANTYQETYKR 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 17  RGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           + RE   IVA+K ++ ++  E      L+E+ ++K L  H N+VRL       +   ++ 
Sbjct: 22  KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E+               ++Y+++ +G    L    + SF +Q+ +G+ F  SR ++HRDL
Sbjct: 81  EFC----------DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY--DNIFSVKSD 193
             +N+LI  N   K+ADFG AR      +  R     +   W  P  +     ++S   D
Sbjct: 128 KPQNLLINRNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +WS G +  E+       +PG    + +K+
Sbjct: 185 MWSAGCIFAELANAARPLFPGNDVDDQLKR 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 25  VAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK + +       L  L +E+ + K L+ HPN+V+L      ++  +++ EY   G++
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIXKVLN-HPNIVKLFEVIETEKTLYLVXEYASGGEV 100
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +L +          HG+     +R   +   Q+   +Q+   + I+HRDL A N+L+ 
Sbjct: 101 FDYLVA----------HGRXKEKEAR---AKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            +   K+ADFGF+ +    +  +    G  P  + APE      +   + D+WS GV+++
Sbjct: 148 ADXNIKIADFGFSNEFTFGNKLDAFC-GAPP--YAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
            +V+ GS P+ G    E+ ++
Sbjct: 205 TLVS-GSLPFDGQNLKELRER 224

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K + +   E E  D + E+ ++ + D HPN+V+LL     +   ++++E
Sbjct: 57  QNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIE 114
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +   G + +             M      LT   +   C Q    + +L    IIHRDL 
Sbjct: 115 FCAGGAVDAV------------MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVK 191
           A N+L   +   K+ADFG +    T  +  R S    P  WMAPE +      D  +  K
Sbjct: 163 AGNILFTLDGDIKLADFGVSAK-NTRXIQRRDSFIGTPY-WMAPEVVMCETSKDRPYDYK 220
Query: 192 SDIWSFGVLIWEIVTL 207
           +D+WS G+ + E+  +
Sbjct: 221 ADVWSLGITLIEMAEI 236

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E+V +  L++F+ +S        + G 
Sbjct: 49  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDAS-------ALTGI 99
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 100 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 152
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 29  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 87
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 88  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 134
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+      + ++ PE +   +   K D+
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPEMIEGRMHDEKVDL 190
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 191 WSLGVLCYEFL-VGKPPFEANTYQETYKR 218

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 30  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 88
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 89  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 135
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+      + ++ PE +   +   K D+
Sbjct: 136 IKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGRMHDEKVDL 191
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 192 WSLGVLCYEFL-VGKPPFEANTYQETYKR 219

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+      + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQETYKR 217

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 31  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 89
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 90  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 136
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R+      + ++ PE +   +   K D+
Sbjct: 137 IKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 193 WSLGVLCYEFL-VGKPPFEANTYQETYKR 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 25  REKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 83
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 84  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 130
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 131 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 186
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 187 WSLGVLCYEFL-VGKPPFEANTYQETYKR 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 28/188 (14%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 101
           LL+E+ V+K LD HPN+++L     +K  ++++ME    G+L           +   +H 
Sbjct: 83  LLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGEL-----------FDEIIH- 129
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARD 158
                   D      QV  G+ +L    I+HRDL   N+L+    ++   K+ DFG    
Sbjct: 130 -RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL--- 185
Query: 159 LMTSSVYE--RKSEGRLPIR-WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
              S+V+E  +K + RL    ++APE L    +  K D+WS GV+++ I+  G  P+ G 
Sbjct: 186 ---SAVFENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILF-ILLAGYPPFGGQ 240
Query: 216 AAAEVMKK 223
              E+++K
Sbjct: 241 TDQEILRK 248

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L++F+ +S        + G 
Sbjct: 53  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDAS-------ALTGI 103
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 104 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 156
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 157 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           H N+V ++    E + ++++MEY+    L  ++ S          HG    L+     +F
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----------HG---PLSVDTAINF 116
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             Q+  G++      I+HRD+  +N+LI  N   K+ DFG A+ L  +S+  + +     
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGT 175
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +++ +PE          +DI+S G++++E++ +G  P+ G  A  +  K
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEML-VGEPPFNGETAVSIAIK 223

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R +    I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 28  REKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDSTRVYLI 86
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 87  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKKVIHRD 133
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 134 IKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      +  K+
Sbjct: 190 WSLGVLCYEFL-VGKPPFEANTYQDTYKR 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 30  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 88
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 89  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 135
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+A+FG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 136 IKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 191
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 192 WSLGVLCYEFL-VGKPPFEANTYQETYKR 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 31  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 89
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 90  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 136
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+A+FG++    +S    R++     + ++ PE +   +   K D+
Sbjct: 137 IKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E + +G  P+      E  K+
Sbjct: 193 WSLGVLCYEFL-VGKPPFEANTYQETYKR 220

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 57  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 107
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 108 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 160
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 161 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 104
           E  V+  LD  P + +L  C    +  + +MEYV  G L           Y+    GK  
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLM----------YHIQQVGKFK 118
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSV 164
              +     +  +++ G+ FL  RGII+RDL   NV++      K+ADFG  ++ M   V
Sbjct: 119 EPQA---VFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV 175
Query: 165 YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
             R+  G     ++APE +    +    D W++GVL++E++  G  P+ G    E+ +
Sbjct: 176 TTREFCGT--PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQ 230

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 49  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 99
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 100 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 152
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 54  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 104
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 105 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 157
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 158 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 21/196 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K + +   E E  D + E+ ++ + D HPN+V+LL     +   ++++E
Sbjct: 57  QNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIE 114
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +   G + +             M      LT   +   C Q    + +L    IIHRDL 
Sbjct: 115 FCAGGAVDAV------------MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVK 191
           A N+L   +   K+ADFG +     +   +R+        WMAPE +      D  +  K
Sbjct: 163 AGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 192 SDIWSFGVLIWEIVTL 207
           +D+WS G+ + E+  +
Sbjct: 221 ADVWSLGITLIEMAEI 236

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 51  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 101
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 102 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 154
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 155 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 49  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 99
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 100 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 152
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 153 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 57  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 107
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 108 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 160
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 161 GVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 52  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 102
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 103 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 155
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 156 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 49  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 99
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 100 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 152
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 19/183 (10%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 81  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 129
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 130 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY----PGMAAAE 219
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+     G+  A+
Sbjct: 187 KQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAK 245
Query: 220 VMK 222
           ++K
Sbjct: 246 IIK 248

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 54  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 104
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 105 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 157
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 158 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 53  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 103
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 104 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 156
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 157 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 52  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 102
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 103 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 155
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 156 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 49  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 99
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 100 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 152
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 51  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 101
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 102 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 154
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 155 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 51  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 101
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 102 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 154
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 155 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 49  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 99
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 100 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 152
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 153 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 53  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 103
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 104 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 156
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 157 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 19/183 (10%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 81  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 129
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 130 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY----PGMAAAE 219
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+     G+  A+
Sbjct: 187 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAK 245
Query: 220 VMK 222
           ++K
Sbjct: 246 IIK 248

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 38/205 (18%)
Query: 24  IVAVKTL--KENAGERERLDLLQELT----VMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           +VA+K+L   ++ GE E ++  QE      +M  L+ HPN+V+L G      P  ++ME+
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM--HNPPRMVMEF 102
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDL 135
           VP G L            Y+ +  K++ +           +A G++++ ++   I+HRDL
Sbjct: 103 VPCGDL------------YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 136 AARNVLI---GENH--CCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESL--YDNI 187
            + N+ +    EN   C KVADFG ++  + S        G L   +WMAPE++   +  
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEES 204
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPY 212
           ++ K+D +SF ++++ I+T G  P+
Sbjct: 205 YTEKADTYSFAMILYTILT-GEGPF 228

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 93/182 (51%), Gaps = 19/182 (10%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +EL ++K L  H NV+ LL   T   P   I ++      + +L ++      NN+  KS
Sbjct: 76  RELRLLKHLK-HENVIGLLDVFT---PATSIEDFS-----EVYLVTTLMGADLNNI-VKS 125
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
            +L+   +    YQ+ RG++++ S GIIHRDL   NV + E+   ++ DFG AR      
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA---- 181
Query: 164 VYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
             + +  G +  RW  APE + + + ++   DIWS G ++ E++  G   +PG    + +
Sbjct: 182 --DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ-GKALFPGSDYIDQL 238
Query: 222 KK 223
           K+
Sbjct: 239 KR 240

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 50  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDAS-------ALTGI 100
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL   N+LI      K+ADFG AR     
Sbjct: 101 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--- 153
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 154 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 52  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 102
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL   N+LI      K+ADFG AR     
Sbjct: 103 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--- 155
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 156 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++ +  L+ F+ +S        + G 
Sbjct: 51  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS-------ALTGI 101
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL   N+LI      K+ADFG AR     
Sbjct: 102 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--- 154
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 155 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 91/187 (48%), Gaps = 32/187 (17%)
Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL-QSFLRSSRAQR 94
           ++ + D  +E+ ++     HPN++ L     + +  +V+ E +  G+L    LR    Q+
Sbjct: 56  DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QK 111
Query: 95  YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKV 150
           ++          + R+ ++  + + + +++L ++G++HRDL   N+L     G     ++
Sbjct: 112 FF----------SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161
Query: 151 ADFGFARDLMTSSVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
            DFGFA+ L       R   G L        ++APE L    +    DIWS GVL++ ++
Sbjct: 162 CDFGFAKQL-------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 206 TLGSTPY 212
           T G TP+
Sbjct: 215 T-GYTPF 220

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 17  RGREGPCIVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           +G      VAVK L    +   E  +    QE+ VM     H N+V LLG  ++ +   +
Sbjct: 49  KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCL 107
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +  Y+P G L   L               +  L+           A G+ FL     IHR
Sbjct: 108 VYVYMPNGSLLDRLSCLDG----------TPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 134 DLAARNVLIGENHCCKVADFGFAR--DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           D+ + N+L+ E    K++DFG AR  +    +V   +  G     +MAPE+L   I + K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTA--YMAPEALRGEI-TPK 214
Query: 192 SDIWSFGVLIWEIVT 206
           SDI+SFGV++ EI+T
Sbjct: 215 SDIYSFGVVLLEIIT 229

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 17  RGREGPCIVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           +G      VAVK L    +   E  +    QE+ VM     H N+V LLG  ++ +   +
Sbjct: 49  KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCL 107
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +  Y+P G L   L               +  L+           A G+ FL     IHR
Sbjct: 108 VYVYMPNGSLLDRLSCLDG----------TPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 134 DLAARNVLIGENHCCKVADFGFAR--DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           D+ + N+L+ E    K++DFG AR  +    +V   +  G     +MAPE+L   I + K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTA--YMAPEALRGEI-TPK 214
Query: 192 SDIWSFGVLIWEIVT 206
           SDI+SFGV++ EI+T
Sbjct: 215 SDIYSFGVVLLEIIT 229

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G L  ++R            G  
Sbjct: 81  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI----------GSF 129
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 130 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +   S  SD+W+ G +I+++V  G  P+
Sbjct: 187 KQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E+V    L+ F+ +S        + G 
Sbjct: 53  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDAS-------ALTGI 103
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 104 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 156
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 157 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 38/205 (18%)
Query: 24  IVAVKTL--KENAGERERLDLLQELT----VMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           +VA+K+L   ++ GE E ++  QE      +M  L+ HPN+V+L G      P  ++ME+
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM--HNPPRMVMEF 102
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDL 135
           VP G L            Y+ +  K++ +           +A G++++ ++   I+HRDL
Sbjct: 103 VPCGDL------------YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 136 AARNVLI---GENH--CCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESL--YDNI 187
            + N+ +    EN   C KVADFG      TS        G L   +WMAPE++   +  
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFG------TSQQSVHSVSGLLGNFQWMAPETIGAEEES 204
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPY 212
           ++ K+D +SF ++++ I+T G  P+
Sbjct: 205 YTEKADTYSFAMILYTILT-GEGPF 228

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 57  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 104
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 105 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 163 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 218
Query: 215 MAAAEVM 221
               E +
Sbjct: 219 DTKQETL 225

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 57  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 104
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 105 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 163 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 218
Query: 215 MAAAEVM 221
               E +
Sbjct: 219 DTKQETL 225

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 29/205 (14%)
Query: 26  AVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           AVK + K +A  ++   +L+E+ ++K LD HPN+++L     +   F+++ E    G+L 
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL- 108
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F    + +R+           +  D      QV  G+ ++    I+HRDL   N+L+  
Sbjct: 109 -FDEIIKRKRF-----------SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 143 GENHC-CKVADFGFARDLMTSSVYERKSEGRLPI---RWMAPESLYDNIFSVKSDIWSFG 198
            E  C  K+ DFG       S+ +++ ++ +  I    ++APE L    +  K D+WS G
Sbjct: 157 KEKDCDIKIIDFGL------STCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAG 209
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G+ P+ G    +++K+
Sbjct: 210 VILY-ILLSGTPPFYGKNEYDILKR 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 79  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 127
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 128 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 185 KQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 79  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 127
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 128 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 185 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 58  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 106
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 107 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 163
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 164 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 211

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 82  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 130
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 131 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 188 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 235

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 81  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 129
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 130 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 187 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 17  RGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R +E   + AVK LK++    + +    + E  ++     HP + +L  C    +  F +
Sbjct: 43  RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           ME+V  G L   ++ SR          + +   +R    +  ++   + FL  +GII+RD
Sbjct: 103 MEFVNGGDLMFHIQKSR----------RFDEARAR---FYAAEIISALMFLHDKGIIYRD 149
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           L   NVL+     CK+ADFG  ++ + + V      G     ++APE L + ++    D 
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT--PDYIAPEILQEMLYGPAVDW 207
Query: 195 WSFGVLIWEIVTLGSTPY 212
           W+ GVL++E++  G  P+
Sbjct: 208 WAMGVLLYEMLC-GHAPF 224

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 81  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 129
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 130 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 187 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 82  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 130
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 131 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 188 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 235

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++    L+ F+ +S        + G 
Sbjct: 53  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDAS-------ALTGI 103
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 104 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 156
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 157 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 56  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 104
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 105 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 161
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 162 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++    L+ F+ +S        + G 
Sbjct: 52  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDAS-------ALTGI 102
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 103 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--- 155
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 156 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 57  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 105
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 106 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 163 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 59  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 107
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 108 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 164
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 165 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 212

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 79  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 127
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 128 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 185 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 81  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 129
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 130 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 187 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +A+K + E    R    L +E+ + K L  H N+V+ LG  +E     + ME VP G L 
Sbjct: 36  IAIKEIPERD-SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLS 93
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           + LRS            K N  T   +  +  Q+  G+++L    I+HRD+   NVLI  
Sbjct: 94  ALLRSKWGPL-------KDNEQT---IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 143
Query: 145 -NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLI 201
            +   K++DFG ++ L   +       G L  ++MAPE +      +   +DIWS G  I
Sbjct: 144 YSGVLKISDFGTSKRLAGINPCTETFTGTL--QYMAPEIIDKGPRGYGKAADIWSLGCTI 201
Query: 202 WEIVTLGSTPY 212
            E+ T G  P+
Sbjct: 202 IEMAT-GKPPF 211

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 84  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 132
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 133 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 189
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 190 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 237

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVI 74
           R  +G  +V  +    +  E E+  L+ E+ +++ L  HPN+VR      ++     +++
Sbjct: 27  RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIV 85
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-SFCYQVARGMQFLSSRGIIHR 133
           MEY   G L S +     +R Y +       +T   L    C++ + G        ++HR
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG-----GHTVLHR 140
Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DL   NV +      K+ DFG AR L   + + +   G  P  +M+PE +    ++ KSD
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPY-YMSPEQMNRMSYNEKSD 198
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           IWS G L++E+  L   P+   +  E+  K
Sbjct: 199 IWSLGCLLYELCAL-MPPFTAFSQKELAGK 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 78  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 126
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 127 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 184 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 78  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 126
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 127 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 184 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 231

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +A+K + E    R    L +E+ + K L  H N+V+ LG  +E     + ME VP G L 
Sbjct: 50  IAIKEIPERD-SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           + LRS            K N  T   +  +  Q+  G+++L    I+HRD+   NVLI  
Sbjct: 108 ALLRSKWGPL-------KDNEQT---IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 145 -NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLI 201
            +   K++DFG ++ L   +       G L  ++MAPE +      +   +DIWS G  I
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTGTL--QYMAPEIIDKGPRGYGKAADIWSLGCTI 215
Query: 202 WEIVTLGSTPY 212
            E+ T G  P+
Sbjct: 216 IEMAT-GKPPF 225

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 79  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 127
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 128 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 185 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVI 74
           R  +G  +V  +    +  E E+  L+ E+ +++ L  HPN+VR      ++     +++
Sbjct: 27  RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIV 85
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-SFCYQVARGMQFLSSRGIIHR 133
           MEY   G L S +     +R Y +       +T   L    C++ + G        ++HR
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG-----GHTVLHR 140
Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DL   NV +      K+ DFG AR L   + + +   G  P  +M+PE +    ++ KSD
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG-TPY-YMSPEQMNRMSYNEKSD 198
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           IWS G L++E+  L   P+   +  E+  K
Sbjct: 199 IWSLGCLLYELCAL-MPPFTAFSQKELAGK 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E  VM  LD HP  V+L     + E  +  + Y   G+L  ++R            G  
Sbjct: 63  RERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSF 111
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           +   +R  T+   ++   +++L  +GIIHRDL   N+L+ E+   ++ DFG A+ L   S
Sbjct: 112 DETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 168
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
              R +      ++++PE L +      SD+W+ G +I+++V  G  P+
Sbjct: 169 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 19/195 (9%)
Query: 17  RGREGPCIVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           +G      VAVK L    +   E  +    QE+ VM     H N+V LLG  ++ +   +
Sbjct: 43  KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCL 101
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +  Y+P G L   L               +  L+           A G+ FL     IHR
Sbjct: 102 VYVYMPNGSLLDRLSCLDG----------TPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 134 DLAARNVLIGENHCCKVADFGFAR--DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK 191
           D+ + N+L+ E    K++DFG AR  +     V   +  G     +MAPE+L   I + K
Sbjct: 152 DIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTA--YMAPEALRGEI-TPK 208
Query: 192 SDIWSFGVLIWEIVT 206
           SDI+SFGV++ EI+T
Sbjct: 209 SDIYSFGVVLLEIIT 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVI 74
           R  +G  +V  +    +  E E+  L+ E+ +++ L  HPN+VR      ++     +++
Sbjct: 27  RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIV 85
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-SFCYQVARGMQFLSSRGIIHR 133
           MEY   G L S +     +R Y +       +T   L    C++ + G        ++HR
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG-----GHTVLHR 140
Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DL   NV +      K+ DFG AR L     + ++  G  P  +M+PE +    ++ KSD
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG-TPY-YMSPEQMNRMSYNEKSD 198
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           IWS G L++E+  L   P+   +  E+  K
Sbjct: 199 IWSLGCLLYELCAL-MPPFTAFSQKELAGK 227

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++    L+ F+ +S        + G 
Sbjct: 53  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDAS-------ALTGI 103
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL   N+LI      K+ADFG AR     
Sbjct: 104 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--- 156
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 157 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 18/166 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L+ HPN+V+LL     +   +++ E++    L+ F+ +S        + G 
Sbjct: 51  IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDAS-------ALTGI 101
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
              L    + S+ +Q+ +G+ F  S  ++HRDL   N+LI      K+ADFG AR     
Sbjct: 102 PLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--- 154
Query: 163 SVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVT 206
            V  R     +   W  APE L     +S   DIWS G +  E+VT
Sbjct: 155 GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 29/205 (14%)
Query: 26  AVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           AVK + K +A  ++   +L+E+ ++K LD HPN+++L     +   F+++ E    G+L 
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL- 108
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F    + +R+           +  D      QV  G+ ++    I+HRDL   N+L+  
Sbjct: 109 -FDEIIKRKRF-----------SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 143 GENHC-CKVADFGFARDLMTSSVYERKSEGRLPI---RWMAPESLYDNIFSVKSDIWSFG 198
            E  C  K+ DFG       S+ +++ ++ +  I    ++APE L    +  K D+WS G
Sbjct: 157 KEKDCDIKIIDFGL------STCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAG 209
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G+ P+ G    +++K+
Sbjct: 210 VILY-ILLSGTPPFYGKNEYDILKR 233

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDL-LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R R+   IVA+K   E+  +     + L+E+ ++K L  HPN+V LL     K    ++ 
Sbjct: 23  RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLVF 81
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY  +  L    R  R              +    + S  +Q  + + F      IHRD+
Sbjct: 82  EYCDHTVLHELDRYQRG-------------VPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLY-DNIFSVKSD 193
              N+LI ++   K+ DFGFAR L   S Y    +  +  RW  +PE L  D  +    D
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSDY---YDDEVATRWYRSPELLVGDTQYGPPVD 185
Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           +W+ G +  E+++ G   +PG +  + +
Sbjct: 186 VWAIGCVFAELLS-GVPLWPGKSDVDQL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 29/205 (14%)
Query: 26  AVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           AVK + K +A  ++   +L+E+ ++K LD HPN+++L     +   F+++ E    G+L 
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL- 108
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F    + +R+           +  D      QV  G+ ++    I+HRDL   N+L+  
Sbjct: 109 -FDEIIKRKRF-----------SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 143 GENHC-CKVADFGFARDLMTSSVYERKSEGRLPI---RWMAPESLYDNIFSVKSDIWSFG 198
            E  C  K+ DFG       S+ +++ ++ +  I    ++APE L    +  K D+WS G
Sbjct: 157 KEKDCDIKIIDFGL------STCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAG 209
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G+ P+ G    +++K+
Sbjct: 210 VILY-ILLSGTPPFYGKNEYDILKR 233

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTPA-FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 89/187 (47%), Gaps = 32/187 (17%)
Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL-QSFLRSSRAQR 94
           ++ + D  +E+ ++     HPN++ L     + +  +V+ E    G+L    LR    Q+
Sbjct: 56  DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILR----QK 111
Query: 95  YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKV 150
           ++          + R+ ++  + + + +++L ++G++HRDL   N+L     G     ++
Sbjct: 112 FF----------SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161
Query: 151 ADFGFARDLMTSSVYERKSEGRLPI-----RWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
            DFGFA+ L       R   G L        ++APE L    +    DIWS GVL++  +
Sbjct: 162 CDFGFAKQL-------RAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXL 214
Query: 206 TLGSTPY 212
           T G TP+
Sbjct: 215 T-GYTPF 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 30/204 (14%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +A K +K   G +++ ++  E++VM  LD H N+++L      K    ++MEYV  G+L 
Sbjct: 117 LAAKIIK-TRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGEL- 173
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                      ++ +  +S +LT  D   F  Q+  G++ +    I+H DL   N+L   
Sbjct: 174 -----------FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 145 NHC--CKVADFGFARDLMTSSVYERKSEGRLPI-----RWMAPESLYDNIFSVKSDIWSF 197
                 K+ DFG AR          K   +L +      ++APE +  +  S  +D+WS 
Sbjct: 223 RDAKQIKIIDFGLAR--------RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 198 GVLIWEIVTLGSTPYPGMAAAEVM 221
           GV+ + +++ G +P+ G   AE +
Sbjct: 275 GVIAYMLLS-GLSPFLGDNDAETL 297

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 19  REGPCIVAVKTLKENAGERER-LDLLQELTVMKTLDP--HPNVVRLLGCCT-----EKEP 70
           + G   VA+K ++   GE    L  ++E+ V++ L+   HPNVVRL   CT      +  
Sbjct: 34  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             ++ E+V    L ++L                  + +  +    +Q+ RG+ FL S  +
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLHSHRV 141
Query: 131 IHRDLAARNVLIGENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDN 186
           +HRDL  +N+L+  +   K+ADFG AR     +  +SV        + + + APE L  +
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-------VTLWYRAPEVLLQS 194
Query: 187 IFSVKSDIWSFGVLIWEI 204
            ++   D+WS G +  E+
Sbjct: 195 SYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 19  REGPCIVAVKTLKENAGERER-LDLLQELTVMKTLDP--HPNVVRLLGCCT-----EKEP 70
           + G   VA+K ++   GE    L  ++E+ V++ L+   HPNVVRL   CT      +  
Sbjct: 34  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             ++ E+V    L ++L                  + +  +    +Q+ RG+ FL S  +
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLHSHRV 141
Query: 131 IHRDLAARNVLIGENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDN 186
           +HRDL  +N+L+  +   K+ADFG AR     +  +SV        + + + APE L  +
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-------VTLWYRAPEVLLQS 194
Query: 187 IFSVKSDIWSFGVLIWEI 204
            ++   D+WS G +  E+
Sbjct: 195 SYATPVDLWSVGCIFAEM 212

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 17  RGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPF-FV 73
           +GR     + VK LK  +   R+  D  +E   ++    HPNV+ +LG C +   P   +
Sbjct: 28  KGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTL 86
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR-DLTSFCYQVARGMQFLSS-RGII 131
           I  ++PYG L            YN +H  +N +  +     F   +ARGM FL +   +I
Sbjct: 87  ITHWMPYGSL------------YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 132 HRD-LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLY---DN 186
            R  L +R+V+I E+   +++        M    +  +S GR+    W+APE+L    ++
Sbjct: 135 PRHALNSRSVMIDEDMTARIS--------MADVKFSFQSPGRMYAPAWVAPEALQKKPED 186
Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
                +D+WSF VL+WE+VT    P+  ++  E+
Sbjct: 187 TNRRSADMWSFAVLLWELVT-REVPFADLSNMEI 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 19  REGPCIVAVKTLKENAGERER-LDLLQELTVMKTLDP--HPNVVRLLGCCT-----EKEP 70
           + G   VA+K ++   GE    L  ++E+ V++ L+   HPNVVRL   CT      +  
Sbjct: 34  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             ++ E+V    L ++L                  + +  +    +Q+ RG+ FL S  +
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLHSHRV 141
Query: 131 IHRDLAARNVLIGENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDN 186
           +HRDL  +N+L+  +   K+ADFG AR     +  +SV        + + + APE L  +
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-------VTLWYRAPEVLLQS 194
Query: 187 IFSVKSDIWSFGVLIWEI 204
            ++   D+WS G +  E+
Sbjct: 195 SYATPVDLWSVGCIFAEM 212

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           C  A+K ++    E  R  +++E+  +  L+ HP +VR      EK     +    P   
Sbjct: 31  CNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVY 89
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY----QVARGMQFLSSRGIIHRDLAAR 138
           L   ++  R +   + M+G+  ++  R+  S C     Q+A  ++FL S+G++HRDL   
Sbjct: 90  LYIQMQLCRKENLKDWMNGRC-TIEERE-RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPS 147
Query: 139 NVLIGENHCCKVADFGFA---------RDLMTSSVYERKSEGRLPIR-WMAPESLYDNIF 188
           N+    +   KV DFG           + ++T      +  G++  + +M+PE ++ N +
Sbjct: 148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207
Query: 189 SVKSDIWSFGVLIWEIVTLGST 210
           S K DI+S G++++E++   ST
Sbjct: 208 SHKVDIFSLGLILFELLYPFST 229

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 32/187 (17%)
Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL-QSFLRSSRAQR 94
           ++ + D  +E+ ++     HPN++ L     + +  +++ E +  G+L    LR    Q+
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR----QK 116
Query: 95  YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKV 150
           ++          + R+ +   + + + +++L S+G++HRDL   N+L     G   C ++
Sbjct: 117 FF----------SEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRI 166
Query: 151 ADFGFARDLMTSSVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
            DFGFA+ L       R   G L        ++APE L    +    DIWS G+L++ ++
Sbjct: 167 CDFGFAKQL-------RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 206 TLGSTPY 212
             G TP+
Sbjct: 220 A-GYTPF 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 38/205 (18%)
Query: 24  IVAVKTL--KENAGERERLDLLQELT----VMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           +VA+K+L   ++ GE E ++  QE      +M  L+ HPN+V+L G      P  ++ME+
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM--HNPPRMVMEF 102
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDL 135
           VP G L            Y+ +  K++ +           +A G++++ ++   I+HRDL
Sbjct: 103 VPCGDL------------YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 136 AARNVLI---GENH--CCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESL--YDNI 187
            + N+ +    EN   C KVADF  ++  + S        G L   +WMAPE++   +  
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV------SGLLGNFQWMAPETIGAEEES 204
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPY 212
           ++ K+D +SF ++++ I+T G  P+
Sbjct: 205 YTEKADTYSFAMILYTILT-GEGPF 228

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 32/187 (17%)
Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL-QSFLRSSRAQR 94
           ++ + D  +E+ ++     HPN++ L     + +  +++ E +  G+L    LR    Q+
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR----QK 116
Query: 95  YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKV 150
           ++          + R+ +   + + + +++L S+G++HRDL   N+L     G   C ++
Sbjct: 117 FF----------SEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRI 166
Query: 151 ADFGFARDLMTSSVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
            DFGFA+ L       R   G L        ++APE L    +    DIWS G+L++ ++
Sbjct: 167 CDFGFAKQL-------RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 206 TLGSTPY 212
             G TP+
Sbjct: 220 A-GYTPF 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +EL ++K L  H NV+ LL   T   P   I ++      + +L ++      NN+  K 
Sbjct: 76  RELRLLKHLK-HENVIGLLDVFT---PATSIEDFS-----EVYLVTTLMGADLNNI-VKC 125
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
            +L+   +    YQ+ RG++++ S GIIHRDL   NV + E+   ++ DFG AR      
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA---- 181
Query: 164 VYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
             + +  G +  RW  APE + + + ++   DIWS G ++ E++  G   +PG    + +
Sbjct: 182 --DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ-GKALFPGSDYIDQL 238
Query: 222 KK 223
           K+
Sbjct: 239 KR 240

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 18/170 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS-FLRSSRAQRYYNNMHG 101
           L+EL ++K    H N++ +           ++   VPYG+ +S ++     +   + +  
Sbjct: 102 LRELKILKHFK-HDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMESDLHQIIH 151
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
            S  LT   +  F YQ+ RG++++ S  +IHRDL   N+L+ EN   K+ DFG AR L T
Sbjct: 152 SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 211
Query: 162 SSV-YERKSEGRLPIRWM-APE---SLYDNIFSVKSDIWSFGVLIWEIVT 206
           S   ++      +  RW  APE   SL++  ++   D+WS G +  E++ 
Sbjct: 212 SPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQAIDLWSVGCIFGEMLA 259

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R D+ +E++++K +  HPNV+ L      K    +I E V  G+L  FL           
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFL----------- 105
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ + +      K+ DFG
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 164 LAHKIDFGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 219
Query: 215 MAAAEVM 221
               E +
Sbjct: 220 DTKQETL 226

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 37  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
           +ER +  +E+ V+  +  HPN+V+      E    +++M+Y   G L            +
Sbjct: 65  KEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDL------------F 111
Query: 97  NNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF 155
             ++ +   L   D +  +  Q+   ++ +  R I+HRD+ ++N+ + ++   ++ DFG 
Sbjct: 112 KRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI 171
Query: 156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           AR L ++    R   G  P  +++PE   +  ++ KSDIW+ G +++E+ TL      G 
Sbjct: 172 ARVLNSTVELARACIG-TPY-YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229
Query: 216 AAAEVMK 222
               V+K
Sbjct: 230 MKNLVLK 236

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 25  VAVKTLKENAGERERLDLL----QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           VAVK L  N  +   LD++    +E+  +K L  HP++++L    +    FF++MEYV  
Sbjct: 39  VAVKIL--NRQKIRSLDVVGKIKREIQNLK-LFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G+L  ++            HG+   + +R L     Q+   + +     ++HRDL   NV
Sbjct: 96  GELFDYICK----------HGRVEEMEARRLFQ---QILSAVDYCHRHMVVHRDLKPENV 142
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGV 199
           L+  +   K+ADFG + ++M+   + R S G     + APE +   +++  + DIWS GV
Sbjct: 143 LLDAHMNAKIADFGLS-NMMSDGEFLRDSCG--SPNYAAPEVISGRLYAGPEVDIWSCGV 199
Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           +++ ++  G+ P+       + KK
Sbjct: 200 ILYALLC-GTLPFDDEHVPTLFKK 222

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 18/170 (10%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS-FLRSSRAQRYYNNMHG 101
           L+EL ++K    H N++ +           ++   VPYG+ +S ++     +   + +  
Sbjct: 101 LRELKILKHFK-HDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMESDLHQIIH 150
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
            S  LT   +  F YQ+ RG++++ S  +IHRDL   N+L+ EN   K+ DFG AR L T
Sbjct: 151 SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210
Query: 162 SSV-YERKSEGRLPIRWM-APE---SLYDNIFSVKSDIWSFGVLIWEIVT 206
           S   ++      +  RW  APE   SL++  ++   D+WS G +  E++ 
Sbjct: 211 SPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQAIDLWSVGCIFGEMLA 258

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 25  VAVKTLKENAGERERLDLL----QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           VAVK L  N  +   LD++    +E+  +K L  HP++++L    +    FF++MEYV  
Sbjct: 39  VAVKIL--NRQKIRSLDVVGKIKREIQNLK-LFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G+L  ++            HG+   + +R L     Q+   + +     ++HRDL   NV
Sbjct: 96  GELFDYICK----------HGRVEEMEARRLFQ---QILSAVDYCHRHMVVHRDLKPENV 142
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGV 199
           L+  +   K+ADFG + ++M+   + R S G     + APE +   +++  + DIWS GV
Sbjct: 143 LLDAHMNAKIADFGLS-NMMSDGEFLRTSCG--SPNYAAPEVISGRLYAGPEVDIWSCGV 199
Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           +++ ++  G+ P+       + KK
Sbjct: 200 ILYALLC-GTLPFDDEHVPTLFKK 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+ +++ +  HPN++ L      K    +I+E V  G+L  FL           
Sbjct: 52  REEIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL----------- 99
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S+ I H DL   N+++ + +      K+ DFG
Sbjct: 100 --AEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 158 IAHKIEAGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 213
Query: 215 MAAAEVM 221
               E +
Sbjct: 214 ETKQETL 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+ +++ +  HPN++ L      K    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S+ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 IAHKIEAGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 ETKQETL 227

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 20/196 (10%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           I+AVK ++    E+E+  LL +L V+      P +V+  G    +   ++ ME       
Sbjct: 49  IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME------- 101
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFCYQVARGMQFLSSR-GIIHRDLAARNVL 141
              L S+   ++Y  ++   + +   + L        + +  L     IIHRD+   N+L
Sbjct: 102 ---LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNIL 158
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSF 197
           +  +   K+ DFG +  L+ S    R +  R    +MAPE +  +     + V+SD+WS 
Sbjct: 159 LDRSGNIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERIDPSASRQGYDVRSDVWSL 215
Query: 198 GVLIWEIVTLGSTPYP 213
           G+ ++E+ T G  PYP
Sbjct: 216 GITLYELAT-GRFPYP 230

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 33/188 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 70  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 116
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 117 -VKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT 175
Query: 158 -DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            D MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG
Sbjct: 176 DDEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPG 225
Query: 215 MAAAEVMK 222
               + +K
Sbjct: 226 TDHIDQLK 233

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+ +++ +  HPN++ L      K    +I+E V  G+L  FL           
Sbjct: 73  REEIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL----------- 120
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SLT  + T F  Q+  G+ +L S+ I H DL   N+++ + +      K+ DFG
Sbjct: 121 --AEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 178
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A  +   +  E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 179 IAHKIEAGN--EFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 234
Query: 215 MAAAEVM 221
               E +
Sbjct: 235 ETKQETL 241

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           C V V + ++   + ++  LL+E+ ++K LD HPN+++L     +K  F+++ E    G+
Sbjct: 60  CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGE 118
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   + S +               +  D      QV  G+ ++    I+HRDL   N+L+
Sbjct: 119 LFDEIISRK-------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 165
Query: 143 ---GENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIWSFG 198
               ++   ++ DFG +     S    +K + ++    ++APE L+   +  K D+WS G
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEAS----KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 220
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G  P+ G    +++KK
Sbjct: 221 VILY-ILLSGCPPFNGANEYDILKK 244

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           C V V + ++   + ++  LL+E+ ++K LD HPN+++L     +K  F+++ E    G+
Sbjct: 54  CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   + S +               +  D      QV  G+ ++    I+HRDL   N+L+
Sbjct: 113 LFDEIISRK-------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159
Query: 143 ---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR-WMAPESLYDNIFSVKSDIWSFG 198
               ++   ++ DFG +     S    +K + ++    ++APE L+   +  K D+WS G
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEAS----KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 214
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G  P+ G    +++KK
Sbjct: 215 VILY-ILLSGCPPFNGANEYDILKK 238

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           C V V + ++   + ++  LL+E+ ++K LD HPN+++L     +K  F+++ E    G+
Sbjct: 78  CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGE 136
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   + S +               +  D      QV  G+ ++    I+HRDL   N+L+
Sbjct: 137 LFDEIISRK-------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 183
Query: 143 ---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR-WMAPESLYDNIFSVKSDIWSFG 198
               ++   ++ DFG +     S    +K + ++    ++APE L+   +  K D+WS G
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEAS----KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 238
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G  P+ G    +++KK
Sbjct: 239 VILY-ILLSGCPPFNGANEYDILKK 262

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           C V V + ++   + ++  LL+E+ ++K LD HPN+++L     +K  F+++ E    G+
Sbjct: 77  CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGE 135
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   + S +               +  D      QV  G+ ++    I+HRDL   N+L+
Sbjct: 136 LFDEIISRK-------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 182
Query: 143 ---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR-WMAPESLYDNIFSVKSDIWSFG 198
               ++   ++ DFG +     S    +K + ++    ++APE L+   +  K D+WS G
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEAS----KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 237
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G  P+ G    +++KK
Sbjct: 238 VILY-ILLSGCPPFNGANEYDILKK 261

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL--QSFLRSSRAQRYYNNM 99
           LL E+ V+K LD HPN+++L     +K  ++++ME    G+L  +  LR           
Sbjct: 68  LLDEVAVLKQLD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR----------- 115
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFA 156
                  +  D      QV  G  +L    I+HRDL   N+L+     +   K+ DFG +
Sbjct: 116 ----QKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS 171
Query: 157 RDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
                      K + RL    ++APE L    +  K D+WS GV+++ I+  G  P+ G 
Sbjct: 172 AHFEVGG----KMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILY-ILLCGYPPFGGQ 225
Query: 216 AAAEVMKK 223
              E++K+
Sbjct: 226 TDQEILKR 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +EL ++K L  H NV+ LL   T   P   I ++      + +L ++      NN+  K 
Sbjct: 68  RELRLLKHLK-HENVIGLLDVFT---PATSIEDFS-----EVYLVTTLMGADLNNI-VKC 117
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
            +L+   +    YQ+ RG++++ S GIIHRDL   NV + E+   ++ DFG AR      
Sbjct: 118 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA---- 173
Query: 164 VYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
             + +  G +  RW  APE + + + ++   DIWS G ++ E++  G   +PG    + +
Sbjct: 174 --DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ-GKALFPGSDYIDQL 230
Query: 222 KK 223
           K+
Sbjct: 231 KR 232

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 32/223 (14%)
Query: 6   VEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLL----QELTVMKTLDPHPNVVRL 61
           V+V KH ++  +       VAVK L  N  +   LD++    +E+  +K    HP++++L
Sbjct: 32  VKVGKHELTGHK-------VAVKIL--NRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKL 81
Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
               +     F++MEYV  G+L  ++              K+  L  ++      Q+  G
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-------------CKNGRLDEKESRRLFQQILSG 128
Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
           + +     ++HRDL   NVL+  +   K+ADFG + ++M+   + R S G     + APE
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXSCGS--PNYAAPE 185
Query: 182 SLYDNIFS-VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            +   +++  + DIWS GV+++ ++  G+ P+       + KK
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKK 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL--QSFLRSSRAQRYYNNM 99
           LL E+ V+K LD HPN+++L     +K  ++++ME    G+L  +  LR           
Sbjct: 51  LLDEVAVLKQLD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR----------- 98
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFA 156
                  +  D      QV  G  +L    I+HRDL   N+L+     +   K+ DFG +
Sbjct: 99  ----QKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS 154
Query: 157 RDLMTSSVYERKSEGRLPIR-WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
                      K + RL    ++APE L    +  K D+WS GV+++ I+  G  P+ G 
Sbjct: 155 AHFEVGG----KMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILY-ILLCGYPPFGGQ 208
Query: 216 AAAEVMKK 223
              E++K+
Sbjct: 209 TDQEILKR 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 17  RGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   IVA+K L ++  E+E ++  L +E+ +   L  HPN++RL     ++   ++I
Sbjct: 43  REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH-HPNILRLYNYFYDRRRIYLI 101
Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G+L   L+             KS +   +   +   ++A  + +   + +IHRD
Sbjct: 102 LEYAPRGELYKELQ-------------KSCTFDEQRTATIMEELADALMYCHGKKVIHRD 148
Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++  +   S+  +   G L   ++ PE +   + + K D+
Sbjct: 149 IKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTL--DYLPPEMIEGRMHNEKVDL 204
Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           W  GVL +E++ +G+ P+   +  E  ++
Sbjct: 205 WCIGVLCYELL-VGNPPFESASHNETYRR 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 123 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD 182
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 183 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 232
Query: 217 AAEVMK 222
             + +K
Sbjct: 233 HIDQLK 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 33/188 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 75  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 121
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 122 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT 180
Query: 158 -DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            D MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG
Sbjct: 181 DDEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPG 230
Query: 215 MAAAEVMK 222
               + +K
Sbjct: 231 TDHIDQLK 238

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 33/188 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 76  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 122
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 123 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT 181
Query: 158 -DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            D MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG
Sbjct: 182 DDEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPG 231
Query: 215 MAAAEVMK 222
               + +K
Sbjct: 232 TDHIDQLK 239

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           KS  LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG  R   D
Sbjct: 118 KSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD 188
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 189 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 238
Query: 217 AAEVMK 222
             + +K
Sbjct: 239 HIDQLK 244

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP+++ L     +    ++++E    G++  +L++ R + +  N           +   F
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSEN-----------EARHF 117
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
            +Q+  GM +L S GI+HRDL   N+L+  N   K+ADFG A  L     +E+       
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLCGT 175
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +++PE    +   ++SD+WS G + + ++ +G  P+        + K
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLL-IGRPPFDTDTVKNTLNK 223

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD 179
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 180 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 229
Query: 217 AAEVMK 222
             + +K
Sbjct: 230 HIDQLK 235

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K ++    E      ++E++++K L  H N+V L      ++   ++ EY+     
Sbjct: 29  LVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYL----- 82
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                    ++Y ++     N +   ++  F +Q+ RG+ +   + ++HRDL  +N+LI 
Sbjct: 83  -----DKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWSFGVLI 201
           E    K+ADFG AR     S+  +  +  +   W  P    L    +S + D+W  G + 
Sbjct: 135 ERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 191
Query: 202 WEIVTLGSTPYPGMAAAEVM 221
           +E+ T G   +PG    E +
Sbjct: 192 YEMAT-GRPLFPGSTVEEQL 210

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 95/194 (48%), Gaps = 28/194 (14%)
Query: 36  ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY 95
           E+   ++  E++++K+LD HPN+++L     +K+ F+++ E+   G+L   +        
Sbjct: 87  EKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII------- 138
Query: 96  YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC---CKVAD 152
             N H         D  +   Q+  G+ +L    I+HRD+   N+L+   +     K+ D
Sbjct: 139 --NRH----KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 153 FGFARDLMTSSVYER--KSEGRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGS 209
           FG       SS + +  K   RL    ++APE L    ++ K D+WS GV+++ I+  G 
Sbjct: 193 FGL------SSFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMY-ILLCGY 244
Query: 210 TPYPGMAAAEVMKK 223
            P+ G    +++KK
Sbjct: 245 PPFGGQNDQDIIKK 258

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 16  ERGREGPC--IVAVKTLKENAGERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFF 72
           E+ R  P   I+AVK ++     +E+  LL +L + M+T+D  P  V   G    +   +
Sbjct: 68  EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVW 126
Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GII 131
           + ME          L  +   ++Y  +  K  ++    L      + + ++ L S+  +I
Sbjct: 127 ICME----------LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI---- 187
           HRD+   NVLI      K+ DFG +   +  SV +    G  P  +MAPE +   +    
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTIDAGCKP--YMAPERINPELNQKG 233
Query: 188 FSVKSDIWSFGVLIWEIVTL 207
           +SVKSDIWS G+ + E+  L
Sbjct: 234 YSVKSDIWSLGITMIELAIL 253

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L  H N+V+L      K+   ++ E++              ++  +   G 
Sbjct: 48  IREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGG 96
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
             S+T++   SF  Q+  G+ +   R ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 97  LESVTAK---SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--- 150
Query: 163 SVYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            +  RK    +   W  AP+ L     +S   DIWS G +  E+V  G+  +PG++ A+ 
Sbjct: 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQ 209
Query: 221 M 221
           +
Sbjct: 210 L 210

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           C V V + ++   + ++  LL+E+ ++K LD HPN+ +L     +K  F+++ E    G+
Sbjct: 54  CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIXKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   + S +               +  D      QV  G+ +     I+HRDL   N+L+
Sbjct: 113 LFDEIISRK-------------RFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLL 159
Query: 143 ---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR-WMAPESLYDNIFSVKSDIWSFG 198
               ++   ++ DFG +     S    +K + ++    ++APE L+   +  K D+WS G
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEAS----KKXKDKIGTAYYIAPEVLH-GTYDEKCDVWSTG 214
Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           V+++ I+  G  P+ G    +++KK
Sbjct: 215 VILY-ILLSGCPPFNGANEYDILKK 238

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V  K++     ++E++    E+ + K+LD +P+VV   G   + +  +V++E        
Sbjct: 74  VVPKSMLLKPHQKEKMS--TEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVLEIC------ 124
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  ++T  +   F  Q  +G+Q+L +  +IHRDL   N+ + +
Sbjct: 125 -------RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 177
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK +      ++APE L     S + DIWS G +++ +
Sbjct: 178 DMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTL 235
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 236 L-VGKPPF 242

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L  H N+V+L      K+   ++ E++              ++  +   G 
Sbjct: 48  IREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGG 96
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
             S+T++   SF  Q+  G+ +   R ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 97  LESVTAK---SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--- 150
Query: 163 SVYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            +  RK    +   W  AP+ L     +S   DIWS G +  E+V  G+  +PG++ A+ 
Sbjct: 151 GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQ 209
Query: 221 M 221
           +
Sbjct: 210 L 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+++++ +  HPN++ L      +    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A ++      E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 LAHEIEDG--VEFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 DTKQETL 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 33/180 (18%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 99  RELRLLKHMK-HENVIGLLDVFT------------PATSLEEFNDVYLVTHLMGADLNNI 145
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 146 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 204
Query: 158 -DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            D MT         G +  RW  APE + + + +++  DIWS G ++ E++T G T +PG
Sbjct: 205 DDEMT---------GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT-GRTLFPG 254

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V  K++     ++E++    E+ + K+LD +P+VV   G   + +  +V++E        
Sbjct: 58  VVPKSMLLKPHQKEKMS--TEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVLEIC------ 108
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  ++T  +   F  Q  +G+Q+L +  +IHRDL   N+ + +
Sbjct: 109 -------RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 161
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK +      ++APE L     S + DIWS G +++ +
Sbjct: 162 DMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTL 219
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 220 L-VGKPPF 226

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 90/192 (46%), Gaps = 26/192 (13%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E+T +K  + HPN+V+L     ++   F++ME +  G+L  F R  + + +        
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHF-------- 103
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARDLM 160
              +  + +    ++   +  +   G++HRDL   N+L     +N   K+ DFGFAR  +
Sbjct: 104 ---SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR--L 158
Query: 161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG------ 214
                +        + + APE L  N +    D+WS GV+++ +++ G  P+        
Sbjct: 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHDRSLT 217
Query: 215 -MAAAEVMKKSK 225
             +A E+MKK K
Sbjct: 218 CTSAVEIMKKIK 229

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           ++E++++K L  H N+V+L      K+   ++ E++              ++  +   G 
Sbjct: 48  IREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGG 96
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
             S+T++   SF  Q+  G+ +   R ++HRDL  +N+LI      K+ADFG AR     
Sbjct: 97  LESVTAK---SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--- 150
Query: 163 SVYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            +  RK    +   W  AP+ L     +S   DIWS G +  E+V  G+  +PG++ A+ 
Sbjct: 151 GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GAPLFPGVSEADQ 209
Query: 221 M 221
           +
Sbjct: 210 L 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 15/185 (8%)
Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPY 80
            VA+K+++  N  E   +  ++E+ +++ L+   HPNVVRL+  C        I   + +
Sbjct: 31  FVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVF 90
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             +   LR+     Y +        L +  +     Q  RG+ FL +  I+HRDL   N+
Sbjct: 91  EHVDQDLRT-----YLDK--APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 143
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLYDNIFSVKSDIWSFGV 199
           L+      K+ADFG AR       Y+   +  +   W  APE L  + ++   D+WS G 
Sbjct: 144 LVTSGGTVKLADFGLAR----IYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 199
Query: 200 LIWEI 204
           +  E+
Sbjct: 200 IFAEM 204

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 124 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 184 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 233
Query: 217 AAEVMK 222
             + +K
Sbjct: 234 HIDQLK 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 124 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 184 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 233
Query: 217 AAEVMK 222
             + +K
Sbjct: 234 HIDQLK 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 124 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 184 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 233
Query: 217 AAEVMK 222
             + +K
Sbjct: 234 HIDQLK 239

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 33/188 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 70  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 116
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 117 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 158 -DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            D MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG
Sbjct: 176 DDEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPG 225
Query: 215 MAAAEVMK 222
               + +K
Sbjct: 226 TDHIDQLK 233

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 9/123 (7%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR    
Sbjct: 138 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-- 195
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
               + +  G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG    +
Sbjct: 196 ----DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHID 250
Query: 220 VMK 222
            +K
Sbjct: 251 QLK 253

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 184
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 185 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 234
Query: 217 AAEVMK 222
             + +K
Sbjct: 235 HIDQLK 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 123 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 183 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 232
Query: 217 AAEVMK 222
             + +K
Sbjct: 233 HIDQLK 238

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 180 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 229
Query: 217 AAEVMK 222
             + +K
Sbjct: 230 HIDQLK 235

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 117 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 176
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 177 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 226
Query: 217 AAEVMK 222
             + +K
Sbjct: 227 HIDQLK 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 185 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 234
Query: 217 AAEVMK 222
             + +K
Sbjct: 235 HIDQLK 240

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 33/188 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 70  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 116
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR-- 157
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 117 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 158 -DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            D MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG
Sbjct: 176 DDEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPG 225
Query: 215 MAAAEVMK 222
               + +K
Sbjct: 226 TDHIDQLK 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 188
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 189 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 238
Query: 217 AAEVMK 222
             + +K
Sbjct: 239 HIDQLK 244

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 180 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 229
Query: 217 AAEVMK 222
             + +K
Sbjct: 230 HIDQLK 235

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 120 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 180 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 229
Query: 217 AAEVMK 222
             + +K
Sbjct: 230 HIDQLK 235

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 185 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 234
Query: 217 AAEVMK 222
             + +K
Sbjct: 235 HIDQLK 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 138 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 198 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 247
Query: 217 AAEVMK 222
             + +K
Sbjct: 248 HIDQLK 253

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 141 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 200
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 201 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 250
Query: 217 AAEVMK 222
             + +K
Sbjct: 251 HIDQLK 256

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 185 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 234
Query: 217 AAEVMK 222
             + +K
Sbjct: 235 HIDQLK 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 137 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 196
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 197 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 246
Query: 217 AAEVMK 222
             + +K
Sbjct: 247 HIDQLK 252

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 138 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 198 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 247
Query: 217 AAEVMK 222
             + +K
Sbjct: 248 HIDQLK 253

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 137 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 196
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 197 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 246
Query: 217 AAEVMK 222
             + +K
Sbjct: 247 HIDQLK 252

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 128 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 187
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 188 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 237
Query: 217 AAEVMK 222
             + +K
Sbjct: 238 HIDQLK 243

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 189
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 190 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 239
Query: 217 AAEVMK 222
             + +K
Sbjct: 240 HIDQLK 245

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 189
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 190 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 239
Query: 217 AAEVMK 222
             + +K
Sbjct: 240 HIDQLK 245

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 189
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 190 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 239
Query: 217 AAEVMK 222
             + +K
Sbjct: 240 HIDQLK 245

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 123 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 183 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 232
Query: 217 AAEVMK 222
             + +K
Sbjct: 233 HIDQLK 238

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 115 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 175 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 224
Query: 217 AAEVMK 222
             + +K
Sbjct: 225 HIDQLK 230

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 174 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 223
Query: 217 AAEVMK 222
             + +K
Sbjct: 224 HIDQLK 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 115 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 175 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 224
Query: 217 AAEVMK 222
             + +K
Sbjct: 225 HIDQLK 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 116 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 175
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 176 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 225
Query: 217 AAEVMK 222
             + +K
Sbjct: 226 HIDQLK 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 174 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 223
Query: 217 AAEVMK 222
             + +K
Sbjct: 224 HIDQLK 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 9/123 (7%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR    
Sbjct: 141 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-- 198
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
               + +  G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG    +
Sbjct: 199 ----DDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHID 253
Query: 220 VMK 222
            +K
Sbjct: 254 QLK 256

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 13/184 (7%)
Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPY 80
            VA+K+++  N  E   +  ++E+ +++ L+   HPNVVRL+  C        I   + +
Sbjct: 31  FVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVF 90
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             +   LR+     Y +        L +  +     Q  RG+ FL +  I+HRDL   N+
Sbjct: 91  EHVDQDLRT-----YLDK--APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 143
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+      K+ADFG AR     S     +   + + + APE L  + ++   D+WS G +
Sbjct: 144 LVTSGGTVKLADFGLAR---IYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 200
Query: 201 IWEI 204
             E+
Sbjct: 201 FAEM 204

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V  K++     ++E++    E+ + K+LD +P+VV   G   + +  +V++E        
Sbjct: 74  VVPKSMLLKPHQKEKMS--TEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVLEIC------ 124
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  ++T  +   F  Q  +G+Q+L +  +IHRDL   N+ + +
Sbjct: 125 -------RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 177
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + DIWS G +++ +
Sbjct: 178 DMDVKIGDFGLATKIEFDG--ERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTL 235
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 236 L-VGKPPF 242

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           V  K++     ++E++    E+ + K+LD +P+VV   G   + +  +V++E        
Sbjct: 74  VVPKSMLLKPHQKEKMS--TEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVLEIC------ 124
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  ++T  +   F  Q  +G+Q+L +  +IHRDL   N+ + +
Sbjct: 125 -------RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 177
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + DIWS G +++ +
Sbjct: 178 DMDVKIGDFGLATKIEFDG--ERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTL 235
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 236 L-VGKPPF 242

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 27/185 (14%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 70  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 116
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL 159
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 117 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 160 MTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
                 + +  G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG   
Sbjct: 176 ------DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDH 228
Query: 218 AEVMK 222
            + +K
Sbjct: 229 IDQLK 233

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 27/185 (14%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF----LRSSRAQRYYNNM 99
           +EL ++K +  H NV+ LL   T            P   L+ F    L +       NN+
Sbjct: 70  RELRLLKHM-KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNI 116
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL 159
             K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR  
Sbjct: 117 -VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 160 MTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
                 + +  G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG   
Sbjct: 176 ------DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDH 228
Query: 218 AEVMK 222
            + +K
Sbjct: 229 IDQLK 233

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 16  ERGREGPC--IVAVKTLKENAGERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFF 72
           E+ R  P   I+AVK ++     +E+  LL +L + M+T+D  P  V   G    +   +
Sbjct: 24  EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVW 82
Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GII 131
           + ME          L  +   ++Y  +  K  ++    L      + + ++ L S+  +I
Sbjct: 83  ICME----------LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI---- 187
           HRD+   NVLI      K+ DFG +   +   V +    G  P  +MAPE +   +    
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDIDAGCKP--YMAPERINPELNQKG 189
Query: 188 FSVKSDIWSFGVLIWEIVTL 207
           +SVKSDIWS G+ + E+  L
Sbjct: 190 YSVKSDIWSLGITMIELAIL 209

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 9/123 (7%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR    
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-- 171
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
               + +  G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG    +
Sbjct: 172 ----DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHID 226
Query: 220 VMK 222
            +K
Sbjct: 227 QLK 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K +K ++ E      ++E+++MK L  H N+VRL      +    ++ E++    L+
Sbjct: 33  VALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLVFEFMD-NDLK 90
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            ++ S       N   G   +L    +  F +Q+ +G+ F     I+HRDL  +N+LI +
Sbjct: 91  KYMDSRTVG---NTPRGLELNL----VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWE 203
               K+ DFG AR      V    SE  + + + AP+ L  +  +S   DIWS G ++ E
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSE-VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           ++T G   +PG    E +K
Sbjct: 202 MIT-GKPLFPGTNDEEQLK 219

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 16/167 (9%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P + +L  C    +  + +MEYV  G L   ++             +           + 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-------------QVGRFKEPHAVFYA 127
Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            ++A G+ FL S+GII+RDL   NV++      K+ADFG  ++ +   V  +   G    
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGT--P 185
Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            ++APE +    +    D W+FGVL++E++  G  P+ G    E+ +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQ 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG AR   D
Sbjct: 114 KCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 174 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 223
Query: 217 AAEVMK 222
             + +K
Sbjct: 224 HIDQLK 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 85/193 (44%), Gaps = 15/193 (7%)
Query: 17  RGREGPCIVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           +G      VAVK L    +   E  +    QE+ V      H N+V LLG  ++ +   +
Sbjct: 40  KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQ-HENLVELLGFSSDGDDLCL 98
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +  Y P G L   L           + G +  L+           A G+ FL     IHR
Sbjct: 99  VYVYXPNGSLLDRLSC---------LDG-TPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           D+ + N+L+ E    K++DFG AR     +     S       + APE+L   I + KSD
Sbjct: 149 DIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI-TPKSD 207
Query: 194 IWSFGVLIWEIVT 206
           I+SFGV++ EI+T
Sbjct: 208 IYSFGVVLLEIIT 220

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 24  IVAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           IVA+K ++ +A E E +    ++E++++K L  HPN+V L+     +    ++ E++   
Sbjct: 47  IVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFME-K 103
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+  L  ++              L    +  + YQ+ RG+       I+HRDL  +N+L
Sbjct: 104 DLKKVLDENKT------------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFGV 199
           I  +   K+ADFG AR      +  R     +   W  AP+ L     +S   DIWS G 
Sbjct: 152 INSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208
Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           +  E++T G   +PG+   + + K
Sbjct: 209 IFAEMIT-GKPLFPGVTDDDQLPK 231

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 24  IVAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           IVA+K ++ +A E E +    ++E++++K L  HPN+V L+     +    ++ E++   
Sbjct: 47  IVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFME-K 103
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+  L  ++              L    +  + YQ+ RG+       I+HRDL  +N+L
Sbjct: 104 DLKKVLDENKT------------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLY-DNIFSVKSDIWSFGV 199
           I  +   K+ADFG AR      +  R     +   W  AP+ L     +S   DIWS G 
Sbjct: 152 INSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208
Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           +  E++T G   +PG+   + + K
Sbjct: 209 IFAEMIT-GKPLFPGVTDDDQLPK 231

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P + +L  C    +  + +MEYV  G L           Y+    G+           + 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLM----------YHIQQVGR---FKEPHAVFYA 448
Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            ++A G+ FL S+GII+RDL   NV++      K+ADFG  ++ +   V  +   G    
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGT--P 506
Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            ++APE +    +    D W+FGVL++E++  G  P+ G    E+ +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQ 552

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 37/182 (20%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKVVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 158 D-----LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
                 +MT  V  R         + APE +    +    DIWS GV++ E++  G   +
Sbjct: 175 TAGTSFMMTPYVVTR--------YYRAPEVILGMGYKENVDIWSVGVIMGEMIK-GGVLF 225
Query: 213 PG 214
           PG
Sbjct: 226 PG 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ D+G AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 17  RGREGPCIVAVKTLK----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
           R +    IVA+K +K      A +      L+E+ +++ L  HPN++ LL     K    
Sbjct: 30  RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNIS 88
Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           ++ +++    L+  ++ +            S  LT   + ++     +G+++L    I+H
Sbjct: 89  LVFDFMET-DLEVIIKDN------------SLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLYD-NIFSV 190
           RDL   N+L+ EN   K+ADFG A+   + +   R    ++  RW  APE L+   ++ V
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYXHQVVTRWYRAPELLFGARMYGV 192
Query: 191 KSDIWSFGVLIWEIV 205
             D+W+ G ++ E++
Sbjct: 193 GVDMWAVGCILAELL 207

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 21/188 (11%)
Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPY 80
            VA+K+++  N  E   +  ++E+ +++ L+   HPNVVRL+  C        I   + +
Sbjct: 31  FVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVF 90
Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             +   LR+     Y +        L +  +     Q  RG+ FL +  I+HRDL   N+
Sbjct: 91  EHVDQDLRT-----YLDK--APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 143
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----WMAPESLYDNIFSVKSDIWS 196
           L+      K+ADFG AR      +Y  +     P+     + APE L  + ++   D+WS
Sbjct: 144 LVTSGGTVKLADFGLAR------IYSYQM-ALFPVVVTLWYRAPEVLLQSTYATPVDMWS 196
Query: 197 FGVLIWEI 204
            G +  E+
Sbjct: 197 VGCIFAEM 204

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 37/182 (20%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKVVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 158 D-----LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
                 +MT  V  R         + APE +    +    DIWS GV++ E++  G   +
Sbjct: 175 TAGTSFMMTPYVVTR--------YYRAPEVILGMGYKENVDIWSVGVIMGEMIK-GGVLF 225
Query: 213 PG 214
           PG
Sbjct: 226 PG 227

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R+   ++AVK ++ +  + E   +L +L V+      P +V+  G        F+ ME
Sbjct: 45  RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDL 135
                     L  + A++    M G    +  R L      + + + +L  + G+IHRD+
Sbjct: 105 ----------LMGTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL-----YDNIFSV 190
              N+L+ E    K+ DFG +  L+     +R +       +MAPE +         + +
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC---AAYMAPERIDPPDPTKPDYDI 208
Query: 191 KSDIWSFGVLIWEIVTLGSTPY 212
           ++D+WS G+ + E+ T G  PY
Sbjct: 209 RADVWSLGISLVELAT-GQFPY 229

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 25/187 (13%)
Query: 24  IVAVKTLKENAGERER--LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K +  +  +      D+++E+  ++ L  HPN ++  GC   +   +++MEY   G
Sbjct: 81  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYC-LG 138
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                L           +H K   L   ++ +  +   +G+ +L S  +IHRD+ A N+L
Sbjct: 139 SASDLLE----------VHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVKSDIWSFG 198
           + E    K+ DFG A  +  ++ +           WMAPE   ++ +  +  K D+WS G
Sbjct: 187 LSEPGLVKLGDFGSASIMAPANXFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 199 VLIWEIV 205
           +   E+ 
Sbjct: 241 ITCIELA 247

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 55  HPNVVRLLGCCTEKEPF----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           HP +V +      + P     +++MEYV    L+  + +                +T + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------------GPMTPKR 117
Query: 111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE 170
                    + + F    GIIHRD+   N+LI   +  KV DFG AR +  S     ++ 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTA 177
Query: 171 GRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +   ++++PE    +    +SD++S G +++E++T G  P+ G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
            +VAVK LKE   +   L    E+  M ++  H N++RL G C       ++  Y+  G 
Sbjct: 63  TLVAVKRLKEERXQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 121
Query: 83  LQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---GIIHRDLAAR 138
           + S LR    +Q   +    +  +L S          ARG+ +L       IIHRD+ A 
Sbjct: 122 VASCLRERPESQPPLDWPKRQRIALGS----------ARGLAYLHDHCDPKIIHRDVKAA 171
Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           N+L+ E     V DFG A+ LM           R  I  +APE L     S K+D++ +G
Sbjct: 172 NILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 230
Query: 199 VLIWEIVT 206
           V++ E++T
Sbjct: 231 VMLLELIT 238

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 16/187 (8%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK LKE   +   L    E+  M ++  H N++RL G C       ++  Y+  G +
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 84  QSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---GIIHRDLAARN 139
            S LR    +Q   +    +  +L S          ARG+ +L       IIHRD+ A N
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGS----------ARGLAYLHDHCDPKIIHRDVKAAN 164
Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+ E     V DFG A+ LM           R  I  +APE L     S K+D++ +GV
Sbjct: 165 ILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGV 223
Query: 200 LIWEIVT 206
           ++ E++T
Sbjct: 224 MLLELIT 230

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+++++ +  H NV+ L      +    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A ++      E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 LAHEIEDG--VEFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 DTKQETL 227

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 55  HPNVVRLLGCCTEKEPF----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           HP +V +      + P     +++MEYV    L+  + +                +T + 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------------GPMTPKR 117
Query: 111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE 170
                    + + F    GIIHRD+   N++I   +  KV DFG AR +  S     ++ 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 171 GRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +   ++++PE    +    +SD++S G +++E++T G  P+ G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 25/186 (13%)
Query: 24  IVAVKTLKENAGERER--LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K +  +  +      D+++E+  ++ L  HPN ++  GC   +   +++MEY   G
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYC-LG 99
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                L           +H K   L   ++ +  +   +G+ +L S  +IHRD+ A N+L
Sbjct: 100 SASDLLE----------VHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---SLYDNIFSVKSDIWSFG 198
           + E    K+ DFG A  +  ++ +           WMAPE   ++ +  +  K D+WS G
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANXFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 199 VLIWEI 204
           +   E+
Sbjct: 202 ITCIEL 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+++++ +  H NV+ L      +    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A ++      E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 LAHEIEDG--VEFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 DTKQETL 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+++++ +  H NV+ L      +    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A ++      E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 LAHEIEDG--VEFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 DTKQETL 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+++++ +  H NV+ L      +    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A ++      E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 LAHEIEDG--VEFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 DTKQETL 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R ++ +E+++++ +  H NV+ L      +    +I+E V  G+L  FL           
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFL----------- 106
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC----CKVADFG 154
              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ + +      K+ DFG
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            A ++      E K+    P  ++APE +      +++D+WS GV+ + I+  G++P+ G
Sbjct: 165 LAHEIEDG--VEFKNIFGTP-EFVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPFLG 220
Query: 215 MAAAEVM 221
               E +
Sbjct: 221 DTKQETL 227

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +  K+L     +RE++ +  E+++ ++L  H +VV   G   + +  FV++E        
Sbjct: 49  IVPKSLLLKPHQREKMSM--EISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELC------ 99
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  +LT  +   +  Q+  G Q+L    +IHRDL   N+ + E
Sbjct: 100 -------RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + D+WS G +++ +
Sbjct: 153 DLEVKIGDFGLATKVEYDG--ERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 210
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 211 L-VGKPPF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +  K+L     +RE++ +  E+++ ++L  H +VV   G   + +  FV++E        
Sbjct: 53  IVPKSLLLKPHQREKMSM--EISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELC------ 103
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  +LT  +   +  Q+  G Q+L    +IHRDL   N+ + E
Sbjct: 104 -------RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 156
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + D+WS G +++ +
Sbjct: 157 DLEVKIGDFGLATKVEYDG--ERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 214
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 215 L-VGKPPF 221

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 48/212 (22%)
Query: 39  RLDLLQELTVMKT-LDPHPNVVRLLG-----CCTEKEPFFVIMEYVPYGKLQSFLRSSRA 92
           R + + E  + +  L  H N+ R +          +  + ++MEY P G L  +L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----- 103
Query: 93  QRYYNNMHGKSNSLTSRDLTSFC---YQVARGMQFLSS---RG------IIHRDLAARNV 140
                       SL + D  S C   + V RG+ +L +   RG      I HRDL +RNV
Sbjct: 104 ------------SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151
Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLP------IRWMAPE------SLYDNIF 188
           L+  +  C ++DFG +  L  + +     E          IR+MAPE      +L D   
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 189 SVKS-DIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           ++K  D+++ G++ WEI    +  +PG +  E
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K + + A E +   +  E+ V+  +  HPN+V L          ++IM+ V  G+L
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL-- 141
             F R      Y           T RD +   +QV   +++L   GI+HRDL   N+L  
Sbjct: 104 --FDRIVEKGFY-----------TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 150
Query: 142 -IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            + E+    ++DFG ++     SV    S       ++APE L    +S   D WS GV+
Sbjct: 151 SLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 201 IWEIVTLGSTPY 212
            + I+  G  P+
Sbjct: 208 AY-ILLCGYPPF 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +  K+L     +RE++ +  E+++ ++L  H +VV   G   + +  FV++E        
Sbjct: 49  IVPKSLLLKPHQREKMSM--EISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELC------ 99
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  +LT  +   +  Q+  G Q+L    +IHRDL   N+ + E
Sbjct: 100 -------RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 152
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + D+WS G +++ +
Sbjct: 153 DLEVKIGDFGLATKVEYDG--ERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 210
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 211 L-VGKPPF 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 55  HPNVVRLLGCCTEKEPF----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           HP +V +      + P     +++MEYV    L+  + +                +T + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------------GPMTPKR 117
Query: 111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE 170
                    + + F    GIIHRD+   N++I   +  KV DFG AR +  S     ++ 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 171 GRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +   ++++PE    +    +SD++S G +++E++T G  P+ G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------F 71
           GR G  +   K  +    E       +EL ++K +  H NV+ LL   T  E       F
Sbjct: 47  GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDF 105
Query: 72  FVIMEYV--PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
           +++M ++    GKL                  K   L    +    YQ+ +G++++ + G
Sbjct: 106 YLVMPFMGTDLGKLM-----------------KHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APESLYDNI- 187
           IIHRDL   N+ + E+   K+ DFG AR        + +  G +  RW  APE + + + 
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQA------DSEMXGXVVTRWYRAPEVILNWMR 202
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           ++   DIWS G ++ E++T G T + G    + +K+
Sbjct: 203 YTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKE 237

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 55  HPNVVRLLGCCTEKEPF----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           HP +V +      + P     +++MEYV    L+  + +                +T + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------------GPMTPKR 117
Query: 111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE 170
                    + + F    GIIHRD+   N++I   +  KV DFG AR +  S     ++ 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 171 GRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +   ++++PE    +    +SD++S G +++E++T G  P+ G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K + + A E +   +  E+ V+  +  HPN+V L          ++IM+ V  G+L
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL-- 141
             F R      Y           T RD +   +QV   +++L   GI+HRDL   N+L  
Sbjct: 104 --FDRIVEKGFY-----------TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 150
Query: 142 -IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            + E+    ++DFG ++     SV    S       ++APE L    +S   D WS GV+
Sbjct: 151 SLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 201 IWEIVTLGSTPY 212
            + I+  G  P+
Sbjct: 208 AY-ILLCGYPPF 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 55  HPNVVRLLGCCTEKEPF----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           HP +V +      + P     +++MEYV    L+  + +                +T + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------------GPMTPKR 117
Query: 111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE 170
                    + + F    GIIHRD+   N++I   +  KV DFG AR +  S     ++ 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 171 GRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +   ++++PE    +    +SD++S G +++E++T G  P+ G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLK-ENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +K E   + E +D +Q E  V +    HP +V L  C   +   F ++EYV  G
Sbjct: 36  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 95
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  R              L       +  +++  + +L  RGII+RDL   NVL
Sbjct: 96  DLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +      K+ D+G  ++ +          G     ++APE L    +    D W+ GVL+
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGT--PNYIAPEILRGEDYGFSVDWWALGVLM 200
Query: 202 WEIVTLGSTPYPGMAAAE 219
           +E++  G +P+  + +++
Sbjct: 201 FEMMA-GRSPFDIVGSSD 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+  FG AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLK-ENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +K E   + E +D +Q E  V +    HP +V L  C   +   F ++EYV  G
Sbjct: 32  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 91
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  R              L       +  +++  + +L  RGII+RDL   NVL
Sbjct: 92  DLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 138
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +      K+ D+G  ++ +     +  S       ++APE L    +    D W+ GVL+
Sbjct: 139 LDSEGHIKLTDYGMCKEGLRPG--DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 196
Query: 202 WEIVTLGSTPYPGMAAAE 219
           +E++  G +P+  + +++
Sbjct: 197 FEMMA-GRSPFDIVGSSD 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 24  IVAVKTLK-ENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +K E   + E +D +Q E  V +    HP +V L  C   +   F ++EYV  G
Sbjct: 47  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 106
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  R              L       +  +++  + +L  RGII+RDL   NVL
Sbjct: 107 DLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 153
Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +      K+ D+G  ++ +     +  S       ++APE L    +    D W+ GVL+
Sbjct: 154 LDSEGHIKLTDYGMCKEGLRPG--DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 211
Query: 202 WEIVTLGSTPYPGMAAAE 219
           +E++  G +P+  + +++
Sbjct: 212 FEMMA-GRSPFDIVGSSD 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 55  HPNVVRLLGCCTEKEPF----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           HP +V +      + P     +++MEYV    L+  + +                +T + 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------------GPMTPKR 134
Query: 111 LTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE 170
                    + + F    GIIHRD+   N++I   +  KV DFG AR +  S     ++ 
Sbjct: 135 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 194
Query: 171 GRL-PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +   ++++PE    +    +SD++S G +++E++T G  P+ G
Sbjct: 195 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 238

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K + + A E +   +  E+ V+  +  HPN+V L          ++IM+ V  G+L
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL-- 141
             F R      Y           T RD +   +QV   +++L   GI+HRDL   N+L  
Sbjct: 104 --FDRIVEKGFY-----------TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 150
Query: 142 -IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            + E+    ++DFG ++     SV    S       ++APE L    +S   D WS GV+
Sbjct: 151 SLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 201 IWEIVTLGSTPY 212
            + I+  G  P+
Sbjct: 208 AY-ILLCGYPPF 218

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 12/164 (7%)
Query: 43  LQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++E+ +++ L+   HPNVVRL+  C        I   + +  +   LR+     Y +   
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT-----YLDK-- 111
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                L +  +     Q  RG+ FL +  I+HRDL   N+L+      K+ADFG AR   
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR--- 168
Query: 161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
             S     +   + + + APE L  + ++   D+WS G +  E+
Sbjct: 169 IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ D G AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K + + A E +   +  E+ V+  +  HPN+V L          ++IM+ V  G+L
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL-- 141
             F R      Y           T RD +   +QV   +++L   GI+HRDL   N+L  
Sbjct: 104 --FDRIVEKGFY-----------TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 150
Query: 142 -IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            + E+    ++DFG ++     SV    S       ++APE L    +S   D WS GV+
Sbjct: 151 SLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 201 IWEIVTLGSTPY 212
            + I+  G  P+
Sbjct: 208 AY-ILLCGYPPF 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    KVADFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +  K+L     +RE++ +  E+++ ++L  H +VV   G   + +  FV++E        
Sbjct: 73  IVPKSLLLKPHQREKMSM--EISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELC------ 123
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  +LT  +   +  Q+  G Q+L    +IHRDL   N+ + E
Sbjct: 124 -------RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 176
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + D+WS G +++ +
Sbjct: 177 DLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 235 L-VGKPPF 241

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +  K+L     +RE++ +  E+++ ++L  H +VV   G   + +  FV++E        
Sbjct: 71  IVPKSLLLKPHQREKMSM--EISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELC------ 121
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  +LT  +   +  Q+  G Q+L    +IHRDL   N+ + E
Sbjct: 122 -------RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 174
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + D+WS G +++ +
Sbjct: 175 DLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 232
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 233 L-VGKPPF 239

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DF  AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +  K+L     +RE++ +  E+++ ++L  H +VV   G   + +  FV++E        
Sbjct: 47  IVPKSLLLKPHQREKMSM--EISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELC------ 97
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
                   +R    +H +  +LT  +   +  Q+  G Q+L    +IHRDL   N+ + E
Sbjct: 98  -------RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 150
Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           +   K+ DFG A  +      ERK        ++APE L     S + D+WS G +++ +
Sbjct: 151 DLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
Query: 205 VTLGSTPY 212
           + +G  P+
Sbjct: 209 L-VGKPPF 215

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ D G AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 25/194 (12%)
Query: 31  KENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 89
           KE   + E +D +Q E  V +    HP +V L  C   +   F ++EYV  G L   ++ 
Sbjct: 87  KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR 146
Query: 90  SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCK 149
            R              L       +  +++  + +L  RGII+RDL   NVL+      K
Sbjct: 147 QR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193
Query: 150 VADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
           + D+G  ++ +    T+S +           ++APE L    +    D W+ GVL++E++
Sbjct: 194 LTDYGMCKEGLRPGDTTSTFCGTP------NYIAPEILRGEDYGFSVDWWALGVLMFEMM 247
Query: 206 TLGSTPYPGMAAAE 219
             G +P+  + +++
Sbjct: 248 A-GRSPFDIVGSSD 260

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR---D 158
           K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ D G AR   D
Sbjct: 118 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD 177
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
            MT         G +  RW  APE + + + ++   DIWS G ++ E++T G T +PG  
Sbjct: 178 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 227
Query: 217 AAEVMK 222
             + +K
Sbjct: 228 HIDQLK 233

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKVVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              TS +       R    + APE +    +    DIWS G ++ E++  G   +PG
Sbjct: 175 TAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPG 227

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 24/197 (12%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL------LGCCTEKEPFFVIMEYV 78
           VA+K  ++    + R     E+ +MK L+ HPNVV        L      +   + MEY 
Sbjct: 43  VAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYC 101
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L+ +L        + N  G    L    + +    ++  +++L    IIHRDL   
Sbjct: 102 EGGDLRKYLNQ------FENCCG----LKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 151
Query: 139 NVLIG---ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           N+++    +    K+ D G+A++L    +    +E    ++++APE L    ++V  D W
Sbjct: 152 NIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYW 208
Query: 196 SFGVLIWEIVTLGSTPY 212
           SFG L +E +T G  P+
Sbjct: 209 SFGTLAFECIT-GFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 24/197 (12%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL------LGCCTEKEPFFVIMEYV 78
           VA+K  ++    + R     E+ +MK L+ HPNVV        L      +   + MEY 
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L+ +L        + N  G    L    + +    ++  +++L    IIHRDL   
Sbjct: 101 EGGDLRKYLNQ------FENCCG----LKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 150
Query: 139 NVLIG---ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           N+++    +    K+ D G+A++L    +    +E    ++++APE L    ++V  D W
Sbjct: 151 NIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYW 207
Query: 196 SFGVLIWEIVTLGSTPY 212
           SFG L +E +T G  P+
Sbjct: 208 SFGTLAFECIT-GFRPF 223

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 17  RGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPF-FV 73
           +GR     + VK LK  +   R+  D  +E   ++    HPNV+ +LG C +   P   +
Sbjct: 28  KGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTL 86
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR-DLTSFCYQVARGMQFLSS-RGII 131
           I  + PYG L            YN +H  +N +  +     F    ARG  FL +   +I
Sbjct: 87  ITHWXPYGSL------------YNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLI 134
Query: 132 HRD-LAARNVLIGENHCCKV--ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---D 185
            R  L +R+V I E+   ++  AD  F+        ++       P  W+APE+L    +
Sbjct: 135 PRHALNSRSVXIDEDXTARISXADVKFS--------FQSPGRXYAPA-WVAPEALQKKPE 185
Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +     +D WSF VL+WE+VT    P+  ++  E+  K
Sbjct: 186 DTNRRSADXWSFAVLLWELVT-REVPFADLSNXEIGXK 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           V+  K+ A  +   ++L+E+        HP +V L+         ++I+EY+  G+L  F
Sbjct: 59  VRNAKDTAHTKAERNILEEVK-------HPFIVDLIYAFQTGGKLYLILEYLSGGEL--F 109
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH 146
           ++  R   +  +               +  +++  +  L  +GII+RDL   N+++    
Sbjct: 110 MQLEREGIFMEDT-----------ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG 158
Query: 147 CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
             K+ DFG  ++ +          G   I +MAPE L  +  +   D WS G L+++++T
Sbjct: 159 HVKLTDFGLCKESIHDGTVTHXFCGT--IEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
Query: 207 LGSTPYPG 214
            G+ P+ G
Sbjct: 217 -GAPPFTG 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKVVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              TS +       R    + APE +    +    DIWS G ++ E++  G   +PG
Sbjct: 175 TAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPG 227

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 88/191 (46%), Gaps = 29/191 (15%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           V+  K+ A  +   ++L+E+        HP +V L+         ++I+EY+  G+L  F
Sbjct: 59  VRNAKDTAHTKAERNILEEVK-------HPFIVDLIYAFQTGGKLYLILEYLSGGEL--F 109
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCY---QVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++  R   +  +              + C+   +++  +  L  +GII+RDL   N+++ 
Sbjct: 110 MQLEREGIFMED--------------TACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
                K+ DFG  ++ +          G   I +MAPE L  +  +   D WS G L+++
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGT--IEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 204 IVTLGSTPYPG 214
           ++T G+ P+ G
Sbjct: 214 MLT-GAPPFTG 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           KS  L++  +  F YQ+ RG++++ S  ++HRDL   N+LI      K+ DFG AR    
Sbjct: 137 KSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADP 196
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 27/177 (15%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              TS +   +   R    + APE +    +    DIWS G ++ E++  G   +PG
Sbjct: 175 TAGTSFMMTPEVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPG 227

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY+P G + S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    KVADFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS + E +   R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY+P G + S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    KVADFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 20/184 (10%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 51  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 99
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 100 ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 156
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
            L+     E  +E      +M+PE L    +SV+SDIWS G+ + E+  +G  P P MA 
Sbjct: 157 QLID----EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPRPPMAI 211
Query: 218 AEVM 221
            E++
Sbjct: 212 FELL 215

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKXVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLXQVIQMELDHER----------------MSYLLYQMLXGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+   A+R    
Sbjct: 58  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--EAKRIPEE 114
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
           + GK               V RG+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 115 ILGK-----------VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 163
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +MAPE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 164 QLIDSMANSFVGTRS-------YMAPERLQGTHYSVQSDIWSMGLSLVEL-AVGRYPIPP 215
Query: 215 MAAAEV 220
             A E+
Sbjct: 216 PDAKEL 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              TS +       R    + APE +    +    DIWS G ++ E++  G   +PG
Sbjct: 175 TAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPG 227

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 32/199 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G ++ E++  G   +PG
Sbjct: 210 SVGCIMGEMIK-GGVLFPG 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLXQVIQMELDHER----------------MSYLLYQMLXGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 32/199 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 53  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 109
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 110 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 153
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 210
Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G ++ E++  G   +PG
Sbjct: 211 SVGCIMGEMIK-GGVLFPG 228

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG----KLQSFLRSSRA-------- 92
           E+ +MK L  HPN+ RL     +++   ++ME    G    KL  F+  S          
Sbjct: 78  EVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 93  -----------QRYYNNMHGKSNSLT----SRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
                      +    ++HG   SL      + +++   Q+   + +L ++GI HRD+  
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 138 RNVLIGENHC--CKVADFGFARD---LMTSSVYERKSEGRLPIRWMAPESL--YDNIFSV 190
            N L   N     K+ DFG +++   L     Y   ++   P  ++APE L   +  +  
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY-FVAPEVLNTTNESYGP 255
Query: 191 KSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           K D WS GVL+  ++ +G+ P+PG+  A+ + +
Sbjct: 256 KCDAWSAGVLL-HLLLMGAVPFPGVNDADTISQ 287

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 75  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 130
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 131 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 174
Query: 163 SVYERKSEGRLPI-----RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 175 ----KRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 229
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 230 IQIYEK 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRLPI-----RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 44  QELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRY-YNNMH 100
           +E+ +++ L  H NV++L+      EK+  +++MEY   G +Q  L S   +R+     H
Sbjct: 55  KEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAH 112
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
           G            FC Q+  G+++L S+GI+H+D+   N+L+      K++  G A  L 
Sbjct: 113 G-----------YFC-QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 161 TSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +  +  R S+G    +     +  D     K DIWS GV ++ I T G  P+ G
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPFEG 215

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 82  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 137
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 138 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 181
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 182 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 236
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 237 IQIYEK 242

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 45  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 101
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 102 ELMDANLXQVIQMELDHER----------------MSYLLYQMLXGIKHLHSAGIIHRDL 145
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 146 KPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 202
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 203 SVGCIMGEMV 212

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 32/199 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G ++ E++  G   +PG
Sbjct: 210 SVGCIMGEMIK-GGVLFPG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 110 LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 165
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 166 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 209
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 210 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 259

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 26/168 (15%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 72  RELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER--- 127
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 128 -------------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIV 205
              TS + E +   R    + APE +    +    D+WS G ++ E+V
Sbjct: 175 TAGTSFMMEPEVVTRY---YRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 32/199 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLSQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G ++ E++  G   +PG
Sbjct: 210 SVGCIMGEMIK-GGVLFPG 227

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 57  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 116
           N V+ +    +K   F+ MEY   G L            Y+ +H ++ +    +      
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTL------------YDLIHSENLNQQRDEYWRLFR 123
Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP-- 174
           Q+   + ++ S+GIIHRDL   N+ I E+   K+ DFG A+++  S    +     LP  
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 175 ----------IRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
                       ++A E L D    ++ K D++S G++ +E++   ST   GM    ++K
Sbjct: 184 SDNLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGIIFFEMIYPFST---GMERVNILK 239
Query: 223 K 223
           K
Sbjct: 240 K 240

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 38/199 (19%)
Query: 43  LQELTVMKTLDPHPNVVRL--------------LGCCTEKEPFFVIMEYVPYGKLQSFLR 88
           L+E+ +++ LD H N+V++              +G  TE    +++ EY     +++ L 
Sbjct: 56  LREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLA 109
Query: 89  SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHC 147
           +   Q      H +           F YQ+ RG++++ S  ++HRDL   N+ I  E+  
Sbjct: 110 NVLEQGPLLEEHARL----------FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159
Query: 148 CKVADFGFARDLMTSSVYERK---SEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWE 203
            K+ DFG AR  +    Y  K   SEG +   + +P  L   N ++   D+W+ G +  E
Sbjct: 160 LKIGDFGLAR--IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
Query: 204 IVTLGSTPYPGMAAAEVMK 222
           ++T G T + G    E M+
Sbjct: 218 MLT-GKTLFAGAHELEQMQ 235

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 137 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 196
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 197 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADP 176
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 230

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 29/173 (16%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P +V+L     +    ++++EY P G++ S LR  R  R+ +  H +           + 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR--RIGRF-SEPHARF----------YA 148
Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-- 173
            Q+    ++L S  +I+RDL   N+LI +    KVADFGFA          ++ +GR   
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA----------KRVKGRTWX 198
Query: 174 ---PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
                 ++APE +    ++   D W+ GVLI+E+   G  P+      ++ +K
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEK 250

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 176
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 180
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADP 178
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 176
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 230

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+    H +
Sbjct: 82  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-XEPHAR 137
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 138 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 181
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 182 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 236
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 237 IQIYEK 242

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 180
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 25/200 (12%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R ++   +VAVK ++   GE+   ++ +E+   ++L  HPN+VR            ++ME
Sbjct: 39  RDKQANELVAVKYIER--GEKIDENVKREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 95
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY-QVARGMQFLSSRGIIHRDL 135
           Y   G+L  F R   A R+            S D   F + Q+  G+ +  +  + HRDL
Sbjct: 96  YASGGEL--FERICNAGRF------------SEDEARFFFQQLISGVSYAHAMQVAHRDL 141
Query: 136 AARNVLIGENHC--CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-S 192
              N L+  +     K+ADFG+++  +  S  + KS    P  ++APE L    +  K +
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSKASVLHS--QPKSAVGTPA-YIAPEVLLKKEYDGKVA 198
Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D+WS GV ++ ++ +G+ P+
Sbjct: 199 DVWSCGVTLY-VMLVGAYPF 217

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-XEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-XEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            F+ ME+   G L+ ++   R +        K + + + +L     Q+ +G+ ++ S+ +
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGE--------KLDKVLALELFE---QITKGVDYIHSKKL 157
Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSV 190
           IHRDL   N+ + +    K+ DFG    L       +++  +  +R+M+PE +    +  
Sbjct: 158 IHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGK 214
Query: 191 KSDIWSFGVLIWEIVTLGSTPY 212
           + D+++ G+++ E++ +  T +
Sbjct: 215 EVDLYALGLILAELLHVCDTAF 236

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 45  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 104
           E  V++ +   P +V L      +    +I++Y+  G+L  F   S+ +R+         
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERF--------- 156
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSV 164
             T  ++  +  ++   ++ L   GII+RD+   N+L+  N    + DFG +++ +    
Sbjct: 157 --TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 165 YERKSEGRLPIRWMAPESLY--DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            ER  +    I +MAP+ +   D+      D WS GVL++E++T G++P+
Sbjct: 215 -ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPF 262

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKXVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLXQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYVP G++ S LR  R  R+    H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR--RIGRF-XEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 73  VIMEYVP---YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
           VIMEYVP   +  L+SF+RS R             S+    ++ + YQ+ R + F+ S G
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGR-------------SIPMNLISIYIYQLFRAVGFIHSLG 161
Query: 130 IIHRDLAARNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI- 187
           I HRD+  +N+L+  +++  K+ DFG A+ L+ S         R    + APE +     
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF---YRAPELMLGATE 218
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           ++   D+WS G +  E++ LG   + G  + + +
Sbjct: 219 YTPSIDLWSIGCVFGELI-LGKPLFSGETSIDQL 251

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 36/203 (17%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC----------------TEKE 69
            +K +K N  + ER     E+  +  LD H N+V   GC                 ++ +
Sbjct: 40  VIKRVKYNNEKAER-----EVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTK 93
Query: 70  PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
             F+ ME+   G L+ ++   R +        K + + + +L     Q+ +G+ ++ S+ 
Sbjct: 94  CLFIQMEFCDKGTLEQWIEKRRGE--------KLDKVLALELFE---QITKGVDYIHSKK 142
Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS 189
           +I+RDL   N+ + +    K+ DFG    L       R S+G L  R+M+PE +    + 
Sbjct: 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR-SKGTL--RYMSPEQISSQDYG 199
Query: 190 VKSDIWSFGVLIWEIVTLGSTPY 212
            + D+++ G+++ E++ +  T +
Sbjct: 200 KEVDLYALGLILAELLHVCDTAF 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 181 DHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKXVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 122 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 181
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 182 DHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL +MK ++ H N++ LL   T      E +  +++ME +     Q        +R   
Sbjct: 74  RELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER--- 129
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                        ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG AR
Sbjct: 130 -------------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176
Query: 158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              TS +       R    + APE +    +    DIWS G ++ E++  G   +PG
Sbjct: 177 TAGTSFMMVPFVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPG 229

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 239

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 115 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 174
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 175 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 115 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 174
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 175 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 122 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 181
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 182 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 123 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 182
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 183 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 114 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 173
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 174 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 178
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 176
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTP-YPG 214
              +       +  RW  APE + ++    KS DIWS G ++ E+  L + P +PG
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM--LSNRPIFPG 230

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 137 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 196
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 197 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E++ +K L  HP++++L    T      +++EY   G+L  ++   +            
Sbjct: 58  REISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKK------------ 103
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
             +T  +   F  Q+   +++     I+HRDL   N+L+ +N   K+ADFG + ++MT  
Sbjct: 104 -RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDG 161
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            + + S G     + APE +   +++  + D+WS G++++ ++ +G  P+       + K
Sbjct: 162 NFLKTSCGSP--NYAAPEVINGKLYAGPEVDVWSCGIVLY-VMLVGRLPFDDEFIPNLFK 218
Query: 223 K 223
           K
Sbjct: 219 K 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 178
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 125 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 184
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 185 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K+  L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 176
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 110 RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 158
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 159 ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 215
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 216 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 267
Query: 215 MAAAEV 220
             A E+
Sbjct: 268 PDAKEL 273

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 27/177 (15%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           H ++V   G C   +   ++ E+V +G L ++L+ ++            N +        
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK------------NCINILWKLEV 118
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLI--------GENHCCKVADFGFARDLMTSSVYE 166
             Q+A  M FL    +IH ++ A+N+L+        G     K++D G +  ++   + +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 167 RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            +      I W+ PE + +    ++ +D WSFG  +WEI + G  P   + +   ++
Sbjct: 179 ER------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 27/191 (14%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL     E+   +++ + V  G+L   
Sbjct: 62  INTKKLSARDFQKLE--REARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL--- 115
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---G 143
                A+ +Y          +  D +    Q+   + +  S GI+HR+L   N+L+    
Sbjct: 116 FEDIVAREFY----------SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165
Query: 144 ENHCCKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +    K+ADFG A ++  S  +     + G     +++PE L  + +S   DIW+ GV++
Sbjct: 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPG-----YLSPEVLKKDPYSKPVDIWACGVIL 220
Query: 202 WEIVTLGSTPY 212
           + I+ +G  P+
Sbjct: 221 Y-ILLVGYPPF 230

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY P G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-XEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 75  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 123
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 124 ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 181 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 232
Query: 215 MAAAEV 220
             A E+
Sbjct: 233 PDAKEL 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 76  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 131
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI E    +V DFGFA      
Sbjct: 132 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA------ 175
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 176 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 230
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 231 IQIYEK 236

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 32/179 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL ++K +  H NV+ LL   T          F+++M +     +Q+ L+     ++  
Sbjct: 72  RELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKF-- 123
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                    +   +    YQ+ +G++++ S G++HRDL   N+ + E+   K+ DFG AR
Sbjct: 124 ---------SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 158 DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
                   + +  G +  RW  APE +   + ++   DIWS G ++ E++T G T + G
Sbjct: 175 HA------DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKG 226

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 32/179 (17%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           +EL ++K +  H NV+ LL   T          F+++M +     +Q+ L+      +  
Sbjct: 90  RELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGMEF-- 141
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                    +   +    YQ+ +G++++ S G++HRDL   N+ + E+   K+ DFG AR
Sbjct: 142 ---------SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192
Query: 158 DLMTSSVYERKSEGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
                   + +  G +  RW  APE +   + ++   DIWS G ++ E++T G T + G
Sbjct: 193 HA------DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKG 244

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 27/191 (14%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL     E+   +++ + V  G+L   
Sbjct: 38  INTKKLSARDFQKLE--REARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL--- 91
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---G 143
                A+ +Y+            D +    Q+   + +  S GI+HR+L   N+L+    
Sbjct: 92  FEDIVAREFYSEA----------DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 141
Query: 144 ENHCCKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +    K+ADFG A ++  S  +     + G     +++PE L  + +S   DIW+ GV++
Sbjct: 142 KGAAVKLADFGLAIEVNDSEAWHGFAGTPG-----YLSPEVLKKDPYSKPVDIWACGVIL 196
Query: 202 WEIVTLGSTPY 212
           + I+ +G  P+
Sbjct: 197 Y-ILLVGYPPF 206

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 48  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 96
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 97  ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 154 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 205
Query: 215 MAAAEV 220
             A E+
Sbjct: 206 PDAKEL 211

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 27/191 (14%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL     E+   +++ + V  G+L   
Sbjct: 39  INTKKLSARDFQKLE--REARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL--- 92
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---G 143
                A+ +Y          +  D +    Q+   + +  S GI+HR+L   N+L+    
Sbjct: 93  FEDIVAREFY----------SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 142
Query: 144 ENHCCKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +    K+ADFG A ++  S  +     + G     +++PE L  + +S   DIW+ GV++
Sbjct: 143 KGAAVKLADFGLAIEVNDSEAWHGFAGTPG-----YLSPEVLKKDPYSKPVDIWACGVIL 197
Query: 202 WEIVTLGSTPY 212
           + I+ +G  P+
Sbjct: 198 Y-ILLVGYPPF 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 48  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 96
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 97  ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 154 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 205
Query: 215 MAAAEV 220
             A E+
Sbjct: 206 PDAKEL 211

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 90  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 146
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 147 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 190
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 247
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 248 SVGCIMGEMV 257

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 27/191 (14%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL     E+   +++ + V  G+L   
Sbjct: 39  INTKKLSARDFQKLE--REARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL--- 92
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---G 143
                A+ +Y+            D +    Q+   + +  S GI+HR+L   N+L+    
Sbjct: 93  FEDIVAREFYSEA----------DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 142
Query: 144 ENHCCKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +    K+ADFG A ++  S  +     + G     +++PE L  + +S   DIW+ GV++
Sbjct: 143 KGAAVKLADFGLAIEVNDSEAWHGFAGTPG-----YLSPEVLKKDPYSKPVDIWACGVIL 197
Query: 202 WEIVTLGSTPY 212
           + I+ +G  P+
Sbjct: 198 Y-ILLVGYPPF 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 48  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 96
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 97  ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 154 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 205
Query: 215 MAAAEV 220
             A E+
Sbjct: 206 PDAKEL 211

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 33/199 (16%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-------EKEPFFVIMEYV 78
           A+K L  N  E+ R  ++QE+  MK L  HPN+V+     +         +  F+++  +
Sbjct: 57  ALKRLLSNEEEKNRA-IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL 115
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLA 136
             G+L  FL+   ++            L+   +    YQ  R +Q +  +   IIHRDL 
Sbjct: 116 CKGQLVEFLKKMESR----------GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLK 165
Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----------WMAPE--SLY 184
             N+L+      K+ DFG A  +     Y   ++ R  +           +  PE   LY
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225
Query: 185 DNI-FSVKSDIWSFGVLIW 202
            N     K DIW+ G +++
Sbjct: 226 SNFPIGEKQDIWALGCILY 244

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 48  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 96
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 97  ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 154 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 205
Query: 215 MAAAEV 220
             A E+
Sbjct: 206 PDAKEL 211

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 48  RNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 96
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 97  ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  +G  P P 
Sbjct: 154 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIPP 205
Query: 215 MAAAE 219
             A E
Sbjct: 206 PDAKE 210

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 46  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 102
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 103 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 146
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 147 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 203
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 204 SVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 90  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 146
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 147 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 190
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 247
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 248 SVGCIMGEMV 257

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 51  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 107
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 108 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 151
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 152 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 208
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 209 SVGCIMGEMV 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA---------RDLMTSSVYER 167
           Q+A  ++FL S+G++HRDL   N+    +   KV DFG           + ++T      
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 168 KSEGRLPIR-WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
              G++  + +M+PE ++ N +S K DI+S G++++E++   ST
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 2/107 (1%)
Query: 102 KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT 161
           K   L++  +  F YQ+ RG++++ S  ++HRDL   N+L+      K+ DFG AR    
Sbjct: 121 KCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 162 SSVYERKSEGRLPIRWM-APESLYDNIFSVKS-DIWSFGVLIWEIVT 206
              +       +  RW  APE + ++    KS DIWS G ++ E+++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 53  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 109
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 110 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 153
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 210
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 211 SVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 46  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 102
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 103 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 146
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 147 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 203
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 204 SVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 53  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 109
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 110 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 153
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 210
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 211 SVGCIMGEMV 220

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 45  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 101
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 102 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 145
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 202
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 203 SVGCIMGEMV 212

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 52  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 109 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    DIW
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIW 209
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 210 SVGCIMGEMV 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 29/189 (15%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           VAVK L    +N    +R    +EL ++K ++ H N++ LL   T   P   + E+    
Sbjct: 52  VAVKKLSRPFQNQTHAKRA--YRELVLLKCVN-HKNIISLLNVFT---PQKTLEEFQDVY 105
Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +   + ++  Q  +         L    ++   YQ+  G++ L S GIIHRDL   N++
Sbjct: 106 LVMELMDANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 142 IGENHCCKVADFGFARD-----LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           +  +   K+ DFG AR      +MT  V  R         + APE +    ++   DIWS
Sbjct: 159 VKSDCTLKILDFGLARTACTNFMMTPYVVTR--------YYRAPEVILGMGYAANVDIWS 210
Query: 197 FGVLIWEIV 205
            G ++ E+V
Sbjct: 211 VGCIMGELV 219

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 25/200 (12%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R ++   +VAVK ++   GE+   ++ +E+   ++L  HPN+VR            ++ME
Sbjct: 39  RDKQSNELVAVKYIER--GEKIAANVKREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 95
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY-QVARGMQFLSSRGIIHRDL 135
           Y   G+L  F R   A R+            S D   F + Q+  G+ +  +  + HRDL
Sbjct: 96  YASGGEL--FERICNAGRF------------SEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 136 AARNVLIGENHC--CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-S 192
              N L+  +     K+ DFG+++  +  S  + KS    P  ++APE L    +  K +
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP-AYIAPEVLLKKEYDGKVA 198
Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D+WS GV ++ ++ +G+ P+
Sbjct: 199 DVWSCGVTLY-VMLVGAYPF 217

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P + +L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P + +L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 239

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E+ +++  D HPNV+R    CTEK+  F   +Y+      + L+    Q+ + ++  + 
Sbjct: 66  REVQLLRESDEHPNVIRYF--CTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEP 120
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC-----CKVADFGFARD 158
            +L          Q   G+  L S  I+HRDL   N+LI   +        ++DFG  + 
Sbjct: 121 ITLLQ--------QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 159 LMTS-SVYERKSEGRLPIRWMAPESLYDNIF---SVKSDIWSFGVLIWEIVTLGSTPY 212
           L      + R+S       W+APE L ++     +   DI+S G + + +++ GS P+
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA+     
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 163 SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            V  R         ++APE +    ++   D W+ GVLI+E+   G  P+      ++ +
Sbjct: 190 RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYE 248
Query: 223 K 223
           K
Sbjct: 249 K 249

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 42/204 (20%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VAVK L    +N    +R    +EL ++K ++ H N++ LL   T      E +  +++M
Sbjct: 50  VAVKKLSRPFQNQTHAKRA--YRELVLLKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 107 ELMDANLCQVIHMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 150
Query: 136 AARNVLIGENHCCKVADFGFARD-----LMTSSVYERKSEGRLPIRWMAPESLYDNIFSV 190
              N+++  +   K+ DFG AR      +MT  V  R         + APE +    +  
Sbjct: 151 KPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTR--------YYRAPEVILGMGYKE 202
Query: 191 KSDIWSFGVLIWEIVTLGSTPYPG 214
             DIWS G ++ E+V  GS  + G
Sbjct: 203 NVDIWSVGCIMGELVK-GSVIFQG 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+    +  YP   A
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM----AAGYPPFFA 240
Query: 218 AE 219
            E
Sbjct: 241 DE 242

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 8   VRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
           V +  +S   G+E     A K LK+   G+  R ++L E+ V++     P V+ L     
Sbjct: 44  VVRQCISKSTGQE----YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
                 +I+EY   G++ S      A+    N           D+     Q+  G+ +L 
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSEN-----------DVIRLIKQILEGVYYLH 148
Query: 127 SRGIIHRDLAARNVLIGENH---CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL 183
              I+H DL  +N+L+   +     K+ DFG +R +      E +     P  ++APE L
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTP-EYLAPEIL 205
Query: 184 YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             +  +  +D+W+ G++ + ++T  ++P+ G
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLT-HTSPFVG 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA+     
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 163 SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            V  R         ++APE +    ++   D W+ GVLI+E+   G  P+      ++ +
Sbjct: 190 RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYE 248
Query: 223 K 223
           K
Sbjct: 249 K 249

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 90  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 244
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 245 IQIYEK 250

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 27/177 (15%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           H ++V   G C   +   ++ E+V +G L ++L+ ++            N +        
Sbjct: 71  HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNK------------NCINILWKLEV 118
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLI--------GENHCCKVADFGFARDLMTSSVYE 166
             Q+A  M FL    +IH ++ A+N+L+        G     K++D G +  ++   + +
Sbjct: 119 AKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 167 RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            +      I W+ PE + +    ++ +D WSFG  +WEI + G  P   + +   ++
Sbjct: 179 ER------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 25/200 (12%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R ++   +VAVK ++   GE+   ++ +E+   ++L  HPN+VR            ++ME
Sbjct: 38  RDKQSNELVAVKYIER--GEKIDENVKREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 94
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY-QVARGMQFLSSRGIIHRDL 135
           Y   G+L  F R   A R+            S D   F + Q+  G+ +  +  + HRDL
Sbjct: 95  YASGGEL--FERICNAGRF------------SEDEARFFFQQLISGVSYCHAMQVCHRDL 140
Query: 136 AARNVLIGENHC--CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-S 192
              N L+  +     K+ DFG+++  +  S  + KS    P  ++APE L    +  K +
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP-AYIAPEVLLKKEYDGKVA 197
Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D+WS GV ++ ++ +G+ P+
Sbjct: 198 DVWSCGVTLY-VMLVGAYPF 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 57  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 113
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 114 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 157
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    D+W
Sbjct: 158 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDLW 214
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 215 SVGCIMGEMV 224

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP V+RLL     +E F +++E           R   AQ  ++ +  K   L       F
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLE-----------RPLPAQDLFDYITEK-GPLGEGPSRCF 144
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRL 173
             QV   +Q   SRG++HRD+   N+LI     C K+ DFG +  L+    Y      R+
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFDGTRV 203
Query: 174 --PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             P  W++    +    ++ + +WS G+L++++V  G  P+
Sbjct: 204 YSPPEWISRHQYH----ALPATVWSLGILLYDMVC-GDIPF 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + +    + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 47  LVAIKKVLQGKAFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPATVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEIXINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMXGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 25  VAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIM 75
           VA+K L    +N    +R    +EL +MK ++ H N++ LL   T      E +  +++M
Sbjct: 46  VAIKKLSRPFQNQTHAKRA--YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVM 102
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +     Q        +R                ++   YQ+  G++ L S GIIHRDL
Sbjct: 103 ELMDANLCQVIQMELDHER----------------MSYLLYQMLCGIKHLHSAGIIHRDL 146
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+++  +   K+ DFG AR   TS +       R    + APE +    +    D+W
Sbjct: 147 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDLW 203
Query: 196 SFGVLIWEIV 205
           S G ++ E+V
Sbjct: 204 SVGCIMGEMV 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P + +L     +    +++MEY P G++ S LR  R  R+    H +
Sbjct: 90  LNEKRILQAVN-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-XEPHAR 145
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFGFA      
Sbjct: 146 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------ 189
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 190 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 239

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 27/198 (13%)
Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VA+K ++ E+  E      ++E++++K L  H N++ L           +I EY      
Sbjct: 62  VAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYA----- 115
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
                 +  ++Y +    K+  ++ R + SF YQ+  G+ F  SR  +HRDL  +N+L+ 
Sbjct: 116 -----ENDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166
Query: 143 ----GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES--LYDNIFSVKSDIWS 196
                E    K+ DFG AR      +  R+    +   W  P    L    +S   DIWS
Sbjct: 167 VSDASETPVLKIGDFGLARAF---GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWS 223
Query: 197 FGVLIWEIVTLGSTPYPG 214
               IW  + + +  +PG
Sbjct: 224 IAC-IWAEMLMKTPLFPG 240

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEIXINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMXGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 20/199 (10%)
Query: 16  ERGREGPC--IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
           E+ R  P   I AVK ++     +E+  LL +L +       P  V   G    +   ++
Sbjct: 51  EKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWI 110
Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIH 132
             E          L  +   ++Y  +  K  ++    L      + + ++ L S+  +IH
Sbjct: 111 CXE----------LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 160
Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI----F 188
           RD+   NVLI      K  DFG +   +   V +    G  P  + APE +   +    +
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDIDAGCKP--YXAPERINPELNQKGY 217
Query: 189 SVKSDIWSFGVLIWEIVTL 207
           SVKSDIWS G+   E+  L
Sbjct: 218 SVKSDIWSLGITXIELAIL 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 57  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 116
           N V+ +    +K   F+ MEY     L            Y+ +H ++ +    +      
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENRTL------------YDLIHSENLNQQRDEYWRLFR 123
Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP-- 174
           Q+   + ++ S+GIIHRDL   N+ I E+   K+ DFG A+++  S    +     LP  
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 175 ----------IRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
                       ++A E L D    ++ K D++S G++ +E++   ST   GM    ++K
Sbjct: 184 SDNLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGIIFFEMIYPFST---GMERVNILK 239
Query: 223 K 223
           K
Sbjct: 240 K 240

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    KV DFG A      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+    H +
Sbjct: 84  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-XEPHAR 139
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 140 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 183
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 184 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 238
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 239 IQIYEK 244

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-XEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMXGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-XEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+    H +
Sbjct: 110 LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-XEPHAR 165
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 166 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 209
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 210 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 259

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 22/186 (11%)
Query: 31  KENAGERERL-DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 89
           K+   ER  + ++ +EL +M+ L+ HP +V L     ++E  F++++ +  G L+  L+ 
Sbjct: 50  KQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ 108
Query: 90  SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCK 149
                   N+H K  ++       F  ++   + +L ++ IIHRD+   N+L+ E+    
Sbjct: 109 --------NVHFKEETVKL-----FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155
Query: 150 VADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI---FSVKSDIWSFGVLIWEIVT 206
           + DF  A  ++          G  P  +MAPE         +S   D WS GV  +E++ 
Sbjct: 156 ITDFNIAA-MLPRETQITTMAGTKP--YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 207 LGSTPY 212
            G  PY
Sbjct: 213 -GRRPY 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMXGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 59  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 112
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 113 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 162
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 163 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 219
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 220 SAGCVLAELL-LGQPIFPGDSGVDQL 244

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 110 LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 165
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA+ +  +
Sbjct: 166 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA 215
Query: 163 SVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           +     +    P  ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 216 TW----TLCGTP-EYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 259

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E++ ++ L  HP++++L      K+   +++EY    +L  ++     QR         
Sbjct: 63  REISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYI----VQR--------- 107
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           + ++ ++   F  Q+   +++     I+HRDL   N+L+ E+   K+ADFG + ++MT  
Sbjct: 108 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDG 166
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            + + S G  P  + APE +   +++  + D+WS GV+++
Sbjct: 167 NFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 204

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 55  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 108
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 109 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 158
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 159 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 215
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 216 SAGCVLAELL-LGQPIFPGDSGVDQL 240

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E++ ++ L  HP++++L      K+   +++EY    +L  ++     QR         
Sbjct: 53  REISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYI----VQR--------- 97
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           + ++ ++   F  Q+   +++     I+HRDL   N+L+ E+   K+ADFG + ++MT  
Sbjct: 98  DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDG 156
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            + + S G  P  + APE +   +++  + D+WS GV+++
Sbjct: 157 NFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 194

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 48  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 101
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 102 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 151
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 152 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 208
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 209 SAGCVLAELL-LGQPIFPGDSGVDQL 233

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 25  VAVKTLKENAGERER-LDLLQELTVMKTLDPHPNVVRL------LGCCTEKEPFF-VIME 76
           VA+K + ++   R R L ++Q+L V+     HPN+V+L      LG    ++ +  V+ME
Sbjct: 51  VAIKKVIQDPRFRNRELQIMQDLAVLH----HPNIVQLQSYFYTLGERDRRDIYLNVVME 106
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR--GMQFLSSRGIIHRD 134
           YVP     +  R  R   YY         L    +  F +Q+ R  G   L S  + HRD
Sbjct: 107 YVP----DTLHRCCR--NYYRRQVAPPPIL----IKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 135 LAARNVLIGE-NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKS 192
           +   NVL+ E +   K+ DFG A+ L  S         R    + APE ++ N  ++   
Sbjct: 157 IKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY---YRAPELIFGNQHYTTAV 213
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAA 218
           DIWS G +  E++ LG   + G  +A
Sbjct: 214 DIWSVGCIFAEMM-LGEPIFRGDNSA 238

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 47  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 66  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 119
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 120 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 169
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 170 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 226
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 227 SAGCVLAELL-LGQPIFPGDSGVDQL 251

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 59  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 112
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 113 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 162
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 163 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 219
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 220 SAGCVLAELL-LGQPIFPGDSGVDQL 244

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E++ ++ L  HP++++L      K+   +++EY    +L  ++     QR         
Sbjct: 62  REISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYI----VQR--------- 106
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           + ++ ++   F  Q+   +++     I+HRDL   N+L+ E+   K+ADFG + ++MT  
Sbjct: 107 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDG 165
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            + + S G  P  + APE +   +++  + D+WS GV+++
Sbjct: 166 NFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 203

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E++ ++ L  HP++++L      K+   +++EY    +L  ++     QR         
Sbjct: 57  REISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYI----VQR--------- 101
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS 163
           + ++ ++   F  Q+   +++     I+HRDL   N+L+ E+   K+ADFG + ++MT  
Sbjct: 102 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDG 160
Query: 164 VYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIW 202
            + + S G  P  + APE +   +++  + D+WS GV+++
Sbjct: 161 NFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 198

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-XEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 47  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 51  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 104
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 105 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 154
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 155 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 211
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 212 SAGCVLAELL-LGQPIFPGDSGVDQL 236

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + +    + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 47  LVAIKKVLQGKAFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+    H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-AEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 81  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 184
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 241
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 242 SAGCVLAELL-LGQPIFPGDSGVDQL 266

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMXGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + +    + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 47  LVAIKKVLQGKAFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL---LGCCTEKEPFF---VIMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL        EK+      ++++Y
Sbjct: 47  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDVVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++APE +    ++   D W+ GVLI+++   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 47  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 150
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 207
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 208 SAGCVLAELL-LGQPIFPGDSGVDQL 232

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
           +  L+   +  F YQ  R ++ L    +IHRDL   N+LI  N   KV DFG AR +  S
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 163 SVYERKSEGR-------LPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYP 213
           +    +  G+       +  RW  APE +  +  +S   D+WS G ++ E+  L    +P
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224
Query: 214 G 214
           G
Sbjct: 225 G 225

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 60  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 113
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 114 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 163
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 164 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 220
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 221 SAGCVLAELL-LGQPIFPGDSGVDQL 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
           +  L+   +  F YQ  R ++ L    +IHRDL   N+LI  N   KV DFG AR +  S
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 163 SVYERKSEGR-------LPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYP 213
           +    +  G+       +  RW  APE +  +  +S   D+WS G ++ E+  L    +P
Sbjct: 166 AADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224
Query: 214 G 214
           G
Sbjct: 225 G 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 87/189 (46%), Gaps = 36/189 (19%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRLPIRW--------MAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
               ++ +GR    W        +APE +    ++   D W+ GVLI+E+   G  P+  
Sbjct: 189 ----KRVKGR---TWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFA 240
Query: 215 MAAAEVMKK 223
               ++ +K
Sbjct: 241 DQPIQIYEK 249

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
           +  L+   +  F YQ  R ++ L    +IHRDL   N+LI  N   KV DFG AR +  S
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 163 SVYERKSEGR-------LPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYP 213
           +    +  G+       +  RW  APE +  +  +S   D+WS G ++ E+  L    +P
Sbjct: 166 AADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224
Query: 214 G 214
           G
Sbjct: 225 G 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 28/203 (13%)
Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEYV 78
           VA+K + ++   + R     EL +M+ +  HPNVV L         +K+  F+  ++EYV
Sbjct: 67  VAIKKVLQDKRFKNR-----ELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
           P           RA R+Y  +      L    +  + YQ+ R + ++ S GI HRD+  +
Sbjct: 121 PE-------TVYRASRHYAKLKQTMPMLL---IKLYMYQLLRSLAYIHSIGICHRDIKPQ 170
Query: 139 NVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWS 196
           N+L+   +   K+ DFG A+ L+           R    + APE ++    ++   DIWS
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY---YRAPELIFGATNYTTNIDIWS 227
Query: 197 FGVLIWEIVTLGSTPYPGMAAAE 219
            G ++ E++  G   +PG +  +
Sbjct: 228 TGCVMAELMQ-GQPLFPGESGID 249

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 25/193 (12%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK ++  A   E  ++ +E+   ++L  HPN+VR            +IMEY   G+L
Sbjct: 47  LVAVKYIERGAAIDE--NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGEL 103
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ-VARGMQFLSSRGIIHRDLAARNVLI 142
             + R   A R+            S D   F +Q +  G+ +  S  I HRDL   N L+
Sbjct: 104 --YERICNAGRF------------SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL 149
Query: 143 GENHC--CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-SDIWSFGV 199
             +     K+ DFG+++  +  S  + KS    P  ++APE L    +  K +D+WS GV
Sbjct: 150 DGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP-AYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 200 LIWEIVTLGSTPY 212
            ++ ++ +G+ P+
Sbjct: 207 TLY-VMLVGAYPF 218

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 75  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 128
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 129 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 178
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 179 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 235
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 236 SAGCVLAELL-LGQPIFPGDSGVDQL 260

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 83  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 136
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 137 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 186
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 187 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 243
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 244 SAGCVLAELL-LGQPIFPGDSGVDQL 268

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 52  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 105
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 106 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 155
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 156 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 212
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 213 SAGCVLAELL-LGQPIFPGDSGVDQL 237

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 81  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 184
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 241
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 242 SAGCVLAELL-LGQPIFPGDSGVDQL 266

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L+E+ +++ +  HPN+++L         FF++ + +  G+L  +L              +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-------------E 117
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
             +L+ ++       +   +  L    I+HRDL   N+L+ ++   K+ DFGF+  L   
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 163 SVYERKSEGRLPIRWMAPE----SLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPY 212
              E+  E      ++APE    S+ DN   +  + D+WS GV+++ ++  GS P+
Sbjct: 178 ---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPF 229

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           + A+K +K++   R+   L  E+ V+K +  H N+V L         ++++M+ V  G+L
Sbjct: 36  LFALKCIKKSPAFRDS-SLENEIAVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F R      Y           T +D +    QV   +++L   GI+HRDL   N+L  
Sbjct: 94  --FDRILERGVY-----------TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140
Query: 143 --GENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
              EN    + DFG ++     +M+++     + G     ++APE L    +S   D WS
Sbjct: 141 TPEENSKIMITDFGLSKMEQNGIMSTAC---GTPG-----YVAPEVLAQKPYSKAVDCWS 192
Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
            GV+ + I+  G  P+     +++ +K K
Sbjct: 193 IGVITY-ILLCGYPPFYEETESKLFEKIK 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 85  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 138
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 139 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 188
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 189 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 245
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 246 SAGCVLAELL-LGQPIFPGDSGVDQL 270

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L+E+ +++ +  HPN+++L         FF++ + +  G+L  +L              +
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-------------E 104
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
             +L+ ++       +   +  L    I+HRDL   N+L+ ++   K+ DFGF+  L   
Sbjct: 105 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 164
Query: 163 SVYERKSEGRLPIRWMAPE----SLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPY 212
              E+  E      ++APE    S+ DN   +  + D+WS GV+++ ++  GS P+
Sbjct: 165 ---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPF 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 51/229 (22%)
Query: 24  IVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGC--CTEKEPFFVIMEYV 78
           +VAVK +    +N+ + +R    +E+ ++  L  H N+V LL           +++ +Y+
Sbjct: 36  VVAVKKIFDAFQNSTDAQRT--FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
               L + +R+              N L         YQ+ + +++L S G++HRD+   
Sbjct: 94  E-TDLHAVIRA--------------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPS 138
Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI----------------------R 176
           N+L+      KVADFG +R    S V  R+    +P+                      R
Sbjct: 139 NILLNAECHVKVADFGLSR----SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194
Query: 177 WM-APESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           W  APE L  +    K  D+WS G ++ EI+  G   +PG +    +++
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSSTMNQLER 242

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEIXINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL----LGCCTEKEPFFV--IMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL         +K+  ++  +++Y
Sbjct: 126 LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 179
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP    +     SRA++    ++ K           + YQ+ R + ++ S GI HRD+  
Sbjct: 180 VPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKP 229
Query: 138 RNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIW 195
           +N+L+  +    K+ DFG A+ L+           R    + APE ++    ++   D+W
Sbjct: 230 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---YRAPELIFGATDYTSSIDVW 286
Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVM 221
           S G ++ E++ LG   +PG +  + +
Sbjct: 287 SAGCVLAELL-LGQPIFPGDSGVDQL 311

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEY P G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N++I +    +V DFG A      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++ +GR         ++APE +    ++   D W+ GVLI+E+   G  P+
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPF 238

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 35/186 (18%)
Query: 38  ERLDLLQELTVMKTLDPHPNVVRLL----GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 93
           ER    +E   +K L  HPN+VR           K+   ++ E    G L+++L+  +  
Sbjct: 68  ERQRFKEEAEXLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVX 126
Query: 94  RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLI-GENHCCKV 150
           +              + L S+C Q+ +G+QFL +R   IIHRDL   N+ I G     K+
Sbjct: 127 KI-------------KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173
Query: 151 ADFGFARDLMTSSVYERKSEGRLPI---RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTL 207
            D G A         +R S  +  I    + APE  Y+  +    D+++FG    E  T 
Sbjct: 174 GDLGLA-------TLKRASFAKAVIGTPEFXAPEX-YEEKYDESVDVYAFGXCXLEXAT- 224
Query: 208 GSTPYP 213
             + YP
Sbjct: 225 --SEYP 228

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 40/155 (25%)
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM-----QFL 125
            ++I +Y   G L  +L              KS +L ++ +    Y    G+     +  
Sbjct: 110 LYLITDYHENGSLYDYL--------------KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 126 SSRG---IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP-------I 175
           S++G   I HRDL ++N+L+ +N  C +AD G A   ++ +     +E  +P        
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT-----NEVDIPPNTRVGTK 210
Query: 176 RWMAP----ESLYDNIFS--VKSDIWSFGVLIWEI 204
           R+M P    ESL  N F   + +D++SFG+++WE+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 49  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 99
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 100 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 153
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 154 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 22/189 (11%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL    +E+   +++ + V  G+L   
Sbjct: 64  INTKKLSARDHQKLE--REARICRLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGEL--- 117
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--- 143
                A+ YY+            D +   +Q+   +  +    I+HRDL   N+L+    
Sbjct: 118 FEDIVAREYYSEA----------DASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKC 167
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    K+ADFG A ++           G     +++PE L  + +    DIW+ GV+++ 
Sbjct: 168 KGAAVKLADFGLAIEVQGEQQAWFGFAG--TPGYLSPEVLRKDPYGKPVDIWACGVILY- 224
Query: 204 IVTLGSTPY 212
           I+ +G  P+
Sbjct: 225 ILLVGYPPF 233

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 85/176 (48%), Gaps = 23/176 (13%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L+E+ +++ +  HPN+++L         FF++ + +  G+L  +L              +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-------------E 117
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
             +L+ ++       +   +  L    I+HRDL   N+L+ ++   K+ DFGF+  L   
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 163 SVYERKSEGRLPIRWMAPE----SLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPY 212
              + +S    P  ++APE    S+ DN   +  + D+WS GV+++ ++  GS P+
Sbjct: 178 E--KLRSVCGTP-SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPF 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR  R  R+ +  H +
Sbjct: 89  LNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF-SEPHAR 144
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTS 162
                      +  Q+    ++L S  +I+RDL   N+LI +    +V DFGFA      
Sbjct: 145 F----------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------ 188
Query: 163 SVYERKSEGRL-----PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA 217
               ++ +GR         ++AP  +    ++   D W+ GVLI+E+   G  P+     
Sbjct: 189 ----KRVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQP 243
Query: 218 AEVMKK 223
            ++ +K
Sbjct: 244 IQIYEK 249

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 50  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 100
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 101 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 154
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 155 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L   +             
Sbjct: 51  NIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------- 101
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
                +   D   F +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  + 
Sbjct: 102 -----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VF 155
Query: 161 TSSVYER---KSEGRLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
             +  ER   K  G LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 156 RYNNRERLLNKMCGTLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 25/172 (14%)
Query: 39  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 98
           R  +++EL V+   +  P +V   G         + ME++  G L   L+          
Sbjct: 67  RNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------- 115
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
              K+  +  + L      V +G+ +L  +  I+HRD+   N+L+      K+ DFG + 
Sbjct: 116 ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 172
Query: 158 DL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
            L   M +S    +S       +M+PE L    +SV+SDIWS G+ + E+  
Sbjct: 173 QLIDSMANSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAV 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 32/201 (15%)
Query: 26  AVKTLKENAGER---ERLDLLQELT-----VMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           AVK + E   ER   E+L+ ++E T     +++ +  HP+++ L+         F++ + 
Sbjct: 123 AVKIM-EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G+L  +L    A             L+ ++  S    +   + FL +  I+HRDL  
Sbjct: 182 MRKGELFDYLTEKVA-------------LSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228
Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI------FSVK 191
            N+L+ +N   +++DFGF+  L      E+  E      ++APE L  ++      +  +
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 192 SDIWSFGVLIWEIVTLGSTPY 212
            D+W+ GV+++ ++  GS P+
Sbjct: 286 VDLWACGVILFTLLA-GSPPF 305

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 46/197 (23%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKE-----PFFVIMEYVPYGKLQSFLRSSRAQRYY 96
           +L+E+ ++  L+ H +VV++L     K+       +V++E         F +  R   Y 
Sbjct: 99  ILREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYL 153
Query: 97  NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA 156
             +H K+            Y +  G++++ S GI+HRDL   N L+ ++   KV DFG A
Sbjct: 154 TELHIKT----------LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 157 R---------------------DLMT---SSVYERKSEGRLPIRWM-APE-SLYDNIFSV 190
           R                     +L+T   +   +R+  G +  RW  APE  L    ++ 
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 191 KSDIWSFGVLIWEIVTL 207
             D+WS G +  E++ +
Sbjct: 264 AIDVWSIGCIFAELLNM 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P VV+L     + +  +++MEY+P G L + + +      +                 + 
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--------------YT 180
Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            +V   +  + S G+IHRD+   N+L+ ++   K+ADFG    +  + +    +    P 
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP- 239
Query: 176 RWMAPESLY----DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML-VGDTPF 279

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 18/199 (9%)
Query: 17  RGREGPCIVAVK-TLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R +E   + AVK ++    G ++R   L E+   + +  HP  VRL     E    +   
Sbjct: 77  RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY--- 133
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
                  LQ+ L     Q++         SL    +  +       +  L S+G++H D+
Sbjct: 134 -------LQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183
Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+ +G    CK+ DFG   +L T+   E + EG    R+MAPE L    +   +D++
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGD--PRYMAPE-LLQGSYGTAADVF 239
Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G+ I E+      P+ G
Sbjct: 240 SLGLTILEVACNMELPHGG 258

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 25/200 (12%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R ++   +VAVK ++   GE+   ++ +E+   ++L  HPN+VR            ++ME
Sbjct: 39  RDKQSNELVAVKYIER--GEKIDENVKREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 95
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY-QVARGMQFLSSRGIIHRDL 135
           Y   G+L  F R   A R+            S D   F + Q+  G+ +  +  + HRDL
Sbjct: 96  YASGGEL--FERICNAGRF------------SEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 136 AARNVLIGENHC--CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-S 192
              N L+  +     K+  FG+++  +  S  + KS    P  ++APE L    +  K +
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHS--QPKSTVGTP-AYIAPEVLLKKEYDGKVA 198
Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D+WS GV ++ ++ +G+ P+
Sbjct: 199 DVWSCGVTLY-VMLVGAYPF 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/184 (22%), Positives = 83/184 (45%), Gaps = 25/184 (13%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           +E++++  +  H N++ L       E   +I E++    L  F R          ++  +
Sbjct: 50  KEISIL-NIARHRNILHLHESFESMEELVMIFEFI--SGLDIFER----------INTSA 96
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADFGFARDLMT 161
             L  R++ S+ +QV   +QFL S  I H D+   N++     +   K+ +FG AR L  
Sbjct: 97  FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 162 SSVYERKSEGRLPI---RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA 218
              +      RL      + APE    ++ S  +D+WS G L++ +++ G  P+      
Sbjct: 157 GDNF------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQ 209
Query: 219 EVMK 222
           ++++
Sbjct: 210 QIIE 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 13  MSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
           +S + G+E     AVK +++ AG   R  + +E+  +     + N++ L+    +   F+
Sbjct: 33  VSLQNGKE----YAVKIIEKQAG-HSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFY 87
Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           ++ E +  G   S L   + Q+++N           R+ +     VA  + FL ++GI H
Sbjct: 88  LVFEKLQGG---SILAHIQKQKHFNE----------REASRVVRDVAAALDFLHTKGIAH 134
Query: 133 RDLAARNVLIGENH---CCKVADF--GFARDLMTSSVYERKSEGRLP---IRWMAPESL- 183
           RDL   N+L          K+ DF  G    L  S       E   P     +MAPE + 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 184 ----YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
                   +  + D+WS GV+++ I+  G  P+ G   A+
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLY-IMLSGYPPFVGHCGAD 233

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 110
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--T 168
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 117
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++   ++ +   
Sbjct: 118 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSL 174
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +E      ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 175 TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 230

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E+ ++   D HPNV+R   C    + F  I   +    LQ  + S         +  +
Sbjct: 74  LMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-------------GENHCCK 149
            N +      S   Q+A G+  L S  IIHRDL  +N+L+              EN    
Sbjct: 133 YNPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 186
Query: 150 VADFGFARDLMTSSVYERKSEGRLP--IRWMAPESLYDNI---FSVKSDIWSFGVLIWEI 204
           ++DFG  + L +     R +         W APE L ++     +   DI+S G + + I
Sbjct: 187 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246
Query: 205 VTLGSTPY 212
           ++ G  P+
Sbjct: 247 LSKGKHPF 254

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E+ ++   D HPNV+R   C    + F  I   +    LQ  + S         +  +
Sbjct: 74  LMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-------------GENHCCK 149
            N +      S   Q+A G+  L S  IIHRDL  +N+L+              EN    
Sbjct: 133 YNPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 186
Query: 150 VADFGFARDLMTSSVYERKSEGRLP--IRWMAPESLYDNI---FSVKSDIWSFGVLIWEI 204
           ++DFG  + L +     R +         W APE L ++     +   DI+S G + + I
Sbjct: 187 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246
Query: 205 VTLGSTPY 212
           ++ G  P+
Sbjct: 247 LSKGKHPF 254

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 115
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 116 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG--T 173
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 210

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 110
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG--T 168
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 119
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 177
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 178 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 232

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 25/200 (12%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R ++   +VAVK ++   GE+   ++ +E+   ++L  HPN+VR            ++ME
Sbjct: 39  RDKQSNELVAVKYIER--GEKIDENVKREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 95
Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY-QVARGMQFLSSRGIIHRDL 135
           Y   G+L  F R   A R+            S D   F + Q+  G+ +  +  + HRDL
Sbjct: 96  YASGGEL--FERICNAGRF------------SEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 136 AARNVLIGENHC--CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-S 192
              N L+  +     K+  FG+++   +S ++ +  +      ++APE L    +  K +
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D+WS GV ++ ++ +G+ P+
Sbjct: 199 DVWSCGVTLY-VMLVGAYPF 217

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 110
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG--T 168
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 110
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG--T 168
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 110
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--T 168
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +           T      +
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVF-----------TEERARFY 113
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++   +++L SR +++RD+   N+++ ++   K+ DFG  ++ ++     +   G   
Sbjct: 114 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--T 171
Query: 175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 208

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 163
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 221
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 222 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 276

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           + AVK + + A + +   +  E+ V++ +  H N+V L          +++M+ V  G+L
Sbjct: 49  LFAVKCIPKKALKGKESSIENEIAVLRKI-KHENIVALEDIYESPNHLYLVMQLVSGGEL 107
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F R      Y           T +D ++   QV   + +L   GI+HRDL   N+L  
Sbjct: 108 --FDRIVEKGFY-----------TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYY 154
Query: 143 --GENHCCKVADFGFAR-----DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              E     ++DFG ++     D+M+++     + G     ++APE L    +S   D W
Sbjct: 155 SQDEESKIMISDFGLSKMEGKGDVMSTAC---GTPG-----YVAPEVLAQKPYSKAVDCW 206
Query: 196 SFGVLIWEIVTLGSTPY 212
           S GV+ + I+  G  P+
Sbjct: 207 SIGVIAY-ILLCGYPPF 222

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 169
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 170 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 227
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 228 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 282

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL    +E+   ++I + V  G+L   
Sbjct: 55  INTKKLSARDHQKLE--REARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGEL--- 108
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--- 143
                A+ YY+            D +    Q+   +      G++HRDL   N+L+    
Sbjct: 109 FEDIVAREYYSEA----------DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKL 158
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    K+ADFG A ++           G     +++PE L  + +    D+W+ GV+++ 
Sbjct: 159 KGAAVKLADFGLAIEVEGEQQAWFGFAG--TPGYLSPEVLRKDPYGKPVDLWACGVILY- 215
Query: 204 IVTLGSTPY 212
           I+ +G  P+
Sbjct: 216 ILLVGYPPF 224

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 117
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 118 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 175
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 176 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 230

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL    +E+   +++ + V  G+L   
Sbjct: 37  INTKKLSARDHQKLE--REARICRLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGEL--- 90
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--- 143
                A+ YY+            D +    Q+   +      GI+HRDL   N+L+    
Sbjct: 91  FEDIVAREYYSEA----------DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKS 140
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    K+ADFG A ++           G     +++PE L  + +    D+W+ GV+++ 
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFGFAGT--PGYLSPEVLRKDPYGKPVDMWACGVILY- 197
Query: 204 IVTLGSTPY 212
           I+ +G  P+
Sbjct: 198 ILLVGYPPF 206

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 119
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 177
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 178 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 232

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 118
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 119 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 176
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 177 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 231

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           H NVV+  G   E    ++ +EY   G+L   +                  +   D   F
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------------MPEPDAQRF 110
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYER---KSEG 171
            +Q+  G+ +L   GI HRD+   N+L+ E    K++DFG A  +   +  ER   K  G
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCG 169
Query: 172 RLPIRWMAPESLYDNIFSVKS-DIWSFGVLIWEIVTLGSTPY 212
            LP  ++APE L    F  +  D+WS G+++  ++  G  P+
Sbjct: 170 TLP--YVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPW 208

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           AVK +++  G   R  + +E+ ++     H NV+ L+    E++ F+++ E +  G + S
Sbjct: 42  AVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 86  FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI--- 142
            +     +R++N +     S+  +D       VA  + FL ++GI HRDL   N+L    
Sbjct: 101 HIHK---RRHFNELEA---SVVVQD-------VASALDFLHNKGIAHRDLKPENILCEHP 147
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRL-----PIRWMAPE-----SLYDNIFSVKS 192
            +    K+ DFG    +  +      S   L        +MAPE     S   +I+  + 
Sbjct: 148 NQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           D+WS GV+++ I+  G  P+ G   ++
Sbjct: 208 DLWSLGVILY-ILLSGYPPFVGRCGSD 233

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  HPN+VRL    +E+   +++ + V  G+L   
Sbjct: 37  INTKKLSARDHQKLE--REARICRLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGEL--- 90
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--- 143
                A+ YY          +  D +    Q+   +      GI+HRDL   N+L+    
Sbjct: 91  FEDIVAREYY----------SEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKS 140
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    K+ADFG A ++           G     +++PE L  + +    D+W+ GV+++ 
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFGFAGT--PGYLSPEVLRKDPYGKPVDMWACGVILY- 197
Query: 204 IVTLGSTPY 212
           I+ +G  P+
Sbjct: 198 ILLVGYPPF 206

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 133
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 134 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 191
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 192 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 246

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 124
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 125 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 182
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 183 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 237

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 123
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 124 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 181
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 182 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 236

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 59  LNVETEIEILKKLN-HPCIIKIKNF-FDAEDYYIVLELMEGGEL------------FDKV 104
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 105 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 163
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 164 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 60  LNVETEIEILKKLN-HPCIIKIKNF-FDAEDYYIVLELMEGGEL------------FDKV 105
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 106 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 165 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 56  PNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 111
           P++VR++         ++   ++ME +  G+L S ++    Q           + T R+ 
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREA 125
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLMTSSVYERK 168
           +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  T+S     
Sbjct: 126 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT 183
Query: 169 SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMK 222
           +    P  ++APE L    +    D+WS GV+++ I+  G  P+    G+A +  MK
Sbjct: 184 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMK 238

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP----IRWMAPESLY 184
            I HRDL ++N+L+ +N  C +AD G A  +M S    +   G  P     R+MAPE L 
Sbjct: 162 AIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 219
Query: 185 DNI----FSV--KSDIWSFGVLIWEI 204
           + I    F    + DIW+FG+++WE+
Sbjct: 220 ETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 15/194 (7%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           + G  +   K L EN  E   +  L+E+ +++ L  H NVV L+  C  K          
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKAS-------- 91
Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSL---TSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           PY + ++ +        ++     SN L   T  ++      +  G+ ++    I+HRD+
Sbjct: 92  PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 136 AARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLY--DNIFSVKS 192
            A NVLI  +   K+ADFG AR   +  +    +   R+   W  P  L   +  +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 193 DIWSFGVLIWEIVT 206
           D+W  G ++ E+ T
Sbjct: 212 DLWGAGCIMAEMWT 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 60  LNVETEIEILKKLN-HPCIIKIKNF-FDAEDYYIVLELMEGGEL------------FDKV 105
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 106 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 165 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 60  LNVETEIEILKKLN-HPCIIKIKNF-FDAEDYYIVLELMEGGEL------------FDKV 105
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 106 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 165 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP----IRWMAPESLY 184
            I HRDL ++N+L+ +N  C +AD G A  +M S    +   G  P     R+MAPE L 
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 185 DNI----FSV--KSDIWSFGVLIWEI 204
           + I    F    + DIW+FG+++WE+
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 66  LNVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGEL------------FDKV 111
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 112 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 170
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 171 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 22/159 (13%)
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             +IME +  G+L S ++    Q           + T R+       +   +QFL S  I
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQ-----------AFTEREAAEIMRDIGTAIQFLHSHNI 130
Query: 131 IHRDLAARNVLIG---ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI 187
            HRD+   N+L     ++   K+ DFGFA++   +++   ++    P  ++APE L    
Sbjct: 131 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPY-YVAPEVLGPEK 186
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMKK 223
           +    D+WS GV+++ I+  G  P+    G A +  MK+
Sbjct: 187 YDKSCDMWSLGVIMY-ILLCGFPPFYSNTGQAISPGMKR 224

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP----IRWMAPESLY 184
            I HRDL ++N+L+ +N  C +AD G A  +M S    +   G  P     R+MAPE L 
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 185 DNI----FSV--KSDIWSFGVLIWEI 204
           + I    F    + DIW+FG+++WE+
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPF------ 71
           + G  +   K L EN  E   +  L+E+ +++ L  H NVV L+  C T+  P+      
Sbjct: 40  KTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGS 98
Query: 72  -FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            +++ ++  +  L   L +   +             T  ++      +  G+ ++    I
Sbjct: 99  IYLVFDFCEHD-LAGLLSNVLVK------------FTLSEIKRVMQMLLNGLYYIHRNKI 145
Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLY--DNI 187
           +HRD+ A NVLI  +   K+ADFG AR   +  +    +   R+   W  P  L   +  
Sbjct: 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD 205
Query: 188 FSVKSDIWSFGVLIWEIVT 206
           +    D+W  G ++ E+ T
Sbjct: 206 YGPPIDLWGAGCIMAEMWT 224

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 22/159 (13%)
Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             +IME +  G+L S ++    Q           + T R+       +   +QFL S  I
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQ-----------AFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 131 IHRDLAARNVLIG---ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI 187
            HRD+   N+L     ++   K+ DFGFA++   +++   ++    P  ++APE L    
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPY-YVAPEVLGPEK 205
Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPY---PGMAAAEVMKK 223
           +    D+WS GV+++ I+  G  P+    G A +  MK+
Sbjct: 206 YDKSCDMWSLGVIMY-ILLCGFPPFYSNTGQAISPGMKR 243

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPF------ 71
           + G  +   K L EN  E   +  L+E+ +++ L  H NVV L+  C T+  P+      
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGS 99
Query: 72  -FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            +++ ++  +  L   L +   +             T  ++      +  G+ ++    I
Sbjct: 100 IYLVFDFCEHD-LAGLLSNVLVK------------FTLSEIKRVMQMLLNGLYYIHRNKI 146
Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLY--DNI 187
           +HRD+ A NVLI  +   K+ADFG AR   +  +    +   R+   W  P  L   +  
Sbjct: 147 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD 206
Query: 188 FSVKSDIWSFGVLIWEIVT 206
           +    D+W  G ++ E+ T
Sbjct: 207 YGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPF------ 71
           + G  +   K L EN  E   +  L+E+ +++ L  H NVV L+  C T+  P+      
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGS 99
Query: 72  -FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            +++ ++  +  L   L +   +             T  ++      +  G+ ++    I
Sbjct: 100 IYLVFDFCEHD-LAGLLSNVLVK------------FTLSEIKRVMQMLLNGLYYIHRNKI 146
Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLY--DNI 187
           +HRD+ A NVLI  +   K+ADFG AR   +  +    +   R+   W  P  L   +  
Sbjct: 147 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD 206
Query: 188 FSVKSDIWSFGVLIWEIVT 206
           +    D+W  G ++ E+ T
Sbjct: 207 YGPPIDLWGAGCIMAEMWT 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 29/192 (15%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E+ ++   D HPNV+R   C    + F  I   +    LQ  + S         +  +
Sbjct: 56  LMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-------------GENHCCK 149
            N +      S   Q+A G+  L S  IIHRDL  +N+L+              EN    
Sbjct: 115 YNPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 150 VADFGFARDLMT--SSVYERKSEGRLPIRWMAPESLYD-NIFSVKS------DIWSFGVL 200
           ++DFG  + L +  SS     +       W APE L + N    K       DI+S G +
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 201 IWEIVTLGSTPY 212
            + I++ G  P+
Sbjct: 229 FYYILSKGKHPF 240

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/190 (18%), Positives = 85/190 (44%), Gaps = 19/190 (10%)
Query: 38  ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 97
           ++  +  E+++M  L  HP ++ L     +K    +I+E++  G+L            ++
Sbjct: 91  DKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGEL------------FD 137
Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL--IGENHCCKVADFGF 155
            +  +   ++  ++ ++  Q   G++ +    I+H D+   N++    +    K+ DFG 
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           A  L    + +  +       + APE +        +D+W+ GVL + +++ G +P+ G 
Sbjct: 198 ATKLNPDEIVKVTTAT---AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGE 253
Query: 216 AAAEVMKKSK 225
              E ++  K
Sbjct: 254 DDLETLQNVK 263

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 43/210 (20%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT-LDPHPNVVRLLGCCTEKE----PF 71
           RG E    VAVK        RE     +E  + +T +  H N++  +    +        
Sbjct: 31  RGEE----VAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 82
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG-----MQFLS 126
           +++ +Y  +G L  +L      RY         ++T   +       A G     M+ + 
Sbjct: 83  WLVSDYHEHGSLFDYL-----NRY---------TVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 127 SRG---IIHRDLAARNVLIGENHCCKVADFGFA--RDLMTSSVYERKSEGRLPIRWMAPE 181
           ++G   I HRDL ++N+L+ +N  C +AD G A   D  T ++    +      R+MAPE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 182 SLYDNI----FSV--KSDIWSFGVLIWEIV 205
            L D+I    F    ++DI++ G++ WEI 
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT-LDPHPNVVRLLGCCTEKE----PF 71
           RG E    VAVK        RE     +E  + +T +  H N++  +    +        
Sbjct: 28  RGEE----VAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 79
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG-----MQFLS 126
           +++ +Y  +G L  +L      RY         ++T   +       A G     M+ + 
Sbjct: 80  WLVSDYHEHGSLFDYL-----NRY---------TVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 127 SRG---IIHRDLAARNVLIGENHCCKVADFGFA--RDLMTSSVYERKSEGRLPIRWMAPE 181
           ++G   I HRDL ++N+L+ +N  C +AD G A   D  T ++    +      R+MAPE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 182 SLYDNI----FSV--KSDIWSFGVLIWEI 204
            L D+I    F    ++DI++ G++ WEI
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 34/183 (18%)
Query: 49  MKTLDPHPNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 104
           M  L  HPN++RL+  C      K   ++++ +   G L + +           +  K N
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE---------RLKDKGN 129
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSV 164
            LT   +      + RG++ + ++G  HRDL   N+L+G+     + D G          
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 165 YERK-------SEGRLPIRWMAPESLYDNIFSVKS--------DIWSFGVLIWEIVTLGS 209
             R+       +  R  I + APE     +FSV+S        D+WS G +++ ++  G 
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMM-FGE 243
Query: 210 TPY 212
            PY
Sbjct: 244 GPY 246

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 43/210 (20%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT-LDPHPNVVRLLGCCTEKE----PF 71
           RG E    VAVK        RE     +E  + +T +  H N++  +    +        
Sbjct: 64  RGEE----VAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG-----MQFLS 126
           +++ +Y  +G L  +L      RY         ++T   +       A G     M+ + 
Sbjct: 116 WLVSDYHEHGSLFDYL-----NRY---------TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 127 SRG---IIHRDLAARNVLIGENHCCKVADFGFA--RDLMTSSVYERKSEGRLPIRWMAPE 181
           ++G   I HRDL ++N+L+ +N  C +AD G A   D  T ++    +      R+MAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 182 SLYDNI----FSV--KSDIWSFGVLIWEIV 205
            L D+I    F    ++DI++ G++ WEI 
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT-LDPHPNVVRLLGCCTEKE----PF 71
           RG E    VAVK        RE     +E  + +T +  H N++  +    +        
Sbjct: 51  RGEE----VAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 102
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG-----MQFLS 126
           +++ +Y  +G L  +L      RY         ++T   +       A G     M+ + 
Sbjct: 103 WLVSDYHEHGSLFDYL-----NRY---------TVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 127 SRG---IIHRDLAARNVLIGENHCCKVADFGFA--RDLMTSSVYERKSEGRLPIRWMAPE 181
           ++G   I HRDL ++N+L+ +N  C +AD G A   D  T ++    +      R+MAPE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 182 SLYDNI----FSV--KSDIWSFGVLIWEI 204
            L D+I    F    ++DI++ G++ WEI
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT-LDPHPNVVRLLGCCTEKE----PF 71
           RG E    VAVK        RE     +E  + +T +  H N++  +    +        
Sbjct: 26  RGEE----VAVKIF----SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 77
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG-----MQFLS 126
           +++ +Y  +G L  +L      RY         ++T   +       A G     M+ + 
Sbjct: 78  WLVSDYHEHGSLFDYL-----NRY---------TVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 127 SRG---IIHRDLAARNVLIGENHCCKVADFGFA--RDLMTSSVYERKSEGRLPIRWMAPE 181
           ++G   I HRDL ++N+L+ +N  C +AD G A   D  T ++    +      R+MAPE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 182 SLYDNI----FSV--KSDIWSFGVLIWEI 204
            L D+I    F    ++DI++ G++ WEI
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 46/86 (53%), Gaps = 12/86 (13%)
Query: 129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP----IRWMAPESLY 184
            I HRD  +RNVL+  N  C +AD G A  +M S   +    G  P     R+MAPE L 
Sbjct: 133 AIAHRDFKSRNVLVKSNLQCCIADLGLA--VMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 185 DNIFS------VKSDIWSFGVLIWEI 204
           + I +        +DIW+FG+++WEI
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 20/189 (10%)
Query: 29  TLKENAGERERLDLLQELTVMKTLDPHPNVVRL--LGCCTEKEPFFVIMEYVPYG--KLQ 84
            LK+  G    +   +E+ +++ L  HPNV+ L  +         +++ +Y  +    + 
Sbjct: 52  ALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F R+S+A +       K   L    + S  YQ+  G+ +L +  ++HRDL   N+L+  
Sbjct: 111 KFHRASKANK-------KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMG 163
Query: 143 --GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR--WMAPESLYDNIFSVKS-DIWSF 197
              E    K+AD GFAR L  S +        + +   + APE L       K+ DIW+ 
Sbjct: 164 EGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222
Query: 198 GVLIWEIVT 206
           G +  E++T
Sbjct: 223 GCIFAELLT 231

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT-LDPHPNVVRLLGCCTEKE----PF 71
           RG E    VAVK        RE     +E  + +T +  H N++  +    +        
Sbjct: 25  RGEE----VAVKIF----SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76
Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG-----MQFLS 126
           +++ +Y  +G L  +L      RY         ++T   +       A G     M+ + 
Sbjct: 77  WLVSDYHEHGSLFDYL-----NRY---------TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 127 SRG---IIHRDLAARNVLIGENHCCKVADFGFA--RDLMTSSVYERKSEGRLPIRWMAPE 181
           ++G   I HRDL ++N+L+ +N  C +AD G A   D  T ++    +      R+MAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 182 SLYDNI----FSV--KSDIWSFGVLIWEI 204
            L D+I    F    ++DI++ G++ WEI
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 77/192 (40%), Gaps = 29/192 (15%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 102
           L E+ ++   D HPNV+R   C    + F  I   +    LQ  + S         +  +
Sbjct: 56  LMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 103 SNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-------------GENHCCK 149
            N +      S   Q+A G+  L S  IIHRDL  +N+L+              EN    
Sbjct: 115 YNPI------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 150 VADFGFARDLMTSSVYERKSEGRLPIR--WMAPESLYD-NIFSVKS------DIWSFGVL 200
           ++DFG  + L +     R +         W APE L + N    K       DI+S G +
Sbjct: 169 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 201 IWEIVTLGSTPY 212
            + I++ G  P+
Sbjct: 229 FYYILSKGKHPF 240

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 115
           P VV+L     +    +++MEY+P G L + + +      +                 + 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--------------YT 179
Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            +V   +  + S G IHRD+   N+L+ ++   K+ADFG    +    +    +    P 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP- 238
Query: 176 RWMAPESLY----DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
            +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 28/165 (16%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS----SRAQRYYNNMHGKSNSLTSRDL 111
           P VV+L     +    +++MEY+P G L + + +     +  R+Y               
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--------------- 178
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEG 171
                +V   +  + S G IHRD+   N+L+ ++   K+ADFG    +    +    +  
Sbjct: 179 ---TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 172 RLPIRWMAPESLY----DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             P  +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 236 GTP-DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPF 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 185 LNVETEIEILKKLN-HPCIIKIKNF-FDAEDYYIVLELMEGGEL------------FDKV 230
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 231 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 290 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 344

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 28/165 (16%)
Query: 56  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS----SRAQRYYNNMHGKSNSLTSRDL 111
           P VV+L     +    +++MEY+P G L + + +     +  R+Y               
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--------------- 173
Query: 112 TSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEG 171
                +V   +  + S G IHRD+   N+L+ ++   K+ADFG    +    +    +  
Sbjct: 174 ---TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 172 RLPIRWMAPESLY----DNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             P  +++PE L     D  +  + D WS GV ++E++ +G TP+
Sbjct: 231 GTP-DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPF 273

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 25/179 (13%)
Query: 40  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 99
           L++  E+ ++K L+ HP ++++     + E +++++E +  G+L            ++ +
Sbjct: 199 LNVETEIEILKKLN-HPCIIKIKNF-FDAEDYYIVLELMEGGEL------------FDKV 244
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFA 156
            G +  L       + YQ+   +Q+L   GIIHRDL   NVL+    E+   K+ DFG +
Sbjct: 245 VG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 303
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           + L  +S+   ++    P  ++APE L       ++   D WS GV+++ I   G  P+
Sbjct: 304 KILGETSLM--RTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 358

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 82/183 (44%), Gaps = 22/183 (12%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           QE+ +MK+LD HPN++RL     +    +++ME    G+L   +   R  R  +      
Sbjct: 55  QEIEIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK 113
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARDLM 160
           + L++    ++C+++           + HRDL   N L      +   K+ DFG A    
Sbjct: 114 DVLSA---VAYCHKL----------NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
Query: 161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
              +   K        +++P+ L + ++  + D WS GV+++ ++  G  P+      EV
Sbjct: 161 PGKMMRTKVGTPY---YVSPQVL-EGLYGPECDEWSAGVMMY-VLLCGYPPFSAPTDXEV 215
Query: 221 MKK 223
           M K
Sbjct: 216 MLK 218

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+E   ++ + T K +A + ++L+  +E  + + L  HPN+VRL    +E+   ++I + 
Sbjct: 36  GQEYAAMI-INTKKLSARDHQKLE--REARICRLLK-HPNIVRLHDSISEEGHHYLIFDL 91
Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V  G+L        A+ YY+            D +    Q+   +      G++HR+L  
Sbjct: 92  VTGGEL---FEDIVAREYYSEA----------DASHCIQQILEAVLHCHQMGVVHRNLKP 138
Query: 138 RNVLIG---ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
            N+L+    +    K+ADFG A ++           G     +++PE L  + +    D+
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG--YLSPEVLRKDPYGKPVDL 196
Query: 195 WSFGVLIWEIVTLGSTPY 212
           W+ GV+++ I+ +G  P+
Sbjct: 197 WACGVILY-ILLVGYPPF 213

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 82/183 (44%), Gaps = 22/183 (12%)
Query: 44  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 103
           QE+ +MK+LD HPN++RL     +    +++ME    G+L   +   R  R  +      
Sbjct: 72  QEIEIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK 130
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARDLM 160
           + L++    ++C+++           + HRDL   N L      +   K+ DFG A    
Sbjct: 131 DVLSA---VAYCHKL----------NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 177
Query: 161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
              +   K        +++P+ L + ++  + D WS GV+++ ++  G  P+      EV
Sbjct: 178 PGKMMRTKVGTPY---YVSPQVL-EGLYGPECDEWSAGVMMY-VLLCGYPPFSAPTDXEV 232
Query: 221 MKK 223
           M K
Sbjct: 233 MLK 235

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 40/213 (18%)
Query: 23  CIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           CI A+K  K+  AG  +  + L+E+     L  H +VVR      E +   +  EY   G
Sbjct: 33  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 92
Query: 82  KLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            L   +  + R   Y+             +L     QV RG++++ S  ++H D+   N+
Sbjct: 93  SLADAISENYRIMSYFKEA----------ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 142
Query: 141 LIGENHC-------------------CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
            I                         K+ D G    + +  V E  S      R++A E
Sbjct: 143 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS------RFLANE 196
Query: 182 SLYDNIFSV-KSDIWSFGVLIWEIVTLGSTPYP 213
            L +N   + K+DI++  + +  +   G+ P P
Sbjct: 197 VLQENYTHLPKADIFALALTV--VXAAGAEPLP 227

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 40/213 (18%)
Query: 23  CIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           CI A+K  K+  AG  +  + L+E+     L  H +VVR      E +   +  EY   G
Sbjct: 37  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96
Query: 82  KLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            L   +  + R   Y+             +L     QV RG++++ S  ++H D+   N+
Sbjct: 97  SLADAISENYRIMSYFKEA----------ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 146
Query: 141 LIGENHC-------------------CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
            I                         K+ D G    + +  V E  S      R++A E
Sbjct: 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS------RFLANE 200
Query: 182 SLYDNIFSV-KSDIWSFGVLIWEIVTLGSTPYP 213
            L +N   + K+DI++  + +  +   G+ P P
Sbjct: 201 VLQENYTHLPKADIFALALTV--VCAAGAEPLP 231

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 2/93 (2%)
Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  Q+  G++ L  R II+RDL   NVL+ ++   +++D G A +L       +   G  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT- 352
Query: 174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
              +MAPE L    +    D ++ GV ++E++ 
Sbjct: 353 -PGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 17  RGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R +      AVK L++ A   ++E   ++ E  V+     HP +V L       +  + +
Sbjct: 58  RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117
Query: 75  MEYVPYGKLQSFLRSSRA-----QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
           ++Y+  G+L   L+  R       R+Y                    ++A  + +L S  
Sbjct: 118 LDYINGGELFYHLQRERCFLEPRARFY------------------AAEIASALGYLHSLN 159
Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLM----TSSVYERKSEGRLPIRWMAPESLYD 185
           I++RDL   N+L+       + DFG  ++ +    T+S +    E      ++APE L+ 
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE------YLAPEVLHK 213
Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
             +    D W  G +++E++  G  P+     AE+
Sbjct: 214 QPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEM 247

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 2/93 (2%)
Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  Q+  G++ L  R II+RDL   NVL+ ++   +++D G A +L       +   G  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT- 352
Query: 174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
              +MAPE L    +    D ++ GV ++E++ 
Sbjct: 353 -PGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 40/213 (18%)
Query: 23  CIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           CI A+K  K+  AG  +  + L+E+     L  H +VVR      E +   +  EY   G
Sbjct: 35  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 94
Query: 82  KLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            L   +  + R   Y+             +L     QV RG++++ S  ++H D+   N+
Sbjct: 95  SLADAISENYRIMSYFKEA----------ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 144
Query: 141 LIGENHC-------------------CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
            I                         K+ D G    + +  V E  S      R++A E
Sbjct: 145 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS------RFLANE 198
Query: 182 SLYDNIFSV-KSDIWSFGVLIWEIVTLGSTPYP 213
            L +N   + K+DI++  + +  +   G+ P P
Sbjct: 199 VLQENYTHLPKADIFALALTV--VCAAGAEPLP 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 2/93 (2%)
Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  Q+  G++ L  R II+RDL   NVL+ ++   +++D G A +L       +   G  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT- 352
Query: 174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
              +MAPE L    +    D ++ GV ++E++ 
Sbjct: 353 -PGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 40/213 (18%)
Query: 23  CIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           CI A+K  K+  AG  +  + L+E+     L  H +VVR      E +   +  EY   G
Sbjct: 35  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 94
Query: 82  KLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
            L   +  + R   Y+             +L     QV RG++++ S  ++H D+   N+
Sbjct: 95  SLADAISENYRIMSYFKEA----------ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 144
Query: 141 LIGENHC-------------------CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
            I                         K+ D G    + +  V E  S      R++A E
Sbjct: 145 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS------RFLANE 198
Query: 182 SLYDNIFSV-KSDIWSFGVLIWEIVTLGSTPYP 213
            L +N   + K+DI++  + +  +   G+ P P
Sbjct: 199 VLQENYTHLPKADIFALALTV--VCAAGAEPLP 229

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 2/93 (2%)
Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  Q+  G++ L  R II+RDL   NVL+ ++   +++D G A +L       +   G  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT- 352
Query: 174 PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT 206
              +MAPE L    +    D ++ GV ++E++ 
Sbjct: 353 -PGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           V V+ +   A   E +  LQ EL V K  + HPN+V            +V+  ++ YG  
Sbjct: 39  VTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSA 97
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           +  +       + + M    N L    +      V + + ++   G +HR + A ++LI 
Sbjct: 98  KDLI----CTHFMDGM----NELA---IAYILQGVLKALDYIHHMGYVHRSVKASHILIS 146
Query: 144 ENHCCKVADFGFARDLMTSSVYERK---------SEGRLPIRWMAPESLYDNI--FSVKS 192
            +   KV   G   +L   S  +R+         S   LP  W++PE L  N+  +  KS
Sbjct: 147 VD--GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKS 202
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           DI+S G+   E+   G  P+  M A +++
Sbjct: 203 DIYSVGITACELAN-GHVPFKDMPATQML 230

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 26  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 85
           AVK +++  G   R  + +E+ ++     H NV+ L+    E++ F+++ E +  G + S
Sbjct: 42  AVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 86  FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI--- 142
            +     +R++N +     S+  +D       VA  + FL ++GI HRDL   N+L    
Sbjct: 101 HIHK---RRHFNELEA---SVVVQD-------VASALDFLHNKGIAHRDLKPENILCEHP 147
Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRL-----PIRWMAPE-----SLYDNIFSVKS 192
            +    K+ DF     +  +      S   L        +MAPE     S   +I+  + 
Sbjct: 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           D+WS GV+++ I+  G  P+ G   ++
Sbjct: 208 DLWSLGVILY-ILLSGYPPFVGRCGSD 233

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 27  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 86
           + T K +A + ++L+  +E  + + L  H N+VRL    +E+   +++ + V  G+L   
Sbjct: 37  INTKKLSARDHQKLE--REARICRLLK-HSNIVRLHDSISEEGFHYLVFDLVTGGEL--- 90
Query: 87  LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--- 143
                A+ YY+            D +    Q+   +      G++HRDL   N+L+    
Sbjct: 91  FEDIVAREYYSEA----------DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKC 140
Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    K+ADFG A ++           G     +++PE L    +    DIW+ GV+++ 
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFGFAG--TPGYLSPEVLRKEAYGKPVDIWACGVILY- 197
Query: 204 IVTLGSTPY 212
           I+ +G  P+
Sbjct: 198 ILLVGYPPF 206

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 54/123 (43%), Gaps = 21/123 (17%)
Query: 106 LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL------ 159
           LT   + +  Y +  G  F+   GIIHRDL   N L+ ++   KV DFG AR +      
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 160 -MTSSVYERKSEG------------RLPIRWM-APE-SLYDNIFSVKSDIWSFGVLIWEI 204
            + + + E +  G             +  RW  APE  L    ++   DIWS G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 205 VTL 207
           + +
Sbjct: 246 LNM 248

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 25  VAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           V V+ +   A   E +  LQ EL V K  + HPN+V            +V+  ++ YG  
Sbjct: 55  VTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSA 113
Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           +  +       + + M    N L    +      V + + ++   G +HR + A ++LI 
Sbjct: 114 KDLI----CTHFMDGM----NELA---IAYILQGVLKALDYIHHMGYVHRSVKASHILIS 162
Query: 144 ENHCCKVADFGFARDLMTSSVYERK---------SEGRLPIRWMAPESLYDNI--FSVKS 192
            +   KV   G   +L   S  +R+         S   LP  W++PE L  N+  +  KS
Sbjct: 163 VD--GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKS 218
Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           DI+S G+   E+   G  P+  M A +++
Sbjct: 219 DIYSVGITACELAN-GHVPFKDMPATQML 246

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL---QSFLRSSRAQRYYNN 98
           +L+E+ ++     HPN++ L          FV  E     KL      +R+  AQ     
Sbjct: 76  VLREIRLLNHFH-HPNILGL-------RDIFVHFEEPAMHKLYLVTELMRTDLAQV---- 123
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD 158
           +H +   ++ + +  F Y +  G+  L   G++HRDL   N+L+ +N+   + DF  AR+
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEI 204
                  +      +  RW  APE +     F+   D+WS G ++ E+
Sbjct: 184 ----DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL---QSFLRSSRAQRYYNN 98
           +L+E+ ++     HPN++ L          FV  E     KL      +R+  AQ     
Sbjct: 76  VLREIRLLNHFH-HPNILGL-------RDIFVHFEEPAMHKLYLVTELMRTDLAQV---- 123
Query: 99  MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD 158
           +H +   ++ + +  F Y +  G+  L   G++HRDL   N+L+ +N+   + DF  AR+
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 159 LMTSSVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEI 204
                  +      +  RW  APE +     F+   D+WS G ++ E+
Sbjct: 184 ----DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 16  ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           ++G + P   A+K LK+   ++    +  E+ V+  L  HPN+++L           +++
Sbjct: 74  QKGTQKP--YALKVLKKTVDKK---IVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVL 127
Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E V  G+L  F R      Y           + RD      Q+   + +L   GI+HRDL
Sbjct: 128 ELVTGGEL--FDRIVEKGYY-----------SERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 136 AARNVLIGE---NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
              N+L      +   K+ADFG ++ ++   V  +   G     + APE L    +  + 
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGT--PGYCAPEILRGCAYGPEV 231
Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           D+WS G++ + I+  G  P+
Sbjct: 232 DMWSVGIITY-ILLCGFEPF 250

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 37/188 (19%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPF--FVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++E  V+K L+ H N+V+L     E       +IME+ P G L + L         +N +
Sbjct: 55  MREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP------SNAY 107
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL--IGEN--HCCKVADFGFA 156
           G    L   +       V  GM  L   GI+HR++   N++  IGE+     K+ DFG A
Sbjct: 108 G----LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 157 RDLMTS----SVYERKSEGRLPIRWMAPESL--------YDNIFSVKSDIWSFGVLIWEI 204
           R+L       S+Y  +        ++ P+          +   +    D+WS GV  +  
Sbjct: 164 RELEDDEQFVSLYGTE-------EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 205 VTLGSTPY 212
            T GS P+
Sbjct: 217 AT-GSLPF 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 41  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL-QSFLRSSRAQRYYNNM 99
           DL +E ++   L  HP++V LL   +     +++ E++    L    ++ + A   Y   
Sbjct: 72  DLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--- 127
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHC-CKVADFGFA 156
              S ++ S     +  Q+   +++     IIHRD+   NVL+   EN    K+ DFG A
Sbjct: 128 ---SEAVASH----YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA 180
Query: 157 RDLMTSSVYERKSEGRLPI-RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
             L  S +    + GR+    +MAPE +    +    D+W  GV+++ I+  G  P+ G
Sbjct: 181 IQLGESGLV---AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF-ILLSGCLPFYG 235

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NVLI   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           E   +  +K +K+N  +RE       + +++ L   PN++ L      K+P    +   P
Sbjct: 63  EKVVVKILKPVKKNKIKRE-------IKILENLRGGPNIITLADIV--KDP----VSRTP 109
Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
               +    +   Q Y         +LT  D+  + Y++ + + +  S GI+HRD+   N
Sbjct: 110 ALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 161
Query: 140 VLIGENH-CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSF 197
           V+I   H   ++ D+G A        Y  +   R    +  PE L D  ++    D+WS 
Sbjct: 162 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---FKGPELLVDYQMYDYSLDMWSL 218
Query: 198 GVLIWEIV 205
           G ++  ++
Sbjct: 219 GCMLASMI 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 39/189 (20%)
Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPF--FVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
           ++E  V+K L+ H N+V+L     E       +IME+ P G L + L         +N +
Sbjct: 55  MREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP------SNAY 107
Query: 101 GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL--IGEN--HCCKVADFGFA 156
           G    L   +       V  GM  L   GI+HR++   N++  IGE+     K+ DFG A
Sbjct: 108 G----LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNI-------------FSVKSDIWSFGVLIWE 203
           R+L        + + +    +   E L+ ++             +    D+WS GV  + 
Sbjct: 164 REL--------EDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
Query: 204 IVTLGSTPY 212
             T GS P+
Sbjct: 216 AAT-GSLPF 223

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 7/112 (6%)
Query: 104 NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARDLM 160
            + T R+ +     +   +Q+L S  I HRD+   N+L      N   K+ DFGFA++  
Sbjct: 156 QAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-- 213
Query: 161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
           T+S     +    P  ++APE L    +    D WS GV+ + I+  G  P+
Sbjct: 214 TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWSLGVIXY-ILLCGYPPF 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 42  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR--YYNNM 99
           +L E+ ++ +L+ H  VVR      E+  F      V   K   F++    +    Y+ +
Sbjct: 49  ILSEVXLLASLN-HQYVVRYYAAWLERRNFVKPXTAVK-KKSTLFIQXEYCENRTLYDLI 106
Query: 100 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL 159
           H ++ +    +      Q+   + ++ S+GIIHR+L   N+ I E+   K+ DFG A+++
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 160 MTSSVYERKSEGRLP------------IRWMAPESLYDNI--FSVKSDIWSFGVLIWEIV 205
             S    +     LP              ++A E L D    ++ K D +S G++ +E +
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVL-DGTGHYNEKIDXYSLGIIFFEXI 225
Query: 206 TLGSTPYPGMAAAEVMKK 223
              ST   G     ++KK
Sbjct: 226 YPFST---GXERVNILKK 240

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 132 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 191
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 192 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 231

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 185 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 186 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 186 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLMTSS 163
           +LT  D+  + Y++ + + +  S GI+HRD+   NV+I   H   ++ D+G A       
Sbjct: 127 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 164 VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIV 205
            Y  +   R    +  PE L D  ++    D+WS G ++  ++
Sbjct: 187 EYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/100 (24%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  ++  G++ L    I++RDL   N+L+ ++   +++D G A  +          +GR+
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----KGRV 346
Query: 174 -PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             + +MAPE + +  ++   D W+ G L++E++  G +P+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPF 385

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/100 (24%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL 173
           +  ++  G++ L    I++RDL   N+L+ ++   +++D G A  +          +GR+
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----KGRV 346
Query: 174 -PIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             + +MAPE + +  ++   D W+ G L++E++  G +P+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPF 385

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 35/172 (20%)
Query: 55  HPNVVRLLGC----CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 110
           H N+++ +G      +     ++I  +   G L  FL              K+N ++  +
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--------------KANVVSWNE 122
Query: 111 LTSFCYQVARGMQFLSSR----------GIIHRDLAARNVLIGENHCCKVADFGFARDLM 160
           L      +ARG+ +L              I HRD+ ++NVL+  N    +ADFG A    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF- 181
Query: 161 TSSVYERKSEGRLPI-RWMAPESLYDNI-FS----VKSDIWSFGVLIWEIVT 206
            +      + G++   R+MAPE L   I F     ++ D+++ G+++WE+ +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +            S D   F
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVF------------SEDRARF 112
Query: 115 C-YQVARGMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
              ++   + +L S + +++RDL   N+++ ++   K+ DFG  ++ +      +   G 
Sbjct: 113 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG- 171
Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 172 -TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +            S D   F
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVF------------SEDRARF 113
Query: 115 C-YQVARGMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
              ++   + +L S + +++RDL   N+++ ++   K+ DFG  ++ +      +   G 
Sbjct: 114 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG- 172
Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 173 -TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 210

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/162 (22%), Positives = 68/162 (41%), Gaps = 25/162 (15%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           H NVV  +G C       +I        L S +R ++              L        
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI------------VLDVNKTRQI 135
Query: 115 CYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP 174
             ++ +GM +L ++GI+H+DL ++NV   +N    + DFG            R+ + R+ 
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 175 -----------IRWMAPESLYDNI-FSVKSDIWSFGVLIWEI 204
                      IR ++P++  D + FS  SD+++ G + +E+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +            S D   F
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVF------------SEDRARF 114
Query: 115 -CYQVARGMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
              ++   + +L S + +++RDL   N+++ ++   K+ DFG  ++ +      +   G 
Sbjct: 115 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG- 173
Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 174 -TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 211

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 2   DCFSVEVRKHPMSPERGREGPC-----------IVAVKTLKENAGERERLDLLQ-ELTVM 49
           +C SV+ R + +  + G  G             I A+K +     + + LD  + E+  +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 50  KTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 108
             L  H + ++RL       +  +++ME      L S+L+             K  S+  
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK-------------KKKSIDP 107
Query: 109 RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM--TSSVYE 166
            +  S+   +   +  +   GI+H DL   N LI +    K+ DFG A  +   T+SV +
Sbjct: 108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 166
Query: 167 RKSEGRLPIRWMAPESLYDNIFSVKS-----------DIWSFGVLIWEIVTLGSTPY 212
               G   + +M PE++ D   S ++           D+WS G +++  +T G TP+
Sbjct: 167 DSQVGT--VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-YMTYGKTPF 220

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +            S D   F
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVF------------SEDRARF 252
Query: 115 -CYQVARGMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
              ++   + +L S + +++RDL   N+++ ++   K+ DFG  ++ +      +   G 
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG- 311
Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 312 -TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 349

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/235 (21%), Positives = 95/235 (40%), Gaps = 40/235 (17%)
Query: 2   DCFSVEVRKHPMSPERGREGPC-----------IVAVKTLKENAGERERLDLLQ-ELTVM 49
           +C SV+ R + +  + G  G             I A+K +     + + LD  + E+  +
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 50  KTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 108
             L  H + ++RL       +  +++ME      L S+L+             K  S+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK-------------KKKSIDP 154
Query: 109 RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERK 168
            +  S+   +   +  +   GI+H DL   N LI +    K+ DFG A  +   +    K
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 213
Query: 169 SEGRLPIRWMAPESLYDNIFSVKS-----------DIWSFGVLIWEIVTLGSTPY 212
                 + +M PE++ D   S ++           D+WS G +++  +T G TP+
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-YMTYGKTPF 267

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
           HP +  L       +    +MEY   G+L  F   SR + +            S D   F
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVF------------SEDRARF 255
Query: 115 -CYQVARGMQFL-SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
              ++   + +L S + +++RDL   N+++ ++   K+ DFG  ++ +      +   G 
Sbjct: 256 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG- 314
Query: 173 LPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               ++APE L DN +    D W  GV+++E++  G  P+
Sbjct: 315 -TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 352

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 2   DCFSVEVRKHPMSPERGREGPC-----------IVAVKTLKENAGERERLDLLQ-ELTVM 49
           +C SV+ R + +  + G  G             I A+K +     + + LD  + E+  +
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 50  KTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 108
             L  H + ++RL       +  +++ME      L S+L+             K  S+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK-------------KKKSIDP 154
Query: 109 RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM--TSSVYE 166
            +  S+   +   +  +   GI+H DL   N LI +    K+ DFG A  +   T+SV +
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 213
Query: 167 RKSEGRLPIRWMAPESLYDNIFSVKS-----------DIWSFGVLIWEIVTLGSTPY 212
               G   + +M PE++ D   S ++           D+WS G +++  +T G TP+
Sbjct: 214 DSQVGT--VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-YMTYGKTPF 267

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 24/126 (19%)
Query: 106 LTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT---- 161
           LT + + +  Y +  G +F+   GIIHRDL   N L+ ++   K+ DFG AR + +    
Sbjct: 128 LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDI 187
Query: 162 ------------------SSVYERKSEGRLPIRWM-APE-SLYDNIFSVKSDIWSFGVLI 201
                             +   +++    +  RW  APE  L    ++   DIWS G + 
Sbjct: 188 HIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIF 247
Query: 202 WEIVTL 207
            E++ +
Sbjct: 248 AELLNM 253

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 2   DCFSVEVRKHPMSPERGREGPC-----------IVAVKTLKENAGERERLDLLQ-ELTVM 49
           +C SV+ R + +  + G  G             I A+K +     + + LD  + E+  +
Sbjct: 5   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 50  KTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 108
             L  H + ++RL       +  +++ME      L S+L+             K  S+  
Sbjct: 65  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK-------------KKKSIDP 110
Query: 109 RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM--TSSVYE 166
            +  S+   +   +  +   GI+H DL   N LI +    K+ DFG A  +   T+SV +
Sbjct: 111 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 169
Query: 167 RKSEGRLPIRWMAPESLYDNIFSVKS-----------DIWSFGVLIWEIVTLGSTPY 212
               G   + +M PE++ D   S ++           D+WS G +++  +T G TP+
Sbjct: 170 DSQVGT--VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-YMTYGKTPF 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 2   DCFSVEVRKHPMSPERGREGPC-----------IVAVKTLKENAGERERLDLLQ-ELTVM 49
           +C SV+ R + +  + G  G             I A+K +     + + LD  + E+  +
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 50  KTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 108
             L  H + ++RL       +  +++ME      L S+L+             K  S+  
Sbjct: 61  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK-------------KKKSIDP 106
Query: 109 RDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM--TSSVYE 166
            +  S+   +   +  +   GI+H DL   N LI +    K+ DFG A  +   T+SV +
Sbjct: 107 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 165
Query: 167 RKSEGRLPIRWMAPESLYDNIFSVKS-----------DIWSFGVLIWEIVTLGSTPY 212
               G   + +M PE++ D   S ++           D+WS G +++  +T G TP+
Sbjct: 166 DSQVGT--VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-YMTYGKTPF 219
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	225
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-121
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-120
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-120
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-120
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-120
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-120
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-119
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-119
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-119
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-116
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-112
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-112
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-111
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-110
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-110
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-109
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-109
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-108
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-105
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-104
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-103
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-103
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-102
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-100
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-99
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-99
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-98
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-98
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-94
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-93
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-93
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-92
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-92
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-91
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-89
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-89
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-88
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-85
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-85
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-69
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-67
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-55
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-40
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-39
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-27
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-25
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  345 bits (887), Expect = e-121
 Identities = 97/218 (44%), Positives = 142/218 (65%), Gaps = 12/218 (5%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +GR G   VAVK LKENA   E  DLL E  V+K ++ HP+V++L G C++  P  +I+E
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVE 106

Query: 77  YVPYGKLQSFLRSSR-----------AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 125
           Y  YG L+ FLR SR           ++   +  H    +LT  DL SF +Q+++GMQ+L
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166

Query: 126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD 185
           +   ++HRDLAARN+L+ E    K++DFG +RD+     Y ++S+GR+P++WMA ESL+D
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +I++ +SD+WSFGVL+WEIVTLG  PYPG+    +   
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  343 bits (883), Expect = e-120
 Identities = 94/212 (44%), Positives = 127/212 (59%), Gaps = 6/212 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             +    VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT   P  VI EY
Sbjct: 49  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108

Query: 78  VPYGKLQSFLRSSRAQRYYN-----NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
             YG L +FLR  R     +      M     +L   DL SF YQVA+GM FL+S+  IH
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           RDLAARN+L+      K+ DFG ARD+   S Y  K   RLP++WMAPES+++ +++ +S
Sbjct: 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAA-AEVMKK 223
           D+WS+G+ +WE+ +LGS+PYPGM   ++  K 
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  344 bits (885), Expect = e-120
 Identities = 96/207 (46%), Positives = 142/207 (68%), Gaps = 3/207 (1%)

Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           +    VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY  
Sbjct: 65  KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124

Query: 80  YGKLQSFLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            G L+ +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLA
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           FGVL+WEI TLG +PYPG+   E+ K 
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEELFKL 271

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  345 bits (886), Expect = e-120
 Identities = 97/218 (44%), Positives = 131/218 (60%), Gaps = 11/218 (5%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
                   VAVK LKE A   ER  L+ EL +M  L  H N+V LLG CT   P ++I E
Sbjct: 70  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKS----------NSLTSRDLTSFCYQVARGMQFLS 126
           Y  YG L ++LRS R +   + +  ++          N LT  DL  F YQVA+GM+FL 
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
            +  +HRDLAARNVL+      K+ DFG ARD+M+ S Y  +   RLP++WMAPESL++ 
Sbjct: 190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA-AEVMKK 223
           I+++KSD+WS+G+L+WEI +LG  PYPG+   A   K 
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  343 bits (882), Expect = e-120
 Identities = 91/211 (43%), Positives = 131/211 (62%), Gaps = 5/211 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIME 76
                  VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E
Sbjct: 53  KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112

Query: 77  YVPYGKLQSFLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           +  +G L ++LRS R               + LT   L  + +QVA+GM+FL+SR  IHR
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DLAARN+L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAA-AEVMKK 223
           +WSFGVL+WEI +LG++PYPG+    E  ++
Sbjct: 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  345 bits (886), Expect = e-120
 Identities = 96/207 (46%), Positives = 142/207 (68%), Gaps = 3/207 (1%)

Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           +    VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY  
Sbjct: 111 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 170

Query: 80  YGKLQSFLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            G L+ +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+  IHRDLA
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+ EN+  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D +++ +SD+WS
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           FGVL+WEI TLG +PYPG+   E+ K 
Sbjct: 291 FGVLMWEIFTLGGSPYPGIPVEELFKL 317

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  342 bits (879), Expect = e-119
 Identities = 92/210 (43%), Positives = 132/210 (62%), Gaps = 6/210 (2%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +        A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +E
Sbjct: 47  KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106

Query: 77  YVPYGKLQSFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           Y P+G L  FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHR
Sbjct: 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 166

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DLAARN+L+GEN+  K+ADFG +R      VY +K+ GRLP+RWMA ESL  ++++  SD
Sbjct: 167 DLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 223

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +WS+GVL+WEIV+LG TPY GM  AE+ +K
Sbjct: 224 VWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  341 bits (878), Expect = e-119
 Identities = 93/208 (44%), Positives = 127/208 (61%), Gaps = 2/208 (0%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             +    VAVK LK  A   E+  L+ EL +M  L  H N+V LLG CT   P  VI EY
Sbjct: 72  KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131

Query: 78  VPYGKLQSFLRSSR-AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
             YG L +FLR               +++ ++RDL  F  QVA+GM FL+S+  IHRD+A
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+   H  K+ DFG ARD+M  S Y  K   RLP++WMAPES++D +++V+SD+WS
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251

Query: 197 FGVLIWEIVTLGSTPYPG-MAAAEVMKK 223
           +G+L+WEI +LG  PYPG +  ++  K 
Sbjct: 252 YGILLWEIFSLGLNPYPGILVNSKFYKL 279

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  343 bits (881), Expect = e-119
 Identities = 99/202 (49%), Positives = 142/202 (70%), Gaps = 3/202 (1%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163

Query: 85  SFLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+S+  IHRDLAARNVL
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D I++ +SD+WSFGVL+
Sbjct: 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WEI TLG +PYPG+   E+ K 
Sbjct: 284 WEIFTLGGSPYPGVPVEELFKL 305

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  333 bits (855), Expect = e-116
 Identities = 83/217 (38%), Positives = 121/217 (55%), Gaps = 12/217 (5%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             E   +VAVK LKE A    + D  +E  +M   D +PN+V+LLG C   +P  ++ EY
Sbjct: 73  PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEY 131

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSN-----------SLTSRDLTSFCYQVARGMQFLS 126
           + YG L  FLRS       +  H   +            L+  +      QVA GM +LS
Sbjct: 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
            R  +HRDLA RN L+GEN   K+ADFG +R++ ++  Y+      +PIRWM PES++ N
Sbjct: 192 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            ++ +SD+W++GV++WEI + G  PY GMA  EV+  
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  323 bits (831), Expect = e-112
 Identities = 82/206 (39%), Positives = 124/206 (60%), Gaps = 4/206 (1%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             E    VA+KT+ E A  RER++ L E +VMK  +   +VVRLLG  ++ +P  VIME 
Sbjct: 51  KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMEL 109

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G L+S+LRS R     N +       +   +     ++A GM +L++   +HRDLAA
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLA---PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
           RN ++ E+   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSF
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           GV++WEI TL   PY G++  +V++ 
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRF 252

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  321 bits (826), Expect = e-112
 Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 4/209 (1%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             E    VA+KTLK+ A    R +   E  +   L  HPNVV LLG  T+ +P  +I  Y
Sbjct: 35  PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSY 93

Query: 78  VPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
             +G L  FL            ++     ++L   D      Q+A GM++LSS  ++H+D
Sbjct: 94  CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 153

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           LA RNVL+ +    K++D G  R++  +  Y+      LPIRWMAPE++    FS+ SDI
Sbjct: 154 LATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 213

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS+GV++WE+ + G  PY G +  +V++ 
Sbjct: 214 WSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  320 bits (822), Expect = e-111
 Identities = 78/207 (37%), Positives = 111/207 (53%), Gaps = 4/207 (1%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             +   +VAVK LKE A E  R D  +E  ++  L  H ++VR  G CTE  P  ++ EY
Sbjct: 67  PEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEY 124

Query: 78  VPYGKLQSFLRSSR--AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           + +G L  FLRS    A+            L    L +   QVA GM +L+    +HRDL
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           A RN L+G+    K+ DFG +RD+ ++  Y       LPIRWM PES+    F+ +SD+W
Sbjct: 185 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           SFGV++WEI T G  P+  ++  E + 
Sbjct: 245 SFGVVLWEIFTYGKQPWYQLSNTEAID 271

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  318 bits (816), Expect = e-110
 Identities = 85/220 (38%), Positives = 122/220 (55%), Gaps = 10/220 (4%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
           EV +  +S       P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   
Sbjct: 45  EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSL 103

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
           +  P F++ME +  G L+SFLR +R +        + +SL   DL      +A G Q+L 
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 127 SRGIIHRDLAARNVLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL 183
               IHRD+AARN L+   G     K+ DFG ARD+  +S Y +     LP++WM PE+ 
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217

Query: 184 YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            + IF+ K+D WSFGVL+WEI +LG  PYP  +  EV++ 
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  316 bits (813), Expect = e-110
 Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 5/209 (2%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
             +   +VAVK LK+      R D  +E  ++  L  H ++V+  G C + +P  ++ EY
Sbjct: 41  PTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEY 98

Query: 78  VPYGKLQSFLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           + +G L  FLR+                   L    +     Q+A GM +L+S+  +HRD
Sbjct: 99  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           LA RN L+G N   K+ DFG +RD+ ++  Y       LPIRWM PES+    F+ +SD+
Sbjct: 159 LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 218

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WSFGV++WEI T G  P+  ++  EV++ 
Sbjct: 219 WSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  317 bits (815), Expect = e-109
 Identities = 80/209 (38%), Positives = 116/209 (55%), Gaps = 10/209 (4%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
               P  VAVKTL E   E++ LD L E  ++   + H N+VR +G   +  P F+++E 
Sbjct: 97  NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLEL 155

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G L+SFLR +R +        + +SL   DL      +A G Q+L     IHRD+AA
Sbjct: 156 MAGGDLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209

Query: 138 RNVLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           RN L+   G     K+ DFG ARD+  +  Y +     LP++WM PE+  + IF+ K+D 
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WSFGVL+WEI +LG  PYP  +  EV++ 
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  314 bits (807), Expect = e-109
 Identities = 79/214 (36%), Positives = 122/214 (57%), Gaps = 15/214 (7%)

Query: 17  RGREGPCI-VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP---- 70
           +  +G  + VAVKT+K +N+ +RE  + L E   MK    HPNV+RLLG C E       
Sbjct: 56  KQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIP 114

Query: 71  -FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG 129
              VI+ ++ YG L ++L  SR              +  + L  F   +A GM++LS+R 
Sbjct: 115 KPMVILPFMKYGDLHTYLLYSRL-------ETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167

Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFS 189
            +HRDLAARN ++ ++    VADFG ++ + +   Y +    ++P++W+A ESL D +++
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227

Query: 190 VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            KSD+W+FGV +WEI T G TPYPG+   E+   
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  313 bits (803), Expect = e-108
 Identities = 78/211 (36%), Positives = 116/211 (54%), Gaps = 15/211 (7%)

Query: 20  EGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FF 72
                VAVK LK +     +  + L+E   MK  D HP+V +L+G               
Sbjct: 49  GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPM 107

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           VI+ ++ +G L +FL +SR             +L  + L  F   +A GM++LSSR  IH
Sbjct: 108 VILPFMKHGDLHAFLLASRI-------GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIH 160

Query: 133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           RDLAARN ++ E+    VADFG +R + +   Y +    +LP++W+A ESL DN+++V S
Sbjct: 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHS 220

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           D+W+FGV +WEI+T G TPY G+  AE+   
Sbjct: 221 DVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  304 bits (780), Expect = e-105
 Identities = 80/202 (39%), Positives = 116/202 (57%), Gaps = 16/202 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
            AVK+L       E    L E  +MK    HPNV+ LLG C   E    V++ Y+ +G L
Sbjct: 56  CAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+              ++ T +DL  F  QVA+GM++L+S+  +HRDLAARN ++ 
Sbjct: 115 RNFIRNET------------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162

Query: 144 ENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+     Y    K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 163 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE++T G+ PYP +   ++   
Sbjct: 223 WELMTRGAPPYPDVNTFDITVY 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  302 bits (776), Expect = e-104
 Identities = 76/207 (36%), Positives = 118/207 (57%), Gaps = 16/207 (7%)

Query: 20  EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYV 78
           +     A+K+L      ++    L+E  +M+ L+ HPNV+ L+G     E    V++ Y+
Sbjct: 47  QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYM 105

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
            +G L  F+RS +             + T +DL SF  QVARGM++L+ +  +HRDLAAR
Sbjct: 106 CHGDLLQFIRSPQ------------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAAR 153

Query: 139 NVLIGENHCCKVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           N ++ E+   KVADFG ARD++    Y  ++    RLP++W A ESL    F+ KSD+WS
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           FGVL+WE++T G+ PY  +   ++   
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDLTHF 240

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  303 bits (778), Expect = e-103
 Identities = 80/202 (39%), Positives = 115/202 (56%), Gaps = 16/202 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKL 83
            AVK+L       E    L E  +MK    HPNV+ LLG C   E    V++ Y+ +G L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           ++F+R+              ++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++ 
Sbjct: 179 RNFIRNET------------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226

Query: 144 ENHCCKVADFGFARDLMTSS--VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL+
Sbjct: 227 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WE++T G+ PYP +   ++   
Sbjct: 287 WELMTRGAPPYPDVNTFDITVY 308

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  301 bits (774), Expect = e-103
 Identities = 77/217 (35%), Positives = 121/217 (55%), Gaps = 15/217 (6%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
            V K    PE G +    VA+K L+E    +   ++L E  VM ++D +P+V RLLG C 
Sbjct: 30  TVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICL 87

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
                 +I + +P+G L  ++R  +              + S+ L ++C Q+A+GM +L 
Sbjct: 88  -TSTVQLITQLMPFGCLLDYVREHKDN------------IGSQYLLNWCVQIAKGMNYLE 134

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
            R ++HRDLAARNVL+      K+ DFG A+ L           G++PI+WMA ES+   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           I++ +SD+WS+GV +WE++T GS PY G+ A+E+   
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  298 bits (764), Expect = e-102
 Identities = 72/217 (33%), Positives = 114/217 (52%), Gaps = 15/217 (6%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
            V K    PE G      V +K +++ +G +    +   +  + +LD H ++VRLLG C 
Sbjct: 28  TVHKGVWIPE-GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP 85

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
                 ++ +Y+P G L   +R  R              L  + L ++  Q+A+GM +L 
Sbjct: 86  G-SSLQLVTQYLPLGSLLDHVRQHRGA------------LGPQLLLNWGVQIAKGMYYLE 132

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
             G++HR+LAARNVL+      +VADFG A  L         SE + PI+WMA ES++  
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            ++ +SD+WS+GV +WE++T G+ PY G+  AEV   
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  292 bits (750), Expect = e-100
 Identities = 92/199 (46%), Positives = 126/199 (63%), Gaps = 15/199 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L 
Sbjct: 41  VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 97

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            +LR    Q            +++  L     Q++  M++L  +  IHRDLAARN L+GE
Sbjct: 98  DYLRECNRQ-----------EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           NH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FGVL+WEI
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

Query: 205 VTLGSTPYPGMAAAEVMKK 223
            T G +PYPG+  ++V + 
Sbjct: 206 ATYGMSPYPGIDLSQVYEL 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  291 bits (746), Expect = 2e-99
 Identities = 76/217 (35%), Positives = 120/217 (55%), Gaps = 15/217 (6%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
            V K    PE  +     VA+K L+E    +   ++L E  VM ++D +P+V RLLG C 
Sbjct: 30  TVYKGLWIPEGEK-VKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICL 87

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
                 +I + +P+G L  ++R  +              + S+ L ++C Q+A+GM +L 
Sbjct: 88  -TSTVQLITQLMPFGCLLDYVREHKDN------------IGSQYLLNWCVQIAKGMNYLE 134

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
            R ++HRDLAARNVL+      K+ DFG A+ L           G++PI+WMA ES+   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           I++ +SD+WS+GV +WE++T GS PY G+ A+E+   
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  288 bits (739), Expect = 4e-99
 Identities = 74/208 (35%), Positives = 110/208 (52%), Gaps = 21/208 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIM 75
            G      VAVK +K +A  +     L E +VM  L  H N+V+LLG   E++   +++ 
Sbjct: 39  LGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVT 94

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY+  G L  +LRS                L    L  F   V   M++L     +HRDL
Sbjct: 95  EYMAKGSLVDYLRSRGRS-----------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+ E++  KV+DFG  ++         +  G+LP++W APE+L +  FS KSD+W
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 198

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SFG+L+WEI + G  PYP +   +V+ +
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPR 226

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  288 bits (738), Expect = 3e-98
 Identities = 79/200 (39%), Positives = 108/200 (54%), Gaps = 14/200 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K LK    ER+R D L E ++M   D HPN++RL G  T      ++ EY+  G L 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR+   Q             T   L      V  GM++LS  G +HRDLAARNVL+  
Sbjct: 139 TFLRTHDGQ------------FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEG-RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG +R L         + G ++PIRW APE++    FS  SD+WSFGV++WE
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           ++  G  PY  M   +V+  
Sbjct: 247 VLAYGERPYWNMTNRDVISS 266

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  285 bits (731), Expect = 6e-98
 Identities = 79/203 (38%), Positives = 111/203 (54%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VAVK+LK+ +   +    L E  +MK L  H  +VRL    T +EP ++I EY+  
Sbjct: 36  GHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQ-HQRLVRLYAVVT-QEPIYIITEYMEN 91

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL++                LT   L     Q+A GM F+  R  IHRDL A N+
Sbjct: 92  GSLVDFLKTPSGI-----------KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +   CK+ADFG AR  +  + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 141 LVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + EIVT G  PYPGM   EV++ 
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQN 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  283 bits (727), Expect = 6e-97
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 30/224 (13%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVI 74
            G      VAVK+LK  +G     DL +E+ +++ L  H N+V+  G CTE       +I
Sbjct: 45  EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLI 103

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           ME++P G L+ +L  ++ +            +  +    +  Q+ +GM +L SR  +HRD
Sbjct: 104 MEFLPSGSLKEYLPKNKNK------------INLKQQLKYAVQICKGMDYLGSRQYVHRD 151

Query: 135 LAARNVLIGENHCCKVADFGFARDLMT-SSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           LAARNVL+   H  K+ DFG  + + T    Y  K +   P+ W APE L  + F + SD
Sbjct: 152 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASD 211

Query: 194 IWSFGVLIWEIVTLGST--------------PYPGMAAAEVMKK 223
           +WSFGV + E++T   +               +  M    ++  
Sbjct: 212 VWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  284 bits (728), Expect = 8e-97
 Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 32/223 (14%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIM 75
                 +VAVK LK +AG + R    QE+ +++TL  H ++++  GCC +       ++M
Sbjct: 56  NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVM 114

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EYVP G L+ +L                  +    L  F  Q+  GM +L ++  IHRDL
Sbjct: 115 EYVPLGSLRDYLPRHS--------------IGLAQLLLFAQQICEGMAYLHAQHYIHRDL 160

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDI 194
           AARNVL+  +   K+ DFG A+ +     Y R  E G  P+ W APE L +  F   SD+
Sbjct: 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 220

Query: 195 WSFGVLIWEIVTLGST--------------PYPGMAAAEVMKK 223
           WSFGV ++E++T   +                  M    + + 
Sbjct: 221 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  286 bits (735), Expect = 3e-96
 Identities = 73/200 (36%), Positives = 109/200 (54%), Gaps = 21/200 (10%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPYGKL 83
           VAVK +K +A  +     L E +VM  L  H N+V+LLG   E++   +++ EY+  G L
Sbjct: 219 VAVKCIKNDATAQ---AFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +LRS                L    L  F   V   M++L     +HRDLAARNVL+ 
Sbjct: 275 VDYLRSRGRS-----------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E++  KV+DFG  ++         +  G+LP++W APE+L +  FS KSD+WSFG+L+WE
Sbjct: 324 EDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 378

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           I + G  PYP +   +V+ +
Sbjct: 379 IYSFGRVPYPRIPLKDVVPR 398

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  279 bits (716), Expect = 8e-96
 Identities = 73/203 (35%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
               VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +
Sbjct: 31  NKDKVAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEH 87

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  +LR+ R                +  L   C  V  GM +L    +IHRDLAARN 
Sbjct: 88  GCLSDYLRTQRGL------------FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN   KV+DFG  R  +    Y   +  + P++W +PE    + +S KSD+WSFGVL
Sbjct: 136 LVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           +WE+ + G  PY   + +EV++ 
Sbjct: 195 MWEVFSEGKIPYENRSNSEVVED 217

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  279 bits (717), Expect = 1e-95
 Identities = 73/203 (35%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+K +KE +   +  + ++E  VM  L  H  +V+L G CT++ P F+I EY+  
Sbjct: 47  GQYDVAIKMIKEGSMSED--EFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMAN 103

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L ++LR  R +              ++ L   C  V   M++L S+  +HRDLAARN 
Sbjct: 104 GCLLNYLREMRHR------------FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+ +    KV+DFG +R  +    Y      + P+RW  PE L  + FS KSDIW+FGVL
Sbjct: 152 LVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           +WEI +LG  PY     +E  + 
Sbjct: 211 MWEIYSLGKMPYERFTNSETAEH 233

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  279 bits (715), Expect = 2e-95
 Identities = 73/199 (36%), Positives = 105/199 (52%), Gaps = 16/199 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK +KE +   +  +  QE   M  L  HP +V+  G C+++ P +++ EY+  G L 
Sbjct: 35  VAVKMIKEGSMSED--EFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           ++LRS                L    L   CY V  GM FL S   IHRDLAARN L+  
Sbjct: 92  NYLRSHGKG------------LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           + C KV+DFG  R  +    Y      + P++W APE  +   +S KSD+W+FG+L+WE+
Sbjct: 140 DLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198

Query: 205 VTLGSTPYPGMAAAEVMKK 223
            +LG  PY     +EV+ K
Sbjct: 199 FSLGKMPYDLYTNSEVVLK 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  278 bits (713), Expect = 4e-95
 Identities = 76/217 (35%), Positives = 118/217 (54%), Gaps = 17/217 (7%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
           +V +              VA+KT K    +  R   LQE   M+  D HP++V+L+G  T
Sbjct: 30  DVHQGIYMSPENPALA--VAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 86

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
            + P ++IME    G+L+SFL+  +              L    L  + YQ++  + +L 
Sbjct: 87  -ENPVWIIMELCTLGELRSFLQVRKYS------------LDLASLILYAYQLSTALAYLE 133

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
           S+  +HRD+AARNVL+  N C K+ DFG +R +   S Y + S+G+LPI+WMAPES+   
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 192

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            F+  SD+W FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  279 bits (717), Expect = 6e-95
 Identities = 74/200 (37%), Positives = 112/200 (56%), Gaps = 14/200 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R+D L E  +M     H N++RL G  ++ +P  +I EY+  G L 
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALD 134

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FLR    +             +   L      +A GM++L++   +HRDLAARN+L+  
Sbjct: 135 KFLREKDGE------------FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 182

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEG-RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG +R L         + G ++PIRW APE++    F+  SD+WSFG+++WE
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           ++T G  PY  ++  EVMK 
Sbjct: 243 VMTYGERPYWELSNHEVMKA 262

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  279 bits (716), Expect = 3e-94
 Identities = 79/200 (39%), Positives = 115/200 (57%), Gaps = 14/200 (7%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK    E++R D L E ++M   D HPN++RL G  T+ +P  ++ EY+  G L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           SFLR   AQ             T   L      +A GM++LS  G +HRDLAARN+LI  
Sbjct: 135 SFLRKHDAQ------------FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEG-RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           N  CKV+DFG  R L         + G ++PIRW +PE++    F+  SD+WS+G+++WE
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           +++ G  PY  M+  +V+K 
Sbjct: 243 VMSYGERPYWEMSNQDVIKA 262

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  276 bits (709), Expect = 7e-94
 Identities = 74/234 (31%), Positives = 117/234 (50%), Gaps = 32/234 (13%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
            V      P     G  +VAVK L+ +  +++R D  +E+ ++K L     +V+  G   
Sbjct: 38  SVELCRYDPLGDNTG-ALVAVKQLQHSGPDQQR-DFQREIQILKALH-SDFIVKYRGVSY 94

Query: 67  E--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
              ++   ++MEY+P G L+ FL+  RA+            L +  L  +  Q+ +GM++
Sbjct: 95  GPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDASRLLLYSSQICKGMEY 142

Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSS-VYERKSEGRLPIRWMAPESL 183
           L SR  +HRDLAARN+L+      K+ADFG A+ L      Y  +  G+ PI W APESL
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 184 YDNIFSVKSDIWSFGVLIWEIVTLGSTPY--------------PGMAAAEVMKK 223
            DNIFS +SD+WSFGV+++E+ T                       A + +++ 
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  274 bits (704), Expect = 2e-93
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 32/217 (14%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGK 82
           VAVK L+ +  E    D  +E+ ++K+L  H N+V+  G C    +    +IMEY+PYG 
Sbjct: 42  VAVKKLQHSTEE-HLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+ +L+  + +            +    L  +  Q+ +GM++L ++  IHRDLA RN+L+
Sbjct: 100 LRDYLQKHKER------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147

Query: 143 GENHCCKVADFGFARDLMTSS-VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
              +  K+ DFG  + L      ++ K  G  PI W APESL ++ FSV SD+WSFGV++
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207

Query: 202 WEIVT---------------LGSTPYPGMAAAEVMKK 223
           +E+ T               +G+     M    +++ 
Sbjct: 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  277 bits (711), Expect = 2e-93
 Identities = 71/199 (35%), Positives = 112/199 (56%), Gaps = 13/199 (6%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK+ +E      +   LQE  ++K    HPN+VRL+G CT+K+P +++ME V  G   
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
           +FLR+                L  + L       A GM++L S+  IHRDLAARN L+ E
Sbjct: 201 TFLRTEG------------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE 248

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
            +  K++DFG +R+             ++P++W APE+L    +S +SD+WSFG+L+WE 
Sbjct: 249 KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308

Query: 205 VTLGSTPYPGMAAAEVMKK 223
            +LG++PYP ++  +  + 
Sbjct: 309 FSLGASPYPNLSNQQTREF 327

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  274 bits (702), Expect = 2e-93
 Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 16/208 (7%)

Query: 17  RGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
              +G  I VAVKT K++     +   + E  +MK LD HP++V+L+G    +EP ++IM
Sbjct: 34  TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE-EEPTWIIM 91

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E  PYG+L  +L  ++            NSL    L  +  Q+ + M +L S   +HRD+
Sbjct: 92  ELYPYGELGHYLERNK------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDI 139

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           A RN+L+    C K+ DFG +R +     Y + S  RLPI+WM+PES+    F+  SD+W
Sbjct: 140 AVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTTASDVW 198

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            F V +WEI++ G  P+  +   +V+  
Sbjct: 199 MFAVCMWEILSFGKQPFFWLENKDVIGV 226

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  275 bits (705), Expect = 2e-93
 Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 32/217 (14%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGK 82
           VAVK L+ +  E    D  +E+ ++K+L  H N+V+  G C    +    +IMEY+PYG 
Sbjct: 73  VAVKKLQHST-EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L+ +L+  + +            +    L  +  Q+ +GM++L ++  IHRDLA RN+L+
Sbjct: 131 LRDYLQKHKER------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178

Query: 143 GENHCCKVADFGFARDLMTSS-VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
              +  K+ DFG  + L      Y+ K  G  PI W APESL ++ FSV SD+WSFGV++
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238

Query: 202 WEIVT---------------LGSTPYPGMAAAEVMKK 223
           +E+ T               +G+     M    +++ 
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  279 bits (716), Expect = 7e-93
 Identities = 91/207 (43%), Positives = 127/207 (61%), Gaps = 17/207 (8%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +       VAVKTLKE+  E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E
Sbjct: 242 KKYSLT--VAVKTLKEDTMEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITE 296

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++ YG L  +LR    Q            +++  L     Q++  M++L  +  IHR+LA
Sbjct: 297 FMTYGNLLDYLRECNRQ-----------EVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARN L+GENH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+
Sbjct: 346 ARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           FGVL+WEI T G +PYPG+  ++V + 
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYEL 431

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  277 bits (711), Expect = 2e-92
 Identities = 80/203 (39%), Positives = 110/203 (54%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
               VAVKT+K  +   E    L E  VMKTL  H  +V+L    T KEP ++I E++  
Sbjct: 211 KHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAK 266

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+S                     L  F  Q+A GM F+  R  IHRDL A N+
Sbjct: 267 GSLLDFLKSDEGS-----------KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+  +  CK+ADFG AR +   + Y  +   + PI+W APE++    F++KSD+WSFG+L
Sbjct: 316 LVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + EIVT G  PYPGM+  EV++ 
Sbjct: 375 LMEIVTYGRIPYPGMSNPEVIRA 397

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  273 bits (700), Expect = 3e-92
 Identities = 89/261 (34%), Positives = 129/261 (49%), Gaps = 55/261 (21%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIME 76
                  VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT    P  VI+E
Sbjct: 48  KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107

Query: 77  YVPYGKLQSFL------------------------------------------------- 87
           +  +G L ++L                                                 
Sbjct: 108 FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167

Query: 88  ----RSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                 S  +          + LT   L  + +QVA+GM+FL+SR  IHRDLAARN+L+ 
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 227

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGVL+WE
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287

Query: 204 IVTLGSTPYPGMAA-AEVMKK 223
           I +LG++PYPG+    E  ++
Sbjct: 288 IFSLGASPYPGVKIDEEFCRR 308

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  280 bits (719), Expect = 1e-91
 Identities = 77/208 (37%), Positives = 118/208 (56%), Gaps = 16/208 (7%)

Query: 17  RGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
              E P + VA+KT K    +  R   LQE   M+  D HP++V+L+G  T + P ++IM
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIM 469

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E    G+L+SFL+  +              L    L  + YQ++  + +L S+  +HRD+
Sbjct: 470 ELCTLGELRSFLQVRKFS------------LDLASLILYAYQLSTALAYLESKRFVHRDI 517

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+  N C K+ DFG +R +   S Y + S+G+LPI+WMAPES+    F+  SD+W
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 576

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 577 MFGVCMWEILMHGVKPFQGVKNNDVIGR 604

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  268 bits (688), Expect = 3e-91
 Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 15/208 (7%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R+    VA+K LK+   + +  ++++E  +M  LD +P +VRL+G C   E   ++ME
Sbjct: 32  RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALMLVME 89

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
               G L  FL   R +            +   ++    +QV+ GM++L  +  +HRDLA
Sbjct: 90  MAGGGPLHKFLVGKREE------------IPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137

Query: 137 ARNVLIGENHCCKVADFGFARDLMT-SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           ARNVL+   H  K++DFG ++ L    S Y  +S G+ P++W APE +    FS +SD+W
Sbjct: 138 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S+GV +WE ++ G  PY  M   EVM  
Sbjct: 198 SYGVTMWEALSYGQKPYKKMKGPEVMAF 225

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  263 bits (675), Expect = 3e-89
 Identities = 74/209 (35%), Positives = 116/209 (55%), Gaps = 17/209 (8%)

Query: 17  RGREGPCIVAVKTLKENAGERERL-DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           + ++    VAVK LK  A +     +LL E  VM+ LD +P +VR++G C   E + ++M
Sbjct: 39  QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE-AESWMLVM 96

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E    G L  +L+ +R              +  +++    +QV+ GM++L     +HRDL
Sbjct: 97  EMAELGPLNKYLQQNR-------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143

Query: 136 AARNVLIGENHCCKVADFGFARDLMT-SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           AARNVL+   H  K++DFG ++ L    + Y+ ++ G+ P++W APE +    FS KSD+
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 203

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WSFGVL+WE  + G  PY GM  +EV   
Sbjct: 204 WSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  268 bits (687), Expect = 6e-89
 Identities = 77/203 (37%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    + +EP +++ EY+  
Sbjct: 207 GTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLR-HEKLVQLYAVVS-EEPIYIVTEYMSK 262

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 263 GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR +   + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 312 LVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQ 393

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  269 bits (690), Expect = 1e-88
 Identities = 78/203 (38%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 21  GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           G   VA+KTLK      E    LQE  VMK L  H  +V+L    +E EP +++ EY+  
Sbjct: 290 GTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSK 345

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L  FL+    +            L    L     Q+A GM ++     +HRDL A N+
Sbjct: 346 GSLLDFLKGETGK-----------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+GEN  CKVADFG AR  +  + Y  +   + PI+W APE+     F++KSD+WSFG+L
Sbjct: 395 LVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           + E+ T G  PYPGM   EV+ +
Sbjct: 454 LTELTTKGRVPYPGMVNREVLDQ 476

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  261 bits (668), Expect = 4e-88
 Identities = 71/211 (33%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 17  RGREGPCI-VAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
               G  + VAVK LK +         D ++E+  M +LD H N++RL G      P  +
Sbjct: 40  DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPMKM 97

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           + E  P G L   LR  +                   L+ +  QVA GM +L S+  IHR
Sbjct: 98  VTELAPLGSLLDRLRKHQGH------------FLLGTLSRYAVQVAEGMGYLESKRFIHR 145

Query: 134 DLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           DLAARN+L+      K+ DFG  R L      Y  +   ++P  W APESL    FS  S
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 205

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           D W FGV +WE+ T G  P+ G+  ++++ K
Sbjct: 206 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  263 bits (674), Expect = 3e-85
 Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 15/208 (7%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R+    VA+K LK+   + +  ++++E  +M  LD +P +VRL+G C   E   ++ME
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEALMLVME 415

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
               G L  FL   R +            +   ++    +QV+ GM++L  +  +HR+LA
Sbjct: 416 MAGGGPLHKFLVGKREE------------IPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463

Query: 137 ARNVLIGENHCCKVADFGFARDLMT-SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           ARNVL+   H  K++DFG ++ L    S Y  +S G+ P++W APE +    FS +SD+W
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S+GV +WE ++ G  PY  M   EVM  
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVMAF 551

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  253 bits (648), Expect = 4e-85
 Identities = 44/215 (20%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 18  GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           G+     V +K L +           +  ++M  L  H ++V   G C   +   ++ E+
Sbjct: 36  GQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLS-HKHLVLNYGVCVCGDENILVQEF 93

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V +G L ++L+ ++            N +          Q+A  M FL    +IH ++ A
Sbjct: 94  VKFGSLDTYLKKNK------------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCA 141

Query: 138 RNVLI--------GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IF 188
           +N+L+        G     K++D G +  ++   +       +  I W+ PE + +    
Sbjct: 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QERIPWVPPECIENPKNL 195

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           ++ +D WSFG  +WEI + G  P   + +   ++ 
Sbjct: 196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  207 bits (530), Expect = 5e-67
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 29/204 (14%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           + +K L     E  +   L+E+ VM+ L+ HPNV++ +G   + +    I EY+  G L+
Sbjct: 38  MVMKELI-RFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLR 95

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             ++S              +        SF   +A GM +L S  IIHRDL + N L+ E
Sbjct: 96  GIIKS------------MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 143

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPI-------------RWMAPESLYDNIFSVK 191
           N    VADFG AR LM     + +    L                WMAPE +    +  K
Sbjct: 144 NKNVVVADFGLAR-LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGM 215
            D++SFG+++ EI+       P  
Sbjct: 203 VDVFSFGIVLCEIIGRV-NADPDY 225

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  204 bits (521), Expect = 6e-66
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 25  VAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L       ++      E+ V++    H N++  +G  T      ++ ++     L
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAIVTQWCEGSSL 106

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L            H        + L     Q ARGM +L ++ IIHRDL + N+ + 
Sbjct: 107 YHHL------------HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 154

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL---YDNIFSVKSDIWSFGVL 200
           E++  K+ DFG A +    S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214

Query: 201 IWEIVTLGSTPYPGMAAAE 219
           ++E++T G  PY  +   +
Sbjct: 215 LYELMT-GQLPYSNINNRD 232

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  190 bits (486), Expect = 6e-61
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 34/211 (16%)

Query: 25  VAVKTLKENAGE---RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           VAVK  + +  E   +   ++ QE  +   L  HPN++ L G C ++    ++ME+   G
Sbjct: 33  VAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGG 91

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---IIHRDLAAR 138
            L   L                  +    L ++  Q+ARGM +L       IIHRDL + 
Sbjct: 92  PLNRVLSG--------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137

Query: 139 NVLIGE--------NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSV 190
           N+LI +        N   K+ DFG AR+   ++    K        WMAPE +  ++FS 
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSK 193

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
            SD+WS+GVL+WE++T G  P+ G+    V 
Sbjct: 194 GSDVWSYGVLLWELLT-GEVPFRGIDGLAVA 223

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  189 bits (483), Expect = 6e-60
 Identities = 73/201 (36%), Positives = 107/201 (53%), Gaps = 19/201 (9%)

Query: 25  VAVKTLKENAGERERL-DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L E     ER+ + L+E+ +MK L  HPN+V  +G  T+     ++ EY+  G L
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVL 141
              L  S A+            L  R   S  Y VA+GM +L +R   I+HR+L + N+L
Sbjct: 122 YRLLHKSGARE----------QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           + + +  KV DFG +R L  S+    KS  G     WMAPE L D   + KSD++SFGV+
Sbjct: 172 VDKKYTVKVCDFGLSR-LKASTFLSSKSAAG--TPEWMAPEVLRDEPSNEKSDVYSFGVI 228

Query: 201 IWEIVTLGSTPYPGMAAAEVM 221
           +WE+ T    P+  +  A+V+
Sbjct: 229 LWELAT-LQQPWGNLNPAQVV 248

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  186 bits (474), Expect = 1e-58
 Identities = 42/210 (20%), Positives = 78/210 (37%), Gaps = 28/210 (13%)

Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VA++ +  E   E +     +E+   +    H NVV  +G C       +I        L
Sbjct: 58  VAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTL 116

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            S +                  L          ++ +GM +L ++GI+H+DL ++NV   
Sbjct: 117 YSVV------------RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY- 163

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLP---IRWMAPE---------SLYDNIFSVK 191
           +N    + DFG            R+ + R+    +  +APE               FS  
Sbjct: 164 DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           SD+++ G + +E+      P+    A  ++
Sbjct: 224 SDVFALGTIWYELHA-REWPFKTQPAEAII 252

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (468), Expect = 4e-58
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 30/208 (14%)

Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYG 81
           + VK LK  +   R+  D  +E   ++    HPNV+ +LG C         +I  ++PYG
Sbjct: 36  IVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYG 94

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARN 139
            L + L             G +  +       F   +ARGM FL +    I    L +R+
Sbjct: 95  SLYNVLHE-----------GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143

Query: 140 VLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESL---YDNIFSVKSDIW 195
           V+I E+   +++             +Y           W+APE+L    ++     +D+W
Sbjct: 144 VMIDEDMTARISMADVKFSFQSPGRMY--------APAWVAPEALQKKPEDTNRRSADMW 195

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SF VL+WE+VT    P+  ++  E+  K
Sbjct: 196 SFAVLLWELVT-REVPFADLSNMEIGMK 222

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (452), Expect = 2e-55
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 30/203 (14%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R ++    VA+K ++    E ER   + EL  +  ++ HPN+V+L G C    P  ++ME
Sbjct: 30  RAKD----VAIKQIES---ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVME 79

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---GIIHR 133
           Y   G L + L  +                T+    S+C Q ++G+ +L S     +IHR
Sbjct: 80  YAEGGSLYNVLHGAE----------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 134 DLAARNVLIGENH-CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           DL   N+L+       K+ DFG A D+ T     + S       WMAPE    + +S K 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS-----AAWMAPEVFEGSNYSEKC 184

Query: 193 DIWSFGVLIWEIVTLGSTPYPGM 215
           D++S+G+++WE++T    P+  +
Sbjct: 185 DVFSWGIILWEVIT-RRKPFDEI 206

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  177 bits (450), Expect = 3e-55
 Identities = 52/214 (24%), Positives = 101/214 (47%), Gaps = 42/214 (19%)

Query: 25  VAVKTLK------ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           VA+K+L       E     +  +  +E+ +M  L+ HPN+V+L G      P  ++ME+V
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHN--PPRMVMEFV 103

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLA 136
           P G L   L              K++ +           +A G++++ ++   I+HRDL 
Sbjct: 104 PCGDLYHRL------------LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151

Query: 137 ARNVLIGENH-----CCKVADFGFAR---DLMTSSVYERKSEGRLPIRWMAPESLY--DN 186
           + N+ +         C KVADFG ++     ++  +      G    +WMAPE++   + 
Sbjct: 152 SPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL------G--NFQWMAPETIGAEEE 203

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
            ++ K+D +SF ++++ I+T G  P+   +  ++
Sbjct: 204 SYTEKADTYSFAMILYTILT-GEGPFDEYSYGKI 236

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  137 bits (347), Expect = 8e-40
 Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 52/233 (22%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCT----EKEPFFVIMEYVP 79
           VAVK        R+     +E  +  T+   H N++  +             ++I  Y  
Sbjct: 34  VAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL--------SSRGII 131
            G L  +L              +  +L +         +A G+  L            I 
Sbjct: 90  MGSLYDYL--------------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135

Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLM-TSSVYERKSEGRLP-IRWMAPESLYDNI-- 187
           HRDL ++N+L+ +N  C +AD G A     +++  +  +  R+   R+MAPE L + I  
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195

Query: 188 ----FSVKSDIWSFGVLIWEIVTLGST---------PYPGM----AAAEVMKK 223
                  + DIW+FG+++WE+     +         P+  +     + E M+K
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  137 bits (347), Expect = 2e-39
 Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 52/234 (22%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKT--LDPHPNVVRLLGCCTE-----KE 69
             R     VAVK          R + + E  + +   ++ H N+ R +          + 
Sbjct: 35  DERP----VAVKVFSF----ANRQNFINEKNIYRVPLME-HDNIARFIVGDERVTADGRM 85

Query: 70  PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL---- 125
            + ++MEY P G L  +L                ++          + V RG+ +L    
Sbjct: 86  EYLLVMEYYPNGSLXKYLSL--------------HTSDWVSSCRLAHSVTRGLAYLHTEL 131

Query: 126 -----SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP------ 174
                    I HRDL +RNVL+  +  C ++DFG +  L  + +     E          
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191

Query: 175 IRWMAPESLYDNI-------FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           IR+MAPE L   +          + D+++ G++ WEI    +  +PG +  E  
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  136 bits (343), Expect = 5e-39
 Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 45/215 (20%)

Query: 25  VAVKTLKENAG---ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEY 77
           VAVK          + E      E+  +  +  H N+++ +G            ++I  +
Sbjct: 50  VAVKIFPIQDKQSWQNE-----YEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAF 103

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL----------SS 127
              G L  FL              K+N ++  +L      +ARG+ +L            
Sbjct: 104 HEKGSLSDFL--------------KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149

Query: 128 RGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLP-IRWMAPESLYDN 186
             I HRD+ ++NVL+  N    +ADFG A     +      + G++   R+MAPE L   
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLAL-KFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208

Query: 187 I-----FSVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
           I       ++ D+++ G+++WE+ +   T   G  
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELAS-RCTAADGPV 242

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (344), Expect = 6e-39
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 39/210 (18%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKE----PFFVIMEYVP 79
           VAVK        RE     +E  + +T+   H N++  +    +        +++ +Y  
Sbjct: 68  VAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL--------SSRGII 131
           +G L  +L                 ++T   +       A G+  L            I 
Sbjct: 124 HGSLFDYL--------------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169

Query: 132 HRDLAARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLP-IRWMAPESLYDNI-- 187
           HRDL ++N+L+ +N  C +AD G A      +   +     R+   R+MAPE L D+I  
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229

Query: 188 ----FSVKSDIWSFGVLIWEIVTLGSTPYP 213
                  ++DI++ G++ WEI    S    
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGI 259

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  136 bits (343), Expect = 7e-39
 Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 39/203 (19%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEKEP----FFVIMEYVP 79
           VAVK         E     +E  + +T+   H N++  +    +        ++I +Y  
Sbjct: 63  VAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL--------SSRGII 131
            G L  +L              KS +L ++ +    Y    G+  L            I 
Sbjct: 119 NGSLYDYL--------------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164

Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLM-TSSVYERKSEGRLP-IRWMAPESLYDNIFS 189
           HRDL ++N+L+ +N  C +AD G A   +  ++  +     R+   R+M PE L +++  
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224

Query: 190 V------KSDIWSFGVLIWEIVT 206
                   +D++SFG+++WE+  
Sbjct: 225 NHFQSYIMADMYSFGLILWEVAR 247

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  132 bits (333), Expect = 9e-38
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGC----CTEKEPFFVIMEYVP 79
           VA   L+     + ER    +E  ++K L  HPN+VR           K+   ++ E + 
Sbjct: 54  VAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMT 112

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAA 137
            G L+++L+             +   +  + L S+C Q+ +G+QFL +R   IIHRDL  
Sbjct: 113 SGTLKTYLK-------------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159

Query: 138 RNVLI-GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
            N+ I G     K+ D G A     S     K+    P  +MAPE +Y+  +    D+++
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTP-EFMAPE-MYEEKYDESVDVYA 214

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           FG+ + E+ T    PY     A  + +
Sbjct: 215 FGMCMLEMAT-SEYPYSECQNAAQIYR 240

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (334), Expect = 1e-37
 Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 18/199 (9%)

Query: 17  RGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           R +E   + AVK       G ++R   L E+   + +  HP  VRL     E    ++  
Sbjct: 77  RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E      LQ    +  A            SL    +  +       +  L S+G++H D+
Sbjct: 137 ELCG-PSLQQHCEAWGA------------SLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              N+ +G    CK+ DFG   +L T+       EG    R+MAPE L  + +   +D++
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAGA-GEVQEG--DPRYMAPELLQGS-YGTAADVF 239

Query: 196 SFGVLIWEIVTLGSTPYPG 214
           S G+ I E+      P+ G
Sbjct: 240 SLGLTILEVACNMELPHGG 258

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (329), Expect = 5e-37
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 14/186 (7%)

Query: 24  IVAVKT--LKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
            VA+K   + +    + R D ++E+ ++K L+ HPNV++      E     +++E    G
Sbjct: 59  PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 117

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++  + Q+           +  R +  +  Q+   ++ + SR ++HRD+   NV 
Sbjct: 118 DLSRMIKHFKKQKRL---------IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           I      K+ D G  R   + +       G  P  +M+PE +++N ++ KSDIWS G L+
Sbjct: 169 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGT-PY-YMSPERIHENGYNFKSDIWSLGCLL 226

Query: 202 WEIVTL 207
           +E+  L
Sbjct: 227 YEMAAL 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (328), Expect = 1e-36
 Identities = 42/201 (20%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
              +K +       +ER +  +E+ V+  +  HPN+V+      E    +++M+Y   G 
Sbjct: 51  QYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGD 109

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   + + +                   +  +  Q+   ++ +  R I+HRD+ ++N+ +
Sbjct: 110 LFKRINAQKGVL-----------FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 158

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
            ++   ++ DFG AR L ++    R   G  P  +++PE   +  ++ KSDIW+ G +++
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGT-PY-YLSPEICENKPYNNKSDIWALGCVLY 216

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           E+ TL    +   +   ++ K
Sbjct: 217 ELCTL-KHAFEAGSMKNLVLK 236

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  126 bits (319), Expect = 3e-35
 Identities = 44/203 (21%), Positives = 70/203 (34%), Gaps = 27/203 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
             AVK ++            +EL     L   P +V L G   E     + ME +  G L
Sbjct: 85  QCAVKKVRLEVFRV------EELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              ++                 L       +  Q   G+++L +R I+H D+ A NVL+ 
Sbjct: 138 GQLIKQMGC-------------LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184

Query: 144 EN-HCCKVADFGFARDLMTSSVYERKSEGRLPIR----WMAPESLYDNIFSVKSDIWSFG 198
            +     + DFG A  L       +       I      MAPE +       K DIWS  
Sbjct: 185 SDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 199 VLIWEIVTLGSTPYPGMAAAEVM 221
            ++  ++  G  P+       + 
Sbjct: 244 CMMLHMLN-GCHPWTQYFRGPLC 265

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (313), Expect = 8e-35
 Identities = 45/213 (21%), Positives = 76/213 (35%), Gaps = 36/213 (16%)

Query: 23  CIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           CI A+K  K   AG  +  + L+E+     L  H +VVR      E +   +  EY   G
Sbjct: 37  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   +  +             +     +L     QV RG++++ S  ++H D+   N+ 
Sbjct: 97  SLADAISENY---------RIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147

Query: 142 IGENHC-------------------CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPES 182
           I                         K+ D G    + +  V E  S      R++A E 
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS------RFLANEV 201

Query: 183 LYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
           L +N     K+DI++  + +         P  G
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  123 bits (311), Expect = 2e-34
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 40/210 (19%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            +A+K + E      +  L +E+ + K L  H N+V+ LG  +E     + ME VP G L
Sbjct: 49  RIAIKEIPERDSRYSQ-PLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSL 106

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            + LR         +  G       + +  +  Q+  G+++L    I+HRD+   NVLI 
Sbjct: 107 SALLR---------SKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156

Query: 144 -ENHCCKVADFGFARDL---------MTSSVYERKSEGRLPIRWMAPE--SLYDNIFSVK 191
             +   K++DFG ++ L          T ++            +MAPE        +   
Sbjct: 157 TYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-----------YMAPEIIDKGPRGYGKA 205

Query: 192 SDIWSFGVLIWEIVTLGSTPYP----GMAA 217
           +DIWS G  I E+ T G  P+       AA
Sbjct: 206 ADIWSLGCTIIEMAT-GKPPFYELGEPQAA 234

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (309), Expect = 4e-34
 Identities = 43/223 (19%), Positives = 82/223 (36%), Gaps = 36/223 (16%)

Query: 23  CIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF----------- 71
           C  A+K ++    E  R  +++E+  +  L+ HP +VR      EK              
Sbjct: 31  CNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVY 89

Query: 72  -FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            ++ M+      L+ ++                             Q+A  ++FL S+G+
Sbjct: 90  LYIQMQLCRKENLKDWMNGRCTIEE----------RERSVCLHIFLQIAEAVEFLHSKGL 139

Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----------WMAP 180
           +HRDL   N+    +   KV DFG    +      +                    +M+P
Sbjct: 140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199

Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           E ++ N +S K DI+S G++++E++         M     +  
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (301), Expect = 4e-33
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--FFVIMEYVPY 80
           I+  K L   +  E E+  L+ E+ +++ L  HPN+VR      ++     +++MEY   
Sbjct: 33  ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEG 91

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----IIHRDL 135
           G L S +     +R Y         L    +     Q+   ++    R      ++HRDL
Sbjct: 92  GDLASVITKGTKERQY---------LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              NV +      K+ DFG AR L   + + +   G  P  +M+PE +    ++ KSDIW
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT-PY-YMSPEQMNRMSYNEKSDIW 200

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S G L++E+  L   P+   +  E+  K
Sbjct: 201 SLGCLLYELCAL-MPPFTAFSQKELAGK 227

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 6e-33
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 29/202 (14%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K +     +    +LL+E+  M     HPN+V        K+  +++M+ +  G +
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSV 100

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              ++             KS  L    + +   +V  G+++L   G IHRD+ A N+L+G
Sbjct: 101 LDIIKHI-----VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG 155

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIR--------WMAPE-----SLYDNIFSV 190
           E+   ++ADFG +  L T     R        R        WMAPE       YD     
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKV-----RKTFVGTPCWMAPEVMEQVRGYDF---- 206

Query: 191 KSDIWSFGVLIWEIVTLGSTPY 212
           K+DIWSFG+   E+ T G+ PY
Sbjct: 207 KADIWSFGITAIELAT-GAAPY 227

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 8e-33
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 19/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA++ +      ++   ++ E+ VM+    +PN+V  L      +  +V+MEY+  G L
Sbjct: 47  EVAIRQMNLQQQPKKE-LIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSL 104

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +                  +    + + C +  + ++FL S  +IHRD+ + N+L+G
Sbjct: 105 TDVV--------------TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K+ DFGF   + T    +R +    P  WMAPE +    +  K DIWS G++  E
Sbjct: 151 MDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIE 208

Query: 204 IVTLGSTPYPGMAAAEVM 221
           ++  G  PY        +
Sbjct: 209 MIE-GEPPYLNENPLRAL 225

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 9e-33
 Identities = 40/207 (19%), Positives = 78/207 (37%), Gaps = 23/207 (11%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
            V V+ +  E         L  EL V K  + HPN+V            +V+  ++ YG 
Sbjct: 54  YVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGS 112

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            +  +                + +    +      V + + ++   G +HR + A ++LI
Sbjct: 113 AKDLIC-----------THFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR------WMAPESLYDNI--FSVKSDI 194
             +    ++       +  S    ++     P        W++PE L  N+  +  KSDI
Sbjct: 162 SVDGKVYLSGLRSNLSM-ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           +S G+   E+   G  P+  M A +++
Sbjct: 221 YSVGITACELAN-GHVPFKDMPATQML 246

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (299), Expect = 2e-32
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 19/189 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VAVK +     +R    L  E+ +M+    H NVV +       E  +V+ME++  G L
Sbjct: 72  QVAVKMMDLRKQQRRE-LLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGAL 129

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +                  L    + + C  V + + +L ++G+IHRD+ + ++L+ 
Sbjct: 130 TDIV--------------SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
            +   K++DFGF   + +  V +RKS    P  WMAPE +  ++++ + DIWS G+++ E
Sbjct: 176 LDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIE 233

Query: 204 IVTLGSTPY 212
           +V  G  PY
Sbjct: 234 MVD-GEPPY 241

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (305), Expect = 4e-32
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 42/217 (19%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF------FVIMEYV 78
           VA+K  ++    + R     E+ +MK L+ HPNVV         +         + MEY 
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L+ +L          N       L    + +    ++  +++L    IIHRDL   
Sbjct: 101 EGGDLRKYL----------NQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 150

Query: 139 NVLI---GENHCCKVADFGFARDL-----MTSSV----YERKSEGRLPIRWMAPESLYDN 186
           N+++    +    K+ D G+A++L      T  V    Y            +APE L   
Sbjct: 151 NIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY------------LAPELLEQK 198

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            ++V  D WSFG L +E +T G  P+           
Sbjct: 199 KYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHG 234

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (294), Expect = 5e-32
 Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 54/231 (23%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF------------ 71
             A+K ++    +   +  L E+ ++ +L+ H  VVR      E+  F            
Sbjct: 33  YYAIKKIRHTEEKLSTI--LSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKST 89

Query: 72  -FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-SFCYQVARGMQFLSSRG 129
            F+ MEY   G L   +                N    RD       Q+   + ++ S+G
Sbjct: 90  LFIQMEYCENGTLYDLIH-------------SENLNQQRDEYWRLFRQILEALSYIHSQG 136

Query: 130 IIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR------------W 177
           IIHRDL   N+ I E+   K+ DFG A+++  S    +     LP              +
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196

Query: 178 MAPE-----SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +A E       Y+     K D++S G++ +E++        GM    ++KK
Sbjct: 197 VATEVLDGTGHYNE----KIDMYSLGIIFFEMIYP---FSTGMERVNILKK 240

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (293), Expect = 6e-32
 Identities = 39/205 (19%), Positives = 81/205 (39%), Gaps = 36/205 (17%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF------------ 71
              +K +K            +E+  +  LD H N+V   GC    +              
Sbjct: 38  TYVIKRVK-----YNNEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSK 91

Query: 72  ----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS 127
               F+ ME+   G L+ ++   R ++           L          Q+ +G+ ++ S
Sbjct: 92  TKCLFIQMEFCDKGTLEQWIEKRRGEK-----------LDKVLALELFEQITKGVDYIHS 140

Query: 128 RGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI 187
           + +I+RDL   N+ + +    K+ DFG    L      +R        R+M+PE +    
Sbjct: 141 KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTL-RYMSPEQISSQD 197

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPY 212
           +  + D+++ G+++ E++ +  T +
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF 222

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 8e-32
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 18/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K +     E E  D+ QE+TV+   D  P V +  G   +    ++IMEY+  G  
Sbjct: 49  VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L              +   L    + +   ++ +G+ +L S   IHRD+ A NVL+ 
Sbjct: 108 LDLL--------------EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ADFG A  L T +  +R +    P  WMAPE +  + +  K+DIWS G+   E
Sbjct: 154 EHGEVKLADFGVAGQL-TDTQIKRNTFVGTP-FWMAPEVIKQSAYDSKADIWSLGITAIE 211

Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  P+  +   +V+
Sbjct: 212 LAR-GEPPHSELHPMKVL 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (291), Expect = 2e-31
 Identities = 51/229 (22%), Positives = 79/229 (34%), Gaps = 51/229 (22%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC--CTEKEPFFVIMEYVPYG 81
           + A+K     +  R     ++E  V+K L+ H N+V+L      T      +IME+ P G
Sbjct: 36  LFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCG 94

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L + L               +  L   +       V  GM  L   GI+HR++   N++
Sbjct: 95  SLYTVLEE----------PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144

Query: 142 IG----ENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNI- 187
                      K+ DFG AR     +   S      Y            + P+     + 
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY------------LHPDMYERAVL 192

Query: 188 -------FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA----EVMKKSK 225
                  +    D+WS GV  +   T GS P+          EVM K  
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPRRNKEVMYKII 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (295), Expect = 3e-31
 Identities = 48/234 (20%), Positives = 86/234 (36%), Gaps = 37/234 (15%)

Query: 3   CFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLL-QELTVMKTLDPHPNVVRL 61
                V +        R+    VAVK +       E      +E+ +++  D HPNV+R 
Sbjct: 36  AEGTIVYRGMFD---NRD----VAVKRIL-----PECFSFADREVQLLRESDEHPNVIRY 83

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
                +++  ++ +E      LQ ++              K  +    +  +   Q   G
Sbjct: 84  FCTEKDRQFQYIAIELCA-ATLQEYVEQ------------KDFAHLGLEPITLLQQTTSG 130

Query: 122 MQFLSSRGIIHRDLAARNVLIGE-----NHCCKVADFGFARDLM--TSSVYERKSEGRLP 174
           +  L S  I+HRDL   N+LI            ++DFG  + L     S   R       
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 175 IRWMAPESLYDNIF---SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
             W+APE L ++     +   DI+S G + + +++ GS P+      +      
Sbjct: 191 G-WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (290), Expect = 9e-31
 Identities = 51/227 (22%), Positives = 79/227 (34%), Gaps = 51/227 (22%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC--CTEKEPFFVIMEYVPYG 81
           + A+K     +  R     ++E  V+K L+ H N+V+L      T      +IME+ P G
Sbjct: 36  LFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCG 94

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L + L               +  L   +       V  GM  L   GI+HR++   N++
Sbjct: 95  SLYTVLEE----------PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144

Query: 142 IG----ENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNI- 187
                      K+ DFG AR     +   S      Y            + P+     + 
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY------------LHPDMYERAVL 192

Query: 188 -------FSVKSDIWSFGVLIWEIVTLGSTPY----PGMAAAEVMKK 223
                  +    D+WS GV  +   T GS P+          EVM K
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPRRNKEVMYK 238

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  115 bits (290), Expect = 1e-30
 Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 33/208 (15%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +  E A  +       E+  +  L      ++RL       +  +++ME     
Sbjct: 82  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-I 140

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L S+L+                 +   +  S+   +   +  +   GI+H DL   N L
Sbjct: 141 DLNSWLKK----------KKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 187

Query: 142 IGENHCCKVADFGFARDLM--TSSVYERKSEGRLPIRWMAPESLYD-----------NIF 188
           I  +   K+ DFG A  +   T+SV +    G +   +M PE++ D           +  
Sbjct: 188 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN--YMPPEAIKDMSSSRENGKSKSKI 244

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
           S KSD+WS G +++ +   G TP+  + 
Sbjct: 245 SPKSDVWSLGCILYYMTY-GKTPFQQII 271

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (285), Expect = 2e-30
 Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 33/208 (15%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +  E A  +       E+  +  L      ++RL       +  +++ME     
Sbjct: 35  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-I 93

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L S+L+                 +   +  S+   +   +  +   GI+H DL   N L
Sbjct: 94  DLNSWLKK----------KKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 140

Query: 142 IGENHCCKVADFGFARDLM--TSSVYERKSEGRLPIRWMAPESLYD-----------NIF 188
           I  +   K+ DFG A  +   T+SV +    G +   +M PE++ D           +  
Sbjct: 141 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN--YMPPEAIKDMSSSRENGKSKSKI 197

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
           S KSD+WS G +++ +   G TP+  + 
Sbjct: 198 SPKSDVWSLGCILYYMTY-GKTPFQQII 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (284), Expect = 3e-30
 Identities = 46/208 (22%), Positives = 82/208 (39%), Gaps = 33/208 (15%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I A+K +  E A  +       E+  +  L      ++RL       +  +++ME     
Sbjct: 54  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-I 112

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L S+L+                 +   +  S+   +   +  +   GI+H DL   N L
Sbjct: 113 DLNSWLKK----------KKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 159

Query: 142 IGENHCCKVADFGFARDLM--TSSVYERKSEGRLPIRWMAPESLYDN-----------IF 188
           I  +   K+ DFG A  +   T+SV +    G +   +M PE++ D              
Sbjct: 160 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN--YMPPEAIKDMSSSRENGKSKSKI 216

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMA 216
           S KSD+WS G +++ +   G TP+  + 
Sbjct: 217 SPKSDVWSLGCILYYMTY-GKTPFQQII 243

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  112 bits (281), Expect = 7e-30
 Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           IVA+K +     E +  ++++E+++M+  D  P+VV+  G   +    +++MEY   G +
Sbjct: 56  IVAIKQVPV---ESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                          +  ++ +LT  ++ +      +G+++L     IHRD+ A N+L+ 
Sbjct: 112 SDI------------IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN 159

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
                K+ADFG A  L T ++ +R +    P  WMAPE + +  ++  +DIWS G+   E
Sbjct: 160 TEGHAKLADFGVAGQL-TDTMAKRNTVIGTPF-WMAPEVIQEIGYNCVADIWSLGITAIE 217

Query: 204 IVTLGSTPYPGMAAAEVM 221
           +   G  PY  +     +
Sbjct: 218 MAE-GKPPYADIHPMRAI 234

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (280), Expect = 7e-30
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           + A K ++  + E    D + E+ ++ T D HP +V+LLG        ++++E+ P G +
Sbjct: 46  LAAAKVIETKSEEELE-DYIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            + +                  LT   +   C Q+   + FL S+ IIHRDL A NVL+ 
Sbjct: 104 DAIMLELD------------RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---------SLYDNIFSVKSDI 194
                ++ADFG +      ++ +R S    P  WMAPE         + YD     K+DI
Sbjct: 152 LEGDIRLADFGVSAKN-LKTLQKRDSFIGTPY-WMAPEVVMCETMKDTPYDY----KADI 205

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVM 221
           WS G+ + E+      P+  +    V+
Sbjct: 206 WSLGITLIEMAQ-IEPPHHELNPMRVL 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 1e-29
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 35/213 (16%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF------VIMEY 77
           + A+K +     E E  ++ QE+ ++K    H N+    G   +K P        ++ME+
Sbjct: 51  LAAIKVMDVTGDEEE--EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G +   ++++           K N+L    +   C ++ RG+  L    +IHRD+  
Sbjct: 109 CGAGSVTDLIKNT-----------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 157

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE---------SLYDNIF 188
           +NVL+ EN   K+ DFG +  L   +V  R +    P  WMAPE         + YD   
Sbjct: 158 QNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTP-YWMAPEVIACDENPDATYDF-- 213

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
             KSD+WS G+   E+   G+ P   M     +
Sbjct: 214 --KSDLWSLGITAIEMAE-GAPPLCDMHPMRAL 243

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (277), Expect = 3e-29
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 18/197 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           I+AVK ++    E+E+  LL +L V+      P +V+  G    +   ++ ME +     
Sbjct: 49  IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSF 107

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARNVLI 142
             F +               + +    L        + +  L  +  IIHRD+   N+L+
Sbjct: 108 DKFYKYV--------YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL 159

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE----SLYDNIFSVKSDIWSFG 198
             +   K+ DFG +  L   S+ + +  G  P  +MAPE    S     + V+SD+WS G
Sbjct: 160 DRSGNIKLCDFGISGQL-VDSIAKTRDAGCRP--YMAPERIDPSASRQGYDVRSDVWSLG 216

Query: 199 VLIWEIVTLGSTPYPGM 215
           + ++E+ T G  PYP  
Sbjct: 217 ITLYELAT-GRFPYPKW 232

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (274), Expect = 4e-29
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 24  IVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I+A+K L +   E+  ++  L +E+ +   L  HPN++RL G   +    ++I+EY P G
Sbjct: 36  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLG 94

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +   L+             K +    +   ++  ++A  + +  S+ +IHRD+   N+L
Sbjct: 95  TVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +G     K+ADFG++  +   S       G L   ++ PE +   +   K D+WS GVL 
Sbjct: 142 LGSAGELKIADFGWS--VHAPSSRRTDLCGTLD--YLPPEMIEGRMHDEKVDLWSLGVLC 197

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           +E +  G  P+      E  K+
Sbjct: 198 YEFLV-GKPPFEANTYQETYKR 218

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 4e-29
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 22/192 (11%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           ++A K +        R  +++EL V+   +  P +V   G         + ME++  G L
Sbjct: 60  VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSL 118

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARNVLI 142
              L+             K+  +  + L      V +G+ +L     I+HRD+   N+L+
Sbjct: 119 DQVLK-------------KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 165

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                 K+ DFG +  L+ S      S  G     +M+PE L    +SV+SDIWS G+ +
Sbjct: 166 NSRGEIKLCDFGVSGQLIDS---MANSFVGTRS--YMSPERLQGTHYSVQSDIWSMGLSL 220

Query: 202 WEIVTLGSTPYP 213
            E+   G  P P
Sbjct: 221 VEMAV-GRYPIP 231

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  108 bits (272), Expect = 1e-28
 Identities = 41/206 (19%), Positives = 85/206 (41%), Gaps = 32/206 (15%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----FFVIMEYVP 79
             A+K +  +  +++R +  +E  + +  + HPN++RL+  C  +       ++++ +  
Sbjct: 56  FYALKRILCH-EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHEAWLLLPFFK 113

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            G L + +           +  K N LT   +      + RG++ + ++G  HRDL   N
Sbjct: 114 RGTLWNEI---------ERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN 164

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW---------MAPE----SLYDN 186
           +L+G+     + D G           E   +      W          APE      +  
Sbjct: 165 ILLGDEGQPVLMDLGSMNQA--CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPY 212
           I   ++D+WS G +++ ++  G  PY
Sbjct: 223 I-DERTDVWSLGCVLYAMMF-GEGPY 246

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (267), Expect = 4e-28
 Identities = 50/202 (24%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 24  IVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           I+A+K L ++  E+E ++  L +E+ +   L  HPN++R+     +++  ++++E+ P G
Sbjct: 41  IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRG 99

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
           +L   L+  +  R+           ++     F  ++A  + +   R +IHRD+   N+L
Sbjct: 100 ELYKELQ--KHGRF-------DEQRSAT----FMEELADALHYCHERKVIHRDIKPENLL 146

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +G     K+ADFG++  +   S+  R   G L   ++ PE +       K D+W  GVL 
Sbjct: 147 MGYKGELKIADFGWS--VHAPSLRRRTMCGTLD--YLPPEMIEGKTHDEKVDLWCAGVLC 202

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           +E +  G  P+   +  E  ++
Sbjct: 203 YEFLV-GMPPFDSPSHTETHRR 223

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  106 bits (267), Expect = 5e-28
 Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 19/198 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           I+AVK ++     +E+  LL +L +       P  V   G    +   ++ ME +    L
Sbjct: 34  IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSL 92

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARNVLI 142
             F +          +  K  ++    L      + + ++ L S   +IHRD+   NVLI
Sbjct: 93  DKFYK---------QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 143

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE----SLYDNIFSVKSDIWSFG 198
                 K+ DFG +  L    V +    G  P  +MAPE     L    +SVKSDIWS G
Sbjct: 144 NALGQVKMCDFGISGYL-VDDVAKDIDAGCKP--YMAPERINPELNQKGYSVKSDIWSLG 200

Query: 199 VLIWEIVTLGSTPYPGMA 216
           + + E+      PY    
Sbjct: 201 ITMIELAI-LRFPYDSWG 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (266), Expect = 5e-28
 Identities = 44/190 (23%), Positives = 86/190 (45%), Gaps = 18/190 (9%)

Query: 24  IVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
            VA+K + + A  +  +   +  E+ +   L  HP+++ L     +    ++++E    G
Sbjct: 38  EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNG 96

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
           ++  +L++            +    +  +   F +Q+  GM +L S GI+HRDL   N+L
Sbjct: 97  EMNRYLKN------------RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL 144

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +  N   K+ADFG A  L           G     +++PE    +   ++SD+WS G + 
Sbjct: 145 LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN--YISPEIATRSAHGLESDVWSLGCMF 202

Query: 202 WEIVTLGSTP 211
           + ++  G  P
Sbjct: 203 YTLLI-GRPP 211

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 2e-27
 Identities = 48/212 (22%), Positives = 82/212 (38%), Gaps = 44/212 (20%)

Query: 24  IVAVKT--LKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           +VA+K           +  D+++E+  ++ L  HPN ++  GC   +   +++MEY    
Sbjct: 81  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS 139

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
                            +      L   ++ +  +   +G+ +L S  +IHRD+ A N+L
Sbjct: 140 ASDL-------------LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 142 IGENHCCKVADFGFA-----RDLMTSSVYERKSEGRLPIRWMAPE-------SLYDNIFS 189
           + E    K+ DFG A      +    + Y           WMAPE         YD    
Sbjct: 187 LSEPGLVKLGDFGSASIMAPANSFVGTPY-----------WMAPEVILAMDEGQYDG--- 232

Query: 190 VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM 221
            K D+WS G+   E+      P   M A   +
Sbjct: 233 -KVDVWSLGITCIELAE-RKPPLFNMNAMSAL 262

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  104 bits (263), Expect = 3e-27
 Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 53/205 (25%)

Query: 24  IVAVKTLKENA------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
            VAVK L           +++     QE+ VM     H N+V LLG  ++ +   ++  Y
Sbjct: 56  TVAVKKLAAMVDITTEELKQQ---FDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVY 111

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLT----SRDLTSFCYQVARGMQFLSSRGIIHR 133
           +P G L   L                 +       R         A G+ FL     IHR
Sbjct: 112 MPNGSLLDRL------------SCLDGTPPLSWHMR--CKIAQGAANGINFLHENHHIHR 157

Query: 134 DLAARNVLIGENHCCKVADFGFARDL-------MTSSV-----YERKSEGRLPIRWMAPE 181
           D+ + N+L+ E    K++DFG AR         MTS +     Y            MAPE
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY------------MAPE 205

Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVT 206
           +L     + KSDI+SFGV++ EI+T
Sbjct: 206 ALRGE-ITPKSDIYSFGVVLLEIIT 229

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (260), Expect = 9e-27
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--------TEKEPFFVIM 75
             A+K L  N  E+ R  ++QE+  MK L  HPN+V+             T +  F ++ 
Sbjct: 55  EYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHR 133
           E    G+L  FL+   ++            L+   +    YQ  R +Q +  +   IIHR
Sbjct: 114 ELCK-GQLVEFLKKMESRGP----------LSCDTVLKIFYQTCRAVQHMHRQKPPIIHR 162

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----------WMAPE-- 181
           DL   N+L+      K+ DFG A  +     Y   ++ R  +           +  PE  
Sbjct: 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222

Query: 182 SLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            LY N     K DIW+ G +++ +      P+   A   ++ 
Sbjct: 223 DLYSNFPIGEKQDIWALGCILYLLCF-RQHPFEDGAKLRIVN 263

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  103 bits (259), Expect = 1e-26
 Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 23/198 (11%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           ++AVK ++ +  + E   +L +L V+      P +V+  G        F+ ME +     
Sbjct: 52  VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE 111

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGIIHRDLAARNVLI 142
           +   R                 +  R L      + + + +L    G+IHRD+   N+L+
Sbjct: 112 KLKKR-------------MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE-----SLYDNIFSVKSDIWSF 197
            E    K+ DFG +  L      + +S G     +MAPE           + +++D+WS 
Sbjct: 159 DERGQIKLCDFGISGRL-VDDKAKDRSAGCAA--YMAPERIDPPDPTKPDYDIRADVWSL 215

Query: 198 GVLIWEIVTLGSTPYPGM 215
           G+ + E+ T G  PY   
Sbjct: 216 GISLVELAT-GQFPYKNC 232

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (257), Expect = 1e-26
 Identities = 42/190 (22%), Positives = 80/190 (42%), Gaps = 19/190 (10%)

Query: 24  IVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A K + ++   +      +  E+++ ++L  H +VV   G   + +  FV++E     
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRR 100

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L    +                 LT  +   +  Q+  G Q+L    +IHRDL   N+ 
Sbjct: 101 SLLELHKR----------RKA---LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E+   K+ DFG A  +      ++   G     ++APE L     S + D+WS G ++
Sbjct: 148 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN--YIAPEVLSKKGHSFEVDVWSIGCIM 205

Query: 202 WEIVTLGSTP 211
           + ++  G  P
Sbjct: 206 YTLLV-GKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  103 bits (258), Expect = 2e-26
 Identities = 41/190 (21%), Positives = 79/190 (41%), Gaps = 19/190 (10%)

Query: 24  IVAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A K + ++   +      +  E+++ ++L  H +VV   G   + +  FV++E     
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRR 126

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L    +                   +R    +  Q+  G Q+L    +IHRDL   N+ 
Sbjct: 127 SLLELHKR----------RKALTEPEAR---YYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + E+   K+ DFG A  +      ++   G     ++APE L     S + D+WS G ++
Sbjct: 174 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN--YIAPEVLSKKGHSFEVDVWSIGCIM 231

Query: 202 WEIVTLGSTP 211
           + ++  G  P
Sbjct: 232 YTLLV-GKPP 240

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (256), Expect = 1e-25
 Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 52/238 (21%)

Query: 3   CFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLL-QELTVMKTLDPHPNVVRL 61
                V +       GR     VAVK +       +  D+   E+ ++   D HPNV+R 
Sbjct: 27  SSGTVVFQGSFQ---GRP----VAVKRML-----IDFCDIALMEIKLLTESDDHPNVIRY 74

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
               T     ++ +E      LQ  + S       N            +  S   Q+A G
Sbjct: 75  YCSETTDRFLYIALELCN-LNLQDLVES------KNVSDENLKLQKEYNPISLLRQIASG 127

Query: 122 MQFLSSRGIIHRDLAARNVLI-------------GENHCCKVADFGFARDLMTSSVYERK 168
           +  L S  IIHRDL  +N+L+              EN    ++DFG  + L +     R 
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 169 -------SEGRLPIRWMAPESLYDNIFSV-------KSDIWSFGVLIWEIVTLGSTPY 212
                  + G     W APE L ++             DI+S G + + I++ G  P+
Sbjct: 188 NLNNPSGTSG-----WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (251), Expect = 6e-25
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 23/203 (11%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            A+K + K +        LL+E+ V+K LD HPN+++L     +K  ++++ME    G+L
Sbjct: 65  RAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGEL 123

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F       ++              D      QV  G+ +L    I+HRDL   N+L+ 
Sbjct: 124 --FDEIIHRMKF-----------NEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170

Query: 143 --GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
              ++   K+ DFG +         + +  G     ++APE L    +  K D+WS GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERL-GT--AYYIAPEVLRKK-YDEKCDVWSIGVI 226

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           ++ ++  G  P+ G    E+++K
Sbjct: 227 LFILLA-GYPPFGGQTDQEILRK 248

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 98.8 bits (247), Expect = 7e-25
 Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 32/195 (16%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VAVK LKE   +   L    E+ ++     H N++RL G C       ++  Y+  G +
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSV 114

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSF--CYQVARGMQFL---SSRGIIHRDLAA 137
            S L              +  S    D           ARG+ +L       IIHRD+ A
Sbjct: 115 ASCL------------RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162

Query: 138 RNVLIGENHCCKVADFGFAR--DLMTSSVYERKSEGRLPIR----WMAPESLYDNIFSVK 191
            N+L+ E     V DFG A+  D   + V          +R     +APE L     S K
Sbjct: 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-------VRGTIGHIAPEYLSTGKSSEK 215

Query: 192 SDIWSFGVLIWEIVT 206
           +D++ +GV++ E++T
Sbjct: 216 TDVFGYGVMLLELIT 230

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.9 bits (244), Expect = 2e-24
 Identities = 40/210 (19%), Positives = 78/210 (37%), Gaps = 36/210 (17%)

Query: 24  IVAVKTLKENAGERERL----------------DLLQELTVMKTLDPHPNVVRLLGCCTE 67
             A+K  +++  E++R                 D   EL ++  +  +   +   G  T 
Sbjct: 56  FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITN 114

Query: 68  KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-S 126
            +  ++I EY+    +  F                +  +  + +      V     ++ +
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDK-----NYTCFIPIQVIKCIIKSVLNSFSYIHN 169

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE----- 181
            + I HRD+   N+L+ +N   K++DFG +   M      + S G     +M PE     
Sbjct: 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKI-KGSRGTYE--FMPPEFFSNE 225

Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVTLGSTP 211
           S Y+     K DIWS G+ ++ +      P
Sbjct: 226 SSYNGA---KVDIWSLGICLYVMFY-NVVP 251

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.4 bits (243), Expect = 2e-24
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VA+K + K          L +E+ +MK L+ HPN+V+L      ++  ++IMEY   G++
Sbjct: 43  VAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEV 101

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +L +          HG+     +R   S   Q+   +Q+   + I+HRDL A N+L+ 
Sbjct: 102 FDYLVA----------HGRMKEKEAR---SKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFGV 199
            +   K+ADFGF+    T         G  P  + APE      YD     + D+WS GV
Sbjct: 149 ADMNIKIADFGFSN-EFTVGGKLDAFCGAPP--YAAPELFQGKKYD---GPEVDVWSLGV 202

Query: 200 LIWEIVTLGSTP 211
           +++ +V+ GS P
Sbjct: 203 ILYTLVS-GSLP 213

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 96.9 bits (242), Expect = 3e-24
 Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 49/201 (24%)

Query: 25  VAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VA+K     +  G  E      E+  +     HP++V L+G C E+    +I +Y+  G 
Sbjct: 66  VALKRRTPESSQGIEE---FETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-----SFCYQVARGMQFLSSRGIIHRDLAA 137
           L+  L            +G      S  ++       C   ARG+ +L +R IIHRD+ +
Sbjct: 122 LKRHL------------YGSDLPTMS--MSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSV------------YERKSEGRLPIRWMAPESLYD 185
            N+L+ EN   K+ DFG ++                   Y            + PE    
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY------------IDPEYFIK 215

Query: 186 NIFSVKSDIWSFGVLIWEIVT 206
              + KSD++SFGV+++E++ 
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLC 236

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 5e-24
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)

Query: 24  IVAVKTLKENAGERERLDL--LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           IVA+K ++ +  + E +    L+E+ ++K L  H N+VRL       +   ++ E+    
Sbjct: 29  IVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ- 85

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+ +  S             +  L    + SF +Q+ +G+ F  SR ++HRDL  +N+L
Sbjct: 86  DLKKYFDS------------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL 133

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM----------APESLY-DNIFSV 190
           I  N   K+A+FG AR               +P+R             P+ L+   ++S 
Sbjct: 134 INRNGELKLANFGLARAF------------GIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPG 214
             D+WS G +  E+   G   +PG
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPG 205

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.0 bits (237), Expect = 1e-23
 Identities = 37/198 (18%), Positives = 73/198 (36%), Gaps = 48/198 (24%)

Query: 25  VAVKTLK--------ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
            AVK +             +  R   L+E+ +++ +  HPN+++L         FF++ +
Sbjct: 45  YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 104

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            +  G+L  F   +                + ++       +   +  L    I+HRDL 
Sbjct: 105 LMKKGEL--FDYLTEKVTL-----------SEKETRKIMRALLEVICALHKLNIVHRDLK 151

Query: 137 ARNVLIGENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNI 187
             N+L+ ++   K+ DFGF+      + +        Y            +APE +  ++
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY------------LAPEIIECSM 199

Query: 188 FSVKS------DIWSFGV 199
                      D+WS GV
Sbjct: 200 NDNHPGYGKEVDMWSTGV 217

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 95.9 bits (239), Expect = 3e-23
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 41/212 (19%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            AVK + K +A  ++   +L+E+ ++K LD HPN+++L     +   F+++ E    G+L
Sbjct: 50  YAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL 108

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F    + +R+           +  D      QV  G+ ++    I+HRDL   N+L+ 
Sbjct: 109 --FDEIIKRKRF-----------SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 143 --GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVK 191
              ++   K+ DFG +        M   +    Y            +APE L    +  K
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY------------IAPEVLRGT-YDEK 202

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            D+WS GV+++ +++ G+ P+ G    +++K+
Sbjct: 203 CDVWSAGVILYILLS-GTPPFYGKNEYDILKR 233

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.5 bits (233), Expect = 3e-23
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 46/191 (24%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            AVK + K +A  ++   +L+E+ ++K LD HPN+++L     +   F+++ E    G+L
Sbjct: 50  YAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL 108

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F    + +R+           +  D      QV  G+ ++    I+HRDL   N+L+ 
Sbjct: 109 --FDEIIKRKRF-----------SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 143 --GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESL---YDNIF 188
              ++   K+ DFG +        M   +    Y            +APE L   YD   
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY------------IAPEVLRGTYDE-- 201

Query: 189 SVKSDIWSFGV 199
             K D+WS GV
Sbjct: 202 --KCDVWSAGV 210

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 94.7 bits (235), Expect = 4e-23
 Identities = 26/218 (11%), Positives = 61/218 (27%), Gaps = 32/218 (14%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
              +K  K  A   E     Q +  +K        ++       +    ++ E   YG L
Sbjct: 97  KFVLKVQKP-ANPWEFYIGTQLMERLKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTL 154

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            + +   +              L       F  ++   ++ +    IIH D+   N ++G
Sbjct: 155 LNAINLYK----NTPEKVMPQGLVIS----FAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206

Query: 144 -----------ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW-----MAPESLYDNI 187
                       +    + D G + D+                +         E L +  
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKL-----FPKGTIFTAKCETSGFQCVEMLSNKP 261

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           ++ + D +     ++ ++  G+         E   +  
Sbjct: 262 WNYQIDYFGVAATVYCMLF-GTYMKVKNEGGECKPEGL 298

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.8 bits (236), Expect = 4e-23
 Identities = 38/197 (19%), Positives = 75/197 (38%), Gaps = 47/197 (23%)

Query: 25  VAVKT-------LKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
            AVK        L     E  R    +E  +++ +  HP+++ L+         F++ + 
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G+L  F   +                + ++  S    +   + FL +  I+HRDL  
Sbjct: 182 MRKGEL--FDYLTEKVAL-----------SEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228

Query: 138 RNVLIGENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIF 188
            N+L+ +N   +++DFGF+      + +        Y            +APE L  ++ 
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY------------LAPEILKCSMD 276

Query: 189 SV------KSDIWSFGV 199
                   + D+W+ GV
Sbjct: 277 ETHPGYGKEVDLWACGV 293

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.5 bits (233), Expect = 4e-23
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 26/198 (13%)

Query: 8   VRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL---LGC 64
           + +    P R        A     +  G  E++   QE+ ++K LD HPNVV+L   L  
Sbjct: 51  LIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV--YQEIAILKKLD-HPNVVKLVEVLDD 107

Query: 65  CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF 124
             E   + V  E V  G +                    +   +R    +   + +G+++
Sbjct: 108 PNEDHLYMV-FELVNQGPVMEVPT-----------LKPLSEDQAR---FYFQDLIKGIEY 152

Query: 125 LSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY 184
           L  + IIHRD+   N+L+GE+   K+ADFG + +   S      + G     +MAPESL 
Sbjct: 153 LHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA--FMAPESLS 210

Query: 185 DNIFSV---KSDIWSFGV 199
           +          D+W+ GV
Sbjct: 211 ETRKIFSGKALDVWAMGV 228

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.1 bits (237), Expect = 6e-23
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 24/204 (11%)

Query: 25  VAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
            AVK + +     + ++  LL+E+ ++K LD HPN+++L     +K  F+++ E    G+
Sbjct: 54  CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGE 112

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L  F      +R+           +  D      QV  G+ ++    I+HRDL   N+L+
Sbjct: 113 L--FDEIISRKRF-----------SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159

Query: 143 ---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
               ++   ++ DFG +     S   + K  G     ++APE L+   +  K D+WS GV
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKI-GT--AYYIAPEVLHGT-YDEKCDVWSTGV 215

Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           +++ +++ G  P+ G    +++KK
Sbjct: 216 ILYILLS-GCPPFNGANEYDILKK 238

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.4 bits (233), Expect = 6e-23
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 42/197 (21%)

Query: 24  IVAVKTLK-ENAGERERLDL--LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           IVA+K ++ +   E E +    ++E++++K L  HPN+V L+     +    ++ E++  
Sbjct: 47  IVALKRIRLDA--EDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEK 103

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             L+  L  ++              L    +  + YQ+ RG+       I+HRDL  +N+
Sbjct: 104 D-LKKVLDENK------------TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150

Query: 141 LIGENHCCKVADFGFARD------LMTSSV----YERKSEGRLPIRWMAPESLY-DNIFS 189
           LI  +   K+ADFG AR         T  V    Y R           AP+ L     +S
Sbjct: 151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY-R-----------APDVLMGSKKYS 198

Query: 190 VKSDIWSFGVLIWEIVT 206
              DIWS G +  E++T
Sbjct: 199 TSVDIWSIGCIFAEMIT 215

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.0 bits (231), Expect = 1e-22
 Identities = 40/233 (17%), Positives = 82/233 (35%), Gaps = 24/233 (10%)

Query: 1   MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR 60
           +  F+  +   P   +   +   +    T    +          ++  M       N V 
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVG 125

Query: 61  LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR 120
            L   + K   ++ M+      L+ ++    +     +                  Q+A 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV----------CLHIFIQIAE 175

Query: 121 GMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR---- 176
            ++FL S+G++HRDL   N+    +   KV DFG    +      +              
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 177 ------WMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
                 +M+PE ++ N +S K DI+S G++++E++   ST    M    ++  
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST---QMERVRIITD 285

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 92.6 bits (231), Expect = 1e-22
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 46/201 (22%)

Query: 24  IVAVKTLKENAGE-------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
            VA+K +K ++ E       RE + L++EL        H N+VRL      +    ++ E
Sbjct: 32  YVALKEVKLDSEEGTPSTAIRE-ISLMKELK-------HENIVRLYDVIHTENKLTLVFE 83

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++    L+ ++ S         +      L    +  F +Q+ +G+ F     I+HRDL 
Sbjct: 84  FMDN-DLKKYMDS-------RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135

Query: 137 ARNVLIGENHCCKVADFGFARD------LMTSSV----YERKSEGRLPIRWMAPESLY-D 185
            +N+LI +    K+ DFG AR         +S V    Y R           AP+ L   
Sbjct: 136 PQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY-R-----------APDVLMGS 183

Query: 186 NIFSVKSDIWSFGVLIWEIVT 206
             +S   DIWS G ++ E++T
Sbjct: 184 RTYSTSIDIWSCGCILAEMIT 204

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 91.5 bits (228), Expect = 2e-22
 Identities = 42/190 (22%), Positives = 80/190 (42%), Gaps = 41/190 (21%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
             +KT+ ++  +     +  E+ V+K+LD HPN++++     +    +++ME    G+L 
Sbjct: 50  RVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELL 108

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
             + S++A         +  +L+   +     Q+   + +  S+ ++H+DL   N+L   
Sbjct: 109 ERIVSAQA---------RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159

Query: 143 -GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESL---YDNIFS 189
              +   K+ DFG A      +  T++     Y            MAPE           
Sbjct: 160 TSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY------------MAPEVFKRDVTF--- 204

Query: 190 VKSDIWSFGV 199
            K DIWS GV
Sbjct: 205 -KCDIWSAGV 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 91.5 bits (228), Expect = 2e-22
 Identities = 44/188 (23%), Positives = 75/188 (39%), Gaps = 39/188 (20%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            A K +  +    R+   L +E  + + L  HPN+VRL     E+   +++ + V  G+L
Sbjct: 34  FAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL 92

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F      + Y           +  D +    Q+   + +  S GI+HR+L   N+L+ 
Sbjct: 93  --FEDIVAREFY-----------SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139

Query: 143 --GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVK 191
              +    K+ADFG A      +          Y            ++PE L  + +S  
Sbjct: 140 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY------------LSPEVLKKDPYSKP 187

Query: 192 SDIWSFGV 199
            DIW+ GV
Sbjct: 188 VDIWACGV 195

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.9 bits (229), Expect = 2e-22
 Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 36/189 (19%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            A K L K   G+  R ++L E+ V++     P V+ L           +I+EY   G++
Sbjct: 57  YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI 116

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
            S      A+             +  D+     Q+  G+ +L    I+H DL  +N+L+ 
Sbjct: 117 FSLCLPELAEMV-----------SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165

Query: 143 --GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVK 191
                   K+ DFG +R       +   +    Y            +APE L  +  +  
Sbjct: 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY------------LAPEILNYDPITTA 213

Query: 192 SDIWSFGVL 200
           +D+W+ G++
Sbjct: 214 TDMWNIGII 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.0 bits (227), Expect = 3e-22
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 40/196 (20%)

Query: 24  IVAVKTLKENAGERERLDL--LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             A+K ++    E E +    ++E++++K L  H N+V+L      K+   ++ E++   
Sbjct: 28  TFALKKIRLEK-EDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQD 85

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L+  L                  L S    SF  Q+  G+ +   R ++HRDL  +N+L
Sbjct: 86  -LKKLLDVCE------------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132

Query: 142 IGENHCCKVADFGFARD------LMTSSV----YERKSEGRLPIRWMAPESLY-DNIFSV 190
           I      K+ADFG AR         T  +    Y R           AP+ L     +S 
Sbjct: 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWY-R-----------APDVLMGSKKYST 180

Query: 191 KSDIWSFGVLIWEIVT 206
             DIWS G +  E+V 
Sbjct: 181 TIDIWSVGCIFAEMVN 196

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.1 bits (227), Expect = 3e-22
 Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 38/186 (20%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A+K +K++   R+   L  E+ V+K +  H N+V L         ++++M+ V  G+L 
Sbjct: 37  FALKCIKKSPAFRDS-SLENEIAVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGEL- 93

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F R      Y           T +D +    QV   +++L   GI+HRDL   N+L   
Sbjct: 94  -FDRILERGVY-----------TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141

Query: 143 -GENHCCKVADFGFAR----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVKSD 193
             EN    + DFG ++     +M+++     Y            +APE L    +S   D
Sbjct: 142 PEENSKIMITDFGLSKMEQNGIMSTACGTPGY------------VAPEVLAQKPYSKAVD 189

Query: 194 IWSFGV 199
            WS GV
Sbjct: 190 CWSIGV 195

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 44/188 (23%), Positives = 75/188 (39%), Gaps = 39/188 (20%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            A K +  +    R+   L +E  + + L  HPN+VRL     E+   +++ + V  G+L
Sbjct: 57  FAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL 115

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F      + Y           +  D +    Q+   + +  S GI+HR+L   N+L+ 
Sbjct: 116 --FEDIVAREFY-----------SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162

Query: 143 --GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVK 191
              +    K+ADFG A      +          Y            ++PE L  + +S  
Sbjct: 163 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY------------LSPEVLKKDPYSKP 210

Query: 192 SDIWSFGV 199
            DIW+ GV
Sbjct: 211 VDIWACGV 218

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.1 bits (227), Expect = 3e-22
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 40/196 (20%)

Query: 24  IVAVKTLKENAGERERLDL--LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           IVA+K   E+  +   +    L+E+ ++K L  HPN+V LL     K    ++ EY  + 
Sbjct: 30  IVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH- 86

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +   L   +              +    + S  +Q  + + F      IHRD+   N+L
Sbjct: 87  TVLHELDRYQ------------RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENIL 134

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM----------APESLY-DNIFSV 190
           I ++   K+ DFGFAR L              P  +           +PE L  D  +  
Sbjct: 135 ITKHSVIKLCDFGFARLL------------TGPSDYYDDEVATRWYRSPELLVGDTQYGP 182

Query: 191 KSDIWSFGVLIWEIVT 206
             D+W+ G +  E+++
Sbjct: 183 PVDVWAIGCVFAELLS 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.1 bits (227), Expect = 4e-22
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 40/196 (20%)

Query: 24  IVAVKTLKENAGERERLDL--LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           IVA+K   E+  + + +    ++E+ ++K L  H N+V LL  C +K+ ++++ E+V + 
Sbjct: 52  IVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH- 108

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            +   L                N L  + +  + +Q+  G+ F  S  IIHRD+   N+L
Sbjct: 109 TILDDLELFP------------NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM----------APESLY-DNIFSV 190
           + ++   K+ DFGFAR L              P              APE L  D  +  
Sbjct: 157 VSQSGVVKLCDFGFARTL------------AAPGEVYDDEVATRWYRAPELLVGDVKYGK 204

Query: 191 KSDIWSFGVLIWEIVT 206
             D+W+ G L+ E+  
Sbjct: 205 AVDVWAIGCLVTEMFM 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.0 bits (224), Expect = 7e-22
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 44/215 (20%)

Query: 24  IVAVKTLKENAGE----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
            VA+K +     E     +R +  +E+     L  H N+V ++    E + ++++MEY+ 
Sbjct: 38  KVAIKAIFIPPREKEETLKRFE--REVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIE 94

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
              L  ++ S          HG    L+     +F  Q+  G++      I+HRD+  +N
Sbjct: 95  GPTLSEYIES----------HGP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQN 141

Query: 140 VLIGENHCCKVADFGFARDL------MTSSV-----YERKSEGRLPIRWMAPESLYDNIF 188
           +LI  N   K+ DFG A+ L       T+ V     Y             +PE       
Sbjct: 142 ILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY------------FSPEQAKGEAT 189

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
              +DI+S G++++E++  G  P+ G  A  +  K
Sbjct: 190 DECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIK 223

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.5 bits (225), Expect = 7e-22
 Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 33/199 (16%)

Query: 25  VAVKTL-KENAGERERLDLLQ----ELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEYV 78
           VA+K + K+   +   L        E+ ++K +      V+RLL      + F +I+E  
Sbjct: 71  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130

Query: 79  -PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
            P   L  F+             G      +R   SF +QV   ++   + G++HRD+  
Sbjct: 131 EPVQDLFDFITE----------RGALQEELAR---SFFWQVLEAVRHCHNCGVLHRDIKD 177

Query: 138 RNVLIGENHCC-KVADFGFARDLMTSSVYERKSEGRLPIRWMAPE----SLYDNIFSVKS 192
            N+LI  N    K+ DFG    L+  +VY    +G     +  PE      Y       +
Sbjct: 178 ENILIDLNRGELKLIDFGSG-ALLKDTVYTD-FDGTRV--YSPPEWIRYHRYH---GRSA 230

Query: 193 DIWSFGVLIWEIVTLGSTP 211
            +WS G+L++++V  G  P
Sbjct: 231 AVWSLGILLYDMVC-GDIP 248

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.2 bits (222), Expect = 1e-21
 Identities = 44/197 (22%), Positives = 71/197 (36%), Gaps = 48/197 (24%)

Query: 19  REGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           +      A K + K    + +     QE+ +MK+LD HPN++RL     +    +++ME 
Sbjct: 31  KGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLD-HPNIIRLYETFEDNTDIYLVMEL 87

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
              G+L  F R    + +              D       V   + +     + HRDL  
Sbjct: 88  CTGGEL--FERVVHKRVF-----------RESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134

Query: 138 RNVLI---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESL-- 183
            N L      +   K+ DFG A       +M + V    Y            ++P+ L  
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY------------VSPQVLEG 182

Query: 184 -YDNIFSVKSDIWSFGV 199
            Y      + D WS GV
Sbjct: 183 LYGP----ECDEWSAGV 195

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 35/201 (17%)

Query: 25  VAVKTL-KENAGERERLDLLQ----ELTVMKTLDP---HPNVVRLLGCCTEKEPFFVIME 76
           VA+K + +        L        E+ ++  +     HP V+RLL     +E F +++E
Sbjct: 59  VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118

Query: 77  Y-VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
             +P   L  ++             G      SR    F  QV   +Q   SRG++HRD+
Sbjct: 119 RPLPAQDLFDYITE----------KGPLGEGPSR---CFFGQVVAAIQHCHSRGVVHRDI 165

Query: 136 AARNVLI-GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE----SLYDNIFSV 190
              N+LI     C K+ DFG    L+    Y    +G     +  PE      Y    ++
Sbjct: 166 KDENILIDLRRGCAKLIDFGSG-ALLHDEPYT-DFDGTRV--YSPPEWISRHQYH---AL 218

Query: 191 KSDIWSFGVLIWEIVTLGSTP 211
            + +WS G+L++++V  G  P
Sbjct: 219 PATVWSLGILLYDMVC-GDIP 238

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.9 bits (224), Expect = 2e-21
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 41/198 (20%)

Query: 24  IVAVKTLKENAGERERLDL----LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           IVA+K +K       +  +    L+E+ +++ L  HPN++ LL     K    ++ +++ 
Sbjct: 37  IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFME 95

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
              L+  ++              S  LT   + ++     +G+++L    I+HRDL   N
Sbjct: 96  TD-LEVIIKD------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 142

Query: 140 VLIGENHCCKVADFGFARDL------MTSSV----YERKSEGRLPIRWMAPESLY-DNIF 188
           +L+ EN   K+ADFG A+         T  V    Y R           APE L+   ++
Sbjct: 143 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY-R-----------APELLFGARMY 190

Query: 189 SVKSDIWSFGVLIWEIVT 206
            V  D+W+ G ++ E++ 
Sbjct: 191 GVGVDMWAVGCILAELLL 208

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.2 bits (222), Expect = 2e-21
 Identities = 48/213 (22%), Positives = 80/213 (37%), Gaps = 57/213 (26%)

Query: 25  VAVKTLKENAGERERLDLLQ---ELTVMKTLDPHPNVVRL---LGCCTEKEPFFVIMEYV 78
            AVK LK+    R          E+ +++ L  H NV++L   L    +++ + V MEY 
Sbjct: 33  RAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMV-MEYC 90

Query: 79  PYGKLQSF-------LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
             G  +             +A  Y                  FC Q+  G+++L S+GI+
Sbjct: 91  VCGMQEMLDSVPEKRFPVCQAHGY------------------FC-QLIDGLEYLHSQGIV 131

Query: 132 HRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-------PIRWMAPE--- 181
           H+D+   N+L+      K++  G       +      +           P  +  PE   
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGV------AEALHPFAADDTCRTSQGSP-AFQPPEIAN 184

Query: 182 --SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY 212
               +      K DIWS GV ++ I T G  P+
Sbjct: 185 GLDTFS---GFKVDIWSAGVTLYNITT-GLYPF 213

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.2 bits (222), Expect = 2e-21
 Identities = 39/190 (20%), Positives = 78/190 (41%), Gaps = 39/190 (20%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            +  +  + +     R ++ +E+++++ +  H NV+ L      +    +I+E V  G+L
Sbjct: 44  FIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGEL 102

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             FL              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ 
Sbjct: 103 FDFLA-------------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 143 ---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSV 190
                    K+ DFG A          +      +            +APE +      +
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF------------VAPEIVNYEPLGL 197

Query: 191 KSDIWSFGVL 200
           ++D+WS GV+
Sbjct: 198 EADMWSIGVI 207

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.5 bits (225), Expect = 2e-21
 Identities = 48/223 (21%), Positives = 96/223 (43%), Gaps = 52/223 (23%)

Query: 25  VAVKTLK------------ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF 72
            A+K +K                E+   ++  E++++K+LD HPN+++L     +K+ F+
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFY 122

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH 132
           ++ E+   G+L  F +     ++              D  +   Q+  G+ +L    I+H
Sbjct: 123 LVTEFYEGGEL--FEQIINRHKF-----------DECDAANIMKQILSGICYLHKHNIVH 169

Query: 133 RDLAARNVLI---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAP 180
           RD+   N+L+         K+ DFG +        +   +    Y            +AP
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY------------IAP 217

Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           E L    ++ K D+WS GV+++ ++  G  P+ G    +++KK
Sbjct: 218 EVLKKK-YNEKCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKK 258

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 40/189 (21%)

Query: 25  VAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            A   +  +    R+   L +E  + + L  HPN+VRL    +E+   ++I + V  G+L
Sbjct: 39  YAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGEL 97

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             F      + Y           +  D +    Q+   +      G++HR+L   N+L+ 
Sbjct: 98  --FEDIVAREYY-----------SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144

Query: 143 --GENHCCKVADFGFAR------DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSV 190
              +    K+ADFG A                  Y            ++PE L  + +  
Sbjct: 145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY------------LSPEVLRKDPYGK 192

Query: 191 KSDIWSFGV 199
             D+W+ GV
Sbjct: 193 PVDLWACGV 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 89.3 bits (222), Expect = 4e-21
 Identities = 39/190 (20%), Positives = 79/190 (41%), Gaps = 39/190 (20%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            +  +  + +     R ++ +E+++++ +  HPN++ L      +    +I+E V  G+L
Sbjct: 44  FIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGEL 102

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             FL              +  SL+  + TSF  Q+  G+ +L ++ I H DL   N+++ 
Sbjct: 103 FDFLA-------------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149

Query: 143 ---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSV 190
                    K+ DFG A          +      +            +APE +      +
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF------------VAPEIVNYEPLGL 197

Query: 191 KSDIWSFGVL 200
           ++D+WS GV+
Sbjct: 198 EADMWSIGVI 207

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.0 bits (219), Expect = 4e-21
 Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 54/208 (25%)

Query: 24  IVAVKTLK---ENAGE--------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-- 70
            VA+K+++      G         RE + LL+ L        HPNVVRL+  C       
Sbjct: 36  FVALKSVRVPNGGGGGGGLPISTVRE-VALLRRLEA----FEHPNVVRLMDVCATSRTDR 90

Query: 71  ---FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS 127
                ++ E+V    L+++L  +               L +  +     Q  RG+ FL +
Sbjct: 91  EIKVTLVFEHVDQ-DLRTYLDKA-----------PPPGLPAETIKDLMRQFLRGLDFLHA 138

Query: 128 RGIIHRDLAARNVLIGENHCCKVADFGFARDL-----MTSSV----YERKSEGRLPIRWM 178
             I+HRDL   N+L+      K+ADFG AR       +T  V    Y R           
Sbjct: 139 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY-R----------- 186

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVT 206
           APE L  + ++   D+WS G +  E+  
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFR 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.5 bits (220), Expect = 4e-21
 Identities = 40/190 (21%), Positives = 75/190 (39%), Gaps = 27/190 (14%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            AVK +++  G   R  + +E+ ++     H NV+ L+    E++ F+++ E +  G + 
Sbjct: 41  YAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI- 98

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
                 + + +              + +     VA  + FL ++GI HRDL   N+L   
Sbjct: 99  -LSHIHKRRHF-----------NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146

Query: 143 -GENHCCKVADFGFARDLMTSSVYERKSEGRLPIR-----WMAPESLYDNIFSVKS---- 192
             +    K+ DF     +  +      S   L        +MAPE +             
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206

Query: 193 -DIWSFGVLI 201
            D+WS GV++
Sbjct: 207 CDLWSLGVIL 216

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.0 bits (219), Expect = 5e-21
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 51/205 (24%)

Query: 24  IVAVKTLK-ENAGE-------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----- 70
            VA+K ++ +   E       RE + +L+ L        HPNVVRL   CT         
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIRE-VAVLRHLET----FEHPNVVRLFDVCTVSRTDRETK 93

Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
             ++ E+V    L ++L                  + +  +    +Q+ RG+ FL S  +
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLHSHRV 141

Query: 131 IHRDLAARNVLIGENHCCKVADFGFARDL-----MTSSV----YERKSEGRLPIRWMAPE 181
           +HRDL  +N+L+  +   K+ADFG AR       +TS V    Y R           APE
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY-R-----------APE 189

Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVT 206
            L  + ++   D+WS G +  E+  
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFR 214

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.0 bits (219), Expect = 5e-21
 Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 45/198 (22%)

Query: 24  IVAVKTLKENAGE-------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           +VA+K ++    E       RE + LL++L        H N+V L      ++   ++ E
Sbjct: 29  LVALKEIRLEHEEGAPCTAIRE-VSLLKDLK-------HANIVTLHDIIHTEKSLTLVFE 80

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           Y+    L+ +L                N +   ++  F +Q+ RG+ +   + ++HRDL 
Sbjct: 81  YLDK-DLKQYLDD------------CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127

Query: 137 ARNVLIGENHCCKVADFGFARD------LMTSSVYERKSEGRLPIRWM-APESLY-DNIF 188
            +N+LI E    K+ADFG AR          + V            W   P+ L     +
Sbjct: 128 PQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------TLWYRPPDILLGSTDY 178

Query: 189 SVKSDIWSFGVLIWEIVT 206
           S + D+W  G + +E+ T
Sbjct: 179 STQIDMWGVGCIFYEMAT 196

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 87.3 bits (217), Expect = 1e-20
 Identities = 40/187 (21%), Positives = 73/187 (39%), Gaps = 38/187 (20%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
              K +K    ++    + +E++++     H N++ L       E   +I E++    + 
Sbjct: 33  YMAKFVKVKGTDQV--LVKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGLDI- 88

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG- 143
            F R          ++  +  L  R++ S+ +QV   +QFL S  I H D+   N++   
Sbjct: 89  -FER----------INTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137

Query: 144 -ENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVKSD 193
             +   K+ +FG AR     D          Y             APE    ++ S  +D
Sbjct: 138 RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY------------YAPEVHQHDVVSTATD 185

Query: 194 IWSFGVL 200
           +WS G L
Sbjct: 186 MWSLGTL 192

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 34/186 (18%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            AVK + +    R   +  +E+T +K  + HPN+V+L     ++   F++ME +  G+L 
Sbjct: 39  FAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL- 93

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F R  + + +           +  + +    ++   +  +   G++HRDL   N+L   
Sbjct: 94  -FERIKKKKHF-----------SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD 141

Query: 143 -GENHCCKVADFGFAR------DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
             +N   K+ DFGFAR        + +  +   +       + APE L  N +    D+W
Sbjct: 142 ENDNLEIKIIDFGFARLKPPDNQPLKTPCF---TLH-----YAAPELLNQNGYDESCDLW 193

Query: 196 SFGVLI 201
           S GV++
Sbjct: 194 SLGVIL 199

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.4 bits (217), Expect = 1e-20
 Identities = 40/186 (21%), Positives = 74/186 (39%), Gaps = 25/186 (13%)

Query: 25  VAVKTLK----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
            AVK +      ++      DL +E ++   L  HP++V LL   +     +++ E++  
Sbjct: 52  FAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDG 110

Query: 81  GKLQSF---LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
             L      ++ + A   Y          +    + +  Q+   +++     IIHRD+  
Sbjct: 111 ADL--CFEIVKRADAGFVY----------SEAVASHYMRQILEALRYCHDNNIIHRDVKP 158

Query: 138 RNVLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
             VL+     +   K+  FG A  L  S +      G  P  +MAPE +    +    D+
Sbjct: 159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT-PH-FMAPEVVKREPYGKPVDV 216

Query: 195 WSFGVL 200
           W  GV+
Sbjct: 217 WGCGVI 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 87.8 bits (218), Expect = 1e-20
 Identities = 44/199 (22%), Positives = 82/199 (41%), Gaps = 49/199 (24%)

Query: 25  VAVKTL-------KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           VA++ +                L++  E+ ++K L+ HP ++++     + E +++++E 
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLEL 220

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G+L   +            + +   L       + YQ+   +Q+L   GIIHRDL  
Sbjct: 221 MEGGELFDKVVG----------NKR---LKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 267

Query: 138 RNVLI---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYD 185
            NVL+    E+   K+ DFG ++      LM +      Y            +APE L  
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY------------LAPEVLVS 315

Query: 186 NIF---SVKSDIWSFGVLI 201
                 +   D WS GV++
Sbjct: 316 VGTAGYNRAVDCWSLGVIL 334

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 39/191 (20%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            +  + L  +     R ++ +E+ +++ +  HPN++ L      K    +I+E V  G+L
Sbjct: 37  FIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGEL 95

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             FL              +  SLT  + T F  Q+  G+ +L S+ I H DL   N+++ 
Sbjct: 96  FDFLA-------------EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142

Query: 143 ---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSV 190
                N   K+ DFG A      +   +      +            +APE +      +
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF------------VAPEIVNYEPLGL 190

Query: 191 KSDIWSFGVLI 201
           ++D+WS GV+ 
Sbjct: 191 EADMWSIGVIT 201

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.7 bits (213), Expect = 2e-20
 Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 43/190 (22%)

Query: 25  VAVKTLKENAGERERL-DLLQ----ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           VAVK +     + +R  D  +    E+ + K L+ H NVV+  G   E    ++ +EY  
Sbjct: 35  VAVKIV-----DMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCS 88

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            G+L  F R                 +   D   F +Q+  G+ +L   GI HRD+   N
Sbjct: 89  GGEL--FDRIEPDIG-----------MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW------MAPESL----YDNIFS 189
           +L+ E    K++DFG       ++V+   +  RL  +       +APE L    +    +
Sbjct: 136 LLLDERDNLKISDFGL------ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH---A 186

Query: 190 VKSDIWSFGV 199
              D+WS G+
Sbjct: 187 EPVDVWSCGI 196

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.0 bits (216), Expect = 3e-20
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 51/202 (25%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC---CTEKEPF---FVIMEYV 78
           VA+K + ++   + R     EL +M+ +  HPNVV L        +K+      +++EYV
Sbjct: 67  VAIKKVLQDKRFKNR-----ELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
           P   +    R     +          ++    +  + YQ+ R + ++ S GI HRD+  +
Sbjct: 121 PE-TVYRASRHYAKLK---------QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170

Query: 139 NVLI-GENHCCKVADFGFARDL-----MTSSV---YERKSEGRLPIRWMAPE-----SLY 184
           N+L+   +   K+ DFG A+ L       S +   Y R           APE     + Y
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR-----------APELIFGATNY 219

Query: 185 DNIFSVKSDIWSFGVLIWEIVT 206
               +   DIWS G ++ E++ 
Sbjct: 220 ----TTNIDIWSTGCVMAELMQ 237

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 86.2 bits (214), Expect = 3e-20
 Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 43/190 (22%)

Query: 25  VAVKTLKENAGERERL-DLLQ----ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           VAVK +     + +R  D  +    E+ + K L+ H NVV+  G   E    ++ +EY  
Sbjct: 35  VAVKIV-----DMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCS 88

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            G+L  F R                 +   D   F +Q+  G+ +L   GI HRD+   N
Sbjct: 89  GGEL--FDRIEPDIG-----------MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW------MAPESL----YDNIFS 189
           +L+ E    K++DFG       ++V+   +  RL  +       +APE L    +    +
Sbjct: 136 LLLDERDNLKISDFGL------ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH---A 186

Query: 190 VKSDIWSFGV 199
              D+WS G+
Sbjct: 187 EPVDVWSCGI 196

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.7 bits (213), Expect = 3e-20
 Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 33/199 (16%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             A+K L K +  +  ++  + +E  VM  LD HP  V+L     + E  +  + Y   G
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNG 115

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
           +L  ++R  +   +                T F Y  ++   +++L  +GIIHRDL   N
Sbjct: 116 ELLKYIR--KIGSF------------DETCTRF-YTAEIVSALEYLHGKGIIHRDLKPEN 160

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKS------EGRLPIRWMAPESLYDNIFSVKSD 193
           +L+ E+   ++ DFG A+ L   S   R +      +      +++PE L +      SD
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ------YVSPELLTEKSACKSSD 214

Query: 194 IWSFGVLIWEIVTLGSTPY 212
           +W+ G +I+++V  G  P+
Sbjct: 215 LWALGCIIYQLVA-GLPPF 232

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.1 bits (214), Expect = 3e-20
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 58/207 (28%)

Query: 24  IVAVKTLK-ENAGE-------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
            VA+K ++ E+  E       RE + LL+EL        H N++ L           +I 
Sbjct: 61  TVAIKRIRLEHEEEGVPGTAIRE-VSLLKELQ-------HRNIIELKSVIHHNHRLHLIF 112

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY     L+ ++  +               ++ R + SF YQ+  G+ F  SR  +HRDL
Sbjct: 113 EYAEN-DLKKYMDKNP-------------DVSMRVIKSFLYQLINGVNFCHSRRCLHRDL 158

Query: 136 AARNVLIGENHCC-----KVADFGFARD------LMTSSV----YERKSEGRLPIRWMAP 180
             +N+L+  +        K+ DFG AR         T  +    Y R            P
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY-R-----------PP 206

Query: 181 ESLY-DNIFSVKSDIWSFGVLIWEIVT 206
           E L     +S   DIWS   +  E++ 
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLM 233

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 4e-20
 Identities = 45/190 (23%), Positives = 78/190 (41%), Gaps = 39/190 (20%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            +  +  K +     R D+ +E++++K +  HPNV+ L      K    +I+E V  G+L
Sbjct: 43  FIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGEL 101

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
             FL              +  SLT  + T F  Q+  G+ +L S  I H DL   N+++ 
Sbjct: 102 FDFLA-------------EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148

Query: 143 ---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSV 190
                    K+ DFG A      +   +      +            +APE +      +
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF------------VAPEIVNYEPLGL 196

Query: 191 KSDIWSFGVL 200
           ++D+WS GV+
Sbjct: 197 EADMWSIGVI 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 86.3 bits (213), Expect = 7e-20
 Identities = 34/227 (14%), Positives = 68/227 (29%), Gaps = 32/227 (14%)

Query: 25  VAVKTL--KENAGERERLDLLQELTVMKTLDP---------------------HPNVVRL 61
             V      E         + +E+  ++ L                        P   ++
Sbjct: 106 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 165

Query: 62  LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG 121
           +    ++   +V+  +  Y ++QS L++        +      SL          QV R 
Sbjct: 166 IRVRLDERDMWVLSRFFLYPRMQSNLQT--FGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
           +  L   G++H  L   ++++ +     +  F        S+V      G  P    A  
Sbjct: 224 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV-SPIGRGFAPPETTAER 282

Query: 182 SLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            L        + +   D W+ G+ I+ I      P    AA    + 
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWC-ADLPNTDDAALGGSEW 328

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.9 bits (213), Expect = 7e-20
 Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 47/201 (23%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF------VIMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL                 ++++Y
Sbjct: 81  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           VP   +    R     +          +L    +  + YQ+ R + ++ S GI HRD+  
Sbjct: 135 VPE-TVYRVARHYSRAK---------QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 184

Query: 138 RNVLIGEN-HCCKVADFGFARDL-----MTSSVYERKSEGRLPIRWM-APE-----SLYD 185
           +N+L+  +    K+ DFG A+ L       S +           R+  APE     + Y 
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---------RYYRAPELIFGATDY- 234

Query: 186 NIFSVKSDIWSFGVLIWEIVT 206
              +   D+WS G ++ E++ 
Sbjct: 235 ---TSSIDVWSAGCVLAELLL 252

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.9 bits (213), Expect = 7e-20
 Identities = 32/180 (17%), Positives = 74/180 (41%), Gaps = 23/180 (12%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
              K +       ++  +  E+++M  L  HP ++ L     +K    +I+E++  G+L 
Sbjct: 79  FVAKFINTPYPL-DKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGEL- 135

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG- 143
                      ++ +  +   ++  ++ ++  Q   G++ +    I+H D+   N++   
Sbjct: 136 -----------FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184

Query: 144 -ENHCCKVADFGFARDLMTSSVYERK--SEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            +    K+ DFG A  L    + +    +       + APE +        +D+W+ GVL
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTTATAE-----FAAPEIVDREPVGFYTDMWAIGVL 239

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 85.3 bits (211), Expect = 8e-20
 Identities = 46/237 (19%), Positives = 90/237 (37%), Gaps = 41/237 (17%)

Query: 25  VAVKTLK----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
            A+K +          ++   +  E+ +MK L  HPN+ RL     +++   ++ME    
Sbjct: 54  RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHG 112

Query: 81  GKL---------------------------QSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 113
           G L                                 +     +            + +++
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172

Query: 114 FCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADFGFARDLMTSSVYERKSEG 171
              Q+   + +L ++GI HRD+   N L    ++   K+ DFG +++    +  E     
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232

Query: 172 RL---PIRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
                P  ++APE L      +  K D WS GVL+  ++  G+ P+PG+  A+ + +
Sbjct: 233 TKAGTPY-FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM-GAVPFPGVNDADTISQ 287

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.5 bits (212), Expect = 9e-20
 Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 37/187 (19%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           +A K +K   G +++ ++  E++VM  LD H N+++L      K    ++MEYV  G+L 
Sbjct: 117 LAAKIIKT-RGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGEL- 173

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG- 143
            F R          +  +S +LT  D   F  Q+  G++ +    I+H DL   N+L   
Sbjct: 174 -FDR----------IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222

Query: 144 -ENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVKSD 193
            +    K+ DFG AR     + +  +     +            +APE +  +  S  +D
Sbjct: 223 RDAKQIKIIDFGLARRYKPREKLKVNFGTPEF------------LAPEVVNYDFVSFPTD 270

Query: 194 IWSFGVL 200
           +WS GV+
Sbjct: 271 MWSVGVI 277

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.2 bits (209), Expect = 9e-20
 Identities = 50/194 (25%), Positives = 94/194 (48%), Gaps = 27/194 (13%)

Query: 25  VAVKTL-KENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK L ++     + +  ++ E+  +K    HP++++L    +    FF++MEYV  G+
Sbjct: 39  VAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFFMVMEYVSGGE 97

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L  ++            HG+   + +R       Q+   + +     ++HRDL   NVL+
Sbjct: 98  LFDYICK----------HGRVEEMEAR---RLFQQILSAVDYCHRHMVVHRDLKPENVLL 144

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFG 198
             +   K+ADFG + ++M+   + R S G     + APE +    Y      + DIWS G
Sbjct: 145 DAHMNAKIADFGLS-NMMSDGEFLRTSCGSPN--YAAPEVISGRLYA---GPEVDIWSCG 198

Query: 199 VLIWEIVTLGSTPY 212
           V+++ ++  G+ P+
Sbjct: 199 VILYALLC-GTLPF 211

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 84.6 bits (210), Expect = 9e-20
 Identities = 42/213 (19%), Positives = 74/213 (34%), Gaps = 44/213 (20%)

Query: 25  VAVKTLKENAGE----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
           VA+K + E        R R+   +E      L   P+VV +          +V M  +  
Sbjct: 62  VALKLMSETLSSDPVFRTRMQ--REARTAGRLQ-EPHVVPIHDFGEIDGQLYVDMRLING 118

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             L + LR                 L      +   Q+   +    + G  HRD+   N+
Sbjct: 119 VDLAAMLRRQGP-------------LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165

Query: 141 LIGENHCCKVADFGFARDL------MTSSV-----YERKSEGRLPIRWMAPESLYDNIFS 189
           L+  +    + DFG A            +      Y            MAPE   ++  +
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY------------MAPERFSESHAT 213

Query: 190 VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
            ++DI++   +++E +T GS PY G   + +  
Sbjct: 214 YRADIYALTCVLYECLT-GSPPYQGDQLSVMGA 245

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.6 bits (210), Expect = 1e-19
 Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 39/201 (19%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC---CTEKEPFFVIMEYVPY 80
            V VK LK    ++    + +E+ +++ L   PN++ L         + P  V  E+V  
Sbjct: 63  KVVVKILKPVKKKK----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVF-EHVNN 117

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
              +   ++                LT  D+  + Y++ + + +  S GI+HRD+   NV
Sbjct: 118 TDFKQLYQT----------------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 161

Query: 141 LIGENHCC-KVADFGFARDLMTSSVYERKSEGRLPIRWM-APESL-----YDNIFSVKSD 193
           +I   H   ++ D+G A          ++   R+  R+   PE L     YD  +S+  D
Sbjct: 162 MIDHEHRKLRLIDWGLAE----FYHPGQEYNVRVASRYFKGPELLVDYQMYD--YSL--D 213

Query: 194 IWSFGVLIWEIVTLGSTPYPG 214
           +WS G ++  ++      + G
Sbjct: 214 MWSLGCMLASMIFRKEPFFHG 234

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 84.3 bits (209), Expect = 1e-19
 Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 49/197 (24%)

Query: 25  VAVKTL-------KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 77
           VA+K +                L++  E+ ++K L+ HP ++++     + E +++++E 
Sbjct: 38  VAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLEL 95

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +  G+L  F +    +R                   + YQ+   +Q+L   GIIHRDL  
Sbjct: 96  MEGGEL--FDKVVGNKRL-----------KEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142

Query: 138 RNVLI---GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYD 185
            NVL+    E+   K+ DFG ++      LM +      Y            +APE L  
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY------------LAPEVLVS 190

Query: 186 NI---FSVKSDIWSFGV 199
                ++   D WS GV
Sbjct: 191 VGTAGYNRAVDCWSLGV 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 85.3 bits (211), Expect = 2e-19
 Identities = 35/188 (18%), Positives = 69/188 (36%), Gaps = 39/188 (20%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A K +       ++  + +E+  M  L  HP +V L     +     +I E++  G+L 
Sbjct: 185 FAAKFVMTPHES-DKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGEL- 241

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG- 143
            F +          +  + N ++  +   +  QV +G+  +     +H DL   N++   
Sbjct: 242 -FEK----------VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290

Query: 144 -ENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESL-YDNIFSVKS 192
             ++  K+ DFG          +  +     +             APE      +    +
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF------------AAPEVAEGKPV-GYYT 337

Query: 193 DIWSFGVL 200
           D+WS GVL
Sbjct: 338 DMWSVGVL 345

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 41/187 (21%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A+K LK+   ++    +  E+ V+  L  HPN+++L           +++E V  G+L 
Sbjct: 81  YALKVLKKTVDKK---IVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGEL- 135

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
            F R      Y           + RD      Q+   + +L   GI+HRDL   N+L   
Sbjct: 136 -FDRIVEKGYY-----------SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183

Query: 143 -GENHCCKVADFGFAR-----DLMTSSV----YERKSEGRLPIRWMAPESLYDNIFSVKS 192
              +   K+ADFG ++      LM +      Y             APE L    +  + 
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY------------CAPEILRGCAYGPEV 231

Query: 193 DIWSFGV 199
           D+WS G+
Sbjct: 232 DMWSVGI 238

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 84.5 bits (209), Expect = 4e-19
 Identities = 35/208 (16%), Positives = 76/208 (36%), Gaps = 44/208 (21%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL------GCCTEKEPFFVIMEYV 78
           V +K L  +     +   + E   +  +  HP++V++           +   + V MEYV
Sbjct: 109 VVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIV-MEYV 166

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G+    L+ S+ Q+           L   +  ++  ++   + +L S G+++ DL   
Sbjct: 167 G-GQS---LKRSKGQK-----------LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE 211

Query: 139 NVLIGENHCCKVADFGFARDL-MTSSV-----YERKSEGRLPIRWMAPESLYDNIFSVKS 192
           N+++ E    K+ D G    +     +     +             APE +     +V +
Sbjct: 212 NIMLTEEQ-LKLIDLGAVSRINSFGYLYGTPGF------------QAPE-IVRTGPTVAT 257

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEV 220
           DI++ G  +  +         G     +
Sbjct: 258 DIYTVGRTLAALTL-DLPTRNGRYVDGL 284

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.4 bits (207), Expect = 4e-19
 Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 32/198 (16%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--------FFVI 74
            VA+K +  EN  E   +  L+E+ +++ L  H NVV L+  C  K           +++
Sbjct: 44  KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLV 102

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
            ++  +  L   L +                 T  ++      +  G+ ++    I+HRD
Sbjct: 103 FDFCEH-DLAGLLSN------------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR----WM-APESLY-DNIF 188
           + A NVLI  +   K+ADFG AR     S+ +     R   R    W   PE L  +  +
Sbjct: 150 MKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 206

Query: 189 SVKSDIWSFGVLIWEIVT 206
               D+W  G ++ E+ T
Sbjct: 207 GPPIDLWGAGCIMAEMWT 224

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 83.3 bits (206), Expect = 6e-19
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 23/144 (15%)

Query: 24  IVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--FFVIMEY 77
             A+K ++      +  RE + LL+EL        HPNV+ L            +++ +Y
Sbjct: 50  DYALKQIEGTGISMSACRE-IALLRELK-------HPNVISLQKVFLSHADRKVWLLFDY 101

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
             +  L   ++  RA    +  + K   L    + S  YQ+  G+ +L +  ++HRDL  
Sbjct: 102 AEH-DLWHIIKFHRA----SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156

Query: 138 RNVLIG----ENHCCKVADFGFAR 157
            N+L+     E    K+AD GFAR
Sbjct: 157 ANILVMGEGPERGRVKIADMGFAR 180

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.7 bits (205), Expect = 7e-19
 Identities = 42/186 (22%), Positives = 85/186 (45%), Gaps = 36/186 (19%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            AVK +     ++ + D  +E+ ++     HPN++ L     + +  +V+ E +  G+L 
Sbjct: 50  FAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL- 103

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-- 142
              +  R + +           + R+ ++  + + + +++L ++G++HRDL   N+L   
Sbjct: 104 -LDKILRQKFF-----------SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151

Query: 143 --GENHCCKVADFGFAR------DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
             G     ++ DFGFA+       L+ +  Y   +       ++APE L    +    DI
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCY---TAN-----FVAPEVLERQGYDAACDI 203

Query: 195 WSFGVL 200
           WS GVL
Sbjct: 204 WSLGVL 209

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.1 bits (203), Expect = 1e-18
 Identities = 43/200 (21%), Positives = 84/200 (42%), Gaps = 33/200 (16%)

Query: 25  VAVKTL-KENAGERERLD------LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME- 76
           V VK + KE   E   ++      +  E+ ++  ++ H N++++L     +  F ++ME 
Sbjct: 52  VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEK 110

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +     L +F+            H + +   +        Q+   + +L  + IIHRD+ 
Sbjct: 111 HGSGLDLFAFIDR----------HPRLDEPLAS---YIFRQLVSAVGYLRLKDIIHRDIK 157

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKS 192
             N++I E+   K+ DFG A   +          G +   + APE L    Y      + 
Sbjct: 158 DENIVIAEDFTIKLIDFGSAA-YLERGKLFYTFCGTIE--YCAPEVLMGNPYR---GPEL 211

Query: 193 DIWSFGVLIWEIVTLGSTPY 212
           ++WS GV ++ +V     P+
Sbjct: 212 EMWSLGVTLYTLVF-EENPF 230

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 82.4 bits (203), Expect = 1e-18
 Identities = 29/221 (13%), Positives = 59/221 (26%), Gaps = 42/221 (19%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------------ 70
             A+K         R  L+ L E T         +            P            
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 71  --------------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 116
                         + ++M       L+    +       + ++          L     
Sbjct: 149 AQLSPGQDDYAVANYLLLMPA-ASVDLELLFST------LDFVYVFRGDEGILALHILTA 201

Query: 117 QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIR 176
           Q+ R    L S+G++H      N+ I  +    + D      +       R     +P+ 
Sbjct: 202 QLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVT 256

Query: 177 WMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGM 215
           +   E L  +   F+   + W  G+ I+ +      P+  +
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWC-LFLPFGLV 296

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 81.5 bits (202), Expect = 1e-18
 Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 50/212 (23%)

Query: 24  IVAVKTLKENAGE----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF----FVIM 75
            VAVK L+ +         R    +E      L+ HP +V +      + P     +++M
Sbjct: 39  DVAVKVLRADLARDPSFYLRFR--REAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVM 95

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EYV    L+  + +                +T +          + + F    GIIHRD+
Sbjct: 96  EYVDGVTLRDIVHTEGP-------------MTPKRAIEVIADACQALNFSHQNGIIHRDV 142

Query: 136 AARNVLIGENHCCKVADFGFARDL--------MTSSV-----YERKSEGRLPIRWMAPES 182
              N++I   +  KV DFG AR +         T++V     Y            ++PE 
Sbjct: 143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY------------LSPEQ 190

Query: 183 LYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              +    +SD++S G +++E++T G  P+ G
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.8 bits (200), Expect = 3e-18
 Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 38/189 (20%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC----TEKEPFFVIMEYVPY 80
            A+K L +           QE+         P++V +L         K    +IME +  
Sbjct: 57  CALKLLYD------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 81  GKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           G+L  F R   R  + +          T R+       +   +QFL S  I HRD+   N
Sbjct: 111 GEL--FSRIQERGDQAF----------TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158

Query: 140 VLI---GENHCCKVADFGFAR----DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           +L     ++   K+ DFGFA+    + + +  Y   +       ++APE L    +    
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPY-----YVAPEVLGPEKYDKSC 210

Query: 193 DIWSFGVLI 201
           D+WS GV++
Sbjct: 211 DMWSLGVIM 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 81.4 bits (201), Expect = 3e-18
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 26/182 (14%)

Query: 25  VAVKTL-KENAGERERLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VAVK L ++     + +  ++ E+  +K    HP++++L    +     F++MEYV  G+
Sbjct: 44  VAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVSGGE 102

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L  ++            +G+ +   SR       Q+  G+ +     ++HRDL   NVL+
Sbjct: 103 LFDYICK----------NGRLDEKESR---RLFQQILSGVDYCHRHMVVHRDLKPENVLL 149

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFG 198
             +   K+ADFG + ++M+   + R S G     + APE +    Y      + DIWS G
Sbjct: 150 DAHMNAKIADFGLS-NMMSDGEFLRTSCGSPN--YAAPEVISGRLYA---GPEVDIWSSG 203

Query: 199 VL 200
           V+
Sbjct: 204 VI 205

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.4 bits (199), Expect = 4e-18
 Identities = 44/193 (22%), Positives = 89/193 (46%), Gaps = 28/193 (14%)

Query: 25  VAVKTLKENAGERERLD--LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VA+K +     ++  +   + +E++ +K L  HP++++L    T      +++EY   G+
Sbjct: 37  VALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYAG-GE 94

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L  ++              +      R    F  Q+   +++     I+HRDL   N+L+
Sbjct: 95  LFDYIVE----------KKRMTEDEGR---RFFQQIICAIEYCHRHKIVHRDLKPENLLL 141

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFG 198
            +N   K+ADFG + ++MT   + + S G     + APE +    Y      + D+WS G
Sbjct: 142 DDNLNVKIADFGLS-NIMTDGNFLKTSCGSPN--YAAPEVINGKLYA---GPEVDVWSCG 195

Query: 199 VLIWEIVTLGSTP 211
           ++++ ++  G  P
Sbjct: 196 IVLYVMLV-GRLP 207

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 80.4 bits (198), Expect = 5e-18
 Identities = 28/217 (12%), Positives = 60/217 (27%), Gaps = 26/217 (11%)

Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEY 77
            E   +  ++ +K     +  L  +    ++K       ++R+              +  
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ-KKKMIRVRLDERDMWVLSRFFLYP 180

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
                LQ+F           +      SL          QV R +  L   G++H  L  
Sbjct: 181 RMQSNLQTFGE------VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 234

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI---------- 187
            ++++ +     +  F              +    +   +  PE                
Sbjct: 235 VDIVLDQRGGVFLTGFEHLVRD------GARVVSSVSRGFEPPELEARRATISYHRDRRT 288

Query: 188 -FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +   D W+ G++I+ I      P    AA    + 
Sbjct: 289 LMTFSFDAWALGLVIYWIWC-ADLPITKDAALGGSEW 324

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 47/194 (24%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG----CCTEKEPFFVIMEYVPY 80
            A+K L      ++     +E+ +       P++VR++         ++   ++ME +  
Sbjct: 90  FALKML------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143

Query: 81  GKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           G+L  F R   R  + +          T R+ +     +   +Q+L S  I HRD+   N
Sbjct: 144 GEL--FSRIQDRGDQAF----------TEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191

Query: 140 VLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW-----MAPESL----YDNI 187
           +L      N   K+ DFGFA+        E  S   L         +APE L    YD  
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK--------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK- 242

Query: 188 FSVKSDIWSFGVLI 201
                D+WS GV++
Sbjct: 243 ---SCDMWSLGVIM 253

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 51/206 (24%)

Query: 24  IVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLL------GCCTEKEPFF-VI 74
            VA+K + ++     RE    LQ +  +  L  HPN+V+L       G    ++ +  V+
Sbjct: 50  SVAIKKVIQDPRFRNRE----LQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIYLNVV 104

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL--SSRGIIH 132
           MEYVP   L    R+   ++          +     +  F +Q+ R +  L   S  + H
Sbjct: 105 MEYVP-DTLHRCCRNYYRRQ---------VAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154

Query: 133 RDLAARNVLI-GENHCCKVADFGFARDL-----MTSSVYERKSEGRLPIRWM-APE---- 181
           RD+   NVL+   +   K+ DFG A+ L       + +           R+  APE    
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS---------RYYRAPELIFG 205

Query: 182 -SLYDNIFSVKSDIWSFGVLIWEIVT 206
              Y    +   DIWS G +  E++ 
Sbjct: 206 NQHY----TTAVDIWSVGCIFAEMML 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 77.8 bits (192), Expect = 4e-17
 Identities = 49/187 (26%), Positives = 74/187 (39%), Gaps = 40/187 (21%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VAVK ++  A   E +   +E+   ++L  HPN+VR            +IMEY   G+L 
Sbjct: 48  VAVKYIERGAAIDENVQ--REIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELY 104

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             + +           G+ +   +R    F  Q+  G+ +  S  I HRDL   N L+  
Sbjct: 105 ERICN----------AGRFSEDEAR---FFFQQLLSGVSYCHSMQICHRDLKLENTLLDG 151

Query: 145 NHCC--KVADFGFARDLMTSSVYERKSEGRLPIRW------MAPESL----YDNIFSVKS 192
           +     K+ DFG+      S           P         +APE L    YD      +
Sbjct: 152 SPAPRLKICDFGY------SKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYD---GKIA 199

Query: 193 DIWSFGV 199
           D+WS GV
Sbjct: 200 DVWSCGV 206

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 39/184 (21%)

Query: 43  LQELTVMKTLDPHPNVVRLL------GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
            +EL +MK ++ H N++ LL          E +  +++ME +    L   ++        
Sbjct: 109 YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME------ 160

Query: 97  NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA 156
                    L    ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG A
Sbjct: 161 ---------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

Query: 157 R-----DLMTSSVYERKSEGRLPIRWM-APESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
           R      +MT  V           R+  APE +    +    DIWS G ++ E+V     
Sbjct: 212 RTAGTSFMMTPYV---------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKI 261

Query: 211 PYPG 214
            +PG
Sbjct: 262 LFPG 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.0 bits (185), Expect = 2e-16
 Identities = 40/188 (21%), Positives = 70/188 (37%), Gaps = 56/188 (29%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC----TEKEPFFVIMEYVPY 80
            A+K L++           +E+ +       P++VR++         ++   ++ME +  
Sbjct: 46  FALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99

Query: 81  GKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           G+L  F R   R  + +          T R+ +     +   +Q+L S  I HRD+   N
Sbjct: 100 GEL--FSRIQDRGDQAF----------TEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147

Query: 140 VLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL---YDNIFSVKSD 193
           +L      N   K+ DFGF                       A E+    YD       D
Sbjct: 148 LLYTSKRPNAILKLTDFGF-----------------------AKETTGEKYDK----SCD 180

Query: 194 IWSFGVLI 201
           +WS GV++
Sbjct: 181 MWSLGVIM 188

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.8 bits (187), Expect = 2e-16
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 40/207 (19%)

Query: 17  RGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           + +E     A+K L K+   + ++++  L E  +++ ++  P +V+L     +    +++
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIH 132
           MEYV  G++ S LR  R  R+            S     F Y  Q+    ++L S  +I+
Sbjct: 120 MEYVAGGEMFSHLR--RIGRF------------SEPHARF-YAAQIVLTFEYLHSLDLIY 164

Query: 133 RDLAARNVLIGENHCCKVADFGFARDL--MTSSV-----YERKSEGRLPIRWMAPESLYD 185
           RDL   N+LI +    +V DFGFA+ +   T ++                  +APE +  
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEA------------LAPEIILS 212

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++   D W+ GVLI+E+   G  P+
Sbjct: 213 KGYNKAVDWWALGVLIYEMAA-GYPPF 238

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 3e-16
 Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 41/185 (22%)

Query: 43  LQELTVMKTLDPHPNVVRLL------GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
            +EL ++K +  H NV+ LL          E    +++   +                  
Sbjct: 76  YRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---------------- 118

Query: 97  NNMHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG 154
            +++   K   LT   +    YQ+ RG++++ S  IIHRDL   N+ + E+   K+ DFG
Sbjct: 119 -DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 177

Query: 155 FAR---DLMTSSVYERKSEGRLPIRW-MAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGS 209
            AR   D MT  V           RW  APE + +   ++   DIWS G ++ E++T G 
Sbjct: 178 LARHTADEMTGYV---------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GR 227

Query: 210 TPYPG 214
           T +PG
Sbjct: 228 TLFPG 232

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.7 bits (184), Expect = 5e-16
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 39/184 (21%)

Query: 43  LQELTVMKTLDPHPNVVRLL------GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
            +EL +MK ++ H N++ LL          E +  +++ME +    L   ++        
Sbjct: 72  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------ 123

Query: 97  NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA 156
                    L    ++   YQ+  G++ L S GIIHRDL   N+++  +   K+ DFG A
Sbjct: 124 ---------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

Query: 157 R-----DLMTSSVYERKSEGRLPIRWM-APESLYDNIFSVKSDIWSFGVLIWEIVTLGST 210
           R      +MT  V           R+  APE +    +    DIWS G ++ E++  G  
Sbjct: 175 RTAGTSFMMTPYV---------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGV 224

Query: 211 PYPG 214
            +PG
Sbjct: 225 LFPG 228

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 74.7 bits (184), Expect = 5e-16
 Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 49/215 (22%)

Query: 26  AVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           A+K + K+   ER  +  + +EL +M+ L+ HP +V L     ++E  F++++ +  G L
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDL 102

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARNVL 141
                  +   +              +     +  ++   + +L ++ IIHRD+   N+L
Sbjct: 103 --RYHLQQNVHF------------KEETVKL-FICELVMALDYLQNQRIIHRDMKPDNIL 147

Query: 142 IGENHCCKVADFGFARDLM----TSSV-----YERKSEGRLPIRWMAPESLYDNI----- 187
           + E+    + DF  A  L      +++     Y            MAPE           
Sbjct: 148 LDEHGHVHITDFNIAAMLPRETQITTMAGTKPY------------MAPEMFSSRKGAGYS 195

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           F+V  D WS GV  +E++  G  PY   ++    +
Sbjct: 196 FAV--DWWSLGVTAYELLR-GRRPYHIRSSTSSKE 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 6e-16
 Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 34/172 (19%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYN 97
           L+E+ ++K    H N++ +         E F   ++I E +                   
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQT----------------- 98

Query: 98  NMHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF 155
           ++H    +  L+   +  F YQ  R ++ L    +IHRDL   N+LI  N   KV DFG 
Sbjct: 99  DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158

Query: 156 ARDLMTSSVYERKSEGRLPI-------RWM-APE-SLYDNIFSVKSDIWSFG 198
           AR +  S+    +  G+          RW  APE  L    +S   D+WS G
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.2 bits (183), Expect = 6e-16
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 44/215 (20%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGC-CTEKEPFFVIMEYVPY 80
             A+K L K+     + ++  + E  V+     HP +  +     T++  FFV MEY+  
Sbjct: 44  FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV-MEYLNG 102

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAAR 138
           G L          ++                 +F Y  ++  G+QFL S+GI++RDL   
Sbjct: 103 GDL--MYHIQSCHKF------------DLSRATF-YAAEIILGLQFLHSKGIVYRDLKLD 147

Query: 139 NVLIGENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAPESLYDNIF 188
           N+L+ ++   K+ADFG  ++ M              Y            +APE L    +
Sbjct: 148 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY------------IAPEILLGQKY 195

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +   D WSFGVL++E++  G +P+ G    E+   
Sbjct: 196 NHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHS 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.3 bits (183), Expect = 7e-16
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 41/185 (22%)

Query: 43  LQELTVMKTLDPHPNVVRLL------GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 96
            +EL ++K +  H NV+ LL          +   F+++M ++                  
Sbjct: 72  YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---------------- 114

Query: 97  NNMHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG 154
            ++    K   L    +    YQ+ +G++++ + GIIHRDL   N+ + E+   K+ DFG
Sbjct: 115 -DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173

Query: 155 FAR---DLMTSSVYERKSEGRLPIRWM-APESLYD-NIFSVKSDIWSFGVLIWEIVTLGS 209
            AR     MT  V           RW  APE + +   ++   DIWS G ++ E++T G 
Sbjct: 174 LARQADSEMTGYV---------VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GK 223

Query: 210 TPYPG 214
           T + G
Sbjct: 224 TLFKG 228

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 42/214 (19%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + AVK L K+   + + ++  + E  V+      P + +L  C    +  + +MEYV  G
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
            L       +  R+                  F Y  ++A G+ FL S+GII+RDL   N
Sbjct: 428 DL--MYHIQQVGRF------------KEPHAVF-YAAEIAIGLFFLQSKGIIYRDLKLDN 472

Query: 140 VLIGENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAPESLYDNIFS 189
           V++      K+ADFG  ++ +   V          Y            +APE +    + 
Sbjct: 473 VMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY------------IAPEIIAYQPYG 520

Query: 190 VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
              D W+FGVL++E++  G  P+ G    E+ + 
Sbjct: 521 KSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQS 553

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 44/215 (20%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY 80
           + AVK L K+   + + ++  + E  ++     HP + +L  C  T    FFV ME+V  
Sbjct: 50  LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV-MEFVNG 108

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAAR 138
           G L       +++R+                  F Y  ++   + FL  +GII+RDL   
Sbjct: 109 GDL--MFHIQKSRRF------------DEARARF-YAAEIISALMFLHDKGIIYRDLKLD 153

Query: 139 NVLIGENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAPESLYDNIF 188
           NVL+     CK+ADFG  ++ + + V          Y            +APE L + ++
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY------------IAPEILQEMLY 201

Query: 189 SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
               D W+ GVL++E++  G  P+      ++ + 
Sbjct: 202 GPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEA 235

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.0 bits (180), Expect = 2e-15
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 40/207 (19%)

Query: 17  RGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R R      A+K L KE     ++++    E  ++  +  HP ++R+ G   + +  F+I
Sbjct: 26  RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 84

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIH 132
           M+Y+  G+L S LR  ++QR+               +  F Y  +V   +++L S+ II+
Sbjct: 85  MDYIEGGELFSLLR--KSQRF------------PNPVAKF-YAAEVCLALEYLHSKDIIY 129

Query: 133 RDLAARNVLIGENHCCKVADFGFARDL--MTSSV-----YERKSEGRLPIRWMAPESLYD 185
           RDL   N+L+ +N   K+ DFGFA+ +  +T ++     Y            +APE +  
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDY------------IAPEVVST 177

Query: 186 NIFSVKSDIWSFGVLIWEIVTLGSTPY 212
             ++   D WSFG+LI+E++  G TP+
Sbjct: 178 KPYNKSIDWWSFGILIYEMLA-GYTPF 203

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.0 bits (180), Expect = 2e-15
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 46/216 (21%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY 80
           + AVK L K+   + + ++  + E  V+      P + +L  C  T    +FV MEYV  
Sbjct: 47  LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV-MEYVNG 105

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAAR 138
           G L       +  R+                  F Y  ++A G+ FL S+GII+RDL   
Sbjct: 106 GDL--MYHIQQVGRF------------KEPHAVF-YAAEIAIGLFFLQSKGIIYRDLKLD 150

Query: 139 NVLI-GENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAPESLYDNI 187
           NV++  E H  K+ADFG  ++ +   V          Y            +APE +    
Sbjct: 151 NVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY------------IAPEIIAYQP 197

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +    D W+FGVL++E++  G  P+ G    E+ + 
Sbjct: 198 YGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQS 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 72.6 bits (179), Expect = 3e-15
 Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 47/216 (21%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY 80
             A+K L KE    ++ +   + E  V++    HP +  L     T     FV MEY   
Sbjct: 32  YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV-MEYANG 89

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAAR 138
           G+L  F   SR + +            + +   F Y  ++   +++L SR +++RD+   
Sbjct: 90  GEL--FFHLSRERVF------------TEERARF-YGAEIVSALEYLHSRDVVYRDIKLE 134

Query: 139 NVLI-GENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAPESLYDNI 187
           N+++  + H  K+ DFG  ++ ++             Y            +APE L DN 
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY------------LAPEVLEDND 181

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +    D W  GV+++E++  G  P+       + + 
Sbjct: 182 YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFEL 216

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 3e-15
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 41/180 (22%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCT--EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 100
            +E+ ++  L  H N+V LL           +++ +Y+                   ++H
Sbjct: 56  FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-----------------DLH 98

Query: 101 G--KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD 158
              ++N L         YQ+ + +++L S G++HRD+   N+L+      KVADFG +R 
Sbjct: 99  AVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158

Query: 159 LMTSSVYERKSEGRLPI------------------RWM-APES-LYDNIFSVKSDIWSFG 198
            +            +                    RW  APE  L    ++   D+WS G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 71.7 bits (176), Expect = 4e-15
 Identities = 24/199 (12%), Positives = 49/199 (24%), Gaps = 48/199 (24%)

Query: 25  VAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           VA+  +       +    + L     +  +D  P V R+L     +    V+ E++  G 
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGS 117

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           LQ    +S                +          +A         G+         V +
Sbjct: 118 LQEVADTS---------------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV 162

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
             +    +A      D                              + + DI   G  ++
Sbjct: 163 SIDGDVVLAYPATMPDA-----------------------------NPQDDIRGIGASLY 193

Query: 203 EIVTLGSTPYPGMAAAEVM 221
            ++     P P       +
Sbjct: 194 ALLV-NRWPLPEAGVRSGL 211

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.3 bits (178), Expect = 4e-15
 Identities = 44/201 (21%), Positives = 87/201 (43%), Gaps = 32/201 (15%)

Query: 25  VAVKTLK--ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEY 77
           VA+K +   E+    +R   L+E+ ++     H N++ +         E     +++ + 
Sbjct: 55  VAIKKISPFEHQTYCQRT--LREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDL 111

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           +                   +++   K+  L++  +  F YQ+ RG++++ S  ++HRDL
Sbjct: 112 MET-----------------DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDL 154

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWM-APE-SLYDNIFSVKSD 193
              N+L+      K+ DFG AR       +       +  RW  APE  L    ++   D
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214

Query: 194 IWSFGVLIWEIVTLGSTPYPG 214
           IWS G ++ E+++     +PG
Sbjct: 215 IWSVGCILAEMLS-NRPIFPG 234

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.4 bits (176), Expect = 5e-15
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 48/216 (22%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPY 80
           + A+K L K     R+R+    E  ++  ++ HP +V+L      TE + + + ++++  
Sbjct: 54  LYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLH-YAFQTEGKLYLI-LDFLRG 110

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAAR 138
           G L  F R S+   +            + +   F Y  ++A  +  L S GII+RDL   
Sbjct: 111 GDL--FTRLSKEVMF------------TEEDVKF-YLAELALALDHLHSLGIIYRDLKPE 155

Query: 139 NVLI-GENHCCKVADFGFARDLM-----TSSV-----YERKSEGRLPIRWMAPESLYDNI 187
           N+L+  E H  K+ DFG +++ +       S      Y            MAPE +    
Sbjct: 156 NILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEY------------MAPEVVNRRG 202

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            +  +D WSFGVL++E++T G+ P+ G    E M  
Sbjct: 203 HTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTM 237

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.6 bits (176), Expect = 8e-15
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 46/219 (21%)

Query: 17  RGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFV 73
           R ++   I A++ + KE   + E +D +  E  V +    HP +V L  C  TE   FFV
Sbjct: 72  RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGII 131
            +EYV  G L       R ++               +   F Y  +++  + +L  RGII
Sbjct: 132 -IEYVNGGDL--MFHMQRQRKL------------PEEHARF-YSAEISLALNYLHERGII 175

Query: 132 HRDLAARNVLI-GENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAP 180
           +RDL   NVL+  E H  K+ D+G  ++ +              Y            +AP
Sbjct: 176 YRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY------------IAP 222

Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           E L    +    D W+ GVL++E++  G +P+  + +++
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSD 260

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 8e-15
 Identities = 41/191 (21%), Positives = 78/191 (40%), Gaps = 38/191 (19%)

Query: 43  LQELTVMKTLDPHPNVVRLL-----------GCCTEKEPF---FVIMEYVPYGKLQSFLR 88
           L+E+ +++ LD H N+V++                        +++ EY+          
Sbjct: 56  LREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-------- 106

Query: 89  SSRAQRYYNNMHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH 146
                    ++    +   L       F YQ+ RG++++ S  ++HRDL   N+ I    
Sbjct: 107 ---------DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157

Query: 147 C-CKVADFGFARDLMTSSVYERKSEGRLPIRWM-APE-SLYDNIFSVKSDIWSFGVLIWE 203
              K+ DFG AR +     ++      L  +W  +P   L  N ++   D+W+ G +  E
Sbjct: 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217

Query: 204 IVTLGSTPYPG 214
           ++T G T + G
Sbjct: 218 MLT-GKTLFAG 227

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.2 bits (175), Expect = 9e-15
 Identities = 40/184 (21%), Positives = 72/184 (39%), Gaps = 36/184 (19%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYN 97
           L+E+ ++     HPN++ L       E+      +++ E +    L   +   R      
Sbjct: 77  LREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR------ 128

Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                   ++ + +  F Y +  G+  L   G++HRDL   N+L+ +N+   + DF  AR
Sbjct: 129 ------IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182

Query: 158 -----DLMTSSVYERKSEGRLPIRWM-APES-LYDNIFSVKSDIWSFGVLIWEIVTLGST 210
                   T  V           RW  APE  +    F+   D+WS G ++ E+      
Sbjct: 183 EDTADANKTHYV---------THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKA 232

Query: 211 PYPG 214
            + G
Sbjct: 233 LFRG 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 9e-15
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 46/219 (21%)

Query: 17  RGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFV 73
           R ++   I A+K + KE   + E +D +  E  V +    HP +V L  C  TE   FFV
Sbjct: 29  RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGII 131
            +EYV  G L       R ++               +   F Y  +++  + +L  RGII
Sbjct: 89  -IEYVNGGDL--MFHMQRQRKL------------PEEHARF-YSAEISLALNYLHERGII 132

Query: 132 HRDLAARNVLI-GENHCCKVADFGFARDLM-----TSSV-----YERKSEGRLPIRWMAP 180
           +RDL   NVL+  E H  K+ D+G  ++ +     TS+      Y            +AP
Sbjct: 133 YRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY------------IAP 179

Query: 181 ESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE 219
           E L    +    D W+ GVL++E++  G +P+  + +++
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSD 217

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 9e-15
 Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 38/183 (20%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYY 96
            +EL ++K +  H NV+ LL   T           +++M ++    LQ  +         
Sbjct: 71  YRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------ 122

Query: 97  NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA 156
                     +   +    YQ+ +G++++ S G++HRDL   N+ + E+   K+ DFG A
Sbjct: 123 ---------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173

Query: 157 R---DLMTSSVYERKSEGRLPIRW-MAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTP 211
           R     MT  V           RW  APE +     ++   DIWS G ++ E++T G T 
Sbjct: 174 RHADAEMTGYV---------VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTL 223

Query: 212 YPG 214
           + G
Sbjct: 224 FKG 226

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 71.4 bits (175), Expect = 1e-14
 Identities = 43/195 (22%), Positives = 79/195 (40%), Gaps = 19/195 (9%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A K L K+   +R+     + E  ++  +     +V L      K    ++M  +  G
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMNGG 270

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
            +          RY+     + N         F Y  Q+  G++ L  R II+RDL   N
Sbjct: 271 DI----------RYHIYNVDEDNPGFQEPRAIF-YTAQIVSGLEHLHQRNIIYRDLKPEN 319

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           VL+ ++   +++D G A +L       +   G     +MAPE L    +    D ++ GV
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYAG--TPGFMAPELLLGEEYDFSVDYFALGV 377

Query: 200 LIWEIVTLGSTPYPG 214
            ++E++     P+  
Sbjct: 378 TLYEMIA-ARGPFRA 391

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.9 bits (174), Expect = 1e-14
 Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             A+K L KE    ++ +   L E  V++    HP +  L       +    +MEY   G
Sbjct: 175 YYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANGG 233

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF-CYQVARGMQFL-SSRGIIHRDLAARN 139
           +L  F   SR + +            S D   F   ++   + +L S + +++RDL   N
Sbjct: 234 EL--FFHLSRERVF------------SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +++ ++   K+ DFG  ++ +      +   G     ++APE L DN +    D W  GV
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT--PEYLAPEVLEDNDYGRAVDWWGLGV 337

Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           +++E++  G  P+      ++ + 
Sbjct: 338 VMYEMMC-GRLPFYNQDHEKLFEL 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.8 bits (171), Expect = 3e-14
 Identities = 49/227 (21%), Positives = 91/227 (40%), Gaps = 52/227 (22%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC-------------CTEKEP 70
             A+K + ++   + R     EL +MK LD H N+++L+                 +   
Sbjct: 34  RFALKKVLQDPRYKNR-----ELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87

Query: 71  FFVIMEYVPYGKLQSFLRSSRAQRYYN--------NMHG--KSNSLTSRDLT-----SFC 115
                        +S + +    +Y N         +H   KS   + R +       + 
Sbjct: 88  KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYI 147

Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLI-GENHCCKVADFGFARDL-----MTSSVYERKS 169
           YQ+ R + F+ S GI HRD+  +N+L+  +++  K+ DFG A+ L       + +     
Sbjct: 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICS--- 204

Query: 170 EGRLPIRWM-APESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
                 R+  APE +     ++   D+WS G +  E++ LG   + G
Sbjct: 205 ------RFYRAPELMLGATEYTPSIDLWSIGCVFGELI-LGKPLFSG 244

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.5 bits (171), Expect = 3e-14
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 54/220 (24%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIME 76
           I A+K LK      NA +        E  +++ +  HP +V L+     T  + + + +E
Sbjct: 47  IFAMKVLKKAMIVRNAKDTAHT--KAERNILEEVK-HPFIVDLI-YAFQTGGKLYLI-LE 101

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRD 134
           Y+  G+L  F++  R   +              D   F Y  +++  +  L  +GII+RD
Sbjct: 102 YLSGGEL--FMQLEREGIF------------MEDTACF-YLAEISMALGHLHQKGIIYRD 146

Query: 135 LAARNVLI-GENHCCKVADFGFARDLM-----TSSV-----YERKSEGRLPIRWMAPESL 183
           L   N+++  + H  K+ DFG  ++ +     T +      Y            MAPE L
Sbjct: 147 LKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEY------------MAPEIL 193

Query: 184 YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             +  +   D WS G L+++++T G+ P+ G    + + K
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDK 232

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.2 bits (170), Expect = 4e-14
 Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 48/217 (22%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVP 79
             AVK L K+   +++    ++ E  V+     HP +V L      T  + +FV ++Y+ 
Sbjct: 65  FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFV-LDYIN 122

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAA 137
            G+L  F    R + +                  F Y  ++A  + +L S  I++RDL  
Sbjct: 123 GGEL--FYHLQRERCF------------LEPRARF-YAAEIASALGYLHSLNIVYRDLKP 167

Query: 138 RNVLI-GENHCCKVADFGFARDLMTSSV----------YERKSEGRLPIRWMAPESLYDN 186
            N+L+  + H   + DFG  ++ +  +           Y            +APE L+  
Sbjct: 168 ENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY------------LAPEVLHKQ 214

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            +    D W  G +++E++  G  P+     AE+   
Sbjct: 215 PYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDN 250

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.0 bits (169), Expect = 5e-14
 Identities = 42/214 (19%), Positives = 77/214 (35%), Gaps = 36/214 (16%)

Query: 24  IVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A+K L +       E     +E  V+   D    +  L     +    +++M+Y   G
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYLVMDYYVGG 159

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
            L + L              K       ++  F Y  ++   +  +     +HRD+   N
Sbjct: 160 DLLTLLS-------------KFEDRLPEEMARF-YLAEMVIAIDSVHQLHYVHRDIKPDN 205

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKS-----EGRLPIRWMAPESLYDNIFSVKS-- 192
           +L+  N   ++ADFG    LM     +        +      +++PE L           
Sbjct: 206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD------YISPEILQAMEGGKGRYG 259

Query: 193 ---DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
              D WS GV ++E++  G TP+   +  E   K
Sbjct: 260 PECDWWSLGVCMYEMLY-GETPFYAESLVETYGK 292

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 41/182 (22%)

Query: 43  LQELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYN 97
           L+E+T++  L     ++RL       +   F   ++++E      L+   ++        
Sbjct: 73  LREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP------- 123

Query: 98  NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR 157
                   LT   + +  Y +  G  F+   GIIHRDL   N L+ ++   KV DFG AR
Sbjct: 124 ------IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

Query: 158 DLMTSSVYERKSEGRLPI-------------------RWM-APE-SLYDNIFSVKSDIWS 196
            + +       ++                        RW  APE  L    ++   DIWS
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237

Query: 197 FG 198
            G
Sbjct: 238 TG 239

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 46/209 (22%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEY 77
           + A+K LK     + A   E      E  V++ +   P +V L     TE +   + ++Y
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHT--RTERQVLEHIRQSPFLVTLHYAFQTETKLHLI-LDY 140

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDL 135
           +  G+L  F   S+ +R+            +       Y  ++   ++ L   GII+RD+
Sbjct: 141 INGGEL--FTHLSQRERF------------TEHEVQI-YVGEIVLALEHLHKLGIIYRDI 185

Query: 136 AARNVLI-GENHCCKVADFGFARDLMTSSVYERKS-----EGRLPIRWMAPESLYDN--- 186
              N+L+    H   + DFG +++ +              E      +MAP+ +      
Sbjct: 186 KLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE------YMAPDIVRGGDSG 238

Query: 187 -IFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              +V  D WS GVL++E++T G++P+  
Sbjct: 239 HDKAV--DWWSLGVLMYELLT-GASPFTV 264

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 51/209 (24%)

Query: 24  IVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIM 75
           +VA+K +    E+  + +R+  L+E+ ++  L+ H +VV++L      + E F   +V++
Sbjct: 80  VVAIKKILRVFEDLIDCKRI--LREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E       +   R+                LT   + +  Y +  G++++ S GI+HRDL
Sbjct: 137 EIADS-DFKKLFRTP-------------VYLTELHIKTLLYNLLVGVKYVHSAGILHRDL 182

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI-------------------- 175
              N L+ ++   KV DFG AR +        +                           
Sbjct: 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242

Query: 176 ----RWM-APE-SLYDNIFSVKSDIWSFG 198
               RW  APE  L    ++   D+WS G
Sbjct: 243 HVVTRWYRAPELILLQENYTEAIDVWSIG 271

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 67.8 bits (166), Expect = 2e-13
 Identities = 46/202 (22%), Positives = 84/202 (41%), Gaps = 37/202 (18%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A+K L K    +R       +E  +M   +  P VV+L     +    +++MEY+P G
Sbjct: 96  VYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEYMPGG 154

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
            L + + +                        F Y  +V   +  + S G IHRD+   N
Sbjct: 155 DLVNLMSNYD---------------VPEKWARF-YTAEVVLALDAIHSMGFIHRDVKPDN 198

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKS-----EGRLPIRWMAPESL----YDNIFSV 190
           +L+ ++   K+ADFG    +    +    +     +      +++PE L     D  +  
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD------YISPEVLKSQGGDGYYGR 252

Query: 191 KSDIWSFGVLIWEIVTLGSTPY 212
           + D WS GV ++E++  G TP+
Sbjct: 253 ECDWWSVGVFLYEMLV-GDTPF 273

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 67.6 bits (165), Expect = 2e-13
 Identities = 33/164 (20%), Positives = 70/164 (42%), Gaps = 29/164 (17%)

Query: 55  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 114
            P +V +       +    I++ +  G L      S+   +            S     F
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVF------------SEADMRF 296

Query: 115 CY--QVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGR 172
            Y  ++  G++ + +R +++RDL   N+L+ E+   +++D G A D       ++K    
Sbjct: 297 -YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-----KKKPHAS 350

Query: 173 L-PIRWMAPESLYDNI---FSVKSDIWSFGVLIWEIVTLGSTPY 212
           +    +MAPE L   +    S   D +S G ++++++  G +P+
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLR-GHSPF 391

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 66.7 bits (163), Expect = 4e-13
 Identities = 39/196 (19%), Positives = 87/196 (44%), Gaps = 24/196 (12%)

Query: 24  IVAVKTL-KENAGERERLDL-LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A K L K+   +R+   + L E  +++ ++    VV L      K+   +++  +  G
Sbjct: 211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGG 269

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
            L+  +       +                  F Y  ++  G++ L    I++RDL   N
Sbjct: 270 DLKFHIYHMGQAGF------------PEARAVF-YAAEICCGLEDLHRERIVYRDLKPEN 316

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIWSFG 198
           +L+ ++   +++D G A  +       +  +GR+  + +MAPE + +  ++   D W+ G
Sbjct: 317 ILLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG 372

Query: 199 VLIWEIVTLGSTPYPG 214
            L++E++  G +P+  
Sbjct: 373 CLLYEMIA-GQSPFQQ 387

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 39/205 (19%), Positives = 76/205 (37%), Gaps = 38/205 (18%)

Query: 24  IVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
           + A+K + K +  +R  +    +E  V+   D    + +L     ++   +++MEY   G
Sbjct: 88  VYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYLVMEYYVGG 146

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY--QVARGMQFLSSRGIIHRDLAARN 139
            L + L              K       ++  F Y  ++   +  +   G +HRD+   N
Sbjct: 147 DLLTLLS-------------KFGERIPAEMARF-YLAEIVMAIDSVHRLGYVHRDIKPDN 192

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKS-----EGRLPIRWMAPESLYDNIFSVKS-- 192
           +L+      ++ADFG    L               +      +++PE L        +  
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD------YLSPEILQAVGGGPGTGS 246

Query: 193 -----DIWSFGVLIWEIVTLGSTPY 212
                D W+ GV  +E+   G TP+
Sbjct: 247 YGPECDWWALGVFAYEMFY-GQTPF 270

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.1 bits (146), Expect = 6e-11
 Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 43/207 (20%)

Query: 23  CIVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHP--NVVRLLGCCTEKEPFFVIM 75
             VA+K ++           E + +L+ L   +  D     NV+ +L   T +    +  
Sbjct: 123 QHVALKMVRNEKRFHRQAAEE-IRILEHL---RKQDKDNTMNVIHMLENFTFRNHICMTF 178

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E +    L   ++        N   G S  L  +    F + + + +  L    IIH DL
Sbjct: 179 ELLSM-NLYELIK-------KNKFQGFSLPLVRK----FAHSILQCLDALHKNRIIHCDL 226

Query: 136 AARNVLIGENHCC--KVADFG---FARDLMTS---SVYERKSEGRLPIRWMAPESLYDNI 187
              N+L+ +      KV DFG   +    + +   S + R           APE +    
Sbjct: 227 KPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR-----------APEVILGAR 275

Query: 188 FSVKSDIWSFGVLIWEIVTLGSTPYPG 214
           + +  D+WS G ++ E++T G    PG
Sbjct: 276 YGMPIDMWSLGCILAELLT-GYPLLPG 301

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.4 bits (139), Expect = 4e-10
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 47/216 (21%)

Query: 23  CIVAVKTLKEN-----AGERERLDLLQELTVMKTLDPHP----NVVRLLGCCTEKEPFFV 73
             VA+K ++ +     A E E + LLQ +              ++++LL     K P  V
Sbjct: 45  THVAMKIVRGDKVYTEAAEDE-IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103

Query: 74  ----IMEYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 128
               + E    G+ L + ++            G    +    +     Q+  G+ ++  R
Sbjct: 104 HVVMVFE--VLGENLLALIK-------KYEHRG----IPLIYVKQISKQLLLGLDYMHRR 150

Query: 129 -GIIHRDLAARNVLIGENHCC------KVADFG---FARDLMTSSVYERKSEGRLPIRWM 178
            GIIH D+   NVL+            K+AD G   +  +  T+S+  R        R  
Sbjct: 151 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR------EYR-- 202

Query: 179 APESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
           +PE L    +   +DIWS   LI+E++T G   +  
Sbjct: 203 SPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEP 237

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 8e-10
 Identities = 48/242 (19%), Positives = 84/242 (34%), Gaps = 78/242 (32%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTL---DP-HPN---VVRLLGCCTEKEPF--FVIM 75
           VA+K +K  + E      L E+ ++K++   DP  PN   VV+LL            + M
Sbjct: 65  VAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM 122

Query: 76  EYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHR 133
            +   G  L  ++  S  Q            L    +     QV +G+ +L ++  IIH 
Sbjct: 123 VFEVLGHHLLKWIIKSNYQG-----------LPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171

Query: 134 DLAARNVLIG-------------------------------------------------E 144
           D+   N+L+                                                  E
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
               K+AD G A       V++  +E     ++ + E L  + ++  +DIWS   + +E+
Sbjct: 232 KLKVKIADLGNAC-----WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFEL 286

Query: 205 VT 206
            T
Sbjct: 287 AT 288

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 49/208 (23%), Positives = 79/208 (37%), Gaps = 45/208 (21%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPH--PNVVRLLGCCTEKEPFFVIME 76
            VA+K +K      N  + E + LL+ +      D      +V L      +    ++ E
Sbjct: 81  WVAIKIIKNKKAFLNQAQIE-VRLLELM---NKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR--GIIHRD 134
            + Y  L   LR         N  G S +LT +    F  Q+   + FL++    IIH D
Sbjct: 137 MLSY-NLYDLLR-------NTNFRGVSLNLTRK----FAQQMCTALLFLATPELSIIHCD 184

Query: 135 LAARNVLIGENHCC--KVADFG---FARDLMTS---SVYERKSEGRLPIRWMAPESLYDN 186
           L   N+L+        K+ DFG        +     S + R           +PE L   
Sbjct: 185 LKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR-----------SPEVLLGM 233

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            + +  D+WS G ++ E+ T G   + G
Sbjct: 234 PYDLAIDMWSLGCILVEMHT-GEPLFSG 260

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.2 bits (118), Expect = 3e-07
 Identities = 43/229 (18%), Positives = 75/229 (32%), Gaps = 62/229 (27%)

Query: 19  REGPCIVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHP--NVVRLLGCCTEKEPF 71
             G   VA+K ++       A   E +++L+++   K  D       V +          
Sbjct: 42  ARGKSQVALKIIRNVGKYREAARLE-INVLKKI---KEKDKENKFLCVLMSDWFNFHGHM 97

Query: 72  FVIMEYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGI 130
            +  E    GK    FL+        NN                 YQ+   ++FL    +
Sbjct: 98  CIAFE--LLGKNTFEFLKE-------NNFQPYPLPHVRH----MAYQLCHALRFLHENQL 144

Query: 131 IHRDLAARNVLIGENHCC-------------------KVADFG---FARDLMT---SSVY 165
            H DL   N+L   +                      +VADFG   F  +  T   ++ +
Sbjct: 145 THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH 204

Query: 166 ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
            R            PE + +  ++   D+WS G +++E    G T +  
Sbjct: 205 YR-----------PPEVILELGWAQPCDVWSIGCILFEYYR-GFTLFQT 241

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.7 bits (115), Expect = 4e-07
 Identities = 23/173 (13%), Positives = 51/173 (29%), Gaps = 32/173 (18%)

Query: 17  RGREGPCIVAVK-------TLKENAGERERLDLLQELTVMKTLDP--------HPNVVRL 61
           +       VA+K        L   + ++   ++L E+ + K L              + L
Sbjct: 38  QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97

Query: 62  LG--CCTEKEPFFVIMEYVPY----GKLQSFLRSSRAQRYYNNM----------HGKSNS 105
               C     P  ++  +  Y    G         +  + +  +            ++  
Sbjct: 98  NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL 157

Query: 106 LTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFAR 157
            +     S  +Q+   +    +     HRDL   NVL+ +    K+      +
Sbjct: 158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 48/226 (21%), Positives = 76/226 (33%), Gaps = 66/226 (29%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHP--NVVRLLGCCTEKEPFFVIME 76
            VAVK +K       A   E + +L+ L    T DP+     V++L          ++ E
Sbjct: 42  HVAVKIVKNVDRYCEAARSE-IQVLEHL---NTTDPNSTFRCVQMLEWFEHHGHICIVFE 97

Query: 77  YVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
               G     F++        N             +    YQ+ + + FL S  + H DL
Sbjct: 98  --LLGLSTYDFIKE-------NGFLP----FRLDHIRKMAYQICKSVNFLHSNKLTHTDL 144

Query: 136 AARNVLIGENHCC-------------------KVADFGFARDLMTSSVYERKSEG----- 171
              N+L  ++                      KV DFG       S+ Y+ +        
Sbjct: 145 KPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVST 197

Query: 172 ---RLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              R      APE +    +S   D+WS G ++ E    G T +P 
Sbjct: 198 RHYR------APEVILALGWSQPCDVWSIGCILIEYYL-GFTVFPT 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 67/229 (29%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVIMEY 77
             AVK ++       + + E  D+L+++   +  D +  N+V+  G     +   +I E 
Sbjct: 62  YYAVKVVRNIKKYTRSAKIE-ADILKKI---QNDDINNNNIVKYHGKFMYYDHMCLIFE- 116

Query: 78  VPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            P G  L   +         NN +G            +C ++ + + +L    + H DL 
Sbjct: 117 -PLGPSLYEIITR-------NNYNGFHIEDIK----LYCIEILKALNYLRKMSLTHTDLK 164

Query: 137 ARNVLIGENHCC-------------------------KVADFGFARDLMTSSVYERKSEG 171
             N+L+ + +                           K+ DFG        + ++  S+ 
Sbjct: 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFK--SDY 215

Query: 172 RLPI------RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG 214
              I      R  APE + +  + V SD+WSFG ++ E+ T GS  +  
Sbjct: 216 HGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYT-GSLLFRT 261

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.7 bits (106), Expect = 9e-06
 Identities = 28/137 (20%), Positives = 50/137 (36%), Gaps = 19/137 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K         +   L  E  + K +     +  +  C  E +   ++ME    G  
Sbjct: 36  EVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL--LGPS 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L          N   +  SL +  +     Q+   ++++ S+  IHRD+   N L+G
Sbjct: 91  LEDLF---------NFCSRKFSLKT--VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139

Query: 144 ENHCCK---VADFGFAR 157
                    + DFG A+
Sbjct: 140 LGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 27/136 (19%), Positives = 50/136 (36%), Gaps = 19/136 (13%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+K         +   LL E  + + L     +  +     E +   ++M+    G   
Sbjct: 35  VAIKLENVKTKHPQ---LLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL--LGPSL 89

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
             L          N   +  SL +  +     Q+   ++F+ S+  +HRD+   N L+G 
Sbjct: 90  EDLF---------NFCSRKLSLKT--VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 145 NHCCK---VADFGFAR 157
                   + DFG A+
Sbjct: 139 GRRANQVYIIDFGLAK 154

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 25/139 (17%), Positives = 50/139 (35%), Gaps = 21/139 (15%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K     +       L  E    K L     + ++       +   +++E    G  
Sbjct: 36  YVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL--LGPS 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L          ++  ++ SL +  +     Q+   M+++ S+ +I+RD+   N LIG
Sbjct: 91  LEDLF---------DLCDRTFSLKT--VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG 139

Query: 144 -----ENHCCKVADFGFAR 157
                      + DF  A+
Sbjct: 140 RPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 24/139 (17%), Positives = 49/139 (35%), Gaps = 21/139 (15%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K     +   +   L  E    K L     +  +     E     ++++    G  
Sbjct: 37  QVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL--LGPS 91

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L          ++ G+  S+ +  +     Q+   +Q +  + +++RD+   N LIG
Sbjct: 92  LEDLL---------DLCGRKFSVKT--VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 140

Query: 144 -----ENHCCKVADFGFAR 157
                  +   V DFG  +
Sbjct: 141 RPNSKNANMIYVVDFGMVK 159

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.6 bits (98), Expect = 9e-05
 Identities = 10/38 (26%), Positives = 22/38 (57%), Gaps = 2/38 (5%)

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKV--ADFGFAR 157
           ++++     +H D+ A N+L+G  +  +V  AD+G + 
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 9/38 (23%), Positives = 20/38 (52%), Gaps = 2/38 (5%)

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKV--ADFGFAR 157
           ++++     +H D+ A N+L+   +  +V   D+G A 
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 10/38 (26%), Positives = 19/38 (50%), Gaps = 2/38 (5%)

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKV--ADFGFAR 157
           ++FL     +H ++ A N+ +      +V  A +GFA 
Sbjct: 172 LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	225
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.27
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.15
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.84
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.1
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.01
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.74
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.61
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.56
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.5
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.21
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.19
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.18
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.82
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.76
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.71
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.28
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.69
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.41
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.1
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	84.74
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.59

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7e-54  Score=336.66  Aligned_cols=202  Identities=26%  Similarity=0.427  Sum_probs=181.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+|+.||+|++....  .......+.+|+.++++++ ||||++++++|++.+.+|+|||||+
T Consensus        43 G~fg-~V~~a~-----~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yivmEy~~  115 (311)
T 4aw0_A           43 GSFS-TVVLAR-----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAK  115 (311)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCC
Confidence            8999 999998     56789999999997542  2334457899999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ||+|.+++.+.             ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..+
T Consensus       116 gG~L~~~i~~~-------------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          116 NGELLKYIRKI-------------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             TEEHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            99999999764             26899999999999999999999999999999999999999999999999999876


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .............||+.|+|||++.+..++.++||||+|+++|+|++ |.+||.+.+..+++++|
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i  246 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAKI  246 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            54444444556679999999999999999999999999999999999 99999999999888776

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-52  Score=334.71  Aligned_cols=202  Identities=20%  Similarity=0.390  Sum_probs=174.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+|+.||||++... ........+.+|+.++++++ ||||+++++++++++.+|+|||||+|
T Consensus        35 G~fg-~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiVmEy~~g  107 (350)
T 4b9d_A           35 GSFG-KAILVK-----STEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEG  107 (350)
T ss_dssp             -----CEEEEE-----ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            8999 999998     4678999999999754 34555678899999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...+           ...+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       108 g~L~~~i~~~~-----------~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          108 GDLFKRINAQK-----------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             CBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             CcHHHHHHHcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            99999997642           3357899999999999999999999999999999999999999999999999997654


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  ......||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+++.+|
T Consensus       177 ~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i  237 (350)
T 4b9d_A          177 STVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKI  237 (350)
T ss_dssp             HHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             CCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHH
Confidence            3221  1223458999999999999999999999999999999999 99999999998888765

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-52  Score=328.79  Aligned_cols=220  Identities=35%  Similarity=0.645  Sum_probs=181.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+.......+++.||||.++... ......+.+|+.++.+++ ||||+++++++.+++..++|||||++|
T Consensus        24 G~fG-~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~~~~lV~Ey~~~G  100 (299)
T 4asz_A           24 GAFG-KVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHG  100 (299)
T ss_dssp             --CC-CEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             CCCc-EEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEEEEEEEcCCCC
Confidence            8999 9999987665566789999999997543 344567899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..................+++.++..++.|+++||.|||+++|+||||||+||++++++.+||+|||++.....
T Consensus       101 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  180 (299)
T 4asz_A          101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS  180 (299)
T ss_dssp             BHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             cHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCC
Confidence            99999987543222211112345689999999999999999999999999999999999999999999999999975544


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........+|+.|+|||++.+..++.++||||+|+++|||+|.|..||.+.+..+++.+|
T Consensus       181 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          181 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            333333334557889999999999999999999999999999998789999999998887765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.4e-52  Score=331.61  Aligned_cols=198  Identities=26%  Similarity=0.479  Sum_probs=176.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+|+.||||++...... ....+.+|+.+++.+. ||||++++++|.+.+.+|+|||||+|+
T Consensus        85 G~fG-~V~~a~-----~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ivmEy~~gg  156 (346)
T 4fih_A           85 GSTG-IVCIAT-----VRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGG  156 (346)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            8999 999999     4678999999999754322 2345789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..+..
T Consensus       157 ~L~~~l~~~--------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          157 ALTDIVTHT--------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999998653              589999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++ |.+||.+.+..+++++|
T Consensus       223 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i  282 (346)
T 4fih_A          223 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMI  282 (346)
T ss_dssp             SS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHH
T ss_pred             CC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHH
Confidence            32  22345678999999999999999999999999999999999 99999999998888765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-51  Score=324.26  Aligned_cols=221  Identities=35%  Similarity=0.607  Sum_probs=181.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|.+.......+++.||||.++..........+.+|+.++.+++ ||||+++++++.+++..++|||||++|
T Consensus        37 G~fG-~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~~~~lV~Ey~~~G  114 (308)
T 4gt4_A           37 DRFG-KVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHG  114 (308)
T ss_dssp             CSSC-EEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCSSC
T ss_pred             CCCc-EEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECCEEEEEEEcCCCC
Confidence            8999 99999976555566789999999987655555667999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc---cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++...........   .......+++.++..++.|+++||+|||+++++||||||+||++++++++||+|||++..
T Consensus       115 ~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~  194 (308)
T 4gt4_A          115 DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE  194 (308)
T ss_dssp             BHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCG
T ss_pred             cHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCccccee
Confidence            99999975432110000   000124589999999999999999999999999999999999999999999999999976


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..............+|+.|+|||++.+..++.++||||||+++|||+|.|..||.+.+..+++..|
T Consensus       195 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i  260 (308)
T 4gt4_A          195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI  260 (308)
T ss_dssp             GGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred             ccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            544443334445678899999999999999999999999999999998789999999999888765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=332.70  Aligned_cols=198  Identities=26%  Similarity=0.479  Sum_probs=176.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+|+.||||++...... ....+.+|+.+++.+. ||||++++++|.+.+.+|+|||||+|+
T Consensus       162 G~fG-~V~~a~-----~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~iVmEy~~gG  233 (423)
T 4fie_A          162 GSTG-IVCIAT-----VRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGG  233 (423)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             CcCc-EEEEEE-----ECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEEEEEeCCCCC
Confidence            8999 999999     4678999999999754322 2346889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..+..
T Consensus       234 ~L~~~i~~~--------------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          234 ALTDIVTHT--------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             cHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            999998653              589999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..  .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+++.+|
T Consensus       300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i  359 (423)
T 4fie_A          300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMI  359 (423)
T ss_dssp             SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHH
T ss_pred             CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHH
Confidence            32  22345568999999999999999999999999999999999 99999999998888765

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.8e-51  Score=314.59  Aligned_cols=198  Identities=20%  Similarity=0.418  Sum_probs=161.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+|+.||+|++....  ......++.+|+.++++++ ||||+++++++.+.+.+|+||||| 
T Consensus        24 G~fg-~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~-   95 (275)
T 3hyh_A           24 GSFG-KVKLAY-----HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYA-   95 (275)
T ss_dssp             ---C-CEEEEE-----CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECC-
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEEeCC-
Confidence            8999 999998     46789999999997542  2333456889999999998 999999999999999999999999 


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.+.             ..+++.++..++.|++.||+|||++||+||||||+||++++++++||+|||++...
T Consensus        96 ~g~L~~~l~~~-------------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           96 GNELFDYIVQR-------------DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             CEEHHHHHHHS-------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            57999988753             36899999999999999999999999999999999999999999999999999754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....   ......||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+..+++++|
T Consensus       163 ~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt-g~~PF~~~~~~~~~~~i  224 (275)
T 3hyh_A          163 TDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKNI  224 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             CCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            3322   2334578999999999998876 579999999999999999 99999999988887765

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.4e-52  Score=324.96  Aligned_cols=203  Identities=27%  Similarity=0.456  Sum_probs=169.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||+++..  .+..+++.||+|+++... ......++.+|+.++.+++ ||||+++++++.+.+.+|+|||||+|
T Consensus        35 G~fg-~Vy~a~~~--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ivmEy~~g  110 (304)
T 3ubd_A           35 GSFG-KVFLVKKI--SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRG  110 (304)
T ss_dssp             GGGC-EEEEEEEC--SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEEETTEEEEEECCCTT
T ss_pred             CCCe-EEEEEEEc--cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEEEcCCC
Confidence            8999 99999732  234568999999997542 2222335788999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++.+.             ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus       111 g~L~~~l~~~-------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          111 GDLFTRLSKE-------------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             CEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999764             268999999999999999999999999999999999999999999999999997543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...  .......||+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+++.+|
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i  238 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMI  238 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh-CCCCCCCcCHHHHHHHH
Confidence            221  22334578999999999999999999999999999999999 99999999999888765

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=322.18  Aligned_cols=220  Identities=35%  Similarity=0.635  Sum_probs=174.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+....+..+++.||||.++... ......+.+|+.++.+++ ||||+++++++.+.+..++|||||++|
T Consensus        52 G~fG-~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~~~~lV~Ey~~~G  128 (329)
T 4aoj_A           52 GAFG-KVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHG  128 (329)
T ss_dssp             CSSE-EEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             CCCc-EEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            8999 9999987655566789999999997543 444567999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhc--ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYN--NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +|.+++..........  .......++++.++..++.|+++||.|||+++|+||||||+||++++++.+||+|||++...
T Consensus       129 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~  208 (329)
T 4aoj_A          129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  208 (329)
T ss_dssp             BHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             cHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceec
Confidence            9999997643211000  00012346899999999999999999999999999999999999999999999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .............+|+.|+|||++.+..++.++||||||+++|||+|.|..||.+.+..+++..|
T Consensus       209 ~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          209 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             -----------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             cCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            44433333445568899999999999999999999999999999998789999999998887765

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.7e-51  Score=324.65  Aligned_cols=196  Identities=24%  Similarity=0.347  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ++.+|+.||||+++....      ..+|+.++..++ ||||+++++++.+++.+|+|||||+|+
T Consensus        69 G~fG-~Vy~a~-----~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           69 GSFG-EVHRMK-----DKQTGFQCAVKKVRLEVF------RVEELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEETTTC------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEECHHHh------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            8999 999998     467899999999975432      246899999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-ceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-~~~l~d~g~~~~~~  160 (225)
                      +|.+++...             ..+++.++..++.|++.||.|||++||+||||||+||+++.++ ++||+|||++..+.
T Consensus       136 ~L~~~l~~~-------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          136 SLGQLIKQM-------------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             BHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             cHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            999999764             2689999999999999999999999999999999999999876 69999999997654


Q ss_pred             Cccccc---cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYE---RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   ......||+.|+|||++.+..++.++||||+||++|+|++ |.+||.+.+..+++.+|
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i  268 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKI  268 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSTTTCCSCCHHHH
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHH
Confidence            432221   1223468999999999999999999999999999999999 99999988776665543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-49  Score=309.34  Aligned_cols=195  Identities=29%  Similarity=0.473  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e   76 (225)
                      |+|| +||++.     +..+++.||+|.+... .......++.+|+.++++++ ||||++++++|.+    .+.+++|||
T Consensus        37 G~fg-~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           37 GSFK-TVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             CcCc-EEEEEE-----ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            8999 999998     4678999999999754 34555667899999999998 9999999999865    345899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEec-CCCceeEeee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIG-ENHCCKVADF  153 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~  153 (225)
                      ||+|++|.+++.+.             ..+++..+..++.|+++||.|||++|  |+||||||+||+++ .++.+||+||
T Consensus       110 y~~gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          110 LMTSGTLKTYLKRF-------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             CCCSCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence            99999999999764             26899999999999999999999999  99999999999997 4789999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA-AEVMK  222 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~-~~~~~  222 (225)
                      |+|......    ......||+.|+|||++.+ .++.++||||+|+++|+|+| |..||.+.+. .++.+
T Consensus       177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~  240 (290)
T 3fpq_A          177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYR  240 (290)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHH
T ss_pred             cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcHHHHHH
Confidence            999643222    2234568999999998865 68999999999999999999 9999986544 44443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=309.60  Aligned_cols=196  Identities=27%  Similarity=0.463  Sum_probs=161.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.+.        ..||||+++.. ...+....+.+|+.++.+++ ||||+++++++.+ +.+++|||||+|
T Consensus        47 G~fG-~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iVmEy~~g  115 (307)
T 3omv_A           47 GSFG-TVYKGKWH--------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIVTQWCEG  115 (307)
T ss_dssp             CSSS-EEEEEESS--------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred             CCCc-EEEEEEEC--------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence            8999 99999852        24899999754 34555677899999999998 9999999998764 568999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++.++..++.|+++||.|||+++|+||||||+||++++++++||+|||++....
T Consensus       116 GsL~~~l~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          116 SSLYKHLHVQ------------ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             CBHHHHHHTS------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             CCHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999753            2468999999999999999999999999999999999999999999999999997654


Q ss_pred             CccccccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ............||+.|+|||++.+   ..++.++||||||+++|||+| |..||.+.+..+.+
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~~~~~  246 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHINNRDQI  246 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHH
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCCCChHHHH
Confidence            4333333445678999999999864   458999999999999999999 99999987655443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.8e-49  Score=314.72  Aligned_cols=217  Identities=43%  Similarity=0.783  Sum_probs=180.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   80 (225)
                      |+|| +||+|.+........++.||||.++..........+.+|+.++.++..||||++++++|.. ++.+++|||||++
T Consensus        75 G~fG-~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~  153 (353)
T 4ase_A           75 GAFG-QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  153 (353)
T ss_dssp             CSSE-EEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTT
T ss_pred             CCCe-EEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCC
Confidence            8999 9999987655556678899999998777666677899999999999856999999999865 4678999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccC---CCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMH---GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      |+|.++++..+.........   .....+++.++..++.|+++||.|||+++++||||||+||++++++.+||+|||++.
T Consensus       154 G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar  233 (353)
T 4ase_A          154 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR  233 (353)
T ss_dssp             EEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             CCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhh
Confidence            99999998754321100000   013458999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ...............+|+.|+|||++.+..++.++||||||+++|||+|.|..||.+.+..+
T Consensus       234 ~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          234 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             CTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             hcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            66554444444556678899999999999999999999999999999987899999876433

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-47  Score=301.22  Aligned_cols=192  Identities=24%  Similarity=0.456  Sum_probs=153.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-----------
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----------   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----------   70 (225)
                      |+|| +||++.     ++.+|+.||||.++..........+.+|+.++++++ ||||+++++++.+.+.           
T Consensus        16 G~fg-~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~~~~~~   88 (299)
T 4g31_A           16 GGFG-VVFEAK-----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKV   88 (299)
T ss_dssp             CC---EEEEEE-----ETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC----------CE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccccccCCCc
Confidence            8999 999998     467899999999987666666678899999999998 9999999999875443           


Q ss_pred             -eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCcee
Q psy15818         71 -FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCK  149 (225)
Q Consensus        71 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~  149 (225)
                       +|+|||||+|++|.+++.....          .....+..++.++.|+++||+|||++||+||||||+||+++.++.+|
T Consensus        89 ~l~ivmE~~~gg~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           89 YLYIQMQLCRKENLKDWMNGRCT----------IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             EEEEEEECCCSCCHHHHHHTCCS----------GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhcCC----------CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence             6999999999999999975421          11245566899999999999999999999999999999999999999


Q ss_pred             EeeecccccccCcccc----------ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        150 VADFGFARDLMTSSVY----------ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       150 l~d~g~~~~~~~~~~~----------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      |+|||++.........          .......||+.|+|||++.+..++.++||||+|+++|||++    ||.+
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~----Pf~~  229 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFST  229 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS----CCSS
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc----CCCC
Confidence            9999999765433211          11233468999999999999999999999999999999995    6754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=307.58  Aligned_cols=201  Identities=26%  Similarity=0.418  Sum_probs=170.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec------CCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE------KEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------~~~~~lv   74 (225)
                      |+|| +||++.     +..+|+.||||+++... ......++.+|+.+++.+. ||||+++++++..      .+.+|+|
T Consensus        65 G~fG-~V~~a~-----~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           65 GAYG-VVSSAR-----RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccccCCEEEEE
Confidence            8999 999998     46789999999997543 3445567889999999998 9999999999754      3678999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ||||. ++|.+++..             ...+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus       138 mE~~~-g~L~~~i~~-------------~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          138 LDLME-SDLHQIIHS-------------SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EECCS-EEHHHHHTS-------------SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EeCCC-CCHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence            99996 679888864             2468999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccc--cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSV--YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++..+.....  ........||+.|+|||++.+. .++.++||||+||++|+|++ |.+||.+.+..+++.+|
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~-G~~pF~g~~~~~~l~~I  275 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFPGKNYVHQLQLI  275 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHH
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            9976543322  2233456789999999998875 46899999999999999999 99999999998888765

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-46  Score=300.33  Aligned_cols=199  Identities=19%  Similarity=0.324  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++...  ....+++.||+|.+......   .++.+|+.++..+.+||||++++++|.+.+.+++||||++|+
T Consensus        32 G~fg-~Vy~a~~~--~~~~~~~~vAiK~i~~~~~~---~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~  105 (361)
T 4f9c_A           32 GTFS-SVYLATAQ--LQVGPEEKIALKHLIPTSHP---IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE  105 (361)
T ss_dssp             CSSE-EEEEEEEE--BTTSCEEEEEEEEECTTSCH---HHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCC
T ss_pred             ccCc-EEEEEEEc--ccCCCCCEEEEEEEccccCH---HHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcc
Confidence            8999 99999731  12346889999998765433   357889999999977999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g~~~~~~  160 (225)
                      +|.+++.                .+++.++..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+|....
T Consensus       106 ~L~~~~~----------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          106 SFLDILN----------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CHHHHHT----------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             cHHHHHc----------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999883                47999999999999999999999999999999999999865 799999999996543


Q ss_pred             Ccccc--------------------------ccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        161 TSSVY--------------------------ERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       161 ~~~~~--------------------------~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      .....                          .......||+.|+|||++.+. .++.++||||+||++|+|++ |..||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~-G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH-CCCCCC
Confidence            22110                          112234689999999999876 48999999999999999999 999985


Q ss_pred             -CCCHHHHhhh
Q psy15818        214 -GMAAAEVMKK  223 (225)
Q Consensus       214 -~~~~~~~~~~  223 (225)
                       +.++.+.+.+
T Consensus       249 ~~~~~~~~l~~  259 (361)
T 4f9c_A          249 KASDDLTALAQ  259 (361)
T ss_dssp             CCSSHHHHHHH
T ss_pred             CCCCHHHHHHH
Confidence             5555555544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.1e-46  Score=315.53  Aligned_cols=190  Identities=22%  Similarity=0.369  Sum_probs=161.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||+++     ++.+|+.||+|++....     ..........++.++..+. ||||++++++|.+.+.+|+|||
T Consensus       200 G~fG-~V~la~-----~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~~lylVmE  272 (689)
T 3v5w_A          200 GGFG-EVYGCR-----KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILD  272 (689)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECCEEEEEEe
Confidence            8999 999999     46789999999996532     1122222233455666666 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ||+||+|.+++...             ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|
T Consensus       273 y~~GGdL~~~l~~~-------------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          273 LMNGGDLHYHLSQH-------------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             CCCSCBHHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence            99999999999764             26899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .......    .....||+.|+|||++.+ ..++.++|+||+||++|+|++ |.+||.+.+
T Consensus       340 ~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt-G~~PF~~~~  395 (689)
T 3v5w_A          340 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHK  395 (689)
T ss_dssp             EECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCGGG
T ss_pred             eecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            7654332    335579999999999964 579999999999999999999 999997643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-45  Score=311.31  Aligned_cols=199  Identities=21%  Similarity=0.379  Sum_probs=174.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ++.+|+.||+|++..... .....+.+|+.+|..++ ||||++++++|.+.+.+++|||||+|+
T Consensus       168 G~fg-~V~~~~-----~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iv~E~~~gg  239 (573)
T 3uto_A          168 GAFG-VVHRVT-----ERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGG  239 (573)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeecCCC
Confidence            8999 999998     467899999999875432 33456889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC--CCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE--NHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~--~~~~~l~d~g~~~~~  159 (225)
                      +|.+++...            ...+++.++..++.||++||.|||++||+||||||+||+++.  .+.+||+|||++..+
T Consensus       240 ~L~~~i~~~------------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          240 ELFEKVADE------------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             BHHHHHTCT------------TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             cHHHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999988542            236899999999999999999999999999999999999974  478999999999866


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   .....||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+++.+|
T Consensus       308 ~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~i  368 (573)
T 3uto_A          308 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNV  368 (573)
T ss_dssp             CTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred             cCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHH
Confidence            44322   223468999999999999999999999999999999999 99999999999888765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.7e-45  Score=289.28  Aligned_cols=186  Identities=24%  Similarity=0.368  Sum_probs=149.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC----CeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE----PFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~   77 (225)
                      |+|| +||++.+       .|+.||||++......+  .....|+..+.+++ ||||+++++++.+++    .+++||||
T Consensus        14 G~fG-~Vy~~~~-------~g~~VAvK~l~~~~~~~--~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A           14 GRFG-EVWRGKW-------RGEEVAVKIFSSREERS--WFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             CSSS-EEEEEEE-------TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             CCCe-EEEEEEE-------CCEEEEEEEECccchhh--HHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceEEEEEecC
Confidence            8999 9999983       47899999997543322  22345666667787 999999999987654    47999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEecCCCcee
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR--------GIIHRDLAARNVLIGENHCCK  149 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--------~i~h~dl~~~nil~~~~~~~~  149 (225)
                      +++++|.++++..              .++++.+..++.|++.||+|||++        +|+||||||+||+++.++++|
T Consensus        83 ~~~gsL~~~l~~~--------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           83 HEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             CTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCcHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            9999999999753              578999999999999999999987        999999999999999999999


Q ss_pred             EeeecccccccCccccc--cccCCCCCccccCCccccCC------CCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        150 VADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDN------IFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       150 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      |+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||+| |.+||.
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~~  219 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGG  219 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH-CCCCCC
Confidence            99999987553332211  22234689999999998764      25678999999999999999 876653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=281.84  Aligned_cols=201  Identities=25%  Similarity=0.466  Sum_probs=171.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|+++...  .........+|..++..+..||||+++++++.+.+..++||||+.
T Consensus        34 G~fg-~V~~~~~-----~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  107 (353)
T 3txo_A           34 GSFG-KVMLARV-----KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN  107 (353)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CCCE-EEEEEEE-----cCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence            8899 9999984     5779999999997642  233344677899999988669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++....             .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       108 gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          108 GGDLMFHIQKSR-------------RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             SCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999997642             5899999999999999999999999999999999999999999999999998643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...  ........+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++..+|
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i  236 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAI  236 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            222  122334568899999999988889999999999999999999 99999999998887765

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-42  Score=275.87  Aligned_cols=200  Identities=21%  Similarity=0.375  Sum_probs=173.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+|+.||+|+++...  .........+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        16 G~fg-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~E~~~   88 (337)
T 1o6l_A           16 GTFG-KVILVR-----EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEEEeCCC
Confidence            8999 999998     45779999999997542  2233456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++....             .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        89 gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           89 GGELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             TCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            999999987542             5899999999999999999999999999999999999999999999999998653


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++.++|
T Consensus       156 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i  217 (337)
T 1o6l_A          156 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI  217 (337)
T ss_dssp             CCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            2221  12334567889999999999999999999999999999999 99999998888776654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.8e-42  Score=273.84  Aligned_cols=199  Identities=26%  Similarity=0.499  Sum_probs=174.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| .||++.     +..+|+.||+|++.... ......++.+|+.+++.++ ||||+++++++.+.+..++||||+++
T Consensus        26 G~~g-~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~   98 (328)
T 3fe3_A           26 GNFA-KVKLAR-----HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASG   98 (328)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEEEECCCC
Confidence            8999 999998     46789999999997543 4555667889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        99 ~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           99 GEVFDYLVAH-------------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CBHHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             CcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999764             258999999999999999999999999999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCccccCCCCC-cchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFS-VKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...   ......+|+.|+|||++.+..+. .++|+||+|+++|+|++ |..||.+.+..++.+++
T Consensus       166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  226 (328)
T 3fe3_A          166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERV  226 (328)
T ss_dssp             SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            332   23445688899999999887764 79999999999999999 99999999888877654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.2e-42  Score=275.26  Aligned_cols=201  Identities=27%  Similarity=0.470  Sum_probs=173.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|+++...  ..........|..++..+..||||+++++++.+.+..++||||++
T Consensus        28 G~fg-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  101 (345)
T 1xjd_A           28 GSFG-KVFLAEF-----KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN  101 (345)
T ss_dssp             CSSS-EEEEEEE-----TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence            8999 9999994     5789999999997642  222334577888888887559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++....             .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus       102 gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A          102 GGDLMYHIQSCH-------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             TCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999997642             5899999999999999999999999999999999999999999999999998653


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++.++|
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i  230 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSI  230 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            2221  12344567899999999999999999999999999999999 99999999988877665

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.9e-42  Score=276.85  Aligned_cols=221  Identities=44%  Similarity=0.831  Sum_probs=181.1

Q ss_pred             CcccceeeecCCCC--CCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSP--ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++....  .....++..||+|+++..........+.+|+.++..+..||||+++++++.+.+..++||||++
T Consensus        92 G~fg-~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  170 (370)
T 2psq_A           92 GCFG-QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  170 (370)
T ss_dssp             CSSS-EEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             CCCe-eEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            8999 999997532  2234568899999998776666677899999999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhc---ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYN---NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++..........   ........+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  250 (370)
T 2psq_A          171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  250 (370)
T ss_dssp             TCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSC
T ss_pred             CCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCC
Confidence            999999998753211000   00011235789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ................+++.|+|||++.+..++.++|+||||+++|+|++.|..||.+.+..++.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             EETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             cccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            7654443333344456678899999999999999999999999999999879999999887776654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6e-42  Score=275.69  Aligned_cols=201  Identities=25%  Similarity=0.431  Sum_probs=174.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|+++...  ..........|..++..+..||+|+++++++.+.+..++||||++
T Consensus        31 G~fg-~V~~~~~-----~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  104 (353)
T 2i0e_A           31 GSFG-KVMLSER-----KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  104 (353)
T ss_dssp             ETTE-EEEEEEE-----TTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CCCE-EEEEEEE-----CCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence            7899 9999984     5679999999997642  223344678899999888669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus       105 gg~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A          105 GGDLMYHIQQV-------------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             SCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999764             25899999999999999999999999999999999999999999999999998753


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..++.++|
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i  233 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSI  233 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            2221  22334568899999999999999999999999999999999 99999999988877654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=270.89  Aligned_cols=197  Identities=27%  Similarity=0.464  Sum_probs=172.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ...+|+.||+|+++...  .......+.+|..++..+. ||||+++++++.+.+..++||||++
T Consensus        17 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~~   89 (318)
T 1fot_A           17 GSFG-RVHLIR-----SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIE   89 (318)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEEEeCCC
Confidence            8999 999998     45679999999997542  1223345778999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++...
T Consensus        90 gg~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           90 GGELFSLLRKS-------------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             SCBHHHHHHHT-------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            99999999753             25899999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+...+|
T Consensus       157 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  215 (318)
T 1fot_A          157 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKI  215 (318)
T ss_dssp             SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             CCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            321     234567889999999999999999999999999999999 99999998887776654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-41  Score=267.21  Aligned_cols=196  Identities=24%  Similarity=0.491  Sum_probs=170.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+++.||+|.+....... ...+.+|+.+++.+. ||||+++++++...+..++||||+.++
T Consensus        31 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~  102 (297)
T 3fxz_A           31 GASG-TVYTAM-----DVATGQEVAIRQMNLQQQPK-KELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGG  102 (297)
T ss_dssp             ETTE-EEEEEE-----BTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEEEEEEECCCCC
Confidence            7899 999998     35778999999987554332 246789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...              .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       103 ~L~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A          103 SLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             BHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            999998653              489999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.
T Consensus       169 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  226 (297)
T 3fxz_A          169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALY  226 (297)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred             cc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            32  22334567889999999999999999999999999999999 999999888766544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=277.87  Aligned_cols=215  Identities=39%  Similarity=0.696  Sum_probs=177.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+....+..+++.||||.++..........+.+|+.++.+++ ||||+++++++.+.+..++||||+.++
T Consensus        82 G~fg-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~g  159 (367)
T 3l9p_A           82 GAFG-EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGG  159 (367)
T ss_dssp             CSSS-CEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             CCCE-EEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCCCEEEEEeCCCC
Confidence            8999 99999976555667889999999987666666667889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g~~~~  158 (225)
                      +|.+++.......      .....+++.+++.++.|+++||.|||++|++||||||+||+++.++   .++|+|||++..
T Consensus       160 ~L~~~l~~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          160 DLKSFLRETRPRP------SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             EHHHHHHHHSCCS------SSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CHHHHHHhhcccc------CccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            9999998753211      1224588999999999999999999999999999999999998444   599999999865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..............+|+.|+|||++.+..++.++|+||||+++|+|++.|..||.+.+..++++.+
T Consensus       234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i  299 (367)
T 3l9p_A          234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  299 (367)
T ss_dssp             HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            433322223334456788999999999999999999999999999997799999999988877654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-41  Score=273.22  Aligned_cols=197  Identities=24%  Similarity=0.391  Sum_probs=173.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+|+.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        52 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~  124 (350)
T 1rdq_E           52 GSFG-RVMLVK-----HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CcCc-EEEEEE-----ECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            8999 999998     35679999999997542  2233456788999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus       125 gg~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          125 GGEMFSHLRRI-------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             TCBHHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence            99999999764             25899999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..++.++|
T Consensus       192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i  250 (350)
T 1rdq_E          192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhh-CCCCCCCCCHHHHHHHH
Confidence            332     234467889999999999999999999999999999999 99999999888877654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.5e-41  Score=269.04  Aligned_cols=191  Identities=25%  Similarity=0.452  Sum_probs=166.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||+++.     ..+++.||+|+++...  .......+.+|..++.++..||||+++++++.+.+..++||||++
T Consensus        20 G~fg-~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~   93 (345)
T 3a8x_A           20 GSYA-KVLLVRL-----KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   93 (345)
T ss_dssp             CSSE-EEEEEEE-----TTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cCCe-EEEEEEE-----CCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence            8999 9999984     5779999999997653  344555678899999988559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++....             .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        94 gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           94 GGDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             SCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             CCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999987542             5899999999999999999999999999999999999999999999999998743


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ....  .......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus       161 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  212 (345)
T 3a8x_A          161 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI  212 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTT
T ss_pred             cCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh-CCCCcCC
Confidence            2221  22334568899999999999999999999999999999999 9999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4e-42  Score=281.47  Aligned_cols=200  Identities=23%  Similarity=0.389  Sum_probs=171.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|+++...  .......+.+|..++..+. ||||+++++++.+.+..++||||++
T Consensus        80 G~fG-~V~~~~-----~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~~  152 (410)
T 3v8s_A           80 GAFG-EVQLVR-----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEYMP  152 (410)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeCCC
Confidence            8999 999998     45779999999997532  1112224778999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...              .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       153 gg~L~~~l~~~--------------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          153 GGDLVNLMSNY--------------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             TEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            99999998653              4899999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCccccCCC----CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNI----FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+|+.|+|||++.+..    ++.++|+||||+++|+|++ |..||.+.+..+...+|
T Consensus       219 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i  285 (410)
T 3v8s_A          219 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKI  285 (410)
T ss_dssp             CTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             ccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCCCCCCChhhHHHHH
Confidence            43321 2233556899999999998665    7789999999999999999 99999999888877665

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-41  Score=273.92  Aligned_cols=199  Identities=25%  Similarity=0.448  Sum_probs=172.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     +..+|+.||+|+++.....     .....+.+|+.++..+. ||||+++++++.+.+..++|||
T Consensus        23 G~fg-~V~~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e   95 (361)
T 2yab_A           23 GQFA-IVKKCR-----EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYENRTDVVLILE   95 (361)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEE
T ss_pred             CcCE-EEEEEE-----ECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEeCCEEEEEEE
Confidence            7899 999998     4678999999999764322     12356889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC----ceeEee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH----CCKVAD  152 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~----~~~l~d  152 (225)
                      |++|++|.+++...             ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++    .++|+|
T Consensus        96 ~~~gg~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           96 LVSGGELFDFLAQK-------------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             CCCSCBHHHHHTTC-------------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             cCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            99999999998542             3689999999999999999999999999999999999998665    799999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++.......   ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.+|
T Consensus       163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~-g~~Pf~~~~~~~~~~~i  230 (361)
T 2yab_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANI  230 (361)
T ss_dssp             CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred             cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            99987554322   2234568899999999998899999999999999999999 99999999888877654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-41  Score=269.80  Aligned_cols=220  Identities=45%  Similarity=0.846  Sum_probs=182.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.....++..+++.||+|+++..........+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        34 G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~  111 (314)
T 2ivs_A           34 GEFG-KVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYG  111 (314)
T ss_dssp             CSSS-EEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             cCCe-eEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecCCceEEEEeecCCC
Confidence            8999 99999865555567789999999987766666778899999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhh-----------hcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         82 KLQSFLRSSRAQRY-----------YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        82 ~L~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      +|.+++........           ..........+++.+++.++.|+++||.+||++|++|+||||+||+++.++.++|
T Consensus       112 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl  191 (314)
T 2ivs_A          112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI  191 (314)
T ss_dssp             BHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEE
T ss_pred             CHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEE
Confidence            99999987532100           0000001234789999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +|||++................+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++.+.
T Consensus       192 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  264 (314)
T 2ivs_A          192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL  264 (314)
T ss_dssp             CCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             ccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999987654444333444556678899999998888999999999999999999879999998887766554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.2e-41  Score=274.82  Aligned_cols=192  Identities=24%  Similarity=0.444  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||+++.     ..+++.||+|+++...  .......+.+|..++.++..||||+++++++.+.+..++||||++
T Consensus        63 G~fG-~V~~~~~-----~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           63 GSYA-KVLLVRL-----KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             CSSE-EEEEEEE-----TTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            8999 9999984     5789999999997653  223334577899999888669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++....             .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       137 gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          137 GGDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             TCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            999999987642             5899999999999999999999999999999999999999999999999998643


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ...  ........+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||...
T Consensus       204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~-G~~Pf~~~  256 (396)
T 4dc2_A          204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIV  256 (396)
T ss_dssp             CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSTTT
T ss_pred             ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccc
Confidence            222  122345568899999999999999999999999999999999 99999643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-41  Score=280.85  Aligned_cols=202  Identities=22%  Similarity=0.338  Sum_probs=172.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..     ..+++.||+|+++....  ......+.+|..++..+. ||||+++++++.+.+..++||||++
T Consensus        85 G~fG-~V~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~lV~Ey~~  157 (437)
T 4aw2_A           85 GAFG-EVAVVKL-----KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYLVMDYYV  157 (437)
T ss_dssp             CSSE-EEEEEEE-----TTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCE-EEEEEEE-----cCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEEEEecCC
Confidence            8999 9999994     56789999999975321  122223778999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...            ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus       158 gg~L~~~l~~~------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          158 GGDLLTLLSKF------------EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             TCBHHHHHHTT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHHc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            99999999752            236899999999999999999999999999999999999999999999999998655


Q ss_pred             cCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+|+.|+|||++.     ...++.++|+||+|+++|||++ |..||.+.+..+...+|
T Consensus       226 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          226 MEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI  293 (437)
T ss_dssp             CTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             ccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCChhHHHHhh
Confidence            33221 1223356899999999987     4568999999999999999999 99999999988877665

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-41  Score=274.43  Aligned_cols=217  Identities=42%  Similarity=0.763  Sum_probs=177.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-eEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~~   80 (225)
                      |.|| +||++.+....+..+++.||||+++..........+.+|+.++.++..||||+++++++.+.+. .++||||+++
T Consensus        33 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~  111 (359)
T 3vhe_A           33 GAFG-QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  111 (359)
T ss_dssp             CSSE-EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTT
T ss_pred             CCCc-eEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCC
Confidence            8999 9999987655567789999999998776666667899999999999669999999999887554 9999999999


Q ss_pred             CCHHHHHHHhhhhhhhc-----------------------------------------------------ccCCCCCCCC
Q psy15818         81 GKLQSFLRSSRAQRYYN-----------------------------------------------------NMHGKSNSLT  107 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~  107 (225)
                      ++|.+++..........                                                     ........++
T Consensus       112 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  191 (359)
T 3vhe_A          112 GNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT  191 (359)
T ss_dssp             EEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBC
T ss_pred             CcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccC
Confidence            99999997653210000                                                     0000012388


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCC
Q psy15818        108 SRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI  187 (225)
Q Consensus       108 ~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  187 (225)
                      +..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++................+|+.|+|||++.+..
T Consensus       192 ~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  271 (359)
T 3vhe_A          192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV  271 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC
Confidence            99999999999999999999999999999999999999999999999997665444444444556778899999999999


Q ss_pred             CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        188 FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       188 ~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ++.++||||+|+++|+|++.|..||.+....+
T Consensus       272 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  303 (359)
T 3vhe_A          272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  303 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             CCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence            99999999999999999976999998776443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.6e-41  Score=263.93  Aligned_cols=198  Identities=24%  Similarity=0.417  Sum_probs=167.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|.+...  .......++.+|+.++.++. ||||+++++++.+.+..++||||++
T Consensus        22 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   94 (294)
T 4eqm_A           22 GGMS-TVYLAE-----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIE   94 (294)
T ss_dssp             ETTE-EEEEEE-----ETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CCCE-EEEEEE-----ECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCeEEEEEeCCC
Confidence            7899 999998     4567899999998643  34455567889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus        95 g~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           95 GPTLSEYIESH-------------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             SCBHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999764             25899999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..... .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..
T Consensus       162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIA  221 (294)
T ss_dssp             --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH-SSCSSCSSCHHHHH
T ss_pred             ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Confidence            33221 12233457888999999999999999999999999999999 99999988776543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-41  Score=270.88  Aligned_cols=221  Identities=38%  Similarity=0.696  Sum_probs=179.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.........+++.||+|.++..........+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        58 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~  135 (343)
T 1luf_A           58 GAFG-RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYG  135 (343)
T ss_dssp             CSSC-EEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             cCCe-eEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEccCCceEEEEecCCCC
Confidence            8899 99999864333345679999999987766666678999999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhc-----------ccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         82 KLQSFLRSSRAQRYYN-----------NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      +|.+++..........           ........+++.+++.++.|+++||.+||++|++|+||||+||+++.++.++|
T Consensus       136 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl  215 (343)
T 1luf_A          136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI  215 (343)
T ss_dssp             BHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             cHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEE
Confidence            9999998642111000           00001246899999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +|||++................+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+....+
T Consensus       216 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  289 (343)
T 1luf_A          216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV  289 (343)
T ss_dssp             CCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             eecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHH
Confidence            99999875544333333344556788999999998889999999999999999998799999998888776543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=277.94  Aligned_cols=202  Identities=22%  Similarity=0.336  Sum_probs=171.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||+++.     ..+|+.||+|+++...  .......+.+|..++..+. ||||+++++++.+.+..++||||++
T Consensus        72 G~fG-~V~~~~~-----~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           72 GAFS-EVAVVKM-----KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             CSSC-EEEEEEE-----TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            8999 9999984     5689999999997532  2222334778999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...            ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       145 gg~L~~~l~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          145 GGDLLTLLSKF------------GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             SCBHHHHHHHH------------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999763            125899999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCcccc-------CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY-------DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... .......+|+.|+|||++.       ...++.++|+||+|+++|+|++ |..||.+.+..+++.+|
T Consensus       213 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i  282 (412)
T 2vd5_A          213 RADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADSTAETYGKI  282 (412)
T ss_dssp             CTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             cCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            33221 1223456889999999987       3567899999999999999999 99999999888877654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=276.75  Aligned_cols=200  Identities=22%  Similarity=0.366  Sum_probs=172.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+|+.||+|++.... .......+.+|+.+++.+. ||||+++++++.+.+..++||||+.|
T Consensus        22 G~fg-~V~~~~-----~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g   94 (444)
T 3soa_A           22 GAFS-VVRRCV-----KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTG   94 (444)
T ss_dssp             C--C-EEEEEE-----ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCEEEEEEEeCCC
Confidence            8999 999998     46789999999997543 3445567889999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~  157 (225)
                      ++|.+.+...             ..+++..+..++.|+++||.|||++||+||||||+||+++   +++.++|+|||++.
T Consensus        95 g~L~~~i~~~-------------~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           95 GELFEDIVAR-------------EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             CBHHHHHHHC-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             CCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999998753             2589999999999999999999999999999999999998   45789999999997


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......  .......+|+.|+|||++.+..++.++||||+|+++|+|++ |.+||.+.+..++..++
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~-G~~Pf~~~~~~~~~~~i  225 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPFWDEDQHRLYQQI  225 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCccHHHHHHHH
Confidence            554332  22234568899999999999899999999999999999999 99999998888777654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-41  Score=271.70  Aligned_cols=222  Identities=45%  Similarity=0.829  Sum_probs=183.3

Q ss_pred             CcccceeeecCCCC--CCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSP--ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++....  ......+..||+|+++..........+.+|+.++.++..||||+++++++.+.+..++||||++
T Consensus        80 G~~g-~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  158 (382)
T 3tt0_A           80 GAFG-QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  158 (382)
T ss_dssp             CSSE-EEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             CCCe-EEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecC
Confidence            8999 999998532  1123456889999998777777777899999999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhh---cccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++.........   .........+++.+++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a  238 (382)
T 3tt0_A          159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  238 (382)
T ss_dssp             TCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCC
T ss_pred             CCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcc
Confidence            99999999875321100   000112245899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ................+++.|+|||++.+..++.++||||||+++++|++.|..||.+.+..++.+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~  306 (382)
T 3tt0_A          239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  306 (382)
T ss_dssp             CCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             cccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            76654443344445566788999999999999999999999999999998799999999888776654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4e-41  Score=272.68  Aligned_cols=200  Identities=23%  Similarity=0.413  Sum_probs=163.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHH-hhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVM-KTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~-~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |+|| .||+++     +..+++.||+|+++...  .......+.+|..++ ..+. ||||+++++++.+.+..++||||+
T Consensus        49 G~fg-~V~~~~-----~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~lv~E~~  121 (373)
T 2r5t_A           49 GSFG-KVLLAR-----HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYI  121 (373)
T ss_dssp             CTTC-EEEEEE-----ETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCCe-EEEEEE-----EcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEEEEEEeCC
Confidence            8999 999998     46778999999997653  233334566677664 4565 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .|++|.+++....             .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus       122 ~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          122 NGGELFYHLQRER-------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             CSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             CCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999997642             588999999999999999999999999999999999999999999999999864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..++.++|
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i  251 (373)
T 2r5t_A          189 NIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNI  251 (373)
T ss_dssp             GBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSBHHHHHHHH
T ss_pred             cccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            32211  12334567899999999999999999999999999999999 99999999888877664

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.6e-41  Score=270.33  Aligned_cols=199  Identities=24%  Similarity=0.404  Sum_probs=171.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     +..+++.||+|++.... .......+.+|+.++..+. ||||+++++++.+.+..++||||+.|
T Consensus        40 G~~g-~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~g  112 (362)
T 2bdw_A           40 GAFS-VVRRCV-----HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTG  112 (362)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            7899 999998     46778999999997543 4445567889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC---CceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN---HCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~---~~~~l~d~g~~~  157 (225)
                      ++|.+.+...             ..+++.+++.++.|++.||.|||++|++|+||||+||+++..   +.++|+|||++.
T Consensus       113 g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          113 GELFEDIVAR-------------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             CBHHHHHTTC-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             CCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999888542             358999999999999999999999999999999999999754   459999999987


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++..+|
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i  242 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQI  242 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            554322   2234567889999999998899999999999999999999 99999998887776554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9e-41  Score=265.36  Aligned_cols=205  Identities=27%  Similarity=0.475  Sum_probs=169.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|.++..........+.+|+.+++++. ||||+++++++.+.+..++||||++ +
T Consensus        16 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~-~   87 (317)
T 2pmi_A           16 GTYA-TVYKGL-----NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLVFEFMD-N   87 (317)
T ss_dssp             ---C-EEEEEE-----CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEEEEecC-C
Confidence            8899 999998     467789999999976544433446789999999998 9999999999999999999999998 5


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.......       ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           88 DLKKYMDSRTVGN-------TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             BHHHHHHHHHSSS-------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             CHHHHHHhccccc-------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            9999887653211       123588999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..  .......+|+.|+|||++.+. .++.++|+||+|+++|+|++ |..||.+.+..+.++.|
T Consensus       161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  221 (317)
T 2pmi_A          161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLKLI  221 (317)
T ss_dssp             CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence            21  122344568889999998764 57999999999999999999 99999999888776543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-40  Score=265.22  Aligned_cols=203  Identities=23%  Similarity=0.413  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||+++..  .+..+++.||+|+++...   .........+|+.+++.+. ||||+++++++.+.+..++||||+
T Consensus        28 G~~g-~V~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3a62_A           28 GGYG-KVFQVRKV--TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGGKLYLILEYL  103 (327)
T ss_dssp             ETTE-EEEEEEEC--SSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CCCE-EEEEEEEe--ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCCEEEEEEeCC
Confidence            7899 99998742  123578999999997643   2233445778999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|++|.+++...             ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus       104 ~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A          104 SGGELFMQLERE-------------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             TTEEHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             CCCcHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999998754             2578999999999999999999999999999999999999999999999999864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+.+.+|
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  233 (327)
T 3a62_A          171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKI  233 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            32221  12234457889999999998889999999999999999999 99999998888776654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-41  Score=266.49  Aligned_cols=198  Identities=21%  Similarity=0.371  Sum_probs=171.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|.++...  .....+.+|+.++..+. ||||+++++++.+.+..++||||++|+
T Consensus        16 G~~g-~Vy~~~-----~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~g~   86 (321)
T 1tki_A           16 GEFG-IVHRCV-----ETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence            8999 999998     46789999999987543  33446889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC--CCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE--NHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~--~~~~~l~d~g~~~~~  159 (225)
                      +|.+++...            ...+++.+++.++.|++.||.|||++|++|+||||+||+++.  ++.++|+|||++...
T Consensus        87 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           87 DIFERINTS------------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             BHHHHHTSS------------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999988542            235899999999999999999999999999999999999986  789999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   .....+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+++.++
T Consensus       155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  215 (321)
T 1tki_A          155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENI  215 (321)
T ss_dssp             CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             CCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHH
Confidence            43322   223456788999999988888999999999999999999 99999998888776654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.1e-41  Score=264.69  Aligned_cols=217  Identities=44%  Similarity=0.762  Sum_probs=178.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++......+..+++.||+|.++..........+.+|+.++.++..||||+++++++.+.+..++||||++++
T Consensus        34 G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  112 (313)
T 1t46_A           34 GAFG-KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG  112 (313)
T ss_dssp             CSSE-EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             cCCc-ceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCC
Confidence            8899 999998655556678999999999877666666789999999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhh-----cccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYY-----NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +|.+++.........     .........+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++
T Consensus       113 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  192 (313)
T 1t46_A          113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA  192 (313)
T ss_dssp             EHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred             CHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccc
Confidence            999999865321000     000011235899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ................+++.|+|||.+.+..++.++|+||+|+++++|++.|..||.+....+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            766554433333344566789999999888999999999999999999987999998776543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=265.26  Aligned_cols=199  Identities=27%  Similarity=0.452  Sum_probs=171.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     +..+++.||+|+++.....     .....+.+|+.++..+. ||||+++++++.+.+..++|||
T Consensus        22 G~~g-~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e   94 (326)
T 2y0a_A           22 GQFA-VVKKCR-----EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILE   94 (326)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEE
Confidence            8999 999998     4667999999998754321     12456889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC----ceeEee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH----CCKVAD  152 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~----~~~l~d  152 (225)
                      |+++++|.+++...             ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++    .++|+|
T Consensus        95 ~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           95 LVAGGELFDFLAEK-------------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             CCCSCBHHHHHTTS-------------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             cCCCCCHHHHHHhc-------------CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            99999999998542             3589999999999999999999999999999999999998766    799999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++.......   ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~  229 (326)
T 2y0a_A          162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANV  229 (326)
T ss_dssp             CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred             CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHH
Confidence            99987653322   2234567889999999988899999999999999999999 99999988887766543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.9e-41  Score=275.32  Aligned_cols=203  Identities=37%  Similarity=0.700  Sum_probs=173.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+     ..+++.||+|.++..........+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus       125 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g  197 (377)
T 3cbl_A          125 GNFG-EVFSGRL-----RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGG  197 (377)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCC-eEEEEEE-----ecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence            7899 9999984     45789999999987665566667889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..+..++.|+++||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       198 ~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          198 DFLTFLRTEG------------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             BHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999997542            2478999999999999999999999999999999999999999999999999875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........+++.|+|||.+.+..++.++|+||||+++|||++.|..||.+.+..+..+.
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~  327 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF  327 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            32221112223456799999998888999999999999999999879999999888776543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-40  Score=261.96  Aligned_cols=200  Identities=34%  Similarity=0.568  Sum_probs=164.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.       ..++.||+|++.... .......+.+|+.++.+++ ||||+++++++.+.+..++||||+++
T Consensus        48 G~~g-~V~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 3p86_A           48 GSFG-TVHRAE-------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSR  118 (309)
T ss_dssp             CSSE-EEEEEE-------ETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred             CCCe-EEEEEE-------ECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceEEEEecCCC
Confidence            8999 999997       357889999987654 4455567889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++|.+++......          ..+++..++.++.|++.||.+||++|  ++|+||||+||+++.++.++|+|||++..
T Consensus       119 ~~L~~~l~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          119 GSLYRLLHKSGAR----------EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CBHHHHHHSTTHH----------HHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             CcHHHHHhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999754211          13899999999999999999999999  99999999999999999999999999864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  250 (309)
T 3p86_A          189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAA  250 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHHH
T ss_pred             ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            32221  12234567888999999999999999999999999999999 9999999888877654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-41  Score=269.24  Aligned_cols=217  Identities=45%  Similarity=0.800  Sum_probs=172.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.........++..||+|+++..........+.+|+.++.++..||||+++++++...+..++||||++++
T Consensus        56 G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g  134 (344)
T 1rjb_A           56 GAFG-KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG  134 (344)
T ss_dssp             CSSE-EEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCc-eeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCC
Confidence            8899 999999755555667889999999866555556678999999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhc--------c--cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEe
Q psy15818         82 KLQSFLRSSRAQRYYN--------N--MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVA  151 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~  151 (225)
                      +|.+++......-...        .  .......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+
T Consensus       135 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~  214 (344)
T 1rjb_A          135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC  214 (344)
T ss_dssp             BHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEEC
T ss_pred             cHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeC
Confidence            9999997643110000        0  00011347899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      |||++................+++.|+|||.+.+..++.++|+||||+++|+|++.|..||.+....+
T Consensus       215 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             CCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            99999765444333333344567789999999888999999999999999999976999998776543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-40  Score=269.77  Aligned_cols=201  Identities=24%  Similarity=0.459  Sum_probs=164.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--CeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~   78 (225)
                      |+|| +||++.     +..+|+.||+|.+... .......+..+|+.++..+.+||||+++++++...+  .+++||||+
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           20 GAYG-IVWKSI-----DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             -----CEEEEE-----ETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            8999 999998     4677999999998654 345555678899999999988999999999997544  689999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      . ++|.+++...              .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        94 ~-~~L~~~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           94 E-TDLHAVIRAN--------------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             S-EEHHHHHHHT--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             C-cCHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            7 6898888653              588999999999999999999999999999999999999999999999999975


Q ss_pred             ccCcc-------------------ccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        159 LMTSS-------------------VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       159 ~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      .....                   .........+|+.|+|||++.+ ..++.++||||+|+++++|++ |.+||.+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  237 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSSTM  237 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence            43210                   1112233467889999999886 568999999999999999999 99999999988


Q ss_pred             HHhhhc
Q psy15818        219 EVMKKS  224 (225)
Q Consensus       219 ~~~~~i  224 (225)
                      +.+.+|
T Consensus       238 ~~~~~i  243 (388)
T 3oz6_A          238 NQLERI  243 (388)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-40  Score=263.72  Aligned_cols=217  Identities=39%  Similarity=0.690  Sum_probs=180.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.........+++.||+|.+...........+.+|+.+++.+. ||||+++++++.+.+..++||||++++
T Consensus        36 G~~g-~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~  113 (322)
T 1p4o_A           36 GSFG-MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRG  113 (322)
T ss_dssp             CSSS-EEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCce-EEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEccCCccEEEEEeCCCC
Confidence            8899 99999853323345689999999987666666667899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...........   ....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       114 ~L~~~l~~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~  190 (322)
T 1p4o_A          114 DLKSYLRSLRPAMANNP---VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE  190 (322)
T ss_dssp             BHHHHHHHHHHHHHHCT---TCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGG
T ss_pred             cHHHHHHHhchhhccCC---CCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccccc
Confidence            99999987543211110   123568999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|+|+++|..||.+.+..+....
T Consensus       191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  252 (322)
T 1p4o_A          191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  252 (322)
T ss_dssp             GGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             ccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence            43333334455677899999998888999999999999999999978999999888776654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=265.70  Aligned_cols=207  Identities=39%  Similarity=0.665  Sum_probs=173.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++....  ....+..||||.++..........+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        60 G~~g-~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  135 (325)
T 3kul_A           60 GDSG-EVCYGRLRV--PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENG  135 (325)
T ss_dssp             TTTE-EEEEEEECC--TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGGCCEEEEECCTTC
T ss_pred             CCCc-EEEEEEEec--CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCccEEEeeCCCCC
Confidence            8999 999998521  123456799999987766666778999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.+++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       136 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          136 SLDTFLRTH------------DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             BHHHHHHTT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             cHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999643            23689999999999999999999999999999999999999999999999999976544


Q ss_pred             cccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++...+
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  267 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV  267 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            3221 12223345677999999988889999999999999999998799999998888776653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=270.61  Aligned_cols=191  Identities=24%  Similarity=0.430  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+++.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||+.
T Consensus        26 G~fG-~V~~~~-----~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~   98 (384)
T 4fr4_A           26 GSFG-KVCIVQ-----KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLL   98 (384)
T ss_dssp             CTTC-CEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEecCC
Confidence            8999 999998     46778999999997542  2333456889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++...             ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        99 gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           99 GGDLRYHLQQN-------------VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             TEEHHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            99999998743             36899999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ...   .......+|+.|+|||++.+   ..++.++|+||||+++|+|++ |..||....
T Consensus       166 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  221 (384)
T 4fr4_A          166 PRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPYHIRS  221 (384)
T ss_dssp             CTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCT
T ss_pred             cCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh-CCCCCCCCC
Confidence            332   22345568899999999864   457899999999999999999 999997543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-40  Score=287.03  Aligned_cols=201  Identities=25%  Similarity=0.429  Sum_probs=175.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+++.||+|+++...  ..........|..++..+..||+|+++++++.+.+.+++||||+.
T Consensus       352 G~fG-~V~~~~~-----~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          352 GSFG-KVMLSER-----KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             TTTB-CEEEEEE-----SSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            8999 9999994     6788999999997542  233344678889999988779999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++....             .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       426 gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          426 GGDLMYHIQQVG-------------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             SCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999997642             5899999999999999999999999999999999999999999999999998743


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......+|+.|+|||++.+..++.++|+||||+++|||++ |..||.+.+..+++.+|
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i  554 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSI  554 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            2221  22345568899999999999999999999999999999999 99999999998887765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.5e-41  Score=269.28  Aligned_cols=195  Identities=25%  Similarity=0.403  Sum_probs=164.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|++...........+.+|+.+++.+. ||||+++++++.+.+..++||||++++
T Consensus        18 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~   90 (323)
T 3tki_A           18 GAYG-EVQLAV-----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGG   90 (323)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence            7899 999998     356789999999976554444567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...             ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        91 ~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           91 ELFDRIEPD-------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EGGGGSBTT-------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            998887532             3589999999999999999999999999999999999999999999999999975543


Q ss_pred             ccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...........+++.|+|||++.+..+ +.++|+||+|+++|+|++ |..||.+...
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  213 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD  213 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSCT
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCch
Confidence            333333445668899999999987765 778999999999999999 9999987654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=268.15  Aligned_cols=199  Identities=13%  Similarity=0.164  Sum_probs=162.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCC--CCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.+....+..+++.||+|+++.....    ...+|+.++..+..  |++++++++++...+..++||||++
T Consensus        76 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  150 (365)
T 3e7e_A           76 GAFA-QVYEATQGDLNDAKNKQKFVLKVQKPANPW----EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS  150 (365)
T ss_dssp             CSSE-EEEEEEC-------CCCCEEEEEESSCCHH----HHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCC
T ss_pred             cCCE-EEEEEEecCCcccccCcEEEEEEeCCCChh----HHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccC
Confidence            8999 999997655456778999999999764322    35566666666542  8999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-----------CCce
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-----------NHCC  148 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-----------~~~~  148 (225)
                      +++|.+++......        ....+++..++.++.|++.||+|||+.||+||||||+||+++.           ++.+
T Consensus       151 ~g~L~~~l~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          151 YGTLLNAINLYKNT--------PEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             SCBHHHHHHHHHTS--------TTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             CCcHHHHHHHhhcc--------cccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            99999999865321        1246899999999999999999999999999999999999988           8899


Q ss_pred             eEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        149 KVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      +|+|||++................+|+.|+|||++.+..++.++|+||||+++|+|++ |..||..
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  287 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF-GTYMKVK  287 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCCCEE
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh-CCCcccc
Confidence            9999999965443333334455678999999999999999999999999999999999 9999854

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-40  Score=268.23  Aligned_cols=201  Identities=19%  Similarity=0.349  Sum_probs=170.1

Q ss_pred             cccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          3 CFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         3 ~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      .|| +||++..     ..+++.||+|++.... .......+.+|+.+++.+. ||||+++++++.+.+..++||||++++
T Consensus        39 ~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  111 (389)
T 3gni_B           39 DLM-TVNLARY-----KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYG  111 (389)
T ss_dssp             TTE-EEEEEEE-----TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             Cce-EEEEEEE-----cCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEEEEEEEccCCC
Confidence            899 9999994     5679999999997653 3445567888999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus       112 ~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          112 SAKDLICTHF-----------MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             BHHHHHHHTC-----------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             CHHHHHhhhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            9999997642           23589999999999999999999999999999999999999999999999998764322


Q ss_pred             cccc-----ccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVY-----ERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~-----~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ....     .......+++.|+|||++.+  ..++.++|+||+|+++|+|++ |..||.+.+..+.+.
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  247 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLL  247 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTCCSTTHHH
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence            2111     11223357788999999987  578999999999999999999 999998877665543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5e-40  Score=264.55  Aligned_cols=196  Identities=23%  Similarity=0.361  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.|| +||++.     +..+++.||+|++....    .......+.+|+.++..+. ||||+++++++.+.+..++||||
T Consensus        35 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~  107 (351)
T 3c0i_A           35 GPFS-VVRRCI-----NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEF  107 (351)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEeC
Confidence            8999 999998     46779999999986432    1112456889999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeec
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFG  154 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g  154 (225)
                      ++|++|.+.+.....         ....+++..++.++.|++.||.|||++|++|+||||+||+++.++   .++|+|||
T Consensus       108 ~~g~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          108 MDGADLCFEIVKRAD---------AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             CSSCBHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CCCCCHHHHHHHhcc---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999988866432         123579999999999999999999999999999999999997554   49999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ++.......  .......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+..
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  237 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPFYGTK  237 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCSSH
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH-CCCCCCCcH
Confidence            987554322  12234467889999999999889999999999999999999 999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.8e-40  Score=261.14  Aligned_cols=198  Identities=27%  Similarity=0.508  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++..      .+++.||+|++.... .......+.+|+.+++++. ||||+++++++.+.+..++||||++ 
T Consensus        32 G~~g-~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~-  102 (311)
T 3niz_A           32 GTYG-VVYKAKD------SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFME-  102 (311)
T ss_dssp             CSSC-EEEEEEE------TTSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred             CCCe-EEEEEEE------CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCEEEEEEcCCC-
Confidence            8999 9999983      358899999997543 3333456889999999998 9999999999999999999999998 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+...            ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       103 ~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          103 KDLKKVLDEN------------KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EEHHHHHHTC------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             CCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            5788877642            2358999999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  .......+++.|+|||++.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       171 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  231 (311)
T 3niz_A          171 IPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLPK  231 (311)
T ss_dssp             SCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTTTHHHH
T ss_pred             CCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            322  22233456888999999876 557999999999999999999 9999998877766554

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.9e-40  Score=255.18  Aligned_cols=200  Identities=37%  Similarity=0.696  Sum_probs=172.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..      .+++.||+|++.......  ..+.+|+.++++++ ||||+++++++.+.+..++||||++++
T Consensus        21 G~~g-~V~~~~~------~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           21 GQFG-LVHLGYW------LNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             CSSC-EEEEEEE------TTTEEEEEEEECTTSBCH--HHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             CCcc-EEEEEEe------cCCCeEEEEEecccccCH--HHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            8999 9999984      357789999998655433  35889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        91 ~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           91 CLSDYLRTQ------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             BHHHHHHTT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             cHHHHHHhc------------CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999653            23589999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+++.|+|||.+.+..++.++|+||+|+++++|++.|..||.+.+..+....+
T Consensus       159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~  220 (269)
T 4hcu_A          159 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  220 (269)
T ss_dssp             HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            32 223334455678999999988899999999999999999998789999999888776654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-40  Score=266.88  Aligned_cols=197  Identities=22%  Similarity=0.441  Sum_probs=167.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|++....  .......+.+|+.+++.+. ||||+++++++.+.+..++||||+ 
T Consensus        20 G~~g-~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~-   91 (336)
T 3h4j_B           20 GSFG-KVKLAT-----HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYA-   91 (336)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEECC-
Confidence            7899 999999     46789999999987542  1222346889999999998 999999999999999999999999 


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++.+++.++.|+++||.|||+.|++|+||||+||++++++.++|+|||++...
T Consensus        92 ~g~l~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           92 GGELFDYIVEK-------------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             CEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             CCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            68888888654             25899999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....   ......+++.|+|||++.+..+ +.++|+||+|+++|+|++ |..||.+....+..++
T Consensus       159 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~  219 (336)
T 3h4j_B          159 TDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV-GRLPFDDEFIPNLFKK  219 (336)
T ss_dssp             TTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH-SSCSSBCSSSTTCBCC
T ss_pred             cCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh-CCCCCCCccHHHHHHH
Confidence            4332   2234567889999999988776 789999999999999999 9999988766555443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-40  Score=276.31  Aligned_cols=200  Identities=22%  Similarity=0.363  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+++.||+|+++...  .........+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus       159 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~  231 (446)
T 4ejn_A          159 GTFG-KVILVK-----EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYAN  231 (446)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEEEECCCS
T ss_pred             CcCE-EEEEEE-----EcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEEEEeeCC
Confidence            7899 999998     46789999999997542  3334456778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +++|..++....             .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++..
T Consensus       232 ~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          232 GGELFFHLSRER-------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             SCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999987542             58999999999999999999998 9999999999999999999999999999864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  ........+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..++...|
T Consensus       299 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i  361 (446)
T 4ejn_A          299 GIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI  361 (446)
T ss_dssp             TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            3222  122344568899999999999999999999999999999999 99999998888776654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-40  Score=266.50  Aligned_cols=207  Identities=39%  Similarity=0.708  Sum_probs=164.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++....  ....+..||+|.++..........+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        56 G~fg-~Vy~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (373)
T 2qol_A           56 GEFG-EVCSGRLKL--PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENG  131 (373)
T ss_dssp             CSSS-EEEEC-CBC--TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEEec--CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCceEEEEeCCCCC
Confidence            8999 999998521  124578899999987666666678999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       132 sL~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          132 SLDSFLRKH------------DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             BHHHHHHTT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             cHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999753            23589999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... ......+++.|+|||.+.+..++.++|+||||+++|++++.|..||.+.+..++.+.+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i  263 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV  263 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            32111 1122334567999999998999999999999999999997699999988887776543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-40  Score=262.81  Aligned_cols=190  Identities=24%  Similarity=0.464  Sum_probs=146.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+++.||+|++....    .....+|+.++..+.+||||+++++++.+.+..++||||++++
T Consensus        22 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           22 GSFS-ICRKCV-----HKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            7899 999998     46779999999996532    2356789999999988999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g~~~~  158 (225)
                      +|.+++...             ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++   .++|+|||++..
T Consensus        92 ~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           92 ELFERIKKK-------------KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             BHHHHHHHC-------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             cHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999753             3689999999999999999999999999999999999997655   799999999865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .....  .......+|+.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.
T Consensus       159 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  214 (325)
T 3kn6_A          159 KPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHDR  214 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHH-SSCTTC----
T ss_pred             cCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCcc
Confidence            43322  12233456788999999999999999999999999999999 9999987543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-40  Score=264.20  Aligned_cols=200  Identities=25%  Similarity=0.432  Sum_probs=163.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC----eEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----FFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~   75 (225)
                      |.|| +||++.     +..+++.||+|+++...  .......+.+|+.++.++. ||||+++++++.....    .++||
T Consensus        23 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~lv~   95 (311)
T 3ork_A           23 GGMS-EVHLAR-----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVM   95 (311)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             CCCE-EEEEEE-----ECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCCCCcccEEEE
Confidence            8899 999998     45779999999997653  3445567889999999997 9999999999876554    39999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||++|++|.+++...             ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus        96 e~~~g~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           96 EYVDGVTLRDIVHTE-------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             ECCCEEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             ecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            999999999999754             2589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        156 ARDLMTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      +......... .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+...
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  229 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAY  229 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            8755433221 12223457888999999999999999999999999999999 999999888776543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=267.01  Aligned_cols=199  Identities=27%  Similarity=0.448  Sum_probs=167.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| .||++.     ...+|+.||+|+++.... .....+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus       100 G~~g-~Vy~a~-----~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A          100 GRFG-QVHKCE-----ETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             -----CEEEEE-----ETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             CcCE-EEEEEE-----EcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            7899 999998     356789999999976433 33457889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe--cCCCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI--GENHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~--~~~~~~~l~d~g~~~~~  159 (225)
                      +|.+.+....            ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++...
T Consensus       172 ~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          172 ELFDRIIDES------------YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEHHHHHHTG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             cHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            9998886532            258899999999999999999999999999999999999  46678999999998765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....   ......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+.+.+|
T Consensus       240 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  300 (373)
T 2x4f_A          240 KPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAETLNNI  300 (373)
T ss_dssp             CTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             CCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            3322   2233457889999999988889999999999999999999 99999999888776654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.2e-40  Score=262.67  Aligned_cols=198  Identities=26%  Similarity=0.484  Sum_probs=171.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..     ..+|+.||||++...... ....+.+|+.++.++. ||||+++++++...+..++||||++++
T Consensus        56 G~~g-~V~~a~~-----~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  127 (321)
T 2c30_A           56 GSTG-IVCLARE-----KHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGG  127 (321)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEEecCCCC
Confidence            7899 9999983     567899999998754432 2346789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..              ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       128 ~L~~~l~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          128 ALTDIVSQ--------------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             BHHHHHTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CHHHHHHh--------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence            99998753              2589999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...  ......+|+.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~pf~~~~~~~~~~~~  253 (321)
T 2c30_A          194 DVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRL  253 (321)
T ss_dssp             SSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHH
T ss_pred             Ccc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            221  2234567889999999998889999999999999999999 99999988877766543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.8e-40  Score=262.89  Aligned_cols=221  Identities=44%  Similarity=0.820  Sum_probs=178.3

Q ss_pred             CcccceeeecCCCC--CCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSP--ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++....  .....++..||+|+++..........+.+|+.++.++..||||+++++++.+.+..++||||++
T Consensus        46 G~~g-~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  124 (334)
T 2pvf_A           46 GAFG-QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  124 (334)
T ss_dssp             CSSC-EEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCT
T ss_pred             cCce-eEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCC
Confidence            8999 999998532  1233568899999998776666677889999999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcc---cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++...........   .......+++.+++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  204 (334)
T 2pvf_A          125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  204 (334)
T ss_dssp             TCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccc
Confidence            9999999976532110000   0001234789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ................+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++.+.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             EECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             ccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence            7655443333444556678899999998888999999999999999999879999999888776654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-40  Score=263.92  Aligned_cols=194  Identities=18%  Similarity=0.259  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||||++.......   .+.+|+.++.++..||||+++++++...+..++||||+ ++
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (330)
T 2izr_A           20 GNFG-ELRLGK-----NLYTNEYVAIKLEPMKSRAP---QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP   89 (330)
T ss_dssp             -CTT-SEEEEE-----ETTTTEEEEEEEEETTCSSC---CHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred             cCCc-eEEEEE-----ECCCCcEEEEEEeccccchH---HHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence            8899 999998     45779999999987543322   47889999999955999999999999999999999999 89


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc-----eeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC-----CKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~-----~~l~d~g~~  156 (225)
                      +|.+++...            ...+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.     ++|+|||++
T Consensus        90 ~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           90 SLEDLFDLC------------DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             BHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             CHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            999999763            236899999999999999999999999999999999999987776     999999999


Q ss_pred             ccccCccccc-----cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        157 RDLMTSSVYE-----RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       157 ~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ..........     ......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~Pf~~~~~~  223 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR-GSLPWQGLKAD  223 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCS
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc-CCCCccccccc
Confidence            7653332211     1235567899999999999999999999999999999999 99999885443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.1e-40  Score=258.05  Aligned_cols=201  Identities=28%  Similarity=0.495  Sum_probs=167.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+++.||+|++.... .........+|+.++.+++ ||||+++++++.+.+..++||||+.+
T Consensus        13 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   85 (292)
T 3o0g_A           13 GTYG-TVFKAK-----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCe-EEEEEE-----ECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEEEecCCC
Confidence            8999 999998     45778999999997543 3444567889999999998 99999999999999999999999975


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                       ++.+.+...            ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus        86 -~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           86 -DLKKYFDSC------------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             -EHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             -CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence             666666542            2368999999999999999999999999999999999999999999999999997553


Q ss_pred             CccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...  .......+|+.|+|||++.+.. ++.++|+||+|+++++|++++.++|.+.+..+.++++
T Consensus       153 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i  215 (292)
T 3o0g_A          153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  215 (292)
T ss_dssp             SCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred             Ccc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            221  2223445688899999988765 7999999999999999998455557787777766543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=258.21  Aligned_cols=194  Identities=31%  Similarity=0.528  Sum_probs=165.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|.+... .......+.+|+.++.+++ ||||+++++++.+.+..++||||++++
T Consensus        21 G~~g-~V~~~~~-----~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           21 GCFG-QAIKVTH-----RETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEEEEecCCC
Confidence            8999 9999984     567899999988653 3445567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.++..++.|+++||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        93 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           93 TLRGIIKSM------------DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             BHHHHHHHC------------CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             cHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999763            23589999999999999999999999999999999999999999999999999975533


Q ss_pred             ccccc------------cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        162 SSVYE------------RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       162 ~~~~~------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .....            ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~~~~~~~  226 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYL  226 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-TCCSSTTTS
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc-CCCCCcchh
Confidence            32211            1114567889999999999999999999999999999999 999987643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-40  Score=264.53  Aligned_cols=217  Identities=43%  Similarity=0.762  Sum_probs=177.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++...........+.||+|.+...........+.+|+.++..+..||||+++++++.+.+..++||||++++
T Consensus        57 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g  135 (333)
T 2i1m_A           57 GAFG-KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG  135 (333)
T ss_dssp             CSSE-EEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             CCCc-ceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCC
Confidence            8899 999998654444455678999999877666666789999999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMH-GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++............. .....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       136 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  215 (333)
T 2i1m_A          136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM  215 (333)
T ss_dssp             EHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGG
T ss_pred             cHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccc
Confidence            9999998654321100000 012357899999999999999999999999999999999999999999999999997654


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|+++|..||.+....+
T Consensus       216 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             GCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             cccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            44333333344556789999999988999999999999999999987999998766544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.4e-40  Score=262.36  Aligned_cols=216  Identities=43%  Similarity=0.783  Sum_probs=175.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-CeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~   80 (225)
                      |.|| +||++......+..+++.||+|+++..........+.+|+.++.++..||||+++++++...+ ..+++|||+++
T Consensus        38 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~  116 (316)
T 2xir_A           38 GAFG-QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  116 (316)
T ss_dssp             CSSE-EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTT
T ss_pred             CCce-eEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCC
Confidence            8899 999998654445678899999999877666666788999999999966999999999987654 59999999999


Q ss_pred             CCHHHHHHHhhhhhhhccc---CCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNM---HGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      ++|.+++............   ......+++..++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus       117 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  196 (316)
T 2xir_A          117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR  196 (316)
T ss_dssp             EEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             CcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcccc
Confidence            9999999764321000000   0001237899999999999999999999999999999999999999999999999997


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ...............+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+....
T Consensus       197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             CTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            6544433333444556778999999999999999999999999999997799999876643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-40  Score=267.38  Aligned_cols=199  Identities=19%  Similarity=0.420  Sum_probs=170.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ...+++.||+|++..... .....+.+|+.++..+. ||||+++++++.+.+..++||||+.++
T Consensus        62 G~~g-~Vy~~~-----~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~gg  133 (387)
T 1kob_A           62 GAFG-VVHRCV-----EKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGG  133 (387)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence            7899 999998     356789999999875432 23346889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC--CCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE--NHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~--~~~~~l~d~g~~~~~  159 (225)
                      +|.+++...            ...+++.+++.++.|++.||.|||++|++|+||||+||+++.  .+.++|+|||++...
T Consensus       134 ~L~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          134 ELFDRIAAE------------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             BHHHHTTCT------------TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             cHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            999888542            235899999999999999999999999999999999999973  567999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   .....+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i  262 (387)
T 1kob_A          202 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNV  262 (387)
T ss_dssp             CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred             CCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            43321   122357888999999999889999999999999999999 99999998887776543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=260.80  Aligned_cols=194  Identities=24%  Similarity=0.406  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--CeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++............+|+.++.+++ ||||+++++++...+  ..++||||++
T Consensus        20 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (319)
T 4euu_A           20 GATA-NVFRGRH-----KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCP   92 (319)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEEEEEeCCC
Confidence            8999 9999984     56789999999986654444556789999999998 999999999988655  7899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe----cCCCceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~----~~~~~~~l~d~g~  155 (225)
                      +++|.+++.....          ...+++.+++.++.|+++||.|||++|++|+||||+||++    +..+.++|+|||+
T Consensus        93 ~~~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           93 CGSLYTVLEEPSN----------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             TCBHHHHHHSGGG----------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             CCCHHHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999976431          2248999999999999999999999999999999999998    6777899999999


Q ss_pred             cccccCccccccccCCCCCccccCCcccc--------CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLY--------DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      +.......   ......+++.|+|||++.        +..++.++|+||+|+++|+|++ |..||....
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  227 (319)
T 4euu_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFE  227 (319)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTT
T ss_pred             ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            97554332   223345788999999886        4678899999999999999999 999997544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.7e-40  Score=262.20  Aligned_cols=215  Identities=40%  Similarity=0.710  Sum_probs=171.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+....+..+++.||+|.+...........+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        41 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  118 (327)
T 2yfx_A           41 GAFG-EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGG  118 (327)
T ss_dssp             -CSS-CEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             CCCe-eEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcCCCCcEEEEecCCCC
Confidence            8899 99999876555567789999999986666666667899999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~~  158 (225)
                      +|.+++.......      .....+++..++.++.|++.||.+||+.|++|+||||+||+++   ++..++|+|||++..
T Consensus       119 ~L~~~l~~~~~~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          119 DLKSFLRETRPRP------SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             EHHHHHHHTSCCS------SSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             cHHHHHHhhcccc------cccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            9999998653110      1123588999999999999999999999999999999999998   345699999999865


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..............+++.|+|||.+.+..++.++|+||||+++|+|+++|..||.+.+..+.++.+
T Consensus       193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            433332233334456778999999988889999999999999999997799999998887766543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.2e-40  Score=260.56  Aligned_cols=208  Identities=39%  Similarity=0.719  Sum_probs=159.0

Q ss_pred             CcccceeeecCCCCCCCCccc---eEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCe------
Q psy15818          2 DCFSVEVRKHPMSPERGREGP---CIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF------   71 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~------   71 (225)
                      |+|| +||++..     ..++   ..||+|.++... .......+.+|+.+++++. ||||+++++++......      
T Consensus        34 G~~g-~Vy~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  106 (323)
T 3qup_A           34 GEFG-SVREAQL-----KQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIP  106 (323)
T ss_dssp             ETTE-EEEEEEC------------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-------CE
T ss_pred             cCCe-EEEEEEE-----cccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeeccccccCCCcc
Confidence            7899 9999985     2333   389999997653 4445667899999999997 99999999999876654      


Q ss_pred             EEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEe
Q psy15818         72 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVA  151 (225)
Q Consensus        72 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~  151 (225)
                      ++++||+.+++|.+++.......       ....+++.+++.++.|+++||.+||++|++|+||||+||+++.++.++|+
T Consensus       107 ~~v~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          107 MVILPFMKHGDLHAFLLASRIGE-------NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             EEEEECCTTCBHHHHHHHHHC----------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeccCCcHHHHHHhhhccc-------cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence            99999999999999997654221       12258999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |||++................+++.|+|||.+.+..++.++|+||+|+++|+|+++|..||.+.+..+..+.
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  251 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY  251 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            999997654444333344455677899999999999999999999999999999988999998888776654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-39  Score=274.74  Aligned_cols=196  Identities=20%  Similarity=0.344  Sum_probs=168.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+|+.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus       196 G~fG-~Vy~a~~-----~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          196 GGFG-EVFACQM-----KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             CSSS-EEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEEEEEecc
Confidence            8999 9999984     5679999999997543  2223346788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++.....         ....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       269 gg~L~~~l~~~~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          269 GGDIRYHIYNVDE---------DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             TCBHHHHHHTSST---------TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCHHHHHHHhhc---------ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999875321         1236899999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .....  ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+
T Consensus       340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt-G~~PF~~~~  393 (543)
T 3c4z_A          340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRARG  393 (543)
T ss_dssp             CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCTT
T ss_pred             cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh-CCCCCCCCc
Confidence            33221  1233468899999999999999999999999999999999 999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-39  Score=254.24  Aligned_cols=205  Identities=38%  Similarity=0.711  Sum_probs=161.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++....  ....+..||+|.++..........+.+|+.++.++. ||||+++++++. .+..++||||++++
T Consensus        26 G~~g-~Vy~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~lv~e~~~~~  100 (281)
T 1mp8_A           26 GQFG-DVHQGIYMS--PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLG  100 (281)
T ss_dssp             CSSS-EEEEEEECC--C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSCEEEEECCTTE
T ss_pred             cCCe-eEEEEEEec--CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cCccEEEEecCCCC
Confidence            8999 999997421  123467899999987666666778899999999998 999999999985 56789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       101 ~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A          101 ELRSFLQVR------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EHHHHHHHT------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999753            23589999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... .......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+.+..+
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i  230 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  230 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence            321 12233445678999999988889999999999999999996599999988877766543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-39  Score=258.93  Aligned_cols=199  Identities=25%  Similarity=0.441  Sum_probs=171.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH-----HHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER-----ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     +..+|+.||+|.++......     ....+.+|+.++.++. ||||+++++++.+.+..++|||
T Consensus        23 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   95 (321)
T 2a2a_A           23 GQFA-IVKKCR-----EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYENRTDVVLILE   95 (321)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCCE-EEEEEE-----ECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEEEE
Confidence            8899 999998     35678999999997643211     2456889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC----ceeEee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH----CCKVAD  152 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~----~~~l~d  152 (225)
                      |+++++|.+++...             ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++    .++|+|
T Consensus        96 ~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           96 LVSGGELFDFLAQK-------------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             CCCSCBHHHHHHTC-------------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             cCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence            99999999999642             3578999999999999999999999999999999999998776    799999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++.......   ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i  230 (321)
T 2a2a_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANI  230 (321)
T ss_dssp             CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred             CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            99987554322   2234457889999999998899999999999999999999 99999998887776543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-39  Score=253.24  Aligned_cols=199  Identities=38%  Similarity=0.726  Sum_probs=170.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .++..||+|+++......  ..+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        19 G~~g-~V~~~~~------~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (268)
T 3sxs_A           19 GQFG-VVKLGKW------KGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNG   88 (268)
T ss_dssp             ETTE-EEEEEEE------TTTEEEEEEEECBTTBCH--HHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             CCCc-eEEEEEe------cCceeEEEEEeccCCCcH--HHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEEEEEccCCC
Confidence            7899 9999974      456789999998655433  35889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        89 ~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           89 CLLNYLRSHG------------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             BHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             cHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999997642            2489999999999999999999999999999999999999999999999999875544


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... .......+++.|+|||.+.+..++.++|+||+|+++++|++.|..||...+..+...+
T Consensus       157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  217 (268)
T 3sxs_A          157 DQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK  217 (268)
T ss_dssp             TCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             hhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH
Confidence            322 2223444567799999998888999999999999999999879999998888776654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.8e-40  Score=261.78  Aligned_cols=206  Identities=37%  Similarity=0.720  Sum_probs=163.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+.. .+.....+||+|.+...........+.+|+.++.++. ||||+++++++.+.. .+++++++.++
T Consensus        26 G~~g-~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~v~e~~~~g  101 (327)
T 3poz_A           26 GAFG-TVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFG  101 (327)
T ss_dssp             ETTE-EEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS-EEEEEECCTTC
T ss_pred             CCCe-EEEEEEEcC-CCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC-eEEEEEecCCC
Confidence            7899 999998521 1222244578898876555555567899999999998 999999999998754 78999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       102 ~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A          102 CLLDYVREH------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             BHHHHHHHS------------TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999763            23589999999999999999999999999999999999999999999999999976554


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++.+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  231 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI  231 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH
Confidence            44433444455677899999999999999999999999999999879999998877766543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.3e-40  Score=256.73  Aligned_cols=198  Identities=26%  Similarity=0.469  Sum_probs=163.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++..      .+++.||+|.+.... .......+.+|+.+++.+. ||||+++++++.+.+..++|||++.+
T Consensus        13 G~~g-~V~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A           13 GTYG-VVYKAQN------NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             ETTE-EEEEEEE------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             CCCE-EEEEEEc------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEEEEecCC
Confidence            7899 9999983      468899999986543 2222346789999999998 99999999999999999999999985


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                       +|.+++...            ...+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus        85 -~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           85 -DLKKLLDVC------------EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             -EHHHHHHTS------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             -CHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence             898888642            2358899999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  .......+|+.|+|||++.+. .++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  212 (288)
T 1ob3_A          152 IPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMR  212 (288)
T ss_dssp             C-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             ccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            221  122334567889999998764 58999999999999999999 9999999887776554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.6e-40  Score=271.82  Aligned_cols=199  Identities=24%  Similarity=0.435  Sum_probs=171.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++.     +..+|+.||+|++....  ..+....+.+|+.+++.+. ||||+++++++.+.+..++||||++
T Consensus        27 G~fg-~V~~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~   99 (476)
T 2y94_A           27 GTFG-KVKVGK-----HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVS   99 (476)
T ss_dssp             CSSS-CEEEEE-----ETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCC
Confidence            8999 999998     45689999999997542  2223456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++..             ...+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus       100 gg~L~~~l~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A          100 GGELFDYICK-------------NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             SEEHHHHTTS-------------SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCcHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            9999998853             236899999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....   ......+++.|+|||++.+..+ +.++|+||+|+++|+|++ |..||.+.+..++.++|
T Consensus       167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i  228 (476)
T 2y94_A          167 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKKI  228 (476)
T ss_dssp             CTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSSCCSSSHHHHHHH
T ss_pred             cccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            3322   2234567889999999988765 689999999999999999 99999988877776654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.4e-40  Score=263.87  Aligned_cols=190  Identities=25%  Similarity=0.422  Sum_probs=153.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+++.||+|++.......  ..+.+|+.+++.++ ||||+++++++.+.+..++||||+.++
T Consensus        31 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           31 GNFG-VARLMR-----DKLTKELVAVKYIERGAAID--ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             STTS-SEEEEE-----ETTTCCEEEEEEEESSTTSC--HHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEecCcccc--HHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            8999 999998     46789999999997644332  35789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc--eeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC--CKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~--~~l~d~g~~~~~  159 (225)
                      +|.+++...             ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...
T Consensus       102 ~L~~~l~~~-------------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A          102 ELYERICNA-------------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             BHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999998754             25899999999999999999999999999999999999986654  999999988633


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcc-hhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVK-SDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...   .......+|+.|+|||++.+..++.. +|+||+|+++|+|++ |..||.+...
T Consensus       169 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~  223 (361)
T 3uc3_A          169 VLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE  223 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH-SSCSCC----
T ss_pred             ccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh-CCCCCCCCcc
Confidence            222   12233457889999999988877655 899999999999999 9999987554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-39  Score=270.53  Aligned_cols=198  Identities=25%  Similarity=0.505  Sum_probs=169.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+++.||+|++.... .......+.+|+.+++++. ||||+++++++.+.+.+++||||+.+
T Consensus        33 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~  105 (486)
T 3mwu_A           33 GSFG-EVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTG  105 (486)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cCCE-EEEEEE-----ECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence            8999 999998     45679999999986532 2233456889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~  157 (225)
                      ++|.+.+...             ..+++..++.++.|++.||.|||++||+||||||+||+++   .++.++|+|||++.
T Consensus       106 ~~L~~~~~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          106 GELFDEIIKR-------------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             CBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             CcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999988754             2589999999999999999999999999999999999995   45679999999987


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   ......+|+.|+|||++.+ .++.++|+||+|+++|+|++ |.+||.+.+..++++++
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  234 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRV  234 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            553332   2234467889999998876 58999999999999999999 99999999988887664

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-39  Score=270.41  Aligned_cols=196  Identities=27%  Similarity=0.391  Sum_probs=162.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |+|| +||++.     +..+++.||+|++... .......++.+|+.+++.+. ||||+++++++...+      ..++|
T Consensus        73 G~~g-~V~~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv  145 (464)
T 3ttj_A           73 GAQG-IVCAAY-----DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLV  145 (464)
T ss_dssp             CSSC-EEEEEE-----ETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccccCCeEEEE
Confidence            8999 999998     4677999999999754 34455567889999999997 999999999996654      46999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+.+ ++.+.+..               .+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||
T Consensus       146 ~E~~~~-~l~~~~~~---------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          146 MELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EECCSE-EHHHHHTS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EeCCCC-CHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            999975 56665532               47899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.......   ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+.+.+|
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pF~g~~~~~~~~~i  275 (464)
T 3ttj_A          210 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKV  275 (464)
T ss_dssp             CC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             eeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            997543321   2234567888999999999999999999999999999999 99999999888776654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.8e-39  Score=252.15  Aligned_cols=198  Identities=26%  Similarity=0.492  Sum_probs=168.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|++.....  ......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   92 (279)
T 3fdn_A           20 GKFG-NVYLAR-----EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAP   92 (279)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCe-EEEEEE-----EccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEEEecCC
Confidence            8899 999998     467788999999865432  222446789999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+.+....             .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~l~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           93 LGTVYRELQKLS-------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             TEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999987642             5899999999999999999999999999999999999999999999999988543


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...    ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+..+++
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~  219 (279)
T 3fdn_A          160 PSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRI  219 (279)
T ss_dssp             ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             Ccc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH-CCCCCCCCcHHHHHHHH
Confidence            222    2233456788999999999889999999999999999999 99999998888776553

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=256.66  Aligned_cols=198  Identities=26%  Similarity=0.436  Sum_probs=161.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-------------------------HHHHHHHHHHHHHhhcCCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-------------------------RERLDLLQELTVMKTLDPHP   56 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~~~~~~~~~   56 (225)
                      |.|| +||++.     +..+++.||+|++......                         .....+.+|+.+++++. ||
T Consensus        24 G~~g-~Vy~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~   96 (298)
T 2zv2_A           24 GSYG-VVKLAY-----NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD-HP   96 (298)
T ss_dssp             --CC-EEEEEE-----ETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC-CT
T ss_pred             cCCE-EEEEEE-----ECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC-CC
Confidence            8999 999998     4577999999998654311                         12345789999999998 99


Q ss_pred             CeeeeeeEEec--CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCC
Q psy15818         57 NVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD  134 (225)
Q Consensus        57 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~d  134 (225)
                      ||+++++++.+  .+..++||||+++++|.+++.              ...+++..++.++.|+++||.+||++|++|+|
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D  162 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--------------LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRD  162 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--------------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence            99999999986  567899999999999876532              23689999999999999999999999999999


Q ss_pred             CCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCC---CCcchhHHHHHHHHHHHHHcCCCC
Q psy15818        135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI---FSVKSDIWSFGVLIWEIVTLGSTP  211 (225)
Q Consensus       135 l~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slg~ll~~l~~~g~~p  211 (225)
                      |||+||+++.++.++|+|||++........  ......+++.|+|||.+.+..   .+.++|+||+|+++|+|++ |..|
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p  239 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF-GQCP  239 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH-SSCS
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH-CCCC
Confidence            999999999999999999999875543221  123456788999999987665   3778999999999999999 9999


Q ss_pred             CCCCCHHHHhhh
Q psy15818        212 YPGMAAAEVMKK  223 (225)
Q Consensus       212 ~~~~~~~~~~~~  223 (225)
                      |.+.+..+...+
T Consensus       240 f~~~~~~~~~~~  251 (298)
T 2zv2_A          240 FMDERIMCLHSK  251 (298)
T ss_dssp             SCCSSHHHHHHH
T ss_pred             CCCccHHHHHHH
Confidence            998877665543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=262.18  Aligned_cols=195  Identities=27%  Similarity=0.467  Sum_probs=164.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |+|| +||++.     +..+|+.||+|.+... .......++.+|+.+++.++ ||||+++++++...+      .+++|
T Consensus        36 G~~g-~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv  108 (367)
T 1cm8_A           36 GAYG-AVCSAV-----DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLV  108 (367)
T ss_dssp             -----CEEEEE-----ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccCceEEEE
Confidence            8899 999998     4577999999998654 34445567889999999998 999999999997653      46999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+ +++|.+++...              .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus       109 ~e~~-~~~L~~~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          109 MPFM-GTDLGKLMKHE--------------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             EECC-SEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence            9999 78999998652              58999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++......     .....+|+.|+|||++.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.+|
T Consensus       174 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i  238 (367)
T 1cm8_A          174 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEI  238 (367)
T ss_dssp             TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             cccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            98754321     234456888999999887 678999999999999999999 99999999887776654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-39  Score=252.37  Aligned_cols=201  Identities=25%  Similarity=0.469  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ...+++.||+|.+...........+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        33 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~  105 (285)
T 3is5_A           33 GAFG-DVHLVE-----ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGG  105 (285)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred             CCCe-EEEEEE-----EccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeEEEEEEeCCCC
Confidence            8999 999998     356789999999987655544567889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~~  158 (225)
                      +|.+.+......         ...+++..++.++.|++.||.+||++|++|+||||+||+++   .++.++|+|||++..
T Consensus       106 ~L~~~l~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          106 ELLERIVSAQAR---------GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             BHHHHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             cHHHHHHhhhhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999998765322         23689999999999999999999999999999999999994   457899999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .....   ......+++.|+|||.+. ..++.++|+||+|+++++|++ |..||.+.+..+...+
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~-g~~pf~~~~~~~~~~~  236 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQK  236 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh-CCCCCCCCCHHHHHhh
Confidence            43322   223445788899999875 567899999999999999999 9999999887776544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.2e-39  Score=260.51  Aligned_cols=197  Identities=21%  Similarity=0.328  Sum_probs=168.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC----CCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----PHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |+|| +||++..     ..+++.||+|+++...  ........|+.+++.+.    .||||+++++++...+..++|||+
T Consensus        46 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~  117 (360)
T 3llt_A           46 GTFG-RVLLCQH-----IDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP  117 (360)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred             cCCe-EEEEEEE-----CCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence            8999 9999984     5678999999997432  23345677888888886    599999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-------------
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-------------  144 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-------------  144 (225)
                      + +++|.+++....           ...+++..++.++.|++.||.|||+.|++|+||||+||+++.             
T Consensus       118 ~-~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          118 L-GPSLYEIITRNN-----------YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             C-CCBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             C-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            9 899999997642           235899999999999999999999999999999999999975             


Q ss_pred             ------------CCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        145 ------------NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       145 ------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                                  ++.++|+|||++......     .....+|+.|+|||++.+..++.++||||+|+++|+|++ |..||
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf  259 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT-GSLLF  259 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSC
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH-CCCCC
Confidence                        778999999998643221     234457888999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHhhhc
Q psy15818        213 PGMAAAEVMKKS  224 (225)
Q Consensus       213 ~~~~~~~~~~~i  224 (225)
                      .+.+..+.+..+
T Consensus       260 ~~~~~~~~~~~~  271 (360)
T 3llt_A          260 RTHEHMEHLAMM  271 (360)
T ss_dssp             CCSSHHHHHHHH
T ss_pred             CCCcHHHHHHHH
Confidence            998887776543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=257.95  Aligned_cols=208  Identities=38%  Similarity=0.690  Sum_probs=168.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..... +...+..||+|.++..........+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        55 G~~g-~Vy~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  131 (333)
T 1mqb_A           55 GEFG-EVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENG  131 (333)
T ss_dssp             CSSS-EEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             CCCe-EEEEEEEecC-CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCCcEEEEeCCCCC
Confidence            8999 9999985311 122356799999987666666678899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       132 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          132 ALDKFLREK------------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EHHHHHHHT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999753            23589999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+++..+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  263 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  263 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            32111 1223345678999999998899999999999999999997799999988887776543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.4e-39  Score=251.04  Aligned_cols=199  Identities=24%  Similarity=0.404  Sum_probs=171.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+++.||+|++.... .......+.+|+.++++++ ||||+++++++.+.+..+++|||+.+
T Consensus        17 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~   89 (284)
T 3kk8_A           17 GAFS-VVRRCV-----HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTG   89 (284)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cCCe-EEEEEE-----EcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEEEEEEecCCC
Confidence            7899 999998     35678999999997653 4455567889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~d~g~~~  157 (225)
                      ++|.+.+...             ..+++..++.++.|++.||.+||++|++|+||||+||+++.++   .++|+|||.+.
T Consensus        90 ~~l~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           90 GELFEDIVAR-------------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            9999888754             2589999999999999999999999999999999999997554   49999999986


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+...++
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  219 (284)
T 3kk8_A          157 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQI  219 (284)
T ss_dssp             ECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             EcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH-CCCCCCCCchhHHHHHH
Confidence            553322   2234557888999999999989999999999999999999 99999988887776553

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-39  Score=275.54  Aligned_cols=193  Identities=19%  Similarity=0.367  Sum_probs=167.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| .||++..     ..+|+.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus       195 G~fG-~Vy~a~~-----~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~~  267 (576)
T 2acx_A          195 GGFG-EVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMN  267 (576)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCCE-EEEEEEE-----CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEEEEEEcCC
Confidence            7899 9999984     5689999999997542  2223345789999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...           ....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus       268 gg~L~~~l~~~-----------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          268 GGDLKFHIYHM-----------GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             SCBHHHHHHSS-----------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999998653           1234899999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ....   ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+
T Consensus       337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLlt-G~~PF~~~~  389 (576)
T 2acx_A          337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK  389 (576)
T ss_dssp             CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHH-SSCSSSCSS
T ss_pred             ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCcccc
Confidence            3322   1234468899999999998889999999999999999999 999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-39  Score=252.64  Aligned_cols=200  Identities=38%  Similarity=0.725  Sum_probs=170.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+      .++..||+|+++......  ..+.+|+.++.++. ||||+++++++.+.+..++||||+.++
T Consensus        35 G~~g-~V~~~~~------~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (283)
T 3gen_A           35 GQFG-VVKYGKW------RGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANG  104 (283)
T ss_dssp             --CE-EEEEEEE------TTTEEEEEEEECTTSBCH--HHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred             CCCc-eEEEEEE------cCCCeEEEEEecCCCCCH--HHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEeccCCC
Confidence            8899 9999984      457789999998654433  35889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       105 ~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          105 CLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             BHHHHHHCGG------------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             cHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999997532            2589999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||...+..+....+
T Consensus       173 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~  234 (283)
T 3gen_A          173 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI  234 (283)
T ss_dssp             HH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             cc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH
Confidence            32 222334455678999999998889999999999999999997799999998887776543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=262.39  Aligned_cols=200  Identities=25%  Similarity=0.488  Sum_probs=162.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ...+++.||+|++...........+.+|+.++..+. ||||+++++++.+.+..++||||+. +
T Consensus        13 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (324)
T 3mtl_A           13 GTYA-TVYKGK-----SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLD-K   84 (324)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEEecccc-c
Confidence            8999 999998     356789999999976544333334567999999998 9999999999999999999999997 5


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~l~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           85 DLKQYLDDC------------GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            888888753            23589999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..  .......+++.|+|||++.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+..+
T Consensus       153 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i  213 (324)
T 3mtl_A          153 PT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFI  213 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             Cc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            22  12223456788999999876 567999999999999999999 99999999888776553

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-39  Score=258.32  Aligned_cols=194  Identities=23%  Similarity=0.414  Sum_probs=160.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-----------
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----------   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----------   70 (225)
                      |+|| +||++.     +..+++.||||+++..........+.+|+.++.+++ ||||+++++++.+...           
T Consensus        17 G~~g-~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~~~~   89 (332)
T 3qd2_B           17 GGFG-VVFEAK-----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQEEMDEIW   89 (332)
T ss_dssp             C-CS-EEEEEE-----ETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhhhhhhhhh
Confidence            8999 999998     356789999999986655556678999999999998 9999999999865432           


Q ss_pred             ----------------------------------------------eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCC
Q psy15818         71 ----------------------------------------------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN  104 (225)
Q Consensus        71 ----------------------------------------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  104 (225)
                                                                    .++||||+++++|.+++.....          ..
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~  159 (332)
T 3qd2_B           90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----------LE  159 (332)
T ss_dssp             ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----------GG
T ss_pred             hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----------cc
Confidence                                                          7999999999999999976421          12


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCcccc----------ccccCCCCC
Q psy15818        105 SLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVY----------ERKSEGRLP  174 (225)
Q Consensus       105 ~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~  174 (225)
                      ..++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........          .......+|
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            3466678999999999999999999999999999999999999999999999765443211          122334678


Q ss_pred             ccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        175 IRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       175 ~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      +.|+|||.+.+..++.++|+||+|+++|+|++ |..|+.
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~~~~~~  277 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-SFSTQM  277 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-CCCCHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHH-cCCChh
Confidence            89999999999999999999999999999999 877653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.8e-39  Score=250.07  Aligned_cols=197  Identities=24%  Similarity=0.379  Sum_probs=169.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     ...++..||+|.+....... ...+.+|+.++++++ ||||+++++++.+.+..++||||++++
T Consensus        20 G~~g-~V~~~~-----~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (277)
T 3f3z_A           20 GSWG-EVKIAV-----QKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGG   91 (277)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             cCCE-EEEEEE-----eCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCeEEEEEeccCCC
Confidence            7899 999998     35678899999987654332 346889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe---cCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~---~~~~~~~l~d~g~~~~  158 (225)
                      +|.+.+....             .+++..++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||.+..
T Consensus        92 ~L~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           92 ELFERVVHKR-------------VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             BHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             cHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            9999887542             58999999999999999999999999999999999999   6788999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   ......+++.|+|||.+.+. ++.++|+||+|+++++|++ |..||.+.+..+...++
T Consensus       159 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  219 (277)
T 3f3z_A          159 FKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC-GYPPFSAPTDSEVMLKI  219 (277)
T ss_dssp             CCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            54332   22344578889999987654 8899999999999999999 99999998888776554

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=253.50  Aligned_cols=205  Identities=35%  Similarity=0.682  Sum_probs=172.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++...   ...++..||+|+++..........+.+|+.++.++. ||||+++++++ ..+..++|||+++++
T Consensus        21 G~~g-~Vy~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           21 GNFG-SVRQGVYR---MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             CTTE-EEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             cCce-eEEEeEec---cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            8999 99998632   234688999999987766667778999999999997 99999999999 456799999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           95 PLHKFLVGK------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EHHHHHTTC------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CHHHHHHhC------------CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999998542            23589999999999999999999999999999999999999999999999999976543


Q ss_pred             cccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+.+..+
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i  226 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI  226 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            3222 22233445778999999988889999999999999999997699999988877766543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=255.99  Aligned_cols=199  Identities=26%  Similarity=0.424  Sum_probs=165.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..     ..+|+.||+|++.... .......+.+|+.++.++. ||||+++++++.+.+..++||||+++
T Consensus        14 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (311)
T 4agu_A           14 GSYG-VVFKCRN-----RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH   86 (311)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             cCCe-EEEEEEe-----CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEEEEeCCC
Confidence            8899 9999983     5679999999987554 3344556789999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|..++...             ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        87 ~~l~~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           87 TVLHELDRYQ-------------RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EHHHHHHHTS-------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             chHHHHHhhh-------------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            8888877532             358999999999999999999999999999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  ......+++.|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+..
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~  214 (311)
T 4agu_A          154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVPLWPGKSDVDQLYL  214 (311)
T ss_dssp             --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            3221  1233456788999999876 567999999999999999999 9999999988776654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-39  Score=260.42  Aligned_cols=195  Identities=26%  Similarity=0.399  Sum_probs=170.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..     ..+++.||+|++...........+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        44 G~~g-~V~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  116 (360)
T 3eqc_A           44 GNGG-VVFKVSH-----KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGG  116 (360)
T ss_dssp             CSSC-EEEEEEE-----TTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEEEEEEECCCCC
Confidence            8999 9999984     56789999999987766666778899999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++....             .+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+|||++....
T Consensus       117 ~L~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          117 SLDQVLKKAG-------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             BHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999997642             588999999999999999999996 99999999999999999999999999885432


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..    ......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||...+..+..
T Consensus       184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~  239 (360)
T 3eqc_A          184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELE  239 (360)
T ss_dssp             HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH-TSCCSSCCCHHHHH
T ss_pred             cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            21    2233457888999999999999999999999999999999 99999988876654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.5e-40  Score=261.24  Aligned_cols=206  Identities=35%  Similarity=0.636  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.... .+.....+||+|.+...........+.+|+.++.++. ||||+++++++. .+..++|+||+.++
T Consensus        24 G~~g-~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~~~~~   99 (325)
T 3kex_A           24 GVFG-TVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GSSLQLVTQYLPLG   99 (325)
T ss_dssp             CSSC-EEEEEEECC-TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BSSEEEEEECCTTC
T ss_pred             cCCc-eEEEEEEcC-CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CCccEEEEEeCCCC
Confidence            8999 999998531 1222244588888765443333345678899999997 999999999986 45689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       100 ~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A          100 SLLDHVRQHR------------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             BSHHHHHSSG------------GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             CHHHHHHHcc------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            9999987531            2588999999999999999999999999999999999999999999999999986654


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+....++...
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  229 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL  229 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH
Confidence            43333334455667899999999889999999999999999999879999998876665543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.3e-39  Score=252.05  Aligned_cols=195  Identities=25%  Similarity=0.403  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|++...........+.+|+.++..+. ||||+++++++.+.+..++|+||++++
T Consensus        18 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (276)
T 2yex_A           18 GAYG-EVQLAV-----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGG   90 (276)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             CCCc-EEEEEE-----ECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEEEEEEecCCC
Confidence            8899 999998     356789999999986655555667899999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..             ...+++..++.++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        91 ~L~~~l~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           91 ELFDRIEP-------------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EGGGGSBT-------------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cHHHHHhh-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            99887743             23589999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...........+++.|+|||.+.+..+ +.++|+||+|+++++|++ |..||.....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~  213 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD  213 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH-SSCCCSCSCT
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Confidence            332233344567888999999887665 778999999999999999 9999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.7e-40  Score=260.53  Aligned_cols=189  Identities=24%  Similarity=0.402  Sum_probs=159.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC----eEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----FFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~e~   77 (225)
                      |.|| +||++..       .++.||||+++.....  .....+|+.++.+++ ||||+++++++.+...    +++||||
T Consensus        35 G~~g-~Vy~~~~-------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           35 GRFG-CVWKAQL-------LNEYVAVKIFPIQDKQ--SWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             STTC-EEEEEEE-------TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cCce-EEEEEEE-------CCCEEEEEEeecCchH--HHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCceEEEEEec
Confidence            8999 9999983       3789999999764332  234566888899998 9999999999987543    6999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCCEEecCCCc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR----------GIIHRDLAARNVLIGENHC  147 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~----------~i~h~dl~~~nil~~~~~~  147 (225)
                      +++++|.+++...              .+++..++.++.|++.||.|||+.          |++|+||||+||+++.++.
T Consensus       104 ~~~g~L~~~l~~~--------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A          104 HEKGSLSDFLKAN--------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             CTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             CCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            9999999999653              489999999999999999999999          9999999999999999999


Q ss_pred             eeEeeecccccccCccccccccCCCCCccccCCccccCC-----CCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        148 CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-----IFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ++|+|||++................+|+.|+|||++.+.     .++.++||||+|+++|+|++ |..||.+..
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~  242 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAADGPV  242 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TBTTSSSCC
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh-CCCCCCCCc
Confidence            999999999765444333334445678999999998763     34567899999999999999 999997653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.4e-39  Score=270.45  Aligned_cols=198  Identities=24%  Similarity=0.509  Sum_probs=167.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch------------HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE------------RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   69 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   69 (225)
                      |+|| +||++.     +..+++.||+|+++.....            .....+.+|+.++.++. ||||+++++++.+.+
T Consensus        47 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  119 (504)
T 3q5i_A           47 GAYG-EVLLCK-----EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKK  119 (504)
T ss_dssp             --CE-EEEEEE-----ETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCC
Confidence            8999 999998     4678899999999754321            23456889999999998 999999999999999


Q ss_pred             CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---
Q psy15818         70 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---  146 (225)
Q Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---  146 (225)
                      ..++|||||+|++|.+.+...             ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++   
T Consensus       120 ~~~lv~e~~~gg~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          120 YFYLVTEFYEGGELFEQIINR-------------HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEEecCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            999999999999999988754             2589999999999999999999999999999999999998665   


Q ss_pred             ceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        147 CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       147 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .++|+|||++.......   ......+|+.|+|||++. ..++.++|+||+|+++|+|++ |..||.+.+..+++.+|
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  259 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKKV  259 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            69999999997554332   223455788999999876 468899999999999999999 99999999998887765

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-38  Score=250.27  Aligned_cols=199  Identities=24%  Similarity=0.412  Sum_probs=172.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     ...+++.||+|++....  .......+.+|+.+++.+. ||||+++++++.+.+..++||||++
T Consensus        26 G~~g-~Vy~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   98 (294)
T 2rku_A           26 GGFA-KCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCR   98 (294)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             cCCE-EEEEEE-----ECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEEEEEecCC
Confidence            7899 999998     45678999999987653  3455567889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++.+++.++.|+++||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        99 ~~~L~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           99 RRSLLELHKRR-------------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             TCBHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99999988654             25899999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+...+
T Consensus       166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~  226 (294)
T 2rku_A          166 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLR  226 (294)
T ss_dssp             CSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHH
T ss_pred             ccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            3222  12234457788999999988889999999999999999999 9999998887766544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.9e-39  Score=255.71  Aligned_cols=199  Identities=24%  Similarity=0.412  Sum_probs=172.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||+.
T Consensus        52 G~~g-~Vy~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           52 GGFA-KCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEEEEEecCC
Confidence            7899 999998     45678999999987553  3455567889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++.+++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus       125 ~~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          125 RRSLLELHKRR-------------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             TCBHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999988653             25899999999999999999999999999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+...+
T Consensus       192 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~  252 (335)
T 2owb_A          192 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLR  252 (335)
T ss_dssp             CSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHH
T ss_pred             ccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH-CcCCCCCCCHHHHHHH
Confidence            3222  12234457788999999998889999999999999999999 9999998887766544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=252.06  Aligned_cols=201  Identities=26%  Similarity=0.478  Sum_probs=163.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc----hHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEecCC-----C
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG----ERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKE-----P   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~-----~   70 (225)
                      |+|| +||++.     +..+++.||+|++.....    ........+|+.+++.+.  .||||+++++++....     .
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~   93 (308)
T 3g33_A           20 GAYG-TVYKAR-----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK   93 (308)
T ss_dssp             SSSC-CEEEEE-----CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence            8999 999998     467899999999874321    111123455666555543  3999999999998765     4


Q ss_pred             eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         71 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      .+++||++. ++|.+++....           ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|
T Consensus        94 ~~lv~e~~~-~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           94 VTLVFEHVD-QDLRTYLDKAP-----------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             EEEEEECCC-CBHHHHHHTCC-----------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             EEEEehhhh-cCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence            899999997 69999987542           234899999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +|||++........   .....+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i  231 (308)
T 3g33_A          162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKI  231 (308)
T ss_dssp             CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT-SSCSCCCSSHHHHHHHH
T ss_pred             eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            99999875533221   223456788999999999999999999999999999999 99999999988877654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-38  Score=250.92  Aligned_cols=192  Identities=17%  Similarity=0.227  Sum_probs=164.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|++.......   .+.+|+.++..+..|++++++++++.+....++||||+ ++
T Consensus        21 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   90 (298)
T 1csn_A           21 GSFG-VIFEGT-----NLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   90 (298)
T ss_dssp             CSSC-EEEEEE-----ETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             cCCE-EEEEEE-----ECCCCcEEEEEEeccCCccH---HHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence            8899 999998     35679999999986543322   47789999999977999999999999999999999999 89


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc-----eeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC-----CKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~-----~~l~d~g~~  156 (225)
                      +|.+++...            ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.     ++|+|||++
T Consensus        91 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           91 SLEDLLDLC------------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             BHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CHHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999753            235899999999999999999999999999999999999976654     999999999


Q ss_pred             ccccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        157 RDLMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       157 ~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .........     .......+|+.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  222 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLK  222 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCC
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc-CCCCcchhh
Confidence            765443221     12334567889999999999899999999999999999999 999998743

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-39  Score=260.39  Aligned_cols=215  Identities=24%  Similarity=0.421  Sum_probs=166.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.|| +||++.     ...+++.||+|++....    .......+.+|+.++.+++ ||||+++++++.+.+..++||||
T Consensus        37 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  109 (345)
T 3hko_A           37 GSYG-VVRVAI-----ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMEL  109 (345)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCe-EEEEEE-----ECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccCCeEEEEEeC
Confidence            8999 999998     46778999999987542    3345567889999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhh-----------------------hccc----CCCCCCCChHHHHHHHHHHHHHHHHHHhCCc
Q psy15818         78 VPYGKLQSFLRSSRAQRY-----------------------YNNM----HGKSNSLTSRDLTSFCYQVARGMQFLSSRGI  130 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~-----------------------~~~~----~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i  130 (225)
                      ++|++|.+++........                       ....    ......+++..++.++.|++.||.+||++|+
T Consensus       110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  189 (345)
T 3hko_A          110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI  189 (345)
T ss_dssp             CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            999999998842110000                       0000    0001124678899999999999999999999


Q ss_pred             ccCCCCCCCEEecCCC--ceeEeeecccccccCcc--ccccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHH
Q psy15818        131 IHRDLAARNVLIGENH--CCKVADFGFARDLMTSS--VYERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEI  204 (225)
Q Consensus       131 ~h~dl~~~nil~~~~~--~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l  204 (225)
                      +|+||||+||+++.++  .++|+|||++.......  .........+++.|+|||.+.+  ..++.++|+||||+++|+|
T Consensus       190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el  269 (345)
T 3hko_A          190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL  269 (345)
T ss_dssp             ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHH
T ss_pred             cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999998665  89999999987543221  1112334567889999999875  6688999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHhhhc
Q psy15818        205 VTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       205 ~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++ |..||.+.+..+.+.++
T Consensus       270 ~~-g~~pf~~~~~~~~~~~~  288 (345)
T 3hko_A          270 LM-GAVPFPGVNDADTISQV  288 (345)
T ss_dssp             HH-SSCSSCCSSHHHHHHHH
T ss_pred             HH-CCCCCCCCChHHHHHHH
Confidence            99 99999998887766543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.4e-39  Score=248.42  Aligned_cols=200  Identities=37%  Similarity=0.701  Sum_probs=171.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .+++.||+|.+.......  ..+.+|+.++.++. ||||+++++++.+.+..+++|||++++
T Consensus        19 G~~g-~V~~~~~------~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A           19 GQFG-LVHLGYW------LNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             ETTE-EEEEEEE------TTTEEEEEEEECTTTBCH--HHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             CCce-eEEEEEe------cCCCeEEEEEccccCCCH--HHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            7899 9999984      356789999998654433  36889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|+++||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        89 ~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           89 CLSDYLRTQR------------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             BHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             cHHHHHhhCc------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            9999997632            3578999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+++.|+|||.+.+..++.++|+||+|+++|+|+++|..||.+.+..+....+
T Consensus       157 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i  218 (267)
T 3t9t_A          157 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  218 (267)
T ss_dssp             HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            22 222334455678999999988889999999999999999998789999998887776543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-39  Score=251.49  Aligned_cols=206  Identities=37%  Similarity=0.644  Sum_probs=171.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCe-EEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF-FVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~-~lv~e~~~~   80 (225)
                      |+|| +||++....  ....+..||+|.+...........+.+|+.+++.++ ||||+++++++.+.+.. ++++||+.+
T Consensus        32 G~~g-~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~v~e~~~~  107 (298)
T 3pls_A           32 GHFG-VVYHGEYID--QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCH  107 (298)
T ss_dssp             ETTE-EEEEEEEEC--SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCCEEEECCCTT
T ss_pred             CCCc-eEEEEEEec--CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCcEEEEecccC
Confidence            8899 999997421  223456899999987666666778899999999998 99999999999876655 999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       108 ~~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          108 GDLLQFIRSP------------QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             CBHHHHHHCT------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             CCHHHHHhcc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999652            2357899999999999999999999999999999999999999999999999997554


Q ss_pred             Cccc--cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSV--YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ....  ........+++.|+|||.+.+..++.++|+||+|+++|+|++++.+||...+..+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~  240 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF  240 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH
Confidence            3322  12223445677899999999999999999999999999999977777777777665543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.9e-39  Score=259.05  Aligned_cols=200  Identities=21%  Similarity=0.377  Sum_probs=170.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e   76 (225)
                      |+|| +||++.     +..+++.||+|++...........+.+|+.++.++. ||||+++++++...     ...++|+|
T Consensus        38 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv~e  110 (364)
T 3qyz_A           38 GAYG-MVCSAY-----DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQD  110 (364)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccccceEEEEEc
Confidence            8999 999998     456789999999987666666678899999999998 99999999998654     46899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ++. ++|.+++...              .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus       111 ~~~-~~L~~~l~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          111 LME-TDLYKLLKTQ--------------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CCS-EEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccC-cCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence            997 5898888653              5899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccc-cccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYE-RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .......... ......+|+.|+|||++.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+.+|
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH-SSCSSCCSSGGGHHHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH-CCCCCCCCChHHHHHHH
Confidence            7554332222 1234467889999998654 458999999999999999999 99999998877776553

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-39  Score=258.34  Aligned_cols=199  Identities=26%  Similarity=0.455  Sum_probs=160.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     +..+++.||+|+++... .......+.+|+.+++++. ||||+++++++.+.+..++||||+. 
T Consensus        45 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-  116 (329)
T 3gbz_A           45 GTYG-EVYKAI-----DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAE-  116 (329)
T ss_dssp             CSSS-EEEEEE-----ETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             cCCe-EEEEEE-----ECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEEEEEecCC-
Confidence            8899 999997     45779999999997543 3333445779999999997 9999999999999999999999998 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-----CCCceeEeeecc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-----ENHCCKVADFGF  155 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-----~~~~~~l~d~g~  155 (225)
                      ++|.+++...             ..+++..++.++.|++.||.+||++|++|+||||+||+++     ..+.++|+|||+
T Consensus       117 ~~L~~~~~~~-------------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          117 NDLKKYMDKN-------------PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             CCHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            5999988754             2589999999999999999999999999999999999994     455699999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +.......  .......+++.|+|||++.+. .++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  250 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKI  250 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCCCHHHHHHHH
Confidence            87543221  122334557889999998875 47999999999999999999 99999998887776543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-38  Score=256.18  Aligned_cols=194  Identities=25%  Similarity=0.473  Sum_probs=166.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||+|++....  .......+.+|+.++.++. ||||+++++++.+.+..++||||+.
T Consensus        65 G~~g-~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~  137 (348)
T 1u5q_A           65 GSFG-AVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCL  137 (348)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCE-EEEEEE-----EccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeEEEEEecCC
Confidence            8899 999998     35789999999997543  3344456889999999998 9999999999999999999999997


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       ++|.+.+...            ...+++.+++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus       138 -g~l~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          138 -GSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             -EEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             -CCHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence             6788777543            235899999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ...      ....+++.|+|||++.   +..++.++|+||||+++++|++ |..||.+.+..+.+.
T Consensus       205 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~  263 (348)
T 1u5q_A          205 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALY  263 (348)
T ss_dssp             SSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred             CCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            322      2345788999999885   4668899999999999999999 999999887766554

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-39  Score=269.57  Aligned_cols=198  Identities=26%  Similarity=0.495  Sum_probs=165.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..++..||+|+++... .......+.+|+.+++.+. ||||+++++++.+.+..++||||+.+
T Consensus        48 G~~g-~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~  120 (494)
T 3lij_A           48 GAYG-EVLLCR-----DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKG  120 (494)
T ss_dssp             C----EEEEEE-----ETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            8999 999998     46778999999997543 2223446889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g~~~  157 (225)
                      ++|.+.+...             ..+++..++.++.|++.||.|||++|++||||||+||+++.   .+.++|+|||++.
T Consensus       121 g~L~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          121 GELFDEIIHR-------------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             CBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999888654             25899999999999999999999999999999999999975   4459999999987


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   ......+|+.|+|||++. ..++.++|+||+|+++|+|++ |.+||.+.+..+++.++
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  249 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKV  249 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            554332   233456788999999875 568999999999999999999 99999999998887664

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.8e-39  Score=249.71  Aligned_cols=197  Identities=24%  Similarity=0.474  Sum_probs=169.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     ...+++.||+|++....  .......+.+|+.++..+. ||||+++++++.+.+..++||||++
T Consensus        25 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   97 (284)
T 2vgo_A           25 GKFG-NVYLAR-----EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAP   97 (284)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEEEEeCC
Confidence            7899 999998     35678999999987542  2222346889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....             .+++..++.++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        98 ~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           98 RGELYKELQKHG-------------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             TEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            999999987642             5899999999999999999999999999999999999999999999999988644


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...    ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+....
T Consensus       165 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~  223 (284)
T 2vgo_A          165 PSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRR  223 (284)
T ss_dssp             SSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHH
T ss_pred             ccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH-CCCCCCCCCHhHHHHH
Confidence            322    1234457888999999998889999999999999999999 9999998887766544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=251.24  Aligned_cols=199  Identities=23%  Similarity=0.443  Sum_probs=147.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.+....  .......+.+|+.++.++. ||||+++++++.+.+..++||||++
T Consensus        22 G~~g-~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   94 (278)
T 3cok_A           22 GSFA-GVYRAES-----IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCH   94 (278)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CCce-EEEEEEE-----ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEEEecCC
Confidence            7899 9999983     5678999999997542  1222356889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...            ...+++..++.++.|+++||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        95 ~~~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           95 NGEMNRYLKNR------------VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             TEEHHHHHHTC------------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCcHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            99999998742            236899999999999999999999999999999999999999999999999998754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .....  ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+.++
T Consensus       163 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~  222 (278)
T 3cok_A          163 KMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI-GRPPFDTDTVKNTLN  222 (278)
T ss_dssp             C------------------------------CTHHHHHHHHHHHHHH-SSCSSCCCSCC----
T ss_pred             cCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCChhHHHHHH
Confidence            32221  1223456788999999988889999999999999999999 999998766555443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-39  Score=260.79  Aligned_cols=195  Identities=23%  Similarity=0.487  Sum_probs=162.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|++.....     ...+|+.++.++..||||+++++++.+.+..++||||+.|+
T Consensus        33 G~~g-~V~~~~-----~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg  101 (342)
T 2qr7_A           33 GSYS-VCKRCI-----HKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG  101 (342)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence            8999 999998     467899999999975432     23467888888866999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC----CceeEeeecccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN----HCCKVADFGFAR  157 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~----~~~~l~d~g~~~  157 (225)
                      +|.+.+...             ..+++.++..++.|++.||.|||++|++||||||+||++.+.    +.++|+|||++.
T Consensus       102 ~L~~~i~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A          102 ELLDKILRQ-------------KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             BHHHHHHTC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             cHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999988643             358999999999999999999999999999999999998532    359999999987


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC---CCHHHHhhh
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG---MAAAEVMKK  223 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~---~~~~~~~~~  223 (225)
                      ......  .......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+   .+..+++.+
T Consensus       169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~  234 (342)
T 2qr7_A          169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILAR  234 (342)
T ss_dssp             ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-SSCSSCSSTTSCHHHHHHH
T ss_pred             cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc-CCCCCCCCCcCCHHHHHHH
Confidence            543322  12234567888999999988778899999999999999999 9999985   344444443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-39  Score=252.21  Aligned_cols=197  Identities=30%  Similarity=0.501  Sum_probs=171.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     ...+++.||+|++...........+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        33 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~  105 (303)
T 3a7i_A           33 GSFG-EVFKGI-----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGG  105 (303)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence            8899 999997     356789999999986655555567899999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++..              ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       106 ~L~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          106 SALDLLEP--------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EHHHHHTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             cHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99998853              2589999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..  .......+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+...
T Consensus       172 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~  229 (303)
T 3a7i_A          172 TQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELHPMKVLF  229 (303)
T ss_dssp             TB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred             cc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc-CCCCCCCcCHHHHHH
Confidence            22  12234457888999999998889999999999999999999 999999887766554

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.5e-40  Score=260.07  Aligned_cols=197  Identities=25%  Similarity=0.464  Sum_probs=165.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .+++.||+|.+..... .....+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        50 G~~g-~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (321)
T 2qkw_B           50 GVFG-KVYKGVL------RDGAKVALKRRTPESS-QGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENG  120 (321)
T ss_dssp             CSSS-EEEEEEC------TTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred             CCCe-eEEEEEE------CCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence            8899 9999984      3578999999876543 23457889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....         ....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       121 ~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          121 NLKRHLYGSDL---------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             BTGGGSSSSCC---------CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             cHHHHHhccCC---------CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99888753210         123588999999999999999999999999999999999999999999999999875433


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+...
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~p~~~~~~  246 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSLP  246 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH-CCTTCSCSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh-CCCcccccCc
Confidence            222222333446788999999988889999999999999999999 9999976544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.4e-39  Score=252.68  Aligned_cols=201  Identities=44%  Similarity=0.800  Sum_probs=172.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|.++....  ....+.+|+.++++++ ||||+++++++.+.+..++||||+.++
T Consensus        24 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~   94 (288)
T 3kfa_A           24 GQYG-EVYEGVW-----KKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYG   94 (288)
T ss_dssp             GTTC-SEEEEEE-----GGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             CCce-eEEEeEe-----cCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence            7899 9999984     56799999999976443  3346889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...           ....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        95 ~L~~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           95 NLLDYLREC-----------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EHHHHHHHC-----------CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             cHHHHHHhc-----------ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999764           223589999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... .......+++.|+|||.+.+..++.++|+||+|+++|+|+++|..||.+.+..+....
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~  224 (288)
T 3kfa_A          164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL  224 (288)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            321 2223344567799999999889999999999999999999879999998887666543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-39  Score=258.65  Aligned_cols=201  Identities=23%  Similarity=0.412  Sum_probs=168.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     ...+++.||+|+++... .......+.+|+.++..+..||||+++++++.+.+..++||||+.+
T Consensus        40 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~  113 (327)
T 3lm5_A           40 GKFA-VVRQCI-----SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG  113 (327)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence            7899 999998     35678999999987543 3333456889999999998789999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g~~~  157 (225)
                      ++|.+++...           ....+++.+++.++.|++.||.+||++|++|+||||+||+++.   ++.++|+|||++.
T Consensus       114 ~~L~~~~~~~-----------~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          114 GEIFSLCLPE-----------LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEGGGGGSSC-----------C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             CcHHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            9998887432           2246899999999999999999999999999999999999986   7899999999997


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .......   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....
T Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  244 (327)
T 3lm5_A          183 KIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLN  244 (327)
T ss_dssp             EC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             ccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Confidence            5533221   223457889999999998999999999999999999999 9999999888776554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.7e-39  Score=255.63  Aligned_cols=194  Identities=23%  Similarity=0.436  Sum_probs=158.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|++..... .....+.+|+.++.++.+||||+++++++.+.+..++||||++++
T Consensus        24 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   96 (316)
T 2ac3_A           24 GAHA-RVQTCI-----NLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG   96 (316)
T ss_dssp             CSSE-EEEEEE-----CSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             CceE-EEEEEE-----EcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence            8899 999998     457789999999975532 223468899999998656999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc---eeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC---CKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~---~~l~d~g~~~~  158 (225)
                      +|.+++....             .+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||++..
T Consensus        97 ~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           97 SILSHIHKRR-------------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             BHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             cHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999997642             5899999999999999999999999999999999999987665   99999999865


Q ss_pred             ccCccc-----cccccCCCCCccccCCccccC-----CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        159 LMTSSV-----YERKSEGRLPIRWMAPESLYD-----NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       159 ~~~~~~-----~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ......     ........+++.|+|||++.+     ..++.++|+||+|+++|+|++ |..||.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  230 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRC  230 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH-CCCCCcccc
Confidence            432211     111223447889999998865     457889999999999999999 999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-39  Score=270.72  Aligned_cols=201  Identities=44%  Similarity=0.810  Sum_probs=172.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+     ..++..||||.++.....  ...+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus       231 G~fg-~Vy~~~~-----~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~E~~~~g  301 (495)
T 1opk_A          231 GQYG-EVYEGVW-----KKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYG  301 (495)
T ss_dssp             GTTS-SEEEEEE-----GGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEE-----cCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEEEEEccCCC
Confidence            8899 9999984     456899999999865433  346889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....           ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus       302 ~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          302 NLLDYLRECN-----------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             BHHHHHHHSC-----------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             CHHHHHHhcC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999997632           23578999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .. ........+++.|+|||.+.+..++.++|+||||+++|+|+++|..||.+.+..++.+.
T Consensus       371 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~  431 (495)
T 1opk_A          371 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL  431 (495)
T ss_dssp             CC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             Cc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            32 12223344567899999998888999999999999999999889999998887766554

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.6e-39  Score=253.04  Aligned_cols=211  Identities=37%  Similarity=0.705  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-----CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-----PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (225)
                      |.|| +||++...  ....+++.||+|.++... .......+.+|+.++.++. ||||+++++++.+.+     ..++|+
T Consensus        45 G~~g-~V~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~v~  120 (313)
T 3brb_A           45 GEFG-SVMEGNLK--QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVIL  120 (313)
T ss_dssp             -CCC-CEEEEEEE--CTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-------CEEEEE
T ss_pred             cCCe-EEEEEEEe--ccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccccCCcccEEEE
Confidence            8899 99998642  123457799999997553 4445567889999999998 999999999987654     359999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+.+++|.+++.......       ....+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||+
T Consensus       121 e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          121 PFMKYGDLHTYLLYSRLET-------GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             ECCTTCBHHHHHHHTTBTT-------SCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             ecccCCCHHHHHHHhhhhc-------CCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence            9999999999996543211       234689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +................+++.|+|||.+.+..++.++|+||||+++|+|+++|..||.+.+..+....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            87654443333334445677899999999999999999999999999999988999998887766543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.1e-39  Score=252.07  Aligned_cols=205  Identities=40%  Similarity=0.715  Sum_probs=167.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEE-ecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC-TEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++....  +......||+|.+...........+.+|+.++++++ ||||+++++++ ...+..+++|||+.+
T Consensus        36 G~~g-~Vy~~~~~~--~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~v~e~~~~  111 (298)
T 3f66_A           36 GHFG-CVYHGTLLD--NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKH  111 (298)
T ss_dssp             ETTE-EEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCCEEEEECCTT
T ss_pred             cCCc-eEEEEEEec--CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCceEEEEeCCCC
Confidence            7899 999998532  122355799999987666667778899999999998 99999999985 556788999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       112 ~~L~~~l~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          112 GDLRNFIRNE------------THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CBHHHHHHCT------------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999642            2357899999999999999999999999999999999999999999999999997654


Q ss_pred             Ccccc--ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        161 TSSVY--ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       161 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .....  .......+++.|+|||.+.+..++.++|+||+|+++++|+++|.+||.+.+..+...
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~  243 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV  243 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            43321  222334566789999999999999999999999999999997888888777655543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.6e-38  Score=248.31  Aligned_cols=198  Identities=26%  Similarity=0.452  Sum_probs=167.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----HHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| +||++..     ..+++.||+|+++.....     .....+.+|+.++.++. ||||+++++++.+.+..++|||
T Consensus        16 G~~g-~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   88 (283)
T 3bhy_A           16 GQFA-IVRKCRQ-----KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTDVVLILE   88 (283)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCce-EEEEEEE-----cCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCCeEEEEEe
Confidence            7899 9999983     567899999998754321     12456889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC----ceeEee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH----CCKVAD  152 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~----~~~l~d  152 (225)
                      |+++++|.+++...             ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++    .++|+|
T Consensus        89 ~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           89 LVSGGELFDFLAEK-------------ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             CCCSCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             ecCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence            99999999999754             2589999999999999999999999999999999999998766    799999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ||.+.......   ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+.+.+
T Consensus       156 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~  222 (283)
T 3bhy_A          156 FGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGETKQETLTN  222 (283)
T ss_dssp             CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHH
T ss_pred             cccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH-CCCCCCCcchHHHHHH
Confidence            99987553322   1223457788999999988889999999999999999999 9999999888776654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-38  Score=251.08  Aligned_cols=197  Identities=26%  Similarity=0.410  Sum_probs=166.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+|+.||+|+++..... ....+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (304)
T 2jam_A           20 GAFS-EVFLVK-----QRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGG   91 (304)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEECC-------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCCc-eEEEEE-----ECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCC-CCCeeehhhhcccCCEEEEEEEcCCCc
Confidence            8899 999998     3567899999999754322 2246789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe---cCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~---~~~~~~~l~d~g~~~~  158 (225)
                      +|.+.+...             ..+++..++.++.|++.||.+||+.|++|+||+|+||++   ++++.++|+|||++..
T Consensus        92 ~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           92 ELFDRILER-------------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             BHHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             cHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            999988654             258999999999999999999999999999999999999   6788999999998864


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....    .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..++..++
T Consensus       159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i  219 (304)
T 2jam_A          159 EQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYEETESKLFEKI  219 (304)
T ss_dssp             CCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHH
T ss_pred             cCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            33221    112246778999999999899999999999999999999 99999998887766553

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.9e-39  Score=263.52  Aligned_cols=189  Identities=22%  Similarity=0.395  Sum_probs=154.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~   77 (225)
                      |+|| +||++.     +..+++.||||++...      ....+|+.++.++..||||+++++++..    .+.+++||||
T Consensus        73 G~~g-~V~~~~-----~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~  140 (400)
T 1nxk_A           73 GING-KVLQIF-----NKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC  140 (400)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence            7899 999998     4678999999998632      2456788887666669999999999875    5678999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeec
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFG  154 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g  154 (225)
                      +.|++|.+++....           ...+++.+++.++.|++.||.|||+.||+||||||+||+++.   ++.++|+|||
T Consensus       141 ~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          141 LDGGELFSRIQDRG-----------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             CCSEEHHHHHHCC--------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCCCcHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999997531           235899999999999999999999999999999999999986   7889999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ++.......   ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+.
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  268 (400)
T 1nxk_A          210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHG  268 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH-SSCSCCCCTT
T ss_pred             cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcc
Confidence            987543221   2234556888999999988999999999999999999999 9999986654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=258.10  Aligned_cols=206  Identities=38%  Similarity=0.725  Sum_probs=163.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..... +.....+|++|.+...........+.+|+.++..+. ||||+++++++.... .+++++++.++
T Consensus        26 G~~g-~Vy~~~~~~~-~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-~~~v~~~~~~g  101 (327)
T 3lzb_A           26 GAFG-TVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFG  101 (327)
T ss_dssp             CSSE-EEEEEEECCT-TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS-EEEEECCCSSC
T ss_pred             CCCe-EEEEEEEcCC-CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC-ceEEEEecCCC
Confidence            8999 9999985311 222234568888766555455567889999999998 999999999998764 88999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       102 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A          102 CLLDYVREH------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             BHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999763            23589999999999999999999999999999999999999999999999999976654


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  231 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI  231 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence            44444444555677899999999999999999999999999999879999998887766543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-38  Score=254.41  Aligned_cols=199  Identities=27%  Similarity=0.507  Sum_probs=165.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     ...+++.||+|++.... .......+.+|+.++.++. ||||+++++++.+.+..++||||+++
T Consensus        36 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~  108 (331)
T 4aaa_A           36 GSYG-MVMKCR-----NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH  108 (331)
T ss_dssp             GTTS-SEEEEE-----ETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             cCCE-EEEEEE-----ECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEEEEecCCc
Confidence            7899 999998     35679999999986553 3444556789999999998 99999999999999999999999998


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|..+...             ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++....
T Consensus       109 ~~l~~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          109 TILDDLELF-------------PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EHHHHHHHS-------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             chHHHHHhh-------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            888877643             2358999999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  .......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       176 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~  236 (331)
T 4aaa_A          176 APG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYH  236 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             CCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Confidence            322  122334567889999998875 67899999999999999999 9999999888776543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-39  Score=270.77  Aligned_cols=198  Identities=26%  Similarity=0.485  Sum_probs=170.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||||++....  .......+.+|+.+++++. ||||+++++++.+.+..++||||+.
T Consensus        37 G~~g-~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~  109 (484)
T 3nyv_A           37 GSFG-EVILCK-----DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYT  109 (484)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCCE-EEEEEE-----ECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEecCC
Confidence            7899 999998     46789999999986542  2334457889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe---cCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~---~~~~~~~l~d~g~~  156 (225)
                      +++|.+.+...             ..+++..++.++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++
T Consensus       110 ~~~L~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          110 GGELFDEIISR-------------KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             SCBHHHHHHTC-------------SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            99999988643             368999999999999999999999999999999999999   46778999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ........   .....+|+.|+|||++.+ .++.++|+||+|+++|+|++ |.+||.+.+..++++++
T Consensus       177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  239 (484)
T 3nyv_A          177 THFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKV  239 (484)
T ss_dssp             HHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             EEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            75533321   122357888999998866 68899999999999999999 99999999988887664

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=259.11  Aligned_cols=191  Identities=23%  Similarity=0.359  Sum_probs=151.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|+++....   ...+.+|+.++.++. ||||+++++++.+.+..++||||++++
T Consensus        64 G~~g-~Vy~~~~-----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  133 (349)
T 2w4o_A           64 GATS-IVYRCKQ-----KGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGG  133 (349)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEEC-------------CHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEeccchh---HHHHHHHHHHHHhCC-CCCCcceeeeEecCCeEEEEEEeCCCC
Confidence            8899 9999984     56788999999976432   235778999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g~~~~  158 (225)
                      +|.+++...             ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.   ++.++|+|||++..
T Consensus       134 ~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          134 ELFDRIVEK-------------GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             BHHHHHTTC-------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             CHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            999988542             35899999999999999999999999999999999999975   78899999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      .....   ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+
T Consensus       201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  257 (349)
T 2w4o_A          201 VEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQ  257 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCTTCHH
T ss_pred             cCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCcccH
Confidence            43321   1223457888999999999899999999999999999999 999997666544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-38  Score=258.35  Aligned_cols=196  Identities=27%  Similarity=0.415  Sum_probs=159.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |+|| +||++.     +..+++.||+|++... ........+.+|+.+++.+. ||||+++++++...+      ..++|
T Consensus        36 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~lv  108 (371)
T 2xrw_A           36 GAQG-IVCAAY-----DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIV  108 (371)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred             cCCE-EEEEEE-----ECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccccccceEEE
Confidence            8999 999998     3567899999999754 34445567889999999998 999999999997665      68999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+. ++|.+.+..               .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus       109 ~e~~~-~~l~~~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          109 MELMD-ANLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EECCS-EEHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             EEcCC-CCHHHHHhh---------------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence            99997 578777742               47899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.......   ......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       173 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  238 (371)
T 2xrw_A          173 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKV  238 (371)
T ss_dssp             C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            987543221   1233457788999999999899999999999999999999 99999998887766543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=256.23  Aligned_cols=200  Identities=25%  Similarity=0.467  Sum_probs=164.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH----HHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER----ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |.|| +||++..     ..+|+.||+|.++......    ....+.+|+.++..+. ||||+++++++.+.+..++||||
T Consensus        21 G~~g-~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~   93 (346)
T 1ua2_A           21 GQFA-TVYKARD-----KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDF   93 (346)
T ss_dssp             ETTE-EEEEEEC-----SSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cCCE-EEEEEEE-----CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCceEEEEEc
Confidence            7899 9999984     5678999999997543211    1235778999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +.+ +|.+.+...            ...+++..++.++.|+++||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        94 ~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           94 MET-DLEVIIKDN------------SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CSE-EHHHHHTTC------------CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CCC-CHHHHHHhc------------CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            985 888777542            2358899999999999999999999999999999999999999999999999997


Q ss_pred             cccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......  .......+|+.|+|||.+.+. .++.++|+||+|+++|+|++ |.+||.+.+..+.+.++
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~~~~~i  225 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRI  225 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            653322  223345578889999998764 47899999999999999999 99999999887776553

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-38  Score=255.71  Aligned_cols=199  Identities=24%  Similarity=0.425  Sum_probs=169.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |+|| .||++..     ..+|+.||||++.....       ......+.+|+.++.++.+||||+++++++...+..++|
T Consensus       105 G~~g-~Vy~a~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A          105 GVSS-VVRRCVH-----RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            7899 9999984     56789999999865431       223456788999999995599999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||++|++|.+++...             ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||
T Consensus       179 ~e~~~g~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEK-------------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             ECCCTTCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEeCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence            9999999999999753             258999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ++.......   ......+|+.|+|||++.+      ..++.++|+||||+++|+|++ |..||.+.+..+.+..
T Consensus       246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~  316 (365)
T 2y7j_A          246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRM  316 (365)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence            987654322   2234567889999998863      357889999999999999999 9999998877766554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-38  Score=265.10  Aligned_cols=200  Identities=41%  Similarity=0.718  Sum_probs=169.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .++..||||.++.....  ...+.+|+.++.++. ||||+++++++. .+..++||||+.++
T Consensus       199 G~fg-~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~lv~e~~~~g  267 (454)
T 1qcf_A          199 GQFG-EVWMATY------NKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKG  267 (454)
T ss_dssp             CSSE-EEEEEEE------TTTEEEEEEEECTTSBC--HHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred             CCce-EEEEEEE------CCccEEEEEEecCCCcc--HHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccEEEEeecCCC
Confidence            8999 9999984      34678999999865433  346889999999998 999999999986 66789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....           ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus       268 ~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          268 SLLDFLKSDEG-----------SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             BHHHHHHSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999975431           1478899999999999999999999999999999999999999999999999976533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+++.|+|||.+....++.++|+||||+++|+|++.|..||.+.+..+++..+
T Consensus       337 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i  398 (454)
T 1qcf_A          337 NE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL  398 (454)
T ss_dssp             HH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             Cc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            22 122233445678999999988889999999999999999998899999999888776653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-38  Score=250.77  Aligned_cols=197  Identities=21%  Similarity=0.341  Sum_probs=159.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|++....  .......+.+|+.++..+. ||||+++++++...+..++++||++
T Consensus        45 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 2h34_A           45 GGMG-DVYEAE-----DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVDMRLIN  117 (309)
T ss_dssp             CSSS-EEEEEE-----ETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             CCCe-eEEEEE-----EcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEEEEEecC
Confidence            7899 999998     35678999999997653  3344567889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       118 ~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          118 GVDLAAMLRRQ-------------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             CEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999764             25899999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      .... ........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+...+
T Consensus       185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~  243 (309)
T 2h34_A          185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQGDQLSVM  243 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH-SSCSSCSCHHHHH
T ss_pred             cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH-CCCCCCCchHHHH
Confidence            3322 112223457788999999998889999999999999999999 9999988766543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=275.48  Aligned_cols=205  Identities=35%  Similarity=0.676  Sum_probs=169.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+.   ...++..||||+++..........+.+|+.++.++. ||||+++++++.. +..++||||+.++
T Consensus       347 G~fG-~Vy~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          347 GNFG-SVRQGVYR---MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             CSSS-EEEEEEEE---CSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             CCCc-EEEEEEEe---cCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            8999 99998742   234578899999987655555567899999999997 9999999999976 5699999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus       421 ~L~~~l~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          421 PLHKFLVGK------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             BHHHHHTTC------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             cHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999998542            23589999999999999999999999999999999999999999999999999976543


Q ss_pred             cccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++.|..||.+.+..+++..|
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i  552 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI  552 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            3221 12223344578999999998999999999999999999997799999998888877654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.1e-39  Score=252.72  Aligned_cols=196  Identities=31%  Similarity=0.414  Sum_probs=165.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc---cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN---AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||++..       .++.||+|.+...   ........+.+|+.++.++. ||||+++++++.+.+..+++|||+
T Consensus        42 G~~g-~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           42 GGFG-VVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             CSSE-EEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECC
T ss_pred             CCCe-EEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEEEec
Confidence            8899 9999983       4788999998653   23444567889999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+++....          ....+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       113 ~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          113 PNGSLLDRLSCLD----------GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             TTCBHHHHHHTGG----------GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            9999999997542          123589999999999999999999999999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ..............+++.|+|||.+.+ .++.++|+||||+++|+|++ |..||.+....
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~  240 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT-GLPAVDEHREP  240 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH-CCCSBCTTBSS
T ss_pred             cccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH-CCCCcccCcch
Confidence            543332223334567889999998765 47889999999999999999 99999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-38  Score=256.40  Aligned_cols=202  Identities=25%  Similarity=0.402  Sum_probs=166.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--------CCCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--------KEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--------~~~~~   72 (225)
                      |.|| +||++.     ...+|+.||+|++.... .........+|+.++..+. ||||+++++++..        .+..+
T Consensus        28 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~  100 (351)
T 3mi9_A           28 GTFG-EVFKAR-----HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIY  100 (351)
T ss_dssp             CSTT-SEEEEE-----ETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--------CEEE
T ss_pred             CCCc-EEEEEE-----ECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccccCCceEE
Confidence            8999 999998     35778999999986543 2333345778999999998 9999999999876        34689


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      +||||+.+ +|.+.+...            ...+++.+++.++.|++.||.+||++|++|+||||+||+++.++.++|+|
T Consensus       101 lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A          101 LVFDFCEH-DLAGLLSNV------------LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             EEEECCSE-EHHHHHHCT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEeccCC-CHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence            99999974 777777542            23589999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCcc--ccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSS--VYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++.......  .........+|+.|+|||++.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.+..+
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  241 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI  241 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence            99987553222  1222334557889999998876 457999999999999999999 99999999888776543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.8e-39  Score=258.76  Aligned_cols=198  Identities=16%  Similarity=0.221  Sum_probs=158.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHH----------HHHHHHHHHHhhcCCCCCeeeeeeEEecC---
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERER----------LDLLQELTVMKTLDPHPNVVRLLGCCTEK---   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---   68 (225)
                      |+|| +||++..........++.||+|++.........          ....+|+..+..+. ||||+++++++...   
T Consensus        46 G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~  123 (364)
T 3op5_A           46 GGFG-CIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVPKYWGSGLHDKNG  123 (364)
T ss_dssp             C-CC-EEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSCCEEEEEEEEETT
T ss_pred             CCCe-EEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCCeEEeeeeeccCC
Confidence            8999 999998755555556899999998754321110          11233445566666 99999999998764   


Q ss_pred             -CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CC
Q psy15818         69 -EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--EN  145 (225)
Q Consensus        69 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~  145 (225)
                       ...++||||+ |++|.+++...            ...+++.+++.++.|++.||.|||++|++||||||+||+++  .+
T Consensus       124 ~~~~~lv~e~~-g~~L~~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          124 KSYRFMIMDRF-GSDLQKIYEAN------------AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEEEECE-EEEHHHHHHHT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             cceEEEEEeCC-CCCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence             4489999999 99999999763            23689999999999999999999999999999999999998  88


Q ss_pred             CceeEeeecccccccCccccc-----cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        146 HCCKVADFGFARDLMTSSVYE-----RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       146 ~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      +.++|+|||++..........     ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~Pf~~~  264 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT-GHLPWEDN  264 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTGGG
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCcccc
Confidence            899999999997654332211     1123448889999999999999999999999999999999 99999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.1e-38  Score=247.44  Aligned_cols=203  Identities=35%  Similarity=0.677  Sum_probs=167.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++....  +...+..||+|.++..........+.+|+.++..+. ||||+++++++.+. ..++||||++++
T Consensus        23 G~~g-~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~e~~~~~   97 (281)
T 3cc6_A           23 GFFG-EVYEGVYTN--HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-PTWIIMELYPYG   97 (281)
T ss_dssp             CSSS-EEEEEEEEC--TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-SCEEEEECCTTC
T ss_pred             cCCe-eEEEeEEcC--CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-CCEEEEecCCCC
Confidence            7899 999987421  233467899999987766666678899999999998 99999999998754 568999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        98 ~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           98 ELGHYLERNK------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             BHHHHHHHHT------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            9999997642            2588999999999999999999999999999999999999999999999999875543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ... .......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||......+...
T Consensus       166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~  225 (281)
T 3cc6_A          166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG  225 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred             ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence            321 122334556789999999888899999999999999999976999998777666544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=250.96  Aligned_cols=190  Identities=25%  Similarity=0.362  Sum_probs=156.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++..     ..+++.||||++... ...........|+..+..+..||||+++++++.+.+..++||||+ +
T Consensus        68 G~~g-~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           68 GSYG-EVFKVRS-----KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             ETTE-EEEEEEE-----TTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             CCCe-EEEEEEE-----CCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            7899 9999984     567999999998654 334444566677777777756999999999999999999999999 5


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+.+...            ...+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||++....
T Consensus       141 ~~L~~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          141 PSLQQHCEAW------------GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             CBHHHHHHHH------------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            7898888654            2358999999999999999999999999999999999999999999999999986553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ...   ......+|+.|+|||++.+ .++.++|+||+|+++++|++ |..|+.+.
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~-g~~~~~~~  258 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC-NMELPHGG  258 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH-TCCCCSSH
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh-CCCCCCCc
Confidence            322   2234457889999998876 68999999999999999999 75555443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-38  Score=263.14  Aligned_cols=194  Identities=39%  Similarity=0.738  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC-CeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~   80 (225)
                      |+|| +||++..       .++.||||+++....   ...+.+|+.++.+++ ||||+++++++.... ..++||||+++
T Consensus       204 G~fg-~V~~~~~-------~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          204 GEFG-DVMLGDY-------RGNKVAVKCIKNDAT---AQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             CSSE-EEEEEEE-------TTEEEEEEEESSCTT---SHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             cCCe-eEEEEEe-------cCCeEEEEEeCCchH---HHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            8999 9999984       367999999986543   235889999999998 999999999976654 79999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++....           ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus       272 g~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          272 GSLVDYLRSRG-----------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CBHHHHHHHHC-----------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999998642           2246899999999999999999999999999999999999999999999999986432


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..     .....+++.|+|||.+.+..++.++|+||||+++|+|++.|..||.+.+..+....
T Consensus       341 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~  398 (450)
T 1k9a_A          341 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  398 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH
T ss_pred             cc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            21     12234567799999999999999999999999999999779999998877766554

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.8e-39  Score=258.64  Aligned_cols=195  Identities=27%  Similarity=0.439  Sum_probs=152.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv   74 (225)
                      |+|| +||++.     +..+|+.||||++... .......++.+|+.+++.+. ||||+++++++...      ...+++
T Consensus        40 G~~g-~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~~lv  112 (367)
T 2fst_X           40 GAYG-SVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLV  112 (367)
T ss_dssp             ---C-CEEEEE-----ETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             cCCe-EEEEEE-----ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCeEEEE
Confidence            8899 999997     4578999999998754 34445567889999999998 99999999998654      568999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      ++++ +++|.+++..              ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus       113 ~e~~-~~~L~~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          113 THLM-GADLNNIVKC--------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             EECC-CEECC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             eccc-CCCHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence            9998 6899888854              258999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++......     .....+|+.|+|||++.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.+|
T Consensus       178 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i  242 (367)
T 2fst_X          178 LARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI  242 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            98654321     233456788999999877 678999999999999999999 99999999887776654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-38  Score=247.02  Aligned_cols=199  Identities=23%  Similarity=0.433  Sum_probs=163.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|.+....  .......+.+|+..+..+. ||||+++++++.+.+..++||||++
T Consensus        22 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   94 (276)
T 2h6d_A           22 GTFG-KVKIGEH-----QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFFMVMEYVS   94 (276)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CCCe-EEEEEEE-----CCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEEEEEeccC
Confidence            7899 9999984     5678999999997542  2233456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....             .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        95 ~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           95 GGELFDYICKHG-------------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             SCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             CCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999997642             5789999999999999999999999999999999999999999999999998765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   .....+++.|+|||.+.+..+ +.++|+||+|+++++|++ |..||.+.+..+..+++
T Consensus       162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  223 (276)
T 2h6d_A          162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKI  223 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Confidence            43221   223456788999999887765 689999999999999999 99999988877766543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-39  Score=261.50  Aligned_cols=204  Identities=40%  Similarity=0.707  Sum_probs=160.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe-cCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++....  ....+..||+|.++..........+.+|+.++.++. ||||+++++++. ..+..++||||+++
T Consensus       100 G~fg-~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~lv~e~~~~  175 (373)
T 3c1x_A          100 GHFG-CVYHGTLLD--NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKH  175 (373)
T ss_dssp             CSSS-EEEEEEEEE--TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSCCEEEEECCTT
T ss_pred             CCCe-EEEEEEEEC--CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCCeEEEEECCCC
Confidence            8999 999998521  122356799999987666666778999999999997 999999999864 45678999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..++.++.|+++||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       176 g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          176 GDLRNFIRNE------------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             CBHHHHHHCT------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCHHHHHhhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999642            2357889999999999999999999999999999999999999999999999997553


Q ss_pred             Cccccc--cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ......  ......+++.|+|||.+.+..++.++|+||||+++|+|+++|.+||.+.+..+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~  306 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT  306 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH
Confidence            322111  1223445678999999999999999999999999999999788999877665544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.6e-38  Score=246.47  Aligned_cols=199  Identities=23%  Similarity=0.394  Sum_probs=169.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l   73 (225)
                      |.|| .||++.     +..+++.||+|++....        .......+.+|+.++.++.+||||+++++++.+.+..++
T Consensus        28 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (298)
T 1phk_A           28 GVSS-VVRRCI-----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL  101 (298)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCce-EEEEEE-----EcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence            7899 999998     46788999999986542        123345678999999999779999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ||||+++++|.+++...             ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus       102 v~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A          102 VFDLMKKGELFDYLTEK-------------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EEECCTTCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEeccCCCcHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999754             25899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCcccc------CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLY------DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |.+.......   ......+++.|+|||.+.      ...++.++|+||+|+++++|++ |..||.+.+..+....
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH-CCCCCcCccHHHHHHH
Confidence            9987553322   223445778899999875      4557889999999999999999 9999998887766554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-38  Score=250.00  Aligned_cols=203  Identities=38%  Similarity=0.714  Sum_probs=167.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++...   ...+++.||+|+++... .......+.+|+.++..+. ||||+++++++ ..+..++||||+++
T Consensus        28 G~~g-~Vy~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~~~lv~e~~~~  101 (291)
T 1xbb_A           28 GNFG-TVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAEL  101 (291)
T ss_dssp             CSSE-EEEEEEEE---CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             ccCe-eeEeeeec---CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence            8899 99999421   35668999999997653 3444567889999999997 99999999998 56778999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++..++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++....
T Consensus       102 ~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A          102 GPLNKYLQQN-------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCHHHHHHhC-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999753             258999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..... .......+++.|+|||.+.+..++.++|+||||+++|+|++.|..||.+.+..++...
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  232 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM  232 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            33222 2222344567899999998888899999999999999999779999999888776654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4e-39  Score=256.60  Aligned_cols=193  Identities=29%  Similarity=0.461  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..      .+++.||+|++...........+.+|+.++..+. ||||+++++++.+.+..++||||+.++
T Consensus        41 G~~g-~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  112 (326)
T 3uim_A           41 GGFG-KVYKGRL------ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANG  112 (326)
T ss_dssp             CSSS-EEEEECC------SSSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCCEEEEECCTTC
T ss_pred             CCCc-EEEEEEe------cCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEecCCceEEEEEeccCC
Confidence            8999 9999983      4588999999986544333335789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~---~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++.....         ....+++..++.++.|++.||.+||+.   |++|+||||+||+++.++.++|+|||++..
T Consensus       113 ~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          113 SVASCLRERPE---------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL  183 (326)
T ss_dssp             BHHHHHHCCST---------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CHHHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence            99999975421         223589999999999999999999999   999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      ...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.
T Consensus       184 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~  236 (326)
T 3uim_A          184 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD  236 (326)
T ss_dssp             CCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH-CCCSBC
T ss_pred             cCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh-CCCccc
Confidence            533221 22333457889999999988889999999999999999999 999995

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-38  Score=264.93  Aligned_cols=200  Identities=41%  Similarity=0.735  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+      .++..||||+++......  ..+.+|+.+++++. ||||+++++++.+ +..++||||++++
T Consensus       195 G~fg-~Vy~~~~------~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~iv~e~~~~g  263 (452)
T 1fmk_A          195 GCFG-EVWMGTW------NGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG  263 (452)
T ss_dssp             CSSC-EEEEEEE------TTTEEEEEEECCTTSSCH--HHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred             CCCe-EEEEEEE------CCCceEEEEEeccCCCCH--HHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceEEEehhhcCC
Confidence            8999 9999985      335679999998654332  36889999999998 9999999999876 6789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....           ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       264 sL~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          264 SLLDFLKGETG-----------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             BHHHHHSHHHH-----------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             CHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999975421           2478999999999999999999999999999999999999999999999999975533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+++.|+|||.+.+..++.++|+||||+++|+|++.|..||.+....+++..+
T Consensus       333 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i  394 (452)
T 1fmk_A          333 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  394 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             Cc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            21 112223345677999999998899999999999999999999889999999888776653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.3e-39  Score=254.96  Aligned_cols=214  Identities=43%  Similarity=0.768  Sum_probs=168.3

Q ss_pred             CcccceeeecCCCCCCCCccceE--EEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCI--VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..++..  ||+|.++..........+.+|+.++.++..||||+++++++.+.+..++||||++
T Consensus        36 G~~g-~Vy~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  109 (327)
T 1fvr_A           36 GNFG-QVLKARI-----KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP  109 (327)
T ss_dssp             GGGC-EEEEEEE-----EETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             CCCc-eEEEEEE-----ccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence            7899 9999984     455664  4999987655555556788999999999559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhh---cccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++.........   .........+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~  189 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  189 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence            99999999764311000   000012346899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   .......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+...++
T Consensus       190 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          190 RGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             ESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             cccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            633211   12233445677999999988888999999999999999997699999999888776654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-38  Score=257.40  Aligned_cols=192  Identities=23%  Similarity=0.387  Sum_probs=158.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCC-CCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..      ..++.||||++.... .......+.+|+.++..+.. ||||+++++++...+..++||| +.
T Consensus        67 G~fg-~Vy~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~  138 (390)
T 2zmd_A           67 GGSS-KVFQVLN------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG  138 (390)
T ss_dssp             CSSE-EEEEEEC------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred             CCCe-EEEEEEc------CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence            8999 9999983      338899999997543 44555678999999999973 6999999999999999999999 56


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++.+++.++.|++.||.|||+.||+||||||+||+++ ++.++|+|||++...
T Consensus       139 ~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          139 NIDLNSWLKKK-------------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             SEEHHHHHHHC-------------SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            78999998753             2578899999999999999999999999999999999995 578999999999766


Q ss_pred             cCccccccccCCCCCccccCCccccC-----------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-----------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .............+|+.|+|||++.+           ..++.++||||||+++|+|++ |..||.+..
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~  271 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII  271 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhh
Confidence            44333333345568899999998865           367889999999999999999 999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.4e-39  Score=251.94  Aligned_cols=206  Identities=27%  Similarity=0.445  Sum_probs=151.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|.+...........+.+|+.++.++. ||||+++++++...+..++||||++++
T Consensus        26 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~   98 (303)
T 2vwi_A           26 GATA-VVQAAYC-----APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGG   98 (303)
T ss_dssp             --CC-CEEEEEC---------CEEEEECCC----------------CCCCCC-CTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred             ccce-EEEEEEE-----CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcEEEehhccCC
Confidence            7899 9999983     56789999999976554445557889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.........     ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        99 ~L~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           99 SVLDIIKHIVAKGEH-----KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT  173 (303)
T ss_dssp             BHHHHHHHHHHTTTT-----TTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred             chHHHHHHHhhcccc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence            999999764322111     234589999999999999999999999999999999999999999999999999865433


Q ss_pred             cccc---ccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        162 SSVY---ERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       162 ~~~~---~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ....   .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||......+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~  235 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKV  235 (303)
T ss_dssp             --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGH
T ss_pred             CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh-CCCCCccCchhhH
Confidence            2211   11223457788999998875 568899999999999999999 9999987765543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-38  Score=262.18  Aligned_cols=194  Identities=23%  Similarity=0.455  Sum_probs=150.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-----CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-----KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (225)
                      |+|| +||++.     +..+++.||||++... .......++.+|+.++..++ ||||+++++++..     ...+++||
T Consensus        64 G~~g-~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~  136 (458)
T 3rp9_A           64 GSYG-HVCEAY-----DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVL  136 (458)
T ss_dssp             -----CEEEEE-----ECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcccCceEEEEE
Confidence            8999 999998     3567999999998654 34445567889999999997 9999999999843     35699999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      |++. ++|.+++...             ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus       137 e~~~-~~L~~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          137 EIAD-SDFKKLFRTP-------------VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CCCS-EEHHHHHHSS-------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eccc-cchhhhcccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence            9984 7898888642             3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcccc-------------------------ccccCCCCCccccCCccc-cCCCCCcchhHHHHHHHHHHHHHc--
Q psy15818        156 ARDLMTSSVY-------------------------ERKSEGRLPIRWMAPESL-YDNIFSVKSDIWSFGVLIWEIVTL--  207 (225)
Q Consensus       156 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slg~ll~~l~~~--  207 (225)
                      +.........                         .......+|+.|+|||++ .+..++.++||||+||++|||+++  
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            9765322111                         122334568889999976 456789999999999999999973  


Q ss_pred             --------CCCCCCCCC
Q psy15818        208 --------GSTPYPGMA  216 (225)
Q Consensus       208 --------g~~p~~~~~  216 (225)
                              |.++|.+.+
T Consensus       283 ~~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSS  299 (458)
T ss_dssp             TTCSSGGGCCCSCC---
T ss_pred             ccccccccccccCCCCc
Confidence                    667776654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=254.11  Aligned_cols=192  Identities=24%  Similarity=0.398  Sum_probs=156.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCC-CCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++..      .+++.||+|++.... .......+.+|+.++..+..| |||+++++++.+.+..++||| +.
T Consensus        20 G~~g-~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~   91 (343)
T 3dbq_A           20 GGSS-KVFQVLN------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG   91 (343)
T ss_dssp             CSSE-EEEEEEC------TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred             CCCe-EEEEEEe------CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CC
Confidence            8999 9999983      458899999987543 444556788999999999822 999999999999999999999 55


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++.++..++.|++.||.|||++|++||||||+||+++ ++.++|+|||++...
T Consensus        92 ~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           92 NIDLNSWLKKK-------------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             SEEHHHHHHHS-------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             CCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            78999999753             2588999999999999999999999999999999999997 567999999999766


Q ss_pred             cCccccccccCCCCCccccCCccccC-----------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-----------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .............+|+.|+|||++.+           ..++.++||||+|+++|+|++ |..||.+..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  224 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII  224 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhhh
Confidence            44433333345568899999999864           667889999999999999999 999998654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.5e-38  Score=248.68  Aligned_cols=197  Identities=34%  Similarity=0.636  Sum_probs=160.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |+|| +||++... ..+..+++.||+|++.... ......+.+|+.++.+++ ||||+++++++..  ....++||||++
T Consensus        21 G~~g-~V~~~~~~-~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~   96 (295)
T 3ugc_A           21 GNFG-SVEMCRYD-PLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLP   96 (295)
T ss_dssp             CSSE-EEEEEEEC-TTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHHHTSCEEEEECCT
T ss_pred             cCCE-EEEEEEEe-cccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCCceEEEEEeCC
Confidence            8999 99999742 2235678999999987543 334457889999999998 9999999999854  456899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....            ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+++++|+|||++...
T Consensus        97 ~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           97 YGSLRDYLQKHK------------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             TCBHHHHHHHCG------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             CCCHHHHHHhcc------------cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            999999997642            24899999999999999999999999999999999999999999999999999765


Q ss_pred             cCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~  220 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSP  220 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH-TTCTTCSH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh-cccccCCC
Confidence            433221 22223445667999999999999999999999999999999 98888654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.8e-38  Score=253.41  Aligned_cols=198  Identities=25%  Similarity=0.395  Sum_probs=165.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e   76 (225)
                      |.|| +||++..     ..+|+.||+|.+...........+.+|+.++..+. ||||+++++++...     ...++++|
T Consensus        22 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e   94 (353)
T 2b9h_A           22 GAYG-VVCSATH-----KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQE   94 (353)
T ss_dssp             CSSE-EEEEEEE-----TTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCccceEEEEEe
Confidence            8899 9999983     56789999999986666666667889999999998 99999999987654     67999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ++. ++|.+++...              .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++
T Consensus        95 ~~~-~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           95 LMQ-TDLHRVISTQ--------------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CCS-EEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccC-ccHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            997 6898888652              5899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccc--------cccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        157 RDLMTSSVYE--------RKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       157 ~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ..........        ......+++.|+|||++.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~  233 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL  233 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Confidence            7654322111        1223457888999998765 678999999999999999999 999999988766554

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-38  Score=247.86  Aligned_cols=195  Identities=28%  Similarity=0.495  Sum_probs=152.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..        ...||+|+++... .......+.+|+.+++++. ||||++++++. .....++||||+.+
T Consensus        35 G~~g-~Vy~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~~~lv~e~~~~  103 (289)
T 3og7_A           35 GSFG-TVYKGKW--------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQLAIVTQWCEG  103 (289)
T ss_dssp             CSSE-EEEEEES--------SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSSCEEEEECCCE
T ss_pred             CCCe-EEEEEEE--------cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCccEEEEEecCC
Confidence            8999 9999984        1249999997553 4455567889999999998 99999999964 56678999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++.+++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       104 ~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          104 SSLYHHLHAS------------ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEHHHHHTTC---------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             CcHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            9999988542            2358999999999999999999999999999999999999999999999999987554


Q ss_pred             CccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ............+++.|+|||.+.   +..++.++|+||+|+++++|++ |..||.+.+..+.
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~  233 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQ  233 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCCHHH
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH-CCCCccccchHHH
Confidence            333333334456788899999886   5667889999999999999999 9999987655443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-38  Score=251.12  Aligned_cols=196  Identities=35%  Similarity=0.641  Sum_probs=162.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~   79 (225)
                      |.|| +||++.+. ..+..+++.||+|+++..........+.+|+.++..+. ||||+++++++.+.  ...++||||++
T Consensus        32 G~~g-~V~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~  108 (302)
T 4e5w_A           32 GHFG-KVELCRYD-PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLP  108 (302)
T ss_dssp             CSSE-EEEEEEEC-TTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC---CCEEEEEECCT
T ss_pred             CCce-EEEEEEEc-cccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCceEEEEEEeCC
Confidence            8999 99999742 22456799999999986655445567889999999998 99999999999876  66899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....            ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus       109 ~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          109 SGSLKEYLPKNK------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             TCBHHHHHHHHT------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCcHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            999999996542            35899999999999999999999999999999999999999999999999999765


Q ss_pred             cCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        160 MTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       160 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      ...... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~  230 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDS  230 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGG
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH-ccCCCc
Confidence            443322 22334556778999999988888999999999999999999 888764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-38  Score=247.11  Aligned_cols=203  Identities=25%  Similarity=0.442  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEE--ecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e   76 (225)
                      |.|| .||++.     +..+++.||+|+++...   .......+.+|+.++.+++ ||||+++++++  .+.+..++|||
T Consensus        16 G~~g-~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e   88 (305)
T 2wtk_C           16 GSYG-KVKEVL-----DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVME   88 (305)
T ss_dssp             CSSC-EEEEEE-----BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---CEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCeEEEEeh
Confidence            8899 999998     45778999999997542   2334567889999999998 99999999998  45568999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |+.++ |.+++...           ....+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||.+
T Consensus        89 ~~~~~-l~~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           89 YCVCG-MQEMLDSV-----------PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             CCSEE-HHHHHHHS-----------TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             hccCC-HHHHHHhC-----------cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            99865 77777653           2236899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCC--CcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIF--SVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ................+++.|+|||.+.+...  +.++|+||+|+++|+|++ |..||.+.+..+....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i  225 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPFEGDNIYKLFENI  225 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHH
Confidence            76543333333345567889999999876543  779999999999999999 99999998877766543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-38  Score=245.03  Aligned_cols=193  Identities=34%  Similarity=0.611  Sum_probs=154.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc---hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG---ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||++..       .++.||+|+++....   ......+.+|+.+++.++ ||||+++++++.+.+..++||||+
T Consensus        18 G~~g-~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~   88 (271)
T 3dtc_A           18 GGFG-KVYRAFW-------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFA   88 (271)
T ss_dssp             ETTE-EEEEEEE-------TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CEEEEECC
T ss_pred             CCCe-EEEEEEE-------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceEEEEEcC
Confidence            7899 9999983       378899999875432   222356789999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCEEecC--------CCc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---IIHRDLAARNVLIGE--------NHC  147 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~---i~h~dl~~~nil~~~--------~~~  147 (225)
                      ++++|.+++..              ..+++..++.++.|+++||.+||++|   ++|+||||+||+++.        ++.
T Consensus        89 ~~~~L~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           89 RGGPLNRVLSG--------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             TTEEHHHHHTS--------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CCCCHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999988843              36899999999999999999999999   889999999999985        677


Q ss_pred             eeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        148 CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ++|+|||.+.......    .....+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+...
T Consensus       155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  224 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAY  224 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHH
T ss_pred             eEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            9999999987543322    223457888999999998889999999999999999999 999999888766543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-39  Score=258.95  Aligned_cols=196  Identities=23%  Similarity=0.411  Sum_probs=161.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |.|| +||+++...  +..+++.||+|+++...   .......+.+|+.++..+..||||+++++++...+..++||||+
T Consensus        65 G~~g-~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~  141 (355)
T 1vzo_A           65 GAYG-KVFLVRKIS--GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI  141 (355)
T ss_dssp             TTTE-EEEEEEECS--STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             CCCE-EEEEEEEcc--cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecC
Confidence            8899 999998421  23578999999987542   22223356778999999856999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+++....             .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus       142 ~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          142 NGGELFTHLSQRE-------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             CSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             CCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999997542             589999999999999999999999999999999999999999999999999875


Q ss_pred             ccCccccccccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      ...... .......+|+.|+|||++.+.  .++.++|+||||+++|+|++ |..||...
T Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  265 (355)
T 1vzo_A          209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVD  265 (355)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCT
T ss_pred             cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH-CCCCCccC
Confidence            433222 122234578899999998853  46889999999999999999 99999754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.2e-38  Score=259.57  Aligned_cols=197  Identities=21%  Similarity=0.316  Sum_probs=166.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC-----CCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     ...+++.||||+++...  .......+|+.++..+.     .|+||+++++++...+..++|||
T Consensus       108 G~fg-~V~~a~-----~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  179 (429)
T 3kvw_A          108 GSFG-QVVKAY-----DHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE  179 (429)
T ss_dssp             SSSE-EEEEEE-----ETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred             CccE-EEEEEE-----ECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence            8999 999997     46779999999997543  23345667777777763     47899999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc--eeEeeec
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC--CKVADFG  154 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~--~~l~d~g  154 (225)
                      ++. ++|.+++....           ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.  ++|+|||
T Consensus       180 ~~~-~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          180 LLS-MNLYELIKKNK-----------FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             CCC-CBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccC-CCHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            996 68999887642           235899999999999999999999999999999999999998876  9999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.....     ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+.+..+
T Consensus       248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~l~~i  311 (429)
T 3kvw_A          248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLACM  311 (429)
T ss_dssp             TCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             cceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            9854322     2234467888999999999999999999999999999999 99999999988776543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-38  Score=272.42  Aligned_cols=204  Identities=37%  Similarity=0.702  Sum_probs=168.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.+.   ....++.||||+++... .......+.+|+.++.++. ||||+++++++.. +..++||||+.+
T Consensus       380 G~fG-~Vy~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          380 GNFG-TVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             CSSE-EEEEEEEE---CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCE-EEEEEEEc---CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEccCC
Confidence            8999 99998431   34568899999998653 3344567899999999998 9999999999874 568999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus       454 g~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          454 GPLNKYLQQN-------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             EEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             CCHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            9999999653             258999999999999999999999999999999999999999999999999997554


Q ss_pred             Cccc-cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSV-YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... ........+++.|+|||++.+..++.++||||||+++|+|++.|..||.+.+..++...+
T Consensus       521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i  585 (635)
T 4fl3_A          521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML  585 (635)
T ss_dssp             C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            3322 122233445678999999999999999999999999999997799999999988876654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=263.93  Aligned_cols=192  Identities=24%  Similarity=0.407  Sum_probs=162.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--CeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|++.............+|+.++++++ ||||+++++++.+.+  ..++||||++
T Consensus        20 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~   92 (396)
T 4eut_A           20 GATA-NVFRGRH-----KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCP   92 (396)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred             CCCe-EEEEEEE-----CCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeEEEEecCC
Confidence            8999 9999984     56789999999986554444556789999999998 999999999998755  6899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe----cCCCceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~----~~~~~~~l~d~g~  155 (225)
                      +++|.+++....          ....+++..++.++.|++.||.|||++|++|+||||+||++    +.++.++|+|||+
T Consensus        93 ~g~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           93 CGSLYTVLEEPS----------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             TEEHHHHTTSGG----------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             CCCHHHHHHhhh----------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999987542          12248999999999999999999999999999999999998    6677899999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccC--------CCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYD--------NIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      +.......   ......+++.|+|||++.+        ..++.++|+||+|+++|+|++ |..||..
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~  225 (396)
T 4eut_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRP  225 (396)
T ss_dssp             CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEEC
T ss_pred             ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCC
Confidence            97654332   2234557888999998865        456789999999999999999 9999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.9e-38  Score=247.34  Aligned_cols=204  Identities=25%  Similarity=0.430  Sum_probs=168.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe--cCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCT--EKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   78 (225)
                      |.|| +||++..     ..+++.||+|.+.... .......+.+|+.++.++. ||||+++++++.  ..+..++||||+
T Consensus        17 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~   89 (279)
T 2w5a_A           17 GSYG-RCQKIRR-----KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYC   89 (279)
T ss_dssp             CSSS-EEEEEEE-----TTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred             CCCc-EEEEEEE-----CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceEEEEEeCC
Confidence            7899 9999984     5678999999997543 4455567889999999998 999999999874  467799999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEecCCCceeEeee
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----IIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++++|.+++......         ...+++..++.++.|++.||.+||+.+     ++|+||+|+||+++.++.++|+||
T Consensus        90 ~~~~L~~~l~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           90 EGGDLASVITKGTKE---------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             TTEEHHHHHHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             CCCCHHHHHHhhccc---------CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            999999999865421         234899999999999999999999999     999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |.+.........  .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..++..++
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i  228 (279)
T 2w5a_A          161 GLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKI  228 (279)
T ss_dssp             CHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             chheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCcccCHHHHHHHH
Confidence            998654332211  112345678999999998889999999999999999999 99999998887766543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-38  Score=244.59  Aligned_cols=193  Identities=27%  Similarity=0.479  Sum_probs=164.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (225)
                      |.|| +||++..       .++.||+|+++... .......+.+|+.++.++. ||||+++++++.+.  +..++||||+
T Consensus        21 G~~g-~V~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           21 NHSG-ELWKGRW-------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             ETTE-EEEEEEE-------TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             CCcc-eEEEEEE-------CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCeEeeeccc
Confidence            7899 9999983       38889999998653 4455567889999999997 99999999999877  7889999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      ++++|.+++...           ....+++..++.++.|+++||.|||+.|  ++|+||||+||+++.++.++++|||+.
T Consensus        92 ~~~~L~~~l~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           92 PYGSLYNVLHEG-----------TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             TTCBHHHHHHSC-----------SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCcHHHHHhhc-----------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence            999999999753           2235899999999999999999999999  999999999999999999999998876


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCc---chhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSV---KSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ....       .....+|+.|+|||.+.+...+.   ++|+||+|+++|+|++ |..||.+.+..+...
T Consensus       161 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~  221 (271)
T 3kmu_A          161 FSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGM  221 (271)
T ss_dssp             CTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTTTSCHHHHHH
T ss_pred             eeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCccccChHHHHH
Confidence            4321       22345678899999988765544   7999999999999999 999999888777644

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=247.47  Aligned_cols=195  Identities=26%  Similarity=0.511  Sum_probs=165.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+|+.||+|.+......   ..+.+|+.++..+. ||||+++++++...+..++||||++++
T Consensus        40 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~  109 (314)
T 3com_A           40 GSYG-SVYKAIH-----KETGQIVAIKQVPVESDL---QEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAG  109 (314)
T ss_dssp             ---C-EEEEEEE-----TTTCCEEEEEEEETTSCC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             CCCe-EEEEEEE-----CCCCCEEEEEecCchHHH---HHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEEEeecCCCC
Confidence            7899 9999983     567899999999765432   35788999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       110 ~L~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          110 SVSDIIRLR------------NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999998643            23689999999999999999999999999999999999999999999999999865533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ..  .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..
T Consensus       178 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~  234 (314)
T 3com_A          178 TM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIHPMRAI  234 (314)
T ss_dssp             TB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHH
T ss_pred             hc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Confidence            22  12234457788999999998889999999999999999999 99999987765544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-37  Score=242.39  Aligned_cols=191  Identities=29%  Similarity=0.469  Sum_probs=161.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e   76 (225)
                      |.|| +||++.     ...++..||+|.+.... .......+.+|+.++.++. ||||+++++++..    ....++|||
T Consensus        37 G~~g-~Vy~~~-----~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           37 GSFK-TVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             CCCe-EEEEeE-----ecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCceEEEEEE
Confidence            8899 999997     45778999999987543 4555667889999999998 9999999999865    355899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEec-CCCceeEeee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIG-ENHCCKVADF  153 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~  153 (225)
                      |+++++|.+++...             ..+++..++.++.|++.||.+||+.+  ++|+||||+||+++ .++.++|+||
T Consensus       110 ~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          110 LMTSGTLKTYLKRF-------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             CCCSCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             ecCCCCHHHHHHHc-------------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            99999999999764             25889999999999999999999999  99999999999997 7889999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      |++.......    .....+++.|+|||.+. ..++.++|+||+|+++++|++ |..||.+....
T Consensus       177 g~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  235 (290)
T 1t4h_A          177 GLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNA  235 (290)
T ss_dssp             TGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSH
T ss_pred             CCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh-CCCCCCCcCcH
Confidence            9986433221    22335678899999876 458899999999999999999 99999874443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=249.50  Aligned_cols=199  Identities=26%  Similarity=0.503  Sum_probs=160.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec------CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE------KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------~~~~~lv~   75 (225)
                      |.|| +||++..     ..+++.||+|++.......  ..+.+|+.++.++..||||+++++++..      .+..++||
T Consensus        35 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~  106 (326)
T 2x7f_A           35 GTYG-QVYKGRH-----VKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM  106 (326)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEEECCSSTT--HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred             CCCE-EEEEEEE-----CCCCCeEEEEEEecCcccH--HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence            7899 9999984     5678999999987554332  3678999999999669999999999976      46789999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||+++++|.+++....           ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus       107 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          107 EFCGAGSVTDLIKNTK-----------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             ECCTTEEHHHHHHHSG-----------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EcCCCCcHHHHHHhcc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            9999999999997642           13588999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      +.......  .......+++.|+|||.+.     +..++.++|+||||+++|+|++ |..||.+.+..+.+.
T Consensus       176 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~  244 (326)
T 2x7f_A          176 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALF  244 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred             ceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Confidence            86543221  1123345788899999987     4567899999999999999999 999999887766544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.6e-39  Score=255.54  Aligned_cols=190  Identities=24%  Similarity=0.385  Sum_probs=161.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |.|| +||++.     +..+++.||+|+++....       ......+.+|+.++.++. ||||+++++++.+.+..++|
T Consensus        35 G~~g-~Vy~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv  107 (335)
T 3dls_A           35 GAFG-FVWTAV-----DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLV  107 (335)
T ss_dssp             SSSC-SEEEEE-----ETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCCE-EEEEEE-----ECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEeeCCEEEEE
Confidence            8999 999998     357799999999975431       112335678999999997 99999999999999999999


Q ss_pred             EeecCCC-CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         75 MEYVPYG-KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        75 ~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ||++.++ +|.+++...             ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+||
T Consensus       108 ~e~~~~g~~l~~~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDRH-------------PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EECCTTSCBHHHHHHTC-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEeCCCCccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeec
Confidence            9998666 999988643             35899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      |++........   .....+|+.|+|||++.+..+ +.++|+||+|+++|+|++ |..||...
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  233 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPFCEL  233 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSCSSG
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh-CCCchhhH
Confidence            99875543322   122357888999999988776 789999999999999999 99999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.7e-38  Score=258.26  Aligned_cols=184  Identities=23%  Similarity=0.427  Sum_probs=152.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (225)
                      |+|| +||++.     +..+++.||||+++.. .......++.+|+.+++.+. ||||+++++++...     ...++||
T Consensus        37 G~~g-~V~~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~  109 (432)
T 3n9x_A           37 GSYG-YVYLAY-----DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVL  109 (432)
T ss_dssp             ETTE-EEEEEE-----ETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             cCCE-EEEEEE-----ECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCcCCeEEEEE
Confidence            7899 999998     4577999999999754 34455567889999999998 99999999998766     5699999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      |++. ++|.+++...             ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus       110 e~~~-~~L~~~~~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          110 EIAD-SDLKKLFKTP-------------IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             ECCS-EEHHHHHHSS-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecCC-cCHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            9986 6999988642             3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcccc--------------------ccccCCCCCccccCCccc-cCCCCCcchhHHHHHHHHHHHHH
Q psy15818        156 ARDLMTSSVY--------------------ERKSEGRLPIRWMAPESL-YDNIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       156 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slg~ll~~l~~  206 (225)
                      +.........                    .......+|+.|+|||++ .+..++.++||||+||++|+|++
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence            9765433211                    122455678899999986 45668999999999999999996

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.4e-38  Score=245.92  Aligned_cols=199  Identities=23%  Similarity=0.446  Sum_probs=162.0

Q ss_pred             CcccceeeecCCCCCC--CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPER--GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++......  ....+..||+|.+..... .....+.+|+.++.++. ||||+++++++.+.+..++||||++
T Consensus        19 G~~g-~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   95 (289)
T 4fvq_A           19 GTFT-KIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVK   95 (289)
T ss_dssp             ETTE-EEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSC-CTTBCCEEEEECCTTCCEEEEECCT
T ss_pred             CCCc-eEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCC-CCCEeEEEEEEEeCCCCEEEEECCC
Confidence            7899 99999842111  011236799999875433 23356889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc--------eeEe
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC--------CKVA  151 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~--------~~l~  151 (225)
                      +++|.+++....            ..+++..++.++.|+++||.+||++|++|+||||+||+++.++.        ++|+
T Consensus        96 ~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           96 FGSLDTYLKKNK------------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             TCBHHHHHHHTG------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CCCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999997642            24899999999999999999999999999999999999987776        9999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      |||.+........      ..+++.|+|||.+.+ ..++.++|+||+|+++|+|++++.+||...+.....
T Consensus       164 Dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~  228 (289)
T 4fvq_A          164 DPGISITVLPKDI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL  228 (289)
T ss_dssp             CCCSCTTTSCHHH------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             cCcccccccCccc------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence            9999865433221      224567999999987 668999999999999999999667777776665543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6e-38  Score=244.56  Aligned_cols=200  Identities=41%  Similarity=0.712  Sum_probs=167.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..      .++..||+|.++......  ..+.+|+.++.++. ||||+++++++. .+..++||||++++
T Consensus        24 G~~g-~Vy~~~~------~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~~~~~   92 (279)
T 1qpc_A           24 GQFG-EVWMGYY------NGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQ-HQRLVRLYAVVT-QEPIYIITEYMENG   92 (279)
T ss_dssp             ETTE-EEEEEEE------TTTEEEEEEEECTTSSCH--HHHHHHHHHHHHCC-CTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEE------cCCcEEEEEEecCCcccH--HHHHHHHHHHHhCC-CcCcceEEEEEc-CCCcEEEEecCCCC
Confidence            7899 9999983      356789999997654332  36889999999997 999999999986 45689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....           ..+++.+++.++.|++.||.+||++|++|+||||+||++++++.++|+|||.+.....
T Consensus        93 ~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           93 SLVDFLKTPSG-----------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             BHHHHTTSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CHHHHHhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            99999865321           1478999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... .......+++.|+|||.+.+..++.++|+||+|+++++|++.|..||.+.+..+.+.++
T Consensus       162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  223 (279)
T 1qpc_A          162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL  223 (279)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             ccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence            321 22233445677999999988888999999999999999998789999998887766543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-37  Score=243.43  Aligned_cols=194  Identities=23%  Similarity=0.346  Sum_probs=161.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..     ..+++.||+|.++.. ..........+|+..+..+..||||+++++++.+.+..++||||+++
T Consensus        22 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           22 GEFG-SVFKCVK-----RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             CCce-EEEEEEE-----cCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            7899 9999983     567899999999754 33445567889999999995599999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC----------------
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE----------------  144 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~----------------  144 (225)
                      ++|.+++......         ...+++.+++.++.|++.||.+||++|++|+||||+||+++.                
T Consensus        96 ~~L~~~l~~~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           96 GSLADAISENYRI---------MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             CBHHHHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             CcHHHHHHhhccc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999875421         135899999999999999999999999999999999999984                


Q ss_pred             ---CCceeEeeecccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        145 ---NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       145 ---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                         ...++|+|||.+......      ....+++.|+|||.+.+. .++.++|+||+|+++++|++ |.+|+.....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~~~~  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG-AEPLPRNGDQ  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCCSSSHH
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCCcchhH
Confidence               347999999998754332      233478889999998766 55689999999999999998 8777655443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.9e-39  Score=261.68  Aligned_cols=201  Identities=14%  Similarity=0.140  Sum_probs=153.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcC--CCCCeeeee-------eEEecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLD--PHPNVVRLL-------GCCTEKEP   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~-------~~~~~~~~   70 (225)
                      |+|| +||++..     ..+|+.||||++...  ........+.+|+.++..+.  .||||++++       +++++.+.
T Consensus        84 G~~g-~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           84 EDPY-AYLEATD-----QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             ETTE-EEEEEEC------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            7899 9999994     567899999999753  23344567889995544443  499999998       77766643


Q ss_pred             -----------------eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccC
Q psy15818         71 -----------------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR  133 (225)
Q Consensus        71 -----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~  133 (225)
                                       .+++|||+ +++|.+++.......      .....+++..++.++.|++.||.|||++|++|+
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS------STHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT------TTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc------cccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                             89999999 579999998653210      011123458888999999999999999999999


Q ss_pred             CCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccCC-----------CCCcchhHHHHHHHHH
Q psy15818        134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-----------IFSVKSDIWSFGVLIW  202 (225)
Q Consensus       134 dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slg~ll~  202 (225)
                      ||||+||+++.++.+||+|||++.....     ......+ +.|+|||++.+.           .++.++|+||||+++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999874322     1223344 779999999877           7899999999999999


Q ss_pred             HHHHcCCCCCCCCCHHHHhh
Q psy15818        203 EIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       203 ~l~~~g~~p~~~~~~~~~~~  222 (225)
                      +|++ |..||.+.+..+...
T Consensus       305 ellt-g~~Pf~~~~~~~~~~  323 (377)
T 3byv_A          305 WIWC-ADLPITKDAALGGSE  323 (377)
T ss_dssp             HHHH-SSCCC------CCSG
T ss_pred             HHHH-CCCCCcccccccchh
Confidence            9999 999998776655443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-38  Score=254.79  Aligned_cols=197  Identities=27%  Similarity=0.443  Sum_probs=161.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-------------
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-------------   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-------------   68 (225)
                      |+|| +||++.     +..+|+.||+|++..+...     ..+|+.+++.+. ||||+++++++...             
T Consensus        18 G~fg-~V~~a~-----~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A           18 GSFG-IVCEVF-----DIESGKRFALKKVLQDPRY-----KNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             C-CE-EEEEEE-----ETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCC-CTTBCCEEEEEEEC-------------
T ss_pred             ccCE-EEEEEE-----ECCCCCEEEEEEEecCcch-----HHHHHHHHHHcC-CCCccchhheeeecCcccccccccccc
Confidence            8999 999998     3578999999998654321     246899999998 99999999998443             


Q ss_pred             -------------------------CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHH
Q psy15818         69 -------------------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQ  123 (225)
Q Consensus        69 -------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~  123 (225)
                                               ...++||||++ ++|.+.+.....         ....+++..++.++.|++.||.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---------SGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ------------------------CCEEEEEECCCS-EEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHH
Confidence                                     33889999998 588888765432         2346899999999999999999


Q ss_pred             HHHhCCcccCCCCCCCEEec-CCCceeEeeecccccccCccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHH
Q psy15818        124 FLSSRGIIHRDLAARNVLIG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLI  201 (225)
Q Consensus       124 ~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll  201 (225)
                      |||+.|++|+||||+||+++ .++.++|+|||++.......   ......+++.|+|||.+.+.. ++.++|+||+|+++
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            99999999999999999997 68899999999997553322   223345678899999887754 89999999999999


Q ss_pred             HHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        202 WEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       202 ~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |+|++ |..||.+.+..+.+.+|
T Consensus       233 ~ell~-g~~pf~~~~~~~~~~~i  254 (383)
T 3eb0_A          233 GELIL-GKPLFSGETSIDQLVRI  254 (383)
T ss_dssp             HHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             HHHHh-CCCCCCCCChHHHHHHH
Confidence            99999 99999999888776553

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.1e-38  Score=253.42  Aligned_cols=194  Identities=25%  Similarity=0.449  Sum_probs=162.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCe------EEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF------FVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~------~lv   74 (225)
                      |+|| +||++.     +..+|+.||+|++.... .......+.+|+.+++.++ ||||+++++++...+..      ++|
T Consensus        53 G~~g-~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv  125 (371)
T 4exu_A           53 GAYG-SVCSAI-----DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLV  125 (371)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcccceeEEEE
Confidence            8999 999998     45789999999997543 4444567889999999998 99999999999877655      999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+. ++|.+.+..               .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus       126 ~e~~~-~~l~~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          126 MPFMQ-TDLQKIMGM---------------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             EECCC-EEHHHHTTS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             Ecccc-ccHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence            99997 677766632               48999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++......     .....+|+.|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+.++
T Consensus       190 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  254 (371)
T 4exu_A          190 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQI  254 (371)
T ss_dssp             CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence            98644322     233456888999999887 678999999999999999999 99999998887766543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-37  Score=242.92  Aligned_cols=192  Identities=28%  Similarity=0.453  Sum_probs=148.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHH-HhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     +..+++.||+|+++.............|... ++.+. ||||+++++++.+.+..++||||++ 
T Consensus        18 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~-   89 (290)
T 3fme_A           18 GAYG-VVEKMR-----HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVWICMELMD-   89 (290)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred             CCCe-EEEEEE-----ecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCEEEEEehhc-
Confidence            8999 999998     4568999999999876544444445555544 55565 9999999999999999999999997 


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ++|.+++.....         ....+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+|||++...
T Consensus        90 ~~l~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           90 TSLDKFYKQVID---------KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             cchHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            588888765432         224689999999999999999999998 9999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccc----cCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ....   ......+++.|+|||.+    .+..++.++|+||+|+++++|++ |..||..
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~  215 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDS  215 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH-TSCSSCC
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH-CCCCccc
Confidence            3322   12233577889999996    45668899999999999999999 9999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.7e-38  Score=249.79  Aligned_cols=197  Identities=35%  Similarity=0.633  Sum_probs=165.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC--CCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~   79 (225)
                      |+|| +||++.+ .+.+..+++.||+|+++..........+.+|+.+++++. ||||+++++++.+.  ...++||||++
T Consensus        42 G~~g-~V~~~~~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~  118 (318)
T 3lxp_A           42 GHFG-KVSLYCY-DPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVP  118 (318)
T ss_dssp             CSSE-EEEEEEE-CSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEEEEEECCCT
T ss_pred             CCCe-EEEEEEE-ccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCceEEEEEeccc
Confidence            8999 9987653 233566899999999987766677778999999999998 99999999999874  56899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...              .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       119 ~~~L~~~l~~~--------------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          119 LGSLRDYLPRH--------------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TCBHHHHGGGS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCcHHHHHhhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999998542              4899999999999999999999999999999999999999999999999999765


Q ss_pred             cCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ...... .......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||....
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~  241 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPP  241 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh-CCCcccccc
Confidence            443222 22334456778999999988888999999999999999999 999997643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-38  Score=266.96  Aligned_cols=200  Identities=41%  Similarity=0.735  Sum_probs=169.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.+      .++..||||+++......  ..+.+|+.+++++. ||||+++++++.+ +..++||||+.++
T Consensus       278 G~fg-~Vy~~~~------~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~lv~e~~~~g  346 (535)
T 2h8h_A          278 GCFG-EVWMGTW------NGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG  346 (535)
T ss_dssp             CSSE-EEEEEEE------TTTEEEEEEEECTTSSCH--HHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred             CCCe-EEEEEEE------CCCceEEEEEeCCCCCCH--HHHHHHHHHHHhCC-CCCEeeEEEEEee-ccceEeeehhcCC
Confidence            8999 9999985      335679999998654332  36889999999998 9999999999876 6789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....           ..+++.+++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++.....
T Consensus       347 sL~~~l~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          347 SLLDFLKGETG-----------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             EHHHHHSHHHH-----------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             cHHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999975421           2478999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........++..|+|||.+.+..++.++||||||+++|+|++.|..||.+....+++..+
T Consensus       416 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i  477 (535)
T 2h8h_A          416 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  477 (535)
T ss_dssp             HH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred             Cc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            22 122233445678999999998899999999999999999999889999999888776654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-37  Score=246.19  Aligned_cols=189  Identities=22%  Similarity=0.407  Sum_probs=159.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|+++...    ...+.+|+.++.++.+||||+++++++.+  ....++||||+.
T Consensus        47 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~  116 (330)
T 3nsz_A           47 GKYS-EVFEAI-----NITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  116 (330)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred             cCCe-EEEEEE-----ECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence            8899 999997     35678999999987433    23578999999999889999999999987  667899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-ceeEeeeccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-CCKVADFGFARD  158 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-~~~l~d~g~~~~  158 (225)
                      +++|.+++.                .+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||++..
T Consensus       117 ~~~l~~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          117 NTDFKQLYQ----------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             CCCHHHHGG----------------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             chhHHHHHH----------------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            999988874                378999999999999999999999999999999999999665 899999999975


Q ss_pred             ccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCC-CCCHHHH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYP-GMAAAEV  220 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~-~~~~~~~  220 (225)
                      .....   ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||. +.+..+.
T Consensus       181 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~  240 (330)
T 3nsz_A          181 YHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQ  240 (330)
T ss_dssp             CCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHH
T ss_pred             cCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh-CCCCcccCCchHHH
Confidence            43322   2234456788999999877 668999999999999999999 999984 4444333

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.8e-38  Score=246.17  Aligned_cols=198  Identities=29%  Similarity=0.521  Sum_probs=162.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|.+...... ....+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        30 G~~g-~V~~~~~-----~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (302)
T 2j7t_A           30 GAFG-KVYKAKN-----KETGALAAAKVIETKSEE-ELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGG  101 (302)
T ss_dssp             STTC-CEEEEEE-----TTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred             CCCe-EEEEEEE-----cCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence            8899 9999984     567899999998754322 2346888999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++....            ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~l~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A          102 AVDAIMLELD------------RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             cHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            9999887532            3589999999999999999999999999999999999999999999999998753211


Q ss_pred             ccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      .  ........+++.|+|||.+.     +..++.++|+||+|+++|+|++ |..||...+..+.+.
T Consensus       170 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~  232 (302)
T 2j7t_A          170 T--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLL  232 (302)
T ss_dssp             H--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred             c--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc-CCCCCccCCHHHHHH
Confidence            1  11223345778899999883     5678899999999999999999 999999888766554

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-37  Score=243.24  Aligned_cols=191  Identities=28%  Similarity=0.513  Sum_probs=158.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch--HHH----HHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE--RER----LDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (225)
                      |.|| +||++..     ..+++.||+|++......  ...    ..+.+|+.++.+++ ||||+++++++.+..  ++||
T Consensus        30 G~~g-~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~lv~  100 (287)
T 4f0f_A           30 GGFG-LVHKGRL-----VKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP--RMVM  100 (287)
T ss_dssp             CSSS-CEEEEEE-----TTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTTT--EEEE
T ss_pred             CCce-eEEEEEE-----cCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCCC--eEEE
Confidence            8899 9999984     567899999998654321  111    46889999999998 999999999987665  6999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCc-----e
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHC-----C  148 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~-----~  148 (225)
                      ||+++++|.+.+...            ...+++..++.++.|++.||.+||+.|  ++|+||||+||+++.++.     +
T Consensus       101 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A          101 EFVPCGDLYHRLLDK------------AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             ECCTTCBHHHHHHCT------------TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             EecCCCCHHHHHhcc------------cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            999999998888643            236899999999999999999999999  999999999999987665     9


Q ss_pred             eEeeecccccccCccccccccCCCCCccccCCcccc--CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        149 KVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY--DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      +|+|||++.....     ......+++.|+|||.+.  ...++.++|+||+|+++|+|++ |..||...+..+
T Consensus       169 kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  235 (287)
T 4f0f_A          169 KVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGK  235 (287)
T ss_dssp             EECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH-SSCTTTTCCCCH
T ss_pred             EeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc-CCCCCccccccH
Confidence            9999999864332     223455778899999884  4456889999999999999999 999998765433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=255.66  Aligned_cols=202  Identities=23%  Similarity=0.380  Sum_probs=151.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe--cCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--EKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~   79 (225)
                      |+|| +||++...   ...+++.||+|.+.......   .+.+|+.+++.+. ||||+++++++.  .....++||||+.
T Consensus        32 G~~g-~Vy~~~~~---~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           32 GTYG-HVYKAKRK---DGKDDKDYALKQIEGTGISM---SACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             -----EEEEEEES---SSSCCCCEEEEECSSSSCCH---HHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             cCCe-EEEEEEEc---cCCCCeEEEEEEECCCCCCH---HHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            8999 99999842   22467899999997654333   4778999999998 999999999994  4678999999997


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe----cCCCceeEeeecc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI----GENHCCKVADFGF  155 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~----~~~~~~~l~d~g~  155 (225)
                       ++|.+++...+.....    .....+++..++.++.|++.||.|||++||+||||||+||++    +.++.++|+|||+
T Consensus       104 -~~l~~~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             -EEHHHHHHHHHHHC-----------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             -CCHHHHHHHhcccccc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence             5888888655432110    012348999999999999999999999999999999999999    6678999999999


Q ss_pred             cccccCccc-cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        156 ARDLMTSSV-YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      +........ ........+|+.|+|||++.+. .++.++||||+|+++|+|++ |.+||.+...
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  241 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE  241 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH-SSCTTCCCC-
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh-CCCCCCCccc
Confidence            976543221 1223345678889999998874 48999999999999999999 9999987655

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.9e-37  Score=243.45  Aligned_cols=195  Identities=25%  Similarity=0.462  Sum_probs=155.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc--cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..     ..+++.||+|+++..  ........+.+|+.++..+. ||||+++++++...+..++||||+.
T Consensus        43 G~~g-~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~  115 (310)
T 2wqm_A           43 GQFS-EVYRAAC-----LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELAD  115 (310)
T ss_dssp             C--C-EEEEEEE-----TTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             CCCc-eEEEEEE-----cCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEEEEEecCC
Confidence            7899 9999983     467899999998753  34455667889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++.....         ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       116 ~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          116 AGDLSRMIKHFKK---------QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             SCBHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             CCCHHHHHHHhcc---------cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999976432         1235899999999999999999999999999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      .....  ......+++.|+|||.+.+..++.++|+||||+++++|++ |..||.+.
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~  239 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGD  239 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTC--
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCCccc
Confidence            33221  1223456788999999999899999999999999999999 99999754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-37  Score=242.40  Aligned_cols=195  Identities=39%  Similarity=0.733  Sum_probs=158.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..       .|+.||+|+++...   ....+.+|+.++.+++ ||||+++++++.+ .+..++||||+++
T Consensus        32 G~~g-~V~~~~~-------~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e~~~~   99 (278)
T 1byg_A           32 GEFG-DVMLGDY-------RGNKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAK   99 (278)
T ss_dssp             CSSC-EEEEEEE-------TTEEEEEEECCCCC-----HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             CCCc-eEEEEEE-------cCCEEEEEEecchh---HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceEEEEecCCC
Confidence            7899 9999973       47899999997543   3346889999999998 9999999999654 4579999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++......           .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       100 ~~L~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A          100 GSLVDYLRSRGRS-----------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEHHHHHHHHHHH-----------HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCHHHHHHhcccc-----------cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            9999999765321           37899999999999999999999999999999999999999999999999886443


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..     .....+++.|+|||.+.+..++.++|+||+|+++++|++.|..||...+..+....+
T Consensus       169 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  227 (278)
T 1byg_A          169 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  227 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             cc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            22     122345677999999988889999999999999999997699999988777665543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=247.46  Aligned_cols=201  Identities=25%  Similarity=0.426  Sum_probs=146.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe--------cCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--------EKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--------~~~~~~l   73 (225)
                      |.|| +||++..     ..+++.||+|++.... ......+.+|+.++.++.+||||+++++++.        ....+++
T Consensus        39 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l  111 (337)
T 3ll6_A           39 GGFA-FVYEAQD-----VGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL  111 (337)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred             CCce-EEEEEEE-----CCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence            8899 9999984     5678999999986543 3344568899999999977999999999984        3445899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEecCCCceeEe
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIGENHCCKVA  151 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~~~~~~~l~  151 (225)
                      ++||+. ++|.+++....          ....+++.+++.++.|++.||.+||+.|  ++|+||||+||+++.++.++|+
T Consensus       112 v~e~~~-g~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          112 LTELCK-GQLVEFLKKME----------SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             EEECCS-EEHHHHHHHHH----------TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             EEEecC-CCHHHHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence            999996 78999887643          2235899999999999999999999999  9999999999999999999999


Q ss_pred             eecccccccCccccc----------cccCCCCCccccCCccc---cCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        152 DFGFARDLMTSSVYE----------RKSEGRLPIRWMAPESL---YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       152 d~g~~~~~~~~~~~~----------~~~~~~~~~~~~~PE~~---~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      |||++..........          ......+++.|+|||++   .+..++.++|+||||+++|+|++ |..||.+....
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~  259 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-RQHPFEDGAKL  259 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHH-SSCCC------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh-CCCCCcchhHH
Confidence            999997654432211          11134477889999988   46678899999999999999999 99999876655


Q ss_pred             HHh
Q psy15818        219 EVM  221 (225)
Q Consensus       219 ~~~  221 (225)
                      +++
T Consensus       260 ~~~  262 (337)
T 3ll6_A          260 RIV  262 (337)
T ss_dssp             ---
T ss_pred             Hhh
Confidence            443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.8e-37  Score=266.26  Aligned_cols=205  Identities=38%  Similarity=0.710  Sum_probs=169.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++....  ....+..||+|.++..........+.+|+.++.++. ||||+++++++. .+..++||||++++
T Consensus       401 G~fG-~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~~lv~E~~~~g  475 (656)
T 2j0j_A          401 GQFG-DVHQGIYMS--PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLG  475 (656)
T ss_dssp             CSSC-CEEEEEECC--SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred             CCCE-EEEEEEEec--CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cCceEEEEEcCCCC
Confidence            8999 999997532  123467899999987666666678999999999998 999999999985 45689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       476 ~L~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          476 ELRSFLQVR------------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             BHHHHHHHT------------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             cHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            999999753            23578999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... .......+++.|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..+.+.++
T Consensus       544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i  605 (656)
T 2j0j_A          544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  605 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            321 12233445678999999988899999999999999999997699999999888776554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.7e-38  Score=258.08  Aligned_cols=191  Identities=25%  Similarity=0.441  Sum_probs=151.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |+|| +||++.     ...+++.||+|++....       .......+.+|+.++.++. ||||+++++++.. +..++|
T Consensus       146 G~~g-~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-~~~~lv  217 (419)
T 3i6u_A          146 GACG-EVKLAF-----ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIV  217 (419)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEES-SEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CceEEE
Confidence            8999 999998     46778999999987532       1222234789999999997 9999999999865 458999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC---CceeEe
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN---HCCKVA  151 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~---~~~~l~  151 (225)
                      |||+++++|.+.+..             ...+++.+++.++.|++.||.|||++|++|+||||+||+++..   ..++|+
T Consensus       218 ~e~~~~g~L~~~l~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          218 LELMEGGELFDKVVG-------------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             EECCTTCBGGGGTSS-------------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             EEcCCCCcHHHHHhc-------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence            999999999877643             2368999999999999999999999999999999999999644   459999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      |||++.......   ......+|+.|+|||++.+   ..++.++|+||+|+++|+|++ |..||.+...
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  349 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRT  349 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCSS
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCcc
Confidence            999997654322   2233457888999998864   567889999999999999999 9999986543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-37  Score=246.53  Aligned_cols=201  Identities=27%  Similarity=0.513  Sum_probs=164.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-HHHHHHHHHHHHHhhcC--CCCCeeeeeeEEe-----cCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLD--PHPNVVRLLGCCT-----EKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~-----~~~~~~l   73 (225)
                      |.|| +||++...    ..+++.||+|+++..... .......+|+.+++.+.  .||||+++++++.     .....++
T Consensus        22 G~~g-~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   96 (326)
T 1blx_A           22 GAYG-KVFKARDL----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   96 (326)
T ss_dssp             ETTE-EEEEEEET----TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             cccE-EEEEEEec----CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence            7899 99999841    256889999999754321 11224556777666662  3999999999987     5567899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ||||+. ++|.+++....           ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+||
T Consensus        97 v~e~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           97 VFEHVD-QDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EEECCS-CBHHHHHHHSC-----------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             EEecCC-CCHHHHHHhcc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence            999997 69999987642           234899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      |++.......   ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~  230 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGK  230 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Confidence            9987553322   2334567788999999998889999999999999999999 9999999888776654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-37  Score=255.39  Aligned_cols=196  Identities=24%  Similarity=0.422  Sum_probs=158.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv~   75 (225)
                      |.|| +||++..     ..+++.||||.+.....     ...+|+.+++.+. ||||+++++++...      ..+++||
T Consensus        65 G~fg-~Vy~~~~-----~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           65 GSFG-VVYQAKL-----CDSGELVAIKKVLQDKR-----FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             CSSE-EEEEEEE-----TTTCCEEEEEEEECCTT-----SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             CCCE-EEEEEEE-----CCCCcEEEEEEecccch-----hHHHHHHHHHHcC-CCCccceeeEEeccCCCCcceeEEeeh
Confidence            8999 9999984     56789999999865322     2346899999998 99999999998532      2367999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeec
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFG  154 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g  154 (225)
                      ||+++ ++.+.+.....         ....+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus       133 e~~~~-~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          133 DYVPE-TVYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             ECCCE-EHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             hcccc-cHHHHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence            99974 67666654321         2246899999999999999999999999999999999999985 4678999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ++.......   ......+|+.|+|||++.+. .++.++||||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       203 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~l~~  268 (420)
T 1j1b_A          203 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVE  268 (420)
T ss_dssp             TCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             hhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            997543322   12334568889999998765 68999999999999999999 9999999887776654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=245.04  Aligned_cols=198  Identities=26%  Similarity=0.446  Sum_probs=158.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe--------------c
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--------------E   67 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--------------~   67 (225)
                      |.|| +||++.     +..+++.||+|.+.... ......+.+|+.+++++. ||||+++++++.              +
T Consensus        22 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           22 GGNG-LVFSAV-----DNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             -----CEEEEE-----ETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             CCCe-EEEEEE-----ECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccccccccccccc
Confidence            7899 999998     35678999999987543 344557889999999998 999999999874              3


Q ss_pred             CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCC
Q psy15818         68 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENH  146 (225)
Q Consensus        68 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~  146 (225)
                      .+..++||||+. ++|.+++..              ..+++..++.++.|++.||.+||++|++|+||||+||+++ +++
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQ--------------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred             cCceeEEeeccC-CCHHHHhhc--------------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence            467899999997 589888843              2588999999999999999999999999999999999997 567


Q ss_pred             ceeEeeecccccccCccc-cccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        147 CCKVADFGFARDLMTSSV-YERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       147 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .++|+|||++........ ........+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+.+.+
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAHELEQMQL  236 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            899999999876533211 112223345778999998865 678999999999999999999 9999999888776554

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-37  Score=242.77  Aligned_cols=193  Identities=18%  Similarity=0.261  Sum_probs=157.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||+|++.......   .+.+|+.++..+..++++..+..++...+..+++|||+ ++
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 4hgt_A           20 GSFG-DIYLGT-----DIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             CSSS-EEEEEE-----ETTTTEEEEEEEEEC---CC---CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             CCCe-EEEEEE-----EcCCCceEEEEeecccccch---HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence            8899 999998     45778999999876543322   47789999999984444444455557778889999999 89


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe---cCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~---~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++...            ...+++.+++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||++..
T Consensus        90 ~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           90 SLEDLFNFC------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             BHHHHHHHT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999998753            2358999999999999999999999999999999999999   7888999999999976


Q ss_pred             ccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        159 LMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       159 ~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .......     .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~  220 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKA  220 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc-CCCCCcccch
Confidence            5443221     12234567889999999999999999999999999999999 9999987543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-37  Score=250.46  Aligned_cols=198  Identities=20%  Similarity=0.369  Sum_probs=157.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc----------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG----------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----   67 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----   67 (225)
                      |+|| +||++..      ..++.||+|++.....          ......+.+|+.++.++. ||||+++++++..    
T Consensus        33 G~~g-~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  104 (362)
T 3pg1_A           33 GSYG-AVCAGVD------SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIFVHFEEP  104 (362)
T ss_dssp             ETTE-EEEEEEC------TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEEEECCTT
T ss_pred             CCCE-EEEEEEC------CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeeeEEeccCC
Confidence            7899 9999983      3489999999865322          223357889999999998 9999999999843    


Q ss_pred             -CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC
Q psy15818         68 -KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH  146 (225)
Q Consensus        68 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~  146 (225)
                       ....++||||+. ++|.+.+...            ...+++..++.++.|++.||.+||++|++|+||||+||+++.++
T Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A          105 AMHKLYLVTELMR-TDLAQVIHDQ------------RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN  171 (362)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHHCT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             CcceEEEEEccCC-CCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence             345899999997 6888887642            23589999999999999999999999999999999999999999


Q ss_pred             ceeEeeecccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        147 CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       147 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+.++++
T Consensus       172 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          172 DITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             CEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             CEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            99999999986433222   2233456788999998877 678999999999999999999 99999998887776553

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.8e-37  Score=245.82  Aligned_cols=197  Identities=24%  Similarity=0.316  Sum_probs=164.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC-----CCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |.|| +||++..    ...+++.||+|+++...  .......+|+.++..+.     .|++++++++++.+.+..++|||
T Consensus        25 G~~g-~V~~~~~----~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   97 (339)
T 1z57_A           25 GAFG-KVVECID----HKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE   97 (339)
T ss_dssp             ETTE-EEEEEEE----TTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred             CCCe-EEEEEEe----cCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence            7899 9999973    13568999999997543  33446778888888775     23459999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC------------
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE------------  144 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~------------  144 (225)
                      |+ +++|.+++....           ...+++..++.++.|+++||+|||++|++|+||||+||+++.            
T Consensus        98 ~~-~~~l~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           98 LL-GLSTYDFIKENG-----------FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             CC-CCBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CC-CCCHHHHHHhcC-----------CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            99 789999987642           235789999999999999999999999999999999999986            


Q ss_pred             -------CCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        145 -------NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       145 -------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                             ++.++|+|||++......     .....+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||...+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~  239 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL-GFTVFPTHDS  239 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSCH
T ss_pred             cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCh
Confidence                   667999999998643221     234457888999999999899999999999999999999 9999999888


Q ss_pred             HHHhhh
Q psy15818        218 AEVMKK  223 (225)
Q Consensus       218 ~~~~~~  223 (225)
                      .+.+..
T Consensus       240 ~~~~~~  245 (339)
T 1z57_A          240 KEHLAM  245 (339)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            776543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.2e-37  Score=241.54  Aligned_cols=198  Identities=25%  Similarity=0.496  Sum_probs=166.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..     ..+++.||+|++.... .......+.+|+.++.++. ||||+++++++.+.+..++++|++.+
T Consensus        33 G~~g-~V~~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~  105 (287)
T 2wei_A           33 GSFG-EVLKCKD-----RITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTG  105 (287)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCCE-EEEEEEE-----cCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCeEEEEEEccCC
Confidence            7899 9999983     5678999999987543 3334457889999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g~~~  157 (225)
                      ++|.+.+....             .+++..++.++.|++.||.+||++|++|+||+|+||+++.   +..++|+|||++.
T Consensus       106 ~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          106 GELFDEIIKRK-------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             CBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             CCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99998886542             5899999999999999999999999999999999999964   3469999999987


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .......   .....+++.|+|||.+.+. ++.++|+||+|+++++|++ |..||.+.+..++++++
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  234 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRV  234 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             eecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            5433221   1222356779999987654 8899999999999999999 99999998888776553

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-37  Score=242.74  Aligned_cols=206  Identities=34%  Similarity=0.598  Sum_probs=161.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.+..  ....+..||+|+++...  .......+.+|+.++.++. ||||+++++++.+.. .++|+|+++
T Consensus        29 G~~g-~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~v~e~~~  103 (291)
T 1u46_A           29 GSFG-VVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-MKMVTELAP  103 (291)
T ss_dssp             ---C-CCEEEEEEC--TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-CEEEEECCT
T ss_pred             CCce-eEEEEEecc--CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-ceeeEeccc
Confidence            7899 999997421  12234579999997642  3445567889999999997 999999999988765 899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....            ..+++..++.++.|+++||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus       104 ~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A          104 LGSLLDRLRKHQ------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             TCBHHHHHHHHG------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCHHHHHHhcc------------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            999999997642            24789999999999999999999999999999999999999999999999998765


Q ss_pred             cCccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....... ......+++.|+|||.+.+..++.++|+||+|+++++|++.|..||.+.+..+.+..+
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  237 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  237 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence            4332221 2223445667999999988888999999999999999998799999998887776543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=243.30  Aligned_cols=194  Identities=28%  Similarity=0.451  Sum_probs=161.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..     ..+++.||+|.+..... .....+.+|+.++..+. ||||+++++++.+.+..++||||++++
T Consensus        33 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  104 (295)
T 2clq_A           33 GTYG-IVYAGRD-----LSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGG  104 (295)
T ss_dssp             CSSS-EEEEEEE-----TTTCCEEEEEEEECCCC----HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             cCcE-EEEEEEE-----CCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence            8899 9999983     56789999999876533 33456889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++....          ....+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+....
T Consensus       105 ~L~~~l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          105 SLSALLRSKW----------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EHHHHHHHTT----------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CHHHHHHhhc----------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            9999997642          1234678899999999999999999999999999999999986 8899999999987543


Q ss_pred             CccccccccCCCCCccccCCccccCCC--CCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI--FSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      ...  .......+++.|+|||.+.+..  ++.++|+||||+++|+|++ |..||....
T Consensus       175 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  229 (295)
T 2clq_A          175 GIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELG  229 (295)
T ss_dssp             C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH-TSCTTGGGS
T ss_pred             CCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH-CCCCccCCC
Confidence            321  1123445788899999987643  7889999999999999999 999997544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=249.59  Aligned_cols=193  Identities=25%  Similarity=0.460  Sum_probs=161.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC------eEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------~~lv   74 (225)
                      |.|| +||++.     +..+|+.||||.+.... .......+.+|+.++..+. ||||+++++++...+.      ++++
T Consensus        35 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           35 GAYG-SVCSAI-----DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccccceeEEEE
Confidence            8899 999998     35679999999997543 4444567889999999998 9999999999987654      4999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+. ++|.+++.               ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus       108 ~e~~~-~~l~~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          108 MPFMQ-TDLQKIMG---------------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             EECCS-EEGGGTTT---------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             ecccc-CCHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence            99997 57766553               248999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+.+..+.+..
T Consensus       172 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~  235 (353)
T 3coi_A          172 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQ  235 (353)
T ss_dssp             CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSSBSSCHHHHHHH
T ss_pred             cccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            98654322     223456788999998877 678899999999999999999 9999999887766554

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.9e-37  Score=248.86  Aligned_cols=197  Identities=23%  Similarity=0.349  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCC-----CeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP-----NVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~-----~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     ...+++.||||+++...  ........|+.++..+..|+     +++++++++...+..++|||
T Consensus        65 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  136 (382)
T 2vx3_A           65 GSFG-QVVKAY-----DRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE  136 (382)
T ss_dssp             ETTE-EEEEEE-----ETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred             cCCE-EEEEEE-----EcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence            7899 999998     35678999999997532  23345677888888776455     49999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEec--CCCceeEee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS--SRGIIHRDLAARNVLIG--ENHCCKVAD  152 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh--~~~i~h~dl~~~nil~~--~~~~~~l~d  152 (225)
                      ++. ++|.+++....           ...+++..+..++.|++.||.+||  +.||+||||||+||+++  .++.++|+|
T Consensus       137 ~~~-~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          137 MLS-YNLYDLLRNTN-----------FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             CCC-CBHHHHHHHTT-----------TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             cCC-CCHHHHHhhcC-----------cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            996 59999987642           235899999999999999999999  57999999999999995  467899999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++.....     ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.+.+|
T Consensus       205 FG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~i  270 (382)
T 2vx3_A          205 FGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKI  270 (382)
T ss_dssp             CTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            999875432     2234567888999999999999999999999999999999 99999999988877654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-37  Score=252.01  Aligned_cols=195  Identities=25%  Similarity=0.425  Sum_probs=154.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC------eEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------~~lv~   75 (225)
                      |+|| +||++..     ..+++ ||+|.+.....     ...+|+.+++.+. ||||+++++++...+.      .++||
T Consensus        51 G~~g-~V~~a~~-----~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           51 GSFG-VVFQAKL-----VESDE-VAIKKVLQDKR-----FKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             ETTE-EEEEEEE-----TTTEE-EEEEEEECCTT-----SCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             CCCe-EEEEEEE-----CCCCe-EEEEEEecCcc-----hHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCceEEEEEe
Confidence            7999 9999984     34444 78887754322     1236899999998 9999999999865443      88999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeeec
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADFG  154 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~g  154 (225)
                      ||++++ +.+.+.....         ....+++..++.++.|++.||.|||++|++||||||+||+++ .++.++|+|||
T Consensus       118 e~~~~~-l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          118 EYVPET-VYRASRHYAK---------LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             ECCSEE-HHHHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eccCcc-HHHHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            999864 4444432211         123689999999999999999999999999999999999998 78999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ++.......   ......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       188 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~l~~  253 (394)
T 4e7w_A          188 SAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVE  253 (394)
T ss_dssp             TCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             CcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            997553322   22344568889999998765 58999999999999999999 9999999888776654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.4e-37  Score=245.65  Aligned_cols=199  Identities=36%  Similarity=0.614  Sum_probs=166.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe--cCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--EKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.+. ..+..+++.||+|++.... ......+.+|+.+++++. ||||+++++++.  +.+..++||||++
T Consensus        34 G~~g-~V~~~~~~-~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~  109 (327)
T 3lxl_A           34 GNFG-SVELCRYD-PLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGRQSLRLVMEYLP  109 (327)
T ss_dssp             ETTE-EEEEEEEC-TTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSSCEEEEEEECCT
T ss_pred             CCCe-EEEEEEec-cCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCCceEEEEEeecC
Confidence            7899 99999742 2235678999999997653 334457889999999997 999999999886  4556899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....            ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus       110 ~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          110 SGCLRDFLQRHR------------ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             TCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999997642            24899999999999999999999999999999999999999999999999999765


Q ss_pred             cCcccc-ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        160 MTSSVY-ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       160 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ...... .......+++.|+|||.+.+..++.++|+||||+++++|++ |..||.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  235 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSA  235 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh-CCCCCccccc
Confidence            433222 22334556778999999988888999999999999999999 9999865543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-37  Score=251.56  Aligned_cols=191  Identities=17%  Similarity=0.164  Sum_probs=143.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcC-CCCCeeeee-------eEEecCCC-
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLD-PHPNVVRLL-------GCCTEKEP-   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~-~~~~i~~~~-------~~~~~~~~-   70 (225)
                      |+|| +||++..     ..+++.||+|++....  .......+.+|+.++..+. .|||+++++       +++...+. 
T Consensus        73 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~  146 (371)
T 3q60_A           73 GDRS-VVFLVRD-----VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP  146 (371)
T ss_dssp             CSSE-EEEEEEE-----TTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred             CCCE-EEEEEEE-----CCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence            8999 9999984     5678999999998654  3344445667754444332 399977755       55544432 


Q ss_pred             ----------------eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHH------HHHHHHHHHHHHHHHhC
Q psy15818         71 ----------------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL------TSFCYQVARGMQFLSSR  128 (225)
Q Consensus        71 ----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ql~~~l~~Lh~~  128 (225)
                                      .++||||++ ++|.+++.....            .+....+      ..++.|+++||+|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF------------VYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH------------SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc------------ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence                            799999998 899999987521            2444555      67779999999999999


Q ss_pred             CcccCCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHH
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~  206 (225)
                      |++||||||+||+++.++.++|+|||++.......     ....+++.|+|||++.+  ..++.++|+||+|+++|+|++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            99999999999999999999999999997553222     13334578999999987  678999999999999999999


Q ss_pred             cCCCCCCCCCH
Q psy15818        207 LGSTPYPGMAA  217 (225)
Q Consensus       207 ~g~~p~~~~~~  217 (225)
                       |..||.+...
T Consensus       289 -g~~Pf~~~~~  298 (371)
T 3q60_A          289 -LFLPFGLVTP  298 (371)
T ss_dssp             -SSCSTTBCCT
T ss_pred             -CCCCCCCcCc
Confidence             9999987743

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.9e-37  Score=239.98  Aligned_cols=191  Identities=18%  Similarity=0.263  Sum_probs=158.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeee-eeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL-LGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~-~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++.     +..+++.||+|++.......   .+.+|+.++..+. |++++.. ..+....+..++||||+ +
T Consensus        20 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~e~~-~   88 (296)
T 3uzp_A           20 GSFG-DIYLGT-----DIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQ-GGVGIPTIRWCGAEGDYNVMVMELL-G   88 (296)
T ss_dssp             ETTE-EEEEEE-----ETTTTEEEEEEEEESCSSCC---HHHHHHHHHHHHT-TSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEecCCcchh---HHHHHHHHHHHhh-cCCCCCccccccCCCCceEEEEEec-C
Confidence            7899 999998     45779999999987654333   4788999999998 6554444 44456677889999999 8


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~  157 (225)
                      ++|.+++...            ...+++..++.++.|++.||.+||++|++|+||||+||+++   .++.++|+|||++.
T Consensus        89 ~~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           89 PSLEDLFNFC------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             CBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCHHHHHHhh------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            9999999753            23589999999999999999999999999999999999994   78899999999997


Q ss_pred             cccCccccc-----cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        158 DLMTSSVYE-----RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       158 ~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .........     ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  219 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLK  219 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCC
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcC
Confidence            654432211     1234567889999999999999999999999999999999 999998744

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.9e-37  Score=246.71  Aligned_cols=200  Identities=27%  Similarity=0.401  Sum_probs=155.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-------eEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-------FFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-------~~lv   74 (225)
                      |+|| +||++.     +..+++.||||++.......  .+..+++..+..+. ||||+++++++...+.       .++|
T Consensus        34 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~~lv  104 (360)
T 3e3p_A           34 GTFG-TVQLGK-----EKSTGMSVAIKKVIQDPRFR--NRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIYLNVV  104 (360)
T ss_dssp             ------CEEEE-----ETTTCCEEEEEEEECCTTCC--CHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEecCcccc--HHHHHHHHHHHhcC-CCCcccHHHhhhccccccccceeEEEE
Confidence            8899 999998     35678999999986543222  24566777778887 9999999999865443       8899


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEecC-CCceeEe
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS--SRGIIHRDLAARNVLIGE-NHCCKVA  151 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh--~~~i~h~dl~~~nil~~~-~~~~~l~  151 (225)
                      |||+.+ +|...+.....         ....+++..++.++.|++.||.+||  +.|++|+||||+||+++. ++.++|+
T Consensus       105 ~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A          105 MEYVPD-TLHRCCRNYYR---------RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             EECCSC-BHHHHHHHHHT---------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             eecccc-cHHHHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence            999985 56555543211         2346789999999999999999999  999999999999999986 8899999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |||++.......   ......+++.|+|||++.+.. ++.++|+||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       175 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          175 DFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             CCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             eCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCcCCCChHHHHHHH
Confidence            999997554322   223345688899999987654 7999999999999999999 99999999887776553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=248.39  Aligned_cols=194  Identities=16%  Similarity=0.205  Sum_probs=154.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHH----------HHHHHHHHHHHhhcCCCCCeeeeeeEEec----
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERE----------RLDLLQELTVMKTLDPHPNVVRLLGCCTE----   67 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----   67 (225)
                      |.|| +||++....  ...++..||+|.+........          .....+|+..+..+. ||||+++++++..    
T Consensus        48 G~~g-~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~~~~~~~~~~~  123 (345)
T 2v62_A           48 GGFG-LIYLAFPTN--KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLFYGSGLTEFKG  123 (345)
T ss_dssp             -----CEEEEEESS--SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCEEEEEEEESSS
T ss_pred             cCCe-EEEEEEecC--CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcceeecccccccCC
Confidence            8899 999998521  123688999999875432111          112456777888887 9999999999887    


Q ss_pred             CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC-
Q psy15818         68 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH-  146 (225)
Q Consensus        68 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~-  146 (225)
                      ....++||||+ +++|.+++....             .+++.+++.++.|++.||.|||+.|++|+||||+||+++.++ 
T Consensus       124 ~~~~~lv~e~~-~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          124 RSYRFMVMERL-GIDLQKISGQNG-------------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             CEEEEEEEECE-EEEHHHHCBGGG-------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             CcEEEEEEecc-CCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            67899999999 899999886532             589999999999999999999999999999999999998776 


Q ss_pred             -ceeEeeecccccccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        147 -CCKVADFGFARDLMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       147 -~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                       .++|+|||++.........     .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~  262 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC-GKLPWEQ  262 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCTTGG
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCccc
Confidence             9999999999765432211     11234567889999999999889999999999999999999 9999965

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.5e-38  Score=250.95  Aligned_cols=203  Identities=18%  Similarity=0.332  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH----------------HHHHHHHHHHHHhhcCCCCCeeeeeeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER----------------ERLDLLQELTVMKTLDPHPNVVRLLGCC   65 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~e~~~~~~~~~~~~i~~~~~~~   65 (225)
                      |.|| +||++..       +++.||+|.+.......                ....+.+|+.++.++. ||||+++++++
T Consensus        42 G~~g-~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~  112 (348)
T 2pml_X           42 GKFN-KIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGII  112 (348)
T ss_dssp             CSSC-CEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTBCCCSEEE
T ss_pred             CCCe-EEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCcceEEEEE
Confidence            8899 9999982       78999999997543211                1156889999999998 99999999999


Q ss_pred             ecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecC
Q psy15818         66 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGE  144 (225)
Q Consensus        66 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~  144 (225)
                      .+.+..++||||+++++|.+++.......     ......+++..++.++.|++.||.+||+ .|++|+||+|+||+++.
T Consensus       113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~-----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          113 TNYDEVYIIYEYMENDSILKFDEYFFVLD-----KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             ESSSEEEEEEECCTTCBSSEESSSEESSC-----SSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             eeCCeEEEEEeccCCCcHHHHHHHhhhhh-----hccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999987732110000     0013468999999999999999999999 99999999999999999


Q ss_pred             CCceeEeeecccccccCccccccccCCCCCccccCCccccCC-CCCc-chhHHHHHHHHHHHHHcCCCCCCCCCH-HHHh
Q psy15818        145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSV-KSDIWSFGVLIWEIVTLGSTPYPGMAA-AEVM  221 (225)
Q Consensus       145 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~Di~slg~ll~~l~~~g~~p~~~~~~-~~~~  221 (225)
                      ++.++|+|||.+......    ......+++.|+|||.+.+. .++. ++|+||+|+++++|++ |..||...+. .+..
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY-NVVPFSLKISLVELF  262 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH-SSCSSCCSSCSHHHH
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Confidence            999999999998755333    23445678889999999877 5555 9999999999999999 9999988776 5555


Q ss_pred             hh
Q psy15818        222 KK  223 (225)
Q Consensus       222 ~~  223 (225)
                      .+
T Consensus       263 ~~  264 (348)
T 2pml_X          263 NN  264 (348)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.4e-37  Score=240.66  Aligned_cols=185  Identities=23%  Similarity=0.450  Sum_probs=158.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--------------
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--------------   67 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--------------   67 (225)
                      |.|| .||++..     ..+++.||+|.++....     ...+|+.++..+. ||||+++++++..              
T Consensus        22 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           22 GGFG-QVFKAKH-----RIDGKTYVIKRVKYNNE-----KAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             SSSC-CEEEEEE-----TTTCCEEEEEEEECCSG-----GGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC---------C
T ss_pred             CCce-EEEEEEE-----cCCCeEEEEEEeccccH-----HHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccccccccc
Confidence            8899 9999984     56789999999975432     4668999999998 9999999998854              


Q ss_pred             --CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC
Q psy15818         68 --KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN  145 (225)
Q Consensus        68 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~  145 (225)
                        ....++||||+++++|.+++...+           ...+++..++.++.|++.||.+||++|++|+||||+||+++++
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR-----------GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG-----------GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence              345899999999999999997642           2358899999999999999999999999999999999999999


Q ss_pred             CceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        146 HCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       146 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      +.++|+|||++.......   ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..|+.
T Consensus       159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~  222 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-VCDTAF  222 (284)
T ss_dssp             TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-CCSSHH
T ss_pred             CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-cCCcch
Confidence            999999999987554332   2233457888999999998889999999999999999999 887774

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.4e-37  Score=249.67  Aligned_cols=189  Identities=24%  Similarity=0.338  Sum_probs=157.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC-------CCCCeeeeeeEEe----cCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-------PHPNVVRLLGCCT----EKEP   70 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~-------~~~~i~~~~~~~~----~~~~   70 (225)
                      |.|| +||++.     +..+++.||+|+++..  ......+.+|+.+++.+.       +||||+++++++.    ....
T Consensus        48 G~~g-~V~~~~-----~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~  119 (397)
T 1wak_A           48 GHFS-TVWLSW-----DIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH  119 (397)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred             cCCe-eEEEEE-----ecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence            8899 999997     3567899999999754  233456788999998885       2788999999987    5567


Q ss_pred             eEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCC---
Q psy15818         71 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENH---  146 (225)
Q Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~---  146 (225)
                      .++||||+ ++++.+.+...           ....+++..++.++.|++.||.|||++ |++||||||+||+++.++   
T Consensus       120 ~~lv~e~~-~~~l~~~~~~~-----------~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          120 ICMVFEVL-GHHLLKWIIKS-----------NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEECCC-CCBHHHHHHHT-----------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             EEEEEecc-CccHHHHHHhc-----------ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            99999999 56676666543           123589999999999999999999998 999999999999998664   


Q ss_pred             ----------------------------------------------ceeEeeecccccccCccccccccCCCCCccccCC
Q psy15818        147 ----------------------------------------------CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAP  180 (225)
Q Consensus       147 ----------------------------------------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~P  180 (225)
                                                                    .++|+|||.+......     .....+|+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                          7999999998654322     2344678899999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        181 ESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       181 E~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      |++.+..++.++||||||+++|+|++ |..||...+
T Consensus       263 E~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  297 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELAT-GDYLFEPHS  297 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCCCCCc
Confidence            99999999999999999999999999 999998665

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.9e-37  Score=254.39  Aligned_cols=193  Identities=19%  Similarity=0.278  Sum_probs=163.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++.     +..+++.||||++.......   .+.+|+.++..+..++++..+..++......++||||+ ++
T Consensus        18 G~fG-~Vy~a~-----~~~~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~   87 (483)
T 3sv0_A           18 GSFG-EIYLGT-----NIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP   87 (483)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             CCCE-EEEEEE-----ECCCCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence            8899 999998     35678999999887544332   47789999999986677777777778888899999999 89


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe---cCCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI---GENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~---~~~~~~~l~d~g~~~~  158 (225)
                      +|.+++...            ...+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++..
T Consensus        88 sL~~ll~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           88 SLEDLFNFC------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             BHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999999753            2368999999999999999999999999999999999999   5788999999999976


Q ss_pred             ccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        159 LMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       159 ~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .......     .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  218 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccc
Confidence            5443321     12225567889999999999999999999999999999999 9999987554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.8e-37  Score=242.37  Aligned_cols=195  Identities=23%  Similarity=0.423  Sum_probs=158.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe----cCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT----EKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~----~~~~~~lv~e~   77 (225)
                      |.|| +||++.     +..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.    .....++|+||
T Consensus        40 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~  111 (317)
T 2buj_A           40 GGFS-YVDLVE-----GLHDGHFYALKRILCHE-QQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHEAWLLLPF  111 (317)
T ss_dssp             --CE-EEEEEE-----ETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred             CCCe-EEEEEE-----ecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCceeEEEEEe
Confidence            7899 999998     35678999999986533 344557889999999997 999999999986    34478999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +.+++|.+++.....         ....+++.+++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus       112 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          112 FKRGTLWNEIERLKD---------KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             CTTCBHHHHHHHHHT---------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             CCCCcHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999986532         12468999999999999999999999999999999999999999999999999876


Q ss_pred             cccCccccc-------cccCCCCCccccCCccccCCC---CCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        158 DLMTSSVYE-------RKSEGRLPIRWMAPESLYDNI---FSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       158 ~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      .........       ......+++.|+|||.+.+..   ++.++|+||||+++|+|++ |..||..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~  248 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-GEGPYDM  248 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH-SSCTTHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh-CCCChhh
Confidence            442211110       111233577899999887654   6889999999999999999 9999953

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-36  Score=259.44  Aligned_cols=195  Identities=26%  Similarity=0.431  Sum_probs=167.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec------CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE------KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------~~~~~lv~   75 (225)
                      |+|| +||++.     +..+|+.||+|+++.........++.+|+.++..+. ||||+++++++..      .+..++||
T Consensus        25 G~fG-~Vyla~-----~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~~~~~LVm   97 (676)
T 3qa8_A           25 GGFG-YVLRWI-----HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAM   97 (676)
T ss_dssp             CSSS-BCCCCC-----CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCCCeEEEEE
Confidence            8899 999998     467789999999987666666778999999999998 9999999999765      67789999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCc---eeEee
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHC---CKVAD  152 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~---~~l~d  152 (225)
                      ||++|++|.+++....          ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.   ++|+|
T Consensus        98 Ey~~ggsL~~~L~~~~----------~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           98 EYCEGGDLRKYLNQFE----------NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             ECCSSCBHHHHHHSSS----------CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             EeCCCCCHHHHHHhcc----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            9999999999997532          2235889999999999999999999999999999999999986554   89999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      ||.+.......   ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+...
T Consensus       168 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt-G~~Pf~~~~~  228 (676)
T 3qa8_A          168 LGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQ  228 (676)
T ss_dssp             CCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS-SCSSCCSSCH
T ss_pred             ccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH-CCCCCCcccc
Confidence            99997654332   2234567888999999999999999999999999999999 9999976543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.4e-37  Score=241.19  Aligned_cols=185  Identities=32%  Similarity=0.614  Sum_probs=151.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |.|| +||++..       .++.||+|.+...   .....+.+|+.++.++. ||||+++++++.+  ..++||||++++
T Consensus        19 G~~g-~V~~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A           19 GAFG-VVCKAKW-------RAKDVAIKQIESE---SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             CSSS-EEEEEEE-------TTEEEEEEECSST---THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             CCCc-eEEEEEE-------CCeeEEEEEecCh---hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            8999 9999983       3688999998643   23456889999999998 9999999998774  479999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCCEEecCCCc-eeEeeecccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS---RGIIHRDLAARNVLIGENHC-CKVADFGFAR  157 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~---~~i~h~dl~~~nil~~~~~~-~~l~d~g~~~  157 (225)
                      +|.+++....          ....+++..++.++.|+++||.+||+   +|++|+||||+||+++.++. ++|+|||++.
T Consensus        85 ~L~~~l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           85 SLYNVLHGAE----------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             BHHHHHHCSS----------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             CHHHHHhccC----------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            9999997532          11246889999999999999999999   89999999999999987776 7999999986


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .....     .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||....
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  207 (307)
T 2eva_A          155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIG  207 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH-TCCTTTTTC
T ss_pred             ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH-CCCCchhhC
Confidence            44322     223357888999999999899999999999999999999 999998543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.6e-37  Score=243.32  Aligned_cols=186  Identities=26%  Similarity=0.441  Sum_probs=150.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhh--cCCCCCeeeeeeEEec----CCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKT--LDPHPNVVRLLGCCTE----KEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~--~~~~~~i~~~~~~~~~----~~~~~lv~   75 (225)
                      |.|| +||++..       +++.||||++.....    ....+|..++..  +. ||||+++++++.+    ....++||
T Consensus        19 G~~g-~V~~~~~-------~~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A           19 GRYG-EVWRGSW-------QGENVAVKIFSSRDE----KSWFRETELYNTVMLR-HENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             CSSE-EEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             CCCc-EEEEEEE-------CCEEEEEEEeccccc----hhhHHHHHHHHHhhcc-CcCeeeEEEeeccccCCCceeEEeh
Confidence            8999 9999973       588999999875432    234455555555  66 9999999998644    34589999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEecCCCc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS--------SRGIIHRDLAARNVLIGENHC  147 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh--------~~~i~h~dl~~~nil~~~~~~  147 (225)
                      ||+++++|.+++..              ..+++..++.++.|++.||.|||        +.+++|+||||+||+++.++.
T Consensus        86 e~~~~g~L~~~l~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           86 HYHEMGSLYDYLQL--------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             CCCTTCBHHHHHTT--------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             hhccCCCHHHHHhh--------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence            99999999999943              25899999999999999999999        999999999999999999999


Q ss_pred             eeEeeecccccccCccccc--cccCCCCCccccCCccccCC------CCCcchhHHHHHHHHHHHHHcC----------C
Q psy15818        148 CKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDN------IFSVKSDIWSFGVLIWEIVTLG----------S  209 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slg~ll~~l~~~g----------~  209 (225)
                      ++|+|||++..........  ......+|+.|+|||++.+.      .++.++|+||+|+++|+|++ |          .
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~  230 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYK  230 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh-hhcCcccccccc
Confidence            9999999986543332221  12334678899999998876      34468999999999999999 8          8


Q ss_pred             CCCCCC
Q psy15818        210 TPYPGM  215 (225)
Q Consensus       210 ~p~~~~  215 (225)
                      .||.+.
T Consensus       231 ~pf~~~  236 (301)
T 3q4u_A          231 PPFYDV  236 (301)
T ss_dssp             CTTTTT
T ss_pred             cccccc
Confidence            888653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=249.48  Aligned_cols=194  Identities=17%  Similarity=0.212  Sum_probs=156.5

Q ss_pred             CcccceeeecCCCCCCC---CccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeee---------------eee
Q psy15818          2 DCFSVEVRKHPMSPERG---REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR---------------LLG   63 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~---------------~~~   63 (225)
                      |.|| +||++.......   ...++.||+|.+...      ..+.+|+.++.++. |||+++               +++
T Consensus        53 G~~g-~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~i~~~~~  124 (352)
T 2jii_A           53 DNQG-ILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLLAIPTCMG  124 (352)
T ss_dssp             ETTE-EEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTCSCCCCCE
T ss_pred             CCCe-EEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhc-ccchhhhhhhhccCCccCccchhh
Confidence            7899 999998532110   114889999998754      25778899999997 988887               566


Q ss_pred             EEec-CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe
Q psy15818         64 CCTE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI  142 (225)
Q Consensus        64 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~  142 (225)
                      ++.. .+..++||||+ +++|.+++...+           ...+++.+++.++.|++.||.|||++|++|+||||+||++
T Consensus       125 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          125 FGVHQDKYRFLVLPSL-GRSLQSALDVSP-----------KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             EEEETTTEEEEEEECC-CEEHHHHHHHSG-----------GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             ccccCCcEEEEEecCC-CcCHHHHHHhCC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence            6665 67889999999 899999998642           2368999999999999999999999999999999999999


Q ss_pred             cCCC--ceeEeeecccccccCccccc-----cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        143 GENH--CCKVADFGFARDLMTSSVYE-----RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       143 ~~~~--~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      +.++  .++|+|||++..........     ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY-GFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCcccC
Confidence            9887  89999999997654332211     1233467889999999999899999999999999999999 99999876


Q ss_pred             C
Q psy15818        216 A  216 (225)
Q Consensus       216 ~  216 (225)
                      .
T Consensus       272 ~  272 (352)
T 2jii_A          272 L  272 (352)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-37  Score=244.41  Aligned_cols=191  Identities=25%  Similarity=0.454  Sum_probs=155.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |.|| +||++.     ...+++.||||++....       .......+.+|+.++..+. ||||+++++++.... .++|
T Consensus        21 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~lv   92 (322)
T 2ycf_A           21 GACG-EVKLAF-----ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDAED-YYIV   92 (322)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEESSS-EEEE
T ss_pred             CCCE-EEEEEE-----EcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEcCCc-eEEE
Confidence            8899 999998     35678999999986532       1223345789999999997 999999999987655 8999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC---ceeEe
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH---CCKVA  151 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~---~~~l~  151 (225)
                      |||+++++|.+.+...             ..+++..++.++.|++.||.+||++|++|+||||+||+++.++   .++|+
T Consensus        93 ~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           93 LELMEGGELFDKVVGN-------------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             EECCTTEETHHHHSTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             EecCCCCcHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence            9999999999888532             3689999999999999999999999999999999999998655   49999


Q ss_pred             eecccccccCccccccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      |||++.........   ....+++.|+|||++.   ...++.++|+||||+++|+|++ |..||.....
T Consensus       160 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~  224 (322)
T 2ycf_A          160 DFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRT  224 (322)
T ss_dssp             CCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTC
T ss_pred             cCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccch
Confidence            99998755433211   1234677899999874   4567899999999999999999 9999976543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.6e-36  Score=240.50  Aligned_cols=195  Identities=27%  Similarity=0.494  Sum_probs=144.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHH-HHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELT-VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..     ..+++.||+|+++.............|+. +++.+. ||||+++++++.+.+..++||||+.+
T Consensus        33 G~~g-~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~-h~niv~~~~~~~~~~~~~lv~e~~~~  105 (327)
T 3aln_A           33 GAYG-SVNKMVH-----KPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD-CPYIVQFYGALFREGDCWICMELMST  105 (327)
T ss_dssp             CSSE-EEEEEEE-----TTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCC-CTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred             CCCE-EEEEEEE-----cCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCC-CCcEeeeeeEEEeCCceEEEEeecCC
Confidence            8899 9999983     56799999999987655555556667776 445555 99999999999999999999999984


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                       +|.+++......        ....+++..++.++.|++.||.+||+. |++|+||||+||+++.++.++|+|||++...
T Consensus       106 -~l~~~~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          106 -SFDKFYKYVYSV--------LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             -EHHHHHHHHHHT--------TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             -ChHHHHHHHHhh--------hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence             888887653211        124689999999999999999999999 9999999999999999999999999998755


Q ss_pred             cCccccccccCCCCCccccCCccc----cCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESL----YDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .....   .....+++.|+|||.+    .+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  233 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWN  233 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence            33221   2233577889999998    45668899999999999999999 999998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-36  Score=243.29  Aligned_cols=196  Identities=20%  Similarity=0.315  Sum_probs=161.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCC------eeeeeeEEecCCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN------VVRLLGCCTEKEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~------i~~~~~~~~~~~~~~lv~   75 (225)
                      |.|| +||++...    ..+++.||+|+++...  .....+.+|+.+++.+. |++      ++.+.+++...+..++||
T Consensus        30 G~~g-~V~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T 2eu9_A           30 GTFG-KVVECLDH----ARGKSQVALKIIRNVG--KYREAARLEINVLKKIK-EKDKENKFLCVLMSDWFNFHGHMCIAF  101 (355)
T ss_dssp             ETTE-EEEEEEET----TTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             cCCe-EEEEEEec----CCCceEEEEEEEcccc--cchhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence            7899 99999841    2334799999997532  33446778888888886 554      999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEe-------------
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI-------------  142 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~-------------  142 (225)
                      ||+ ++++.+.+...           ....+++..++.++.|++.||.+||++|++|+||||+||++             
T Consensus       102 e~~-~~~l~~~l~~~-----------~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A          102 ELL-GKNTFEFLKEN-----------NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             ECC-CCBHHHHHHHT-----------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             ecc-CCChHHHHHhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            999 57777777653           12358999999999999999999999999999999999999             


Q ss_pred             ------cCCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        143 ------GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       143 ------~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                            +.++.++|+|||++.....     ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  243 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR-GFTLFQTHE  243 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Confidence                  5678899999999864322     2234467889999999999999999999999999999999 999999888


Q ss_pred             HHHHhhh
Q psy15818        217 AAEVMKK  223 (225)
Q Consensus       217 ~~~~~~~  223 (225)
                      ..+.+..
T Consensus       244 ~~~~~~~  250 (355)
T 2eu9_A          244 NREHLVM  250 (355)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            7765543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=242.35  Aligned_cols=196  Identities=35%  Similarity=0.629  Sum_probs=162.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC--CeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~   79 (225)
                      |.|| +||++... ..+..+++.||+|.+.... ......+.+|+.++.+++ ||||+++++++...+  ..++||||++
T Consensus        52 G~~g-~V~~~~~~-~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~  127 (326)
T 2w1i_A           52 GNFG-SVEMCRYD-PLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLP  127 (326)
T ss_dssp             CSSE-EEEEEEEC-TTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC----CCEEEECCCT
T ss_pred             CCCe-EEEEEEec-cccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecCCCceEEEEECCC
Confidence            8899 99998742 2234578999999997643 344457889999999998 999999999986644  7899999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...            ...+++..++.++.|+++||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       128 ~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          128 YGSLRDYLQKH------------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             TCBHHHHHHHS------------TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            99999999763            235899999999999999999999999999999999999999999999999999765


Q ss_pred             cCccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        160 MTSSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       160 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ....... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||..
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~  250 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKS  250 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHH-TTCGGGS
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHh-cCCCCCC
Confidence            4433221 2233455667999999988888999999999999999999 9888864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.1e-36  Score=238.67  Aligned_cols=192  Identities=24%  Similarity=0.392  Sum_probs=155.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCC-CCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++..      .+++.||+|++... ........+.+|+.++.++.. ||||+++++++.+.+..+++|| +.
T Consensus        39 G~~g-~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~  110 (313)
T 3cek_A           39 GGSS-KVFQVLN------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG  110 (313)
T ss_dssp             CSSE-EEEEEEC------TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred             CCCE-EEEEEEc------CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence            8999 9999984      34889999999754 344555678899999999973 6999999999999999999999 55


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++...             ..+++..++.++.|+++||.+||++|++|+||||+||++++ +.++|+|||++...
T Consensus       111 ~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          111 NIDLNSWLKKK-------------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             SEEHHHHHHHC-------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             CCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            78999999753             25789999999999999999999999999999999999964 78999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccC-----------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD-----------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                      .............+++.|+|||.+.+           ..++.++|+||||+++|+|++ |..||....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  243 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII  243 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhhHH
Confidence            44333222334457889999998865           467889999999999999999 999998654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-36  Score=240.85  Aligned_cols=187  Identities=25%  Similarity=0.483  Sum_probs=149.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhc-CCCCCeeeeeeEEecC----CCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL-DPHPNVVRLLGCCTEK----EPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~----~~~~lv~e   76 (225)
                      |.|| +||++..       .++.||+|++.....    ....+|..++... ..||||+++++++...    ...++|||
T Consensus        48 G~~g-~V~~~~~-------~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           48 GRYG-EVWMGKW-------RGEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             ETTE-EEEEEEE-------TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             CCCe-EEEEEEE-------CCceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            7899 9999983       388999999865332    2334455555443 1499999999998876    67999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEecCCCce
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR--------GIIHRDLAARNVLIGENHCC  148 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--------~i~h~dl~~~nil~~~~~~~  148 (225)
                      |+++++|.+++...              .+++..++.++.|++.||.|||++        |++|+||||+||+++.++.+
T Consensus       116 ~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          116 YHENGSLYDYLKST--------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             CCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             ccCCCcHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            99999999999653              589999999999999999999999        99999999999999999999


Q ss_pred             eEeeecccccccCccccc--cccCCCCCccccCCccccCCCCCcc------hhHHHHHHHHHHHHHcC----------CC
Q psy15818        149 KVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVK------SDIWSFGVLIWEIVTLG----------ST  210 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~------~Di~slg~ll~~l~~~g----------~~  210 (225)
                      +|+|||++..........  ......+|+.|+|||++.+......      +|+||+|+++|+|++ |          ..
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~~~~~~~~~~~  260 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQL  260 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCC
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh-ccCcccccccccc
Confidence            999999986553332221  1224467889999999987766554      999999999999999 8          77


Q ss_pred             CCCCC
Q psy15818        211 PYPGM  215 (225)
Q Consensus       211 p~~~~  215 (225)
                      ||...
T Consensus       261 p~~~~  265 (337)
T 3mdy_A          261 PYHDL  265 (337)
T ss_dssp             TTTTT
T ss_pred             cHhhh
Confidence            77653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.6e-37  Score=245.39  Aligned_cols=191  Identities=24%  Similarity=0.387  Sum_probs=135.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~   77 (225)
                      |.|| +||++.     +..+++.||+|++....      ...+|+....+..+|||++++++++..    ....++||||
T Consensus        40 G~~g-~V~~~~-----~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  107 (336)
T 3fhr_A           40 GVNG-KVLECF-----HRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC  107 (336)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence            7899 999998     35679999999986532      123334433333359999999999876    4458999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeec
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFG  154 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g  154 (225)
                      +++++|.+++...           ....+++.+++.++.|++.||.+||++|++|+||||+||+++.   ++.++|+|||
T Consensus       108 ~~gg~L~~~l~~~-----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          108 MEGGELFSRIQER-----------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             CTTEEHHHHHHTC------------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             cCCCCHHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            9999999999753           2235899999999999999999999999999999999999975   4559999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ++......    ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+......
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~  237 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAI  237 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHH-SSCCC--------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCccchhh
Confidence            98654322    1233456788999999988888999999999999999999 9999977665543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-36  Score=249.71  Aligned_cols=198  Identities=24%  Similarity=0.316  Sum_probs=148.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||.+.      ..+|+.||||.+....    .....+|+.++.++..||||+++++++.+.+..++||||+. +
T Consensus        26 G~~g-~V~~~~------~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           26 GSSG-TVVFQG------SFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             CSTT-CEEEEE------ESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             CCCe-EEEEEE------EECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            8999 887654      3568999999987532    23467899999887559999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-------------Cce
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-------------HCC  148 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-------------~~~  148 (225)
                      +|.+++........      .....++..++.++.|++.||.|||++|++|+||||+||+++..             ..+
T Consensus        94 sL~~~l~~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           94 NLQDLVESKNVSDE------NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             EHHHHHHTC------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             CHHHHHhccCCCch------hhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99999975431110      00112445678899999999999999999999999999999643             479


Q ss_pred             eEeeecccccccCcccc--ccccCCCCCccccCCccccC-------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        149 KVADFGFARDLMTSSVY--ERKSEGRLPIRWMAPESLYD-------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      +|+|||++.........  .......+|+.|+|||++.+       ..++.++||||+|+++|+|+++|..||.+...
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            99999999765443211  11233467889999999875       56789999999999999999878999976543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.6e-36  Score=236.63  Aligned_cols=184  Identities=26%  Similarity=0.458  Sum_probs=149.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-------------C
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-------------K   68 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-------------~   68 (225)
                      |.|| +||++.     +..+++.||+|.+...  ......+.+|+.++.++. ||||+++++++.+             .
T Consensus        17 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (303)
T 1zy4_A           17 GAFG-QVVKAR-----NALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKK   87 (303)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC------CE
T ss_pred             CCcE-EEEEEE-----EcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhhcccccC
Confidence            8899 999998     3567899999999653  334457889999999998 9999999998754             3


Q ss_pred             CCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCce
Q psy15818         69 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCC  148 (225)
Q Consensus        69 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~  148 (225)
                      +..++||||+++++|.+++...            ...+++..++.++.|+++||.+||++|++|+||||+||+++.++.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           88 STLFIQMEYCENGTLYDLIHSE------------NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHS------------CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred             CceEEEEecCCCCCHHHhhhcc------------ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence            5689999999999999999753            2246889999999999999999999999999999999999999999


Q ss_pred             eEeeecccccccCccc------------cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHH
Q psy15818        149 KVADFGFARDLMTSSV------------YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       149 ~l~d~g~~~~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~  206 (225)
                      +|+|||.+........            ........+++.|+|||.+.+. .++.++|+||+|+++|+|++
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            9999999875532211            1122334567889999998765 68999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.7e-36  Score=236.59  Aligned_cols=196  Identities=26%  Similarity=0.487  Sum_probs=145.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHH-HHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELT-VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++..     ..+++.||+|.+..........+...|+. ++..+. ||||+++++++.+.+..++||||+ +
T Consensus        36 G~~g-~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lv~e~~-~  107 (318)
T 2dyl_A           36 GTCG-QVWKMRF-----RKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVFIAMELM-G  107 (318)
T ss_dssp             -----CEEEEEE-----TTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred             cCCe-eEEEEEE-----ecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecc-C
Confidence            7899 9999984     56789999999986654444444444544 455565 999999999999999999999999 5


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ..+..+....            ...+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus       108 ~~~~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          108 TCAEKLKKRM------------QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcHHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            6666555432            23589999999999999999999996 9999999999999999999999999998654


Q ss_pred             cCccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHh
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGM-AAAEVM  221 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~-~~~~~~  221 (225)
                      ....   ......+++.|+|||.+.     +..++.++|+||+|+++|+|++ |..||... ...+.+
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~  239 (318)
T 2dyl_A          176 VDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVL  239 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHH
T ss_pred             cCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccHHHH
Confidence            3322   122345678899999984     4567889999999999999999 99999873 333333

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-36  Score=246.71  Aligned_cols=194  Identities=23%  Similarity=0.345  Sum_probs=149.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +|+...      ..+++.||||++......    ...+|+.+++.+..||||+++++++.+.+..++|||++. +
T Consensus        35 G~~G-~V~~~~------~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           35 GAEG-TIVYRG------MFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             CGGG-CEEEEE------ESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             CcCE-EEEEEE------EeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            8899 765433      356889999998654322    256789999998569999999999999999999999996 6


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---C--CceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---N--HCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~--~~~~l~d~g~~  156 (225)
                      +|.+++...            .....+..++.++.|++.||.|||+.||+||||||+||+++.   +  ..++|+|||++
T Consensus       103 ~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A          103 TLQEYVEQK------------DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EHHHHHHSS------------SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             CHHHHHHhc------------CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            999998753            223556677899999999999999999999999999999952   2  35779999999


Q ss_pred             ccccCccc-cccccCCCCCccccCCcccc---CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        157 RDLMTSSV-YERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       157 ~~~~~~~~-~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ........ ........+|+.|+|||++.   ...++.++||||+|+++|+|+++|..||.......
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~  237 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ  237 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence            76543321 12233456889999999987   45667899999999999999998999997655443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=244.39  Aligned_cols=185  Identities=25%  Similarity=0.413  Sum_probs=144.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-----CCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-----KEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e   76 (225)
                      |.|| +||++.       .+++.||+|++........  ....++..+..+. ||||+++++.+..     ...+++|||
T Consensus        24 G~~g-~Vy~~~-------~~~~~vavK~~~~~~~~~~--~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           24 GRYG-AVYKGS-------LDERPVAVKVFSFANRQNF--INEKNIYRVPLME-HDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             CSSE-EEEEEE-------ETTEEEEEEEEEGGGHHHH--HHHHHHHTSTTCC-CTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             CCCe-EEEEEE-------ECCeEEEEEEeeccchhhH--HHHHHHHHHHhcc-CcchhhheecccccccCCCceEEEEEe
Confidence            8999 999996       3578999999975432221  2233444444566 9999999986532     335789999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCEEecCCCc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---------GIIHRDLAARNVLIGENHC  147 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~---------~i~h~dl~~~nil~~~~~~  147 (225)
                      |+++++|.+++...              ..++..++.++.|+++||.|||+.         |++|+||||+||+++.++.
T Consensus        93 ~~~~g~L~~~l~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           93 YYPNGSLXKYLSLH--------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             cCCCCcHHHHHhhc--------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence            99999999999654              358889999999999999999999         9999999999999999999


Q ss_pred             eeEeeecccccccCccc------cccccCCCCCccccCCccccC-------CCCCcchhHHHHHHHHHHHHHcCCCCC
Q psy15818        148 CKVADFGFARDLMTSSV------YERKSEGRLPIRWMAPESLYD-------NIFSVKSDIWSFGVLIWEIVTLGSTPY  212 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slg~ll~~l~~~g~~p~  212 (225)
                      ++|+|||++........      ........+|+.|+|||++.+       ..++.++||||||+++|+|++ |..||
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~  235 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDL  235 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT-TBGGG
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh-cCCcC
Confidence            99999999976543221      122224457889999999876       345678999999999999999 64444

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6e-36  Score=239.57  Aligned_cols=186  Identities=26%  Similarity=0.456  Sum_probs=154.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhh--cCCCCCeeeeeeEEecCC----CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKT--LDPHPNVVRLLGCCTEKE----PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~--~~~~~~i~~~~~~~~~~~----~~~lv~   75 (225)
                      |.|| +||++..       .++.||+|++....    ...+.+|..++..  +. ||||+++++++....    ..++||
T Consensus        53 G~~g-~Vy~~~~-------~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           53 GRFG-EVWRGKW-------RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             ETTE-EEEEEEE-------TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCC-CTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             CCCc-EEEEEEE-------cCccEEEEEeCchh----HHHHHHHHHHHHHhhcC-CCcEEEEEeeecccCCccceeEEEE
Confidence            7899 9999983       48899999997532    2346678888777  55 999999999998776    799999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEecCCCc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS--------SRGIIHRDLAARNVLIGENHC  147 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh--------~~~i~h~dl~~~nil~~~~~~  147 (225)
                      ||+++++|.+++...              .+++..++.++.|++.||.+||        +.+++|+||||+||+++.+++
T Consensus       120 e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CCCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             eecCCCcHHHHHhcc--------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence            999999999999653              4789999999999999999999        899999999999999999999


Q ss_pred             eeEeeecccccccCccccc--cccCCCCCccccCCccccCCC------CCcchhHHHHHHHHHHHHHcC----------C
Q psy15818        148 CKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNI------FSVKSDIWSFGVLIWEIVTLG----------S  209 (225)
Q Consensus       148 ~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slg~ll~~l~~~g----------~  209 (225)
                      ++|+|||++..........  ......+++.|+|||.+.+..      ++.++|+||||+++|+|++ |          .
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~  264 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQ  264 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh-ccCcCCcccccc
Confidence            9999999987553332211  233446788999999987653      2368999999999999999 8          7


Q ss_pred             CCCCCC
Q psy15818        210 TPYPGM  215 (225)
Q Consensus       210 ~p~~~~  215 (225)
                      .||.+.
T Consensus       265 ~p~~~~  270 (342)
T 1b6c_B          265 LPYYDL  270 (342)
T ss_dssp             CTTTTT
T ss_pred             cCcccc
Confidence            898765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-36  Score=241.23  Aligned_cols=190  Identities=22%  Similarity=0.363  Sum_probs=160.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----HHHHHHHHHHHHHhhcC-CCCCeeeeeeEEecCCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~   75 (225)
                      |.|| +||++.     ...+++.||+|.+......     .....+.+|+.++.++. +|||++++++++...+..++++
T Consensus        54 G~~g-~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~  127 (320)
T 3a99_A           54 GGFG-SVYSGI-----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL  127 (320)
T ss_dssp             SSSC-EEEEEE-----ETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence            8899 999997     3567899999999764321     12234667899999987 3799999999999999999999


Q ss_pred             eecCC-CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeee
Q psy15818         76 EYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADF  153 (225)
Q Consensus        76 e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~  153 (225)
                      |++.+ ++|.+++...             ..+++..++.++.|+++||.+||+.|++|+||||+||+++ +++.++|+||
T Consensus       128 e~~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          128 ERPEPVQDLFDFITER-------------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             ECCSSEEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EcCCCCccHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            99976 8999998764             2589999999999999999999999999999999999998 7889999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      |++.......    .....+++.|+|||++.+..+ +.++|+||||+++|+|++ |..||...
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~  252 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHD  252 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred             cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH-CCCCCCCh
Confidence            9987553321    233457888999999877665 678999999999999999 99999754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-36  Score=243.49  Aligned_cols=189  Identities=21%  Similarity=0.316  Sum_probs=155.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC----------CCCCeeeeeeEEecCC--
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----------PHPNVVRLLGCCTEKE--   69 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~----------~~~~i~~~~~~~~~~~--   69 (225)
                      |.|| +||++.     +..+++.||+|++....  .......+|+.++.++.          +||||+++++++...+  
T Consensus        30 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  101 (373)
T 1q8y_A           30 GHFS-TVWLAK-----DMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN  101 (373)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred             cCCe-EEEEEE-----ecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence            8899 999998     45779999999997533  23345778888887765          2789999999987654  


Q ss_pred             --CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEec---
Q psy15818         70 --PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLIG---  143 (225)
Q Consensus        70 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~i~h~dl~~~nil~~---  143 (225)
                        ..+++||++ +++|.+++....           ...+++..++.++.|++.||.+||++ |++|+||||+||+++   
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A          102 GVHVVMVFEVL-GENLLALIKKYE-----------HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEEEECCC-CEEHHHHHHHTT-----------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             CceEEEEEecC-CCCHHHHHHHhh-----------ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence              689999999 899999997642           23589999999999999999999998 999999999999994   


Q ss_pred             ---CCCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        144 ---ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       144 ---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                         ..+.++|+|||++......     .....+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  239 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDE  239 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC----
T ss_pred             CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCc
Confidence               3347999999998654322     234467889999999999999999999999999999999 999998665

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-36  Score=260.53  Aligned_cols=183  Identities=17%  Similarity=0.245  Sum_probs=154.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCC-----eEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----FFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~e   76 (225)
                      |.|| +||++...    ..+++.||||.+...........+.+|+.++.++. ||||+++++++...+.     .++|||
T Consensus        91 G~~g-~Vy~a~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~lv~E  164 (681)
T 2pzi_A           91 GGLG-WIYLALDR----NVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVME  164 (681)
T ss_dssp             ETTE-EEEEEEEG----GGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred             CCCe-EEEEEEEc----CCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCCceeEEEEE
Confidence            7899 99999841    22689999999876655666667889999999998 9999999999987665     799999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |++|++|.+.+..               .+++.+++.++.|++++|.|||++||+|+||||+||+++.+ .++|+|||++
T Consensus       165 ~~~g~~L~~~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          165 YVGGQSLKRSKGQ---------------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             CCCCEECC----C---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eCCCCcHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence            9999999876642               58999999999999999999999999999999999999875 8999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      ......      ....+|+.|+|||++.+.. +.++||||||+++++|++ |..||.+
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~-g~~~~~~  278 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL-DLPTRNG  278 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHS-CCCEETT
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHh-CCCCCcc
Confidence            654322      3455788999999887654 889999999999999999 9988865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=241.83  Aligned_cols=198  Identities=21%  Similarity=0.335  Sum_probs=158.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |.|| +||++...        ..||+|.++... .......+.+|+.++.++. ||||+++++++.+.+..++++||+++
T Consensus        44 G~~g-~V~~~~~~--------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~  113 (319)
T 2y4i_B           44 GRFG-QVYHGRWH--------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKG  113 (319)
T ss_dssp             SSSS-EEEEEEES--------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred             CCce-EEEEEEEc--------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEEEeecccC
Confidence            8899 99999841        248999987542 2222335678899999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..++.++.|++.||.+||++|++|+||||+||+++ ++.++|+|||++....
T Consensus       114 ~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          114 RTLYSVVRDA------------KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             EEHHHHTTSS------------CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999998542            23589999999999999999999999999999999999998 5789999999876432


Q ss_pred             Ccc---ccccccCCCCCccccCCccccC---------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSS---VYERKSEGRLPIRWMAPESLYD---------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~---~~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...   .........+++.|+|||.+.+         ..++.++|+||||+++|+|++ |..||.+....+...+
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~  254 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQPAEAIIWQ  254 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSSCCHHHHHHH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            211   1122233457788999998864         346889999999999999999 9999999888776654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-36  Score=236.48  Aligned_cols=190  Identities=25%  Similarity=0.438  Sum_probs=153.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----HHHHHHHHHHHHHhhcC---CCCCeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLD---PHPNVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~~~~~~---~~~~i~~~~~~~~~~~~~~l   73 (225)
                      |.|| +||++.     +..+++.||+|++......     .......+|+.++.++.   .||||+++++++.+.+..++
T Consensus        42 G~~g-~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~  115 (312)
T 2iwi_A           42 GGFG-TVFAGH-----RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML  115 (312)
T ss_dssp             ETTE-EEEEEE-----CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred             CCCE-EEEEEE-----EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence            7899 999998     3567899999999754321     12234567888888882   39999999999999999999


Q ss_pred             EEee-cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEe
Q psy15818         74 IMEY-VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVA  151 (225)
Q Consensus        74 v~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~  151 (225)
                      |+|+ +.+++|.+++...             ..+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+
T Consensus       116 v~e~~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          116 VLERPLPAQDLFDYITEK-------------GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EEECCSSEEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence            9999 7889999999764             2589999999999999999999999999999999999998 78899999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      |||++.......    .....+++.|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~  242 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-GDIPFERD  242 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH-CCCCCCCh
Confidence            999987554322    234457788999998877665 458999999999999999 99999753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.2e-35  Score=228.23  Aligned_cols=166  Identities=14%  Similarity=0.123  Sum_probs=143.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |.|| +||++.     +..+++.||+|++....  .......+.+|+..+.++. ||||+++++++.+.+..++||||++
T Consensus        42 G~~g-~Vy~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~  114 (286)
T 3uqc_A           42 VPPL-QFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIR  114 (286)
T ss_dssp             STTC-EEEEEE-----ETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             cCCe-EEEEEE-----ecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcEEEEEEecC
Confidence            8899 999998     35678999999998653  2445567889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++..               ...+.++..++.|++.||.|||++|++|+||||+||+++.++.++|++++     
T Consensus       115 g~~L~~~l~~---------------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          115 GGSLQEVADT---------------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEEHHHHHTT---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             CCCHHHHHhc---------------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            9999999843               23566789999999999999999999999999999999999999987433     


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                                       |++|       ++.++|+||||+++|+|++ |..||.+.+..+
T Consensus       175 -----------------~~~~-------~~~~~Di~slG~il~ellt-g~~Pf~~~~~~~  209 (286)
T 3uqc_A          175 -----------------TMPD-------ANPQDDIRGIGASLYALLV-NRWPLPEAGVRS  209 (286)
T ss_dssp             -----------------CCTT-------CCHHHHHHHHHHHHHHHHH-SEECSCCCSBCC
T ss_pred             -----------------ccCC-------CCchhHHHHHHHHHHHHHH-CCCCCCcCCcch
Confidence                             3443       5889999999999999999 999998766543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-34  Score=227.24  Aligned_cols=171  Identities=22%  Similarity=0.419  Sum_probs=141.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~   77 (225)
                      |.|| +||++.     +..+++.||+|+++..      ....+|+.++.+...||||+++++++..    .+..++||||
T Consensus        29 G~~g-~V~~~~-----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~   96 (299)
T 3m2w_A           29 GING-KVLQIF-----NKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   96 (299)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             CCCe-EEEEEE-----EcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence            7899 999998     3567899999998642      2456788888666569999999999876    6779999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeec
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFG  154 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g  154 (225)
                      +++++|.+++...           ....+++..++.++.|++.||.|||+.|++|+||||+||+++.   ++.++|+|||
T Consensus        97 ~~~~~L~~~l~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           97 LDGGELFSRIQDR-----------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             CCSCBHHHHHHHC-----------TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             cCCCcHHHHHHhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            9999999999864           2235899999999999999999999999999999999999987   7889999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ++....                        +..++.++|+||+|+++|+|++ |..||.+.+..+.
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~  206 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAI  206 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHH-SSCSCCC------
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHH-CCCCCCCCcchhh
Confidence            874321                        2345789999999999999999 9999987665543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-35  Score=233.93  Aligned_cols=182  Identities=18%  Similarity=0.171  Sum_probs=145.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-------chHHHHHHHHHHHHHhhcC--------CCCCeeeeeeEE-
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLD--------PHPNVVRLLGCC-   65 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~~~~~~--------~~~~i~~~~~~~-   65 (225)
                      |+|| +||++..       +|+.||+|+++...       .......+.+|+.+++.+.        .|||++++.+.+ 
T Consensus        31 G~~g-~V~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~  102 (336)
T 2vuw_A           31 GVFG-EVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC  102 (336)
T ss_dssp             ETTE-EEEEEEE-------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred             cCce-EEEEEEe-------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence            7899 9999983       57999999997643       2222346778888888775        477777776654 


Q ss_pred             ----------------e-------------cCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHH
Q psy15818         66 ----------------T-------------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY  116 (225)
Q Consensus        66 ----------------~-------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  116 (225)
                                      .             +.+..++||||+.++++.+.+..              ..+++..++.++.
T Consensus       103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------------~~~~~~~~~~i~~  168 (336)
T 2vuw_A          103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------------KLSSLATAKSILH  168 (336)
T ss_dssp             EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------------TCCCHHHHHHHHH
T ss_pred             ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------------cCCCHHHHHHHHH
Confidence                            2             26789999999998876555522              2579999999999


Q ss_pred             HHHHHHHHHH-hCCcccCCCCCCCEEecCCC--------------------ceeEeeecccccccCccccccccCCCCCc
Q psy15818        117 QVARGMQFLS-SRGIIHRDLAARNVLIGENH--------------------CCKVADFGFARDLMTSSVYERKSEGRLPI  175 (225)
Q Consensus       117 ql~~~l~~Lh-~~~i~h~dl~~~nil~~~~~--------------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  175 (225)
                      |++.||.||| +.||+||||||+||+++.++                    .+||+|||++......       ...+|+
T Consensus       169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~  241 (336)
T 2vuw_A          169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred             HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence            9999999999 99999999999999998776                    8999999999754322       235778


Q ss_pred             cccCCccccCCCCCcchhHHHHHHH-HHHHHHcCCCCCCC
Q psy15818        176 RWMAPESLYDNIFSVKSDIWSFGVL-IWEIVTLGSTPYPG  214 (225)
Q Consensus       176 ~~~~PE~~~~~~~~~~~Di~slg~l-l~~l~~~g~~p~~~  214 (225)
                      .|+|||++.+.. +.++||||++.+ .+++++ |..||.+
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~  279 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSN  279 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcc
Confidence            899999998776 889999998766 677787 9999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-34  Score=236.52  Aligned_cols=200  Identities=15%  Similarity=0.119  Sum_probs=147.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCC-CC---------eeeeeeE-----
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPH-PN---------VVRLLGC-----   64 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~-~~---------i~~~~~~-----   64 (225)
                      |+|| +||++..     ..+|+.||||+++....  ......+.+|+.++..+. | ++         ++...+.     
T Consensus        89 G~fG-~Vy~a~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           89 EDPY-AYLEATD-----QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             ETTE-EEEEEEE-----TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             CCCE-EEEEEEe-----cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhhcccCC
Confidence            8899 9999994     56789999999874332  222456788998888886 4 21         1111111     


Q ss_pred             -------Eec-----CCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCccc
Q psy15818         65 -------CTE-----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH  132 (225)
Q Consensus        65 -------~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h  132 (225)
                             +..     ....+++|+.+ +++|.+++........      ....+++..++.++.|+++||.|||++||+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS------THKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTT------TSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                   111     22467777766 5899999864422110      1234678889999999999999999999999


Q ss_pred             CCCCCCCEEecCCCceeEeeecccccccCccccccccCCCCCccccCCccc----------cCCCCCcchhHHHHHHHHH
Q psy15818        133 RDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL----------YDNIFSVKSDIWSFGVLIW  202 (225)
Q Consensus       133 ~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~~~~~~~~~Di~slg~ll~  202 (225)
                      |||||+||+++.++.+||+|||++......     .....+ +.|+|||++          .+..++.++|+||||+++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998654322     223344 789999998          5556788999999999999


Q ss_pred             HHHHcCCCCCCCCCHHHHhh
Q psy15818        203 EIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       203 ~l~~~g~~p~~~~~~~~~~~  222 (225)
                      +|++ |..||.+.+..+...
T Consensus       309 ellt-g~~Pf~~~~~~~~~~  327 (413)
T 3dzo_A          309 WIWC-ADLPNTDDAALGGSE  327 (413)
T ss_dssp             HHHH-SSCCCCTTGGGSCSG
T ss_pred             HHHH-CCCCCCCcchhhhHH
Confidence            9999 999998876655443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.1e-34  Score=246.12  Aligned_cols=168  Identities=15%  Similarity=0.142  Sum_probs=123.1

Q ss_pred             ccceEEEEeeecccc---------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHh
Q psy15818         20 EGPCIVAVKTLKENA---------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS   90 (225)
Q Consensus        20 ~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   90 (225)
                      -.|+.|++|.+....         .+.....+.+|+.+|+++..|+||+++++++++++..||||||++|++|.+++...
T Consensus       257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~  336 (569)
T 4azs_A          257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG  336 (569)
T ss_dssp             EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred             cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence            358899999996531         23344568899999999988999999999999999999999999999999999753


Q ss_pred             hhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccCccccccccC
Q psy15818         91 RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSE  170 (225)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  170 (225)
                                   ..+++.   +++.||++||+|+|++||+||||||+||++++++++||+|||++.......  .....
T Consensus       337 -------------~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t  398 (569)
T 4azs_A          337 -------------EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTN  398 (569)
T ss_dssp             -------------CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHH
T ss_pred             -------------CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccC
Confidence                         245544   578999999999999999999999999999999999999999987553322  12223


Q ss_pred             CCCCccccCCccccCCCCCcchhHHHHHHHHHHHHH
Q psy15818        171 GRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVT  206 (225)
Q Consensus       171 ~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~  206 (225)
                      ..+|+.|++||++.+. +...+|+||+|++++++.+
T Consensus       399 ~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~  433 (569)
T 4azs_A          399 LVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQ  433 (569)
T ss_dssp             HHHHHHHHHHHHC------------------CCCCT
T ss_pred             ceechhhccHHHhCCC-CCCcccccccccchhhhcc
Confidence            4578899999988764 4567999999988765533

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3.9e-28  Score=204.99  Aligned_cols=179  Identities=12%  Similarity=0.094  Sum_probs=140.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-------chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (225)
                      |+|| +||++.       ..++.+++|......       ......++.+|+.++.+++ ||||+++..++...+..++|
T Consensus       347 G~fg-~Vy~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          347 GAEA-DIKRDS-------YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             -CCE-EEEEEE-------CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTEEE
T ss_pred             CCCE-EEEEEE-------ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccEEE
Confidence            8999 999995       336778888764321       1122345789999999998 99999665555577778999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||++|++|.+++..                     +..++.|++++|.|||++||+||||||+||++++  .++|+|||
T Consensus       418 mE~~~ggsL~~~l~~---------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFG  474 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFG  474 (540)
T ss_dssp             EECCCSEEHHHHSTT---------------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred             EECCCCCCHHHHHHH---------------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECc
Confidence            999999999888741                     5689999999999999999999999999999998  89999999


Q ss_pred             ccccccCccccc-----cccCCCCCccccCCccccC--CCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        155 FARDLMTSSVYE-----RKSEGRLPIRWMAPESLYD--NIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       155 ~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                      ++..........     ......+|+.|+|||++..  ..|+..+|+|+..+-..+-+. ++-+|.
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~-~r~rY~  539 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE-RRARYV  539 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH-hccccC
Confidence            998664432211     1123457888999999976  567788999999988888776 666654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=5.2e-24  Score=166.08  Aligned_cols=123  Identities=20%  Similarity=0.130  Sum_probs=98.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccch-----------------HHHHHHHHHHHHHhhcCCCCCeeeeeeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGE-----------------RERLDLLQELTVMKTLDPHPNVVRLLGC   64 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~~~~~~~~~~i~~~~~~   64 (225)
                      |.|| .||++..      .+|+.||+|.++.....                 .....+.+|+.++.++. |+++..   +
T Consensus       101 G~~g-~Vy~~~~------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~---~  169 (282)
T 1zar_A          101 GKES-AVFNCYS------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK---V  169 (282)
T ss_dssp             CSSE-EEEEEEE------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC---E
T ss_pred             CCCc-eEEEEEe------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe---E
Confidence            7899 9999983      56899999999643211                 23456889999999998 555444   4


Q ss_pred             EecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC
Q psy15818         65 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE  144 (225)
Q Consensus        65 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~  144 (225)
                      +.. +..++||||++|++|.+ +                   .......++.|++.||.+||+.|++|+||||+||+++ 
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l-------------------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-V-------------------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-C-------------------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred             Eec-cceEEEEEecCCCcHHH-c-------------------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence            433 56799999999999976 3                   1223557999999999999999999999999999999 


Q ss_pred             CCceeEeeecccc
Q psy15818        145 NHCCKVADFGFAR  157 (225)
Q Consensus       145 ~~~~~l~d~g~~~  157 (225)
                      ++.++|+|||++.
T Consensus       228 ~~~vkl~DFG~a~  240 (282)
T 1zar_A          228 EEGIWIIDFPQSV  240 (282)
T ss_dssp             TTEEEECCCTTCE
T ss_pred             CCcEEEEECCCCe
Confidence            9999999999885

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=3.5e-20  Score=142.68  Aligned_cols=128  Identities=17%  Similarity=0.135  Sum_probs=95.8

Q ss_pred             CcccceeeecCCCCCCCCccceE--EEEeeeccccch-----------------------HHHHHHHHHHHHHhhcCCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCI--VAVKTLKENAGE-----------------------RERLDLLQELTVMKTLDPHP   56 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~~~~~~~~~   56 (225)
                      |+|| .||++..     ..+|+.  ||||+++.....                       .....+.+|+.++..+. |+
T Consensus        58 G~~g-~Vy~a~~-----~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~  130 (258)
T 1zth_A           58 GKEA-NVFYADG-----VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK-EA  130 (258)
T ss_dssp             CSSE-EEEEEEE-----EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             cceE-EEEEEEE-----cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH-hC
Confidence            8999 9999983     356888  999987543211                       11235778999999987 66


Q ss_pred             Ce--eeeeeEEecCCCeEEEEeecCC-C----CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH-hC
Q psy15818         57 NV--VRLLGCCTEKEPFFVIMEYVPY-G----KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS-SR  128 (225)
Q Consensus        57 ~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~  128 (225)
                      ++  +.+++.    +..++||||+.+ +    +|.+....                .++..+..++.|++.+|.+|| +.
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----------------~~~~~~~~i~~qi~~~l~~lH~~~  190 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----------------LKELDVEGIFNDVVENVKRLYQEA  190 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----------------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----------------cChHHHHHHHHHHHHHHHHHHHHC
Confidence            53  333432    357899999942 3    55544311                235678899999999999999 99


Q ss_pred             CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      |++|+||||+||++++  .++|+|||++..
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            9999999999999988  899999999854

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1.9e-17  Score=133.18  Aligned_cols=129  Identities=18%  Similarity=0.133  Sum_probs=89.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc----------------h-----HHHHHHHHHHHHHhhcCCCCCeee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG----------------E-----RERLDLLQELTVMKTLDPHPNVVR   60 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~----------------~-----~~~~~~~~e~~~~~~~~~~~~i~~   60 (225)
                      |.+| .||++..      .+|+.||||+++....                .     ..+....+|...+.++. ++++..
T Consensus       106 Gk~a-~VY~a~d------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~gv~v  177 (397)
T 4gyi_A          106 GKES-DIMIVAD------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEGFPV  177 (397)
T ss_dssp             CSSE-EEEEEEC------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTTCSC
T ss_pred             CCce-EEEEEEC------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcCCCC
Confidence            8899 9999983      4689999998753210                0     01111345667777764 444322


Q ss_pred             eeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q psy15818         61 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV  140 (225)
Q Consensus        61 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~ni  140 (225)
                      ..-+..  ...++||||++|.+|.++.                   ..+....++.|++.++.+||+.|++||||||.||
T Consensus       178 p~p~~~--~~~~LVME~i~G~~L~~l~-------------------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI  236 (397)
T 4gyi_A          178 PEPIAQ--SRHTIVMSLVDALPMRQVS-------------------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNI  236 (397)
T ss_dssp             CCEEEE--ETTEEEEECCSCEEGGGCC-------------------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred             Ceeeec--cCceEEEEecCCccHhhhc-------------------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence            211111  1347999999988774321                   2234567889999999999999999999999999


Q ss_pred             EecCCC----------ceeEeeecccccc
Q psy15818        141 LIGENH----------CCKVADFGFARDL  159 (225)
Q Consensus       141 l~~~~~----------~~~l~d~g~~~~~  159 (225)
                      ++++++          .+.++||+.+...
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccC
Confidence            997655          3789999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.3e-13  Score=106.07  Aligned_cols=128  Identities=14%  Similarity=0.050  Sum_probs=97.3

Q ss_pred             cccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCC
Q psy15818          3 CFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK   82 (225)
Q Consensus         3 ~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (225)
                      +.+ .||+..       ..+..+++|+....... ....+.+|..+++.+..+..+.+++++..+.+..++|||+++|.+
T Consensus        26 s~~-~v~~~~-------~~~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           26 SPA-KVYKLV-------GENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             SSS-EEEEEE-------CSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             CCC-eEEEEE-------CCCCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            445 788876       23578999998753211 123588899999998767788899999988889999999999998


Q ss_pred             HHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-----------------------------------
Q psy15818         83 LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-----------------------------------  127 (225)
Q Consensus        83 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-----------------------------------  127 (225)
                      +.+.+                  .+......++.++.+++..||+                                   
T Consensus        97 l~~~~------------------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           97 CSEEY------------------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             HHHHC------------------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             hhhcc------------------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            86542                  1222334677888888899998                                   


Q ss_pred             ------------------------CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 ------------------------RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ------------------------~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                                              ..++|+|++|.||+++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                    348999999999999876556799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=2.1e-12  Score=98.79  Aligned_cols=72  Identities=21%  Similarity=0.138  Sum_probs=52.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCC-eeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN-VVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |..+ .||+...      .+|..+++|+.....    ...+.+|..+++.+..+.- +.+++.+...++..++|||+++|
T Consensus        31 g~~~-~v~~~~~------~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           31 CSDA-AVFRLSA------QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             TSSC-EEEEEEC------TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CCCc-eEEEEec------CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            3456 7888762      346779999976531    1246788888888864422 56688888888889999999998


Q ss_pred             CCHH
Q psy15818         81 GKLQ   84 (225)
Q Consensus        81 ~~L~   84 (225)
                      .++.
T Consensus       100 ~~l~  103 (264)
T 1nd4_A          100 QDLL  103 (264)
T ss_dssp             EETT
T ss_pred             cccC
Confidence            8774

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.27  E-value=1.3e-11  Score=99.01  Aligned_cols=134  Identities=16%  Similarity=0.167  Sum_probs=94.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeec--cccchHHHHHHHHHHHHHhhcCC-CCCeeeeeeEEecC---CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLK--ENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEK---EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~---~~~~lv~   75 (225)
                      |.++ .+|+...       .+..+++|+..  ..........+.+|..+++.+.. +..+.+++.++.+.   +..++||
T Consensus        49 G~sn-~~y~v~~-------~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           49 GQSN-PTFKLVT-------PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             -CCS-CEEEEEC-------SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             cccc-eEEEEEE-------CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            5566 7787762       24578889886  43322233467889999988873 34577888887766   5589999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh----------------------------
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS----------------------------  127 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~----------------------------  127 (225)
                      |+++|..+.+..               ...+++.+...++.++...|..||+                            
T Consensus       121 e~v~G~~l~~~~---------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          121 EFVSGRVLWDQS---------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             ECCCCBCCCCTT---------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             EecCCeecCCCc---------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            999987763211               1135677788888899999999986                            


Q ss_pred             ------------------------------CCcccCCCCCCCEEecCCC-c-eeEeeeccccc
Q psy15818        128 ------------------------------RGIIHRDLAARNVLIGENH-C-CKVADFGFARD  158 (225)
Q Consensus       128 ------------------------------~~i~h~dl~~~nil~~~~~-~-~~l~d~g~~~~  158 (225)
                                                    ..++|+|+++.||+++.++ . +.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                          3589999999999998664 3 58999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.15  E-value=7.1e-11  Score=92.66  Aligned_cols=169  Identities=20%  Similarity=0.221  Sum_probs=101.6

Q ss_pred             EEEEeeeccccchHHHHHHHHHHHHHhhcCCCCC--eeeeeeEEecCC---CeEEEEeecCCCCHHHHHHHhhhhhhhcc
Q psy15818         24 IVAVKTLKENAGERERLDLLQELTVMKTLDPHPN--VVRLLGCCTEKE---PFFVIMEYVPYGKLQSFLRSSRAQRYYNN   98 (225)
Q Consensus        24 ~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   98 (225)
                      .+++|+....   .....+.+|...++.+..+..  +.+++......+   ..|+||++++|.++......         
T Consensus        42 ~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~---------  109 (304)
T 3sg8_A           42 DFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN---------  109 (304)
T ss_dssp             SEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH---------
T ss_pred             EEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc---------
Confidence            4788987543   334568889999888753433  334444433332   35889999999887653321         


Q ss_pred             cCCCCCCCChHHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q psy15818         99 MHGKSNSLTSRDLTSFCYQVARGMQFLSS---------------------------------------------------  127 (225)
Q Consensus        99 ~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~---------------------------------------------------  127 (225)
                            .++.++...++.|+...+..||+                                                   
T Consensus       110 ------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  183 (304)
T 3sg8_A          110 ------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILEN  183 (304)
T ss_dssp             ------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTC
T ss_pred             ------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhc
Confidence                  24555555666666666666654                                                   


Q ss_pred             -------CCcccCCCCCCCEEecC--CCceeEeeecccccccCccccccccCCCCCccccCCcccc------CCCC----
Q psy15818        128 -------RGIIHRDLAARNVLIGE--NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY------DNIF----  188 (225)
Q Consensus       128 -------~~i~h~dl~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~----  188 (225)
                             ..++|+|++|.||++++  +..+.++||+.+................   .-.+|+...      +...    
T Consensus       184 ~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l~~Y~~~~~~~~  260 (304)
T 3sg8_A          184 EIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKILNHYKHKDIPTV  260 (304)
T ss_dssp             GGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHHHHHTCSCHHHH
T ss_pred             cccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHHHHcCCCCcHHH
Confidence                   24799999999999987  4567899999876432221111111110   001222111      0000    


Q ss_pred             ----CcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        189 ----SVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       189 ----~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                          ....+.|+++.+++.+.+ |..+|..
T Consensus       261 ~~r~~~~~~~~~l~~~~~~~~~-g~~~~~~  289 (304)
T 3sg8_A          261 LEKYRMKEKYWSFEKIIYGKEY-GYMDWYE  289 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHT-TCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHc-CCHHHHH
Confidence                112689999999999999 8877643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=99.00  E-value=7.5e-09  Score=79.58  Aligned_cols=125  Identities=14%  Similarity=0.115  Sum_probs=87.6

Q ss_pred             eeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHH
Q psy15818          7 EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF   86 (225)
Q Consensus         7 ~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   86 (225)
                      +||+..     ...++..+++|+.+..    ....+.+|...++.+..+--+.+++.++.+.+..++||++++|.++.+.
T Consensus        40 ~v~rl~-----~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           40 TIYRLY-----GKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEEEEE-----CCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             eEEEEE-----ecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            467655     2345677889987643    2345778888888887655577888888889999999999999887765


Q ss_pred             HHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy15818         87 LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS---------------------------------------  127 (225)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~---------------------------------------  127 (225)
                      ....                 ......+..++...|..||+                                       
T Consensus       111 ~~~~-----------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A          111 LEEY-----------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             HHHC-----------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             ccCC-----------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            5321                 12223344444444444442                                       


Q ss_pred             ------------C-------CcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 ------------R-------GIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ------------~-------~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                                  .       .++|+|+.+.||++++++.+-|+||+.+.
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1       27899999999999877666799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=3.1e-07  Score=71.99  Aligned_cols=60  Identities=15%  Similarity=0.013  Sum_probs=41.9

Q ss_pred             eEEEEeeeccccchHHHHHHHHHHHHHhhcCCCC--CeeeeeeEEe-cCCCeEEEEeecCCCCHHH
Q psy15818         23 CIVAVKTLKENAGERERLDLLQELTVMKTLDPHP--NVVRLLGCCT-EKEPFFVIMEYVPYGKLQS   85 (225)
Q Consensus        23 ~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~--~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~   85 (225)
                      ..+++|+...   ......+.+|..+++.+..+-  .+.+++.+.. ..+..+++|++++|..+..
T Consensus        40 ~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           40 GDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             TTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             CEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            4578888543   233456889999999987432  3556666653 4566889999999987765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=7.4e-07  Score=71.16  Aligned_cols=63  Identities=14%  Similarity=0.063  Sum_probs=39.6

Q ss_pred             ceEEEEeeeccccc--hHHHHHHHHHHHHHhhcCCC--CCeeeeeeEEecC---CCeEEEEeecCCCCHH
Q psy15818         22 PCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPH--PNVVRLLGCCTEK---EPFFVIMEYVPYGKLQ   84 (225)
Q Consensus        22 ~~~vavK~~~~~~~--~~~~~~~~~e~~~~~~~~~~--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~   84 (225)
                      +..+++|+......  ......+.+|..+++.+..+  ..+.+++.+..+.   +..++|||+++|..+.
T Consensus        52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            67788998764330  00012466777777766533  3466677766554   4578999999986543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=4.1e-05  Score=60.40  Aligned_cols=31  Identities=29%  Similarity=0.368  Sum_probs=27.3

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ..++|+|+++.||+++.++.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998777899999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.01  E-value=8.5e-06  Score=66.01  Aligned_cols=72  Identities=17%  Similarity=0.021  Sum_probs=41.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc------hHHHHHHHHHHHHHhhcCCC-C-CeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG------ERERLDLLQELTVMKTLDPH-P-NVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~~~~~~~~-~-~i~~~~~~~~~~~~~~l   73 (225)
                      |..+ .||++..     ..+++.|++|.......      .....+...|..++..+... | .+.+++.+  +....++
T Consensus        41 G~~n-~vyrv~~-----~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           41 GNLN-YVFHIYD-----QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             SSSE-EEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             CceE-EEEEEEE-----CCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5677 8888863     23467899998653211      01122456777777776432 3 33445543  3445689


Q ss_pred             EEeecCCC
Q psy15818         74 IMEYVPYG   81 (225)
Q Consensus        74 v~e~~~~~   81 (225)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999863

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.74  E-value=8.1e-05  Score=57.89  Aligned_cols=29  Identities=17%  Similarity=0.226  Sum_probs=24.3

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5566789999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.71  E-value=0.00023  Score=57.32  Aligned_cols=130  Identities=17%  Similarity=0.167  Sum_probs=72.9

Q ss_pred             cceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHH-----------HHHH
Q psy15818         21 GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS-----------FLRS   89 (225)
Q Consensus        21 ~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-----------~~~~   89 (225)
                      .++.|++|+.-....  ......+|..+++.+..+.-..++++.+.+    .+|+||++|..+..           +...
T Consensus        81 ~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~  154 (379)
T 3feg_A           81 EPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATK  154 (379)
T ss_dssp             CCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHH
T ss_pred             CCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHH
Confidence            357888998743221  223456888888777644444666766543    29999999854421           1111


Q ss_pred             hhhhhhhcccCCCCCCC--ChHHHHHHHHHHHH-------------------HHHHHH----h----CCcccCCCCCCCE
Q psy15818         90 SRAQRYYNNMHGKSNSL--TSRDLTSFCYQVAR-------------------GMQFLS----S----RGIIHRDLAARNV  140 (225)
Q Consensus        90 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~ql~~-------------------~l~~Lh----~----~~i~h~dl~~~ni  140 (225)
                      ....... ... .....  -...+..|..++-.                   .+..|.    .    ..++|+|+.+.||
T Consensus       155 La~LH~~-~~~-~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Ni  232 (379)
T 3feg_A          155 MAQFHGM-EMP-FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNI  232 (379)
T ss_dssp             HHHHHTC-CCS-SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGE
T ss_pred             HHHHhCC-CCC-CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeE
Confidence            1111100 011 11111  13455555554422                   123332    2    2589999999999


Q ss_pred             EecCC----CceeEeeeccccc
Q psy15818        141 LIGEN----HCCKVADFGFARD  158 (225)
Q Consensus       141 l~~~~----~~~~l~d~g~~~~  158 (225)
                      +++.+    +.+.++||..+..
T Consensus       233 l~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          233 LLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEESCC---CCEEECCCTTCEE
T ss_pred             EEcCCCCccCcEEEEecccCCc
Confidence            99865    6899999998863

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=0.0004  Score=56.61  Aligned_cols=33  Identities=24%  Similarity=0.369  Sum_probs=28.0

Q ss_pred             HhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818        126 SSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       126 h~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +...++|+|++|.||+++.++ +.++||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            456799999999999998766 999999887643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.61  E-value=0.00047  Score=53.96  Aligned_cols=70  Identities=19%  Similarity=0.115  Sum_probs=49.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCC--CCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |... .+|+..       .++..+++|+.....    ...+..|...++.+..  ...+.+++.+....+..++|||+++
T Consensus        47 G~~n-~~y~v~-------~~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           47 GEMN-EIWLIN-------DEVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             SSSS-EEEEEE-------SSSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             ccce-eeeEEE-------ECCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            4556 677766       235678889876432    3356778777777653  3567888888887888999999999


Q ss_pred             CCCH
Q psy15818         80 YGKL   83 (225)
Q Consensus        80 ~~~L   83 (225)
                      |..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.56  E-value=0.00046  Score=50.78  Aligned_cols=105  Identities=17%  Similarity=0.183  Sum_probs=68.7

Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS-SRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      .+|.+++...            +.+++|+++|.++.|.+.+|..+- ...-...-+.|..|++..+|.|.+.+-. ..  
T Consensus        33 vSL~eIL~~~------------~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~-s~--   97 (229)
T 2yle_A           33 LSLEEILRLY------------NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAA-DD--   97 (229)
T ss_dssp             EEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC------
T ss_pred             ccHHHHHHHc------------CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccccc-cc--
Confidence            5788998763            568999999999999999988762 2222344556788999888887765311 00  


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCC
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYP  213 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~  213 (225)
                                  .....+.|||... ...+.+.-|||||+++|..+-.|..+=+
T Consensus        98 ------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e  138 (229)
T 2yle_A           98 ------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE  138 (229)
T ss_dssp             ---------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE
T ss_pred             ------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc
Confidence                        0112377888652 3446778899999999998876655443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.50  E-value=0.0014  Score=51.29  Aligned_cols=29  Identities=28%  Similarity=0.213  Sum_probs=24.7

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ..++|+|+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999998 4 789999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00055  Score=53.89  Aligned_cols=32  Identities=31%  Similarity=0.260  Sum_probs=26.9

Q ss_pred             CCcccCCCCCCCEEecCC----CceeEeeecccccc
Q psy15818        128 RGIIHRDLAARNVLIGEN----HCCKVADFGFARDL  159 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~----~~~~l~d~g~~~~~  159 (225)
                      ..++|+|+.+.||+++.+    +.+.++||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999864    67899999988643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.21  E-value=0.0016  Score=50.17  Aligned_cols=70  Identities=16%  Similarity=0.035  Sum_probs=43.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCC--CeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP--NVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~--~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |..+ .||+...      .+|+.|++|+........ ...+..|...|+.+....  -+.+++.+    +..+++||++.
T Consensus        26 G~~~-~vyrv~l------~DG~~~~vK~~~~~~~~~-~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~   93 (288)
T 3f7w_A           26 SHRW-HLYRVEL------ADGTPLFVKALPDDAPAL-DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVD   93 (288)
T ss_dssp             ETTE-EEEEEEE------TTSCEEEEEECCTTCCCC-TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCC
T ss_pred             CCCe-EEEEEEE------CCCCEEEEEEeCCCCcch-hhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeec
Confidence            4556 7888873      567889999876443211 123567888887775332  23444443    23478999998


Q ss_pred             CCCH
Q psy15818         80 YGKL   83 (225)
Q Consensus        80 ~~~L   83 (225)
                      +...
T Consensus        94 ~~~~   97 (288)
T 3f7w_A           94 ERPP   97 (288)
T ss_dssp             CCCC
T ss_pred             ccCC
Confidence            7543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.19  E-value=0.0019  Score=50.48  Aligned_cols=30  Identities=37%  Similarity=0.505  Sum_probs=25.5

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .+++|+|+.+.||+++++..+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            368999999999999876556799998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.18  E-value=0.00077  Score=55.17  Aligned_cols=54  Identities=19%  Similarity=0.219  Sum_probs=33.0

Q ss_pred             ceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCC
Q psy15818         22 PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK   82 (225)
Q Consensus        22 ~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (225)
                      +..+++|+.... ..  ...+..|..++..+..+.-..++++.+.+    .+|++|++|.+
T Consensus       105 ~~~~vlRi~~~~-~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A          105 PNKVLLRVYFNP-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             CSEEEEEEECSC-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             CceEEEEEeCCC-Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            567889988432 11  02344688777777644334566665542    38999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.82  E-value=0.0069  Score=48.29  Aligned_cols=28  Identities=21%  Similarity=0.432  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .++|+|+.+.||+++++. +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999997654 8999998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.76  E-value=0.015  Score=48.01  Aligned_cols=56  Identities=13%  Similarity=0.017  Sum_probs=34.3

Q ss_pred             ceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCH
Q psy15818         22 PCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL   83 (225)
Q Consensus        22 ~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   83 (225)
                      +..+++|+.......  ..+..+|..++..+..+.-..++++.+. +   ..|++|++|.++
T Consensus       133 ~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          133 QAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             TEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred             CceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence            477889987543211  1123578888888874444456676663 2   259999987443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.28  E-value=0.021  Score=46.54  Aligned_cols=29  Identities=21%  Similarity=0.390  Sum_probs=25.3

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7777899999998863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.59  E-value=0.026  Score=45.66  Aligned_cols=29  Identities=24%  Similarity=0.375  Sum_probs=24.4

Q ss_pred             cccCCCCCCCEEec------CCCceeEeeeccccc
Q psy15818        130 IIHRDLAARNVLIG------ENHCCKVADFGFARD  158 (225)
Q Consensus       130 i~h~dl~~~nil~~------~~~~~~l~d~g~~~~  158 (225)
                      ++|+|+.+.||++.      +...+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            68999999999993      456799999998863

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.69  E-value=0.043  Score=43.25  Aligned_cols=32  Identities=25%  Similarity=0.321  Sum_probs=27.3

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ..++|+|+.+.||++++++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            36899999999999987778999999877543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.41  E-value=1.2  Score=32.69  Aligned_cols=84  Identities=8%  Similarity=-0.006  Sum_probs=58.9

Q ss_pred             CCCCeeeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccC
Q psy15818         54 PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR  133 (225)
Q Consensus        54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~  133 (225)
                      .+|++  -..+-.+.+.+.+.++.-++..-...++                ..+..+.++++.+++..... |...-+|-
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----------------~~~~~eKlrll~nl~~L~~~-~~~~r~tf  108 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----------------KTTLLSRIRAAIHLVSKVKH-HSARRLIF  108 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----------------TSCHHHHHHHHHHHHHHHSS-CCSSSEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----------------hcCHHHHHHHHHHHHHHHHH-hhhCceeE
Confidence            38888  4444466777777777653333333332                47889999999888886551 23456788


Q ss_pred             CCCCCCEEecCCCceeEeeeccc
Q psy15818        134 DLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus       134 dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      -++|+|++++.++.+++.--|+-
T Consensus       109 ~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          109 IVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             CCCGGGEEECTTCCEEESCCEET
T ss_pred             EEeCceEEEeCCCcEEEEEcCCc
Confidence            99999999999999999877753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.10  E-value=0.81  Score=33.44  Aligned_cols=83  Identities=10%  Similarity=0.109  Sum_probs=57.7

Q ss_pred             CCCCeeeeeeEEecCCCeEEEEeecC-CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCccc
Q psy15818         54 PHPNVVRLLGCCTEKEPFFVIMEYVP-YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIH  132 (225)
Q Consensus        54 ~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h  132 (225)
                      .+|++++. .+-++.+.+.+.++.-+ +-++.. ++                ..+..+.++++.+|+....++  ..-+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----------------~~~~~eKlr~l~ni~~l~~~~--~~r~t  102 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----------------SFTKNEKLRYLLNIKNLEEVN--RTRYT  102 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----------------GSCHHHHHHHHHHGGGGGGGG--GSSEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----------------hcCHHHHHHHHHHHHHHHHHh--cCceE
Confidence            48988877 45555666666655443 223322 21                478889999999998876333  33567


Q ss_pred             CCCCCCCEEecCCCceeEeeeccc
Q psy15818        133 RDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus       133 ~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      --++|+|++++.++.+++.--|+-
T Consensus       103 f~L~P~NL~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          103 FVLAPDELFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             CCCSGGGEEECTTSCEEESCCEET
T ss_pred             EEEecceEEEcCCCCEEEEEccCc
Confidence            899999999999999998766653

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=84.74  E-value=17  Score=31.51  Aligned_cols=94  Identities=13%  Similarity=0.175  Sum_probs=53.6

Q ss_pred             eeeeeEEecCCCeEEEEeecCCCCHHHHHHHhhhhh-hhcc-cCCCCCCC--ChHHHHHHHHHHH--HHHHHHHhCCccc
Q psy15818         59 VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR-YYNN-MHGKSNSL--TSRDLTSFCYQVA--RGMQFLSSRGIIH  132 (225)
Q Consensus        59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~-~~~~~~~~--~~~~~~~~~~ql~--~~l~~Lh~~~i~h  132 (225)
                      +..+.+...+....++ |+++..++.+++....... +... ........  ..+....+..+++  +.+.|+=.    -
T Consensus       476 i~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILG----l  550 (696)
T 2x6h_A          476 LTPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLG----V  550 (696)
T ss_dssp             CCCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHT----C
T ss_pred             EeccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHcc----C
Confidence            4556666666666666 6667677777775432100 0000 00111111  2233445554443  33344422    3


Q ss_pred             CCCCCCCEEecCCCceeEeeecccc
Q psy15818        133 RDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       133 ~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +|=+++||+++.+|.+.-+|||.+.
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhh
Confidence            5889999999999999999999874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.59  E-value=0.19  Score=41.37  Aligned_cols=57  Identities=11%  Similarity=0.188  Sum_probs=14.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEE------eeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAV------KTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCT   66 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vav------K~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   66 (225)
                      | || +||.+.+..     ...+||+      |..+... ..+....+.+|..++..+. |||+++.+.+..
T Consensus       151 G-fG-~v~~g~~~~-----~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~  214 (463)
T 3cxl_A          151 G-YT-TLNREPAYK-----KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV  214 (463)
T ss_dssp             S-BC-CC--------------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             C-ch-hhhcccccc-----cCCchhhhhccCcccccccccccccccccccccccccccc-ccccCCCcceEE
Confidence            5 99 999999732     2357888      6665432 3333345677788888887 999999988743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	225
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-50
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-49
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-43
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-32
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-09

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 8e-58
 Identities = 96/210 (45%), Positives = 127/210 (60%), Gaps = 10/210 (4%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VAVK LKE A   ER  L+ EL +M  L  H N+V LLG CT   P ++I EY  YG L
Sbjct: 69  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128

Query: 84  QSFLRSSRAQ----------RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
            ++LRS R +          +         N LT  DL  F YQVA+GM+FL  +  +HR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188

Query: 134 DLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSD 193
           DLAARNVL+      K+ DFG ARD+M+ S Y  +   RLP++WMAPESL++ I+++KSD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +WS+G+L+WEI +LG  PYPG+       K
Sbjct: 249 VWSYGILLWEIFSLGVNPYPGIPVDANFYK 278

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-53
 Identities = 95/222 (42%), Positives = 128/222 (57%), Gaps = 5/222 (2%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
           +V +         +    VAVK LK +A   ER  L+ EL V+  L  H N+V LLG CT
Sbjct: 38  KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARG 121
              P  VI EY  YG L +FLR  R     +      M     +L   DL SF YQVA+G
Sbjct: 98  IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157

Query: 122 MQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPE 181
           M FL+S+  IHRDLAARN+L+      K+ DFG ARD+   S Y  K   RLP++WMAPE
Sbjct: 158 MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217

Query: 182 SLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S+++ +++ +SD+WS+G+ +WE+ +LGS+PYPGM       K
Sbjct: 218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-52
 Identities = 99/217 (45%), Positives = 144/217 (66%), Gaps = 3/217 (1%)

Query: 10  KHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE 69
           +     +        VAVK LK +A E++  DL+ E+ +MK +  H N++ LLG CT+  
Sbjct: 33  EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92

Query: 70  PFFVIMEYVPYGKLQSFLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS 126
           P +VI+EY   G L+ +L++ R    +  YN  H     L+S+DL S  YQVARGM++L+
Sbjct: 93  PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152

Query: 127 SRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN 186
           S+  IHRDLAARNVL+ E++  K+ADFG ARD+     Y++ + GRLP++WMAPE+L+D 
Sbjct: 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212

Query: 187 IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           I++ +SD+WSFGVL+WEI TLG +PYPG+   E+ K 
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-52
 Identities = 91/202 (45%), Positives = 130/202 (64%), Gaps = 6/202 (2%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
            A+K +KE A + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L 
Sbjct: 40  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 99

Query: 85  SFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            FLR SR       +   +  +++L+S+ L  F   VARGM +LS +  IHRDLAARN+L
Sbjct: 100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           +GEN+  K+ADFG +R       Y +K+ GRLP+RWMA ESL  ++++  SD+WS+GVL+
Sbjct: 160 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           WEIV+LG TPY GM  AE+ +K
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEK 238

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-50
 Identities = 79/200 (39%), Positives = 112/200 (56%), Gaps = 16/200 (8%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VAVK+LK+ +   +    L E  +MK L  H  +VRL    T+ EP ++I EY+  G L
Sbjct: 39  KVAVKSLKQGSMSPDAF--LAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSL 94

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             FL++    +           LT   L     Q+A GM F+  R  IHRDL A N+L+ 
Sbjct: 95  VDFLKTPSGIK-----------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +   CK+ADFG AR L+  + Y  +   + PI+W APE++    F++KSD+WSFG+L+ E
Sbjct: 144 DTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           IVT G  PYPGM   EV++ 
Sbjct: 203 IVTHGRIPYPGMTNPEVIQN 222

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 5e-50
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 19/203 (9%)

Query: 25  VAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           VAVK L       ++      E+ V++    H N++  +G  T  +   V  ++     L
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTAPQLAIV-TQWCEGSSL 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              L            H          L     Q A+GM +L ++ IIHRDL + N+ + 
Sbjct: 91  YHHL------------HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY---DNIFSVKSDIWSFGVL 200
           E+   K+ DFG A      S   +  +    I WMAPE +     N +S +SD+++FG++
Sbjct: 139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           ++E++T G  PY  +   + +  
Sbjct: 199 LYELMT-GQLPYSNINNRDQIIF 220

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-49
 Identities = 73/208 (35%), Positives = 112/208 (53%), Gaps = 15/208 (7%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           R R+    VA+K LK+   + +  ++++E  +M  LD +P +VRL+G C  +    V ME
Sbjct: 31  RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAEALMLV-ME 88

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
               G L  FL             GK   +   ++    +QV+ GM++L  +  +HRDLA
Sbjct: 89  MAGGGPLHKFL------------VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136

Query: 137 ARNVLIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           ARNVL+   H  K++DFG ++ L    S Y  +S G+ P++W APE +    FS +SD+W
Sbjct: 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S+GV +WE ++ G  PY  M   EVM  
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAF 224

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-49
 Identities = 75/208 (36%), Positives = 109/208 (52%), Gaps = 21/208 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIM 75
            G      VAVK +K +A  +     L E +VM  L  H N+V+LLG   E K   +++ 
Sbjct: 25  LGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVT 80

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           EY+  G L  +LRS                L    L  F   V   M++L     +HRDL
Sbjct: 81  EYMAKGSLVDYLRSRGRSV-----------LGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 129

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+ E++  KV+DFG  ++         +  G+LP++W APE+L +  FS KSD+W
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           SFG+L+WEI + G  PYP +   +V+ +
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPR 212

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (407), Expect = 3e-49
 Identities = 84/228 (36%), Positives = 124/228 (54%), Gaps = 12/228 (5%)

Query: 7   EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT 66
            V +         E   +VAVK LKE A    + D  +E  +M   D +PN+V+LLG C 
Sbjct: 28  RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCA 86

Query: 67  EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS-----------LTSRDLTSFC 115
             +P  ++ EY+ YG L  FLRS       +  H   ++           L+  +     
Sbjct: 87  VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 146

Query: 116 YQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPI 175
            QVA GM +LS R  +HRDLA RN L+GEN   K+ADFG +R++ ++  Y+      +PI
Sbjct: 147 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206

Query: 176 RWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           RWM PES++ N ++ +SD+W++GV++WEI + G  PY GMA  EV+  
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 8e-49
 Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 16/200 (8%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K +KE +   +    ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L
Sbjct: 30  DVAIKMIKEGSMSEDEF--IEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCL 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            ++L                +   ++ L   C  V   M++L S+  +HRDLAARN L+ 
Sbjct: 87  LNYL------------REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           +    KV+DFG +R  +    Y      + P+RW  PE L  + FS KSDIW+FGVL+WE
Sbjct: 135 DQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 193

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           I +LG  PY     +E  + 
Sbjct: 194 IYSLGKMPYERFTNSETAEH 213

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-48
 Identities = 72/208 (34%), Positives = 116/208 (55%), Gaps = 14/208 (6%)

Query: 16  ERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
             G +    VA+K L+E    +   ++L E  VM ++D +P+V RLLG C        I 
Sbjct: 32  PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTSTVQL-IT 89

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           + +P+G L             + +    +++ S+ L ++C Q+A+GM +L  R ++HRDL
Sbjct: 90  QLMPFGCL------------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
           AARNVL+      K+ DFG A+ L           G++PI+WMA ES+   I++ +SD+W
Sbjct: 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 197

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S+GV +WE++T GS PY G+ A+E+   
Sbjct: 198 SYGVTVWELMTFGSKPYDGIPASEISSI 225

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-48
 Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 20/200 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           ++A K +        R  +++EL V+   +  P +V   G         + ME++  G L
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSL 91

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GIIHRDLAARNVLI 142
              L+             K+  +  + L      V +G+ +L  +  I+HRD+   N+L+
Sbjct: 92  DQVLK-------------KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
                 K+ DFG +  L+ S              +M+PE L    +SV+SDIWS G+ + 
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANSFVG----TRSYMSPERLQGTHYSVQSDIWSMGLSLV 194

Query: 203 EIVTLGSTPYPGMAAAEVMK 222
           E+   G  P P   A E+  
Sbjct: 195 EMAV-GRYPIPPPDAKELEL 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (396), Expect = 1e-47
 Identities = 73/203 (35%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+KTLK    E++R D L E ++M   D HPNV+ L G  T+  P  +I E++  G L
Sbjct: 56  FVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSL 114

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
            SF            +       T   L      +A GM++L+    +HRDLAARN+L+ 
Sbjct: 115 DSF------------LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN 162

Query: 144 ENHCCKVADFGFARDL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            N  CKV+DFG +R L    +   Y     G++PIRW APE++    F+  SD+WS+G++
Sbjct: 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIV 222

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           +WE+++ G  PY  M   +V+  
Sbjct: 223 MWEVMSYGERPYWDMTNQDVINA 245

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-47
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
           + +E   + A K +   + E E  D + E+ ++ + D HPN+V+LL     +   ++++E
Sbjct: 32  QNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIE 89

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           +   G + +             M      LT   +   C Q    + +L    IIHRDL 
Sbjct: 90  FCAGGAVDAV------------MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLY-----DNIFSVK 191
           A N+L   +   K+ADFG +     +        G     WMAPE +      D  +  K
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG--TPYWMAPEVVMCETSKDRPYDYK 195

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +D+WS G+ + E+      P+  +    V+ K
Sbjct: 196 ADVWSLGITLIEMAE-IEPPHHELNPMRVLLK 226

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-47
 Identities = 75/209 (35%), Positives = 114/209 (54%), Gaps = 17/209 (8%)

Query: 17  RGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
           + ++    VAVK LK  A +    D LL E  VM+ LD +P +VR++G C E E + ++M
Sbjct: 29  QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAESWMLVM 86

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           E    G L  +L+             ++  +  +++    +QV+ GM++L     +HRDL
Sbjct: 87  EMAELGPLNKYLQ-------------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSE-GRLPIRWMAPESLYDNIFSVKSDI 194
           AARNVL+   H  K++DFG ++ L     Y +    G+ P++W APE +    FS KSD+
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WSFGVL+WE  + G  PY GM  +EV   
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (391), Expect = 4e-47
 Identities = 90/205 (43%), Positives = 125/205 (60%), Gaps = 15/205 (7%)

Query: 19  REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           ++    VAVKTLKE+  E E    L+E  VMK +  HPN+V+LLG CT + PF++I E++
Sbjct: 39  KKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFM 95

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
            YG L  +L                  +++  L     Q++  M++L  +  IHRDLAAR
Sbjct: 96  TYGNLLDYL-----------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144

Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           N L+GENH  KVADFG +R LMT   Y   +  + PI+W APESL  N FS+KSD+W+FG
Sbjct: 145 NCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203

Query: 199 VLIWEIVTLGSTPYPGMAAAEVMKK 223
           VL+WEI T G +PYPG+  ++V + 
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYEL 228

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 2e-46
 Identities = 79/203 (38%), Positives = 115/203 (56%), Gaps = 16/203 (7%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGK 82
             AVK+L       E    L E  +MK    HPNV+ LLG C   E    V++ Y+ +G 
Sbjct: 57  HCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGD 115

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L++F            +  ++++ T +DL  F  QVA+GM+FL+S+  +HRDLAARN ++
Sbjct: 116 LRNF------------IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 163

Query: 143 GENHCCKVADFGFARDLMTSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
            E    KVADFG ARD+          K+  +LP++WMA ESL    F+ KSD+WSFGVL
Sbjct: 164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           +WE++T G+ PYP +   ++   
Sbjct: 224 LWELMTRGAPPYPDVNTFDITVY 246

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 4e-46
 Identities = 70/200 (35%), Positives = 107/200 (53%), Gaps = 16/200 (8%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+KT++E A   E  D ++E  VM  L  HP +V+L G C E+ P  ++ E++ +G L
Sbjct: 31  KVAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCL 87

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             +            +  +     +  L   C  V  GM +L    +IHRDLAARN L+G
Sbjct: 88  SDY------------LRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 135

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           EN   KV+DFG  R  +    Y   +  + P++W +PE    + +S KSD+WSFGVL+WE
Sbjct: 136 ENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 194

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           + + G  PY   + +EV++ 
Sbjct: 195 VFSEGKIPYENRSNSEVVED 214

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 8e-46
 Identities = 80/200 (40%), Positives = 122/200 (61%), Gaps = 4/200 (2%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+KT+ E A  RER++ L E +VMK  +   +VVRLLG  ++ +P  VIME +  G L
Sbjct: 52  RVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDL 110

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
           +S+LRS    R     +      +   +     ++A GM +L++   +HRDLAARN ++ 
Sbjct: 111 KSYLRS---LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWE 203
           E+   K+ DFG  RD+  +  Y +  +G LP+RWM+PESL D +F+  SD+WSFGV++WE
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227

Query: 204 IVTLGSTPYPGMAAAEVMKK 223
           I TL   PY G++  +V++ 
Sbjct: 228 IATLAEQPYQGLSNEQVLRF 247

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 8e-45
 Identities = 74/207 (35%), Positives = 113/207 (54%), Gaps = 15/207 (7%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 76
                   VA+KT K    +  R   LQE   M+  D HP++V+L+G  TE   + + ME
Sbjct: 30  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITENPVWII-ME 87

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
               G+L+SF            +  +  SL    L  + YQ++  + +L S+  +HRD+A
Sbjct: 88  LCTLGELRSF------------LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           ARNVL+  N C K+ DFG +R +   S Y + S+G+LPI+WMAPES+    F+  SD+W 
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           FGV +WEI+  G  P+ G+   +V+ +
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGR 221

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-44
 Identities = 76/199 (38%), Positives = 107/199 (53%), Gaps = 16/199 (8%)

Query: 25  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 84
           VA+KTLK      E    LQE  VMK L  H  +V+L    + +EP +++ EY+  G L 
Sbjct: 44  VAIKTLKPGTMSPE--AFLQEAQVMKKLR-HEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99

Query: 85  SFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE 144
            FL+    +                 L     Q+A GM ++     +HRDL A N+L+GE
Sbjct: 100 DFLKGETGKYLRL-----------PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 148

Query: 145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEI 204
           N  CKVADFG AR L+  + Y  +   + PI+W APE+     F++KSD+WSFG+L+ E+
Sbjct: 149 NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 207

Query: 205 VTLGSTPYPGMAAAEVMKK 223
            T G  PYPGM   EV+ +
Sbjct: 208 TTKGRVPYPGMVNREVLDQ 226

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-44
 Identities = 73/210 (34%), Positives = 112/210 (53%), Gaps = 14/210 (6%)

Query: 15  PERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
                +    VA+KTLK    E++R+D L E  +M     H N++RL G  ++ +P  +I
Sbjct: 29  KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMII 87

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
            EY+  G L  F            +  K    +   L      +A GM++L++   +HRD
Sbjct: 88  TEYMENGALDKF------------LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRD 135

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEG-RLPIRWMAPESLYDNIFSVKSD 193
           LAARN+L+  N  CKV+DFG +R L         + G ++PIRW APE++    F+  SD
Sbjct: 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           +WSFG+++WE++T G  PY  ++  EVMK 
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKA 225

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-44
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--PFFVIMEYVPY 80
           I+  K L   +  E E+  L+ E+ +++ L  HPN+VR      ++     +++MEY   
Sbjct: 31  ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEG 89

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----IIHRDL 135
           G L S +     +R Y         L    +     Q+   ++    R      ++HRDL
Sbjct: 90  GDLASVITKGTKERQY---------LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 140

Query: 136 AARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
              NV +      K+ DFG AR L   +             +M+PE +    ++ KSDIW
Sbjct: 141 KPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S G L++E+      P+   +  E+  K
Sbjct: 199 SLGCLLYELCA-LMPPFTAFSQKELAGK 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 6e-44
 Identities = 68/204 (33%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 23  CIVAVKTLKENAGERERL--DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 80
             VAVK LK +   +     D ++E+  M +LD H N++RL G         V  E  P 
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPPMKMV-TELAPL 94

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
           G L               +           L+ +  QVA GM +L S+  IHRDLAARN+
Sbjct: 95  GSLLDR------------LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142

Query: 141 LIGENHCCKVADFGFARDL-MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           L+      K+ DFG  R L      Y  +   ++P  W APESL    FS  SD W FGV
Sbjct: 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202

Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
            +WE+ T G  P+ G+  ++++ K
Sbjct: 203 TLWEMFTYGQEPWIGLNGSQILHK 226

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-43
 Identities = 91/204 (44%), Positives = 133/204 (65%), Gaps = 4/204 (1%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGK 82
            VAVK LKE A   E   L+ EL ++  +  H NVV LLG CT+   P  VI+E+  +G 
Sbjct: 45  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104

Query: 83  LQSFLRSSRAQRYYNNMHGKS---NSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
           L ++LRS R +     +  +    + LT   L  + +QVA+GM+FL+SR  IHRDLAARN
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+ E +  K+ DFG ARD+     Y RK + RLP++WMAPE+++D +++++SD+WSFGV
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224

Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           L+WEI +LG++PYPG+   E   +
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCR 248

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (365), Expect = 8e-43
 Identities = 46/212 (21%), Positives = 87/212 (41%), Gaps = 26/212 (12%)

Query: 17  RGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R      +VA+K +  +      +  D+++E+  ++ L  HPN ++  GC   +   +++
Sbjct: 35  RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLV 93

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           MEY             +              L   ++ +  +   +G+ +L S  +IHRD
Sbjct: 94  MEYCLGSASDLLEVHKK-------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL---YDNIFSVK 191
           + A N+L+ E    K+ DFG A  +  ++ +           WMAPE +    +  +  K
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYWMAPEVILAMDEGQYDGK 194

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            D+WS G+   E+      P   M A   +  
Sbjct: 195 VDVWSLGITCIELAE-RKPPLFNMNAMSALYH 225

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-42
 Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 21/201 (10%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
            VA++ +  +   ++E +  + E+ VM+    +PN+V  L      +  +V+MEY+  G 
Sbjct: 47  EVAIRQMNLQQQPKKELI--INEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGS 103

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
           L   +  +                    + + C +  + ++FL S  +IHRD+ + N+L+
Sbjct: 104 LTDVVTETCM--------------DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
           G +   K+ DFGF   +           G     WMAPE +    +  K DIWS G++  
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVDIWSLGIMAI 207

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           E++  G  PY        +  
Sbjct: 208 EMIE-GEPPYLNENPLRALYL 227

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-42
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 17  RGREGPCIVAVKTLKENAGERE--RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R ++   I+A+K L +   E+      L +E+ +   L  HPN++RL G   +    ++I
Sbjct: 26  REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 84

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           +EY P G +   L+             K +    +   ++  ++A  + +  S+ +IHRD
Sbjct: 85  LEYAPLGTVYRELQ-------------KLSKFDEQRTATYITELANALSYCHSKRVIHRD 131

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           +   N+L+G     K+ADFG++    +S            + ++ PE +   +   K D+
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDEKVDL 187

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GVL +E +  G  P+      E  K+
Sbjct: 188 WSLGVLCYEFLV-GKPPFEANTYQETYKR 215

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  141 bits (356), Expect = 3e-41
 Identities = 40/202 (19%), Positives = 79/202 (39%), Gaps = 20/202 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
             A K +     E ++  + +E+  M  L  HP +V L     +     +I E++  G+L
Sbjct: 53  NFAAKFVM-TPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +              + N ++  +   +  QV +G+  +     +H DL   N++  
Sbjct: 111 FEKV------------ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158

Query: 144 --ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
              ++  K+ DFG    L      +          + APE          +D+WS GVL 
Sbjct: 159 TKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 215

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           + +++ G +P+ G    E ++ 
Sbjct: 216 YILLS-GLSPFGGENDDETLRN 236

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 4e-41
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)

Query: 24  IVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             A+K LK++    + +    + E  V+     HP +  +      KE  F +MEY+  G
Sbjct: 29  FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
            L   ++               +       T +  ++  G+QFL S+GI++RDL   N+L
Sbjct: 89  DLMYHIQ-------------SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + ++   K+ADFG  ++ M          G     ++APE L    ++   D WSFGVL+
Sbjct: 136 LDKDGHIKIADFGMCKENMLGDAKTNTFCG--TPDYIAPEILLGQKYNHSVDWWSFGVLL 193

Query: 202 WEIVTLGSTPYPGMAAAEVMK 222
           +E++  G +P+ G    E+  
Sbjct: 194 YEMLI-GQSPFHGQDEEELFH 213

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 5e-41
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 17  RGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R        A+K L++     E +   + +E  VM  LD HP  V+L     + E  +  
Sbjct: 28  RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 86

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           + Y   G+L  ++R             K  S        +  ++   +++L  +GIIHRD
Sbjct: 87  LSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 133

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           L   N+L+ E+   ++ DFG A+ L   S   R +      ++++PE L +      SD+
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 193

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           W+ G +I+++V  G  P+       + +K
Sbjct: 194 WALGCIIYQLVA-GLPPFRAGNEYLIFQK 221

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  139 bits (352), Expect = 1e-40
 Identities = 36/202 (17%), Positives = 84/202 (41%), Gaps = 20/202 (9%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +   K +       ++  +  E+++M  L  HP ++ L     +K    +I+E++  G+L
Sbjct: 56  VFVAKFIN-TPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGEL 113

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              + +            +   ++  ++ ++  Q   G++ +    I+H D+   N++  
Sbjct: 114 FDRIAA------------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161

Query: 144 ENHCC--KVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                  K+ DFG A  L    + +          + APE +        +D+W+ GVL 
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREPVGFYTDMWAIGVLG 218

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           + +++ G +P+ G    E ++ 
Sbjct: 219 YVLLS-GLSPFAGEDDLETLQN 239

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-40
 Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VAVK +          ++ +E+ + K L+ H NVV+  G   E    ++ +EY   G+L
Sbjct: 32  AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGEL 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              +                  +   D   F +Q+  G+ +L   GI HRD+   N+L+ 
Sbjct: 91  FDRIEPDI-------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137

Query: 144 ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIW 202
           E    K++DFG A     ++     ++    + ++APE L    F +   D+WS G+++ 
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
            ++  G  P+   + +     
Sbjct: 198 AMLA-GELPWDQPSDSCQEYS 217

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 8e-39
 Identities = 40/202 (19%), Positives = 83/202 (41%), Gaps = 21/202 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
               K +K    ++  +   +E++++     H N++ L       E   +I E++    +
Sbjct: 32  TYMAKFVKVKGTDQVLV--KKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGLDI 88

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
              + +S               L  R++ S+ +QV   +QFL S  I H D+   N++  
Sbjct: 89  FERINTSA------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136

Query: 144 ENHCC--KVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
                  K+ +FG AR L     +           + APE    ++ S  +D+WS G L+
Sbjct: 137 TRRSSTIKIIEFGQARQLKPGDNFRLLFTAP---EYYAPEVHQHDVVSTATDMWSLGTLV 193

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           + +++ G  P+      ++++ 
Sbjct: 194 YVLLS-GINPFLAETNQQIIEN 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 3e-38
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
           +VA+K + + A E +   +  E+ V+  +  HPN+V L          ++IM+ V  G+L
Sbjct: 36  LVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGEL 94

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI- 142
              +              +    T RD +   +QV   +++L   GI+HRDL   N+L  
Sbjct: 95  FDRIV-------------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141

Query: 143 --GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
              E+    ++DFG ++     SV    S       ++APE L    +S   D WS GV+
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
            + ++  G  P+     A++ ++
Sbjct: 199 AYILLC-GYPPFYDENDAKLFEQ 220

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-38
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 28/213 (13%)

Query: 19  REGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC----TEKEPFFV 73
            E    VA   L      + ER    +E  ++K L  HPN+VR           K+   +
Sbjct: 31  TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL 89

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--II 131
           + E +  G L+++L+             +   +  + L S+C Q+ +G+QFL +R   II
Sbjct: 90  VTELMTSGTLKTYLK-------------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 136

Query: 132 HRDLAARNVLI-GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSV 190
           HRDL   N+ I G     K+ D G A     S              +MAPE +Y+  +  
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG----TPEFMAPE-MYEEKYDE 191

Query: 191 KSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
             D+++FG+ + E+ T    PY     A  + +
Sbjct: 192 SVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYR 223

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  131 bits (330), Expect = 5e-38
 Identities = 40/211 (18%), Positives = 84/211 (39%), Gaps = 25/211 (11%)

Query: 24  IVAVKTLKENAG--------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 75
             AVK +    G        +  R   L+E+ +++ +  HPN+++L         FF++ 
Sbjct: 30  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89

Query: 76  EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL 135
           + +  G+L  +L              +  +L+ ++       +   +  L    I+HRDL
Sbjct: 90  DLMKKGELFDYLT-------------EKVTLSEKETRKIMRALLEVICALHKLNIVHRDL 136

Query: 136 AARNVLIGENHCCKVADFGFARDL---MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
              N+L+ ++   K+ DFGF+  L                 P       +     +  + 
Sbjct: 137 KPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           D+WS GV+++ ++  GS P+       +++ 
Sbjct: 197 DMWSTGVIMYTLLA-GSPPFWHRKQMLMLRM 226

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  127 bits (321), Expect = 1e-36
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 22/207 (10%)

Query: 24  IVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----FFVIMEY 77
            VAVK L+ +        L   +E      L+ HP +V +      + P     +++MEY
Sbjct: 34  DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEY 92

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           V    L+  +                  +T +          + + F    GIIHRD+  
Sbjct: 93  VDGVTLRDIVH-------------TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL-PIRWMAPESLYDNIFSVKSDIWS 196
            N++I   +  KV DFG AR +  S     ++   +   ++++PE    +    +SD++S
Sbjct: 140 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            G +++E++T G  P+ G +   V  +
Sbjct: 200 LGCVLYEVLT-GEPPFTGDSPVSVAYQ 225

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 4e-34
 Identities = 42/207 (20%), Positives = 83/207 (40%), Gaps = 28/207 (13%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC----TEKEPFFVIMEYVP 79
             A+K L++           +E+ +       P++VR++         ++   ++ME + 
Sbjct: 39  KFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
            G+L S ++    Q             T R+ +     +   +Q+L S  I HRD+   N
Sbjct: 93  GGELFSRIQDRGDQA-----------FTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141

Query: 140 VLI---GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
           +L      N   K+ DFGFA++  + +             ++APE L    +    D+WS
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWS 198

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            GV+++ ++  G  P+       +   
Sbjct: 199 LGVIMYILLC-GYPPFYSNHGLAISPG 224

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 8e-34
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 17  RGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           R R      A+K LK+      ++      E  ++  +  HP ++R+ G   + +  F+I
Sbjct: 24  RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 82

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           M+Y+  G+L S             +  KS    +     +  +V   +++L S+ II+RD
Sbjct: 83  MDYIEGGELFS-------------LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           L   N+L+ +N   K+ DFGFA+ +      +          ++APE +    ++   D 
Sbjct: 130 LKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WSFG+LI+E++  G TP+      +  +K
Sbjct: 185 WSFGILIYEMLA-GYTPFYDSNTMKTYEK 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  121 bits (304), Expect = 2e-33
 Identities = 38/208 (18%), Positives = 86/208 (41%), Gaps = 25/208 (12%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
           + A+K L         GE   L+    L+++ T D  P +V +       +    I++ +
Sbjct: 31  MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLM 89

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G L   L              +    +  D+  +  ++  G++ + +R +++RDL   
Sbjct: 90  NGGDLHYHLS-------------QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136

Query: 139 NVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSF 197
           N+L+ E+   +++D G A D      +           +MAPE L   + +   +D +S 
Sbjct: 137 NILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMAPEVLQKGVAYDSSADWFSL 192

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKKSK 225
           G ++++++  G +P+      +  +  +
Sbjct: 193 GCMLFKLLR-GHSPFRQHKTKDKHEIDR 219

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-33
 Identities = 45/210 (21%), Positives = 79/210 (37%), Gaps = 37/210 (17%)

Query: 17  RGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----FF 72
           RG+     VAVK            +   E+     L  H N++  +    +        +
Sbjct: 21  RGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLR-HENILGFIAADNKDNGTWTQLW 77

Query: 73  VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL------- 125
           ++ +Y  +G L  +L                  +T   +       A G+  L       
Sbjct: 78  LVSDYHEHGSLFDYLNRYT--------------VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 126 -SSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRL--PIRWMAPES 182
                I HRDL ++N+L+ +N  C +AD G A    +++     +        R+MAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 183 LYDNI------FSVKSDIWSFGVLIWEIVT 206
           L D+I         ++DI++ G++ WEI  
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIAR 213

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-33
 Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 26/207 (12%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEY 77
           +VA+K + ++   + R     EL +M+ LD H N+VRL                 ++++Y
Sbjct: 47  LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDL-A 136
           VP    +     SRA++          +L    +  + YQ+ R + ++ S GI HRD+  
Sbjct: 101 VPETVYRVARHYSRAKQ----------TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
              +L  +    K+ DFG A+ L+        S                  ++   D+WS
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWS 208

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            G ++ E++  G   +PG +  + + +
Sbjct: 209 AGCVLAELLL-GQPIFPGDSGVDQLVE 234

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-32
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 14/203 (6%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPY 80
            VA+K ++ +   E   L  ++E+ V++ L+   HPNVVRL   CT           + +
Sbjct: 35  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94

Query: 81  GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNV 140
             +                      + +  +    +Q+ RG+ FL S  ++HRDL  +N+
Sbjct: 95  EHVDQ-------DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 147

Query: 141 LIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           L+  +   K+ADFG AR               + + + APE L  + ++   D+WS G +
Sbjct: 148 LVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVLLQSSYATPVDLWSVGCI 204

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
             E+       + G +  + + K
Sbjct: 205 FAEMFR-RKPLFRGSSDVDQLGK 226

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-32
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 78
             A K +K      +     R D+ +E++++K +  HPNV+ L      K    +I+E V
Sbjct: 37  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELV 95

Query: 79  PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAAR 138
             G+L              +   +  SLT  + T F  Q+  G+ +L S  I H DL   
Sbjct: 96  AGGELF-------------DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142

Query: 139 NVLIGENHC----CKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           N+++ + +      K+ DFG A  +   +             ++APE +      +++D+
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADM 199

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           WS GV+ + +++ G++P+ G    E +  
Sbjct: 200 WSIGVITYILLS-GASPFLGDTKQETLAN 227

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 4e-32
 Identities = 39/208 (18%), Positives = 73/208 (35%), Gaps = 25/208 (12%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K         +   L  E  + K +     +  +  C  E +   ++ME +     
Sbjct: 34  EVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE 90

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
             F   SR               + + +     Q+   ++++ S+  IHRD+   N L+G
Sbjct: 91  DLFNFCSR-------------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137

Query: 144 ENHCCKVA---DFGFARDLMTSSV-----YERKSEGRLPIRWMAPESLYDNIFSVKSDIW 195
                 +    DFG A+    +       Y          R+ +  +      S + D+ 
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLE 197

Query: 196 SFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           S G ++      GS P+ G+ AA   +K
Sbjct: 198 SLGYVLMYFNL-GSLPWQGLKAATKRQK 224

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-32
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           +VA+K ++ +   E      ++E++++K L+ HPN+V+LL     +   +++ E++    
Sbjct: 29  VVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLHQDL 87

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            +    S+               +    + S+ +Q+ +G+ F  S  ++HRDL  +N+LI
Sbjct: 88  KKFMDASAL------------TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLI 201
                 K+ADFG AR               L   + APE L     +S   DIWS G + 
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLW--YRAPEILLGCKYYSTAVDIWSLGCIF 193

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
            E+VT     +PG +  + + +
Sbjct: 194 AEMVT-RRALFPGDSEIDQLFR 214

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  115 bits (288), Expect = 9e-32
 Identities = 32/210 (15%), Positives = 69/210 (32%), Gaps = 27/210 (12%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 83
            VA+K     +   +   L  E    K L     +  +     E     ++++ +     
Sbjct: 32  QVAIKFEPRRSDAPQ---LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS-- 86

Query: 84  QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG 143
                        + +       + + +     Q+   +Q +  + +++RD+   N LIG
Sbjct: 87  -----------LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135

Query: 144 ENHCC-----KVADFGFARDLMTSSVYERKSEGRL-----PIRWMAPESLYDNIFSVKSD 193
             +        V DFG  +        +              R+M+  +      S + D
Sbjct: 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDD 195

Query: 194 IWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           + + G +    +  GS P+ G+ AA   +K
Sbjct: 196 LEALGHVFMYFLR-GSLPWQGLKAATNKQK 224

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-31
 Identities = 42/204 (20%), Positives = 84/204 (41%), Gaps = 20/204 (9%)

Query: 24  IVAVKTLK----ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP 79
           IVA+K +K      A +      L+E+ +++ L  HPN++ LL     K    ++ +++ 
Sbjct: 25  IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFME 83

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
                              +   S  LT   + ++     +G+++L    I+HRDL   N
Sbjct: 84  TDLEVI-------------IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 130

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV 199
           +L+ EN   K+ADFG A+   + +                       ++ V  D+W+ G 
Sbjct: 131 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGC 189

Query: 200 LIWEIVTLGSTPYPGMAAAEVMKK 223
           ++ E++       PG +  + + +
Sbjct: 190 ILAELLL-RVPFLPGDSDLDQLTR 212

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-31
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 22/206 (10%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC----TEKEPFFVIMEYVP 79
            VA+K +     +      L+E+ ++     H N++ +         E+     ++ ++ 
Sbjct: 35  RVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM 93

Query: 80  YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARN 139
              L   L++                L++  +  F YQ+ RG++++ S  ++HRDL   N
Sbjct: 94  GADLYKLLKTQH--------------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 139

Query: 140 VLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRW-MAPESLYDNIFSVKS-DIWSF 197
           +L+      K+ DFG AR       +       +  RW  APE + ++    KS DIWS 
Sbjct: 140 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           G ++ E+++     +PG    + +  
Sbjct: 200 GCILAEMLS-NRPIFPGKHYLDQLNH 224

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-31
 Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 27/212 (12%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--------FFVI 74
            VA+K +  EN  E   +  L+E+ +++ L  H NVV L+  C  K           +++
Sbjct: 37  KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLV 95

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
            ++  +                  +       T  ++      +  G+ ++    I+HRD
Sbjct: 96  FDFCEHDLAGL-------------LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 142

Query: 135 LAARNVLIGENHCCKVADFGFARDL--MTSSVYERKSEGRLPIRWMAPESL-YDNIFSVK 191
           + A NVLI  +   K+ADFG AR      +S   R +   + + +  PE L  +  +   
Sbjct: 143 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 202

Query: 192 SDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            D+W  G ++ E+ T  S    G      +  
Sbjct: 203 IDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 233

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 4e-31
 Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 19/202 (9%)

Query: 24  IVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG 81
             A+K L++     + E    + E  V++    HP +  L       +    +MEY   G
Sbjct: 32  YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANGG 90

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
           +L   L              +    T      +  ++   +++L SR +++RD+   N++
Sbjct: 91  ELFFHLS-------------RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137

Query: 142 IGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLI 201
           + ++   K+ DFG  ++ ++     +   G     ++APE L DN +    D W  GV++
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCG--TPEYLAPEVLEDNDYGRAVDWWGLGVVM 195

Query: 202 WEIVTLGSTPYPGMAAAEVMKK 223
           +E++  G  P+       + + 
Sbjct: 196 YEMMC-GRLPFYNQDHERLFEL 216

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 9e-31
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
           IVA+K ++ ++  E      L+E+ ++K L  H N+VRL       +   ++ E+     
Sbjct: 29  IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ-- 85

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
                               +  L    + SF +Q+ +G+ F  SR ++HRDL  +N+LI
Sbjct: 86  -----------DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
             N   K+A+FG AR      V    +E                ++S   D+WS G +  
Sbjct: 135 NRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           E+   G   +PG    + +K+
Sbjct: 194 ELANAGRPLFPGNDVDDQLKR 214

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  111 bits (278), Expect = 2e-30
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 17/201 (8%)

Query: 24  IVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK 82
             A+K ++ E   E      ++E++++K L  H N+V+L      K+   ++ E++    
Sbjct: 28  TFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDL 86

Query: 83  LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLI 142
            +                     L S    SF  Q+  G+ +   R ++HRDL  +N+LI
Sbjct: 87  KKLLDV-------------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133

Query: 143 GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIW 202
                 K+ADFG AR      V +   E            +    +S   DIWS G +  
Sbjct: 134 NREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFA 192

Query: 203 EIVTLGSTPYPGMAAAEVMKK 223
           E+V  G+  +PG++ A+ + +
Sbjct: 193 EMVN-GTPLFPGVSEADQLMR 212

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-30
 Identities = 41/200 (20%), Positives = 78/200 (39%), Gaps = 25/200 (12%)

Query: 24  IVAVKTLK-----ENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEY 77
            VA+K ++     +         +  E+ ++K +      V+RLL      + F +I+E 
Sbjct: 31  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
               +      + R             +L      SF +QV   ++   + G++HRD+  
Sbjct: 91  PEPVQDLFDFITER------------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138

Query: 138 RNVLIGEN-HCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESL-YDNIFSVKSDIW 195
            N+LI  N    K+ DFG    L  +   +          +  PE + Y       + +W
Sbjct: 139 ENILIDLNRGELKLIDFGSGALLKDTVYTDFDG----TRVYSPPEWIRYHRYHGRSAAVW 194

Query: 196 SFGVLIWEIVTLGSTPYPGM 215
           S G+L++++V  G  P+   
Sbjct: 195 SLGILLYDMVC-GDIPFEHD 213

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 2e-29
 Identities = 40/211 (18%), Positives = 84/211 (39%), Gaps = 18/211 (8%)

Query: 17  RGREGPCIVAVKTLKE---NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV 73
            G +   + A+K LK+       +       E  V++ +   P +V L      +    +
Sbjct: 47  SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 106

Query: 74  IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHR 133
           I++Y+  G+L + L              +    T  ++  +  ++   ++ L   GII+R
Sbjct: 107 ILDYINGGELFTHLS-------------QRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153

Query: 134 DLAARNVLIGENHCCKVADFGFARDLM-TSSVYERKSEGRLPIRWMAPESLYDNIFSVKS 192
           D+   N+L+  N    + DFG +++ +   +       G +           D+      
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213

Query: 193 DIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK 223
           D WS GVL++E++T G++P+          +
Sbjct: 214 DWWSLGVLMYELLT-GASPFTVDGEKNSQAE 243

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 3e-27
 Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 22/208 (10%)

Query: 17  RGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI 74
           + +E     A+K L +      ++    L E  +++ ++  P +V+L     +    +++
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119

Query: 75  MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRD 134
           MEYV  G++ S LR             +    +      +  Q+    ++L S  +I+RD
Sbjct: 120 MEYVAGGEMFSHLR-------------RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166

Query: 135 LAARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDI 194
           L   N+LI +    +V DFGFA+      V  R          +APE +    ++   D 
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 195 WSFGVLIWEIVTLGSTPYPGMAAAEVMK 222
           W+ GVLI+E+   G  P+      ++ +
Sbjct: 222 WALGVLIYEMAA-GYPPFFADQPIQIYE 248

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  103 bits (257), Expect = 5e-27
 Identities = 35/203 (17%), Positives = 79/203 (38%), Gaps = 25/203 (12%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYG 81
            V VK LK    ++    + +E+ +++ L   PN++ L     +       ++ E+V   
Sbjct: 62  KVVVKILKPVKKKK----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVL 141
             +   ++                LT  D+  + Y++ + + +  S GI+HRD+   NV+
Sbjct: 118 DFKQLYQT----------------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161

Query: 142 IG-ENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVL 200
           I  E+   ++ D+G A        Y  +              +   ++    D+WS G +
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS--RYFKGPELLVDYQMYDYSLDMWSLGCM 219

Query: 201 IWEIVTLGSTPYPGMAAAEVMKK 223
           +  ++      + G    + + +
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVR 242

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-25
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 28/207 (13%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIME 76
            VA+K L +    E       +EL ++K +  H NV+ LL   T  E       F+++M 
Sbjct: 45  KVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMP 103

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
           ++     +                 K   L    +    YQ+ +G++++ + GIIHRDL 
Sbjct: 104 FMGTDLGKLM---------------KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 148

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
             N+ + E+   K+ DFG AR   +    E                L    ++   DIWS
Sbjct: 149 PGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            G ++ E++T G T + G    + +K+
Sbjct: 205 VGCIMAEMIT-GKTLFKGSDHLDQLKE 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 1e-24
 Identities = 51/206 (24%), Positives = 80/206 (38%), Gaps = 26/206 (12%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF-----FVIMEY 77
            VAVK L +            +EL ++K +  H NV+ LL   T            ++ +
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTH 103

Query: 78  VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAA 137
           +                   N   K   LT   +    YQ+ RG++++ S  IIHRDL  
Sbjct: 104 LMGA--------------DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 149

Query: 138 RNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSF 197
            N+ + E+   K+ DFG AR        E                L    ++   DIWS 
Sbjct: 150 SNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205

Query: 198 GVLIWEIVTLGSTPYPGMAAAEVMKK 223
           G ++ E++T G T +PG    + +K 
Sbjct: 206 GCIMAELLT-GRTLFPGTDHIDQLKL 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 1e-23
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 24  IVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIME 76
            VA+K L +    +       +EL +MK ++ H N++ LL   T      E +  +++ME
Sbjct: 44  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVME 102

Query: 77  YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLA 136
            +     Q                          ++   YQ+  G++ L S GIIHRDL 
Sbjct: 103 LMDANLCQVIQMEL----------------DHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146

Query: 137 ARNVLIGENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWS 196
             N+++  +   K+ DFG AR   TS      +   +   + APE +    +    DIWS
Sbjct: 147 PSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWS 203

Query: 197 FGVLIWEIVTLGSTPYPGMAAAEVMKK 223
            G ++ E+V      +PG    +   K
Sbjct: 204 VGCIMGEMVR-HKILFPGRDYIDQWNK 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 74.7 bits (182), Expect = 2e-16
 Identities = 31/196 (15%), Positives = 65/196 (33%), Gaps = 9/196 (4%)

Query: 24  IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYG 81
            VA+K ++ +    E      E+ +++ ++   +  +          +         P G
Sbjct: 40  HVAMKIVRGDKVYTEAA--EDEIKLLQRVN-DADNTKEDSMGANHILKLLDHFNHKGPNG 96

Query: 82  KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT-SFCYQVARGMQFLS-SRGIIHRDLAARN 139
                +     +     +    +             Q+  G+ ++    GIIH D+   N
Sbjct: 97  VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156

Query: 140 VLI-GENHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFG 198
           VL+   +    +     A         E  +       + +PE L    +   +DIWS  
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 216

Query: 199 VLIWEIVTLGSTPYPG 214
            LI+E++T G   +  
Sbjct: 217 CLIFELIT-GDFLFEP 231

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.6 bits (128), Expect = 1e-09
 Identities = 30/188 (15%), Positives = 56/188 (29%), Gaps = 44/188 (23%)

Query: 24  IVAVKTLKENAGERERLDL--------LQELTVMKTLDPHPNVVRLLGCCTEK----EPF 71
              VK  K      +++             L +    +    + +L G    K    E  
Sbjct: 26  ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN 85

Query: 72  FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGII 131
            V+ME +   +L      +  +                        +   +     RGI+
Sbjct: 86  AVLMELIDAKELYRVRVENPDE--------------------VLDMILEEVAKFYHRGIV 125

Query: 132 HRDLAARNVLIGENHCCKVADFGFARDL---MTSSVYERKSEGRLPIRWMAPESLYDNIF 188
           H DL+  NVL+ E     + DF  + ++       + ER       I +      +   +
Sbjct: 126 HGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRN--IITY------FSRTY 176

Query: 189 SVKSDIWS 196
             + DI S
Sbjct: 177 RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	225
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.82
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.53
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.72
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.36
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.49

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=309.72  Aligned_cols=198  Identities=25%  Similarity=0.484  Sum_probs=175.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ++.+++.||+|++....  .......+.+|+.++++++ ||||+++++++.+++.+++|||||+
T Consensus        17 G~fg-~Vy~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~ivmEy~~   89 (263)
T d2j4za1          17 GKFG-NVYLAR-----EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAP   89 (263)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CCCc-EEEEEE-----ECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEEEeecC
Confidence            8999 999998     46789999999987542  2333456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|.+++....             .+++.++..++.|+++||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        90 ~g~L~~~l~~~~-------------~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          90 LGTVYRELQKLS-------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             TCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             CCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence            999999997642             6899999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....    .....||+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+++++|
T Consensus       157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i  216 (263)
T d2j4za1         157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRI  216 (263)
T ss_dssp             CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc-CCCCCCCCCHHHHHHHH
Confidence            3322    234568899999999999999999999999999999999 99999999998887765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=314.48  Aligned_cols=202  Identities=26%  Similarity=0.425  Sum_probs=174.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+|+.||||++....  .......+.+|+.++++++ ||||+++++++.+.+.+++|||||+
T Consensus        19 G~fg-~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ivmEy~~   91 (288)
T d1uu3a_          19 GSFS-TVVLAR-----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAK   91 (288)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEEECCCT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEEEEccC
Confidence            8999 999998     45779999999997542  2333456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++...             ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||++..+
T Consensus        92 gg~L~~~~~~~-------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          92 NGELLKYIRKI-------------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             TEEHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCHHHhhhcc-------------CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence            99999988764             26899999999999999999999999999999999999999999999999999866


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .............||+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+++++|
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i  222 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKI  222 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh-CCCCCCCcCHHHHHHHH
Confidence            55444444445678999999999999999999999999999999999 99999999998887765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=315.31  Aligned_cols=196  Identities=25%  Similarity=0.403  Sum_probs=167.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ++.+|+.||||++......+...++.+|+.++++++ ||||+++++++.+++..++|||||+|+
T Consensus        16 G~fg-~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~gg   88 (271)
T d1nvra_          16 GAYG-EVQLAV-----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGG   88 (271)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEEEEeccCCC
Confidence            8999 999998     467899999999976554445567899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...             ..+++.+++.++.|+++||+|||++||+||||||+||++++++.+||+|||++.....
T Consensus        89 ~L~~~l~~~-------------~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          89 ELFDRIEPD-------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EGGGGSBTT-------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            999888532             3689999999999999999999999999999999999999999999999999986644


Q ss_pred             ccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ...........||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+..
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~-G~~pf~~~~~~  212 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDS  212 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSSTT
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh-CCCCCCCCChH
Confidence            433334455678999999999988775 578999999999999999 99999766543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=310.48  Aligned_cols=198  Identities=24%  Similarity=0.481  Sum_probs=174.1

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      -|+|| +||++.     +..+|+.||||+++...... ...+.+|+.++++++ ||||+++++++.+.+.+++|||||+|
T Consensus        30 ~G~fg-~Vy~a~-----~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          30 QGASG-TVYTAM-----DVATGQEVAIRQMNLQQQPK-KELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             CSSSC-EEEEEE-----BTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cCcCc-EEEEEE-----ECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEEEEEEecCC
Confidence            38999 999998     46779999999987554332 346889999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...              .+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.
T Consensus       102 g~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1         102 GSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             CBHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            9999887643              58999999999999999999999999999999999999999999999999997654


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ...  .......||+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       168 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~  227 (293)
T d1yhwa1         168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYL  227 (293)
T ss_dssp             STT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHH
T ss_pred             ccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh-CCCCCCCCCHHHHHHH
Confidence            332  22344568999999999999999999999999999999999 9999999888776654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=304.50  Aligned_cols=204  Identities=25%  Similarity=0.422  Sum_probs=165.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (225)
                      |+|| +||++.     ++.+|+.||+|.+.... .+.....+.+|+.+++++. ||||+++++++.+  .+.+++|||||
T Consensus        15 G~fg-~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ivmEy~   87 (269)
T d2java1          15 GSYG-RCQKIR-----RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYC   87 (269)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEEEEEECC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEEEEEecC
Confidence            8999 999998     46789999999997653 4555567889999999998 9999999999864  56789999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEecCCCceeEeee
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----IIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++++|.+++......         ...+++..++.++.|+++||.|||+++     |+||||||+||+++.++.+||+||
T Consensus        88 ~~g~L~~~i~~~~~~---------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          88 EGGDLASVITKGTKE---------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             TTEEHHHHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             CCCcHHHHHHhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            999999999765432         236899999999999999999999976     999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |++........  ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..++..+|
T Consensus       159 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t-g~~Pf~~~~~~~~~~~i  226 (269)
T d2java1         159 GLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKI  226 (269)
T ss_dssp             HHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            99976543322  2234567899999999999999999999999999999999 99999999998887665

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=307.21  Aligned_cols=200  Identities=27%  Similarity=0.482  Sum_probs=172.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+++.||+|++..... .....+.+|+.++++++ ||||+++++++.+.+..++|||||+++
T Consensus        23 G~fg-~Vy~~~-----~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          23 GAFG-KVYKAQ-----NKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGG   94 (288)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             CCCc-EEEEEE-----ECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence            8999 999998     467899999999875432 23346889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.++..++.|+++||.|||++||+||||||+||+++.++++||+|||++.....
T Consensus        95 ~L~~~~~~~------------~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          95 AVDAVMLEL------------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999987653            23589999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccCCCCCccccCCcccc-----CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLY-----DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .  ........||+.|+|||++.     +..++.++||||+|+++|+|++ |..||.+.+..+++.+|
T Consensus       163 ~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~~~~~~~i  227 (288)
T d2jfla1         163 T--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKI  227 (288)
T ss_dssp             H--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHH
T ss_pred             C--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            2  12234567899999999884     4557899999999999999999 99999999888877654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=309.14  Aligned_cols=200  Identities=21%  Similarity=0.375  Sum_probs=177.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||+++     +..+|+.||+|+++...  .......+.+|+.+++++. ||||+++++++.+.+.+++||||++
T Consensus        16 G~fg-~V~~~~-----~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv~ey~~   88 (337)
T d1o6la_          16 GTFG-KVILVR-----EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccceeccC
Confidence            8999 999998     46789999999997542  2334456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|.+++....             .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        89 gg~L~~~~~~~~-------------~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          89 GGELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             TCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCchhhhhhccc-------------CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            999999988653             6899999999999999999999999999999999999999999999999999754


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....  .......||+.|+|||++.+..++.++|+||+||++|+|++ |.+||.+.+..++.+++
T Consensus       156 ~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~i  217 (337)
T d1o6la_         156 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI  217 (337)
T ss_dssp             CCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH-CCCCCCCcCHHHHHHHH
Confidence            3322  22344568999999999999999999999999999999999 99999999998887765

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=311.99  Aligned_cols=193  Identities=26%  Similarity=0.402  Sum_probs=170.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+|+.||+|+++..........+.+|+.++++++ ||||++++++|.+.+.+++||||++|+
T Consensus        17 G~fg-~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          17 GNGG-VVFKVS-----HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGG   89 (322)
T ss_dssp             CSSC-CEEEEE-----ETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            8999 999998     467899999999987666666678899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +|.+++.+.             ..+++..++.++.|+++||.|||+ +||+||||||+||++++++++||+|||+|....
T Consensus        90 ~L~~~l~~~-------------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          90 SLDQVLKKA-------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             cHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            999999764             258999999999999999999997 499999999999999999999999999987542


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAE  219 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~  219 (225)
                      ..    ......||+.|+|||++.+..++.++||||+||++|||++ |+.||.+.+..+
T Consensus       157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~-G~~Pf~~~~~~~  210 (322)
T d1s9ja_         157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKE  210 (322)
T ss_dssp             HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHH-SSCCSSCCCTTH
T ss_pred             CC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHH
Confidence            21    2234578999999999999999999999999999999999 999998766543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-49  Score=308.51  Aligned_cols=199  Identities=27%  Similarity=0.424  Sum_probs=159.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     ++.+++.||||++...........+.+|+.++.+++ ||||+++++++.+++.+++|||||+|+
T Consensus        20 G~fg-~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lvmE~~~gg   92 (307)
T d1a06a_          20 GAFS-EVILAE-----DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGG   92 (307)
T ss_dssp             GGGG-GEEEEE-----ETTTCCEEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            8999 999998     467899999999986654444556789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~~  158 (225)
                      +|.+++...             ..+++.++..++.|++.||.|||++|++||||||+||++.   +++.+||+|||++..
T Consensus        93 ~L~~~l~~~-------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          93 ELFDRIVEK-------------GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             BHHHHHHTC-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             cHHHhhhcc-------------cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            999999643             3689999999999999999999999999999999999995   477899999999975


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   ......||+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..++..+|
T Consensus       160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i  221 (307)
T d1a06a_         160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQI  221 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            43332   2234568899999999999999999999999999999999 99999999888877654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-48  Score=305.70  Aligned_cols=197  Identities=27%  Similarity=0.464  Sum_probs=175.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||+++     ++.+|+.||||+++...  .......+.+|+.++++++ ||||+++++++.+.+.+++||||+.
T Consensus        15 G~fg-~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~   87 (316)
T d1fota_          15 GSFG-RVHLIR-----SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIE   87 (316)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcCc-EEEEEE-----ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeEeeecC
Confidence            8999 999999     46789999999997542  2333456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|..++...             ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        88 gg~l~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          88 GGELFSLLRKS-------------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             SCBHHHHHHHT-------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             Ccccccccccc-------------ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence            99999988754             35788999999999999999999999999999999999999999999999999755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....||+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+++.+|
T Consensus       155 ~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i  213 (316)
T d1fota_         155 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKI  213 (316)
T ss_dssp             SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             ccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh-CCCCCCCcCHHHHHHHH
Confidence            332     234678999999999999999999999999999999999 99999999998887765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-48  Score=303.27  Aligned_cols=196  Identities=24%  Similarity=0.422  Sum_probs=170.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     +..+++.||||+++...  .......+.+|+.+++++. ||||+++++++.+++..++|||||.
T Consensus        26 G~fg-~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~   98 (309)
T d1u5ra_          26 GSFG-AVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCL   98 (309)
T ss_dssp             CSSS-EEEEEE-----ETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEEEEEecC
Confidence            8999 999998     46789999999987553  3444567889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      +++|..++...             ..+++.+++.++.|+++||.|||++||+||||||+||++++++.+||+|||++...
T Consensus        99 ~g~l~~~~~~~-------------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          99 GSASDLLEVHK-------------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEHHHHHHHHT-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             CCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            98887665432             36899999999999999999999999999999999999999999999999999754


Q ss_pred             cCccccccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..      .....||+.|+|||++.+   ..++.++||||+|+++|+|++ |..||.+.+..+.+.++
T Consensus       166 ~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~~~~~~~~i  226 (309)
T d1u5ra_         166 AP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHI  226 (309)
T ss_dssp             SS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHH
T ss_pred             CC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            32      234568999999999864   457889999999999999999 99999998888776653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.5e-48  Score=301.44  Aligned_cols=207  Identities=37%  Similarity=0.690  Sum_probs=166.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.....  ......||||.+..........++.+|+.++.+++ ||||+++++++.+.+..++|||||+++
T Consensus        37 G~fg-~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~iv~Ey~~~g  112 (299)
T d1jpaa_          37 GEFG-EVCSGHLKLP--GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENG  112 (299)
T ss_dssp             CSSS-EEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             CCCe-EEEEEEEeCC--CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEEEEEEEecCCC
Confidence            8999 9999985211  11234799999887766667778999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++.++..++.|+++||.|||+++++||||||+||+++.++++||+|||++.....
T Consensus       113 ~L~~~~~~~------------~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         113 SLDSFLRQN------------DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EHHHHHHTT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             cceeeeccc------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999988753            23589999999999999999999999999999999999999999999999999976544


Q ss_pred             ccccc---cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYE---RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   ......+|+.|+|||.+.+..++.++||||||+++|||+|.|..||.+.+..+++++|
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i  246 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI  246 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            32222   1222346788999999999999999999999999999998789999999998887765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=307.00  Aligned_cols=220  Identities=44%  Similarity=0.785  Sum_probs=175.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+...........||+|.+...........+.+|+.++.++..||||+++++++.+.+..++|||||+++
T Consensus        48 G~fG-~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g  126 (325)
T d1rjba_          48 GAFG-KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG  126 (325)
T ss_dssp             CSSE-EEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCC
Confidence            8999 999998754444555678999999776655566678999999999955999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc----------cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEe
Q psy15818         82 KLQSFLRSSRAQRYYNN----------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVA  151 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~  151 (225)
                      +|.+++...+.......          .......+++.+++.++.|+++||+|||+++|+||||||+||+++.++.+||+
T Consensus       127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~  206 (325)
T d1rjba_         127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC  206 (325)
T ss_dssp             BHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEEC
T ss_pred             cHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEe
Confidence            99999976532100000          00012458999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        152 DFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       152 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      |||++................+|+.|+|||++.+..++.++||||+|+++|||+|.|..||.+.+..+.+.
T Consensus       207 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~  277 (325)
T d1rjba_         207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY  277 (325)
T ss_dssp             CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             eccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999765444433334455678899999999999999999999999999999976899999876655443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=293.08  Aligned_cols=196  Identities=29%  Similarity=0.480  Sum_probs=165.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e   76 (225)
                      |+|| +||++.     +..+++.||+|.+.... .......+.+|+.++++++ ||||+++++++.+    ...+++|||
T Consensus        20 G~fg-~Vy~~~-----~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          20 GSFK-TVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             CcCc-EEEEEE-----ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEEEEe
Confidence            8999 999998     45778999999987553 4555667889999999998 9999999999865    345899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEec-CCCceeEeee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--IIHRDLAARNVLIG-ENHCCKVADF  153 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~  153 (225)
                      |+++++|.+++.+..             .+++.++..++.|+++||+|||+++  |+||||||+||+++ +++.+||+||
T Consensus        93 ~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             CCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCCCcHHHHHhccc-------------cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            999999999997642             5899999999999999999999999  99999999999996 5789999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHhhh
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA-AEVMKK  223 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~-~~~~~~  223 (225)
                      |++......    ......||+.|+|||++.+ .++.++||||+|+++|+|++ |..||.+... .++.++
T Consensus       160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~-g~~Pf~~~~~~~~~~~~  224 (270)
T d1t4ha_         160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRR  224 (270)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHH
T ss_pred             CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHH-CCCCCCCcccHHHHHHH
Confidence            999643222    1224568999999998865 58999999999999999999 9999986544 444443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=299.31  Aligned_cols=206  Identities=35%  Similarity=0.676  Sum_probs=175.1

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      -|+|| +||+|.+.   ...++..||||.++.........++.+|+.++.+++ ||||+++++++.+ +..++||||+++
T Consensus        19 ~G~fg-~Vy~~~~~---~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~~~lvmE~~~~   92 (285)
T d1u59a_          19 CGNFG-SVRQGVYR---MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEMAGG   92 (285)
T ss_dssp             CCTTE-EEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             cccCe-EEEEEEEe---cCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-CeEEEEEEeCCC
Confidence            38999 99999642   234567899999987766667778999999999998 9999999999875 468999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++.++..++.|+++||+|||+++++||||||+||+++.++.+||+|||++....
T Consensus        93 g~L~~~l~~~------------~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          93 GPLHKFLVGK------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEHHHHHTTC------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CcHHHHhhcc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999987542            2368999999999999999999999999999999999999999999999999998654


Q ss_pred             Cccc-cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSV-YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... ........+|+.|+|||++.+..++.++||||+|+++|||+|.|..||.+.+..+++..|
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i  225 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI  225 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            4332 223334567889999999998899999999999999999998789999999888877654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.8e-48  Score=307.61  Aligned_cols=199  Identities=19%  Similarity=0.413  Sum_probs=173.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+|+.||+|+++.... .....+.+|+.+++++. ||||++++++|.+.+.+++|||||+|+
T Consensus        40 G~fg-~V~~a~-----~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~gg  111 (352)
T d1koba_          40 GAFG-VVHRCV-----EKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGG  111 (352)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            8999 999998     467899999999875443 23456889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CCCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~~~~~l~d~g~~~~~  159 (225)
                      +|.+.+...            ...+++.+++.++.|++.||.|||++||+||||||+||+++  .++.+||+|||++...
T Consensus       112 ~L~~~~~~~------------~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         112 ELFDRIAAE------------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             BHHHHTTCT------------TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             hHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            998876532            33689999999999999999999999999999999999997  5688999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....   ......+|+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+++.+|
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i  240 (352)
T d1koba_         180 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNV  240 (352)
T ss_dssp             CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred             CCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            4332   1233456888999999999999999999999999999999 99999999998887765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-47  Score=305.34  Aligned_cols=199  Identities=21%  Similarity=0.379  Sum_probs=173.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+|+.||||++..... .....+.+|+.++.+++ ||||+++++++.+.+.+++|||||+|+
T Consensus        37 G~fg-~Vy~~~-----~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~gg  108 (350)
T d1koaa2          37 GAFG-VVHRVT-----ERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGG  108 (350)
T ss_dssp             ETTE-EEEEEE-----ETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            8999 999998     467899999999975433 33457889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec--CCCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG--ENHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~--~~~~~~l~d~g~~~~~  159 (225)
                      +|.+++...            ...+++.++..++.||+.||.|||++|++||||||+||+++  .++.+||+|||++...
T Consensus       109 ~L~~~l~~~------------~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         109 ELFEKVADE------------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             BHHHHHTCT------------TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             CHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999988542            23689999999999999999999999999999999999996  4678999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   .....+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+++.+|
T Consensus       177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i  237 (350)
T d1koaa2         177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNV  237 (350)
T ss_dssp             CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            43321   233467889999999999999999999999999999999 99999999998887765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=296.58  Aligned_cols=199  Identities=27%  Similarity=0.449  Sum_probs=173.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     ++.+|+.||||+++...     .......+.+|+.++++++ ||||+++++++.+.+.+++|||
T Consensus        21 G~fg-~Vy~~~-----~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E   93 (293)
T d1jksa_          21 GQFA-VVKKCR-----EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILE   93 (293)
T ss_dssp             CSSE-EEEEEE-----ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEE
Confidence            8999 999998     46789999999986532     1223456889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCC----ceeEee
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENH----CCKVAD  152 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~----~~~l~d  152 (225)
                      ||+|++|.+++...             ..+++..++.++.|+++||+|||++|++||||||+||+++.++    .+|++|
T Consensus        94 ~~~gg~L~~~i~~~-------------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          94 LVAGGELFDFLAEK-------------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             CCCSCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             cCCCccccchhccc-------------cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence            99999999999764             2689999999999999999999999999999999999998655    599999


Q ss_pred             ecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++.......   ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+.+++|
T Consensus       161 fG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i  228 (293)
T d1jksa_         161 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANV  228 (293)
T ss_dssp             CTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             hhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            99987653332   2334567889999999999999999999999999999999 99999999998887765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-47  Score=304.36  Aligned_cols=197  Identities=24%  Similarity=0.391  Sum_probs=175.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.     ++.+|+.||||++....  .......+.+|+.+++.+. ||||+++++++.+....++||||+.
T Consensus        52 G~fg-~Vy~a~-----~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v~e~~~  124 (350)
T d1rdqe_          52 GSFG-RVMLVK-----HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CcCc-EEEEEE-----ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccccccccccc
Confidence            8999 999998     46789999999987532  2333456889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      |++|...+...             ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       125 ~g~l~~~l~~~-------------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         125 GGEMFSHLRRI-------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             TCBHHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccchhhhHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            99999998764             25899999999999999999999999999999999999999999999999999765


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...     .....||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+++.+|
T Consensus       192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i  250 (350)
T d1rdqe_         192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh-CCCCCCCcCHHHHHHHH
Confidence            332     234568899999999999999999999999999999999 99999999988887765

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-47  Score=297.23  Aligned_cols=201  Identities=44%  Similarity=0.800  Sum_probs=172.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|..     ..+++.||||+++.+....  ..+.+|+.++.+++ ||||+++++++.+.+..++||||++++
T Consensus        28 G~fg-~Vy~a~~-----~~~~~~vAvK~i~~~~~~~--~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~~g   98 (287)
T d1opja_          28 GQYG-EVYEGVW-----KKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYG   98 (287)
T ss_dssp             TTTS-SEEEEEE-----GGGTEEEEEEECCTTCSCH--HHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEE-----CCCCeEEEEEEECCccchH--HHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEEeecccCc
Confidence            8999 9999984     5779999999997654433  36889999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...           ....+++..+..++.|+++||+|||++||+||||||+||++++++++||+|||++.....
T Consensus        99 ~l~~~l~~~-----------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          99 NLLDYLREC-----------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             BHHHHHHHS-----------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             chHHHhhhc-----------cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            999998764           234689999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ... .......+++.|+|||++.+..++.++||||+|+++|||+++|.+||.+.+..++.+.
T Consensus       168 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~  228 (287)
T d1opja_         168 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL  228 (287)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH
Confidence            322 2233345678899999999999999999999999999999956667777777766554

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=299.54  Aligned_cols=200  Identities=27%  Similarity=0.479  Sum_probs=173.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHh-hcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMK-TLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~-~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |+|| +||++.     +..+++.||||+++...  ..........|..++. .++ ||||+++++++.+++.+|+||||+
T Consensus        13 G~fg-~Vy~~~-----~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~~~~yivmEy~   85 (320)
T d1xjda_          13 GSFG-KVFLAE-----FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKENLFFVMEYL   85 (320)
T ss_dssp             CSSS-EEEEEE-----ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCCc-EEEEEE-----ECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccCCceeEEEeec
Confidence            8999 999998     46789999999997542  2233345667777766 465 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      ++++|.+++....             .+++.+++.++.|++.||.|||++|++||||||+||++++++.+||+|||++..
T Consensus        86 ~~g~L~~~i~~~~-------------~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          86 NGGDLMYHIQSCH-------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             TTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCCcHHHHhhccC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence            9999999997642             589999999999999999999999999999999999999999999999999975


Q ss_pred             ccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....  .......||+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+++++|
T Consensus       153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i  215 (320)
T d1xjda_         153 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSI  215 (320)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            53322  23344568899999999999999999999999999999999 99999999999988776

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=297.61  Aligned_cols=204  Identities=37%  Similarity=0.697  Sum_probs=170.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||+|.+.   ....++.||||+++.. ........+.+|+.++.+++ ||||+++++++.+ +..++||||+++
T Consensus        18 G~fG-~Vy~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          18 GNFG-TVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             CSSE-EEEEEEEE---CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCe-EEEEEEEc---cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEcCCC
Confidence            8999 99999742   3456789999999754 34445567899999999998 9999999999865 467899999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...             ..+++.++..++.|++.||+|||+++++||||||+||+++.++.++++|||++....
T Consensus        92 g~L~~~l~~~-------------~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~  158 (277)
T d1xbba_          92 GPLNKYLQQN-------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  158 (277)
T ss_dssp             EEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CcHHHHHhhc-------------cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence            9999998753             258999999999999999999999999999999999999999999999999997654


Q ss_pred             Cccc-cccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSV-YERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... ........+|+.|+|||.+.+..++.++||||||+++|||++.|..||.+.+..++...|
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i  223 (277)
T d1xbba_         159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML  223 (277)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence            4322 223334567889999999999999999999999999999997789999999988877654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=294.18  Aligned_cols=196  Identities=27%  Similarity=0.452  Sum_probs=160.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++...        ..||||+++.. ........+.+|+.++.+++ ||||+++++++. .+.+++|||||++
T Consensus        19 G~fg-~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~~~lv~Ey~~~   87 (276)
T d1uwha_          19 GSFG-TVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAIVTQWCEG   87 (276)
T ss_dssp             CSSC-EEEEEESS--------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEEEEECCCE
T ss_pred             CCCc-EEEEEEEC--------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccEEEEEEecCCC
Confidence            8999 99999841        24999999754 34555667899999999998 999999999865 4568999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..+..++.|+++||+|||+++|+||||||+||+++.++.+||+|||++....
T Consensus        88 g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          88 SSLYHHLHII------------ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEHHHHHHTS------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             CCHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999653            2368999999999999999999999999999999999999999999999999997655


Q ss_pred             CccccccccCCCCCccccCCccccC---CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYD---NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ............+|+.|+|||++.+   ..++.++||||+|+++|||+| |..||.+.+..+.+
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~~~~~  218 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQI  218 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHH
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH-CCCCCCCCChHHHH
Confidence            4443334445678999999999864   347889999999999999999 99999987765443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=291.95  Aligned_cols=201  Identities=36%  Similarity=0.676  Sum_probs=164.9

Q ss_pred             CCcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          1 MDCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         1 ~g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      .|+|| +||++.+      .+++.||||.++......  .++.+|+.++.+++ ||||+++++++.+++..++||||+++
T Consensus        15 ~G~fg-~Vy~~~~------~~~~~vAvK~i~~~~~~~--~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_          15 SGQFG-LVHLGYW------LNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             CCSSC-CEEEEEE------TTTEEEEEEECCSSSSCH--HHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eCCCe-EEEEEEE------CCCCEEEEEEECCCcCcH--HHHHHHHHHHHhcC-CCCcccccceeccCCceEEEEEecCC
Confidence            48999 9999984      356789999998654433  36899999999998 99999999999999999999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..+..++.|+++||.|||+++++||||||+||++++++.+||+|||++....
T Consensus        85 g~L~~~l~~~------------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          85 GCLSDYLRTQ------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             CBHHHHHHTT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             CcHHHHhhcc------------ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheecc
Confidence            9999998653            2357899999999999999999999999999999999999999999999999987553


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .... .......+|+.|+|||++.+..++.++||||+|+++|||+|+|.+||...+..+++..+
T Consensus       153 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i  215 (263)
T d1sm2a_         153 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  215 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH
T ss_pred             CCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            3322 22234557888999999999999999999999999999999778889988888877654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-46  Score=288.89  Aligned_cols=200  Identities=23%  Similarity=0.399  Sum_probs=173.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc--------hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG--------ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l   73 (225)
                      |+|| +||+++     +..+|+.||||+++....        .....++.+|+.++.++..||||+++++++.+++.+|+
T Consensus        14 G~~g-~V~~~~-----~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i   87 (277)
T d1phka_          14 GVSS-VVRRCI-----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL   87 (277)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence            8999 999998     467899999999865421        22344678999999999889999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ||||++|++|.+++...             ..+++.+++.++.|+++||+|||++|++||||||+||+++.++.+||+||
T Consensus        88 vmE~~~~g~L~~~l~~~-------------~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          88 VFDLMKKGELFDYLTEK-------------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             EEECCTTCBHHHHHHHH-------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEcCCCchHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccc
Confidence            99999999999999754             26899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccC------CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYD------NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |++.......   ......+|+.|+|||.+.+      ..++.++||||+|+++|+|++ |+.||.+.+..+.+++|
T Consensus       155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~~~~~~~~i  227 (277)
T d1phka_         155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRMI  227 (277)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc-CCCCCCCCCHHHHHHHH
Confidence            9997654432   2234567889999998863      346889999999999999999 99999999988877654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.4e-46  Score=290.28  Aligned_cols=201  Identities=24%  Similarity=0.412  Sum_probs=166.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC----CeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE----PFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~   75 (225)
                      |+|| +||++.     +..+|+.||||+++...  ......++.+|+.+++.++ ||||+++++++...+    ..|+||
T Consensus        18 G~fg-~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~~~~~~lvm   90 (277)
T d1o6ya_          18 GGMS-EVHLAR-----DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVM   90 (277)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCCCceEEEEE
Confidence            8999 999998     46789999999997653  3455567899999999998 999999999987644    389999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      ||++|++|.+++...             ..+++.+++.++.|+++||.|||++|++||||||+||+++.++..+++|||.
T Consensus        91 E~~~g~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          91 EYVDGVTLRDIVHTE-------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             ECCCEEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             ECCCCCEehhhhccc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhh
Confidence            999999999888654             2689999999999999999999999999999999999999999999999998


Q ss_pred             cccccCcc-ccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        156 ARDLMTSS-VYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       156 ~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      +....... .........||+.|+|||++.+..++.++||||+|+++|+|++ |.+||.+.+..+++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~  225 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQ  225 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh-CCCCCCCcCHHHHHHH
Confidence            86543332 2223344568899999999999999999999999999999999 9999999988877654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=286.46  Aligned_cols=200  Identities=38%  Similarity=0.725  Sum_probs=174.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++++      .+++.||||.++......  ..+.+|+.++.+++ ||||+++++++.+++.+++||||+.++
T Consensus        15 G~fg-~Vy~~~~------~~~~~vAvK~l~~~~~~~--~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_          15 GQFG-VVKYGKW------RGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             ETTE-EEEEEEE------TTTEEEEEEEEESSSSCH--HHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             CCCe-EEEEEEE------CCCCEEEEEEECcCcCCH--HHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEccCCC
Confidence            8999 9999994      367889999998655433  36899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..++....            ..+++..++.++.|+++||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus        85 ~l~~~~~~~~------------~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          85 CLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EHHHHHHSGG------------GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             cHHHhhhccc------------cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            9999876532            3578999999999999999999999999999999999999999999999999975543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+|+.|+|||.+.+..++.++||||+|+++|||+|.|..||.+.+..++..+|
T Consensus       153 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i  214 (258)
T d1k2pa_         153 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI  214 (258)
T ss_dssp             SS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred             CC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence            32 223334567888999999999999999999999999999998789999999999888765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=293.26  Aligned_cols=200  Identities=24%  Similarity=0.436  Sum_probs=166.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchH----HHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGER----ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (225)
                      |+|| +||++.     +..+|+.||||+++......    ....+.+|+.++++++ ||||+++++++.+.+.+++||||
T Consensus         9 G~fg-~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           9 GQFA-TVYKAR-----DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             ETTE-EEEEEE-----CSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CcCe-EEEEEE-----ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhhh
Confidence            8999 999999     46789999999997543221    2235789999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +.++++..+..             ....+++.++..++.|+++||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~~~~~~~~-------------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          82 METDLEVIIKD-------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             CSEEHHHHHTT-------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             hcchHHhhhhh-------------cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccc
Confidence            98776655443             23468999999999999999999999999999999999999999999999999997


Q ss_pred             cccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......  .......+|+.|+|||++.+. .++.++||||+|+++|+|++ |.+||.+.+..+++.+|
T Consensus       149 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~l~~i  213 (299)
T d1ua2a_         149 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRI  213 (299)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             ccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh-CcCCCCCCCHHHHHHHH
Confidence            554332  222344678899999988754 57999999999999999999 99999999998887654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-46  Score=287.72  Aligned_cols=208  Identities=38%  Similarity=0.690  Sum_probs=169.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|.+... +......||||.++..........+.+|+.++.+++ ||||+++++++.+.+..++||||+.++
T Consensus        18 G~fG-~Vy~~~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~~~~v~e~~~~~   94 (283)
T d1mqba_          18 GEFG-EVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENG   94 (283)
T ss_dssp             CSSS-EEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             CCCe-EEEEEEEeCC-CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCceEEEEEecccC
Confidence            8999 9999985321 122346899999987766666667899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      ++.+.+...            ...+++.++..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~l~~~~~~~------------~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          95 ALDKFLREK------------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EHHHHHHHT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cchhhhhcc------------cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999887653            24689999999999999999999999999999999999999999999999999976544


Q ss_pred             ccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..... ......+|+.|+|||.+.+..++.++||||||+++|||+++|.+|+.+.+..++++.+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i  226 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  226 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence            32222 2233457888999999999999999999999999999999677788888888777654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=290.54  Aligned_cols=218  Identities=43%  Similarity=0.776  Sum_probs=170.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.+....+..+++.||||.++..........+.+|...+.++..|+||+.+++++.. .+.+++|||||++
T Consensus        24 G~fG-~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~  102 (299)
T d1ywna1          24 GAFG-QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  102 (299)
T ss_dssp             CSSC-EEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTT
T ss_pred             cCCe-EEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCC
Confidence            8999 9999987666667788999999998776666667788899999988779999999998765 4568999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccC---CCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMH---GKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      ++|.+++...+.........   .....+++.++..++.|+++||.|||+++|+||||||+||++++++.+||+|||++.
T Consensus       103 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~  182 (299)
T d1ywna1         103 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR  182 (299)
T ss_dssp             CBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC-----
T ss_pred             CcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchh
Confidence            99999998754321111100   012358899999999999999999999999999999999999999999999999997


Q ss_pred             cccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        158 DLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ...............+|+.|+|||.+.+..++.++||||+|+++|||++++.+||.+.+..+.
T Consensus       183 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             -CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             hccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            655444444445567889999999999999999999999999999999956789987665443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=287.74  Aligned_cols=200  Identities=41%  Similarity=0.712  Sum_probs=169.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+      .+++.||||.++......  ..+.+|+.++.+++ ||||+++++++.+ +..++||||++++
T Consensus        24 G~fg-~Vy~~~~------~~~~~vAvK~~~~~~~~~--~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~iv~Ey~~~g   92 (272)
T d1qpca_          24 GQFG-EVWMGYY------NGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENG   92 (272)
T ss_dssp             ETTE-EEEEEEE------TTTEEEEEEEECTTSSCH--HHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred             CCCc-EEEEEEE------CCCCEEEEEEEccCcCCH--HHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence            8999 9999984      357889999997654433  36899999999997 9999999998754 5679999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++.....           ..+++..+..++.|+++||.|||+++|+||||||+||++++++.+||+|||++.....
T Consensus        93 ~L~~~~~~~~~-----------~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          93 SLVDFLKTPSG-----------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             BHHHHTTSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cHHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            99987754422           2489999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ... .......+++.|+|||++.+..++.++||||+|+++|||+|+|.+||...+..+++.++
T Consensus       162 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i  223 (272)
T d1qpca_         162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL  223 (272)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             Ccc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            322 22334567888999999998889999999999999999999778888888888777654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-46  Score=291.23  Aligned_cols=221  Identities=38%  Similarity=0.695  Sum_probs=182.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|+.....+..+++.||||+++.....+...++.+|+.++.+++ |||++++++++.+.+..++++|+++++
T Consensus        24 G~fG-~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~~v~e~~~~g  101 (301)
T d1lufa_          24 GAFG-RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYG  101 (301)
T ss_dssp             CSSC-EEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeeeccCCceEEEEEecCCC
Confidence            8999 99999865444566789999999987766667778999999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc-----------cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeE
Q psy15818         82 KLQSFLRSSRAQRYYNN-----------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKV  150 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l  150 (225)
                      +|.+++...........           .......+++..+..++.|++.||+|||+++++||||||+||+++.++.+||
T Consensus       102 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl  181 (301)
T d1lufa_         102 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI  181 (301)
T ss_dssp             BHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             cHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEE
Confidence            99999975432111100           0012345889999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        151 ADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       151 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++++.+||.+.+..+++.++
T Consensus       182 ~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v  255 (301)
T d1lufa_         182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV  255 (301)
T ss_dssp             CCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             ccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHH
Confidence            99999875544433334445567888999999999999999999999999999999557899999999988765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-46  Score=292.35  Aligned_cols=198  Identities=21%  Similarity=0.369  Sum_probs=172.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.     +..+++.||+|.++.....  ...+.+|+.++..++ ||||+++++++.+.+.+|+|||||+|+
T Consensus        16 G~fg-~Vy~~~-----~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lvmE~~~gg   86 (321)
T d1tkia_          16 GEFG-IVHRCV-----ETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             CCCe-EEEEEE-----ECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEecCCCC
Confidence            8999 999998     4678999999999765432  345789999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC--CCceeEeeecccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE--NHCCKVADFGFARDL  159 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~--~~~~~l~d~g~~~~~  159 (225)
                      +|.+++...            ...+++.+++.++.|+++||.|||++||+||||||+||+++.  ...++|+|||++...
T Consensus        87 ~L~~~i~~~------------~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          87 DIFERINTS------------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             BHHHHHTSS------------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            999998642            236899999999999999999999999999999999999974  457999999998755


Q ss_pred             cCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .....   .....+++.|+|||...+..++.++|+||+|+++|+|++ |..||.+.+..+.+++|
T Consensus       155 ~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~~i  215 (321)
T d1tkia_         155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENI  215 (321)
T ss_dssp             CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred             ccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            33322   223456788999999999999999999999999999999 99999999998887765

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-45  Score=296.28  Aligned_cols=192  Identities=21%  Similarity=0.368  Sum_probs=161.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-----chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEe
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME   76 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (225)
                      |+|| +||++.     +..+|+.||+|++....     ......+...++.++..+. ||||+++++++.+.+.+++|||
T Consensus        15 G~fg-~Vy~~~-----~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~~ivmE   87 (364)
T d1omwa3          15 GGFG-EVYGCR-----KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILD   87 (364)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEEEEEEE
Confidence            8999 999998     46789999999986432     1111122234466666776 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         77 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      |++|++|.+++....             .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus        88 ~~~gg~L~~~l~~~~-------------~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          88 LMNGGDLHYHLSQHG-------------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             CCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             ecCCCcHHHHHHhcc-------------cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence            999999999997642             5789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAA  218 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~  218 (225)
                      ......    ......||+.|+|||++.+ ..++.++||||+||++|+|++ |..||.+.+..
T Consensus       155 ~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~  212 (364)
T d1omwa3         155 CDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTK  212 (364)
T ss_dssp             EECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCSSCSS
T ss_pred             eecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh-CCCCCCCCCHH
Confidence            755433    2334568999999999874 568999999999999999999 99999876543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=295.21  Aligned_cols=192  Identities=22%  Similarity=0.392  Sum_probs=162.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec----CCCeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~   77 (225)
                      |+|| +||+|.     +..+++.||||+++..      ....+|+.++.++..||||++++++|++    ...+|+||||
T Consensus        23 G~fg-~Vy~a~-----~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy   90 (335)
T d2ozaa1          23 GING-KVLQIF-----NKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   90 (335)
T ss_dssp             CSSC-EEEEEE-----ETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             ccCe-EEEEEE-----ECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence            8999 999998     4678899999998642      2466889887776559999999999875    4568999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC---CCceeEeeec
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE---NHCCKVADFG  154 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~---~~~~~l~d~g  154 (225)
                      |+|++|.+++...           ....+++.+++.++.|++.||+|||++||+||||||+||+++.   .+.+||+|||
T Consensus        91 ~~gg~L~~~i~~~-----------~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          91 LDGGELFSRIQDR-----------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             CCSEEHHHHHHSC-----------SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCCcHHHHHHhc-----------CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence            9999999999753           2346899999999999999999999999999999999999974   4579999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      ++.......   ......+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+..+.
T Consensus       160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt-g~~Pf~~~~~~~~  221 (335)
T d2ozaa1         160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAI  221 (335)
T ss_dssp             TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT-SSCSCEETTCC--
T ss_pred             eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh-CCCCCCCCCHHHH
Confidence            997553322   2345568999999999999999999999999999999999 9999987665443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=290.69  Aligned_cols=207  Identities=37%  Similarity=0.713  Sum_probs=167.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+.. .+.....+||+|.++..........+.+|+.++.+++ ||||+++++++.++ ..+++++++.++
T Consensus        20 G~fG-~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~~~v~e~~~~~   95 (317)
T d1xkka_          20 GAFG-TVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TVQLITQLMPFG   95 (317)
T ss_dssp             CSSE-EEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SEEEEEECCTTC
T ss_pred             CCCe-EEEEEEEcC-CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-CeeEEEEeccCC
Confidence            8999 999998521 1222345799999876655555567899999999998 99999999999865 577888999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+.+...            ...+++..++.++.|+++||.|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        96 ~l~~~~~~~------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          96 CLLDYVREH------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             BHHHHHHHT------------SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             ccccccccc------------ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            999887653            34689999999999999999999999999999999999999999999999999986654


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........+|+.|+|||.+.+..++.++||||+|+++|||+|+|.+||.+.+..++.+.+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i  226 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL  226 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            443333444567889999999999999999999999999999998789999998888776654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=282.93  Aligned_cols=205  Identities=38%  Similarity=0.726  Sum_probs=164.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|....  ....+..||+|.++..........+.+|+.++++++ ||||+++++++. .+..++||||++++
T Consensus        18 G~fg-~Vy~a~~~~--~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~~iv~E~~~~g   92 (273)
T d1mp8a_          18 GQFG-DVHQGIYMS--PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLG   92 (273)
T ss_dssp             CSSS-EEEEEEECC--C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSCEEEEECCTTE
T ss_pred             CCCc-EEEEEEEec--CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCeEEEEEEeccCC
Confidence            8999 999997421  123356899999987766777778999999999998 999999999986 46789999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...            ...+++..++.++.|+++||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~l~~~~~~~------------~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          93 ELRSFLQVR------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EHHHHHHHT------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             cHHhhhhcc------------CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            999987653            23689999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+|+.|+|||.+.+..++.++||||+|+++|||++.|.+||.+.+..++++++
T Consensus       161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i  222 (273)
T d1mp8a_         161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  222 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             Cc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            32 222334567888999999999999999999999999999998799999999998887664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=286.58  Aligned_cols=220  Identities=43%  Similarity=0.755  Sum_probs=184.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++.+....+...++.||||+++..........+.+|+.++..+.+||||+++++++.+....+++||||+++
T Consensus        34 G~fg-~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g  112 (311)
T d1t46a_          34 GAFG-KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG  112 (311)
T ss_dssp             CSSE-EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             cCCe-EEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCC
Confidence            8999 999998766666788999999999877766677788999999999966999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcc-----cCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNN-----MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +|.+++...........     .......+++..+..++.|+++|++|||+++++||||||+||+++.++.++++|||.+
T Consensus       113 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~  192 (311)
T d1t46a_         113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA  192 (311)
T ss_dssp             EHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred             CHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchh
Confidence            99999987542111110     1112346899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhh
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMK  222 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~  222 (225)
                      ................+|+.|+|||.+.+..++.++||||||+++|||+|+|.+||.+.+..+.+.
T Consensus       193 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             eeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            876554444444556778999999999999999999999999999999987888888777655443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=284.47  Aligned_cols=222  Identities=45%  Similarity=0.823  Sum_probs=179.6

Q ss_pred             CcccceeeecCCCCCC--CCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPER--GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||+++.....  ....+..||||.++..........+.+|...+.++..||||+++++++.+++..++||||++
T Consensus        24 G~fg-~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~  102 (299)
T d1fgka_          24 GAFG-QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  102 (299)
T ss_dssp             -----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             cCCc-EEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccC
Confidence            8999 99999743221  12345789999998877777777889999999999669999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhhh---cccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++.........   .........+++.++..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++
T Consensus       103 ~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~  182 (299)
T d1fgka_         103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  182 (299)
T ss_dssp             TCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred             CCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhh
Confidence            99999999765321100   011112356899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ................+++.|+|||.+.+..++.++||||||+++|||+++|.+||.+.+..++.+.+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i  250 (299)
T d1fgka_         183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  250 (299)
T ss_dssp             CCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            86655544444455667888999999999999999999999999999998789999999988877654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-45  Score=283.11  Aligned_cols=200  Identities=41%  Similarity=0.734  Sum_probs=164.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||++..      .+++.||||+++......  ..+.+|+.++.+++ ||||+++++++.+ +.+++||||++++
T Consensus        28 G~fg-~Vy~~~~------~~~~~vAiK~l~~~~~~~--~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~lv~Ey~~~g   96 (285)
T d1fmka3          28 GCFG-EVWMGTW------NGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG   96 (285)
T ss_dssp             CSSC-EEEEEEE------TTTEEEEEEECCTTSSCH--HHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred             CCCe-EEEEEEE------CCCCEEEEEEECcccCCH--HHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEEEEEecCCC
Confidence            8999 9999984      345679999997654433  36889999999998 9999999999854 5689999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|..++....           ...+++.+++.++.|++.||+|||++|++||||||+||+++.++++||+|||++.....
T Consensus        97 ~l~~~~~~~~-----------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          97 SLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             BHHHHHSHHH-----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             chhhhhhhcc-----------cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            9998886643           23589999999999999999999999999999999999999999999999999975533


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .. ........+|+.|+|||.+.+..++.++||||+|+++|||+++|.+|+.+....+++..+
T Consensus       166 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i  227 (285)
T d1fmka3         166 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  227 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             CC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            22 223334567889999999999999999999999999999999778888888888887764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=283.74  Aligned_cols=200  Identities=27%  Similarity=0.504  Sum_probs=165.8

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+|+.||||+++.... +.....+.+|+.+++++. ||||+++++++.+.+.+++||||+.+
T Consensus        13 G~fg-~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv~e~~~~   85 (298)
T d1gz8a_          13 GTYG-VVYKAR-----NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLHQ   85 (298)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEEEeecCC
Confidence            8999 999998     467899999999975432 223456889999999998 99999999999999999999999975


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                       ++.+++...           ....+++.+++.++.|+++||+|||++||+||||||+||+++.++.++|+|||.+....
T Consensus        86 -~~~~~~~~~-----------~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          86 -DLKKFMDAS-----------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             -EHHHHHHHT-----------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             -chhhhhhhh-----------cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence             555555432           23468999999999999999999999999999999999999999999999999996543


Q ss_pred             CccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ..  ........+|+.|+|||.+.... ++.++|+||+|+++|+|++ |..||.+.+..+.+.+
T Consensus       154 ~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~-G~~Pf~~~~~~~~~~~  214 (298)
T d1gz8a_         154 VP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFR  214 (298)
T ss_dssp             CC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             CC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhh-CCCCCCCCCHHHHHHH
Confidence            32  22334456788999999877665 5789999999999999999 9999999888777654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=283.05  Aligned_cols=218  Identities=39%  Similarity=0.686  Sum_probs=185.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|.+........+..||||+++..........+.+|+.++.++. ||||+++++++...+..++||||+.++
T Consensus        31 G~fG-~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g  108 (308)
T d1p4oa_          31 GSFG-MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRG  108 (308)
T ss_dssp             CSSS-EEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCe-EEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCCceeEEEeecCCC
Confidence            8999 99999864333345578999999987766666677899999999998 999999999999999999999999999


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccccC
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLMT  161 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~~  161 (225)
                      +|.+++...+.......   ....++...+..++.|+++||.|||+++++||||||+||++++++++||+|||++.....
T Consensus       109 ~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~  185 (308)
T d1p4oa_         109 DLKSYLRSLRPAMANNP---VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE  185 (308)
T ss_dssp             BHHHHHHHHHHHHHHCT---TCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGG
T ss_pred             CHHHHHHhccccccccc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccC
Confidence            99999987643332211   223568899999999999999999999999999999999999999999999999976655


Q ss_pred             ccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        162 SSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|||+|++.+||.+.+..+++..+
T Consensus       186 ~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             GGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            444444455567899999999999999999999999999999999557999999998887754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=275.47  Aligned_cols=195  Identities=39%  Similarity=0.731  Sum_probs=161.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEe-cCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.+       .|+.||||.++.+..   ...+.+|+.++.+++ ||||+++++++. +.+.+++||||+++
T Consensus        18 G~fg-~Vy~~~~-------~~~~vAvK~i~~~~~---~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_          18 GEFG-DVMLGDY-------RGNKVAVKCIKNDAT---AQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             CSSC-EEEEEEE-------TTEEEEEEECCCCC-----HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             CCCe-EEEEEEE-------CCeEEEEEEECcHHH---HHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            8999 9999984       367899999976433   245889999999997 999999999885 45678999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++......           .+++..++.++.|++.||.|||+.+++||||||+||+++.++.++++|||++....
T Consensus        86 g~L~~~l~~~~~~-----------~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          86 GSLVDYLRSRGRS-----------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEHHHHHHHHHHH-----------HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCHHHHHHhcCCC-----------CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999765322           37899999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ..     .....+++.|+|||.+.+..++.++||||||+++|||+|+|.+||...+..++.++|
T Consensus       155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i  213 (262)
T d1byga_         155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  213 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            22     233455678999999999999999999999999999998789999999988888765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=277.08  Aligned_cols=206  Identities=35%  Similarity=0.613  Sum_probs=164.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc--chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.....  ......||||.++...  ..+...++.+|+.++.+++ ||||+++++++.+ ...++||||++
T Consensus        19 G~fg-~Vy~~~~~~~--~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~~lv~e~~~   93 (273)
T d1u46a_          19 GSFG-VVRRGEWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPMKMVTELAP   93 (273)
T ss_dssp             ---C-CCEEEEEECT--TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             CCCe-EEEEEEEECC--CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cchheeeeeec
Confidence            8999 9999974211  2234579999987542  3444567899999999997 9999999999976 46789999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDL  159 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~  159 (225)
                      ++++.+.+....            ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        94 ~~~l~~~~~~~~------------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          94 LGSLLDRLRKHQ------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             TCBHHHHHHHHG------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             Ccchhhhhhccc------------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            999998887642            25899999999999999999999999999999999999999999999999999865


Q ss_pred             cCccccc-cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        160 MTSSVYE-RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       160 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||+|.|..||.+.+..+++++|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i  227 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  227 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence            4443222 2223446678999999999999999999999999999998689999999999987765

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=278.52  Aligned_cols=202  Identities=26%  Similarity=0.471  Sum_probs=162.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-hHHHHHHHHHHHHHhhcC--CCCCeeeeeeEEec-----CCCeEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLD--PHPNVVRLLGCCTE-----KEPFFV   73 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~-----~~~~~l   73 (225)
                      |+|| +||++...    ..+++.||||+++.... ........+|+.+++.+.  .||||++++++|..     ....++
T Consensus        18 G~fg-~V~~a~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~   92 (305)
T d1blxa_          18 GAYG-KVFKARDL----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   92 (305)
T ss_dssp             ETTE-EEEEEEET----TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             ccCe-EEEEEEEE----CCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence            8999 99999831    23478899999975432 222224567777776652  39999999999853     346899


Q ss_pred             EEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeee
Q psy15818         74 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADF  153 (225)
Q Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~  153 (225)
                      ++|++.++.+......            ....+++..++.++.|+++||+|||++||+||||||+||++++.+.++|+||
T Consensus        93 ~~e~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          93 VFEHVDQDLTTYLDKV------------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEECCSCBHHHHHHHS------------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             EEEeccCCchhhhhhc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence            9999987665443332            2346899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      |++......   .......+|+.|+|||++.+..++.++||||+|+++|+|++ |.+||.+.+..+.+.+|
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  227 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKI  227 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            998644322   23445678999999999999999999999999999999999 99999999988877654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-44  Score=279.99  Aligned_cols=214  Identities=43%  Similarity=0.778  Sum_probs=170.5

Q ss_pred             CcccceeeecCCCCCCCCccce--EEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPC--IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (225)
                      |+|| +||++.+     +.+|.  .||||.++.....+....+.+|+.++.++.+||||+++++++.+.+..++||||++
T Consensus        21 G~fg-~Vy~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          21 GNFG-QVLKARI-----KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             GGGC-EEEEEEE-----EETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             CCCc-EEEEEEE-----CCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            8999 9999985     34444  57788876655555566789999999998559999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhhhh---hcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccc
Q psy15818         80 YGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFA  156 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~  156 (225)
                      +++|.+++........   ..........+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a  174 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  174 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence            9999999975421100   0000113456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        157 RDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ......   .......+|+.|+|||.+.+..++.++||||||+++|||++++.+||.+.+..+++.+|
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         175 RGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             ESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             cccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            644222   12234457788999999999999999999999999999999667899999999988765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-43  Score=278.19  Aligned_cols=200  Identities=21%  Similarity=0.343  Sum_probs=166.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC----CeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE----PFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~   77 (225)
                      |+|| +||+|.     +..+|+.||||++..........++.+|+.+++++. |||++++++++....    ..++++++
T Consensus        19 G~fg-~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~~~~~l~~~   91 (345)
T d1pmea_          19 GAYG-MVCSAY-----DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLVTH   91 (345)
T ss_dssp             --CC-CEEEEE-----ETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             ccCe-EEEEEE-----ECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccccceEEEEEe
Confidence            8999 999998     467899999999987666666678899999999998 999999999987643    23455566


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      +.+++|.+++...              .+++..++.++.|++.||+|||++||+||||||+||++++++.+||+|||++.
T Consensus        92 ~~~g~L~~~l~~~--------------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          92 LMGADLYKLLKTQ--------------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CCCEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ecCCchhhhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            7789999999643              58999999999999999999999999999999999999999999999999997


Q ss_pred             cccCccccc-cccCCCCCccccCCcccc-CCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        158 DLMTSSVYE-RKSEGRLPIRWMAPESLY-DNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      ......... ......+++.|+|||.+. +..++.++|+||+|+++|+|++ |..||.+.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~-g~~pf~~~~~~~~~~~  224 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNH  224 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh-CCCCCCCCCHHHHHHH
Confidence            654433222 233455788999999885 4567899999999999999999 9999998887666543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-43  Score=275.99  Aligned_cols=199  Identities=25%  Similarity=0.428  Sum_probs=164.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++..      .+|+.||||+++... ......++.+|+.++++++ ||||+++++++.+.+..+++++++.+
T Consensus        13 G~fg-~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_          13 GTYG-VVYKAQN------NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             ETTE-EEEEEEE------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             CCCc-EEEEEEe------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEEEEeehh
Confidence            8999 9999983      467899999997543 2333457889999999998 99999999999999999999999986


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +.+..+...             ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+|++|||.+....
T Consensus        85 ~~~~~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          85 DLKKLLDVC-------------EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             EHHHHHHTS-------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             hhHHHHHhh-------------cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            665555432             3468999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .+..  ......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |+.||.+.+..+.+.++
T Consensus       152 ~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~-G~~pf~~~~~~~~~~~i  213 (286)
T d1ob3a_         152 IPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRI  213 (286)
T ss_dssp             C-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            3322  22334567889999998765 46899999999999999999 99999999888876653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-44  Score=275.19  Aligned_cols=190  Identities=22%  Similarity=0.356  Sum_probs=158.7

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-----hHHHHHHHHHHHHHhhcC-CCCCeeeeeeEEecCCCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-----ERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~   75 (225)
                      |+|| +||++.     +..+|+.||||++.....     .....++.+|+.+++++. +||||+++++++.+++..++||
T Consensus        15 G~fg-~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~   88 (273)
T d1xwsa_          15 GGFG-SVYSGI-----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL   88 (273)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence            8999 999998     467899999999875421     111224668999999886 4899999999999999999999


Q ss_pred             eecCC-CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec-CCCceeEeee
Q psy15818         76 EYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG-ENHCCKVADF  153 (225)
Q Consensus        76 e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~-~~~~~~l~d~  153 (225)
                      |++.+ +++.+++...             ..+++.+++.++.|+++||+|||++|++||||||+||+++ +++.++|+||
T Consensus        89 e~~~~~~~l~~~~~~~-------------~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          89 ERPEPVQDLFDFITER-------------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             ECCSSEEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EeccCcchHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcc
Confidence            99976 5777777653             2689999999999999999999999999999999999998 4578999999


Q ss_pred             cccccccCccccccccCCCCCccccCCccccCCCC-CcchhHHHHHHHHHHHHHcCCCCCCCC
Q psy15818        154 GFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIF-SVKSDIWSFGVLIWEIVTLGSTPYPGM  215 (225)
Q Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slg~ll~~l~~~g~~p~~~~  215 (225)
                      |++......    ......||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.
T Consensus       156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~  213 (273)
T d1xwsa_         156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHD  213 (273)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred             ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh-CCCCCCCc
Confidence            998654322    2334568999999999887665 677999999999999999 99999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=272.30  Aligned_cols=204  Identities=40%  Similarity=0.708  Sum_probs=163.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec-CCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   80 (225)
                      |+|| +||+|......  .....||||.++.........++.+|+.++.+++ ||||+++++++.+ ++..++|||||.+
T Consensus        38 G~fg-~Vyk~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~E~~~~  113 (311)
T d1r0pa_          38 GHFG-CVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKH  113 (311)
T ss_dssp             ETTE-EEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEEEECCTT
T ss_pred             cCCe-EEEEEEEECCC--CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEEEEEeec
Confidence            8999 99999853211  1245799999986666667778999999999998 9999999999764 5689999999999


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      ++|.+++...            ...+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||++....
T Consensus       114 g~l~~~~~~~------------~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         114 GDLRNFIRNE------------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             CBHHHHHHCT------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             Cchhhhhccc------------cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999988653            2346778899999999999999999999999999999999999999999999997654


Q ss_pred             Cccccc--cccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        161 TSSVYE--RKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       161 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||+++|.+|+...+..++.
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~  244 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT  244 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            432221  2223457889999999999999999999999999999999555555555544443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=276.04  Aligned_cols=194  Identities=27%  Similarity=0.471  Sum_probs=163.4

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccc-cchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC------CeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE------PFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------~~~lv   74 (225)
                      |+|| +||++.     +..+|+.||||+++.. ........+.+|+.+++++. |||+++++++|...+      .+++|
T Consensus        29 G~fg-~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv  101 (346)
T d1cm8a_          29 GAYG-AVCSAV-----DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLV  101 (346)
T ss_dssp             -----CEEEEE-----ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccccccceEEEE
Confidence            8999 999998     4577999999999754 34455667889999999998 999999999997655      47999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+ +.+|..+....              .+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus       102 ~e~~-~~~l~~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_         102 MPFM-GTDLGKLMKHE--------------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             EECC-SEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             Eecc-cccHHHHHHhc--------------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence            9999 57787776542              58999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhh
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKK  223 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~  223 (225)
                      .+.....     ......+|+.|+|||.+.+. .++.++|+||+|+++|+|++ |.+||.+.+..+.+.+
T Consensus       167 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~  230 (346)
T d1cm8a_         167 LARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKE  230 (346)
T ss_dssp             TCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             ceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH-CcCCCCCCChHHHHHH
Confidence            9975433     23445678899999998764 56899999999999999999 9999999988777654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.9e-42  Score=267.31  Aligned_cols=193  Identities=18%  Similarity=0.229  Sum_probs=163.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|.     +..+|+.||||++.......   .+.+|++.+..+..+++++.+++++...+..++|||++ ++
T Consensus        16 G~fG-~Vy~a~-----~~~~~~~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~   85 (293)
T d1csna_          16 GSFG-VIFEGT-----NLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   85 (293)
T ss_dssp             CSSC-EEEEEE-----ETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence            8999 999998     45679999999986543322   46778889999986799999999999999999999999 68


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-----CCceeEeeeccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-----NHCCKVADFGFA  156 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-----~~~~~l~d~g~~  156 (225)
                      +|.+++...            ...+++.++..++.|++.||++||++|++||||||+||+++.     .+.++|+|||++
T Consensus        86 ~l~~~~~~~------------~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          86 SLEDLLDLC------------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             BHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CHHHHHHhh------------ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            999888653            236899999999999999999999999999999999999963     567999999999


Q ss_pred             ccccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        157 RDLMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       157 ~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .........     .......||+.|+|||++.+..++.++|+||+|+++|+|++ |..||.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~  218 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKA  218 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCS
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh-CCCcCCCccc
Confidence            765432211     12234468999999999999999999999999999999999 9999986543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=274.05  Aligned_cols=197  Identities=24%  Similarity=0.407  Sum_probs=159.3

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC------CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK------EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv~   75 (225)
                      |+|| +||++.     +..+|+.||||+++....     ...+|+.++++++ ||||++++++|...      ..+++||
T Consensus        31 G~fg-~Vy~a~-----~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          31 GSFG-VVYQAK-----LCDSGELVAIKKVLQDKR-----FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             ETTE-EEEEEE-----ETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEECccch-----HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceEEEEEE
Confidence            8999 999999     467899999999975432     2347899999998 99999999998543      2478999


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCC-CceeEeeec
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGEN-HCCKVADFG  154 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~-~~~~l~d~g  154 (225)
                      ||++++ +.+.+.....         ....+++.+++.++.|++.||+|||++||+||||||+||+++.+ ..+||+|||
T Consensus        99 Ey~~~~-~~~~l~~~~~---------~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          99 DYVPET-VYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             ECCSEE-HHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             eccCCc-cHHHHHhhhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence            999755 4444432211         23468999999999999999999999999999999999999865 489999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccC-CCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYD-NIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ++.......   ......+++.|+|||.+.+ ..++.++||||+|+++|||++ |..||...+..+.+.+|
T Consensus       169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~-g~~pf~~~~~~~~l~~i  235 (350)
T d1q5ka_         169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEI  235 (350)
T ss_dssp             TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHH
T ss_pred             chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhh-CCCCCCCCCHHHHHHHH
Confidence            987553332   2234467788999998775 468999999999999999999 99999999888776553

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=273.25  Aligned_cols=202  Identities=22%  Similarity=0.394  Sum_probs=167.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc---chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeec
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV   78 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (225)
                      |+|| +||++..  ..++.+|+.||||+++...   .......+.+|+.++++++.||||+++++++.+....++++||+
T Consensus        35 G~fg-~Vy~~~~--~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~  111 (322)
T d1vzoa_          35 GAYG-KVFLVRK--ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI  111 (322)
T ss_dssp             TTTE-EEEEEEE--CSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             CCCe-EEEEEEE--CccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecc
Confidence            8999 9999973  1234578999999986532   22333467899999999984589999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818         79 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .+++|.+++....             .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus       112 ~~~~L~~~i~~~~-------------~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         112 NGGELFTHLSQRE-------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             CSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             cccHHHHHHHhcc-------------cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999997653             578999999999999999999999999999999999999999999999999976


Q ss_pred             ccCccccccccCCCCCccccCCccccCC--CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHh
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN--IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVM  221 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~  221 (225)
                      ...... .......+++.|++||.+.+.  .++.++||||+||++|+|++ |..||.+.+..+..
T Consensus       179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt-G~~PF~~~~~~~~~  241 (322)
T d1vzoa_         179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQ  241 (322)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCH
T ss_pred             hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence            543322 223345677889999998764  36789999999999999999 99999877655443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-42  Score=269.92  Aligned_cols=202  Identities=24%  Similarity=0.372  Sum_probs=162.1

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--------CCCeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--------KEPFF   72 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--------~~~~~   72 (225)
                      |+|| +||+|.     +..+|+.||||++.... ......++.+|+.++++++ |||++++++++..        .+..+
T Consensus        21 G~fg-~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~~~~~~~   93 (318)
T d3blha1          21 GTFG-EVFKAR-----HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIY   93 (318)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----------CEE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccccccCceEE
Confidence            8999 999998     45789999999986542 3333446789999999998 9999999999855        34689


Q ss_pred             EEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEee
Q psy15818         73 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVAD  152 (225)
Q Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d  152 (225)
                      ++||++.++.+.....             ....+++..++.++.|+++||.|||++||+||||||+||+++.++.++++|
T Consensus        94 iv~e~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          94 LVFDFCEHDLAGLLSN-------------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             EEEECCCEEHHHHHTC-------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEeccCCCccchhhh-------------cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeee
Confidence            9999998665543322             234689999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCccc--cccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        153 FGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       153 ~g~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      ||++........  ........+|+.|+|||.+.+. .++.++||||+|+++|+|++ |+.||.+.+..+.+..+
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~-g~~pf~~~~~~~~~~~i  234 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI  234 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh-CCCCCCCCCHHHHHHHH
Confidence            999975543322  2223334688999999998765 68899999999999999999 99999998888776553

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=262.27  Aligned_cols=200  Identities=28%  Similarity=0.474  Sum_probs=167.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY   80 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (225)
                      |+|| +||++.     +..+++.||||+++... ......++.+|+.+++.++ ||||+++++++.+....+++++++.+
T Consensus        13 G~fg-~V~~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv~~~~~~   85 (292)
T d1unla_          13 GTYG-TVFKAK-----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             CSSS-EEEEEE-----ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred             CcCe-EEEEEE-----ECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEEeeeccc
Confidence            8999 999999     46789999999997543 4445667899999999998 99999999999999999999999998


Q ss_pred             CCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeeccccccc
Q psy15818         81 GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGFARDLM  160 (225)
Q Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~~~~~~  160 (225)
                      +++..++...             ..+++..++.++.|+++||+|||++||+||||||+||+++.++.++|+|||.+....
T Consensus        86 ~~l~~~~~~~-------------~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          86 DLKKYFDSCN-------------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EHHHHHHHTT-------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccccccccc-------------cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence            8888777543             367899999999999999999999999999999999999999999999999997654


Q ss_pred             CccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCC-CCCCCHHHHhhhc
Q psy15818        161 TSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTP-YPGMAAAEVMKKS  224 (225)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p-~~~~~~~~~~~~i  224 (225)
                      .+..  ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++ |..| |.+.+..+.+.++
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~-g~~p~~~~~~~~~~~~~~  215 (292)
T d1unla_         153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRI  215 (292)
T ss_dssp             SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT-TSCCSCCCSSHHHHHHHH
T ss_pred             CCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh-CCCCCCCCCCHHHHHHHH
Confidence            4322  222334566789999887665 6899999999999999999 6666 5666766665543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-41  Score=270.14  Aligned_cols=196  Identities=27%  Similarity=0.377  Sum_probs=157.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec------CCCeEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE------KEPFFVI   74 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------~~~~~lv   74 (225)
                      |+|| +||++.     +..+|+.||||+++... ......++.+|+.++++++ ||||++++++|..      ...+|+|
T Consensus        28 G~fg-~V~~~~-----d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~~~~~iv  100 (355)
T d2b1pa1          28 GAQG-IVCAAY-----DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLV  100 (355)
T ss_dssp             C--C-EEEEEE-----ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccccCceeEEE
Confidence            8999 999998     46789999999997553 4455567889999999998 9999999999954      3578999


Q ss_pred             EeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeec
Q psy15818         75 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFG  154 (225)
Q Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g  154 (225)
                      |||+.+ ++.+.+.               ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus       101 ~Ey~~~-~l~~~~~---------------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1         101 MELMDA-NLCQVIQ---------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EECCSE-EHHHHHT---------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             Eeccch-HHHHhhh---------------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechh
Confidence            999975 4544442               257999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        155 FARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      .+......   .......+|+.|+|||++.+..++.++|+||+||++++|++ |.+||.+.+..+.+.++
T Consensus       165 ~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~-g~~pF~~~~~~~~~~~i  230 (355)
T d2b1pa1         165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKV  230 (355)
T ss_dssp             C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             hhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhh-CCCCCCCCCHHHHHHHH
Confidence            87654332   23334457888999999999999999999999999999999 99999998888776553

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-41  Score=261.95  Aligned_cols=196  Identities=19%  Similarity=0.266  Sum_probs=158.5

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYG   81 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (225)
                      |+|| +||+|..     ..+|+.||||++.......   .+.+|+.+++.+..|++++.+.+++.+.+..++||||+ ++
T Consensus        18 G~fG-~Vy~a~~-----~~~~~~vAvK~~~~~~~~~---~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~   87 (299)
T d1ckia_          18 GSFG-DIYLGTD-----IAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   87 (299)
T ss_dssp             CSSS-EEEEEEE-----TTTTEEEEEEEEESCTTSC---CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             CCCc-EEEEEEE-----CCCCCEEEEEEEchhccCH---HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence            8999 9999983     5678999999987644332   46789999999985666777777778888999999999 46


Q ss_pred             CHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEec---CCCceeEeeeccccc
Q psy15818         82 KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIG---ENHCCKVADFGFARD  158 (225)
Q Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~---~~~~~~l~d~g~~~~  158 (225)
                      ++...+...            ...+++.++..++.|++.||+|||++||+||||||+||+++   .+..++++|||++..
T Consensus        88 ~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          88 SLEDLFNFC------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             BHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             chhhhhhhc------------cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            776666542            34689999999999999999999999999999999999985   455799999999986


Q ss_pred             ccCcccc-----ccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy15818        159 LMTSSVY-----ERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEV  220 (225)
Q Consensus       159 ~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~  220 (225)
                      .......     .......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||.+....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t-g~~P~~~~~~~~~  221 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATK  221 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH-SSCTTCCCC----
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh-CCCcccccchHHH
Confidence            5433221     12334568999999999999999999999999999999999 9999987665544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.2e-41  Score=264.91  Aligned_cols=186  Identities=22%  Similarity=0.381  Sum_probs=156.9

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEec--CCCeEEEEeecC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVP   79 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~   79 (225)
                      |+|| +||+|+     +..+|+.||+|+++...    ..++.+|+.++.++..||||+++++++..  ...+++||||+.
T Consensus        46 G~fg-~V~~a~-----~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~  115 (328)
T d3bqca1          46 GKYS-EVFEAI-----NITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  115 (328)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred             CcCe-EEEEEE-----ECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence            8999 999998     46789999999987533    23578899999999779999999999974  456999999999


Q ss_pred             CCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC-CCceeEeeeccccc
Q psy15818         80 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE-NHCCKVADFGFARD  158 (225)
Q Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~-~~~~~l~d~g~~~~  158 (225)
                      +++|....                ..+++.+++.++.|++.||.|||++||+||||||+||+++. ++.++|+|||++..
T Consensus       116 ~~~L~~~~----------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         116 NTDFKQLY----------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             SCBGGGTT----------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CCcHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence            99986543                25899999999999999999999999999999999999985 45699999999975


Q ss_pred             ccCccccccccCCCCCccccCCccccCC-CCCcchhHHHHHHHHHHHHHcCCCCCCCCCH
Q psy15818        159 LMTSSVYERKSEGRLPIRWMAPESLYDN-IFSVKSDIWSFGVLIWEIVTLGSTPYPGMAA  217 (225)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slg~ll~~l~~~g~~p~~~~~~  217 (225)
                      .....   ......+|+.|+|||.+.+. .++.++|+||+|+++++|++ |..||.....
T Consensus       180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~-g~~pf~~~~~  235 (328)
T d3bqca1         180 YHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHD  235 (328)
T ss_dssp             CCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSS
T ss_pred             ccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc-CCCCCCCCch
Confidence            53332   23344578889999998765 47999999999999999999 9999975543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=268.70  Aligned_cols=196  Identities=27%  Similarity=0.401  Sum_probs=162.0

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeecccc-chHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecC-----CCeEEEE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-----EPFFVIM   75 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (225)
                      |+|| +||++.     +..+|+.||||+++... ......++.+|+.++++++ |||++++++++...     ...++++
T Consensus        29 G~fg-~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~~~~~~i~  101 (348)
T d2gfsa1          29 GAYG-SVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLV  101 (348)
T ss_dssp             GTTS-SEEEEE-----ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccccCceEEEE
Confidence            8999 999998     46789999999997543 4445557889999999998 99999999998643     3346667


Q ss_pred             eecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecCCCceeEeeecc
Q psy15818         76 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGENHCCKVADFGF  155 (225)
Q Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~~~~~~l~d~g~  155 (225)
                      +++.|++|.+++..              ..+++.+++.++.|++.||.|||++||+||||||+||+++.++.++++|||.
T Consensus       102 ~~~~gg~L~~~~~~--------------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1         102 THLMGADLNNIVKC--------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             EECCSEEHHHHHTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             EeecCCchhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence            77889999998843              2589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccccCCCCCccccCCccccCCC-CCcchhHHHHHHHHHHHHHcCCCCCCCCCHHHHhhhc
Q psy15818        156 ARDLMTSSVYERKSEGRLPIRWMAPESLYDNI-FSVKSDIWSFGVLIWEIVTLGSTPYPGMAAAEVMKKS  224 (225)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slg~ll~~l~~~g~~p~~~~~~~~~~~~i  224 (225)
                      +.....     ......+++.|+|||...+.. ++.++|+||+|+++|+|++ |.+||.+.+..+...+|
T Consensus       168 a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~-g~~pF~~~~~~~~~~~i  231 (348)
T d2gfsa1         168 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI  231 (348)
T ss_dssp             --CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             hcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            864422     234456778899999877654 6889999999999999999 99999998887776554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=262.67  Aligned_cols=187  Identities=25%  Similarity=0.366  Sum_probs=150.2

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCC----CeEEEEee
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE----PFFVIMEY   77 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~   77 (225)
                      |+|| +||+++.       .|+.||||.++......  .....|+..+.+++ ||||+++++++.+.+    .+++||||
T Consensus        14 G~fg-~Vy~~~~-------~g~~vAvK~~~~~~~~~--~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_          14 GRFG-EVWRGKW-------RGEEVAVKIFSSREERS--WFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             CSSS-EEEEEEE-------TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             CCCe-EEEEEEE-------CCEEEEEEEECccchhH--HHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcceEEEEEEec
Confidence            8999 9999983       57899999997543322  12334555556777 999999999987643    47999999


Q ss_pred             cCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCEEecCCCcee
Q psy15818         78 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS--------RGIIHRDLAARNVLIGENHCCK  149 (225)
Q Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~--------~~i~h~dl~~~nil~~~~~~~~  149 (225)
                      +++++|.+++.+.              .++...++.++.|++.||.+||+        +||+||||||+||+++.++.+|
T Consensus        83 ~~~g~L~~~l~~~--------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          83 HEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             CTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             ccCCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            9999999999763              57899999999999999999996        5999999999999999999999


Q ss_pred             EeeecccccccCccc--cccccCCCCCccccCCccccCCC------CCcchhHHHHHHHHHHHHHcCCCCCCC
Q psy15818        150 VADFGFARDLMTSSV--YERKSEGRLPIRWMAPESLYDNI------FSVKSDIWSFGVLIWEIVTLGSTPYPG  214 (225)
Q Consensus       150 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slg~ll~~l~~~g~~p~~~  214 (225)
                      |+|||++........  ........+|+.|+|||++.+..      ++.++||||||+++|||+| |..||..
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~~  220 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGI  220 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTB
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh-CCCCCCc
Confidence            999999976543322  12233456899999999887643      4568999999999999999 8887743

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-34  Score=228.06  Aligned_cols=191  Identities=21%  Similarity=0.284  Sum_probs=147.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcC----------CCCCeeeeeeEEec--CC
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----------PHPNVVRLLGCCTE--KE   69 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~----------~~~~i~~~~~~~~~--~~   69 (225)
                      |+|| +||++.     +..+|+.||||+++....  ......+|+.+++.+.          .|+||+++++++..  ..
T Consensus        24 G~fg-~Vy~~~-----~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~   95 (362)
T d1q8ya_          24 GHFS-TVWLAK-----DMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN   95 (362)
T ss_dssp             CSSE-EEEEEE-----ETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred             CCCe-EEEEEE-----ECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence            8999 999998     467899999999975432  2235677887777664          26889999999754  45


Q ss_pred             CeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEecCCC--
Q psy15818         70 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGIIHRDLAARNVLIGENH--  146 (225)
Q Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~i~h~dl~~~nil~~~~~--  146 (225)
                      ..++++.++.............          ....+++..++.++.|+++||++||+ .||+||||||+||+++.++  
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          96 GVHVVMVFEVLGENLLALIKKY----------EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEEEEECCCCEEHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             ceeeeeeecccccccccccccc----------cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            5677777766554433333222          23468999999999999999999998 8999999999999997543  


Q ss_pred             ----ceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHHHHHHHHHcCCCCCCCCC
Q psy15818        147 ----CCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGVLIWEIVTLGSTPYPGMA  216 (225)
Q Consensus       147 ----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~ll~~l~~~g~~p~~~~~  216 (225)
                          .++++|||.+.....     ......+++.|+|||++.+..++.++|+||+|+++++|++ |..||....
T Consensus       166 ~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pF~~~~  233 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDE  233 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC----
T ss_pred             cccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHH-CCCCCCCCc
Confidence                489999998864322     2344567889999999999999999999999999999999 999997544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.1e-22  Score=148.14  Aligned_cols=160  Identities=18%  Similarity=0.102  Sum_probs=110.6

Q ss_pred             CcccceeeecCCCCCCCCccceEEEEeeeccccc-----------------hHHHHHHHHHHHHHhhcCCCCCeeeeeeE
Q psy15818          2 DCFSVEVRKHPMSPERGREGPCIVAVKTLKENAG-----------------ERERLDLLQELTVMKTLDPHPNVVRLLGC   64 (225)
Q Consensus         2 g~~g~~v~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   64 (225)
                      |+|| +||++..      .+|+.||||+++....                 ........+|...+.++. |++++..++.
T Consensus        11 G~~g-~Vy~a~~------~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~~~~   82 (191)
T d1zara2          11 GKES-AVFNCYS------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKVYAW   82 (191)
T ss_dssp             CSSE-EEEEEEE------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCEEEE
T ss_pred             Ccce-EEEEEEC------CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceEEEe
Confidence            8999 9999972      4688999998754211                 111233456788888887 9999888765


Q ss_pred             EecCCCeEEEEeecCCCCHHHHHHHhhhhhhhcccCCCCCCCChHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEecC
Q psy15818         65 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGIIHRDLAARNVLIGE  144 (225)
Q Consensus        65 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~i~h~dl~~~nil~~~  144 (225)
                      ..    .+++||++++..+.                    .+++..+..++.|++.++++||++|++|+||||+||++++
T Consensus        83 ~~----~~lvme~~~~~~~~--------------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~  138 (191)
T d1zara2          83 EG----NAVLMELIDAKELY--------------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE  138 (191)
T ss_dssp             ET----TEEEEECCCCEEGG--------------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred             cC----CEEEEEeecccccc--------------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence            32    37999999875432                    3566677889999999999999999999999999999986


Q ss_pred             CCceeEeeecccccccCccccccccCCCCCccccCCccccCCCCCcchhHHHHHH
Q psy15818        145 NHCCKVADFGFARDLMTSSVYERKSEGRLPIRWMAPESLYDNIFSVKSDIWSFGV  199 (225)
Q Consensus       145 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slg~  199 (225)
                      ++ ++|+|||.+.....+....-.. ...+   .-.+ +....++..+|+||+.-
T Consensus       139 ~~-~~liDFG~a~~~~~~~~~~~l~-rd~~---~~~~-~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         139 EG-IWIIDFPQSVEVGEEGWREILE-RDVR---NIIT-YFSRTYRTEKDINSAID  187 (191)
T ss_dssp             TE-EEECCCTTCEETTSTTHHHHHH-HHHH---HHHH-HHHHHHCCCCCHHHHHH
T ss_pred             CC-EEEEECCCcccCCCCCcHHHHH-HHHH---HHHH-HHcCCCCCcccHHHHHH
Confidence            54 8999999886443221111000 0000   0001 11355678899999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.82  E-value=1.1e-08  Score=76.45  Aligned_cols=72  Identities=14%  Similarity=-0.053  Sum_probs=49.6

Q ss_pred             eeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCHHHH
Q psy15818          7 EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF   86 (225)
Q Consensus         7 ~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   86 (225)
                      .||+..       .++..+++|+........ ...+.+|...+..+.++--+.+++.+..+++..++||++++|.++.+.
T Consensus        29 ~v~rv~-------~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          29 KVYKLV-------GENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             EEEEEE-------CSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             cEEEEE-------eCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence            577665       346667788876443211 124667888777776555567778888888899999999998776543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.53  E-value=1.6e-07  Score=69.59  Aligned_cols=67  Identities=22%  Similarity=0.202  Sum_probs=44.8

Q ss_pred             eeeecCCCCCCCCccceEEEEeeeccccchHHHHHHHHHHHHHhhcCCC-CCeeeeeeEEecCCCeEEEEeecCCCCH
Q psy15818          7 EVRKHPMSPERGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVIMEYVPYGKL   83 (225)
Q Consensus         7 ~v~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L   83 (225)
                      .||+..      ..++..+++|........    .+..|...++.+..+ --+.+++.+..+++..+++|++++|.++
T Consensus        26 ~v~r~~------~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          26 AVFRLS------AQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEEE------CTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             eEEEEE------eCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            677776      345667889987654322    355566666554422 2256677777888899999999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.03  E-value=9.6e-06  Score=63.79  Aligned_cols=29  Identities=34%  Similarity=0.436  Sum_probs=25.1

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      .++|+|+.|.||+++++. ++++|+..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            599999999999998765 89999988753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.72  E-value=9.1e-05  Score=56.47  Aligned_cols=28  Identities=29%  Similarity=0.279  Sum_probs=23.2

Q ss_pred             CcccCCCCCCCEEecCCCceeEeeeccccc
Q psy15818        129 GIIHRDLAARNVLIGENHCCKVADFGFARD  158 (225)
Q Consensus       129 ~i~h~dl~~~nil~~~~~~~~l~d~g~~~~  158 (225)
                      +++|+|+.+.||+++++  ..++||+.|..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            68999999999999744  45899998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.36  E-value=0.00027  Score=55.26  Aligned_cols=56  Identities=20%  Similarity=0.229  Sum_probs=36.1

Q ss_pred             cceEEEEeeeccccchHHHHHHHHHHHHHhhcCCCCCeeeeeeEEecCCCeEEEEeecCCCCH
Q psy15818         21 GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL   83 (225)
Q Consensus        21 ~~~~vavK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   83 (225)
                      .++.|++++.-.... .  .+..+|..+++.+..+.-..++++++.+    +.|++|.+|..+
T Consensus        73 ~~~~vllRi~g~~~~-~--idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          73 EPNKVLLRVYFNPET-E--SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             CCSEEEEEEECSCCC-H--HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             CCCcEEEEecCCcch-h--hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            456677777653222 2  2456788888888755555677777643    589999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.49  E-value=0.0065  Score=45.40  Aligned_cols=30  Identities=37%  Similarity=0.505  Sum_probs=26.6

Q ss_pred             CCcccCCCCCCCEEecCCCceeEeeecccc
Q psy15818        128 RGIIHRDLAARNVLIGENHCCKVADFGFAR  157 (225)
Q Consensus       128 ~~i~h~dl~~~nil~~~~~~~~l~d~g~~~  157 (225)
                      .|++|+|+.++|++++++...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999987767899999885